<HTML>
<HEAD>
<TITLE>FORM S-1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->
</DIV><!-- END PAGE WIDTH -->
<DIV style="width: 94%; margin-left: 3%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>As filed with the Securities and Exchange Commission on
    May&#160;27, 2009</B>
</DIV>

<DIV align="right" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Registration
    No.&#160;333-&#160;&#160;&#160;&#160;&#160;&#160;</B>
</DIV>

<CENTER style="font-size: 1pt; width: 100%; border-bottom: 2pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=0 -->

<CENTER style="font-size: 1pt; width: 100%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=0 -->

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 14pt">UNITED STATES SECURITIES AND
    EXCHANGE COMMISSION</FONT></B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 12pt">Washington,&#160;D.C.
    20549</FONT></B>
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<CENTER style="font-size: 1pt; width: 15%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=84 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 18pt"><FONT style="white-space: nowrap">Form&#160;S-1</FONT></FONT></B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 12pt">REGISTRATION
    STATEMENT</FONT></B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 12pt">UNDER</FONT></B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 12pt">THE SECURITIES ACT OF
    1933</FONT></B>
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<CENTER style="font-size: 1pt; width: 15%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=84 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 24pt">HCA Inc.</FONT></B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I><FONT style="font-size: 8pt">(Exact name of registrant issuer
    as specified in its charter)</FONT></I>
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<CENTER style="font-size: 1pt; width: 15%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=84 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>SEE TABLE OF ADDITIONAL REGISTRANTS</B>
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<CENTER style="font-size: 1pt; width: 15%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=84 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="35%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="31%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="31%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="center" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <B>Delaware</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    <B>8062</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    <B>75-2497104</B>
</TD>
</TR>
<TR valign="bottom">
<TD align="center" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <I><FONT style="font-size: 8pt">(State or other jurisdiction <BR>
    of incorporation)</FONT></I>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    <I><FONT style="font-size: 8pt">(Primary Standard Industrial <BR>
    Classification Code Number)</FONT></I>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    <I><FONT style="font-size: 8pt">(I.R.S. Employer <BR>
    Identification Number)</FONT></I><FONT style="font-size: 8pt">
    </FONT>
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<CENTER style="font-size: 1pt; width: 15%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=84 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>One Park Plaza</B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Nashville, Tennessee 37203</B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(615)&#160;344-9551</B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I><FONT style="font-size: 8pt">(Address, including zip code,
    and telephone number, including area code, of registrants&#146;
    principal executive offices)</FONT></I>
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>John M. Franck II,&#160;Esq.</B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>HCA Inc.</B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Vice President and Corporate Secretary</B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>One Park Plaza</B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Nashville, Tennessee 37203</B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Telephone: (615)&#160;344-9551</B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I><FONT style="font-size: 8pt">(Name, address, including zip
    code, and telephone number, including area code, of agent for
    service)</FONT></I>
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<CENTER style="font-size: 1pt; width: 15%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=84 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><I>With a copy to:</I></B>
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Richard A. Fenyes,&#160;Esq.</B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>John C. Ericson,&#160;Esq.</B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Simpson Thacher &#038; Bartlett LLP</B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>425 Lexington Avenue</B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>New York, New York 10017-3954</B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Telephone: (212)&#160;455-2000</B>
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<CENTER style="font-size: 1pt; width: 15%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=84 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 3%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Approximate date of commencement of proposed sale to
    public:</B>&#160;&#160;From time to time after this registration
    statement becomes effective.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 3%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If any of the securities being registered on this Form are to be
    offered on a delayed or continuous basis pursuant to
    Rule&#160;415 under the Securities Act of 1933 check the
    following
    box:&#160;&#160;<FONT style="font-family: Wingdings; font-variant: normal">&#254;
    </FONT>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 3%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If this Form is filed to register additional securities for an
    offering pursuant to Rule&#160;462(b) under the Securities Act,
    please check the following box and list the Securities Act
    registration statement number of the earlier effective
    registration statement for the same
    offering.&#160;&#160;<FONT style="font-family: Wingdings; font-variant: normal">&#111;
    </FONT>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 3%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If this Form is a post-effective amendment filed pursuant to
    Rule&#160;462(c) under the Securities Act, check the following
    box and list the Securities Act registration statement number of
    the earlier effective registration statement for the same
    offering.&#160;&#160;<FONT style="font-family: Wingdings; font-variant: normal">&#111;
    </FONT>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 3%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If this Form is a post-effective amendment filed pursuant to
    Rule&#160;462(d) under the Securities Act, check the following
    box and list the Securities Act registration statement number of
    the earlier effective registration statement for the same
    offering.&#160;&#160;<FONT style="font-family: Wingdings; font-variant: normal">&#111;
    </FONT>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 3%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Indicate by check mark whether the registrant is a large
    accelerated filer, an accelerated filer, a non-accelerated
    filer, or a smaller reporting company. See the definitions of
    &#147;large accelerated filer,&#148; &#147;accelerated
    filer&#148; and &#147;smaller reporting company&#148; in Rule
    <FONT style="white-space: nowrap">12b-2</FONT> of the
    Exchange Act. (Check one):
</DIV>

<DIV style="margin-top: 5pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

<TR>
    <TD width="25%"></TD>
    <TD width="25%"></TD>
    <TD width="25%"></TD>
    <TD width="25%"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">    <FONT style="font-family: 'Times New Roman', Times">Large
    accelerated
    filer&#160;<FONT style="font-family: Wingdings; font-variant: normal">&#111;</FONT>
    </FONT></TD>
    <TD nowrap align="center">    <FONT style="font-family: 'Times New Roman', Times"> Accelerated
    filer&#160;<FONT style="font-family: Wingdings; font-variant: normal">&#111;</FONT>
    </FONT></TD>
    <TD nowrap align="center">    <FONT style="font-family: 'Times New Roman', Times">
    <FONT style="white-space: nowrap">Non-accelerated</FONT>
    filer&#160;<FONT style="font-family: Wingdings; font-variant: normal">&#254;</FONT>
    </FONT></TD>
    <TD nowrap align="right">    <FONT style="font-family: 'Times New Roman', Times"> Smaller
    reporting
    company&#160;<FONT style="font-family: Wingdings; font-variant: normal">&#111;</FONT>
    </FONT></TD>
</TR>

</TABLE>



<DIV align="center" style="margin-left: 22%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (Do not check if a smaller reporting company)
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<CENTER style="font-size: 1pt; width: 100%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=0 -->

<CENTER style="font-size: 1pt; width: 100%; border-bottom: 2pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=0 -->

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 94%; margin-left: 3%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">CALCULATION
    OF REGISTRATION FEE</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="50%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutterleft -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutterright -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="6%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=03 type=gutterleft -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=03 type=gutterright -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=03 type=lead -->
    <TD width="10%" align="right">&nbsp;</TD>	<!-- colindex=03 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=03 type=hang1 -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=04 type=gutterleft -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=04 type=gutterright -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=04 type=lead -->
    <TD width="10%" align="right">&nbsp;</TD>	<!-- colindex=04 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=04 type=hang1 -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=05 type=gutterleft -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=05 type=gutterright -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=05 type=lead -->
    <TD width="8%" align="right">&nbsp;</TD>	<!-- colindex=05 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=05 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="center" valign="bottom" style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-top: 3px double #000000">
    <B>Proposed Maximum<BR>
    </B>
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-top: 3px double #000000">
    <B>Proposed Maximum<BR>
    </B>
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-top: 3px double #000000">
    <B>Amount of<BR>
    </B>
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="center" valign="bottom">
    <B>Title of Each Class of<BR>
    </B>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B>Amount to<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B>Offering<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B>Aggregate<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B>Registration<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="center" valign="bottom">
    <B>Securities to be Registered</B>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B>be Registered</B>
</TD>
<TD>
&nbsp;
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B>Price per Note</B>
</TD>
<TD>
&nbsp;
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B>Offering Price</B>
</TD>
<TD>
&nbsp;
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom">
    <B>Fee</B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    5.50%&#160;Senior Notes due 2009
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    8.75%&#160;Senior Notes due 2010
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    8.75%&#160;Senior Notes due 2010
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    7.875%&#160;Senior Notes due 2011
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    6.95%&#160;Senior Notes due 2012
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    6.30%&#160;Senior Notes due 2012
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    6.25%&#160;Senior Notes due 2013
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    6.75%&#160;Senior Notes due 2013
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    5.75%&#160;Senior Notes due 2014
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    6.375%&#160;Senior Notes due 2015
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    6.50%&#160;Senior Notes due 2016
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    7.69%&#160;Notes due 2025
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    7.50%&#160;Senior Notes due 2033
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    7.19%&#160;Debentures due 2015
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    7.50%&#160;Debentures due 2023
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    8.36%&#160;Debentures due 2024
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    7.05%&#160;Debentures due 2027
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    7.75%&#160;Debentures due 2036
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    7.50%&#160;Debentures due 2095
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    8.70% Medium-Term Notes due 2010
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    9.00% Medium-Term Notes due 2014
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    7.58% Medium-Term Notes due 2025
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    9<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;Senior
    Secured Notes due 2014
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    9<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">4</FONT>%&#160;Senior
    Secured Notes due 2016
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    9<FONT style="vertical-align: text-top; font-size: 70%;">5</FONT>/<FONT style="font-size: 70%;">8</FONT>/10<FONT style="vertical-align: text-top; font-size: 70%;">3</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;Senior
    Secured Toggle Notes due 2016
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    9<FONT style="vertical-align: text-top; font-size: 70%;">7</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;Senior
    Secured Notes due 2017
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    8<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">2</FONT>%&#160;Senior
    Secured Notes due 2019
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    Guarantees of
    9<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;Senior
    Secured Notes due 2014(2)
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    Guarantees of
    9<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">4</FONT>%&#160;Senior
    Secured Notes due 2016(2)
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    Guarantees of
    9<FONT style="vertical-align: text-top; font-size: 70%;">5</FONT>/<FONT style="font-size: 70%;">8</FONT>/10<FONT style="vertical-align: text-top; font-size: 70%;">3</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;Senior
    Secured Toggle Notes due 2016(2)
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    Guarantees of
    9<FONT style="vertical-align: text-top; font-size: 70%;">7</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;Senior
    Secured Notes due 2017(2)
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    Guarantees of
    8<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">2</FONT>%&#160;Senior
    Secured Notes due 2019(2)
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 1px solid #000000">
    (1
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 1px solid #000000">
    )
</TD>
</TR>
<TR style="font-size: 1pt">
<TD nowrap align="left" valign="bottom" style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom" style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 3px double #000000">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>



<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

<TR>
    <TD width="1%"></TD>
    <TD width="1%"></TD>
    <TD width="98%"></TD>
</TR>

<TR>
    <TD align="right" valign="top">
    (1) </TD>
    <TD></TD>
    <TD valign="bottom">
    An indeterminate amount of securities are being registered
    hereby to be offered solely for market-making purposes by
    affiliates of the registrant. Pursuant to Rule&#160;457(q) under
    the Securities Act of 1933, as amended, no filing fee is
    required.</TD>
</TR>


<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR>
    <TD align="right" valign="top">
    (2) </TD>
    <TD></TD>
    <TD valign="bottom">
    See inside facing page for additional registrant guarantors.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 3%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>The Registrants hereby amend this Registration Statement on
    such date or dates as may be necessary to delay its effective
    date until the Registrants shall file a further amendment which
    specifically states that this Registration Statement shall
    thereafter become effective in accordance with Section&#160;8(a)
    of the Securities Act of 1933, as amended, or until the
    Registration Statement shall become effective on such date as
    the Securities and Exchange Commission, acting pursuant to said
    Section&#160;8(a), may determine.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<CENTER style="font-size: 1pt; width: 100%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=0 -->

<CENTER style="font-size: 1pt; width: 100%; border-bottom: 2pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=0 -->

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 94%; margin-left: 3%"><!-- BEGIN PAGE WIDTH -->
</DIV><!-- END PAGE WIDTH -->
<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Table of
    Additional Registrant Guarantors</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 9pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="57%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="16%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Address, Including<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Zip Code, and<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Telephone Number,<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Including Area<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>State or Other<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Code, of Registrant<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Jurisdiction of<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>I.R.S. Employer<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Guarantor&#146;s<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
    <B>Exact Name of Registrant Guarantor as Specified<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Incorporation or<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Identification<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Principal Executive<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>in its Charter (or Other Organizational Document)</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Organization</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Number</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Offices</B>
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    American Medicorp Development Co.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    23-1696018
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Bay Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-0976863
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Brigham City Community Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Utah
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    87-0318837
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Brookwood Medical Center of Gulfport, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Mississippi
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    63-0751470
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Capital Division, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Virginia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1668319
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Centerpoint Medical Center of Independence, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    45-0503121
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Central Florida Regional Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    59-1978725
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Central Shared Services, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Virginia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    76-0771216
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Central Tennessee Hospital Corporation
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Tennessee
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1620866
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    CHCA Bayshore, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1801359
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    CHCA Conroe, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1801361
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    CHCA Mainland, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1801362
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    CHCA West Houston, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1801363
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    CHCA Woman&#146;s Hospital, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1810381
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Chippenham&#160;&#038; Johnston-Willis Hospitals, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Virginia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    54-1779911
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    CMS GP, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1778113
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
</TABLE>

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 9pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="57%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="16%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Address, Including<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Zip Code, and<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Telephone Number,<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Including Area<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>State or Other<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Code, of Registrant<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Jurisdiction of<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>I.R.S. Employer<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Guarantor&#146;s<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
    <B>Exact Name of Registrant Guarantor as Specified<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Incorporation or<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Identification<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Principal Executive<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>in its Charter (or Other Organizational Document)</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Organization</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Number</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Offices</B>
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Colorado Health Systems, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Colorado
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1593008
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Columbia ASC Management, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    California
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    33-0539838
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Columbia Jacksonville Healthcare System, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    61-1272241
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Columbia LaGrange Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Illinois
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    61-1276162
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Columbia Medical Center of Arlington Subsidiary, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Texas
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1682201
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Columbia Medical Center of Denton Subsidiary, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Texas
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1682213
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Columbia Medical Center of Las Colinas, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Texas
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1650582
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Columbia Medical Center of Lewisville Subsidiary, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Texas
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1682210
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Columbia Medical Center of McKinney Subsidiary, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Texas
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1682207
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Columbia Medical Center of Plano Subsidiary, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Texas
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1682203
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Columbia North Hills Hospital Subsidiary, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Texas
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1682205
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Columbia Ogden Medical Center, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Utah
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1650578
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Columbia Parkersburg Healthcare System, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    West Virginia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1634494
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Columbia Plaza Medical Center of Fort&#160;Worth Subsidiary,
    L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Texas
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1682202
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Columbia Polk General Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Georgia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1619423
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Columbia Rio Grande Healthcare, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1656022
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
</TABLE>

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 9pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="57%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="16%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Address, Including<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Zip Code, and<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Telephone Number,<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Including Area<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>State or Other<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Code, of Registrant<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Jurisdiction of<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>I.R.S. Employer<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Guarantor&#146;s<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
    <B>Exact Name of Registrant Guarantor as Specified<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Incorporation or<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Identification<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Principal Executive<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>in its Charter (or Other Organizational Document)</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Organization</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Number</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Offices</B>
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Columbia Riverside, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    California
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1664328
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Columbia Valley Healthcare System, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1669572
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Columbia/Alleghany Regional Hospital, Incorporated
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Virginia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    54-1761046
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Columbia/HCA John Randolph, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Virginia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    61-1272888
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Columbine Psychiatric Center, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Colorado
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    84-1042212
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Columbus Cardiology, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Georgia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    58-1941109
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Conroe Hospital Corporation
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Texas
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    74-2467524
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Dallas/Ft.&#160;Worth Physician, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1769694
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Dauterive Hospital Corporation
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Louisiana
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    58-1741846
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Dublin Community Hospital, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Georgia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    58-1431023
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Eastern Idaho Health Services, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Idaho
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    82-0436622
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Edmond Regional Medical Center, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1757655
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Edward White Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    59-3089836
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    El&#160;Paso Surgicenter, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Texas
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    74-2361005
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Encino Hospital Corporation, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    California
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    95-4113862
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    EP Health, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1769682
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
</TABLE>

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 9pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="57%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="16%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Address, Including<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Zip Code, and<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Telephone Number,<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Including Area<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>State or Other<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Code, of Registrant<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Jurisdiction of<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>I.R.S. Employer<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Guarantor&#146;s<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
    <B>Exact Name of Registrant Guarantor as Specified<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Incorporation or<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Identification<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Principal Executive<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>in its Charter (or Other Organizational Document)</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Organization</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Number</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Offices</B>
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Fairview Park GP, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1815913
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Fairview Park, Limited Partnership
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Georgia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1817469
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Frankfort Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Kentucky
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    61-0859329
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Galen Property, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Virginia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    35-2260545
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    General Healthserv, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1769690
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Good Samaritan Hospital, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1763090
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Goppert-Trinity Family Care, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    76-0726651
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    GPCH-GP, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    64-0805500
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Grand Strand Regional Medical Center, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1768105
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Green Oaks Hospital Subsidiary, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Texas
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1797829
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Greenview Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Kentucky
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    61-0724492
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Hamilton Medical Center, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Louisiana
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    58-1741727
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    HCA&#160;&#151; IT&#038;S Field Operations, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    06-1795732
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    HCA&#160;&#151; IT&#038;S Inventory Management, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    06-1796286
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    HCA Central Group, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Tennessee
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    02-0762180
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    HCA Health Services of Florida, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1113740
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
</TABLE>

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 9pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="57%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="16%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Address, Including<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Zip Code, and<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Telephone Number,<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Including Area<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>State or Other<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Code, of Registrant<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Jurisdiction of<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>I.R.S. Employer<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Guarantor&#146;s<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
    <B>Exact Name of Registrant Guarantor as Specified<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Incorporation or<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Identification<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Principal Executive<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>in its Charter (or Other Organizational Document)</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Organization</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Number</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Offices</B>
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    HCA Health Services of Louisiana, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Louisiana
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1113736
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    HCA Health Services of Oklahoma, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Oklahoma
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1106156
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    HCA Health Services of Tennessee, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Tennessee
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1113737
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    HCA Health Services of Virginia, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Virginia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1113733
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    HCA Management Services, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1778108
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    HCA Realty, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Tennessee
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    06-1106160
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    HD&#038;S Corp. Successor, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1657694
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Health Midwest Office Facilities Corporation
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Missouri
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    43-1175071
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Health Midwest Ventures Group, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Missouri
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    43-1315348
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Healthtrust MOB, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1824860
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Hendersonville Hospital Corporation
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Tennessee
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1321255
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Hospital Corporation of Tennessee
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Tennessee
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1124446
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Hospital Corporation of Utah
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Utah
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    87-0322019
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Hospital Development Properties, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1321246
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    HSS Holdco, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1839825
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    HSS Systems VA, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1804832
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
</TABLE>

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 9pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="57%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="16%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Address, Including<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Zip Code, and<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Telephone Number,<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Including Area<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>State or Other<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Code, of Registrant<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Jurisdiction of<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>I.R.S. Employer<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Guarantor&#146;s<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
    <B>Exact Name of Registrant Guarantor as Specified<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Incorporation or<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Identification<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Principal Executive<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>in its Charter (or Other Organizational Document)</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Organization</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Number</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Offices</B>
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    HSS Systems, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1804834
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    HSS Virginia, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Virginia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1848294
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    HTI Memorial Hospital Corporation
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Tennessee
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1560757
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Integrated Regional Lab, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    36-4576441
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Integrated Regional Laboratories, LLP
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1687140
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    JFK Medical Center Limited Partnership
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1694180
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    KPH-Consolidation, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Texas
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1619857
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Lakeland Medical Center, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1762603
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Lakeview Medical Center, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1762416
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Largo Medical Center, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1026428
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Las Vegas Surgicare, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Nevada
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    75-1890731
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Lawnwood Medical Center, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    59-1764486
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Lewis-Gale Hospital, Incorporated
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Virginia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    54-0218835
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Lewis-Gale Medical Center, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1760148
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Lewis-Gale Physicians, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Virginia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    06-1755234
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Los Robles Regional Medical Center
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    California
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    95-2321136
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
</TABLE>

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 9pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="57%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="16%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Address, Including<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Zip Code, and<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Telephone Number,<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Including Area<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>State or Other<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Code, of Registrant<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Jurisdiction of<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>I.R.S. Employer<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Guarantor&#146;s<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
    <B>Exact Name of Registrant Guarantor as Specified<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Incorporation or<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Identification<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Principal Executive<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>in its Charter (or Other Organizational Document)</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Organization</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Number</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Offices</B>
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Management Services Holdings, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1874287
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Marietta Surgical Center, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Georgia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    58-1539547
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Marion Community Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    59-1479652
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    MCA Investment Company
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    California
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    33-0539836
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Medical Centers of Oklahoma, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1771846
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Medical Office Buildings of Kansas, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1789791
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Memorial Healthcare Group, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    59-3283127
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Midwest Division&#160;&#151; ACH, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    48-1301811
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Midwest Division&#160;&#151; LRHC, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    48-1301817
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Midwest Division&#160;&#151; LSH, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    45-0503141
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Midwest Division&#160;&#151; MCI, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    45-0503127
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Midwest Division&#160;&#151; MMC, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    48-1301826
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Midwest Division&#160;&#151; OPRMC, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    45-0503116
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Midwest Division&#160;&#151; PFC, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    48-1302330
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Midwest Division&#160;&#151; RBH, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Missouri
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    20-0851062
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Midwest Division&#160;&#151; RMC, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    54-2092552
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
</TABLE>

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 9pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="57%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="16%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Address, Including<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Zip Code, and<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Telephone Number,<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Including Area<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>State or Other<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Code, of Registrant<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Jurisdiction of<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>I.R.S. Employer<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Guarantor&#146;s<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
    <B>Exact Name of Registrant Guarantor as Specified<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Incorporation or<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Identification<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Principal Executive<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>in its Charter (or Other Organizational Document)</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Organization</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Number</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Offices</B>
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Midwest Division&#160;&#151; RPC, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    48-1301829
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Midwest Holdings, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    11-3676736
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Montgomery Regional Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Virginia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    54-0889154
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Mountain View Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Utah
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    87-0333048
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Nashville Shared Services General Partnership
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1841237
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    National Patient Account Services, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Texas
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1645596
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    New Port Richey Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    59-2047041
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    New Rose Holding Company, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Colorado
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1617432
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    North Florida Immediate Care Center, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    58-2075775
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    North Florida Regional Medical Center, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    61-1269294
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Northern Utah Healthcare Corporation
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Utah
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1650573
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Northern Virginia Community Hospital, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Virginia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    04-3665595
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Northlake Medical Center, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Georgia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    58-2433434
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Notami Hospitals of Louisiana, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Louisiana
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    95-4176923
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Notami Hospitals, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1761993
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Okaloosa Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    59-1836808
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
</TABLE>

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 9pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="57%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="16%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Address, Including<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Zip Code, and<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Telephone Number,<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Including Area<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>State or Other<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Code, of Registrant<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Jurisdiction of<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>I.R.S. Employer<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Guarantor&#146;s<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
    <B>Exact Name of Registrant Guarantor as Specified<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Incorporation or<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Identification<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Principal Executive<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>in its Charter (or Other Organizational Document)</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Organization</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Number</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Offices</B>
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Okeechobee Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    59-1833934
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Outpatient Cardiovascular Center of Central Florida, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    52-2448149
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Palms West Hospital Limited Partnership
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1694178
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Palmyra Park Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Georgia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    58-1091107
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Pasadena Bayshore Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Texas
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    74-1616679
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Plantation General Hospital, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1372389
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Pulaski Community Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Virginia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    54-0941129
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Redmond Park Hospital, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Georgia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    58-1123037
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Redmond Physician Practice Company
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Georgia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1662134
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Reston Hospital Center, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1777534
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Retreat Hospital, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Virginia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    61-1272890
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Rio Grande Regional Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Texas
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    61-1276564
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Riverside Healthcare System, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    California
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    33-0751869
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Riverside Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    74-2600687
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Samaritan, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1762605
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    San&#160;Jose Healthcare System, LP
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    77-0498674
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
</TABLE>

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 9pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="57%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="16%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Address, Including<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Zip Code, and<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Telephone Number,<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Including Area<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>State or Other<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Code, of Registrant<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Jurisdiction of<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>I.R.S. Employer<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Guarantor&#146;s<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
    <B>Exact Name of Registrant Guarantor as Specified<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Incorporation or<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Identification<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Principal Executive<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>in its Charter (or Other Organizational Document)</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Organization</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Number</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Offices</B>
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    San&#160;Jose Hospital, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1763091
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    San&#160;Jose Medical Center, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1762609
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    San&#160;Jose, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1756992
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Sarasota Doctors Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    61-1258724
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    SJMC, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1762613
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Southern Hills Medical Center, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Nevada
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    74-3048428
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Spotsylvania Medical Center, Inc
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Virginia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    06-1760818
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Spring Branch Medical Center, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Texas
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    61-1261492
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Spring Hill Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Tennessee
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    84-1706716
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    St. Mark&#146;s Lone Peak Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Utah
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    25-1925376
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Sun City Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    59-2822337
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Sunrise Mountainview Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Nevada
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1600397
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Surgicare of Brandon, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    58-1819994
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Surgicare of Florida, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    95-3947578
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Surgicare of Houston Women&#146;s, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Texas
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    72-1563673
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Surgicare of Manatee, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    75-2364410
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
</TABLE>

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 9pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="57%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="16%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Address, Including<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Zip Code, and<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Telephone Number,<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Including Area<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>State or Other<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Code, of Registrant<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Jurisdiction of<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>I.R.S. Employer<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Guarantor&#146;s<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
    <B>Exact Name of Registrant Guarantor as Specified<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Incorporation or<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Identification<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Principal Executive<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>in its Charter (or Other Organizational Document)</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Organization</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Number</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Offices</B>
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Surgicare of New Port Richey, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    75-2243308
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Surgicare of Palms West, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    20-1008436
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Surgicare of Riverside, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    California
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    26-0047096
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Tallahassee Medical Center, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1091430
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    TCMC Madison-Portland, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Tennessee
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    76-0811731
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Terre Haute Hospital GP, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1861156
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Terre Haute Hospital Holdings, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1861158
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Terre Haute MOB, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Indiana
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    76-0775694
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Terre Haute Regional Hospital, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    35-1461805
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Timpanogos Regional Medical Services, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Utah
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1831495
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Trident Medical Center, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1768106
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Utah Medco, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1769672
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    VH Holdco, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Nevada
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1749073
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    VH Holdings, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Nevada
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1720399
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Virginia Psychiatric Company, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Virginia
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1410313
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    W&#160;&#038; C Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Texas
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    61-1259838
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
</TABLE>

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 9pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="57%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="16%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Address, Including<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Zip Code, and<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Telephone Number,<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Including Area<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>State or Other<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Code, of Registrant<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Jurisdiction of<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>I.R.S. Employer<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Guarantor&#146;s<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
    <B>Exact Name of Registrant Guarantor as Specified<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Incorporation or<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Identification<BR>
    </B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Principal Executive<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>in its Charter (or Other Organizational Document)</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Organization</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Number</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Offices</B>
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Walterboro Community Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    South Carolina
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    57-0712623
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Wesley Medical Center, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Delaware
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1762545
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    West Florida Regional Medical Center, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Florida
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    59-1525468
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    West Valley Medical Center, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Idaho
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    36-3525049
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Western Plains Capital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Nevada
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    62-1727347
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    WHMC, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Texas
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    61-1261485
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Woman&#146;s Hospital of Texas, Incorporated
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Texas
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    74-1991424
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Women&#146;s and Children&#146;s Hospital, Inc.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
    Louisiana
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    58-1741726
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    One Park Plaza<BR>
    Nashville, TN 37203<BR>
    (615) 344-9551
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE style="color: #FF0000" width="100%" border="1" cellpadding="5"><TR><TD style=text-align:justify>
<FONT style="font-size: 9pt; font-family: Arial, Helvetica; color: #E8112D">The
information in this prospectus is not complete and may be
changed. We may not sell these securities until the registration
statement filed with the Securities and Exchange Commission is
effective. This prospectus is not an offer to sell these
securities and it is not soliciting an offer to buy these
securities in any state where the offer or sale is not
permitted.<BR>
</FONT>
</TD></TR></TABLE>

<DIV style="margin-top: 1pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <FONT style="color: #E8112D">SUBJECT TO COMPLETION, DATED MAY
    27, 2009
    </FONT>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Preliminary Prospectus
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <IMG src="y77125y7712513.gif" alt="(HCA LOGO)">
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 18pt; font-family: Arial, Helvetica">HCA
    Inc.</FONT></B>
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 15pt; font-family: Arial, Helvetica">Debt
    Securities</FONT></B>
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<CENTER style="font-size: 1pt; width: 26%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=456 length=120 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Neither the Securities and Exchange Commission nor any state
    securities commission has approved or disapproved of the notes
    or passed upon the adequacy or accuracy of this prospectus. Any
    representation to the contrary is a criminal offense.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    This prospectus has been prepared for and may be used by Banc of
    America Securities LLC, Merrill Lynch, Pierce,
    Fenner&#160;&#038; Smith Incorporated and their affiliates in
    connection with offers and sales of the debt securities
    referenced herein related to market-making transactions in such
    debt securities effected from time to time. Such affiliates may
    act as principal or agent in such transactions, including as
    agent for the counterparty when acting as principal or as agent
    for both counterparties, and may receive compensation in the
    form of discounts and commissions, including from both
    counterparties, when they act as agents for both. Such sales
    will be made at prevailing market prices at the time of sale, at
    prices related thereto or at negotiated prices. We will not
    receive any proceeds from such sales.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    You should rely only on the information contained in this
    prospectus. We have not authorized anyone to provide you with
    different information. The prospectus may be used only for the
    purposes for which it has been published and no person has been
    authorized to give any information not contained herein. If you
    receive any other information, you should not rely on it. We are
    not making an offer of these securities in any state where the
    offer is not permitted.
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<CENTER style="font-size: 1pt; width: 26%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=456 length=120 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Investing in the notes involves risks. See &#147;Risk
    Factors&#148; beginning on page&#160;6 for a discussion of
    certain risks that you should consider before investing in the
    securities.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We are offering to sell these securities only in places where
    sales are permitted.
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <FONT style="font-size: 9pt">The date of this prospectus
    is&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
    2009.
    </FONT>
</DIV>

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">TABLE OF
    CONTENTS</FONT></B>
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>
<DIV align="left">
<!-- TOC -->
</DIV>

<DIV align="left">
<A name="tocpage"></A>
</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="95%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=quadleft -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=quadright -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <A HREF='#101'>Where You Can Find More Information About HCA
    Inc.&#160;</A>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD>&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    2
</TD>
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <A HREF='#102'>HCA Inc.&#160;</A>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD>&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    5
</TD>
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <A HREF='#103'>Risk Factors</A>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD>&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    6
</TD>
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <A HREF='#104'>Use of Proceeds</A>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD>&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    21
</TD>
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <A HREF='#105'>Description of Other Indebtedness</A>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD>&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    22
</TD>
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <A HREF='#106'>Description of Notes</A>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD>&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    28
</TD>
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <A HREF='#107'>Book-Entry Issuance</A>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD>&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    260
</TD>
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <A HREF='#108'>Certain U.S. Federal Tax Consequences</A>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD>&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    263
</TD>
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <A HREF='#109'>Plan of Distribution</A>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD>&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    271
</TD>
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <A HREF='#110'>Experts</A>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD>&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    272
</TD>
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <A HREF='#111'>Legal Opinions</A>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD>&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    272
</TD>
<TD>&nbsp;
</TD>
</TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv3w3.htm">EX-3.3: AMERICAN MEDICORP DEVELOPMENT CO. ARTICLES OF INCORPORATION</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv3w4.htm">EX-3.4: AMERICAN MEDICORP DEVELOPMENT CO. BY-LAWS</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv3w60.htm">EX-3.60: COLUMBIA PARKERSBURG HEALTHCARE SYSTEM, LLC ARTICLES OF CONVERSION</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv3w124.htm">EX-3.124: HCA-IT&S FIELD OPERATIONS, INC. ARTICLES OF INCORPORATION</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv3w125.htm">EX-3.125: HCA-IT&S FIELD OPERATIONS, INC. BY-LAWS</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv3w126.htm">EX-3.126: HCA-IT&S INVENTORY MANAGEMENT, INC. ARTICLES OF INCORPORATION</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv3w127.htm">EX-3.127: HCA-IT&S INVENTORY MANAGEMENT, INC. BY-LAWS</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv3w142.htm">EX-3.142: HCA REALTY, INC. CHARTER</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv3w143.htm">EX-3.143: HCA REALTY, INC. BY-LAWS</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv3w267.htm">EX-3.267: PASADENA BAYSHORE HOSPITAL, INC. ARTICLES OF INCORPORATION</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv3w268.htm">EX-3.268: PASADENA BAYSHORE HOSPITAL INC. BY-LAWS</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv3w279.htm">EX-3.279: RETREAT HOSPITAL, LLC ARTICLES OF INCORPORATION</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv3w280.htm">EX-3.280: RETREAT HOSPITAL, LLC LIMITED LIABILITY COMPANY AGREEMENT</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv5w1.htm">EX-5.1: OPINION OF SIMPSON THACHER & BARTLETT LLP</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv5w2.htm">EX-5.2: OPINION OF ROBERT A. WATERMAN</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv12w1.htm">EX-12.1: STATEMENT REGARDING COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv21w1.htm">EX-21.1: SUBSIDIARIES</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv23w3.htm">EX-23.3: CONSENT OF ERNST & YOUNG LLP</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv25w1.htm">EX-25.1: FORM T-1 STATEMENT OF ELIGIBILITY</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv25w2.htm">EX-25.2: FORM T-1 STATEMENT OF ELIGIBILITY</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv25w3.htm">EX-25.3: FORM T-1 STATEMENT OF ELIGIBILITY</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y77125exv25w4.htm">EX-25.4: FORM T-1 STATEMENT OF ELIGIBILITY</A></FONT></TD></TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV align="left">
<!-- /TOC -->
</DIV>

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->
<A name='101'>
<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">WHERE YOU
    CAN FIND MORE INFORMATION ABOUT HCA INC.</FONT></B>
</DIV>
</A>
<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We file certain reports with the Securities and Exchange
    Commission (the &#147;SEC&#148;), including annual reports on
    <FONT style="white-space: nowrap">Form&#160;10-K,</FONT>
    quarterly reports on
    <FONT style="white-space: nowrap">Form&#160;10-Q</FONT>
    and current reports on
    <FONT style="white-space: nowrap">Form&#160;8-K.</FONT>
    The public may read and copy any materials we file with the SEC
    at the SEC&#146;s Public Reference Room at
    100&#160;F&#160;Street, N.E., Washington, DC 20549. The public
    may obtain information on the operation of the Public Reference
    Room by calling the SEC at
    <FONT style="white-space: nowrap">1-800-SEC-0330.</FONT>
    We are an electronic filer, and the SEC maintains an Internet
    site at
    <FONT style="white-space: nowrap">http://www.sec.gov</FONT>
    that contains the reports and other information we file
    electronically. Our website address is www.hcahealthcare.com.
    Please note that our website address is provided as an inactive
    textual reference only. The information provided on our website
    is not part of this prospectus and is therefore not incorporated
    by reference unless such information is specifically referenced
    elsewhere in this prospectus. We make available free of charge,
    through our website, our annual report on
    <FONT style="white-space: nowrap">Form&#160;10-K,</FONT>
    quarterly reports on
    <FONT style="white-space: nowrap">Form&#160;10-Q,</FONT>
    current reports on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    and all amendments to those reports filed or furnished pursuant
    to Section&#160;15(d) of the Exchange Act, as soon as reasonably
    practicable after such material is electronically filed with or
    furnished to the SEC.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The SEC allows us to &#147;incorporate by reference&#148; into
    this prospectus the information in documents we file with the
    SEC, which means that we can disclose important information to
    you by referring you to those documents. The information
    incorporated by reference is considered to be a part of this
    prospectus, and later information that we file with the SEC will
    update and supersede this information. The information contained
    in this prospectus supersedes any inconsistent information
    contained in the documents incorporated by reference herein.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We incorporate by reference the documents listed below other
    than, in each case, those documents or the portions of those
    documents which are furnished and not filed:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    HCA Inc.&#146;s annual report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the year ended December&#160;31, 2008;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    HCA Inc.&#146;s quarterly report on
    <FONT style="white-space: nowrap">Form&#160;10-Q</FONT>
    for the quarter ended March&#160;31, 2009;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    HCA Inc.&#146;s current reports on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    filed on February&#160;11, 2009 (Item&#160;5.02),
    February&#160;25, 2009, April&#160;27, 2009, April&#160;28,
    2009, May&#160;7, 2009 and May&#160;27, 2009; and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the descriptions of the terms of the specified debt securities
    contained under the captions indicated in the following
    documents filed with the SEC:
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="6%"></TD>
    <TD width="2%"></TD>
    <TD width="92%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the description of the 5.50%&#160;Senior Notes Due 2009 and the
    6.375%&#160;Senior Notes Due 2015 set forth under the caption
    &#147;Description of the Notes&#148; in the prospectus
    supplement dated November&#160;16, 2004, and under the caption
    &#147;Description of the Debt Securities&#148; in the prospectus
    dated October&#160;16, 2003, each filed with the SEC on
    November&#160;17, 2004 (SEC File
    <FONT style="white-space: nowrap">No.&#160;333-107536);</FONT>
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the description of the $750,000,000 in aggregate principal
    amount of 8.75%&#160;Senior Notes Due 2010 set forth under the
    caption &#147;Description of the Notes&#148; in the prospectus
    supplement dated August&#160;18, 2000, and under the caption
    &#147;Description of the Debt Securities&#148; in the prospectus
    dated August&#160;5, 1999, each filed with the SEC on
    August&#160;21, 2000 (SEC File
    <FONT style="white-space: nowrap">No.&#160;333-82219);</FONT>
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the description of the &#163;150,000,000 in aggregate principal
    amount of 8.75%&#160;Senior Notes Due 2010 set forth under the
    caption &#147;Description of the Notes&#148; in the prospectus
    supplement dated October&#160;25, 2000, and under the caption
    &#147;Description of the Debt Securities&#148; in the prospectus
    dated August&#160;5, 1999, each filed with the SEC on
    October&#160;27, 2000 (SEC File
    <FONT style="white-space: nowrap">No.&#160;333-82219);</FONT>
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the description of the 7.875%&#160;Senior Notes Due 2011 set
    forth under the caption &#147;Description of the Notes&#148; in
    the prospectus supplement dated January&#160;23, 2001, and under
    the caption &#147;Description of the Debt Securities&#148; in
    the prospectus dated December&#160;19, 2000, each filed with the
    SEC on January&#160;24, 2001 (SEC File
    <FONT style="white-space: nowrap">No.&#160;333-51540);</FONT>
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the description of the 6.95%&#160;Senior Notes Due 2012 set
    forth under the caption &#147;Description of the Notes&#148; in
    the prospectus supplement dated April&#160;23, 2002, and under
    the caption &#147;Description of the
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    2
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="6%"></TD>
    <TD width="2%"></TD>
    <TD width="92%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>
</TD>
    <TD align="left">
    Debt Securities&#148; in the prospectus dated December&#160;19,
    2000, each filed with the SEC on April&#160;26, 2002 (SEC File
    <FONT style="white-space: nowrap">No.&#160;333-51540);</FONT>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="6%"></TD>
    <TD width="2%"></TD>
    <TD width="92%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the description of the 6.30%&#160;Senior Notes Due 2012 set
    forth under the caption &#147;Description of the Notes&#148; in
    the prospectus supplement dated September&#160;18, 2002, and
    under the caption &#147;Description of the Debt Securities&#148;
    in the prospectus dated May&#160;16, 2002, each filed with the
    SEC on September&#160;20, 2002 (SEC File
    <FONT style="white-space: nowrap">No.&#160;333-87588);</FONT>
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the description of the 6.25%&#160;Senior Notes Due 2013 set
    forth under the caption &#147;Description of the Notes&#148; in
    the prospectus supplement dated February&#160;5, 2003, and under
    the caption &#147;Description of the Debt Securities&#148; in
    the prospectus dated May&#160;16, 2002, each filed with the SEC
    on February&#160;7, 2003 (SEC File
    <FONT style="white-space: nowrap">No.&#160;333-87588);</FONT>
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the description of the 6.75%&#160;Senior Notes Due 2013 set
    forth under the caption &#147;Description of the Notes&#148; in
    the prospectus supplement dated July&#160;23, 2003, and under
    the caption &#147;Description of the Debt Securities&#148; in
    the prospectus dated May&#160;16, 2002, each filed with the SEC
    on July&#160;25, 2003 (SEC File
    <FONT style="white-space: nowrap">No.&#160;333-87588);</FONT>
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the description of the 5.75%&#160;Senior Notes Due 2014 set
    forth under the caption &#147;Description of the Notes&#148; in
    the prospectus supplement dated March&#160;3, 2004, and under
    the caption &#147;Description of the Debt Securities&#148; in
    the prospectus dated October&#160;16, 2003, each filed with the
    SEC on March&#160;5, 2004 (SEC File
    <FONT style="white-space: nowrap">No.&#160;333-107536);</FONT>
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the description of the 6.50%&#160;Senior Notes Due 2016 set
    forth under the caption &#147;Description of the Notes&#148; in
    the prospectus supplement dated February&#160;3, 2006, and under
    the caption &#147;Description of the Debt Securities&#148; in
    the prospectus dated April&#160;21, 2005, each filed with the
    SEC on February&#160;6, 2006 (SEC File
    <FONT style="white-space: nowrap">No.&#160;333-121520);</FONT>
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the description of the 7.69%&#160;Notes Due 2025 set forth under
    the caption &#147;Description of New Securities&#148; in the
    prospectus and consent solicitation dated May&#160;25, 1995,
    filed with the SEC on May&#160;26,1995 (SEC File
    <FONT style="white-space: nowrap">No.&#160;33-58919);</FONT>
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the description of the 7.50%&#160;Senior Notes Due 2033 set
    forth under the caption &#147;Description of the Notes&#148; in
    the prospectus supplement dated October&#160;31, 2003, and under
    the caption &#147;Description of the Debt Securities&#148; in
    the prospectus dated October&#160;16, 2003, each filed with the
    SEC on November&#160;4, 2003 (SEC File
    <FONT style="white-space: nowrap">No.&#160;333-107536);</FONT>
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the description of the 7.19%&#160;Debentures Due 2015 set forth
    under the caption &#147;Description of the Notes&#148; in the
    prospectus supplement dated November&#160;20, 1995, and under
    the caption &#147;Description of the Debt Securities&#148; in
    the prospectus dated November&#160;17, 1995, each filed with the
    SEC on November&#160;22, 1995 (SEC File
    <FONT style="white-space: nowrap">No.&#160;33-64105);</FONT>
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the description of the 7.50%&#160;Debentures Due 2023 set forth
    under the caption &#147;Description of the Securities&#148; in
    the prospectus supplement dated December&#160;9, 1993, and under
    the caption &#147;Description of the Debt Securities&#148; in
    the prospectus dated November&#160;22, 1993, each filed with the
    SEC on December&#160;17, 1993 (SEC File
    <FONT style="white-space: nowrap">No.&#160;33-50985);</FONT>
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the description of the 8.36%&#160;Debentures Due 2024 set forth
    under the caption &#147;Description of the Debentures&#148; in
    the prospectus supplement dated April&#160;20, 1994, and under
    the caption &#147;Description of the Debt Securities&#148; in
    the prospectus dated November&#160;22, 1993, each filed with the
    SEC on April&#160;21, 1994 (SEC File
    <FONT style="white-space: nowrap">No.&#160;33-50985);</FONT>
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the description of the 7.05%&#160;Debentures Due 2027 set forth
    under the caption &#147;Description of the Debentures&#148; in
    the prospectus supplement dated December&#160;5, 1995, and under
    the caption &#147;Description of the Debt Securities&#148; in
    the prospectus dated November&#160;17, 1995, each filed with the
    SEC on December&#160;7, 1995 (SEC File
    <FONT style="white-space: nowrap">No.&#160;33-64105);</FONT>
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the description of the 7.50%&#160;Debentures Due 2095 set forth
    under the caption &#147;Description of the Debentures&#148; in
    the prospectus supplement dated November&#160;20, 1995, and
    under the caption
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    3
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="8%"></TD>
    <TD width="2%"></TD>
    <TD width="90%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>
</TD>
    <TD align="left">
    &#147;Description of the Debt Securities&#148; in the prospectus
    dated November&#160;17, 1995, each filed with the SEC on
    November&#160;22, 1995 (SEC File
    <FONT style="white-space: nowrap">No.&#160;33-64105);</FONT>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="6%"></TD>
    <TD width="2%"></TD>
    <TD width="92%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the description of the 8.70% Medium-Term Notes Due 2010 set
    forth in the Pricing Supplement, dated February&#160;1, 1995,
    filed with the SEC on February&#160;2, 1995 (SEC File
    <FONT style="white-space: nowrap">No.&#160;33-53409),</FONT>
    and under the caption &#147;Description of Notes&#148; in the
    prospectus supplement dated July&#160;11, 1994, and under the
    caption &#147;Description of the Debt Securities&#148; in the
    prospectus dated May&#160;13, 1994, each filed with the SEC on
    July&#160;12, 1994 (SEC File
    <FONT style="white-space: nowrap">No.&#160;33-53409);</FONT>
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the description of the 9.00% Medium-Term Notes Due 2014 set
    forth in the Pricing Supplement, dated January&#160;12, 1995,
    filed with the SEC on January&#160;13, 1995 (SEC File
    <FONT style="white-space: nowrap">No.&#160;33-53409),</FONT>
    and under the caption &#147;Description of Notes&#148; in the
    prospectus supplement dated July&#160;11, 1994, and under the
    caption &#147;Description of the Debt Securities&#148; in the
    prospectus dated May&#160;13, 1994, each filed with the SEC on
    July&#160;12, 1994 (SEC File
    <FONT style="white-space: nowrap">No.&#160;33-53409);&#160;and</FONT>
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the description of the 7.58% Medium-Term Notes Due 2025 set
    forth in the Pricing Supplement, dated September&#160;11, 1995,
    filed with the SEC on September&#160;13, 1995 (SEC File
    <FONT style="white-space: nowrap">No.&#160;33-53409),</FONT>
    and under the caption &#147;Description of Notes&#148; in the
    prospectus supplement dated July&#160;11, 1994, and under the
    caption &#147;Description of the Debt Securities&#148; in the
    prospectus dated May&#160;13, 1994, each filed with the SEC on
    July&#160;12, 1994 (SEC File
    <FONT style="white-space: nowrap">No.&#160;33-53409).</FONT>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    You may request a copy of these filings, at no cost, by writing
    or calling us at the following address or telephone number:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <FONT style="font-family: 'Times New Roman', Times">Corporate
    Secretary<BR>
    HCA Inc.<BR>
    One Park Plaza<BR>
    Nashville, Tennessee 37203
    </FONT>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <FONT style="white-space: nowrap">(615)&#160;344-9551</FONT>
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    4
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->
<A name='102'>
<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">HCA
    INC.</FONT></B>
</DIV>
</A>
<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>The terms &#147;Company,&#148; &#147;HCA,&#148;
    &#147;we,&#148; &#147;our&#148; or &#147;us,&#148; as used
    herein, refer to HCA Inc. and its affiliates unless otherwise
    stated or indicated by context. The term &#147;affiliates&#148;
    means direct and indirect subsidiaries of HCA Inc. and
    partnerships and joint ventures in which such subsidiaries are
    partners.</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We are one of the leading health care services companies in the
    United States. At March&#160;31, 2009, we operated 163
    hospitals, comprised of 157 general, acute care hospitals; five
    psychiatric hospitals; and one rehabilitation hospital. The 163
    hospital total includes eight hospitals (seven general, acute
    care hospitals and one rehabilitation hospital) owned by joint
    ventures in which an affiliate of HCA is a partner, and these
    joint ventures are accounted for using the equity method. In
    addition, we operated 105 freestanding surgery centers, eight of
    which are owned by joint ventures in which an affiliate of HCA
    is a partner, and these joint ventures are accounted for using
    the equity method. Our facilities are located in 20&#160;states
    and England. For the year ended December&#160;31, 2008, we
    generated revenues of $28.374&#160;billion and net income
    attributable to HCA Inc. of $673&#160;million, and for the three
    months ended March&#160;31, 2009, we generated revenues of
    $7.431&#160;billion and net income attributable to HCA Inc. of
    $360&#160;million.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Our primary objective is to provide a comprehensive array of
    quality health care services in the most cost-effective manner
    possible. Our general, acute care hospitals typically provide a
    full range of services to accommodate such medical specialties
    as internal medicine, general surgery, cardiology, oncology,
    neurosurgery, orthopedics and obstetrics, as well as diagnostic
    and emergency services. Outpatient and ancillary health care
    services are provided by our general, acute care hospitals,
    freestanding surgery centers, diagnostic centers and
    rehabilitation facilities. Our psychiatric hospitals provide a
    full range of mental health care services through inpatient,
    partial hospitalization and outpatient settings.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We also provide a variety of management services to our health
    care facilities, including patient safety programs; ethics and
    compliance programs; national supply contracts; equipment
    purchasing and leasing contracts; accounting, financial and
    clinical systems; governmental reimbursement assistance;
    construction planning and coordination; information technology
    systems and solutions; legal counsel; human resources services;
    and internal audit services.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<CENTER style="font-size: 1pt; width: 18%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=456 length=84 -->

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    HCA Inc. was incorporated in Nevada in January 1990 and
    reincorporated in Delaware in September 1993. Our principal
    executive offices are located at One Park Plaza, Nashville,
    Tennessee 37203, and our telephone number is
    <FONT style="white-space: nowrap">(615)&#160;344-9551.</FONT>
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    5
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->
<A name='103'>
<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">RISK
    FACTORS</FONT></B>
</DIV>
</A>
<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>You should carefully consider the risk factors set forth
    below as well as the risk factors incorporated herein by
    reference to our annual report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2008 (the &#147;2008
    <FONT style="white-space: nowrap">10-K&#148;)</FONT>
    and our quarterly report on
    <FONT style="white-space: nowrap">Form&#160;10-Q</FONT>
    for the quarter ended March&#160;31, 2009 (the &#147;2009 First
    Quarter
    <FONT style="white-space: nowrap">10-Q&#148;)</FONT>
    and the other information contained in this prospectus before
    purchasing the notes. This prospectus contains forward-looking
    statements that involve risks and uncertainties. Any of the
    following risks could materially and adversely affect our
    business, financial condition or results of operations.
    Additional risks and uncertainties not currently known to us or
    those we currently view to be immaterial may also materially and
    adversely affect our business, financial condition or results of
    operations. In such a case, you may lose all or part of your
    original investment.</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>As used herein, the &#147;senior secured credit
    facilities&#148; refer to, collectively, our senior secured cash
    flow credit facility, dated as of November&#160;17, 2006, as
    amended on February&#160;16, 2007, and as amended on
    March&#160;2, 2009 (the &#147;cash flow credit facility&#148;),
    and our senior secured asset-based revolving credit facility,
    dated as of November&#160;17, 2006, as amended and restated as
    of June&#160;20, 2007, and as amended on March&#160;2, 2009 (the
    &#147;asset-based revolving credit facility&#148;). We refer to
    the &#147;senior notes&#148; as those notes, debentures and
    medium-term notes issued under the indenture, dated as of
    December&#160;16, 1993, as amended or supplemented, to the
    &#147;second lien notes&#148; as those notes issued under,
    collectively, the indenture dated as of November&#160;17, 2006
    and the indenture dated as of February&#160;19, 2009, each as
    amended or supplemented, to the &#147;first lien notes&#148; as
    those notes issued under the indenture, dated as of
    April&#160;22, 2009, as amended or supplemented, and to the
    &#147;senior secured notes&#148; as, collectively, the second
    lien notes and the first lien notes. We refer to the
    &#147;notes&#148; as, collectively, the senior notes and the
    senior secured notes. For a more detailed description of the
    notes and the indentures and agreements governing such notes,
    see &#147;Description of Notes.&#148;</I>
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Risks
    Related to Our Indebtedness</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Our
    substantial leverage could adversely affect our ability to raise
    additional capital to fund our operations, limit our ability to
    react to changes in the economy or our industry, expose us to
    interest rate risk to the extent of our variable rate debt and
    prevent us from meeting our obligations.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Since completing our recapitalization in November 2006 we are
    highly leveraged. As of March&#160;31, 2009 our total
    indebtedness was $26.567&#160;billion. Our high degree of
    leverage could have important consequences, including:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    increasing our vulnerability to downturns or adverse changes in
    general economic, industry or competitive conditions and adverse
    changes in government regulations;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    requiring a substantial portion of cash flow from operations to
    be dedicated to the payment of principal and interest on our
    indebtedness, therefore reducing our ability to use our cash
    flow to fund our operations, capital expenditures and future
    business opportunities;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    exposing us to the risk of increased interest rates as certain
    of our unhedged borrowings are at variable rates of interest;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    limiting our ability to make strategic acquisitions or causing
    us to make nonstrategic divestitures;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    limiting our ability to obtain additional financing for working
    capital, capital expenditures, product or service line
    development, debt service requirements, acquisitions and general
    corporate or other purposes;&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    limiting our ability to adjust to changing market conditions and
    placing us at a competitive disadvantage compared to our
    competitors who are less highly leveraged.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We and our subsidiaries have the ability to incur additional
    indebtedness in the future, subject to the restrictions
    contained in our senior secured credit facilities and the
    indentures governing our outstanding notes. If new indebtedness
    is added to our current debt levels, the related risks that we
    now face could intensify.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    6
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">We may
    not be able to generate sufficient cash to service all of our
    indebtedness and may not be able to refinance our indebtedness
    on favorable terms. If we are unable to do so, we may be forced
    to take other actions to satisfy our obligations under our
    indebtedness, which may not be successful.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Our ability to make scheduled payments on or to refinance our
    debt obligations depends on our financial condition and
    operating performance, which are subject to prevailing economic
    and competitive conditions and to certain financial, business
    and other factors beyond our control. We cannot assure you that
    we will maintain a level of cash flows from operating activities
    sufficient to permit us to pay the principal, premium, if any,
    and interest on our indebtedness.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    As of March&#160;31, 2009, our substantial indebtedness included
    $13.356&#160;billion of indebtedness under our senior secured
    credit facilities that matures in 2012 and 2013,
    $6.000&#160;billion of second lien notes maturing in 2014, 2016
    and 2017 and $6.826&#160;billion of unsecured senior notes and
    debentures that mature on various dates from 2009 to 2095
    (including $5.437&#160;billion maturing through 2016). Because a
    significant portion of our indebtedness matures in the next few
    years, we may find it necessary or prudent to refinance that
    indebtedness with longer-maturity debt at a higher interest
    rate. In April 2009, for example, we issued $1.500&#160;billion
    of
    8<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">2</FONT>%&#160;Senior
    Secured Notes due 2019. We used the net proceeds of that
    offering to prepay term loans under our cash flow credit
    facility, which currently bears interest at a lower floating
    rate. Our ability to refinance our indebtedness on favorable
    terms, or at all, is directly affected by the current global
    economic and financial crisis. In addition, our ability to incur
    secured indebtedness (which may enable us to achieve better
    pricing than the incurrence of unsecured indebtedness) depends
    in part on the value of our assets, which depends, in turn, on
    the strength of our cash flows and results of operations, and on
    economic and market conditions and other factors.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If our cash flows and capital resources are insufficient to fund
    our debt service obligations or we are unable to refinance our
    indebtedness, we may be forced to reduce or delay investments
    and capital expenditures, or to sell assets, seek additional
    capital or restructure our indebtedness. These alternative
    measures may not be successful and may not permit us to meet our
    scheduled debt service obligations. If our operating results and
    available cash are insufficient to meet our debt service
    obligations, we could face substantial liquidity problems and
    might be required to dispose of material assets or operations to
    meet our debt service and other obligations. We may not be able
    to consummate those dispositions, or the proceeds from the
    dispositions may not be adequate to meet any debt service
    obligations then due.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Our
    debt agreements contain restrictions that limit our flexibility
    in operating our business.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Our senior secured credit facilities and the indentures
    governing our outstanding notes contain various covenants that
    limit our ability to engage in specified types of transactions.
    These covenants limit our and certain of our subsidiaries&#146;
    ability to, among other things:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    incur additional indebtedness or issue certain preferred shares;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    pay dividends on, repurchase or make distributions in respect of
    our capital stock or make other restricted payments;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    make certain investments;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    sell or transfer assets;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    create liens;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    consolidate, merge, sell or otherwise dispose of all or
    substantially all of our assets;&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    enter into certain transactions with our affiliates.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under our asset-based revolving credit facility, when (and for
    as long as) the combined availability under our asset-based
    revolving credit facility and our senior secured revolving
    credit facility is less than a specified amount for a certain
    period of time or, if a payment or bankruptcy event of default
    has occurred and is continuing, funds deposited into any of our
    depository accounts will be transferred on a daily basis into a
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    7
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    blocked account with the administrative agent and applied to
    prepay loans under the asset-based revolving credit facility and
    to cash collateralize letters of credit issued thereunder.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under our senior secured credit facilities, we are required to
    satisfy and maintain specified financial ratios. Our ability to
    meet those financial ratios can be affected by events beyond our
    control, and there can be no assurance that we will continue to
    meet those ratios. A breach of any of these covenants could
    result in a default under both our cash flow credit facility and
    our asset-based revolving credit facility. Upon the occurrence
    of an event of default under our senior secured credit
    facilities, our lenders could elect to declare all amounts
    outstanding under our senior secured credit facilities to be
    immediately due and payable and terminate all commitments to
    extend further credit. If we were unable to repay those amounts,
    the lenders under our senior secured credit facilities could
    proceed against the collateral granted to them to secure such
    indebtedness. We have pledged a significant portion of our
    assets as collateral under our senior secured credit facilities.
    If any of the lenders under our senior secured credit facilities
    accelerate the repayment of borrowings, we cannot assure you
    that we will have sufficient assets to repay our senior secured
    credit facilities and the notes.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Risks
    Related to the Notes</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Your
    ability to transfer the notes may be limited by the absence of
    an active trading market, and there is no assurance that any
    active trading market for the notes exists or will
    continue.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We do not intend to apply for a listing of the notes on a
    securities exchange or automated dealer quotation system. We
    cannot assure you as to the liquidity of markets that may
    develop for the notes, your ability to sell the notes or the
    price at which you would be able to sell the notes. No financial
    institution is obligated to make a market in any of the notes,
    and any financial institutions that do so may discontinue their
    market-making activities at any time without notice. Therefore,
    an active market for any of the notes, if developed, may not
    continue. Because Banc of America Securities LLC, Merrill Lynch,
    Pierce, Fenner&#160;&#038; Smith Incorporated and their
    respective affiliates (collectively, the &#147;market
    makers&#148;) may be considered affiliates of ours, they are
    required to deliver a current &#147;market-maker&#148;
    prospectus in connection with any secondary market sale of the
    notes, which may affect their ability to continue market-making
    activities. Historically, the market for non investment-grade
    debt has been subject to disruptions that have caused
    substantial volatility in the prices of securities similar to
    the notes. The market, if any, for any of the notes may not be
    free from similar disruptions and any such disruptions may
    adversely affect the prices at which you may sell your notes. In
    addition, the notes may trade at a discount from your purchase
    price, depending upon prevailing interest rates, the market for
    similar notes, our performance and other factors.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">If we
    default on our obligations to pay our indebtedness, we may not
    be able to make payments on the notes.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any default under the agreements governing our indebtedness,
    including a default under our senior secured credit facilities
    that is not waived by the required lenders or a default under
    any of the indentures governing the notes, and the remedies
    sought by the holders of such indebtedness, could prevent us
    from paying principal, premium, if any, and interest on the
    notes and substantially decrease the market value of the notes.
    If we are unable to generate sufficient cash flow and are
    otherwise unable to obtain funds necessary to meet required
    payments of principal, premium, if any, and interest on our
    indebtedness, or if we otherwise fail to comply with the various
    covenants, including financial and operating covenants, in the
    instruments governing our indebtedness (including covenants in
    our senior secured credit facilities and the indentures
    governing the notes), we could be in default under the terms of
    the agreements governing such indebtedness. In the event of such
    default, the holders of such indebtedness could elect to declare
    all the funds borrowed thereunder to be due and payable,
    together with accrued and unpaid interest, the lenders under our
    senior secured credit facilities could elect to terminate their
    commitments thereunder, cease making further loans and institute
    foreclosure proceedings against our assets, and we could be
    forced into bankruptcy or liquidation. If our operating
    performance declines, we may in the future need to obtain
    waivers from the required lenders under our senior secured
    credit facilities to avoid being in default. If we breach our
    covenants under our senior secured credit facilities and seek a
    waiver, we may not be able to obtain a waiver from the required
    lenders. If
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    8
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    this occurs, we would be in default under the instruments
    governing that indebtedness, the lenders could exercise their
    rights, as described above, and we could be forced into
    bankruptcy or liquidation.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Federal
    and state fraudulent transfer laws may permit a court to void
    the notes, and with respect to the senior secured notes, the
    guarantees, and, if that occurs, you may not receive any
    payments on the notes.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Federal and state fraudulent transfer and conveyance statutes
    may apply to the issuance of the notes and, with respect to the
    senior secured notes, the incurrence of the guarantees. Under
    federal bankruptcy law and comparable provisions of state
    fraudulent transfer or conveyance laws, which may vary from
    state to state, the notes or guarantees could be voided as a
    fraudulent transfer or conveyance if (1)&#160;we or any of the
    guarantors, as applicable, issued the notes or incurred the
    guarantees with the intent of hindering, delaying or defrauding
    creditors or (2)&#160;we or any of the guarantors, as
    applicable, received less than reasonably equivalent value or
    fair consideration in return for either issuing the notes or
    incurring the guarantees and, in the case of (2)&#160;only, one
    of the following is also true at the time thereof:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    we or any of the guarantors, as applicable, were insolvent or
    rendered insolvent by reason of the issuance of the notes or the
    incurrence of the guarantees;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the issuance of the notes or the incurrence of the guarantees
    left us or any of the guarantors, as applicable, with an
    unreasonably small amount of capital to carry on the business;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    we or any of the guarantors intended to, or believed that we or
    such guarantor would, incur debts beyond our or such
    guarantor&#146;s ability to pay as they mature;&#160;or
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    we were or any of the guarantors was a defendant in an action
    for money damages, or had a judgment for money damages docketed
    against us or such guarantor if, in either case, after final
    judgment, the judgment was unsatisfied.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If a court were to find that the issuance of the notes or the
    incurrence of any guarantee were a fraudulent transfer or
    conveyance, the court could void the payment obligations under
    the notes or such guarantee or further subordinate the notes or
    such guarantee to presently existing and future indebtedness of
    ours or of the related guarantor, or require the holders of the
    notes to repay any amounts received with respect to such
    guarantee. In the event of a finding that a fraudulent transfer
    or conveyance occurred, you may not receive any repayment on the
    notes. Further, the voidance of the notes could result in an
    event of default with respect to our and our subsidiaries&#146;
    other debt that could result in acceleration of such debt.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    As a general matter, value is given for a transfer or an
    obligation if, in exchange for the transfer or obligation,
    property is transferred or an antecedent debt is secured or
    satisfied. A debtor will generally not be considered to have
    received value in connection with a debt offering if the debtor
    uses the proceeds of that offering to make a dividend payment or
    otherwise retire or redeem equity securities issued by the
    debtor.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We cannot be certain as to the standards a court would use to
    determine whether or not we or the guarantors were solvent at
    the relevant time or, regardless of the standard that a court
    uses, that the issuance of the guarantees would not be further
    subordinated to our or any of our guarantors&#146; other debt.
    Generally, however, an entity would be considered insolvent if,
    at the time it incurred indebtedness:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the sum of its debts, including contingent liabilities, was
    greater than the fair saleable value of all its assets;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the present fair saleable value of its assets was less than the
    amount that would be required to pay its probable liability on
    its existing debts, including contingent liabilities, as they
    become absolute and mature;&#160;or
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    it could not pay its debts as they become due.
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    9
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Risks
    Related to the Senior Notes</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">The
    senior notes are unsecured and effectively junior to our secured
    indebtedness, including our senior secured credit facilities and
    our senior secured notes, to the extent of the value of the
    collateral securing such secured indebtedness.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Our obligations under our senior notes are unsecured and are
    effectively junior to our secured indebtedness to the extent of
    the value of the collateral securing such secured indebtedness.
    Our senior secured credit facilities and our senior secured
    notes are collateralized by, among other things, the capital
    stock of any wholly owned first-tier subsidiary of our company
    or of any U.S.&#160;subsidiary guarantor, substantially all of
    our and the U.S.&#160;subsidiary guarantors&#146; other tangible
    and intangible assets and accounts receivable of our company and
    certain of our domestic subsidiaries, subject to exceptions. Our
    senior secured credit facilities and the indentures governing
    our senior secured notes also permit us to incur additional
    secured indebtedness. The senior notes are effectively
    subordinated to all such secured indebtedness to the extent of
    the value of that collateral. If an event of default occurs
    under the senior secured credit facilities or under the
    indentures governing our senior secured notes, the holders of
    such senior secured indebtedness will have a prior right to our
    assets, to the exclusion of the holders of our senior notes,
    even if we are in default with respect to such notes. In that
    event, our assets would first be used to repay in full all
    indebtedness and other obligations secured by them (including
    all amounts outstanding under the senior secured credit
    facilities and the senior secured notes), resulting in all or a
    portion of our assets being unavailable to satisfy the claims of
    the holders of the senior notes and other unsecured
    indebtedness. Therefore, in the event of any distribution or
    payment of our assets in any foreclosure, dissolution,
    <FONT style="white-space: nowrap">winding-up,</FONT>
    liquidation, reorganization, or other bankruptcy proceeding,
    holders of the senior notes will participate in our remaining
    assets ratably with each other and with all holders of our
    unsecured indebtedness that is deemed to be of the same class as
    such notes, and potentially with all of our other general
    creditors, based upon the respective amounts owed to each holder
    or creditor. In any of the foregoing events, we cannot assure
    you that there will be sufficient assets to pay amounts due on
    the senior notes. As a result, holders of such notes may receive
    less, ratably, than holders of secured indebtedness.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    As of March&#160;31, 2009, on an as adjusted basis after giving
    effect to our offering of $1.500&#160;billion aggregate
    principal amount of first lien notes in April 2009 and the use
    of proceeds therefrom, we had outstanding an aggregate principal
    amount of $19.855&#160;billion of senior secured indebtedness.
    This senior secured indebtedness includes that outstanding under
    our senior secured credit facilities, including letters of
    credit, the senior secured notes, capital leases and other
    secured debt. We also had an additional $2.198&#160;billion
    available for borrowing under our senior secured revolving
    credit facilities after giving effect to certain outstanding
    letters of credit.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Claims
    of holders of our senior notes will be structurally subordinate
    to claims of creditors of all of our subsidiaries that do not
    guarantee such notes.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The senior notes are not guaranteed by any of our subsidiaries.
    Accordingly, claims of holders of the senior notes are
    structurally subordinate to the claims of creditors of these
    non-guarantor subsidiaries, including trade creditors. All
    obligations of our subsidiaries that do not guarantee the senior
    notes will have to be satisfied before any of the assets of such
    subsidiaries would be available for distribution, upon a
    liquidation or otherwise, to holders of the senior notes. In
    addition, the indentures governing the notes permit, subject to
    some limitations, these subsidiaries to incur additional
    indebtedness and do not contain limitations on the amount of
    certain other liabilities, such as trade payables, that may be
    incurred by these subsidiaries.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Risks
    Related to the Senior Secured Notes</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">The
    value of the collateral securing the senior secured notes may
    not be sufficient to satisfy our obligations under such
    notes.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    No appraisal of the value of the collateral was made in
    connection with the offerings of each series of senior secured
    notes, and the fair market value of the collateral is subject to
    fluctuations based on factors that include, among others,
    general economic conditions and similar factors. The amount to
    be received upon a
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    10
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    sale of the collateral would be dependent on numerous factors,
    including, but not limited to, the actual fair market value of
    the collateral at such time, the timing and the manner of the
    sale and the availability of buyers. By its nature, portions of
    the collateral may be illiquid and may have no readily
    ascertainable market value. In the event of a foreclosure,
    liquidation, bankruptcy or similar proceeding, the collateral
    may not be sold in a timely or orderly manner and the proceeds
    from any sale or liquidation of this collateral may not be
    sufficient to pay our obligations under the senior secured notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    To the extent that liens securing obligations under the senior
    secured credit facilities, pre-existing liens, liens permitted
    under the indentures governing the senior secured notes and
    other rights, including liens on excluded assets, such as those
    securing purchase money obligations and capital lease
    obligations granted to other parties (in addition to the holders
    of any other obligations secured by higher-priority liens),
    encumber any of the collateral securing the senior secured notes
    and the guarantees, those parties have or may exercise rights
    and remedies with respect to the collateral that could adversely
    affect the value of the collateral and the ability of the
    collateral agents, the trustees or the holders of the senior
    secured notes to realize or foreclose on the collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, the senior secured notes and the related guarantees
    are not secured by any of the European collateral described
    under &#147;Description of Other Indebtedness&#160;&#151; Senior
    Secured Credit Facilities&#160;&#151; Guarantee and
    Security.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    There may not be sufficient collateral to pay off all amounts we
    may borrow under our senior secured credit facilities, the
    existing senior secured notes and additional notes that we may
    offer that would be secured on the same basis as the existing
    senior secured notes. Consequently, liquidating the collateral
    securing the senior secured notes may not result in proceeds in
    an amount sufficient to pay any amounts due under such notes
    after also satisfying the obligations to pay any creditors with
    prior liens. In addition, we may be required to repay
    obligations under our cash flow credit facility with proceeds
    from a sale of assets before repaying the senior secured notes.
    If the proceeds of any sale of collateral are not sufficient to
    repay all amounts due on the senior secured notes, the holders
    of such notes (to the extent not repaid from the proceeds of the
    sale of the collateral) would have only a senior unsecured,
    unsubordinated claim against our and the subsidiary
    guarantors&#146; remaining assets.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Claims
    of holders of our senior secured notes are structurally
    subordinate to claims of creditors of all of our
    <FONT style="white-space: nowrap">non-U.S.</FONT>
    subsidiaries and some of our U.S. subsidiaries because they do
    not guarantee such notes.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The senior secured notes are not guaranteed by any of our
    <FONT style="white-space: nowrap">non-U.S.&#160;subsidiaries,</FONT>
    our less than wholly-owned U.S.&#160;subsidiaries or certain
    other U.S.&#160;subsidiaries. Accordingly, claims of holders of
    the senior secured notes are structurally subordinate to the
    claims of creditors of these non-guarantor subsidiaries,
    including trade creditors. All obligations of our non-guarantor
    subsidiaries will have to be satisfied before any of the assets
    of such subsidiaries would be available for distribution, upon a
    liquidation or otherwise, to us or a guarantor of the senior
    secured notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On an as adjusted basis after giving effect to our offering of
    $1.500&#160;billion aggregate principal amount of first lien
    notes in April 2009 and the use of proceeds therefrom, our
    non-guarantor subsidiaries would have accounted for
    approximately $11.867&#160;billion, or 41.8%, of our total
    revenues for the year ended December&#160;31, 2008,
    approximately $3.038&#160;billion, or 40.9%, of our total
    revenues for the three months ended March&#160;31, 2009,
    approximately $9.876&#160;billion, or 40.7%, of our total
    assets, and approximately $7.517&#160;billion, or 22.5%, of our
    total liabilities, in each case as of December&#160;31, 2008,
    and approximately $9.817&#160;billion, or 40.4%, of our total
    assets, and approximately $7.224&#160;billion, or 21.9%, of our
    total liabilities, in each case as of March&#160;31, 2009.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">There
    are circumstances other than repayment or discharge of the
    senior secured notes under which the collateral securing such
    notes and guarantees will be released automatically, without
    your consent or the consent of the applicable
    trustee.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under various circumstances, collateral securing the senior
    secured notes will be released automatically, including:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a sale, transfer or other disposal of such collateral in a
    transaction not prohibited under the indentures governing the
    senior secured notes;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    with respect to collateral held by a guarantor, upon the release
    of such guarantor from its guarantee;
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    11
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    with respect to collateral that is capital stock, upon the
    dissolution of the issuer of such capital stock in accordance
    with the indentures governing the senior secured notes;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    with respect to any collateral in which the second lien notes
    have a second-priority or third-priority lien, upon any release
    by the lenders under our senior secured credit facilities of
    their first-priority or second-priority security interest in
    such collateral unless such release occurs in connection with a
    discharge in full in cash of first lien obligations, which
    discharge is not in connection with a foreclosure of, or other
    exercise of remedies with respect to, non-receivables collateral
    by the first lien secured parties (such discharge not in
    connection with any such foreclosure or exercise of remedies, a
    &#147;Payment Discharge&#148;); provided that, in the case of a
    Payment Discharge, the lien on any non-receivables collateral
    disposed of in satisfaction in whole or in part of first lien
    obligations shall be automatically released but any proceeds
    thereof not used for purposes of the discharge of first lien
    obligations in full in cash or otherwise in accordance with the
    indentures governing the second lien notes shall be subject to a
    lien in favor of the collateral agent for the second lien
    noteholders;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    with respect to any receivables collateral in which the first
    lien notes have a second-priority lien, upon any release by the
    lenders under our asset-based revolving credit facility of their
    first-priority security interest in such collateral; provided
    that, if the release occurs in connection with a foreclosure or
    exercise of remedies by the collateral agent for the lenders
    under our asset-based revolving credit facility, the lien on
    that collateral will be automatically released but any proceeds
    thereof not used to repay the obligations under our asset-based
    revolving credit facility will be subject to lien in favor of
    the collateral agent for the first lien noteholders and our cash
    flow credit facility;&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    with respect to the collateral upon which the first notes have a
    first-priority lien, upon any release in connection with a
    foreclosure or exercise of remedies with respect to that
    collateral directed by the authorized representative of the
    lenders under our cash flow credit facility during any period
    that such authorized representative controls actions with
    respect to the collateral pursuant to the first lien
    intercreditor agreement. Even though the holders of the notes
    share ratably with the lenders under our cash flow credit
    facility, the authorized representative of the lenders under our
    cash flow credit facility will initially control actions with
    respect to the collateral, whether or not the holders of the
    first lien notes agree or disagree with those actions. See
    &#147;&#151;&#160;Risks Related to the First Lien Senior Secured
    Notes&#160;&#151;&#160;Even though the holders of the first lien
    notes have the benefit of a first-priority lien on the
    collateral that secures our cash flow credit facility, the
    representative of the lenders under the cash flow credit
    facility will initially control most actions with respect to
    that collateral.&#148;
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, the guarantee of a subsidiary guarantor will be
    automatically released to the extent it is released under the
    senior secured credit facilities or in connection with a sale of
    such subsidiary guarantor in a transaction not prohibited by the
    indentures.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The indentures governing the senior secured notes also permit us
    to designate one or more of our restricted subsidiaries that is
    a guarantor of the senior secured notes as an unrestricted
    subsidiary. If we designate a subsidiary guarantor as an
    unrestricted subsidiary for purposes of the indentures governing
    the senior secured notes, all of the liens on any collateral
    owned by such subsidiary or any of its subsidiaries and any
    guarantees of the notes by such subsidiary or any of its
    subsidiaries will be released under the indentures but not
    necessarily under our senior secured credit facilities.
    Designation of an unrestricted subsidiary will reduce the
    aggregate value of the collateral securing the notes to the
    extent that liens on the assets of the unrestricted subsidiary
    and its subsidiaries are released. In addition, the creditors of
    the unrestricted subsidiary and its subsidiaries will have a
    senior claim on the assets of such unrestricted subsidiary and
    its subsidiaries. See &#147;Description of Notes.&#148;
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">We
    will in most cases have control over the collateral, and the
    sale of particular assets by us could reduce the pool of assets
    securing the senior secured notes and the
    guarantees.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The collateral documents allow us to remain in possession of,
    retain exclusive control over, freely operate, and collect,
    invest and dispose of any income from, the collateral securing
    the senior secured notes and the
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    12
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    guarantees, except, under certain circumstances, cash
    transferred to accounts controlled by the administrative agent
    under our asset-based revolving credit facility.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, we are not required to comply with all or any
    portion of Section&#160;314(d) of the Trust&#160;Indenture Act
    of 1939 (the &#147;Trust&#160;Indenture Act&#148;) if we
    determine, in good faith based on advice of counsel, that, under
    the terms of that Section
    <FONT style="white-space: nowrap">and/or</FONT> any
    interpretation or guidance as to the meaning thereof of the SEC
    and its staff, including &#147;no action&#148; letters or
    exemptive orders, all or such portion of Section&#160;314(d) of
    the Trust&#160;Indenture Act is inapplicable to the released
    collateral. For example, so long as no default or event of
    default under the indentures governing the senior secured notes
    would result therefrom and such transaction would not violate
    the Trust&#160;Indenture Act, we may, among other things,
    without any release or consent by the applicable trustees,
    conduct ordinary course activities with respect to collateral,
    such as selling, factoring, abandoning or otherwise disposing of
    collateral and making ordinary course cash payments (including
    repayments of indebtedness). See &#147;Description of
    Notes.&#148;
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">The
    imposition of certain permitted liens will cause the assets on
    which such liens are imposed to be excluded from the collateral
    securing the senior secured notes and the guarantees. There are
    also certain other categories of property that are also excluded
    from the collateral.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The indentures governing the senior secured notes permit liens
    in favor of third parties to secure additional debt, including
    purchase money indebtedness and capital lease obligations, and
    any assets subject to such liens will be automatically excluded
    from the collateral securing the senior secured notes and the
    guarantees. Our ability to incur purchase money indebtedness and
    capital lease obligations is subject to the limitations as
    described in &#147;Description of Notes.&#148; In addition,
    certain categories of assets are excluded from the collateral
    securing the senior secured notes and the guarantees. Excluded
    assets include the assets of our non-guarantor subsidiaries and
    equity investees, certain capital stock and other securities of
    our subsidiaries and equity investees, certain properties that
    do not secure our senior secured credit facilities, deposit
    accounts, other bank or securities accounts, cash, leaseholds
    and motor vehicles, and the proceeds from any of the foregoing.
    The assets excluded from the collateral for the second lien
    secured notes include the properties defined as &#147;principal
    properties&#148; under our indenture dated as of
    December&#160;16, 1993, so long as that indenture remains in
    effect. Although the first lien secured notes share a lien on
    such &#147;principal properties,&#148; that lien is limited to
    securing a portion of the indebtedness under the senior secured
    notes and our cash flow credit facility that, in the aggregate,
    does not exceed 10% of our consolidated net tangible assets. See
    &#147;Description of Notes.&#148; If an event of default occurs
    and the senior secured notes are accelerated, such notes and the
    guarantees will rank equally with the holders of other
    unsubordinated and unsecured indebtedness of the relevant entity
    with respect to such excluded property.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On an as adjusted basis after giving effect to our offering of
    $1.500&#160;billion aggregate principal amount of first lien
    notes in April 2009 and the use of proceeds therefrom, our
    non-guarantor subsidiaries would have accounted for
    approximately $9.817&#160;billion, or 40.4%, of our total assets
    as of March&#160;31, 2009.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">The
    pledge of the capital stock, other securities and similar items
    of our subsidiaries that secure the senior secured notes will
    automatically be released from the lien on them and no longer
    constitute collateral for so long as the pledge of such capital
    stock or such other securities would require the filing of
    separate financial statements with the SEC for that
    subsidiary.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The senior secured notes and the guarantees are secured by a
    pledge of the stock of some of our subsidiaries. Under the SEC
    regulations in effect as of the issue date of the senior secured
    notes, if the par value, book value as carried by us or market
    value (whichever is greatest) of the capital stock, other
    securities or similar items of a subsidiary pledged as part of
    the collateral is greater than or equal to 20% of the aggregate
    principal amount of the senior secured notes then outstanding,
    such a subsidiary would be required to provide separate
    financial statements to the SEC. Therefore, the indentures
    governing the senior secured notes and the collateral documents
    provide that any capital stock and other securities of any of
    our subsidiaries will be excluded from the collateral for so
    long as the pledge of such capital stock or other securities to
    secure the senior secured notes would cause such subsidiary to
    be required to file separate financial statements with the SEC
    pursuant to
    <FONT style="white-space: nowrap">Rule&#160;3-16</FONT>
    of
    <FONT style="white-space: nowrap">Regulation&#160;S-X</FONT>
    (as in effect from time to time).
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    13
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    As a result, holders of the senior secured notes could lose a
    portion or all of their security interest in the capital stock
    or other securities of those subsidiaries during such period. It
    may be more difficult, costly and time-consuming for holders of
    the senior secured notes to foreclose on the assets of a
    subsidiary than to foreclose on its capital stock or other
    securities, so the proceeds realized upon any such foreclosure
    could be significantly less than those that would have been
    received upon any sale of the capital stock or other securities
    of such subsidiary. See &#147;Description of Notes.&#148;
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Your
    rights in the collateral may be adversely affected by the
    failure to perfect security interests in certain collateral in
    the future.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Applicable law requires that certain property and rights
    acquired after the grant of a general security interest, such as
    real property, equipment subject to a certificate and certain
    proceeds, can only be perfected at the time such property and
    rights are acquired and identified. The trustees or the
    collateral agents for the senior secured notes may not monitor,
    or we may not inform the trustees or the collateral agents for
    the senior secured notes of, the future acquisition of property
    and rights that constitute collateral, and necessary action may
    not be taken to properly perfect the security interest in such
    after-acquired collateral. The collateral agents for the senior
    secured notes have no obligation to monitor the acquisition of
    additional property or rights that constitute collateral or the
    perfection of any security interest in favor of the senior
    secured notes against third parties. Such failure may result in
    the loss of the security interest therein or the priority of the
    security interest in favor of the senior secured notes against
    third parties.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">The
    collateral is subject to casualty risks.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We intend to maintain insurance or otherwise insure against
    hazards in a manner appropriate and customary for our business.
    There are, however, certain losses that may be either
    uninsurable or not economically insurable, in whole or in part.
    Insurance proceeds may not compensate us fully for our losses.
    If there is a complete or partial loss of any of the pledged
    collateral, the insurance proceeds may not be sufficient to
    satisfy all of the secured obligations, including the senior
    secured notes and the guarantees.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">We may
    not be able to repurchase the senior secured notes upon a change
    of control.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Upon the occurrence of specific kinds of change of control
    events, we will be required to offer to repurchase all
    outstanding senior secured notes at 101% of their principal
    amount plus accrued and unpaid interest. The source of funds for
    any such purchase of such notes will be our available cash or
    cash generated from our subsidiaries&#146; operations or other
    sources, including borrowings, sales of assets or sales of
    equity. We may not be able to repurchase the senior secured
    notes upon a change of control because we may not have
    sufficient financial resources to purchase all of the senior
    secured notes that are tendered upon a change of control.
    Further, we are contractually restricted under the terms of our
    senior secured credit facilities from repurchasing all of the
    notes tendered by holders upon a change of control. Accordingly,
    we may not be able to satisfy our obligations to purchase the
    senior secured notes unless we are able to refinance or obtain
    waivers under the instruments governing that indebtedness. Our
    failure to repurchase the senior secured notes upon a change of
    control would cause a default under the indentures governing the
    senior secured notes and a cross-default under the instruments
    governing our senior secured credit facilities. The instruments
    governing our senior secured credit facilities also provide that
    a change of control will be a default that permits lenders to
    accelerate the maturity of borrowings thereunder. Any of our
    future debt agreements may contain similar provisions.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">In the
    event of our bankruptcy, the ability of the holders of the
    senior secured notes to realize upon the collateral will be
    subject to certain bankruptcy law limitations.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The ability of holders of the senior secured notes to realize
    upon the collateral will be subject to certain bankruptcy law
    limitations in the event of our bankruptcy. Under applicable
    U.S.&#160;federal bankruptcy laws, secured creditors are
    prohibited from repossessing their security from a debtor in a
    bankruptcy case without bankruptcy court approval and may be
    prohibited from disposing of security repossessed from such a
    debtor without bankruptcy court approval. Moreover, applicable
    federal bankruptcy laws generally permit the debtor
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    14
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    to continue to retain collateral, including cash collateral,
    even though the debtor is in default under the applicable debt
    instruments, provided that the secured creditor is given
    &#147;adequate protection.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The meaning of the term &#147;adequate protection&#148; may vary
    according to the circumstances, but is intended generally to
    protect the value of the secured creditor&#146;s interest in the
    collateral at the commencement of the bankruptcy case and may
    include cash payments or the granting of additional security if
    and at such times as the court, in its discretion, determines
    that a diminution in the value of the collateral occurs as a
    result of the stay of repossession or the disposition of the
    collateral during the pendency of the bankruptcy case. In view
    of the lack of a precise definition of the term &#147;adequate
    protection&#148; and the broad discretionary powers of a
    U.S.&#160;bankruptcy court, we cannot predict whether or when
    the collateral agents
    <FONT style="white-space: nowrap">and/or</FONT> the
    trustees under the indentures which govern senior secured notes
    could foreclose upon or sell the collateral or whether or to
    what extent holders of senior secured notes would be compensated
    for any delay in payment or loss of value of the collateral
    through the requirement of &#147;adequate protection.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Moreover, the collateral agents for the senior secured notes may
    need to evaluate the impact of the potential liabilities before
    determining to foreclose on collateral consisting of real
    property, if any, because secured creditors that hold a security
    interest in real property may be held liable under environmental
    laws for the costs of remediating or preventing the release or
    threatened releases of hazardous substances at such real
    property. Consequently, the collateral agents for the senior
    secured notes may decline to foreclose on such collateral or
    exercise remedies available in respect thereof if they do not
    receive indemnification to their satisfaction from the holders
    of the senior secured notes.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Certain
    series of senior secured notes were issued with original issue
    discount for U.S. federal income tax purposes.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The
    9<FONT style="vertical-align: text-top; font-size: 70%;">5</FONT>/<FONT style="font-size: 70%;">8</FONT>%/10<FONT style="vertical-align: text-top; font-size: 70%;">3</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;senior
    secured toggle notes due 2016, the
    9<FONT style="vertical-align: text-top; font-size: 70%;">7</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;senior
    secured notes due 2017 and the
    8<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">2</FONT>%&#160;senior
    secured notes due 2019 (collectively, the &#147;OID Notes&#148;)
    were issued with original issue discount (&#147;OID&#148;) for
    U.S.&#160;federal income tax purposes. Thus, in addition to
    stated interest on the OID Notes, U.S.&#160;holders (as defined
    in &#147;Certain U.S.&#160;Federal Tax Consequences&#148;) will
    be required to include amounts representing the OID in gross
    income on a constant yield to maturity basis in advance of the
    receipt of cash payment thereof, regardless of a
    U.S.&#160;holder&#146;s method of accounting for
    U.S.&#160;federal income tax purposes. With respect to the
    9<FONT style="vertical-align: text-top; font-size: 70%;">5</FONT>/<FONT style="font-size: 70%;">8</FONT>%/10<FONT style="vertical-align: text-top; font-size: 70%;">3</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;senior
    secured toggle notes due 2016, U.S.&#160;holders will be
    required to include such OID in gross income even if we do not
    pay cash interest. For more information about the
    U.S.&#160;federal income tax consequences of owning the OID
    Notes, see &#147;Certain U.S.&#160;Federal Tax
    Consequences.&#148;
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">If a
    bankruptcy petition were filed by or against us, holders of the
    OID Notes may receive a lesser amount for their claim than they
    would have been entitled to receive under the indenture
    governing such notes.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If a bankruptcy petition were filed by or against us under the
    U.S.&#160;Bankruptcy Code after the issuance of the OID Notes,
    the claim by any holder of the notes for the principal amount of
    the notes may be limited to an amount equal to the sum of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the original issue price for such notes;&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    that portion of the original issue discount that does not
    constitute &#147;unmatured interest&#148; for purposes of the
    U.S.&#160;Bankruptcy Code.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any original issue discount that was not amortized as of the
    date of the bankruptcy filing would constitute unmatured
    interest. Accordingly, holders of the OID Notes under these
    circumstances may receive a lesser amount than they would be
    entitled to receive under the terms of the indenture governing
    such notes, even if sufficient funds are available.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    15
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Risks
    Related to the Second Lien Senior Secured Notes</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Other
    secured indebtedness, including our senior secured credit
    facilities and first lien notes, is effectively senior to the
    second lien notes to the extent of the value of the collateral
    securing such indebtedness on a higher priority
    basis.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Our cash flow credit facility and our first lien notes are
    collateralized by a first-priority lien, subject to permitted
    liens, in, among other things, the capital stock of any wholly
    owned first-tier subsidiary of our company or of any
    U.S.&#160;subsidiary guarantor and substantially all of our and
    the U.S.&#160;subsidiary guarantors&#146; other tangible and
    intangible assets, subject to exceptions. In addition, our
    asset-based revolving credit facility has a first-priority lien
    in the accounts receivable of our company and certain of our
    subsidiaries, and our first lien notes and our cash flow credit
    facility, other than the European term loan facility, have a
    second-priority lien in those receivables (except for those of
    certain special purpose subsidiaries that only guarantee and
    pledge their assets under our asset-based revolving credit
    facility). Our senior secured credit facilities and the
    indentures governing our senior secured notes also permit us to
    incur additional indebtedness secured on a first-priority basis
    by such assets in the future. The first- and second-priority
    liens in the collateral securing indebtedness under our senior
    secured credit facilities and our first lien notes, as the case
    may be, and any such future indebtedness is higher in priority
    as to such collateral than the security interests securing the
    second lien notes and the guarantees of such notes. The second
    lien notes and the related guarantees are secured, subject to
    permitted liens, by a second-priority lien or a third-priority
    lien, as the case may be, in the assets that secure our cash
    flow credit facility and first lien notes on a first-priority or
    second-priority basis, as the case may be. Holders of the
    indebtedness under our senior secured credit facilities, the
    first lien notes and any other indebtedness collateralized by a
    higher-priority lien in such collateral will be entitled to
    receive proceeds from the realization of value of such
    collateral to repay such indebtedness in full before the holders
    of the second lien notes will be entitled to any recovery from
    such collateral. As a result, holders of the second lien notes
    will only be entitled to receive proceeds from the realization
    of value of assets securing our senior secured credit facilities
    and first lien notes on a higher-priority basis after all
    indebtedness and other obligations under our senior secured
    credit facilities, first lien notes and any other obligations
    secured by higher-priority liens on such assets are repaid in
    full. The second lien notes are effectively junior in right of
    payment to indebtedness under our senior secured credit
    facilities, the first lien notes and any other indebtedness
    collateralized by a higher-priority lien in our assets, to the
    extent of the realizable value of such collateral. In addition,
    the indentures governing the second lien notes permit us to
    incur additional indebtedness secured by a lien that ranks
    equally with the second lien notes. Any such indebtedness may
    further limit the recovery from the realization of the value of
    such collateral available to satisfy holders of the second lien
    notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    As of March&#160;31, 2009, on an as adjusted basis after giving
    effect to our offering of $1.500&#160;billion aggregate
    principal amount of first lien notes in April 2009 and the use
    of proceeds therefrom, we had outstanding an aggregate principal
    amount of $13.855&#160;billion of senior secured indebtedness
    secured by liens ranking senior to those securing the second
    lien notes. This indebtedness includes that outstanding under
    our senior secured credit facilities, including letters of
    credit, the first lien notes, capital leases and other debt
    secured on a first priority basis. We also had an additional
    $2.198&#160;billion available for borrowing under our senior
    secured revolving credit facilities after giving effect to
    certain outstanding letters of credit.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">The
    lien ranking provisions of the indentures and other agreements
    relating to the collateral securing the second lien notes limit
    the rights of holders of such notes with respect to that
    collateral, even during an event of default.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The rights of the holders of the second lien notes with respect
    to the collateral that secures the notes on a second-priority or
    third-priority basis, as the case may be, are substantially
    limited by the terms of the lien ranking agreements set forth in
    the indentures and the intercreditor agreements, even during an
    event of default. Under the indentures and the intercreditor
    agreements, at any time that obligations that have the benefit
    of the higher-priority liens are outstanding, any actions that
    may be taken with respect to such collateral, including the
    ability to cause the commencement of enforcement proceedings
    against such collateral and to control the conduct of such
    proceedings, and the approval of amendments to, releases of such
    collateral from the lien of, and waivers of past defaults under,
    such documents relating to such collateral, will be at the
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    16
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    direction of the holders of the obligations secured by the
    first-priority and second-priority liens, as applicable, and the
    holders of the notes secured by lower-priority liens may be
    adversely affected.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, the indentures and the intercreditor agreements
    contain certain provisions benefiting holders of indebtedness
    under our senior secured credit facilities, including provisions
    requiring the second lien trustees and the second lien
    collateral agent not to object following the filing of a
    bankruptcy petition to a number of important matters regarding
    the collateral. After such filing, the value of this collateral
    could materially deteriorate, and holders of the second lien
    notes would be unable to raise an objection. In addition, the
    right of holders of obligations secured by first-priority and
    second-priority liens, as applicable, to foreclose upon and sell
    such collateral upon the occurrence of an event of default also
    would be subject to limitations under applicable bankruptcy laws
    if we or any of our subsidiaries become subject to a bankruptcy
    proceeding.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The collateral that secures the second lien notes and guarantees
    on a lower-priority basis will also be subject to any and all
    exceptions, defects, encumbrances, liens and other imperfections
    as may be accepted by the lenders under our senior secured
    credit facilities, the holders of our first lien notes and other
    creditors that have the benefit of higher-priority liens on such
    collateral from time to time, whether on or after the date the
    second lien notes and guarantees are issued. The existence of
    any such exceptions, defects, encumbrances, liens and other
    imperfections could adversely affect the value of the collateral
    securing the second lien notes as well as the ability of the
    second lien collateral agent to realize or foreclose on such
    collateral.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">The
    lenders under our senior secured credit facilities will have the
    discretion to release the guarantors under the instruments
    governing that indebtedness in a variety of circumstances, which
    will cause those guarantors to be released from their guarantees
    of the second lien notes.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    While any obligations under our senior secured credit facilities
    remain outstanding, any guarantee of the second lien notes may
    be released without action by, or consent of, any holder of the
    second lien notes or the trustees under the indentures governing
    the second lien notes, at the discretion of lenders under our
    senior secured credit facilities, if the related guarantor is no
    longer a guarantor of obligations under that indebtedness or any
    other indebtedness. See &#147;Description of Notes.&#148; The
    lenders under our senior secured credit facilities will have the
    discretion to release the guarantees under the senior secured
    credit facilities in a variety of circumstances. You will not
    have a claim as a creditor against any subsidiary that is no
    longer a guarantor of the second lien notes, and the
    indebtedness and other liabilities, including trade payables,
    whether secured or unsecured, of those subsidiaries will
    effectively be senior to claims of holders of such notes.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Risks
    Related to the First Lien Senior Secured Notes</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">The
    secured indebtedness under our senior secured asset-based
    revolving credit facility is effectively senior to the first
    lien notes to the extent of the value of the receivables
    collateral securing such facility on a first-priority
    basis.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Our asset-based revolving credit facility has a first-priority
    lien in the accounts receivable of our company and our domestic
    subsidiaries, with certain exceptions. Our other senior secured
    credit facilities have, and our first lien notes have, a
    second-priority lien in those receivables (except for those of
    certain special purpose subsidiaries that only guarantee and
    pledge their assets under our asset-based revolving credit
    facility). The indentures governing both the second lien notes
    and the first lien notes permit us to incur additional
    indebtedness secured on a first-priority basis by such assets in
    the future. The first-priority liens in the collateral securing
    indebtedness under our asset-based revolving credit facility and
    any such future indebtedness is higher in priority as to such
    collateral than the security interests securing the first lien
    notes and the guarantees. Holders of the indebtedness under our
    asset-based revolving credit facility and any other indebtedness
    secured by higher priority liens on such collateral will be
    entitled to receive proceeds from the realization of value of
    such collateral to repay such indebtedness in full before the
    holders of the first lien notes will be entitled to any recovery
    from such collateral. As a result, holders of the first lien
    notes will only be entitled to receive proceeds from the
    realization of value of assets securing our asset-based
    revolving credit facility on a higher priority basis after all
    indebtedness and other obligations under our asset-based
    revolving credit facility and any other obligations secured by
    higher priority liens on such assets are repaid in full. The
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    17
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    first lien notes are effectively junior in right of payment to
    indebtedness under our asset-based revolving credit facility and
    any other indebtedness secured by higher priority liens on such
    collateral to the extent of the realizable value of such
    collateral. Even if there were receivables collateral or
    proceeds left over to pay the first lien notes and the cash flow
    credit facility after a foreclosure on that collateral and
    payment of the outstanding amounts under the asset-based
    revolving credit facility, that collateral would be subject to
    the first lien intercreditor agreement, and the representative
    of the lenders under the cash flow credit facility would
    initially control actions with respect to that collateral. See
    &#147;&#151;&#160;Even though the holders of the first lien
    notes have the benefit of a first-priority lien on the
    collateral that secures our cash flow credit facility, the
    representative of the lenders under the cash flow credit
    facility will initially control actions with respect to that
    collateral.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    As of March&#160;31, 2009, the first lien notes would have been
    effectively junior to $1.715&#160;billion of indebtedness
    outstanding under our asset-based revolving credit facility to
    the extent of the value of collateral securing such indebtedness.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">The
    lien ranking provisions of the indenture and other agreements
    relating to the collateral securing the first lien notes limit
    the rights of holders of the first lien notes with respect to
    that collateral, even during an event of default.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The rights of the holders of the first lien notes with respect
    to the receivables collateral that secures the asset-based
    revolving credit facility on a first-priority basis and that
    secures our cash flow credit facility and the first lien notes
    on a second-priority basis are substantially limited by the
    terms of the lien ranking agreements set forth in the indenture
    governing the first lien notes and the applicable receivables
    intercreditor agreement, even during an event of default. Under
    the indenture governing the first lien notes and the applicable
    receivables intercreditor agreement, at any time that
    obligations that have the benefit of the higher priority liens
    are outstanding, any actions that may be taken with respect to
    such collateral, including the ability to cause the commencement
    of enforcement proceedings against such collateral, to control
    the conduct of such proceedings and to approve amendments to
    releases of such collateral from the lien of, and waive past
    defaults under, such documents relating to such collateral, will
    be at the direction of the holders of the obligations secured by
    the first-priority liens, and the holders of the first lien
    notes secured by lower-priority liens may be adversely affected.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, the indenture governing the first lien notes and
    the applicable receivables intercreditor agreement contain
    certain provisions benefiting holders of indebtedness under our
    asset-based revolving credit facility, including provisions
    requiring the trustee and the collateral agent for the first
    lien notes not to object following the filing of a bankruptcy
    petition to certain important matters regarding the receivables
    collateral. After such filing, the value of this collateral
    could materially deteriorate, and holders of the first lien
    notes would be unable to raise an objection.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The receivables collateral that secures the first lien notes and
    guarantees on a lower-priority basis will also be subject to any
    and all exceptions, defects, encumbrances, liens and other
    imperfections as may be accepted by the lenders under our
    asset-based revolving credit facility, whether on or after the
    date the first lien notes and guarantees were issued. The
    existence of any such exceptions, defects, encumbrances, liens
    and other imperfections could adversely affect the value of the
    collateral securing the first lien notes, as well as the ability
    of the collateral agent to realize or foreclose on such
    collateral.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Even
    though the holders of the first lien notes have the benefit of a
    first-priority lien on the collateral that secures our cash flow
    credit facility, the representative of the lenders under the
    cash flow credit facility will initially control actions with
    respect to that collateral.</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The rights of the holders of the first lien notes with respect
    to the collateral that secures such notes on a first-priority
    basis are subject to a first lien intercreditor agreement among
    all holders of obligations secured by that collateral on a
    first-priority basis, including the obligations under our cash
    flow credit facility. Under that intercreditor agreement, any
    actions that may be taken with respect to such collateral,
    including the ability to cause the commencement of enforcement
    proceedings against such collateral, to control such proceedings
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    18
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    and to approve amendments to releases of such collateral from
    the lien of, and waive past defaults under, such documents
    relating to such collateral, will be at the direction of the
    authorized representative of the lenders under the cash flow
    credit facility until (1)&#160;our obligations under the cash
    flow credit facility are discharged (which discharge does not
    include certain refinancings of the cash flow credit facility)
    or (2)&#160;90&#160;days after the occurrence of an event of
    default under the indenture governing the first lien notes, if
    the authorized representative of the holders of the first lien
    notes represents the largest outstanding principal amount of
    indebtedness secured by a first-priority lien on the collateral
    (other than the cash flow credit facility) and has complied with
    the applicable notice provisions.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    However, even if the authorized representative of the first lien
    notes gains the right to direct the collateral agent in the
    circumstances described in clause&#160;(2) above, the authorized
    representative must stop doing so (and those powers with respect
    to the collateral would revert to the authorized representative
    of the lenders under the cash flow credit facility) if the
    lenders&#146; authorized representative has commenced and is
    diligently pursuing enforcement action with respect to the
    collateral or the grantor of the security interest in that
    collateral (whether our company or the applicable subsidiary
    guarantor) is then a debtor under or with respect to (or
    otherwise subject to) an insolvency or liquidation proceeding.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, the senior secured credit facilities and the
    indenture governing the first lien notes permit us to issue
    additional series of notes that also have a first-priority lien
    on the same collateral. At any time that the representative of
    the lenders under the cash flow credit facility does not have
    the right to take actions with respect to the collateral
    pursuant to the first lien intercreditor agreement, that right
    passes to the authorized representative of the holders of the
    next largest outstanding principal amount of indebtedness
    secured by a first-priority lien on the collateral. If we issue
    additional first lien notes in the future in a greater principal
    amount than the existing first lien notes, then the authorized
    representative for those additional notes would be next in line
    to exercise rights under the first lien intercreditor agreement,
    rather than the authorized representative for the existing first
    lien notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under the first lien intercreditor agreement, the authorized
    representative of the holders of the first lien notes may not
    object following the filing of a bankruptcy petition to any
    <FONT style="white-space: nowrap">debtor-in-possession</FONT>
    financing or to the use of the shared collateral to secure that
    financing, subject to conditions and limited exceptions. After
    such a filing, the value of this collateral could materially
    deteriorate, and holders of the first lien notes would be unable
    to raise an objection.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The collateral that secures the first lien notes and guarantees
    on a first-priority basis will also be subject to any and all
    exceptions, defects, encumbrances, liens and other imperfections
    as may be accepted by the authorized representative of the
    lenders under our cash flow credit facility during any period
    that such authorized representative controls actions with
    respect to the collateral pursuant to the first lien
    intercreditor agreement. The existence of any such exceptions,
    defects, encumbrances, liens and other imperfections could
    adversely affect the value of the collateral securing the first
    lien notes as well as the ability of the collateral agent to
    realize or foreclose on such collateral for the benefit of the
    holders of the first lien notes.
</DIV>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">FORWARD-LOOKING
    STATEMENTS</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    This prospectus and the documents incorporated herein by
    reference contain &#147;forward-looking statements&#148; within
    the meaning of the federal securities laws, which involve risks
    and uncertainties. Forward-looking statements include all
    statements that do not relate solely to historical or current
    facts, and you can identify forward-looking statements because
    they contain words such as &#147;believes,&#148;
    &#147;expects,&#148; &#147;may,&#148; &#147;will,&#148;
    &#147;should,&#148; &#147;seeks,&#148;
    &#147;approximately,&#148; &#147;intends,&#148;
    &#147;plans,&#148; &#147;estimates,&#148; &#147;projects,&#148;
    &#147;continue,&#148; &#147;initiative&#148; or
    &#147;anticipates&#148; or similar expressions that concern our
    prospects, objectives, strategies, plans or intentions. All
    statements made relating to our estimated and projected
    earnings, margins, costs, expenditures, cash flows, growth rates
    and financial results or to the impact of existing or proposed
    laws or regulations described, or incorporated by reference, in
    this prospectus are forward-looking statements. These
    forward-looking statements are subject to risks and
    uncertainties that may change at any time, and, therefore, our
    actual results may differ materially from those expected. We
    derive many of our forward-looking statements from our operating
    budgets and forecasts, which are based upon many detailed
    assumptions. While we believe that our assumptions are
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    19
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    reasonable, it is very difficult to predict the impact of known
    factors, and, of course, it is impossible to anticipate all
    factors that could affect our actual results.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Some of the important factors that could cause actual results to
    differ materially from our expectations are disclosed under
    &#147;Risk Factors&#148; and elsewhere in this prospectus as
    well as in our 2008
    <FONT style="white-space: nowrap">10-K</FONT> and
    2009 First Quarter
    <FONT style="white-space: nowrap">10-Q</FONT>
    incorporated herein by reference. All subsequent written and
    oral forward-looking statements attributable to us, or persons
    acting on our behalf, are expressly qualified in their entirety
    by these cautionary statements.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We do not undertake any obligation to publicly update or revise
    any forward-looking statement as a result of new information,
    future events or otherwise, except as otherwise required by law.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    20
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->
<A name='104'>
<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">USE OF
    PROCEEDS</FONT></B>
</DIV>
</A>
<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    This prospectus is delivered in connection with the sale of
    notes by Banc of America Securities LLC, Merrill Lynch, Pierce,
    Fenner&#160;&#038; Smith Incorporated and their affiliates in
    market-making transactions. We will not receive any of the
    proceeds from such transactions.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    21
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->
<A name='105'>
<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">DESCRIPTION
    OF OTHER INDEBTEDNESS</FONT></B>
</DIV>
</A>
<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Senior
    Secured Credit Facilities</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On November&#160;17, 2006 in connection with our
    recapitalization, we entered into the senior secured credit
    facilities with Banc of America Securities LLC, J.P.&#160;Morgan
    Securities Inc., Citigroup Global Markets Inc. and Merrill
    Lynch, Pierce, Fenner&#160;&#038; Smith Incorporated, as joint
    lead arrangers and bookrunners, Bank of America, N.A., as
    administrative agent, JPMorgan Chase Bank, N.A. and Citicorp
    North America, Inc., as co-syndication agents and Merrill Lynch
    Capital Corporation, as documentation agent.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The senior secured credit facilities provide senior secured
    financing of $16.800&#160;billion, consisting of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $12.800&#160;billion-equivalent in term loan facilities,
    comprised of a $2.750&#160;billion senior secured term loan A
    facility with a term of six years, a $8.800&#160;billion senior
    secured term loan B facility with a term of seven years and a
    &#128;1.000&#160;billion ($1.250&#160;billion) senior secured
    European term loan facility with a term of seven years;&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $4.000&#160;billion in revolving credit facilities, comprised of
    a $2.000&#160;billion senior secured asset-based revolving
    credit facility available in dollars with a term of six years
    and a $2.000&#160;billion senior secured revolving credit
    facility available in dollars, euros and pounds sterling with a
    term of six years. Availability under the asset-based revolving
    credit facility is subject to a borrowing base of 85% of
    eligible accounts receivable less customary reserves.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We refer to these senior secured credit facilities, excluding
    the asset-based revolving credit facility, as the &#147;cash
    flow credit facility&#148; and, collectively with the
    asset-based revolving credit facility, the &#147;senior secured
    credit facilities.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    HCA Inc. is the primary borrower under the senior secured credit
    facilities, except that a U.K. subsidiary is the borrower under
    the European term loan facility. The revolving credit facilities
    include capacity available for the issuance of letters of credit
    and for borrowings on
    <FONT style="white-space: nowrap">same-day</FONT>
    notice, referred to as the swingline loans. A portion of the
    letter of credit availability under the cash-flow revolving
    credit facility is available in euros, dollars and pounds
    sterling. Lenders under the cash flow credit facility are
    subject to a loss sharing agreement pursuant to which, upon the
    occurrence of certain events, including a bankruptcy event of
    default under the cash flow credit facility, each such lender
    will automatically be deemed to have exchanged its interest in a
    particular tranche of the cash flow credit facility for a pro
    rata percentage in all of the tranches of the cash flow credit
    facility.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The asset-based revolving credit facility is documented in a
    separate loan agreement from the other senior secured credit
    facilities.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On February&#160;16, 2007, we amended our cash flow credit
    facility to reduce the applicable margins with respect to the
    term borrowings thereunder. On June&#160;20, 2007, we amended
    our asset-based revolving credit facility to reduce the
    applicable margin with respect to borrowings thereunder.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On March&#160;2, 2009, we amended our cash flow credit facility
    to allow for one or more future issuances of additional secured
    notes, which may include notes that are secured on a pari passu
    basis or on a junior basis with the obligations under the cash
    flow credit facility, so long as (1)&#160;such notes do not
    require, subject to certain exceptions, scheduled repayments,
    payment of principal or redemption prior to the scheduled term
    loan B maturity date as currently in effect, (2)&#160;the terms
    of such notes, taken as a whole, are not more restrictive than
    those in the cash flow credit facility and (3)&#160;the proceeds
    from any such issuance are used within three business days of
    receipt to permanently prepay term loans under the cash flow
    credit facility in accordance with the terms of the cash flow
    credit facility. The U.S.&#160;security documents related to the
    cash flow credit facility were also amended and restated or, in
    the case of the U.S.&#160;mortgages, will be amended and
    restated, in connection with the amendment in order to give
    effect to the security interests to be granted to holders of
    such additional secured notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On March&#160;2, 2009, we also amended our asset-based revolving
    credit facility to allow for one or more future issuances of
    additional secured notes or loans, which may include notes or
    loans that are secured on a
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    22
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    pari passu basis or on a junior basis with the obligations under
    the cash flow credit facility, so long as (1)&#160;such notes or
    loans do not require, subject to certain exceptions, scheduled
    repayments, payment of principal or redemption prior to the
    scheduled term loan B final maturity date as currently in
    effect, (2)&#160;the terms of such notes or loans, as
    applicable, taken as a whole, are not more restrictive than
    those in the cash flow credit facility and (3)&#160;the proceeds
    from any such issuance are used within three business days of
    receipt to permanently prepay term loans under the cash flow
    credit facility in accordance with the terms of the cash flow
    credit facility. The amendment to the asset-based revolving
    credit facility also altered the excess facility availability
    requirement to include a separate minimum facility availability
    requirement applicable to the asset-based revolving credit
    facility and increased the applicable LIBOR and asset-based
    revolving margins for all borrowings under the asset-based
    revolving credit facility by 0.25% each.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    See also our 2008
    <FONT style="white-space: nowrap">10-K</FONT> under
    &#147;Item&#160;13. Certain Relationships and Related
    Transactions&#148; for a description of certain relationships
    between our company and Bank of America, N.A., the
    administrative agent under the cash flow credit facility and the
    asset-based revolving credit facility.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Interest
    Rate and Fees</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Borrowings under the senior secured credit facilities bear
    interest at a rate equal to, at our option, either
    (a)&#160;LIBOR for deposits in the applicable currency plus an
    applicable margin or (b)&#160;the higher of (1)&#160;the prime
    rate of Bank of America, N.A. and (2)&#160;the federal funds
    effective rate plus 0.50%, plus an applicable margin. The
    applicable margins currently in effect for borrowings are
    (w)&#160;under the asset-based revolving credit facility, 0.50%
    with respect to base rate borrowings and 1.50% with respect to
    LIBOR borrowings, (x)&#160;under the senior secured revolving
    credit facility and the term loan B facility, 1.25% with respect
    to base rate borrowings and 2.25% with respect to LIBOR
    borrowings, (y)&#160;under the term loan A facility, 1.00% with
    respect to base rate borrowings and 2.00% with respect to LIBOR
    borrowings and (z)&#160;under the European term loan facility,
    2.00% with respect to LIBOR borrowings. The applicable margins
    may be reduced or increased depending on our leverage ratios.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition to paying interest on outstanding principal under
    the senior secured credit facilities, we are required to pay a
    commitment fee to the lenders under the revolving credit
    facilities in respect of the unutilized commitments thereunder.
    The initial commitment fee rate is 0.50% per annum for the
    revolving credit facility and 0.375% for the asset-based
    revolving credit facility. Each of these commitment fee rates
    may be reduced subject to our reducing our leverage to specified
    ratios. We must also pay customary letter of credit fees.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Prepayments</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The cash flow credit facility requires us to prepay outstanding
    term loans, subject to certain exceptions, with:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    50% (which percentage will be reduced to 25% if our total
    leverage ratio is 5.50x or less and to 0% if our total leverage
    ratio is 5.00x or less) of our annual excess cash flow;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    100% of the net cash proceeds of all nonordinary course asset
    sales or other dispositions of property, other than the
    Receivables Collateral, as defined below, if we do not
    (1)&#160;reinvest or commit to reinvest those proceeds in assets
    to be used in our business or to make certain other permitted
    investments within 15&#160;months as long as, in the case of any
    such commitment to reinvest or make certain other permitted
    investments, such investment is completed within such
    <FONT style="white-space: nowrap">15-month</FONT>
    period or, if later, within 180&#160;days after such commitment
    is made or (2)&#160;apply such proceeds within 15&#160;months to
    repay debt of HCA Inc. that was outstanding on the effective
    date of the Merger scheduled to mature prior to the earliest
    final maturity of the senior secured credit facilities then
    outstanding;&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    100% of the net cash proceeds of any incurrence of debt, other
    than proceeds from the receivables facilities and other debt
    permitted under the senior secured credit facilities.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The foregoing mandatory prepayments are applied among the term
    loan facilities (1)&#160;during the first three years after the
    effective date of the Merger, pro rata to such facilities based
    on the respective aggregate
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    23
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    amounts of unpaid principal installments thereof due during such
    period, with amounts allocated to each facility being applied to
    the remaining installments thereof in direct order of maturity
    and (2)&#160;thereafter, pro rata to such facilities, with
    amounts allocated to each facility being applied, in the case of
    the term loan A facility, pro rata to the remaining installments
    thereof and, in the case of the term loan B facility or the
    European term loan facility, to the next eight unpaid scheduled
    installments of principal of such facility and then pro rata to
    the remaining amortization payments under such facility.
    Notwithstanding the foregoing, (i)&#160;proceeds of asset sales
    by foreign subsidiaries are applied solely to prepay European
    term loans until such term loans have been repaid in full and
    (ii)&#160;we are not required to prepay loans under the term
    loan A facility or the term loan B facility with net cash
    proceeds of asset sales or with excess cash flow, in each case
    attributable to foreign subsidiaries, to the extent that the
    repatriation of such amounts is prohibited or delayed by
    applicable local law or would result in material adverse tax
    consequences.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The asset-based revolving credit facility requires us to prepay
    outstanding loans if borrowings exceed the borrowing base.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We may voluntarily repay outstanding loans under the senior
    secured credit facilities at any time without premium or
    penalty, other than customary &#147;breakage&#148; costs with
    respect to LIBOR loans.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Amortization</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We are required to repay the loans under the term loan
    facilities as follows:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the term loan A facility amortizes in quarterly installments
    such that the aggregate amount of the original funded principal
    amount of such facility repaid pursuant to such amortization
    payments in each year, commencing with the year ending
    December&#160;31, 2007, is equal to $112.5&#160;million in years
    1 and 2, $225&#160;million in years 3 and 4, $450&#160;million
    in year 5 and $1.625&#160;billion in year 6;&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    each of the term loan B facility and the European term loan
    facility amortizes in equal quarterly installments that
    commenced on March&#160;31, 2007 in aggregate annual amounts
    equal to 1% of the original funded principal amount of such
    facility, with the balance being payable on the final maturity
    date of such term loans.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Principal amounts outstanding under the revolving credit
    facilities are due and payable in full at maturity, six years
    from the date of the closing of the senior secured credit
    facilities.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Guarantee
    and Security</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    All obligations under the senior secured credit facilities are
    unconditionally guaranteed by substantially all existing and
    future, direct and indirect, wholly-owned material domestic
    subsidiaries that are &#147;Unrestricted Subsidiaries&#148;
    under the 1993 Indenture (except for certain special purpose
    subsidiaries that only guarantee and pledge their assets under
    the asset-based revolving credit facility), and the obligations
    under the European term loan facility are also unconditionally
    guaranteed by HCA Inc. and each of our existing and future
    wholly owned material subsidiaries formed under the laws of
    England and Wales, subject, in each of the foregoing cases, to
    any applicable legal, regulatory or contractual constraints and
    to the requirement that such guarantee does not cause adverse
    tax consequences.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    All obligations under the asset-based revolving credit facility,
    and the guarantees of those obligations, are secured, subject to
    permitted liens and other exceptions, by a first-priority lien
    on substantially all of the receivables of the borrowers and
    each guarantor under such asset-based revolving credit facility
    (the &#147;Receivables Collateral&#148;).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    All obligations under the cash flow credit facility and the
    guarantees of such obligations, are secured, subject to
    permitted liens and other exceptions, by:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a first-priority lien on the capital stock owned by HCA Inc. or
    by any U.S.&#160;guarantor in each of their respective
    first-tier subsidiaries (limited, in the case of foreign
    subsidiaries, to 65% of the voting stock of such subsidiaries);
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    24
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a first-priority lien on substantially all present and future
    assets of HCA Inc. and of each U.S.&#160;guarantor other than
    (i)&#160;&#147;Principal Properties&#148; (as defined in the
    1993 Indenture), except for certain &#147;Principal
    Properties&#148; the aggregate amount of indebtedness secured
    thereby in respect of the cash flow credit facility and the
    notes offered hereby and any future First Lien Obligations,
    taken as a whole, do not exceed 10% of &#147;Consolidated Net
    Tangible Assets&#148; (as defined under the 1993 Indenture),
    (ii)&#160;certain other real properties and (iii)&#160;deposit
    accounts, other bank or securities accounts, cash, leaseholds,
    motor-vehicles and certain other exceptions (such collateral
    under this and the preceding bullet, the &#147;Non-Receivables
    Collateral&#148;);&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a second-priority lien on certain of the Receivables Collateral
    (such portion of the Receivables Collateral, the &#147;Shared
    Receivables Collateral&#148;; the Receivables Collateral that
    does not secure such cash flow credit facility on a
    second-priority basis is referred to as the &#147;Separate
    Receivables Collateral&#148;).
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The obligations of the borrowers and the guarantors under the
    European term loan facility are also secured by substantially
    all present and future assets of the European subsidiary
    borrower and each European guarantor (the &#147;European
    Collateral&#148;), subject to permitted liens and other
    exceptions (including, without limitation, exceptions for
    deposit accounts, other bank or securities accounts, cash,
    leaseholds, motor-vehicles and certain other exceptions) and
    subject to such security interests otherwise being permitted by
    applicable law and contract and not resulting in adverse tax
    consequences. The notes offered hereby will not be secured by
    any of the European Collateral.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Certain
    Covenants and Events of Default</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The senior secured credit facilities contain a number of
    covenants that, among other things, restrict, subject to certain
    exceptions, our ability to:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    incur additional indebtedness;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    create liens;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    enter into sale and leaseback transactions;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    engage in mergers or consolidations;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    sell or transfer assets;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    pay dividends and distributions or repurchase our capital stock;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    make investments, loans or advances;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    prepay certain subordinated indebtedness (including the notes
    and certain other indebtedness existing on the effective date of
    the Merger (&#147;Retained Indebtedness&#148;)), subject to
    exceptions for repayments of Retained Indebtedness maturing
    prior to the senior secured credit facilities and, in certain
    cases, to satisfaction of a maximum first-lien leverage
    condition;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    make certain acquisitions;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    engage in certain transactions with affiliates;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    amend material agreements governing certain subordinated
    indebtedness (including the senior secured second-lien notes
    offered hereby);&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    change our lines of business.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, the senior secured credit facilities require us to
    maintain the following financial covenants:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    in the case of the asset-based revolving credit facility, a
    minimum interest coverage ratio (applicable only when
    availability under such facility is less than 10% of the
    borrowing base thereunder);&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    in the case of the other senior secured credit facilities, a
    maximum total leverage ratio.
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    25
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The senior secured credit facilities also contain certain
    customary affirmative covenants and events of default, including
    a change of control.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Existing
    Indebtedness</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Existing
    Senior Notes, Debentures and Medium-Term Notes</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    As of March&#160;31, 2009, we had outstanding an aggregate
    principal amount of $6.296&#160;billion and
    &#163;122&#160;million of senior notes and debentures,
    consisting of the following series:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $3,488,000 aggregate principal amount of 5.50%&#160;Senior Notes
    due 2009;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $440,020,000 aggregate principal amount of 8.75%&#160;Senior
    Notes due 2010;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    &#163;122, 259,000 aggregate principal amount of
    8.75%&#160;Senior Notes due 2010;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $273,321,000 aggregate principal amount of 7.875%&#160;Senior
    Notes due 2011;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $402,499,000 aggregate principal amount of 6.95%&#160;Senior
    Notes due 2012;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $500,000,000 aggregate principal amount of 6.30%&#160;Senior
    Notes due 2012;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $500,000,000 aggregate principal amount of 6.25%&#160;Senior
    Notes due 2013;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $500,000,000 aggregate principal amount of 6.75%&#160;Senior
    Notes due 2013;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $500,000,000 aggregate principal amount of 5.75%&#160;Senior
    Notes due 2014;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $750,000,000 aggregate principal amount of 6.375%&#160;Senior
    Notes due 2015;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $1,000,000,000 aggregate principal amount of 6.50%&#160;Senior
    Notes due 2016;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $291,436,000 aggregate principal amount of 7.69%&#160;Notes due
    2025;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $250,000,000 aggregate principal amount of 7.50%&#160;Senior
    Notes due 2033;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $150,000,000 aggregate principal amount of 7.19%&#160;Debentures
    due 2015;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $135,645,000 aggregate principal amount of 7.50%&#160;Debentures
    due 2023;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $150,000,000 aggregate principal amount of 8.36%&#160;Debentures
    due 2024;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $150,000,000 aggregate principal amount of 7.05%&#160;Debentures
    due 2027;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $100,000,000 aggregate principal amount of 7.75%&#160;Debentures
    due 2036;&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $200,000,000 aggregate principal amount of 7.50%&#160;Debentures
    due 2095.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    As of March&#160;31, 2009, we also had outstanding $121,180,000
    aggregate principal amount of our 8.70% Medium-Term Notes due
    2010; $121,110,000 aggregate principal amount of our 9.00%
    Medium-Term Notes due 2014; and $125,000,000 aggregate principal
    amount of our 7.58% Medium-Term Notes due 2025.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    All of our outstanding series of senior notes, debentures and
    medium-term notes were issued under the 1993 Indenture. The
    terms of the 1993 Indenture governing the existing senior notes,
    debentures and medium-term notes provide that in addition to
    customary events of default and a customary covenant limiting
    mergers and consolidations of HCA, the aggregate amount of all
    other indebtedness of HCA secured by mortgages on
    &#147;Principal Properties&#148; (as such term is defined in the
    indenture) together with the aggregate principal amount of all
    indebtedness of restricted subsidiaries (as such term is defined
    in the indenture) and the attributable debt in respect of
    sale-leasebacks of Principal Properties, may not exceed 15% of
    the consolidated net tangible assets of HCA and its consolidated
    subsidiaries, subject to exceptions for certain permitted
    mortgages and debt. See &#147;Description of Notes&#160;&#151;
    Senior Notes, Debentures and Medium-Term Notes Issued Under the
    1993 Indenture.&#148;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    26
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Existing
    Senior Secured Notes</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Also in connection with the Recapitalization, we issued
    $4.200&#160;billion of senior secured notes (comprised of
    $1.000&#160;billion of
    9<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;notes
    due 2014 and $3.200&#160;billion of
    9<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">4</FONT>%&#160;notes
    due 2016)&#160;and $1.500&#160;billion of
    9<FONT style="vertical-align: text-top; font-size: 70%;">5</FONT>/<FONT style="font-size: 70%;">8</FONT>/10<FONT style="vertical-align: text-top; font-size: 70%;">3</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;senior
    secured toggle notes (which allow us, at our option, to pay
    interest in kind during the first five years at the higher
    interest rate of
    10<FONT style="vertical-align: text-top; font-size: 70%;">3</FONT>/<FONT style="font-size: 70%;">8</FONT>%)
    due 2016. See &#147;Description of Notes&#160;&#151; Senior
    Secured Notes Issued Under the 2006 Indenture.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    As of March&#160;31, 2009, we had outstanding an aggregate
    principal amount of $5.700&#160;billion of senior secured notes
    consisting of the following series:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $1,000,000,000 aggregate principal amount of
    9<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;Senior
    Secured Notes due 2014;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $3,200,000,000 aggregate principal amount of
    9<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">4</FONT>%&#160;Senior
    Secured Notes due 2016;&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    $1,500,000,000 aggregate principal amount of
    9<FONT style="vertical-align: text-top; font-size: 70%;">5</FONT>/<FONT style="font-size: 70%;">8</FONT>/10<FONT style="vertical-align: text-top; font-size: 70%;">3</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;Senior
    Secured Toggle Notes due 2016.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In November 2008, we elected to make an interest payment on the
    senior secured toggle notes for the interest period ending in
    May 2009 by paying in kind (&#147;PIK&#148;) at the PIK interest
    rate of
    10<FONT style="vertical-align: text-top; font-size: 70%;">3</FONT>/<FONT style="font-size: 70%;">8</FONT>%
    instead of paying interest in cash. On May&#160;15, 2009, the
    aggregate principal amount of the senior secured toggle notes
    increased by $77,813,000 as a result of the PIK interest payment.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On February&#160;19, 2009, we issued $310&#160;million aggregate
    principal amount of
    9<FONT style="vertical-align: text-top; font-size: 70%;">7</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;senior
    secured notes due 2017 at a price of 96.673% of their face
    value, resulting in approximately $300&#160;million of gross
    proceeds. These notes and the related guarantees are secured by
    second-priority liens, subject to permitted liens, on our and
    our subsidiary guarantors&#146; assets, subject to certain
    exceptions, that secure our cash flow credit facility on a
    first-priority basis and are secured by third-priority liens,
    subject to permitted liens, on our and our subsidiary
    guarantors&#146; assets that secure our asset-based revolving
    credit facility on a first priority basis and our other cash
    flow credit facility on a second-priority basis. See
    &#147;Description of Notes&#160;&#151; Senior Secured Notes
    Issued Under the 2009 Second Lien Indenture.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On April&#160;22, 2009 we issued $1.500&#160;billion aggregate
    principal amount of
    8<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">2</FONT>%&#160;senior
    secured notes due 2019 at a price of 96.755% of their face
    value, resulting in approximately $1.451&#160;billion of gross
    proceeds. These notes and the related guarantees are secured by
    first-priority liens, subject to permitted liens, on our and our
    subsidiary guarantors&#146; assets, subject to certain
    exceptions, that secure our cash flow credit facility on a
    first-priority basis and are secured by second priority liens,
    subject to permitted liens, on our and our subsidiary
    guarantors&#146; assets that secure our asset-based revolving
    credit facility on a first priority basis and our other cash
    flow credit facility on a second-priority basis. See
    &#147;Description of Notes&#160;&#151; Senior Secured Notes
    Issued Under the 2009 First Lien Indenture.&#148;
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Other
    Existing Secured Indebtedness</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We had outstanding approximately $385&#160;million of capital
    leases and other secured debt as of March&#160;31, 2009.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under our lease with HRT of Roanoke, Inc., effective
    December&#160;20, 2005, we make annual payments for rent and
    additional expenses for the use of premises in Roanoke and
    Salem, Virginia. The rent payments will increase each year
    beginning January&#160;1, 2007 by the lesser of 3% or the change
    in the Consumer Price Index. The lease is for a fixed-term of
    12&#160;years with the option to extend the lease for another
    ten years.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under our lease with Medical City Dallas Limited, effective
    March&#160;18, 2004, we make annual payments for rent for the
    use of premises that are a part of a complex known as
    &#147;Medical City Dallas&#148; located in Dallas, Texas. The
    rent payment is adjusted yearly based on the fair market value
    of the premises and a capitalization rate. The initial term is
    240&#160;months with the option to extend for two more terms of
    240&#160;months each.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    27
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->
<A name='106'>
<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">DESCRIPTION
    OF NOTES</FONT></B>
</DIV>
</A>
<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We have issued senior debt securities, debentures and
    medium-term notes, each as described below under
    &#147;&#151;&#160;Senior Notes, Debentures and Medium-Term Notes
    Issued Under the 1993 Indenture&#148; and senior secured notes
    as described under &#147;&#151;&#160;Senior Secured Notes Issued
    Under the 2006 Indenture,&#148; &#147;&#151;&#160;Senior Secured
    Notes Issued Under the 2009 Second Lien Indenture&#148; and
    &#147;&#151;&#160;Senior Secured Notes Issued Under the 2009
    First Lien Indenture.&#148; The terms used in each respective
    section apply only to that section, and the summaries contained
    therein are qualified in their entirety by the actual text of
    the applicable agreements and indentures, each of which are
    filed as an exhibit to the registration statement, of which this
    prospectus is a part or which may be requested by contacting us
    at the address set forth under &#147;Where You Can Find More
    Information about HCA Inc.&#148;
</DIV>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Senior
    Notes, Debentures and Medium-Term Notes Issued Under the 1993
    Indenture</FONT></B>
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">General</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The below description of the debt securities begins with a
    summary of certain of the terms of the Indenture. Following that
    summary, specific securities and relevant terms are listed,
    divided into two categories of debt securities issued:
    (a)&#160;notes and debentures and (b)&#160;medium-term notes.
    Each series of these debt securities has been issued under the
    Indenture, dated as of December&#160;16, 1993, between Columbia
    Healthcare Corporation and The First National Bank of Chicago,
    as Trustee, as supplemented or amended by the First Supplemental
    Indenture, dated as of May&#160;25, 2000, between the Issuer and
    Bank One Trust&#160;Company, N.A., as Trustee, the Second
    Supplemental Indenture, dated as of July&#160;1, 2001, between
    the Issuer and Bank One Trust&#160;Company, N.A., as Trustee,
    the Third Supplemental Indenture, dated as of December&#160;5,
    2001, between the Issuer and The Bank of New York, and the
    Fourth Supplemental Indenture, dated as of November&#160;14,
    2006, between the Company and The Bank of New York, as Trustee
    <I>(&#147;Trustee&#148;) </I>(as may be further amended or
    supplemented, the <I>&#147;Indenture&#148;</I>).
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Ranking</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The debt securities are our senior unsecured obligations and
    rank equally in right of payment to any of our existing and
    future senior indebtedness, are senior in right of payment to
    all of our existing and future subordinated indebtedness, are
    effectively subordinated in right of payment to our secured
    obligations to the extent of the value of the collateral
    securing such obligations and are structurally subordinated in
    right of payment to all existing and future indebtedness of our
    subsidiaries that do not guarantee the debt securities. In a
    liquidation or reorganization of any of our subsidiaries, the
    right of holders of the debt securities to participate in any
    distribution is subject to the prior claims of creditors of that
    subsidiary, except to the extent that we are a creditor.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Limitations
    on Us and Our Subsidiaries</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Limitation
    on Mortgages</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that neither we nor any of our
    subsidiaries will issue, assume or guarantee any indebtedness or
    obligation secured by mortgages, liens, pledges or other
    encumbrances (referred to collectively as &#147;mortgages&#148;)
    upon any principal property (as defined below under
    &#147;&#160;&#151; Certain Definitions&#148;), unless the debt
    securities shall be secured equally and ratably with (or prior
    to) such debt. This restriction will not apply to:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    mortgages securing the purchase price or cost of construction of
    property or additions, substantial repairs, alterations or
    improvements, if the debt and the mortgages are incurred within
    18&#160;months of the acquisition or completion of construction
    and full operation or additions, repairs, alterations or
    improvements;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    mortgages existing on property at the time of its acquisition by
    us or our subsidiary or on the property of a corporation at the
    time of the acquisition of such corporation by us or our
    subsidiary;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    mortgages to secure debt on which the interest payments are
    exempt from federal income tax under Section&#160;103 of the
    Internal Revenue Code;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    mortgages in favor of us or a consolidated subsidiary;
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    28
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    mortgages existing on the date of the Indenture;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    certain mortgages to governmental entities;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    mortgages incurred in connection with the borrowing of funds
    used to repay debt within 120&#160;days in the same principal
    amount secured by other mortgages on principal property with at
    least the same appraised fair market value;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    mortgages incurred within 90&#160;days (or any longer period,
    not in excess of one year, as permitted by law) after
    acquisition of the related property or equipment arising solely
    in connection with the transfer of tax benefits in accordance
    with Section 168(f)(8) of the Internal Revenue Code;&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    any extension, renewal or replacement of any mortgage referred
    to above, provided the amount secured is not increased and it
    relates to the same property.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 9pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Limitation
    on Sale and Lease-Back Transactions</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that neither we nor any subsidiary will
    enter into any sale and lease-back transaction with respect to
    any principal property involving a lease of more than three
    years with another person (other than our company or a
    subsidiary) unless either:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    we or our subsidiary could incur indebtedness secured by a
    mortgage on the property to be leased;&#160;or
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    within 120&#160;days, we apply the greater of the net proceeds
    of the sale of the leased property or the fair value of the
    leased property, as determined by our chief financial officer
    (less the principal amount of any debt securities delivered
    within 120&#160;days for retirement or cancellation or other
    funded debt voluntarily retired within 120&#160;days) to the
    voluntary retirement of our long-term funded debt or the
    acquisition or construction of a principal property.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 9pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Limitation
    on Subsidiary Debt and Preferred Stock</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that none of our restricted subsidiaries
    may, directly or indirectly, create, incur, issue, assume or
    otherwise become liable with respect to, extend the maturity of,
    or become responsible for the payment of, any debt or preferred
    stock except:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    debt outstanding on the date of the Indenture;&#160;or
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    debt representing the assumption by one restricted subsidiary of
    debt of another;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    debt or preferred stock of any corporation or partnership
    existing when it becomes a subsidiary;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    debt of a restricted subsidiary arising from agreements
    providing for indemnification, adjustment of purchase price or
    similar obligations or from guarantees, letters of credit,
    surety bonds or performance bonds securing any of our
    obligations or those of our subsidiaries incurred or assumed in
    connection with the disposition of any business, property or
    subsidiary, except for the purpose of financing an acquisition,
    provided that the maximum aggregate liability does not exceed
    the gross proceeds from the disposition;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    debt of a restricted subsidiary in respect of performance,
    surety and other similar bonds, bankers acceptances and letters
    of credit provided in the ordinary course of business;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    debt secured by a mortgage incurred to finance the purchase
    price or cost of construction of property or additions,
    substantial repairs, alterations or improvements, if the
    mortgage and debt are incurred within 18&#160;months of the
    later of the acquisition or completion of construction and full
    operation or additions, repairs, alterations or improvements and
    the mortgage does not relate to any other property;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    permitted subsidiary refinancing debt (as defined below under
    &#147;&#151; Certain Definitions&#148;);
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    debt, including guarantees, of a restricted subsidiary to us or
    another subsidiary as long as we hold it;&#160;or
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    any obligation pursuant to a permitted sale and lease-back
    transaction.
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    29
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Exempted
    Transactions</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Even if otherwise prohibited by these limitations, if the
    aggregate outstanding principal amount of all our other debt and
    that of our subsidiaries subject to these limitations does not
    exceed 15% of our consolidated net tangible assets, then:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    we or any of our subsidiaries may issue, assume or guarantee
    debt secured by mortgages;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    we or any of our subsidiaries may enter into any sale and
    lease-back transaction;&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    any restricted subsidiary may issue, assume or become liable for
    any debt or preferred stock.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Events of
    Default</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under the Indenture, an event of default applicable to the debt
    securities of any series means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    failure to pay the principal or any premium on any debt
    securities of that series when due;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    failure to pay any interest on any debt securities of that
    series when due, continued for 30&#160;days;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    failure to deposit any sinking fund payment in respect of any
    debt securities of that series when due;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    failure to perform, or the breach of, any of our other
    applicable covenants or warranties in the Indenture, continued
    for 60&#160;days after written notice;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    events in bankruptcy, insolvency or reorganization;&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    any other event of default provided with respect to debt
    securities of that series.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If any event of default with respect to debt securities of any
    series occurs and is continuing, either the Trustee or the
    holders of at least 25% in aggregate principal amount of the
    outstanding debt securities of that series may declare the
    principal amount, or in the case of discount securities, the
    applicable portion of the principal amount, of all the debt
    securities of that series to be due and payable immediately. The
    holders may, under certain circumstances, rescind and annul this
    acceleration prior to obtaining a judgment or decree.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Other than the duties of the Trustee during a default to act
    with the required standard of care, the Trustee is not obligated
    to exercise any of its rights or powers under the Indenture at
    the request or direction of any of the holders unless the
    holders shall have offered to the Trustee reasonable indemnity.
    Subject to these indemnification provisions and certain other
    conditions described in the Indenture, the holders of a majority
    in aggregate principal amount of the outstanding debt securities
    of any series may direct the time, method and place of
    conducting any proceeding for any remedy available to the
    Trustee, or exercising any trust or power conferred on the
    Trustee, with respect to the debt securities of that series.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We will furnish the Trustee annually with a statement as to our
    performance of our obligations under the Indenture and as to any
    default in our performance.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Modification
    and Waiver</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We and the Trustee may modify and amend the Indenture with the
    consent of the holders of a majority in aggregate principal
    amount of the outstanding debt securities of each series
    affected voting separately. We must have the consent of the
    holder of each outstanding debt security affected to:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    change the stated maturity of the principal of, or any
    installment of interest on, any debt security;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    reduce the principal, premium or interest on any debt security;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    reduce the amount of principal of discount securities payable
    upon acceleration of the maturity;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    change the currency of payment of principal, premium or interest
    on any debt security;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    impair the right to institute suit for the enforcement of any
    payment on or with respect to any debt securities;&#160;or
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    30
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    reduce the percentage of holders of any series whose consent is
    required for modification or amendment of the Indenture or for
    waiver of compliance with certain provisions of the Indenture or
    certain defaults.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The holders of a majority in aggregate principal amount of the
    outstanding debt securities of each series may, on behalf of all
    holders of that series, waive any past default under the
    Indenture with respect to debt securities of that series.
    However, such holders may not waive a past default in the
    payment of principal, premium or interest, or any sinking fund
    installment with respect to the debt securities, or waive a
    covenant or provision that cannot be modified or amended without
    the consent of the holders of each outstanding debt security
    affected.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We and the Trustee may modify and amend the Indenture without
    the consent of the holders of the debt securities to, among
    other things:
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    evidence the succession of another corporation to our company;
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    add to the covenants for the benefit of the holders or surrender
    any right or power conferred upon our company;
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    add additional events of default;
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    secure the debt securities;
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    supplement the Indenture to the extent necessary to permit or
    facilitate defeasance and discharge of any series of debt
    securities; <I>provided </I>that this action does not adversely
    affect the holders of debt securities in any material respect;
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    establish the form and terms of debt securities of any new
    series;
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    provide for a successor trustee or for co-trustees;
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    cure any ambiguity, correct or supplement any provision of the
    Indenture that may be defective or inconsistent with any other
    provision, or make any other provisions that are not
    inconsistent with any provision of the Indenture; <I>provided
    </I>that those other provisions do not adversely affect the
    interests of the holders of outstanding debt securities of any
    series in any material respect;&#160;or
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    change any place where principal, premium (if any) and interest
    is payable, where debt securities may be surrendered for
    registration, transfer or exchange or where notices or demands
    on our company may be served.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 8pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Consolidation,
    Merger, Sale or Lease of Assets</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We may consolidate with or merge into, or transfer or lease our
    assets substantially as an entirety to any corporation without
    the consent of the holders of any of the outstanding debt
    securities under the Indenture if:
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the successor corporation is a corporation organized under the
    laws of the United&#160;States, any state there of or the
    District of Columbia and expressly assumes our obligations on
    the debt securities and under the Indenture;
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    after giving effect to the transaction, no event of default, and
    no event which, after notice or lapse of time or both, would
    become an event of default, shall have occurred and be
    continuing;
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    if, as a result of the transaction, our company would become
    subject to a mortgage, pledge, lien, security interest or other
    encumbrance that would not be permitted by the Indenture, we or
    the successor corporation will secure the debt securities
    equally and ratably with (or prior to) all indebtedness secured
    thereby;&#160;and
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    we have delivered to the Trustee an officers&#146; certificate
    and an opinion of counsel stating that the transaction complies
    with the Indenture and that all conditions precedent have been
    complied with.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 8pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Defeasance</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If so specified in the terms of any series of debt securities,
    we may be discharged from all obligations under the debt
    securities of any series, and we will not be subject to the
    limitations in the Indenture discussed in the above sections
    (known as legal defeasance) or we may cease to be under any
    obligation to comply with
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    31
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    specified covenants in the Indenture (known as covenant
    defeasance), if (1) we deposit with the Trustee trust money or
    U.S.&#160;government obligations that are sufficient to pay all
    principal, premium and interest on the debt securities of the
    series and certain other conditions are met. We would deliver to
    the Trustee an opinion of counsel to the effect that the deposit
    and related defeasance would not (1)&#160;cause the holders of
    the debt securities of the series to recognize income, gain or
    loss for United States income tax purposes or (2)&#160;result in
    the delisting of the debt securities from any national
    securities exchange (if so listed).
</DIV>

<DIV style="margin-top: 8pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Optional
    Redemption</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If the terms of any series of debt securities (other than the
    &#163;150,000,000 in aggregate principal amount of
    8.75%&#160;Senior Notes Due 2010, which are discussed below
    under the heading &#147;&#151;&#160;Provisions that Apply Only
    to the &#163;150,000,000 8.75%&#160;Senior Notes Due 2010&#148;)
    indicate that they are redeemable at the option of our company,
    the debt securities of that series will be redeemable, at our
    option, at any time in whole, or in part from time to time, at a
    redemption price equal to the greater of (1)&#160;100% of the
    principal amount of the notes to be redeemed or (2)&#160;the sum
    of the present values of the remaining scheduled payments of
    principal and interest on the notes to be redeemed (exclusive of
    interest accrued to the date of redemption) discounted to the
    date of redemption on a semiannual basis (assuming a
    <FONT style="white-space: nowrap">360-day</FONT> year
    consisting of twelve
    <FONT style="white-space: nowrap">30-day</FONT>
    months) at the then current Treasury Rate (as defined below),
    plus the number of basis points specified in the terms of the
    debt securities. In each case, we will pay accrued and unpaid
    interest on the principal amount being redeemed to the date of
    redemption.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We will mail notice of any redemption between 30 and
    60&#160;days preceding the redemption date to each holder of the
    debt securities to be redeemed.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The notice of the redemption for such debt securities will
    state, among other things, the principal amount of the debt
    securities to be redeemed, the redemption price and the place or
    places that payment will be made upon presentation and surrender
    of the debt securities to be redeemed.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Unless we default in payment of the redemption price, on and
    after the redemption date, interest will cease to accrue on the
    debt securities or portions called for redemption.
</DIV>

<DIV style="margin-top: 8pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Method
    for Determining the Treasury Rate for any Optional Redemption of
    the 5.50%&#160;Senior Notes due 2009, the 6.30%&#160;Senior
    Notes due 2012, the 6.25%&#160;Senior Notes due 2013, the
    6.75%&#160;Senior Notes due 2013, the 5.75%&#160;Senior Notes
    due 2014, the 6.375%&#160;Senior Notes due 2015, the
    6.50%&#160;Senior Notes due 2016 and the 7.50%&#160;Senior Notes
    due 2033</FONT></I></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    With respect to each of the series of redeemable debt securities
    listed above, for the purposes of determining the applicable
    redemption price, &#147;Treasury Rate&#148; and the other
    defined terms listed below have the respective meanings assigned
    to them in this subsection.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Treasury Rate&#148;</I> means, with respect to any
    redemption date, the rate per year equal to: (1)&#160;the yield
    under the heading which represents the average for the
    immediately preceding week, appearing in the most recently
    published statistical release designated &#147;H.15(519)&#148;
    or any successor publication which is published weekly by the
    Board of Governors of the Federal Reserve System and which
    establishes yields on actively traded United States Treasury
    securities adjusted to constant maturity under the caption
    &#147;Treasury Constant Maturities,&#148; for the maturity
    corresponding to the Comparable Treasury Issue; <I>provided
    </I>that, if no maturity is within three months before or after
    the Remaining Life of the notes to be redeemed, yields for the
    two published maturities most closely corresponding to the
    Comparable Treasury Issue shall be determined and the Treasury
    Rate shall be interpolated or extrapolated from those yields on
    a straight line basis, rounding to the nearest month; or
    (2)&#160;if such release (or any successor release) is not
    published during the week preceding the calculation date or does
    not contain such yields, the rate per year equal to the
    semiannual equivalent yield to maturity of the Comparable
    Treasury Issue, calculated using a price for the Comparable
    Treasury Issue (expressed as a percentage of its principal
    amount) equal to the Comparable Treasury Price for such
    redemption date. The Treasury Rate shall be calculated on the
    third business day preceding the redemption date.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Comparable Treasury Issue&#148;</I> means the United
    States Treasury security selected by an Independent Investment
    Banker and having a maturity comparable to the remaining term of
    the debt securities to be
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    32
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    redeemed that would be utilized, at the time of selection and in
    accordance with customary financial practice, in pricing new
    issues of corporate debt securities of comparable maturity to
    the remaining term of such debt securities.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Remaining Life&#148;</I> means the maturity of a United
    States Treasury security selected by an Independent Investment
    Banker that is comparable to the remaining term of such debt
    securities.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Independent Investment Banker&#148;</I> means one of
    the Reference Treasury Dealers appointed by the Trustee after
    consultation with us.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Comparable Treasury Price&#148;</I> means, with respect
    to any redemption date, (a)&#160;the average of the Reference
    Treasury Dealer Quotations for the redemption date, after
    excluding the highest and lowest Reference Treasury Dealer
    Quotations, or (b)&#160;if the Trustee obtains fewer than four
    Reference Treasury Dealer Quotations, the average of all the
    quotations.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Reference Treasury Dealer Quotations&#148;</I> means,
    with respect to each Reference Treasury Dealer and any
    redemption date, the average, as determined by the Trustee, of
    the bid and asked prices for the Comparable Treasury Issue
    (expressed in each case as a percentage of its principal amount)
    quoted in writing to the Trustee by the Reference Treasury
    Dealer at 5:00&#160;p.m. on the third business day preceding the
    redemption date.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Reference Treasury Dealer&#148;</I> means each of the
    financial institutions specified in the terms of the securities
    and their respective successors; <I>provided however</I>, that
    if any of the foregoing shall cease to be a primary
    U.S.&#160;government securities dealer in New York City (a
    <I>&#147;Primary Treasury Dealer&#148;</I>), we shall substitute
    another Primary Treasury Dealer.
</DIV>

<DIV style="margin-top: 8pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Method
    for Determining the Treasury Rate for any Optional Redemption of
    the 8.75%&#160;Senior Notes due 2010, the 7.875%&#160;Senior
    Notes due 2011, the 6.95%&#160;Senior Notes due 2012 and the
    7.19%&#160;Debentures due 2015</FONT></I></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    With respect to each of the series of redeemable debt securities
    listed above, for the purposes of determining the applicable
    redemption price, &#147;Treasury Rate&#148; and the other
    defined terms listed below have the respective meanings assigned
    to them in this subsection.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Treasury Rate&#148;</I> means, with respect to any
    redemption date, the rate per annum equal to the semiannual
    equivalent yield to maturity of the Comparable Treasury Issue,
    assuming a price for the Comparable Treasury Issue (expressed as
    a percentage of its principal amount) equal to the Comparable
    Treasury Price for the redemption date.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Comparable Treasury Issue&#148;</I> means the United
    States Treasury security selected by an Independent Investment
    Banker and having a maturity comparable to the remaining term of
    the debt securities to be redeemed that would be utilized, at
    the time of selection and in accordance with customary financial
    practice, in pricing new issues of corporate debt securities of
    comparable maturity to the remaining term of such debt
    securities.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Independent Investment Banker&#148;</I> means one of
    the Reference Treasury Dealers appointed by the Trustee after
    consultation with us, except that with respect to the
    7.19%&#160;Debentures due 2015, such term means Morgan
    Stanley&#160;&#038; Co. Incorporated or, if such firm is
    unwilling or unable to select the Comparable Treasury Issue, an
    independent banking institution of national standing appointed
    by the Trustee.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Comparable Treasury Price&#148;</I> means, with respect
    to any redemption date, (1)&#160;the average of the bid and
    asked prices for the Comparable Treasury Issue (expressed in
    each case as a percentage of its principal amount) on the third
    business day preceding the redemption date, as set forth in the
    daily statistical release (or any successor release) published
    by the Federal Reserve Bank of New York and designated
    &#147;Composite 3:30&#160;p.m.&#160;Quotations for
    U.S.&#160;Government Securities&#148; or (2)&#160;if the release
    (or any successor release) is not published or does not contain
    the prices on that business day, (a)&#160;the average of the
    Reference Treasury Dealer Quotations for the redemption date,
    after excluding the highest and lowest Reference Treasury Dealer
    Quotations, or (b)&#160;if the Trustee obtains fewer than four
    Reference Treasury Dealer Quotations, the average of all the
    quotations.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    33
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Reference Treasury Dealer Quotations&#148;</I> means,
    with respect to each Reference Treasury Dealer and any
    redemption date, the average, as determined by the Trustee, of
    the bid and asked prices for the Comparable Treasury Issue
    (expressed in each case as a percentage of its principal amount)
    quoted in writing to the Trustee by the Reference Treasury
    Dealer at 5:00&#160;p.m. on the third business day preceding the
    redemption date.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Reference Treasury Dealer&#148;</I> means each of the
    financial institutions specified in the terms of the securities
    and their respective successors; <I>provided however</I>, that
    if any of the foregoing shall cease to be a primary
    U.S.&#160;Government securities dealer in New York City (a
    &#147;<I>Primary Treasury Dealer</I>&#148;), we shall substitute
    another Primary Treasury Dealer.
</DIV>

<DIV style="margin-top: 8pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Provisions
    that Apply Only to the &#163;150,000,000 8.75%&#160;Senior Notes
    Due 2010</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Optional
    Redemption of the &#163;150,000,000 8.75%&#160;Senior Notes Due
    2010</FONT></I></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The &#163;150,000,000 in aggregate principal amount of
    8.75%&#160;Senior Notes Due 2010 (the <I>&#147;2010 Pounds
    Sterling Notes&#148;</I>) will be redeemable as a whole or in
    part, at our option, at any time after November&#160;1, 2003, at
    a redemption price equal to the greater of (1)&#160;100% of the
    principal amount of such notes and (2)&#160;as determined by the
    Calculation Agent, the price at which the Gross
    Redemption&#160;Yield on the outstanding principal amount of the
    notes on the Reference Date is equal to the Gross
    Redemption&#160;Yield (determined by reference to the
    middle-market price) at 3:00&#160;p.m. (London time) on that
    date on the Benchmark Gilt, plus 50&#160;basis points, in either
    case, plus accrued and unpaid interest on the notes up to, but
    excluding, the date specified as the redemption date (the
    <I>&#147;Redemption&#160;Price&#148;</I>).
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Gross Redemption&#160;Yield&#148;</I> means a yield
    calculated on the basis indicated by the Joint Index and
    Classification Committee of the Institute and Faculty of
    Actuaries as reported in the Journal of the Institute of
    Actuaries, Vol. 105, Part&#160;1, 1978, page&#160;18 or on such
    other basis as the Trustee may approve.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Reference Date&#148;</I> means the date which is the
    first dealing day in London prior to the publication of the
    notice of redemption referred to below.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Benchmark Gilt&#148;</I> means the 5.75% Treasury Stock
    due December&#160;7, 2009 or such other United Kingdom
    government stock as the Calculation Agent may, with the advice
    of three brokers
    <FONT style="white-space: nowrap">and/or</FONT>
    United Kingdom gilt-edged market makers or such other three
    persons operating in the United Kingdom gilt-edged market as the
    Calculation Agent may determine from time to time to be the most
    appropriate benchmark United Kingdom government stock for the
    notes.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Calculation Agent&#148;</I> means Deutsche Bank AG
    London or any successor entity.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We will give notice of any redemption between 30 and
    60&#160;days preceding the redemption date to each holder of the
    notes to be redeemed.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In the case of any partial redemption, selection of the notes
    for redemption will be made by the Trustee in compliance with
    the requirements of the principal securities exchange, if any,
    on which the notes are listed or, if the notes are not so listed
    or such exchange prescribes no method of selection, on a pro
    rata basis, by lot or by such other method as the Trustee in its
    sole discretion shall deem to be fair and appropriate, although
    no note of &#163;1,000 in original principal amount or less
    shall be redeemed in part. If any note is to be redeemed in part
    only, the notice of redemption relating to the note shall state
    the portion of the principal amount thereof to be redeemed. A
    new note in principal amount equal to the unredeemed portion
    thereof will be issued and delivered to the Trustee, or its
    nominee, or, in the case of notes in definitive form, issued in
    the name of the holder thereof, in each case upon cancellation
    of the original note.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Unless we default in payment of the Redemption&#160;Price, on
    and after the redemption date, interest will cease to accrue on
    the notes or portions called for redemption.
</DIV>

<DIV style="margin-top: 8pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Tax
    Redemption of the &#163;150,000,000 8.75%&#160;Senior Notes Due
    2010</FONT></I></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The 2010 Pounds Sterling Notes may be redeemed at our option, in
    whole but not in part, at a redemption price equal to 100% of
    the principal amount of the notes to be redeemed, together with
    interest accrued and
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    34
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    unpaid to the date fixed for redemption, at any time, on giving
    not less than 30 nor more than 60&#160;days&#146; notice, which
    notice shall be irrevocable, if:
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    we have or will become obliged to pay Additional Amounts (as
    defined under &#147;&#151;&#160;Additional Amounts&#148; below)
    as a result of any change in or amendment to the laws,
    regulations or rulings of the United States or any political
    subdivision or any taxing authority of or in the United States
    affecting taxation, or any change in or amendment to an official
    application, interpretation, administration or enforcement of
    such laws, regulations or rulings, which change or amendment is
    announced or becomes effective on or after November&#160;1,
    2000;&#160;or
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    any action shall have been taken by a taxing authority, or any
    action has been brought in a court of competent jurisdiction, in
    the United States or any political subdivision or taxing
    authority of or in the United States, including any of those
    actions specified in the first bullet point above, whether or
    not such action was taken or brought with respect to our
    company, or any change, clarification, amendment, application or
    interpretation of such laws, regulations or rulings shall be
    officially proposed, in any such case, on or after
    October&#160;25, 2000, which results in a substantial likelihood
    that we will be required to pay Additional Amounts on the next
    interest payment date.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    However, no such notice of redemption shall be given earlier
    than 90&#160;days prior to the earliest date on which we would
    be, in the case of a redemption for the reasons specified in the
    first bullet point above, or there would be a substantial
    likelihood that we would be, in the case of a redemption for the
    reasons specified in the second bullet point above, obligated to
    pay such Additional Amounts if a payment in respect of the notes
    were then due.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Prior to the publication of any notice of redemption pursuant to
    this subsection, we will deliver to the Trustee:
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a certificate signed by one of our duly authorized officers
    stating that we are entitled to effect such redemption and
    setting forth a statement of facts showing that the conditions
    precedent to our right so to redeem have occurred;&#160;and
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a written opinion of independent legal counsel of recognized
    standing to the effect that we have or will become obligated to
    pay such Additional Amounts as a result of such change or
    amendment or that there is a substantial likelihood that we will
    be required to pay such Additional Amounts as a result of such
    action or proposed change, clarification, amendment, application
    or interpretation, as the case may be.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Such notice, once delivered by us to the Trustee, will be
    irrevocable.
</DIV>

<DIV style="margin-top: 8pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Additional
    Amounts</FONT></I></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    All payments of principal and interest in respect of the 2010
    Pounds Sterling Notes will be made without deduction or
    withholding for or on account of any present or future taxes,
    duties, assessments or other governmental charges of whatsoever
    nature imposed, levied, collected, withheld or assessed by the
    United States or any political subdivision or taxing authority
    of or in the United States, unless such withholding or deduction
    is required by law.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In the event such withholding or deduction is required by law,
    subject to the limitations described below, we will pay as
    additional interest on the notes to the holder or beneficial
    owner of any note who is a
    <FONT style="white-space: nowrap">non-U.S.&#160;holder</FONT>
    (as defined below), such additional amounts <I>(&#147;Additional
    Amounts&#148;)</I> as may be necessary in order that every net
    payment by us or any paying agent of principal of or interest on
    the notes (including upon redemption), after deduction or
    withholding for or on account of any present or future tax,
    duty, assessment or other governmental charge imposed upon or as
    a result of such payment by the United States or any political
    subdivision or taxing authority of or in the United States, will
    not be less than the amount provided for in such note to be then
    due and payable before any such tax, duty, assessment or other
    governmental charge.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    35
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    However, our obligation to pay Additional Amounts shall not
    apply to:
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;any tax, duty, assessment or other governmental charge
    which would not have been so imposed but for:
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the existence of any present or former connection
    between such holder or beneficial owner (or between a fiduciary,
    settlor, beneficiary, member or shareholder or other equity
    owner of, or a person having a power over, such holder or
    beneficial owner, if such holder or beneficial owner is an
    estate, a trust, a limited liability company, a partnership, a
    corporation or other entity) and the United States, including,
    without limitation, such holder or beneficial owner (or such
    fiduciary, settlor, beneficiary, member, shareholder or other
    equity owner or person having such a power) being or having been
    a citizen or resident or treated as a resident of the United
    States or being or having been engaged in a trade or business in
    the United States or being or having been present in the United
    States or having had a permanent establishment in the United
    States;
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the failure of such holder or beneficial owner to
    comply with any requirement under United States tax laws and
    regulations to establish entitlement to a partial or complete
    exemption from such tax, duty, assessment or other governmental
    charge (including, but not limited to, the requirement to
    provide Internal Revenue Service
    <FONT style="white-space: nowrap">Forms&#160;W-8BEN,</FONT>
    <FONT style="white-space: nowrap">Forms&#160;W-8ECI,</FONT>
    or any subsequent versions thereof or successor thereto);&#160;or
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;such holder&#146;s or beneficial owner&#146;s present
    or former status as a personal holding company or a foreign
    personal holding company with respect to the United States, as a
    controlled foreign corporation with respect to the United
    States, as a passive foreign investment company with respect to
    the United States, as a private foundation or other tax exempt
    organization with respect to the United States or as a
    corporation which accumulates earnings to avoid United States
    federal income tax;
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;any tax, duty, assessment or other governmental charge
    imposed by reason of the holder or beneficial owner:
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;owning or having owned, directly or indirectly,
    actually or constructively, 10% or more of the total combined
    voting power of all classes of HCA Inc.&#146;s stock;
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;being a bank receiving interest described in
    section&#160;881(c)(3)(A) of the Internal Revenue Code;&#160;or
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;being a controlled foreign corporation with respect to
    the United States that is related to HCA Inc. by stock ownership;
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;any tax, duty, assessment or other governmental charge
    which would not have been so imposed but for the presentation by
    the holder or beneficial owner of such note for payment on a
    date more than 30&#160;days after the date on which such payment
    became due and payable or the date on which payment of the note
    is duly provided for and notice is given to holders, whichever
    occurs later, except to the extent that the holder or beneficial
    owner would have been entitled to such additional amounts on
    presenting such note on any date during such
    <FONT style="white-space: nowrap">30-day</FONT>
    period;
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;any estate, inheritance, gift, sales, transfer,
    personal property, wealth, interest equalization or similar tax,
    assessment or other governmental charge;
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;any tax, duty, assessment or other governmental charge
    which is payable otherwise than by withholding from payment of
    principal of or interest on such note;
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (f)&#160;any tax, duty, assessment or other governmental charge
    which is payable by a holder that is not the beneficial owner of
    the note, or a portion of the note, or that is a fiduciary,
    partnership, limited liability company or other similar entity,
    but only to the extent that a beneficial owner, a beneficiary or
    settlor with respect to such fiduciary or member of such
    partnership, limited liability company or similar entity would
    not have been entitled to the payment of an additional amount
    had such beneficial owner, settlor, beneficiary or member
    received directly its beneficial or distributive share of the
    payment;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    36
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (g)&#160;any tax, duty, assessment or other governmental charge
    required to be withheld by any paying agent from any payment of
    principal of or interest on any note, if such payment can be
    made without such withholding by any other paying agent;&#160;or
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (h)&#160;any combination of items (a), (b), (c), (d), (e),
    (f)&#160;and (g).
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For purposes of this subsection, the holding of or the receipt
    of any payment with respect to a note will not constitute a
    connection&#160;(1) between the holder or beneficial owner and
    the United States or (2)&#160;between a fiduciary, settlor,
    beneficiary, member or shareholder or other equity owner of, or
    a person having a power over, such holder or beneficial owner,
    if such holder or beneficial owner is an estate, a trust, a
    limited liability company, a partnership, a corporation or other
    entity, and the United States or any political subdivision or
    taxing authority thereof or therein.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any reference in this prospectus, in the Indenture or in the
    notes to principal or interest with respect to the 2010 Pounds
    Sterling Notes shall be deemed to refer also to Additional
    Amounts which may be payable under the provisions of this
    subsection.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We will pay all stamp and other duties, if any, which may be
    imposed by the United States or any political subdivision
    thereof or taxing authority therein with respect to the issuance
    of the notes.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Except as specifically provided in the notes, we will not be
    required to make any payment with respect to any tax, duty,
    assessment or other governmental charge imposed by any
    government or any political subdivision or taxing authority of
    or in the United States.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Unless previously redeemed or repurchased and cancelled, the
    notes will be payable at par, including Additional Amounts, if
    any, on November&#160;1, 2010 or such earlier date on which the
    applicable notes shall be due and payable in accordance with the
    terms and conditions of the applicable notes. However, if the
    maturity date of the applicable notes is not a Business Day, the
    notes will be payable on the next succeeding business day and no
    interest shall accrue for the period from the maturity date to
    such payment date.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For purposes of the 2010 Pounds Sterling Notes, a
    <I><FONT style="white-space: nowrap">&#147;non-U.S.&#160;holder&#148;</FONT></I>
    is a beneficial owner of the notes that is not a
    U.S.&#160;holder. A <I>&#147;U.S.&#160;holder&#148;</I> is a
    beneficial owner of the notes that is for United States federal
    income tax purposes:
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a United States citizen or resident alien individual;
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a corporation or partnership created or organized in or under
    the laws of the United States or any State thereof (including
    the District of Columbia);
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    an estate if its income is subject to United States federal
    income taxation regardless of its source;&#160;or
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a trust (1)&#160;that validly elects to be treated as a United
    States person for United States federal income tax purposes or
    (2)(a) the administration over which a U.S.&#160;court can
    exercise primary supervision and (b)&#160;all of the substantial
    decisions of which one or more United States persons has the
    authority to control.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 8pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Issuance
    of Additional Debt Securities</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If the terms of any series of debt securities so indicate, we
    may, without the consent of the holders of that series of debt
    securities, increase the principal amount of the debt securities
    of that series by issuing additional debt securities in the
    future on the same terms and conditions, except for any
    differences in the issue price and interest accrued prior to the
    issue date of the additional debt securities, and with the same
    CUSIP number as existing debt securities of that series. The
    existing debt securities of that series and any additional debt
    securities of that series would rank equally and ratably for all
    purposes under the Indenture.
</DIV>

<DIV style="margin-top: 8pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Governing
    Law</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We will construe the Indenture and the debt securities in
    accordance with the laws of the State of New&#160;York.
</DIV>

<DIV style="margin-top: 8pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Certain
    Definitions</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Set forth below are certain defined terms used in the Indenture.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    37
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;joint venture subsidiary&#148;</I> means a subsidiary
    as of the date of the Indenture of which we, directly or
    indirectly, own less than 100% of the voting securities
    entitling the holders thereof to elect a majority of the
    directors (or, in the case of a partnership, of which we,
    directly or indirectly, own less than 100% of the general
    partnership interests therein).
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;permitted subsidiary refinancing debt&#148;</I> means
    debt of any subsidiary, the proceeds of which are used to renew,
    extend, refinance or refund outstanding debt of that subsidiary;
    <I>provided </I>that the debt is scheduled to mature no earlier
    than the debt being renewed, extended, refinanced or refunded;
    <I>provided</I>, <I>further</I>, that the debt will be permitted
    subsidiary refinancing debt only to the extent that the
    aggregate principal amount of that debt (or, if that debt is
    issued at a price less than the principal amount thereof, the
    aggregate amount of gross proceeds therefrom) does not exceed
    the aggregate principal amount then outstanding under the debt
    being renewed, extended, refinanced or refunded (or if the debt
    being renewed, extended, refinanced or refunded was issued at a
    price less than the principal amount thereof, then not in excess
    of the amount of liability in respect thereof determined in
    accordance with generally accepted accounting principles.)
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;principal property&#148;</I> means each acute care
    hospital providing general medical and surgical services
    (excluding equipment, personal property and hospitals that
    primarily provide specialty medical services, such as
    psychiatric and obstetrical and gynecological services) owned
    solely by our company
    <FONT style="white-space: nowrap">and/or</FONT> one
    or more of our subsidiaries and located in the United States of
    America.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;restricted subsidiary&#148;</I> means (1)&#160;any
    subsidiary other than an unrestricted subsidiary and
    (2)&#160;any subsidiary that was an unrestricted subsidiary but
    which, subsequent to the date hereof, is designated by our
    company (by board resolution) to be a restricted subsidiary;
    <I>provided</I>, that we may not designate any such subsidiary
    to be a restricted subsidiary if we would thereby breach any
    covenant or agreement contained in the Indenture (on the
    assumption that any transaction to which that subsidiary was a
    party at the time of such designation and which would have given
    rise to debt or preferred stock or constituted a sale and
    lease-back transaction at the time it was entered into had that
    subsidiary then been a restricted subsidiary was entered into at
    the time of that designation).
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;subsidiary&#148;</I> means (1)&#160;any corporation of
    which at least a majority of the outstanding stock having
    ordinary voting power to elect a majority of the directors of
    that corporation, whether or not at the time stock of any other
    class or classes of that corporation have or might have voting
    power by reason of the happening of any contingency, is at the
    time, directly or indirectly, owned or controlled by our company
    or by one or more of our subsidiaries, or by our company and one
    or more of our subsidiaries or (2)&#160;any partnership or joint
    venture of which at least a majority of the equity ownership,
    whether in the form of membership, general, special or limited
    partnership interests or otherwise, is directly or indirectly
    owned or controlled by our company or by one or more of our
    subsidiaries, or by our company and one or more of our
    subsidiaries; <I>provided</I>, that the term
    &#147;subsidiary&#148; does not include any corporation or
    partnership controlled by our company (referred to in this
    definition as an <I>&#147;affiliated entity&#148;</I>) that:
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    does not transact any substantial portion of its business or
    regularly maintain any substantial portion of its operating
    assets within the continental limits of the United States of
    America;
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    is principally engaged in the business of financing (including,
    without limitation, the purchase, holding, sale or discounting
    of or lending upon any notes, contracts, leases or other forms
    of obligations) the sale or lease of merchandise, equipment or
    services (1)&#160;by our company, (2)&#160;by a subsidiary
    (whether such sales or leases have been made before or after the
    date when the corporation or partnership became a subsidiary),
    (3)&#160;by another affiliated entity or (4)&#160;by any
    corporation or partnership prior to the time when substantially
    all its assets have been or are acquired by our company;
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    is principally engaged in the business of owning, leasing,
    dealing in or developing real property;
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    is principally engaged in the holding of stock in,
    <FONT style="white-space: nowrap">and/or</FONT> the
    financing of operations of, an affiliated entity;&#160;or
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    is principally engaged in the business of (1)&#160;offering
    health benefit products or (2)&#160;insuring against
    professional and general liability risks of our company.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;unrestricted subsidiary&#148;</I> means (1)&#160;any
    subsidiary acquired or organized after the date hereof;
    <I>provided</I>, that the subsidiary is not a successor,
    directly or indirectly, to, and does not directly or indirectly
    own any equity interest in, any restricted subsidiary;
    (2)&#160;any subsidiary the principal business of which consists
    of
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    38
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    obtaining financing in capital markets outside the United States
    of America or financing the acquisition or disposition of
    machinery, equipment, inventory, accounts receivable and other
    real, personal and intangible property by persons including our
    company or a subsidiary; (3)&#160;any subsidiary the principal
    business of which is owning, leasing, dealing in or developing
    real property for residential or office building purposes or
    land, buildings or related real property owned by our company or
    any subsidiary as of the date of the Indenture; (4)&#160;any
    joint venture subsidiary; or (5)&#160;stock or other securities
    of an unrestricted subsidiary of the character described in
    clauses&#160;(1) through (4)&#160;of this definition, unless and
    until, in each of the cases specified in this paragraph, any
    such subsidiary has been designated a restricted subsidiary
    pursuant to clause&#160;(2) of the definition of
    &#147;restricted subsidiary.&#148;
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Senior
    Notes and Debentures</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The principal terms of the debt securities issued and
    outstanding as of the date of this prospectus are set forth
    below. Interest on the below series of debt securities accrues
    at the annual rate indicated in the title of the series and is
    payable on the indicated interest payment dates to the
    registered holders on the preceding record date. The debt
    securities of the series listed below are not subject to a
    sinking fund.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">5.50%&#160;Senior
    Notes Due 2009</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Principal amount of the series: $500,000,000
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Maturity date: December&#160;1, 2009
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Interest payment dates: June 1 and December 1
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Record dates: May 15 and November 15
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Issuance date: November&#160;19, 2004
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus&#160;30 basis points)
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">8.75%&#160;Senior
    Notes Due 2010</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Principal amount of the series: $750,000,000
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Maturity date: September&#160;1, 2010
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Interest payment dates: March 1 and September 1
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Record dates: February 15 and August 15
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Issuance date: August&#160;23, 2000
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus 50 basis points)
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">8.75%&#160;Senior
    Notes Due 2010</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Principal amount of the series: &#163;150,000,000
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Maturity date: November&#160;1, 2010
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Interest payment dates: May 1 and November 1
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Record dates: April 15 and October 15
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Issuance date: November&#160;1, 2000
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Redemption prior to maturity: Redeemable after November&#160;1,
    2003 at an applicable premium and redeemable at any time upon
    certain events related to U.S.&#160;taxation, in each case as
    described above under &#147;&#151; Provisions that Apply Only to
    the 2010 Pounds Sterling Note&#148;
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">7.875%&#160;Senior
    Notes Due 2011</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Principal amount of the series: $500,000,000
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Maturity date: February&#160;1, 2011
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    39
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Interest payment dates: February 1 and August 1
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Record dates: January 15 and July 15
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Issuance date: January&#160;26, 2001
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus 50&#160;basis points)
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">6.95%&#160;Senior
    Notes Due 2012</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Principal amount of the series: $500,000,000
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Maturity date: May&#160;1, 2012
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Interest payment dates: May 1 and November 1
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Record dates: April 15 and October 15
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Issuance date: April&#160;26, 2002
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus 25&#160;basis points)
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">6.30%&#160;Senior
    Notes Due 2012</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Principal amount of the series: $500,000,000
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Maturity date: October&#160;1, 2012
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Interest payment dates: April 1 and October 1
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Record dates: March 15 and September 15
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Issuance date: September&#160;23, 2002
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus&#160;37.5 basis points)
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">6.25%&#160;Senior
    Notes Due 2013</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Principal amount of the series: $500,000,000
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Maturity date: February&#160;15, 2013
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Interest payment dates: August 15 and February 15
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Record dates: August 1 and February 1
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Issuance date: February&#160;10, 2003
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus&#160;35 basis points)
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">6.75%&#160;Senior
    Notes Due 2013</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Principal amount of the series: $500,000,000
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Maturity date: July&#160;15, 2013
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Interest payment dates: January 15 and July 15
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Record dates: January 1 and July 1
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Issuance date: July&#160;28, 2003
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus&#160;35 basis points)
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">5.75%&#160;Senior
    Notes Due 2014</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Principal amount of the series: $500,000,000
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Maturity date: March&#160;15, 2014
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    40
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Interest payment dates: March 15 and September 15
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Record dates: March 1 and September 1
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Issuance date: March&#160;8, 2004
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus&#160;30 basis points)
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">6.375%&#160;Senior
    Notes Due 2015</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Principal amount of the series: $750,000,000
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Maturity date: January&#160;15, 2015
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Interest payment dates: January 15 and July 15
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Record dates: January 1 and July 1
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Issuance date: November&#160;19, 2004
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus&#160;35 basis points)
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">6.50%&#160;Senior
    Notes due 2016</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Principal amount of the series: $1,000,000,000
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Maturity date: February&#160;15, 2016
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Interest payment dates: February 15 and August 15
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Record dates: February 1 and August 1
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Issuance date: February&#160;8, 2006
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus&#160;30 basis points)
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">7.69%&#160;Notes
    Due 2025</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Principal amount of the series: $300,000,000
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Maturity date: June&#160;15, 2025
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Interest payment dates: June 15 and December 15
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Record dates: June 1 and December 1
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Issuance date: June&#160;30, 1995
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Redemption prior to maturity: Not redeemable prior to maturity
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">7.50%&#160;Senior
    Notes Due 2033</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Principal amount of the series: $250,000,000
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Maturity date: November&#160;6, 2033
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Interest payment dates: May 6 and November 6
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Record dates: April&#160;21, and October 21
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Issuance date: November&#160;6, 2003
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus&#160;37.5 basis points)
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">7.19%&#160;Debentures
    Due 2015</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Principal amount of the series: $150,000,000
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Maturity date: November&#160;15, 2015
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Interest payment dates: May 15 and November 15
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    41
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Record dates: May 1 and November 1
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Issuance date: November&#160;27, 1995
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus&#160;20 basis points)
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 8pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">7.50%&#160;Debentures
    Due 2023</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Principal amount of the series: $150,000,000
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Maturity date: December&#160;15, 2023
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Interest payment dates: June 15 and December 15
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Record dates: June 1 and December 1
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Issuance date: December&#160;16, 1993
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Redemption prior to maturity: Not redeemable prior to maturity
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 8pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">8.36%&#160;Debentures
    Due 2024</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Principal amount of the series: $150,000,000
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Maturity date: April&#160;15, 2024
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Interest payment dates: April 15 and October 15
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Record dates: April 1 and October 1
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Issuance date: April&#160;27, 1994
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Redemption prior to maturity: Not redeemable prior to maturity
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 8pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">7.05%&#160;Debentures
    Due 2027</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Principal amount of the series: $150,000,000
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Maturity date: December&#160;1, 2027
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Interest payment dates: June 1 and December 1
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Record dates: May 15 and November 15
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Issuance date: December&#160;8, 1995
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Redemption prior to maturity: Not redeemable prior to maturity
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 8pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">7.75%&#160;Debentures
    Due 2036</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Principal amount of the series: $100,000,000
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Maturity date: July&#160;15, 2036
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Interest payment dates: July 15 and January 15
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Record dates: July 1 and January 1
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Issuance date: July&#160;8, 1996
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Redemption prior to maturity: Not redeemable prior to maturity
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 8pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">7.50%&#160;Debentures
    Due 2095</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Principal amount of the series: $200,000,000
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Maturity date: November&#160;15, 2095
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Interest payment dates: May 15 and November 15
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Record dates: May 1 and November 1
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Issuance date: November&#160;27, 1995
</TD>
</TR>


<TR style="line-height: 4pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    Redemption prior to maturity: Not redeemable prior to maturity
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    42
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Medium-Term
    Notes</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In the table below, we specify the following terms of the
    Medium-Term Notes (the &#147;Medium-Term Notes&#148;): issuance
    date; principal amount; maturity date; interest rate; and
    redemption terms, if any.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Medium-Term Notes are not subject to a sinking fund and are
    not redeemable prior to maturity unless indicated below.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="33%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="11%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="17%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="29%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Issuance Date</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Principal Amount</B>
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Maturity Date</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Interest Rate/Redemption Terms</B>
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    February&#160;8, 1995
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    150,000,000
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="bottom">
    February 10, 2010
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    8.70%
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="bottom">
    Not redeemable prior to maturity
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    January&#160;20, 1995
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    150,000,000
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="bottom">
    December 15, 2014
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    9.00%
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="bottom">
    Not redeemable prior to maturity
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    September&#160;14, 1995
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    125,000,000
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="bottom">
    September 15, 2025
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    7.58%
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="bottom">
    Not redeemable prior to maturity
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Senior
    Secured Notes Issued Under the 2006 Indenture</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We have issued senior secured notes as described below under an
    indenture, dated as of November&#160;17, 2006, among the
    Company, the guarantors named therein and The Bank of New York,
    as trustee. Terms used in this &#147;&#151;&#160;Senior Secured
    Notes Issued Under the 2006 Indenture&#148; apply only to the
    Notes described herein.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">General</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Certain terms used in this description are defined under the
    subheading &#147;Certain Definitions.&#148; In this description,
    the terms <I>&#147;we</I>,&#148; <I>&#147;our,&#148;</I>
    <I>&#147;us&#148;</I> and <I>&#147;the Company&#148;</I> each
    refer to HCA Inc. (the <I>&#147;Issuer&#148;</I>) and its
    consolidated Subsidiaries.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer issued $1,000,000,000 aggregate principal amount of
    9<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;senior
    secured notes due 2014 (the <I>&#147;2014 Cash Pay
    Notes&#148;</I>), $3,200,000,000 aggregate principal amount of
    9<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">4</FONT>%&#160;senior
    secured notes due 2016 (the <I>&#147;2016 Cash Pay
    Notes&#148;</I> and, together with the 2014 Cash Pay Notes, the
    <I>&#147;Cash Pay Notes&#148;</I>) and $1,500,000,000 aggregate
    principal amount of
    9<FONT style="vertical-align: text-top; font-size: 70%;">5</FONT>/<FONT style="font-size: 70%;">8</FONT>%/10<FONT style="vertical-align: text-top; font-size: 70%;">3</FONT>/<FONT style="font-size: 70%;">8</FONT>%
    optional PIK interest senior secured notes due 2016 (the
    <I>&#147;Toggle Notes&#148;</I> and, together with the Cash Pay
    Notes, the <I>&#147;Notes&#148;</I>) under the indenture dated
    November&#160;17, 2006 (the <I>&#147;Indenture&#148;</I>) among
    the Issuer, the Guarantors and The Bank of New York, as trustee
    (the <I>&#147;Trustee&#148;</I>). The Notes were issued in a
    private transaction that was not subject to the registration
    requirements of the Securities Act. Except as set forth herein,
    the terms of the Notes are substantially identical and include
    those stated in the Indenture and those made part of the
    Indenture by reference to the Trust&#160;Indenture Act.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The following description is only a summary of the material
    provisions of the Indenture, does not purport to be complete and
    is qualified in its entirety by reference to the provisions of
    that agreement, including the definitions therein of certain
    terms used below. We urge you to read the Indenture because it,
    and not this description, will define your rights as Holders of
    the Notes.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Brief
    Description of Notes</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Notes are:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    general senior obligations of the Issuer;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    secured on a second-priority basis, equally and ratably with all
    existing and future obligations of the Issuer and the Guarantors
    under any future Junior Lien Obligations, by all of the assets
    of the Issuer and the Guarantors which are not Principal
    Properties and which secure the General Credit Facility (other
    than the European Collateral), subject to the Liens securing the
    Issuer&#146;s and the Guarantors&#146; obligations under the
    General Credit Facility and any other Priority Lien Obligations
    and other Permitted Liens;
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    43
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    secured on a third-priority basis, equally and ratably with all
    existing and future obligations of the Issuer and the Guarantors
    under any future Junior Lien Obligations, by all of the assets
    of the Issuer and the Guarantors securing the ABL Facility which
    also secure the General Credit Facility, subject to the Liens
    securing the Issuer&#146;s and the Guarantors&#146; obligations
    under the Senior Credit Facilities and any other Priority Lien
    Obligations and other Permitted Liens;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    effectively subordinated, to the extent of the value of the
    assets securing such Indebtedness (which, in any event, exclude
    the European Collateral, which does not secure the Notes), to
    the Issuer&#146;s and the Guarantors&#146; obligations under the
    General Credit Facility and any future Priority Lien
    Obligations, that will be secured (A)&#160;on a first-priority
    basis by the same assets of the Issuer and the Guarantors that
    secure the Notes and by certain other assets of the Issuer and
    the Guarantors, including the Principal Properties, that do not
    secure the Notes and (B)&#160;on a second-priority basis by the
    Shared Receivables Collateral;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    effectively subordinated to the Issuer&#146;s and the
    Guarantors&#146; obligations under the ABL Facility, to the
    extent of the value of the Shared Receivables Collateral;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    effectively subordinated to any obligations secured by Permitted
    Liens, to the extent of the value of the assets of the Issuer
    and the Guarantors subject to those Permitted Liens;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    structurally subordinated to any existing and future
    indebtedness and liabilities of non-guarantor Subsidiaries,
    including the ABL Financing Entities and the Issuer&#146;s
    Foreign Subsidiaries and any Unrestricted Subsidiaries;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    ranked equally in right of payment with all existing and future
    senior Indebtedness of the Issuer and the Guarantors but, to the
    extent of the value of the Collateral, are effectively senior to
    all of the Issuer&#146;s and the Guarantors&#146; unsecured
    senior Indebtedness (including the Existing Notes);
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    senior in right of payment to any future Subordinated
    Indebtedness (as defined with respect to the Notes) of the
    Issuer;&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    initially unconditionally guaranteed on a joint and several and
    senior basis by each Restricted Subsidiary that guarantees the
    General Credit Facility (other than any Foreign Subsidiary).
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Guarantees</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Guarantors, as primary obligors and not merely as sureties,
    jointly and severally fully and unconditionally guaranteed, on a
    senior basis, the performance and full and punctual payment when
    due, whether at maturity, by acceleration or otherwise, of all
    obligations of the Issuer under the Indenture and the Notes,
    whether for payment of principal of, premium, if any, or
    interest or Additional Interest in respect of the Notes,
    expenses, indemnification or otherwise, on the terms set forth
    in the Indenture by executing the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Restricted Subsidiaries which guarantee the General Credit
    Facility guarantee the Notes. Each of the Guarantees of the
    Notes is a general senior obligation of each Guarantor and is
    secured by a second-priority lien on all of the assets of each
    Guarantor which secure the General Credit Facility and which are
    not Principal Properties and by a third-priority lien on all of
    the assets of each Guarantor which secure the ABL Facility. The
    Guarantees rank equally in right of payment with all existing
    and future senior Indebtedness of the Guarantor but, to the
    extent of the value of the Collateral, are effectively senior to
    all of the Guarantor&#146;s unsecured senior Indebtedness and,
    to the extent of the Collateral, are effectively subordinated to
    the Guarantor&#146;s Obligations under the Senior Credit
    Facilities and any future Priority Lien Obligations. The
    Guarantees are senior in right of payment to all existing and
    future Subordinated Indebtedness of each Guarantor. The Notes
    are structurally subordinated to Indebtedness and other
    liabilities of Subsidiaries of the Issuer that do not Guarantee
    the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Not all of the Issuer&#146;s Subsidiaries Guarantee the Notes.
    In the event of a bankruptcy, liquidation or reorganization of
    any of these non-guarantor Subsidiaries, the non-guarantor
    Subsidiaries will pay the holders of their debt and their trade
    creditors before they will be able to distribute any of their
    assets to the Issuer.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    44
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    None of our Subsidiaries which are &#147;Restricted
    Subsidiaries&#148; for purposes of the Existing Notes Indenture,
    Foreign Subsidiaries, ABL Financing Entities, non-Wholly Owned
    Subsidiaries or any Receivables Subsidiaries guarantee the
    Notes. The obligations of each Guarantor under its Guarantee are
    limited as necessary to prevent the Guarantee from constituting
    a fraudulent conveyance under applicable law.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On an as adjusted basis after giving effect to our offering of
    $1.500&#160;billion aggregate principal amount of first lien
    notes in April 2009 and the use of proceeds therefrom, our
    non-guarantor subsidiaries would have accounted for
    approximately $11.867&#160;billion, or 41.8%, of our total
    revenues for the year ended December&#160;31, 2008,
    approximately $3.038&#160;billion, or 40.9%, of our total
    revenues for the three months ended March&#160;31, 2009,
    approximately $9.876&#160;billion, or 40.7%, of our total
    assets, and approximately $7.517&#160;billion, or 22.5%, of our
    total liabilities, in each case, as of December&#160;31, 2008,
    and approximately $9.817&#160;billion, or 40.4%, of our total
    assets, and approximately $7.224&#160;billion, or 21.9%, of our
    total liabilities, in each case, as of March&#160;31, 2009.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any entity that makes a payment under its Guarantee is entitled
    upon payment in full of all guaranteed obligations under the
    Indenture to a contribution from each other Guarantor in an
    amount equal to such other Guarantor&#146;s pro rata portion of
    such payment based on the respective net assets of all the
    Guarantors at the time of such payment determined in accordance
    with GAAP.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If a Guarantee were rendered voidable, it could be subordinated
    by a court to all other indebtedness (including guarantees and
    other contingent liabilities) of the Guarantor, and, depending
    on the amount of such indebtedness, a Guarantor&#146;s liability
    on its Guarantee could be reduced to zero. See &#147;Risk
    Factors&#160;&#151; Risks Related to the Notes&#160;&#151;
    Federal and state fraudulent transfer laws may permit a court to
    void the notes, and with respect to the senior secured notes,
    the guarantees, and, if that occurs, you may not receive any
    payment on the notes.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each Guarantee by a Guarantor provides by its terms that it will
    be automatically and unconditionally released and discharged
    upon:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;(a)&#160;any sale, exchange or transfer (by merger or
    otherwise) of the Capital Stock of such Guarantor (including any
    sale, exchange or transfer), after which the applicable
    Guarantor is no longer a Restricted Subsidiary or all or
    substantially all the assets of such Guarantor, which sale,
    exchange or transfer is made in compliance with the applicable
    provisions of the Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the release or discharge of the guarantee by such
    Guarantor of the Senior Credit Facilities or such other
    guarantee that resulted in the creation of such Guarantee,
    except a discharge or release by or as a result of payment under
    such guarantee;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;the designation of any Restricted Subsidiary that is a
    Guarantor as an Unrestricted Subsidiary in compliance with the
    applicable provisions of the Indenture;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;the exercise by the Issuer of its legal defeasance
    option or covenant defeasance option as described under
    &#147;Legal Defeasance and Covenant Defeasance&#148; or the
    discharge of the Issuer&#146;s obligations under the Indenture
    in accordance with the terms of the Indenture;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;such Guarantor delivering to the Trustee an
    Officer&#146;s Certificate and an Opinion of Counsel, each
    stating that all conditions precedent provided for in the
    Indenture relating to such transaction have been complied with.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Holding
    Company Structure</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer is a holding company for its Subsidiaries, with no
    material operations of its own and only limited assets.
    Accordingly, the Issuer is dependent upon the distribution of
    the earnings of its Subsidiaries, whether in the form of
    dividends, advances or payments on account of intercompany
    obligations, to service its debt obligations.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    45
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Security</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">General</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Notes and the Guarantees are secured by perfected
    second-priority security interests in the Non-Receivables
    Collateral (second in priority to the Liens on the
    Non-Receivables Collateral securing the First Lien Obligations)
    and by perfected third-priority security interests in the Shared
    Receivables Collateral (third in priority to the first-priority
    and second-priority Liens on the Shared Receivables Collateral
    securing the ABL Obligations and the First Lien Obligations,
    respectively), in each case, subject to Permitted Liens;
    <I>provided</I>, that with respect to the portion of the
    Collateral comprised of real property, the Issuer and the
    Guarantors have such time as is reasonably necessary from the
    Issue Date to complete the actions required to perfect the
    second-priority Lien on such Collateral. The Cash Pay Notes and
    the Toggle Notes share in the benefit of such security interests
    <I>pro rata </I>based on the respective amounts of the
    Obligations thereunder. Notwithstanding the foregoing, neither
    the Notes nor the Guarantees are or will be secured by the
    European Collateral or the Separate Receivables Collateral and,
    until after the Discharge of the First Lien Obligations, the
    Notes and the Guarantees will not be secured by any Principal
    Properties. Upon the Discharge of First Lien Obligations and so
    long as no First Lien Obligations are outstanding, the Principal
    Properties that constituted &#147;Collateral&#148; under the
    First Lien Security Documents Facility will become Collateral
    with respect to the Notes, subject to the same limitation on the
    amount of Obligations secured thereby as contained in the First
    Lien Security Documents. See also &#147;&#151;&#160;Certain
    Limitations on the Collateral&#148; below. Priority Lien Secured
    Parties have rights and remedies with respect to the Collateral
    that, if exercised, could adversely affect the value of the
    Collateral or the ability of the respective agents under the
    Intercreditor Agreements to realize or foreclose on the
    Collateral on behalf of holders of the Notes. For a description
    of the Shared Receivables Collateral and the Non-Receivables
    Collateral, see &#147;Description of Other
    Indebtedness&#160;&#151; Senior Secured Credit
    Facilities&#160;&#151; Guarantee and Security.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer and the Guarantors are and will be able to incur
    additional Indebtedness in the future which could share in the
    Collateral, including additional First Lien Obligations,
    additional ABL Obligations, additional Junior Lien Obligations
    and Obligations secured by Permitted Liens. The amount of such
    additional Obligations are and will be limited by the covenant
    described under &#147;Certain Covenants&#160;&#151; Liens&#148;
    and the covenant described under &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock.&#148;
    Under certain circumstances, the amount of any such additional
    Obligations could be significant.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">After-Acquired
    Collateral</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    From and after the Issue Date and subject to certain limitations
    and exceptions, (a)&#160;if the Issuer or any Guarantor creates
    any additional security interest upon any property or asset that
    would constitute Collateral to secure any First Lien Obligations
    (other than Principal Properties prior to the Discharge of First
    Lien Obligations and so long as no First Lien Obligations are
    outstanding and other than European Collateral and Separate
    Receivables Collateral), it must concurrently grant a
    second-priority perfected security interest (subject to
    Permitted Liens) upon such property as security for the Notes
    and (b)&#160;if the Issuer or any Guarantor creates any
    additional security interest upon any property or asset that
    would constitute Shared Receivables Collateral to secure any
    Priority Lien Obligations, it must concurrently grant a
    third-priority perfected security interest (subject to Permitted
    Liens) upon such property as security for the Notes.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Liens
    with Respect to the Collateral</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <I><FONT style="font-family: 'Times New Roman', Times">Security
    Documents and Intercreditor Agreements</FONT></I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer, the Guarantors and the Junior Lien Collateral Agent
    entered into the Security Documents with respect to the
    Collateral defining the terms of the security interests that
    secure the Notes and the Guarantees with respect to such
    Collateral. These security interests secure the payment and
    performance when due of all of the Obligations of the Issuer and
    the Guarantors under the Notes, the Indenture, the Guarantees
    and the Security Documents, as provided in the Security
    Documents.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    46
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Junior Lien Collateral Agent and the First Lien Collateral
    Agent entered into the General Intercreditor Agreement (as the
    same may be amended from time to time, the <I>&#147;General
    Intercreditor Agreement&#148;</I>) with respect to the
    Collateral. The First Lien Collateral Agent is initially the
    Collateral Agent under the General Credit Facility. The Junior
    Lien Collateral Agent is initially the Trustee. Pursuant to the
    terms of the General Intercreditor Agreement, prior to the
    Discharge of First Lien Obligations, the First Lien Collateral
    Agent, acting on behalf of the First Lien Secured Parties, will
    determine the time and method by which the security interests in
    the Collateral will be enforced and will have the sole and
    exclusive right to manage, perform and enforce the terms of the
    Security Documents relating to the Collateral and to exercise
    and enforce all privileges, rights and remedies thereunder
    according to its direction, including to take or retake control
    or possession of such Collateral and to hold, prepare for sale,
    marshall, process, sell, lease, dispose of or liquidate such
    Collateral, including, without limitation, following the
    occurrence of a Default or Event of Default under the Indenture.
    The Junior Lien Collateral Agent will not be permitted to
    enforce the security interests even if any Event of Default
    under the Indenture has occurred and the Notes have been
    accelerated except (a)&#160;in any insolvency or liquidation
    proceeding, solely as necessary to file a proof of claim or
    statement of interest with respect to the Junior Lien
    Obligations or (b)&#160;as necessary to take any action in order
    to prove, preserve, perfect or protect (but not enforce) its
    security interest and rights in, and the perfection and priority
    of its Lien on, the Collateral. See &#147;Risk
    Factors&#160;&#151; Risks Related to the Notes&#160;&#151; The
    lien ranking provisions of the Indenture and other agreements
    relating to the collateral securing the notes will limit the
    rights of holders of the notes with respect to that collateral,
    even during an event of default.&#148; After the Discharge of
    First Lien Obligations, the Junior Lien Collateral Agent in
    accordance with the provisions of the Junior Lien Documents will
    distribute all cash proceeds (after payment of the costs of
    enforcement and collateral administration and any other amounts
    owed to the Junior Lien Collateral Agent) of the Collateral
    received by it under the Security Documents for the ratable
    benefit of the holders of Junior Lien Obligations. The proceeds
    from the sale of the Collateral remaining after the satisfaction
    of all First Lien Obligations may not be sufficient to satisfy
    the Junior Lien Obligations. By its nature some or all of the
    Collateral is and will be illiquid and may have no readily
    ascertainable market value. Accordingly, the Collateral may not
    be able to be sold in a short period of time, if salable. See
    &#147;Risk Factors&#160;&#151; Risks Related to the
    Notes&#160;&#151; The value of the collateral securing the notes
    may not be sufficient to satisfy our obligations under the
    notes.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Junior Lien Collateral Agent, for itself and on behalf of
    each Junior Lien Secured Party, has agreed in the General
    Intercreditor Agreement that (a)&#160;it will not (and thereby
    waives any right to) take any action to challenge, contest or
    support any other Person in contesting or challenging, directly
    or indirectly, in any proceeding (including any insolvency or
    liquidation proceeding), the validity, perfection, priority or
    enforceability of a Lien securing any First Lien Obligations
    held (or purported to be held) by or on behalf of the First Lien
    Collateral Agent or any of the First Lien Secured Parties or any
    agent or trustee therefor in any Collateral or other First Lien
    Collateral and (b)&#160;it will not oppose or otherwise contest
    (or support any other Person contesting) any request for
    judicial relief made in any court by the First Lien Collateral
    Agent or any First Lien Secured Parties relating to the lawful
    enforcement of any First Priority Lien on Collateral or other
    First Lien Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, the Security Documents provide that, prior to the
    Discharge of First Lien Obligations, (1)&#160;the First Lien
    Collateral Agent may take actions with respect to the Collateral
    (including the release of Collateral and the manner of
    realization (subject to the provisions described under
    &#147;&#151;&#160;Release of Collateral&#148;)) without the
    consent of the Junior Lien Collateral Agent or other Junior Lien
    Secured Parties and (2)&#160;the Issuer and the Guarantors may
    require the Junior Lien Collateral Agent to agree to modify the
    Security Documents, or the General Intercreditor Agreement,
    without the consent of the Junior Lien Collateral Agent or other
    Junior Lien Secured Parties, to secure additional extensions of
    credit and add additional First Lien Secured Parties or Junior
    Lien Secured Parties so long as such modifications do not
    expressly violate the provisions of the General Credit Facility
    or the Indenture. In addition, the General Intercreditor
    Agreement provides that with respect to Collateral in the event
    that the First Lien Collateral Agent or the First Lien Secured
    Parties enter into any amendment, waiver or consent in respect
    of or replace any of the First Lien Security Documents for the
    purpose of adding to, or deleting from, or waiving or consenting
    to any departures from any provisions of, any First Lien
    Security Document or changing in any manner the rights of the
    First Lien Collateral Agent, the First Lien Secured Parties, the
    Issuer or any Guarantor thereunder (including the release of any
    Liens in
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    47
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Collateral in accordance with the provisions described under
    &#147;&#151;&#160;Release of Collateral&#148;), then such
    amendment, waiver or consent shall apply automatically to any
    comparable provision of each comparable Security Document in
    favor of the Junior Lien Obligations without the consent of the
    Junior Lien Collateral Agent, any Junior Lien Representative or
    any Junior Lien Secured Party and without any action by the
    Junior Lien Collateral Agent, any Junior Lien Representative,
    the Issuer or any Guarantor; <I>provided</I> that such
    amendment, waiver or consent does not materially adversely
    affect the rights of the Junior Lien Secured Parties or the
    interests of the Junior Lien Secured Parties in the Collateral
    in a manner materially different from that affecting the rights
    of the First Lien Secured Parties thereunder or therein. Any
    provider of additional extensions of credit shall be entitled to
    rely on the determination of an Officer that such modifications
    do not expressly violate the provisions of the General Credit
    Facility or the Indenture if such determination is set forth in
    an Officer&#146;s Certificate delivered to such provider.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    So long as the Discharge of First Lien Obligations has not
    occurred, the Collateral or proceeds thereof received in
    connection with the sale or other disposition of, or collection
    on, such Non-Receivables Collateral upon the exercise of
    remedies will be applied by the First Lien Collateral Agent to
    the First Lien Obligations in such order as specified in the
    relevant First Lien Documents until the Discharge of First Lien
    Obligations has occurred. Upon the Discharge of First Lien
    Obligations, the First Lien Collateral Agent shall deliver to
    the Junior Lien Collateral Agent (for the benefit of all Junior
    Lien Secured Parties) any remaining proceeds of Collateral held
    by it in the same form as received, with any necessary
    endorsements or as a court of competent jurisdiction may
    otherwise direct to be applied by the Junior Lien Collateral
    Agent to the Junior Lien Obligations in such order as specified
    in the Junior Lien Documents.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, so long as the Discharge of First Lien Obligations
    has not occurred, neither the Junior Lien Collateral Agent nor
    any Junior Lien Representative shall acquire or hold any Lien on
    any assets of the Issuer or any Subsidiary (and neither the
    Issuer nor any Subsidiary shall grant such Lien) securing any
    Junior Lien Obligations that are not also subject to the First
    Priority Lien in respect of the First Lien Obligations under the
    First Lien Documents. If the Junior Lien Collateral Agent or any
    Junior Lien Representative shall acquire or hold any Lien on any
    assets of the Issuer or any Subsidiary that is not also subject
    to the First Priority Lien in respect of the First Lien
    Obligations under the First Lien Documents, then such Junior
    Lien Collateral Agent or other Junior Lien Representative shall,
    without the need for any further consent of any party and
    notwithstanding anything to the contrary in any other document,
    be deemed to also hold and have held such Lien for the benefit
    of the First Lien Collateral Agent as security for the First
    Lien Obligations (subject to the lien priority and other terms
    hereof).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Junior Lien Collateral Agent and each other Junior Lien
    Secured Party have agreed that any Lien purported to be granted
    on any Collateral as security for First Lien Obligations shall
    be deemed to be and shall be deemed to remain senior in all
    respects and prior to all Liens on the Collateral securing any
    Junior Lien Obligations for all purposes regardless of whether
    the Lien purported to be granted is found to be improperly
    granted, improperly perfected, preferential, a fraudulent
    conveyance or legally or otherwise deficient or invalid, in
    whole or in part, in any manner.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any Collateral or proceeds thereof received by any Junior Lien
    Secured Party at a time when such receipt is not expressly
    permitted by the terms of the General Intercreditor Agreement or
    prior to the Discharge of First Lien Obligations shall be
    segregated and held in trust for the benefit of and forthwith
    paid over to the First Lien Collateral Agent (and/or its
    designees) for the benefit of the First Lien Secured Parties in
    the same form as received, with any necessary endorsements or as
    a court of competent jurisdiction may otherwise direct.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If any First Lien Secured Party is required in any insolvency or
    liquidation proceeding or otherwise to turn over or otherwise
    pay to the estate of the Issuer or any other Guarantor (or any
    trustee, receiver or similar person therefor), because the
    payment of such amount was declared to be fraudulent or
    preferential in any respect or for any other reason, any amount
    (a <I>&#147;Recovery&#148;</I>), whether received as proceeds of
    security, enforcement of any right of setoff or otherwise, then
    as among the parties hereto, the First Lien Obligations shall be
    deemed to be reinstated to the extent of such Recovery and to be
    outstanding as if such payment had not occurred and such First
    Lien Secured Party shall be entitled to a reinstatement of First
    Lien Obligations
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    48
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    with respect to all such recovered amounts and shall have all
    rights hereunder. If the General Intercreditor Agreement shall
    have been terminated prior to such Recovery, the General
    Intercreditor Agreement shall be reinstated in full force and
    effect, and such prior termination shall not diminish, release,
    discharge, impair or otherwise affect the obligations of the
    parties thereto. Any Collateral or other First Lien Collateral
    or proceeds thereof received by any Junior Lien Secured Party
    prior to the time of such Recovery shall be deemed to have been
    received prior to the Discharge of First Lien Obligations and
    subject to the provisions of the immediately preceding paragraph.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, if at any time in connection with or after the
    Discharge of First Lien Obligations the Issuer either in
    connection therewith or thereafter enters into any Refinancing
    of any First Lien Document evidencing a First Lien Obligation,
    then such Discharge of First Lien Obligations shall
    automatically be deemed not to have occurred for all purposes of
    the General Intercreditor Agreement, the First Lien Documents
    and the Junior Lien Documents, and the obligations under such
    Refinancing shall automatically be treated as First Lien
    Obligations for all purposes of the General Intercreditor
    Agreement, including for purposes of the Lien priorities and
    rights in respect of Collateral set forth therein, the related
    documents shall be treated as First Lien Documents for all
    purposes of the General Intercreditor Agreement and the first
    lien collateral agent under such Refinanced First Lien Documents
    shall be First Lien Collateral Agent for all purposes of the
    General Intercreditor Agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The General Intercreditor Agreement provides that, prior to the
    Discharge of First Lien Obligations, neither the Junior Lien
    Collateral Agent nor any other Junior Lien Secured Parties may
    assert or enforce any right of marshalling accorded to a junior
    lienholder, as against the First Lien Collateral Agent or any
    First Lien Secured Party (in their capacity as priority
    lienholders). Following the Discharge of First Lien Obligations,
    the Junior Lien Secured Parties may assert their right under the
    Uniform Commercial Code or otherwise to any proceeds remaining
    following a sale or other disposition of Collateral by, or on
    behalf of, the First Lien Collateral Agent or the First Lien
    Secured Parties. This waiver of all rights of marshalling prior
    to the Discharge of First Lien Obligations may result in
    proceeds from the sale of Collateral (in which the Junior Lien
    Secured Parties have second-priority Liens) being applied to
    repay First Lien Obligations prior to the application of the
    proceeds of Shared Receivables Collateral (in which the Junior
    Lien Secured Parties have third-priority Liens), the Principal
    Properties (in which the Junior Lien Secured Parties will not
    have a security interest prior to the Discharge of First Lien
    Obligations and during any time that any First Lien Obligations
    are outstanding) or the European Collateral or the Separate
    Receivables Collateral (in which the Junior Lien Secured Parties
    do not have a security interest). In that scenario, Junior Lien
    Secured Parties may recover less than they would have if such
    proceeds were applied in the order most favorable to the Junior
    Lien Secured Parties.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    So long as the Discharge of First Lien Obligations has not
    occurred, whether or not any insolvency or liquidation
    proceeding has been commenced by or against the Issuer or any
    Guarantor, (i)&#160;neither the Junior Lien Collateral Agent,
    any Junior Lien Representative nor any Junior Lien Secured Party
    will (x)&#160;exercise or seek to exercise any rights or
    remedies (including setoff or the right to credit bid debt
    (except as set forth in the next paragraph below)) with respect
    to any Collateral in respect of any applicable Junior Lien
    Obligations, or institute any action or proceeding with respect
    to such rights or remedies (including any action of
    foreclosure), (y)&#160;contest, protest or otherwise object to
    any foreclosure or enforcement proceeding or action brought with
    respect to the Collateral or any other collateral by the First
    Lien Collateral Agent or any First Lien Secured Party in respect
    of the First Lien Obligations, the exercise of any right by the
    First Lien Collateral Agent or any First Lien Secured Party (or
    any agent or
    <FONT style="white-space: nowrap">sub-agent</FONT> on
    their behalf) in respect of the First Lien Obligations under any
    control agreement, lockbox agreement, landlord waiver or
    bailee&#146;s letter or similar agreement or arrangement to
    which the Junior Lien Collateral Agent, any Junior Lien
    Representative or any Junior Lien Secured Party either is a
    party or may have rights as a third-party beneficiary, or any
    other exercise by any such party of any rights and remedies as a
    secured party relating to the Collateral or any other collateral
    under the First Lien Documents or otherwise in respect of First
    Lien Obligations, or (z)&#160;object to any waiver or
    forbearance by the First Lien Secured Parties from or in respect
    of bringing or pursuing any foreclosure proceeding or action or
    any other exercise of any rights or remedies relating to the
    Collateral or any other collateral in respect of First Lien
    Obligations and (ii)&#160;except as otherwise provided in the
    General
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    49
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Intercreditor Agreement, the First Lien Collateral Agent and the
    First Lien Secured Parties shall have the sole and exclusive
    right to enforce rights, exercise remedies (including setoff and
    the right to credit bid their debt), marshal, process and make
    determinations regarding the release, disposition or
    restrictions, or waiver or forbearance of rights or remedies
    with respect to the Collateral without any consultation with or
    the consent of the Junior Lien Collateral Agent, any Junior Lien
    Representative or any Junior Lien Secured Party.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding the foregoing, the General Intercreditor
    Agreement shall not be construed to in any way limit or impair
    the right of any Junior Lien Secured Party from exercising a
    credit bid with respect to the Junior Lien Obligations in a sale
    or other disposition of Collateral under Section&#160;363 of the
    Bankruptcy Code; <I>provided </I>that in connection with and
    immediately after giving effect to such sale and credit bid
    there occurs a Discharge of First Lien Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, the Junior Lien Collateral Agent, each Junior Lien
    Representative and each other Junior Lien Secured Party have
    agreed that if the Issuer or any Guarantor is subject to any
    insolvency or liquidation proceeding:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;if the First Lien Collateral Agent acting on behalf of
    First Lien Secured Parties desires to permit the use of cash
    collateral or to permit the Issuer or any Guarantor to obtain
    financing under Section&#160;363 or Section&#160;364 of the
    Bankruptcy Code or any similar provision in any Bankruptcy Law
    <I>(&#147;DIP Financing&#148;)</I>, including if such DIP
    Financing is secured by Liens senior in priority to the Liens
    securing the Notes or other Junior Lien Obligations, then the
    Junior Lien Collateral Agent and each Junior Lien
    Representative, on behalf of itself and each applicable Junior
    Lien Secured Party, agrees not to object to such use of cash
    collateral or DIP Financing and will not request adequate
    protection or any other relief in connection therewith (except
    to the extent permitted by the General Intercreditor Agreement,
    as set forth below) and, to the extent the Liens securing the
    First Lien Obligations are subordinated or <I>pari passu
    </I>with such DIP Financing, will subordinate its Liens in the
    Collateral and any other collateral to such DIP Financing (and
    all Obligations relating thereto) on the same basis as they are
    subordinated to the First Lien Obligations;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;none of them will object to, or otherwise contest (or
    support any other Person contesting), any motion for relief from
    the automatic stay or from any injunction against foreclosure or
    enforcement in respect of the First Lien Obligations made by the
    First Lien Collateral Agent or any First Lien Secured Party;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;none of them will object to, or otherwise contest (or
    support any other Person contesting), any order relating to a
    sale of assets of any Issuer or Guarantor for which the First
    Lien Collateral Agent has consented that provides, to the extent
    that sale is to be free and clear of Liens, that the Liens
    securing the First Lien Obligations and the Junior Lien
    Obligations will attach to the proceeds of the sale on the same
    basis of priority as the existing Liens in accordance with the
    General Intercreditor Agreement;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;none of them will seek relief from the automatic stay
    or any other stay in any insolvency or liquidation proceeding in
    respect of the Collateral or any other First Lien Collateral,
    without the prior written consent of the First Lien Collateral
    Agent;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;none of them will object to, or otherwise contest (or
    support any other Person contesting), (a)&#160;any request by
    the First Lien Collateral Agent or any First Lien Secured Party
    for adequate protection or (b)&#160;any objection by the First
    Lien Collateral Agent or any First Lien Secured Party to any
    motion, relief, action or proceeding based on the First Lien
    Collateral Agent&#146;s or such First Lien Secured Party&#146;s
    claiming a lack of adequate protection;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;none of them will assert or enforce (or support any
    Person asserting or enforcing) any claim under
    Section&#160;506(c) of the Bankruptcy Code senior to or on a
    parity with the Liens securing the First Lien Obligations for
    costs or expenses of preserving or disposing of any Collateral
    or First Lien Collateral;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    50
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;none of them will oppose or otherwise contest (or
    support any other Person contesting) any lawful exercise by the
    First Lien Collateral Agent or any First Lien Secured Party of
    the right to credit bid First Lien Obligations at any sale of
    Collateral or First Lien Collateral;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;none of them will challenge (or support any other
    person challenging) the validity, enforceability, perfection or
    priority of the First Priority Liens on Collateral or First Lien
    Collateral (and the General Intercreditor Agreement will provide
    that the First Lien Secured Parties agree that none of them will
    challenge the validity, enforceability, perfection or priority
    of the Liens in favor of the Trustee and each other Junior Lien
    Secured Party on the Collateral).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, neither the Junior Lien Collateral Agent, any
    Junior Lien Representative nor any other Junior Lien Secured
    Party will file or prosecute in any insolvency or liquidation
    proceeding any motion for adequate protection (or any comparable
    request for relief) based upon their respective security
    interests in the Collateral, except that:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any of them may freely seek and obtain relief granting
    a junior Lien co-extensive in all respects with, but
    subordinated to, all Liens granted in the insolvency or
    liquidation proceeding to, or for the benefit of, the First Lien
    Secured Parties (and the General Intercreditor Agreement will
    provide that the First Lien Secured Parties will not object to
    the granting of such a junior Lien);&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any of them may freely seek and obtain any relief upon
    a motion for adequate protection (or any comparable relief),
    without any condition or restriction whatsoever, at any time
    after the Discharge of First Lien Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Without limiting the generality of any provisions of the General
    Intercreditor Agreement, any vote to accept, and any other act
    to support the confirmation or approval of, any Non-Conforming
    Plan of Reorganization shall be inconsistent with and,
    accordingly, a violation of the terms of the General
    Intercreditor Agreement, and the First Lien Collateral Agent
    shall be entitled to have any such vote to accept a
    Non-Conforming Plan of Reorganization dismissed and any such
    support of any Non-Conforming Plan of Reorganization withdrawn.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Subject to the terms of the Security Documents, the Issuer and
    the Guarantors have the right to remain in possession and retain
    exclusive control of the Collateral securing the Notes and the
    Junior Lien Obligations (other than securities, instruments and
    chattel paper constituting part of the Collateral and deposited
    with the First Lien Collateral Agent in accordance with the
    provisions of the First Lien Security Documents and any Shared
    Receivables Collateral subject to a control agreement under the
    circumstances described in the First Lien Security Documents),
    to freely operate the Collateral and to collect, invest and
    dispose of any income therefrom.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Junior Lien Collateral Agent and each Junior Lien
    Representative, on behalf of the Junior Lien Secured Parties,
    have acknowledged and agreed in the General Intercreditor
    Agreement that (a)&#160;the Junior Lien Secured Parties&#146;
    claims against the Issuer
    <FONT style="white-space: nowrap">and/or</FONT> any
    Guarantor in respect of the Collateral constitute junior claims
    separate and apart (and of a different class) from the senior
    claims of the First Lien Secured Parties against the Issuer and
    the Guarantor in respect of the Collateral, (b)&#160;the First
    Lien Obligations include all interest that accrues after the
    commencement of any insolvency or liquidation proceeding of the
    Issuer or any Guarantor at the rate provided for in the
    applicable First Lien Documents governing the same, whether or
    not a claim for post-petition interest is allowed or allowable
    in any such insolvency or liquidation proceeding and
    (c)&#160;the Intercreditor Agreement constitutes a
    &#147;subordination agreement&#148; under Section&#160;510 of
    the Bankruptcy Code.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    51
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Release
    of Collateral</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer and the Guarantors are entitled to the release of
    property and other assets constituting Collateral from the Liens
    securing the Notes and the Junior Lien Obligations under any one
    or more of the following circumstances:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;to enable us to consummate the sale, transfer or other
    disposition of such property or assets to the extent not
    prohibited under the covenant described under
    &#147;&#151;&#160;Repurchase at the Option of
    Holders&#160;&#151; Asset Sales&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the release of Excess Proceeds or Collateral Excess
    Proceeds that remain unexpended after the conclusion of an Asset
    Sale Offer or a Collateral Asset Sale Offer conducted in
    accordance with the Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;in the case of a Guarantor that is released from its
    Guarantee with respect to the Notes pursuant to the terms of the
    Indenture, the release of the property and assets of such
    Guarantor;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;with the consent of the holders of at least 75% of the
    aggregate principal amount of the Notes then outstanding and
    affected thereby and a majority of all Junior Lien Obligations
    (including the Notes) then outstanding and affected thereby
    (including, without limitation, consents obtained in connection
    with a tender offer or exchange offer for, or purchase of,
    Junior Lien Obligations);&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;as described under &#147;&#151;&#160;Amendment,
    Supplement and Waiver&#148; below.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Junior Liens on any Collateral securing the Junior Lien
    Obligations will also terminate and be released automatically if
    the First Priority Liens on such Collateral securing First Lien
    Obligations are released by the First Lien Collateral Agent on
    behalf of the First Lien Secured Parties, unless such release
    occurs in connection with, and after giving effect to, a
    Discharge of First Lien Obligations, which discharge is not in
    connection with a foreclosure of, or other exercise of remedies
    with respect to, Collateral by the First Lien Secured Parties
    (such discharge not in connection with any such foreclosure or
    exercise of remedies, a <I>&#147;Payment Discharge&#148;</I>)
    (<I>provided </I>that, in the case of a Payment Discharge, the
    Liens on any Collateral disposed of in connection with the
    satisfaction in whole or in part of First Lien Obligations shall
    be automatically released but any proceeds thereof not used for
    purposes of the Discharge of First Lien Obligations or otherwise
    in accordance with the Indenture shall be subject to Liens in
    favor of the Junior Lien Secured Parties). In the event of a
    Payment Discharge, the Junior Liens on Collateral shall become
    first-priority security interests, subject to Permitted Liens,
    any intercreditor agreements or arrangements among Junior Lien
    Secured Parties permitted under the General Intercreditor
    Agreement and, with respect to Shared Receivables Collateral,
    subject to the Shared Receivables Intercreditor Agreement;
    <I>provided </I>that if the Issuer or the Guarantors incur at
    any time thereafter any new or replacement First Lien
    Obligations permitted under the Indenture, then such Payment
    Discharge shall automatically be deemed not to have occurred for
    all purposes of the General Intercreditor Agreement, the First
    Lien Documents and the Junior Lien Documents, and such new
    Obligations shall automatically be treated as First Lien
    Obligations for all purposes of the General Intercreditor
    Agreement, including for purposes of the Lien priorities and
    rights in respect of Collateral set forth therein, and the
    related documents shall be treated as First Lien Documents.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    To the extent necessary and for so long as required for such
    Subsidiary not to be subject to any requirement pursuant to
    <FONT style="white-space: nowrap">Rule&#160;3-16</FONT>
    of
    <FONT style="white-space: nowrap">Regulation&#160;S-X</FONT>
    under the Securities Act to file separate financial statements
    with the SEC (or any other governmental agency), the Capital
    Stock of any Subsidiary of the Company shall not be included in
    the Collateral with respect to the respective Notes so affected
    (as described under &#147;&#151;&#160;Certain Limitations on the
    Collateral&#148;) and shall not be subject to the Liens securing
    such Notes and the Junior Lien Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Junior Liens on the Collateral securing the Notes and the
    Guarantees also will be released upon (i)&#160;payment in full
    of the principal of, together with accrued and unpaid interest
    (including Additional Interest, if any) on, the Notes and all
    other Obligations under the Indenture, the Guarantees and the
    Security Documents that are due and payable at or prior to the
    time such principal, together with accrued and unpaid interest
    (including Additional Interest, if any), are paid or (ii)&#160;a
    legal defeasance or covenant defeasance under
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    52
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    the Indenture as described below under &#147;Legal Defeasance
    and Covenant Defeasance&#148; or a discharge of the Indenture as
    described under &#147;Satisfaction and Discharge.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any certificate or opinion required by Section&#160;314(d) of
    the Trust&#160;Indenture Act may be made by an Officer of the
    Company, except in cases where Section&#160;314(d) requires that
    such certificate or opinion be made by an independent engineer,
    appraiser or other expert.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding anything to the contrary herein, the Issuer and
    its Subsidiaries will not be required to comply with all or any
    portion of Section&#160;314(d) of the Trust&#160;Indenture Act
    if they determine, in good faith based on advice of counsel,
    that under the terms of that section
    <FONT style="white-space: nowrap">and/or</FONT> any
    interpretation or guidance as to the meaning thereof of the SEC
    and its staff, including &#147;no action&#148; letters or
    exemptive orders, all or any portion of Section&#160;314(d) of
    the Trust&#160;Indenture Act is inapplicable to the released
    Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Without limiting the generality of the foregoing, certain no
    action letters issued by the SEC have permitted an indenture
    qualified under the Trust&#160;Indenture Act to contain
    provisions permitting the release of collateral from Liens under
    such indenture in the ordinary course of the issuer&#146;s
    business without requiring the issuer to provide certificates
    and other documents under Section&#160;314(d) of the
    Trust&#160;Indenture Act. The Issuer and the Guarantors may,
    subject to the provisions of the Indenture, among other things,
    without any release or consent by the Junior Lien Collateral
    Agent, conduct ordinary course activities with respect to the
    Collateral, including, without limitation:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    selling or otherwise disposing of, in any transaction or series
    of related transactions, any property subject to the Lien of the
    Security Documents that has become worn out, defective, obsolete
    or not used or useful in the business;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    abandoning, terminating, canceling, releasing or making
    alterations in or substitutions of any leases or contracts
    subject to the Lien of the Indenture or any of the Security
    Documents;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    surrendering or modifying any franchise, license or permit
    subject to the Lien of the Security Documents that it may own or
    under which it may be operating;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    altering, repairing, replacing, changing the location or
    position of and adding to its structures, machinery, systems,
    equipment, fixtures and appurtenances;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    granting a license of any intellectual property;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    selling, transferring or otherwise disposing of inventory in the
    ordinary course of business;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    collecting accounts receivable in the ordinary course of
    business as permitted by the covenant described under
    &#147;Repurchase at the Option of Holders&#160;&#151; Asset
    Sales&#148;;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    making cash payments (including for the repayment of
    Indebtedness or interest) from cash that is at any time part of
    the Collateral in the ordinary course of business that are not
    otherwise prohibited by the Indenture and the Security
    Documents;&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    abandoning any intellectual property that is no longer used or
    useful in the Issuer&#146;s business.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer must deliver an Officer&#146;s Certificate to the
    Junior Lien Collateral Agent within 30 calendar days following
    the end of each six-month period beginning on May 15 and
    November 15 of each year, to the effect that all such releases
    and withdrawals during the preceding six-month period (or since
    the Issue Date, in the case of the first such certificate) in
    the ordinary course of the Issuer&#146;s or the Guarantors&#146;
    business, as described in the preceding paragraph, were not
    prohibited by the Indenture.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Shared
    Receivables Intercreditor Agreement</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, the Junior Lien Collateral Agent, the First Lien
    Collateral Agent and the collateral agent with respect to the
    ABL Facility (the <I>&#147;ABL Collateral Agent&#148;</I>)
    entered into a Shared Receivables Intercreditor Agreement (as
    the same may be amended from time to time, the <I>&#147;Shared
    Receivables Intercreditor Agreement&#148;</I>) with respect to
    the Shared Receivables Collateral. The Shared Receivables
    Intercreditor Agreement contains provisions with respect to the
    Shared Receivables Collateral and the relative rights,
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    53
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    privileges and obligations relating thereto as between
    (a)&#160;the Junior Lien Collateral Agent, the other Junior Lien
    Secured Parties, the First Lien Collateral Agent and the First
    Lien Secured Parties and (b)&#160;the ABL Collateral Agent and
    the ABL Secured Parties. The Shared Receivables Intercreditor
    Agreement provides for first-priority Liens in the Shared
    Receivables Collateral in favor of the ABL Secured Parties,
    second-priority Liens in the Shared Receivables Collateral in
    favor of the First Lien Secured Parties and third-priority
    security interests in the Shared Receivables Collateral in favor
    of the Junior Lien Secured Parties, in each case, subject to
    Permitted Liens. The relative rights, privileges and obligations
    with respect to the Shared Receivables Collateral of the ABL
    Secured Parties, on the one hand, and the Junior Lien Collateral
    Agent, the other Junior Lien Secured Parties, the First Lien
    Collateral Agent and the First Lien Secured Parties, on the
    other, are substantially identical to the relative rights,
    privileges and obligations with respect to the Non-Receivables
    Collateral of the First Lien Secured Parties, on the one hand,
    and the Junior Lien Secured Parties, on the other, respectively,
    except that the Liens of the Junior Lien Secured Parties in the
    Shared Receivables Collateral are third-priority Liens and
    except to the extent customary or necessary with respect to
    collateral of the type that constitutes Shared Receivables
    Collateral.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Certain
    Limitations on the Collateral</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Collateral securing the Notes does not and will not include
    any of the following assets:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the property or assets owned by any Subsidiary of the
    Issuer that is not a Guarantor, including each ABL Financing
    Entity;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any rights or interests of the Issuer or any Guarantor
    in, to or under any agreement, contract, license, instrument,
    document or other general intangible (referred to solely for
    purposes of this clause&#160;(2) as a
    <I>&#147;Contract&#148;</I>), any intellectual property or any
    security or other investment property (i)&#160;to the extent the
    security interest in such Collateral is prohibited by any
    applicable contract, agreement or other instrument without the
    consent of any other party thereto (other than a party to the
    General Credit Facility or the Indenture or, in the case of
    investment property, a Wholly-Owned Subsidiary), (ii)&#160;to
    the extent the security interest in such Contract would give any
    other party (other than a party to the General Credit Facility
    or the Indenture or, in the case of investment property, a
    Wholly-Owned Subsidiary) to such Collateral the right to
    terminate its obligations thereunder or (iii)&#160;to the extent
    all necessary consents to such grant of a security interest have
    not been obtained from the other parties thereto (other than to
    the extent that any such prohibition referred to in clauses (i),
    (ii)&#160;and (iii)&#160;would be rendered ineffective pursuant
    to
    <FONT style="white-space: nowrap">Sections&#160;9-406,</FONT>
    9-407, 9-408 or 9-409 of the Uniform Commercial Code (or any
    successor provision or provisions) of any relevant jurisdiction
    or any other applicable law)); <I>provided</I> that this
    limitation shall not affect, limit, restrict or impair the grant
    by the Issuer or such Guarantor of a security interest in any
    account receivable or any money or other amounts due or to
    become due under any Contract;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;any equipment of the Issuer or any Guarantor that is
    subject to, or secured by, a Capitalized Lease Obligation or
    Purchase Money Obligations and any equipment that constitutes an
    asset of an entity acquired in a transaction permitted by the
    Indenture to the extent that such equipment subject to a Lien
    permitted by the Indenture and the terms of the Indebtedness
    secured by such Lien prohibit assignment of, or granting of a
    security interest in, the Issuer&#146;s or such Guarantor&#146;s
    rights and interests therein (other than to the extent that any
    such prohibition would be rendered ineffective pursuant to
    <FONT style="white-space: nowrap">Sections&#160;9-406,</FONT>
    <FONT style="white-space: nowrap">9-407,</FONT> 9-408
    or 9-409 of the Uniform Commercial Code (or any successor
    provision or provisions) of any relevant jurisdiction or any
    other applicable law); <I>provided </I>that immediately upon the
    repayment of all Indebtedness secured by such Lien, the Issuer
    or the Guarantor, as the case may be, shall be deemed to have
    granted a security interest in all the rights and interests with
    respect to such equipment;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;any Voting Stock that is issued by any Foreign
    Subsidiary, if and to the extent that the inclusion of such
    Voting Stock in the Collateral would cause the Collateral
    pledged by the Issuer or the applicable Guarantor, as the case
    may be, to include in the aggregate more than 65% of the total
    combined voting power of all classes of Voting Stock of such
    Foreign Subsidiary;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    54
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;any Capital Stock that is issued by a Subsidiary that
    is not owned directly by the Issuer or a Guarantor;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;prior to the Discharge of First Lien Obligations and so
    long as any First Lien Obligations are outstanding, any
    Principal Properties;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;any Capital Stock and other securities of a Subsidiary
    (excluding Healthtrust, Inc.&#160;&#151; The Hospital Company, a
    Delaware corporation and its successors and assigns) to the
    extent that the pledge of such Capital Stock and other
    securities results in the Company&#146;s being required to file
    separate financial statements of such Subsidiary with the SEC,
    but only to the extent necessary to not be subject to such
    requirement and only for so long as such requirement is in
    existence and only with respect to the relevant Notes affected;
    <I>provided</I> that neither the Issuer nor any Subsidiary shall
    take any action in the form of a reorganization, merger or other
    restructuring a principal purpose of which is to provide for the
    release of the Lien on any Capital Stock pursuant to this clause
    (7). In addition, in the event that
    <FONT style="white-space: nowrap">Rule&#160;3-16</FONT>
    of
    <FONT style="white-space: nowrap">Regulation&#160;S-X</FONT>
    under the Securities Act is amended, modified or interpreted by
    the SEC to require (or is replaced with another rule or
    regulation, or any other law, rule or regulation is adopted,
    which would require) the filing with the SEC (or any other
    governmental agency) of separate financial statements of any
    Subsidiary of the Company due to the fact that such
    Subsidiary&#146;s Capital Stock secures the Notes affected
    thereby, then the Capital Stock of such Subsidiary will
    automatically be deemed not to be part of the Collateral
    securing the relevant Notes affected thereby but only to the
    extent necessary to not be subject to such requirement and only
    for so long as required to not be subject to such requirement.
    In such event, the Security Documents may be amended or
    modified, without the consent of any holder of such Notes, to
    the extent necessary to release the security interests in favor
    of the applicable collateral agents on the shares of Capital
    Stock that are so deemed to no longer constitute part of the
    Collateral for the relevant Notes. In the event that Rule 3-16
    of
    <FONT style="white-space: nowrap">Regulation&#160;S-X</FONT>
    under the Securities Act is amended, modified or interpreted by
    the SEC to permit (or is replaced with another rule or
    regulation, or any other law, rule or regulation is adopted,
    which would permit) such Subsidiary&#146;s Capital Stock to
    secure the Notes in excess of the amount then pledged without
    the filing with the SEC (or any other governmental agency) of
    separate financial statements of such Subsidiary, then the
    Capital Stock of such Subsidiary will automatically be deemed to
    be a part of the Collateral for the relevant Notes but only to
    the extent necessary to not be subject to any such financial
    statement requirement;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;certain non-Principal Properties that do not constitute
    Non-Receivables Collateral;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;any deposit accounts, other bank or securities accounts
    or cash of the Issuer or any Guarantor;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;any leaseholds and motor vehicles of the Issuer or any
    Guarantor;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;any Capital Stock or securities convertible into or
    exchangeable for Capital Stock (i)&#160;if, in the reasonable
    judgment of the Issuer, the cost or other consequences of
    pledging such Collateral shall be excessive in view of the
    benefits to be obtained by the Junior Lien Secured Parties
    therefrom or (ii)&#160;the pledge of such Collateral would
    result in adverse tax consequences to the Issuer or any of its
    Subsidiaries as reasonably determined by the Issuer and
    identified in writing to the Junior Lien Collateral Agent;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;any collateral to the extent the grant of the security
    interest therein would violate any requirement of law;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;proceeds and products from any and all of the
    foregoing excluded collateral described in clauses&#160;(1)
    through (12), unless such proceeds or products would otherwise
    constitute Collateral securing the Notes.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Sufficiency
    of Collateral</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The fair market value of the Collateral is subject to
    fluctuations based on factors that include, among others, the
    condition of the healthcare industry, the ability to sell the
    Collateral in an orderly sale, general economic conditions, the
    availability of buyers and similar factors. The amount to be
    received upon a sale of the Collateral would also be dependent
    on numerous factors, including, but not limited to, the actual
    fair
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    55
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    market value of the Collateral at such time and the timing and
    the manner of the sale. By their nature, portions of the
    Collateral may be illiquid and may have no readily ascertainable
    market value. Accordingly, there can be no assurance that the
    Collateral can be sold in a short period of time or in an
    orderly manner. In addition, in the event of a bankruptcy, the
    ability of the holders to realize upon any of the Collateral may
    be subject to certain bankruptcy law limitations as described
    below.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Certain
    Bankruptcy Limitations</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The right of the Trustee to repossess and dispose of the
    Collateral upon the occurrence of an Event of Default would be
    significantly impaired by any Bankruptcy Law in the event that a
    bankruptcy case were to be commenced by or against the Company
    or any Guarantor prior to the Trustee&#146;s having repossessed
    and disposed of the Collateral. Upon the commencement of a case
    for relief under the Bankruptcy Code, a secured creditor such as
    the Trustee is prohibited from repossessing its security from a
    debtor in a bankruptcy case, or from disposing of security
    without bankruptcy court approval.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In view of the broad equitable powers of a U.S.&#160;bankruptcy
    court, it is impossible to predict how long payments under the
    Notes could be delayed following commencement of a bankruptcy
    case, whether or when the Trustee could repossess or dispose of
    the Collateral, the value of the Collateral at any time during a
    bankruptcy case or whether or to what extent holders of the
    Notes would be compensated for any delay in payment or loss of
    value of the Collateral. The Bankruptcy Code permits only the
    payment
    <FONT style="white-space: nowrap">and/or</FONT>
    accrual of post-petition interest, costs and attorneys&#146;
    fees to a secured creditor during a debtor&#146;s bankruptcy
    case to the extent the value of such creditor&#146;s interest in
    the Collateral is determined by the bankruptcy court to exceed
    the aggregate outstanding principal amount of the obligations
    secured by the Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Furthermore, in the event a domestic or foreign bankruptcy court
    determines that the value of the Collateral is not sufficient to
    repay all amounts due on the Notes, the holders of the Notes
    would hold secured claims only to the extent of the value of the
    Collateral to which the holders of the Notes are entitled, and
    unsecured claims with respect to such shortfall.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Paying
    Agent and Registrar for the Notes</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer must maintain one or more paying agents for the Notes
    in the Borough of Manhattan, City of New York. The initial
    paying agent for the Notes is the Trustee.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer must also maintain a registrar with offices in the
    Borough of Manhattan, City of New York. The initial registrar is
    the Trustee. The registrar maintains a register reflecting
    ownership of the Notes outstanding from time to time and makes
    payments on and facilitates transfer of Notes on behalf of the
    Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer may change the paying agents or the registrars
    without prior notice to the Holders. The Issuer or any of its
    Subsidiaries may act as a paying agent or registrar.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Transfer
    and Exchange</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    A Holder may transfer or exchange Notes in accordance with the
    Indenture. The registrar and the Trustee may require a Holder to
    furnish appropriate endorsements and transfer documents in
    connection with a transfer of Notes. Holders will be required to
    pay all taxes due on transfer. The Issuer will not be required
    to transfer or exchange any Note selected for redemption. Also,
    the Issuer will not be required to transfer or exchange any Note
    for a period of 15&#160;days before a selection of Notes to be
    redeemed.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Principal,
    Maturity and Interest</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer issued $5,700,000,000 in aggregate principal amount
    of Notes in a private transaction that was not subject to the
    registration requirements of the Securities Act, of which
    $1,000,000,000 in aggregate principal amount are 2014 Cash Pay
    Notes, $3,200,000,000 in aggregate principal amount are 2016
    Cash Pay Notes and $1,500,000,000 in aggregate principal amount
    are Toggle Notes. The 2014 Cash Pay Notes will mature on
    November&#160;15, 2014, the 2016 Cash Pay Notes will mature on
    November&#160;15, 2016 and the Toggle Notes will mature on
    November&#160;15, 2016. Subject to compliance with the covenant
    described below under the
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    56
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    caption &#147;Certain Covenants&#160;&#151; Limitation on
    Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock,&#148; the Issuer may issue additional 2014
    Cash Pay Notes, 2016 Cash Pay Notes
    <FONT style="white-space: nowrap">and/or</FONT>
    Toggle Notes from time to time after this offering under the
    Indenture (any such 2014 Cash Pay Notes, 2016 Cash Pay Notes or
    Toggle Notes, <I>&#147;Additional Notes&#148;</I>). In addition,
    in connection with the payment of PIK Interest or Partial PIK
    Interest in respect of the Toggle Notes, the Issuer is entitled
    to, without the consent of the Holders, increase the outstanding
    principal amount of the Toggle Notes or issue additional Toggle
    Notes (the <I>&#147;PIK Notes&#148;</I>) under the Indenture on
    the same terms and conditions as the Toggle Notes (in each case,
    the <I>&#147;PIK Payment&#148;</I>). The Cash Pay Notes and the
    Toggle Notes are each separate series of Notes but are treated
    as a single class of securities under the Indenture, except as
    otherwise stated herein. As a result, Holders of each series of
    Notes do not have separate rights to, among other things, give
    notice of Defaults or to direct the Trustee to exercise remedies
    during Event of Default or otherwise. Except as described under
    &#147;Amendment, Supplement and Waiver,&#148; the Notes offered
    by the Issuer, the PIK Notes and any Additional Notes
    subsequently issued under the Indenture will be treated as a
    single class for all purposes under the Indenture, including
    waivers, amendments, redemptions and offers to purchase. Unless
    the context requires otherwise, references to &#147;Notes&#148;
    for all purposes of the Indenture and this &#147;Description of
    Notes&#148; include any PIK Notes and Additional Notes that are
    actually issued, and references to &#147;principal amount&#148;
    of the Notes includes any increase in the principal amount of
    the outstanding Notes as a result of a PIK Payment.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Cash
    Pay Notes</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <I><FONT style="font-family: 'Times New Roman', Times">2014 Cash
    Pay Notes</FONT></I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Interest on the 2014 Cash Pay Notes accrues at the rate of
    9<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">8</FONT>%
    per annum and is payable semi-annually in arrears on May 15 and
    November&#160;15, commencing on May&#160;15, 2007, to the
    Holders of 2014 Cash Pay Notes of record on the immediately
    preceding May 1 and November&#160;1. Interest on the 2014 Cash
    Pay Notes accrues from the most recent date to which interest
    has been paid or, if no interest has been paid, from and
    including the Issue Date. Interest on the 2014 Cash Pay Notes is
    computed on the basis of a
    <FONT style="white-space: nowrap">360-day</FONT> year
    comprised of twelve
    <FONT style="white-space: nowrap">30-day</FONT>
    months.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <I><FONT style="font-family: 'Times New Roman', Times">2016 Cash
    Pay Notes</FONT></I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Interest on the 2016 Cash Pay Notes accrues at the rate of
    9<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">4</FONT>%
    per annum and is payable semi-annually in arrears on May 15 and
    November&#160;15, commencing on May&#160;15, 2007, to the
    Holders of 2016 Cash Pay Notes of record on the immediately
    preceding May 1 and November&#160;1. Interest on the 2016 Cash
    Pay Notes accrues from the most recent date to which interest
    has been paid or, if no interest has been paid, from and
    including the Issue Date. Interest on the 2016 Cash Pay Notes is
    computed on the basis of a
    <FONT style="white-space: nowrap">360-day</FONT> year
    comprised of twelve
    <FONT style="white-space: nowrap">30-day</FONT>
    months.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Toggle
    Notes</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Interest on the Toggle Notes is payable semi-annually in arrears
    on May 15 and November&#160;15, commencing on May&#160;15, 2007,
    to the Holders of Toggle Notes of record on the immediately
    preceding May 1 and November&#160;1. Interest on the Toggle
    Notes accrues from the most recent date to which interest has
    been paid or, if no interest has been paid, from and including
    the Issue Date. Interest on the Toggle Notes is computed on the
    basis of a
    <FONT style="white-space: nowrap">360-day</FONT> year
    comprised of twelve
    <FONT style="white-space: nowrap">30-day</FONT>
    months.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For any interest payment period after the initial interest
    payment period and prior to November&#160;15, 2011, the Issuer
    may, at its option, elect to pay interest on the Toggle Notes:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    entirely in cash <I>(&#147;Cash Interest&#148;)</I>;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    entirely by increasing the principal amount of the outstanding
    Toggle Notes or by issuing PIK Notes <I>(&#147;PIK
    Interest&#148;)</I>;&#160;or
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    on 50% of the outstanding principal amount of the Toggle Notes
    in cash and on 50% of the principal amount by increasing the
    principal amount of the outstanding Toggle Notes or by issuing
    PIK Notes <I>(&#147;Partial PIK Interest&#148;)</I>.
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    57
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer must elect the form of interest payment with respect
    to each interest period by delivering a notice to the Trustee
    prior to the beginning of each interest period. The Trustee
    shall promptly deliver a corresponding notice to the Holders. In
    the absence of such an election for any interest period,
    interest on the Toggle Notes shall be payable according to the
    election for the previous interest period. Interest for the
    first interest period commencing on the Issue Date shall be
    payable entirely in cash. After November&#160;15, 2011, the
    Issuer will make all interest payments on the Toggle Notes
    entirely in cash. Notwithstanding anything to the contrary, the
    payment of accrued interest in connection with any redemption of
    Toggle Notes as described under &#147;&#151;&#160;Optional
    Redemption&#160;&#151; Toggle Notes&#148; or &#147;Repurchase at
    the Option of Holders&#148; shall be made solely in cash.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Cash Interest on the Toggle Notes accrues at a rate of
    9<FONT style="vertical-align: text-top; font-size: 70%;">5</FONT>/<FONT style="font-size: 70%;">8</FONT>%
    per annum and is payable in cash. PIK Interest on the Toggle
    Notes accrues at a rate of
    10<FONT style="vertical-align: text-top; font-size: 70%;">3</FONT>/<FONT style="font-size: 70%;">8</FONT>%
    per annum and is payable (x)&#160;with respect to Toggle Notes
    represented by one or more global notes registered in the name
    of, or held by, The Depository Trust&#160;Company
    <I>(&#147;DTC&#148;)</I> or its nominee on the relevant record
    date, by increasing the principal amount of the outstanding
    global Toggle Note by an amount equal to the amount of PIK
    Interest for the applicable interest period (rounded up to the
    nearest $1,000) and (y)&#160;with respect to Toggle Notes
    represented by certificated notes, by issuing PIK Notes in
    certificated form in an aggregate principal amount equal to the
    amount of PIK Interest for the applicable period (rounded up to
    the nearest whole dollar), and the Trustee will, at the request
    of the Issuer, authenticate and deliver such PIK Notes in
    certificated form for original issuance to the Holders on the
    relevant record date, as shown by the records of the register of
    Holders. In the event that the Issuer elects to pay Partial PIK
    Interest for any interest period, each Holder will be entitled
    to receive Cash Interest in respect of 50% of the principal
    amount of the Toggle Notes held by such Holder on the relevant
    record date and PIK Interest in respect of 50% of the principal
    amount of the Toggle Notes held by such Holder on the relevant
    record date. Following an increase in the principal amount of
    the outstanding global Toggle Notes as a result of a PIK
    Payment, the global Toggle Notes will bear interest on such
    increased principal amount from and after the date of such PIK
    Payment. Any PIK Notes issued in certificated form will be dated
    as of the applicable interest payment date and will bear
    interest from and after such date. All Toggle Notes issued
    pursuant to a PIK Payment will mature on November&#160;15, 2016
    and will be governed by, and subject to the terms, provisions
    and conditions of, the Indenture and shall have the same rights
    and benefits as the Toggle Notes issued on the Issue Date. Any
    certificated PIK Notes will be issued with the description PIK
    on the face of such PIK Note.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If the toggle notes would otherwise constitute &#147;applicable
    high yield discount obligations&#148; within the meaning of
    Section&#160;163(i)(1) of the Code, at the end of the first
    accrual period ending after the fifth anniversary of the toggle
    notes&#146; issuance (the <I>&#147;AHYDO redemption
    date&#148;</I>), the Issuer will be required to redeem for cash
    a portion of each toggle note then outstanding equal to the
    &#147;Mandatory Principal Redemption&#160;Amount&#148; (such
    redemption, a <I>&#147;Mandatory Principal
    Redemption&#148;</I>). The redemption price for the portion of
    each toggle note redeemed pursuant to a Mandatory Principal
    Redemption will be 100% of the principal amount of such portion
    plus any accrued interest thereon on the date of redemption. The
    <I>&#147;Mandatory Principal Redemption&#160;Amount&#148;</I>
    means the portion of a toggle note required to be redeemed to
    prevent such toggle note from being treated as an
    &#147;applicable high yield discount obligation&#148; within the
    meaning of Section&#160;163(i)(1) of the Code. No partial
    redemption or repurchase of the toggle notes prior to the AHYDO
    redemption date pursuant to any other provision of the indenture
    will alter the Issuer&#146;s obligation to make the Mandatory
    Principal Redemption with respect to any toggle notes that
    remain outstanding on the AHYDO redemption date.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Additional
    Interest</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Additional Interest may accrue on the Notes in certain
    circumstances pursuant to the Registration Rights Agreement. Any
    Additional Interest on the Notes will be payable in the same
    form elected by the Issuer for payment of interest for the
    applicable interest payment period. All references in the
    Indenture, in any context, to any interest or other amount
    payable on or with respect to the Notes shall be deemed to
    include any Additional Interest pursuant to the Registration
    Rights Agreement.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    58
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Principal of, premium, if any, and interest on the Notes will be
    payable at the office or agency of the Issuer maintained for
    such purpose within the City and State of New York or, at the
    option of the Issuer, payment of interest may be made by check
    mailed to the Holders of the Notes at their respective addresses
    set forth in the register of Holders; <I>provided </I>that all
    payments of principal, premium, if any, and interest with
    respect to the Notes represented by one or more global notes
    registered in the name of or held by DTC or its nominee will be
    made by wire transfer of immediately available funds to the
    accounts specified by the Holder or Holders thereof. Until
    otherwise designated by the Issuer, the Issuer&#146;s office or
    agency in New York will be the office of the Trustee maintained
    for such purpose.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Mandatory
    Redemption; Offers to Purchase; Open Market Purchases</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Except as set forth in the last paragraph under &#147;Principal,
    Maturity and Interest&#160;&#151; Toggle Notes&#148; the Issuer
    is not required to make any mandatory redemption or sinking fund
    payments with respect to the Notes. However, under certain
    circumstances, the Issuer may be required to offer to purchase
    Notes as described under the caption &#147;Repurchase at the
    Option of Holders.&#148; The Issuer may at any time and from
    time to time purchase Notes in the open market or otherwise.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Optional
    Redemption</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">2014
    Cash Pay Notes</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Except as set forth below, the Issuer is not entitled to redeem
    2014 Cash Pay Notes at its option prior to November&#160;15,
    2010.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    At any time prior to November&#160;15, 2010, the Issuer may
    redeem all or a part of the 2014 Cash Pay Notes, upon not less
    than 30 nor more than 60&#160;days&#146; prior notice mailed by
    first-class mail to the registered address of each Holder of
    2014 Cash Pay Notes or otherwise in accordance with the
    procedures of DTC, at a redemption price equal to 100% of the
    principal amount of the 2014 Cash Pay Notes redeemed plus the
    Applicable Premium as of, and accrued and unpaid interest and
    Additional Interest, if any, to the date of redemption (the
    <I>&#147;Redemption&#160;Date&#148;</I>), subject to the rights
    of Holders of 2014 Cash Pay Notes on the relevant record date to
    receive interest due on the relevant interest payment date.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On and after November&#160;15, 2010, the Issuer may redeem the
    2014 Cash Pay Notes, in whole or in part, upon not less than 30
    nor more than 60&#160;days&#146; prior notice mailed by
    first-class mail to the registered address of each Holder of
    2014 Cash Pay Notes or otherwise in accordance with the
    procedures of DTC, at the redemption prices (expressed as
    percentages of principal amount of the 2014 Cash Pay Notes to be
    redeemed) set forth below, plus accrued and unpaid interest
    thereon and Additional Interest, if any, to the applicable
    Redemption&#160;Date, subject to the right of Holders of 2014
    Cash Pay Notes of record on the relevant record date to receive
    interest due on the relevant interest payment date, if redeemed
    during the twelve-month period beginning on November 15 of each
    of the years indicated below:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="90%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="6%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Year</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Percentage</B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    2010
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    104.563
</TD>
<TD nowrap align="left" valign="bottom">
    %
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    2011
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    102.281
</TD>
<TD nowrap align="left" valign="bottom">
    %
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    2012 and thereafter
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    100.000
</TD>
<TD nowrap align="left" valign="bottom">
    %
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, until November&#160;15, 2009, the Issuer may, at
    its option, on one or more occasions redeem up to 35% of the
    aggregate principal amount of 2014 Cash Pay Notes at a
    redemption price equal to 109.125% of the aggregate principal
    amount thereof, plus accrued and unpaid interest thereon and
    Additional Interest, if any, to the applicable
    Redemption&#160;Date, subject to the right of Holders of 2014
    Cash Pay Notes of record on the relevant record date to receive
    interest due on the relevant interest payment date, with the net
    cash proceeds of one or more Equity Offerings; <I>provided
    </I>that at least 50% of the sum of the original aggregate
    principal amount of 2014 Cash Pay Notes issued under the
    Indenture and the original principal amount of any Additional
    Notes that are 2014 Cash Pay Notes issued under the Indenture
    after the Issue Date remains outstanding immediately after the
    occurrence of each such redemption; <I>provided further </I>that
    each such redemption occurs within 90&#160;days of the date of
    closing of each such Equity Offering.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    59
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any notice of any redemption may be given prior to the
    redemption thereof, and any such redemption or notice may, at
    the Issuer&#146;s discretion, be subject to one or more
    conditions precedent, including, but not limited to, completion
    of an Equity Offering or other corporate transaction.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If the Issuer redeems less than all of the outstanding 2014 Cash
    Pay Notes, the Trustee shall select the 2014 Cash Pay Notes to
    be redeemed in the manner described under &#147;Repurchase at
    the Option of Holders&#160;&#151; Selection and Notice.&#148;
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">2016
    Cash Pay Notes</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Except as set forth below, the Issuer is not entitled to redeem
    2016 Cash Pay Notes at its option prior to November&#160;15,
    2011.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    At any time prior to November&#160;15, 2011, the Issuer may
    redeem all or a part of the 2016 Cash Pay Notes, upon not less
    than 30 nor more than 60&#160;days&#146; prior notice mailed by
    first-class mail to the registered address of each Holder of
    2016 Cash Pay Notes or otherwise in accordance with the
    procedures of DTC, at a redemption price equal to 100% of the
    principal amount of the 2016 Cash Pay Notes redeemed plus the
    Applicable Premium as of, and accrued and unpaid interest and
    Additional Interest, if any, to the Redemption&#160;Date,
    subject to the rights of Holders of 2016 Cash Pay Notes on the
    relevant record date to receive interest due on the relevant
    interest payment date.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On and after November&#160;15, 2011, the Issuer may redeem the
    2016 Cash Pay Notes, in whole or in part, upon not less than 30
    nor more than 60&#160;days&#146; prior notice mailed by
    first-class mail to the registered address of each Holder of
    2016 Cash Pay Notes or otherwise in accordance with the
    procedures of DTC, at the redemption prices (expressed as
    percentages of principal amount of the 2016 Cash Pay Notes to be
    redeemed) set forth below, plus accrued and unpaid interest
    thereon and Additional Interest, if any, to the applicable
    Redemption&#160;Date, subject to the right of Holders of 2016
    Cash Pay Notes of record on the relevant record date to receive
    interest due on the relevant interest payment date, if redeemed
    during the twelve-month period beginning on November 15 of each
    of the years indicated below:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="90%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="6%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Year</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Percentage</B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    2011
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    104.625
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    2012
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    103.083
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    2013
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    101.542
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    2014 and thereafter
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    100.000
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, until November&#160;15, 2009, the Issuer may, at
    its option, on one or more occasions redeem up to 35% of the
    aggregate principal amount of 2016 Cash Pay Notes at a
    redemption price equal to 109.250% of the aggregate principal
    amount thereof, plus accrued and unpaid interest thereon and
    Additional Interest, if any, to the applicable
    Redemption&#160;Date, subject to the right of Holders of 2016
    Cash Pay Notes of record on the relevant record date to receive
    interest due on the relevant interest payment date, with the net
    cash proceeds of one or more Equity Offerings; <I>provided
    </I>that at least 50% of the sum of the original aggregate
    principal amount of 2016 Cash Pay Notes issued under the
    Indenture and the original principal amount of any Additional
    Notes that are 2016 Cash Pay Notes issued under the Indenture
    after the Issue Date remains outstanding immediately after the
    occurrence of each such redemption; <I>provided further </I>that
    each such redemption occurs within 90&#160;days of the date of
    closing of each such Equity Offering.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any notice of any redemption may be given prior to the
    redemption thereof, and any such redemption or notice may, at
    the Issuer&#146;s discretion, be subject to one or more
    conditions precedent, including, but not limited to, completion
    of an Equity Offering or other corporate transaction.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If the Issuer redeems less than all of the outstanding 2016 Cash
    Pay Notes, the Trustee shall select the 2016 Cash Pay Notes to
    be redeemed in the manner described under &#147;Repurchase at
    the Option of Holders&#160;&#151; Selection and Notice.&#148;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    60
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Toggle
    Notes</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Except as set forth below, the Issuer is not entitled to redeem
    Toggle Notes at its option prior to November&#160;15, 2011.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    At any time prior to November&#160;15, 2011, the Issuer may
    redeem all or a part of the Toggle Notes, upon not less than 30
    nor more than 60&#160;days&#146; prior notice mailed by
    first-class mail to the registered address of each Holder of
    Toggle Notes or otherwise in accordance with the procedures of
    DTC, at a redemption price equal to 100% of the principal amount
    of the Toggle Notes redeemed plus the Applicable Premium as of,
    and accrued and unpaid interest and Additional Interest, if any,
    to the Redemption&#160;Date, subject to the rights of Holders of
    Toggle Notes on the relevant record date to receive interest due
    on the relevant interest payment date.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On and after November&#160;15, 2011, the Issuer may redeem the
    Toggle Notes, in whole or in part, upon not less than 30 nor
    more than 60&#160;days&#146; prior notice mailed by first-class
    mail to the registered address of each Holder of Toggle Notes or
    otherwise in accordance with the procedures of DTC, at the
    redemption prices (expressed as percentages of principal amount
    of the Toggle Notes to be redeemed) set forth below, plus
    accrued and unpaid interest thereon and Additional Interest, if
    any, to the applicable Redemption&#160;Date, subject to the
    right of Holders of Toggle Notes of record on the relevant
    record date to receive interest due on the relevant interest
    payment date, if redeemed during the twelve-month period
    beginning on November 15 of each of the years indicated below:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="90%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="6%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Year</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Percentage</B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    2011
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    104.813
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    2012
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    103.208
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    2013
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    101.604
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    2014 and thereafter
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    100.000
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, until November&#160;15, 2009, the Issuer may, at
    its option, on one or more occasions redeem up to 35% of the
    aggregate principal amount of Toggle Notes at a redemption price
    equal to 109.625% of the aggregate principal amount thereof,
    plus accrued and unpaid interest thereon and Additional
    Interest, if any, to the applicable Redemption&#160;Date,
    subject to the right of Holders of Toggle Notes of record on the
    relevant record date to receive interest due on the relevant
    interest payment date, with the net cash proceeds of one or more
    Equity Offerings; <I>provided </I>that at least 50% of the sum
    of the original aggregate principal amount of Toggle Notes
    issued under the Indenture and the original principal amount of
    any Additional Notes that are Toggle Notes issued under the
    Indenture after the Issue Date remains outstanding immediately
    after the occurrence of each such redemption; <I>provided
    further </I>that each such redemption occurs within 90&#160;days
    of the date of closing of each such Equity Offering.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any notice of any redemption may be given prior to the
    redemption thereof, and any such redemption or notice may, at
    the Issuer&#146;s discretion, be subject to one or more
    conditions precedent, including, but not limited to, completion
    of an Equity Offering or other corporate transaction.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If the Issuer redeems less than all of the outstanding Toggle
    Notes, the Trustee shall select the Toggle Notes to be redeemed
    in the manner described under &#147;Repurchase at the Option of
    Holders&#160;&#151; Selection and Notice.&#148;
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Repurchase
    at the Option of Holders</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Change
    of Control</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Notes provide that if a Change of Control occurs, unless the
    Issuer has previously or concurrently mailed a redemption notice
    with respect to all the outstanding Notes as described under
    &#147;Optional Redemption,&#148; the Issuer will make an offer
    to purchase all of the Notes pursuant to the offer described
    below (the &#147;Change of Control Offer&#148;) at a price in
    cash (the &#147;Change of Control Payment&#148;) equal to 101%
    of the aggregate principal amount thereof plus accrued and
    unpaid interest and Additional Interest, if any, to the date of
    purchase, subject to the right of Holders of the Notes of record
    on the relevant record date to receive
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    61
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    interest due on the relevant interest payment date. Within
    30&#160;days following any Change of Control, the Issuer will
    send notice of such Change of Control Offer by first-class mail,
    with a copy to the Trustee, to each Holder of Notes to the
    address of such Holder appearing in the security register with a
    copy to the Trustee or otherwise in accordance with the
    procedures of DTC, with the following information:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;that a Change of Control Offer is being made pursuant
    to the covenant entitled &#147;Change of Control&#148; and that
    all Notes properly tendered pursuant to such Change of Control
    Offer will be accepted for payment by the Issuer;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the purchase price and the purchase date, which will be
    no earlier than 30&#160;days nor later than 60&#160;days from
    the date such notice is mailed (the <I>&#147;Change of Control
    Payment Date&#148;</I>);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;that any Note not properly tendered will remain
    outstanding and continue to accrue interest;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;that unless the Issuer defaults in the payment of the
    Change of Control Payment, all Notes accepted for payment
    pursuant to the Change of Control Offer will cease to accrue
    interest on the Change of Control Payment Date;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;that Holders electing to have any Notes purchased
    pursuant to a Change of Control Offer will be required to
    surrender such Notes, with the form entitled &#147;Option of
    Holder to Elect Purchase&#148; on the reverse of such Notes
    completed, to the paying agent specified in the notice at the
    address specified in the notice prior to the close of business
    on the third Business Day preceding the Change of Control
    Payment Date;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;that Holders will be entitled to withdraw their
    tendered Notes and their election to require the Issuer to
    purchase such Notes; <I>provided </I>that the paying agent
    receives, not later than the close of business on the
    30th&#160;day following the date of the Change of Control
    notice, a telegram, facsimile transmission or letter setting
    forth the name of the Holder of the Notes, the principal amount
    of Notes tendered for purchase, and a statement that such Holder
    is withdrawing its tendered Notes and its election to have such
    Notes purchased;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;that if the Issuer is redeeming less than all of the
    Notes, the Holders of the remaining Notes will be issued new
    Notes and such new Notes will be equal in principal amount to
    the unpurchased portion of the Notes surrendered. The
    unpurchased portion of the Notes must be equal to $2,000 or an
    integral multiple of $1,000 in excess thereof;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;the other instructions, as determined by us, consistent
    with the covenant described hereunder, that a Holder must follow.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will comply with the requirements of
    <FONT style="white-space: nowrap">Rule&#160;14e-1</FONT>
    under the Exchange Act and any other securities laws and
    regulations thereunder to the extent such laws or regulations
    are applicable in connection with the repurchase of Notes
    pursuant to a Change of Control Offer. To the extent that the
    provisions of any securities laws or regulations conflict with
    the provisions of the Indenture, the Issuer will comply with the
    applicable securities laws and regulations and shall not be
    deemed to have breached its obligations described in the
    Indenture by virtue thereof.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On the Change of Control Payment Date, the Issuer will, to the
    extent permitted by law,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;accept for payment all Notes issued by it or portions
    thereof properly tendered pursuant to the Change of Control
    Offer;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;deposit with the paying agent an amount equal to the
    aggregate Change of Control Payment in respect of all Notes or
    portions thereof so tendered;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;deliver, or cause to be delivered, to the Trustee for
    cancellation the Notes so accepted together with an
    Officer&#146;s Certificate to the Trustee stating that such
    Notes or portions thereof have been tendered to and purchased by
    the Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Senior Credit Facilities, and future credit agreements or
    other agreements relating to Senior Indebtedness to which the
    Issuer becomes a party may, provide that certain change of
    control events with
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    62
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    respect to the Issuer would constitute a default thereunder
    (including a Change of Control under the Indenture). If we
    experience a change of control that triggers a default under our
    Senior Credit Facilities, we could seek a waiver of such default
    or seek to refinance our Senior Credit Facilities. In the event
    we do not obtain such a waiver or refinance the Senior Credit
    Facilities, such default could result in amounts outstanding
    under our Senior Credit Facilities being declared due and
    payable and could cause a Receivables Facility to be wound down.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Our ability to pay cash to the Holders of Notes following the
    occurrence of a Change of Control may be limited by our
    then-existing financial resources. Therefore, sufficient funds
    may not be available when necessary to make any required
    repurchases.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Change of Control purchase feature of the Notes may in
    certain circumstances make more difficult or discourage a sale
    or takeover of us and, thus, the removal of incumbent
    management. The Change of Control purchase feature is a result
    of negotiations between the Initial Purchasers and us. We have
    no present intention to engage in a transaction involving a
    Change of Control, although it is possible that we could decide
    to do so in the future. Subject to the limitations discussed
    below, we could, in the future, enter into certain transactions,
    including acquisitions, refinancings or other recapitalizations,
    that would not constitute a Change of Control under the
    Indenture, but that could increase the amount of indebtedness
    outstanding at such time or otherwise affect our capital
    structure or credit ratings. Restrictions on our ability to
    incur additional Indebtedness are contained in the covenants
    described under &#147;Certain Covenants&#160;&#151; Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock&#148; and &#147;Certain
    Covenants&#160;&#151; Liens.&#148; Such restrictions in the
    Indenture can be waived only with the consent of the Holders of
    a majority in principal amount of the Notes then outstanding.
    Except for the limitations contained in such covenants, however,
    the Indenture does not contain any covenants or provisions that
    may afford Holders of the Notes protection in the event of a
    highly leveraged transaction.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer is not required to make a Change of Control Offer
    following a Change of Control if a third party makes the Change
    of Control Offer in the manner, at the times and otherwise in
    compliance with the requirements set forth in the Indenture
    applicable to a Change of Control Offer made by us and purchases
    all Notes validly tendered and not withdrawn under such Change
    of Control Offer. Notwithstanding anything to the contrary
    herein, a Change of Control Offer may be made in advance of a
    Change of Control, conditional upon such Change of Control, if a
    definitive agreement is in place for the Change of Control at
    the time of making of the Change of Control Offer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The definition of &#147;Change of Control&#148; includes a
    disposition of all or substantially all of the assets of the
    Issuer to any Person. Although there is a limited body of case
    law interpreting the phrase &#147;substantially all,&#148; there
    is no precise established definition of the phrase under
    applicable law. Accordingly, in certain circumstances there may
    be a degree of uncertainty as to whether a particular
    transaction would involve a disposition of &#147;all or
    substantially all&#148; of the assets of the Issuer. As a
    result, it may be unclear as to whether a Change of Control has
    occurred and whether a Holder of Notes may require the Issuer to
    make an offer to repurchase the Notes as described above.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The provisions under the Indenture relating to the Issuer&#146;s
    obligation to make an offer to repurchase the Notes as a result
    of a Change of Control may be waived or modified with the
    written consent of the Holders of a majority in principal amount
    of the Notes.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Asset
    Sales</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that the Issuer will not, and will not
    permit any of its Restricted Subsidiaries to consummate,
    directly or indirectly, an Asset Sale, unless:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the Issuer or such Restricted Subsidiary, as the case
    may be, receives consideration at the time of such Asset Sale at
    least equal to the fair market value (as determined in good
    faith by the Issuer) of the assets sold or otherwise disposed
    of;&#160;and
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    63
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;except in the case of a Permitted Asset Swap, at least
    75% of the consideration therefor received by the Issuer or such
    Restricted Subsidiary, as the case may be, is in the form of
    cash or Cash Equivalents; <I>provided </I>that the amount of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;any liabilities (as shown on the Issuer&#146;s or such
    Restricted Subsidiary&#146;s most recent balance sheet or in the
    footnotes thereto) of the Issuer or such Restricted Subsidiary,
    other than liabilities that are by their terms subordinated to
    the Notes, that are assumed by the transferee of any such assets
    and for which the Issuer and all of its Restricted Subsidiaries
    have been validly released by all creditors in writing,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;any securities received by the Issuer or such
    Restricted Subsidiary from such transferee that are converted by
    the Issuer or such Restricted Subsidiary into cash (to the
    extent of the cash received) within 180&#160;days following the
    closing of such Asset Sale,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;any Designated Non-cash Consideration received by the
    Issuer or such Restricted Subsidiary in such Asset Sale having
    an aggregate fair market value, taken together with all other
    Designated Non-cash Consideration received pursuant to this
    clause&#160;(c) that is at that time outstanding, not to exceed
    5% of Total Assets at the time of the receipt of such Designated
    Non-cash Consideration, with the fair market value of each item
    of Designated Non-cash Consideration being measured at the time
    received and without giving effect to subsequent changes in
    value, shall be deemed to be cash for purposes of this provision
    and for no other purpose.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Within 450&#160;days after the receipt of any Net Proceeds of
    any Asset Sale, the Issuer or such Restricted Subsidiary, at its
    option, may apply the Net Proceeds from such Asset Sale,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;to permanently reduce:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;Obligations under Priority Lien Obligations and to
    correspondingly reduce commitments with respect thereto;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;Obligations under Senior Indebtedness (other than any
    Junior Lien Obligation) that is secured by a Lien permitted
    under the Indenture (which Lien is senior to the Lien of the
    Notes with respect to the Collateral), and to correspondingly
    reduce commitments with respect thereto;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;Obligations under Junior Lien Obligations (and to
    correspondingly reduce commitments with respect thereto) through
    open-market purchases (to the extent such purchases are at or
    above 100% of the principal amount thereof) or by making an
    Asset Sale Offer or a Collateral Asset Sale Offer in accordance
    with the procedures set forth below; <I>provided </I>that the
    Issuer shall equally and ratably reduce Obligations under the
    Notes as provided under &#147;Optional Redemption,&#148; through
    open-market purchases or otherwise by making an offer (in
    accordance with the procedures set forth below for an Asset Sale
    Offer or a Collateral Asset Sale Offer) to all Holders to
    purchase their Notes at 100% of the principal amount thereof,
    plus the amount of accrued but unpaid interest, if any, on the
    amount of the Notes that would otherwise be prepaid;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;Obligations under the Existing Notes which have a final
    maturity date (as in effect on the Issue Date) on or prior to
    November&#160;15, 2016; <I>provided </I>that, at the time of,
    and after giving effect to, such repurchase, redemption or
    defeasance, the aggregate amount of Net Proceeds used to
    repurchase, redeem or defease Existing Notes pursuant to this
    subclause&#160;(d) following the Issue Date shall not exceed 5%
    of the consolidated total assets of the Issuer and its
    subsidiaries at such time;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;Indebtedness of a Restricted Subsidiary that is not a
    Guarantor, other than Indebtedness owed to the Issuer or another
    Restricted Subsidiary (or any affiliate thereof);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;to make (a)&#160;an Investment in any one or more
    businesses, <I>provided </I>that such Investment in any business
    is in the form of the acquisition of Capital Stock and results
    in the Issuer or another of its Restricted Subsidiaries, as the
    case may be, owning an amount of the Capital Stock of such
    business such that it constitutes a Restricted Subsidiary,
    (b)&#160;capital expenditures or (c)&#160;acquisitions of other
    assets, in each of (a), (b)&#160;and (c), used or useful in a
    Similar Business;&#160;or
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    64
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;to make an investment in (a)&#160;any one or more
    businesses, <I>provided </I>that such Investment in any business
    is in the form of the acquisition of Capital Stock and results
    in the Issuer or another of its Restricted Subsidiaries, as the
    case may be, owning an amount of the Capital Stock of such
    business such that it constitutes a Restricted Subsidiary,
    (b)&#160;properties or (c)&#160;acquisitions of other assets
    that, in each of (a), (b)&#160;and (c), replace the businesses,
    properties
    <FONT style="white-space: nowrap">and/or</FONT>
    assets that are the subject of such Asset Sale;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided </I>that, in the case of clauses&#160;(2) and
    (3)&#160;above, a binding commitment shall be treated as a
    permitted application of the Net Proceeds from the date of such
    commitment so long as the Issuer, or such other Restricted
    Subsidiary enters into such commitment with the good faith
    expectation that such Net Proceeds will be applied to satisfy
    such commitment within 180&#160;days of such commitment (an
    <I>&#147;Acceptable Commitment&#148;</I>) and, in the event any
    Acceptable Commitment is later cancelled or terminated for any
    reason before the Net Proceeds are applied in connection
    therewith, the Issuer or such Restricted Subsidiary enters into
    another Acceptable Commitment (a <I>&#147;Second
    Commitment&#148;</I>) within 180&#160;days of such cancellation
    or termination; <I>provided</I>, <I>further</I>, that if any
    Second Commitment is later cancelled or terminated for any
    reason before such Net Proceeds are applied, then such Net
    Proceeds shall constitute Excess Proceeds.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any Net Proceeds from Asset Sales of Collateral that are not
    invested or applied as set forth in the first sentence of the
    preceding paragraph will be deemed to constitute
    <I>&#147;Collateral Excess Proceeds</I>.&#148; When the
    aggregate amount of Collateral Excess Proceeds exceeds
    $200.0&#160;million, the Issuer shall make an offer to all
    Holders of the Notes and, if required by the terms of any Junior
    Lien Obligations which are not subordinated to the Notes or
    Obligations secured by a Lien permitted under the Indenture
    (which Lien is not subordinate to the Lien of the Notes with
    respect to the Collateral), to the holders of such Junior Lien
    Obligations or such other Obligations (a <I>&#147;Collateral
    Asset Sale Offer&#148;</I>), to purchase the maximum aggregate
    principal amount of the Notes and such Junior Lien Obligations
    or such other Obligations that is a minimum of $2,000 or an
    integral multiple of $1,000 in excess thereof that may be
    purchased out of the Collateral Excess Proceeds at an offer
    price in cash in an amount equal to 100% of the principal amount
    thereof, plus accrued and unpaid interest and Additional
    Interest, if any, to the date fixed for the closing of such
    offer, in accordance with the procedures set forth in the
    Indenture. The Issuer will commence a Collateral Asset Sale
    Offer with respect to Collateral Excess Proceeds within ten
    Business Days after the date that Collateral Excess Proceeds
    exceed $200.0&#160;million by mailing the notice required
    pursuant to the terms of the Indenture, with a copy to the
    Trustee.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any Net Proceeds from Asset Sales of non-Collateral that are not
    invested or applied as provided and within the time period set
    forth in the first sentence of the second preceding paragraph
    will be deemed to constitute <I>&#147;Excess Proceeds</I>.&#148;
    When the aggregate amount of Excess Proceeds exceeds
    $200.0&#160;million, the Issuer shall make an offer to all
    Holders of the Notes and, if required or permitted by the terms
    of any Senior Indebtedness, to the holders of such Senior
    Indebtedness (an <I>&#147;Asset Sale Offer&#148;</I>), to
    purchase the maximum aggregate principal amount of the Notes and
    such Senior Indebtedness that is a minimum of $2,000 or an
    integral multiple of $1,000 in excess thereof that may be
    purchased out of the Excess Proceeds at an offer price in cash
    in an amount equal to 100% of the principal amount thereof, plus
    accrued and unpaid interest and Additional Interest, if any, to
    the date fixed for the closing of such offer, in accordance with
    the procedures set forth in the Indenture. The Issuer will
    commence an Asset Sale Offer with respect to Excess Proceeds
    within ten Business Days after the date that Excess Proceeds
    exceed $200.0&#160;million by mailing the notice required
    pursuant to the terms of the Indenture, with a copy to the
    Trustee.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    To the extent that the aggregate amount of Notes and such Junior
    Lien Obligations or Obligations secured by a Lien permitted by
    the Indenture (which Lien is not subordinate to the Lien of the
    Notes with respect to the Collateral) tendered pursuant to a
    Collateral Asset Sale Offer is less than the Collateral Excess
    Proceeds, the Issuer may use any remaining Collateral Excess
    Proceeds for general corporate purposes, subject to other
    covenants contained in the Indenture. To the extent that the
    aggregate amount of Notes and such Senior Indebtedness tendered
    pursuant to an Asset Sale Offer is less than the Excess
    Proceeds, the Issuer may use any remaining Excess Proceeds for
    general corporate purposes, subject to other covenants contained
    in the Indenture. If the aggregate principal amount of Notes or
    Junior Lien Obligations or such other Obligations surrendered by
    such holders thereof exceeds the amount of Collateral Excess
    Proceeds, the Trustee shall select the Notes and such Junior
    Lien Obligations or such other Obligations to be purchased on a
    pro rata basis
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    65
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    based on the accreted value or principal amount of the Notes or
    such Junior Lien Obligations or such other Obligations tendered.
    If the aggregate principal amount of Notes or the Senior
    Indebtedness surrendered by such holders thereof exceeds the
    amount of Excess Proceeds, the Trustee shall select the Notes
    and such Senior Indebtedness to be purchased on a pro rata basis
    based on the accreted value or principal amount of the Notes or
    such Senior Indebtedness tendered. Upon completion of any such
    Collateral Asset Sale Offer or Asset Sale Offer, the amount of
    Collateral Excess Proceeds or Excess Proceeds, as the case may
    be, shall be reset at zero. Additionally, the Issuer may, at its
    option, make a Collateral Asset Sale Offer or an Asset Sale
    Offer using proceeds from any Asset Sale at any time after
    consummation of such Asset Sale; <I>provided </I>that such
    Collateral Asset Sale Offer or Asset Sale Offer shall be in an
    aggregate amount of not less than $50.0&#160;million. Upon
    consummation of such Collateral Asset Sale Offer or Asset Sale
    Offer, any Net Proceeds not required to be used to purchase
    Notes shall not be deemed Excess Proceeds.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pending the final application of any Net Proceeds pursuant to
    this covenant, the holder of such Net Proceeds may apply such
    Net Proceeds temporarily to reduce Indebtedness outstanding
    under a revolving credit facility or otherwise invest such Net
    Proceeds in any manner not prohibited by the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will comply with the requirements of
    <FONT style="white-space: nowrap">Rule&#160;14e-1</FONT>
    under the Exchange Act and any other securities laws and
    regulations thereunder to the extent such laws or regulations
    are applicable in connection with the repurchase of the Notes
    pursuant to a Collateral Asset Sale Offer or an Asset Sale
    Offer. To the extent that the provisions of any securities laws
    or regulations conflict with the provisions of the Indenture,
    the Issuer will comply with the applicable securities laws and
    regulations and shall not be deemed to have breached its
    obligations described in the Indenture by virtue thereof.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Selection
    and Notice</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If the Issuer is redeeming less than all of the Notes issued by
    it at any time, the Trustee will select the Notes to be redeemed
    (a)&#160;if the Notes are listed on any national securities
    exchange, in compliance with the requirements of the principal
    national securities exchange on which the Notes are listed,
    (b)&#160;on a pro rata basis to the extent practicable or
    (c)&#160;by lot or such other similar method in accordance with
    the procedures of DTC.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notices of purchase or redemption shall be mailed by first-class
    mail, postage prepaid, at least 30 but not more than
    60&#160;days before the purchase or Redemption&#160;Date to each
    Holder of Notes at such Holder&#146;s registered address or
    otherwise in accordance with the procedures of DTC, except that
    redemption notices may be mailed more than 60&#160;days prior to
    a Redemption&#160;Date if the notice is issued in connection
    with a defeasance of the Notes or a satisfaction and discharge
    of the Indenture. If any Note is to be purchased or redeemed in
    part only, any notice of purchase or redemption that relates to
    such Note shall state the portion of the principal amount
    thereof that has been or is to be purchased or redeemed.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will issue a new Note in a principal amount equal to
    the unredeemed portion of the original Note in the name of the
    Holder upon cancellation of the original Note. Notes called for
    redemption become due on the date fixed for redemption. On and
    after the Redemption&#160;Date, interest ceases to accrue on
    Notes or portions thereof called for redemption.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Certain
    Covenants</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Set forth below are summaries of certain covenants contained in
    the Indenture. If on any date following the Issue Date
    (i)&#160;the Notes have Investment Grade Ratings from both
    Rating Agencies, and (ii)&#160;no Default has occurred and is
    continuing under the Indenture (the occurrence of the events
    described in the foregoing clauses&#160;(i) and (ii)&#160;being
    collectively referred to as a <I>&#147;Covenant Suspension
    Event&#148;</I>), the Issuer and the Restricted Subsidiaries
    will not be subject to the following covenants (collectively,
    the <I>&#147;Suspended Covenants&#148;</I>):
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;&#147;Repurchase at the Option of Holders&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;&#147;&#151; Limitation on Restricted Payments&#148;;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    66
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;&#147;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;clause&#160;(4) of the first paragraph of
    &#147;&#151;&#160;Merger, Consolidation or Sale of All or
    Substantially All Assets&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;&#147;&#151; Transactions with
    Affiliates&#148;;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;&#147;&#151; Dividend and Other Payment Restrictions
    Affecting Restricted Subsidiaries.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In the event that the Issuer and the Restricted Subsidiaries are
    not subject to the Suspended Covenants under the Indenture for
    any period of time as a result of the foregoing, and on any
    subsequent date (the <I>&#147;Reversion Date&#148;</I>) one or
    both of the Rating Agencies (a)&#160;withdraw their Investment
    Grade Rating or downgrade the rating assigned to the Notes below
    an Investment Grade Rating
    <FONT style="white-space: nowrap">and/or</FONT>
    (b)&#160;the Issuer or any of its Affiliates enter into an
    agreement to effect a transaction that would result in a Change
    of Control and one or more of the Rating Agencies indicate that
    if consummated, such transaction (alone or together with any
    related recapitalization or refinancing transactions) would
    cause such Rating Agency to withdraw its Investment Grade Rating
    or downgrade the ratings assigned to the Notes below an
    Investment Grade Rating, then the Issuer and the Restricted
    Subsidiaries will thereafter again be subject to the Suspended
    Covenants under the Indenture with respect to future events,
    including, without limitation, a proposed transaction described
    in clause&#160;(b) above.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The period of time between the Suspension Date and the Reversion
    Date is referred to in this description as the
    <I>&#147;Suspension Period</I>.&#148; Additionally, upon the
    occurrence of a Covenant Suspension Event, the amount of Excess
    Proceeds from Net Proceeds shall be reset at zero. In the event
    of any such reinstatement, no action taken or omitted to be
    taken by the Issuer or any of its Restricted Subsidiaries prior
    to such reinstatement will give rise to a Default or Event of
    Default under the Indentures with respect to Notes; provided
    that (1)&#160;with respect to Restricted Payments made after any
    such reinstatement, the amount of Restricted Payments made will
    be calculated as though the covenant described under the caption
    &#147;&#151;&#160;Limitation on Restricted Payments&#148; had
    been in effect prior to, but not during the Suspension Period,
    provided that any Subsidiaries designated as Unrestricted
    Subsidiaries during the Suspension Period shall automatically
    become Restricted Subsidiaries on the Reversion Date (subject to
    the Issuer&#146;s right to subsequently designate them as
    Unrestricted Subsidiaries in compliance with the covenants set
    out below) and (2)&#160;all Indebtedness incurred, or
    Disqualified Stock or Preferred Stock issued, during the
    Suspension Period will be classified to have been incurred or
    issued pursuant to clause&#160;(3) of the second paragraph of
    &#147;&#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    There can be no assurance that the Notes will ever achieve or
    maintain Investment Grade Ratings.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Limitation
    on Restricted Payments</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, directly or indirectly:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (I)&#160;declare or pay any dividend or make any payment or
    distribution on account of the Issuer&#146;s, or any of its
    Restricted Subsidiaries&#146; Equity Interests, including any
    dividend or distribution payable in connection with any merger
    or consolidation other than:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;dividends or distributions by the Issuer payable solely
    in Equity Interests (other than Disqualified Stock) of the
    Issuer;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;dividends or distributions by a Restricted Subsidiary
    so long as, in the case of any dividend or distribution payable
    on or in respect of any class or series of securities issued by
    a Restricted Subsidiary other than a Wholly-Owned Subsidiary,
    the Issuer or a Restricted Subsidiary receives at least its pro
    rata share of such dividend or distribution in accordance with
    its Equity Interests in such class or series of securities;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    67
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (II)&#160;purchase, redeem, defease or otherwise acquire or
    retire for value any Equity Interests of the Issuer or any
    direct or indirect parent of the Issuer, including in connection
    with any merger or consolidation;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (III)&#160;make any principal payment on, or redeem, repurchase,
    defease or otherwise acquire or retire for value in each case,
    prior to any scheduled repayment, sinking fund payment or
    maturity, any Subordinated Indebtedness, other than:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;Indebtedness permitted under clauses&#160;(7) and
    (8)&#160;of the covenant described under
    &#147;&#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock&#148;;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the purchase, repurchase or other acquisition of
    Subordinated Indebtedness purchased in anticipation of
    satisfying a sinking fund obligation, principal installment or
    final maturity, in each case due within one year of the date of
    purchase, repurchase or acquisition;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (IV)&#160;make any Restricted Investment
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (all such payments and other actions set forth in
    clauses&#160;(I) through (IV)&#160;above (other than any
    exception thereto) being collectively referred to as
    <I>&#147;Restricted Payments&#148;</I>), unless, at the time of
    such Restricted Payment:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;no Default shall have occurred and be continuing or
    would occur as a consequence thereof;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;immediately after giving effect to such transaction on
    a <I>pro forma </I>basis, the Issuer could incur $1.00 of
    additional Indebtedness under the provisions of the first
    paragraph of the covenant described under
    &#147;&#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred
    Stock&#148;;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;such Restricted Payment, together with the aggregate
    amount of all other Restricted Payments made by the Issuer and
    its Restricted Subsidiaries after the Issue Date (including
    Restricted Payments permitted by clauses (1), (2) (with respect
    to the payment of dividends on Refunding Capital Stock (as
    defined below) pursuant to clause&#160;(b) thereof only),
    (6)(c), (9)&#160;and (14)&#160;of the next succeeding paragraph,
    but excluding all other Restricted Payments permitted by the
    next succeeding paragraph), is less than the sum of (without
    duplication):
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;50% of the Consolidated Net Income of the Issuer for
    the period (taken as one accounting period) beginning
    October&#160;1, 2006, to the end of the Issuer&#146;s most
    recently ended fiscal quarter for which internal financial
    statements are available at the time of such Restricted Payment,
    or, in the case such Consolidated Net Income for such period is
    a deficit, minus 100% of such deficit; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;100% of the aggregate net cash proceeds and the fair
    market value, as determined in good faith by the Issuer, of
    marketable securities or other property received by the Issuer
    since immediately after the Issue Date (other than net cash
    proceeds to the extent such net cash proceeds have been used to
    incur Indebtedness, Disqualified Stock or Preferred Stock
    pursuant to clause (12)(a) of the second paragraph of
    &#147;&#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock&#148;) from
    the issue or sale of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (i)&#160;(A)&#160;Equity Interests of the Issuer, including
    Treasury Capital Stock (as defined below), but excluding cash
    proceeds and the fair market value, as determined in good faith
    by the Issuer, of marketable securities or other property
    received from the sale of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 17%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (x)&#160;Equity Interests to members of management, directors or
    consultants of the Issuer, any direct or indirect parent company
    of the Issuer and the Issuer&#146;s Subsidiaries after the Issue
    Date to the extent such amounts have been applied to Restricted
    Payments made in accordance with clause&#160;(4) of the next
    succeeding paragraph;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 17%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (y)&#160;Designated Preferred Stock;&#160;and
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    68
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (B)&#160;to the extent such net cash proceeds are actually
    contributed to the Issuer, Equity Interests of the Issuer&#146;s
    direct or indirect parent companies (excluding contributions of
    the proceeds from the sale of Designated Preferred Stock of such
    companies or contributions to the extent such amounts have been
    applied to Restricted Payments made in accordance with
    clause&#160;(4) of the next succeeding paragraph);&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (ii)&#160;debt securities of the Issuer that have been converted
    into or exchanged for such Equity Interests of the Issuer;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    provided, <I>however</I>, that this clause&#160;(b) shall not
    include the proceeds from (V)&#160;Refunding Capital Stock (as
    defined below), (W)&#160;Equity Interests or convertible debt
    securities of the Issuer sold to a Restricted Subsidiary, as the
    case may be, (X)&#160;Disqualified Stock or debt securities that
    have been converted into Disqualified Stock, (Y)&#160;Excluded
    Contributions or (Z)&#160;the Delayed Equity Amount; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;100% of the aggregate amount of cash and the fair
    market value, as determined in good faith by the Issuer, of
    marketable securities or other property contributed to the
    capital of the Issuer following the Issue Date (other than net
    cash proceeds to the extent such net cash proceeds (i)&#160;have
    been used to incur Indebtedness, Disqualified Stock or Preferred
    Stock pursuant to clause (12)(a) of the second paragraph of
    &#147;&#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock&#148;,
    (ii)&#160;are contributed by a Restricted Subsidiary,
    (iii)&#160;constitute Excluded Contributions or
    (iv)&#160;constitute the Delayed Equity Amount); <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;100% of the aggregate amount received in cash and the
    fair market value, as determined in good faith by the Issuer, of
    marketable securities or other property received by means of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (i)&#160;the sale or other disposition (other than to the Issuer
    or a Restricted Subsidiary) of Restricted Investments made by
    the Issuer or its Restricted Subsidiaries and repurchases and
    redemptions of such Restricted Investments from the Issuer or
    its Restricted Subsidiaries and repayments of loans or advances,
    and releases of guarantees, which constitute Restricted
    Investments by the Issuer or its Restricted Subsidiaries, in
    each case after the Issue Date;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (ii)&#160;the sale (other than to the Issuer or a Restricted
    Subsidiary) of the stock of an Unrestricted Subsidiary or a
    distribution from an Unrestricted Subsidiary (other than in each
    case to the extent the Investment in such Unrestricted
    Subsidiary was made by the Issuer or a Restricted Subsidiary
    pursuant to clause&#160;(7) of the next succeeding paragraph or
    to the extent such Investment constituted a Permitted
    Investment) or a dividend from an Unrestricted Subsidiary after
    the Issue Date; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;in the case of the redesignation of an Unrestricted
    Subsidiary as a Restricted Subsidiary after the Issue Date, the
    fair market value of the Investment in such Unrestricted
    Subsidiary, as determined by the Issuer in good faith (or if
    such fair market value exceeds $250.0&#160;million, in writing
    by an Independent Financial Advisor), at the time of the
    redesignation of such Unrestricted Subsidiary as a Restricted
    Subsidiary other than to the extent the Investment in such
    Unrestricted Subsidiary was made by the Issuer or a Restricted
    Subsidiary pursuant to clause&#160;(7) of the next succeeding
    paragraph or to the extent such Investment constituted a
    Permitted Investment.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The foregoing provisions will not prohibit:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the payment of any dividend within 60&#160;days after
    the date of declaration thereof, if at the date of declaration
    such payment would have complied with the provisions of the
    Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;(a)&#160;the redemption, repurchase, retirement or
    other acquisition of any Equity Interests <I>(&#147;Treasury
    Capital Stock&#148;)</I> or Subordinated Indebtedness of the
    Issuer or any Equity Interests of any direct or indirect parent
    company of the Issuer, in exchange for, or out of the proceeds
    of the substantially concurrent sale (other than to a Restricted
    Subsidiary) of, Equity Interests of the Issuer or any direct or
    indirect parent company of the Issuer to the extent contributed
    to the Issuer (in each case, other than any Disqualified Stock)
    <I>(&#147;Refunding Capital Stock&#148;)</I> and (b)&#160;if
    immediately prior to the retirement of
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    69
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Treasury Capital Stock, the declaration and payment of dividends
    thereon was permitted under clause&#160;(6) of this paragraph,
    the declaration and payment of dividends on the Refunding
    Capital Stock (other than Refunding Capital Stock the proceeds
    of which were used to redeem, repurchase, retire or otherwise
    acquire any Equity Interests of any direct or indirect parent
    company of the Issuer) in an aggregate amount per year no
    greater than the aggregate amount of dividends per annum that
    were declarable and payable on such Treasury Capital Stock
    immediately prior to such retirement;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;the redemption, repurchase or other acquisition or
    retirement of Subordinated Indebtedness of the Issuer or a
    Guarantor made in exchange for, or out of the proceeds of the
    substantially concurrent sale of, new Indebtedness of the Issuer
    or a Guarantor, as the case may be, which is incurred in
    compliance with &#147;&#151;&#160;Limitation on Incurrence of
    Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock&#148; so long as:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;the principal amount (or accreted value) of such new
    Indebtedness does not exceed the principal amount of (or
    accreted value, if applicable), plus any accrued and unpaid
    interest on, the Subordinated Indebtedness being so redeemed,
    repurchased, acquired or retired for value, plus the amount of
    any reasonable premium (including reasonable tender premiums),
    defeasance costs and any reasonable fees and expenses incurred
    in connection with the issuance of such new Indebtedness;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;such new Indebtedness is subordinated to the Notes or
    the applicable Guarantee at least to the same extent as such
    Subordinated Indebtedness so purchased, exchanged, redeemed,
    repurchased, acquired or retired for value;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;such new Indebtedness has a final scheduled maturity
    date equal to or later than the final scheduled maturity date of
    the Subordinated Indebtedness being so redeemed, repurchased,
    acquired or retired;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;such new Indebtedness has a Weighted Average Life to
    Maturity equal to or greater than the remaining Weighted Average
    Life to Maturity of the Subordinated Indebtedness being so
    redeemed, repurchased, acquired or retired;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;a Restricted Payment to pay for the repurchase,
    retirement or other acquisition or retirement for value of
    Equity Interests (other than Disqualified Stock) of the Issuer
    or any of its direct or indirect parent companies held by any
    future, present or former employee, director or consultant of
    the Issuer, any of its Subsidiaries or any of its direct or
    indirect parent companies pursuant to any management equity plan
    or stock option plan or any other management or employee benefit
    plan or agreement, including any Equity Interests rolled over by
    management of the Company or any of its direct or indirect
    parent companies in connection with the Transaction;
    <I>provided</I>, <I>however</I>, that the aggregate Restricted
    Payments made under this clause&#160;(4) do not exceed in any
    calendar year $75.0&#160;million (which shall increase to
    $150.0&#160;million subsequent to the consummation of an
    underwritten public Equity Offering by the Issuer or any direct
    or indirect parent entity of the Issuer) (with unused amounts in
    any calendar year being carried over to succeeding calendar
    years subject to a maximum (without giving effect to the
    following proviso) of $225.0&#160;million in any calendar year
    (which shall increase to $450.0&#160;million subsequent to the
    consummation of an underwritten public Equity Offering by the
    Issuer or any direct or indirect parent corporation of the
    Issuer)); <I>provided further </I>that such amount in any
    calendar year may be increased by an amount not to exceed:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;the cash proceeds from the sale of Equity Interests
    (other than Disqualified Stock) of the Issuer and, to the extent
    contributed to the Issuer, Equity Interests of any of the
    Issuer&#146;s direct or indirect parent companies, in each case
    to members of management, directors or consultants of the
    Issuer, any of its Subsidiaries or any of its direct or indirect
    parent companies that occurs after the Issue Date, to the extent
    the cash proceeds from the sale of such Equity Interests have
    not otherwise been applied to the payment of Restricted Payments
    by virtue of clause&#160;(3) of the preceding paragraph;
    <I>plus</I>
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    70
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the cash proceeds of key man life insurance policies
    received by the Issuer or its Restricted Subsidiaries after the
    Issue Date; <I>less</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;the amount of any Restricted Payments previously made
    with the cash proceeds described in clauses&#160;(a) and
    (b)&#160;of this clause (4);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    and <I>provided</I>, <I>further</I>, that cancellation of
    Indebtedness owing to the Issuer or any Restricted Subsidiary
    from members of management of the Issuer, any of the
    Issuer&#146;s direct or indirect parent companies or any of the
    Issuer&#146;s Restricted Subsidiaries in connection with a
    repurchase of Equity Interests of the Issuer or any of its
    direct or indirect parent companies will not be deemed to
    constitute a Restricted Payment for purposes of this covenant or
    any other provision of the Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;the declaration and payment of dividends to holders of
    any class or series of Disqualified Stock of the Issuer or any
    of its Restricted Subsidiaries or any class or series of
    Preferred Stock of any Restricted Subsidiary issued in
    accordance with the covenant described under
    &#147;&#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock&#148; to the
    extent such dividends are included in the definition of
    &#147;Fixed Charges&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;(a)&#160;the declaration and payment of dividends to
    holders of any class or series of Designated Preferred Stock
    (other than Disqualified Stock) issued by the Issuer after the
    Issue Date;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the declaration and payment of dividends to a direct or
    indirect parent company of the Issuer, the proceeds of which
    will be used to fund the payment of dividends to holders of any
    class or series of Designated Preferred Stock (other than
    Disqualified Stock) of such parent corporation issued after the
    Issue Date; <I>provided </I>that the amount of dividends paid
    pursuant to this clause&#160;(b) shall not exceed the aggregate
    amount of cash actually contributed to the Issuer from the sale
    of such Designated Preferred Stock;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;the declaration and payment of dividends on Refunding
    Capital Stock that is Preferred Stock in excess of the dividends
    declarable and payable thereon pursuant to clause&#160;(2) of
    this paragraph;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided</I>, <I>however</I>, in the case of each of
    (a)&#160;and (c)&#160;of this clause (6), that for the most
    recently ended four full fiscal quarters for which internal
    financial statements are available immediately preceding the
    date of issuance of such Designated Preferred Stock or the
    declaration of such dividends on Refunding Capital Stock that is
    Preferred Stock, after giving effect to such issuance or
    declaration on a <I>pro forma </I>basis, the Issuer and its
    Restricted Subsidiaries on a consolidated basis would have had a
    Fixed Charge Coverage Ratio of at least 2.00 to 1.00;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;Investments in Unrestricted Subsidiaries having an
    aggregate fair market value, taken together with all other
    Investments made pursuant to this clause&#160;(7) that are at
    the time outstanding, without giving effect to the sale of an
    Unrestricted Subsidiary to the extent the proceeds of such sale
    do not consist of cash or marketable securities, not to exceed
    2.5% of Total Assets at the time of such Investment (with the
    fair market value of each Investment being measured at the time
    made and without giving effect to subsequent changes in value);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;repurchases of Equity Interests deemed to occur upon
    exercise of stock options or warrants if such Equity Interests
    represent a portion of the exercise price of such options or
    warrants;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;the declaration and payment of dividends on the
    Issuer&#146;s common stock (or the payment of dividends to any
    direct or indirect parent entity to fund a payment of dividends
    on such entity&#146;s common stock), following consummation of
    the first public offering of the Issuer&#146;s common stock or
    the common stock of any of its direct or indirect parent
    companies after the Issue Date, of up to 6% per annum of the net
    cash proceeds received by or contributed to the Issuer in or
    from any such public offering, other than public offerings with
    respect to the Issuer&#146;s common stock registered on
    <FONT style="white-space: nowrap">Form&#160;S-8</FONT>
    and other than any public sale constituting an Excluded
    Contribution;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;Restricted Payments that are made with Excluded
    Contributions;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    71
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;other Restricted Payments in an aggregate amount taken
    together with all other Restricted Payments made pursuant to
    this clause&#160;(11) not to exceed 3.0% of Total Assets at the
    time made;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;distributions or payments of Receivables Fees;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;any Restricted Payment made as part of the Transaction
    and the fees and expenses related thereto or used to fund
    amounts owed to Affiliates (including dividends to any direct or
    indirect parent of the Issuer to permit payment by such parent
    of such amount), in each case to the extent permitted by the
    covenant described under &#147;&#151;&#160;Transactions with
    Affiliates&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (14)&#160;the repurchase, redemption or other acquisition or
    retirement for value of any Subordinated Indebtedness in
    accordance with the provisions similar to those described under
    the captions &#147;Repurchase at the Option of
    Holders&#160;&#151; Change of Control&#148; and &#147;Repurchase
    at the Option of Holders&#160;&#151; Asset Sales&#148;;
    <I>provided </I>that all Notes tendered by Holders in connection
    with a Change of Control Offer, Collateral Asset Sale Offer or
    Asset Sale Offer, as applicable, have been repurchased, redeemed
    or acquired for value;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (15)&#160;the declaration and payment of dividends by the Issuer
    to, or the making of loans to, any direct or indirect parent in
    amounts required for any direct or indirect parent companies to
    pay, in each case without duplication,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;franchise and excise taxes and other fees, taxes and
    expenses required to maintain their corporate existence;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;foreign, federal, state and local income taxes, to the
    extent such income taxes are attributable to the income of the
    Issuer and its Restricted Subsidiaries and, to the extent of the
    amount actually received from its Unrestricted Subsidiaries, in
    amounts required to pay such taxes to the extent attributable to
    the income of such Unrestricted Subsidiaries; <I>provided
    </I>that in each case the amount of such payments in any fiscal
    year does not exceed the amount that the Issuer and its
    Restricted Subsidiaries would be required to pay in respect of
    foreign, federal, state and local taxes for such fiscal year
    were the Issuer, its Restricted Subsidiaries and its
    Unrestricted Subsidiaries (to the extent described above) to pay
    such taxes separately from any such parent entity;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;for as long as Hercules Holding II, LLC is a parent of
    the Issuer, distributions equal to any taxable income of
    Hercules Holding II, LLC resulting from the Hedging Arrangements
    multiplied by 45%;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;customary salary, bonus and other benefits payable to
    officers and employees of any direct or indirect parent company
    of the Issuer to the extent such salaries, bonuses and other
    benefits are attributable to the ownership or operation of the
    Issuer and its Restricted Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;general corporate operating and overhead costs and
    expenses of any direct or indirect parent company of the Issuer
    to the extent such costs and expenses are attributable to the
    ownership or operation of the Issuer and its Restricted
    Subsidiaries;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (f)&#160;fees and expenses other than to Affiliates of the
    Issuer related to any unsuccessful equity or debt offering of
    such parent entity;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (16)&#160;the distribution, by dividend or otherwise, of shares
    of Capital Stock of, or Indebtedness owed to the Issuer or a
    Restricted Subsidiary by, Unrestricted Subsidiaries (other than
    Unrestricted Subsidiaries, the primary assets of which are cash
    <FONT style="white-space: nowrap">and/or</FONT> Cash
    Equivalents);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided</I>, <I>however</I>, that at the time of, and after
    giving effect to, any Restricted Payment permitted under
    clauses&#160;(11) and (16), no Default shall have occurred and
    be continuing or would occur as a consequence thereof.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    As of the Issue Date, all of the Issuer&#146;s Subsidiaries were
    Restricted Subsidiaries. The Issuer will not permit any
    Unrestricted Subsidiary to become a Restricted Subsidiary except
    pursuant to the last sentence of the definition of
    &#147;Unrestricted Subsidiary.&#148; For purposes of designating
    any Restricted Subsidiary as an
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    72
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Unrestricted Subsidiary, all outstanding Investments by the
    Issuer and its Restricted Subsidiaries (except to the extent
    repaid) in the Subsidiary so designated will be deemed to be
    Restricted Payments in an amount determined as set forth in the
    last sentence of the definition of &#147;Investment.&#148; Such
    designation will be permitted only if a Restricted Payment in
    such amount would be permitted at such time, whether pursuant to
    the first paragraph of this covenant or under clause (7),
    (10)&#160;or (11)&#160;of the second paragraph of this covenant,
    or pursuant to the definition of &#147;Permitted
    Investments,&#148; and if such Subsidiary otherwise meets the
    definition of an Unrestricted Subsidiary. Unrestricted
    Subsidiaries are not subject to any of the restrictive covenants
    set forth in the Indenture.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, directly or indirectly, create, incur, issue,
    assume, guarantee or otherwise become directly or indirectly
    liable, contingently or otherwise (collectively,
    <I>&#147;incur&#148;</I> and collectively, an
    <I>&#147;incurrence&#148;</I>) with respect to any Indebtedness
    (including Acquired Indebtedness), and the Issuer will not issue
    any shares of Disqualified Stock and will not permit any
    Restricted Subsidiary to issue any shares of Disqualified Stock
    or Preferred Stock; <I>provided</I>, <I>however</I>, that the
    Issuer may incur Indebtedness (including Acquired Indebtedness)
    or issue shares of Disqualified Stock, and any of its Restricted
    Subsidiaries may incur Indebtedness (including Acquired
    Indebtedness), issue shares of Disqualified Stock and issue
    shares of Preferred Stock, if the Fixed Charge Coverage Ratio on
    a consolidated basis for the Issuer and its Restricted
    Subsidiaries&#146; most recently ended four fiscal quarters for
    which internal financial statements are available immediately
    preceding the date on which such additional Indebtedness is
    incurred or such Disqualified Stock or Preferred Stock is issued
    would have been at least 2.00 to 1.00, determined on a <I>pro
    forma </I>basis (including a <I>pro forma </I>application of the
    net proceeds therefrom), as if the additional Indebtedness had
    been incurred, or the Disqualified Stock or Preferred Stock had
    been issued, as the case may be, and the application of proceeds
    therefrom had occurred at the beginning of such four-quarter
    period; <I>provided, further,</I> that Restricted Subsidiaries
    that are not Guarantors may not incur Indebtedness or
    Disqualified Stock or Preferred Stock if, after giving <I>pro
    forma </I>effect to such incurrence or issuance (including a
    <I>pro forma </I>application of the net proceeds therefrom),
    more than an aggregate of $2,000.0&#160;million of Indebtedness
    or Disqualified Stock or Preferred Stock of Restricted
    Subsidiaries that are not Guarantors would be outstanding
    pursuant to this paragraph and clauses (12), (14)&#160;and
    (19)&#160;below at such time.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The foregoing limitations will not apply to:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the incurrence of Indebtedness under (x)&#160;Credit
    Facilities (other than the ABL Facility) by the Issuer or any of
    its Restricted Subsidiaries and the issuance and creation of
    letters of credit and bankers&#146; acceptances thereunder (with
    letters of credit and bankers&#146; acceptances being deemed to
    have a principal amount equal to the face amount thereof), up to
    an aggregate principal amount of $16,500.0&#160;million
    outstanding at any one time and (y)&#160;the ABL Facility by the
    Issuer or any of its Restricted Subsidiaries and the issuance
    and creation of letters of credit and bankers&#146; acceptances
    thereunder (with letters of credit and bankers&#146; acceptances
    being deemed to have a principal amount equal to the face amount
    thereof), up to an aggregate principal amount equal to the ABL
    Facility Cap;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the incurrence by the Issuer and any Guarantor of
    Indebtedness represented by the Notes (including any PIK Notes
    and any Guarantee) (other than any Additional Notes (including
    Guarantees thereof));
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;Indebtedness of the Issuer and its Restricted
    Subsidiaries in existence on the Issue Date (other than
    Indebtedness described in clauses&#160;(1) and (2)), including
    the Existing Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;Indebtedness consisting of Capitalized Lease
    Obligations and Purchase Money Obligations; so long as such
    Indebtedness exists at the date of such purchase, lease or
    improvement, or is created within 270&#160;days thereafter;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;Indebtedness incurred by the Issuer or any of its
    Restricted Subsidiaries constituting reimbursement obligations
    with respect to letters of credit issued in the ordinary course
    of business, including letters of credit in respect of
    workers&#146; compensation, medical malpractice or employee
    health claims, or
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    73
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    other Indebtedness with respect to reimbursement-type
    obligations regarding workers&#146; compensation, medical
    malpractice or employee health claims; <I>provided</I>,
    <I>however</I>, that upon the drawing of such letters of credit
    or the incurrence of such Indebtedness, such obligations are
    reimbursed within 30&#160;days following such drawing or
    incurrence;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;Indebtedness arising from agreements of the Issuer or
    its Restricted Subsidiaries providing for indemnification,
    adjustment of purchase price or similar obligations, in each
    case, incurred or assumed in connection with the disposition of
    any business, assets or a Subsidiary, other than guarantees of
    Indebtedness incurred by any Person acquiring all or any portion
    of such business, assets or a Subsidiary for the purpose of
    financing such acquisition; <I>provided</I>, <I>however</I>,
    that such Indebtedness is not reflected on the balance sheet of
    the Issuer, or any of its Restricted Subsidiaries (contingent
    obligations referred to in a footnote to financial statements
    and not otherwise reflected on the balance sheet will not be
    deemed to be reflected on such balance sheet for purposes of
    this clause (6));
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;Indebtedness of the Issuer to a Restricted Subsidiary;
    <I>provided </I>that any such Indebtedness owing to a Restricted
    Subsidiary that is not a Guarantor is expressly subordinated in
    right of payment to the Notes; <I>provided</I>, <I>further</I>,
    that any subsequent issuance or transfer of any Capital Stock or
    any other event which results in any Restricted Subsidiary
    ceasing to be a Restricted Subsidiary or any other subsequent
    transfer of any such Indebtedness (except to the Issuer or
    another Restricted Subsidiary) shall be deemed, in each case, to
    be an incurrence of such Indebtedness;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;Indebtedness of a Restricted Subsidiary to the Issuer
    or another Restricted Subsidiary; <I>provided </I>that if a
    Guarantor incurs such Indebtedness to a Restricted Subsidiary
    that is not a Guarantor, such Indebtedness is expressly
    subordinated in right of payment to the Guarantee of the Notes
    of such Guarantor; <I>provided</I>, <I>further</I>, that any
    subsequent transfer of any such Indebtedness (except to the
    Issuer or another Restricted Subsidiary) shall be deemed, in
    each case, to be an incurrence of such Indebtedness not
    permitted by this clause;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;shares of Preferred Stock of a Restricted Subsidiary
    issued to the Issuer or another Restricted Subsidiary;
    <I>provided </I>that any subsequent issuance or transfer of any
    Capital Stock or any other event which results in any such
    Restricted Subsidiary ceasing to be a Restricted Subsidiary or
    any other subsequent transfer of any such shares of Preferred
    Stock (except to the Issuer or another of its Restricted
    Subsidiaries) shall be deemed in each case to be an issuance of
    such shares of Preferred Stock not permitted by this clause;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;Hedging Obligations (excluding Hedging Obligations
    entered into for speculative purposes) for the purpose of
    limiting interest rate risk with respect to any Indebtedness
    permitted to be incurred pursuant to
    &#147;&#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock,&#148;
    exchange rate risk or commodity pricing risk;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;obligations in respect of performance, bid, appeal and
    surety bonds and completion guarantees provided by the Issuer or
    any of its Restricted Subsidiaries in the ordinary course of
    business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;(a)&#160;Indebtedness or Disqualified Stock of the
    Issuer and Indebtedness, Disqualified Stock or Preferred Stock
    of the Issuer or any Restricted Subsidiary equal to 200.0% of
    the net cash proceeds received by the Issuer since immediately
    after the Issue Date from the issue or sale of Equity Interests
    of the Issuer or cash contributed to the capital of the Issuer
    (in each case, other than Excluded Contributions or proceeds of
    Disqualified Stock or sales of Equity Interests to the Issuer or
    any of its Subsidiaries) as determined in accordance with
    clauses (3)(b) and (3)(c) of the first paragraph of
    &#147;&#151;&#160;Limitation on Restricted Payments&#148; to the
    extent such net cash proceeds or cash have not been applied
    pursuant to such clauses to make Restricted Payments or to make
    other Investments, payments or exchanges pursuant to the second
    paragraph of &#147;&#151;&#160;Limitation on Restricted
    Payments&#148; or to make Permitted Investments (other than
    Permitted Investments specified in clauses&#160;(1) and
    (3)&#160;of the definition thereof) and (b)&#160;Indebtedness or
    Disqualified Stock of Issuer and Indebtedness, Disqualified
    Stock or Preferred Stock of the Issuer or any Restricted
    Subsidiary not otherwise permitted hereunder in an aggregate
    principal amount or liquidation preference, which when
    aggregated with the principal amount and liquidation preference
    of all
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    74
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    other Indebtedness, Disqualified Stock and Preferred Stock then
    outstanding and incurred pursuant to this clause (12)(b), does
    not at any one time outstanding exceed $1,500.0&#160;million;
    <I>provided</I>, <I>however </I>that on a pro forma basis,
    together with any amounts incurred and outstanding by Restricted
    Subsidiaries that are not Guarantors pursuant to the second
    proviso to the first paragraph of this covenant and
    clauses&#160;(14) and (19), no more than $2,000.0&#160;million
    of Indebtedness, Disqualified Stock or Preferred Stock at any
    one time outstanding and incurred pursuant to this clause
    (12)(b) shall be incurred by Restricted Subsidiaries that are
    not Guarantors (it being understood that any Indebtedness,
    Disqualified Stock or Preferred Stock incurred pursuant to this
    clause (12)(b) shall cease to be deemed incurred or outstanding
    for purposes of this clause (12)(b) but shall be deemed incurred
    for the purposes of the first paragraph of this covenant from
    and after the first date on which the Issuer or such Restricted
    Subsidiary could have incurred such Indebtedness, Disqualified
    Stock or Preferred Stock under the first paragraph of this
    covenant without reliance on this clause (12)(b));
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;the incurrence or issuance by the Issuer or any
    Restricted Subsidiary of Indebtedness, Disqualified Stock or
    Preferred Stock which serves to refund or refinance any
    Indebtedness, Disqualified Stock or Preferred Stock of the
    Issuer or any Restricted Subsidiary incurred as permitted under
    the first paragraph of this covenant and clauses (2), (3),
    (4)&#160;and (12)(a) above, this clause&#160;(13) and
    clause&#160;(14) below or any Indebtedness, Disqualified Stock
    or Preferred Stock of the Issuer or any Restricted Subsidiary
    issued to so refund or refinance such Indebtedness, Disqualified
    Stock or Preferred Stock of the Issuer or any Restricted
    Subsidiary including additional Indebtedness, Disqualified Stock
    or Preferred Stock incurred to pay premiums (including
    reasonable tender premiums), defeasance costs and fees in
    connection therewith (the <I>&#147;Refinancing
    Indebtedness&#148;</I>) prior to its respective maturity;
    <I>provided</I>, <I>however</I>, that such Refinancing
    Indebtedness:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;has a Weighted Average Life to Maturity at the time
    such Refinancing Indebtedness is incurred which is not less than
    the remaining Weighted Average Life to Maturity of the
    Indebtedness, Disqualified Stock or Preferred Stock being
    refunded or refinanced,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;to the extent such Refinancing Indebtedness refinances
    (i)&#160;Indebtedness subordinated or <I>pari passu </I>to the
    Notes or any Guarantee thereof, such Refinancing Indebtedness is
    subordinated or <I>pari passu </I>to the Notes or the Guarantee
    at least to the same extent as the Indebtedness being refinanced
    or refunded or (ii)&#160;Disqualified Stock or Preferred Stock,
    such Refinancing Indebtedness must be Disqualified Stock or
    Preferred Stock, respectively,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;shall not include Indebtedness, Disqualified Stock or
    Preferred Stock of a Subsidiary of the Issuer that is not a
    Guarantor that refinances Indebtedness, Disqualified Stock or
    Preferred Stock of the Issuer or a Guarantor;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    and, <I>provided further, </I>that subclause&#160;(a) of this
    clause&#160;(13) will not apply to any refunding or refinancing
    of any Priority Lien Obligations and Obligations secured by
    Permitted Liens;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (14)&#160;Indebtedness, Disqualified Stock or Preferred Stock of
    (x)&#160;the Issuer or a Restricted Subsidiary incurred to
    finance an acquisition or (y)&#160;Persons that are acquired by
    the Issuer or any Restricted Subsidiary or merged into the
    Issuer or a Restricted Subsidiary in accordance with the terms
    of the Indenture; <I>provided </I>that after giving effect to
    such acquisition or merger, either
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;the Issuer would be permitted to incur at least $1.00
    of additional Indebtedness pursuant to the Fixed Charge Coverage
    Ratio test set forth in the first sentence of this
    covenant,&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the Fixed Charge Coverage Ratio of the Issuer and the
    Restricted Subsidiaries is greater than immediately prior to
    such acquisition or merger;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided</I>, <I>however </I>that on a pro forma basis,
    together with amounts incurred and outstanding pursuant to the
    second proviso to the first paragraph of this covenant and
    clauses&#160;(12) and (19), no more than $2,000.0&#160;million
    of Indebtedness, Disqualified Stock or Preferred Stock at any
    one time outstanding and incurred by Restricted Subsidiaries
    that are not Guarantors pursuant to this clause&#160;(14) shall
    be incurred and outstanding;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    75
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (15)&#160;Indebtedness arising from the honoring by a bank or
    other financial institution of a check, draft or similar
    instrument drawn against insufficient funds in the ordinary
    course of business; <I>provided </I>that such Indebtedness is
    extinguished within two Business Days of its incurrence;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (16)&#160;Indebtedness of the Issuer or any of its Restricted
    Subsidiaries supported by a letter of credit issued pursuant to
    any Credit Facilities, in a principal amount not in excess of
    the stated amount of such letter of credit;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (17)&#160;(a)&#160;any guarantee by the Issuer or a Restricted
    Subsidiary of Indebtedness or other obligations of any
    Restricted Subsidiary, so long as the incurrence of such
    Indebtedness incurred by such Restricted Subsidiary is permitted
    under the terms of the Indenture, or (b)&#160;any guarantee by a
    Restricted Subsidiary of Indebtedness of the Issuer; <I>provided
    </I>that such guarantee is incurred in accordance with the
    covenant described below under &#147;&#151;&#160;Limitation on
    Guarantees of Indebtedness by Restricted Subsidiaries&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (18)&#160;Indebtedness of Foreign Subsidiaries of the Issuer in
    an amount not to exceed at any one time outstanding and together
    with any other Indebtedness incurred under this clause&#160;(18)
    7.5% of the Total Assets of the Foreign Subsidiaries (it being
    understood that any Indebtedness incurred pursuant to this
    clause&#160;(18) shall cease to be deemed incurred or
    outstanding for purposes of this clause&#160;(18) but shall be
    deemed incurred for the purposes of the first paragraph of this
    covenant from and after the first date on which the Issuer or
    such Restricted Subsidiaries could have incurred such
    Indebtedness under the first paragraph of this covenant without
    reliance on this clause (18));
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (19)&#160;Indebtedness, Disqualified Stock or Preferred Stock of
    a Restricted Subsidiary incurred to finance or assumed in
    connection with an acquisition in a principal amount not to
    exceed $200.0&#160;million in the aggregate at any one time
    outstanding together with all other Indebtedness, Disqualified
    Stock <FONT style="white-space: nowrap">and/or</FONT>
    Preferred Stock issued under this clause (19) (it being
    understood that any Indebtedness, Disqualified Stock or
    Preferred Stock incurred pursuant to this clause&#160;(19) shall
    cease to be deemed incurred or outstanding for purposes of this
    clause&#160;(19) but shall be deemed incurred for the purposes
    of the first paragraph of this covenant from and after the first
    date on which such Restricted Subsidiary could have incurred
    such Indebtedness, Disqualified Stock or Preferred Stock under
    the first paragraph of this covenant without reliance on this
    clause (19)); <I>provided, however</I>, that, on a pro forma
    basis, together with amounts incurred and outstanding by
    Restricted Subsidiaries that are not Guarantors pursuant to the
    second proviso to the first paragraph of this covenant and
    clauses&#160;(12) and (14), no more than $2,000.0&#160;million
    of Indebtedness would be incurred and outstanding by Restricted
    Subsidiaries that are not Guarantors;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (20)&#160;Indebtedness of the Issuer or any of its Restricted
    Subsidiaries consisting of (i)&#160;the financing of insurance
    premiums or
    <FONT style="white-space: nowrap">(ii)&#160;take-or-pay</FONT>
    obligations contained in supply arrangements, in each case,
    incurred in the ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (21)&#160;Indebtedness consisting of Indebtedness issued by the
    Issuer or any of its Restricted Subsidiaries to current or
    former officers, directors and employees thereof, their
    respective estates, spouses or former spouses, in each case to
    finance the purchase or redemption of Equity Interests of the
    Issuer or any direct or indirect parent company of the Issuer to
    the extent described in clause&#160;(4) of the second paragraph
    under the caption &#147;&#151;&#160;Limitation on Restricted
    Payments&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (22)&#160;Physician Support Obligations incurred by the Issuer
    or any Restricted Subsidiary;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (23)&#160;Indebtedness of the Issuer or any of its Restricted
    Subsidiaries undertaken in connection with cash management and
    related activities with respect to any Subsidiary or joint
    venture operating one or more healthcare facilities, including,
    without limitation, hospitals, ambulatory surgery centers,
    outpatient diagnostic centers or imaging centers, in each case,
    in the ordinary course of business.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For purposes of determining compliance with this covenant:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;in the event that an item of Indebtedness, Disqualified
    Stock or Preferred Stock (or any portion thereof) meets the
    criteria of more than one of the categories of permitted
    Indebtedness, Disqualified Stock or Preferred Stock described in
    clauses&#160;(1) through (23)&#160;above or is entitled to be
    incurred pursuant
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    76
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    to the first paragraph of this covenant, the Issuer, in its sole
    discretion, will classify or reclassify such item of
    Indebtedness, Disqualified Stock or Preferred Stock (or any
    portion thereof) and will only be required to include the amount
    and type of such Indebtedness, Disqualified Stock or Preferred
    Stock in one of the above clauses; <I>provided </I>that all
    Indebtedness outstanding under the Credit Facilities on the
    Issue Date will be treated as incurred on the Issue Date under
    clause&#160;(1) of the preceding paragraph;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;at the time of incurrence, the Issuer will be entitled
    to divide and classify an item of Indebtedness in more than one
    of the types of Indebtedness described in the first and second
    paragraphs above.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Accrual of interest, the accretion of accreted value and the
    payment of interest in the form of additional Indebtedness,
    Disqualified Stock or Preferred Stock will not be deemed to be
    an incurrence of Indebtedness, Disqualified Stock or Preferred
    Stock for purposes of this covenant.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For purposes of determining compliance with any
    U.S.&#160;dollar-denominated restriction on the incurrence of
    Indebtedness, the U.S.&#160;dollar-equivalent principal amount
    of Indebtedness denominated in a foreign currency shall be
    calculated based on the relevant currency exchange rate in
    effect on the date such Indebtedness was incurred, in the case
    of term debt, or first committed, in the case of revolving
    credit debt; <I>provided </I>that if such Indebtedness is
    incurred to refinance other Indebtedness denominated in a
    foreign currency, and such refinancing would cause the
    applicable U.S.&#160;dollar-denominated restriction to be
    exceeded if calculated at the relevant currency exchange rate in
    effect on the date of such refinancing, such
    U.S.&#160;dollar-denominated restriction shall be deemed not to
    have been exceeded so long as the principal amount of such
    refinancing Indebtedness does not exceed the principal amount of
    such Indebtedness being refinanced.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The principal amount of any Indebtedness incurred to refinance
    other Indebtedness, if incurred in a different currency from the
    Indebtedness being refinanced, shall be calculated based on the
    currency exchange rate applicable to the currencies in which
    such respective Indebtedness is denominated that is in effect on
    the date of such refinancing.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that the Issuer will not, and will not
    permit any Guarantor to, directly or indirectly, incur any
    Indebtedness (including Acquired Indebtedness) that is
    subordinated or junior in right of payment to any Indebtedness
    of the Issuer or such Guarantor, as the case may be, unless such
    Indebtedness is expressly subordinated in right of payment to
    the Notes or such Guarantor&#146;s Guarantee to the extent and
    in the same manner as such Indebtedness is subordinated to other
    Indebtedness of the Issuer or such Guarantor, as the case may be.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture does not treat (1)&#160;unsecured Indebtedness as
    subordinated or junior to Secured Indebtedness merely because it
    is unsecured or (2)&#160;Senior Indebtedness as subordinated or
    junior to any other Senior Indebtedness merely because it has a
    junior priority with respect to the same collateral.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Limitation
    on Prepayment or Modification of Existing Notes</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, directly or indirectly purchase, redeem,
    defease or otherwise acquire or retire for value any of the
    Existing Notes prior to the final maturity date thereof (as in
    effect on the Issue Date); <I>provided </I>that the Issuer may:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;purchase, redeem, defease or otherwise acquire or
    retire for value any of the Existing Notes which have a final
    maturity date (as in effect on the Issue Date) on or prior to
    December&#160;31, 2011;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;purchase, redeem, defease or otherwise acquire or
    retire for value any other Existing Notes which have a final
    maturity date (as in effect on the Issue Date) on or prior to
    November&#160;15, 2016; <I>provided </I>that, in the case of any
    such prepayment funded with the proceeds of the issuance of
    Secured Indebtedness, at the time of incurrence and after giving
    <I>pro forma</I> effect thereto and to the application of the
    proceeds thereof, (x)&#160;the Consolidated Secured Debt Ratio
    would be no greater than 5.25 to 1.0 and (y)&#160;the
    Consolidated Leverage Ratio would be no greater than 7.0 to 1.0.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, amend the Existing Notes Indenture, or any
    supplemental indenture in respect thereof, in any way to advance
    the final maturity date or
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    77
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    shorten the Weighted Average Life to Maturity of any series of
    the Existing Notes such that any Existing Notes with a maturity
    date following the maturity of the Notes would have a maturity
    date on or prior to the date one year following the maturity
    date of the 2016 Cash Pay Notes or which would prohibit the
    making of the Guarantees or the creation of Liens in favor of
    the Notes and the Guarantees on the Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, designate any additional subsidiaries as
    &#147;Restricted Subsidiaries&#148; (as defined in the Existing
    Notes Indenture) for purposes of the Existing Notes Indenture.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Liens</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any Guarantor to,
    directly or indirectly, create, incur, assume or suffer to exist
    any Lien (except Permitted Liens) that secures obligations under
    any Indebtedness or any related Guarantee, on any asset or
    property of the Issuer or any Guarantor, or any income or
    profits therefrom, or assign or convey any right to receive
    income therefrom, unless:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;in the case of Liens securing Subordinated
    Indebtedness, the Notes and related Guarantees are secured by a
    Lien on such property, assets or proceeds that is senior in
    priority to such Liens;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;in all other cases, the Notes or the Guarantees are
    equally and ratably secured or are secured by a Lien on such
    property, assets or proceeds that is senior in priority to such
    Liens;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    except that the foregoing shall not apply to (a)&#160;Liens
    securing the Notes and the related Guarantees, (b)&#160;Liens
    securing Indebtedness permitted to be incurred under Credit
    Facilities, including any letter of credit relating thereto,
    that was permitted by the terms of the Indenture to be incurred
    pursuant to clause&#160;(1) of the second paragraph under
    &#147;&#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock&#148;;
    <I>provided </I>that, with respect to Liens securing Obligations
    permitted under this subclause (b), the Notes and the related
    Guarantees are secured by Liens on the assets subject to such
    Liens (except any European Collateral) to the extent, with the
    priority and subject to intercreditor arrangements, in each case
    no less favorable to the holders of the Notes than those
    described under &#147;Security&#148; above and (c)&#160;Liens
    which are senior in priority to the Liens securing the Notes and
    related Guarantees and are incurred to secure Obligations in
    respect of any Indebtedness permitted to be incurred pursuant to
    the covenant described above under &#147;&#151;&#160;Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock&#148;; <I>provided </I>that, with respect to
    Liens securing Obligations permitted under this subclause (c),
    (i)&#160;at the time of incurrence and after giving pro forma
    effect thereto, the ratio of (1)&#160;the aggregate amount of
    Indebtedness subject to a Lien incurred pursuant to
    subclause&#160;(b) above, this subclause&#160;(c) and
    clause&#160;(6) of the definition of &#147;Permitted Liens&#148;
    (other than Liens securing Indebtedness incurred pursuant to
    clauses&#160;(4) and (18)&#160;of the covenant described above
    under &#147;&#151;&#160;Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock&#148;) to
    (2)&#160;the Issuer&#146;s EBITDA for the most recently ended
    four full fiscal quarters for which internal financial
    statements are available immediately preceding the date on which
    such event for which such calculation is being made shall occur,
    in each case with such <I>pro forma </I>adjustments to
    Indebtedness and EBITDA as are appropriate and consistent with
    the <I>pro forma </I>adjustment provisions set forth in the
    definition of Fixed Charge Coverage Ratio would be no greater
    than 4.25 to 1.0 and (ii)&#160;the Notes and the Guarantees are
    secured by Liens with the priority and subject to intercreditor
    arrangements no less favorable to the holders of the Notes than
    those described under &#147;&#151;&#160;Security&#148; above.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Merger,
    Consolidation or Sale of All or Substantially All
    Assets</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer may not consolidate or merge with or into or wind up
    into (whether or not the Issuer is the surviving corporation),
    or sell, assign, transfer, lease, convey or otherwise dispose of
    all or substantially all of its properties or assets, in one or
    more related transactions, to any Person unless:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the Issuer is the surviving corporation or the Person
    formed by or surviving any such consolidation or merger (if
    other than the Issuer) or to which such sale, assignment,
    transfer, lease, conveyance or other disposition will have been
    made is a corporation organized or existing under the
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    78
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    laws of the jurisdiction of organization of the Issuer or the
    laws of the United States, any state thereof, the District of
    Columbia, or any territory thereof (such Person, as the case may
    be, being herein called the <I>&#147;Successor
    Company&#148;</I>);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the Successor Company, if other than the Issuer,
    expressly assumes all the obligations of the Issuer under the
    Notes and the Security Documents pursuant to supplemental
    indentures or other documents or instruments in form reasonably
    satisfactory to the Trustee;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;immediately after such transaction, no Default exists;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;immediately after giving <I>pro forma </I>effect to
    such transaction and any related financing transactions, as if
    such transactions had occurred at the beginning of the
    applicable four-quarter period,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;the Successor Company would be permitted to incur at
    least $1.00 of additional Indebtedness pursuant to the Fixed
    Charge Coverage Ratio test set forth in the first sentence of
    the covenant described under &#147;&#151;&#160;Limitation on
    Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock,&#148;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the Fixed Charge Coverage Ratio for the Successor
    Company, the Issuer and its Restricted Subsidiaries would be
    greater than such ratio for the Issuer and its Restricted
    Subsidiaries immediately prior to such transaction;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;each Guarantor, unless it is the other party to the
    transactions described above, in which case clause&#160;(b) of
    the second succeeding paragraph shall apply, shall have by
    supplemental indenture confirmed that its Guarantee shall apply
    to such Person&#146;s obligations under the Indenture, the Notes
    and the Registration Rights Agreement;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;the Collateral owned by the Successor Company will
    (a)&#160;continue to constitute Collateral under the Indenture
    and the Security Documents, (b)&#160;be subject to a Lien in
    favor of the Junior Lien Collateral Agent for the benefit of the
    Trustee and the Holders of the Notes and (c)&#160;not be subject
    to any other Lien, other than Permitted Liens;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;to the extent any assets of the Person which is merged
    or consolidated with or into the Successor Company are assets of
    the type which would constitute Collateral under the Security
    Documents, the Successor Company will take such action as may be
    reasonably necessary to cause such property and assets to be
    made subject to the Lien of the Security Documents in the manner
    and to the extent required in the Indenture or any of the
    Security Documents and shall take all reasonably necessary
    action so that such Lien is perfected to the extent required by
    the Security Documents;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;the Issuer shall have delivered to the Trustee an
    Officer&#146;s Certificate and an Opinion of Counsel, each
    stating that such consolidation, merger or transfer and such
    supplemental indentures, if any, comply with the Indenture and,
    if a supplemental indenture or any supplement to any Security
    Document is required in connection with such transaction, such
    supplement shall comply with the applicable provisions of the
    Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Successor Company will succeed to, and be substituted for
    the Issuer, as the case may be, under the Indenture, the
    Guarantees and the Notes, as applicable. Notwithstanding the
    foregoing clauses&#160;(3) and (4),
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any Restricted Subsidiary may consolidate with or merge
    into or transfer all or part of its properties and assets to the
    Issuer,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the Issuer may merge with an Affiliate of the Issuer,
    as the case may be, solely for the purpose of reincorporating
    the Issuer in a State of the United States or any state thereof,
    the District of Columbia or any territory thereof so long as the
    amount of Indebtedness of the Issuer and its Restricted
    Subsidiaries is not increased thereby.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Subject to certain limitations described in the Indenture
    governing release of a Guarantee upon the sale, disposition or
    transfer of a Guarantor, no Guarantor will, and the Issuer will
    not permit any Guarantor to, consolidate or merge with or into
    or wind up into (whether or not the Issuer or Guarantor is the
    surviving
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    79
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    corporation), or sell, assign, transfer, lease, convey or
    otherwise dispose of all or substantially all of its properties
    or assets, in one or more related transactions, to any Person
    unless:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;(a)&#160;such Guarantor is the surviving corporation or
    the Person formed by or surviving any such consolidation or
    merger (if other than such Guarantor) or to which such sale,
    assignment, transfer, lease, conveyance or other disposition
    will have been made is a corporation, partnership, limited
    partnership, limited liability corporation or trust organized or
    existing under the laws of the jurisdiction of organization of
    such Guarantor, as the case may be, or the laws of the United
    States, any state thereof, the District of Columbia, or any
    territory thereof (such Guarantor or such Person, as the case
    may be, being herein called the <I>&#147;Successor
    Person&#148;</I>);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the Successor Person, if other than such Guarantor,
    expressly assumes all the obligations of such Guarantor under
    the Indenture and such Guarantor&#146;s related Guarantee
    pursuant to supplemental indentures or other documents or
    instruments in form reasonably satisfactory to the Trustee;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;immediately after such transaction, no Default
    exists;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;the Issuer shall have delivered to the Trustee an
    Officer&#146;s Certificate, each stating that such
    consolidation, merger or transfer and such supplemental
    indentures, if any, comply with the Indenture;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the transaction is made in compliance with the covenant
    described under &#147;Repurchase at the Option of
    Holders&#160;&#151; Asset Sales.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Subject to certain limitations described in the Indenture, the
    Successor Person will succeed to, and be substituted for, such
    Guarantor under the Indenture and such Guarantor&#146;s
    Guarantee. Notwithstanding the foregoing, any Guarantor may
    (i)&#160;merge into or transfer all or part of its properties
    and assets to another Guarantor or the Issuer, (ii)&#160;merge
    with an Affiliate of the Company solely for the purpose of
    reincorporating the Guarantor in the United States, any state
    thereof, the District of Columbia or any territory thereof or
    (iii)&#160;convert into a corporation, partnership, limited
    partnership, limited liability corporation or trust organized or
    existing under the laws of the jurisdiction of organization of
    such Guarantor.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Transactions
    with Affiliates</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, make any payment to, or sell, lease, transfer
    or otherwise dispose of any of its properties or assets to, or
    purchase any property or assets from, or enter into or make or
    amend any transaction, contract, agreement, understanding, loan,
    advance or guarantee with, or for the benefit of, any Affiliate
    of the Issuer (each of the foregoing, an <I>&#147;Affiliate
    Transaction&#148;</I>) involving aggregate payments or
    consideration in excess of $40.0&#160;million, unless:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;such Affiliate Transaction is on terms that are not
    materially less favorable to the Issuer or its relevant
    Restricted Subsidiary than those that would have been obtained
    in a comparable transaction by the Issuer or such Restricted
    Subsidiary with an unrelated Person on an arm&#146;s-length
    basis;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the Issuer delivers to the Trustee with respect to any
    Affiliate Transaction or series of related Affiliate
    Transactions involving aggregate payments or consideration in
    excess of $80.0&#160;million, a resolution adopted by the
    majority of the board of directors of the Issuer approving such
    Affiliate Transaction and set forth in an Officer&#146;s
    Certificate certifying that such Affiliate Transaction complies
    with clause&#160;(1) above.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The foregoing provisions will not apply to the following:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;transactions between or among the Issuer or any of its
    Restricted Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;Restricted Payments permitted by the provisions of the
    Indenture described above under the covenant
    &#147;&#151;&#160;Limitation on Restricted Payments&#148; and
    the definition of &#147;Permitted Investments&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;the payment of management, consulting, monitoring and
    advisory fees and related expenses to the Investors and the
    Frist Entities pursuant to the Sponsor Management Agreement
    (plus any unpaid management, consulting, monitoring and advisory
    fees and related expenses accrued in any prior year)
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    80
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    and the termination fees pursuant to the Sponsor Management
    Agreement, in each case as in effect on the Issue Date, or any
    amendment thereto (so long as any such amendment is not
    disadvantageous in the good faith judgment of the board of
    directors of the Issuer to the Holders when taken as a whole as
    compared to the Sponsor Management Agreement in effect on the
    Issue Date);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;the payment of reasonable and customary fees paid to,
    and indemnities provided for the benefit of, officers,
    directors, employees or consultants of Issuer, any of its direct
    or indirect parent companies or any of its Restricted
    Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;transactions in which the Issuer or any of its
    Restricted Subsidiaries, as the case may be, delivers to the
    Trustee a letter from an Independent Financial Advisor stating
    that such transaction is fair to the Issuer or such Restricted
    Subsidiary from a financial point of view or stating that the
    terms are not materially less favorable to the Issuer or its
    relevant Restricted Subsidiary than those that would have been
    obtained in a comparable transaction by the Issuer or such
    Restricted Subsidiary with an unrelated Person on an
    arm&#146;s-length basis;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;any agreement as in effect as of the Issue Date, or any
    amendment thereto (so long as any such amendment is not
    disadvantageous to the Holders when taken as a whole as compared
    to the applicable agreement as in effect on the Issue Date);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;the existence of, or the performance by the Issuer or
    any of its Restricted Subsidiaries of its obligations under the
    terms of, any stockholders agreement (including any registration
    rights agreement or purchase agreement related thereto) to which
    it is a party as of the Issue Date and any similar agreements
    which it may enter into thereafter; <I>provided</I>,
    <I>however</I>, that the existence of, or the performance by the
    Issuer or any of its Restricted Subsidiaries of obligations
    under any future amendment to any such existing agreement or
    under any similar agreement entered into after the Issue Date
    shall only be permitted by this clause&#160;(7) to the extent
    that the terms of any such amendment or new agreement are not
    otherwise disadvantageous to the Holders when taken as a whole;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;the Transaction and the payment of all fees and
    expenses related to the Transaction, in each case as disclosed
    in the Offering Memorandum;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;transactions with customers, clients, suppliers, or
    purchasers or sellers of goods or services, in each case in the
    ordinary course of business and otherwise in compliance with the
    terms of the Indenture which are fair to the Issuer and its
    Restricted Subsidiaries, in the reasonable determination of the
    board of directors of the Issuer or the senior management
    thereof, or are on terms at least as favorable as might
    reasonably have been obtained at such time from an unaffiliated
    party;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;the issuance of Equity Interests (other than
    Disqualified Stock) of the Issuer to any Permitted Holder or to
    any director, officer, employee or consultant;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;sales of accounts receivable, or participations
    therein, in connection with the ABL Facility and any Receivables
    Facility;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;payments by the Issuer or any of its Restricted
    Subsidiaries to any of the Investors made for any financial
    advisory, financing, underwriting or placement services or in
    respect of other investment banking activities, including,
    without limitation, in connection with acquisitions or
    divestitures, which payments are approved by a majority of the
    board of directors of the Issuer in good faith;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;payments or loans (or cancellation of loans) to
    employees or consultants of the Issuer, any of its direct or
    indirect parent companies or any of its Restricted Subsidiaries
    and employment agreements, stock option plans and other similar
    arrangements with such employees or consultants which, in each
    case, are approved by the Issuer in good faith;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (14)&#160;investments by the Investors or the Frist Entities in
    securities of the Issuer or any of its Restricted Subsidiaries
    so long as (i)&#160;the investment is being offered generally to
    other investors on the same or more favorable terms and
    (ii)&#160;the investment constitutes less than 5% of the
    proposed or outstanding issue amount of such class of securities;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    81
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (15)&#160;payments to or from, and transactions with, any joint
    venture owning or operating one or more healthcare facilities,
    including, without limitation, hospitals, ambulatory surgery
    centers, outpatient diagnostic centers or imaging centers, in
    each case in the ordinary course of business (including, without
    limitation, any cash management activities related
    thereto);&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (16)&#160;payments by the Issuer (and any direct or indirect
    parent thereof) and its Subsidiaries pursuant to tax sharing
    agreements among the Issuer (and any such parent) and its
    Subsidiaries on customary terms to the extent attributable to
    the ownership or operation of the Issuer and its Subsidiaries;
    <I>provided </I>that in each case the amount of such payments in
    any fiscal year does not exceed the amount that the Issuer, its
    Restricted Subsidiaries and its Unrestricted Subsidiaries (to
    the extent of amounts received from Unrestricted Subsidiaries)
    would be required to pay in respect of foreign, federal, state
    and local taxes for such fiscal year were the Issuer and its
    Restricted Subsidiaries (to the extent described above) to pay
    such taxes separately from any such parent entity.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Dividend
    and Other Payment Restrictions Affecting Restricted
    Subsidiaries</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any of its Restricted
    Subsidiaries that are not Guarantors to, directly or indirectly,
    create or otherwise cause or suffer to exist or become effective
    any consensual encumbrance or consensual restriction on the
    ability of any such Restricted Subsidiary to:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;(a)&#160;pay dividends or make any other distributions
    to the Issuer or any of its Restricted Subsidiaries on its
    Capital Stock or with respect to any other interest or
    participation in, or measured by, its profits,&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;pay any Indebtedness owed to the Issuer or any of its
    Restricted Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;make loans or advances to the Issuer or any of its
    Restricted Subsidiaries;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;sell, lease or transfer any of its properties or assets
    to the Issuer or any of its Restricted Subsidiaries,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    except (in each case) for such encumbrances or restrictions
    existing under or by reason of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;contractual encumbrances or restrictions in effect on
    the Issue Date, including pursuant to the Senior Credit
    Facilities and the related documentation and the Existing Notes
    Indenture and the related documentation;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the Indenture and the Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;purchase money obligations for property acquired in the
    ordinary course of business that impose restrictions of the
    nature discussed in clause&#160;(3) above on the property so
    acquired;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;applicable law or any applicable rule, regulation or
    order;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;any agreement or other instrument of a Person acquired
    by the Issuer or any Restricted Subsidiary in existence at the
    time of such acquisition (but not created in contemplation
    thereof), which encumbrance or restriction is not applicable to
    any Person, or the properties or assets of any Person, other
    than the Person and its Subsidiaries, or the property or assets
    of the Person and its Subsidiaries, so acquired;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (f)&#160;contracts for the sale of assets, including customary
    restrictions with respect to a Subsidiary of the Issuer pursuant
    to an agreement that has been entered into for the sale or
    disposition of all or substantially all of the Capital Stock or
    assets of such Subsidiary;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (g)&#160;Secured Indebtedness that limits the right of the
    debtor to dispose of the assets securing such Indebtedness that
    is otherwise permitted to be incurred pursuant to the covenants
    described under &#147;&#151;&#160;Limitation on Incurrence of
    Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock&#148; and &#147;&#151;&#160;Liens&#148;;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    82
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (h)&#160;restrictions on cash or other deposits or net worth
    imposed by customers under contracts entered into in the
    ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (i)&#160;other Indebtedness, Disqualified Stock or Preferred
    Stock of Foreign Subsidiaries permitted to be incurred
    subsequent to the Issue Date pursuant to the provisions of the
    covenant described under &#147;&#151;&#160;Limitation on
    Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (j)&#160;customary provisions in joint venture agreements and
    other agreements or arrangements relating solely to such joint
    venture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (k)&#160;customary provisions contained in leases or licenses of
    intellectual property and other agreements, in each case entered
    into in the ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (l)&#160;any encumbrances or restrictions of the type referred
    to in clauses (1), (2)&#160;and (3)&#160;above imposed by any
    amendments, modifications, restatements, renewals, increases,
    supplements, refundings, replacements or refinancings of the
    contracts, instruments or obligations referred to in
    clauses&#160;(a) through (k)&#160;above; <I>provided </I>that
    such amendments, modifications, restatements, renewals,
    increases, supplements, refundings, replacements or refinancings
    are, in the good faith judgment of the Issuer, no more
    restrictive with respect to such encumbrance and other
    restrictions taken as a whole than those prior to such
    amendment, modification, restatement, renewal, increase,
    supplement, refunding, replacement or refinancing;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (m)&#160;restrictions created in connection with any Receivables
    Facility that, in the good faith determination of the Issuer,
    are necessary or advisable to effect the transactions
    contemplated under such Receivables Facility.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Limitation
    on Guarantees of Indebtedness by Restricted
    Subsidiaries</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not permit any of its Wholly-Owned Subsidiaries
    that are Restricted Subsidiaries (and non-Wholly-Owned
    Subsidiaries if such non-Wholly-Owned Subsidiaries guarantee
    other capital markets debt securities of the Issuer or any
    Guarantor), other than a Guarantor, a Foreign Subsidiary or a
    Receivables Subsidiary, to guarantee the payment of any
    Indebtedness of the Issuer or any other Guarantor unless:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;such Restricted Subsidiary within 30&#160;days executes
    and delivers a supplemental indenture to the Indenture providing
    for a Guarantee by such Restricted Subsidiary, except that with
    respect to a guarantee of Indebtedness of the Issuer or any
    Guarantor:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;if the Notes or such Guarantor&#146;s Guarantee are
    subordinated in right of payment to such Indebtedness, the
    Guarantee under the supplemental indenture shall be subordinated
    to such Restricted Subsidiary&#146;s guarantee with respect to
    such Indebtedness substantially to the same extent as the Notes
    are subordinated to such Indebtedness;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;if such Indebtedness is by its express terms
    subordinated in right of payment to the Notes or such
    Guarantor&#146;s Guarantee, any such guarantee by such
    Restricted Subsidiary with respect to such Indebtedness shall be
    subordinated in right of payment to such Guarantee substantially
    to the same extent as such Indebtedness is subordinated to the
    Notes;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;such Restricted Subsidiary waives, and will not in any
    manner whatsoever claim or take the benefit or advantage of, any
    rights of reimbursement, indemnity or subrogation or any other
    rights against the Issuer or any other Restricted Subsidiary as
    a result of any payment by such Restricted Subsidiary under its
    Guarantee;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided </I>that this covenant shall not be applicable to
    (i)&#160;any guarantee of any Restricted Subsidiary that existed
    at the time such Person became a Restricted Subsidiary and was
    not incurred in connection with, or in contemplation of, such
    Person becoming a Restricted Subsidiary and (ii)&#160;guarantees
    of the ABL Facility by the ABL Financing Entities or of any
    Receivables Facility by any Receivables Subsidiary.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    83
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Reports
    and Other Information</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding that the Issuer may not be subject to the
    reporting requirements of Section&#160;13 or 15(d) of the
    Exchange Act or otherwise report on an annual and quarterly
    basis on forms provided for such annual and quarterly reporting
    pursuant to rules and regulations promulgated by the SEC, the
    Indenture requires the Issuer to file with the SEC (and make
    available to the Trustee and Holders of the Notes (without
    exhibits), without cost to any Holder, within 15&#160;days after
    it files them with the SEC) from and after the Issue Date,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;within 90&#160;days (or any other time period then in
    effect under the rules and regulations of the Exchange Act with
    respect to the filing of a
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    by a non-accelerated filer) after the end of each fiscal year,
    annual reports on
    <FONT style="white-space: nowrap">Form&#160;10-K,</FONT>
    or any successor or comparable form, containing the information
    required to be contained therein, or required in such successor
    or comparable form;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;within 45&#160;days after the end of each of the first
    three fiscal quarters of each fiscal year, reports on
    <FONT style="white-space: nowrap">Form&#160;10-Q</FONT>
    containing all quarterly information that would be required to
    be contained in
    <FONT style="white-space: nowrap">Form&#160;10-Q,</FONT>
    or any successor or comparable form;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;promptly from time to time after the occurrence of an
    event required to be therein reported, such other reports on
    <FONT style="white-space: nowrap">Form&#160;8-K,</FONT>
    or any successor or comparable form;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;any other information, documents and other reports
    which the Issuer would be required to file with the SEC if it
    were subject to Section&#160;13 or 15(d) of the Exchange Act;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    in each case in a manner that complies in all material respects
    with the requirements specified in such form; <I>provided
    </I>that the Issuer shall not be so obligated to file such
    reports with the SEC if the SEC does not permit such filing, in
    which event the Issuer will make available such information to
    prospective purchasers of Notes, in addition to providing such
    information to the Trustee and the Holders of the Notes, in each
    case within 15&#160;days after the time the Issuer would be
    required to file such information with the SEC if it were
    subject to Section&#160;13 or 15(d) of the Exchange Act. In
    addition, to the extent not satisfied by the foregoing, the
    Issuer has agreed that, for so long as any Notes are
    outstanding, it will furnish to Holders and to securities
    analysts and prospective investors, upon their request, the
    information required to be delivered pursuant to
    Rule&#160;144A(d)(4) under the Securities Act.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In the event that any direct or indirect parent company of the
    Issuer becomes a Guarantor of the Notes, the Indenture permits
    the Issuer to satisfy its obligations in this covenant with
    respect to financial information relating to the Issuer by
    furnishing financial information relating to such parent;
    <I>provided </I>that the same is accompanied by consolidating
    information that explains in reasonable detail the differences
    between the information relating to such parent, on the one
    hand, and the information relating to the Issuer and its
    Restricted Subsidiaries on a standalone basis, on the other hand.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding the foregoing, such requirements shall be deemed
    satisfied prior to the commencement of the exchange offers or
    the effectiveness of the shelf registration statement described
    in the Registration Rights Agreement (1)&#160;by the filing with
    the SEC of the exchange offer registration statement or shelf
    registration statement (or any other similar registration
    statement), and any amendments thereto, with such financial
    information that satisfies
    <FONT style="white-space: nowrap">Regulation&#160;S-X,</FONT>
    subject to exceptions consistent with the presentation of
    financial information in the Offering Memorandum, to the extent
    filed within the times specified above, or (2)&#160;by posting
    reports that would be required to be filed substantially in the
    form required by the SEC on the Company&#146;s website (or that
    of any of its parent companies) or providing such reports to the
    Trustee within 15&#160;days after the time the Issuer would be
    required to file such information with the SEC if it were
    subject to Section&#160;13 or 15(d) of the Exchange Act, the
    financial information (including a &#147;Management&#146;s
    Discussion and Analysis of Financial Condition and Results of
    Operations&#148; section) that would be required to be included
    in such reports, subject to exceptions consistent with the
    presentation of financial information in the Offering
    Memorandum, to the extent filed within the times specified above.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    84
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Events of
    Default and Remedies</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that each of the following is an
    <I>&#147;Event of Default&#148;</I>:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;default in payment when due and payable, upon
    redemption, acceleration or otherwise, of principal of, or
    premium, if any, on the Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;default for 30&#160;days or more in the payment when
    due of interest or Additional Interest on or with respect to the
    Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;failure by the Issuer or any Guarantor for 60&#160;days
    after receipt of written notice given by the Trustee or the
    Holders of not less 30% in principal amount of the Notes to
    comply with any of its obligations, covenants or agreements
    (other than a default referred to in clauses&#160;(1) and
    (2)&#160;above) contained in the Indenture or the Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;default under any mortgage, indenture or instrument
    under which there is issued or by which there is secured or
    evidenced any Indebtedness for money borrowed by the Issuer or
    any of its Restricted Subsidiaries or the payment of which is
    guaranteed by the Issuer or any of its Restricted Subsidiaries,
    other than Indebtedness owed to the Issuer or a Restricted
    Subsidiary, whether such Indebtedness or guarantee now exists or
    is created after the issuance of the Notes, if both:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;such default either results from the failure to pay any
    principal of such Indebtedness at its stated final maturity
    (after giving effect to any applicable grace periods) or relates
    to an obligation other than the obligation to pay principal of
    any such Indebtedness at its stated final maturity and results
    in the holder or holders of such Indebtedness causing such
    Indebtedness to become due prior to its stated maturity;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the principal amount of such Indebtedness, together
    with the principal amount of any other such Indebtedness in
    default for failure to pay principal at stated final maturity
    (after giving effect to any applicable grace periods), or the
    maturity of which has been so accelerated, aggregate
    $200.0&#160;million or more at any one time outstanding;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;failure by the Issuer or any Significant Subsidiary to
    pay final judgments aggregating in excess of
    $200.0&#160;million, which final judgments remain unpaid,
    undischarged and unstayed for a period of more than 60&#160;days
    after such judgment becomes final, and in the event such
    judgment is covered by insurance, an enforcement proceeding has
    been commenced by any creditor upon such judgment or decree
    which is not promptly stayed;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;certain events of bankruptcy or insolvency with respect
    to the Issuer or any Significant Subsidiary;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;the Guarantee of any Significant Subsidiary shall for
    any reason cease to be in full force and effect or be declared
    null and void or any responsible officer of any Guarantor that
    is a Significant Subsidiary, as the case may be, denies that it
    has any further liability under its Guarantee or gives notice to
    such effect, other than by reason of the termination of the
    Indenture or the release of any such Guarantee in accordance
    with the Indenture;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;with respect to any Collateral having a fair market
    value in excess of $200&#160;million, individually or in the
    aggregate, (a)&#160;the security interest under the Security
    Documents, at any time, ceases to be in full force and effect
    for any reason other than in accordance with the terms of the
    Indenture, the Security Documents and the Intercreditor
    Agreements, (b)&#160;any security interest created thereunder or
    under the Indenture is declared invalid or unenforceable by a
    court of competent jurisdiction or (c)&#160;the Issuer or any
    Guarantor asserts, in any pleading in any court of competent
    jurisdiction, that any such security interest is invalid or
    unenforceable.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If any Event of Default (other than of a type specified in
    clause&#160;(6) above) occurs and is continuing under the
    Indenture, the Trustee or the Holders of at least 30% in
    principal amount of the then total outstanding Notes may declare
    the principal, premium, if any, interest and any other monetary
    obligations on all the then outstanding Notes to be due and
    payable immediately.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    85
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Upon the effectiveness of such declaration, such principal and
    interest will be due and payable immediately. Notwithstanding
    the foregoing, in the case of an Event of Default arising under
    clause&#160;(6) of the first paragraph of this section, all
    outstanding Notes will become due and payable without further
    action or notice. The Indenture provides that the Trustee may
    withhold from the Holders notice of any continuing Default,
    except a Default relating to the payment of principal, premium,
    if any, or interest, if it determines that withholding notice is
    in their interest. In addition, the Trustee shall have no
    obligation to accelerate the Notes if in the best judgment of
    the Trustee acceleration is not in the best interest of the
    Holders of the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that the Holders of a majority in
    aggregate principal amount of the then outstanding Notes by
    notice to the Trustee may on behalf of the Holders of all of the
    Notes waive any existing Default and its consequences under the
    Indenture except a continuing Default in the payment of interest
    on, premium, if any, or the principal of any Note held by a
    non-consenting Holder. In the event of any Event of Default
    specified in clause&#160;(4) above, such Event of Default and
    all consequences thereof (excluding any resulting payment
    default, other than as a result of acceleration of the Notes)
    shall be annulled, waived and rescinded, automatically and
    without any action by the Trustee or the Holders, if within
    20&#160;days after such Event of Default arose:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the Indebtedness or guarantee that is the basis for
    such Event of Default has been discharged;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;holders thereof have rescinded or waived the
    acceleration, notice or action (as the case may be) giving rise
    to such Event of Default;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;the default that is the basis for such Event of Default
    has been cured.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Subject to the provisions of the Indenture relating to the
    duties of the Trustee thereunder, in case an Event of Default
    occurs and is continuing, the Trustee is under no obligation to
    exercise any of the rights or powers under the Indenture at the
    request or direction of any of the Holders of the Notes unless
    the Holders have offered to the Trustee reasonable indemnity or
    security against any loss, liability or expense. Except to
    enforce the right to receive payment of principal, premium, if
    any, or interest when due, no Holder of a Note may pursue any
    remedy with respect to the Indenture or the Notes unless:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;such Holder has previously given the Trustee notice
    that an Event of Default is continuing;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;Holders of at least 30% in principal amount of the
    total outstanding Notes have requested the Trustee to pursue the
    remedy;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;Holders of the Notes have offered the Trustee
    reasonable security or indemnity against any loss, liability or
    expense;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;the Trustee has not complied with such request within
    60&#160;days after the receipt thereof and the offer of security
    or indemnity;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;Holders of a majority in principal amount of the total
    outstanding Notes have not given the Trustee a direction
    inconsistent with such request within such
    <FONT style="white-space: nowrap">60-day</FONT>
    period.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Subject to certain restrictions, under the Indenture the Holders
    of a majority in principal amount of the total outstanding Notes
    are given the right to direct the time, method and place of
    conducting any proceeding for any remedy available to the
    Trustee or of exercising any trust or power conferred on the
    Trustee. The Trustee, however, may refuse to follow any
    direction that conflicts with law or the Indenture or that the
    Trustee determines is unduly prejudicial to the rights of any
    other Holder of a Note or that would involve the Trustee in
    personal liability.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that the Issuer is required to deliver to
    the Trustee annually a statement regarding compliance with the
    Indenture, and the Issuer is required, within five Business
    Days, upon becoming aware of any Default, to deliver to the
    Trustee a statement specifying such Default.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    86
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">No
    Personal Liability of Directors, Officers, Employees and
    Stockholders</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    No director, officer, employee, incorporator or stockholder of
    the Issuer or any Guarantor or any of their parent companies
    (other than the Issuer and the Guarantors) shall have any
    liability for any obligations of the Issuer or the Guarantors
    under the Notes, the Guarantees or the Indenture or for any
    claim based on, in respect of, or by reason of such obligations
    or their creation. Each Holder by accepting the Notes waives and
    releases all such liability. The waiver and release are part of
    the consideration for issuance of the Notes. Such waiver may not
    be effective to waive liabilities under the federal securities
    laws, and it is the view of the SEC that such a waiver is
    against public policy.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Legal
    Defeasance and Covenant Defeasance</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The obligations of the Issuer and the Guarantors under the
    Indenture will terminate (other than certain obligations) and
    will be released upon payment in full of all of the Notes. The
    Issuer may, at its option and at any time, elect to have all of
    its obligations discharged with respect to the Notes and have
    the Issuer&#146;s and each Guarantor&#146;s obligation
    discharged with respect to its Guarantee <I>(&#147;Legal
    Defeasance&#148;)</I> and cure all then existing Events of
    Default except for:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the rights of Holders of Notes to receive payments in
    respect of the principal of, premium, if any, and interest on
    the Notes when such payments are due solely out of the trust
    created pursuant to the Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the Issuer&#146;s obligations with respect to Notes
    concerning issuing temporary Notes, registration of such Notes,
    mutilated, destroyed, lost or stolen Notes and the maintenance
    of an office or agency for payment and money for security
    payments held in trust;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;the rights, powers, trusts, duties and immunities of
    the Trustee, and the Issuer&#146;s obligations in connection
    therewith;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;the Legal Defeasance provisions of the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, the Issuer may, at its option and at any time,
    elect to have its obligations and those of each Guarantor
    released with respect to certain covenants that are described in
    the Indenture <I>(&#147;Covenant Defeasance&#148;)</I> and
    thereafter any omission to comply with such obligations shall
    not constitute a Default with respect to the Notes. In the event
    Covenant Defeasance occurs, certain events (not including
    bankruptcy, receivership, rehabilitation and insolvency events
    pertaining to the Issuer) described under &#147;Events of
    Default and Remedies&#148; will no longer constitute an Event of
    Default with respect to the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In order to exercise either Legal Defeasance or Covenant
    Defeasance with respect to the Notes:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the Issuer must irrevocably deposit with the Trustee,
    in trust, for the benefit of the Holders of the Notes, cash in
    U.S.&#160;dollars, Government Securities, or a combination
    thereof, in such amounts as will be sufficient, in the opinion
    of a nationally recognized firm of independent public
    accountants, to pay the principal of, premium, if any, and
    interest due on the Notes on the stated maturity date or on the
    redemption date, as the case may be, of such principal, premium,
    if any, or interest on such Notes, and the Issuer must specify
    whether such Notes are being defeased to maturity or to a
    particular redemption date;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;in the case of Legal Defeasance, the Issuer shall have
    delivered to the Trustee an Opinion of Counsel reasonably
    acceptable to the Trustee confirming that, subject to customary
    assumptions and exclusions,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;the Issuer has received from, or there has been
    published by, the United States Internal Revenue Service a
    ruling,&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;since the issuance of the Notes, there has been a
    change in the applicable U.S.&#160;federal income tax law,
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    87
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    in either case to the effect that, and based thereon such
    Opinion of Counsel shall confirm that, subject to customary
    assumptions and exclusions, the Holders of the Notes will not
    recognize income, gain or loss for U.S.&#160;federal income tax
    purposes, as applicable, as a result of such Legal Defeasance
    and will be subject to U.S.&#160;federal income tax on the same
    amounts, in the same manner and at the same times as would have
    been the case if such Legal Defeasance had not occurred;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;in the case of Covenant Defeasance, the Issuer shall
    have delivered to the Trustee an Opinion of Counsel reasonably
    acceptable to the Trustee confirming that, subject to customary
    assumptions and exclusions, the Holders of the Notes will not
    recognize income, gain or loss for U.S.&#160;federal income tax
    purposes as a result of such Covenant Defeasance and will be
    subject to such tax on the same amounts, in the same manner and
    at the same times as would have been the case if such Covenant
    Defeasance had not occurred;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;no Default (other than that resulting from borrowing
    funds to be applied to make such deposit and any similar and
    simultaneous deposit relating to other Indebtedness and, in each
    case, the granting of Liens in connection therewith) shall have
    occurred and be continuing on the date of such deposit;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;such Legal Defeasance or Covenant Defeasance shall not
    result in a breach or violation of, or constitute a default
    under the Senior Credit Facilities or any other material
    agreement or instrument (other than the Indenture) to which the
    Issuer or any Guarantor is a party or by which the Issuer or any
    Guarantor is bound (other than that resulting from borrowing
    funds to be applied to make such deposit and any similar and
    simultaneous deposit relating to other Indebtedness and, in each
    case, the granting of Liens in connection therewith);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;the Issuer shall have delivered to the Trustee an
    Opinion of Counsel to the effect that, as of the date of such
    opinion and subject to customary assumptions and exclusions
    following the deposit, the trust funds will not be subject to
    the effect of Section&#160;547 of Title&#160;11 of the United
    States Code;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;the Issuer shall have delivered to the Trustee an
    Officer&#146;s Certificate stating that the deposit was not made
    by the Issuer with the intent of defeating, hindering, delaying
    or defrauding any creditors of the Issuer or any Guarantor or
    others;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;the Issuer shall have delivered to the Trustee an
    Officer&#146;s Certificate and an Opinion of Counsel (which
    Opinion of Counsel may be subject to customary assumptions and
    exclusions) each stating that all conditions precedent provided
    for or relating to the Legal Defeasance or the Covenant
    Defeasance, as the case may be, have been complied with.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Satisfaction
    and Discharge</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture will be discharged and will cease to be of further
    effect as to all Notes, when either:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;all Notes theretofore authenticated and delivered,
    except lost, stolen or destroyed Notes which have been replaced
    or paid and Notes for whose payment money has theretofore been
    deposited in trust, have been delivered to the Trustee for
    cancellation;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;(a)&#160;all Notes not theretofore delivered to the
    Trustee for cancellation have become due and payable by reason
    of the making of a notice of redemption or otherwise, will
    become due and payable within one year or may be called for
    redemption within one year under arrangements satisfactory to
    the Trustee for the giving of notice of redemption by the
    Trustee in the name, and at the expense, of the Issuer, and the
    Issuer or any Guarantor has irrevocably deposited or caused to
    be deposited with the Trustee as trust funds in trust solely for
    the benefit of the Holders of the Notes, cash in
    U.S.&#160;dollars, Government Securities, or a combination
    thereof, in such amounts as will be sufficient without
    consideration of any reinvestment of interest to pay and
    discharge the entire indebtedness on the Notes not theretofore
    delivered to the Trustee for cancellation for principal,
    premium, if any, and accrued interest to the date of maturity or
    redemption;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;no Default (other than that resulting from borrowing
    funds to be applied to make such deposit and any similar and
    simultaneous deposit relating to other Indebtedness and, in each
    case, the granting of
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    88
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Liens in connection therewith) with respect to the Indenture or
    the Notes shall have occurred and be continuing on the date of
    such deposit or shall occur as a result of such deposit, and
    such deposit will not result in a breach or violation of, or
    constitute a default under, the Senior Credit Facilities or any
    other material agreement or instrument (other than the
    Indenture) to which the Issuer or any Guarantor is a party or by
    which the Issuer or any Guarantor is bound (other than that
    resulting from borrowing funds to be applied to make such
    deposit and any similar and simultaneous deposit relating to
    other Indebtedness and, in each case, the granting of Liens in
    connection therewith);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;the Issuer has paid or caused to be paid all sums
    payable by it under the Indenture;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;the Issuer has delivered irrevocable instructions to
    the Trustee to apply the deposited money toward the payment of
    the Notes at maturity or the redemption date, as the case may be.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, the Issuer must deliver an Officer&#146;s
    Certificate and an Opinion of Counsel to the Trustee stating
    that all conditions precedent to satisfaction and discharge have
    been satisfied.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Amendment,
    Supplement and Waiver</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Except as provided in the next two succeeding paragraphs, the
    Indenture, any Guarantee, any Security Document and the Notes
    may be amended or supplemented with the consent of the Holders
    of at least a majority in principal amount of the Notes then
    outstanding, including consents obtained in connection with a
    purchase of, or tender offer or exchange offer for, Notes, and
    any existing Default or compliance with any provision of the
    Indenture, the Notes issued thereunder, any Guarantee or the
    Security Documents may be waived with the consent of the Holders
    of a majority in principal amount of the then outstanding Notes,
    other than Notes beneficially owned by the Issuer or its
    Affiliates (including consents obtained in connection with a
    purchase of or tender offer or exchange offer for the Notes);
    <I>provided</I>, <I>however</I>, that that if any amendment,
    waiver or other modification will affect only the Cash Pay Notes
    or Toggle Notes, only the consent of the Holders of at least a
    majority in principal amount of the then outstanding Cash Pay
    Notes or Toggle Notes (and not the consent of at least a
    majority of all Notes), as the case may be, shall be required.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that, without the consent of each
    affected Holder of Notes, an amendment or waiver may not, with
    respect to any Notes held by a non-consenting Holder:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;reduce the principal amount of such Notes whose Holders
    must consent to an amendment, supplement or waiver;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;reduce the principal of or change the fixed final
    maturity of any such Note or alter or waive the provisions with
    respect to the redemption of such Notes (other than provisions
    relating to the covenants described above under the caption
    &#147;Repurchase at the Option of Holders&#148;);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;reduce the rate of or change the time for payment of
    interest on any Note;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;waive a Default in the payment of principal of or
    premium, if any, or interest on the Notes, except a rescission
    of acceleration of the Notes by the Holders of at least a
    majority in aggregate principal amount of the Notes and a waiver
    of the payment default that resulted from such acceleration, or
    in respect of a covenant or provision contained in the Indenture
    or any Guarantee which cannot be amended or modified without the
    consent of all Holders;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;make any Note payable in money other than that stated
    therein;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;make any change in the provisions of the Indenture
    relating to waivers of past Defaults or the rights of Holders to
    receive payments of principal of or premium, if any, or interest
    on the Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;make any change in these amendment and waiver
    provisions;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;impair the right of any Holder to receive payment of
    principal of, or interest on such Holder&#146;s Notes on or
    after the due dates therefor or to institute suit for the
    enforcement of any payment on or with respect to such
    Holder&#146;s Notes;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    89
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;make any change to or modify the ranking of the Notes
    or the subordination of the Liens with respect to the Notes that
    would adversely affect the Holders;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;except as expressly permitted by the Indenture, modify
    the Guarantees of any Significant Subsidiary in any manner
    adverse to the Holders of the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, without the consent of at least 75% in aggregate
    principal amount of Notes then outstanding, an amendment,
    supplement or waiver may not:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;modify any Security Document or the provisions of the
    Indenture dealing with the Security Documents or application of
    trust moneys, or otherwise release any Collateral, in any manner
    materially adverse to the Holders other than in accordance with
    the Indenture, the Security Documents and the Intercreditor
    Agreements;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;modify any Intercreditor Agreement in any manner
    materially adverse to the Holders other than in accordance with
    the Indenture, the Security Documents and the Intercreditor
    Agreements.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding the foregoing, the Issuer, any Guarantor (with
    respect to a Guarantee or the Indenture to which it is a party)
    and the Trustee may amend or supplement the Indenture, any
    Security Document and any Guarantee or Notes without the consent
    of any Holder;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;to cure any ambiguity, omission, mistake, defect or
    inconsistency;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;to provide for uncertificated Notes of such series in
    addition to or in place of certificated Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;to comply with the covenant relating to mergers,
    consolidations and sales of assets;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;to provide for the assumption of the Issuer&#146;s or
    any Guarantor&#146;s obligations to the Holders;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;to make any change that would provide any additional
    rights or benefits to the Holders or that does not adversely
    affect the legal rights under the Indenture of any such Holder;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;to add covenants for the benefit of the Holders or to
    surrender any right or power conferred upon the Issuer or any
    Guarantor;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;to comply with requirements of the SEC in order to
    effect or maintain the qualification of the Indenture under the
    Trust&#160;Indenture Act;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;to evidence and provide for the acceptance and
    appointment under the Indenture of a successor Trustee
    thereunder pursuant to the requirements thereof;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;to provide for the issuance of Exchange Notes or
    private exchange notes, which are identical to Exchange Notes
    except that they are not freely transferable;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;to add a Guarantor under the Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;to conform the text of the Indenture, Security
    Documents, Guarantees or the Notes to any provision of this
    &#147;Description of Notes&#148; to the extent that such
    provision in this &#147;Description of Notes&#148; was intended
    to be a verbatim recitation of a provision of the Indenture,
    Security Documents, Guarantee or Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;to make any amendment to the provisions of the
    Indenture relating to the transfer and legending of Notes as
    permitted by the Indenture, including, without limitation to
    facilitate the issuance and administration of the Notes;
    <I>provided</I>, <I>however</I>, that (i)&#160;compliance with
    the Indenture as so amended would not result in Notes being
    transferred in violation of the Securities Act or any applicable
    securities law and (ii)&#160;such amendment does not materially
    and adversely affect the rights of Holders to transfer Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;to mortgage, pledge, hypothecate or grant any other
    Lien in favor of the Trustee for the benefit of the Holders of
    the Notes, as additional security for the payment and
    performance of all or any portion of the Obligations, in any
    property or assets, including any which are required to be
    mortgaged, pledged
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    90
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    or hypothecated, or in which a Lien is required to be granted to
    or for the benefit of the Trustee or the Collateral Agent
    pursuant to the Indenture, any of the Security Documents or
    otherwise;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (14)&#160;to release Collateral from the Lien of the Indenture
    and the Security Documents when permitted or required by the
    Security Documents or the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The consent of the Holders is not necessary under the Indenture
    to approve the particular form of any proposed amendment. It is
    sufficient if such consent approves the substance of the
    proposed amendment.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Notices</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notices given by publication will be deemed given on the first
    date on which publication is made and notices given by
    first-class mail, postage prepaid, will be deemed given five
    calendar days after mailing.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Concerning
    the Trustee</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture contains certain limitations on the rights of the
    Trustee thereunder, should it become a creditor of the Issuer,
    to obtain payment of claims in certain cases, or to realize on
    certain property received in respect of any such claim as
    security or otherwise. The Trustee is permitted to engage in
    other transactions; however, if it acquires any conflicting
    interest it must eliminate such conflict within 90&#160;days,
    apply to the SEC for permission to continue or resign.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that the Holders of a majority in
    principal amount of the outstanding Notes have the right to
    direct the time, method and place of conducting any proceeding
    for exercising any remedy available to the Trustee, subject to
    certain exceptions. The Indenture provides that in case an Event
    of Default shall occur (which shall not be cured), the Trustee
    will be required, in the exercise of its power, to use the
    degree of care of a prudent person in the conduct of his own
    affairs. Subject to such provisions, the Trustee is under no
    obligation to exercise any of its rights or powers under the
    Indenture at the request of any Holder of the Notes, unless such
    Holder shall have offered to the Trustee security and indemnity
    satisfactory to it against any loss, liability or expense.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Governing
    Law</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture, the Notes and any Guarantee are governed by and
    construed in accordance with the laws of the State of New York.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Certain
    Definitions</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Set forth below are certain defined terms used in the Indenture.
    For purposes of the Indenture, unless otherwise specifically
    indicated, the term &#147;consolidated&#148; with respect to any
    Person refers to such Person on a consolidated basis in
    accordance with GAAP, but excluding from such consolidation any
    Unrestricted Subsidiary as if such Unrestricted Subsidiary were
    not an Affiliate of such Person.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;ABL Facility&#148; </I>means the Asset-Based Revolving
    Credit Agreement entered into as of the Issue Date by and among
    the Issuer, the lenders party thereto in their capacities as
    lenders thereunder and Bank of America, N.A., as Administrative
    Agent, including any guarantees, collateral documents,
    instruments and agreements executed in connection therewith, and
    any amendments, supplements, modifications, extensions,
    renewals, restatements, refundings or refinancings thereof and
    any indentures or credit facilities or commercial paper
    facilities with banks or other institutional lenders or
    investors that replace, refund or refinance any part of the
    loans, notes, other credit facilities or commitments thereunder,
    including any such replacement, refunding or refinancing
    facility or indenture that increases the amount borrowable
    thereunder or alters the maturity thereof (<I>provided </I>that
    such increase in borrowings is permitted under &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock&#148;
    above).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;ABL Facility Cap&#148;</I> means an amount equal to the
    greater of (x)&#160;$2,000.0&#160;million and (y)&#160;75% of
    the consolidated accounts receivable of the Issuer and its
    subsidiaries determined in accordance with GAAP.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    91
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;ABL Financing Entity&#148;</I> means the Issuer and
    certain of its subsidiaries from time to time named as borrowers
    or guarantors under the ABL Facility.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;ABL Obligations&#148;</I> means Obligations under the
    ABL Facility.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;ABL Secured Parties&#148;</I> means each of
    (i)&#160;the ABL Collateral Agent on behalf of itself and the
    lenders under the ABL Facility and lenders or their affiliates
    counterparty to related Hedging Obligations and (ii)&#160;each
    other holder of ABL Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Acquired Indebtedness&#148;</I> means, with respect to
    any specified Person,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;Indebtedness of any other Person existing at the time
    such other Person is merged with or into or became a Restricted
    Subsidiary of such specified Person, including Indebtedness
    incurred in connection with, or in contemplation of, such other
    Person merging with or into or becoming a Restricted Subsidiary
    of such specified Person,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;Indebtedness secured by a Lien encumbering any asset
    acquired by such specified Person.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Additional Interest&#148; </I>means all additional
    interest then owing pursuant to the Registration Rights
    Agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Affiliate&#148; </I>of any specified Person means any
    other Person directly or indirectly controlling or controlled by
    or under direct or indirect common control with such specified
    Person. For purposes of this definition, &#147;control&#148;
    (including, with correlative meanings, the terms
    &#147;controlling,&#148; &#147;controlled by&#148; and
    &#147;under common control with&#148;), as used with respect to
    any Person, shall mean the possession, directly or indirectly,
    of the power to direct or cause the direction of the management
    or policies of such Person, whether through the ownership of
    voting securities, by agreement or otherwise.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Applicable Premium&#148;</I> means, with respect to any
    Note on any Redemption&#160;Date, the greater of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;1.0% of the principal amount of such Note;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;(A)&#160;with respect to the 2016 Cash Pay Notes and
    the Toggle Notes, the excess, if any, of (a)&#160;the present
    value at such Redemption&#160;Date of (i)&#160;the redemption
    price of such Note at November&#160;15, 2011 (such redemption
    price being set forth in the tables appearing above under the
    captions &#147;Optional Redemption&#160;&#151; 2016 Cash Pay
    Notes&#148; and &#147;Optional Redemption&#160;&#151; Toggle
    Notes&#148;), plus (ii)&#160;all required interest payments (in
    the case of the Toggle Notes, calculated based on the cash
    interest rate payable on the Toggle Notes) due on such Note
    through November&#160;15, 2011 (excluding accrued but unpaid
    interest to the Redemption&#160;Date), computed using a discount
    rate equal to the Treasury Rate as of such Redemption&#160;Date
    plus 50&#160;basis points; over (b)&#160;the principal amount of
    such Note,&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (B)&#160;with respect to the 2014 Cash Pay Notes, the excess, if
    any, of (a)&#160;the present value at such Redemption&#160;Date
    of (i)&#160;the redemption price of such 2014 Cash Pay Note at
    November&#160;15, 2010 (such redemption price being set forth in
    the tables appearing above under the caption &#147;Optional
    Redemption&#160;&#151; 2014 Cash Pay Notes&#148;), <I>plus
    </I>(ii)&#160;all required interest payments due on such 2014
    Cash Pay Note through November&#160;15, 2010 (excluding accrued
    but unpaid interest to the Redemption&#160;Date), computed using
    a discount rate equal to the Treasury Rate as of such
    Redemption&#160;Date plus 50&#160;basis points; over
    (b)&#160;the principal amount of such 2014 Cash Pay Note.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Asset Sale&#148;</I> means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the sale, conveyance, transfer or other disposition,
    whether in a single transaction or a series of related
    transactions, of property or assets (including by way of a Sale
    and Lease-Back Transaction) of the Issuer or any of its
    Restricted Subsidiaries (each referred to in this definition as
    a &#147;<I>disposition</I>&#148;);&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the issuance or sale of Equity Interests of any
    Restricted Subsidiary, whether in a single transaction or a
    series of related transactions (other than Preferred Stock of
    Restricted Subsidiaries issued in compliance with the covenant
    described under &#147;Certain Covenants&#160;&#151; Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock&#148;);
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    92
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    in each case, other than:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;any disposition of Cash Equivalents or Investment Grade
    Securities or obsolete or worn out equipment in the ordinary
    course of business or any disposition of inventory or goods (or
    other assets) held for sale in the ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the disposition of all or substantially all of the
    assets of the Issuer in a manner permitted pursuant to the
    provisions described above under &#147;Certain
    Covenants&#160;&#151; Merger, Consolidation or Sale of All or
    Substantially All Assets&#148; or any disposition that
    constitutes a Change of Control pursuant to the Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;the making of any Restricted Payment or Permitted
    Investment that is permitted to be made, and is made, under the
    covenant described above under &#147;Certain
    Covenants&#160;&#151; Limitation on Restricted Payments&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;any disposition of assets or issuance or sale of Equity
    Interests of any Restricted Subsidiary in any transaction or
    series of related transactions with an aggregate fair market
    value of less than $100.0&#160;million;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;any disposition of property or assets or issuance of
    securities by a Restricted Subsidiary of the Issuer to the
    Issuer or by the Issuer or a Restricted Subsidiary of the Issuer
    to another Restricted Subsidiary of the Issuer;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (f)&#160;to the extent allowable under Section&#160;1031 of the
    Code or any comparable or successor provision, any exchange of
    like property (excluding any boot thereon) for use in a Similar
    Business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (g)&#160;the lease, assignment or
    <FONT style="white-space: nowrap">sub-lease</FONT> of
    any real or personal property in the ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (h)&#160;any issuance or sale of Equity Interests in, or
    Indebtedness or other securities of, an Unrestricted Subsidiary;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (i)&#160;foreclosures on assets;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (j)&#160;sales of accounts receivable, or participations
    therein, in connection with the ABL Facility or any Receivables
    Facility;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (k)&#160;any financing transaction with respect to property
    built or acquired by the Issuer or any Restricted Subsidiary
    after the Issue Date, including Sale and Lease-Back Transactions
    and asset securitizations permitted by the Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (l)&#160;dispositions in the ordinary course of business by any
    Restricted Subsidiary (including, without limitation, HCI)
    engaged in the insurance business in order to provide insurance
    to the Issuer and its Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (m)&#160;sales, transfers and other dispositions of Investments
    in joint ventures to the extent required by, or made pursuant
    to, customary buy/sell arrangements between the joint venture
    parties set forth in joint venture arrangements and similar
    binding arrangements;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (n)&#160;any issuance or sale of Equity Interests or
    dispositions in connection with ordinary course syndications of
    Subsidiaries or joint ventures owning or operating one or more
    healthcare facilities, including, without limitation, hospitals,
    ambulatory surgery centers, outpatient diagnostic centers or
    imaging centers in any transaction or series of related
    transactions with an aggregate fair market value of less than
    $100.0&#160;million;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (o)&#160;any issuance or sale of Equity Interests of any
    Restricted Subsidiary (including, without limitation,
    HealthTrust Purchasing Group, L.P.) to any Person operating in a
    Similar Business for which such Restricted Subsidiary provides
    shared purchasing, billing, collection or similar services in
    the ordinary course of business.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    93
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Asset Sale Offer&#148;</I> has the meaning set forth in
    the fourth paragraph under &#147;Repurchase at the Option of
    Holders&#160;&#151; Asset Sales.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Bankruptcy Code&#148;</I> means Title&#160;11 of the
    United States Code, as amended.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Bankruptcy Law&#148;</I> means the Bankruptcy Code and
    any similar federal, state or foreign law for the relief of
    debtors.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Business Day&#148;</I> means each day which is not a
    Legal Holiday.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Capital Stock&#148;</I> means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;in the case of a corporation, corporate stock;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;in the case of an association or business entity, any
    and all shares, interests, participations, rights or other
    equivalents (however designated) of corporate stock;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;in the case of a partnership or limited liability
    company, partnership or membership interests (whether general or
    limited);&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;any other interest or participation that confers on a
    Person the right to receive a share of the profits and losses
    of, or distributions of assets of, the issuing Person.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Capitalized Lease Obligation&#148;</I> means, at the
    time any determination thereof is to be made, the amount of the
    liability in respect of a capital lease that would at such time
    be required to be capitalized and reflected as a liability on a
    balance sheet (excluding the footnotes thereto) in accordance
    with GAAP.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Capitalized Software Expenditures&#148;</I> means, for
    any period, the aggregate of all expenditures (whether paid in
    cash or accrued as liabilities) by a Person and its Restricted
    Subsidiaries during such period in respect of purchased software
    or internally developed software and software enhancements that,
    in conformity with GAAP, are or are required to be reflected as
    capitalized costs on the consolidated balance sheet of a Person
    and its Restricted Subsidiaries.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Cash Equivalents&#148;</I> means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;United States dollars;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;euro or any national currency of any participating
    member state of the EMU or such local currencies held by the
    Company and its Restricted Subsidiaries from time to time in the
    ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;securities issued or directly and fully and
    unconditionally guaranteed or insured by the
    U.S.&#160;government (or any agency or instrumentality thereof
    the securities of which are unconditionally guaranteed as a full
    faith and credit obligation of the U.S.&#160;government) with
    maturities of 24&#160;months or less from the date of
    acquisition;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;certificates of deposit, time deposits and eurodollar
    time deposits with maturities of one year or less from the date
    of acquisition, bankers&#146; acceptances with maturities not
    exceeding one year and overnight bank deposits, in each case
    with any commercial bank having capital and surplus of not less
    than $500.0&#160;million in the case of U.S.&#160;banks and
    $100.0&#160;million (or the U.S.&#160;dollar equivalent as of
    the date of determination) in the case of
    <FONT style="white-space: nowrap">non-U.S.&#160;banks;</FONT>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;repurchase obligations for underlying securities of the
    types described in clauses&#160;(3) and (4)&#160;entered into
    with any financial institution meeting the qualifications
    specified in clause&#160;(4) above;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;commercial paper rated at least
    <FONT style="white-space: nowrap">P-1</FONT> by
    Moody&#146;s or at least
    <FONT style="white-space: nowrap">A-1</FONT> by
    S&#038;P and in each case maturing within 24&#160;months after
    the date of creation thereof;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;marketable short-term money market and similar
    securities having a rating of at least
    <FONT style="white-space: nowrap">P-2</FONT> or
    <FONT style="white-space: nowrap">A-2</FONT> from
    either Moody&#146;s or S&#038;P, respectively (or, if at any
    time neither Moody&#146;s nor S&#038;P shall be rating such
    obligations, an equivalent rating from another Rating Agency)
    and in each case maturing within 24&#160;months after the date
    of creation thereof;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    94
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;investment funds investing 95% of their assets in
    securities of the types described in clauses&#160;(1) through
    (7)&#160;above;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;readily marketable direct obligations issued by any
    state, commonwealth or territory of the United States or any
    political subdivision or taxing authority thereof having an
    Investment Grade Rating from either Moody&#146;s or S&#038;P
    with maturities of 24&#160;months or less from the date of
    acquisition;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;Indebtedness or Preferred Stock issued by Persons with
    a rating of &#147;A&#148; or higher from S&#038;P or
    &#147;A2&#148; or higher from Moody&#146;s with maturities of
    24&#160;months or less from the date of acquisition;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;Investments with average maturities of 24&#160;months
    or less from the date of acquisition in money market funds rated
    AAA- (or the equivalent thereof) or better by S&#038;P or Aaa3
    (or the equivalent thereof) or better by Moody&#146;s.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding the foregoing, Cash Equivalents shall include
    amounts denominated in currencies other than those set forth in
    clauses&#160;(1) and (2)&#160;above; <I>provided </I>that such
    amounts are converted into any currency listed in
    clauses&#160;(1) and (2)&#160;as promptly as practicable and in
    any event within ten Business Days following the receipt of such
    amounts.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Cash Interest&#148;</I> has the meaning set forth under
    &#147;Principal, Maturity and Interest&#160;&#151; Toggle
    Notes.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Change of Control&#148;</I> means the occurrence of any
    of the following:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the sale, lease or transfer, in one or a series of
    related transactions, of all or substantially all of the assets
    of the Issuer and its Subsidiaries, taken as a whole, to any
    Person other than a Permitted Holder;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the Issuer becomes aware (by way of a report or any
    other filing pursuant to Section 13(d) of the Exchange Act,
    proxy, vote, written notice or otherwise) of the acquisition by
    any Person or group (within the meaning of Section&#160;13(d)(3)
    or Section&#160;14(d)(2) of the Exchange Act, or any successor
    provision), including any group acting for the purpose of
    acquiring, holding or disposing of securities (within the
    meaning of
    <FONT style="white-space: nowrap">Rule&#160;13d-5(b)(1)</FONT>
    under the Exchange Act), other than the Permitted Holders, in a
    single transaction or in a related series of transactions, by
    way of merger, consolidation or other business combination or
    purchase of beneficial ownership (within the meaning of
    <FONT style="white-space: nowrap">Rule&#160;13d-3</FONT>
    under the Exchange Act, or any successor provision) of 50% or
    more of the total voting power of the Voting Stock of the Issuer
    or any of its direct or indirect parent companies holding
    directly or indirectly 100% of the total voting power of the
    Voting Stock of the Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Code&#148;</I> means the Internal Revenue Code of 1986,
    as amended, or any successor thereto.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Collateral&#148;</I> means, collectively, the Shared
    Receivables Collateral and Non-Receivables Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Collateral Asset Sale Offer&#148;</I> has the meaning
    set forth in the third paragraph under &#147;Repurchase at the
    Option of Holders&#160;&#151; Asset Sales.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Collateral Excess Proceeds&#148;</I> has the meaning
    set forth in the third paragraph under &#147;Repurchase at the
    Option of Holders&#160;&#151; Asset Sales.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Consolidated Depreciation and Amortization
    Expense&#148;</I> means with respect to any Person for any
    period, the total amount of depreciation and amortization
    expense, including the amortization of deferred financing fees,
    debt issuance costs, commissions, fees and expenses and
    Capitalized Software Expenditures, of such Person and its
    Restricted Subsidiaries for such period on a consolidated basis
    and otherwise determined in accordance with GAAP.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Consolidated Interest Expense&#148;</I> means, with
    respect to any Person for any period, without duplication, the
    sum of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;consolidated interest expense of such Person and its
    Restricted Subsidiaries for such period, to the extent such
    expense was deducted (and not added back) in computing
    Consolidated Net Income (including (a)&#160;amortization of
    original issue discount resulting from the issuance of
    Indebtedness at less
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    95
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    than par, (b)&#160;all commissions, discounts and other fees and
    charges owed with respect to letters of credit or bankers&#146;
    acceptances, (c)&#160;non-cash interest payments (but excluding
    any non-cash interest expense attributable to the movement in
    the mark to market valuation of Hedging Obligations or other
    derivative instruments pursuant to GAAP), (d)&#160;the interest
    component of Capitalized Lease Obligations, and (e)&#160;net
    payments, if any, pursuant to interest rate Hedging Obligations
    with respect to Indebtedness, and excluding (u)&#160;accretion
    or accrual of discounted liabilities not constituting
    Indebtedness, (v)&#160;any expense resulting from the
    discounting of the Existing Notes or other Indebtedness in
    connection with the application of recapitalization accounting
    or, if applicable, purchase accounting, (w)&#160;any Additional
    Interest and any comparable &#147;additional interest&#148; with
    respect to other securities, (x)&#160;amortization of deferred
    financing fees, debt issuance costs, commissions, fees and
    expenses, (y)&#160;any expensing of bridge, commitment and other
    financing fees and (z)&#160;commissions, discounts, yield and
    other fees and charges (including any interest expense) related
    to any Receivables Facility); plus
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;consolidated capitalized interest of such Person and
    its Restricted Subsidiaries for such period, whether paid or
    accrued; less
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;interest income for such period.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For purposes of this definition, interest on a Capitalized Lease
    Obligation shall be deemed to accrue at an interest rate
    reasonably determined by such Person to be the rate of interest
    implicit in such Capitalized Lease Obligation in accordance with
    GAAP.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Consolidated Leverage Ratio&#148;</I>, with respect to
    any Person as of any date of determination, means the ratio of
    (x)&#160;Consolidated Total Indebtedness of such Person as of
    the end of the most recent fiscal quarter for which internal
    financial statements are available immediately preceding the
    date on which such event for which such calculation is being
    made shall occur to (y)&#160;the aggregate amount of EBITDA of
    such Person for the period of the most recently ended four full
    consecutive fiscal quarters for which internal financial
    statements are available immediately preceding the date on which
    such event for which such calculation is being made shall occur,
    in each case with such <I>pro forma </I>adjustments to
    Consolidated Total Indebtedness and EBITDA as are appropriate
    and consistent with the <I>pro forma </I>adjustment provisions
    set forth in the definition of &#147;Fixed Charge Coverage
    Ratio.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Consolidated Net Income&#148;</I> means, with respect
    to any Person for any period, the aggregate of the Net Income of
    such Person for such period, on a consolidated basis, and
    otherwise determined in accordance with GAAP; <I>provided</I>,
    <I>however</I>, that, without duplication,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any after-tax effect of extraordinary, non-recurring or
    unusual gains or losses (less all fees and expenses relating
    thereto) or expenses (including relating to the Transaction to
    the extent incurred on or prior to December&#160;31, 2007),
    severance, relocation costs, consolidation and closing costs,
    integration and facilities opening costs, business optimization
    costs, transition costs, restructuring costs, signing, retention
    or completion bonuses, and curtailments or modifications to
    pension and post-retirement employee benefit plans shall be
    excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the cumulative effect of a change in accounting
    principles during such period shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;any after-tax effect of income (loss) from disposed,
    abandoned or discontinued operations and any net after-tax gains
    or losses on disposal of disposed, abandoned, transferred,
    closed or discontinued operations shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;any after-tax effect of gains or losses (less all fees
    and expenses relating thereto) attributable to asset
    dispositions or abandonments other than in the ordinary course
    of business, as determined in good faith by the Issuer, shall be
    excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;the Net Income for such period of any Person that is an
    Unrestricted Subsidiary shall be excluded, and, solely for the
    purpose of determining the amount available for Restricted
    Payments under clause&#160;3(a) of the first paragraph of
    &#147;Certain Covenants&#160;&#151; Limitation on Restricted
    Payments,&#148; the Net Income for such period of any Person
    that is not a Subsidiary or that is accounted for by the equity
    method of accounting shall be excluded; <I>provided </I>that
    Consolidated Net Income of the Issuer shall be increased by the
    amount of
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    96
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    dividends or distributions or other payments that are actually
    paid in cash (or to the extent converted into cash) to the
    referent Person or a Restricted Subsidiary thereof in respect of
    such period,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;solely for the purpose of determining the amount
    available for Restricted Payments under clause (3)(a) of the
    first paragraph of &#147;Certain Covenants&#160;&#151;
    Limitation on Restricted Payments,&#148; the Net Income for such
    period of any Restricted Subsidiary (other than any Guarantor)
    shall be excluded to the extent that the declaration or payment
    of dividends or similar distributions by that Restricted
    Subsidiary of its Net Income is not at the date of determination
    wholly permitted without any prior governmental approval (which
    has not been obtained) or, directly or indirectly, by the
    operation of the terms of its charter or any agreement,
    instrument, judgment, decree, order, statute, rule, or
    governmental regulation applicable to that Restricted Subsidiary
    or its stockholders, unless such restriction with respect to the
    payment of dividends or similar distributions has been legally
    waived; <I>provided</I> that Consolidated Net Income of the
    Issuer will be increased by the amount of dividends or other
    distributions or other payments actually paid in cash (or to the
    extent converted into cash) or Cash Equivalents to the Issuer or
    a Restricted Subsidiary thereof in respect of such period, to
    the extent not already included therein,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;effects of adjustments (including the effects of such
    adjustments pushed down to the Issuer and its Restricted
    Subsidiaries) in the property, equipment, inventory, software
    and other intangible assets, deferred revenue and debt line
    items in such Person&#146;s consolidated financial statements
    pursuant to GAAP resulting from the application of
    recapitalization accounting or, if applicable, purchase
    accounting in relation to the Transaction or any consummated
    acquisition or the amortization or write-off of any amounts
    thereof, net of taxes, shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;any after-tax effect of income (loss) from the early
    extinguishment of Indebtedness or Hedging Obligations or other
    derivative instruments shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;any impairment charge or asset write-off, including,
    without limitation, impairment charges or asset write-offs
    related to intangible assets, long-lived assets or investments
    in debt and equity securities, in each case, pursuant to GAAP
    and the amortization of intangibles arising pursuant to GAAP
    shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;any non-cash compensation expense recorded from grants
    of stock appreciation or similar rights, stock options,
    restricted stock or other rights, and any cash charges
    associated with the rollover, acceleration or payout of Equity
    Interests by management of the Company or any of its direct or
    indirect parent companies in connection with the Transaction,
    shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;any fees and expenses incurred during such period, or
    any amortization thereof for such period, in connection with any
    acquisition, Investment, Asset Sale, issuance or repayment of
    Indebtedness, issuance of Equity Interests, refinancing
    transaction or amendment or modification of any debt instrument
    (in each case, including any such transaction consummated prior
    to the Issue Date and any such transaction undertaken but not
    completed) and any charges or non-recurring merger costs
    incurred during such period as a result of any such transaction
    shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;accruals and reserves that are established or adjusted
    within twelve months after the Issue Date that are so required
    to be established as a result of the Transaction in accordance
    with GAAP, or changes as a result of adoption or modification of
    accounting policies, shall be excluded,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;to the extent covered by insurance and actually
    reimbursed, or, so long as the Issuer has made a determination
    that there exists reasonable evidence that such amount will in
    fact be reimbursed by the insurer and only to the extent that
    such amount is (a)&#160;not denied by the applicable carrier in
    writing within 180&#160;days and (b)&#160;in fact reimbursed
    within 365&#160;days of the date of such evidence (with a
    deduction for any amount so added back to the extent not so
    reimbursed within 365&#160;days), expenses with respect to
    liability or casualty events or business interruption shall be
    excluded.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding the foregoing, for the purpose of the covenant
    described under &#147;Certain Covenants&#160;&#151; Limitation
    on Restricted Payments&#148; only (other than clause (3)(d)
    thereof), there shall be excluded from Consolidated Net Income
    any income arising from any sale or other disposition of
    Restricted Investments made by the Issuer and its Restricted
    Subsidiaries, any repurchases and redemptions of Restricted
    Investments
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    97
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    from the Issuer and its Restricted Subsidiaries, any repayments
    of loans and advances which constitute Restricted Investments by
    the Issuer or any of its Restricted Subsidiaries, any sale of
    the stock of an Unrestricted Subsidiary or any distribution or
    dividend from an Unrestricted Subsidiary, in each case only to
    the extent such amounts increase the amount of Restricted
    Payments permitted under such covenant pursuant to clause (3)(d)
    thereof.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Consolidated Secured Debt Ratio&#148;</I> as of any
    date of determination, means the ratio of (1)&#160;Consolidated
    Total Indebtedness of the Issuer and its Restricted Subsidiaries
    that is secured by Liens as of the end of the most recent fiscal
    period for which internal financial statements are available
    immediately preceding the date on which such event for which
    such calculation is being made shall occur to (2)&#160;the
    Issuer&#146;s EBITDA for the most recently ended four full
    fiscal quarters for which internal financial statements are
    available immediately preceding the date on which such event for
    which such calculation is being made shall occur, in each case
    with such <I>pro forma</I> adjustments to Consolidated Total
    Indebtedness and EBITDA as are appropriate and consistent with
    the <I>pro forma </I>adjustment provisions set forth in the
    definition of &#147;Fixed Charge Coverage Ratio.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Consolidated Total Indebtedness&#148;</I> means, as at
    any date of determination, an amount equal to the sum of
    (1)&#160;the aggregate amount of all outstanding Indebtedness of
    the Issuer and its Restricted Subsidiaries on a consolidated
    basis consisting of Indebtedness for borrowed money, Obligations
    in respect of Capitalized Lease Obligations and debt obligations
    evidenced by promissory notes and similar instruments (and
    excluding, for the avoidance of doubt, all obligations relating
    to Receivables Facilities) and (2)&#160;the aggregate amount of
    all outstanding Disqualified Stock of the Issuer and all
    Preferred Stock of its Restricted Subsidiaries on a consolidated
    basis, with the amount of such Disqualified Stock and Preferred
    Stock equal to the greater of their respective voluntary or
    involuntary liquidation preferences and maximum fixed repurchase
    prices, in each case determined on a consolidated basis in
    accordance with GAAP. For purposes hereof, the &#147;maximum
    fixed repurchase price&#148; of any Disqualified Stock or
    Preferred Stock that does not have a fixed repurchase price
    shall be calculated in accordance with the terms of such
    Disqualified Stock or Preferred Stock as if such Disqualified
    Stock or Preferred Stock were purchased on any date on which
    Consolidated Total Indebtedness shall be required to be
    determined pursuant to the Indenture, and if such price is based
    upon, or measured by, the fair market value of such Disqualified
    Stock or Preferred Stock, such fair market value shall be
    determined reasonably and in good faith by the Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Contingent Obligations&#148;</I> means, with respect to
    any Person, any obligation of such Person guaranteeing any
    leases, dividends or other obligations that do not constitute
    Indebtedness <I>(&#147;primary obligations&#148;) </I>of any
    other Person (the <I>&#147;primary obligor&#148;</I>) in any
    manner, whether directly or indirectly, including, without
    limitation, any obligation of such Person, whether or not
    contingent,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;to purchase any such primary obligation or any property
    constituting direct or indirect security therefor,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;to advance or supply funds
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;for the purchase or payment of any such primary
    obligation,&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;to maintain working capital or equity capital of the
    primary obligor or otherwise to maintain the net worth or
    solvency of the primary obligor,&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;to purchase property, securities or services primarily
    for the purpose of assuring the owner of any such primary
    obligation of the ability of the primary obligor to make payment
    of such primary obligation against loss in respect thereof.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Credit Facilities&#148;</I> means, with respect to the
    Issuer or any of its Restricted Subsidiaries, one or more debt
    facilities, including the Senior Credit Facilities, or other
    financing arrangements (including, without limitation,
    commercial paper facilities or indentures) providing for
    revolving credit loans, term loans, letters of credit or other
    long-term indebtedness, including any notes, mortgages,
    guarantees, collateral documents, instruments and agreements
    executed in connection therewith, and any amendments,
    supplements, modifications, extensions, renewals, restatements
    or refundings thereof and any indentures or credit facilities or
    commercial paper facilities that replace, refund or refinance
    any part of the loans, notes, other credit facilities
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    98
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    or commitments thereunder, including any such replacement,
    refunding or refinancing facility or indenture that increases
    the amount permitted to be borrowed thereunder or alters the
    maturity thereof (<I>provided </I>that such increase in
    borrowings is permitted under &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock&#148;) or
    adds Restricted Subsidiaries as additional borrowers or
    guarantors thereunder and whether by the same or any other
    agent, lender or group of lenders.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Default&#148;</I> means any event that is, or with the
    passage of time or the giving of notice or both would be, an
    Event of Default.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Delayed Equity Amount&#148;</I> means any equity
    contribution of the Investors, the Frist Entities or certain
    other management investors described in the Offering Memorandum
    on or before March&#160;31, 2007, the proceeds of which were
    used to repay borrowings under the senior secured revolving
    credit facility included in the General Credit Facility or the
    ABL Facility in the manner described in the Offering Memorandum.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Designated Non-cash Consideration&#148;</I> means the
    fair market value of non-cash consideration received by the
    Issuer or a Restricted Subsidiary in connection with an Asset
    Sale that is so designated as Designated Non-cash Consideration
    pursuant to an Officer&#146;s Certificate, setting forth the
    basis of such valuation, executed by the principal financial
    officer of the Issuer, less the amount of cash or Cash
    Equivalents received in connection with a subsequent sale of or
    collection on such Designated Non-cash Consideration.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Designated Preferred Stock&#148;</I> means Preferred
    Stock of the Issuer or any parent corporation thereof (in each
    case other than Disqualified Stock) that is issued for cash
    (other than to a Restricted Subsidiary or an employee stock
    ownership plan or trust established by the Issuer or any of its
    Subsidiaries) and is so designated as Designated Preferred
    Stock, pursuant to an Officer&#146;s Certificate executed by the
    principal financial officer of the Issuer or the applicable
    parent corporation thereof, as the case may be, on the issuance
    date thereof, the cash proceeds of which are excluded from the
    calculation set forth in clause&#160;(3) of the first paragraph
    under &#147;Certain Covenants&#160;&#151; Limitation on
    Restricted Payments.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Discharge of First Lien Obligations&#148;</I> shall
    mean the satisfaction and discharge of all of the First Lien
    Obligations in full in cash, pursuant to the First Lien
    Documents and the General Intercreditor Agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Disqualified Stock&#148;</I> means, with respect to any
    Person, any Capital Stock of such Person which, by its terms, or
    by the terms of any security into which it is convertible or for
    which it is putable or exchangeable, or upon the happening of
    any event, matures or is mandatorily redeemable (other than
    solely as a result of a change of control or asset sale)
    pursuant to a sinking fund obligation or otherwise, or is
    redeemable at the option of the holder thereof (other than
    solely as a result of a change of control or asset sale), in
    whole or in part, in each case prior to the date 91&#160;days
    after the earlier of the maturity date of the Notes or the date
    the Notes are no longer outstanding; <I>provided</I>,
    <I>however</I>, that if such Capital Stock is issued to any plan
    for the benefit of employees of the Issuer or its Subsidiaries
    or by any such plan to such employees, such Capital Stock shall
    not constitute Disqualified Stock solely because it may be
    required to be repurchased by the Issuer or its Subsidiaries in
    order to satisfy applicable statutory or regulatory obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;EBITDA&#148;</I> means, with respect to any Person for
    any period, the Consolidated Net Income of such Person for such
    period
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;increased (without duplication) by:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;provision for taxes based on income or profits or
    capital gains, including, without limitation, foreign, federal,
    state, franchise and similar taxes (such as the Pennsylvania
    capital tax) and foreign withholding taxes (including penalties
    and interest related to such taxes or arising from tax
    examinations) of such Person paid or accrued during such period
    deducted (and not added back) in computing Consolidated Net
    Income; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;Fixed Charges of such Person for such period (including
    (x)&#160;net losses on Hedging Obligations or other derivative
    instruments entered into for the purpose of hedging interest
    rate risk and (y)&#160;costs of surety bonds in connection with
    financing activities, in each case, to the extent included in
    Fixed Charges), together with items excluded from the definition
    of &#147;Consolidated Interest Expense&#148; pursuant
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    99
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    to clauses (1)(u), (v), (w), (x), (y)&#160;and (z)&#160;of the
    definition thereof, and, in each such case, to the extent the
    same were deducted (and not added back) in calculating such
    Consolidated Net Income; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;Consolidated Depreciation and Amortization Expense of
    such Person for such period to the extent the same was deducted
    (and not added back) in computing Consolidated Net Income;
    <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;any expenses or charges (other than depreciation or
    amortization expense) related to any Equity Offering, Permitted
    Investment, acquisition, disposition, recapitalization or the
    incurrence of Indebtedness permitted to be incurred by the
    Indenture (including a refinancing thereof) (whether or not
    successful), including (i)&#160;such fees, expenses or charges
    related to the offering of the Notes and any Credit Facilities
    and (ii)&#160;any amendment or other modification of the Notes,
    and, in each case, deducted (and not added back) in computing
    Consolidated Net Income; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;the amount of any restructuring charge or reserve
    deducted (and not added back) in such period in computing
    Consolidated Net Income, including any one-time costs incurred
    in connection with acquisitions after the Issue Date and costs
    related to the closure
    <FONT style="white-space: nowrap">and/or</FONT>
    consolidation of facilities; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (f)&#160;any other non-cash charges, including any write-offs or
    write-downs, reducing Consolidated Net Income for such period
    (<I>provided </I>that if any such non-cash charges represent an
    accrual or reserve for potential cash items in any future
    period, the cash payment in respect thereof in such future
    period shall be subtracted from EBITDA to such extent, and
    excluding amortization of a prepaid cash item that was paid in a
    prior period); <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (g)&#160;the amount of any minority interest expense consisting
    of income attributable to minority equity interests of third
    parties deducted (and not added back) in such period in
    calculating Consolidated Net Income; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (h)&#160;the amount of management, monitoring, consulting and
    advisory fees and related expenses paid in such period to the
    Investors and the Frist Entities to the extent otherwise
    permitted under &#147;Certain Covenants&#160;&#151; Transactions
    with Affiliates&#148;; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (i)&#160;the amount of net cost savings projected by the Issuer
    in good faith to be realized as a result of specified actions
    taken or to be taken (calculated on a <I>pro forma </I>basis as
    though such cost savings had been realized on the first day of
    such period), net of the amount of actual benefits realized
    during such period from such actions; <I>provided </I>that
    (w)&#160;such cost savings are reasonably identifiable and
    factually supportable, (x)&#160;such actions have been taken or
    are to be taken within 15&#160;months after the date of
    determination to take such action, (y)&#160;no cost savings
    shall be added pursuant to this clause&#160;(i) to the extent
    duplicative of any expenses or charges relating to such cost
    savings that are included in clause&#160;(e) above with respect
    to such period and (z)&#160;the aggregate amount of cost savings
    added pursuant to this clause&#160;(i) shall not exceed
    $150.0&#160;million for any four consecutive quarter period
    (which adjustments may be incremental to <I>pro forma
    </I>adjustments made pursuant to the second paragraph of the
    definition of &#147;Fixed Charge Coverage Ratio&#148;);
    <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (j)&#160;the amount of loss on sales of receivables and related
    assets to the Receivables Subsidiary in connection with a
    Receivables Facility; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (k)&#160;any costs or expense incurred by the Issuer or a
    Restricted Subsidiary pursuant to any management equity plan or
    stock option plan or any other management or employee benefit
    plan or agreement or any stock subscription or shareholder
    agreement, to the extent that such cost or expenses are funded
    with cash proceeds contributed to the capital of the Issuer or
    net cash proceeds of an issuance of Equity Interests of the
    Issuer (other than Disqualified Stock) solely to the extent that
    such net cash proceeds are excluded from the calculation set
    forth in clause&#160;(3) of the first paragraph under
    &#147;Certain Covenants&#160;&#151; Limitation on Restricted
    Payments&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;decreased by (without duplication) non-cash gains
    increasing Consolidated Net Income of such Person for such
    period, excluding any non-cash gains to the extent they
    represent the reversal of an accrual or reserve for a potential
    cash item that reduced EBITDA in any prior period;&#160;and
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    100
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;increased or decreased by (without duplication):
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;any net gain or loss resulting in such period from
    Hedging Obligations and the application of Statement of
    Financial Accounting Standards No.&#160;133; <I>plus </I>or
    <I>minus</I>, as applicable,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;any net gain or loss resulting in such period from
    currency translation gains or losses related to currency
    remeasurements of Indebtedness (including any net loss or gain
    resulting from Hedging Obligations for currency exchange risk).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;EMU&#148;</I> means the economic and monetary union as
    contemplated in the Treaty on European Union.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Equity Interests&#148;</I> means Capital Stock and all
    warrants, options or other rights to acquire Capital Stock, but
    excluding any debt security that is convertible into, or
    exchangeable for, Capital Stock.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Equity Offering&#148;</I> means any public or private
    sale of common stock or Preferred Stock of the Issuer or any of
    its direct or indirect parent companies (excluding Disqualified
    Stock), other than:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;public offerings with respect to the Issuer&#146;s or
    any direct or indirect parent company&#146;s common stock
    registered on
    <FONT style="white-space: nowrap">Form&#160;S-8;</FONT>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;issuances to any Subsidiary of the Issuer;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;any such public or private sale that constitutes an
    Excluded Contribution.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;euro&#148;</I> means the single currency of
    participating member states of the EMU.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;European Collateral&#148;</I> has the meaning set forth
    under &#147;Description of Other Indebtedness&#160;&#151; Senior
    Secured Credit Facilities&#160;&#151; Guarantee and
    Security.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Event of Default&#148;</I> has the meaning set forth
    under &#147;Events of Default and Remedies.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Excess Proceeds&#148;</I> has the meaning set forth in
    the fourth paragraph under &#147;Repurchase at the Option of
    Holders&#160;&#151; Asset Sales.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Exchange Act&#148;</I> means the Securities Exchange
    Act of 1934, as amended, and the rules and regulations of the
    SEC promulgated thereunder.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Exchange Notes&#148;</I> means any notes issued in
    exchange for the Notes pursuant to the Registration Rights
    Agreement or similar agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Excluded Contribution&#148;</I> means net cash
    proceeds, marketable securities or Qualified Proceeds received
    by the Issuer after the Issue Date from
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;contributions to its common equity capital,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the sale (other than to a Subsidiary of the Issuer or
    to any management equity plan or stock option plan or any other
    management or employee benefit plan or agreement of the Issuer)
    of Capital Stock (other than Disqualified Stock and Designated
    Preferred Stock) of the Issuer,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    in each case designated as Excluded Contributions pursuant to an
    Officer&#146;s Certificate executed by the principal financial
    officer of the Issuer on the date such capital contributions are
    made or the date such Equity Interests are sold, as the case may
    be, which are excluded from the calculation set forth in
    clause&#160;(3) of the first paragraph under &#147;Certain
    Covenants&#160;&#151; Limitation on Restricted Payments.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Existing Notes&#148;</I> means the $121.2&#160;million
    aggregate principal amount of 8.700% medium-term notes due 2010,
    $691.2&#160;million aggregate principal amount of
    8.750%&#160;notes due 2010, &#163;150.0&#160;million aggregate
    principal amount of 8.750%&#160;notes due 2010,
    $475.8&#160;million aggregate principal amount of
    7.875%&#160;notes due 2011, $500.0&#160;million aggregate
    principal amount of 6.950%&#160;notes due 2012,
    $500.0&#160;million aggregate principal amount of
    6.300%&#160;notes due 2012, $500.0&#160;million aggregate
    principal amount of 6.250%&#160;notes due 2013,
    $500.0&#160;million aggregate principal amount of
    6.750%&#160;notes due 2013, $500.0&#160;million aggregate
    principal amount of 5.750%&#160;notes due 2014,
    $121.1&#160;million aggregate principal amount of 9.000%
    medium-term notes due 2014, $750.0&#160;million aggregate
    principal amount of 6.375%&#160;notes due 2015,
    $150.0&#160;million aggregate
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    101
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    principal amount of 7.190%&#160;debentures due 2015,
    $1,000.0&#160;million aggregate principal amount of
    6.500%&#160;notes due 2016, $135.6&#160;million aggregate
    principal amount of 7.500%&#160;debentures due 2023,
    $150.0&#160;million aggregate principal amount of
    8.360%&#160;debentures due 2024, $291.4&#160;million aggregate
    principal amount of 7.690%&#160;notes due 2025,
    $125.0&#160;million aggregate principal amount of 7.580%
    medium-term notes due 2025, $150.0&#160;million aggregate
    principal amount of 7.050%&#160;debentures due 2027,
    $250.0&#160;million aggregate principal amount of
    7.500%&#160;notes due 2033, $100.0&#160;million aggregate
    principal amount of 7.750%&#160;debentures due 2036 and
    $200.0&#160;million aggregate principal amount of
    7.500%&#160;debentures due 2095, each issued by the Issuer and
    outstanding on the Issue Date.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Existing Notes Indenture&#148;</I> means that certain
    Indenture, dated as of December&#160;16, 1993, between Columbia
    Healthcare Corporation and The First National Bank of Chicago,
    as Trustee, as amended by the First Supplemental Indenture,
    dated as of May&#160;25, 2000, between the Issuer and Bank One
    Trust&#160;Company, N.A., as Trustee, the Second Supplemental
    Indenture, dated as of July&#160;1, 2001, between the Issuer and
    Bank One Trust&#160;Company, N.A., as Trustee, and the Third
    Supplemental Indenture, dated as of December&#160;5, 2001,
    between the Issuer and The Bank of New York, as Trustee.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;First Lien Collateral&#148;</I> means all of the assets
    of the Issuer or any Guarantor, whether real, personal or mixed,
    with respect to which a Lien has been granted as security for
    any First Lien Obligations pursuant to a First Lien Document.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;First Lien Collateral Agent&#148;</I> shall mean Bank
    of America, N.A., in its capacity as administrative agent and
    collateral agent for the lenders and other secured parties under
    the General Credit Facility and the other First Lien Documents,
    together with its successors and permitted assigns under the
    General Credit Facility exercising substantially the same rights
    and powers; and in each case provided that if such First Lien
    Collateral Agent is not Bank of America, N.A., such First Lien
    Collateral Agent shall have become a party to the Intercreditor
    Agreements and the other applicable First Lien Security
    Documents.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;First Lien Documents&#148;</I> means the credit,
    guarantee and security documents governing the First Lien
    Obligations, including, without limitation, the General Credit
    Facility and the First Lien Security Documents.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;First Lien Obligations&#148;</I> shall mean
    (a)&#160;all General Credit Facility Obligations and
    (b)&#160;all other Obligations of the Issuer and its
    Subsidiaries under any refinancings of the General Credit
    Facility Obligations (and any related Hedging Obligations). For
    the avoidance of doubt, Obligations with respect to the ABL
    Facility shall not constitute First Lien Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;First Lien Secured Parties&#148;</I> means, at any
    relevant time, the holders of First Lien Obligations at such
    time, including, without limitation, the lenders and agents
    under the General Credit Facility and the First Lien Collateral
    Agent.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;First Lien Security Documents&#148;</I> means the
    Security Documents (as defined in the General Credit Facility)
    and any other agreement, document or instrument pursuant to
    which a Lien is granted or purported to be granted securing
    First Lien Obligations or under which rights or remedies with
    respect to such Liens are governed.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;First Priority Liens&#148;</I> means the first priority
    Liens securing the First Lien Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Fixed Charge Coverage Ratio&#148;</I> means, with
    respect to any Person for any period, the ratio of EBITDA of
    such Person for such period to the Fixed Charges of such Person
    for such period. In the event that the Issuer or any Restricted
    Subsidiary incurs, assumes, guarantees, redeems, retires or
    extinguishes any Indebtedness (other than Indebtedness incurred
    under any revolving credit facility unless such Indebtedness has
    been permanently repaid and has not been replaced) or issues or
    redeems Disqualified Stock or Preferred Stock subsequent to the
    commencement of the period for which the Fixed Charge Coverage
    Ratio is being calculated but prior to or simultaneously with
    the event for which the calculation of the Fixed Charge Coverage
    Ratio is made (the <I>&#147;Fixed Charge Coverage Ratio
    Calculation Date&#148;</I>), then the Fixed Charge Coverage
    Ratio shall be calculated giving <I>pro forma </I>effect to such
    incurrence, assumption, guarantee, redemption, retirement or
    extinguishment of Indebtedness, or such issuance or redemption
    of Disqualified Stock or Preferred Stock, as if the same had
    occurred at the beginning of the applicable four-quarter period.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    102
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For purposes of making the computation referred to above,
    Investments, acquisitions, dispositions, mergers, consolidations
    and disposed operations (as determined in accordance with GAAP)
    that have been made by the Issuer or any of its Restricted
    Subsidiaries during the four-quarter reference period or
    subsequent to such reference period and on or prior to or
    simultaneously with the Fixed Charge Coverage Ratio Calculation
    Date shall be calculated on a <I>pro forma </I>basis assuming
    that all such Investments, acquisitions, dispositions, mergers,
    consolidations and disposed operations (and the change in any
    associated fixed charge obligations and the change in EBITDA
    resulting therefrom) had occurred on the first day of the
    four-quarter reference period. If, since the beginning of such
    period, any Person that subsequently became a Restricted
    Subsidiary or was merged with or into the Issuer or any of its
    Restricted Subsidiaries since the beginning of such period shall
    have made any Investment, acquisition, disposition, merger,
    consolidation or disposed operation that would have required
    adjustment pursuant to this definition, then the Fixed Charge
    Coverage Ratio shall be calculated giving <I>pro forma
    </I>effect thereto for such period as if such Investment,
    acquisition, disposition, merger, consolidation or disposed
    operation had occurred at the beginning of the applicable
    four-quarter period.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For purposes of this definition, whenever <I>pro forma
    </I>effect is to be given to a transaction, the <I>pro forma
    </I>calculations shall be made in good faith by a responsible
    financial or accounting officer of the Issuer. If any
    Indebtedness bears a floating rate of interest and is being
    given <I>pro forma </I>effect, the interest on such Indebtedness
    shall be calculated as if the rate in effect on the Fixed Charge
    Coverage Ratio Calculation Date had been the applicable rate for
    the entire period (taking into account any Hedging Obligations
    applicable to such Indebtedness). Interest on a Capitalized
    Lease Obligation shall be deemed to accrue at an interest rate
    reasonably determined by a responsible financial or accounting
    officer of the Issuer to be the rate of interest implicit in
    such Capitalized Lease Obligation in accordance with GAAP. For
    purposes of making the computation referred to above, interest
    on any Indebtedness under a revolving credit facility computed
    on a <I>pro forma </I>basis shall be computed based upon the
    average daily balance of such Indebtedness during the applicable
    period except as set forth in the first paragraph of this
    definition. Interest on Indebtedness that may optionally be
    determined at an interest rate based upon a factor of a prime or
    similar rate, a eurocurrency interbank offered rate or other
    rate shall be deemed to have been based upon the rate actually
    chosen, or, if none, then based upon such optional rate chosen
    as the Issuer may designate.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Fixed Charges&#148;</I> means, with respect to any
    Person for any period, the sum of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;Consolidated Interest Expense of such Person for such
    period;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;all cash dividends or other distributions paid
    (excluding items eliminated in consolidation) on any series of
    Preferred Stock during such period;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;all cash dividends or other distributions paid
    (excluding items eliminated in consolidation) on any series of
    Disqualified Stock during such period.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Foreign Subsidiary&#148;</I> means, with respect to any
    Person, any Restricted Subsidiary of such Person that is not
    organized or existing under the laws of the United States, any
    state thereof or the District of Columbia and any Restricted
    Subsidiary of such Foreign Subsidiary.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Frist Entities&#148;</I> means Dr.&#160;Thomas F.
    Frist,&#160;Jr., any Person controlled by Dr.&#160;Frist and any
    charitable organization selected by Dr.&#160;Frist that holds
    Equity Interests of the Issuer on the Issue Date.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;GAAP&#148;</I> means generally accepted accounting
    principles in the United States which are in effect on the Issue
    Date.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;General Credit Facility&#148;</I> means the credit
    agreement entered into as of the Issue Date by and among the
    Issuer, the European subsidiary borrowers party thereto, the
    lenders party thereto in their capacities as lenders thereunder
    and Bank of America, N.A., as U.S.&#160;Administrative Agent and
    as European Administrative Agent, including any guarantees,
    collateral documents, instruments and agreements executed in
    connection therewith, and any amendments, supplements,
    modifications, extensions, renewals, restatements, refundings or
    refinancings thereof and any indentures or credit facilities or
    commercial paper facilities with banks or other institutional
    lenders or investors that replace, refund or refinance any part
    of the loans, notes, other credit
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    103
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    facilities or commitments thereunder, including any such
    replacement, refunding or refinancing facility or indenture that
    increases the amount borrowable thereunder or alters the
    maturity thereof (<I>provided</I> that such increase in
    borrowings is permitted under &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock&#148;
    above).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;General Credit Facility Obligations&#148;</I> means
    <I>&#147;Obligations&#148;</I> as defined in the General Credit
    Facility.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;General Intercreditor Agreement&#148;</I> has the
    meaning set forth under &#147;Security&#160;&#151; Liens with
    Respect to the Collateral.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Government Securities&#148;</I> means securities that
    are:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;direct obligations of the United States of America for
    the timely payment of which its full faith and credit is
    pledged;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;obligations of a Person controlled or supervised by and
    acting as an agency or instrumentality of the United States of
    America the timely payment of which is unconditionally
    guaranteed as a full faith and credit obligation by the United
    States of America,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    which, in either case, are not callable or redeemable at the
    option of the issuers thereof, and shall also include a
    depository receipt issued by a bank (as defined in
    Section&#160;3(a)(2) of the Securities Act), as custodian with
    respect to any such Government Securities or a specific payment
    of principal of or interest on any such Government Securities
    held by such custodian for the account of the holder of such
    depository receipt; <I>provided </I>that (except as required by
    law) such custodian is not authorized to make any deduction from
    the amount payable to the holder of such depository receipt from
    any amount received by the custodian in respect of the
    Government Securities or the specific payment of principal of or
    interest on the Government Securities evidenced by such
    depository receipt.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;guarantee&#148;</I> means a guarantee (other than by
    endorsement of negotiable instruments for collection in the
    ordinary course of business), direct or indirect, in any manner
    (including letters of credit and reimbursement agreements in
    respect thereof), of all or any part of any Indebtedness or
    other obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Guarantee&#148;</I> means the guarantee by any
    Guarantor of the Issuer&#146;s Obligations under the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Guarantor&#148;</I> means each Restricted Subsidiary
    that Guarantees the Notes in accordance with the terms of the
    Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;HCI&#148;</I> means Health Care Indemnity, Inc., an
    insurance company formed under the laws of the State of Colorado
    and a Wholly-Owned Subsidiary of the Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Hedging Arrangements&#148;</I> means the fixed-pay
    interest rate swap agreements, entered into by Hercules Holding
    on or about September&#160;13, 2006 and with respect to which
    the Issuer will be the counterparty in connection with the
    Recapitalization, relating to $8,000&#160;million of the
    outstanding principal amount under the First Lien Obligations
    and the ABL Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Hedging Obligations&#148;</I> means, with respect to
    any Person, the obligations of such Person under any interest
    rate swap agreement, interest rate cap agreement, interest rate
    collar agreement, commodity swap agreement, commodity cap
    agreement, commodity collar agreement, foreign exchange
    contract, currency swap agreement or similar agreement providing
    for the transfer or mitigation of interest rate or currency
    risks either generally or under specific contingencies.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Holder&#148;</I> means the Person in whose name a Note
    is registered on the registrar&#146;s books.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Indebtedness&#148;</I> means, with respect to any
    Person, without duplication:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any indebtedness (including principal and premium) of
    such Person, whether or not contingent:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;in respect of borrowed money;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;evidenced by bonds, notes, debentures or similar
    instruments or letters of credit or bankers&#146; acceptances
    (or, without duplication, reimbursement agreements in respect
    thereof);
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    104
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;representing the balance deferred and unpaid of the
    purchase price of any property (including Capitalized Lease
    Obligations), except (i)&#160;any such balance that constitutes
    a trade payable or similar obligation to a trade creditor, in
    each case accrued in the ordinary course of business and
    (ii)&#160;any earn-out obligations until such obligation becomes
    a liability on the balance sheet of such Person in accordance
    with GAAP;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;representing any Hedging Obligations;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    if and to the extent that any of the foregoing Indebtedness
    (other than letters of credit and Hedging Obligations) would
    appear as a liability upon a balance sheet (excluding the
    footnotes thereto) of such Person prepared in accordance with
    GAAP;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;to the extent not otherwise included, any obligation by
    such Person to be liable for, or to pay, as obligor, guarantor
    or otherwise on, the obligations of the type referred to in
    clause&#160;(1) of a third Person (whether or not such items
    would appear upon the balance sheet of the such obligor or
    guarantor), other than by endorsement of negotiable instruments
    for collection in the ordinary course of business;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;to the extent not otherwise included, the obligations
    of the type referred to in clause&#160;(1) of a third Person
    secured by a Lien on any asset owned by such first Person,
    whether or not such Indebtedness is assumed by such first Person;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided</I>, <I>however</I>, that notwithstanding the
    foregoing, Indebtedness shall be deemed not to include
    (a)&#160;Contingent Obligations incurred in the ordinary course
    of business or (b)&#160;obligations under or in respect of
    Receivables Facilities.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Independent Financial Advisor&#148;</I> means an
    accounting, appraisal, investment banking firm or consultant to
    Persons engaged in Similar Businesses of nationally recognized
    standing that is, in the good faith judgment of the Issuer,
    qualified to perform the task for which it has been engaged.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Initial Purchasers&#148;</I> means Citigroup Global
    Markets Inc., Banc of America Securities LLC, J.P.&#160;Morgan
    Securities Inc., Merrill Lynch, Pierce, Fenner&#160;&#038; Smith
    Incorporated, Deutsche Bank Securities Inc. and Wachovia Capital
    Markets, LLC.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;insolvency or liquidation proceeding&#148; </I>means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any case commenced by or against the Issuer or any
    Guarantor under any Bankruptcy Law for the relief of debtors,
    any other proceeding for the reorganization, recapitalization or
    adjustment or marshalling of the assets or liabilities of the
    Issuer or any Guarantor, any receivership or assignment for the
    benefit of creditors relating to the Issuer or any Guarantor or
    any similar case or proceeding relative to the Issuer or any
    Guarantor or its creditors, as such, in each case whether or not
    voluntary;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any liquidation, dissolution, marshalling of assets or
    liabilities or other winding up of or relating to the Issuer or
    any Guarantor, in each case whether or not voluntary and whether
    or not involving bankruptcy or insolvency;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;any other proceeding of any type or nature in which
    substantially all claims of creditors of the Issuer or any
    Guarantor are determined and any payment or distribution is or
    may be made on account of such claims.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Intercreditor Agreements&#148;</I> means, collectively,
    the Shared Receivables Intercreditor Agreement and the General
    Intercreditor Agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Investment Grade Rating&#148;</I> means a rating equal
    to or higher than Baa3 (or the equivalent) by Moody&#146;s and
    BBB- (or the equivalent) by S&#038;P, or an equivalent rating by
    any other Rating Agency.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Investment Grade Securities&#148;</I> means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;securities issued or directly and fully guaranteed or
    insured by the United States government or any agency or
    instrumentality thereof (other than Cash Equivalents);
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    105
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;debt securities or debt instruments with an Investment
    Grade Rating, but excluding any debt securities or instruments
    constituting loans or advances among the Issuer and its
    Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;investments in any fund that invests exclusively in
    investments of the type described in clauses&#160;(1) and
    (2)&#160;which fund may also hold immaterial amounts of cash
    pending investment or distribution;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;corresponding instruments in countries other than the
    United States customarily utilized for high quality investments.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Investments&#148;</I> means, with respect to any
    Person, all investments by such Person in other Persons
    (including Affiliates) in the form of loans (including
    guarantees), advances or capital contributions (excluding
    accounts receivable, trade credit, advances to customers,
    commissions, travel and similar advances to officers and
    employees, in each case made in the ordinary course of
    business), purchases or other acquisitions for consideration of
    Indebtedness, Equity Interests or other securities issued by any
    other Person and investments that are required by GAAP to be
    classified on the balance sheet (excluding the footnotes) of the
    Issuer in the same manner as the other investments included in
    this definition to the extent such transactions involve the
    transfer of cash or other property. For purposes of the
    definition of &#147;Unrestricted Subsidiary&#148; and the
    covenant described under &#147;Certain Covenants&#160;&#151;
    Limitation on Restricted Payments&#148;:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;<I>&#147;Investments&#148; </I>shall include the
    portion (proportionate to the Issuer&#146;s equity interest in
    such Subsidiary) of the fair market value of the net assets of a
    Subsidiary of the Issuer at the time that such Subsidiary is
    designated an Unrestricted Subsidiary; <I>provided</I>,
    <I>however</I>, that upon a redesignation of such Subsidiary as
    a Restricted Subsidiary, the Issuer shall be deemed to continue
    to have a permanent &#147;Investment&#148; in an Unrestricted
    Subsidiary in an amount (if positive) equal to:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;the Issuer&#146;s &#147;Investment&#148; in such
    Subsidiary at the time of such redesignation; <I>less</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the portion (proportionate to the Issuer equity
    interest in such Subsidiary) of the fair market value of the net
    assets of such Subsidiary at the time of such
    redesignation;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any property transferred to or from an Unrestricted
    Subsidiary shall be valued at its fair market value at the time
    of such transfer, in each case as determined in good faith by
    the Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Investors&#148;</I> means Bain Capital Partners, LLC,
    Kohlberg Kravis Roberts&#160;&#038; Co. L.P., Merrill Lynch
    Global Partners, Inc. and each of their respective Affiliates
    but not including, however, any portfolio companies of any of
    the foregoing.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Issue Date&#148;</I> means November&#160;17, 2006.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Issuer&#148;</I> has the meaning set forth in the first
    paragraph under &#147;General&#148;; <I>provided </I>that when
    used in the context of determining the fair market value of an
    asset or liability under the Indenture, &#147;Issuer&#148; shall
    be deemed to mean the board of directors of the Issuer when the
    fair market value is equal to or in excess of
    $500.0&#160;million (unless otherwise expressly stated).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Junior Lien Collateral Agent&#148;</I> shall mean
    (i)&#160;so long as the Notes are outstanding, the Trustee, in
    its capacity as Trustee and collateral agent for the Holders and
    other secured parties under the Indenture and the Security
    Documents, and (ii)&#160;at any time thereafter, such agent or
    trustee as is designated &#147;Junior Lien Collateral
    Agent&#148; by Junior Lien Secured Parties holding a majority in
    principal amount of the Junior Lien Obligations then outstanding
    or pursuant to such other arrangements as agreed to among the
    holders of the Junior Lien Obligations, it being understood that
    as of the Issue Date, the Trustee shall be so designated Junior
    Lien Collateral Agent.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Junior Lien Documents&#148;</I> means the credit and
    security documents governing the Junior Lien Obligations,
    including, without limitation, the Indenture, the related
    Security Documents and Intercreditor Agreements.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Junior Lien Obligations&#148;</I> means the Notes and
    Obligations with respect to other Indebtedness permitted to be
    incurred under the Indenture and the General Credit Facility
    which is by its terms intended to be secured equally and ratably
    with the Notes or on a basis junior to the Liens securing the
    Notes; <I>provided </I>such Lien is
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    106
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    permitted to be incurred under the Indenture and the General
    Credit Facility; <I>provided, further</I>, that the holders of
    such Indebtedness or their Junior Lien Representative is a party
    to the Security Documents in accordance with the terms thereof
    and has appointed the Junior Lien Collateral Agent as collateral
    agent for such holders of Junior Lien Obligations with respect
    to all or a portion of the Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Junior Lien Representative&#148;</I> means any duly
    authorized representative of any holders of Junior Lien
    Obligations, which representative is party to the Security
    Documents.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Junior Lien Secured Parties&#148;</I> means
    (i)&#160;Holders (including the Holders of any Additional Notes
    subsequently issued under and in compliance with the terms of
    the Indenture), (ii)&#160;the Junior Lien Collateral Agent and
    (iii)&#160;the holders from time to time of any other Junior
    Lien Obligations and each Junior Lien Representative.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Junior Liens&#148;</I> means the Liens securing the
    Junior Lien Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Legal Holiday&#148;</I> means a Saturday, a Sunday or a
    day on which commercial banking institutions are not required to
    be open in the State of New York.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Lien&#148;</I> means, with respect to any asset, any
    mortgage, lien (statutory or otherwise), pledge, hypothecation,
    charge, security interest, preference, priority or encumbrance
    of any kind in respect of such asset, whether or not filed,
    recorded or otherwise perfected under applicable law, including
    any conditional sale or other title retention agreement, any
    lease in the nature thereof, any option or other agreement to
    sell or give a security interest in and any filing of or
    agreement to give any financing statement under the Uniform
    Commercial Code (or equivalent statutes) of any jurisdiction;
    <I>provided </I>that in no event shall an operating lease be
    deemed to constitute a Lien.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Moody&#146;s&#148;</I> means Moody&#146;s Investors
    Service, Inc. and any successor to its rating agency business.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Net Income&#148;</I> means, with respect to any Person,
    the net income (loss) of such Person, determined in accordance
    with GAAP and before any reduction in respect of Preferred Stock
    dividends.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Net Proceeds&#148;</I> means the aggregate cash
    proceeds received by the Issuer or any of its Restricted
    Subsidiaries in respect of any Asset Sale, including any cash
    received upon the sale or other disposition of any Designated
    Non-cash Consideration received in any Asset Sale, net of the
    direct costs relating to such Asset Sale and the sale or
    disposition of such Designated Non-cash Consideration, including
    legal, accounting and investment banking fees, and brokerage and
    sales commissions, any relocation expenses incurred as a result
    thereof, taxes paid or payable as a result thereof (after taking
    into account any available tax credits or deductions and any tax
    sharing arrangements), amounts required to be applied to the
    repayment of principal, premium, if any, and interest on Senior
    Indebtedness required (other than required by clause&#160;(1) of
    the second paragraph of &#147;Repurchase at the Option of
    Holders&#160;&#151; Asset Sales&#148;) to be paid as a result of
    such transaction and any deduction of appropriate amounts to be
    provided by the Issuer or any of its Restricted Subsidiaries as
    a reserve in accordance with GAAP against any liabilities
    associated with the asset disposed of in such transaction and
    retained by the Issuer or any of its Restricted Subsidiaries
    after such sale or other disposition thereof, including pension
    and other post-employment benefit liabilities and liabilities
    related to environmental matters or against any indemnification
    obligations associated with such transaction.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Non-Conforming Plan of Reorganization&#148;</I> means
    any Plan of Reorganization that grants the Junior Lien
    Collateral Agent or any Junior Lien Secured Party any right or
    benefit, directly or indirectly, which right or benefit is
    prohibited at such time by the provisions of the General
    Intercreditor Agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Non-Receivables Collateral&#148;</I> has the meaning
    set forth under &#147;Description of Other
    Indebtedness&#160;&#151; Senior Secured Credit
    Facilities&#160;&#151; Guarantee and Security,&#148; subject to
    the provisions of the third and fourth sentences of the first
    paragraph under &#147;&#151;&#160;Security&#160;&#151;
    General.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Obligations&#148;</I> means any principal, interest
    (including any interest accruing subsequent to the filing of a
    petition in bankruptcy, reorganization or similar proceeding at
    the rate provided for in the documentation with respect thereto,
    whether or not such interest is an allowed claim under
    applicable state, federal or foreign law), premium, penalties,
    fees, indemnifications, reimbursements (including reimbursement
    obligations with respect
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    107
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    to letters of credit and bankers&#146; acceptances), damages and
    other liabilities, and guarantees of payment of such principal,
    interest, penalties, fees, indemnifications, reimbursements,
    damages and other liabilities, payable under the documentation
    governing any Indebtedness.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Offering Memorandum&#148;</I> means the offering
    memorandum, dated November&#160;9, 2006, relating to the initial
    private offering of the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Officer&#148;</I> means the Chairman of the Board, the
    Chief Executive Officer, the President, any Executive Vice
    President, Senior Vice President or Vice President, the
    Treasurer or the Secretary of the Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Officer&#146;s Certificate&#148;</I> means a
    certificate signed on behalf of the Issuer by an Officer of the
    Issuer, who must be the principal executive officer, the
    principal financial officer, the treasurer or the principal
    accounting officer of the Issuer, that meets the requirements
    set forth in the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Opinion of Counsel&#148;</I> means a written opinion
    from legal counsel who is acceptable to the Trustee. The counsel
    may be an employee of or counsel to the Issuer or the Trustee.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Partial PIK Interest&#148;</I> has the meaning set
    forth under &#147;Principal, Maturity and Interest&#160;&#151;
    Toggle Notes.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Permitted Asset Swap&#148;</I> means the concurrent
    purchase and sale or exchange of Related Business Assets or a
    combination of Related Business Assets and cash or Cash
    Equivalents between the Issuer or any of its Restricted
    Subsidiaries and another Person; <I>provided</I>, that any cash
    or Cash Equivalents received must be applied in accordance with
    the covenant described under &#147;Repurchase at the Option of
    Holders&#160;&#151; Asset Sales.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Permitted Holders&#148;</I> means each of the
    Investors, the Frist Entities, the Management Participants (as
    defined in the Offering Memorandum), Citigroup Inc. and Banc of
    America Securities LLC (which institutions are assignees of
    certain equity commitments of the Investors as of the Issue
    Date) who are holders of Equity Interests of the Issuer (or any
    of its direct or indirect parent companies) and any group
    (within the meaning of Section&#160;13(d)(3) or
    Section&#160;14(d)(2) of the Exchange Act or any successor
    provision) of which any of the foregoing are members;
    <I>provided </I>that, in the case of such group and without
    giving effect to the existence of such group or any other group,
    such Investors, Frist Entities, members of management and
    assignees of the equity commitments of the Investors,
    collectively, have beneficial ownership of more than 50% of the
    total voting power of the Voting Stock of the Issuer or any of
    its direct or indirect parent companies.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Permitted Investments&#148;</I> means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any Investment in the Issuer or any of its Restricted
    Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any Investment in cash and Cash Equivalents or
    Investment Grade Securities;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;any Investment by the Issuer or any of its Restricted
    Subsidiaries in a Person that is engaged in a Similar Business
    if as a result of such Investment:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;such Person becomes a Restricted Subsidiary;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;such Person, in one transaction or a series of related
    transactions, is merged or consolidated with or into, or
    transfers or conveys substantially all of its assets to, or is
    liquidated into, the Issuer or a Restricted Subsidiary, and, in
    each case, any Investment held by such Person; <I>provided,
    </I>that such Investment was not acquired by such Person in
    contemplation of such acquisition, merger, consolidation or
    transfer;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;any Investment in securities or other assets not
    constituting cash, Cash Equivalents or Investment Grade
    Securities and received in connection with an Asset Sale made
    pursuant to the provisions described under &#147;Repurchase at
    the Option of Holders&#160;&#151; Asset Sales&#148; or any other
    disposition of assets not constituting an Asset Sale;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;any Investment existing on the Issue Date;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    108
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;any Investment acquired by the Issuer or any of its
    Restricted Subsidiaries:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;in exchange for any other Investment or accounts
    receivable held by the Issuer or any such Restricted Subsidiary
    in connection with or as a result of a bankruptcy, workout,
    reorganization or recapitalization of the issuer of such other
    Investment or accounts receivable;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;as a result of a foreclosure by the Issuer or any of
    its Restricted Subsidiaries with respect to any secured
    Investment or other transfer of title with respect to any
    secured Investment in default;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;Hedging Obligations permitted under clause&#160;(10) of
    the second paragraph of the covenant described in &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;any Investment in a Similar Business having an
    aggregate fair market value, taken together with all other
    Investments made pursuant to this clause&#160;(8) that are at
    that time outstanding, not to exceed 5% of Total Assets at the
    time of such Investment (with the fair market value of each
    Investment being measured at the time made and without giving
    effect to subsequent changes in value);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;Investments the payment for which consists of Equity
    Interests (exclusive of Disqualified Stock) of the Issuer or any
    of its direct or indirect parent companies; <I>provided</I>,
    <I>however</I>, that such Equity Interests will not increase the
    amount available for Restricted Payments under clause&#160;(3)
    of the first paragraph under the covenant described in
    &#147;Certain Covenants&#160;&#151; Limitations on Restricted
    Payments&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;guarantees of Indebtedness permitted under the
    covenant described in &#147;Certain Covenants&#160;&#151;
    Limitation on Incurrence of Indebtedness and Issuance of
    Disqualified Stock and Preferred Stock&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;any transaction to the extent it constitutes an
    Investment that is permitted and made in accordance with the
    provisions of the second paragraph of the covenant described
    under &#147;Certain Covenants&#160;&#151; Transactions with
    Affiliates&#148; (except transactions described in clauses (2),
    (5)&#160;and (9)&#160;of such paragraph);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;Investments consisting of purchases and acquisitions
    of inventory, supplies, material or equipment;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;additional Investments having an aggregate fair market
    value, taken together with all other Investments made pursuant
    to this clause&#160;(13) that are at that time outstanding
    (without giving effect to the sale of an Unrestricted Subsidiary
    to the extent the proceeds of such sale do not consist of cash
    or marketable securities), not to exceed 5% of Total Assets at
    the time of such Investment (with the fair market value of each
    Investment being measured at the time made and without giving
    effect to subsequent changes in value);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (14)&#160;Investments relating to an ABL Financing Entity or a
    Receivables Subsidiary that, in the good faith determination of
    the Issuer, are necessary or advisable to effect the ABL
    Facility or any Receivables Facility, as the case may be;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (15)&#160;advances to, or guarantees of Indebtedness of,
    employees not in excess of $50.0&#160;million outstanding at any
    one time, in the aggregate;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (16)&#160;loans and advances to officers, directors and
    employees for business-related travel expenses, moving expenses
    and other similar expenses, in each case incurred in the
    ordinary course of business or consistent with past practices or
    to fund such Person&#146;s purchase of Equity Interests of the
    Issuer or any direct or indirect parent company thereof;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (17)&#160;Physician Support Obligations made by the Issuer or
    any Restricted Subsidiary;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (18)&#160;any Investment in any joint venture existing on the
    Issue Date that owns or operates one or more healthcare
    facilities, including, without limitation, hospitals, ambulatory
    surgery centers, outpatient diagnostic centers or imaging
    centers to the extent contemplated by the organizational
    documents of such joint venture as in existence on the Issue
    Date;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    109
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (19)&#160;any Investment in the ordinary course of business or
    as may be required by applicable law by any Restricted
    Subsidiary (including, without limitation, HCI) engaged in the
    insurance business in order to provide insurance to the Issuer
    and its Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (20)&#160;any Investment pursuant to any customary buy/sell
    arrangement in favor of investors or joint venture parties in
    connection with syndications of healthcare facilities,
    including, without limitation, hospitals, ambulatory surgery
    centers, outpatient diagnostic centers or imaging
    centers;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (21)&#160;any Investment in any Subsidiary or any joint venture
    in connection with intercompany cash management arrangements or
    related activities arising in the ordinary course of business.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Permitted Liens&#148;</I> means, with respect to any
    Person:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;pledges or deposits by such Person under workmen&#146;s
    compensation laws, unemployment insurance laws or similar
    legislation, or good faith deposits in connection with bids,
    tenders, contracts (other than for the payment of Indebtedness)
    or leases to which such Person is a party, or deposits to secure
    public or statutory obligations of such Person or deposits of
    cash or U.S.&#160;government bonds to secure surety or appeal
    bonds to which such Person is a party, or deposits as security
    for contested taxes or import duties or for the payment of rent,
    in each case incurred in the ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;Liens imposed by law, such as carriers&#146;,
    warehousemen&#146;s and mechanics&#146; Liens, in each case for
    sums not yet overdue for a period of more than 30&#160;days or
    being contested in good faith by appropriate proceedings or
    other Liens arising out of judgments or awards against such
    Person with respect to which such Person shall then be
    proceeding with an appeal or other proceedings for review if
    adequate reserves with respect thereto are maintained on the
    books of such Person in accordance with GAAP;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;Liens for taxes, assessments or other governmental
    charges not yet overdue for a period of more than 30&#160;days
    or payable or subject to penalties for nonpayment or which are
    being contested in good faith by appropriate proceedings
    diligently conducted, if adequate reserves with respect thereto
    are maintained on the books of such Person in accordance with
    GAAP;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;Liens in favor of issuers of performance and surety
    bonds or bid bonds or with respect to other regulatory
    requirements or letters of credit issued pursuant to the request
    of and for the account of such Person in the ordinary course of
    its business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;minor survey exceptions, minor encumbrances, easements
    or reservations of, or rights of others for, licenses,
    <FONT style="white-space: nowrap">rights-of-way,</FONT>
    sewers, electric lines, telegraph and telephone lines and other
    similar purposes, or zoning or other restrictions as to the use
    of real properties or Liens incidental to the conduct of the
    business of such Person or to the ownership of its properties
    which were not incurred in connection with Indebtedness and
    which do not in the aggregate materially adversely affect the
    value of said properties or materially impair their use in the
    operation of the business of such Person;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;Liens securing Indebtedness permitted to be incurred
    pursuant to clause (4), (12), (13), (18)&#160;or (19)&#160;of
    the second paragraph under &#147;Certain Covenants&#160;&#151;
    Limitation on Incurrence of Indebtedness and Issuance of
    Disqualified Stock and Preferred Stock&#148;; <I>provided
    </I>that (a)&#160;Liens securing Indebtedness, Disqualified
    Stock or Preferred Stock permitted to be incurred pursuant to
    clause&#160;(13) relate only to Refinancing Indebtedness that
    serves to refund or refinance Indebtedness, Disqualified Stock
    or Preferred Stock incurred under clause&#160;(4) or
    (12)&#160;of the second paragraph under &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock,&#148;
    (b)&#160;Liens securing Indebtedness permitted to be incurred
    pursuant to clause&#160;(18) extend only to the assets of
    Foreign Subsidiaries, (c)&#160;Liens securing Indebtedness
    permitted to be incurred pursuant to clause&#160;(19) are solely
    on acquired property or the assets of the acquired entity, as
    the case may be and (d)&#160;Liens securing Indebtedness,
    Disqualified Stock or Preferred Stock permitted to be incurred
    pursuant to clause&#160;(4) of the second paragraph under
    &#147;Certain Covenants&#160;&#151; Limitation on Incurrence of
    Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock&#148; extend only to the assets so financed, purchased,
    constructed or improved;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    110
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;Liens existing on the Issue Date (other than Liens in
    favor of the lenders under the Senior Credit Facilities);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;Liens on property or shares of stock of a Person at the
    time such Person becomes a Subsidiary; <I>provided</I>,
    <I>however</I>, such Liens are not created or incurred in
    connection with, or in contemplation of, such other Person
    becoming such a Subsidiary; <I>provided</I>, <I>further</I>,
    <I>however</I>, that such Liens may not extend to any other
    property owned by the Issuer or any of its Restricted
    Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;Liens on property at the time the Issuer or a
    Restricted Subsidiary acquired the property, including any
    acquisition by means of a merger or consolidation with or into
    the Issuer or any of its Restricted Subsidiaries;
    <I>provided</I>, <I>however</I>, that such Liens are not created
    or incurred in connection with, or in contemplation of, such
    acquisition; <I>provided</I>, <I>further</I>, <I>however</I>,
    that the Liens may not extend to any other property owned by the
    Issuer or any of its Restricted Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;Liens securing Indebtedness or other obligations of a
    Restricted Subsidiary owing to the Issuer or another Restricted
    Subsidiary permitted to be incurred in accordance with the
    covenant described under &#147;Certain Covenants&#160;&#151;
    Limitation on Incurrence of Indebtedness and Issuance of
    Disqualified Stock and Preferred Stock&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;Liens securing Hedging Obligations so long as the
    related Indebtedness is, and is permitted to be under the
    Indenture, secured by a Lien on the same property securing such
    Hedging Obligations;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;Liens on specific items of inventory or other goods
    and proceeds of any Person securing such Person&#146;s
    obligations in respect of bankers&#146; acceptances issued or
    created for the account of such Person to facilitate the
    purchase, shipment or storage of such inventory or other goods;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;leases, subleases, licenses or sublicenses granted to
    others in the ordinary course of business which do not
    materially interfere with the ordinary conduct of the business
    of the Issuer or any of its Restricted Subsidiaries and do not
    secure any Indebtedness;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (14)&#160;Liens arising from Uniform Commercial Code financing
    statement filings regarding operating leases entered into by the
    Issuer and its Restricted Subsidiaries in the ordinary course of
    business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (15)&#160;Liens in favor of the Issuer or any Guarantor;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (16)&#160;Liens on equipment of the Issuer or any of its
    Restricted Subsidiaries granted in the ordinary course of
    business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (17)&#160;Liens on accounts receivable and related assets
    incurred in connection with a Receivables Facility;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (18)&#160;Liens to secure any refinancing, refunding, extension,
    renewal or replacement (or successive refinancing, refunding,
    extensions, renewals or replacements) as a whole, or in part, of
    any Indebtedness secured by any Lien referred to in the
    foregoing clauses (6), (7), (8)&#160;and (9); <I>provided</I>,
    <I>however</I>, that (a)&#160;such new Lien shall be limited to
    all or part of the same property that secured the original Lien
    (plus improvements on such property), and (b)&#160;the
    Indebtedness secured by such Lien at such time is not increased
    to any amount greater than the sum of (i)&#160;the outstanding
    principal amount or, if greater, committed amount of the
    Indebtedness described under clauses (6), (7), (8)&#160;and
    (9)&#160;at the time the original Lien became a Permitted Lien
    under the Indenture, and (ii)&#160;an amount necessary to pay
    any fees and expenses, including premiums, related to such
    refinancing, refunding, extension, renewal or replacement;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (19)&#160;deposits made in the ordinary course of business to
    secure liability to insurance carriers;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (20)&#160;other Liens securing obligations incurred in the
    ordinary course of business which obligations do not exceed
    $100.0&#160;million at any one time outstanding;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (21)&#160;Liens securing judgments for the payment of money not
    constituting an Event of Default under clause&#160;(5) under the
    caption &#147;Events of Default and Remedies&#148; so long as
    such Liens are adequately bonded and any appropriate legal
    proceedings that may have been duly initiated for the review of
    such
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    111
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    judgment have not been finally terminated or the period within
    which such proceedings may be initiated has not expired;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (22)&#160;Liens in favor of customs and revenue authorities
    arising as a matter of law to secure payment of customs duties
    in connection with the importation of goods in the ordinary
    course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (23)&#160;Liens (i)&#160;of a collection bank arising under
    <FONT style="white-space: nowrap">Section&#160;4-210</FONT>
    of the Uniform Commercial Code, or any comparable or successor
    provision, on items in the course of collection,
    (ii)&#160;attaching to commodity trading accounts or other
    commodity brokerage accounts incurred in the ordinary course of
    business, and (iii)&#160;in favor of banking institutions
    arising as a matter of law encumbering deposits (including the
    right of set-off) and which are within the general parameters
    customary in the banking industry;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (24)&#160;Liens deemed to exist in connection with Investments
    in repurchase agreements permitted under &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock&#148;;
    <I>provided </I>that such Liens do not extend to any assets
    other than those that are the subject of such repurchase
    agreements;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (25)&#160;Liens encumbering reasonable customary initial
    deposits and margin deposits and similar Liens attaching to
    commodity trading accounts or other brokerage accounts incurred
    in the ordinary course of business and not for speculative
    purposes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (26)&#160;Liens that are contractual rights of set-off
    (i)&#160;relating to the establishment of depository relations
    with banks not given in connection with the issuance of
    Indebtedness, (ii)&#160;relating to pooled deposit or sweep
    accounts of the Issuer or any of its Restricted Subsidiaries to
    permit satisfaction of overdraft or similar obligations incurred
    in the ordinary course of business of the Issuer and its
    Restricted Subsidiaries or (iii)&#160;relating to purchase
    orders and other agreements entered into with customers of the
    Issuer or any of its Restricted Subsidiaries in the ordinary
    course of business;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (27)&#160;Liens arising out of conditional sale, title
    retention, consignment or similar arrangements for the sale or
    purchase of goods entered into by the Issuer or any Restricted
    Subsidiary in the ordinary course of business.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For purposes of this definition, the term
    &#147;Indebtedness&#148; shall be deemed to include interest on
    such Indebtedness.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Person&#148;</I> means any individual, corporation,
    limited liability company, partnership, joint venture,
    association, joint stock company, trust, unincorporated
    organization, government or any agency or political subdivision
    thereof or any other entity.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Physician Support Obligation&#148;</I> means (1)&#160;a
    loan to or on behalf of, or a guarantee of Indebtedness or
    income of, a physician or healthcare professional providing
    service to patients in the service area of a healthcare facility
    operated by the Issuer, any of its Restricted Subsidiaries or
    any affiliated joint venture otherwise permitted by the
    Indenture made or given by the Issuer or any Restricted
    Subsidiary of the Issuer in the ordinary course of business and
    pursuant to a written agreement having a period not to exceed
    five years or (2)&#160;guarantees by the Issuer or any
    Restricted Subsidiary of the Issuer of leases and loans to
    acquire property (real or personal) for or on behalf of a
    physician or healthcare professional providing service to
    patients in the service area of a healthcare facility operated
    by the Issuer, any of its Restricted Subsidiaries or any
    affiliated joint venture otherwise permitted by the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;PIK Interest&#148;</I> has the meaning set forth under
    &#147;Principal, Maturity and Interest&#160;&#151; Toggle
    Notes.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;PIK Notes&#148;</I> has the meaning set forth under
    &#147;Principal, Maturity and Interest.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;PIK Payment&#148;</I> has the meaning set forth under
    &#147;Principal, Maturity and Interest.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Plan of Reorganization&#148;</I> means any plan of
    reorganization, plan of liquidation, agreement for composition,
    or other type of plan of arrangement proposed in or in
    connection with any insolvency or liquidation proceeding.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    112
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Preferred Stock&#148;</I> means any Equity Interest
    with preferential rights of payment of dividends or upon
    liquidation, dissolution or winding up.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Principal Property&#148;</I> means each acute care
    hospital providing general medical and surgical services
    (excluding equipment, personal property and hospitals that
    primarily provide specialty medical services, such as
    psychiatric and obstetrical and gynecological services) owned
    solely by the Issuer
    <FONT style="white-space: nowrap">and/or</FONT> one
    or more of its Subsidiaries (used in this definition as defined
    in the Existing Notes Indenture) and located in the
    United&#160;States of America.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Priority Lien Obligations&#148;</I> means,
    collectively, ABL Obligations and First Lien Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Priority Lien Secured Parties&#148;</I> means,
    collectively, the ABL Secured Parties and the First Lien Secured
    Parties.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Purchase Money Obligations&#148;</I> means any
    Indebtedness incurred to finance or refinance the acquisition,
    leasing, construction or improvement of property (real or
    personal) or assets (other than Capital Stock), and whether
    acquired through the direct acquisition of such property or
    assets, or otherwise.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Qualified Proceeds&#148;</I> means assets that are used
    or useful in, or Capital Stock of any Person engaged in, a
    Similar Business; <I>provided </I>that the fair market value of
    any such assets or Capital Stock shall be determined by the
    Issuer in good faith.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Rating Agencies&#148;</I> means Moody&#146;s and
    S&#038;P or if Moody&#146;s or S&#038;P or both shall not make a
    rating on the Notes publicly available, a nationally recognized
    statistical rating agency or agencies, as the case may be,
    selected by the Issuer which shall be substituted for
    Moody&#146;s or S&#038;P or both, as the case may be.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Receivables Facility&#148;</I> means any of one or more
    receivables financing facilities as amended, supplemented,
    modified, extended, renewed, restated or refunded from time to
    time, the Obligations of which are non-recourse (except for
    customary representations, warranties, covenants and indemnities
    made in connection with such facilities) to the Issuer or any of
    its Restricted Subsidiaries (other than a Receivables
    Subsidiary) pursuant to which the Issuer or any of its
    Restricted Subsidiaries purports to sell its accounts receivable
    to either (a)&#160;a Person that is not a Restricted Subsidiary
    or (b)&#160;a Receivables Subsidiary that in turn funds such
    purchase by purporting to sell its accounts receivable to a
    Person that is not a Restricted Subsidiary or by borrowing from
    such a Person or from another Receivables Subsidiary that in
    turn funds itself by borrowing from such a Person.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Receivables Fees&#148;</I> means distributions or
    payments made directly or by means of discounts with respect to
    any accounts receivable or participation interest therein issued
    or sold in connection with, and other fees paid to a Person that
    is not a Restricted Subsidiary in connection with any
    Receivables Facility.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Receivables Subsidiary&#148;</I> means any Subsidiary
    formed for the purpose of facilitating or entering into one or
    more Receivables Facilities, and in each case engages only in
    activities reasonably related or incidental thereto.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Redemption&#160;Date&#148;</I> has the meaning set
    forth under &#147;Optional Redemption&#160;&#151; Cash Pay
    Notes.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Registration Rights Agreement&#148;</I> means the
    Registration Rights Agreement related to the Notes, dated as of
    the Issue Date, among the Issuer, the Guarantors and the Initial
    Purchasers.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Related Business Assets&#148;</I> means assets (other
    than cash or Cash Equivalents) used or useful in a Similar
    Business; <I>provided </I>that any assets received by the Issuer
    or a Restricted Subsidiary in exchange for assets transferred by
    the Issuer or a Restricted Subsidiary will not be deemed to be
    Related Business Assets if they consist of securities of a
    Person, unless upon receipt of the securities of such Person,
    such Person would become a Restricted Subsidiary.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Restricted Investment&#148;</I> means an Investment
    other than a Permitted Investment.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Restricted Subsidiary&#148;</I> means, at any time, any
    direct or indirect Subsidiary of the Issuer (including any
    Foreign Subsidiary) that is not then an Unrestricted Subsidiary;
    <I>provided</I>, <I>however</I>, that upon an Unrestricted
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    113
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Subsidiary&#146;s ceasing to be an Unrestricted Subsidiary, such
    Subsidiary shall be included in the definition of
    &#147;Restricted Subsidiary.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;S&#038;P&#148;</I> means Standard&#160;&#038;
    Poor&#146;s, a division of The McGraw-Hill Companies, Inc., and
    any successor to its rating agency business.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Sale and Lease-Back Transaction&#148;</I> means any
    arrangement providing for the leasing by the Issuer or any of
    its Restricted Subsidiaries of any real or tangible personal
    property, which property has been or is to be sold or
    transferred by the Issuer or such Restricted Subsidiary to a
    third Person in contemplation of such leasing.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;SEC&#148;</I> means the U.S.&#160;Securities and
    Exchange Commission.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Secured Indebtedness&#148;</I> means any Indebtedness
    of the Issuer or any of its Restricted Subsidiaries secured by a
    Lien.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Securities Act&#148;</I> means the Securities Act of
    1933, as amended, and the rules and regulations of the SEC
    promulgated thereunder.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Security Documents&#148;</I> means, collectively, the
    Intercreditor Agreements, the security agreements relating to
    the Collateral and the mortgages and instruments filed and
    recorded in appropriate jurisdictions to preserve and protect
    the Liens on the Collateral (including, without limitation,
    financing statements under the Uniform Commercial Code of the
    relevant states) applicable to the Collateral, each as in effect
    on the Issue Date and as amended, amended and restated,
    modified, renewed or replaced from time to time.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Senior Credit Facilities&#148;</I> means the ABL
    Facility and the General Credit Facility.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Senior Indebtedness&#148;</I> means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;all Indebtedness of the Issuer or any Guarantor
    outstanding under the Senior Credit Facilities or Notes and
    related Guarantees (including interest accruing on or after the
    filing of any petition in bankruptcy or similar proceeding or
    for reorganization of the Issuer or any Guarantor (at the rate
    provided for in the documentation with respect thereto,
    regardless of whether or not a claim for post-filing interest is
    allowed in such proceedings)), and any and all other fees,
    expense reimbursement obligations, indemnification amounts,
    penalties, and other amounts (whether existing on the Issue Date
    or thereafter created or incurred) and all obligations of the
    Issuer or any Guarantor to reimburse any bank or other Person in
    respect of amounts paid under letters of credit, acceptances or
    other similar instruments;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;all Hedging Obligations (and guarantees thereof) owing
    to a Lender (as defined in the Senior Credit Facilities) or any
    Affiliate of such Lender (or any Person that was a Lender or an
    Affiliate of such Lender at the time the applicable agreement
    giving rise to such Hedging Obligation was entered into);
    <I>provided </I>that such Hedging Obligations are permitted to
    be incurred under the terms of the Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;any other Indebtedness of the Issuer or any Guarantor
    permitted to be incurred under the terms of the Indenture,
    unless the instrument under which such Indebtedness is incurred
    expressly provides that it is subordinated in right of payment
    to the Notes or any related Guarantee;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;all Obligations with respect to the items listed in the
    preceding clauses (1), (2)&#160;and (3);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided</I>, <I>however</I>, that Senior Indebtedness shall
    not include:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;any obligation of such Person to the Issuer or any of
    its Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;any liability for federal, state, local or other taxes
    owed or owing by such Person;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;any accounts payable or other liability to trade
    creditors arising in the ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;any Indebtedness or other Obligation of such Person
    which is subordinate or junior in any respect to any other
    Indebtedness or other Obligation of such Person;&#160;or
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    114
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;that portion of any Indebtedness which at the time of
    incurrence is incurred in violation of the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Separate Receivables Collateral&#148;</I> has the
    meaning set forth under &#147;Description of Other
    Indebtedness&#160;&#151; Senior Secured Credit
    Facilities&#160;&#151; Guarantee and Security.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Shared Receivables Collateral&#148;</I> has the meaning
    set forth under &#147;Description of Other
    Indebtedness&#160;&#151; Senior Secured Credit
    Facilities&#160;&#151; Guarantee and Security.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Shared Receivables Intercreditor Agreement&#148;</I>
    has the meaning set forth under &#147;Security&#160;&#151; Liens
    with Respect to Shared Receivables Collateral.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Significant Subsidiary&#148;</I> means any Restricted
    Subsidiary that would be a &#147;significant subsidiary&#148; as
    defined in Article&#160;1,
    <FONT style="white-space: nowrap">Rule&#160;1-02</FONT>
    of
    <FONT style="white-space: nowrap">Regulation&#160;S-X,</FONT>
    promulgated pursuant to the Securities Act, as such regulation
    is in effect on the Issue Date.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Similar Business&#148;</I> means any business conducted
    or proposed to be conducted by the Issuer and its Restricted
    Subsidiaries on the Issue Date or any business that is similar,
    reasonably related, incidental or ancillary thereto.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Sponsor Management Agreement&#148;</I> means the
    management agreement between certain of the management companies
    associated with the Investors, the Frist Entities and the Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Subordinated Indebtedness&#148;</I> means, with respect
    to the Notes,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any Indebtedness of the Issuer which is by its terms
    subordinated in right of payment to the Notes,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any Indebtedness of any Guarantor which is by its terms
    subordinated in right of payment to the Guarantee of such entity
    of the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Subsidiary&#148;</I> means, with respect to any Person:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any corporation, association, or other business entity
    (other than a partnership, joint venture, limited liability
    company or similar entity) of which more than 50% of the total
    voting power of shares of Capital Stock entitled (without regard
    to the occurrence of any contingency) to vote in the election of
    directors, managers or trustees thereof is at the time of
    determination owned or controlled, directly or indirectly, by
    such Person or one or more of the other Subsidiaries of that
    Person or a combination thereof or is consolidated under GAAP
    with such Person at such time;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any partnership, joint venture, limited liability
    company or similar entity of which
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (x)&#160;more than 50% of the capital accounts, distribution
    rights, total equity and voting interests or general or limited
    partnership interests, as applicable, are owned or controlled,
    directly or indirectly, by such Person or one or more of the
    other Subsidiaries of that Person or a combination thereof
    whether in the form of membership, general, special or limited
    partnership or otherwise,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (y)&#160;such Person or any Restricted Subsidiary of such Person
    is a controlling general partner or otherwise controls such
    entity.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Total Assets&#148;</I> means the total assets of the
    Issuer and its Restricted Subsidiaries on a consolidated basis,
    as shown on the most recent consolidated balance sheet of the
    Issuer or such other Person as may be expressly stated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Transaction&#148;</I> means the transactions
    contemplated by the Transaction Agreement, the issuance of the
    Notes and borrowings under the Senior Credit Facilities as in
    effect on the Issue Date.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Transaction Agreement&#148;</I> means the Agreement and
    Plan of Merger, dated as of July&#160;24, 2006, between Hercules
    Holding II, LLC, Hercules Acquisition Corporation and the
    Issuer, as amended prior to the Issue Date.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    115
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Treasury Rate&#148;</I> means, as of any
    Redemption&#160;Date, the yield to maturity as of such
    Redemption&#160;Date of United States Treasury securities with a
    constant maturity (as compiled and published in the most recent
    Federal Reserve Statistical Release H.15 (519)&#160;that has
    become publicly available at least two Business Days prior to
    the Redemption&#160;Date (or, if such Statistical Release is no
    longer published, any publicly available source of similar
    market data)) most nearly equal to the period from the
    Redemption&#160;Date to November&#160;15, 2010 with respect to
    the 2014 Cash Pay Notes and November&#160;15, 2011 with respect
    to the 2016 Cash Pay Notes and the Toggle Notes;
    <I>provided</I>, <I>however</I>, that if the period from the
    Redemption&#160;Date to November&#160;15, 2010 with respect to
    the 2014 Cash Pay Notes and November&#160;15, 2011 with respect
    to the 2016 Cash Pay Notes and the Toggle Notes is less than one
    year, the weekly average yield on actually traded United States
    Treasury securities adjusted to a constant maturity of one year
    will be used.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Trust&#160;Indenture Act&#148;</I> means the
    Trust&#160;Indenture Act of 1939, as amended (15&#160;U.S.C.
    <FONT style="white-space: nowrap">&#167;&#167;&#160;77aaa-777bbbb).</FONT>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Unrestricted Subsidiary&#148;</I> means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any Subsidiary of the Issuer which at the time of
    determination is an Unrestricted Subsidiary (as designated by
    the Issuer, as provided below);&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any Subsidiary of an Unrestricted Subsidiary.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer may designate any Subsidiary of the Issuer (including
    any existing Subsidiary and any newly acquired or newly formed
    Subsidiary) to be an Unrestricted Subsidiary unless such
    Subsidiary or any of its Subsidiaries owns any Equity Interests
    or Indebtedness of, or owns or holds any Lien on, any property
    of, the Issuer or any Subsidiary of the Issuer (other than
    solely any Subsidiary of the Subsidiary to be so designated);
    <I>provided </I>that
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any Unrestricted Subsidiary must be an entity of which
    the Equity Interests entitled to cast at least a majority of the
    votes that may be cast by all Equity Interests having ordinary
    voting power for the election of directors or Persons performing
    a similar function are owned, directly or indirectly, by the
    Issuer;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;such designation complies with the covenants described
    under &#147;Certain Covenants&#160;&#151; Limitation on
    Restricted Payments&#148;;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;each of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;the Subsidiary to be so designated;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;its Subsidiaries has not at the time of designation,
    and does not thereafter, create, incur, issue, assume, guarantee
    or otherwise become directly or indirectly liable with respect
    to any Indebtedness pursuant to which the lender has recourse to
    any of the assets of the Issuer or any Restricted Subsidiary.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer may designate any Unrestricted Subsidiary to be a
    Restricted Subsidiary; <I>provided</I> that, immediately after
    giving effect to such designation, no Default shall have
    occurred and be continuing and either:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the Issuer could incur at least $1.00 of additional
    Indebtedness pursuant to the Fixed Charge Coverage Ratio test
    described in the first paragraph under &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred
    Stock&#148;;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the Fixed Charge Coverage Ratio for the Issuer and its
    Restricted Subsidiaries would be greater than such ratio for the
    Issuer and its Restricted Subsidiaries immediately prior to such
    designation, in each case on a <I>pro forma </I>basis taking
    into account such designation.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any such designation by the Issuer shall be notified by the
    Issuer to the Trustee by promptly filing with the Trustee a copy
    of the resolution of the board of directors of the Issuer or any
    committee thereof giving effect to such designation and an
    Officer&#146;s Certificate certifying that such designation
    complied with the foregoing provisions.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Voting Stock&#148;</I> of any Person as of any date
    means the Capital Stock of such Person that is at the time
    entitled to vote in the election of the board of directors of
    such Person.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    116
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Weighted Average Life to Maturity&#148;</I> means, when
    applied to any Indebtedness, Disqualified Stock or Preferred
    Stock, as the case may be, at any date, the quotient obtained by
    dividing:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the sum of the products of the number of years from the
    date of determination to the date of each successive scheduled
    principal payment of such Indebtedness or redemption or similar
    payment with respect to such Disqualified Stock or Preferred
    Stock multiplied by the amount of such payment; by
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the sum of all such payments.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Wholly-Owned Subsidiary&#148;</I> of any Person means a
    Subsidiary of such Person, 100% of the outstanding Equity
    Interests of which (other than directors&#146; qualifying
    shares) shall at the time be owned by such Person or by one or
    more Wholly-Owned Subsidiaries of such Person.
</DIV>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Senior
    Secured Notes Issued Under the 2009 Second Lien
    Indenture</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    HCA Inc. has issued senior secured notes as described below
    under an indenture, dated as of February&#160;19, 2009, among
    the Issuer, the Guarantors, The Bank of New York Mellon as
    collateral agent and The Bank of New York Mellon
    Trust&#160;Company, N.A., as trustee. Terms used in this
    &#147;&#151;&#160;Senior Secured Notes Issued Under the 2009
    Second Lien Indenture&#148; apply only to the Notes described
    herein.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">General</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Certain terms used in this description are defined under the
    subheading &#147;Certain Definitions.&#148; In this description,
    the terms <I>&#147;we</I>,&#148; <I>&#147;our,&#148;</I>
    <I>&#147;us&#148;</I> and <I>&#147;the Company&#148;</I> each
    refer to HCA Inc. (the <I>&#147;Issuer&#148;</I>) and its
    consolidated Subsidiaries.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer issued $310.0&#160;million aggregate principal amount
    of
    9<FONT style="vertical-align: text-top; font-size: 70%;">7</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;senior
    secured notes due 2017 (the <I>&#147;Notes&#148;</I>) under an
    indenture dated as of February&#160;19, 2009 (the
    <I>&#147;Indenture&#148;</I>) among the Issuer, the Guarantors
    and The Bank of New York Mellon Trust&#160;Company, N.A., as
    trustee (the <I>&#147;Trustee&#148;</I>). The Notes were issued
    in a private transaction that was not subject to the
    registration requirements of the Securities Act. Except as set
    forth herein, the terms of the Notes are substantially identical
    and include those stated in the Indenture and those made part of
    the Indenture by reference to the Trust&#160;Indenture Act.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The following description is only a summary of the material
    provisions of the Indenture, does not purport to be complete and
    is qualified in its entirety by reference to the provisions of
    those agreements, including the definitions therein of certain
    terms used below. We urge you to read the Indenture because it,
    and not this description, will define your rights as Holders of
    the Notes.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Brief
    Description of Notes</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Notes:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    are general senior obligations of the Issuer;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    are secured on a second-priority basis, equally and ratably with
    the 2006 Notes and all future obligations of the Issuer and the
    Guarantors under any future Junior Lien Obligations, by all of
    the assets of the Issuer and the Guarantors which are not
    Principal Properties and which secure the General Credit
    Facility (other than the European Collateral), subject to the
    Liens securing the Issuer&#146;s and the Guarantors&#146;
    obligations under the General Credit Facility and any other
    Priority Lien Obligations and other Permitted Liens;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    are secured on a third-priority basis, equally and ratably with
    the 2006 Notes and all future obligations of the Issuer and the
    Guarantors under any future Junior Lien Obligations, by all of
    the assets of the Issuer and the Guarantors securing the ABL
    Facility which also secure the General Credit Facility, subject
    to the Liens securing the Issuer&#146;s and the Guarantors&#146;
    obligations under the Senior Credit Facilities and any other
    Priority Lien Obligations and other Permitted Liens;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    are effectively subordinated, to the extent of the value of the
    assets securing such Indebtedness (which, in any event, exclude
    the European Collateral, which does not secure the Notes), to
    the Issuer&#146;s and the
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    117
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>
</TD>
    <TD align="left">
    Guarantors&#146; obligations under the General Credit Facility
    and any future Priority Lien Obligations, that will be secured
    (A)&#160;on a first-priority basis by the same assets of the
    Issuers and the Guarantors that secure the Notes and by certain
    other assets of the Issuer and the Guarantors, including the
    Principal Properties, that do not secure the Notes and
    (B)&#160;on a second-priority basis by the Shared Receivables
    Collateral;
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    are effectively subordinated to the Issuer&#146;s and the
    Guarantors&#146; obligations under the ABL Facility, to the
    extent of the value of the Shared Receivables Collateral;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    are effectively subordinated to any obligations secured by
    Permitted Liens, to the extent of the value of the assets of the
    Issuer and the Guarantors subject to those Permitted Liens;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    are structurally subordinated to any existing and future
    indebtedness and liabilities of non-guarantor Subsidiaries,
    including the ABL Financing Entities and the Issuer&#146;s
    Foreign Subsidiaries and any Unrestricted Subsidiaries;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    rank equally in right of payment with all existing and future
    senior Indebtedness of the Issuer and the Guarantors but, to the
    extent of the value of the Collateral, will be effectively
    senior to all of the Issuer&#146;s and the Guarantors&#146;
    unsecured senior Indebtedness (including the Existing Notes);
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    are senior in right of payment to any future Subordinated
    Indebtedness (as defined with respect to the Notes) of the
    Issuer;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    are initially unconditionally guaranteed on a joint and several
    and senior basis by each Restricted Subsidiary that guarantees
    the General Credit Facility (other than any Foreign
    Subsidiary);&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    are subject to registration with the SEC pursuant to the
    Registration Rights Agreement.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Guarantees</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Guarantors, as primary obligors and not merely as sureties,
    jointly and severally fully and unconditionally guaranteed, on a
    senior basis, the performance and full and punctual payment when
    due, whether at maturity, by acceleration or otherwise, of all
    obligations of the Issuer under the Indenture and the Notes,
    whether for payment of principal of, premium, if any, or
    interest or Additional Interest in respect of the Notes,
    expenses, indemnification or otherwise, on the terms set forth
    in the Indenture by executing the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Restricted Subsidiaries which guarantee the General Credit
    Facility guarantee the Notes. Each of the Guarantees of the
    Notes is a general senior obligation of each Guarantor and is
    secured by a second-priority lien on all of the assets of each
    Guarantor which secure the General Credit Facility and which are
    not Principal Properties and by a third-priority lien on all of
    the assets of each Guarantor which secure the ABL Facility. The
    Guarantees rank equally in right of payment with all existing
    and future senior Indebtedness of the Guarantor but, to the
    extent of the value of the Collateral, are effectively senior to
    all of the Guarantor&#146;s unsecured senior Indebtedness and,
    to the extent of the Collateral, are effectively subordinated to
    the Guarantor&#146;s Obligations under the Senior Credit
    Facilities and any future Priority Lien Obligations. The
    Guarantees are senior in right of payment to all existing and
    future Subordinated Indebtedness of each Guarantor. The Notes
    are structurally subordinated to Indebtedness and other
    liabilities of Subsidiaries of the Issuer that do not Guarantee
    the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Not all of the Issuer&#146;s Subsidiaries Guarantee the Notes.
    In the event of a bankruptcy, liquidation or reorganization of
    any of these non-guarantor Subsidiaries, the non-guarantor
    Subsidiaries will pay the holders of their debt and their trade
    creditors before they will be able to distribute any of their
    assets to the Issuer. None of our Subsidiaries which are
    &#147;Restricted Subsidiaries&#148; for purposes of the Existing
    Notes Indenture, Foreign Subsidiaries, ABL Financing Entities,
    non-Wholly Owned Subsidiaries or any Receivables Subsidiaries
    will guarantee the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On an as adjusted basis after giving effect to our offering of
    $1.500&#160;billion aggregate principal amount of first lien
    notes in April 2009 and the use of proceeds therefrom, our
    non-guarantor subsidiaries would have
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    118
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    accounted for approximately $11.867&#160;billion, or 41.8%, of
    our total revenues for the year ended December&#160;31, 2008,
    approximately $3.038&#160;billion, or 40.9%, of our total
    revenues for the three months ended March&#160;31, 2009,
    approximately $9.876&#160;billion, or 40.7%, of our total
    assets, and approximately $7.517&#160;billion, or 22.5%, of our
    total liabilities, in each case, as of December&#160;31, 2008,
    and approximately $9.817&#160;billion, or 40.4%, of our total
    assets, and approximately $7.224&#160;billion, or 21.9%, of our
    total liabilities, in each case, as of March&#160;31, 2009.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The obligations of each Guarantor under its Guarantee are
    limited as necessary to prevent the Guarantee from constituting
    a fraudulent conveyance under applicable law.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any entity that makes a payment under its Guarantee is entitled
    upon payment in full of all guaranteed obligations under the
    Indenture to a contribution from each other Guarantor in an
    amount equal to such other Guarantor&#146;s pro rata portion of
    such payment based on the respective net assets of all the
    Guarantors at the time of such payment determined in accordance
    with GAAP.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If a Guarantee were rendered voidable, it could be subordinated
    by a court to all other indebtedness (including guarantees and
    other contingent liabilities) of the Guarantor, and, depending
    on the amount of such indebtedness, a Guarantor&#146;s liability
    on its Guarantee could be reduced to zero. See &#147;Risk
    Factors&#160;&#151; Risks Related to the Notes&#160;&#151;
    Federal and state fraudulent transfer laws may permit a court to
    void the notes, and with respect to the senior secured notes,
    the guarantees, and, if that occurs, you may not receive any
    payment on the notes.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each Guarantee by a Guarantor provides by its terms that it will
    be automatically and unconditionally released and discharged
    upon:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;(a)&#160;any sale, exchange or transfer (by merger or
    otherwise) of the Capital Stock of such Guarantor (including any
    sale, exchange or transfer), after which the applicable
    Guarantor is no longer a Restricted Subsidiary or all or
    substantially all the assets of such Guarantor, which sale,
    exchange or transfer is made in compliance with the applicable
    provisions of the Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the release or discharge of the guarantee by such
    Guarantor of the Senior Credit Facilities or such other
    guarantee that resulted in the creation of such Guarantee,
    except a discharge or release by or as a result of payment under
    such guarantee;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;the designation of any Restricted Subsidiary that is a
    Guarantor as an Unrestricted Subsidiary in compliance with the
    applicable provisions of the Indenture;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;the exercise by the Issuer of its legal defeasance
    option or covenant defeasance option as described under
    &#147;Legal Defeasance and Covenant Defeasance&#148; or the
    discharge of the Issuer&#146;s obligations under the Indenture
    in accordance with the terms of the Indenture;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;such Guarantor delivering to the Trustee an
    Officer&#146;s Certificate and an Opinion of Counsel, each
    stating that all conditions precedent provided for in the
    Indenture relating to such transaction have been complied with.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Holding
    Company Structure</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer is a holding company for its Subsidiaries, with no
    material operations of its own and only limited assets.
    Accordingly, the Issuer is dependent upon the distribution of
    the earnings of its Subsidiaries, whether in the form of
    dividends, advances or payments on account of intercompany
    obligations, to service its debt obligations.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Security</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">General</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Notes and the Guarantees are secured by perfected
    second-priority security interests in the Non-Receivables
    Collateral (second in priority to the Liens on the
    Non-Receivables Collateral securing the First Lien Obligations)
    and by perfected third-priority security interests in the Shared
    Receivables Collateral (third
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    119
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    in priority to the first-priority and second-priority Liens on
    the Shared Receivables Collateral securing the ABL Obligations
    and the First Lien Obligations, respectively), in each case,
    equally and ratably with the 2006 Notes and subject to Permitted
    Liens. Notwithstanding the foregoing, neither the Notes nor the
    Guarantees are secured by the European Collateral or the
    Separate Receivables Collateral and, until after the Discharge
    of the First Lien Obligations, the Notes and the Guarantees will
    not be secured by any Principal Properties. Upon the Discharge
    of First Lien Obligations and so long as no First Lien
    Obligations are outstanding, the Principal Properties that
    constituted &#147;Collateral&#148; under the First Lien Security
    Documents Facility will become Collateral with respect to the
    Notes, subject to the same limitation on the amount of
    Obligations secured thereby as contained in the First Lien
    Security Documents. See also &#147;&#151;&#160;Certain
    Limitations on the Collateral&#148; below. Priority Lien Secured
    Parties have rights and remedies with respect to the Collateral
    that, if exercised, could adversely affect the value of the
    Collateral or the ability of the respective agents under the
    Intercreditor Agreements to realize or foreclose on the
    Collateral on behalf of holders of the Notes. For a description
    of the Shared Receivables Collateral and the Non-Receivables
    Collateral, see &#147;Description of Other
    Indebtedness&#160;&#151; Senior Secured Credit
    Facilities&#160;&#151; Guarantee and Security.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer and the Guarantors are and will be able to incur
    additional Indebtedness in the future which could share in the
    Collateral, including additional First Lien Obligations,
    additional ABL Obligations, additional Junior Lien Obligations
    and Obligations secured by Permitted Liens. The amount of such
    additional Obligations is and will be limited by the covenant
    described under &#147;Certain Covenants&#160;&#151; Liens&#148;
    and the covenant described under &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock.&#148;
    Under certain circumstances, the amount of any such additional
    Obligations could be significant.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">After-Acquired
    Collateral</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    From and after the Issue Date and subject to certain limitations
    and exceptions, (a)&#160;if the Issuer or any Guarantor creates
    any additional security interest upon any property or asset that
    would constitute Collateral to secure any First Lien Obligations
    (other than Principal Properties prior to the Discharge of First
    Lien Obligations and so long as no First Lien Obligations are
    outstanding and other than European Collateral and Separate
    Receivables Collateral), it must concurrently grant a
    second-priority perfected security interest (subject to
    Permitted Liens) upon such property as security for the Notes
    and (b)&#160;if the Issuer or any Guarantor creates any
    additional security interest upon any property or asset that
    would constitute Shared Receivables Collateral to secure any
    Priority Lien Obligations, it must concurrently grant a
    third-priority perfected security interest (subject to Permitted
    Liens) upon such property as security for the Notes.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Liens
    with Respect to the Collateral</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <I><FONT style="font-family: 'Times New Roman', Times">Security
    Documents and Intercreditor Agreements</FONT></I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer, the Guarantors and the Junior Lien Collateral Agent
    entered into Security Documents in connection with the 2006
    Notes with respect to the Collateral defining the terms of the
    security interests that secure the 2006 Notes and the Guarantees
    with respect to such Collateral and that will define the terms
    of the security interests that secure the Notes and the
    Guarantees with respect to such collateral. These security
    interests will secure the payment and performance when due of
    all of the Obligations of the Issuers and the Guarantors under
    the Notes, the Indenture, the Guarantees and the Security
    Documents, as provided in the Security Documents.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Junior Lien Collateral Agent and the First Lien Collateral
    Agent entered into a joinder to the General Intercreditor
    Agreement dated as of November&#160;17, 2006 by and among the
    trustee under the 2006 Notes and the administrative agent under
    the General Credit Facility (as the same may be amended from
    time to time, the <I>&#147;General Intercreditor
    Agreement&#148;</I>) with respect to the Collateral. The First
    Lien Collateral Agent is initially the Collateral Agent under
    the General Credit Facility. The Junior Lien Collateral Agent is
    initially the trustee under the 2006 Notes. Pursuant to the
    terms of the General Intercreditor Agreement, prior to the
    Discharge of First Lien Obligations, the First Lien Collateral
    Agent, acting on behalf of the First Lien Secured Parties, will
    determine the time and method by which the security interests in
    the Collateral will be enforced
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    120
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    and will have the sole and exclusive right to manage, perform
    and enforce the terms of the Security Documents relating to the
    Collateral and to exercise and enforce all privileges, rights
    and remedies thereunder according to its direction, including to
    take or retake control or possession of such Collateral and to
    hold, prepare for sale, marshall, process, sell, lease, dispose
    of or liquidate such Collateral, including, without limitation,
    following the occurrence of a Default or Event of Default under
    the Indenture. The Junior Lien Collateral Agent will not be
    permitted to enforce the security interests even if any Event of
    Default under the Indenture has occurred and the Notes have been
    accelerated except (a)&#160;in any insolvency or liquidation
    proceeding, solely as necessary to file a proof of claim or
    statement of interest with respect to the Junior Lien
    Obligations or (b)&#160;as necessary to take any action in order
    to prove, preserve, perfect or protect (but not enforce) its
    security interest and rights in, and the perfection and priority
    of its Lien on, the Collateral. See &#147;Risk
    Factors&#160;&#151; Risks Related to the Notes&#160;&#151; The
    lien ranking provisions of the Indenture and other agreements
    relating to the collateral securing the notes will limit the
    rights of holders of the notes with respect to that collateral,
    even during an event of default.&#148; After the Discharge of
    First Lien Obligations, the Junior Lien Collateral Agent in
    accordance with the provisions of the Junior Lien Documents will
    distribute all cash proceeds (after payment of the costs of
    enforcement and collateral administration and any other amounts
    owed to the Junior Lien Collateral Agent) of the Collateral
    received by it under the Security Documents for the ratable
    benefit of the holders of Junior Lien Obligations. The proceeds
    from the sale of the Collateral remaining after the satisfaction
    of all First Lien Obligations may not be sufficient to satisfy
    the Junior Lien Obligations. By its nature some or all of the
    Collateral is and will be illiquid and may have no readily
    ascertainable market value. Accordingly, the Collateral may not
    be able to be sold in a short period of time, if salable. See
    &#147;Risk Factors &#151;&#160;Risks Related to the
    Notes&#160;&#151; The value of the collateral securing the notes
    may not be sufficient to satisfy our obligations under the
    notes.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Junior Lien Collateral Agent, for itself and on behalf of
    each Junior Lien Secured Party, has agreed pursuant to the
    General Intercreditor Agreement that (a)&#160;it will not (and
    thereby waives any right to) take any action to challenge,
    contest or support any other Person in contesting or
    challenging, directly or indirectly, in any proceeding
    (including any insolvency or liquidation proceeding), the
    validity, perfection, priority or enforceability of a Lien
    securing any First Lien Obligations held (or purported to be
    held) by or on behalf of the First Lien Collateral Agent or any
    of the First Lien Secured Parties or any agent or trustee
    therefor in any Collateral or other First Lien Collateral and
    (b)&#160;it will not oppose or otherwise contest (or support any
    other Person contesting) any request for judicial relief made in
    any court by the First Lien Collateral Agent or any First Lien
    Secured Parties relating to the lawful enforcement of any First
    Priority Lien on Collateral or other First Lien Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, the Security Documents provide that, prior to the
    Discharge of First Lien Obligations, (1)&#160;the First Lien
    Collateral Agent may take actions with respect to the Collateral
    (including the release of Collateral and the manner of
    realization (subject to the provisions described under
    &#147;&#151;&#160;Release of Collateral&#148;)) without the
    consent of the Junior Lien Collateral Agent or other Junior Lien
    Secured Parties and (2)&#160;the Issuer and the Guarantors may
    require the Junior Lien Collateral Agent to agree to modify the
    Security Documents, or the General Intercreditor Agreement,
    without the consent of the Junior Lien Collateral Agent or other
    Junior Lien Secured Parties, to secure additional extensions of
    credit and add additional First Lien Secured Parties or Junior
    Lien Secured Parties so long as such modifications do not
    expressly violate the provisions of the General Credit Facility
    or the Indenture. In addition, the General Intercreditor
    Agreement provides that with respect to Collateral in the event
    that the First Lien Collateral Agent or the First Lien Secured
    Parties enter into any amendment, waiver or consent in respect
    of or replace any of the First Lien Security Documents for the
    purpose of adding to, or deleting from, or waiving or consenting
    to any departures from any provisions of, any First Lien
    Security Document or changing in any manner the rights of the
    First Lien Collateral Agent, the First Lien Secured Parties, the
    Issuer or any Guarantor thereunder (including the release of any
    Liens in Collateral in accordance with the provisions described
    under &#147;&#151;&#160;Release of Collateral&#148;), then such
    amendment, waiver or consent shall apply automatically to any
    comparable provision of each comparable Security Document in
    favor of the Junior Lien Obligations without the consent of the
    Junior Lien Collateral Agent, any Junior Lien Representative or
    any Junior Lien Secured Party and without any action by the
    Junior Lien Collateral Agent, any Junior Lien Representative,
    the Issuer or any Guarantor; <I>provided </I>that such
    amendment, waiver or consent does not materially adversely
    affect the rights of the Junior Lien Secured Parties or the
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    121
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    interests of the Junior Lien Secured Parties in the Collateral
    in a manner materially different from that affecting the rights
    of the First Lien Secured Parties thereunder or therein. Any
    provider of additional extensions of credit shall be entitled to
    rely on the determination of an Officer that such modifications
    do not expressly violate the provisions of the General Credit
    Facility or the Indenture if such determination is set forth in
    an Officer&#146;s Certificate delivered to such provider.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    So long as the Discharge of First Lien Obligations has not
    occurred, the Collateral or proceeds thereof received in
    connection with the sale or other disposition of, or collection
    on, such Non-Receivables Collateral upon the exercise of
    remedies will be applied by the First Lien Collateral Agent to
    the First Lien Obligations in such order as specified in the
    relevant First Lien Documents until the Discharge of First Lien
    Obligations has occurred. Upon the Discharge of First Lien
    Obligations, the First Lien Collateral Agent shall deliver to
    the Junior Lien Collateral Agent (for the benefit of all Junior
    Lien Secured Parties) any remaining proceeds of Collateral held
    by it in the same form as received, with any necessary
    endorsements or as a court of competent jurisdiction may
    otherwise direct to be applied by the Junior Lien Collateral
    Agent to the Junior Lien Obligations in such order as specified
    in the Junior Lien Documents.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, so long as the Discharge of First Lien Obligations
    has not occurred, neither the Junior Lien Collateral Agent nor
    any Junior Lien Representative shall acquire or hold any Lien on
    any assets of the Issuer or any Subsidiary (and neither the
    Issuer nor any Subsidiary shall grant such Lien) securing any
    Junior Lien Obligations that are not also subject to the First
    Priority Lien in respect of the First Lien Obligations under the
    First Lien Documents. If the Junior Lien Collateral Agent or any
    Junior Lien Representative shall acquire or hold any Lien on any
    assets of the Issuer or any Subsidiary that is not also subject
    to the First Priority Lien in respect of the First Lien
    Obligations under the First Lien Documents, then such Junior
    Lien Collateral Agent or other Junior Lien Representative shall,
    without the need for any further consent of any party and
    notwithstanding anything to the contrary in any other document,
    be deemed to also hold and have held such Lien for the benefit
    of the First Lien Collateral Agent as security for the First
    Lien Obligations (subject to the lien priority and other terms
    hereof).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Junior Lien Collateral Agent and each other Junior Lien
    Secured Party have agreed that any Lien purported to be granted
    on any Collateral as security for First Lien Obligations shall
    be deemed to be and shall be deemed to remain senior in all
    respects and prior to all Liens on the Collateral securing any
    Junior Lien Obligations for all purposes regardless of whether
    the Lien purported to be granted is found to be improperly
    granted, improperly perfected, preferential, a fraudulent
    conveyance or legally or otherwise deficient or invalid, in
    whole or in part, in any manner.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any Collateral or proceeds thereof received by any Junior Lien
    Secured Party at a time when such receipt is not expressly
    permitted by the terms of the General Intercreditor Agreement or
    prior to the Discharge of First Lien Obligations shall be
    segregated and held in trust for the benefit of and forthwith
    paid over to the First Lien Collateral Agent (and/or its
    designees) for the benefit of the First Lien Secured Parties in
    the same form as received, with any necessary endorsements or as
    a court of competent jurisdiction may otherwise direct.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If any First Lien Secured Party is required in any insolvency or
    liquidation proceeding or otherwise to turn over or otherwise
    pay to the estate of the Issuer or any other Guarantor (or any
    trustee, receiver or similar person therefor), because the
    payment of such amount was declared to be fraudulent or
    preferential in any respect or for any other reason, any amount
    (a <I>&#147;Recovery&#148;</I>), whether received as proceeds of
    security, enforcement of any right of setoff or otherwise, then
    as among the parties hereto, the First Lien Obligations shall be
    deemed to be reinstated to the extent of such Recovery and to be
    outstanding as if such payment had not occurred and such First
    Lien Secured Party shall be entitled to a reinstatement of First
    Lien Obligations with respect to all such recovered amounts and
    shall have all rights hereunder. If the General Intercreditor
    Agreement shall have been terminated prior to such Recovery, the
    General Intercreditor Agreement shall be reinstated in full
    force and effect, and such prior termination shall not diminish,
    release, discharge, impair or otherwise affect the obligations
    of the parties thereto. Any Collateral or other First Lien
    Collateral or proceeds thereof received by any Junior Lien
    Secured Party prior to the time of such Recovery shall be deemed
    to have
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    122
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    been received prior to the Discharge of First Lien Obligations
    and subject to the provisions of the immediately preceding
    paragraph.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, if at any time in connection with or after the
    Discharge of First Lien Obligations the Issuer either in
    connection therewith or thereafter enters into any Refinancing
    of any First Lien Document evidencing a First Lien Obligation,
    then such Discharge of First Lien Obligations shall
    automatically be deemed not to have occurred for all purposes of
    the General Intercreditor Agreement, the First Lien Documents
    and the Junior Lien Documents, and the obligations under such
    Refinancing shall automatically be treated as First Lien
    Obligations for all purposes of the General Intercreditor
    Agreement, including for purposes of the Lien priorities and
    rights in respect of Collateral set forth therein, the related
    documents shall be treated as First Lien Documents for all
    purposes of the General Intercreditor Agreement and the first
    lien collateral agent under such Refinanced First Lien Documents
    shall be First Lien Collateral Agent for all purposes of the
    General Intercreditor Agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The General Intercreditor Agreement provides that, prior to the
    Discharge of First Lien Obligations, neither the Junior Lien
    Collateral Agent nor any other Junior Lien Secured Parties may
    assert or enforce any right of marshalling accorded to a junior
    lienholder, as against the First Lien Collateral Agent or any
    First Lien Secured Party (in their capacity as priority
    lienholders). Following the Discharge of First Lien Obligations,
    the Junior Lien Secured Parties may assert their right under the
    Uniform Commercial Code or otherwise to any proceeds remaining
    following a sale or other disposition of Collateral by, or on
    behalf of, the First Lien Collateral Agent or the First Lien
    Secured Parties. This waiver of all rights of marshalling prior
    to the Discharge of First Lien Obligations may result in
    proceeds from the sale of Collateral (in which the Junior Lien
    Secured Parties have second-priority Liens) being applied to
    repay First Lien Obligations prior to the application of the
    proceeds of Shared Receivables Collateral (in which the Junior
    Lien Secured Parties have third-priority Liens), the Principal
    Properties (in which the Junior Lien Secured Parties will not
    have a security interest prior to the Discharge of First Lien
    Obligations and during any time that any First Lien Obligations
    are outstanding) or the European Collateral or the Separate
    Receivables Collateral (in which the Junior Lien Secured Parties
    do not have a security interest). In that scenario, Junior Lien
    Secured Parties may recover less than they would have if such
    proceeds were applied in the order most favorable to the Junior
    Lien Secured Parties.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    So long as the Discharge of First Lien Obligations has not
    occurred, whether or not any insolvency or liquidation
    proceeding has been commenced by or against the Issuer or any
    Guarantor, (i)&#160;neither the Junior Lien Collateral Agent,
    any Junior Lien Representative nor any Junior Lien Secured Party
    will (x)&#160;exercise or seek to exercise any rights or
    remedies (including setoff or the right to credit bid debt
    (except as set forth in the next paragraph below)) with respect
    to any Collateral in respect of any applicable Junior Lien
    Obligations, or institute any action or proceeding with respect
    to such rights or remedies (including any action of
    foreclosure), (y)&#160;contest, protest or otherwise object to
    any foreclosure or enforcement proceeding or action brought with
    respect to the Collateral or any other collateral by the First
    Lien Collateral Agent or any First Lien Secured Party in respect
    of the First Lien Obligations, the exercise of any right by the
    First Lien Collateral Agent or any First Lien Secured Party (or
    any agent or
    <FONT style="white-space: nowrap">sub-agent</FONT> on
    their behalf) in respect of the First Lien Obligations under any
    control agreement, lockbox agreement, landlord waiver or
    bailee&#146;s letter or similar agreement or arrangement to
    which the Junior Lien Collateral Agent, any Junior Lien
    Representative or any Junior Lien Secured Party either is a
    party or may have rights as a third-party beneficiary, or any
    other exercise by any such party of any rights and remedies as a
    secured party relating to the Collateral or any other collateral
    under the First Lien Documents or otherwise in respect of First
    Lien Obligations, or (z)&#160;object to any waiver or
    forbearance by the First Lien Secured Parties from or in respect
    of bringing or pursuing any foreclosure proceeding or action or
    any other exercise of any rights or remedies relating to the
    Collateral or any other collateral in respect of First Lien
    Obligations and (ii)&#160;except as otherwise provided in the
    General Intercreditor Agreement, the First Lien Collateral Agent
    and the First Lien Secured Parties shall have the sole and
    exclusive right to enforce rights, exercise remedies (including
    setoff and the right to credit bid their debt), marshal, process
    and make determinations regarding the release, disposition or
    restrictions, or waiver or forbearance of rights or remedies
    with respect to the Collateral without any consultation with or
    the consent of the Junior Lien Collateral Agent, any Junior Lien
    Representative or any Junior Lien Secured Party.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    123
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding the foregoing, the General Intercreditor
    Agreement shall not be construed to in any way limit or impair
    the right of any Junior Lien Secured Party from exercising a
    credit bid with respect to the Junior Lien Obligations in a sale
    or other disposition of Collateral under Section&#160;363 of the
    Bankruptcy Code; <I>provided </I>that in connection with and
    immediately after giving effect to such sale and credit bid
    there occurs a Discharge of First Lien Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, the Junior Lien Collateral Agent, each Junior Lien
    Representative and each other Junior Lien Secured Party have
    agreed that if the Issuer or any Guarantor is subject to any
    insolvency or liquidation proceeding:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;if the First Lien Collateral Agent acting on behalf of
    First Lien Secured Parties desires to permit the use of cash
    collateral or to permit the Issuer or any Guarantor to obtain
    financing under Section&#160;363 or Section&#160;364 of the
    Bankruptcy Code or any similar provision in any Bankruptcy Law
    (<I>&#147;DIP Financing&#148;</I>), including if such DIP
    Financing is secured by Liens senior in priority to the Liens
    securing the Notes or other Junior Lien Obligations, then the
    Junior Lien Collateral Agent and each Junior Lien
    Representative, on behalf of itself and each applicable Junior
    Lien Secured Party, agrees not to object to such use of cash
    collateral or DIP Financing and will not request adequate
    protection or any other relief in connection therewith (except
    to the extent permitted by the General Intercreditor Agreement,
    as set forth below) and, to the extent the Liens securing the
    First Lien Obligations are subordinated or <I>pari passu
    </I>with such DIP Financing, will subordinate its Liens in the
    Collateral and any other collateral to such DIP Financing (and
    all Obligations relating thereto) on the same basis as they are
    subordinated to the First Lien Obligations;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;none of them will object to, or otherwise contest (or
    support any other Person contesting), any motion for relief from
    the automatic stay or from any injunction against foreclosure or
    enforcement in respect of the First Lien Obligations made by the
    First Lien Collateral Agent or any First Lien Secured Party;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;none of them will object to, or otherwise contest (or
    support any other Person contesting), any order relating to a
    sale of assets of any Issuer or Guarantor for which the First
    Lien Collateral Agent has consented that provides, to the extent
    that sale is to be free and clear of Liens, that the Liens
    securing the First Lien Obligations and the Junior Lien
    Obligations will attach to the proceeds of the sale on the same
    basis of priority as the existing Liens in accordance with the
    General Intercreditor Agreement;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;none of them will seek relief from the automatic stay
    or any other stay in any insolvency or liquidation proceeding in
    respect of the Collateral or any other First Lien Collateral,
    without the prior written consent of the First Lien Collateral
    Agent;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;none of them will object to, or otherwise contest (or
    support any other Person contesting), (a)&#160;any request by
    the First Lien Collateral Agent or any First Lien Secured Party
    for adequate protection or (b)&#160;any objection by the First
    Lien Collateral Agent or any First Lien Secured Party to any
    motion, relief, action or proceeding based on the First Lien
    Collateral Agent&#146;s or such First Lien Secured Party&#146;s
    claiming a lack of adequate protection;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;none of them will assert or enforce (or support any
    Person asserting or enforcing) any claim under
    Section&#160;506(c) of the Bankruptcy Code senior to or on a
    parity with the Liens securing the First Lien Obligations for
    costs or expenses of preserving or disposing of any Collateral
    or First Lien Collateral;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;none of them will oppose or otherwise contest (or
    support any other Person contesting) any lawful exercise by the
    First Lien Collateral Agent or any First Lien Secured Party of
    the right to credit bid First Lien Obligations at any sale of
    Collateral or First Lien Collateral;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;none of them will challenge (or support any other
    person challenging) the validity, enforceability, perfection or
    priority of the First Priority Liens on Collateral or First Lien
    Collateral (and the General Intercreditor Agreement will provide
    that the First Lien Secured Parties agree that none of them will
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    124
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    challenge the validity, enforceability, perfection or priority
    of the Liens in favor of the Trustee and each other Junior Lien
    Secured Party on the Collateral).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, neither the Junior Lien Collateral Agent, any
    Junior Lien Representative nor any other Junior Lien Secured
    Party will file or prosecute in any insolvency or liquidation
    proceeding any motion for adequate protection (or any comparable
    request for relief) based upon their respective security
    interests in the Collateral, except that:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any of them may freely seek and obtain relief granting
    a junior Lien co-extensive in all respects with, but
    subordinated to, all Liens granted in the insolvency or
    liquidation proceeding to, or for the benefit of, the First Lien
    Secured Parties (and the General Intercreditor Agreement will
    provide that the First Lien Secured Parties will not object to
    the granting of such a junior Lien);&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any of them may freely seek and obtain any relief upon
    a motion for adequate protection (or any comparable relief),
    without any condition or restriction whatsoever, at any time
    after the Discharge of First Lien Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Without limiting the generality of any provisions of the General
    Intercreditor Agreement, any vote to accept, and any other act
    to support the confirmation or approval of, any Non-Conforming
    Plan of Reorganization shall be inconsistent with and,
    accordingly, a violation of the terms of the General
    Intercreditor Agreement, and the First Lien Collateral Agent
    shall be entitled to have any such vote to accept a
    Non-Conforming Plan of Reorganization dismissed and any such
    support of any Non-Conforming Plan of Reorganization withdrawn.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Subject to the terms of the Security Documents, the Issuer and
    the Guarantors have the right to remain in possession and retain
    exclusive control of the Collateral securing the Notes and the
    Junior Lien Obligations (other than securities, instruments and
    chattel paper constituting part of the Collateral and deposited
    with the First Lien Collateral Agent in accordance with the
    provisions of the First Lien Security Documents and any Shared
    Receivables Collateral subject to a control agreement under the
    circumstances described in the First Lien Security Documents),
    to freely operate the Collateral and to collect, invest and
    dispose of any income therefrom.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Junior Lien Collateral Agent and each Junior Lien
    Representative, on behalf of the Junior Lien Secured Parties,
    have acknowledged and agreed in the General Intercreditor
    Agreement that (a)&#160;the Junior Lien Secured Parties&#146;
    claims against the Issuer
    <FONT style="white-space: nowrap">and/or</FONT> any
    Guarantor in respect of the Collateral constitute junior claims
    separate and apart (and of a different class) from the senior
    claims of the First Lien Secured Parties against the Issuer and
    the Guarantor in respect of the Collateral, (b)&#160;the First
    Lien Obligations include all interest that accrues after the
    commencement of any insolvency or liquidation proceeding of the
    Issuer or any Guarantor at the rate provided for in the
    applicable First Lien Documents governing the same, whether or
    not a claim for post-petition interest is allowed or allowable
    in any such insolvency or liquidation proceeding and
    (c)&#160;the Intercreditor Agreement constitutes a
    &#147;subordination agreement&#148; under Section&#160;510 of
    the Bankruptcy Code.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Release
    of Collateral</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer and the Guarantors are entitled to the release of
    property and other assets constituting Collateral from the Liens
    securing the Notes and the Junior Lien Obligations under any one
    or more of the following circumstances:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;to enable us to consummate the sale, transfer or other
    disposition of such property or assets to the extent not
    prohibited under the covenant described under
    &#147;&#151;&#160;Repurchase at the Option of
    Holders&#160;&#151; Asset Sales&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the release of Excess Proceeds or Collateral Excess
    Proceeds that remain unexpended after the conclusion of an Asset
    Sale Offer or a Collateral Asset Sale Offer conducted in
    accordance with the Indenture;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    125
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;in the case of a Guarantor that is released from its
    Guarantee with respect to the Notes pursuant to the terms of the
    Indenture, the release of the property and assets of such
    Guarantor;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;with the consent of the holders of at least 75% of the
    aggregate principal amount of the Notes then outstanding and
    affected thereby and a majority of all Junior Lien Obligations
    (including the Notes) then outstanding and affected thereby
    (including, without limitation, consents obtained in connection
    with a tender offer or exchange offer for, or purchase of,
    Junior Lien Obligations);&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;as described under &#147;&#151;&#160;Amendment,
    Supplement and Waiver&#148; below.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Junior Liens on any Collateral securing the Junior Lien
    Obligations will also terminate and be released automatically if
    the First Priority Liens on such Collateral securing First Lien
    Obligations are released by the First Lien Collateral Agent on
    behalf of the First Lien Secured Parties, unless such release
    occurs in connection with, and after giving effect to, a
    Discharge of First Lien Obligations, which discharge is not in
    connection with a foreclosure of, or other exercise of remedies
    with respect to, Collateral by the First Lien Secured Parties
    (such discharge not in connection with any such foreclosure or
    exercise of remedies, a <I>&#147;Payment Discharge&#148;</I>)
    (<I>provided </I>that, in the case of a Payment Discharge, the
    Liens on any Collateral disposed of in connection with the
    satisfaction in whole or in part of First Lien Obligations shall
    be automatically released but any proceeds thereof not used for
    purposes of the Discharge of First Lien Obligations or otherwise
    in accordance with the Indenture shall be subject to Liens in
    favor of the Junior Lien Secured Parties). In the event of a
    Payment Discharge, the Junior Liens on Collateral shall become
    first-priority security interests, subject to Permitted Liens,
    any intercreditor agreements or arrangements among Junior Lien
    Secured Parties permitted under the General Intercreditor
    Agreement and, with respect to Shared Receivables Collateral,
    subject to the Shared Receivables Intercreditor Agreement;
    <I>provided </I>that if the Issuer or the Guarantors incur at
    any time thereafter any new or replacement First Lien
    Obligations permitted under the Indenture, then such Payment
    Discharge shall automatically be deemed not to have occurred for
    all purposes of the General Intercreditor Agreement, the First
    Lien Documents and the Junior Lien Documents, and such new
    Obligations shall automatically be treated as First Lien
    Obligations for all purposes of the General Intercreditor
    Agreement, including for purposes of the Lien priorities and
    rights in respect of Collateral set forth therein, and the
    related documents shall be treated as First Lien Documents.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    To the extent necessary and for so long as required for such
    Subsidiary not to be subject to any requirement pursuant to
    <FONT style="white-space: nowrap">Rule&#160;3-16</FONT>
    of
    <FONT style="white-space: nowrap">Regulation&#160;S-X</FONT>
    under the Securities Act to file separate financial statements
    with the SEC (or any other governmental agency), the Capital
    Stock of any Subsidiary of the Company (excluding Healthtrust,
    Inc.&#160;&#151; The Hospital Company, a Delaware corporation
    and its successors and assigns) shall not be included in the
    Collateral with respect to the respective Notes so affected (as
    described under &#147;&#151;&#160;Certain Limitations on the
    Collateral&#148;) and shall not be subject to the Liens securing
    such Notes and the Junior Lien Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Junior Liens on the Collateral securing the Notes and the
    Guarantees also will be released upon (i)&#160;payment in full
    of the principal of, together with accrued and unpaid interest
    (including Additional Interest, if any) on, the Notes and all
    other Obligations under the Indenture, the Guarantees and the
    Security Documents (including the 2006 Notes) that are due and
    payable at or prior to the time such principal, together with
    accrued and unpaid interest (including Additional Interest, if
    any), are paid or (ii)&#160;a legal defeasance or covenant
    defeasance under the Indenture as described below under
    &#147;Legal Defeasance and Covenant Defeasance&#148; or a
    discharge of the Indenture as described under &#147;Satisfaction
    and Discharge.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any certificate or opinion required by Section&#160;314(d) of
    the Trust&#160;Indenture Act may be made by an Officer of the
    Company, except in cases where Section&#160;314(d) requires that
    such certificate or opinion be made by an independent engineer,
    appraiser or other expert.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding anything to the contrary herein, the Issuer and
    its Subsidiaries will not be required to comply with all or any
    portion of Section&#160;314(d) of the Trust&#160;Indenture Act
    if they determine, in good faith based on advice of counsel,
    that under the terms of that section
    <FONT style="white-space: nowrap">and/or</FONT> any
    interpretation or guidance as to the meaning thereof of the SEC
    and its staff, including &#147;no action&#148; letters or
    exemptive orders, all or any portion of Section&#160;314(d) of
    the Trust&#160;Indenture Act is inapplicable to the released
    Collateral.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    126
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Without limiting the generality of the foregoing, certain no
    action letters issued by the SEC have permitted an indenture
    qualified under the Trust&#160;Indenture Act to contain
    provisions permitting the release of collateral from Liens under
    such indenture in the ordinary course of the issuer&#146;s
    business without requiring the issuer to provide certificates
    and other documents under Section&#160;314(d) of the
    Trust&#160;Indenture Act. The Issuer and the Guarantors may,
    subject to the provisions of the Indenture, among other things,
    without any release or consent by the Junior Lien Collateral
    Agent, conduct ordinary course activities with respect to the
    Collateral, including, without limitation:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    selling or otherwise disposing of, in any transaction or series
    of related transactions, any property subject to the Lien of the
    Security Documents that has become worn out, defective, obsolete
    or not used or useful in the business;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    abandoning, terminating, canceling, releasing or making
    alterations in or substitutions of any leases or contracts
    subject to the Lien of the Indenture or any of the Security
    Documents;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    surrendering or modifying any franchise, license or permit
    subject to the Lien of the Security Documents that it may own or
    under which it may be operating;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    altering, repairing, replacing, changing the location or
    position of and adding to its structures, machinery, systems,
    equipment, fixtures and appurtenances;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    granting a license of any intellectual property;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    selling, transferring or otherwise disposing of inventory in the
    ordinary course of business;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    collecting accounts receivable in the ordinary course of
    business as permitted by the covenant described under
    &#147;Repurchase at the Option of Holders&#160;&#151; Asset
    Sales&#148;;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    making cash payments (including for the repayment of
    Indebtedness or interest) from cash that is at any time part of
    the Collateral in the ordinary course of business that are not
    otherwise prohibited by the Indenture and the Security
    Documents;&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    abandoning any intellectual property that is no longer used or
    useful in the Issuer&#146;s business.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer must deliver an Officer&#146;s Certificate to the
    Junior Lien Collateral Agent within 30 calendar days following
    the end of each six-month period beginning on May 15 and
    November 15 of each year, to the effect that all such releases
    and withdrawals during the preceding six-month period in the
    ordinary course of the Issuer&#146;s or the Guarantors&#146;
    business, as described in the preceding paragraph, were not
    prohibited by the Indenture.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Shared
    Receivables Intercreditor Agreement</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, the Junior Lien Collateral Agent, have entered into
    a joinder to the Shared Receivables Intercreditor Agreement
    dated as of November&#160;17, 2006 by and among the trustee
    under the 2006 Notes, the administrative agent under the General
    Credit Facility and the administrative agent under the ABL
    Facility (as the same may be amended from time to time, the
    <I>&#147;Shared Receivables Intercreditor Agreement&#148;</I>)
    with respect to the Shared Receivables Collateral. The Shared
    Receivables Intercreditor Agreement contains provisions with
    respect to the Shared Receivables Collateral and the relative
    rights, privileges and obligations relating thereto as between
    (a)&#160;the Junior Lien Collateral Agent, the other Junior Lien
    Secured Parties, the First Lien Collateral Agent and the First
    Lien Secured Parties and (b)&#160;the collateral agent with
    respect to the ABL Facility (the &#147;ABL Collateral
    Agent&#148;) and the ABL Secured Parties. The Shared Receivables
    Intercreditor Agreement provides for first-priority Liens in the
    Shared Receivables Collateral in favor of the ABL Secured
    Parties, second-priority Liens in the Shared Receivables
    Collateral in favor of the First Lien Secured Parties and
    third-priority security interests in the Shared Receivables
    Collateral in favor of the Junior Lien Secured Parties, in each
    case, subject to Permitted Liens. The relative rights,
    privileges and obligations with respect to the Shared
    Receivables Collateral of the ABL Secured Parties, on the one
    hand, and the Junior Lien Collateral Agent, the other Junior
    Lien Secured Parties, the First Lien Collateral Agent and the
    First Lien Secured Parties, on the other, are substantially
    identical to the relative rights, privileges and obligations
    with respect to the Non-
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    127
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Receivables Collateral of the First Lien Secured Parties, on the
    one hand, and the Junior Lien Secured Parties, on the other,
    respectively, except that the Liens of the Junior Lien Secured
    Parties in the Shared Receivables Collateral are third-priority
    Liens and except to the extent customary or necessary with
    respect to collateral of the type that constitutes Shared
    Receivables Collateral.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Certain
    Limitations on the Collateral</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Collateral securing the Notes does not include any of the
    following assets:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the property or assets owned by any Subsidiary of the
    Issuer that is not a Guarantor, including each ABL Financing
    Entity;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any rights or interests of the Issuer or any Guarantor
    in, to or under any agreement, contract, license, instrument,
    document or other general intangible (referred to solely for
    purposes of this clause&#160;(2) as a
    <I>&#147;Contract&#148;</I>), any intellectual property or any
    security or other investment property (i)&#160;to the extent the
    security interest in such Collateral is prohibited by any
    applicable contract, agreement or other instrument without the
    consent of any other party thereto (other than a party to the
    General Credit Facility or the Indenture or, in the case of
    investment property, a Wholly-Owned Subsidiary), (ii)&#160;to
    the extent the security interest in such Contract would give any
    other party (other than a party to the General Credit Facility
    or the Indenture or, in the case of investment property, a
    Wholly-Owned Subsidiary) to such Collateral the right to
    terminate its obligations thereunder or (iii)&#160;to the extent
    all necessary consents to such grant of a security interest have
    not been obtained from the other parties thereto (other than to
    the extent that any such prohibition referred to in clauses (i),
    (ii)&#160;and (iii)&#160;would be rendered ineffective pursuant
    to
    <FONT style="white-space: nowrap">Sections&#160;9-406,</FONT>
    9-407, 9-408 or 9-409 of the Uniform Commercial Code (or any
    successor provision or provisions) of any relevant jurisdiction
    or any other applicable law); <I>provided</I> that this
    limitation shall not affect, limit, restrict or impair the grant
    by the Issuer or such Guarantor of a security interest in any
    account receivable or any money or other amounts due or to
    become due under any Contract;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;any equipment of the Issuer or any Guarantor that is
    subject to, or secured by, a Capitalized Lease Obligation or
    Purchase Money Obligations and any equipment that constitutes an
    asset of an entity acquired in a transaction permitted by the
    Indenture to the extent that such equipment subject to a Lien
    permitted by the Indenture and the terms of the Indebtedness
    secured by such Lien prohibit assignment of, or granting of a
    security interest in, the Issuer&#146;s or such Guarantor&#146;s
    rights and interests therein (other than to the extent that any
    such prohibition would be rendered ineffective pursuant to
    <FONT style="white-space: nowrap">Sections&#160;9-406,</FONT>
    9-407, 9-408 or 9-409 of the Uniform Commercial Code (or any
    successor provision or provisions) of any relevant jurisdiction
    or any other applicable law); <I>provided </I>that immediately
    upon the repayment of all Indebtedness secured by such Lien, the
    Issuer or the Guarantor, as the case may be, shall be deemed to
    have granted a security interest in all the rights and interests
    with respect to such equipment;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;any Voting Stock that is issued by any Foreign
    Subsidiary, if and to the extent that the inclusion of such
    Voting Stock in the Collateral would cause the Collateral
    pledged by the Issuer or the applicable Guarantor, as the case
    may be, to include in the aggregate more than 65% of the total
    combined voting power of all classes of Voting Stock of such
    Foreign Subsidiary;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;any Capital Stock that is issued by a Subsidiary that
    is not owned directly by the Issuer or a Guarantor;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;prior to the Discharge of First Lien Obligations and so
    long as any First Lien Obligations are outstanding, any
    Principal Properties;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;any Capital Stock and other securities of a Subsidiary
    (excluding Healthtrust, Inc.&#160;&#151; The Hospital Company, a
    Delaware corporation and its successors and assigns) to the
    extent that the pledge of such Capital Stock and other
    securities results in the Company&#146;s being required to file
    separate financial statements of such Subsidiary with the SEC,
    but only to the extent necessary to not be subject to such
    requirement and only for so long as such requirement is in
    existence and only with respect to the relevant Notes affected;
    <I>provided</I> that neither the Issuer nor any Subsidiary shall
    take any action in the form of a
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    128
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    reorganization, merger or other restructuring a principal
    purpose of which is to provide for the release of the Lien on
    any Capital Stock pursuant to this clause (7). In addition, in
    the event that
    <FONT style="white-space: nowrap">Rule&#160;3-16</FONT>
    of
    <FONT style="white-space: nowrap">Regulation&#160;S-X</FONT>
    under the Securities Act is amended, modified or interpreted by
    the SEC to require (or is replaced with another rule or
    regulation, or any other law, rule or regulation is adopted,
    which would require) the filing with the SEC (or any other
    governmental agency) of separate financial statements of any
    Subsidiary of the Company (excluding Healthtrust,
    Inc.&#160;&#151; The Hospital Company, a Delaware corporation
    and its successors and assigns) due to the fact that such
    Subsidiary&#146;s Capital Stock secures the Notes affected
    thereby, then the Capital Stock of such Subsidiary will
    automatically be deemed not to be part of the Collateral
    securing the relevant Notes affected thereby but only to the
    extent necessary to not be subject to such requirement and only
    for so long as required to not be subject to such requirement.
    In such event, the Security Documents may be amended or
    modified, without the consent of any holder of such Notes, to
    the extent necessary to release the security interests in favor
    of the applicable collateral agents on the shares of Capital
    Stock that are so deemed to no longer constitute part of the
    Collateral for the relevant Notes. In the event that
    <FONT style="white-space: nowrap">Rule&#160;3-16</FONT>
    of
    <FONT style="white-space: nowrap">Regulation&#160;S-X</FONT>
    under the Securities Act is amended, modified or interpreted by
    the SEC to permit (or is replaced with another rule or
    regulation, or any other law, rule or regulation is adopted,
    which would permit) such Subsidiary&#146;s Capital Stock to
    secure the Notes in excess of the amount then pledged without
    the filing with the SEC (or any other governmental agency) of
    separate financial statements of such Subsidiary, then the
    Capital Stock of such Subsidiary will automatically be deemed to
    be a part of the Collateral for the relevant Notes but only to
    the extent necessary to not be subject to any such financial
    statement requirement;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;certain non-Principal Properties that do not constitute
    Non-Receivables Collateral;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;any deposit accounts, other bank or securities accounts
    or cash of the Issuer or any Guarantor;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;any leaseholds and motor vehicles of the Issuer or any
    Guarantor;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;any Capital Stock or securities convertible into or
    exchangeable for Capital Stock (i)&#160;if, in the reasonable
    judgment of the Issuer, the cost or other consequences of
    pledging such Collateral shall be excessive in view of the
    benefits to be obtained by the Junior Lien Secured Parties
    therefrom or (ii)&#160;the pledge of such Collateral would
    result in adverse tax consequences to the Issuer or any of its
    Subsidiaries as reasonably determined by the Issuer and
    identified in writing to the Junior Lien Collateral Agent;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;any collateral to the extent the grant of the security
    interest therein would violate any requirement of law;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;proceeds and products from any and all of the
    foregoing excluded collateral described in clauses&#160;(1)
    through (12), unless such proceeds or products would otherwise
    constitute Collateral securing the Notes.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Sufficiency
    of Collateral</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The fair market value of the Collateral is subject to
    fluctuations based on factors that include, among others, the
    condition of the healthcare industry, the ability to sell the
    Collateral in an orderly sale, general economic conditions, the
    availability of buyers and similar factors. The amount to be
    received upon a sale of the Collateral would also be dependent
    on numerous factors, including, but not limited to, the actual
    fair market value of the Collateral at such time and the timing
    and the manner of the sale. By their nature, portions of the
    Collateral may be illiquid and may have no readily ascertainable
    market value. Accordingly, there can be no assurance that the
    Collateral can be sold in a short period of time or in an
    orderly manner. In addition, in the event of a bankruptcy, the
    ability of the holders to realize upon any of the Collateral may
    be subject to certain bankruptcy law limitations as described
    below.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Certain
    Bankruptcy Limitations</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The right of the Trustee to repossess and dispose of the
    Collateral upon the occurrence of an Event of Default would be
    significantly impaired by any Bankruptcy Law in the event that a
    bankruptcy case were to be commenced by or against the Company
    or any Guarantor prior to the Trustee&#146;s having repossessed
    and
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    129
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    disposed of the Collateral. Upon the commencement of a case for
    relief under the Bankruptcy Code, a secured creditor such as the
    Trustee is prohibited from repossessing its security from a
    debtor in a bankruptcy case, or from disposing of security
    without bankruptcy court approval.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In view of the broad equitable powers of a U.S.&#160;bankruptcy
    court, it is impossible to predict how long payments under the
    Notes could be delayed following commencement of a bankruptcy
    case, whether or when the Trustee could repossess or dispose of
    the Collateral, the value of the Collateral at any time during a
    bankruptcy case or whether or to what extent holders of the
    Notes would be compensated for any delay in payment or loss of
    value of the Collateral. The Bankruptcy Code permits only the
    payment
    <FONT style="white-space: nowrap">and/or</FONT>
    accrual of post-petition interest, costs and attorneys&#146;
    fees to a secured creditor during a debtor&#146;s bankruptcy
    case to the extent the value of such creditor&#146;s interest in
    the Collateral is determined by the bankruptcy court to exceed
    the aggregate outstanding principal amount of the obligations
    secured by the Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Furthermore, in the event a domestic or foreign bankruptcy court
    determines that the value of the Collateral is not sufficient to
    repay all amounts due on the Notes, the holders of the Notes
    would hold secured claims only to the extent of the value of the
    Collateral to which the holders of the Notes are entitled, and
    unsecured claims with respect to such shortfall.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Paying
    Agent and Registrar for the Notes</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer must maintain one or more paying agents for the Notes
    in the Borough of Manhattan, City of New York or Atlanta,
    Georgia. The initial paying agent for the Notes is the Trustee.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer must also maintain a registrar with offices in the
    Borough of Manhattan, City of New York or Atlanta, Georgia. The
    initial registrar is the Trustee. The registrar maintains a
    register reflecting ownership of the Notes outstanding from time
    to time and makes payments on and facilitates transfer of Notes
    on behalf of the Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer may change the paying agents or the registrars
    without prior notice to the Holders. The Issuer or any of its
    Subsidiaries may act as a paying agent or registrar.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Transfer
    and Exchange</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    A Holder may transfer or exchange Notes in accordance with the
    Indenture. The registrar and the Trustee may require a Holder to
    furnish appropriate endorsements and transfer documents in
    connection with a transfer of Notes. Holders will be required to
    pay all taxes due on transfer. The Issuer will not be required
    to transfer or exchange any Note selected for redemption. Also,
    the Issuer will not be required to transfer or exchange any Note
    for a period of 15&#160;days before a selection of Notes to be
    redeemed.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Principal,
    Maturity and Interest</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer issued $310.0&#160;million in aggregate principal
    amount of Notes in this offering. The Notes will mature on
    February&#160;15, 2017. Subject to compliance with the covenant
    described below under the caption &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock,&#148;
    the Issuer may issue additional Notes, from time to time after
    this offering under the Indenture (any such Notes,
    <I>&#147;Additional Notes&#148;</I>). Except as described under
    &#147;Amendment, Supplement and Waiver,&#148; the Notes offered
    by the Issuer and any Additional Notes subsequently issued under
    the Indenture will be treated as a single class for all purposes
    under the Indenture, including waivers, amendments, redemptions
    and offers to purchase. Unless the context requires otherwise,
    references to &#147;Notes&#148; for all purposes of the
    Indenture and this &#147;Description of Notes&#148; include any
    Additional Notes that are actually issued.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Interest on the Notes will accrue at the rate of
    9<FONT style="vertical-align: text-top; font-size: 70%;">7</FONT>/<FONT style="font-size: 70%;">8</FONT>%
    per annum and is payable semi-annually in arrears on February 15
    and August 15 commencing August&#160;15, 2009, to the Holders of
    record on the immediately preceding February 1 and
    August&#160;1. Interest on the Notes will accrue from the most
    recent date to which interest has been paid or, if no interest
    has been paid, from and including the Issue Date. Interest on
    the Notes will be computed on the basis of a
    <FONT style="white-space: nowrap">360-day</FONT> year
    comprised of twelve
    <FONT style="white-space: nowrap">30-day</FONT>
    months.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    130
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Additional
    Interest</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Additional Interest may accrue on the Notes in certain
    circumstances pursuant to the Registration Rights Agreement. All
    references in the Indenture, in any context, to any interest or
    other amount payable on or with respect to the Notes shall be
    deemed to include any Additional Interest pursuant to the
    Registration Rights Agreement. Principal of, premium, if any,
    and interest on the Notes will be payable at the office or
    agency of the Issuer maintained for such purpose within the City
    and State of New York or, at the option of the Issuer, payment
    of interest may be made by check mailed to the Holders of the
    Notes at their respective addresses set forth in the register of
    Holders; <I>provided </I>that all payments of principal,
    premium, if any, and interest with respect to the Notes
    represented by one or more global notes registered in the name
    of or held by DTC or its nominee will be made by wire transfer
    of immediately available funds to the accounts specified by the
    Holder or Holders thereof. Until otherwise designated by the
    Issuer, the Issuer&#146;s office or agency in New York will be
    the office of the Trustee maintained for such purpose.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Mandatory
    Redemption; Offers to Purchase; Open Market Purchases</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not be required to make any mandatory redemption
    or sinking fund payments with respect to the Notes. However,
    under certain circumstances, the Issuer may be required to offer
    to purchase Notes as described under the caption
    &#147;Repurchase at the Option of Holders.&#148; The Issuer may
    at any time and from time to time purchase Notes in the open
    market or otherwise.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Optional
    Redemption</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Except as set forth below, the Issuer is not entitled to redeem
    Notes at its option prior to February&#160;15, 2013.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    At any time prior to February&#160;15, 2013, the Issuer may
    redeem all or a part of the Notes, upon not less than 30 nor
    more than 60&#160;days&#146; prior notice mailed by first-class
    mail to the registered address of each Holder or otherwise in
    accordance with the procedures of DTC, at a redemption price
    equal to 100% of the principal amount of the Notes redeemed plus
    the Applicable Premium as of, and accrued and unpaid interest
    and Additional Interest, if any, to the date of redemption (the
    <I>&#147;Redemption&#160;Date&#148;</I>), subject to the rights
    of Holders of Notes on the relevant record date to receive
    interest due on the relevant interest payment date.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On and after February&#160;15, 2013, the Issuer may redeem the
    Notes, in whole or in part, upon not less than 30 nor more than
    60&#160;days&#146; prior notice mailed by first-class mail to
    the registered address of each Holder or otherwise in accordance
    with the procedures of DTC, at the redemption prices (expressed
    as percentages of principal amount of the Notes to be redeemed)
    set forth below, plus accrued and unpaid interest thereon and
    Additional Interest, if any, to the applicable
    Redemption&#160;Date, subject to the right of Holders of record
    on the relevant record date to receive interest due on the
    relevant interest payment date, if redeemed during the
    twelve-month period beginning on February 15 of each of the
    years indicated below:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="90%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="6%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Year</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Percentage</B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    2013
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    104.938
</TD>
<TD nowrap align="left" valign="bottom">
    %
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    2014
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    102.469
</TD>
<TD nowrap align="left" valign="bottom">
    %
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    2015 and thereafter
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    100.000
</TD>
<TD nowrap align="left" valign="bottom">
    %
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, until February&#160;15, 2012, the Issuer may, at
    its option, on one or more occasions redeem up to 35% of the
    aggregate principal amount of Notes at a redemption price equal
    to 109.875% of the aggregate principal amount thereof, plus
    accrued and unpaid interest thereon and Additional Interest, if
    any, to the applicable Redemption&#160;Date, subject to the
    right of Holders of record on the relevant record date to
    receive interest due on the relevant interest payment date, with
    the net cash proceeds of one or more Equity Offerings;
    <I>provided </I>that at least 50% of the sum of the original
    aggregate principal amount of Notes issued under the Indenture
    and the original principal amount of any Additional Notes that
    are Notes issued under the Indenture after the Issue Date
    remains outstanding immediately after the occurrence of each
    such redemption; <I>provided further </I>that each such
    redemption occurs within 90&#160;days of the date of closing of
    each such Equity Offering.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    131
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any notice of any redemption may be given prior to the
    redemption thereof, and any such redemption or notice may, at
    the Issuer&#146;s discretion, be subject to one or more
    conditions precedent, including, but not limited to, completion
    of an Equity Offering or other corporate transaction.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If the Issuer redeems less than all of the outstanding Notes,
    the Trustee shall select the Notes to be redeemed in the manner
    described under &#147;Repurchase at the Option of
    Holders&#160;&#151; Selection and Notice.&#148;
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Repurchase
    at the Option of Holders</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Change
    of Control</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Notes provide that if a Change of Control occurs, unless the
    Issuer has previously or concurrently mailed a redemption notice
    with respect to all the outstanding Notes as described under
    &#147;Optional Redemption,&#148; the Issuer will make an offer
    to purchase all of the Notes pursuant to the offer described
    below (the <I>&#147;Change of Control Offer&#148;</I>) at a
    price in cash (the <I>&#147;Change of Control Payment&#148;</I>)
    equal to 101% of the aggregate principal amount thereof plus
    accrued and unpaid interest and Additional Interest, if any, to
    the date of purchase, subject to the right of Holders of the
    Notes of record on the relevant record date to receive interest
    due on the relevant interest payment date. Within 30&#160;days
    following any Change of Control, the Issuer will send notice of
    such Change of Control Offer by first-class mail, with a copy to
    the Trustee, to each Holder of Notes to the address of such
    Holder appearing in the security register with a copy to the
    Trustee or otherwise in accordance with the procedures of DTC,
    with the following information:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;that a Change of Control Offer is being made pursuant
    to the covenant entitled &#147;Change of Control&#148; and that
    all Notes properly tendered pursuant to such Change of Control
    Offer will be accepted for payment by the Issuer;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the purchase price and the purchase date, which will be
    no earlier than 30&#160;days nor later than 60&#160;days from
    the date such notice is mailed (the <I>&#147;Change of Control
    Payment Date&#148;</I>);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;that any Note not properly tendered will remain
    outstanding and continue to accrue interest;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;that unless the Issuer defaults in the payment of the
    Change of Control Payment, all Notes accepted for payment
    pursuant to the Change of Control Offer will cease to accrue
    interest on the Change of Control Payment Date;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;that Holders electing to have any Notes purchased
    pursuant to a Change of Control Offer will be required to
    surrender such Notes, with the form entitled &#147;Option of
    Holder to Elect Purchase&#148; on the reverse of such Notes
    completed, to the paying agent specified in the notice at the
    address specified in the notice prior to the close of business
    on the third Business Day preceding the Change of Control
    Payment Date;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;that Holders will be entitled to withdraw their
    tendered Notes and their election to require the Issuer to
    purchase such Notes; provided that the paying agent receives,
    not later than the close of business on the 30th&#160;day
    following the date of the Change of Control notice, a telegram,
    facsimile transmission or letter setting forth the name of the
    Holder of the Notes, the principal amount of Notes tendered for
    purchase, and a statement that such Holder is withdrawing its
    tendered Notes and its election to have such Notes purchased;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;that if the Issuer is redeeming less than all of the
    Notes, the Holders of the remaining Notes will be issued new
    Notes and such new Notes will be equal in principal amount to
    the unpurchased portion of the Notes surrendered. The
    unpurchased portion of the Notes must be equal to $2,000 or an
    integral multiple of $1,000 in excess thereof;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;the other instructions, as determined by us, consistent
    with the covenant described hereunder, that a Holder must follow.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will comply with the requirements of
    <FONT style="white-space: nowrap">Rule&#160;14e-1</FONT>
    under the Exchange Act and any other securities laws and
    regulations thereunder to the extent such laws or regulations
    are applicable in connection with the repurchase of Notes
    pursuant to a Change of Control Offer. To the extent that the
    provisions of any
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    132
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    securities laws or regulations conflict with the provisions of
    the Indenture, the Issuer will comply with the applicable
    securities laws and regulations and shall not be deemed to have
    breached its obligations described in the Indenture by virtue
    thereof.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On the Change of Control Payment Date, the Issuer will, to the
    extent permitted by law,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;accept for payment all Notes issued by it or portions
    thereof properly tendered pursuant to the Change of Control
    Offer;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;deposit with the paying agent an amount equal to the
    aggregate Change of Control Payment in respect of all Notes or
    portions thereof so tendered;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;deliver, or cause to be delivered, to the Trustee for
    cancellation the Notes so accepted together with an
    Officer&#146;s Certificate to the Trustee stating that such
    Notes or portions thereof have been tendered to and purchased by
    the Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Senior Credit Facilities provide, and future credit
    agreements or other agreements relating to Senior Indebtedness
    to which the Issuer becomes a party may, provide that certain
    change of control events with respect to the Issuer would
    constitute a default thereunder (including a Change of Control
    under the Indenture). If we experience a change of control that
    triggers a default under our Senior Credit Facilities, we could
    seek a waiver of such default or seek to refinance our Senior
    Credit Facilities. In the event we do not obtain such a waiver
    or refinance the Senior Credit Facilities, such default could
    result in amounts outstanding under our Senior Credit Facilities
    being declared due and payable and could cause a Receivables
    Facility to be wound down.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Our ability to pay cash to the Holders of Notes following the
    occurrence of a Change of Control may be limited by our
    then-existing financial resources. Therefore, sufficient funds
    may not be available when necessary to make any required
    repurchases.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Change of Control purchase feature of the Notes may in
    certain circumstances make more difficult or discourage a sale
    or takeover of us and, thus, the removal of incumbent
    management. The Change of Control purchase feature is a result
    of negotiations between the Initial Purchasers and us. We have
    no present intention to engage in a transaction involving a
    Change of Control, although it is possible that we could decide
    to do so in the future. Subject to the limitations discussed
    below, we could, in the future, enter into certain transactions,
    including acquisitions, refinancings or other recapitalizations,
    that would not constitute a Change of Control under the
    Indenture, but that could increase the amount of indebtedness
    outstanding at such time or otherwise affect our capital
    structure or credit ratings. Restrictions on our ability to
    incur additional Indebtedness are contained in the covenants
    described under &#147;Certain Covenants&#160;&#151; Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock&#148; and &#147;Certain
    Covenants&#160;&#151; Liens.&#148; Such restrictions in the
    Indenture can be waived only with the consent of the Holders of
    a majority in principal amount of the Notes then outstanding.
    Except for the limitations contained in such covenants, however,
    the Indenture does not contain any covenants or provisions that
    may afford Holders of the Notes protection in the event of a
    highly leveraged transaction.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer is not required to make a Change of Control Offer
    following a Change of Control if a third party makes the Change
    of Control Offer in the manner, at the times and otherwise in
    compliance with the requirements set forth in the Indenture
    applicable to a Change of Control Offer made by us and purchases
    all Notes validly tendered and not withdrawn under such Change
    of Control Offer. Notwithstanding anything to the contrary
    herein, a Change of Control Offer may be made in advance of a
    Change of Control, conditional upon such Change of Control, if a
    definitive agreement is in place for the Change of Control at
    the time of making of the Change of Control Offer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The definition of &#147;Change of Control&#148; includes a
    disposition of all or substantially all of the assets of the
    Issuer to any Person. Although there is a limited body of case
    law interpreting the phrase &#147;substantially all,&#148; there
    is no precise established definition of the phrase under
    applicable law. Accordingly, in certain circumstances there may
    be a degree of uncertainty as to whether a particular
    transaction would involve a disposition of &#147;all or
    substantially all&#148; of the assets of the Issuer. As a
    result, it may be unclear as to whether
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    133
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    a Change of Control has occurred and whether a Holder of Notes
    may require the Issuer to make an offer to repurchase the Notes
    as described above.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The provisions under the Indenture relating to the Issuer&#146;s
    obligation to make an offer to repurchase the Notes as a result
    of a Change of Control may be waived or modified with the
    written consent of the Holders of a majority in principal amount
    of the Notes.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Asset
    Sales</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that the Issuer will not, and will not
    permit any of its Restricted Subsidiaries to consummate,
    directly or indirectly, an Asset Sale, unless:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the Issuer or such Restricted Subsidiary, as the case
    may be, receives consideration at the time of such Asset Sale at
    least equal to the fair market value (as determined in good
    faith by the Issuer) of the assets sold or otherwise disposed
    of;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;except in the case of a Permitted Asset Swap, at least
    75% of the consideration therefor received by the Issuer or such
    Restricted Subsidiary, as the case may be, is in the form of
    cash or Cash Equivalents; <I>provided </I>that the amount of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;any liabilities (as shown on the Issuer&#146;s or such
    Restricted Subsidiary&#146;s most recent balance sheet or in the
    footnotes thereto) of the Issuer or such Restricted Subsidiary,
    other than liabilities that are by their terms subordinated to
    the Notes, that are assumed by the transferee of any such assets
    and for which the Issuer and all of its Restricted Subsidiaries
    have been validly released by all creditors in writing,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;any securities received by the Issuer or such
    Restricted Subsidiary from such transferee that are converted by
    the Issuer or such Restricted Subsidiary into cash (to the
    extent of the cash received) within 180&#160;days following the
    closing of such Asset Sale,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;any Designated Non-cash Consideration received by the
    Issuer or such Restricted Subsidiary in such Asset Sale having
    an aggregate fair market value, taken together with all other
    Designated Non-cash Consideration received pursuant to this
    clause&#160;(c) that is at that time outstanding, not to exceed
    5% of Total Assets at the time of the receipt of such Designated
    Non-cash Consideration, with the fair market value of each item
    of Designated Non-cash Consideration being measured at the time
    received and without giving effect to subsequent changes in
    value, shall be deemed to be cash for purposes of this provision
    and for no other purpose.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Within 450&#160;days after the receipt of any Net Proceeds of
    any Asset Sale, the Issuer or such Restricted Subsidiary, at its
    option, may apply the Net Proceeds from such Asset Sale,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;to permanently reduce:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;Obligations under Priority Lien Obligations and to
    correspondingly reduce commitments with respect thereto;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;Obligations under Senior Indebtedness (other than any
    Junior Lien Obligation) that is secured by a Lien permitted
    under the Indenture (which Lien is senior to the Lien of the
    Notes with respect to the Collateral), and to correspondingly
    reduce commitments with respect thereto;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;Obligations under Junior Lien Obligations (and to
    correspondingly reduce commitments with respect thereto) through
    open-market purchases (to the extent such purchases are at or
    above 100% of the principal amount thereof) or by making an
    Asset Sale Offer or a Collateral Asset Sale Offer in accordance
    with the procedures set forth below; <I>provided </I>that the
    Issuer shall equally and ratably reduce Obligations under the
    Notes as provided under &#147;Optional Redemption&#148;, through
    open-market purchases or otherwise by making an offer (in
    accordance with the procedures set forth below for an Asset Sale
    Offer or a Collateral Asset Sale Offer) to all Holders to
    purchase their Notes at 100% of the principal amount thereof,
    plus the amount of accrued but unpaid interest, if any, on the
    amount of the Notes that would otherwise be prepaid;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    134
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;Obligations under the Existing Notes which have a final
    maturity date (as in effect on the Issue Date) on or prior to
    November&#160;15, 2016; <I>provided </I>that, at the time of,
    and after giving effect to, such repurchase, redemption or
    defeasance, the aggregate amount of Net Proceeds used to
    repurchase, redeem or defease Existing Notes pursuant to this
    subclause&#160;(d) following the Issue Date shall not exceed 5%
    of the consolidated total assets of the Issuer and its
    subsidiaries at such time;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;Indebtedness of a Restricted Subsidiary that is not a
    Guarantor, other than Indebtedness owed to the Issuer or another
    Restricted Subsidiary (or any affiliate thereof);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;to make (a)&#160;an Investment in any one or more
    businesses, <I>provided </I>that such Investment in any business
    is in the form of the acquisition of Capital Stock and results
    in the Issuer or another of its Restricted Subsidiaries, as the
    case may be, owning an amount of the Capital Stock of such
    business such that it constitutes a Restricted Subsidiary,
    (b)&#160;capital expenditures or (c)&#160;acquisitions of other
    assets, in each of (a), (b)&#160;and (c), used or useful in a
    Similar Business;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;to make an investment in (a)&#160;any one or more
    businesses, <I>provided </I>that such Investment in any business
    is in the form of the acquisition of Capital Stock and results
    in the Issuer or another of its Restricted Subsidiaries, as the
    case may be, owning an amount of the Capital Stock of such
    business such that it constitutes a Restricted Subsidiary,
    (b)&#160;properties or (c)&#160;acquisitions of other assets
    that, in each of (a), (b)&#160;and (c), replace the businesses,
    properties
    <FONT style="white-space: nowrap">and/or</FONT>
    assets that are the subject of such Asset Sale;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided </I>that, in the case of clauses&#160;(2) and
    (3)&#160;above, a binding commitment shall be treated as a
    permitted application of the Net Proceeds from the date of such
    commitment so long as the Issuer, or such other Restricted
    Subsidiary enters into such commitment with the good faith
    expectation that such Net Proceeds will be applied to satisfy
    such commitment within 180&#160;days of such commitment (an
    <I>&#147;Acceptable Commitment&#148;</I>) and, in the event any
    Acceptable Commitment is later cancelled or terminated for any
    reason before the Net Proceeds are applied in connection
    therewith, the Issuer or such Restricted Subsidiary enters into
    another Acceptable Commitment (a <I>&#147;Second
    Commitment&#148;</I>) within 180&#160;days of such cancellation
    or termination; <I>provided</I>, <I>further</I>, that if any
    Second Commitment is later cancelled or terminated for any
    reason before such Net Proceeds are applied, then such Net
    Proceeds shall constitute Excess Proceeds.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any Net Proceeds from Asset Sales of Collateral that are not
    invested or applied as set forth in the first sentence of the
    preceding paragraph will be deemed to constitute
    <I>&#147;Collateral Excess Proceeds</I>.&#148; When the
    aggregate amount of Collateral Excess Proceeds exceeds
    $200.0&#160;million, the Issuer shall make an offer to all
    Holders of the Notes and, if required by the terms of any Junior
    Lien Obligations, including the 2006 Notes, which are not
    subordinated to the Notes or Obligations secured by a Lien
    permitted under the Indenture (which Lien is not subordinate to
    the Lien of the Notes with respect to the Collateral), to the
    holders of such Junior Lien Obligations or such other
    Obligations (a <I>&#147;Collateral Asset Sale Offer&#148;</I>),
    to purchase the maximum aggregate principal amount of the Notes
    and such Junior Lien Obligations or such other Obligations that
    is a minimum of $2,000 or an integral multiple of $1,000 in
    excess thereof that may be purchased out of the Collateral
    Excess Proceeds at an offer price in cash in an amount equal to
    100% of the principal amount thereof, plus accrued and unpaid
    interest and Additional Interest, if any, to the date fixed for
    the closing of such offer, in accordance with the procedures set
    forth in the Indenture. The Issuer will commence a Collateral
    Asset Sale Offer with respect to Collateral Excess Proceeds
    within ten Business Days after the date that Collateral Excess
    Proceeds exceed $200.0&#160;million by mailing the notice
    required pursuant to the terms of the Indenture, with a copy to
    the Trustee.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any Net Proceeds from Asset Sales of non-Collateral that are not
    invested or applied as provided and within the time period set
    forth in the first sentence of the second preceding paragraph
    will be deemed to constitute <I>&#147;Excess Proceeds</I>.&#148;
    When the aggregate amount of Excess Proceeds exceeds
    $200.0&#160;million, the Issuer shall make an offer to all
    Holders of the Notes and, if required or permitted by the terms
    of any Senior Indebtedness, to the holders of such Senior
    Indebtedness (an <I>&#147;Asset Sale Offer&#148;</I>), to
    purchase the maximum aggregate principal amount of the Notes and
    such Senior Indebtedness that is a minimum of $2,000 or an
    integral multiple of $1,000 in excess thereof that may be
    purchased out of the Excess Proceeds at an offer price in cash
    in an amount equal to 100% of the principal amount thereof, plus
    accrued and unpaid interest and Additional Interest, if any, to
    the date fixed for the closing of such offer, in accordance with
    the
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    135
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    procedures set forth in the Indenture. The Issuer will commence
    an Asset Sale Offer with respect to Excess Proceeds within ten
    Business Days after the date that Excess Proceeds exceed
    $200.0&#160;million by mailing the notice required pursuant to
    the terms of the Indenture, with a copy to the Trustee.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    To the extent that the aggregate amount of Notes and such Junior
    Lien Obligations or Obligations secured by a Lien permitted by
    the Indenture (which Lien is not subordinate to the Lien of the
    Notes with respect to the Collateral) tendered pursuant to a
    Collateral Asset Sale Offer is less than the Collateral Excess
    Proceeds, the Issuer may use any remaining Collateral Excess
    Proceeds for general corporate purposes, subject to other
    covenants contained in the Indenture. To the extent that the
    aggregate amount of Notes and such Senior Indebtedness tendered
    pursuant to an Asset Sale Offer is less than the Excess
    Proceeds, the Issuer may use any remaining Excess Proceeds for
    general corporate purposes, subject to other covenants contained
    in the Indenture. If the aggregate principal amount of Notes or
    Junior Lien Obligations or such other Obligations surrendered by
    such holders thereof exceeds the amount of Collateral Excess
    Proceeds, the Trustee shall select the Notes and such Junior
    Lien Obligations or such other Obligations to be purchased on a
    pro rata basis based on the accreted value or principal amount
    of the Notes or such Junior Lien Obligations or such other
    Obligations tendered. If the aggregate principal amount of Notes
    or the Senior Indebtedness surrendered by such holders thereof
    exceeds the amount of Excess Proceeds, the Trustee shall select
    the Notes and such Senior Indebtedness to be purchased on a pro
    rata basis based on the accreted value or principal amount of
    the Notes or such Senior Indebtedness tendered. Upon completion
    of any such Collateral Asset Sale Offer or Asset Sale Offer, the
    amount of Collateral Excess Proceeds or Excess Proceeds, as the
    case may be, shall be reset at zero. Additionally, the Issuer
    may, at its option, make a Collateral Asset Sale Offer or an
    Asset Sale Offer using proceeds from any Asset Sale at any time
    after consummation of such Asset Sale; <I>provided </I>that such
    Collateral Asset Sale Offer or Asset Sale Offer shall be in an
    aggregate amount of not less than $50.0&#160;million. Upon
    consummation of such Collateral Asset Sale Offer or Asset Sale
    Offer, any Net Proceeds not required to be used to purchase
    Notes shall not be deemed Excess Proceeds.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pending the final application of any Net Proceeds pursuant to
    this covenant, the holder of such Net Proceeds may apply such
    Net Proceeds temporarily to reduce Indebtedness outstanding
    under a revolving credit facility or otherwise invest such Net
    Proceeds in any manner not prohibited by the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will comply with the requirements of
    <FONT style="white-space: nowrap">Rule&#160;14e-1</FONT>
    under the Exchange Act and any other securities laws and
    regulations thereunder to the extent such laws or regulations
    are applicable in connection with the repurchase of the Notes
    pursuant to a Collateral Asset Sale Offer or an Asset Sale
    Offer. To the extent that the provisions of any securities laws
    or regulations conflict with the provisions of the Indenture,
    the Issuer will comply with the applicable securities laws and
    regulations and shall not be deemed to have breached its
    obligations described in the Indenture by virtue thereof.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Selection
    and Notice</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If the Issuer is redeeming less than all of the Notes issued by
    it at any time, the Trustee will select the Notes to be redeemed
    (a)&#160;if the Notes are listed on any national securities
    exchange, in compliance with the requirements of the principal
    national securities exchange on which the Notes are listed,
    (b)&#160;on a pro rata basis to the extent practicable or
    (c)&#160;by lot or such other similar method in accordance with
    the procedures of DTC.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notices of purchase or redemption shall be mailed by first-class
    mail, postage prepaid, at least 30 but not more than
    60&#160;days before the purchase or Redemption&#160;Date to each
    Holder of Notes at such Holder&#146;s registered address or
    otherwise in accordance with the procedures of DTC, except that
    redemption notices may be mailed more than 60&#160;days prior to
    a Redemption&#160;Date if the notice is issued in connection
    with a defeasance of the Notes or a satisfaction and discharge
    of the Indenture. If any Note is to be purchased or redeemed in
    part only, any notice of purchase or redemption that relates to
    such Note shall state the portion of the principal amount
    thereof that has been or is to be purchased or redeemed.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will issue a new Note in a principal amount equal to
    the unredeemed portion of the original Note in the name of the
    Holder upon cancellation of the original Note. Notes called for
    redemption become due on the date fixed for redemption. On and
    after the Redemption&#160;Date, interest ceases to accrue on
    Notes or portions thereof called for redemption.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    136
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Certain
    Covenants</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Set forth below are summaries of certain covenants contained in
    the Indenture. If on any date following the Issue Date
    (i)&#160;the Notes have Investment Grade Ratings from both
    Rating Agencies, and (ii)&#160;no Default has occurred and is
    continuing under the Indenture (the occurrence of the events
    described in the foregoing clauses&#160;(i) and (ii)&#160;being
    collectively referred to as a <I>&#147;Covenant Suspension
    Event&#148;</I>), the Issuer and the Restricted Subsidiaries
    will not be subject to the following covenants (collectively,
    the <I>&#147;Suspended Covenants&#148;</I>):
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;&#147;Repurchase at the Option of Holders&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;&#147;&#151; Limitation on Restricted Payments&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;&#147;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;clause&#160;(4) of the first paragraph of
    &#147;&#151;&#160;Merger, Consolidation or Sale of All or
    Substantially All Assets&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;&#147;&#151; Transactions with
    Affiliates&#148;;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;&#147;&#151; Dividend and Other Payment Restrictions
    Affecting Restricted Subsidiaries.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In the event that the Issuer and the Restricted Subsidiaries are
    not subject to the Suspended Covenants under the Indenture for
    any period of time as a result of the foregoing, and on any
    subsequent date (the <I>&#147;Reversion Date&#148;</I>) one or
    both of the Rating Agencies (a)&#160;withdraw their Investment
    Grade Rating or downgrade the rating assigned to the Notes below
    an Investment Grade Rating
    <FONT style="white-space: nowrap">and/or</FONT>
    (b)&#160;the Issuer or any of its Affiliates enters into an
    agreement to effect a transaction that would result in a Change
    of Control and one or more of the Rating Agencies indicate that
    if consummated, such transaction (alone or together with any
    related recapitalization or refinancing transactions) would
    cause such Rating Agency to withdraw its Investment Grade Rating
    or downgrade the ratings assigned to the Notes below an
    Investment Grade Rating, then the Issuer and the Restricted
    Subsidiaries will thereafter again be subject to the Suspended
    Covenants under the Indenture with respect to future events,
    including, without limitation, a proposed transaction described
    in clause&#160;(b) above.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The period of time between the Suspension Date and the Reversion
    Date is referred to in this description as the
    <I>&#147;Suspension Period</I>.&#148; Additionally, upon the
    occurrence of a Covenant Suspension Event, the amount of Excess
    Proceeds from Net Proceeds shall be reset at zero. In the event
    of any such reinstatement, no action taken or omitted to be
    taken by the Issuer or any of its Restricted Subsidiaries prior
    to such reinstatement will give rise to a Default or Event of
    Default under the Indentures with respect to Notes; <I>provided
    </I>that (1)&#160;with respect to Restricted Payments made after
    any such reinstatement, the amount of Restricted Payments made
    will be calculated as though the covenant described under the
    caption &#147;&#151;&#160;Limitation on Restricted
    Payments&#148; had been in effect prior to, but not during the
    Suspension Period, <I>provided </I>that any Subsidiaries
    designated as Unrestricted Subsidiaries during the Suspension
    Period shall automatically become Restricted Subsidiaries on the
    Reversion Date (subject to the Issuer&#146;s right to
    subsequently designate them as Unrestricted Subsidiaries in
    compliance with the covenants set out below), and (2)&#160;all
    Indebtedness incurred, or Disqualified Stock or Preferred Stock
    issued, during the Suspension Period will be classified to have
    been incurred or issued pursuant to clause&#160;(3) of the
    second paragraph of &#147;&#151;&#160;Limitation on Incurrence
    of Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    There can be no assurance that the Notes will ever achieve or
    maintain Investment Grade Ratings.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    137
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Limitation
    on Restricted Payments</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, directly or indirectly:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (I)&#160;declare or pay any dividend or make any payment or
    distribution on account of the Issuer&#146;s, or any of its
    Restricted Subsidiaries&#146; Equity Interests, including any
    dividend or distribution payable in connection with any merger
    or consolidation other than:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;dividends or distributions by the Issuer payable solely
    in Equity Interests (other than Disqualified Stock) of the
    Issuer;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;dividends or distributions by a Restricted Subsidiary
    so long as, in the case of any dividend or distribution payable
    on or in respect of any class or series of securities issued by
    a Restricted Subsidiary other than a Wholly-Owned Subsidiary,
    the Issuer or a Restricted Subsidiary receives at least its pro
    rata share of such dividend or distribution in accordance with
    its Equity Interests in such class or series of securities;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (II)&#160;purchase, redeem, defease or otherwise acquire or
    retire for value any Equity Interests of the Issuer or any
    direct or indirect parent of the Issuer, including in connection
    with any merger or consolidation;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (III)&#160;make any principal payment on, or redeem, repurchase,
    defease or otherwise acquire or retire for value in each case,
    prior to any scheduled repayment, sinking fund payment or
    maturity, any Subordinated Indebtedness, other than:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;Indebtedness permitted under clauses&#160;(7) and
    (8)&#160;of the covenant described under
    &#147;&#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock&#148;;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the purchase, repurchase or other acquisition of
    Subordinated Indebtedness purchased in anticipation of
    satisfying a sinking fund obligation, principal installment or
    final maturity, in each case due within one year of the date of
    purchase, repurchase or acquisition;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (IV)&#160;make any Restricted Investment
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (all such payments and other actions set forth in
    clauses&#160;(I) through (IV)&#160;above (other than any
    exception thereto) being collectively referred to as
    <I>&#147;Restricted Payments&#148;</I>), unless, at the time of
    such Restricted Payment:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;no Default shall have occurred and be continuing or
    would occur as a consequence thereof;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;immediately after giving effect to such transaction on
    a pro forma basis, the Issuer could incur $1.00 of additional
    Indebtedness under the provisions of the first paragraph of the
    covenant described under &#147;&#151;&#160;Limitation on
    Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock&#148;;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;such Restricted Payment, together with the aggregate
    amount of all other Restricted Payments made by the Issuer and
    its Restricted Subsidiaries after November&#160;17, 2006
    (including Restricted Payments permitted by clauses (1), (2)
    (with respect to the payment of dividends on Refunding Capital
    Stock (as defined below) pursuant to clause&#160;(b) thereof
    only), (6)(c), (9)&#160;and (14)&#160;of the next succeeding
    paragraph, but excluding all other Restricted Payments permitted
    by the next succeeding paragraph), is less than the sum of
    (without duplication):
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;50% of the Consolidated Net Income of the Issuer for
    the period (taken as one accounting period) beginning
    October&#160;1, 2006, to the end of the Issuer&#146;s most
    recently ended fiscal quarter for which internal financial
    statements are available at the time of such Restricted Payment,
    or, in the case such Consolidated Net Income for such period is
    a deficit, minus 100% of such deficit; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;100% of the aggregate net cash proceeds and the fair
    market value, as determined in good faith by the Issuer, of
    marketable securities or other property received by the Issuer
    since
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    138
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    immediately after November&#160;17, 2006 (other than net cash
    proceeds to the extent such net cash proceeds have been used to
    incur Indebtedness, Disqualified Stock or Preferred Stock
    pursuant to clause (12)(a) of the second paragraph of
    &#147;&#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock&#148;) from
    the issue or sale of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (i)&#160;(A)&#160;Equity Interests of the Issuer, including
    Treasury Capital Stock (as defined below), but excluding cash
    proceeds and the fair market value, as determined in good faith
    by the Issuer, of marketable securities or other property
    received from the sale of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (x)&#160;Equity Interests to members of management, directors or
    consultants of the Issuer, any direct or indirect parent company
    of the Issuer and the Issuer&#146;s Subsidiaries after
    November&#160;17, 2006 to the extent such amounts have been
    applied to Restricted Payments made in accordance with
    clause&#160;(4) of the next succeeding paragraph;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (y)&#160;Designated Preferred Stock;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (B)&#160;to the extent such net cash proceeds are actually
    contributed to the Issuer, Equity Interests of the Issuer&#146;s
    direct or indirect parent companies (excluding contributions of
    the proceeds from the sale of Designated Preferred Stock of such
    companies or contributions to the extent such amounts have been
    applied to Restricted Payments made in accordance with
    clause&#160;(4) of the next succeeding paragraph);&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (ii)&#160;debt securities of the Issuer that have been converted
    into or exchanged for such Equity Interests of the Issuer;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided</I>, <I>however</I>, that this clause&#160;(b) shall
    not include the proceeds from (V)&#160;Refunding Capital Stock
    (as defined below), (W)&#160;Equity Interests or convertible
    debt securities of the Issuer sold to a Restricted Subsidiary,
    as the case may be, (X)&#160;Disqualified Stock or debt
    securities that have been converted into Disqualified Stock,
    (Y)&#160;Excluded Contributions or (Z)&#160;the Delayed Equity
    Amount; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;100% of the aggregate amount of cash and the fair
    market value, as determined in good faith by the Issuer, of
    marketable securities or other property contributed to the
    capital of the Issuer following November&#160;17, 2006 (other
    than net cash proceeds to the extent such net cash proceeds
    (i)&#160;have been used to incur Indebtedness, Disqualified
    Stock or Preferred Stock pursuant to clause (12)(a) of the
    second paragraph of &#147;&#151;&#160;Limitation on Incurrence
    of Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock,&#148; (ii)&#160;are contributed by a Restricted
    Subsidiary, (iii)&#160;constitute Excluded Contributions or
    (iv)&#160;constitute the Delayed Equity Amount); <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;100% of the aggregate amount received in cash and the
    fair market value, as determined in good faith by the Issuer, of
    marketable securities or other property received by means of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (i)&#160;the sale or other disposition (other than to the Issuer
    or a Restricted Subsidiary) of Restricted Investments made by
    the Issuer or its Restricted Subsidiaries and repurchases and
    redemptions of such Restricted Investments from the Issuer or
    its Restricted Subsidiaries and repayments of loans or advances,
    and releases of guarantees, which constitute Restricted
    Investments by the Issuer or its Restricted Subsidiaries, in
    each case after November&#160;17, 2006;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (ii)&#160;the sale (other than to the Issuer or a Restricted
    Subsidiary) of the stock of an Unrestricted Subsidiary or a
    distribution from an Unrestricted Subsidiary (other than in each
    case to the extent the Investment in such Unrestricted
    Subsidiary was made by the Issuer or a Restricted Subsidiary
    pursuant to clause&#160;(7) of the next succeeding paragraph or
    to the extent such Investment constituted a Permitted
    Investment) or a dividend from an Unrestricted Subsidiary after
    November&#160;17, 2006; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;in the case of the redesignation of an Unrestricted
    Subsidiary as a Restricted Subsidiary after November&#160;17,
    2006, the fair market value of the Investment in such
    Unrestricted Subsidiary, as
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    139
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    determined by the Issuer in good faith (or if such fair market
    value exceeds $250.0&#160;million, in writing by an Independent
    Financial Advisor), at the time of the redesignation of such
    Unrestricted Subsidiary as a Restricted Subsidiary other than to
    the extent the Investment in such Unrestricted Subsidiary was
    made by the Issuer or a Restricted Subsidiary pursuant to
    clause&#160;(7) of the next succeeding paragraph or to the
    extent such Investment constituted a Permitted Investment.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The foregoing provisions will not prohibit:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the payment of any dividend within 60&#160;days after
    the date of declaration thereof, if at the date of declaration
    such payment would have complied with the provisions of the
    Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;(a)&#160;the redemption, repurchase, retirement or
    other acquisition of any Equity Interests <I>(&#147;Treasury
    Capital Stock&#148;) </I>or Subordinated Indebtedness of the
    Issuer or any Equity Interests of any direct or indirect parent
    company of the Issuer, in exchange for, or out of the proceeds
    of the substantially concurrent sale (other than to a Restricted
    Subsidiary) of, Equity Interests of the Issuer or any direct or
    indirect parent company of the Issuer to the extent contributed
    to the Issuer (in each case, other than any Disqualified Stock)
    <I>(&#147;Refunding Capital Stock&#148;)</I> and (b)&#160;if
    immediately prior to the retirement of Treasury Capital Stock,
    the declaration and payment of dividends thereon was permitted
    under clause&#160;(6) of this paragraph, the declaration and
    payment of dividends on the Refunding Capital Stock (other than
    Refunding Capital Stock the proceeds of which were used to
    redeem, repurchase, retire or otherwise acquire any Equity
    Interests of any direct or indirect parent company of the
    Issuer) in an aggregate amount per year no greater than the
    aggregate amount of dividends per annum that were declarable and
    payable on such Treasury Capital Stock immediately prior to such
    retirement;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;the redemption, repurchase or other acquisition or
    retirement of Subordinated Indebtedness of the Issuer or a
    Guarantor made in exchange for, or out of the proceeds of the
    substantially concurrent sale of, new Indebtedness of the Issuer
    or a Guarantor, as the case may be, which is incurred in
    compliance with &#147;&#151;&#160;Limitation on Incurrence of
    Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock&#148; so long as:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;the principal amount (or accreted value) of such new
    Indebtedness does not exceed the principal amount of (or
    accreted value, if applicable), plus any accrued and unpaid
    interest on, the Subordinated Indebtedness being so redeemed,
    repurchased, acquired or retired for value, plus the amount of
    any reasonable premium (including reasonable tender premiums),
    defeasance costs and any reasonable fees and expenses incurred
    in connection with the issuance of such new Indebtedness;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;such new Indebtedness is subordinated to the Notes or
    the applicable Guarantee at least to the same extent as such
    Subordinated Indebtedness so purchased, exchanged, redeemed,
    repurchased, acquired or retired for value;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;such new Indebtedness has a final scheduled maturity
    date equal to or later than the final scheduled maturity date of
    the Subordinated Indebtedness being so redeemed, repurchased,
    acquired or retired;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;such new Indebtedness has a Weighted Average Life to
    Maturity equal to or greater than the remaining Weighted Average
    Life to Maturity of the Subordinated Indebtedness being so
    redeemed, repurchased, acquired or retired;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;a Restricted Payment to pay for the repurchase,
    retirement or other acquisition or retirement for value of
    Equity Interests (other than Disqualified Stock) of the Issuer
    or any of its direct or indirect parent companies held by any
    future, present or former employee, director or consultant of
    the Issuer, any of its Subsidiaries or any of its direct or
    indirect parent companies pursuant to any management equity plan
    or stock option plan or any other management or employee benefit
    plan or agreement, including any Equity Interests rolled over by
    management of the Company or any of its direct or indirect
    parent companies in connection with the Transaction;
    <I>provided</I>, <I>however</I>, that the aggregate Restricted
    Payments made under this clause&#160;(4) do not exceed in any
    calendar year $75.0&#160;million (which shall increase to
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    140
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    $150.0&#160;million subsequent to the consummation of an
    underwritten public Equity Offering by the Issuer or any direct
    or indirect parent entity of the Issuer) (with unused amounts in
    any calendar year being carried over to succeeding calendar
    years subject to a maximum (without giving effect to the
    following proviso) of $225.0&#160;million in any calendar year
    (which shall increase to $450.0&#160;million subsequent to the
    consummation of an underwritten public Equity Offering by the
    Issuer or any direct or indirect parent corporation of the
    Issuer)); <I>provided further </I>that such amount in any
    calendar year may be increased by an amount not to exceed:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;the cash proceeds from the sale of Equity Interests
    (other than Disqualified Stock) of the Issuer and, to the extent
    contributed to the Issuer, Equity Interests of any of the
    Issuer&#146;s direct or indirect parent companies, in each case
    to members of management, directors or consultants of the
    Issuer, any of its Subsidiaries or any of its direct or indirect
    parent companies that occurs after November&#160;17, 2006, to
    the extent the cash proceeds from the sale of such Equity
    Interests have not otherwise been applied to the payment of
    Restricted Payments by virtue of clause&#160;(3) of the
    preceding paragraph; plus
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the cash proceeds of key man life insurance policies
    received by the Issuer or its Restricted Subsidiaries after
    November&#160;17, 2006; less
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;the amount of any Restricted Payments previously made
    with the cash proceeds described in clauses&#160;(a) and
    (b)&#160;of this clause (4);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    and <I>provided</I>, <I>further</I>, that cancellation of
    Indebtedness owing to the Issuer or any Restricted Subsidiary
    from members of management of the Issuer, any of the
    Issuer&#146;s direct or indirect parent companies or any of the
    Issuer&#146;s Restricted Subsidiaries in connection with a
    repurchase of Equity Interests of the Issuer or any of its
    direct or indirect parent companies will not be deemed to
    constitute a Restricted Payment for purposes of this covenant or
    any other provision of the Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;the declaration and payment of dividends to holders of
    any class or series of Disqualified Stock of the Issuer or any
    of its Restricted Subsidiaries or any class or series of
    Preferred Stock of any Restricted Subsidiary issued in
    accordance with the covenant described under
    &#147;&#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock&#148; to the
    extent such dividends are included in the definition of
    &#147;Fixed Charges&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;(a)&#160;the declaration and payment of dividends to
    holders of any class or series of Designated Preferred Stock
    (other than Disqualified Stock) issued by the Issuer after
    November&#160;17, 2006;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the declaration and payment of dividends to a direct or
    indirect parent company of the Issuer, the proceeds of which
    will be used to fund the payment of dividends to holders of any
    class or series of Designated Preferred Stock (other than
    Disqualified Stock) of such parent corporation issued after the
    Issue Date; provided that the amount of dividends paid pursuant
    to this clause&#160;(b) shall not exceed the aggregate amount of
    cash actually contributed to the Issuer from the sale of such
    Designated Preferred Stock;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;the declaration and payment of dividends on Refunding
    Capital Stock that is Preferred Stock in excess of the dividends
    declarable and payable thereon pursuant to clause&#160;(2) of
    this paragraph;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided</I>, <I>however</I>, in the case of each of
    (a)&#160;and (c)&#160;of this clause (6), that for the most
    recently ended four full fiscal quarters for which internal
    financial statements are available immediately preceding the
    date of issuance of such Designated Preferred Stock or the
    declaration of such dividends on Refunding Capital Stock that is
    Preferred Stock, after giving effect to such issuance or
    declaration on a pro forma basis, the Issuer and its Restricted
    Subsidiaries on a consolidated basis would have had a Fixed
    Charge Coverage Ratio of at least 2.00 to 1.00;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;Investments in Unrestricted Subsidiaries having an
    aggregate fair market value, taken together with all other
    Investments made pursuant to this clause&#160;(7) that are at
    the time outstanding, without giving effect to the sale of an
    Unrestricted Subsidiary to the extent the proceeds of such sale
    do not consist of cash or marketable securities, not to exceed
    2.5% of Total Assets at the time of such Investment (with the
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    141
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    fair market value of each Investment being measured at the time
    made and without giving effect to subsequent changes in value);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;repurchases of Equity Interests deemed to occur upon
    exercise of stock options or warrants if such Equity Interests
    represent a portion of the exercise price of such options or
    warrants;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;the declaration and payment of dividends on the
    Issuer&#146;s common stock (or the payment of dividends to any
    direct or indirect parent entity to fund a payment of dividends
    on such entity&#146;s common stock), following consummation of
    the first public offering of the Issuer&#146;s common stock or
    the common stock of any of its direct or indirect parent
    companies after November&#160;17, 2006, of up to 6% per annum of
    the net cash proceeds received by or contributed to the Issuer
    in or from any such public offering, other than public offerings
    with respect to the Issuer&#146;s common stock registered on
    <FONT style="white-space: nowrap">Form&#160;S-8</FONT>
    and other than any public sale constituting an Excluded
    Contribution;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;Restricted Payments that are made with Excluded
    Contributions;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;other Restricted Payments in an aggregate amount taken
    together with all other Restricted Payments made pursuant to
    this clause&#160;(11) not to exceed 3.0% of Total Assets at the
    time made;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;distributions or payments of Receivables Fees;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;any Restricted Payment used to fund amounts owed to
    Affiliates (including dividends to any direct or indirect parent
    of the Issuer to permit payment by such parent of such amount),
    in each case to the extent permitted by the covenant described
    under &#147;&#151;&#160;Transactions with Affiliates&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (14)&#160;the repurchase, redemption or other acquisition or
    retirement for value of any Subordinated Indebtedness in
    accordance with the provisions similar to those described under
    the captions &#147;Repurchase at the Option of
    Holders&#160;&#151; Change of Control&#148; and &#147;Repurchase
    at the Option of Holders&#160;&#151; Asset Sales&#148;; provided
    that all Notes tendered by Holders in connection with a Change
    of Control Offer, Collateral Asset Sale Offer or Asset Sale
    Offer, as applicable, have been repurchased, redeemed or
    acquired for value;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (15)&#160;the declaration and payment of dividends by the Issuer
    to, or the making of loans to, any direct or indirect parent in
    amounts required for any direct or indirect parent companies to
    pay, in each case without duplication,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;franchise and excise taxes and other fees, taxes and
    expenses required to maintain their corporate existence;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;foreign, federal, state and local income taxes, to the
    extent such income taxes are attributable to the income of the
    Issuer and its Restricted Subsidiaries and, to the extent of the
    amount actually received from its Unrestricted Subsidiaries, in
    amounts required to pay such taxes to the extent attributable to
    the income of such Unrestricted Subsidiaries; provided that in
    each case the amount of such payments in any fiscal year does
    not exceed the amount that the Issuer and its Restricted
    Subsidiaries would be required to pay in respect of foreign,
    federal, state and local taxes for such fiscal year were the
    Issuer, its Restricted Subsidiaries and its Unrestricted
    Subsidiaries (to the extent described above) to pay such taxes
    separately from any such parent entity;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;for as long as Hercules Holding II, LLC is a parent of
    the Issuer, distributions equal to any taxable income of
    Hercules Holding II, LLC resulting from the Hedging Arrangements
    multiplied by 45%;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;customary salary, bonus and other benefits payable to
    officers and employees of any direct or indirect parent company
    of the Issuer to the extent such salaries, bonuses and other
    benefits are attributable to the ownership or operation of the
    Issuer and its Restricted Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;general corporate operating and overhead costs and
    expenses of any direct or indirect parent company of the Issuer
    to the extent such costs and expenses are attributable to the
    ownership or operation of the Issuer and its Restricted
    Subsidiaries;&#160;and
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    142
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (f)&#160;fees and expenses other than to Affiliates of the
    Issuer related to any unsuccessful equity or debt offering of
    such parent entity;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (16)&#160;the distribution, by dividend or otherwise, of shares
    of Capital Stock of, or Indebtedness owed to the Issuer or a
    Restricted Subsidiary by, Unrestricted Subsidiaries (other than
    Unrestricted Subsidiaries, the primary assets of which are cash
    <FONT style="white-space: nowrap">and/or</FONT> Cash
    Equivalents);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided</I>, <I>however</I>, that at the time of, and after
    giving effect to, any Restricted Payment permitted under
    clauses&#160;(11) and (16), no Default shall have occurred and
    be continuing or would occur as a consequence thereof.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    As of the Issue Date, all of the Issuer&#146;s Subsidiaries are
    Restricted Subsidiaries. The Issuer will not permit any
    Unrestricted Subsidiary to become a Restricted Subsidiary except
    pursuant to the last sentence of the definition of
    &#147;Unrestricted Subsidiary.&#148; For purposes of designating
    any Restricted Subsidiary as an Unrestricted Subsidiary, all
    outstanding Investments by the Issuer and its Restricted
    Subsidiaries (except to the extent repaid) in the Subsidiary so
    designated will be deemed to be Restricted Payments in an amount
    determined as set forth in the last sentence of the definition
    of &#147;Investment.&#148; Such designation will be permitted
    only if a Restricted Payment in such amount would be permitted
    at such time, whether pursuant to the first paragraph of this
    covenant or under clause (7), (10)&#160;or (11)&#160;of the
    second paragraph of this covenant, or pursuant to the definition
    of &#147;Permitted Investments,&#148; and if such Subsidiary
    otherwise meets the definition of an Unrestricted Subsidiary.
    Unrestricted Subsidiaries are not be subject to any of the
    restrictive covenants set forth in the Indenture.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, directly or indirectly, create, incur, issue,
    assume, guarantee or otherwise become directly or indirectly
    liable, contingently or otherwise (collectively,
    <I>&#147;incur&#148;</I> and collectively, an
    <I>&#147;incurrence&#148;</I>) with respect to any Indebtedness
    (including Acquired Indebtedness), and the Issuer will not issue
    any shares of Disqualified Stock and will not permit any
    Restricted Subsidiary to issue any shares of Disqualified Stock
    or Preferred Stock; <I>provided</I>, <I>however</I>, that the
    Issuer may incur Indebtedness (including Acquired Indebtedness)
    or issue shares of Disqualified Stock, and any of its Restricted
    Subsidiaries may incur Indebtedness (including Acquired
    Indebtedness), issue shares of Disqualified Stock and issue
    shares of Preferred Stock, if the Fixed Charge Coverage Ratio on
    a consolidated basis for the Issuer and its Restricted
    Subsidiaries&#146; most recently ended four fiscal quarters for
    which internal financial statements are available immediately
    preceding the date on which such additional Indebtedness is
    incurred or such Disqualified Stock or Preferred Stock is issued
    would have been at least 2.00 to 1.00, determined on a pro forma
    basis (including a pro forma application of the net proceeds
    therefrom), as if the additional Indebtedness had been incurred,
    or the Disqualified Stock or Preferred Stock had been issued, as
    the case may be, and the application of proceeds therefrom had
    occurred at the beginning of such four-quarter period;
    <I>provided, further,</I> that Restricted Subsidiaries that are
    not Guarantors may not incur Indebtedness or Disqualified Stock
    or Preferred Stock if, after giving pro forma effect to such
    incurrence or issuance (including a pro forma application of the
    net proceeds therefrom), more than an aggregate of
    $2,000.0&#160;million of Indebtedness or Disqualified Stock or
    Preferred Stock of Restricted Subsidiaries that are not
    Guarantors would be outstanding pursuant to this paragraph and
    clauses (12), (14)&#160;and (19)&#160;below at such time.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The foregoing limitations will not apply to:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the incurrence of Indebtedness under (x)&#160;Credit
    Facilities (other than the ABL Facility) by the Issuer or any of
    its Restricted Subsidiaries and the issuance and creation of
    letters of credit and bankers&#146; acceptances thereunder (with
    letters of credit and bankers&#146; acceptances being deemed to
    have a principal amount equal to the face amount thereof), up to
    an aggregate principal amount of $16,500.0&#160;million
    outstanding at any one time and (y)&#160;the ABL Facility by the
    Issuer or any of its Restricted Subsidiaries and the issuance
    and creation of letters of credit and bankers&#146; acceptances
    thereunder (with letters of credit and bankers&#146; acceptances
    being deemed to have a principal amount equal to the face amount
    thereof), up to an aggregate principal amount equal to the ABL
    Facility Cap;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    143
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the incurrence by the Issuer and any Guarantor of
    Indebtedness represented by the Notes (including any Guarantee)
    (other than any Additional Notes and any Exchange Notes
    (including Guarantees thereof));
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;Indebtedness of the Issuer and its Restricted
    Subsidiaries in existence on the Issue Date (other than
    Indebtedness described in clauses&#160;(1) and (2)), including
    the 2006 Notes and the Existing Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;Indebtedness consisting of Capitalized Lease
    Obligations and Purchase Money Obligations; so long as such
    Indebtedness exists at the date of such purchase, lease or
    improvement, or is created within 270&#160;days thereafter;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;Indebtedness incurred by the Issuer or any of its
    Restricted Subsidiaries constituting reimbursement obligations
    with respect to letters of credit issued in the ordinary course
    of business, including letters of credit in respect of
    workers&#146; compensation, medical malpractice or employee
    health claims, or other Indebtedness with respect to
    reimbursement-type obligations regarding workers&#146;
    compensation, medical malpractice or employee health claims;
    provided, however, that upon the drawing of such letters of
    credit or the incurrence of such Indebtedness, such obligations
    are reimbursed within 30&#160;days following such drawing or
    incurrence;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;Indebtedness arising from agreements of the Issuer or
    its Restricted Subsidiaries providing for indemnification,
    adjustment of purchase price or similar obligations, in each
    case, incurred or assumed in connection with the disposition of
    any business, assets or a Subsidiary, other than guarantees of
    Indebtedness incurred by any Person acquiring all or any portion
    of such business, assets or a Subsidiary for the purpose of
    financing such acquisition; provided, however, that such
    Indebtedness is not reflected on the balance sheet of the
    Issuer, or any of its Restricted Subsidiaries (contingent
    obligations referred to in a footnote to financial statements
    and not otherwise reflected on the balance sheet will not be
    deemed to be reflected on such balance sheet for purposes of
    this clause (6));
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;Indebtedness of the Issuer to a Restricted Subsidiary;
    provided that any such Indebtedness owing to a Restricted
    Subsidiary that is not a Guarantor is expressly subordinated in
    right of payment to the Notes; provided, further, that any
    subsequent issuance or transfer of any Capital Stock or any
    other event which results in any Restricted Subsidiary ceasing
    to be a Restricted Subsidiary or any other subsequent transfer
    of any such Indebtedness (except to the Issuer or another
    Restricted Subsidiary) shall be deemed, in each case, to be an
    incurrence of such Indebtedness;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;Indebtedness of a Restricted Subsidiary to the Issuer
    or another Restricted Subsidiary; provided that if a Guarantor
    incurs such Indebtedness to a Restricted Subsidiary that is not
    a Guarantor, such Indebtedness is expressly subordinated in
    right of payment to the Guarantee of the Notes of such
    Guarantor; provided, further, that any subsequent transfer of
    any such Indebtedness (except to the Issuer or another
    Restricted Subsidiary) shall be deemed, in each case, to be an
    incurrence of such Indebtedness not permitted by this clause (8);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;shares of Preferred Stock of a Restricted Subsidiary
    issued to the Issuer or another Restricted Subsidiary; provided
    that any subsequent issuance or transfer of any Capital Stock or
    any other event which results in any such Restricted Subsidiary
    ceasing to be a Restricted Subsidiary or any other subsequent
    transfer of any such shares of Preferred Stock (except to the
    Issuer or another of its Restricted Subsidiaries) shall be
    deemed in each case to be an issuance of such shares of
    Preferred Stock not permitted by this clause (9);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;Hedging Obligations (excluding Hedging Obligations
    entered into for speculative purposes) for the purpose of
    limiting interest rate risk with respect to any Indebtedness
    permitted to be incurred pursuant to
    &#147;&#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock,&#148;
    exchange rate risk or commodity pricing risk;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;obligations in respect of performance, bid, appeal and
    surety bonds and completion guarantees provided by the Issuer or
    any of its Restricted Subsidiaries in the ordinary course of
    business;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    144
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;(a)&#160;Indebtedness or Disqualified Stock of the
    Issuer and Indebtedness, Disqualified Stock or Preferred Stock
    of the Issuer or any Restricted Subsidiary equal to 200.0% of
    the net cash proceeds received by the Issuer since immediately
    after November&#160;17, 2006 from the issue or sale of Equity
    Interests of the Issuer or cash contributed to the capital of
    the Issuer (in each case, other than Excluded Contributions or
    proceeds of Disqualified Stock or sales of Equity Interests to
    the Issuer or any of its Subsidiaries) as determined in
    accordance with clauses (3)(b) and (3)(c) of the first paragraph
    of &#147;&#151;&#160;Limitation on Restricted Payments&#148; to
    the extent such net cash proceeds or cash have not been applied
    pursuant to such clauses to make Restricted Payments or to make
    other Investments, payments or exchanges pursuant to the second
    paragraph of &#147;&#151;&#160;Limitation on Restricted
    Payments&#148; or to make Permitted Investments (other than
    Permitted Investments specified in clauses&#160;(1) and
    (3)&#160;of the definition thereof) and (b)&#160;Indebtedness or
    Disqualified Stock of Issuer and Indebtedness, Disqualified
    Stock or Preferred Stock of the Issuer or any Restricted
    Subsidiary not otherwise permitted hereunder in an aggregate
    principal amount or liquidation preference, which when
    aggregated with the principal amount and liquidation preference
    of all other Indebtedness, Disqualified Stock and Preferred
    Stock then outstanding and incurred pursuant to this clause
    (12)(b), does not at any one time outstanding exceed
    $1,500.0&#160;million; provided, however, that on a pro forma
    basis, together with any amounts incurred and outstanding by
    Restricted Subsidiaries that are not Guarantors pursuant to the
    second proviso to the first paragraph of this covenant and
    clauses&#160;(14) and (19), no more than $2,000.0&#160;million
    of Indebtedness, Disqualified Stock or Preferred Stock at any
    one time outstanding and incurred pursuant to this clause
    (12)(b) shall be incurred by Restricted Subsidiaries that are
    not Guarantors (it being understood that any Indebtedness,
    Disqualified Stock or Preferred Stock incurred pursuant to this
    clause (12)(b) shall cease to be deemed incurred or outstanding
    for purposes of this clause (12)(b) but shall be deemed incurred
    for the purposes of the first paragraph of this covenant from
    and after the first date on which the Issuer or such Restricted
    Subsidiary could have incurred such Indebtedness, Disqualified
    Stock or Preferred Stock under the first paragraph of this
    covenant without reliance on this clause (12)(b));
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;the incurrence or issuance by the Issuer or any
    Restricted Subsidiary of Indebtedness, Disqualified Stock or
    Preferred Stock which serves to refund or refinance any
    Indebtedness, Disqualified Stock or Preferred Stock of the
    Issuer or any Restricted Subsidiary incurred as permitted under
    the first paragraph of this covenant and clauses (2), (3),
    (4)&#160;and (12)(a) above, this clause&#160;(13) and
    clause&#160;(14) below or any Indebtedness, Disqualified Stock
    or Preferred Stock of the Issuer or any Restricted Subsidiary
    issued to so refund or refinance such Indebtedness, Disqualified
    Stock or Preferred Stock of the Issuer or any Restricted
    Subsidiary including additional Indebtedness, Disqualified Stock
    or Preferred Stock incurred to pay premiums (including
    reasonable tender premiums), defeasance costs and fees in
    connection therewith (the &#147;Refinancing Indebtedness&#148;)
    prior to its respective maturity; provided, however, that such
    Refinancing Indebtedness:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;has a Weighted Average Life to Maturity at the time
    such Refinancing Indebtedness is incurred which is not less than
    the remaining Weighted Average Life to Maturity of the
    Indebtedness, Disqualified Stock or Preferred Stock being
    refunded or refinanced,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;to the extent such Refinancing Indebtedness refinances
    (i)&#160;Indebtedness subordinated or <I>pari passu </I>to the
    Notes or any Guarantee thereof, such Refinancing Indebtedness is
    subordinated or <I>pari passu </I>to the Notes or the Guarantee
    at least to the same extent as the Indebtedness being refinanced
    or refunded or (ii)&#160;Disqualified Stock or Preferred Stock,
    such Refinancing Indebtedness must be Disqualified Stock or
    Preferred Stock, respectively,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;shall not include Indebtedness, Disqualified Stock or
    Preferred Stock of a Subsidiary of the Issuer that is not a
    Guarantor that refinances Indebtedness, Disqualified Stock or
    Preferred Stock of the Issuer or a Guarantor;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    and, <I>provided</I>, <I>further</I>, that subclause&#160;(a) of
    this clause&#160;(13) will not apply to any refunding or
    refinancing of any Priority Lien Obligations and Obligations
    secured by Permitted Liens;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (14)&#160;Indebtedness, Disqualified Stock or Preferred Stock of
    (x)&#160;the Issuer or a Restricted Subsidiary incurred to
    finance an acquisition or (y)&#160;Persons that are acquired by
    the Issuer or any Restricted
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    145
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Subsidiary or merged into the Issuer or a Restricted Subsidiary
    in accordance with the terms of the Indenture; <I>provided
    </I>that after giving effect to such acquisition or merger,
    either
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;the Issuer would be permitted to incur at least $1.00
    of additional Indebtedness pursuant to the Fixed Charge Coverage
    Ratio test set forth in the first sentence of this
    covenant,&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the Fixed Charge Coverage Ratio of the Issuer and the
    Restricted Subsidiaries is greater than immediately prior to
    such acquisition or merger;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided</I>, <I>however</I>, that on a pro forma basis,
    together with amounts incurred and outstanding pursuant to the
    second proviso to the first paragraph of this covenant and
    clauses&#160;(12) and (19), no more than $2,000.0&#160;million
    of Indebtedness, Disqualified Stock or Preferred Stock at any
    one time outstanding and incurred by Restricted Subsidiaries
    that are not Guarantors pursuant to this clause&#160;(14) shall
    be incurred and outstanding;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (15)&#160;Indebtedness arising from the honoring by a bank or
    other financial institution of a check, draft or similar
    instrument drawn against insufficient funds in the ordinary
    course of business; <I>provided </I>that such Indebtedness is
    extinguished within two Business Days of its incurrence;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (16)&#160;Indebtedness of the Issuer or any of its Restricted
    Subsidiaries supported by a letter of credit issued pursuant to
    any Credit Facilities, in a principal amount not in excess of
    the stated amount of such letter of credit;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (17)&#160;(a)&#160;any guarantee by the Issuer or a Restricted
    Subsidiary of Indebtedness or other obligations of any
    Restricted Subsidiary, so long as the incurrence of such
    Indebtedness incurred by such Restricted Subsidiary is permitted
    under the terms of the Indenture, or (b)&#160;any guarantee by a
    Restricted Subsidiary of Indebtedness of the Issuer; <I>provided
    </I>that such guarantee is incurred in accordance with the
    covenant described below under &#147;&#151;&#160;Limitation on
    Guarantees of Indebtedness by Restricted Subsidiaries&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (18)&#160;Indebtedness of Foreign Subsidiaries of the Issuer in
    an amount not to exceed at any one time outstanding and together
    with any other Indebtedness incurred under this clause&#160;(18)
    7.5% of the Total Assets of the Foreign Subsidiaries (it being
    understood that any Indebtedness incurred pursuant to this
    clause&#160;(18) shall cease to be deemed incurred or
    outstanding for purposes of this clause&#160;(18) but shall be
    deemed incurred for the purposes of the first paragraph of this
    covenant from and after the first date on which the Issuer or
    such Restricted Subsidiaries could have incurred such
    Indebtedness under the first paragraph of this covenant without
    reliance on this clause (18));
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (19)&#160;Indebtedness, Disqualified Stock or Preferred Stock of
    a Restricted Subsidiary incurred to finance or assumed in
    connection with an acquisition in a principal amount not to
    exceed $200.0&#160;million in the aggregate at any one time
    outstanding together with all other Indebtedness, Disqualified
    Stock <FONT style="white-space: nowrap">and/or</FONT>
    Preferred Stock issued under this clause (19) (it being
    understood that any Indebtedness, Disqualified Stock or
    Preferred Stock incurred pursuant to this clause&#160;(19) shall
    cease to be deemed incurred or outstanding for purposes of this
    clause&#160;(19) but shall be deemed incurred for the purposes
    of the first paragraph of this covenant from and after the first
    date on which such Restricted Subsidiary could have incurred
    such Indebtedness, Disqualified Stock or Preferred Stock under
    the first paragraph of this covenant without reliance on this
    clause (19)); <I>provided</I>, <I>however</I>, that on a pro
    forma basis, together with amounts incurred and outstanding by
    Restricted Subsidiaries that are not Guarantors pursuant to the
    second proviso to the first paragraph of this covenant and
    clauses&#160;(12) and (14), no more than $2,000.0&#160;million
    of Indebtedness would be incurred and outstanding by Restricted
    Subsidiaries that are not Guarantors;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (20)&#160;Indebtedness of the Issuer or any of its Restricted
    Subsidiaries consisting of (i)&#160;the financing of insurance
    premiums or
    <FONT style="white-space: nowrap">(ii)&#160;take-or-pay</FONT>
    obligations contained in supply arrangements, in each case,
    incurred in the ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (21)&#160;Indebtedness consisting of Indebtedness issued by the
    Issuer or any of its Restricted Subsidiaries to current or
    former officers, directors and employees thereof, their
    respective estates, spouses or former spouses, in each case to
    finance the purchase or redemption of Equity Interests of the
    Issuer or
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    146
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    any direct or indirect parent company of the Issuer to the
    extent described in clause&#160;(4) of the second paragraph
    under the caption &#147;&#151;&#160;Limitation on Restricted
    Payments&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (22)&#160;Physician Support Obligations incurred by the Issuer
    or any Restricted Subsidiary;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (23)&#160;Indebtedness of the Issuer or any of its Restricted
    Subsidiaries undertaken in connection with cash management and
    related activities with respect to any Subsidiary or joint
    venture operating one or more healthcare facilities, including,
    without limitation, hospitals, ambulatory surgery centers,
    outpatient diagnostic centers or imaging centers, in each case,
    in the ordinary course of business.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For purposes of determining compliance with this covenant:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;in the event that an item of Indebtedness, Disqualified
    Stock or Preferred Stock (or any portion thereof) meets the
    criteria of more than one of the categories of permitted
    Indebtedness, Disqualified Stock or Preferred Stock described in
    clauses&#160;(1) through (23)&#160;above or is entitled to be
    incurred pursuant to the first paragraph of this covenant, the
    Issuer, in its sole discretion, will classify or reclassify such
    item of Indebtedness, Disqualified Stock or Preferred Stock (or
    any portion thereof) and will only be required to include the
    amount and type of such Indebtedness, Disqualified Stock or
    Preferred Stock in one of the above clauses; <I>provided
    </I>that all Indebtedness outstanding under the Credit
    Facilities on November&#160;17, 2006 will be treated as incurred
    on November&#160;17, 2006 under clause&#160;(1) of the preceding
    paragraph;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;at the time of incurrence, the Issuer will be entitled
    to divide and classify an item of Indebtedness in more than one
    of the types of Indebtedness described in the first and second
    paragraphs above.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Accrual of interest, the accretion of accreted value and the
    payment of interest in the form of additional Indebtedness,
    Disqualified Stock or Preferred Stock will not be deemed to be
    an incurrence of Indebtedness, Disqualified Stock or Preferred
    Stock for purposes of this covenant.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For purposes of determining compliance with any
    U.S.&#160;dollar-denominated restriction on the incurrence of
    Indebtedness, the U.S.&#160;dollar-equivalent principal amount
    of Indebtedness denominated in a foreign currency shall be
    calculated based on the relevant currency exchange rate in
    effect on the date such Indebtedness was incurred, in the case
    of term debt, or first committed, in the case of revolving
    credit debt; <I>provided </I>that if such Indebtedness is
    incurred to refinance other Indebtedness denominated in a
    foreign currency, and such refinancing would cause the
    applicable U.S.&#160;dollar-denominated restriction to be
    exceeded if calculated at the relevant currency exchange rate in
    effect on the date of such refinancing, such
    U.S.&#160;dollar-denominated restriction shall be deemed not to
    have been exceeded so long as the principal amount of such
    refinancing Indebtedness does not exceed the principal amount of
    such Indebtedness being refinanced.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The principal amount of any Indebtedness incurred to refinance
    other Indebtedness, if incurred in a different currency from the
    Indebtedness being refinanced, shall be calculated based on the
    currency exchange rate applicable to the currencies in which
    such respective Indebtedness is denominated that is in effect on
    the date of such refinancing.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that the Issuer will not, and will not
    permit any Guarantor to, directly or indirectly, incur any
    Indebtedness (including Acquired Indebtedness) that is
    subordinated or junior in right of payment to any Indebtedness
    of the Issuer or such Guarantor, as the case may be, unless such
    Indebtedness is expressly subordinated in right of payment to
    the Notes or such Guarantor&#146;s Guarantee to the extent and
    in the same manner as such Indebtedness is subordinated to other
    Indebtedness of the Issuer or such Guarantor, as the case may be.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture does not treat (1)&#160;unsecured Indebtedness as
    subordinated or junior to Secured Indebtedness merely because it
    is unsecured or (2)&#160;Senior Indebtedness as subordinated or
    junior to any other Senior Indebtedness merely because it has a
    junior priority with respect to the same collateral.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    147
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Limitation
    on Prepayment or Modification of Existing Notes</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, directly or indirectly purchase, redeem,
    defease or otherwise acquire or retire for value any of the
    Existing Notes prior to the final maturity date thereof (as in
    effect on November&#160;17, 2006); <I>provided </I>that the
    Issuer may:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;purchase, redeem, defease or otherwise acquire or
    retire for value any of the Existing Notes which have a final
    maturity date (as in effect on November&#160;17, 2006)&#160;on
    or prior to December&#160;31, 2011;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;purchase, redeem, defease or otherwise acquire or
    retire for value any other Existing Notes which have a final
    maturity date (as in effect on November&#160;17, 2006)&#160;on
    or prior to November&#160;15, 2016; <I>provided </I>that, in the
    case of any such prepayment funded with the proceeds of the
    issuance of Secured Indebtedness, at the time of incurrence and
    after giving pro forma effect thereto and to the application of
    the proceeds thereof, (x)&#160;the Consolidated Secured Debt
    Ratio would be no greater than 5.25 to 1.0 and (y)&#160;the
    Consolidated Leverage Ratio would be no greater than 7.0 to 1.0.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, amend the Existing Notes Indenture, or any
    supplemental indenture in respect thereof, in any way to advance
    the final maturity date or shorten the Weighted Average Life to
    Maturity of any series of the Existing Notes such that any
    Existing Notes with a maturity date following the maturity of
    the Notes would have a maturity date on or prior to the date one
    year following the maturity date of the
    9<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">4</FONT>%
    2006 Notes or which would prohibit the making of the Guarantees
    or the creation of Liens in favor of the Notes and the
    Guarantees on the Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, designate any additional subsidiaries as
    &#147;Restricted Subsidiaries&#148; (as defined in the Existing
    Notes Indenture) for purposes of the Existing Notes Indenture.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Liens</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any Guarantor to,
    directly or indirectly, create, incur, assume or suffer to exist
    any Lien (except Permitted Liens) that secures obligations under
    any Indebtedness or any related Guarantee, on any asset or
    property of the Issuer or any Guarantor, or any income or
    profits therefrom, or assign or convey any right to receive
    income therefrom, unless:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;in the case of Liens securing Subordinated
    Indebtedness, the Notes and related Guarantees are secured by a
    Lien on such property, assets or proceeds that is senior in
    priority to such Liens;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;in all other cases, the Notes or the Guarantees are
    equally and ratably secured or are secured by a Lien on such
    property, assets or proceeds that is senior in priority to such
    Liens;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    except that the foregoing shall not apply to (a)&#160;Liens
    securing the Notes and the related Guarantees, (b)&#160;Liens
    securing Indebtedness permitted to be incurred under Credit
    Facilities, including any letter of credit relating thereto,
    that was permitted by the terms of the Indenture to be incurred
    pursuant to clause&#160;(1) of the second paragraph under
    &#147;&#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock&#148;;
    <I>provided </I>that, with respect to Liens securing Obligations
    permitted under this subclause (b), the Notes and the related
    Guarantees are secured by Liens on the assets subject to such
    Liens (except any European Collateral) to the extent, with the
    priority and subject to intercreditor arrangements, in each case
    no less favorable to the holders of the Notes than those
    described under &#147;Security&#148; above and (c)&#160;Liens
    which are senior in priority to the Liens securing the Notes and
    related Guarantees and are incurred to secure Obligations in
    respect of any Indebtedness permitted to be incurred pursuant to
    the covenant described above under &#147;&#151;&#160;Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock&#148;; <I>provided</I> that, with respect to
    Liens securing Obligations permitted under this subclause (c),
    (i)&#160;at the time of incurrence and after giving pro forma
    effect thereto, the ratio of (1)&#160;the aggregate amount of
    Indebtedness subject to a Lien incurred pursuant to
    subclause&#160;(b) above, this subclause&#160;(c) and
    clause&#160;(6) of the definition of &#147;Permitted Liens&#148;
    (other than Liens securing Indebtedness incurred pursuant to
    clauses&#160;(4) and (18)&#160;of the covenant
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    148
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    described above under &#147;&#151;&#160;Limitation on Incurrence
    of Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock&#148;) to (2)&#160;the Issuer&#146;s EBITDA for the most
    recently ended four full fiscal quarters for which internal
    financial statements are available immediately preceding the
    date on which such event for which such calculation is being
    made shall occur, in each case with such pro forma adjustments
    to Indebtedness and EBITDA as are appropriate and consistent
    with the pro forma adjustment provisions set forth in the
    definition of Fixed Charge Coverage Ratio would be no greater
    than 4.25 to 1.0 and (ii)&#160;the Notes and the Guarantees are
    secured by Liens with the priority and subject to intercreditor
    arrangements no less favorable to the holders of the Notes than
    those described under &#147;&#151;&#160;Security&#148; above.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Merger,
    Consolidation or Sale of All or Substantially All
    Assets</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer may not consolidate or merge with or into or wind up
    into (whether or not the Issuer is the surviving corporation),
    or sell, assign, transfer, lease, convey or otherwise dispose of
    all or substantially all of its properties or assets, in one or
    more related transactions, to any Person unless:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the Issuer is the surviving corporation or the Person
    formed by or surviving any such consolidation or merger (if
    other than the Issuer) or to which such sale, assignment,
    transfer, lease, conveyance or other disposition will have been
    made is a corporation organized or existing under the laws of
    the jurisdiction of organization of the Issuer or the laws of
    the United States, any state thereof, the District of Columbia,
    or any territory thereof (such Person, as the case may be, being
    herein called the <I>&#147;Successor Company&#148;</I>);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the Successor Company, if other than the Issuer,
    expressly assumes all the obligations of the Issuer under the
    Notes and the Security Documents pursuant to supplemental
    indentures or other documents or instruments in form reasonably
    satisfactory to the Trustee;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;immediately after such transaction, no Default exists;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;immediately after giving pro forma effect to such
    transaction and any related financing transactions, as if such
    transactions had occurred at the beginning of the applicable
    four-quarter period,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;the Successor Company would be permitted to incur at
    least $1.00 of additional Indebtedness pursuant to the Fixed
    Charge Coverage Ratio test set forth in the first sentence of
    the covenant described under &#147;&#151;&#160;Limitation on
    Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock,&#148;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the Fixed Charge Coverage Ratio for the Successor
    Company, the Issuer and its Restricted Subsidiaries would be
    greater than such ratio for the Issuer and its Restricted
    Subsidiaries immediately prior to such transaction;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;each Guarantor, unless it is the other party to the
    transactions described above, in which case clause&#160;(b) of
    the second succeeding paragraph shall apply, shall have by
    supplemental indenture confirmed that its Guarantee shall apply
    to such Person&#146;s obligations under the Indenture, the Notes
    and the Registration Rights Agreement;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;the Collateral owned by the Successor Company will
    (a)&#160;continue to constitute Collateral under the Indenture
    and the Security Documents, (b)&#160;be subject to a Lien in
    favor of the Junior Lien Collateral Agent for the benefit of the
    Trustee and the Holders of the Notes and (c)&#160;not be subject
    to any other Lien, other than Permitted Liens;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;to the extent any assets of the Person which is merged
    or consolidated with or into the Successor Company are assets of
    the type which would constitute Collateral under the Security
    Documents, the Successor Company will take such action as may be
    reasonably necessary to cause such property and assets to be
    made subject to the Lien of the Security Documents in the manner
    and to the extent required in the Indenture or any of the
    Security Documents and shall take all reasonably necessary
    action so that such Lien is perfected to the extent required by
    the Security Documents;&#160;and
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    149
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;the Issuer shall have delivered to the Trustee an
    Officer&#146;s Certificate and an Opinion of Counsel, each
    stating that such consolidation, merger or transfer and such
    supplemental indentures, if any, comply with the Indenture and,
    if a supplemental indenture or any supplement to any Security
    Document is required in connection with such transaction, such
    supplement shall comply with the applicable provisions of the
    Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Successor Company will succeed to, and be substituted for
    the Issuer, as the case may be, under the Indenture, the
    Guarantees and the Notes, as applicable. Notwithstanding the
    foregoing clauses&#160;(3) and (4),
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any Restricted Subsidiary may consolidate with or merge
    into or transfer all or part of its properties and assets to the
    Issuer,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the Issuer may merge with an Affiliate of the Issuer,
    as the case may be, solely for the purpose of reincorporating
    the Issuer in a State of the United States or any state thereof,
    the District of Columbia or any territory thereof so long as the
    amount of Indebtedness of the Issuer and its Restricted
    Subsidiaries is not increased thereby.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Subject to certain limitations described in the Indenture
    governing release of a Guarantee upon the sale, disposition or
    transfer of a Guarantor, no Guarantor will, and the Issuer will
    not permit any Guarantor to, consolidate or merge with or into
    or wind up into (whether or not the Issuer or Guarantor is the
    surviving corporation), or sell, assign, transfer, lease, convey
    or otherwise dispose of all or substantially all of its
    properties or assets, in one or more related transactions, to
    any Person unless:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;(a)&#160;such Guarantor is the surviving corporation or
    the Person formed by or surviving any such consolidation or
    merger (if other than such Guarantor) or to which such sale,
    assignment, transfer, lease, conveyance or other disposition
    will have been made is a corporation, partnership, limited
    partnership, limited liability corporation or trust organized or
    existing under the laws of the jurisdiction of organization of
    such Guarantor, as the case may be, or the laws of the United
    States, any state thereof, the District of Columbia, or any
    territory thereof (such Guarantor or such Person, as the case
    may be, being herein called the &#147;Successor Person&#148;);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the Successor Person, if other than such Guarantor,
    expressly assumes all the obligations of such Guarantor under
    the Indenture and such Guarantor&#146;s related Guarantee
    pursuant to supplemental indentures or other documents or
    instruments in form reasonably satisfactory to the Trustee;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;immediately after such transaction, no Default
    exists;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;the Issuer shall have delivered to the Trustee an
    Officer&#146;s Certificate, each stating that such
    consolidation, merger or transfer and such supplemental
    indentures, if any, comply with the Indenture;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the transaction is made in compliance with the covenant
    described under &#147;Repurchase at the Option of
    Holders&#160;&#151; Asset Sales.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Subject to certain limitations described in the Indenture, the
    Successor Person will succeed to, and be substituted for, such
    Guarantor under the Indenture and such Guarantor&#146;s
    Guarantee. Notwithstanding the foregoing, any Guarantor may
    (i)&#160;merge into or transfer all or part of its properties
    and assets to another Guarantor or the Issuer, (ii)&#160;merge
    with an Affiliate of the Company solely for the purpose of
    reincorporating the Guarantor in the United States, any state
    thereof, the District of Columbia or any territory thereof or
    (iii)&#160;convert into a corporation, partnership, limited
    partnership, limited liability corporation or trust organized or
    existing under the laws of the jurisdiction of organization of
    such Guarantor.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Transactions
    with Affiliates</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, make any payment to, or sell, lease, transfer
    or otherwise dispose of any of its properties or assets to, or
    purchase any property or assets from, or enter into or make or
    amend any transaction, contract, agreement, understanding, loan,
    advance or
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    150
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    guarantee with, or for the benefit of, any Affiliate of the
    Issuer (each of the foregoing, an <I>&#147;Affiliate
    Transaction&#148;</I>) involving aggregate payments or
    consideration in excess of $40.0&#160;million, unless:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;such Affiliate Transaction is on terms that are not
    materially less favorable to the Issuer or its relevant
    Restricted Subsidiary than those that would have been obtained
    in a comparable transaction by the Issuer or such Restricted
    Subsidiary with an unrelated Person on an arm&#146;s-length
    basis;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the Issuer delivers to the Trustee with respect to any
    Affiliate Transaction or series of related Affiliate
    Transactions involving aggregate payments or consideration in
    excess of $80.0&#160;million, a resolution adopted by the
    majority of the board of directors of the Issuer approving such
    Affiliate Transaction and set forth in an Officer&#146;s
    Certificate certifying that such Affiliate Transaction complies
    with clause&#160;(1) above.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The foregoing provisions will not apply to the following:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;transactions between or among the Issuer or any of its
    Restricted Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;Restricted Payments permitted by the provisions of the
    Indenture described above under the covenant
    &#147;&#151;&#160;Limitation on Restricted Payments&#148; and
    the definition of &#147;Permitted Investments&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;the payment of management, consulting, monitoring and
    advisory fees and related expenses to the Investors and the
    Frist Entities pursuant to the Sponsor Management Agreement
    (plus any unpaid management, consulting, monitoring and advisory
    fees and related expenses accrued in any prior year) and the
    termination fees pursuant to the Sponsor Management Agreement,
    in each case as in effect on the Issue Date, or any amendment
    thereto (so long as any such amendment is not disadvantageous in
    the good faith judgment of the board of directors of the Issuer
    to the Holders when taken as a whole as compared to the Sponsor
    Management Agreement in effect on the Issue Date);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;the payment of reasonable and customary fees paid to,
    and indemnities provided for the benefit of, officers,
    directors, employees or consultants of Issuer, any of its direct
    or indirect parent companies or any of its Restricted
    Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;transactions in which the Issuer or any of its
    Restricted Subsidiaries, as the case may be, delivers to the
    Trustee a letter from an Independent Financial Advisor stating
    that such transaction is fair to the Issuer or such Restricted
    Subsidiary from a financial point of view or stating that the
    terms are not materially less favorable to the Issuer or its
    relevant Restricted Subsidiary than those that would have been
    obtained in a comparable transaction by the Issuer or such
    Restricted Subsidiary with an unrelated Person on an
    arm&#146;s-length basis;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;any agreement as in effect as of the Issue Date, or any
    amendment thereto (so long as any such amendment is not
    disadvantageous to the Holders when taken as a whole as compared
    to the applicable agreement as in effect on the Issue Date);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;the existence of, or the performance by the Issuer or
    any of its Restricted Subsidiaries of its obligations under the
    terms of, any stockholders agreement (including any registration
    rights agreement or purchase agreement related thereto) to which
    it is a party as of the Issue Date and any similar agreements
    which it may enter into thereafter; provided, however, that the
    existence of, or the performance by the Issuer or any of its
    Restricted Subsidiaries of obligations under any future
    amendment to any such existing agreement or under any similar
    agreement entered into after the Issue Date shall only be
    permitted by this clause&#160;(7) to the extent that the terms
    of any such amendment or new agreement are not otherwise
    disadvantageous to the Holders when taken as a whole;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;[reserved];
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;transactions with customers, clients, suppliers, or
    purchasers or sellers of goods or services, in each case in the
    ordinary course of business and otherwise in compliance with the
    terms of the Indenture which are fair to the Issuer and its
    Restricted Subsidiaries, in the reasonable determination of the
    board of directors of the Issuer or the senior management
    thereof, or are on terms at least as favorable as might
    reasonably have been obtained at such time from an unaffiliated
    party;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    151
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;the issuance of Equity Interests (other than
    Disqualified Stock) of the Issuer to any Permitted Holder or to
    any director, officer, employee or consultant;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;sales of accounts receivable, or participations
    therein, in connection with the ABL Facility and any Receivables
    Facility;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;payments by the Issuer or any of its Restricted
    Subsidiaries to any of the Investors made for any financial
    advisory, financing, underwriting or placement services or in
    respect of other investment banking activities, including,
    without limitation, in connection with acquisitions or
    divestitures, which payments are approved by a majority of the
    board of directors of the Issuer in good faith;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;payments or loans (or cancellation of loans) to
    employees or consultants of the Issuer, any of its direct or
    indirect parent companies or any of its Restricted Subsidiaries
    and employment agreements, stock option plans and other similar
    arrangements with such employees or consultants which, in each
    case, are approved by the Issuer in good faith;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (14)&#160;investments by the Investors or the Frist Entities in
    securities of the Issuer or any of its Restricted Subsidiaries
    so long as (i)&#160;the investment is being offered generally to
    other investors on the same or more favorable terms and
    (ii)&#160;the investment constitutes less than 5% of the
    proposed or outstanding issue amount of such class of securities;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (15)&#160;payments to or from, and transactions with, any joint
    venture owning or operating one or more healthcare facilities,
    including, without limitation, hospitals, ambulatory surgery
    centers, outpatient diagnostic centers or imaging centers, in
    each case in the ordinary course of business (including, without
    limitation, any cash management activities related
    thereto);&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (16)&#160;payments by the Issuer (and any direct or indirect
    parent thereof) and its Subsidiaries pursuant to tax sharing
    agreements among the Issuer (and any such parent) and its
    Subsidiaries on customary terms to the extent attributable to
    the ownership or operation of the Issuer and its Subsidiaries;
    provided that in each case the amount of such payments in any
    fiscal year does not exceed the amount that the Issuer, its
    Restricted Subsidiaries and its Unrestricted Subsidiaries (to
    the extent of amounts received from Unrestricted Subsidiaries)
    would be required to pay in respect of foreign, federal, state
    and local taxes for such fiscal year were the Issuer and its
    Restricted Subsidiaries (to the extent described above) to pay
    such taxes separately from any such parent entity.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Dividend
    and Other Payment Restrictions Affecting Restricted
    Subsidiaries</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any of its Restricted
    Subsidiaries that are not Guarantors to, directly or indirectly,
    create or otherwise cause or suffer to exist or become effective
    any consensual encumbrance or consensual restriction on the
    ability of any such Restricted Subsidiary to:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;(a)&#160;pay dividends or make any other distributions
    to the Issuer or any of its Restricted Subsidiaries on its
    Capital Stock or with respect to any other interest or
    participation in, or measured by, its profits,&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;pay any Indebtedness owed to the Issuer or any of its
    Restricted Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;make loans or advances to the Issuer or any of its
    Restricted Subsidiaries;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;sell, lease or transfer any of its properties or assets
    to the Issuer or any of its Restricted Subsidiaries, except (in
    each case) for such encumbrances or restrictions existing under
    or by reason of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;contractual encumbrances or restrictions in effect on
    the Issue Date, including pursuant to the Senior Credit
    Facilities and the related documentation, the Existing Notes
    Indenture and the related documentation and the 2006 Notes
    Indenture and the related documentation;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the Indenture and the Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;purchase money obligations for property acquired in the
    ordinary course of business that impose restrictions of the
    nature discussed in clause&#160;(3) above on the property so
    acquired;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    152
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;applicable law or any applicable rule, regulation or
    order;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;any agreement or other instrument of a Person acquired
    by the Issuer or any Restricted Subsidiary in existence at the
    time of such acquisition (but not created in contemplation
    thereof), which encumbrance or restriction is not applicable to
    any Person, or the properties or assets of any Person, other
    than the Person and its Subsidiaries, or the property or assets
    of the Person and its Subsidiaries, so acquired;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (f)&#160;contracts for the sale of assets, including customary
    restrictions with respect to a Subsidiary of the Issuer pursuant
    to an agreement that has been entered into for the sale or
    disposition of all or substantially all of the Capital Stock or
    assets of such Subsidiary;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (g)&#160;Secured Indebtedness that limits the right of the
    debtor to dispose of the assets securing such Indebtedness that
    is otherwise permitted to be incurred pursuant to the covenants
    described under &#147;&#151;&#160;Limitation on Incurrence of
    Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock&#148; and &#147;&#151;&#160;Liens&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (h)&#160;restrictions on cash or other deposits or net worth
    imposed by customers under contracts entered into in the
    ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (i)&#160;other Indebtedness, Disqualified Stock or Preferred
    Stock of Foreign Subsidiaries permitted to be incurred
    subsequent to the Issue Date pursuant to the provisions of the
    covenant described under &#147;&#151;&#160;Limitation on
    Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (j)&#160;customary provisions in joint venture agreements and
    other agreements or arrangements relating solely to such joint
    venture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (k)&#160;customary provisions contained in leases or licenses of
    intellectual property and other agreements, in each case entered
    into in the ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (l)&#160;any encumbrances or restrictions of the type referred
    to in clauses (1), (2)&#160;and (3)&#160;above imposed by any
    amendments, modifications, restatements, renewals, increases,
    supplements, refundings, replacements or refinancings of the
    contracts, instruments or obligations referred to in
    clauses&#160;(a) through (k)&#160;above; provided that such
    amendments, modifications, restatements, renewals, increases,
    supplements, refundings, replacements or refinancings are, in
    the good faith judgment of the Issuer, no more restrictive with
    respect to such encumbrance and other restrictions taken as a
    whole than those prior to such amendment, modification,
    restatement, renewal, increase, supplement, refunding,
    replacement or refinancing;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (m)&#160;restrictions created in connection with any Receivables
    Facility that, in the good faith determination of the Issuer,
    are necessary or advisable to effect the transactions
    contemplated under such Receivables Facility.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Limitation
    on Guarantees of Indebtedness by Restricted
    Subsidiaries</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not permit any of its Wholly-Owned Subsidiaries
    that are Restricted Subsidiaries (and non-Wholly-Owned
    Subsidiaries if such non-Wholly-Owned Subsidiaries guarantee
    other capital markets debt securities of the Issuer or any
    Guarantor), other than a Guarantor, a Foreign Subsidiary or a
    Receivables Subsidiary, to guarantee the payment of any
    Indebtedness of the Issuer or any other Guarantor unless:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;such Restricted Subsidiary within 30&#160;days executes
    and delivers a supplemental indenture to the Indenture providing
    for a Guarantee by such Restricted Subsidiary, except that with
    respect to a guarantee of Indebtedness of the Issuer or any
    Guarantor:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;if the Notes or such Guarantor&#146;s Guarantee is
    subordinated in right of payment to such Indebtedness, the
    Guarantee under the supplemental indenture shall be subordinated
    to such Restricted Subsidiary&#146;s guarantee with respect to
    such Indebtedness substantially to the same extent as the Notes
    are subordinated to such Indebtedness;&#160;and
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    153
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;if such Indebtedness is by its express terms
    subordinated in right of payment to the Notes or such
    Guarantor&#146;s Guarantee, any such guarantee by such
    Restricted Subsidiary with respect to such Indebtedness shall be
    subordinated in right of payment to such Guarantee substantially
    to the same extent as such Indebtedness is subordinated to the
    Notes;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;such Restricted Subsidiary waives, and will not in any
    manner whatsoever claim or take the benefit or advantage of, any
    rights of reimbursement, indemnity or subrogation or any other
    rights against the Issuer or any other Restricted Subsidiary as
    a result of any payment by such Restricted Subsidiary under its
    Guarantee;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided </I>that this covenant shall not be applicable to
    (i)&#160;any guarantee of any Restricted Subsidiary that existed
    at the time such Person became a Restricted Subsidiary and was
    not incurred in connection with, or in contemplation of, such
    Person becoming a Restricted Subsidiary and (ii)&#160;guarantees
    of the ABL Facility by the ABL Financing Entities or of any
    Receivables Facility by any Receivables Subsidiary.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Reports
    and Other Information</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding that the Issuer may not be subject to the
    reporting requirements of Section&#160;13 or 15(d) of the
    Exchange Act or otherwise report on an annual and quarterly
    basis on forms provided for such annual and quarterly reporting
    pursuant to rules and regulations promulgated by the SEC, the
    Indenture requires the Issuer to file with the SEC (and make
    available to the Trustee and Holders of the Notes (without
    exhibits), without cost to any Holder, within 15&#160;days after
    it files them with the SEC) from and after the Issue Date,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;within 90&#160;days (or any other time period then in
    effect under the rules and regulations of the Exchange Act with
    respect to the filing of a
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    by a non-accelerated filer) after the end of each fiscal year,
    annual reports on
    <FONT style="white-space: nowrap">Form&#160;10-K,</FONT>
    or any successor or comparable form, containing the information
    required to be contained therein, or required in such successor
    or comparable form;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;within 45&#160;days after the end of each of the first
    three fiscal quarters of each fiscal year, reports on
    <FONT style="white-space: nowrap">Form&#160;10-Q</FONT>
    containing all quarterly information that would be required to
    be contained in
    <FONT style="white-space: nowrap">Form&#160;10-Q,</FONT>
    or any successor or comparable form;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;promptly from time to time after the occurrence of an
    event required to be therein reported, such other reports on
    <FONT style="white-space: nowrap">Form&#160;8-K,</FONT>
    or any successor or comparable form;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;any other information, documents and other reports
    which the Issuer would be required to file with the SEC if it
    were subject to Section&#160;13 or 15(d) of the Exchange Act;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    in each case in a manner that complies in all material respects
    with the requirements specified in such form; <I>provided
    </I>that the Issuer shall not be so obligated to file such
    reports with the SEC if the SEC does not permit such filing, in
    which event the Issuer will make available such information to
    prospective purchasers of Notes, in addition to providing such
    information to the Trustee and the Holders of the Notes, in each
    case within 15&#160;days after the time the Issuer would be
    required to file such information with the SEC if it were
    subject to Section&#160;13 or 15(d) of the Exchange Act. In
    addition, to the extent not satisfied by the foregoing, the
    Issuer has agreed that, for so long as any Notes are
    outstanding, it will furnish to Holders and to securities
    analysts and prospective investors, upon their request, the
    information required to be delivered pursuant to
    Rule&#160;144A(d)(4) under the Securities Act.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In the event that any direct or indirect parent company of the
    Issuer becomes a Guarantor of the Notes, the Indenture permits
    the Issuer to satisfy its obligations in this covenant with
    respect to financial information relating to the Issuer by
    furnishing financial information relating to such parent;
    <I>provided </I>that the same is accompanied by consolidating
    information that explains in reasonable detail the differences
    between the information relating to such parent, on the one
    hand, and the information relating to the Issuer and its
    Restricted Subsidiaries on a standalone basis, on the other hand.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding the foregoing, such requirements shall be deemed
    satisfied prior to the commencement of the exchange offer or the
    effectiveness of the shelf registration statement described in
    the Registration Rights Agreement (1)&#160;by the filing with
    the SEC of the exchange offer registration statement or shelf
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    154
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    registration statement (or any other similar registration
    statement), and any amendments thereto, with such financial
    information that satisfies
    <FONT style="white-space: nowrap">Regulation&#160;S-X,</FONT>
    subject to exceptions consistent with the presentation of
    financial information in the Offering Memorandum, to the extent
    filed within the times specified above, or (2)&#160;by posting
    reports that would be required to be filed substantially in the
    form required by the SEC on the Company&#146;s website (or that
    of any of its parent companies) or providing such reports to the
    Trustee within 15&#160;days after the time the Issuer would be
    required to file such information with the SEC if it were
    subject to Section&#160;13 or 15(d) of the Exchange Act, the
    financial information (including a &#147;Management&#146;s
    Discussion and Analysis of Financial Condition and Results of
    Operations&#148; section) that would be required to be included
    in such reports, subject to exceptions consistent with the
    presentation of financial information in the Offering
    Memorandum, to the extent filed within the times specified above.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Events of
    Default and Remedies</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that each of the following is an
    <I>&#147;Event of Default&#148;</I>:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;default in payment when due and payable, upon
    redemption, acceleration or otherwise, of principal of, or
    premium, if any, on the Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;default for 30&#160;days or more in the payment when
    due of interest or Additional Interest on or with respect to the
    Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;failure by the Issuer or any Guarantor for 60&#160;days
    after receipt of written notice given by the Trustee or the
    Holders of not less 30% in principal amount of the Notes to
    comply with any of its obligations, covenants or agreements
    (other than a default referred to in clauses&#160;(1) and
    (2)&#160;above) contained in the Indenture or the Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;default under any mortgage, indenture or instrument
    under which there is issued or by which there is secured or
    evidenced any Indebtedness for money borrowed by the Issuer or
    any of its Restricted Subsidiaries or the payment of which is
    guaranteed by the Issuer or any of its Restricted Subsidiaries,
    other than Indebtedness owed to the Issuer or a Restricted
    Subsidiary, whether such Indebtedness or guarantee now exists or
    is created after the issuance of the Notes, if both:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;such default either results from the failure to pay any
    principal of such Indebtedness at its stated final maturity
    (after giving effect to any applicable grace periods) or relates
    to an obligation other than the obligation to pay principal of
    any such Indebtedness at its stated final maturity and results
    in the holder or holders of such Indebtedness causing such
    Indebtedness to become due prior to its stated maturity;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the principal amount of such Indebtedness, together
    with the principal amount of any other such Indebtedness in
    default for failure to pay principal at stated final maturity
    (after giving effect to any applicable grace periods), or the
    maturity of which has been so accelerated, aggregate
    $200.0&#160;million or more at any one time outstanding;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;failure by the Issuer or any Significant Subsidiary to
    pay final judgments aggregating in excess of
    $200.0&#160;million, which final judgments remain unpaid,
    undischarged and unstayed for a period of more than 60&#160;days
    after such judgment becomes final, and in the event such
    judgment is covered by insurance, an enforcement proceeding has
    been commenced by any creditor upon such judgment or decree
    which is not promptly stayed;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;certain events of bankruptcy or insolvency with respect
    to the Issuer or any Significant Subsidiary;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;the Guarantee of any Significant Subsidiary shall for
    any reason cease to be in full force and effect or be declared
    null and void or any responsible officer of any Guarantor that
    is a Significant Subsidiary, as the case may be, denies that it
    has any further liability under its Guarantee or gives notice to
    such effect, other than by reason of the termination of the
    Indenture or the release of any such Guarantee in accordance
    with the Indenture;&#160;or
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    155
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;with respect to any Collateral having a fair market
    value in excess of $200&#160;million, individually or in the
    aggregate, (a)&#160;the security interest under the Security
    Documents, at any time, ceases to be in full force and effect
    for any reason other than in accordance with the terms of the
    Indenture, the Security Documents and the Intercreditor
    Agreements, (b)&#160;any security interest created thereunder or
    under the Indenture is declared invalid or unenforceable by a
    court of competent jurisdiction or (c)&#160;the Issuer or any
    Guarantor asserts, in any pleading in any court of competent
    jurisdiction, that any such security interest is invalid or
    unenforceable.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If any Event of Default (other than of a type specified in
    clause&#160;(6) above) occurs and is continuing under the
    Indenture, the Trustee or the Holders of at least 30% in
    principal amount of the then total outstanding Notes may declare
    the principal, premium, if any, interest and any other monetary
    obligations on all the then outstanding Notes to be due and
    payable immediately.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Upon the effectiveness of such declaration, such principal and
    interest will be due and payable immediately. Notwithstanding
    the foregoing, in the case of an Event of Default arising under
    clause&#160;(6) of the first paragraph of this section, all
    outstanding Notes will become due and payable without further
    action or notice. The Indenture provides that the Trustee may
    withhold from the Holders notice of any continuing Default,
    except a Default relating to the payment of principal, premium,
    if any, or interest, if it determines that withholding notice is
    in their interest. In addition, the Trustee shall have no
    obligation to accelerate the Notes if in the best judgment of
    the Trustee acceleration is not in the best interest of the
    Holders of the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that the Holders of a majority in
    aggregate principal amount of the then outstanding Notes by
    notice to the Trustee may on behalf of the Holders of all of the
    Notes waive any existing Default and its consequences under the
    Indenture except a continuing Default in the payment of interest
    on, premium, if any, or the principal of any Note held by a
    non-consenting Holder. In the event of any Event of Default
    specified in clause&#160;(4) above, such Event of Default and
    all consequences thereof (excluding any resulting payment
    default, other than as a result of acceleration of the Notes)
    shall be annulled, waived and rescinded, automatically and
    without any action by the Trustee or the Holders, if within
    20&#160;days after such Event of Default arose:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the Indebtedness or guarantee that is the basis for
    such Event of Default has been discharged;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;holders thereof have rescinded or waived the
    acceleration, notice or action (as the case may be) giving rise
    to such Event of Default;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;the default that is the basis for such Event of Default
    has been cured.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Subject to the provisions of the Indenture relating to the
    duties of the Trustee thereunder, in case an Event of Default
    occurs and is continuing, the Trustee is under no obligation to
    exercise any of the rights or powers under the Indenture at the
    request or direction of any of the Holders of the Notes unless
    the Holders have offered to the Trustee reasonable indemnity or
    security against any loss, liability or expense. Except to
    enforce the right to receive payment of principal, premium, if
    any, or interest when due, no Holder of a Note may pursue any
    remedy with respect to the Indenture or the Notes unless:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;such Holder has previously given the Trustee notice
    that an Event of Default is continuing;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;Holders of at least 30% in principal amount of the
    total outstanding Notes have requested the Trustee to pursue the
    remedy;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;Holders of the Notes have offered the Trustee
    reasonable security or indemnity against any loss, liability or
    expense;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;the Trustee has not complied with such request within
    60&#160;days after the receipt thereof and the offer of security
    or indemnity;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;Holders of a majority in principal amount of the total
    outstanding Notes have not given the Trustee a direction
    inconsistent with such request within such
    <FONT style="white-space: nowrap">60-day</FONT>
    period.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    156
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Subject to certain restrictions, under the Indenture the Holders
    of a majority in principal amount of the total outstanding Notes
    are given the right to direct the time, method and place of
    conducting any proceeding for any remedy available to the
    Trustee or of exercising any trust or power conferred on the
    Trustee. The Trustee, however, may refuse to follow any
    direction that conflicts with law or the Indenture or that the
    Trustee determines is unduly prejudicial to the rights of any
    other Holder of a Note or that would involve the Trustee in
    personal liability.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that the Issuer is required to deliver to
    the Trustee annually a statement regarding compliance with the
    Indenture, and the Issuer is required, within five Business
    Days, upon becoming aware of any Default, to deliver to the
    Trustee a statement specifying such Default.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">No
    Personal Liability of Directors, Officers, Employees and
    Stockholders</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    No director, officer, employee, incorporator or stockholder of
    the Issuer or any Guarantor or any of their parent companies
    (other than the Issuer and the Guarantors) shall have any
    liability for any obligations of the Issuer or the Guarantors
    under the Notes, the Guarantees or the Indenture or for any
    claim based on, in respect of, or by reason of such obligations
    or their creation. Each Holder by accepting the Notes waives and
    releases all such liability. The waiver and release are part of
    the consideration for issuance of the Notes. Such waiver may not
    be effective to waive liabilities under the federal securities
    laws, and it is the view of the SEC that such a waiver is
    against public policy.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Legal
    Defeasance and Covenant Defeasance</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The obligations of the Issuer and the Guarantors under the
    Indenture will terminate (other than certain obligations) and
    will be released upon payment in full of all of the Notes. The
    Issuer may, at its option and at any time, elect to have all of
    its obligations discharged with respect to the Notes and have
    the Issuer&#146;s and each Guarantor&#146;s obligation
    discharged with respect to its Guarantee <I>(&#147;Legal
    Defeasance&#148;) </I>and cure all then existing Events of
    Default except for:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the rights of Holders of Notes to receive payments in
    respect of the principal of, premium, if any, and interest on
    the Notes when such payments are due solely out of the trust
    created pursuant to the Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the Issuer&#146;s obligations with respect to Notes
    concerning issuing temporary Notes, registration of such Notes,
    mutilated, destroyed, lost or stolen Notes and the maintenance
    of an office or agency for payment and money for security
    payments held in trust;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;the rights, powers, trusts, duties and immunities of
    the Trustee, and the Issuer&#146;s obligations in connection
    therewith;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;the Legal Defeasance provisions of the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, the Issuer may, at its option and at any time,
    elect to have its obligations and those of each Guarantor
    released with respect to certain covenants that are described in
    the Indenture <I>(&#147;Covenant Defeasance&#148;) </I>and
    thereafter any omission to comply with such obligations shall
    not constitute a Default with respect to the Notes. In the event
    Covenant Defeasance occurs, certain events (not including
    bankruptcy, receivership, rehabilitation and insolvency events
    pertaining to the Issuer) described under &#147;Events of
    Default and Remedies&#148; will no longer constitute an Event of
    Default with respect to the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In order to exercise either Legal Defeasance or Covenant
    Defeasance with respect to the Notes:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the Issuer must irrevocably deposit with the Trustee,
    in trust, for the benefit of the Holders of the Notes, cash in
    U.S.&#160;dollars, Government Securities, or a combination
    thereof, in such amounts as will be sufficient, in the opinion
    of a nationally recognized firm of independent public
    accountants, to pay the principal of, premium, if any, and
    interest due on the Notes on the stated maturity date or on the
    redemption date, as the case may be, of such principal, premium,
    if any, or interest on such Notes, and the Issuer must specify
    whether such Notes are being defeased to maturity or to a
    particular redemption date;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    157
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;in the case of Legal Defeasance, the Issuer shall have
    delivered to the Trustee an Opinion of Counsel reasonably
    acceptable to the Trustee confirming that, subject to customary
    assumptions and exclusions,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;the Issuer has received from, or there has been
    published by, the United States Internal Revenue Service a
    ruling,&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;since the issuance of the Notes, there has been a
    change in the applicable U.S.&#160;federal income tax law,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    in either case to the effect that, and based thereon such
    Opinion of Counsel shall confirm that, subject to customary
    assumptions and exclusions, the Holders of the Notes will not
    recognize income, gain or loss for U.S.&#160;federal income tax
    purposes, as applicable, as a result of such Legal Defeasance
    and will be subject to U.S.&#160;federal income tax on the same
    amounts, in the same manner and at the same times as would have
    been the case if such Legal Defeasance had not occurred;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;in the case of Covenant Defeasance, the Issuer shall
    have delivered to the Trustee an Opinion of Counsel reasonably
    acceptable to the Trustee confirming that, subject to customary
    assumptions and exclusions, the Holders of the Notes will not
    recognize income, gain or loss for U.S.&#160;federal income tax
    purposes as a result of such Covenant Defeasance and will be
    subject to such tax on the same amounts, in the same manner and
    at the same times as would have been the case if such Covenant
    Defeasance had not occurred;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;no Default (other than that resulting from borrowing
    funds to be applied to make such deposit and any similar and
    simultaneous deposit relating to other Indebtedness and, in each
    case, the granting of Liens in connection therewith) shall have
    occurred and be continuing on the date of such deposit;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;such Legal Defeasance or Covenant Defeasance shall not
    result in a breach or violation of, or constitute a default
    under the Senior Credit Facilities or any other material
    agreement or instrument (other than the Indenture) to which the
    Issuer or any Guarantor is a party or by which the Issuer or any
    Guarantor is bound (other than that resulting from borrowing
    funds to be applied to make such deposit and any similar and
    simultaneous deposit relating to other Indebtedness and, in each
    case, the granting of Liens in connection therewith);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;the Issuer shall have delivered to the Trustee an
    Opinion of Counsel to the effect that, as of the date of such
    opinion and subject to customary assumptions and exclusions
    following the deposit, the trust funds will not be subject to
    the effect of Section&#160;547 of Title&#160;11 of the United
    States Code;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;the Issuer shall have delivered to the Trustee an
    Officer&#146;s Certificate stating that the deposit was not made
    by the Issuer with the intent of defeating, hindering, delaying
    or defrauding any creditors of the Issuer or any Guarantor or
    others;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;the Issuer shall have delivered to the Trustee an
    Officer&#146;s Certificate and an Opinion of Counsel (which
    Opinion of Counsel may be subject to customary assumptions and
    exclusions) each stating that all conditions precedent provided
    for or relating to the Legal Defeasance or the Covenant
    Defeasance, as the case may be, have been complied with.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Satisfaction
    and Discharge</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture will be discharged and will cease to be of further
    effect as to all Notes, when either:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;all Notes theretofore authenticated and delivered,
    except lost, stolen or destroyed Notes which have been replaced
    or paid and Notes for whose payment money has theretofore been
    deposited in trust, have been delivered to the Trustee for
    cancellation;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;(a)&#160;all Notes not theretofore delivered to the
    Trustee for cancellation have become due and payable by reason
    of the making of a notice of redemption or otherwise, will
    become due and payable within one year or may be called for
    redemption within one year under arrangements satisfactory to
    the Trustee for the giving of notice of redemption by the
    Trustee in the name, and at the expense, of the
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    158
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Issuer, and the Issuer or any Guarantor has irrevocably
    deposited or caused to be deposited with the Trustee as trust
    funds in trust solely for the benefit of the Holders of the
    Notes, cash in U.S.&#160;dollars, Government Securities, or a
    combination thereof, in such amounts as will be sufficient
    without consideration of any reinvestment of interest to pay and
    discharge the entire indebtedness on the Notes not theretofore
    delivered to the Trustee for cancellation for principal,
    premium, if any, and accrued interest to the date of maturity or
    redemption;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;no Default (other than that resulting from borrowing
    funds to be applied to make such deposit and any similar and
    simultaneous deposit relating to other Indebtedness and, in each
    case, the granting of Liens in connection therewith) with
    respect to the Indenture or the Notes shall have occurred and be
    continuing on the date of such deposit or shall occur as a
    result of such deposit, and such deposit will not result in a
    breach or violation of, or constitute a default under, the
    Senior Credit Facilities or any other material agreement or
    instrument (other than the Indenture) to which the Issuer or any
    Guarantor is a party or by which the Issuer or any Guarantor is
    bound (other than that resulting from borrowing funds to be
    applied to make such deposit and any similar and simultaneous
    deposit relating to other Indebtedness and, in each case, the
    granting of Liens in connection therewith);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;the Issuer has paid or caused to be paid all sums
    payable by it under the Indenture;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;the Issuer has delivered irrevocable instructions to
    the Trustee to apply the deposited money toward the payment of
    the Notes at maturity or the redemption date, as the case may be.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, the Issuer must deliver an Officer&#146;s
    Certificate and an Opinion of Counsel to the Trustee stating
    that all conditions precedent to satisfaction and discharge have
    been satisfied.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Amendment,
    Supplement and Waiver</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Except as provided in the next two succeeding paragraphs, the
    Indenture, any Guarantee, any Security Document and the Notes
    may be amended or supplemented with the consent of the Holders
    of at least a majority in principal amount of the Notes then
    outstanding, including consents obtained in connection with a
    purchase of, or tender offer or exchange offer for, Notes, and
    any existing Default or compliance with any provision of the
    Indenture, the Notes issued thereunder, any Guarantee or the
    Security Documents may be waived with the consent of the Holders
    of a majority in principal amount of the then outstanding Notes,
    other than Notes beneficially owned by the Issuer or its
    Affiliates (including consents obtained in connection with a
    purchase of or tender offer or exchange offer for the Notes).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that, without the consent of each
    affected Holder of Notes, an amendment or waiver may not, with
    respect to any Notes held by a non-consenting Holder:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;reduce the principal amount of such Notes whose Holders
    must consent to an amendment, supplement or waiver;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;reduce the principal of or change the fixed final
    maturity of any such Note or alter or waive the provisions with
    respect to the redemption of such Notes (other than provisions
    relating to the covenants described above under the caption
    &#147;Repurchase at the Option of Holders&#148;);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;reduce the rate of or change the time for payment of
    interest on any Note;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;waive a Default in the payment of principal of or
    premium, if any, or interest on the Notes, except a rescission
    of acceleration of the Notes by the Holders of at least a
    majority in aggregate principal amount of the Notes and a waiver
    of the payment default that resulted from such acceleration, or
    in respect of a covenant or provision contained in the Indenture
    or any Guarantee which cannot be amended or modified without the
    consent of all Holders;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;make any Note payable in money other than that stated
    therein;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;make any change in the provisions of the Indenture
    relating to waivers of past Defaults or the rights of Holders to
    receive payments of principal of or premium, if any, or interest
    on the Notes;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    159
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;make any change in these amendment and waiver
    provisions;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;impair the right of any Holder to receive payment of
    principal of, or interest on such Holder&#146;s Notes on or
    after the due dates therefor or to institute suit for the
    enforcement of any payment on or with respect to such
    Holder&#146;s Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;make any change to or modify the ranking of the Notes
    or the subordination of the Liens with respect to the Notes that
    would adversely affect the Holders;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;except as expressly permitted by the Indenture, modify
    the Guarantees of any Significant Subsidiary in any manner
    adverse to the Holders of the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, without the consent of at least 75% in aggregate
    principal amount of Notes then outstanding, an amendment,
    supplement or waiver may not:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;modify any Security Document or the provisions of the
    Indenture dealing with the Security Documents or application of
    trust moneys, or otherwise release any Collateral, in any manner
    materially adverse to the Holders other than in accordance with
    the Indenture, the Security Documents and the Intercreditor
    Agreements;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;modify any Intercreditor Agreement in any manner
    materially adverse to the Holders other than in accordance with
    the Indenture, the Security Documents and the Intercreditor
    Agreements.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding the foregoing, the Issuer, any Guarantor (with
    respect to a Guarantee or the Indenture to which it is a party)
    and the Trustee may amend or supplement the Indenture, any
    Security Document and any Guarantee or Notes without the consent
    of any Holder;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;to cure any ambiguity, omission, mistake, defect or
    inconsistency;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;to provide for uncertificated Notes of such series in
    addition to or in place of certificated Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;to comply with the covenant relating to mergers,
    consolidations and sales of assets;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;to provide for the assumption of the Issuer&#146;s or
    any Guarantor&#146;s obligations to the Holders;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;to make any change that would provide any additional
    rights or benefits to the Holders or that does not adversely
    affect the legal rights under the Indenture of any such Holder;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;to add covenants for the benefit of the Holders or to
    surrender any right or power conferred upon the Issuer or any
    Guarantor;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;to comply with requirements of the SEC in order to
    effect or maintain the qualification of the Indenture under the
    Trust&#160;Indenture Act;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;to evidence and provide for the acceptance and
    appointment under the Indenture of a successor Trustee
    thereunder pursuant to the requirements thereof;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;to provide for the issuance of Exchange Notes or
    private exchange notes, which are identical to Exchange Notes
    except that they are not freely transferable;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;to add a Guarantor under the Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;to conform the text of the Indenture, Security
    Documents, Guarantees or the Notes to any provision of this
    &#147;Description of Notes&#148; to the extent that such
    provision in this &#147;Description of Notes&#148; was intended
    to be a verbatim recitation of a provision of the Indenture,
    Security Documents, Guarantee or Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;to make any amendment to the provisions of the
    Indenture relating to the transfer and legending of Notes as
    permitted by the Indenture, including, without limitation to
    facilitate the issuance and administration of the Notes;
    <I>provided</I>, <I>however</I>, that (i)&#160;compliance with
    the Indenture as so amended would not result in Notes being
    transferred in violation of the Securities Act or any applicable
    securities
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    160
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    law and (ii)&#160;such amendment does not materially and
    adversely affect the rights of Holders to transfer Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;to mortgage, pledge, hypothecate or grant any other
    Lien in favor of the Trustee for the benefit of the Holders of
    the Notes, as additional security for the payment and
    performance of all or any portion of the Obligations, in any
    property or assets, including any which are required to be
    mortgaged, pledged or hypothecated, or in which a Lien is
    required to be granted to or for the benefit of the Trustee or
    the Collateral Agent pursuant to the Indenture, any of the
    Security Documents or otherwise;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (14)&#160;to release Collateral from the Lien of the Indenture
    and the Security Documents when permitted or required by the
    Security Documents or the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The consent of the Holders is not necessary under the Indenture
    to approve the particular form of any proposed amendment. It is
    sufficient if such consent approves the substance of the
    proposed amendment.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Notices</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notices given by publication will be deemed given on the first
    date on which publication is made and notices given by
    first-class mail, postage prepaid, will be deemed given five
    calendar days after mailing.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Concerning
    the Trustee</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture contains certain limitations on the rights of the
    Trustee thereunder, should it become a creditor of the Issuer,
    to obtain payment of claims in certain cases, or to realize on
    certain property received in respect of any such claim as
    security or otherwise. The Trustee is permitted to engage in
    other transactions; however, if it acquires any conflicting
    interest it must eliminate such conflict within 90&#160;days,
    apply to the SEC for permission to continue or resign.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that the Holders of a majority in
    principal amount of the outstanding Notes will have the right to
    direct the time, method and place of conducting any proceeding
    for exercising any remedy available to the Trustee, subject to
    certain exceptions. The Indenture provides that in case an Event
    of Default shall occur (which shall not be cured), the Trustee
    will be required, in the exercise of its power, to use the
    degree of care of a prudent person in the conduct of his own
    affairs. Subject to such provisions, the Trustee is under no
    obligation to exercise any of its rights or powers under the
    Indenture at the request of any Holder of the Notes, unless such
    Holder shall have offered to the Trustee security and indemnity
    satisfactory to it against any loss, liability or expense.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Governing
    Law</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture, the Notes and any Guarantee are governed by and
    construed in accordance with the laws of the State of New York.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Certain
    Definitions</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Set forth below are certain defined terms used in the Indenture.
    For purposes of the Indenture, unless otherwise specifically
    indicated, the term <I>&#147;consolidated&#148;</I> with respect
    to any Person refers to such Person on a consolidated basis in
    accordance with GAAP, but excluding from such consolidation any
    Unrestricted Subsidiary as if such Unrestricted Subsidiary were
    not an Affiliate of such Person.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;2006 Notes&#148;</I> means the $1,000,000,000 aggregate
    principal amount of
    9<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;Senior
    Secured Notes due 2014, the $3,200,000,000 aggregate principal
    amount of
    9<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">4</FONT>%&#160;Senior
    Secured Notes due 2016 and the $1,500,000,000
    9<FONT style="vertical-align: text-top; font-size: 70%;">5</FONT>/<FONT style="font-size: 70%;">8</FONT>%/10<FONT style="vertical-align: text-top; font-size: 70%;">3</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;Senior
    Secured Toggle Notes due 2016, each issued by the Issuer under
    the 2006 Notes Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;2006 Notes Indenture&#148;</I> means that certain
    Indenture, dated as of November&#160;17, 2006, among the Issuer,
    the guarantors named on Schedule&#160;I thereto and The Bank of
    New York, as trustee.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    161
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;ABL Facility&#148;</I> means the Asset-Based Revolving
    Credit Agreement entered into as of November&#160;17, 2006 by
    and among the Issuer, the lenders party thereto in their
    capacities as lenders thereunder and Bank of America, N.A., as
    Administrative Agent, including any guarantees, collateral
    documents, instruments and agreements executed in connection
    therewith, and any amendments, supplements, modifications,
    extensions, renewals, restatements, refundings or refinancings
    thereof and any indentures or credit facilities or commercial
    paper facilities with banks or other institutional lenders or
    investors that replace, refund or refinance any part of the
    loans, notes, other credit facilities or commitments thereunder,
    including any such replacement, refunding or refinancing
    facility or indenture that increases the amount borrowable
    thereunder or alters the maturity thereof (<I>provided </I>that
    such increase in borrowings is permitted under &#147;Certain
    Covenants &#151;&#160;Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock&#148;
    above).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;ABL Facility Cap&#148;</I> means an amount equal to the
    greater of (x)&#160;$2,000.0&#160;million and (y)&#160;75% of
    the consolidated accounts receivable of the Issuer and its
    subsidiaries determined in accordance with GAAP.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;ABL Financing Entity&#148;</I> means the Issuer and
    certain of its subsidiaries from time to time named as borrowers
    or guarantors under the ABL Facility.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;ABL Obligations&#148;</I> means Obligations under the
    ABL Facility.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;ABL Secured Parties&#148;</I> means each of
    (i)&#160;the ABL Collateral Agent on behalf of itself and the
    lenders under the ABL Facility and lenders or their affiliates
    counterparty to related Hedging Obligations and (ii)&#160;each
    other holder of ABL Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Acquired Indebtedness&#148;</I> means, with respect to
    any specified Person,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;Indebtedness of any other Person existing at the time
    such other Person is merged with or into or became a Restricted
    Subsidiary of such specified Person, including Indebtedness
    incurred in connection with, or in contemplation of, such other
    Person merging with or into or becoming a Restricted Subsidiary
    of such specified Person,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;Indebtedness secured by a Lien encumbering any asset
    acquired by such specified Person.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Additional Interest&#148;</I> means all additional
    interest then owing pursuant to the Registration Rights
    Agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Affiliate&#148;</I> of any specified Person means any
    other Person directly or indirectly controlling or controlled by
    or under direct or indirect common control with such specified
    Person. For purposes of this definition, &#147;control&#148;
    (including, with correlative meanings, the terms
    &#147;controlling,&#148; &#147;controlled by&#148; and
    &#147;under common control with&#148;), as used with respect to
    any Person, shall mean the possession, directly or indirectly,
    of the power to direct or cause the direction of the management
    or policies of such Person, whether through the ownership of
    voting securities, by agreement or otherwise.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Applicable Premium&#148;</I> means, with respect to any
    Note on any Redemption&#160;Date, the greater of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;1.0% of the principal amount of such Note;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the excess, if any, of (a)&#160;the present value at
    such Redemption&#160;Date of (i)&#160;the redemption price of
    such Note at February&#160;15, 2013 (such redemption price being
    set forth in the tables appearing above under the caption
    &#147;Optional Redemption&#148;), plus (ii)&#160;all required
    interest payments due on such Note through February&#160;15,
    2013 (excluding accrued but unpaid interest to the
    Redemption&#160;Date), computed using a discount rate equal to
    the Treasury Rate as of such Redemption&#160;Date plus
    50&#160;basis points; over (b)&#160;the principal amount of such
    Note.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Asset Sale&#148;</I> means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the sale, conveyance, transfer or other disposition,
    whether in a single transaction or a series of related
    transactions, of property or assets (including by way of a Sale
    and Lease-Back Transaction) of the Issuer or any of its
    Restricted Subsidiaries (each referred to in this definition as
    a &#147;disposition&#148;);&#160;or
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    162
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the issuance or sale of Equity Interests of any
    Restricted Subsidiary, whether in a single transaction or a
    series of related transactions (other than Preferred Stock of
    Restricted Subsidiaries issued in compliance with the covenant
    described under &#147;Certain Covenants&#160;&#151; Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock&#148;);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    in each case, other than:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;any disposition of Cash Equivalents or Investment Grade
    Securities or obsolete or worn out equipment in the ordinary
    course of business or any disposition of inventory or goods (or
    other assets) held for sale in the ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the disposition of all or substantially all of the
    assets of the Issuer in a manner permitted pursuant to the
    provisions described above under &#147;Certain
    Covenants&#160;&#151; Merger, Consolidation or Sale of All or
    Substantially All Assets&#148; or any disposition that
    constitutes a Change of Control pursuant to the Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;the making of any Restricted Payment or Permitted
    Investment that is permitted to be made, and is made, under the
    covenant described above under &#147;Certain
    Covenants&#160;&#151; Limitation on Restricted Payments&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;any disposition of assets or issuance or sale of Equity
    Interests of any Restricted Subsidiary in any transaction or
    series of related transactions with an aggregate fair market
    value of less than $100.0&#160;million;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;any disposition of property or assets or issuance of
    securities by a Restricted Subsidiary of the Issuer to the
    Issuer or by the Issuer or a Restricted Subsidiary of the Issuer
    to another Restricted Subsidiary of the Issuer;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (f)&#160;to the extent allowable under Section&#160;1031 of the
    Code or any comparable or successor provision, any exchange of
    like property (excluding any boot thereon) for use in a Similar
    Business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (g)&#160;the lease, assignment or
    <FONT style="white-space: nowrap">sub-lease</FONT> of
    any real or personal property in the ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (h)&#160;any issuance or sale of Equity Interests in, or
    Indebtedness or other securities of, an Unrestricted Subsidiary;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (i)&#160;foreclosures on assets;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (j)&#160;sales of accounts receivable, or participations
    therein, in connection with the ABL Facility or any Receivables
    Facility;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (k)&#160;any financing transaction with respect to property
    built or acquired by the Issuer or any Restricted Subsidiary
    after November&#160;17, 2006, including Sale and Lease-Back
    Transactions and asset securitizations permitted by the
    Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (l)&#160;dispositions in the ordinary course of business by any
    Restricted Subsidiary (including, without limitation, HCI)
    engaged in the insurance business in order to provide insurance
    to the Issuer and its Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (m)&#160;sales, transfers and other dispositions of Investments
    in joint ventures to the extent required by, or made pursuant
    to, customary buy/sell arrangements between the joint venture
    parties set forth in joint venture arrangements and similar
    binding arrangements;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (n)&#160;any issuance or sale of Equity Interests or
    dispositions in connection with ordinary course syndications of
    Subsidiaries or joint ventures owning or operating one or more
    healthcare facilities, including, without limitation, hospitals,
    ambulatory surgery centers, outpatient diagnostic centers or
    imaging centers in any transaction or series of related
    transactions with an aggregate fair market value of less than
    $100.0&#160;million;&#160;and
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    163
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (o)&#160;any issuance or sale of Equity Interests of any
    Restricted Subsidiary (including, without limitation,
    HealthTrust Purchasing Group, L.P.) to any Person operating in a
    Similar Business for which such Restricted Subsidiary provides
    shared purchasing, billing, collection or similar services in
    the ordinary course of business.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Asset Sale Offer&#148;</I> has the meaning set forth in
    the fourth paragraph under &#147;Repurchase at the Option of
    Holders&#160;&#151; Asset Sales.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Bankruptcy Code&#148;</I> means Title&#160;11 of the
    United States Code, as amended.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Bankruptcy Law&#148;</I> means the Bankruptcy Code and
    any similar federal, state or foreign law for the relief of
    debtors.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Business Day&#148;</I> means each day which is not a
    Legal Holiday.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Capital Stock&#148;</I> means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;in the case of a corporation, corporate stock;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;in the case of an association or business entity, any
    and all shares, interests, participations, rights or other
    equivalents (however designated) of corporate stock;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;in the case of a partnership or limited liability
    company, partnership or membership interests (whether general or
    limited);&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;any other interest or participation that confers on a
    Person the right to receive a share of the profits and losses
    of, or distributions of assets of, the issuing Person.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Capitalized Lease Obligation&#148;</I> means, at the
    time any determination thereof is to be made, the amount of the
    liability in respect of a capital lease that would at such time
    be required to be capitalized and reflected as a liability on a
    balance sheet (excluding the footnotes thereto) in accordance
    with GAAP.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Capitalized Software Expenditures&#148;</I> means, for
    any period, the aggregate of all expenditures (whether paid in
    cash or accrued as liabilities) by a Person and its Restricted
    Subsidiaries during such period in respect of purchased software
    or internally developed software and software enhancements that,
    in conformity with GAAP, are or are required to be reflected as
    capitalized costs on the consolidated balance sheet of a Person
    and its Restricted Subsidiaries.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Cash Equivalents&#148;</I> means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;United States dollars;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;euros or any national currency of any participating
    member state of the EMU or such local currencies held by the
    Company and its Restricted Subsidiaries from time to time in the
    ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;securities issued or directly and fully and
    unconditionally guaranteed or insured by the
    U.S.&#160;government (or any agency or instrumentality thereof
    the securities of which are unconditionally guaranteed as a full
    faith and credit obligation of the U.S.&#160;government) with
    maturities of 24&#160;months or less from the date of
    acquisition;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;certificates of deposit, time deposits and eurodollar
    time deposits with maturities of one year or less from the date
    of acquisition, bankers&#146; acceptances with maturities not
    exceeding one year and overnight bank deposits, in each case
    with any commercial bank having capital and surplus of not less
    than $500.0&#160;million in the case of U.S.&#160;banks and
    $100.0&#160;million (or the U.S.&#160;dollar equivalent as of
    the date of determination) in the case of
    <FONT style="white-space: nowrap">non-U.S.&#160;banks;</FONT>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;repurchase obligations for underlying securities of the
    types described in clauses&#160;(3) and (4)&#160;entered into
    with any financial institution meeting the qualifications
    specified in clause&#160;(4) above;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;commercial paper rated at least
    <FONT style="white-space: nowrap">P-1</FONT> by
    Moody&#146;s or at least
    <FONT style="white-space: nowrap">A-1</FONT> by
    S&#038;P and in each case maturing within 24&#160;months after
    the date of creation thereof;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    164
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;marketable short-term money market and similar
    securities having a rating of at least
    <FONT style="white-space: nowrap">P-2</FONT> or
    <FONT style="white-space: nowrap">A-2</FONT> from
    either Moody&#146;s or S&#038;P, respectively (or, if at any
    time neither Moody&#146;s nor S&#038;P shall be rating such
    obligations, an equivalent rating from another Rating Agency)
    and in each case maturing within 24&#160;months after the date
    of creation thereof;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;investment funds investing 95% of their assets in
    securities of the types described in clauses&#160;(1) through
    (7)&#160;above;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;readily marketable direct obligations issued by any
    state, commonwealth or territory of the United States or any
    political subdivision or taxing authority thereof having an
    Investment Grade Rating from either Moody&#146;s or S&#038;P
    with maturities of 24&#160;months or less from the date of
    acquisition;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;Indebtedness or Preferred Stock issued by Persons with
    a rating of A or higher from S&#038;P or A2 or higher from
    Moody&#146;s with maturities of 24&#160;months or less from the
    date of acquisition;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;Investments with average maturities of 24&#160;months
    or less from the date of acquisition in money market funds rated
    AAA- (or the equivalent thereof) or better by S&#038;P or Aaa3
    (or the equivalent thereof) or better by Moody&#146;s.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding the foregoing, Cash Equivalents shall include
    amounts denominated in currencies other than those set forth in
    clauses&#160;(1) and (2)&#160;above; <I>provided </I>that such
    amounts are converted into any currency listed in
    clauses&#160;(1) and (2)&#160;as promptly as practicable and in
    any event within ten Business Days following the receipt of such
    amounts.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Change of Control&#148;</I> means the occurrence of any
    of the following:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the sale, lease or transfer, in one or a series of
    related transactions, of all or substantially all of the assets
    of the Issuer and its Subsidiaries, taken as a whole, to any
    Person other than a Permitted Holder;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the Issuer becomes aware (by way of a report or any
    other filing pursuant to Section 13(d) of the Exchange Act,
    proxy, vote, written notice or otherwise) of the acquisition by
    any Person or group (within the meaning of Section&#160;13(d)(3)
    or Section&#160;14(d)(2) of the Exchange Act, or any successor
    provision), including any group acting for the purpose of
    acquiring, holding or disposing of securities (within the
    meaning of
    <FONT style="white-space: nowrap">Rule&#160;13d-5(b)(1)</FONT>
    under the Exchange Act), other than the Permitted Holders, in a
    single transaction or in a related series of transactions, by
    way of merger, consolidation or other business combination or
    purchase of beneficial ownership (within the meaning of
    <FONT style="white-space: nowrap">Rule&#160;13d-3</FONT>
    under the Exchange Act, or any successor provision) of 50% or
    more of the total voting power of the Voting Stock of the Issuer
    or any of its direct or indirect parent companies holding
    directly or indirectly 100% of the total voting power of the
    Voting Stock of the Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Code&#148;</I> means the Internal Revenue Code of 1986,
    as amended, or any successor thereto.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Collateral&#148;</I> means, collectively, the Shared
    Receivables Collateral and Non-Receivables Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Collateral Asset Sale Offer&#148;</I> has the meaning
    set forth in the third paragraph under &#147;Repurchase at the
    Option of Holders&#160;&#151; Asset Sales.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Collateral Excess Proceeds&#148;</I> has the meaning
    set forth in the third paragraph under &#147;Repurchase at the
    Option of Holders&#160;&#151; Asset Sales.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Consolidated Depreciation and Amortization
    Expense&#148;</I> means with respect to any Person for any
    period, the total amount of depreciation and amortization
    expense, including the amortization of deferred financing fees,
    debt issuance costs, commissions, fees and expenses and
    Capitalized Software Expenditures, of such Person and its
    Restricted Subsidiaries for such period on a consolidated basis
    and otherwise determined in accordance with GAAP.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    165
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Consolidated Interest Expense&#148;</I> means, with
    respect to any Person for any period, without duplication, the
    sum of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;consolidated interest expense of such Person and its
    Restricted Subsidiaries for such period, to the extent such
    expense was deducted (and not added back) in computing
    Consolidated Net Income (including (a)&#160;amortization of
    original issue discount resulting from the issuance of
    Indebtedness at less than par, (b)&#160;all commissions,
    discounts and other fees and charges owed with respect to
    letters of credit or bankers&#146; acceptances,
    (c)&#160;non-cash interest payments (but excluding any non-cash
    interest expense attributable to the movement in the mark to
    market valuation of Hedging Obligations or other derivative
    instruments pursuant to GAAP), (d)&#160;the interest component
    of Capitalized Lease Obligations, and (e)&#160;net payments, if
    any, pursuant to interest rate Hedging Obligations with respect
    to Indebtedness, and excluding (u)&#160;accretion or accrual of
    discounted liabilities not constituting Indebtedness,
    (v)&#160;any expense resulting from the discounting of the
    Existing Notes or other Indebtedness in connection with the
    application of recapitalization accounting or, if applicable,
    purchase accounting, (w)&#160;any Additional Interest and any
    comparable &#147;additional interest&#148; with respect to other
    securities, (x)&#160;amortization of deferred financing fees,
    debt issuance costs, commissions, fees and expenses,
    (y)&#160;any expensing of bridge, commitment and other financing
    fees and (z)&#160;commissions, discounts, yield and other fees
    and charges (including any interest expense) related to any
    Receivables Facility); plus
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;consolidated capitalized interest of such Person and
    its Restricted Subsidiaries for such period, whether paid or
    accrued; less
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;interest income for such period.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For purposes of this definition, interest on a Capitalized Lease
    Obligation shall be deemed to accrue at an interest rate
    reasonably determined by such Person to be the rate of interest
    implicit in such Capitalized Lease Obligation in accordance with
    GAAP.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Consolidated Leverage Ratio&#148;</I>, with respect to
    any Person as of any date of determination, means the ratio of
    (x)&#160;Consolidated Total Indebtedness of such Person as of
    the end of the most recent fiscal quarter for which internal
    financial statements are available immediately preceding the
    date on which such event for which such calculation is being
    made shall occur to (y)&#160;the aggregate amount of EBITDA of
    such Person for the period of the most recently ended four full
    consecutive fiscal quarters for which internal financial
    statements are available immediately preceding the date on which
    such event for which such calculation is being made shall occur,
    in each case with such pro forma adjustments to Consolidated
    Total Indebtedness and EBITDA as are appropriate and consistent
    with the pro forma adjustment provisions set forth in the
    definition of &#147;Fixed Charge Coverage Ratio.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Consolidated Net Income&#148;</I> means, with respect
    to any Person for any period, the aggregate of the Net Income of
    such Person for such period, on a consolidated basis, and
    otherwise determined in accordance with GAAP; <I>provided</I>,
    <I>however</I>, that, without duplication,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any after-tax effect of extraordinary, non-recurring or
    unusual gains or losses (less all fees and expenses relating
    thereto) or expenses, severance, relocation costs, consolidation
    and closing costs, integration and facilities opening costs,
    business optimization costs, transition costs, restructuring
    costs, signing, retention or completion bonuses, and
    curtailments or modifications to pension and post-retirement
    employee benefit plans shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the cumulative effect of a change in accounting
    principles during such period shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;any after-tax effect of income (loss) from disposed,
    abandoned or discontinued operations and any net after-tax gains
    or losses on disposal of disposed, abandoned, transferred,
    closed or discontinued operations shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;any after-tax effect of gains or losses (less all fees
    and expenses relating thereto) attributable to asset
    dispositions or abandonments other than in the ordinary course
    of business, as determined in good faith by the Issuer, shall be
    excluded,
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    166
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;the Net Income for such period of any Person that is an
    Unrestricted Subsidiary shall be excluded, and, solely for the
    purpose of determining the amount available for Restricted
    Payments under clause&#160;3(a) of the first paragraph of
    &#147;Certain Covenants&#160;&#151; Limitation on Restricted
    Payments,&#148; the Net Income for such period of any Person
    that is not a Subsidiary or that is accounted for by the equity
    method of accounting shall be excluded; provided that
    Consolidated Net Income of the Issuer shall be increased by the
    amount of dividends or distributions or other payments that are
    actually paid in cash (or to the extent converted into cash) to
    the referent Person or a Restricted Subsidiary thereof in
    respect of such period,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;solely for the purpose of determining the amount
    available for Restricted Payments under clause (3)(a) of the
    first paragraph of &#147;Certain Covenants&#160;&#151;
    Limitation on Restricted Payments,&#148; the Net Income for such
    period of any Restricted Subsidiary (other than any Guarantor)
    shall be excluded to the extent that the declaration or payment
    of dividends or similar distributions by that Restricted
    Subsidiary of its Net Income is not at the date of determination
    wholly permitted without any prior governmental approval (which
    has not been obtained) or, directly or indirectly, by the
    operation of the terms of its charter or any agreement,
    instrument, judgment, decree, order, statute, rule, or
    governmental regulation applicable to that Restricted Subsidiary
    or its stockholders, unless such restriction with respect to the
    payment of dividends or similar distributions has been legally
    waived; provided that Consolidated Net Income of the Issuer will
    be increased by the amount of dividends or other distributions
    or other payments actually paid in cash (or to the extent
    converted into cash) or Cash Equivalents to the Issuer or a
    Restricted Subsidiary thereof in respect of such period, to the
    extent not already included therein,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;effects of adjustments (including the effects of such
    adjustments pushed down to the Issuer and its Restricted
    Subsidiaries) in the property, equipment, inventory, software
    and other intangible assets, deferred revenue and debt line
    items in such Person&#146;s consolidated financial statements
    pursuant to GAAP resulting from the application of
    recapitalization accounting or, if applicable, purchase
    accounting in relation to the Transactions or any consummated
    acquisition or the amortization or write-off of any amounts
    thereof, net of taxes, shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;any after-tax effect of income (loss) from the early
    extinguishment of Indebtedness or Hedging Obligations or other
    derivative instruments shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;any impairment charge or asset write-off, including,
    without limitation, impairment charges or asset write-offs
    related to intangible assets, long-lived assets or investments
    in debt and equity securities, in each case, pursuant to GAAP
    and the amortization of intangibles arising pursuant to GAAP
    shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;any non-cash compensation expense recorded from grants
    of stock appreciation or similar rights, stock options,
    restricted stock or other rights, and any cash charges
    associated with the rollover, acceleration or payout of Equity
    Interests by management of the Company or any of its direct or
    indirect parent companies in connection with the Transaction,
    shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;any fees and expenses incurred during such period, or
    any amortization thereof for such period, in connection with any
    acquisition, Investment, Asset Sale, issuance or repayment of
    Indebtedness, issuance of Equity Interests, refinancing
    transaction or amendment or modification of any debt instrument
    (in each case, including any such transaction consummated prior
    to the Issue Date and any such transaction undertaken but not
    completed) and any charges or non-recurring merger costs
    incurred during such period as a result of any such transaction
    shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;accruals and reserves that are established or adjusted
    within twelve months after November&#160;17, 2006 that are so
    required to be established as a result of the Transaction in
    accordance with GAAP, or changes as a result of adoption or
    modification of accounting policies, shall be excluded,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;to the extent covered by insurance and actually
    reimbursed, or, so long as the Issuer has made a determination
    that there exists reasonable evidence that such amount will in
    fact be reimbursed by the insurer and only to the extent that
    such amount is (a)&#160;not denied by the applicable carrier in
    writing within 180&#160;days and (b)&#160;in fact reimbursed
    within 365&#160;days of the date of such evidence (with a
    deduction for any amount so added back to the extent not so
    reimbursed within 365&#160;days), expenses with respect to
    liability or casualty events or business interruption shall be
    excluded.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    167
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding the foregoing, for the purpose of the covenant
    described under &#147;Certain Covenants&#160;&#151; Limitation
    on Restricted Payments&#148; only (other than clause (3)(d)
    thereof), there shall be excluded from Consolidated Net Income
    any income arising from any sale or other disposition of
    Restricted Investments made by the Issuer and its Restricted
    Subsidiaries, any repurchases and redemptions of Restricted
    Investments from the Issuer and its Restricted Subsidiaries, any
    repayments of loans and advances which constitute Restricted
    Investments by the Issuer or any of its Restricted Subsidiaries,
    any sale of the stock of an Unrestricted Subsidiary or any
    distribution or dividend from an Unrestricted Subsidiary, in
    each case only to the extent such amounts increase the amount of
    Restricted Payments permitted under such covenant pursuant to
    clause (3)(d) thereof.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Consolidated Secured Debt Ratio&#148;</I> as of any
    date of determination, means the ratio of (1)&#160;Consolidated
    Total Indebtedness of the Issuer and its Restricted Subsidiaries
    that is secured by Liens as of the end of the most recent fiscal
    period for which internal financial statements are available
    immediately preceding the date on which such event for which
    such calculation is being made shall occur to (2)&#160;the
    Issuer&#146;s EBITDA for the most recently ended four full
    fiscal quarters for which internal financial statements are
    available immediately preceding the date on which such event for
    which such calculation is being made shall occur, in each case
    with such pro forma adjustments to Consolidated Total
    Indebtedness and EBITDA as are appropriate and consistent with
    the pro forma adjustment provisions set forth in the definition
    of &#147;Fixed Charge Coverage Ratio.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Consolidated Total Indebtedness&#148;</I> means, as at
    any date of determination, an amount equal to the sum of
    (1)&#160;the aggregate amount of all outstanding Indebtedness of
    the Issuer and its Restricted Subsidiaries on a consolidated
    basis consisting of Indebtedness for borrowed money, Obligations
    in respect of Capitalized Lease Obligations and debt obligations
    evidenced by promissory notes and similar instruments (and
    excluding, for the avoidance of doubt, all obligations relating
    to Receivables Facilities) and (2)&#160;the aggregate amount of
    all outstanding Disqualified Stock of the Issuer and all
    Preferred Stock of its Restricted Subsidiaries on a consolidated
    basis, with the amount of such Disqualified Stock and Preferred
    Stock equal to the greater of their respective voluntary or
    involuntary liquidation preferences and maximum fixed repurchase
    prices, in each case determined on a consolidated basis in
    accordance with GAAP. For purposes hereof, the &#147;maximum
    fixed repurchase price&#148; of any Disqualified Stock or
    Preferred Stock that does not have a fixed repurchase price
    shall be calculated in accordance with the terms of such
    Disqualified Stock or Preferred Stock as if such Disqualified
    Stock or Preferred Stock were purchased on any date on which
    Consolidated Total Indebtedness shall be required to be
    determined pursuant to the Indenture, and if such price is based
    upon, or measured by, the fair market value of such Disqualified
    Stock or Preferred Stock, such fair market value shall be
    determined reasonably and in good faith by the Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Contingent Obligations&#148;</I> means, with respect to
    any Person, any obligation of such Person guaranteeing any
    leases, dividends or other obligations that do not constitute
    Indebtedness <I>(&#147;primary obligations&#148;) </I>of any
    other Person (the <I>&#147;primary obligor&#148;</I>) in any
    manner, whether directly or indirectly, including, without
    limitation, any obligation of such Person, whether or not
    contingent,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;to purchase any such primary obligation or any property
    constituting direct or indirect security therefor,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;to advance or supply funds
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;for the purchase or payment of any such primary
    obligation,&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;to maintain working capital or equity capital of the
    primary obligor or otherwise to maintain the net worth or
    solvency of the primary obligor,&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;to purchase property, securities or services primarily
    for the purpose of assuring the owner of any such primary
    obligation of the ability of the primary obligor to make payment
    of such primary obligation against loss in respect thereof.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Credit Facilities&#148;</I> means, with respect to the
    Issuer or any of its Restricted Subsidiaries, one or more debt
    facilities, including the Senior Credit Facilities, or other
    financing arrangements (including, without
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    168
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    limitation, commercial paper facilities or indentures) providing
    for revolving credit loans, term loans, letters of credit or
    other long-term indebtedness, including any notes, mortgages,
    guarantees, collateral documents, instruments and agreements
    executed in connection therewith, and any amendments,
    supplements, modifications, extensions, renewals, restatements
    or refundings thereof and any indentures or credit facilities or
    commercial paper facilities that replace, refund or refinance
    any part of the loans, notes, other credit facilities or
    commitments thereunder, including any such replacement,
    refunding or refinancing facility or indenture that increases
    the amount permitted to be borrowed thereunder or alters the
    maturity thereof (<I>provided </I>that such increase in
    borrowings is permitted under &#147;Certain Covenants
    &#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock&#148;) or
    adds Restricted Subsidiaries as additional borrowers or
    guarantors thereunder and whether by the same or any other
    agent, lender or group of lenders.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Default&#148;</I> means any event that is, or with the
    passage of time or the giving of notice or both would be, an
    Event of Default.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Delayed Equity Amount&#148;</I> means any equity
    contribution of the Investors, the Frist Entities or certain
    other management investors described in the Offering Memorandum
    on or before March&#160;31, 2007, the proceeds of which are used
    to repay borrowings under the senior secured revolving credit
    facility included in the General Credit Facility or the ABL
    Facility in the manner described in the Offering Memorandum.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Designated Non-cash Consideration&#148;</I> means the
    fair market value of non-cash consideration received by the
    Issuer or a Restricted Subsidiary in connection with an Asset
    Sale that is so designated as Designated Non-cash Consideration
    pursuant to an Officer&#146;s Certificate, setting forth the
    basis of such valuation, executed by the principal financial
    officer of the Issuer, less the amount of cash or Cash
    Equivalents received in connection with a subsequent sale of or
    collection on such Designated Non-cash Consideration.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Designated Preferred Stock&#148;</I> means Preferred
    Stock of the Issuer or any parent corporation thereof (in each
    case other than Disqualified Stock) that is issued for cash
    (other than to a Restricted Subsidiary or an employee stock
    ownership plan or trust established by the Issuer or any of its
    Subsidiaries) and is so designated as Designated Preferred
    Stock, pursuant to an Officer&#146;s Certificate executed by the
    principal financial officer of the Issuer or the applicable
    parent corporation thereof, as the case may be, on the issuance
    date thereof, the cash proceeds of which are excluded from the
    calculation set forth in clause&#160;(3) of the first paragraph
    under &#147;Certain Covenants&#160;&#151; Limitation on
    Restricted Payments.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Discharge of First Lien Obligations&#148;</I> shall
    mean the satisfaction and discharge of all of the First Lien
    Obligations in full in cash, pursuant to the First Lien
    Documents and the General Intercreditor Agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Disqualified Stock&#148;</I> means, with respect to any
    Person, any Capital Stock of such Person which, by its terms, or
    by the terms of any security into which it is convertible or for
    which it is putable or exchangeable, or upon the happening of
    any event, matures or is mandatorily redeemable (other than
    solely as a result of a change of control or asset sale)
    pursuant to a sinking fund obligation or otherwise, or is
    redeemable at the option of the holder thereof (other than
    solely as a result of a change of control or asset sale), in
    whole or in part, in each case prior to the date 91&#160;days
    after the earlier of the maturity date of the Notes or the date
    the Notes are no longer outstanding; <I>provided</I>,
    <I>however</I>, that if such Capital Stock is issued to any plan
    for the benefit of employees of the Issuer or its Subsidiaries
    or by any such plan to such employees, such Capital Stock shall
    not constitute Disqualified Stock solely because it may be
    required to be repurchased by the Issuer or its Subsidiaries in
    order to satisfy applicable statutory or regulatory obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;EBITDA&#148;</I> means, with respect to any Person for
    any period, the Consolidated Net Income of such Person for such
    period
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;increased (without duplication) by:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;provision for taxes based on income or profits or
    capital gains, including, without limitation, foreign, federal,
    state, franchise and similar taxes (such as the Pennsylvania
    capital tax) and foreign withholding taxes (including penalties
    and interest related to such taxes or arising from tax
    examinations) of such Person paid or accrued during such period
    deducted (and not added back) in computing Consolidated Net
    Income; <I>plus</I>
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    169
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;Fixed Charges of such Person for such period (including
    (x)&#160;net losses on Hedging Obligations or other derivative
    instruments entered into for the purpose of hedging interest
    rate risk and (y)&#160;costs of surety bonds in connection with
    financing activities, in each case, to the extent included in
    Fixed Charges), together with items excluded from the definition
    of &#147;Consolidated Interest Expense&#148; pursuant to clauses
    (1)(u), (v), (w), (x), (y)&#160;and (z)&#160;of the definition
    thereof, and, in each such case, to the extent the same were
    deducted (and not added back) in calculating such Consolidated
    Net Income; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;Consolidated Depreciation and Amortization Expense of
    such Person for such period to the extent the same was deducted
    (and not added back) in computing Consolidated Net Income;
    <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;any expenses or charges (other than depreciation or
    amortization expense) related to any Equity Offering, Permitted
    Investment, acquisition, disposition, recapitalization or the
    incurrence of Indebtedness permitted to be incurred by the
    Indenture (including a refinancing thereof) (whether or not
    successful), including (i)&#160;such fees, expenses or charges
    related to the offering of the Notes and any Credit Facilities
    and (ii)&#160;any amendment or other modification of the Notes,
    and, in each case, deducted (and not added back) in computing
    Consolidated Net Income; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;the amount of any restructuring charge or reserve
    deducted (and not added back) in such period in computing
    Consolidated Net Income, including any one-time costs incurred
    in connection with acquisitions after November&#160;17, 2006 and
    costs related to the closure
    <FONT style="white-space: nowrap">and/or</FONT>
    consolidation of facilities; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (f)&#160;any other non-cash charges, including any write-offs or
    write-downs, reducing Consolidated Net Income for such period
    (provided that if any such non-cash charges represent an accrual
    or reserve for potential cash items in any future period, the
    cash payment in respect thereof in such future period shall be
    subtracted from EBITDA to such extent, and excluding
    amortization of a prepaid cash item that was paid in a prior
    period); <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (g)&#160;the amount of any minority interest expense consisting
    of income attributable to minority equity interests of third
    parties deducted (and not added back) in such period in
    calculating Consolidated Net Income; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (h)&#160;the amount of management, monitoring, consulting and
    advisory fees and related expenses paid in such period to the
    Investors and the Frist Entities to the extent otherwise
    permitted under &#147;Certain Covenants&#160;&#151; Transactions
    with Affiliates&#148;; plus
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (i)&#160;the amount of net cost savings projected by the Issuer
    in good faith to be realized as a result of specified actions
    taken or to be taken (calculated on a pro forma basis as though
    such cost savings had been realized on the first day of such
    period), net of the amount of actual benefits realized during
    such period from such actions; provided that (w)&#160;such cost
    savings are reasonably identifiable and factually supportable,
    (x)&#160;such actions have been taken or are to be taken within
    15&#160;months after the date of determination to take such
    action, (y)&#160;no cost savings shall be added pursuant to this
    clause&#160;(i) to the extent duplicative of any expenses or
    charges relating to such cost savings that are included in
    clause&#160;(e) above with respect to such period and
    (z)&#160;the aggregate amount of cost savings added pursuant to
    this clause&#160;(i) shall not exceed $150.0&#160;million for
    any four consecutive quarter period (which adjustments may be
    incremental to pro forma adjustments made pursuant to the second
    paragraph of the definition of &#147;Fixed Charge Coverage
    Ratio&#148;); plus
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (j)&#160;the amount of loss on sales of receivables and related
    assets to the Receivables Subsidiary in connection with a
    Receivables Facility; plus
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (k)&#160;any costs or expense incurred by the Issuer or a
    Restricted Subsidiary pursuant to any management equity plan or
    stock option plan or any other management or employee benefit
    plan or agreement or any stock subscription or shareholder
    agreement, to the extent that such cost or expenses are funded
    with cash proceeds contributed to the capital of the Issuer or
    net cash proceeds of an issuance of Equity Interests of the
    Issuer (other than Disqualified Stock) solely to the extent that
    such net cash
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    170
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    proceeds are excluded from the calculation set forth in
    clause&#160;(3) of the first paragraph under &#147;Certain
    Covenants&#160;&#151; Limitation on Restricted Payments&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;decreased by (without duplication) non-cash gains
    increasing Consolidated Net Income of such Person for such
    period, excluding any non-cash gains to the extent they
    represent the reversal of an accrual or reserve for a potential
    cash item that reduced EBITDA in any prior period;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;increased or decreased by (without duplication):
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;any net gain or loss resulting in such period from
    Hedging Obligations and the application of Statement of
    Financial Accounting Standards No.&#160;133; plus or minus, as
    applicable,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;any net gain or loss resulting in such period from
    currency translation gains or losses related to currency
    remeasurements of Indebtedness (including any net loss or gain
    resulting from Hedging Obligations for currency exchange risk).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;EMU&#148;</I> means the economic and monetary union as
    contemplated in the Treaty on European Union.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Equity Interests&#148;</I> means Capital Stock and all
    warrants, options or other rights to acquire Capital Stock, but
    excluding any debt security that is convertible into, or
    exchangeable for, Capital Stock.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Equity Offering&#148;</I> means any public or private
    sale of common stock or Preferred Stock of the Issuer or any of
    its direct or indirect parent companies (excluding Disqualified
    Stock), other than:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;public offerings with respect to the Issuer&#146;s or
    any direct or indirect parent company&#146;s common stock
    registered on
    <FONT style="white-space: nowrap">Form&#160;S-8;</FONT>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;issuances to any Subsidiary of the Issuer;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;any such public or private sale that constitutes an
    Excluded Contribution.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;euro&#148;</I> means the single currency of
    participating member states of the EMU.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;European Collateral&#148;</I> has the meaning set forth
    under &#147;Description of Other Indebtedness&#160;&#151; Senior
    Secured Credit Facilities&#160;&#151; Guarantee and
    Security.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Event of Default&#148;</I> has the meaning set forth
    under &#147;Events of Default and Remedies.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Excess Proceeds&#148;</I> has the meaning set forth in
    the fourth paragraph under &#147;Repurchase at the Option of
    Holders&#160;&#151; Asset Sales.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Exchange Act&#148;</I> means the Securities Exchange
    Act of 1934, as amended, and the rules and regulations of the
    SEC promulgated thereunder.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Exchange Notes&#148;</I> means any notes issued in
    exchange for the Notes pursuant to the Registration Rights
    Agreement or similar agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Excluded Contribution&#148;</I> means net cash
    proceeds, marketable securities or Qualified Proceeds received
    by the Issuer after November&#160;17, 2006 from
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;contributions to its common equity capital,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the sale (other than to a Subsidiary of the Issuer or
    to any management equity plan or stock option plan or any other
    management or employee benefit plan or agreement of the Issuer)
    of Capital Stock (other than Disqualified Stock and Designated
    Preferred Stock) of the Issuer,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    in each case designated as Excluded Contributions pursuant to an
    Officer&#146;s Certificate executed by the principal financial
    officer of the Issuer on the date such capital contributions are
    made or the date such Equity Interests are sold, as the case may
    be, which are excluded from the calculation set forth in
    clause&#160;(3) of the first paragraph under &#147;Certain
    Covenants&#160;&#151; Limitation on Restricted Payments.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Existing Notes&#148;</I> means the $121.2&#160;million
    aggregate principal amount of 8.700% medium-term notes due 2010,
    $691.2&#160;million aggregate principal amount of
    8.750%&#160;notes due 2010, &#163;150.0&#160;million aggregate
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    171
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    principal amount of 8.750%&#160;notes due 2010,
    $475.8&#160;million aggregate principal amount of
    7.875%&#160;notes due 2011, $500.0&#160;million aggregate
    principal amount of 6.950%&#160;notes due 2012,
    $500.0&#160;million aggregate principal amount of
    6.300%&#160;notes due 2012, $500.0&#160;million aggregate
    principal amount of 6.250%&#160;notes due 2013,
    $500.0&#160;million aggregate principal amount of
    6.750%&#160;notes due 2013, $500.0&#160;million aggregate
    principal amount of 5.750%&#160;notes due 2014,
    $121.1&#160;million aggregate principal amount of 9.000%
    medium-term notes due 2014, $750.0&#160;million aggregate
    principal amount of 6.375%&#160;notes due 2015,
    $150.0&#160;million aggregate principal amount of
    7.190%&#160;debentures due 2015, $1,000.0&#160;million aggregate
    principal amount of 6.500%&#160;notes due 2016,
    $135.6&#160;million aggregate principal amount of
    7.500%&#160;debentures due 2023, $150.0&#160;million aggregate
    principal amount of 8.360%&#160;debentures due 2024,
    $291.4&#160;million aggregate principal amount of
    7.690%&#160;notes due 2025, $125.0&#160;million aggregate
    principal amount of 7.580% medium-term notes due 2025,
    $150.0&#160;million aggregate principal amount of
    7.050%&#160;debentures due 2027, $250.0&#160;million aggregate
    principal amount of 7.500%&#160;notes due 2033,
    $100.0&#160;million aggregate principal amount of
    7.750%&#160;debentures due 2036 and $200.0&#160;million
    aggregate principal amount of 7.500%&#160;debentures due 2095,
    each issued by the Issuer and outstanding on November&#160;17,
    2006.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Existing Notes Indenture&#148;</I> means that certain
    Indenture, dated as of December&#160;16, 1993, between Columbia
    Healthcare Corporation and The First National Bank of Chicago,
    as Trustee, as amended by the First Supplemental Indenture,
    dated as of May&#160;25, 2000, between the Issuer and Bank One
    Trust&#160;Company, N.A., as Trustee, the Second Supplemental
    Indenture, dated as of July&#160;1, 2001, between the Issuer and
    Bank One Trust&#160;Company, N.A., as Trustee, and the Third
    Supplemental Indenture, dated as of December&#160;5, 2001,
    between the Issuer and The Bank of New York, as Trustee.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;First Lien Collateral&#148;</I> means all of the assets
    of the Issuer or any Guarantor, whether real, personal or mixed,
    with respect to which a Lien has been granted as security for
    any First Lien Obligations pursuant to a First Lien Document.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;First Lien Collateral Agent&#148;</I> shall mean Bank
    of America, N.A., in its capacity as administrative agent and
    collateral agent for the lenders and other secured parties under
    the General Credit Facility and the other First Lien Documents,
    together with its successors and permitted assigns under the
    General Credit Facility exercising substantially the same rights
    and powers; and in each case provided that if such First Lien
    Collateral Agent is not Bank of America, N.A., such First Lien
    Collateral Agent shall have become a party to the Intercreditor
    Agreements and the other applicable First Lien Security
    Documents.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;First Lien Documents&#148;</I> means the credit,
    guarantee and security documents governing the First Lien
    Obligations, including, without limitation, the General Credit
    Facility and the First Lien Security Documents.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;First Lien Obligations&#148;</I> shall mean
    (a)&#160;all General Credit Facility Obligations and
    (b)&#160;all other Obligations of the Issuer and its
    Subsidiaries under any refinancings of the General Credit
    Facility Obligations (and any related Hedging Obligations). For
    the avoidance of doubt, Obligations with respect to the ABL
    Facility shall not constitute First Lien Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;First Lien Secured Parties&#148;</I> means, at any
    relevant time, the holders of First Lien Obligations at such
    time, including, without limitation, the lenders and agents
    under the General Credit Facility and the First Lien Collateral
    Agent.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;First Lien Security Documents&#148;</I> means the
    Security Documents (as defined in the General Credit Facility)
    and any other agreement, document or instrument pursuant to
    which a Lien is granted or purported to be granted securing
    First Lien Obligations or under which rights or remedies with
    respect to such Liens are governed.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;First Priority Liens&#148;</I> means the first priority
    Liens securing the First Lien Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Fixed Charge Coverage Ratio&#148;</I> means, with
    respect to any Person for any period, the ratio of EBITDA of
    such Person for such period to the Fixed Charges of such Person
    for such period. In the event that the Issuer or any Restricted
    Subsidiary incurs, assumes, guarantees, redeems, retires or
    extinguishes any Indebtedness (other than Indebtedness incurred
    under any revolving credit facility unless such Indebtedness has
    been permanently repaid and has not been replaced) or issues or
    redeems Disqualified Stock or Preferred Stock
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    172
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    subsequent to the commencement of the period for which the Fixed
    Charge Coverage Ratio is being calculated but prior to or
    simultaneously with the event for which the calculation of the
    Fixed Charge Coverage Ratio is made (the <I>&#147;Fixed Charge
    Coverage Ratio Calculation Date&#148;</I>), then the Fixed
    Charge Coverage Ratio shall be calculated giving pro forma
    effect to such incurrence, assumption, guarantee, redemption,
    retirement or extinguishment of Indebtedness, or such issuance
    or redemption of Disqualified Stock or Preferred Stock, as if
    the same had occurred at the beginning of the applicable
    four-quarter period.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For purposes of making the computation referred to above,
    Investments, acquisitions, dispositions, mergers, consolidations
    and disposed operations (as determined in accordance with GAAP)
    that have been made by the Issuer or any of its Restricted
    Subsidiaries during the four-quarter reference period or
    subsequent to such reference period and on or prior to or
    simultaneously with the Fixed Charge Coverage Ratio Calculation
    Date shall be calculated on a pro forma basis assuming that all
    such Investments, acquisitions, dispositions, mergers,
    consolidations and disposed operations (and the change in any
    associated fixed charge obligations and the change in EBITDA
    resulting therefrom) had occurred on the first day of the
    four-quarter reference period. If, since the beginning of such
    period, any Person that subsequently became a Restricted
    Subsidiary or was merged with or into the Issuer or any of its
    Restricted Subsidiaries since the beginning of such period shall
    have made any Investment, acquisition, disposition, merger,
    consolidation or disposed operation that would have required
    adjustment pursuant to this definition, then the Fixed Charge
    Coverage Ratio shall be calculated giving pro forma effect
    thereto for such period as if such Investment, acquisition,
    disposition, merger, consolidation or disposed operation had
    occurred at the beginning of the applicable four-quarter period.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For purposes of this definition, whenever pro forma effect is to
    be given to a transaction, the pro forma calculations shall be
    made in good faith by a responsible financial or accounting
    officer of the Issuer. If any Indebtedness bears a floating rate
    of interest and is being given pro forma effect, the interest on
    such Indebtedness shall be calculated as if the rate in effect
    on the Fixed Charge Coverage Ratio Calculation Date had been the
    applicable rate for the entire period (taking into account any
    Hedging Obligations applicable to such Indebtedness). Interest
    on a Capitalized Lease Obligation shall be deemed to accrue at
    an interest rate reasonably determined by a responsible
    financial or accounting officer of the Issuer to be the rate of
    interest implicit in such Capitalized Lease Obligation in
    accordance with GAAP. For purposes of making the computation
    referred to above, interest on any Indebtedness under a
    revolving credit facility computed on a pro forma basis shall be
    computed based upon the average daily balance of such
    Indebtedness during the applicable period except as set forth in
    the first paragraph of this definition. Interest on Indebtedness
    that may optionally be determined at an interest rate based upon
    a factor of a prime or similar rate, a eurocurrency interbank
    offered rate or other rate shall be deemed to have been based
    upon the rate actually chosen, or, if none, then based upon such
    optional rate chosen as the Issuer may designate.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Fixed Charges&#148;</I> means, with respect to any
    Person for any period, the sum of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;Consolidated Interest Expense of such Person for such
    period;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;all cash dividends or other distributions paid
    (excluding items eliminated in consolidation) on any series of
    Preferred Stock during such period;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;all cash dividends or other distributions paid
    (excluding items eliminated in consolidation) on any series of
    Disqualified Stock during such period.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Foreign Subsidiary&#148;</I> means, with respect to any
    Person, any Restricted Subsidiary of such Person that is not
    organized or existing under the laws of the United States, any
    state thereof or the District of Columbia and any Restricted
    Subsidiary of such Foreign Subsidiary.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Frist Entities&#148;</I> means Dr.&#160;Thomas F.
    Frist,&#160;Jr., any Person controlled by Dr.&#160;Frist and any
    charitable organization selected by Dr.&#160;Frist that holds
    Equity Interests of the Issuer on November&#160;17, 2006.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;GAAP&#148;</I> means generally accepted accounting
    principles in the United States which are in effect on
    November&#160;17, 2006.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    173
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;General Credit Facility&#148;</I> means the credit
    agreement entered into as of November&#160;17, 2006 by and among
    the Issuer, the European subsidiary borrowers party thereto, the
    lenders party thereto in their capacities as lenders thereunder
    and Bank of America, N.A., as U.S.&#160;Administrative Agent and
    as European Administrative Agent, including any guarantees,
    collateral documents, instruments and agreements executed in
    connection therewith, and any amendments, supplements,
    modifications, extensions, renewals, restatements, refundings or
    refinancings thereof and any indentures or credit facilities or
    commercial paper facilities with banks or other institutional
    lenders or investors that replace, refund or refinance any part
    of the loans, notes, other credit facilities or commitments
    thereunder, including any such replacement, refunding or
    refinancing facility or indenture that increases the amount
    borrowable thereunder or alters the maturity thereof
    (<I>provided</I> that such increase in borrowings is permitted
    under &#147;Certain Covenants&#160;&#151; Limitation on
    Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock&#148; above).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;General Credit Facility Obligations&#148;</I> means
    &#147;Obligations&#148; as defined in the General Credit
    Facility.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;General Intercreditor Agreement&#148;</I> has the
    meaning set forth under &#147;Security&#160;&#151; Liens with
    Respect to the Collateral.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Government Securities&#148;</I> means securities that
    are:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;direct obligations of the United States of America for
    the timely payment of which its full faith and credit is
    pledged;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;obligations of a Person controlled or supervised by and
    acting as an agency or instrumentality of the United States of
    America the timely payment of which is unconditionally
    guaranteed as a full faith and credit obligation by the United
    States of America,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    which, in either case, are not callable or redeemable at the
    option of the issuers thereof, and shall also include a
    depository receipt issued by a bank (as defined in
    Section&#160;3(a)(2) of the Securities Act), as custodian with
    respect to any such Government Securities or a specific payment
    of principal of or interest on any such Government Securities
    held by such custodian for the account of the holder of such
    depository receipt; <I>provided </I>that (except as required by
    law) such custodian is not authorized to make any deduction from
    the amount payable to the holder of such depository receipt from
    any amount received by the custodian in respect of the
    Government Securities or the specific payment of principal of or
    interest on the Government Securities evidenced by such
    depository receipt.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;guarantee&#148;</I> means a guarantee (other than by
    endorsement of negotiable instruments for collection in the
    ordinary course of business), direct or indirect, in any manner
    (including letters of credit and reimbursement agreements in
    respect thereof), of all or any part of any Indebtedness or
    other obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Guarantee&#148;</I> means the guarantee by any
    Guarantor of the Issuer&#146;s Obligations under the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Guarantor&#148;</I> means each Restricted Subsidiary
    that Guarantees the Notes in accordance with the terms of the
    Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;HCI&#148;</I> means Health Care Indemnity, Inc., an
    insurance company formed under the laws of the State of Colorado
    and a Wholly-Owned Subsidiary of the Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Hedging Arrangements&#148;</I> means the fixed-pay
    interest rate swap agreements, entered into by Hercules Holding
    on or about September&#160;13, 2006 and with respect to which
    the Issuer will be the counterparty in connection with the
    Recapitalization, relating to $8,000&#160;million of the
    outstanding principal amount under the First Lien Obligations
    and the ABL Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Hedging Obligations&#148;</I> means, with respect to
    any Person, the obligations of such Person under any interest
    rate swap agreement, interest rate cap agreement, interest rate
    collar agreement, commodity swap agreement, commodity cap
    agreement, commodity collar agreement, foreign exchange
    contract, currency swap agreement or similar agreement providing
    for the transfer or mitigation of interest rate or currency
    risks either generally or under specific contingencies.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Holder&#148;</I> means the Person in whose name a Note
    is registered on the registrar&#146;s books.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    174
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Indebtedness&#148;</I> means, with respect to any
    Person, without duplication:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any indebtedness (including principal and premium) of
    such Person, whether or not contingent:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;in respect of borrowed money;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;evidenced by bonds, notes, debentures or similar
    instruments or letters of credit or bankers&#146; acceptances
    (or, without duplication, reimbursement agreements in respect
    thereof);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;representing the balance deferred and unpaid of the
    purchase price of any property (including Capitalized Lease
    Obligations), except (i)&#160;any such balance that constitutes
    a trade payable or similar obligation to a trade creditor, in
    each case accrued in the ordinary course of business and
    (ii)&#160;any earn-out obligations until such obligation becomes
    a liability on the balance sheet of such Person in accordance
    with GAAP;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;representing any Hedging Obligations;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    if and to the extent that any of the foregoing Indebtedness
    (other than letters of credit and Hedging Obligations) would
    appear as a liability upon a balance sheet (excluding the
    footnotes thereto) of such Person prepared in accordance with
    GAAP;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;to the extent not otherwise included, any obligation by
    such Person to be liable for, or to pay, as obligor, guarantor
    or otherwise on, the obligations of the type referred to in
    clause&#160;(1) of a third Person (whether or not such items
    would appear upon the balance sheet of the such obligor or
    guarantor), other than by endorsement of negotiable instruments
    for collection in the ordinary course of business;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;to the extent not otherwise included, the obligations
    of the type referred to in clause&#160;(1) of a third Person
    secured by a Lien on any asset owned by such first Person,
    whether or not such Indebtedness is assumed by such first Person;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided</I>, <I>however</I>, that notwithstanding the
    foregoing, Indebtedness shall be deemed not to include
    (a)&#160;Contingent Obligations incurred in the ordinary course
    of business or (b)&#160;obligations under or in respect of
    Receivables Facilities.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Independent Financial Advisor&#148;</I> means an
    accounting, appraisal, investment banking firm or consultant to
    Persons engaged in Similar Businesses of nationally recognized
    standing that is, in the good faith judgment of the Issuer,
    qualified to perform the task for which it has been engaged.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Initial Purchasers&#148;</I> means Banc of America
    Securities LLC, Citigroup Global Markets, Inc., J.P.&#160;Morgan
    Securities Inc., Wachovia Capital Markets, LLC and the other
    initial purchasers party to the purchase agreement related to
    the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;insolvency or liquidation proceeding&#148; </I>means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any case commenced by or against the Issuer or any
    Guarantor under any Bankruptcy Law for the relief of debtors,
    any other proceeding for the reorganization, recapitalization or
    adjustment or marshalling of the assets or liabilities of the
    Issuer or any Guarantor, any receivership or assignment for the
    benefit of creditors relating to the Issuer or any Guarantor or
    any similar case or proceeding relative to the Issuer or any
    Guarantor or its creditors, as such, in each case whether or not
    voluntary;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any liquidation, dissolution, marshalling of assets or
    liabilities or other winding up of or relating to the Issuer or
    any Guarantor, in each case whether or not voluntary and whether
    or not involving bankruptcy or insolvency;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;any other proceeding of any type or nature in which
    substantially all claims of creditors of the Issuer or any
    Guarantor are determined and any payment or distribution is or
    may be made on account of such claims.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Intercreditor Agreements&#148;</I> means, collectively,
    the Shared Receivables Intercreditor Agreement and the General
    Intercreditor Agreement.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    175
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Investment Grade Rating&#148;</I> means a rating equal
    to or higher than Baa3 (or the equivalent) by Moody&#146;s and
    BBB- (or the equivalent) by S&#038;P, or an equivalent rating by
    any other Rating Agency.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Investment Grade Securities&#148;</I> means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;securities issued or directly and fully guaranteed or
    insured by the United States government or any agency or
    instrumentality thereof (other than Cash Equivalents);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;debt securities or debt instruments with an Investment
    Grade Rating, but excluding any debt securities or instruments
    constituting loans or advances among the Issuer and its
    Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;investments in any fund that invests exclusively in
    investments of the type described in clauses&#160;(1) and
    (2)&#160;which fund may also hold immaterial amounts of cash
    pending investment or distribution;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;corresponding instruments in countries other than the
    United States customarily utilized for high quality investments.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Investments&#148;</I> means, with respect to any
    Person, all investments by such Person in other Persons
    (including Affiliates) in the form of loans (including
    guarantees), advances or capital contributions (excluding
    accounts receivable, trade credit, advances to customers,
    commissions, travel and similar advances to officers and
    employees, in each case made in the ordinary course of
    business), purchases or other acquisitions for consideration of
    Indebtedness, Equity Interests or other securities issued by any
    other Person and investments that are required by GAAP to be
    classified on the balance sheet (excluding the footnotes) of the
    Issuer in the same manner as the other investments included in
    this definition to the extent such transactions involve the
    transfer of cash or other property. For purposes of the
    definition of &#147;Unrestricted Subsidiary&#148; and the
    covenant described under &#147;Certain Covenants&#160;&#151;
    Limitation on Restricted Payments&#148;:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;<I>&#147;Investments&#148; </I>shall include the
    portion (proportionate to the Issuer&#146;s equity interest in
    such Subsidiary) of the fair market value of the net assets of a
    Subsidiary of the Issuer at the time that such Subsidiary is
    designated an Unrestricted Subsidiary; <I>provided</I>,
    <I>however</I>, that upon a redesignation of such Subsidiary as
    a Restricted Subsidiary, the Issuer shall be deemed to continue
    to have a permanent &#147;Investment&#148; in an Unrestricted
    Subsidiary in an amount (if positive) equal to:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;the Issuer&#146;s &#147;Investment&#148; in such
    Subsidiary at the time of such redesignation; <I>less</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the portion (proportionate to the Issuer equity
    interest in such Subsidiary) of the fair market value of the net
    assets of such Subsidiary at the time of such
    redesignation;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any property transferred to or from an Unrestricted
    Subsidiary shall be valued at its fair market value at the time
    of such transfer, in each case as determined in good faith by
    the Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Investors&#148;</I> means Bain Capital Partners, LLC,
    Kohlberg Kravis Roberts&#160;&#038; Co. L.P., Merrill Lynch
    Global Partners, Inc. and each of their respective Affiliates
    but not including, however, any portfolio companies of any of
    the foregoing.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Issue Date&#148;</I> means February&#160;19, 2009.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Issuer&#148;</I> has the meaning set forth in the first
    paragraph under &#147;General&#148;; <I>provided </I>that when
    used in the context of determining the fair market value of an
    asset or liability under the Indenture, &#147;Issuer&#148; shall
    be deemed to mean the board of directors of the Issuer when the
    fair market value is equal to or in excess of
    $500.0&#160;million (unless otherwise expressly stated).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Junior Lien Collateral Agent&#148;</I> shall mean
    (i)&#160;so long as the Notes are outstanding, The Bank of New
    York Mellon, in its capacity as trustee and collateral agent for
    the holders of the 2006 Notes and other secured parties under
    the 2006 Notes Indenture and the Security Documents (including
    the Holders), and (ii)&#160;at any time thereafter, such agent
    or trustee as is designated &#147;Junior Lien Collateral
    Agent&#148; by Junior Lien Secured Parties holding a majority in
    principal amount of the Junior Lien Obligations then outstanding
    or pursuant to such other arrangements as agreed to among the
    holders of the Junior Lien Obligations, it being understood that
    as of the Issue Date, the trustee under the 2006 Notes Indenture
    shall be the Junior Lien Collateral Agent.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    176
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Junior Lien Documents&#148;</I> means the credit and
    security documents governing the Junior Lien Obligations,
    including, without limitation, the Indenture, the related
    Security Documents and Intercreditor Agreements.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Junior Lien Obligations&#148;</I> means the Notes and
    Obligations with respect to other Indebtedness (including the
    2006 Notes and any permitted refinancing thereof) permitted to
    be incurred under the Indenture and the General Credit Facility
    which is by its terms intended to be secured equally and ratably
    with the Notes or on a basis junior to the Liens securing the
    Notes; <I>provided </I>such Lien is permitted to be incurred
    under the Indenture and the General Credit Facility;
    <I>provided, further</I>, that the holders of such Indebtedness
    or their Junior Lien Representative is a party to the Security
    Documents in accordance with the terms thereof and has appointed
    the Junior Lien Collateral Agent as collateral agent for such
    holders of Junior Lien Obligations with respect to all or a
    portion of the Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Junior Lien Representative&#148;</I> means any duly
    authorized representative of any holders of Junior Lien
    Obligations, which representative is party to the Security
    Documents.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Junior Lien Secured Parties&#148;</I> means
    (i)&#160;Holders (including the Holders of any Additional Notes
    subsequently issued under and in compliance with the terms of
    the Indenture), (ii)&#160;the Junior Lien Collateral Agent and
    (iii)&#160;the holders from time to time of any other Junior
    Lien Obligations and each Junior Lien Representative.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Junior Liens&#148;</I> means the Liens securing the
    Junior Lien Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Legal Holiday&#148;</I> means a Saturday, a Sunday or a
    day on which commercial banking institutions are not required to
    be open in the State of New York.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Lien&#148;</I> means, with respect to any asset, any
    mortgage, lien (statutory or otherwise), pledge, hypothecation,
    charge, security interest, preference, priority or encumbrance
    of any kind in respect of such asset, whether or not filed,
    recorded or otherwise perfected under applicable law, including
    any conditional sale or other title retention agreement, any
    lease in the nature thereof, any option or other agreement to
    sell or give a security interest in and any filing of or
    agreement to give any financing statement under the Uniform
    Commercial Code (or equivalent statutes) of any jurisdiction;
    <I>provided </I>that in no event shall an operating lease be
    deemed to constitute a Lien.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Moody&#146;s&#148;</I> means Moody&#146;s Investors
    Service, Inc. and any successor to its rating agency business.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Net Income&#148;</I> means, with respect to any Person,
    the net income (loss) of such Person, determined in accordance
    with GAAP and before any reduction in respect of Preferred Stock
    dividends.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Net Proceeds&#148;</I> means the aggregate cash
    proceeds received by the Issuer or any of its Restricted
    Subsidiaries in respect of any Asset Sale, including any cash
    received upon the sale or other disposition of any Designated
    Non-cash Consideration received in any Asset Sale, net of the
    direct costs relating to such Asset Sale and the sale or
    disposition of such Designated Non-cash Consideration, including
    legal, accounting and investment banking fees, and brokerage and
    sales commissions, any relocation expenses incurred as a result
    thereof, taxes paid or payable as a result thereof (after taking
    into account any available tax credits or deductions and any tax
    sharing arrangements), amounts required to be applied to the
    repayment of principal, premium, if any, and interest on Senior
    Indebtedness required (other than required by clause&#160;(1) of
    the second paragraph of &#147;Repurchase at the Option of
    Holders&#160;&#151; Asset Sales&#148;) to be paid as a result of
    such transaction and any deduction of appropriate amounts to be
    provided by the Issuer or any of its Restricted Subsidiaries as
    a reserve in accordance with GAAP against any liabilities
    associated with the asset disposed of in such transaction and
    retained by the Issuer or any of its Restricted Subsidiaries
    after such sale or other disposition thereof, including pension
    and other post-employment benefit liabilities and liabilities
    related to environmental matters or against any indemnification
    obligations associated with such transaction.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Non-Conforming Plan of Reorganization&#148;</I> means
    any Plan of Reorganization that grants the Junior Lien
    Collateral Agent or any Junior Lien Secured Party any right or
    benefit, directly or indirectly, which right or benefit is
    prohibited at such time by the provisions of the General
    Intercreditor Agreement.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    177
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Non-Receivables Collateral&#148;</I> has the meaning
    set forth under &#147;Description of Other
    Indebtedness&#160;&#151; Senior Secured Credit
    Facilities&#160;&#151; Guarantee and Security,&#148; subject to
    the provisions of the third and fourth sentences of the first
    paragraph under &#147;&#151;&#160;Security&#160;&#151;
    General.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Obligations&#148;</I> means any principal, interest
    (including any interest accruing subsequent to the filing of a
    petition in bankruptcy, reorganization or similar proceeding at
    the rate provided for in the documentation with respect thereto,
    whether or not such interest is an allowed claim under
    applicable state, federal or foreign law), premium, penalties,
    fees, indemnifications, reimbursements (including reimbursement
    obligations with respect to letters of credit and bankers&#146;
    acceptances), damages and other liabilities, and guarantees of
    payment of such principal, interest, penalties, fees,
    indemnifications, reimbursements, damages and other liabilities,
    payable under the documentation governing any Indebtedness.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Offering Memorandum&#148;</I> means the offering
    memorandum, dated February&#160;11, 2009, relating to the
    initial private offering of the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Officer&#148;</I> means the Chairman of the Board, the
    Chief Executive Officer, the President, any Executive Vice
    President, Senior Vice President or Vice President, the
    Treasurer or the Secretary of the Issuer or a Guarantor, as
    applicable.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Officer&#146;s Certificate&#148;</I> means a
    certificate signed on behalf of the Issuer by an Officer of the
    Issuer or on behalf of a Guarantor by an Officer of such
    Guarantor, who must be the principal executive officer, the
    principal financial officer, the treasurer or the principal
    accounting officer of the Issuer or Guarantor, as applicable,
    that meets the requirements set forth in the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Opinion of Counsel&#148;</I> means a written opinion
    from legal counsel who is acceptable to the Trustee. The counsel
    may be an employee of or counsel to the Issuer or the Trustee.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Permitted Asset Swap&#148;</I> means the concurrent
    purchase and sale or exchange of Related Business Assets or a
    combination of Related Business Assets and cash or Cash
    Equivalents between the Issuer or any of its Restricted
    Subsidiaries and another Person; <I>provided</I>, that any cash
    or Cash Equivalents received must be applied in accordance with
    the covenant described under &#147;Repurchase at the Option of
    Holders&#160;&#151; Asset Sales.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Permitted Holders&#148;</I> means each of the
    Investors, the Frist Entities, members of management of the
    Issuer (or its direct or indirect parent) and any assignees of
    the equity commitments of the Investors on November&#160;17,
    2006 who are (or will be, pursuant to the agreements described
    under &#147;Management&#160;&#151; Equity Investment by Senior
    Management Participants&#148; and &#147;&#151;&#160;Equity
    Investment by Other Management Participants&#148;) holders of
    Equity Interests of the Issuer (or any of its direct or indirect
    parent companies) and any group (within the meaning of
    Section&#160;13(d)(3) or Section&#160;14(d)(2) of the Exchange
    Act or any successor provision) of which any of the foregoing
    are members; <I>provided </I>that, in the case of such group and
    without giving effect to the existence of such group or any
    other group, such Investors, Frist Entities, members of
    management and assignees of the equity commitments of the
    Investors, collectively, have beneficial ownership of more than
    50% of the total voting power of the Voting Stock of the Issuer
    or any of its direct or indirect parent companies.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Permitted Investments&#148;</I> means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any Investment in the Issuer or any of its Restricted
    Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any Investment in cash and Cash Equivalents or
    Investment Grade Securities;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;any Investment by the Issuer or any of its Restricted
    Subsidiaries in a Person that is engaged in a Similar Business
    if as a result of such Investment:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;such Person becomes a Restricted Subsidiary;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;such Person, in one transaction or a series of related
    transactions, is merged or consolidated with or into, or
    transfers or conveys substantially all of its assets to, or is
    liquidated into, the Issuer or a Restricted Subsidiary, and, in
    each case, any Investment held by such Person; <I>provided
    </I>that such
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    178
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Investment was not acquired by such Person in contemplation of
    such acquisition, merger, consolidation or transfer;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;any Investment in securities or other assets not
    constituting cash, Cash Equivalents or Investment Grade
    Securities and received in connection with an Asset Sale made
    pursuant to the provisions described under &#147;Repurchase at
    the Option of Holders&#160;&#151; Asset Sales&#148; or any other
    disposition of assets not constituting an Asset Sale;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;any Investment existing on the Issue Date;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;any Investment acquired by the Issuer or any of its
    Restricted Subsidiaries:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;in exchange for any other Investment or accounts
    receivable held by the Issuer or any such Restricted Subsidiary
    in connection with or as a result of a bankruptcy, workout,
    reorganization or recapitalization of the issuer of such other
    Investment or accounts receivable;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;as a result of a foreclosure by the Issuer or any of
    its Restricted Subsidiaries with respect to any secured
    Investment or other transfer of title with respect to any
    secured Investment in default;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;Hedging Obligations permitted under clause&#160;(10) of
    the second paragraph of the covenant described in &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;any Investment in a Similar Business having an
    aggregate fair market value, taken together with all other
    Investments made pursuant to this clause&#160;(8) that are at
    that time outstanding, not to exceed 5% of Total Assets at the
    time of such Investment (with the fair market value of each
    Investment being measured at the time made and without giving
    effect to subsequent changes in value);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;Investments the payment for which consists of Equity
    Interests (exclusive of Disqualified Stock) of the Issuer or any
    of its direct or indirect parent companies; <I>provided</I>,
    <I>however</I>, that such Equity Interests will not increase the
    amount available for Restricted Payments under clause&#160;(3)
    of the first paragraph under the covenant described in
    &#147;Certain Covenants&#160;&#151; Limitations on Restricted
    Payments&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;guarantees of Indebtedness permitted under the
    covenant described in &#147;Certain Covenants&#160;&#151;
    Limitation on Incurrence of Indebtedness and Issuance of
    Disqualified Stock and Preferred Stock&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;any transaction to the extent it constitutes an
    Investment that is permitted and made in accordance with the
    provisions of the second paragraph of the covenant described
    under &#147;Certain Covenants&#160;&#151; Transactions with
    Affiliates&#148; (except transactions described in clauses (2),
    (5)&#160;and (9)&#160;of such paragraph);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;Investments consisting of purchases and acquisitions
    of inventory, supplies, material or equipment;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;additional Investments having an aggregate fair market
    value, taken together with all other Investments made pursuant
    to this clause&#160;(13) that are at that time outstanding
    (without giving effect to the sale of an Unrestricted Subsidiary
    to the extent the proceeds of such sale do not consist of cash
    or marketable securities), not to exceed 5% of Total Assets at
    the time of such Investment (with the fair market value of each
    Investment being measured at the time made and without giving
    effect to subsequent changes in value);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (14)&#160;Investments relating to an ABL Financing Entity or a
    Receivables Subsidiary that, in the good faith determination of
    the Issuer, are necessary or advisable to effect the ABL
    Facility or any Receivables Facility, as the case may be;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (15)&#160;advances to, or guarantees of Indebtedness of,
    employees not in excess of $50.0&#160;million outstanding at any
    one time, in the aggregate;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (16)&#160;loans and advances to officers, directors and
    employees for business-related travel expenses, moving expenses
    and other similar expenses, in each case incurred in the
    ordinary course of business or
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    179
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    consistent with past practices or to fund such Person&#146;s
    purchase of Equity Interests of the Issuer or any direct or
    indirect parent company thereof;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (17)&#160;Physician Support Obligations made by the Issuer or
    any Restricted Subsidiary;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (18)&#160;any Investment in any joint venture existing on the
    Issue Date that owns or operates one or more healthcare
    facilities, including, without limitation, hospitals, ambulatory
    surgery centers, outpatient diagnostic centers or imaging
    centers to the extent contemplated by the organizational
    documents of such joint venture as in existence on the Issue
    Date;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (19)&#160;any Investment in the ordinary course of business or
    as may be required by applicable law by any Restricted
    Subsidiary (including, without limitation, HCI) engaged in the
    insurance business in order to provide insurance to the Issuer
    and its Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (20)&#160;any Investment pursuant to any customary buy/sell
    arrangement in favor of investors or joint venture parties in
    connection with syndications of healthcare facilities,
    including, without limitation, hospitals, ambulatory surgery
    centers, outpatient diagnostic centers or imaging
    centers;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (21)&#160;any Investment in any Subsidiary or any joint venture
    in connection with intercompany cash management arrangements or
    related activities arising in the ordinary course of business.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Permitted Liens&#148;</I> means, with respect to any
    Person:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;pledges or deposits by such Person under workmen&#146;s
    compensation laws, unemployment insurance laws or similar
    legislation, or good faith deposits in connection with bids,
    tenders, contracts (other than for the payment of Indebtedness)
    or leases to which such Person is a party, or deposits to secure
    public or statutory obligations of such Person or deposits of
    cash or U.S.&#160;government bonds to secure surety or appeal
    bonds to which such Person is a party, or deposits as security
    for contested taxes or import duties or for the payment of rent,
    in each case incurred in the ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;Liens imposed by law, such as carriers&#146;,
    warehousemen&#146;s and mechanics&#146; Liens, in each case for
    sums not yet overdue for a period of more than 30&#160;days or
    being contested in good faith by appropriate proceedings or
    other Liens arising out of judgments or awards against such
    Person with respect to which such Person shall then be
    proceeding with an appeal or other proceedings for review if
    adequate reserves with respect thereto are maintained on the
    books of such Person in accordance with GAAP;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;Liens for taxes, assessments or other governmental
    charges not yet overdue for a period of more than 30&#160;days
    or payable or subject to penalties for nonpayment or which are
    being contested in good faith by appropriate proceedings
    diligently conducted, if adequate reserves with respect thereto
    are maintained on the books of such Person in accordance with
    GAAP;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;Liens in favor of issuers of performance and surety
    bonds or bid bonds or with respect to other regulatory
    requirements or letters of credit issued pursuant to the request
    of and for the account of such Person in the ordinary course of
    its business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;minor survey exceptions, minor encumbrances, easements
    or reservations of, or rights of others for, licenses,
    <FONT style="white-space: nowrap">rights-of-way,</FONT>
    sewers, electric lines, telegraph and telephone lines and other
    similar purposes, or zoning or other restrictions as to the use
    of real properties or Liens incidental to the conduct of the
    business of such Person or to the ownership of its properties
    which were not incurred in connection with Indebtedness and
    which do not in the aggregate materially adversely affect the
    value of said properties or materially impair their use in the
    operation of the business of such Person;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;Liens securing Indebtedness permitted to be incurred
    pursuant to clause (4), (12), (13), (18)&#160;or (19)&#160;of
    the second paragraph under &#147;Certain Covenants&#160;&#151;
    Limitation on Incurrence of Indebtedness and Issuance of
    Disqualified Stock and Preferred Stock&#148;; provided that
    (a)&#160;Liens securing Indebtedness, Disqualified Stock or
    Preferred Stock permitted to be incurred pursuant to
    clause&#160;(13) relate only to Refinancing Indebtedness that
    serves to refund or refinance Indebtedness, Disqualified Stock
    or Preferred Stock incurred under clause&#160;(4) or
    (12)&#160;of the second paragraph under &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock,&#148;
    (b)&#160;Liens securing
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    180
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Indebtedness permitted to be incurred pursuant to
    clause&#160;(18) extend only to the assets of Foreign
    Subsidiaries, (c)&#160;Liens securing Indebtedness permitted to
    be incurred pursuant to clause&#160;(19) are solely on acquired
    property or the assets of the acquired entity, as the case may
    be and (d)&#160;Liens securing Indebtedness, Disqualified Stock
    or Preferred Stock permitted to be incurred pursuant to
    clause&#160;(4) of the second paragraph under &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock&#148;
    extend only to the assets so financed, purchased, constructed or
    improved;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;Liens existing on the Issue Date (other than Liens in
    favor of (i)&#160;the lenders under the Senior Credit Facilities
    ranking senior to the Liens securing the Notes and (ii)&#160;the
    holders of the 2006 Notes);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;Liens on property or shares of stock of a Person at the
    time such Person becomes a Subsidiary; provided, however, such
    Liens are not created or incurred in connection with, or in
    contemplation of, such other Person becoming such a Subsidiary;
    provided, further, however, that such Liens may not extend to
    any other property owned by the Issuer or any of its Restricted
    Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;Liens on property at the time the Issuer or a
    Restricted Subsidiary acquired the property, including any
    acquisition by means of a merger or consolidation with or into
    the Issuer or any of its Restricted Subsidiaries; provided,
    however, that such Liens are not created or incurred in
    connection with, or in contemplation of, such acquisition;
    provided, further, however, that the Liens may not extend to any
    other property owned by the Issuer or any of its Restricted
    Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;Liens securing Indebtedness or other obligations of a
    Restricted Subsidiary owing to the Issuer or another Restricted
    Subsidiary permitted to be incurred in accordance with the
    covenant described under &#147;Certain Covenants&#160;&#151;
    Limitation on Incurrence of Indebtedness and Issuance of
    Disqualified Stock and Preferred Stock&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;Liens securing Hedging Obligations so long as the
    related Indebtedness is, and is permitted to be under the
    Indenture, secured by a Lien on the same property securing such
    Hedging Obligations;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;Liens on specific items of inventory or other goods
    and proceeds of any Person securing such Person&#146;s
    obligations in respect of bankers&#146; acceptances issued or
    created for the account of such Person to facilitate the
    purchase, shipment or storage of such inventory or other goods;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;leases, subleases, licenses or sublicenses granted to
    others in the ordinary course of business which do not
    materially interfere with the ordinary conduct of the business
    of the Issuer or any of its Restricted Subsidiaries and do not
    secure any Indebtedness;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (14)&#160;Liens arising from Uniform Commercial Code financing
    statement filings regarding operating leases entered into by the
    Issuer and its Restricted Subsidiaries in the ordinary course of
    business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (15)&#160;Liens in favor of the Issuer or any Guarantor;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (16)&#160;Liens on equipment of the Issuer or any of its
    Restricted Subsidiaries granted in the ordinary course of
    business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (17)&#160;Liens on accounts receivable and related assets
    incurred in connection with a Receivables Facility;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (18)&#160;Liens to secure any refinancing, refunding, extension,
    renewal or replacement (or successive refinancing, refunding,
    extensions, renewals or replacements) as a whole, or in part, of
    any Indebtedness secured by any Lien referred to in the
    foregoing clauses (6), (7), (8)&#160;and (9); provided, however,
    that (a)&#160;such new Lien shall be limited to all or part of
    the same property that secured the original Lien (plus
    improvements on such property), and (b)&#160;the Indebtedness
    secured by such Lien at such time is not increased to any amount
    greater than the sum of (i)&#160;the outstanding principal
    amount or, if greater, committed amount of the Indebtedness
    described under clauses (6), (7), (8)&#160;and (9)&#160;at the
    time the original Lien became a Permitted Lien under the
    Indenture, and (ii)&#160;an amount necessary to pay any fees and
    expenses, including premiums, related to such refinancing,
    refunding, extension, renewal or replacement;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    181
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (19)&#160;deposits made in the ordinary course of business to
    secure liability to insurance carriers;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (20)&#160;other Liens securing obligations incurred in the
    ordinary course of business which obligations do not exceed
    $100.0&#160;million at any one time outstanding;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (21)&#160;Liens securing judgments for the payment of money not
    constituting an Event of Default under clause&#160;(5) under the
    caption &#147;Events of Default and Remedies&#148; so long as
    such Liens are adequately bonded and any appropriate legal
    proceedings that may have been duly initiated for the review of
    such judgment have not been finally terminated or the period
    within which such proceedings may be initiated has not expired;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (22)&#160;Liens in favor of customs and revenue authorities
    arising as a matter of law to secure payment of customs duties
    in connection with the importation of goods in the ordinary
    course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (23)&#160;Liens (i)&#160;of a collection bank arising under
    <FONT style="white-space: nowrap">Section&#160;4-210</FONT>
    of the Uniform Commercial Code, or any comparable or successor
    provision, on items in the course of collection,
    (ii)&#160;attaching to commodity trading accounts or other
    commodity brokerage accounts incurred in the ordinary course of
    business, and (iii)&#160;in favor of banking institutions
    arising as a matter of law encumbering deposits (including the
    right of set-off) and which are within the general parameters
    customary in the banking industry;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (24)&#160;Liens deemed to exist in connection with Investments
    in repurchase agreements permitted under &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock&#148;;
    provided that such Liens do not extend to any assets other than
    those that are the subject of such repurchase agreements;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (25)&#160;Liens encumbering reasonable customary initial
    deposits and margin deposits and similar Liens attaching to
    commodity trading accounts or other brokerage accounts incurred
    in the ordinary course of business and not for speculative
    purposes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (26)&#160;Liens that are contractual rights of set-off
    (i)&#160;relating to the establishment of depository relations
    with banks not given in connection with the issuance of
    Indebtedness, (ii)&#160;relating to pooled deposit or sweep
    accounts of the Issuer or any of its Restricted Subsidiaries to
    permit satisfaction of overdraft or similar obligations incurred
    in the ordinary course of business of the Issuer and its
    Restricted Subsidiaries or (iii)&#160;relating to purchase
    orders and other agreements entered into with customers of the
    Issuer or any of its Restricted Subsidiaries in the ordinary
    course of business;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (27)&#160;Liens arising out of conditional sale, title
    retention, consignment or similar arrangements for the sale or
    purchase of goods entered into by the Issuer or any Restricted
    Subsidiary in the ordinary course of business.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For purposes of this definition, the term
    &#147;Indebtedness&#148; shall be deemed to include interest on
    such Indebtedness.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Person&#148;</I> means any individual, corporation,
    limited liability company, partnership, joint venture,
    association, joint stock company, trust, unincorporated
    organization, government or any agency or political subdivision
    thereof or any other entity.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Physician Support Obligation&#148;</I> means (1)&#160;a
    loan to or on behalf of, or a guarantee of Indebtedness or
    income of, a physician or healthcare professional providing
    service to patients in the service area of a healthcare facility
    operated by the Issuer, any of its Restricted Subsidiaries or
    any affiliated joint venture otherwise permitted by the
    Indenture made or given by the Issuer or any Restricted
    Subsidiary of the Issuer in the ordinary course of business and
    pursuant to a written agreement having a period not to exceed
    five years or (2)&#160;guarantees by the Issuer or any
    Restricted Subsidiary of the Issuer of leases and loans to
    acquire property (real or personal) for or on behalf of a
    physician or healthcare professional providing service to
    patients in the service area of a healthcare facility operated
    by the Issuer, any of its Restricted Subsidiaries or any
    affiliated joint venture otherwise permitted by the Indenture.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    182
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Plan of Reorganization&#148;</I> means any plan of
    reorganization, plan of liquidation, agreement for composition,
    or other type of plan of arrangement proposed in or in
    connection with any insolvency or liquidation proceeding.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Preferred Stock&#148;</I> means any Equity Interest
    with preferential rights of payment of dividends or upon
    liquidation, dissolution or winding up.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Principal Property&#148;</I> means each acute care
    hospital providing general medical and surgical services
    (excluding equipment, personal property and hospitals that
    primarily provide specialty medical services, such as
    psychiatric and obstetrical and gynecological services) owned
    solely by the Issuer
    <FONT style="white-space: nowrap">and/or</FONT> one
    or more of its Subsidiaries (used in this definition as defined
    in the Existing Notes Indenture) and located in the
    United&#160;States of America.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Priority Lien Obligations&#148;</I> means,
    collectively, ABL Obligations and First Lien Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Priority Lien Secured Parties&#148;</I> means,
    collectively, the ABL Secured Parties and the First Lien Secured
    Parties.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Purchase Money Obligations&#148;</I> means any
    Indebtedness incurred to finance or refinance the acquisition,
    leasing, construction or improvement of property (real or
    personal) or assets (other than Capital Stock), and whether
    acquired through the direct acquisition of such property or
    assets, or otherwise.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Qualified Proceeds&#148;</I> means assets that are used
    or useful in, or Capital Stock of any Person engaged in, a
    Similar Business; <I>provided </I>that the fair market value of
    any such assets or Capital Stock shall be determined by the
    Issuer in good faith.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Rating Agencies&#148;</I> means Moody&#146;s and
    S&#038;P or if Moody&#146;s or S&#038;P or both shall not make a
    rating on the Notes publicly available, a nationally recognized
    statistical rating agency or agencies, as the case may be,
    selected by the Issuer which shall be substituted for
    Moody&#146;s or S&#038;P or both, as the case may be.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Receivables Facility&#148;</I> means any of one or more
    receivables financing facilities as amended, supplemented,
    modified, extended, renewed, restated or refunded from time to
    time, the Obligations of which are non-recourse (except for
    customary representations, warranties, covenants and indemnities
    made in connection with such facilities) to the Issuer or any of
    its Restricted Subsidiaries (other than a Receivables
    Subsidiary) pursuant to which the Issuer or any of its
    Restricted Subsidiaries purports to sell its accounts receivable
    to either (a)&#160;a Person that is not a Restricted Subsidiary
    or (b)&#160;a Receivables Subsidiary that in turn funds such
    purchase by purporting to sell its accounts receivable to a
    Person that is not a Restricted Subsidiary or by borrowing from
    such a Person or from another Receivables Subsidiary that in
    turn funds itself by borrowing from such a Person.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Receivables Fees&#148;</I> means distributions or
    payments made directly or by means of discounts with respect to
    any accounts receivable or participation interest therein issued
    or sold in connection with, and other fees paid to a Person that
    is not a Restricted Subsidiary in connection with any
    Receivables Facility.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Receivables Subsidiary&#148;</I> means any Subsidiary
    formed for the purpose of facilitating or entering into one or
    more Receivables Facilities, and in each case engages only in
    activities reasonably related or incidental thereto.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Redemption&#160;Date&#148;</I> has the meaning set
    forth under &#147;Optional Redemption.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Registration Rights Agreement&#148;</I> means the
    Registration Rights Agreement related to the Notes, dated as of
    the Issue Date, among the Issuer, the Guarantors and the Initial
    Purchasers.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Related Business Assets&#148;</I> means assets (other
    than cash or Cash Equivalents) used or useful in a Similar
    Business; <I>provided </I>that any assets received by the Issuer
    or a Restricted Subsidiary in exchange for assets transferred by
    the Issuer or a Restricted Subsidiary will not be deemed to be
    Related Business Assets if they consist of securities of a
    Person, unless upon receipt of the securities of such Person,
    such Person would become a Restricted Subsidiary.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Restricted Investment&#148;</I> means an Investment
    other than a Permitted Investment.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    183
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Restricted Subsidiary&#148;</I> means, at any time, any
    direct or indirect Subsidiary of the Issuer (including any
    Foreign Subsidiary) that is not then an Unrestricted Subsidiary;
    <I>provided</I>, <I>however</I>, that upon an Unrestricted
    Subsidiary&#146;s ceasing to be an Unrestricted Subsidiary, such
    Subsidiary shall be included in the definition of
    &#147;Restricted Subsidiary.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;S&#038;P&#148;</I> means Standard&#160;&#038;
    Poor&#146;s, a division of The McGraw-Hill Companies, Inc., and
    any successor to its rating agency business.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Sale and Lease-Back Transaction&#148;</I> means any
    arrangement providing for the leasing by the Issuer or any of
    its Restricted Subsidiaries of any real or tangible personal
    property, which property has been or is to be sold or
    transferred by the Issuer or such Restricted Subsidiary to a
    third Person in contemplation of such leasing.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;SEC&#148;</I> means the U.S.&#160;Securities and
    Exchange Commission.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Secured Indebtedness&#148;</I> means any Indebtedness
    of the Issuer or any of its Restricted Subsidiaries secured by a
    Lien.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Securities Act&#148;</I> means the Securities Act of
    1933, as amended, and the rules and regulations of the SEC
    promulgated thereunder.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Security Documents&#148;</I> means, collectively, the
    Intercreditor Agreements, the security agreements relating to
    the Collateral and the mortgages and instruments filed and
    recorded in appropriate jurisdictions to preserve and protect
    the Liens on the Collateral (including, without limitation,
    financing statements under the Uniform Commercial Code of the
    relevant states) applicable to the Collateral, each as in effect
    on the Issue Date and as amended, amended and restated,
    modified, renewed or replaced from time to time.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Senior Credit Facilities&#148;</I> means the ABL
    Facility and the General Credit Facility.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Senior Indebtedness&#148;</I> means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;all Indebtedness of the Issuer or any Guarantor
    outstanding under the Senior Credit Facilities or Notes and
    related Guarantees (including interest accruing on or after the
    filing of any petition in bankruptcy or similar proceeding or
    for reorganization of the Issuer or any Guarantor (at the rate
    provided for in the documentation with respect thereto,
    regardless of whether or not a claim for post-filing interest is
    allowed in such proceedings)), and any and all other fees,
    expense reimbursement obligations, indemnification amounts,
    penalties, and other amounts (whether existing on the Issue Date
    or thereafter created or incurred) and all obligations of the
    Issuer or any Guarantor to reimburse any bank or other Person in
    respect of amounts paid under letters of credit, acceptances or
    other similar instruments;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;all Hedging Obligations (and guarantees thereof) owing
    to a Lender (as defined in the Senior Credit Facilities) or any
    Affiliate of such Lender (or any Person that was a Lender or an
    Affiliate of such Lender at the time the applicable agreement
    giving rise to such Hedging Obligation was entered into);
    provided that such Hedging Obligations are permitted to be
    incurred under the terms of the Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;any other Indebtedness of the Issuer or any Guarantor
    permitted to be incurred under the terms of the Indenture,
    unless the instrument under which such Indebtedness is incurred
    expressly provides that it is subordinated in right of payment
    to the Notes or any related Guarantee;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;all Obligations with respect to the items listed in the
    preceding clauses (1), (2)&#160;and (3);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided</I>, <I>however</I>, that Senior Indebtedness shall
    not include:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;any obligation of such Person to the Issuer or any of
    its Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;any liability for federal, state, local or other taxes
    owed or owing by such Person;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;any accounts payable or other liability to trade
    creditors arising in the ordinary course of business;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    184
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;any Indebtedness or other Obligation of such Person
    which is subordinate or junior in any respect to any other
    Indebtedness or other Obligation of such Person;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;that portion of any Indebtedness which at the time of
    incurrence is incurred in violation of the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Separate Receivables Collateral&#148;</I> has the
    meaning set forth under &#147;Description of Other
    Indebtedness&#160;&#151; Senior Secured Credit
    Facilities&#160;&#151; Guarantee and Security.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Shared Receivables Collateral&#148;</I> has the meaning
    set forth under &#147;Description of Other
    Indebtedness&#160;&#151; Senior Secured Credit
    Facilities&#160;&#151; Guarantee and Security.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Shared Receivables Intercreditor Agreement&#148;</I>
    has the meaning set forth under &#147;Security&#160;&#151; Liens
    with Respect to Shared Receivables Collateral.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Significant Subsidiary&#148;</I> means any Restricted
    Subsidiary that would be a &#147;significant subsidiary&#148; as
    defined in Article&#160;1,
    <FONT style="white-space: nowrap">Rule&#160;1-02</FONT>
    of
    <FONT style="white-space: nowrap">Regulation&#160;S-X,</FONT>
    promulgated pursuant to the Securities Act, as such regulation
    is in effect on the Issue Date.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Similar Business&#148;</I> means any business conducted
    or proposed to be conducted by the Issuer and its Restricted
    Subsidiaries on the Issue Date or any business that is similar,
    reasonably related, incidental or ancillary thereto.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Sponsor Management Agreement&#148;</I> means the
    management agreement between certain of the management companies
    associated with the Investors, the Frist Entities and the Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Subordinated Indebtedness&#148;</I> means, with respect
    to the Notes,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any Indebtedness of the Issuer which is by its terms
    subordinated in right of payment to the Notes,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any Indebtedness of any Guarantor which is by its terms
    subordinated in right of payment to the Guarantee of such entity
    of the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Subsidiary&#148;</I> means, with respect to any Person:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any corporation, association, or other business entity
    (other than a partnership, joint venture, limited liability
    company or similar entity) of which more than 50% of the total
    voting power of shares of Capital Stock entitled (without regard
    to the occurrence of any contingency) to vote in the election of
    directors, managers or trustees thereof is at the time of
    determination owned or controlled, directly or indirectly, by
    such Person or one or more of the other Subsidiaries of that
    Person or a combination thereof or is consolidated under GAAP
    with such Person at such time;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any partnership, joint venture, limited liability
    company or similar entity of which
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (x)&#160;more than 50% of the capital accounts, distribution
    rights, total equity and voting interests or general or limited
    partnership interests, as applicable, are owned or controlled,
    directly or indirectly, by such Person or one or more of the
    other Subsidiaries of that Person or a combination thereof
    whether in the form of membership, general, special or limited
    partnership or otherwise,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (y)&#160;such Person or any Restricted Subsidiary of such Person
    is a controlling general partner or otherwise controls such
    entity.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Total Assets&#148;</I> means the total assets of the
    Issuer and its Restricted Subsidiaries on a consolidated basis,
    as shown on the most recent consolidated balance sheet of the
    Issuer or such other Person as may be expressly stated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Transaction&#148;</I> means the transactions
    contemplated by the Transaction Agreement, the issuance of the
    Notes and borrowings under the Senior Credit Facilities as in
    effect on November&#160;17, 2006.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    185
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Transaction Agreement&#148;</I> means the Agreement and
    Plan of Merger, dated as of July&#160;24, 2006, between Hercules
    Holding II, LLC, Hercules Acquisition Corporation and the
    Issuer, as the same may be amended prior to the Issue Date.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Treasury Rate&#148;</I> means, as of any
    Redemption&#160;Date, the yield to maturity as of such
    Redemption&#160;Date of United States Treasury securities with a
    constant maturity (as compiled and published in the most recent
    Federal Reserve Statistical Release H.15 (519)&#160;that has
    become publicly available at least two Business Days prior to
    the Redemption&#160;Date (or, if such Statistical Release is no
    longer published, any publicly available source of similar
    market data)) most nearly equal to the period from the
    Redemption&#160;Date to February&#160;15, 2013; <I>provided</I>,
    <I>however</I>, that if the period from the Redemption&#160;Date
    to February&#160;15, 2013 is less than one year, the weekly
    average yield on actually traded United States Treasury
    securities adjusted to a constant maturity of one year will be
    used.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Trust&#160;Indenture Act&#148;</I> means the
    Trust&#160;Indenture Act of 1939, as amended (15&#160;U.S.C.
    <FONT style="white-space: nowrap">&#167;&#167;&#160;77aaa-777bbbb).</FONT>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Unrestricted Subsidiary&#148;</I> means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any Subsidiary of the Issuer which at the time of
    determination is an Unrestricted Subsidiary (as designated by
    the Issuer, as provided below);&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any Subsidiary of an Unrestricted Subsidiary.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer may designate any Subsidiary of the Issuer (including
    any existing Subsidiary and any newly acquired or newly formed
    Subsidiary) to be an Unrestricted Subsidiary unless such
    Subsidiary or any of its Subsidiaries owns any Equity Interests
    or Indebtedness of, or owns or holds any Lien on, any property
    of, the Issuer or any Subsidiary of the Issuer (other than
    solely any Subsidiary of the Subsidiary to be so designated);
    <I>provided </I>that
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any Unrestricted Subsidiary must be an entity of which
    the Equity Interests entitled to cast at least a majority of the
    votes that may be cast by all Equity Interests having ordinary
    voting power for the election of directors or Persons performing
    a similar function are owned, directly or indirectly, by the
    Issuer;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;such designation complies with the covenants described
    under &#147;Certain Covenants&#160;&#151; Limitation on
    Restricted Payments&#148;;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;each of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;the Subsidiary to be so designated;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;its Subsidiaries has not at the time of designation,
    and does not thereafter, create, incur, issue, assume, guarantee
    or otherwise become directly or indirectly liable with respect
    to any Indebtedness pursuant to which the lender has recourse to
    any of the assets of the Issuer or any Restricted Subsidiary.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer may designate any Unrestricted Subsidiary to be a
    Restricted Subsidiary; <I>provided</I> that, immediately after
    giving effect to such designation, no Default shall have
    occurred and be continuing and either:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the Issuer could incur at least $1.00 of additional
    Indebtedness pursuant to the Fixed Charge Coverage Ratio test
    described in the first paragraph under &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred
    Stock&#148;;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the Fixed Charge Coverage Ratio for the Issuer and its
    Restricted Subsidiaries would be greater than such ratio for the
    Issuer and its Restricted Subsidiaries immediately prior to such
    designation, in each case on a pro forma basis taking into
    account such designation.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any such designation by the Issuer shall be notified by the
    Issuer to the Trustee by promptly filing with the Trustee a copy
    of the resolution of the board of directors of the Issuer or any
    committee thereof giving effect to such designation and an
    Officer&#146;s Certificate certifying that such designation
    complied with the foregoing provisions.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    186
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Voting Stock&#148;</I> of any Person as of any date
    means the Capital Stock of such Person that is at the time
    entitled to vote in the election of the board of directors of
    such Person.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Weighted Average Life to Maturity&#148;</I> means, when
    applied to any Indebtedness, Disqualified Stock or Preferred
    Stock, as the case may be, at any date, the quotient obtained by
    dividing:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the sum of the products of the number of years from the
    date of determination to the date of each successive scheduled
    principal payment of such Indebtedness or redemption or similar
    payment with respect to such Disqualified Stock or Preferred
    Stock multiplied by the amount of such payment; by
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the sum of all such payments.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Wholly-Owned Subsidiary&#148;</I> of any Person means a
    Subsidiary of such Person, 100% of the outstanding Equity
    Interests of which (other than directors&#146; qualifying
    shares) shall at the time be owned by such Person or by one or
    more Wholly-Owned Subsidiaries of such Person.
</DIV>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Senior
    Secured Notes Issued Under the 2009 First Lien
    Indenture</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    HCA Inc. has issued senior secured notes as described below
    under an indenture, dated as of April&#160;22, 2009, among the
    Issuer, the Guarantors, Deutsche Bank Trust&#160;Company
    Americas, paying agent, registrar and transfer agent and Law
    Debenture Trust&#160;Company of New York, as trustee. Terms used
    in this &#147;&#151;&#160;Senior Secured Notes Issued Under the
    2009 First Lien Indenture&#148; apply only to the Notes
    described herein.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">General</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Certain terms used in this description are defined under the
    subheading &#147;Certain Definitions. &#148; In this
    description, the terms <I>&#147;we,&#148; &#147;our,&#148;</I>
    <I>&#147;us&#148;</I> and <I>&#147;the Company&#148;</I> each
    refer to HCA Inc. (the <I>&#147;Issuer&#148;</I>) and its
    consolidated Subsidiaries.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer issued $1,500,000,000 aggregate principal amount of
    8<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">2</FONT>%&#160;senior
    secured notes due 2019 (the <I>&#147;Notes&#148;</I>) under an
    indenture to be dated as of the closing date of the offering of
    the Notes (the <I>&#147;Indenture&#148;</I>) among the Issuer,
    the Guarantors and Law Debenture Trust&#160;Company of New York,
    as trustee (the <I>&#147;Trustee&#148;</I>), Deutsche Bank
    Trust&#160;Company Americas, as Paying Agent, Registrar and
    Transfer Agent and Bank of America, N.A., as collateral agent.
    The Notes were issued in a private transaction that was not
    subject to the registration requirements of the Securities Act.
    Except as set forth herein, the terms of the Notes include those
    stated in the Indenture and those made part of the Indenture by
    reference to the Trust&#160;Indenture Act.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The following description is only a summary of the material
    provisions of the Indenture, does not purport to be complete and
    is qualified in its entirety by reference to the provisions of
    those agreements, including the definitions therein of certain
    terms used below. We urge you to read the Indenture because it,
    and not this description, will define your rights as Holders of
    the Notes.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Brief
    Description of Notes</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Notes:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    are general senior obligations of the Issuer;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    are secured on a first-priority basis, equally and ratably with
    all existing and future obligations of the Issuer and the
    Guarantors under any existing and future First Lien Obligations,
    by all of the assets of the Issuer and the Guarantors which
    secure the General Credit Facility (other than the European
    Collateral), subject to the Liens securing the Issuer&#146;s and
    the Guarantors&#146; ABL Obligations and other Permitted Liens;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    are secured on a second-priority basis, equally and ratably with
    all existing and future obligations of the Issuer and the
    Guarantors under any existing and future First Lien Obligations,
    by all of the assets of the Issuer and the Guarantors securing
    the ABL Facility which also secure the General Credit Facility,
    subject to the Liens securing the Issuer&#146;s and the
    Guarantors&#146; ABL Obligations and other Permitted Liens;
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    187
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    are effectively subordinated to the Issuer&#146;s and the
    Guarantors&#146; obligations under the ABL Facility, to the
    extent of the value of the Shared Receivables Collateral;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    are effectively subordinated to any obligations secured by
    Permitted Liens, to the extent of the value of the assets of the
    Issuer and the Guarantors subject to those Permitted Liens;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    are structurally subordinated to any existing and future
    indebtedness and liabilities of non-guarantor Subsidiaries,
    including the ABL Financing Entities and the Issuer&#146;s
    Foreign Subsidiaries and any Unrestricted Subsidiaries and
    including indebtedness under the Company&#146;s senior secured
    European term loan facility included in the General Credit
    Facility;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    rank equally in right of payment with all existing and future
    senior Indebtedness of the Issuer and the Guarantors but, to the
    extent of the value of the Collateral, are effectively senior to
    all of the Issuer&#146;s and the Guarantors&#146; unsecured
    senior Indebtedness (including the Existing Notes) and Junior
    Lien Obligations (including the Existing Second Priority Notes);
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    are senior in right of payment to any future Subordinated
    Indebtedness (as defined with respect to the Notes) of the
    Issuer;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    are initially unconditionally guaranteed on a joint and several
    and senior basis by each Restricted Subsidiary that guarantees
    the General Credit Facility (other than any Foreign
    Subsidiary);&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    are subject to registration with the SEC pursuant to the
    Registration Rights Agreement.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Guarantees</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Guarantors, as primary obligors and not merely as sureties,
    jointly and severally fully and unconditionally guaranteed, on a
    senior basis, the performance and full and punctual payment when
    due, whether at maturity, by acceleration or otherwise, of all
    obligations of the Issuer under the Indenture and the Notes,
    whether for payment of principal of, premium, if any, or
    interest or Additional Interest in respect of the Notes,
    expenses, indemnification or otherwise, on the terms set forth
    in the Indenture by executing the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Restricted Subsidiaries which guarantee the General Credit
    Facility guarantee the Notes. Each of the Guarantees of the
    Notes is a general senior obligation of each Guarantor and is
    secured by a first-priority lien on all of the assets of each
    Guarantor which secure the General Credit Facility (other than
    the European Collateral) and by a second-priority lien on all of
    the assets of each Guarantor which secure the ABL Facility. The
    Guarantees rank equally in right of payment with all existing
    and future senior Indebtedness of the Guarantor but, to the
    extent of the value of the Collateral, are effectively senior to
    all of the Guarantor&#146;s unsecured senior Indebtedness and
    Junior Lien Obligations and, to the extent of the Shared
    Receivables Collateral, are effectively subordinated to the
    Guarantor&#146;s Obligations under the ABL Facility and any
    future ABL Obligations. The Guarantees are senior in right of
    payment to all existing and future Subordinated Indebtedness of
    each Guarantor. The Notes are structurally subordinated to
    Indebtedness and other liabilities of Subsidiaries of the Issuer
    that do not Guarantee the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Not all of the Issuer&#146;s Subsidiaries Guarantee the Notes.
    In the event of a bankruptcy, liquidation or reorganization of
    any of these non-guarantor Subsidiaries, the non-guarantor
    Subsidiaries will pay the holders of their debt and their trade
    creditors before they will be able to distribute any of their
    assets to the Issuer. None of our Subsidiaries which are
    &#147;Restricted Subsidiaries&#148; for purposes of the Existing
    Notes Indenture, Foreign Subsidiaries, ABL Financing Entities,
    non-Wholly Owned Subsidiaries or any Receivables Subsidiaries
    will guarantee the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On an as adjusted basis after giving effect to our offering of
    $1.500&#160;billion aggregate principal amount of first lien
    notes in April 2009 and the use of proceeds therefrom, our
    non-guarantor subsidiaries would have accounted for
    approximately $11.867&#160;billion, or 41.8%, of our total
    revenues for the year ended December&#160;31, 2008,
    approximately $3.038&#160;billion, or 40.9%, of our total
    revenues for the three months ended March&#160;31, 2009,
    approximately $9.876&#160;billion, or 40.7%, of our total
    assets, and approximately $7.517&#160;billion, or 22.5%, of our
    total liabilities, in each case, as of December&#160;31, 2008,
    and approximately $9.817&#160;billion, or 40.4%, of
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    188
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    our total assets, and approximately $7.224&#160;billion, or
    21.9%, of our total liabilities, in each case, as of
    March&#160;31, 2009.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The obligations of each Guarantor under its Guarantee are
    limited as necessary to prevent the Guarantee from constituting
    a fraudulent conveyance under applicable law.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any entity that makes a payment under its Guarantee is entitled
    upon payment in full of all guaranteed obligations under the
    Indenture to a contribution from each other Guarantor in an
    amount equal to such other Guarantor&#146;s pro rata portion of
    such payment based on the respective net assets of all the
    Guarantors at the time of such payment determined in accordance
    with GAAP.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If a Guarantee were rendered voidable, it could be subordinated
    by a court to all other indebtedness (including guarantees and
    other contingent liabilities) of the Guarantor, and, depending
    on the amount of such indebtedness, a Guarantor&#146;s liability
    on its Guarantee could be reduced to zero. See &#147;Risk
    Factors&#160;&#151; Risks Related to the Notes&#160;&#151;
    Federal and state fraudulent transfer laws may permit a court to
    void the notes, and with respect to the senior secured notes,
    the guarantees, and, if that occurs, you may not receive any
    payment on the notes.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each Guarantee by a Guarantor provides by its terms that it will
    be automatically and unconditionally released and discharged
    upon:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    1.&#160;(a)&#160;any sale, exchange or transfer (by merger or
    otherwise) of the Capital Stock of such Guarantor (including any
    sale, exchange or transfer), after which the applicable
    Guarantor is no longer a Restricted Subsidiary or all or
    substantially all the assets of such Guarantor, which sale,
    exchange or transfer is made in compliance with the applicable
    provisions of the Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    the release or discharge of the guarantee by such Guarantor of
    the Senior Credit Facilities or such other guarantee that
    resulted in the creation of such Guarantee, except a discharge
    or release by or as a result of payment under such guarantee;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    the designation of any Restricted Subsidiary that is a Guarantor
    as an Unrestricted Subsidiary in compliance with the applicable
    provisions of the Indenture;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    the exercise by the Issuer of its legal defeasance option or
    covenant defeasance option as described under &#147;Legal
    Defeasance and Covenant Defeasance&#148; or the discharge of the
    Issuer&#146;s obligations under the Indenture in accordance with
    the terms of the Indenture;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    2.&#160;such Guarantor delivering to the Trustee an
    Officer&#146;s Certificate and an Opinion of Counsel, each
    stating that all conditions precedent provided for in the
    Indenture relating to such transaction have been complied with.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Holding
    Company Structure</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer is a holding company for its Subsidiaries, with no
    material operations of its own and only limited assets.
    Accordingly, the Issuer is dependent upon the distribution of
    the earnings of its Subsidiaries, whether in the form of
    dividends, advances or payments on account of intercompany
    obligations, to service its debt obligations.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Security</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">General</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Notes and the Guarantees are secured by perfected
    first-priority security interests in the Non-Receivables
    Collateral and by perfected second-priority security interests
    in the Shared Receivables Collateral (second in priority to the
    first-priority Liens on the Shared Receivables Collateral
    securing the ABL Obligations), in each case, subject to
    Permitted Liens. Notwithstanding the foregoing, neither the
    Notes nor the Guarantees are secured by the European Collateral
    or the Separate Receivables Collateral. The ABL Secured Parties
    have rights and remedies with respect to the Shared Receivables
    Collateral that, if exercised, could adversely affect the value
    of the Shared Receivables Collateral or the ability of the
    respective agents
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    189
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    under the Intercreditor Agreements to realize or foreclose on
    the Shared Receivables Collateral on behalf of the First Lien
    Secured Parties. First Lien Secured Parties other than the
    Holders of the Notes have rights and remedies with respect to
    the Collateral that, if exercised, could also adversely affect
    the value of the Collateral on behalf of the Holders of the
    Notes, particularly the rights described below under
    &#147;&#151;&#160;First Lien Intercreditor Agreement.&#148; For
    a description of the Shared Receivables Collateral and the
    Non-Receivables Collateral, see &#147;Description of Other
    Indebtedness&#160;&#151; Senior Secured Credit
    Facilities&#160;&#151; Guarantee and Security.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer and the Guarantors are and will be able to incur
    additional Indebtedness in the future which could share in the
    Collateral, including additional First Lien Obligations,
    additional ABL Obligations, additional Junior Lien Obligations
    and Obligations secured by Permitted Liens. The amount of such
    additional Obligations is and will be limited by the covenant
    described under &#147;Certain Covenants&#160;&#151; Liens&#148;
    and the covenant described under &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock.&#148;
    Under certain circumstances, the amount of any such additional
    Obligations could be significant.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">After-Acquired
    Collateral</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    From and after the Issue Date and subject to certain limitations
    and exceptions, (a)&#160;if the Issuer or any Guarantor creates
    any additional security interest upon any property or asset that
    would constitute Collateral to secure any First Lien Obligations
    (other than European Collateral and Separate Receivables
    Collateral), it must concurrently grant a first-priority
    perfected security interest (subject to Permitted Liens) upon
    such property as security for the Notes and (b)&#160;if the
    Issuer or any Guarantor creates any additional security interest
    upon any property or asset that would constitute Shared
    Receivables Collateral to secure any ABL Obligations, it must
    concurrently grant a second-priority perfected security interest
    (subject to Permitted Liens) upon such property as security for
    the Notes.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Liens
    with Respect to the Collateral</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer, the Guarantors and the First Lien Collateral Agent
    entered into Security Documents in connection with the General
    Credit Facility with respect to the Collateral defining the
    terms of the security interests that secure the General Credit
    Facility with respect to such Collateral and that also define
    the terms of the security interests that secure the Notes and
    the Guarantees with respect to such Collateral. These security
    interests secure the payment and performance when due of all of
    the Obligations of the Issuers and the Guarantors under the
    Notes, the Indenture, the Guarantees and the Security Documents,
    as provided in the Security Documents.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">First
    Lien Intercreditor Agreement</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Trustee and the First Lien Collateral Agent entered into a
    First Lien Intercreditor Agreement (as the same may be amended
    from time to time, the <I>&#147;First Lien Intercreditor
    Agreement&#148;</I>) with the Authorized Representative of the
    General Credit Facility Obligations with respect to the
    Collateral, which may be amended from time to time without the
    consent of the Holders to add other parties holding First Lien
    Obligations permitted to be incurred under the Indenture,
    General Credit Facility and the First Lien Intercreditor
    Agreement. The First Lien Collateral Agent is initially the
    collateral agent under the General Credit Facility.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under the First Lien Intercreditor Agreement, as described
    below, the &#147;Applicable Authorized Representative&#148; has
    the right to direct foreclosures and take other actions with
    respect to the Common Collateral, and the Authorized
    Representatives of other Series of First Lien Obligations have
    no right to take actions with respect to the Common Collateral.
    The Applicable Authorized Representative is initially the
    administrative agent under the General Credit Facility, and the
    Trustee for the Holders, as Authorized Representative in respect
    of the Notes, has no rights to take any action under the First
    Lien Intercreditor Agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The administrative agent under the General Credit Facility will
    remain the Applicable Authorized Representative until the
    earlier of (1)&#160;the Discharge of General Credit Facility
    Obligations and (2)&#160;the Non-Controlling Authorized
    Representative Enforcement Date (such date, the
    <I>&#147;Applicable Authorized Agent </I>
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    190
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Date&#148;</I>). After the Applicable Authorized Agent Date,
    the Applicable Authorized Representative will be the Authorized
    Representative of the Series of Additional First Lien
    Obligations that constitutes the largest outstanding principal
    amount of any then outstanding Series of First Lien Obligations,
    other than the General Credit Facility Obligations, with respect
    to the Common Collateral (the <I>&#147;Major Non-Controlling
    Authorized Representative&#148;</I>).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The <I>&#147;Non-Controlling Authorized Representative
    Enforcement Date&#148;</I> is the date that is 90&#160;days
    (throughout which
    <FONT style="white-space: nowrap">90-day</FONT>
    period the applicable Authorized Representative was the Major
    Non-Controlling Authorized Representative) after the occurrence
    of both (a)&#160;an event of default, as defined in the
    Indenture or other applicable indenture for that Series of First
    Lien Obligations, and (b)&#160;the First Lien Collateral
    Agent&#146;s and each other Authorized Representative&#146;s
    receipt of written notice from that Authorized Representative
    certifying that (i)&#160;such Authorized Representative is the
    Major Non-Controlling Authorized Representative and that an
    event of default, as defined in the Indenture or other
    applicable indenture for that Series of First Lien Obligations,
    has occurred and is continuing and (ii)&#160;the First Lien
    Obligations of that Series are currently due and payable in full
    (whether as a result of acceleration thereof or otherwise) in
    accordance with the Indenture or other applicable indenture for
    that Series of First Lien Obligations; <I>provided </I>that the
    Non-Controlling Authorized Representative Enforcement Date shall
    be stayed and shall not occur and shall be deemed not to have
    occurred with respect to any Shared Collateral (1)&#160;at any
    time the administrative agent under the General Credit Facility
    or the First Lien Collateral Agent has commenced and is
    diligently pursuing any enforcement action with respect to such
    Common Collateral or (2)&#160;at any time the Issuer or the
    Guarantor that has granted a security interest in such Common
    Collateral is then a debtor under or with respect to (or
    otherwise subject to) any insolvency or liquidation proceeding.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Applicable Authorized Representative shall have the sole
    right to instruct the First Lien Collateral Agent to act or
    refrain from acting with respect to the Common Collateral,
    (b)&#160;the First Lien Collateral Agent shall not follow any
    instructions with respect to such Common Collateral from any
    representative of any Non-Controlling Secured Party or other
    First Lien Secured Party (other than the Applicable Authorized
    Representative), and (c)&#160;no Authorized Representative of
    any Non-Controlling Secured Party or other First Lien Secured
    Party (other than the Applicable Authorized Representative) will
    instruct the First Lien Collateral Agent to commence any
    judicial or non-judicial foreclosure proceedings with respect
    to, seek to have a trustee, receiver, liquidator or similar
    official appointed for or over, attempt any action to take
    possession of, exercise any right, remedy or power with respect
    to, or otherwise take any action to enforce its interests in or
    realize upon, or take any other action available to it in
    respect of, the Common Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding the equal priority of the Liens, the First Lien
    Collateral Agent, acting on the instructions of the Applicable
    Authorized Representative, may deal with the Common Collateral
    as if such Applicable Authorized Representative had a senior
    Lien on such Collateral. No representative of any
    Non-Controlling Secured Party may contest, protest or object to
    any foreclosure proceeding or action brought by the First Lien
    Collateral Agent, Applicable Authorized Representative or
    Controlling Secured Party. The Trustee and each other Authorized
    Representative will agree that it will not accept any Lien on
    any Collateral for the benefit of the Holders (other than funds
    deposited for the discharge or defeasance of the Notes) other
    than pursuant to the First Lien Security Documents. Each of the
    First Lien Secured Parties also will agree that it will not
    contest or support any other person in contesting, in any
    proceeding (including any insolvency or liquidation proceeding),
    the perfection, priority, validity or enforceability of a Lien
    held by or on behalf of any of the First Lien Secured Parties in
    all or any part of the Collateral, or the provisions of the
    First Lien Intercreditor Agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If a First Lien Event of Default has occurred and is continuing
    and the First Lien Collateral Agent is taking action to enforce
    rights in respect of any Common Collateral, or any distribution
    is made with respect to any Common Collateral in any bankruptcy
    case of the Issuer or any Guarantor, the proceeds of any sale,
    collection or other liquidation of any such Collateral by the
    First Lien Collateral Agent or any other First Lien Secured
    Party (or received pursuant to any other intercreditor
    agreement), as applicable, and proceeds of any such distribution
    (subject, in the case of any such distribution, to the paragraph
    immediately following) to which the First Lien Obligations are
    entitled under any other intercreditor agreement shall be
    applied among
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    191
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    the First Lien Obligations to the payment in full of the First
    Lien Obligations on a ratable basis, after payment of all
    amounts owing to the First Lien Collateral Agent.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding the foregoing, with respect to any Common
    Collateral for which a third party (other than a First Lien
    Secured Party) has a lien or security interest that is junior in
    priority to the security interest of any Series of First Lien
    Obligations but senior (as determined by appropriate legal
    proceedings in the case of any dispute) to the security interest
    of any other Series of First Lien Obligations (such third party,
    an <I>&#147;Intervening Creditor&#148;</I>), the value of any
    Common Collateral or proceeds which are allocated to such
    Intervening Creditor shall be deducted on a ratable basis solely
    from the Common Collateral or proceeds to be distributed in
    respect of the Series of First Lien Obligations with respect to
    which such Impairment exists.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    None of the First Lien Secured Parties may institute any suit or
    assert in any suit, bankruptcy, insolvency or other proceeding
    any claim against the First Lien Collateral Agent or any other
    First Lien Secured Party seeking damages from or other relief by
    way of specific performance, instructions or otherwise with
    respect to any Common Collateral. In addition, none of the First
    Lien Secured Parties may seek to have any Common Collateral or
    any part thereof marshaled upon any foreclosure or other
    disposition of such Collateral. If any First Lien Secured Party
    obtains possession of any Common Collateral or realizes any
    proceeds or payment in respect thereof, at any time prior to the
    discharge of each of the First Lien Obligations, then it must
    hold such Common Collateral, proceeds or payment in trust for
    the other First Lien Secured Parties and promptly transfer such
    Common Collateral, proceeds or payment to the First Lien
    Collateral Agent to be distributed in accordance with the First
    Lien Intercreditor Agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If the Issuer or any Guarantor becomes subject to any bankruptcy
    case, the First Lien Intercreditor Agreement provides that
    (1)&#160;if the Issuer or any Guarantor shall, as
    debtor(s)-in-possession, move for approval of financing (the
    <I>&#147;DIP Financing&#148;</I>) to be provided by one or more
    lenders (the <I>&#147;DIP Lenders&#148;</I>) under
    Section&#160;364 of the Bankruptcy Code or the use of cash
    collateral under Section&#160;363 of the Bankruptcy Code, each
    First Lien Secured Party will agree not to object to any such
    financing or to the Liens on the Common Collateral securing the
    same (the <I>&#147;DIP Financing Liens&#148;</I>) or to any use
    of cash collateral that constitutes Common Collateral, unless
    any Controlling Secured Party, or an Authorized Representative
    of any Controlling Secured Party, shall then oppose or object to
    such DIP Financing or such DIP Financing Liens or use of cash
    collateral (and (i)&#160;to the extent that such DIP Financing
    Liens are senior to the Liens on any such Common Collateral for
    the benefit of the Controlling Secured Parties, each
    Non-Controlling Secured Party will subordinate its Liens with
    respect to such Common Collateral on the same terms as the Liens
    of the Controlling Secured Parties (other than any Liens of any
    First Lien Secured Parties constituting DIP Financing Liens) are
    subordinated thereto, and (ii)&#160;to the extent that such DIP
    Financing Liens rank <I>pari passu </I>with the Liens on any
    such Common Collateral granted to secure the First Lien
    Obligations of the Controlling Secured Parties, each
    Non-Controlling Secured Party will confirm the priorities with
    respect to such Common Collateral as set forth in the First Lien
    Intercreditor Agreement), in each case so long as;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (A)&#160;the First Lien Secured Parties of each Series retain
    the benefit of their Liens on all such Common Collateral pledged
    to the DIP Lenders, including proceeds thereof arising after the
    commencement of such proceeding, with the same priority
    <FONT style="white-space: nowrap">vis-a-vis</FONT>
    all the other First Lien Secured Parties (other than any Liens
    of the First Lien Secured Parties constituting DIP Financing
    Liens) as existed prior to the commencement of the bankruptcy
    case,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (B)&#160;the First Lien Secured Parties of each Series are
    granted Liens on any additional collateral pledged to any First
    Lien Secured Parties as adequate protection or otherwise in
    connection with such DIP Financing or use of cash collateral,
    with the same priority
    <FONT style="white-space: nowrap">vis-a-vis</FONT>
    the First Lien Secured Parties as set forth in the First Lien
    Intercreditor Agreement,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (C)&#160;if any amount of such DIP Financing or cash collateral
    is applied to repay any of the First Lien Obligations, such
    amount is applied pursuant to the First Lien Intercreditor
    Agreement,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (D)&#160;if any First Lien Secured Parties are granted adequate
    protection, including in the form of periodic payments, in
    connection with such DIP Financing or use of cash collateral,
    the proceeds of such adequate protection is applied pursuant to
    the First Lien Intercreditor Agreement;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    192
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided </I>that the First Lien Secured Parties of each
    Series shall have a right to object to the grant of a Lien to
    secure the DIP Financing over any Collateral subject to Liens in
    favor of the First Lien Secured Parties of such Series or its
    representative that shall not constitute Common Collateral; and
    <I>provided</I>, <I>further</I>, that the First Lien Secured
    Parties receiving adequate protection shall not object to any
    other First Lien Secured Party receiving adequate protection
    comparable to any adequate protection granted to such First Lien
    Secured Parties in connection with a DIP Financing or use of
    cash collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The First Lien Secured Parties acknowledge that the First Lien
    Obligations of any Series may, subject to the limitations set
    forth in the other First Lien Documents, be increased, extended,
    renewed, replaced, restated, supplemented, restructured, repaid,
    refunded, refinanced or otherwise amended or modified from time
    to time, all without affecting the priorities set forth in the
    First Lien Intercreditor Agreement defining the relative rights
    of the First Lien Secured Parties of any Series.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Additional
    General Intercreditor Agreement</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The First Lien Collateral Agent is a party to an Additional
    General Intercreditor Agreement dated as of the Issue Date, (as
    the same may be amended from time to time, the
    <I>&#147;Additional General Intercreditor Agreement&#148;</I>),
    by and among the First Lien Collateral Agent, the Junior Lien
    Collateral Agent and the trustees under the Existing Second
    Priority Notes Indentures, by which the Notes are given the same
    ranking and rights with respect to the Collateral as provided to
    the General Credit Facility under the General Intercreditor
    Agreement, dated as of November&#160;17, 2006, by and among the
    First Lien Collateral Agent and the Junior Lien Collateral
    Agent. Pursuant to the terms of the Additional General
    Intercreditor Agreement and subject to the First-Lien
    Intercreditor Agreement, prior to the Discharge of New First
    Lien Obligations, the First Lien Collateral Agent, acting on
    behalf of the New First Lien Secured Parties, will determine the
    time and method by which the security interests in the
    Collateral will be enforced and will have the sole and exclusive
    right to manage, perform and enforce the terms of the Security
    Documents relating to the Collateral and to exercise and enforce
    all privileges, rights and remedies thereunder according to its
    direction, including to take or retake control or possession of
    such Collateral and to hold, prepare for sale, marshall,
    process, sell, lease, dispose of or liquidate such Collateral,
    including, without limitation, following the occurrence of a
    Default or Event of Default under the Indenture. The Junior Lien
    Collateral Agent will not be permitted to enforce the security
    interests even if any event of default under an Existing Second
    Priority Notes Indenture has occurred and the Existing Second
    Priority Notes issued thereunder have been accelerated except
    (a)&#160;in any insolvency or liquidation proceeding, solely as
    necessary to file a proof of claim or statement of interest with
    respect to the Junior Lien Obligations or (b)&#160;as necessary
    to take any action in order to prove, preserve, perfect or
    protect (but not enforce) its security interest and rights in,
    and the perfection and priority of its Lien on, the Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Junior Lien Collateral Agent, for itself and on behalf of
    each Junior Lien Secured Party, has agreed pursuant to the
    Additional General Intercreditor Agreement that (a)&#160;it will
    not (and thereby waives any right to) take any action to
    challenge, contest or support any other Person in contesting or
    challenging, directly or indirectly, in any proceeding
    (including any insolvency or liquidation proceeding), the
    validity, perfection, priority or enforceability of a Lien
    securing any New First Lien Obligations held (or purported to be
    held) by or on behalf of the First Lien Collateral Agent or any
    of the New First Lien Secured Parties or any agent or trustee
    therefor in any Collateral or other collateral securing both the
    New First Lien Obligations and any Junior Lien Obligations and
    (b)&#160;it will not oppose or otherwise contest (or support any
    other Person contesting) any request for judicial relief made in
    any court by the First Lien Collateral Agent or any New First
    Lien Secured Parties relating to the lawful enforcement of any
    First Priority Lien on Collateral or other collateral securing
    both the New First Lien Obligations and any Junior Lien
    Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, the Security Documents provide that, subject to the
    First Lien Intercreditor Agreement, prior to the Discharge of
    New First Lien Obligations, the First Lien Collateral Agent may
    take actions with respect to the Collateral (including the
    release of Collateral and the manner of realization (subject to
    the provisions described under &#147;&#151;&#160;Release of
    Collateral&#148;)) without the consent of the Junior Lien
    Collateral Agent or other Junior Lien Secured Parties.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    193
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Collateral or proceeds thereof received in connection with
    the sale or other disposition of, or collection on, such
    Non-Receivables Collateral upon the exercise of remedies will be
    applied to the First Lien Obligations to be distributed in
    accordance with the First Lien Intercreditor Agreement prior to
    application to any Junior Lien Obligations in such order as
    specified in the relevant First Lien Documents until the
    Discharge of New First Lien Obligations has occurred.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, so long as the Discharge of New First Lien
    Obligations has not occurred, neither the Junior Lien Collateral
    Agent nor any Junior Lien Representative shall acquire or hold
    any Lien on any assets of the Issuer or any Subsidiary (and
    neither the Issuer nor any Subsidiary shall grant such Lien)
    securing any Junior Lien Obligations that are not also subject
    to the First Priority Lien in respect of the New First Lien
    Obligations under the First Lien Documents.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Junior Lien Collateral Agent and each other Junior Lien
    Secured Party have agreed that any Lien purported to be granted
    on any collateral as security for New First Lien Obligations
    shall be deemed to be and shall be deemed to remain senior in
    all respects and prior to all Liens on such collateral securing
    any Junior Lien Obligations for all purposes regardless of
    whether the Lien purported to be granted is found to be
    improperly granted, improperly perfected, preferential, a
    fraudulent conveyance or legally or otherwise deficient in any
    manner.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If any New First Lien Secured Party is required in any
    insolvency or liquidation proceeding or otherwise to turn over
    or otherwise pay to the estate of the Issuer or any other
    Guarantor (or any trustee, receiver or similar person therefor),
    because the payment of such amount was declared to be fraudulent
    or preferential in any respect or for any other reason, any
    amount (a <I>&#147;Recovery&#148;</I>), whether received as
    proceeds of security, enforcement of any right of setoff or
    otherwise, then as among the parties hereto, the New First Lien
    Obligations shall be deemed to be reinstated to the extent of
    such Recovery and to be outstanding as if such payment had not
    occurred and such New First Lien Secured Party shall be entitled
    to a reinstatement of New First Lien Obligations with respect to
    all such recovered amounts and shall have all rights hereunder.
    If the Additional General Intercreditor Agreement shall have
    been terminated prior to such Recovery, the Additional General
    Intercreditor Agreement shall be reinstated in full force and
    effect, and such prior termination shall not diminish, release,
    discharge, impair or otherwise affect the obligations of the
    parties thereto.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Additional General Intercreditor Agreement provides that so
    long as the Discharge of New First Lien Obligations has not
    occurred, whether or not any insolvency or liquidation
    proceeding has been commenced by or against the Issuer or any
    Guarantor, (i)&#160;neither the Junior Lien Collateral Agent,
    any Junior Lien Representative nor any Junior Lien Secured Party
    will (x)&#160;exercise or seek to exercise any rights or
    remedies (including setoff or the right to credit bid debt
    (except under limited circumstances)) with respect to any
    collateral securing both the New First Lien Obligations and any
    Junior Lien Obligations in respect of any applicable Junior Lien
    Obligations, or institute any action or proceeding with respect
    to such rights or remedies (including any action of
    foreclosure), (y)&#160;contest, protest or otherwise object to
    any foreclosure or enforcement proceeding or action brought with
    respect to the Collateral or any other collateral by the First
    Lien Collateral Agent or any New First Lien Secured Party in
    respect of the New First Lien Obligations, the exercise of any
    right by the First Lien Collateral Agent or any New First Lien
    Secured Party (or any agent or
    <FONT style="white-space: nowrap">sub-agent</FONT> on
    their behalf) in respect of the New First Lien Obligations under
    any control agreement, lockbox agreement, landlord waiver or
    bailee&#146;s letter or similar agreement or arrangement to
    which the Junior Lien Collateral Agent, any Junior Lien
    Representative or any Junior Lien Secured Party either is a
    party or may have rights as a third-party beneficiary, or any
    other exercise by any such party of any rights and remedies as a
    secured party relating to such collateral or any other
    collateral under the First Lien Documents or otherwise in
    respect of New First Lien Obligations, or (z)&#160;object to any
    waiver or forbearance by the First Lien Secured Parties from or
    in respect of bringing or pursuing any foreclosure proceeding or
    action or any other exercise of any rights or remedies relating
    to such collateral or any other collateral in respect of New
    First Lien Obligations and (ii)&#160;except as otherwise
    provided in the Additional General Intercreditor Agreement, the
    First Lien Collateral Agent and the New First Lien Secured
    Parties shall have the sole and exclusive right to enforce
    rights, exercise remedies (including setoff and the right to
    credit bid their debt), marshal, process and make determinations
    regarding the release, disposition or restrictions, or waiver or
    forbearance of rights or remedies
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    194
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    with respect to such collateral without any consultation with or
    the consent of the Junior Lien Collateral Agent, any Junior Lien
    Representative or any Junior Lien Secured Party.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, the Junior Lien Collateral Agent, each Junior Lien
    Representative and each other Junior Lien Secured Party have
    agreed, among other things, that if the Issuer or any Guarantor
    is subject to any insolvency or liquidation proceeding if the
    First Lien Collateral Agent, subject to the First Lien
    Intercreditor Agreement, desires to permit the use of cash
    collateral or to permit the Issuer or any Guarantor to obtain
    financing under Section&#160;363 or Section&#160;364 of the
    Bankruptcy Code or any similar provision in any Bankruptcy Law
    (<I>&#147;DIP Financing&#148;</I>), including if such DIP
    Financing is secured by Liens senior in priority to the Liens
    securing the Junior Lien Obligations, then the Junior Lien
    Collateral Agent and each Junior Lien Representative, on behalf
    of itself and each applicable Junior Lien Secured Party, agrees
    not to object to such use of cash collateral or DIP Financing
    and will not request adequate protection or any other relief in
    connection therewith (except to the extent permitted by the
    Additional General Intercreditor Agreement) and, to the extent
    the Liens securing the new First Lien Obligations are
    subordinated or <I>pari passu </I>with such DIP Financing, will
    subordinate its Liens in the Collateral and any other collateral
    to such DIP Financing (and all Obligations relating thereto) on
    the same basis as they are subordinated to the New First Lien
    Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Subject to the terms of the Security Documents, the Issuer and
    the Guarantors have the right to remain in possession and retain
    exclusive control of the Collateral securing the Notes and the
    Notes Obligations (other than securities, instruments and
    chattel paper constituting part of the Collateral and deposited
    with the First Lien Collateral Agent in accordance with the
    provisions of the First Lien Security Documents and any Shared
    Receivables Collateral subject to a control agreement under the
    circumstances described in the First Lien Security Documents),
    to freely operate the Collateral and to collect, invest and
    dispose of any income therefrom.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Release
    of Collateral</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under the First Lien Intercreditor Agreement, if at any time the
    Applicable Authorized Representative forecloses upon or
    otherwise exercises remedies against any Common Collateral, then
    (whether or not any insolvency or liquidation proceeding is
    pending at the time) the Liens in favor of the First Lien
    Collateral Agent for the benefit of the Trustee and the Holders
    of the Notes and each other Series of First Lien Secured Parties
    upon such Common Collateral will automatically be released and
    discharged. However, any proceeds of any Common Collateral
    realized therefrom will be applied as described under
    &#147;&#151;&#160;First Lien Intercreditor Agreement.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under the Additional Receivables Intercreditor Agreement, if at
    any time the Issuer or any Guarantor or any ABL Secured Party
    delivers notice that any Shared Receivables Collateral is sold,
    transferred or otherwise disposed of by the owner of that
    Collateral in a transaction permitted under the ABL Facility,
    the General Credit Facility and the Indenture or the ABL Secured
    Parties are releasing or have released their Liens on such
    Shared Receivables Collateral in connection with a disposition
    in connection with an exercise of remedies with respect to such
    Collateral, then the Liens on such Shared Receivables Collateral
    securing New First Lien Obligations or Junior Lien Obligations
    will automatically be released and discharged as and when, but
    only to the extent, such Liens on such Shared Receivables
    Collateral securing ABL Obligations are released and discharged,
    provided that in the case of a disposition in connection with an
    exercise of remedies, any proceeds thereof not applied to repay
    ABL Obligations shall be subject to the Liens securing the First
    Lien Obligations and the Junior Lien Obligations and shall be
    applied pursuant to the Additional Receivables Intercreditor
    Agreement and the First Lien Intercreditor Agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer and the Guarantors are entitled to the release of
    property and other assets constituting Collateral from the Liens
    securing the Notes and the Notes Obligations under any one or
    more of the following circumstances:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;to enable us to consummate the sale, transfer or other
    disposition of such property or assets to the extent not
    prohibited under the covenant described under
    &#147;&#151;&#160;Repurchase at the Option of
    Holders&#160;&#151; Asset Sales&#148;;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    195
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the release of Excess Proceeds or Collateral Excess
    Proceeds that remain unexpended after the conclusion of an Asset
    Sale Offer or a Collateral Asset Sale Offer conducted in
    accordance with the Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;in the case of a Guarantor that is released from its
    Guarantee with respect to the Notes pursuant to the terms of the
    Indenture, the release of the property and assets of such
    Guarantor;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;with the consent of the holders of at least 75% of the
    aggregate principal amount of the Notes then outstanding and
    affected thereby and a majority of all Junior Lien Obligations
    (including the Existing Second Priority Notes) then outstanding
    and affected thereby (including, without limitation, consents
    obtained in connection with a tender offer or exchange offer
    for, or purchase of, Junior Lien Obligations);&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;as described under &#147;&#151;&#160;Amendment,
    Supplement and Waiver&#148; below.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    To the extent necessary and for so long as required for such
    Subsidiary not to be subject to any requirement pursuant to
    <FONT style="white-space: nowrap">Rule&#160;3-16</FONT>
    of
    <FONT style="white-space: nowrap">Regulation&#160;S-X</FONT>
    under the Securities Act to file separate financial statements
    with the SEC (or any other governmental agency), the Capital
    Stock of any Subsidiary of the Company (excluding Healthtrust,
    Inc.&#160;&#151; The Hospital Company, a Delaware corporation
    and its successors and assigns) shall not be included in the
    Collateral with respect to the respective Notes so affected (as
    described under &#147;&#151;&#160;Certain Limitations on the
    Collateral&#148;) and shall not be subject to the Liens securing
    such Notes and the Notes Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Liens on the Collateral securing the Notes and the
    Guarantees also will be released upon (i)&#160;payment in full
    of the principal of, together with accrued and unpaid interest
    (including Additional Interest, if any) on, the Notes and all
    other Obligations under the Indenture, the Guarantees and the
    Security Documents that are due and payable at or prior to the
    time such principal, together with accrued and unpaid interest
    (including Additional Interest, if any), are paid or (ii)&#160;a
    legal defeasance or covenant defeasance under the Indenture as
    described below under &#147;Legal Defeasance and Covenant
    Defeasance&#148; or a discharge of the Indenture as described
    under &#147;Satisfaction and Discharge.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any certificate or opinion required by Section&#160;314(d) of
    the Trust&#160;Indenture Act may be made by an Officer of the
    Company, except in cases where Section&#160;314(d) requires that
    such certificate or opinion be made by an independent engineer,
    appraiser or other expert.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding anything to the contrary herein, the Issuer and
    its Subsidiaries will not be required to comply with all or any
    portion of Section&#160;314(d) of the Trust&#160;Indenture Act
    if they determine, in good faith based on advice of counsel,
    that under the terms of that section
    <FONT style="white-space: nowrap">and/or</FONT> any
    interpretation or guidance as to the meaning thereof of the SEC
    and its staff, including &#147;no action&#148; letters or
    exemptive orders, all or any portion of Section&#160;314(d) of
    the Trust&#160;Indenture Act is inapplicable to the released
    Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Without limiting the generality of the foregoing, certain no
    action letters issued by the SEC have permitted an indenture
    qualified under the Trust&#160;Indenture Act to contain
    provisions permitting the release of collateral from Liens under
    such indenture in the ordinary course of the issuer&#146;s
    business without requiring the issuer to provide certificates
    and other documents under Section&#160;314(d) of the
    Trust&#160;Indenture Act. The Issuer and the Guarantors may,
    subject to the provisions of the Indenture, among other things,
    without any release or consent by the First Lien Collateral
    Agent, conduct ordinary course activities with respect to the
    Collateral, including, without limitation:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    selling or otherwise disposing of, in any transaction or series
    of related transactions, any property subject to the Lien of the
    Security Documents that has become worn out, defective, obsolete
    or not used or useful in the business;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    abandoning, terminating, canceling, releasing or making
    alterations in or substitutions of any leases or contracts
    subject to the Lien of the Indenture or any of the Security
    Documents;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    surrendering or modifying any franchise, license or permit
    subject to the Lien of the Security Documents that it may own or
    under which it may be operating;
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    196
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    altering, repairing, replacing, changing the location or
    position of and adding to its structures, machinery, systems,
    equipment, fixtures and appurtenances;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    granting a license of any intellectual property;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    selling, transferring or otherwise disposing of inventory in the
    ordinary course of business;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    collecting accounts receivable in the ordinary course of
    business as permitted by the covenant described under
    &#147;Repurchase at the Option of Holders&#160;&#151; Asset
    Sales&#148;;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    making cash payments (including for the repayment of
    Indebtedness or interest) from cash that is at any time part of
    the Collateral in the ordinary course of business that are not
    otherwise prohibited by the Indenture and the Security
    Documents;&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    abandoning any intellectual property that is no longer used or
    useful in the Issuer&#146;s business.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer must deliver an Officer&#146;s Certificate to the
    First Lien Collateral Agent within 30 calendar days following
    the end of each six-month period beginning on May 15 and
    November 15 of each year, to the effect that all such releases
    and withdrawals during the preceding six-month period in the
    ordinary course of the Issuer&#146;s or the Guarantors&#146;
    business, as described in the preceding paragraph, were not
    prohibited by the Indenture.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Additional
    Receivables Intercreditor Agreement</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, the First Lien Collateral Agent is a party to an
    Additional Receivables Intercreditor Agreement, dated as of the
    Issue Date, (as the same may be amended from time to time, the
    <I>&#147;Additional Receivables Intercreditor
    Agreement&#148;</I>), by and between the First Lien Collateral
    Agent and the collateral agent under the ABL Facility (the
    <I>&#147;ABL Collateral Agent&#148;</I>), by which the Notes are
    given the same ranking and rights with respect to the Shared
    Receivables Collateral as provided to the General Credit
    Facility under the Receivables Intercreditor Agreement dated as
    of November&#160;17, 2006 by and among the Junior Lien
    Collateral Agent, the First Lien Collateral Agent and the ABL
    Collateral Agent. The Additional Receivables Intercreditor
    Agreement contains provisions with respect to the Shared
    Receivables Collateral and the relative rights, privileges and
    obligations relating thereto as between (a)&#160;the First Lien
    Collateral Agent and the New First Lien Secured Parties and
    (b)&#160;the ABL Collateral Agent and the ABL Secured Parties.
    The Additional Receivables Intercreditor Agreement provides for
    first-priority Liens in the Shared Receivables Collateral in
    favor of the ABL Secured Parties and junior priority Liens in
    the Shared Receivables Collateral in favor of the New First Lien
    Secured Parties, subject to Permitted Liens. The relative
    rights, privileges and obligations with respect to the Shared
    Receivables Collateral of the ABL Secured Parties, on the one
    hand, and the New First Lien Secured Parties, on the other, are
    substantially similar to the relative rights, privileges and
    obligations with respect to the Non-Receivables Collateral of
    the New First Lien Secured Parties, on the one hand, and the
    Junior Lien Secured Parties, on the other, respectively, except
    that the Liens of the New First Lien Secured Parties in the
    Shared Receivables Collateral are second-priority Liens and the
    Liens of the ABL Secured Parties in the Shared Receivables
    Collateral are first-priority liens and except to the extent
    customary or necessary with respect to collateral of the type
    that constitutes Shared Receivables Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The relative rights, privileges and obligations with respect to
    the Shared Receivables Collateral (a)&#160;as between the First
    Lien Collateral Agent and the First Lien Secured Parties, on the
    one hand, and the Junior Lien Collateral Agent and the Junior
    Lien Secured Parties, on the other, are governed by the
    Additional General Intercreditor Agreement described above and
    (b)&#160;as among the First Lien Secured Parties, are governed
    by the First Lien Intercreditor Agreement described above.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Certain
    Limitations on the Collateral</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Collateral securing the Notes does not include any of the
    following assets:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the property or assets owned by any Subsidiary of the
    Issuer that is not a Guarantor, including each ABL Financing
    Entity;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    197
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any rights or interests of the Issuer or any Guarantor
    in, to or under any agreement, contract, license, instrument,
    document or other general intangible (referred to solely for
    purposes of this clause&#160;(2) as a
    <I>&#147;Contract&#148;</I>), any intellectual property or any
    security or other investment property (i)&#160;to the extent the
    security interest in such Collateral is prohibited by any
    applicable contract, agreement or other instrument without the
    consent of any other party thereto (other than a party to the
    General Credit Facility or the Indenture or, in the case of
    investment property, a Wholly-Owned Subsidiary), (ii)&#160;to
    the extent the security interest in such Contract would give any
    other party (other than a party to the General Credit Facility
    or the Indenture or, in the case of investment property, a
    Wholly-Owned Subsidiary) to such Collateral the right to
    terminate its obligations thereunder or (iii)&#160;to the extent
    all necessary consents to such grant of a security interest have
    not been obtained from the other parties thereto (other than to
    the extent that any such prohibition referred to in clauses (i),
    (ii)&#160;and (iii)&#160;would be rendered ineffective pursuant
    to
    <FONT style="white-space: nowrap">Sections&#160;9-406,</FONT>
    9-407, 9-408 or 9-409 of the Uniform Commercial Code (or any
    successor provision or provisions) of any relevant jurisdiction
    or any other applicable law); <I>provided</I> that this
    limitation shall not affect, limit, restrict or impair the grant
    by the Issuer or such Guarantor of a security interest in any
    account receivable or any money or other amounts due or to
    become due under any Contract;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;any equipment of the Issuer or any Guarantor that is
    subject to, or secured by, a Capitalized Lease Obligation or
    Purchase Money Obligations and any equipment that constitutes an
    asset of an entity acquired in a transaction permitted by the
    Indenture to the extent that such equipment subject to a Lien
    permitted by the Indenture and the terms of the Indebtedness
    secured by such Lien prohibit assignment of, or granting of a
    security interest in, the Issuer&#146;s or such Guarantor&#146;s
    rights and interests therein (other than to the extent that any
    such prohibition would be rendered ineffective pursuant to
    <FONT style="white-space: nowrap">Sections&#160;9-406,</FONT>
    <FONT style="white-space: nowrap">9-407,</FONT> 9-408
    or 9-409 of the Uniform Commercial Code (or any successor
    provision or provisions) of any relevant jurisdiction or any
    other applicable law); <I>provided </I>that immediately upon the
    repayment of all Indebtedness secured by such Lien, the Issuer
    or the Guarantor, as the case may be, shall be deemed to have
    granted a security interest in all the rights and interests with
    respect to such equipment;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;any Voting Stock that is issued by any Foreign
    Subsidiary, if and to the extent that the inclusion of such
    Voting Stock in the Collateral would cause the Collateral
    pledged by the Issuer or the applicable Guarantor, as the case
    may be, to include in the aggregate more than 65% of the total
    combined voting power of all classes of Voting Stock of such
    Foreign Subsidiary;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;any Capital Stock that is issued by a Subsidiary that
    is not owned directly by the Issuer or a Guarantor;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;any Capital Stock and other securities of a Subsidiary
    (excluding Healthtrust, Inc.&#160;&#151; The Hospital Company, a
    Delaware corporation and its successors and assigns) to the
    extent that the pledge of such Capital Stock and other
    securities results in the Company&#146;s being required to file
    separate financial statements of such Subsidiary with the SEC,
    but only to the extent necessary to not be subject to such
    requirement and only for so long as such requirement is in
    existence and only with respect to the relevant Notes affected;
    <I>provided</I> that neither the Issuer nor any Subsidiary shall
    take any action in the form of a reorganization, merger or other
    restructuring a principal purpose of which is to provide for the
    release of the Lien on any Capital Stock pursuant to this clause
    (6). In addition, in the event that
    <FONT style="white-space: nowrap">Rule&#160;3-16</FONT>
    of
    <FONT style="white-space: nowrap">Regulation&#160;S-X</FONT>
    under the Securities Act is amended, modified or interpreted by
    the SEC to require (or is replaced with another rule or
    regulation, or any other law, rule or regulation is adopted,
    which would require) the filing with the SEC (or any other
    governmental agency) of separate financial statements of any
    Subsidiary of the Company (excluding Healthtrust,
    Inc.&#160;&#151; The Hospital Company, a Delaware corporation
    and its successors and assigns) due to the fact that such
    Subsidiary&#146;s Capital Stock secures the Notes affected
    thereby, then the Capital Stock of such Subsidiary will
    automatically be deemed not to be part of the Collateral
    securing the relevant Notes affected thereby but only to the
    extent necessary to not be subject to such requirement and only
    for so long as required to not be subject to such requirement.
    In such event, the Security Documents may be amended or
    modified, without the consent of any holder of such Notes, to
    the extent necessary to release the security interests in favor
    of the First Lien Collateral Agent on the shares of Capital
    Stock that are so deemed to no longer constitute part of the
    Collateral for
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    198
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    the relevant Notes. In the event that
    <FONT style="white-space: nowrap">Rule&#160;3-16</FONT>
    of
    <FONT style="white-space: nowrap">Regulation&#160;S-X</FONT>
    under the Securities Act is amended, modified or interpreted by
    the SEC to permit (or is replaced with another rule or
    regulation, or any other law, rule or regulation is adopted,
    which would permit) such Subsidiary&#146;s Capital Stock to
    secure the Notes in excess of the amount then pledged without
    the filing with the SEC (or any other governmental agency) of
    separate financial statements of such Subsidiary, then the
    Capital Stock of such Subsidiary will automatically be deemed to
    be a part of the Collateral for the relevant Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;certain non-Principal Properties that do not constitute
    Non-Receivables Collateral;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;any deposit accounts, other bank or securities accounts
    or cash of the Issuer or any Guarantor;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;any leaseholds and motor vehicles of the Issuer or any
    Guarantor;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;any Capital Stock or securities convertible into or
    exchangeable for Capital Stock (i)&#160;if, in the reasonable
    judgment of the Issuer, the cost or other consequences of
    pledging such Collateral shall be excessive in view of the
    benefits to be obtained by the First Lien Secured Parties
    therefrom or (ii)&#160;the pledge of such Collateral would
    result in adverse tax consequences to the Issuer or any of its
    Subsidiaries as reasonably determined by the Issuer and
    identified in writing to the First Lien Collateral Agent;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;any collateral to the extent the grant of the security
    interest therein would violate any requirement of law;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;proceeds and products from any and all of the
    foregoing excluded collateral described in clauses&#160;(1)
    through (11), unless such proceeds or products would otherwise
    constitute Collateral securing the Notes.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Sufficiency
    of Collateral</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The fair market value of the Collateral is subject to
    fluctuations based on factors that include, among others, the
    condition of the health care industry, the ability to sell the
    Collateral in an orderly sale, general economic conditions, the
    availability of buyers and similar factors. The amount to be
    received upon a sale of the Collateral would also be dependent
    on numerous factors, including, but not limited to, the actual
    fair market value of the Collateral at such time and the timing
    and the manner of the sale. By their nature, portions of the
    Collateral may be illiquid and may have no readily ascertainable
    market value. Accordingly, there can be no assurance that the
    Collateral can be sold in a short period of time or in an
    orderly manner. In addition, in the event of a bankruptcy, the
    ability of the holders to realize upon any of the Collateral may
    be subject to certain bankruptcy law limitations as described
    below.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Certain
    Bankruptcy Limitations</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The right of the Trustee to repossess and dispose of the
    Collateral upon the occurrence of an Event of Default would be
    significantly impaired by any Bankruptcy Law in the event that a
    bankruptcy case were to be commenced by or against the Company
    or any Guarantor prior to the Trustee&#146;s having repossessed
    and disposed of the Collateral. Upon the commencement of a case
    for relief under the Bankruptcy Code, a secured creditor such as
    the Trustee is prohibited from repossessing its security from a
    debtor in a bankruptcy case, or from disposing of security
    without bankruptcy court approval.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In view of the broad equitable powers of a U.S.&#160;bankruptcy
    court, it is impossible to predict how long payments under the
    Notes could be delayed following commencement of a bankruptcy
    case, whether or when the Trustee could repossess or dispose of
    the Collateral, the value of the Collateral at any time during a
    bankruptcy case or whether or to what extent Holders of the
    Notes would be compensated for any delay in payment or loss of
    value of the Collateral. The Bankruptcy Code permits only the
    payment
    <FONT style="white-space: nowrap">and/or</FONT>
    accrual of post-petition interest, costs and attorneys&#146;
    fees to a secured creditor during a debtor&#146;s bankruptcy
    case to the extent the value of such creditor&#146;s interest in
    the Collateral is determined by the bankruptcy court to exceed
    the aggregate outstanding principal amount of the obligations
    secured by the Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Furthermore, in the event a domestic or foreign bankruptcy court
    determines that the value of the Collateral is not sufficient to
    repay all amounts due on the Notes, the Holders of the Notes
    would hold secured
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    199
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    claims only to the extent of the value of the Collateral to
    which the Holders of the Notes are entitled, and unsecured
    claims with respect to such shortfall.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Paying
    Agent and Registrar for the Notes</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer must maintain one or more paying agents for the Notes
    in the Borough of Manhattan, City of New York. The initial
    paying agent for the Notes is Deutsche Bank Trust&#160;Company
    Americas.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer must also maintain a registrar with offices in the
    Borough of Manhattan, City of New York. The initial registrar is
    Deutsche Bank Trust&#160;Company Americas. The registrar
    maintains a register reflecting ownership of the Notes
    outstanding from time to time and will make payments on and
    facilitate transfer of Notes on behalf of the Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer may change the paying agents or the registrars
    without prior notice to the Holders. The Issuer or any of its
    Subsidiaries may act as a paying agent or registrar.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Transfer
    and Exchange</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    A Holder may transfer or exchange Notes in accordance with the
    Indenture. The registrar and the Trustee may require a Holder to
    furnish appropriate endorsements and transfer documents in
    connection with a transfer of Notes. Holders will be required to
    pay all taxes due on transfer. The Issuer will not be required
    to transfer or exchange any Note selected for redemption. Also,
    the Issuer will not be required to transfer or exchange any Note
    for a period of 15&#160;days before a selection of Notes to be
    redeemed.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Principal,
    Maturity and Interest</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer issued $1,500,000,000 in aggregate principal amount
    of Notes in this offering. The Notes will mature on
    April&#160;15, 2019. Subject to compliance with the covenant
    described below under the caption &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock,&#148;
    the Issuer may issue additional Notes, from time to time after
    this offering under the Indenture (any such Notes,
    <I>&#147;Additional Notes&#148;</I>). Except as described under
    &#147;Amendment, Supplement and Waiver,&#148; the Notes of the
    Issuer and any Additional Notes subsequently issued under the
    Indenture will be treated as a single class for all purposes
    under the Indenture, including waivers, amendments, redemptions
    and offers to purchase. Unless the context requires otherwise,
    references to &#147;Notes&#148; for all purposes of the
    Indenture and this &#147;Description of Notes&#148; include any
    Additional Notes that are actually issued.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Interest on the Notes will accrue at the rate of
    8<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">2</FONT>%
    per annum and is payable semi-annually in arrears on April 15
    and October 15 commencing October&#160;15, 2009, to the Holders
    of record on the immediately preceding April 1 and
    October&#160;1. Interest on the Notes will accrue from the most
    recent date to which interest has been paid or, if no interest
    has been paid, from and including the Issue Date. Interest on
    the Notes is computed on the basis of a
    <FONT style="white-space: nowrap">360-day</FONT> year
    comprised of twelve
    <FONT style="white-space: nowrap">30-day</FONT>
    months.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Additional
    Interest</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Additional Interest may accrue on the Notes in certain
    circumstances pursuant to the Registration Rights Agreement. All
    references in the Indenture, in any context, to any interest or
    other amount payable on or with respect to the Notes shall be
    deemed to include any Additional Interest pursuant to the
    Registration Rights Agreement. Principal of, premium, if any,
    and interest on the Notes is payable at the office or agency of
    the Issuer maintained for such purpose within the City and State
    of New York or, at the option of the Issuer, payment of interest
    may be made by check mailed to the Holders of the Notes at their
    respective addresses set forth in the register of Holders;
    <I>provided </I>that all payments of principal, premium, if any,
    and interest with respect to the Notes represented by one or
    more global notes registered in the name of or held by DTC or
    its nominee will be made by wire transfer of immediately
    available funds to the accounts specified by the Holder or
    Holders thereof. Until otherwise designated by the Issuer, the
    Issuer&#146;s office or agency in New York will be the office of
    the Registrar and Paying Agent maintained for such purpose.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    200
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Mandatory
    Redemption; Offers to Purchase; Open Market Purchases</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not be required to make any mandatory redemption
    or sinking fund payments with respect to the Notes. However,
    under certain circumstances, the Issuer may be required to offer
    to purchase Notes as described under the caption
    &#147;Repurchase at the Option of Holders.&#148; The Issuer may
    at any time and from time to time purchase Notes in the open
    market or otherwise.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Optional
    Redemption</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Except as set forth below, the Issuer is not entitled to redeem
    Notes at its option prior to April&#160;15, 2014.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    At any time prior to April&#160;15, 2014, the Issuer may redeem
    all or a part of the Notes, upon not less than 30 nor more than
    60&#160;days&#146; prior notice mailed by first-class mail to
    the registered address of each Holder or otherwise in accordance
    with the procedures of DTC, at a redemption price equal to 100%
    of the principal amount of the Notes redeemed plus the
    Applicable Premium as of, and accrued and unpaid interest and
    Additional Interest, if any, to the date of redemption (the
    <I>&#147;Redemption&#160;Date&#148;</I>), subject to the rights
    of Holders of the Notes on the relevant record date to receive
    interest due on the relevant interest payment date.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On and after April&#160;15, 2014 the Issuer may redeem the
    Notes, in whole or in part, upon not less than 30 nor more than
    60&#160;days&#146; prior notice mailed by first-class mail to
    the registered address of each Holder or otherwise in accordance
    with the procedures of DTC, at the redemption prices (expressed
    as percentages of principal amount of the Notes to be redeemed)
    set forth below, plus accrued and unpaid interest thereon and
    Additional Interest, if any, to the applicable
    Redemption&#160;Date, subject to the right of Holders of record
    on the relevant record date to receive interest due on the
    relevant interest payment date, if redeemed during the
    twelve-month period beginning on April 15 of each of the years
    indicated below:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="90%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="6%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="left" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Year</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="2" nowrap align="center" valign="bottom" style="border-bottom: 1px solid #000000">
    <B>Percentage</B>
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    2014
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    104.250
</TD>
<TD nowrap align="left" valign="bottom">
    %
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    2015
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    102.833
</TD>
<TD nowrap align="left" valign="bottom">
    %
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    2016
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    101.417
</TD>
<TD nowrap align="left" valign="bottom">
    %
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    2017 and thereafter
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    100.000
</TD>
<TD nowrap align="left" valign="bottom">
    %
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, until April&#160;15, 2012, the Issuer may, at its
    option, on one or more occasions redeem up to 35% of the
    aggregate principal amount of Notes at a redemption price equal
    to 108.500% of the aggregate principal amount thereof, plus
    accrued and unpaid interest thereon and Additional Interest, if
    any, to the applicable Redemption&#160;Date, subject to the
    right of Holders of record on the relevant record date to
    receive interest due on the relevant interest payment date, with
    the net cash proceeds of one or more Equity Offerings;
    <I>provided </I>that at least 50% of the sum of the original
    aggregate principal amount of Notes issued under the Indenture
    and the original principal amount of any Additional Notes that
    are Notes issued under the Indenture after the Issue Date
    remains outstanding immediately after the occurrence of each
    such redemption; <I>provided further </I>that each such
    redemption occurs within 90&#160;days of the date of closing of
    each such Equity Offering.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any notice of any redemption may be given prior to the
    redemption thereof, and any such redemption or notice may, at
    the Issuer&#146;s discretion, be subject to one or more
    conditions precedent, including, but not limited to, completion
    of an Equity Offering or other corporate transaction.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If the Issuer redeems less than all of the outstanding Notes,
    the Registrar and Paying Agent shall select the Notes to be
    redeemed in the manner described under &#147;Repurchase at the
    Option of Holders&#160;&#151; Selection and Notice.&#148;
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Repurchase
    at the Option of Holders</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Change
    of Control</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Notes provide that if a Change of Control occurs, unless the
    Issuer has previously or concurrently mailed a redemption notice
    with respect to all the outstanding Notes as described under
    &#147;Optional Redemption,&#148; the Issuer will make an offer
    to purchase all of the Notes pursuant to the offer described
    below
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    201
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (the <I>&#147;Change of Control Offer&#148;</I>) at a price in
    cash (the <I>&#147;Change of Control Payment&#148;</I>) equal to
    101% of the aggregate principal amount thereof plus accrued and
    unpaid interest and Additional Interest, if any, to the date of
    purchase, subject to the right of Holders of the Notes of record
    on the relevant record date to receive interest due on the
    relevant interest payment date. Within 30&#160;days following
    any Change of Control, the Issuer will send notice of such
    Change of Control Offer by first-class mail, with a copy to the
    Trustee and the Registrar, to each Holder of Notes to the
    address of such Holder appearing in the security register with a
    copy to the Trustee and the Registrar or otherwise in accordance
    with the procedures of DTC, with the following information:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;that a Change of Control Offer is being made pursuant
    to the covenant entitled &#147;Change of Control&#148; and that
    all Notes properly tendered pursuant to such Change of Control
    Offer will be accepted for payment by the Issuer;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the purchase price and the purchase date, which will be
    no earlier than 30&#160;days nor later than 60&#160;days from
    the date such notice is mailed (the <I>&#147;Change of Control
    Payment Date&#148;</I>);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;that any Note not properly tendered will remain
    outstanding and continue to accrue interest;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;that unless the Issuer defaults in the payment of the
    Change of Control Payment, all Notes accepted for payment
    pursuant to the Change of Control Offer will cease to accrue
    interest on the Change of Control Payment Date;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;that Holders electing to have any Notes purchased
    pursuant to a Change of Control Offer will be required to
    surrender such Notes, with the form entitled &#147;Option of
    Holder to Elect Purchase&#148; on the reverse of such Notes
    completed, to the paying agent specified in the notice at the
    address specified in the notice prior to the close of business
    on the third Business Day preceding the Change of Control
    Payment Date;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;that Holders will be entitled to withdraw their
    tendered Notes and their election to require the Issuer to
    purchase such Notes; <I>provided </I>that the paying agent
    receives, not later than the close of business on the
    30th&#160;day following the date of the Change of Control
    notice, a telegram, facsimile transmission or letter setting
    forth the name of the Holder of the Notes, the principal amount
    of Notes tendered for purchase, and a statement that such Holder
    is withdrawing its tendered Notes and its election to have such
    Notes purchased;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;that if the Issuer is redeeming less than all of the
    Notes, the Holders of the remaining Notes will be issued new
    Notes and such new Notes will be equal in principal amount to
    the unpurchased portion of the Notes surrendered. The
    unpurchased portion of the Notes must be equal to $2,000 or an
    integral multiple of $1,000 in excess thereof;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;the other instructions, as determined by us, consistent
    with the covenant described hereunder, that a Holder must follow.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will comply with the requirements of
    <FONT style="white-space: nowrap">Rule&#160;14e-1</FONT>
    under the Exchange Act and any other securities laws and
    regulations thereunder to the extent such laws or regulations
    are applicable in connection with the repurchase of Notes
    pursuant to a Change of Control Offer. To the extent that the
    provisions of any securities laws or regulations conflict with
    the provisions of the Indenture, the Issuer will comply with the
    applicable securities laws and regulations and shall not be
    deemed to have breached its obligations described in the
    Indenture by virtue thereof.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On the Change of Control Payment Date, the Issuer will, to the
    extent permitted by law,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;accept for payment all Notes issued by it or portions
    thereof properly tendered pursuant to the Change of Control
    Offer;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;deposit with the paying agent an amount equal to the
    aggregate Change of Control Payment in respect of all Notes or
    portions thereof so tendered;&#160;and
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    202
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;deliver, or cause to be delivered, to the Trustee for
    cancellation the Notes so accepted together with an
    Officer&#146;s Certificate to the Trustee stating that such
    Notes or portions thereof have been tendered to and purchased by
    the Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Senior Credit Facilities provide, and future credit
    agreements or other agreements relating to Senior Indebtedness
    to which the Issuer becomes a party may provide, that certain
    change of control events with respect to the Issuer would
    constitute a default thereunder (including a Change of Control
    under the Indenture). If we experience a change of control that
    triggers a default under our Senior Credit Facilities, we could
    seek a waiver of such default or seek to refinance our Senior
    Credit Facilities. In the event we do not obtain such a waiver
    or refinance the Senior Credit Facilities, such default could
    result in amounts outstanding under our Senior Credit Facilities
    being declared due and payable and could cause a Receivables
    Facility to be wound down.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Our ability to pay cash to the Holders of the Notes following
    the occurrence of a Change of Control may be limited by our
    then-existing financial resources. Therefore, sufficient funds
    may not be available when necessary to make any required
    repurchases.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Change of Control purchase feature of the Notes may in
    certain circumstances make more difficult or discourage a sale
    or takeover of us and, thus, the removal of incumbent
    management. The Change of Control purchase feature is a result
    of negotiations between the Initial Purchasers and us. After the
    Issue Date, we have no present intention to engage in a
    transaction involving a Change of Control, although it is
    possible that we could decide to do so in the future. Subject to
    the limitations discussed below, we could, in the future, enter
    into certain transactions, including acquisitions, refinancings
    or other recapitalizations, that would not constitute a Change
    of Control under the Indenture, but that could increase the
    amount of indebtedness outstanding at such time or otherwise
    affect our capital structure or credit ratings. Restrictions on
    our ability to incur additional Indebtedness are contained in
    the covenants described under &#147;Certain Covenants
    &#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock&#148; and
    &#147;Certain Covenants&#160;&#151; Liens.&#148; Such
    restrictions in the Indenture can be waived only with the
    consent of the Holders of a majority in principal amount of the
    Notes then outstanding. Except for the limitations contained in
    such covenants, however, the Indenture will not contain any
    covenants or provisions that may afford Holders of the Notes
    protection in the event of a highly leveraged transaction.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer is not required to make a Change of Control Offer
    following a Change of Control if a third party makes the Change
    of Control Offer in the manner, at the times and otherwise in
    compliance with the requirements set forth in the Indenture
    applicable to a Change of Control Offer made by us and purchases
    all Notes validly tendered and not withdrawn under such Change
    of Control Offer. Notwithstanding anything to the contrary
    herein, a Change of Control Offer may be made in advance of a
    Change of Control, conditional upon such Change of Control, if a
    definitive agreement is in place for the Change of Control at
    the time of making of the Change of Control Offer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The definition of &#147;Change of Control&#148; includes a
    disposition of all or substantially all of the assets of the
    Issuer to any Person. Although there is a limited body of case
    law interpreting the phrase &#147;substantially all,&#148; there
    is no precise established definition of the phrase under
    applicable law. Accordingly, in certain circumstances there may
    be a degree of uncertainty as to whether a particular
    transaction would involve a disposition of &#147;all or
    substantially all&#148; of the assets of the Issuer. As a
    result, it may be unclear as to whether a Change of Control has
    occurred and whether a Holder of Notes may require the Issuer to
    make an offer to repurchase the Notes as described above.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The provisions under the Indenture relating to the Issuer&#146;s
    obligation to make an offer to repurchase the Notes as a result
    of a Change of Control may be waived or modified with the
    written consent of the Holders of a majority in principal amount
    of the Notes.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    203
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Asset
    Sales</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that the Issuer will not, and will not
    permit any of its Restricted Subsidiaries to consummate,
    directly or indirectly, an Asset Sale, unless:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the Issuer or such Restricted Subsidiary, as the case
    may be, receives consideration at the time of such Asset Sale at
    least equal to the fair market value (as determined in good
    faith by the Issuer) of the assets sold or otherwise disposed
    of;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;except in the case of a Permitted Asset Swap, at least
    75% of the consideration therefor received by the Issuer or such
    Restricted Subsidiary, as the case may be, is in the form of
    cash or Cash Equivalents; provided that the amount of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;any liabilities (as shown on the Issuer&#146;s or such
    Restricted Subsidiary&#146;s most recent balance sheet or in the
    footnotes thereto) of the Issuer or such Restricted Subsidiary,
    other than liabilities that are by their terms subordinated to
    the Notes, that are assumed by the transferee of any such assets
    and for which the Issuer and all of its Restricted Subsidiaries
    have been validly released by all creditors in writing,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;any securities received by the Issuer or such
    Restricted Subsidiary from such transferee that are converted by
    the Issuer or such Restricted Subsidiary into cash (to the
    extent of the cash received) within 180&#160;days following the
    closing of such Asset Sale,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;any Designated Non-cash Consideration received by the
    Issuer or such Restricted Subsidiary in such Asset Sale having
    an aggregate fair market value, taken together with all other
    Designated Non-cash Consideration received pursuant to this
    clause&#160;(c) that is at that time outstanding, not to exceed
    5% of Total Assets at the time of the receipt of such Designated
    Non-cash Consideration, with the fair market value of each item
    of Designated Non-cash Consideration being measured at the time
    received and without giving effect to subsequent changes in
    value,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    shall be deemed to be cash for purposes of this provision and
    for no other purpose.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Within 450&#160;days after the receipt of any Net Proceeds of
    any Asset Sale, the Issuer or such Restricted Subsidiary, at its
    option, may apply the Net Proceeds from such Asset Sale,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;to permanently reduce:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;Obligations constituting First Lien Obligations (and,
    if the Indebtedness repaid is revolving credit Indebtedness, to
    correspondingly reduce commitments with respect thereto)
    (<I>provided </I>that (x)&#160;to the extent that the terms of
    First Lien Obligations other than Obligations under the Notes
    require that such First Lien Obligations are repaid with the Net
    Proceeds of Asset Sales prior to repayment of other
    Indebtedness, the Issuer and its Restricted Subsidiaries shall
    be entitled to repay such other First Lien Obligations prior to
    repaying the Obligations under the Notes and (y)&#160;subject to
    the foregoing clause (x), if the Issuer or any Guarantor shall
    so reduce First Lien Obligations, the Issuer will equally and
    ratably reduce Obligations under the Notes through open-market
    purchases (<I>provided </I>that such purchases are at or above
    100% of the principal amount thereof) or by making an offer (in
    accordance with the procedures set forth below for an Asset Sale
    Offer) to all holders to purchase at a purchase price equal to
    100% of the principal amount thereof, plus accrued and unpaid
    interest and additional interest, if any, on the pro rata
    principal amount of Notes);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;Obligations under the Existing Notes which have a final
    maturity date (as in effect on the Issue Date) on or prior to
    the maturity date of the Notes; <I>provided </I>that, at the
    time of, and after giving effect to, such repurchase, redemption
    or defeasance, the aggregate amount of Net Proceeds used to
    repurchase, redeem or defease Existing Notes pursuant to this
    subclause&#160;(b) following the Issue Date shall not exceed 5%
    of the consolidated total assets of the Issuer and is
    subsidiaries at such time;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;Indebtedness of a Restricted Subsidiary that is not a
    Guarantor, other than Indebtedness owed to the Issuer or another
    Restricted Subsidiary (or any affiliate thereof);
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    204
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;to make (a)&#160;an Investment in any one or more
    businesses, <I>provided </I>that such Investment in any business
    is in the form of the acquisition of Capital Stock and results
    in the Issuer or another of its Restricted Subsidiaries, as the
    case may be, owning an amount of the Capital Stock of such
    business such that it constitutes a Restricted Subsidiary,
    (b)&#160;capital expenditures or (c)&#160;acquisitions of other
    assets, in each of (a), (b)&#160;and (c), used or useful in a
    Similar Business;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;to make an investment in (a)&#160;any one or more
    businesses, <I>provided </I>that such Investment in any business
    is in the form of the acquisition of Capital Stock and results
    in the Issuer or another of its Restricted Subsidiaries, as the
    case may be, owning an amount of the Capital Stock of such
    business such that it constitutes a Restricted Subsidiary,
    (b)&#160;properties or (c)&#160;acquisitions of other assets
    that, in each of (a), (b)&#160;and (c), replace the businesses,
    properties
    <FONT style="white-space: nowrap">and/or</FONT>
    assets that are the subject of such Asset Sale;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided </I>that, in the case of clauses&#160;(2) and
    (3)&#160;above, a binding commitment shall be treated as a
    permitted application of the Net Proceeds from the date of such
    commitment so long as the Issuer, or such other Restricted
    Subsidiary enters into such commitment with the good faith
    expectation that such Net Proceeds will be applied to satisfy
    such commitment within 180&#160;days of such commitment (an
    <I>&#147;Acceptable Commitment&#148;</I>) and, in the event any
    Acceptable Commitment is later cancelled or terminated for any
    reason before the Net Proceeds are applied in connection
    therewith, the Issuer or such Restricted Subsidiary enters into
    another Acceptable Commitment (a <I>&#147;Second
    Commitment&#148;</I>) within 180&#160;days of such cancellation
    or termination; <I>provided</I>, <I>further</I>, that if any
    Second Commitment is later cancelled or terminated for any
    reason before such Net Proceeds are applied, then such Net
    Proceeds shall constitute Excess Proceeds.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any Net Proceeds from Asset Sales of Collateral that are not
    invested or applied as set forth in the first sentence of the
    preceding paragraph will be deemed to constitute
    <I>&#147;Collateral Excess Proceeds.&#148;</I> When the
    aggregate amount of Collateral Excess Proceeds exceeds
    $200.0&#160;million, the Issuer shall make an offer to all
    Holders of the Notes and, if required by the terms of any First
    Lien Obligations or Obligations secured by a Lien permitted
    under the Indenture (which Lien is not subordinate to the Lien
    of the Notes with respect to the Collateral), to the holders of
    such First Lien Obligations or such other Obligations (a
    <I>&#147;Collateral Asset Sale Offer&#148;</I>), to purchase the
    maximum aggregate principal amount of the Notes and such First
    Lien Obligations or such other Obligations that is a minimum of
    $2,000 or an integral multiple of $1,000 in excess thereof that
    may be purchased out of the Collateral Excess Proceeds at an
    offer price in cash in an amount equal to 100% of the principal
    amount thereof, plus accrued and unpaid interest and Additional
    Interest, if any, to the date fixed for the closing of such
    offer, in accordance with the procedures set forth in the
    Indenture. The Issuer will commence a Collateral Asset Sale
    Offer with respect to Collateral Excess Proceeds within ten
    Business Days after the date that Collateral Excess Proceeds
    exceed $200.0&#160;million by mailing the notice required
    pursuant to the terms of the Indenture, with a copy to the
    Trustee.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any Net Proceeds from Asset Sales of non-Collateral that are not
    invested or applied as provided and within the time period set
    forth in the first sentence of the second preceding paragraph
    will be deemed to constitute <I>&#147;Excess Proceeds.&#148;</I>
    When the aggregate amount of Excess Proceeds exceeds
    $200.0&#160;million, the Issuer shall make an offer to all
    Holders of the Notes and, if required or permitted by the terms
    of any Senior Indebtedness, to the holders of such Senior
    Indebtedness (an <I>&#147;Asset Sale Offer&#148;</I>), to
    purchase the maximum aggregate principal amount of the Notes and
    such Senior Indebtedness that is a minimum of $2,000 or an
    integral multiple of $1,000 in excess thereof that may be
    purchased out of the Excess Proceeds at an offer price in cash
    in an amount equal to 100% of the principal amount thereof, plus
    accrued and unpaid interest and Additional Interest, if any, to
    the date fixed for the closing of such offer, in accordance with
    the procedures set forth in the Indenture. The Issuer will
    commence an Asset Sale Offer with respect to Excess Proceeds
    within ten Business Days after the date that Excess Proceeds
    exceed $200.0&#160;million by mailing the notice required
    pursuant to the terms of the Indenture, with a copy to the
    Trustee.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    To the extent that the aggregate amount of Notes and such other
    First Lien Obligations or Obligations secured by a Lien
    permitted by the Indenture (which Lien is not subordinate to the
    Lien of the Notes with respect to the Collateral) tendered
    pursuant to a Collateral Asset Sale Offer is less than the
    Collateral Excess Proceeds, the Issuer may use any remaining
    Collateral Excess Proceeds for general corporate purposes,
    subject to other covenants contained in the Indenture. To the
    extent that the aggregate amount of Notes and such
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    205
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Senior Indebtedness tendered pursuant to an Asset Sale Offer is
    less than the Excess Proceeds, the Issuer may use any remaining
    Excess Proceeds for general corporate purposes, subject to other
    covenants contained in the Indenture. If the aggregate principal
    amount of Notes or other First Lien Obligations or such other
    Obligations surrendered by such holders thereof exceeds the
    amount of Collateral Excess Proceeds, the Trustee shall select
    the Notes and such other First Lien Obligations or such other
    Obligations to be purchased on a pro rata basis based on the
    accreted value or principal amount of the Notes or such other
    First Lien Obligations or such other Obligations tendered. If
    the aggregate principal amount of Notes or the Senior
    Indebtedness surrendered by such holders thereof exceeds the
    amount of Excess Proceeds, the Trustee shall select the Notes
    and such Senior Indebtedness to be purchased on a pro rata basis
    based on the accreted value or principal amount of the Notes or
    such Senior Indebtedness tendered. Upon completion of any such
    Collateral Asset Sale Offer or Asset Sale Offer, the amount of
    Collateral Excess Proceeds or Excess Proceeds, as the case may
    be, shall be reset at zero. Additionally, the Issuer may, at its
    option, make a Collateral Asset Sale Offer or an Asset Sale
    Offer using proceeds from any Asset Sale at any time after
    consummation of such Asset Sale; <I>provided </I>that such
    Collateral Asset Sale Offer or Asset Sale Offer shall be in an
    aggregate amount of not less than $50.0&#160;million. Upon
    consummation of such Collateral Asset Sale Offer or Asset Sale
    Offer, any Net Proceeds not required to be used to purchase
    Notes shall not be deemed Excess Proceeds.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pending the final application of any Net Proceeds pursuant to
    this covenant, the holder of such Net Proceeds may apply such
    Net Proceeds temporarily to reduce Indebtedness outstanding
    under a revolving credit facility or otherwise invest such Net
    Proceeds in any manner not prohibited by the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will comply with the requirements of
    <FONT style="white-space: nowrap">Rule&#160;14e-1</FONT>
    under the Exchange Act and any other securities laws and
    regulations thereunder to the extent such laws or regulations
    are applicable in connection with the repurchase of the Notes
    pursuant to a Collateral Asset Sale Offer or an Asset Sale
    Offer. To the extent that the provisions of any securities laws
    or regulations conflict with the provisions of the Indenture,
    the Issuer will comply with the applicable securities laws and
    regulations and shall not be deemed to have breached its
    obligations described in the Indenture by virtue thereof.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Selection
    and Notice</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If the Issuer is redeeming less than all of the Notes issued by
    it at any time, the Registrar and Paying Agent will select the
    Notes to be redeemed (a)&#160;if the Notes are listed on any
    national securities exchange, in compliance with the
    requirements of the principal national securities exchange on
    which the Notes are listed, (b)&#160;on a pro rata basis to the
    extent practicable or (c)&#160;by lot or such other similar
    method in accordance with the procedures of DTC.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notices of purchase or redemption shall be mailed by first-class
    mail, postage prepaid, at least 30 but not more than
    60&#160;days before the purchase or Redemption&#160;Date to each
    Holder of Notes at such Holder&#146;s registered address or
    otherwise in accordance with the procedures of DTC, except that
    redemption notices may be mailed more than 60&#160;days prior to
    a Redemption&#160;Date if the notice is issued in connection
    with a defeasance of the Notes or a satisfaction and discharge
    of the Indenture. If any Note is to be purchased or redeemed in
    part only, any notice of purchase or redemption that relates to
    such Note shall state the portion of the principal amount
    thereof that has been or is to be purchased or redeemed.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will issue a new Note in a principal amount equal to
    the unredeemed portion of the original Note in the name of the
    Holder upon cancellation of the original Note. Notes called for
    redemption become due on the date fixed for redemption. On and
    after the Redemption&#160;Date, interest ceases to accrue on
    Notes or portions thereof called for redemption.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Certain
    Covenants</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Set forth below are summaries of certain covenants contained in
    the Indenture. If on any date following the Issue Date
    (i)&#160;the Notes have Investment Grade Ratings from both
    Rating Agencies, and (ii)&#160;no Default has occurred and is
    continuing under the Indenture (the occurrence of the events
    described in the foregoing clauses&#160;(i) and (ii)&#160;being
    collectively referred to as a <I>&#147;Covenant Suspension
    Event&#148;</I>), the Issuer and the
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    206
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Restricted Subsidiaries will not be subject to the following
    covenants (collectively, the <I>&#147;Suspended
    Covenants&#148;</I>):
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;&#147;Repurchase at the Option of Holders&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;&#147;&#151;&#160;Limitation on Restricted
    Payments&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;&#147;&#151;&#160;Limitation on Incurrence of
    Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;clause&#160;(4) of the first paragraph of
    &#147;&#151;&#160;Merger, Consolidation or Sale of All or
    Substantially All Assets&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;&#147;&#151; Transactions with
    Affiliates&#148;;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;&#147;&#151; Dividend and Other Payment Restrictions
    Affecting Restricted Subsidiaries.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In the event that the Issuer and the Restricted Subsidiaries are
    not subject to the Suspended Covenants under the Indenture for
    any period of time as a result of the foregoing, and on any
    subsequent date (the <I>&#147;Reversion Date&#148;</I>) one or
    both of the Rating Agencies (a)&#160;withdraw their Investment
    Grade Rating or downgrade the rating assigned to the Notes below
    an Investment Grade Rating
    <FONT style="white-space: nowrap">and/or</FONT>
    (b)&#160;the Issuer or any of its Affiliates enters into an
    agreement to effect a transaction that would result in a Change
    of Control and one or more of the Rating Agencies indicate that
    if consummated, such transaction (alone or together with any
    related recapitalization or refinancing transactions) would
    cause such Rating Agency to withdraw its Investment Grade Rating
    or downgrade the ratings assigned to the Notes below an
    Investment Grade Rating, then the Issuer and the Restricted
    Subsidiaries will thereafter again be subject to the Suspended
    Covenants under the Indenture with respect to future events,
    including, without limitation, a proposed transaction described
    in clause&#160;(b) above.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The period of time between the Suspension Date and the Reversion
    Date is referred to in this description as the
    <I>&#147;Suspension Period.&#148;</I> Additionally, upon the
    occurrence of a Covenant Suspension Event, the amount of Excess
    Proceeds from Net Proceeds shall be reset at zero. In the event
    of any such reinstatement, no action taken or omitted to be
    taken by the Issuer or any of its Restricted Subsidiaries prior
    to such reinstatement will give rise to a Default or Event of
    Default under the Indentures with respect to Notes; <I>provided
    </I>that (1)&#160;with respect to Restricted Payments made after
    any such reinstatement, the amount of Restricted Payments made
    will be calculated as though the covenant described under the
    caption &#147;&#151;&#160;Limitation on Restricted
    Payments&#148; had been in effect prior to, but not during the
    Suspension Period, <I>provided </I>that any Subsidiaries
    designated as Unrestricted Subsidiaries during the Suspension
    Period shall automatically become Restricted Subsidiaries on the
    Reversion Date (subject to the Issuer&#146;s right to
    subsequently designate them as Unrestricted Subsidiaries in
    compliance with the covenants set out below), and (2)&#160;all
    Indebtedness incurred, or Disqualified Stock or Preferred Stock
    issued, during the Suspension Period will be classified to have
    been incurred or issued pursuant to clause&#160;(3) of the
    second paragraph of &#147;&#151;&#160;Limitation on Incurrence
    of Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    There can be no assurance that the Notes will ever achieve or
    maintain Investment Grade Ratings.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Limitation
    on Restricted Payments</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, directly or indirectly:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (I)&#160;declare or pay any dividend or make any payment or
    distribution on account of the Issuer&#146;s, or any of its
    Restricted Subsidiaries&#146; Equity Interests, including any
    dividend or distribution payable in connection with any merger
    or consolidation other than:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;dividends or distributions by the Issuer payable solely
    in Equity Interests (other than Disqualified Stock) of the
    Issuer;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;dividends or distributions by a Restricted Subsidiary
    so long as, in the case of any dividend or distribution payable
    on or in respect of any class or series of securities issued by
    a Restricted
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    207
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Subsidiary other than a Wholly-Owned Subsidiary, the Issuer or a
    Restricted Subsidiary receives at least its pro rata share of
    such dividend or distribution in accordance with its Equity
    Interests in such class or series of securities;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (II)&#160;purchase, redeem, defease or otherwise acquire or
    retire for value any Equity Interests of the Issuer or any
    direct or indirect parent of the Issuer, including in connection
    with any merger or consolidation;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (III)&#160;make any principal payment on, or redeem, repurchase,
    defease or otherwise acquire or retire for value in each case,
    prior to any scheduled repayment, sinking fund payment or
    maturity, any Subordinated Indebtedness, other than:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;Indebtedness permitted under clauses&#160;(7) and
    (8)&#160;of the covenant described under
    &#147;&#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock&#148;;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the purchase, repurchase or other acquisition of
    Subordinated Indebtedness purchased in anticipation of
    satisfying a sinking fund obligation, principal installment or
    final maturity, in each case due within one year of the date of
    purchase, repurchase or acquisition;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (IV)&#160;make any Restricted Investment
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (all such payments and other actions set forth in
    clauses&#160;(I) through (IV)&#160;above (other than any
    exception thereto) being collectively referred to as
    <I>&#147;Restricted Payments&#148;</I>), unless, at the time of
    such Restricted Payment:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;no Default shall have occurred and be continuing or
    would occur as a consequence thereof;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;immediately after giving effect to such transaction on
    a pro forma basis, the Issuer could incur $1.00 of additional
    Indebtedness under the provisions of the first paragraph of the
    covenant described under &#147;&#151;&#160;Limitation on
    Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock&#148;;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;such Restricted Payment, together with the aggregate
    amount of all other Restricted Payments made by the Issuer and
    its Restricted Subsidiaries after November&#160;17, 2006
    (including Restricted Payments permitted by clauses (1), (2)
    (with respect to the payment of dividends on Refunding Capital
    Stock (as defined below) pursuant to clause&#160;(b) thereof
    only), (6)(c), (9)&#160;and (14)&#160;of the next succeeding
    paragraph, but excluding all other Restricted Payments permitted
    by the next succeeding paragraph), is less than the sum of
    (without duplication):
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;50% of the Consolidated Net Income of the Issuer for
    the period (taken as one accounting period) beginning
    October&#160;1, 2006, to the end of the Issuer&#146;s most
    recently ended fiscal quarter for which internal financial
    statements are available at the time of such Restricted Payment,
    or, in the case such Consolidated Net Income for such period is
    a deficit, minus 100% of such deficit; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;100% of the aggregate net cash proceeds and the fair
    market value, as determined in good faith by the Issuer, of
    marketable securities or other property received by the Issuer
    since immediately after November&#160;17, 2006 (other than net
    cash proceeds to the extent such net cash proceeds have been
    used to incur Indebtedness, Disqualified Stock or Preferred
    Stock pursuant to clause (12)(a) of the second paragraph of
    &#147;&#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock&#148;) from
    the issue or sale of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (i)&#160;(A)&#160;Equity Interests of the Issuer, including
    Treasury Capital Stock (as defined below), but excluding cash
    proceeds and the fair market value, as determined in good faith
    by the Issuer, of marketable securities or other property
    received from the sale of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 17%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (x)&#160;Equity Interests to members of management, directors or
    consultants of the Issuer, any direct or indirect parent company
    of the Issuer and the Issuer&#146;s Subsidiaries after
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    208
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 17%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    November&#160;17, 2006 to the extent such amounts have been
    applied to Restricted Payments made in accordance with
    clause&#160;(4) of the next succeeding paragraph;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 17%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (y)&#160;Designated Preferred Stock;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (B)&#160;to the extent such net cash proceeds are actually
    contributed to the Issuer, Equity Interests of the Issuer&#146;s
    direct or indirect parent companies (excluding contributions of
    the proceeds from the sale of Designated Preferred Stock of such
    companies or contributions to the extent such amounts have been
    applied to Restricted Payments made in accordance with
    clause&#160;(4) of the next succeeding paragraph);&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (ii)&#160;debt securities of the Issuer that have been converted
    into or exchanged for such Equity Interests of the Issuer;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided</I>, <I>however</I>, that this clause&#160;(b) shall
    not include the proceeds from (V)&#160;Refunding Capital Stock
    (as defined below), (W)&#160;Equity Interests or convertible
    debt securities of the Issuer sold to a Restricted Subsidiary,
    as the case may be, (X)&#160;Disqualified Stock or debt
    securities that have been converted into Disqualified Stock,
    (Y)&#160;Excluded Contributions or (Z)&#160;the Delayed Equity
    Amount; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;100% of the aggregate amount of cash and the fair
    market value, as determined in good faith by the Issuer, of
    marketable securities or other property contributed to the
    capital of the Issuer following November&#160;17, 2006 (other
    than net cash proceeds to the extent such net cash proceeds
    (i)&#160;have been used to incur Indebtedness, Disqualified
    Stock or Preferred Stock pursuant to clause (12)(a) of the
    second paragraph of &#147;&#151;&#160;Limitation on Incurrence
    of Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock,&#148; (ii)&#160;are contributed by a Restricted
    Subsidiary, (iii)&#160;constitute Excluded Contributions or
    (iv)&#160;constitute the Delayed Equity Amount); <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;100% of the aggregate amount received in cash and the
    fair market value, as determined in good faith by the Issuer, of
    marketable securities or other property received by means of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (i)&#160;the sale or other disposition (other than to the Issuer
    or a Restricted Subsidiary) of Restricted Investments made by
    the Issuer or its Restricted Subsidiaries and repurchases and
    redemptions of such Restricted Investments from the Issuer or
    its Restricted Subsidiaries and repayments of loans or advances,
    and releases of guarantees, which constitute Restricted
    Investments by the Issuer or its Restricted Subsidiaries, in
    each case after November&#160;17, 2006;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (ii)&#160;the sale (other than to the Issuer or a Restricted
    Subsidiary) of the stock of an Unrestricted Subsidiary or a
    distribution from an Unrestricted Subsidiary (other than in each
    case to the extent the Investment in such Unrestricted
    Subsidiary was made by the Issuer or a Restricted Subsidiary
    pursuant to clause&#160;(7) of the next succeeding paragraph or
    to the extent such Investment constituted a Permitted
    Investment) or a dividend from an Unrestricted Subsidiary after
    November&#160;17, 2006; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;in the case of the redesignation of an Unrestricted
    Subsidiary as a Restricted Subsidiary after November&#160;17,
    2006, the fair market value of the Investment in such
    Unrestricted Subsidiary, as determined by the Issuer in good
    faith (or if such fair market value exceeds $250.0&#160;million,
    in writing by an Independent Financial Advisor), at the time of
    the redesignation of such Unrestricted Subsidiary as a
    Restricted Subsidiary other than to the extent the Investment in
    such Unrestricted Subsidiary was made by the Issuer or a
    Restricted Subsidiary pursuant to clause&#160;(7) of the next
    succeeding paragraph or to the extent such Investment
    constituted a Permitted Investment.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The foregoing provisions will not prohibit:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the payment of any dividend within 60&#160;days after
    the date of declaration thereof, if at the date of declaration
    such payment would have complied with the provisions of the
    Indenture;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    209
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;(a)&#160;the redemption, repurchase, retirement or
    other acquisition of any Equity Interests <I>(&#147;Treasury
    Capital Stock&#148;) </I>or Subordinated Indebtedness of the
    Issuer or any Equity Interests of any direct or indirect parent
    company of the Issuer, in exchange for, or out of the proceeds
    of the substantially concurrent sale (other than to a Restricted
    Subsidiary) of, Equity Interests of the Issuer or any direct or
    indirect parent company of the Issuer to the extent contributed
    to the Issuer (in each case, other than any Disqualified Stock)
    <I>(&#147;Refunding Capital Stock&#148;) </I>and (b)&#160;if
    immediately prior to the retirement of Treasury Capital Stock,
    the declaration and payment of dividends thereon was permitted
    under clause&#160;(6) of this paragraph, the declaration and
    payment of dividends on the Refunding Capital Stock (other than
    Refunding Capital Stock the proceeds of which were used to
    redeem, repurchase, retire or otherwise acquire any Equity
    Interests of any direct or indirect parent company of the
    Issuer) in an aggregate amount per year no greater than the
    aggregate amount of dividends per annum that were declarable and
    payable on such Treasury Capital Stock immediately prior to such
    retirement;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;the redemption, repurchase or other acquisition or
    retirement of Subordinated Indebtedness of the Issuer or a
    Guarantor made in exchange for, or out of the proceeds of the
    substantially concurrent sale of, new Indebtedness of the Issuer
    or a Guarantor, as the case may be, which is incurred in
    compliance with &#147;&#151;&#160;Limitation on Incurrence of
    Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock&#148; so long as:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;the principal amount (or accreted value) of such new
    Indebtedness does not exceed the principal amount of (or
    accreted value, if applicable), plus any accrued and unpaid
    interest on, the Subordinated Indebtedness being so redeemed,
    repurchased, acquired or retired for value, plus the amount of
    any reasonable premium (including reasonable tender premiums),
    defeasance costs and any reasonable fees and expenses incurred
    in connection with the issuance of such new Indebtedness;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;such new Indebtedness is subordinated to the Notes or
    the applicable Guarantee at least to the same extent as such
    Subordinated Indebtedness so purchased, exchanged, redeemed,
    repurchased, acquired or retired for value;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;such new Indebtedness has a final scheduled maturity
    date equal to or later than the final scheduled maturity date of
    the Subordinated Indebtedness being so redeemed, repurchased,
    acquired or retired;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;such new Indebtedness has a Weighted Average Life to
    Maturity equal to or greater than the remaining Weighted Average
    Life to Maturity of the Subordinated Indebtedness being so
    redeemed, repurchased, acquired or retired;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;a Restricted Payment to pay for the repurchase,
    retirement or other acquisition or retirement for value of
    Equity Interests (other than Disqualified Stock) of the Issuer
    or any of its direct or indirect parent companies held by any
    future, present or former employee, director or consultant of
    the Issuer, any of its Subsidiaries or any of its direct or
    indirect parent companies pursuant to any management equity plan
    or stock option plan or any other management or employee benefit
    plan or agreement, including any Equity Interests rolled over by
    management of the Company or any of its direct or indirect
    parent companies in connection with the Transaction;
    <I>provided</I>, <I>however</I>, that the aggregate Restricted
    Payments made under this clause&#160;(4) do not exceed in any
    calendar year $75.0&#160;million (which shall increase to
    $150.0&#160;million subsequent to the consummation of an
    underwritten public Equity Offering by the Issuer or any direct
    or indirect parent entity of the Issuer) (with unused amounts in
    any calendar year being carried over to succeeding calendar
    years subject to a maximum (without giving effect to the
    following proviso) of $225.0&#160;million in any calendar year
    (which shall increase to $450.0&#160;million subsequent to the
    consummation of an underwritten public Equity Offering by the
    Issuer or any direct or indirect parent corporation of the
    Issuer)); <I>provided further </I>that such amount in any
    calendar year may be increased by an amount not to exceed:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;the cash proceeds from the sale of Equity Interests
    (other than Disqualified Stock) of the Issuer and, to the extent
    contributed to the Issuer, Equity Interests of any of the
    Issuer&#146;s direct or
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    210
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    indirect parent companies, in each case to members of
    management, directors or consultants of the Issuer, any of its
    Subsidiaries or any of its direct or indirect parent companies
    that occurs after November&#160;17, 2006, to the extent the cash
    proceeds from the sale of such Equity Interests have not
    otherwise been applied to the payment of Restricted Payments by
    virtue of clause&#160;(3) of the preceding paragraph; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the cash proceeds of key man life insurance policies
    received by the Issuer or its Restricted Subsidiaries after
    November&#160;17, 2006; <I>less</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;the amount of any Restricted Payments previously made
    with the cash proceeds described in clauses&#160;(a) and
    (b)&#160;of this clause (4);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    and <I>provided</I>, <I>further</I>, that cancellation of
    Indebtedness owing to the Issuer or any Restricted Subsidiary
    from members of management of the Issuer, any of the
    Issuer&#146;s direct or indirect parent companies or any of the
    Issuer&#146;s Restricted Subsidiaries in connection with a
    repurchase of Equity Interests of the Issuer or any of its
    direct or indirect parent companies will not be deemed to
    constitute a Restricted Payment for purposes of this covenant or
    any other provision of the Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;the declaration and payment of dividends to holders of
    any class or series of Disqualified Stock of the Issuer or any
    of its Restricted Subsidiaries or any class or series of
    Preferred Stock of any Restricted Subsidiary issued in
    accordance with the covenant described under
    &#147;&#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock&#148; to the
    extent such dividends are included in the definition of
    &#147;Fixed Charges&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;(a)&#160;the declaration and payment of dividends to
    holders of any class or series of Designated Preferred Stock
    (other than Disqualified Stock) issued by the Issuer after
    November&#160;17, 2006;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the declaration and payment of dividends to a direct or
    indirect parent company of the Issuer, the proceeds of which
    will be used to fund the payment of dividends to holders of any
    class or series of Designated Preferred Stock (other than
    Disqualified Stock) of such parent corporation issued after the
    Issue Date; <I>provided </I>that the amount of dividends paid
    pursuant to this clause&#160;(b) shall not exceed the aggregate
    amount of cash actually contributed to the Issuer from the sale
    of such Designated Preferred Stock;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;the declaration and payment of dividends on Refunding
    Capital Stock that is Preferred Stock in excess of the dividends
    declarable and payable thereon pursuant to clause&#160;(2) of
    this paragraph;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided</I>, <I>however</I>, in the case of each of
    (a)&#160;and (c)&#160;of this clause (6), that for the most
    recently ended four full fiscal quarters for which internal
    financial statements are available immediately preceding the
    date of issuance of such Designated Preferred Stock or the
    declaration of such dividends on Refunding Capital Stock that is
    Preferred Stock, after giving effect to such issuance or
    declaration on a pro forma basis, the Issuer and its Restricted
    Subsidiaries on a consolidated basis would have had a Fixed
    Charge Coverage Ratio of at least 2.00 to 1.00;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;Investments in Unrestricted Subsidiaries having an
    aggregate fair market value, taken together with all other
    Investments made pursuant to this clause&#160;(7) that are at
    the time outstanding, without giving effect to the sale of an
    Unrestricted Subsidiary to the extent the proceeds of such sale
    do not consist of cash or marketable securities, not to exceed
    2.5% of Total Assets at the time of such Investment (with the
    fair market value of each Investment being measured at the time
    made and without giving effect to subsequent changes in value);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;repurchases of Equity Interests deemed to occur upon
    exercise of stock options or warrants if such Equity Interests
    represent a portion of the exercise price of such options or
    warrants;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;the declaration and payment of dividends on the
    Issuer&#146;s common stock (or the payment of dividends to any
    direct or indirect parent entity to fund a payment of dividends
    on such entity&#146;s common stock), following consummation of
    the first public offering of the Issuer&#146;s common stock or
    the common
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    211
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    stock of any of its direct or indirect parent companies after
    November&#160;17, 2006, of up to 6% per annum of the net cash
    proceeds received by or contributed to the Issuer in or from any
    such public offering, other than public offerings with respect
    to the Issuer&#146;s common stock registered on
    <FONT style="white-space: nowrap">Form&#160;S-8</FONT>
    and other than any public sale constituting an Excluded
    Contribution;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;Restricted Payments that are made with Excluded
    Contributions;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;other Restricted Payments in an aggregate amount taken
    together with all other Restricted Payments made pursuant to
    this clause&#160;(11) not to exceed 3.0% of Total Assets at the
    time made;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;distributions or payments of Receivables Fees;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;any Restricted Payment used to fund amounts owed to
    Affiliates (including dividends to any direct or indirect parent
    of the Issuer to permit payment by such parent of such amount),
    in each case to the extent permitted by the covenant described
    under &#147;&#151;&#160;Transactions with Affiliates&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (14)&#160;the repurchase, redemption or other acquisition or
    retirement for value of any Subordinated Indebtedness in
    accordance with the provisions similar to those described under
    the captions &#147;Repurchase at the Option of
    Holders&#160;&#151; Change of Control&#148; and &#147;Repurchase
    at the Option of Holders&#160;&#151; Asset Sales&#148;;
    <I>provided </I>that all Notes tendered by Holders in connection
    with a Change of Control Offer, Collateral Asset Sale Offer or
    Asset Sale Offer, as applicable, have been repurchased, redeemed
    or acquired for value;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (15)&#160;the declaration and payment of dividends by the Issuer
    to, or the making of loans to, any direct or indirect parent in
    amounts required for any direct or indirect parent companies to
    pay, in each case without duplication,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;franchise and excise taxes and other fees, taxes and
    expenses required to maintain their corporate existence;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;foreign, federal, state and local income taxes, to the
    extent such income taxes are attributable to the income of the
    Issuer and its Restricted Subsidiaries and, to the extent of the
    amount actually received from its Unrestricted Subsidiaries, in
    amounts required to pay such taxes to the extent attributable to
    the income of such Unrestricted Subsidiaries; <I>provided
    </I>that in each case the amount of such payments in any fiscal
    year does not exceed the amount that the Issuer and its
    Restricted Subsidiaries would be required to pay in respect of
    foreign, federal, state and local taxes for such fiscal year
    were the Issuer, its Restricted Subsidiaries and its
    Unrestricted Subsidiaries (to the extent described above) to pay
    such taxes separately from any such parent entity;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;for as long as Hercules Holding II, LLC is a parent of
    the Issuer, distributions equal to any taxable income of
    Hercules Holding II, LLC resulting from the Hedging Arrangements
    multiplied by 45%;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;customary salary, bonus and other benefits payable to
    officers and employees of any direct or indirect parent company
    of the Issuer to the extent such salaries, bonuses and other
    benefits are attributable to the ownership or operation of the
    Issuer and its Restricted Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;general corporate operating and overhead costs and
    expenses of any direct or indirect parent company of the Issuer
    to the extent such costs and expenses are attributable to the
    ownership or operation of the Issuer and its Restricted
    Subsidiaries;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (f)&#160;fees and expenses other than to Affiliates of the
    Issuer related to any unsuccessful equity or debt offering of
    such parent entity;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (16)&#160;the distribution, by dividend or otherwise, of shares
    of Capital Stock of, or Indebtedness owed to the Issuer or a
    Restricted Subsidiary by, Unrestricted Subsidiaries (other than
    Unrestricted Subsidiaries, the primary assets of which are cash
    <FONT style="white-space: nowrap">and/or</FONT> Cash
    Equivalents);
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    212
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided</I>, <I>however</I>, that at the time of, and after
    giving effect to, any Restricted Payment permitted under
    clauses&#160;(11) and (16), no Default shall have occurred and
    be continuing or would occur as a consequence thereof.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    As of the Issue Date, all of the Issuer&#146;s Subsidiaries are
    Restricted Subsidiaries. The Issuer will not permit any
    Unrestricted Subsidiary to become a Restricted Subsidiary except
    pursuant to the last sentence of the definition of
    &#147;Unrestricted Subsidiary.&#148; For purposes of designating
    any Restricted Subsidiary as an Unrestricted Subsidiary, all
    outstanding Investments by the Issuer and its Restricted
    Subsidiaries (except to the extent repaid) in the Subsidiary so
    designated will be deemed to be Restricted Payments in an amount
    determined as set forth in the last sentence of the definition
    of &#147;Investment.&#148; Such designation will be permitted
    only if a Restricted Payment in such amount would be permitted
    at such time, whether pursuant to the first paragraph of this
    covenant or under clause (7), (10)&#160;or (11)&#160;of the
    second paragraph of this covenant, or pursuant to the definition
    of &#147;Permitted Investments,&#148; and if such Subsidiary
    otherwise meets the definition of an Unrestricted Subsidiary.
    Unrestricted Subsidiaries are not subject to any of the
    restrictive covenants set forth in the Indenture.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, directly or indirectly, create, incur, issue,
    assume, guarantee or otherwise become directly or indirectly
    liable, contingently or otherwise (collectively,
    <I>&#147;incur&#148;</I> and collectively, an
    <I>&#147;incurrence&#148;</I>) with respect to any Indebtedness
    (including Acquired Indebtedness), and the Issuer will not issue
    any shares of Disqualified Stock and will not permit any
    Restricted Subsidiary to issue any shares of Disqualified Stock
    or Preferred Stock; <I>provided</I>, <I>however</I>, that the
    Issuer may incur Indebtedness (including Acquired Indebtedness)
    or issue shares of Disqualified Stock, and any of its Restricted
    Subsidiaries may incur Indebtedness (including Acquired
    Indebtedness), issue shares of Disqualified Stock and issue
    shares of Preferred Stock, if the Fixed Charge Coverage Ratio on
    a consolidated basis for the Issuer and its Restricted
    Subsidiaries&#146; most recently ended four fiscal quarters for
    which internal financial statements are available immediately
    preceding the date on which such additional Indebtedness is
    incurred or such Disqualified Stock or Preferred Stock is issued
    would have been at least 2.00 to 1.00, determined on a pro forma
    basis (including a pro forma application of the net proceeds
    therefrom), as if the additional Indebtedness had been incurred,
    or the Disqualified Stock or Preferred Stock had been issued, as
    the case may be, and the application of proceeds therefrom had
    occurred at the beginning of such four-quarter period;
    <I>provided, further</I>, that Restricted Subsidiaries that are
    not Guarantors may not incur Indebtedness or Disqualified Stock
    or Preferred Stock if, after giving pro forma effect to such
    incurrence or issuance (including a pro forma application of the
    net proceeds therefrom), more than an aggregate of
    $2,000.0&#160;million of Indebtedness or Disqualified Stock or
    Preferred Stock of Restricted Subsidiaries that are not
    Guarantors would be outstanding pursuant to this paragraph and
    clauses (12), (14)&#160;and (19)&#160;below at such time.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The foregoing limitations will not apply to:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the incurrence of Indebtedness under (x)&#160;Credit
    Facilities (other than the ABL Facility) by the Issuer or any of
    its Restricted Subsidiaries and the issuance and creation of
    letters of credit and bankers&#146; acceptances thereunder (with
    letters of credit and bankers&#146; acceptances being deemed to
    have a principal amount equal to the face amount thereof), up to
    an aggregate principal amount of $16,500.0&#160;million
    (including any Indebtedness incurred and represented by the
    Notes (including the Guarantees) or any Additional First Lien
    Obligations by the Issuer or any Guarantor, the proceeds of
    which Notes or Additional First Lien Obligations are used to
    repay such Credit Facilities) outstanding at any one time and
    (y)&#160;the ABL Facility by the Issuer or any of its Restricted
    Subsidiaries and the issuance and creation of letters of credit
    and bankers&#146; acceptances thereunder (with letters of credit
    and bankers&#146; acceptances being deemed to have a principal
    amount equal to the face amount thereof), up to an aggregate
    principal amount equal to the ABL Facility Cap;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;reserved;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    213
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;Indebtedness of the Issuer and its Restricted
    Subsidiaries in existence on the Issue Date (other than
    Indebtedness described in clause (1)), including the Existing
    Second Priority Notes and the Existing Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;Indebtedness consisting of Capitalized Lease
    Obligations and Purchase Money Obligations; so long as such
    Indebtedness exists at the date of such purchase, lease or
    improvement, or is created within 270&#160;days thereafter;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;Indebtedness incurred by the Issuer or any of its
    Restricted Subsidiaries constituting reimbursement obligations
    with respect to letters of credit issued in the ordinary course
    of business, including letters of credit in respect of
    workers&#146; compensation, medical malpractice or employee
    health claims, or other Indebtedness with respect to
    reimbursement-type obligations regarding workers&#146;
    compensation, medical malpractice or employee health claims;
    <I>provided</I>, <I>however</I>, that upon the drawing of such
    letters of credit or the incurrence of such Indebtedness, such
    obligations are reimbursed within 30&#160;days following such
    drawing or incurrence;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;Indebtedness arising from agreements of the Issuer or
    its Restricted Subsidiaries providing for indemnification,
    adjustment of purchase price or similar obligations, in each
    case, incurred or assumed in connection with the disposition of
    any business, assets or a Subsidiary, other than guarantees of
    Indebtedness incurred by any Person acquiring all or any portion
    of such business, assets or a Subsidiary for the purpose of
    financing such acquisition; <I>provided</I>, <I>however</I>,
    that such Indebtedness is not reflected on the balance sheet of
    the Issuer, or any of its Restricted Subsidiaries (contingent
    obligations referred to in a footnote to financial statements
    and not otherwise reflected on the balance sheet will not be
    deemed to be reflected on such balance sheet for purposes of
    this clause (6));
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;Indebtedness of the Issuer to a Restricted Subsidiary;
    <I>provided </I>that any such Indebtedness owing to a Restricted
    Subsidiary that is not a Guarantor is expressly subordinated in
    right of payment to the Notes; <I>provided</I>, <I>further</I>,
    that any subsequent issuance or transfer of any Capital Stock or
    any other event which results in any Restricted Subsidiary
    ceasing to be a Restricted Subsidiary or any other subsequent
    transfer of any such Indebtedness (except to the Issuer or
    another Restricted Subsidiary) shall be deemed, in each case, to
    be an incurrence of such Indebtedness;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;Indebtedness of a Restricted Subsidiary to the Issuer
    or another Restricted Subsidiary; <I>provided </I>that if a
    Guarantor incurs such Indebtedness to a Restricted Subsidiary
    that is not a Guarantor, such Indebtedness is expressly
    subordinated in right of payment to the Guarantee of the Notes
    of such Guarantor; <I>provided</I>, <I>further</I>, that any
    subsequent transfer of any such Indebtedness (except to the
    Issuer or another Restricted Subsidiary) shall be deemed, in
    each case, to be an incurrence of such Indebtedness not
    permitted by this clause (8);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;shares of Preferred Stock of a Restricted Subsidiary
    issued to the Issuer or another Restricted Subsidiary;
    <I>provided </I>that any subsequent issuance or transfer of any
    Capital Stock or any other event which results in any such
    Restricted Subsidiary ceasing to be a Restricted Subsidiary or
    any other subsequent transfer of any such shares of Preferred
    Stock (except to the Issuer or another of its Restricted
    Subsidiaries) shall be deemed in each case to be an issuance of
    such shares of Preferred Stock not permitted by this clause (9);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;Hedging Obligations (excluding Hedging Obligations
    entered into for speculative purposes) for the purpose of
    limiting interest rate risk with respect to any Indebtedness
    permitted to be incurred pursuant to
    &#147;&#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock,&#148;
    exchange rate risk or commodity pricing risk;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;obligations in respect of performance, bid, appeal and
    surety bonds and completion guarantees provided by the Issuer or
    any of its Restricted Subsidiaries in the ordinary course of
    business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;(a)&#160;Indebtedness or Disqualified Stock of the
    Issuer and Indebtedness, Disqualified Stock or Preferred Stock
    of the Issuer or any Restricted Subsidiary equal to 200.0% of
    the net cash proceeds received by the Issuer since immediately
    after November&#160;17, 2006 from the issue or sale of Equity
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    214
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Interests of the Issuer or cash contributed to the capital of
    the Issuer (in each case, other than Excluded Contributions or
    proceeds of Disqualified Stock or sales of Equity Interests to
    the Issuer or any of its Subsidiaries) as determined in
    accordance with clauses (3)(b) and (3)(c) of the first paragraph
    of &#147;&#151;&#160;Limitation on Restricted Payments&#148; to
    the extent such net cash proceeds or cash have not been applied
    pursuant to such clauses to make Restricted Payments or to make
    other Investments, payments or exchanges pursuant to the second
    paragraph of &#147;&#151;&#160;Limitation on Restricted
    Payments&#148; or to make Permitted Investments (other than
    Permitted Investments specified in clauses&#160;(1) and
    (3)&#160;of the definition thereof) and (b)&#160;Indebtedness or
    Disqualified Stock of Issuer and Indebtedness, Disqualified
    Stock or Preferred Stock of the Issuer or any Restricted
    Subsidiary not otherwise permitted hereunder in an aggregate
    principal amount or liquidation preference, which when
    aggregated with the principal amount and liquidation preference
    of all other Indebtedness, Disqualified Stock and Preferred
    Stock then outstanding and incurred pursuant to this clause
    (12)(b), does not at any one time outstanding exceed
    $1,500.0&#160;million; <I>provided</I>, <I>however</I>, that on
    a pro forma basis, together with any amounts incurred and
    outstanding by Restricted Subsidiaries that are not Guarantors
    pursuant to the second proviso to the first paragraph of this
    covenant and clauses&#160;(14) and (19), no more than
    $2,000.0&#160;million of Indebtedness, Disqualified Stock or
    Preferred Stock at any one time outstanding and incurred
    pursuant to this clause (12)(b) shall be incurred by Restricted
    Subsidiaries that are not Guarantors (it being understood that
    any Indebtedness, Disqualified Stock or Preferred Stock incurred
    pursuant to this clause (12)(b) shall cease to be deemed
    incurred or outstanding for purposes of this clause (12)(b) but
    shall be deemed incurred for the purposes of the first paragraph
    of this covenant from and after the first date on which the
    Issuer or such Restricted Subsidiary could have incurred such
    Indebtedness, Disqualified Stock or Preferred Stock under the
    first paragraph of this covenant without reliance on this clause
    (12)(b));
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;the incurrence or issuance by the Issuer or any
    Restricted Subsidiary of Indebtedness, Disqualified Stock or
    Preferred Stock which serves to refund or refinance any
    Indebtedness, Disqualified Stock or Preferred Stock of the
    Issuer or any Restricted Subsidiary incurred as permitted under
    the first paragraph of this covenant and clauses (3),
    (4)&#160;and (12)(a) above, this clause&#160;(13) and
    clause&#160;(14) below or any Indebtedness, Disqualified Stock
    or Preferred Stock of the Issuer or any Restricted Subsidiary
    issued to so refund or refinance such Indebtedness, Disqualified
    Stock or Preferred Stock of the Issuer or any Restricted
    Subsidiary including additional Indebtedness, Disqualified Stock
    or Preferred Stock incurred to pay premiums (including
    reasonable tender premiums), defeasance costs and fees in
    connection therewith (the <I>&#147;Refinancing
    Indebtedness&#148;</I>) prior to its respective maturity;
    <I>provided</I>, <I>however</I>, that such Refinancing
    Indebtedness:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;has a Weighted Average Life to Maturity at the time
    such Refinancing Indebtedness is incurred which is not less than
    the remaining Weighted Average Life to Maturity of the
    Indebtedness, Disqualified Stock or Preferred Stock being
    refunded or refinanced,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;to the extent such Refinancing Indebtedness refinances
    (i)&#160;Indebtedness subordinated or <I>pari passu </I>to the
    Notes or any Guarantee thereof, such Refinancing Indebtedness is
    subordinated or <I>pari passu </I>to the Notes or the Guarantee
    at least to the same extent as the Indebtedness being refinanced
    or refunded or (ii)&#160;Disqualified Stock or Preferred Stock,
    such Refinancing Indebtedness must be Disqualified Stock or
    Preferred Stock, respectively,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;shall not include Indebtedness, Disqualified Stock or
    Preferred Stock of a Subsidiary of the Issuer that is not a
    Guarantor that refinances Indebtedness, Disqualified Stock or
    Preferred Stock of the Issuer or a Guarantor;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    and, <I>provided</I>, <I>further</I>, that subclause&#160;(a) of
    this clause&#160;(13) will not apply to any refunding or
    refinancing of any ABL Obligations and Obligations secured by
    Permitted Liens;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (14)&#160;Indebtedness, Disqualified Stock or Preferred Stock of
    (x)&#160;the Issuer or a Restricted Subsidiary incurred to
    finance an acquisition or (y)&#160;Persons that are acquired by
    the Issuer or any Restricted Subsidiary or merged into the
    Issuer or a Restricted Subsidiary in accordance with the terms
    of the Indenture; <I>provided </I>that after giving effect to
    such acquisition or merger, either
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    215
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;the Issuer would be permitted to incur at least $1.00
    of additional Indebtedness pursuant to the Fixed Charge Coverage
    Ratio test set forth in the first sentence of this
    covenant,&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the Fixed Charge Coverage Ratio of the Issuer and the
    Restricted Subsidiaries is greater than immediately prior to
    such acquisition or merger;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided</I>, <I>however</I>, that on a pro forma basis,
    together with amounts incurred and outstanding pursuant to the
    second proviso to the first paragraph of this covenant and
    clauses&#160;(12) and (19), no more than $2,000.0&#160;million
    of Indebtedness, Disqualified Stock or Preferred Stock at any
    one time outstanding and incurred by Restricted Subsidiaries
    that are not Guarantors pursuant to this clause&#160;(14) shall
    be incurred and outstanding;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (15)&#160;Indebtedness arising from the honoring by a bank or
    other financial institution of a check, draft or similar
    instrument drawn against insufficient funds in the ordinary
    course of business; <I>provided </I>that such Indebtedness is
    extinguished within two Business Days of its incurrence;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (16)&#160;Indebtedness of the Issuer or any of its Restricted
    Subsidiaries supported by a letter of credit issued pursuant to
    any Credit Facilities, in a principal amount not in excess of
    the stated amount of such letter of credit;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (17)&#160;(a)&#160;any guarantee by the Issuer or a Restricted
    Subsidiary of Indebtedness or other obligations of any
    Restricted Subsidiary, so long as the incurrence of such
    Indebtedness incurred by such Restricted Subsidiary is permitted
    under the terms of the Indenture, or (b)&#160;any guarantee by a
    Restricted Subsidiary of Indebtedness of the Issuer; <I>provided
    </I>that such guarantee is incurred in accordance with the
    covenant described below under &#147;&#151;&#160;Limitation on
    Guarantees of Indebtedness by Restricted Subsidiaries&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (18)&#160;Indebtedness of Foreign Subsidiaries of the Issuer in
    an amount not to exceed at any one time outstanding and together
    with any other Indebtedness incurred under this clause&#160;(18)
    7.5% of the Total Assets of the Foreign Subsidiaries (it being
    understood that any Indebtedness incurred pursuant to this
    clause&#160;(18) shall cease to be deemed incurred or
    outstanding for purposes of this clause&#160;(18) but shall be
    deemed incurred for the purposes of the first paragraph of this
    covenant from and after the first date on which the Issuer or
    such Restricted Subsidiaries could have incurred such
    Indebtedness under the first paragraph of this covenant without
    reliance on this clause (18));
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (19)&#160;Indebtedness, Disqualified Stock or Preferred Stock of
    a Restricted Subsidiary incurred to finance or assumed in
    connection with an acquisition in a principal amount not to
    exceed $200.0&#160;million in the aggregate at any one time
    outstanding together with all other Indebtedness, Disqualified
    Stock <FONT style="white-space: nowrap">and/or</FONT>
    Preferred Stock issued under this clause (19) (it being
    understood that any Indebtedness, Disqualified Stock or
    Preferred Stock incurred pursuant to this clause&#160;(19) shall
    cease to be deemed incurred or outstanding for purposes of this
    clause&#160;(19) but shall be deemed incurred for the purposes
    of the first paragraph of this covenant from and after the first
    date on which such Restricted Subsidiary could have incurred
    such Indebtedness, Disqualified Stock or Preferred Stock under
    the first paragraph of this covenant without reliance on this
    clause (19)); <I>provided</I>, <I>however</I>, that on a pro
    forma basis, together with amounts incurred and outstanding by
    Restricted Subsidiaries that are not Guarantors pursuant to the
    second proviso to the first paragraph of this covenant and
    clauses&#160;(12) and (14), no more than $2,000.0&#160;million
    of Indebtedness would be incurred and outstanding by Restricted
    Subsidiaries that are not Guarantors;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (20)&#160;Indebtedness of the Issuer or any of its Restricted
    Subsidiaries consisting of (i)&#160;the financing of insurance
    premiums or
    <FONT style="white-space: nowrap">(ii)&#160;take-or-pay</FONT>
    obligations contained in supply arrangements, in each case,
    incurred in the ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (21)&#160;Indebtedness consisting of Indebtedness issued by the
    Issuer or any of its Restricted Subsidiaries to current or
    former officers, directors and employees thereof, their
    respective estates, spouses or former spouses, in each case to
    finance the purchase or redemption of Equity Interests of the
    Issuer or any direct or indirect parent company of the Issuer to
    the extent described in clause&#160;(4) of the second paragraph
    under the caption &#147;&#151;&#160;Limitation on Restricted
    Payments&#148;;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    216
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (22)&#160;Physician Support Obligations incurred by the Issuer
    or any Restricted Subsidiary;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (23)&#160;Indebtedness of the Issuer or any of its Restricted
    Subsidiaries undertaken in connection with cash management and
    related activities with respect to any Subsidiary or joint
    venture operating one or more health care facilities, including,
    without limitation, hospitals, ambulatory surgery centers,
    outpatient diagnostic centers or imaging centers, in each case,
    in the ordinary course of business.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For purposes of determining compliance with this covenant:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;in the event that an item of Indebtedness, Disqualified
    Stock or Preferred Stock (or any portion thereof) meets the
    criteria of more than one of the categories of permitted
    Indebtedness, Disqualified Stock or Preferred Stock described in
    clauses&#160;(1) through (23)&#160;above or is entitled to be
    incurred pursuant to the first paragraph of this covenant, the
    Issuer, in its sole discretion, will classify or reclassify such
    item of Indebtedness, Disqualified Stock or Preferred Stock (or
    any portion thereof) and will only be required to include the
    amount and type of such Indebtedness, Disqualified Stock or
    Preferred Stock in one of the above clauses; <I>provided
    </I>that all Indebtedness outstanding under the Credit
    Facilities on November&#160;17, 2006 will be treated as incurred
    on November&#160;17, 2006 under clause&#160;(1) of the preceding
    paragraph;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;at the time of incurrence, the Issuer will be entitled
    to divide and classify an item of Indebtedness in more than one
    of the types of Indebtedness described in the first and second
    paragraphs above.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Accrual of interest, the accretion of accreted value and the
    payment of interest in the form of additional Indebtedness,
    Disqualified Stock or Preferred Stock will not be deemed to be
    an incurrence of Indebtedness, Disqualified Stock or Preferred
    Stock for purposes of this covenant.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For purposes of determining compliance with any
    U.S.&#160;dollar-denominated restriction on the incurrence of
    Indebtedness, the U.S.&#160;dollar-equivalent principal amount
    of Indebtedness denominated in a foreign currency shall be
    calculated based on the relevant currency exchange rate in
    effect on the date such Indebtedness was incurred, in the case
    of term debt, or first committed, in the case of revolving
    credit debt; <I>provided </I>that if such Indebtedness is
    incurred to refinance other Indebtedness denominated in a
    foreign currency, and such refinancing would cause the
    applicable U.S.&#160;dollar-denominated restriction to be
    exceeded if calculated at the relevant currency exchange rate in
    effect on the date of such refinancing, such
    U.S.&#160;dollar-denominated restriction shall be deemed not to
    have been exceeded so long as the principal amount of such
    refinancing Indebtedness does not exceed the principal amount of
    such Indebtedness being refinanced.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The principal amount of any Indebtedness incurred to refinance
    other Indebtedness, if incurred in a different currency from the
    Indebtedness being refinanced, shall be calculated based on the
    currency exchange rate applicable to the currencies in which
    such respective Indebtedness is denominated that is in effect on
    the date of such refinancing.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that the Issuer will not, and will not
    permit any Guarantor to, directly or indirectly, incur any
    Indebtedness (including Acquired Indebtedness) that is
    subordinated or junior in right of payment to any Indebtedness
    of the Issuer or such Guarantor, as the case may be, unless such
    Indebtedness is expressly subordinated in right of payment to
    the Notes or such Guarantor&#146;s Guarantee to the extent and
    in the same manner as such Indebtedness is subordinated to other
    Indebtedness of the Issuer or such Guarantor, as the case may be.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture does not treat (1)&#160;unsecured Indebtedness as
    subordinated or junior to Secured Indebtedness merely because it
    is unsecured or (2)&#160;Senior Indebtedness as subordinated or
    junior to any other Senior Indebtedness merely because it has a
    junior priority with respect to the same collateral.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    217
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Limitation
    on Prepayment or Modification of Existing Notes</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, directly or indirectly purchase, redeem,
    defease or otherwise acquire or retire for value any of the
    Existing Notes prior to the final maturity date thereof (as in
    effect on the Issue Date); <I>provided </I>that the Issuer may:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;purchase, redeem, defease or otherwise acquire or
    retire for value any of the Existing Notes which have a final
    maturity date (as in effect on the Issue Date) on or prior to
    December&#160;31, 2011;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;purchase, redeem, defease or otherwise acquire or
    retire for value any other Existing Notes which have a final
    maturity date (as in effect on the Issue Date) on or prior to
    the maturity date of the Notes; <I>provided </I>that, in the
    case of any such prepayment funded with the proceeds of the
    issuance of Secured Indebtedness, at the time of incurrence and
    after giving pro forma effect thereto and to the application of
    the proceeds thereof, (x)&#160;the Consolidated Secured Debt
    Ratio would be no greater than 5.25 to 1.0 and (y)&#160;the
    Consolidated Leverage Ratio would be no greater than 7.0 to 1.0.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, amend the Existing Notes Indenture, or any
    supplemental indenture in respect thereof, in any way to advance
    the final maturity date or shorten the Weighted Average Life to
    Maturity of any series of the Existing Notes such that any
    Existing Notes with a maturity date following the maturity of
    the Notes would have a maturity date on or prior to the date one
    year following the maturity date of the Notes or which would
    prohibit the making of the Guarantees or the creation of Liens
    in favor of the Notes and the Guarantees on the Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, designate any additional subsidiaries as
    &#147;Restricted Subsidiaries&#148; (as defined in the Existing
    Notes Indenture) for purposes of the Existing Notes Indenture.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Liens</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any Guarantor to,
    directly or indirectly, create, incur, assume or suffer to exist
    any Lien (except Permitted Liens) that secures obligations under
    any Indebtedness or any related Guarantee, on any asset or
    property of the Issuer or any Guarantor, or any income or
    profits therefrom, or assign or convey any right to receive
    income therefrom, other than Liens securing Indebtedness that
    are junior in priority to the Liens on such property, assets or
    proceeds securing the Notes and related Guarantees.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The foregoing shall not apply to (a)&#160;Liens securing the
    Notes and the related Guarantees, (b)&#160;Liens securing
    Indebtedness permitted to be incurred under Credit Facilities,
    including any letter of credit relating thereto, that was
    permitted by the terms of the Indenture to be incurred pursuant
    to clause&#160;(1) of the second paragraph under
    &#147;&#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock&#148;;
    <I>provided </I>that, with respect to Liens securing Obligations
    permitted under this subclause (b), the Notes and the related
    Guarantees are secured by Liens on the assets subject to such
    Liens (except any European Collateral) to the extent, with the
    priority and subject to intercreditor arrangements, in each case
    no less favorable to the Holders of the Notes than those
    described under &#147;Security&#148; above and (c)&#160;Liens
    which are <I>pari passu </I>in priority to the Liens securing
    the Notes and related Guarantees and are incurred to secure
    Obligations in respect of any Indebtedness permitted to be
    incurred pursuant to the covenant described above under
    &#147;&#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock&#148;;
    <I>provided </I>that, with respect to Liens securing Obligations
    permitted under this subclause (c), at the time of incurrence
    and after giving pro forma effect thereto, the ratio of
    (1)&#160;the aggregate amount of Indebtedness secured by
    property, assets or proceeds that secure the Notes and related
    Guarantees that are subject to a Lien that is <I>pari passu
    </I>or senior in priority to the Liens securing the Notes and
    the related Guarantees incurred pursuant to subclause&#160;(b)
    above, this subclause&#160;(c) and clause&#160;(6) of the
    definition of &#147;Permitted Liens&#148; (other than Liens
    securing Indebtedness incurred pursuant to clauses&#160;(4) and
    (18)&#160;of the covenant described above under
    &#147;&#151;&#160;Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock&#148;) to
    (2)&#160;the Issuer&#146;s EBITDA for the most recently ended
    four full fiscal quarters for which internal financial
    statements are available immediately preceding the date on which
    such event for which such calculation is being made shall occur,
    in each case with such pro forma adjustments to Indebtedness and
    EBITDA as are
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    218
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    appropriate and consistent with the pro forma adjustment
    provisions set forth in the definition of Fixed Charge Coverage
    Ratio would be no greater than 4.25 to 1.0; <I>provided
    </I>that, with respect to Liens securing Obligations permitted
    under this subclause (c), the Notes and the related Guarantees
    are secured by Liens on the assets subject to such Liens (except
    any European Collateral) to the extent, with the priority and
    subject to intercreditor arrangements, in each case no less
    favorable to the Holders of the Notes than those described under
    &#147;Security&#148; above.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Merger,
    Consolidation or Sale of All or Substantially All
    Assets</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer may not consolidate or merge with or into or wind up
    into (whether or not the Issuer is the surviving corporation),
    or sell, assign, transfer, lease, convey or otherwise dispose of
    all or substantially all of its properties or assets, in one or
    more related transactions, to any Person unless:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the Issuer is the surviving corporation or the Person
    formed by or surviving any such consolidation or merger (if
    other than the Issuer) or to which such sale, assignment,
    transfer, lease, conveyance or other disposition will have been
    made is a corporation organized or existing under the laws of
    the jurisdiction of organization of the Issuer or the laws of
    the United States, any state thereof, the District of Columbia,
    or any territory thereof (such Person, as the case may be, being
    herein called the <I>&#147;Successor Company&#148;</I>);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the Successor Company, if other than the Issuer,
    expressly assumes all the obligations of the Issuer under the
    Notes and the Security Documents pursuant to supplemental
    indentures or other documents or instruments in form reasonably
    satisfactory to the Trustee;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;immediately after such transaction, no Default exists;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;immediately after giving pro forma effect to such
    transaction and any related financing transactions, as if such
    transactions had occurred at the beginning of the applicable
    four-quarter period,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;the Successor Company would be permitted to incur at
    least $1.00 of additional Indebtedness pursuant to the Fixed
    Charge Coverage Ratio test set forth in the first sentence of
    the covenant described under &#147;&#151;&#160;Limitation on
    Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock,&#148;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the Fixed Charge Coverage Ratio for the Successor
    Company, the Issuer and its Restricted Subsidiaries would be
    greater than such ratio for the Issuer and its Restricted
    Subsidiaries immediately prior to such transaction;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;each Guarantor, unless it is the other party to the
    transactions described above, in which case clause&#160;(b) of
    the second succeeding paragraph shall apply, shall have by
    supplemental indenture confirmed that its Guarantee shall apply
    to such Person&#146;s obligations under the Indenture, the Notes
    and the Registration Rights Agreement;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;the Collateral owned by the Successor Company will
    (a)&#160;continue to constitute Collateral under the Indenture
    and the Security Documents, (b)&#160;be subject to a Lien in
    favor of the Junior Lien Collateral Agent for the benefit of the
    Trustee and the Holders of the Notes and (c)&#160;not be subject
    to any other Lien, other than Permitted Liens;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;to the extent any assets of the Person which is merged
    or consolidated with or into the Successor Company are assets of
    the type which would constitute Collateral under the Security
    Documents, the Successor Company will take such action as may be
    reasonably necessary to cause such property and assets to be
    made subject to the Lien of the Security Documents in the manner
    and to the extent required in the Indenture or any of the
    Security Documents and shall take all reasonably necessary
    action so that such Lien is perfected to the extent required by
    the Security Documents;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;the Issuer shall have delivered to the Trustee an
    Officer&#146;s Certificate and an Opinion of Counsel, each
    stating that such consolidation, merger or transfer and such
    supplemental indentures, if any, comply with the Indenture and,
    if a supplemental indenture or any supplement to any Security
    Document is
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    219
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    required in connection with such transaction, such supplement
    shall comply with the applicable provisions of the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Successor Company will succeed to, and be substituted for
    the Issuer, as the case may be, under the Indenture, the
    Guarantees and the Notes, as applicable. Notwithstanding the
    foregoing clauses&#160;(3) and (4),
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any Restricted Subsidiary may consolidate with or merge
    into or transfer all or part of its properties and assets to the
    Issuer,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the Issuer may merge with an Affiliate of the Issuer,
    as the case may be, solely for the purpose of reincorporating
    the Issuer in a State of the United States or any state thereof,
    the District of Columbia or any territory thereof so long as the
    amount of Indebtedness of the Issuer and its Restricted
    Subsidiaries is not increased thereby.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Subject to certain limitations described in the Indenture
    governing release of a Guarantee upon the sale, disposition or
    transfer of a Guarantor, no Guarantor will, and the Issuer will
    not permit any Guarantor to, consolidate or merge with or into
    or wind up into (whether or not the Issuer or Guarantor is the
    surviving corporation), or sell, assign, transfer, lease, convey
    or otherwise dispose of all or substantially all of its
    properties or assets, in one or more related transactions, to
    any Person unless:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;(a)&#160;such Guarantor is the surviving corporation or
    the Person formed by or surviving any such consolidation or
    merger (if other than such Guarantor) or to which such sale,
    assignment, transfer, lease, conveyance or other disposition
    will have been made is a corporation, partnership, limited
    partnership, limited liability corporation or trust organized or
    existing under the laws of the jurisdiction of organization of
    such Guarantor, as the case may be, or the laws of the United
    States, any state thereof, the District of Columbia, or any
    territory thereof (such Guarantor or such Person, as the case
    may be, being herein called the <I>&#147;Successor
    Person&#148;</I>);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the Successor Person, if other than such Guarantor,
    expressly assumes all the obligations of such Guarantor under
    the Indenture and such Guarantor&#146;s related Guarantee
    pursuant to supplemental indentures or other documents or
    instruments in form reasonably satisfactory to the Trustee;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;immediately after such transaction, no Default
    exists;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;the Issuer shall have delivered to the Trustee an
    Officer&#146;s Certificate, each stating that such
    consolidation, merger or transfer and such supplemental
    indentures, if any, comply with the Indenture;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the transaction is made in compliance with the covenant
    described under &#147;Repurchase at the Option of
    Holders&#160;&#151; Asset Sales.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Subject to certain limitations described in the Indenture, the
    Successor Person will succeed to, and be substituted for, such
    Guarantor under the Indenture and such Guarantor&#146;s
    Guarantee. Notwithstanding the foregoing, any Guarantor may
    (i)&#160;merge into or transfer all or part of its properties
    and assets to another Guarantor or the Issuer, (ii)&#160;merge
    with an Affiliate of the Company solely for the purpose of
    reincorporating the Guarantor in the United States, any state
    thereof, the District of Columbia or any territory thereof or
    (iii)&#160;convert into a corporation, partnership, limited
    partnership, limited liability corporation or trust organized or
    existing under the laws of the jurisdiction of organization of
    such Guarantor.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Transactions
    with Affiliates</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, make any payment to, or sell, lease, transfer
    or otherwise dispose of any of its properties or assets to, or
    purchase any property or assets from, or enter into or make or
    amend any transaction, contract, agreement, understanding, loan,
    advance or guarantee with, or for the benefit of, any Affiliate
    of the Issuer (each of the foregoing, an <I>&#147;Affiliate
    Transaction&#148;</I>) involving aggregate payments or
    consideration in excess of $40.0&#160;million, unless:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;such Affiliate Transaction is on terms that are not
    materially less favorable to the Issuer or its relevant
    Restricted Subsidiary than those that would have been obtained
    in a comparable transaction by the Issuer or such Restricted
    Subsidiary with an unrelated Person on an arm&#146;s-length
    basis;&#160;and
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    220
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the Issuer delivers to the Trustee with respect to any
    Affiliate Transaction or series of related Affiliate
    Transactions involving aggregate payments or consideration in
    excess of $80.0&#160;million, a resolution adopted by the
    majority of the board of directors of the Issuer approving such
    Affiliate Transaction and set forth in an Officer&#146;s
    Certificate certifying that such Affiliate Transaction complies
    with clause&#160;(1) above.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The foregoing provisions will not apply to the following:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;transactions between or among the Issuer or any of its
    Restricted Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;Restricted Payments permitted by the provisions of the
    Indenture described above under the covenant
    &#147;&#151;&#160;Limitation on Restricted Payments&#148; and
    the definition of &#147;Permitted Investments&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;the payment of management, consulting, monitoring and
    advisory fees and related expenses to the Investors and the
    Frist Entities pursuant to the Sponsor Management Agreement
    (plus any unpaid management, consulting, monitoring and advisory
    fees and related expenses accrued in any prior year) and the
    termination fees pursuant to the Sponsor Management Agreement,
    in each case as in effect on the Issue Date, or any amendment
    thereto (so long as any such amendment is not disadvantageous in
    the good faith judgment of the board of directors of the Issuer
    to the Holders when taken as a whole as compared to the Sponsor
    Management Agreement in effect on the Issue Date);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;the payment of reasonable and customary fees paid to,
    and indemnities provided for the benefit of, officers,
    directors, employees or consultants of Issuer, any of its direct
    or indirect parent companies or any of its Restricted
    Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;transactions in which the Issuer or any of its
    Restricted Subsidiaries, as the case may be, delivers to the
    Trustee a letter from an Independent Financial Advisor stating
    that such transaction is fair to the Issuer or such Restricted
    Subsidiary from a financial point of view or stating that the
    terms are not materially less favorable to the Issuer or its
    relevant Restricted Subsidiary than those that would have been
    obtained in a comparable transaction by the Issuer or such
    Restricted Subsidiary with an unrelated Person on an
    arm&#146;s-length basis;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;any agreement as in effect as of the Issue Date, or any
    amendment thereto (so long as any such amendment is not
    disadvantageous to the Holders when taken as a whole as compared
    to the applicable agreement as in effect on the Issue Date);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;the existence of, or the performance by the Issuer or
    any of its Restricted Subsidiaries of its obligations under the
    terms of, any stockholders agreement (including any registration
    rights agreement or purchase agreement related thereto) to which
    it is a party as of the Issue Date and any similar agreements
    which it may enter into thereafter; provided, however, that the
    existence of, or the performance by the Issuer or any of its
    Restricted Subsidiaries of obligations under any future
    amendment to any such existing agreement or under any similar
    agreement entered into after the Issue Date shall only be
    permitted by this clause&#160;(7) to the extent that the terms
    of any such amendment or new agreement are not otherwise
    disadvantageous to the Holders when taken as a whole;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;reserved;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;transactions with customers, clients, suppliers, or
    purchasers or sellers of goods or services, in each case in the
    ordinary course of business and otherwise in compliance with the
    terms of the Indenture which are fair to the Issuer and its
    Restricted Subsidiaries, in the reasonable determination of the
    board of directors of the Issuer or the senior management
    thereof, or are on terms at least as favorable as might
    reasonably have been obtained at such time from an unaffiliated
    party;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;the issuance of Equity Interests (other than
    Disqualified Stock) of the Issuer to any Permitted Holder or to
    any director, officer, employee or consultant;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;sales of accounts receivable, or participations
    therein, in connection with the ABL Facility and any Receivables
    Facility;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    221
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;payments by the Issuer or any of its Restricted
    Subsidiaries to any of the Investors made for any financial
    advisory, financing, underwriting or placement services or in
    respect of other investment banking activities, including,
    without limitation, in connection with acquisitions or
    divestitures, which payments are approved by a majority of the
    board of directors of the Issuer in good faith;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;payments or loans (or cancellation of loans) to
    employees or consultants of the Issuer, any of its direct or
    indirect parent companies or any of its Restricted Subsidiaries
    and employment agreements, stock option plans and other similar
    arrangements with such employees or consultants which, in each
    case, are approved by the Issuer in good faith;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (14)&#160;investments by the Investors or the Frist Entities in
    securities of the Issuer or any of its Restricted Subsidiaries
    so long as (i)&#160;the investment is being offered generally to
    other investors on the same or more favorable terms and
    (ii)&#160;the investment constitutes less than 5% of the
    proposed or outstanding issue amount of such class of securities;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (15)&#160;payments to or from, and transactions with, any joint
    venture owning or operating one or more health care facilities,
    including, without limitation, hospitals, ambulatory surgery
    centers, outpatient diagnostic centers or imaging centers, in
    each case in the ordinary course of business (including, without
    limitation, any cash management activities related
    thereto);&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (16)&#160;payments by the Issuer (and any direct or indirect
    parent thereof) and its Subsidiaries pursuant to tax sharing
    agreements among the Issuer (and any such parent) and its
    Subsidiaries on customary terms to the extent attributable to
    the ownership or operation of the Issuer and its Subsidiaries;
    provided that in each case the amount of such payments in any
    fiscal year does not exceed the amount that the Issuer, its
    Restricted Subsidiaries and its Unrestricted Subsidiaries (to
    the extent of amounts received from Unrestricted Subsidiaries)
    would be required to pay in respect of foreign, federal, state
    and local taxes for such fiscal year were the Issuer and its
    Restricted Subsidiaries (to the extent described above) to pay
    such taxes separately from any such parent entity.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Dividend
    and Other Payment Restrictions Affecting Restricted
    Subsidiaries</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not, and will not permit any of its Restricted
    Subsidiaries that are not Guarantors to, directly or indirectly,
    create or otherwise cause or suffer to exist or become effective
    any consensual encumbrance or consensual restriction on the
    ability of any such Restricted Subsidiary to:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;(a)&#160;pay dividends or make any other distributions
    to the Issuer or any of its Restricted Subsidiaries on its
    Capital Stock or with respect to any other interest or
    participation in, or measured by, its profits,&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;pay any Indebtedness owed to the Issuer or any of its
    Restricted Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;make loans or advances to the Issuer or any of its
    Restricted Subsidiaries;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;sell, lease or transfer any of its properties or assets
    to the Issuer or any of its Restricted Subsidiaries,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    except (in each case) for such encumbrances or restrictions
    existing under or by reason of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;contractual encumbrances or restrictions in effect on
    the Issue Date, including pursuant to the Senior Credit
    Facilities and the related documentation, the Existing Notes
    Indenture and the related documentation and the Existing Second
    Priority Notes Indentures and the related documentation;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the Indenture and the Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;purchase money obligations for property acquired in the
    ordinary course of business that impose restrictions of the
    nature discussed in clause&#160;(3) above on the property so
    acquired;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;applicable law or any applicable rule, regulation or
    order;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    222
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;any agreement or other instrument of a Person acquired
    by the Issuer or any Restricted Subsidiary in existence at the
    time of such acquisition (but not created in contemplation
    thereof), which encumbrance or restriction is not applicable to
    any Person, or the properties or assets of any Person, other
    than the Person and its Subsidiaries, or the property or assets
    of the Person and its Subsidiaries, so acquired;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (f)&#160;contracts for the sale of assets, including customary
    restrictions with respect to a Subsidiary of the Issuer pursuant
    to an agreement that has been entered into for the sale or
    disposition of all or substantially all of the Capital Stock or
    assets of such Subsidiary;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (g)&#160;Secured Indebtedness that limits the right of the
    debtor to dispose of the assets securing such Indebtedness that
    is otherwise permitted to be incurred pursuant to the covenants
    described under &#147;&#151;&#160;Limitation on Incurrence of
    Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock&#148; and &#147;&#151;&#160;Liens&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (h)&#160;restrictions on cash or other deposits or net worth
    imposed by customers under contracts entered into in the
    ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (i)&#160;other Indebtedness, Disqualified Stock or Preferred
    Stock of Foreign Subsidiaries permitted to be incurred
    subsequent to the Issue Date pursuant to the provisions of the
    covenant described under &#147;&#151;&#160;Limitation on
    Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (j)&#160;customary provisions in joint venture agreements and
    other agreements or arrangements relating solely to such joint
    venture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (k)&#160;customary provisions contained in leases or licenses of
    intellectual property and other agreements, in each case entered
    into in the ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (l)&#160;any encumbrances or restrictions of the type referred
    to in clauses (1), (2)&#160;and (3)&#160;above imposed by any
    amendments, modifications, restatements, renewals, increases,
    supplements, refundings, replacements or refinancings of the
    contracts, instruments or obligations referred to in
    clauses&#160;(a) through (k)&#160;above; <I>provided </I>that
    such amendments, modifications, restatements, renewals,
    increases, supplements, refundings, replacements or refinancings
    are, in the good faith judgment of the Issuer, no more
    restrictive with respect to such encumbrance and other
    restrictions taken as a whole than those prior to such
    amendment, modification, restatement, renewal, increase,
    supplement, refunding, replacement or refinancing;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (m)&#160;restrictions created in connection with any Receivables
    Facility that, in the good faith determination of the Issuer,
    are necessary or advisable to effect the transactions
    contemplated under such Receivables Facility.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Limitation
    on Guarantees of Indebtedness by Restricted
    Subsidiaries</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer will not permit any of its Wholly-Owned Subsidiaries
    that are Restricted Subsidiaries (and non-Wholly-Owned
    Subsidiaries if such non-Wholly-Owned Subsidiaries guarantee
    other capital markets debt securities of the Issuer or any
    Guarantor), other than a Guarantor, a Foreign Subsidiary or a
    Receivables Subsidiary, to guarantee the payment of any
    Indebtedness of the Issuer or any other Guarantor unless:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;such Restricted Subsidiary within 30&#160;days executes
    and delivers a supplemental indenture to the Indenture providing
    for a Guarantee by such Restricted Subsidiary, except that with
    respect to a guarantee of Indebtedness of the Issuer or any
    Guarantor:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;if the Notes or such Guarantor&#146;s Guarantee is
    subordinated in right of payment to such Indebtedness, the
    Guarantee under the supplemental indenture shall be subordinated
    to such Restricted Subsidiary&#146;s guarantee with respect to
    such Indebtedness substantially to the same extent as the Notes
    are subordinated to such Indebtedness;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;if such Indebtedness is by its express terms
    subordinated in right of payment to the Notes or such
    Guarantor&#146;s Guarantee, any such guarantee by such
    Restricted Subsidiary with respect to
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    223
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    such Indebtedness shall be subordinated in right of payment to
    such Guarantee substantially to the same extent as such
    Indebtedness is subordinated to the Notes;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;such Restricted Subsidiary waives, and will not in any
    manner whatsoever claim or take the benefit or advantage of, any
    rights of reimbursement, indemnity or subrogation or any other
    rights against the Issuer or any other Restricted Subsidiary as
    a result of any payment by such Restricted Subsidiary under its
    Guarantee;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided </I>that this covenant shall not be applicable to
    (i)&#160;any guarantee of any Restricted Subsidiary that existed
    at the time such Person became a Restricted Subsidiary and was
    not incurred in connection with, or in contemplation of, such
    Person becoming a Restricted Subsidiary and (ii)&#160;guarantees
    of the ABL Facility by the ABL Financing Entities or of any
    Receivables Facility by any Receivables Subsidiary.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Reports
    and Other Information</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding that the Issuer may not be subject to the
    reporting requirements of Section&#160;13 or 15(d) of the
    Exchange Act or otherwise report on an annual and quarterly
    basis on forms provided for such annual and quarterly reporting
    pursuant to rules and regulations promulgated by the SEC, the
    Indenture requires the Issuer to file with the SEC (and make
    available to the Trustee and Holders of the Notes (without
    exhibits), without cost to any Holder, within 15&#160;days after
    it files them with the SEC) from and after the Issue Date,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;within 90&#160;days (or any other time period then in
    effect under the rules and regulations of the Exchange Act with
    respect to the filing of a
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    by a non-accelerated filer) after the end of each fiscal year,
    annual reports on
    <FONT style="white-space: nowrap">Form&#160;10-K,</FONT>
    or any successor or comparable form, containing the information
    required to be contained therein, or required in such successor
    or comparable form;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;within 45&#160;days after the end of each of the first
    three fiscal quarters of each fiscal year, reports on
    <FONT style="white-space: nowrap">Form&#160;10-Q</FONT>
    containing all quarterly information that would be required to
    be contained in
    <FONT style="white-space: nowrap">Form&#160;10-Q,</FONT>
    or any successor or comparable form;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;promptly from time to time after the occurrence of an
    event required to be therein reported, such other reports on
    <FONT style="white-space: nowrap">Form&#160;8-K,</FONT>
    or any successor or comparable form;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;any other information, documents and other reports
    which the Issuer would be required to file with the SEC if it
    were subject to Section&#160;13 or 15(d) of the Exchange Act;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    in each case in a manner that complies in all material respects
    with the requirements specified in such form; <I>provided
    </I>that the Issuer shall not be so obligated to file such
    reports with the SEC if the SEC does not permit such filing, in
    which event the Issuer will make available such information to
    prospective purchasers of Notes, in addition to providing such
    information to the Trustee and the Holders of the Notes, in each
    case within 15&#160;days after the time the Issuer would be
    required to file such information with the SEC if it were
    subject to Section&#160;13 or 15(d) of the Exchange Act. In
    addition, to the extent not satisfied by the foregoing, the
    Issuer has agreed that, for so long as any Notes are
    outstanding, it will furnish to Holders and to securities
    analysts and prospective investors, upon their request, the
    information required to be delivered pursuant to
    Rule&#160;144A(d)(4) under the Securities Act.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In the event that any direct or indirect parent company of the
    Issuer becomes a Guarantor of the Notes, the Indenture permits
    the Issuer to satisfy its obligations in this covenant with
    respect to financial information relating to the Issuer by
    furnishing financial information relating to such parent;
    <I>provided </I>that the same is accompanied by consolidating
    information that explains in reasonable detail the differences
    between the information relating to such parent, on the one
    hand, and the information relating to the Issuer and its
    Restricted Subsidiaries on a standalone basis, on the other hand.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding the foregoing, such requirements shall be deemed
    satisfied prior to the commencement of the exchange offer or the
    effectiveness of the shelf registration statement described in
    the Registration Rights Agreement (1)&#160;by the filing with
    the SEC of the exchange offer registration statement or shelf
    registration statement (or any other similar registration
    statement), and any amendments thereto, with such financial
    information that satisfies
    <FONT style="white-space: nowrap">Regulation&#160;S-X,</FONT>
    subject to exceptions consistent with the presentation of
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    224
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    financial information in the Offering Memorandum, to the extent
    filed within the times specified above, or (2)&#160;by posting
    reports that would be required to be filed substantially in the
    form required by the SEC on the Company&#146;s website (or that
    of any of its parent companies) or providing such reports to the
    Trustee within 15&#160;days after the time the Issuer would be
    required to file such information with the SEC if it were
    subject to Section&#160;13 or 15(d) of the Exchange Act, the
    financial information (including a &#147;Management&#146;s
    Discussion and Analysis of Financial Condition and Results of
    Operations&#148; section) that would be required to be included
    in such reports, subject to exceptions consistent with the
    presentation of financial information in the Offering
    Memorandum, to the extent filed within the times specified above.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Events
    of Default and Remedies</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that each of the following is an
    <I>&#147;Event of Default&#148;</I>:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;default in payment when due and payable, upon
    redemption, acceleration or otherwise, of principal of, or
    premium, if any, on the Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;default for 30&#160;days or more in the payment when
    due of interest or Additional Interest on or with respect to the
    Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;failure by the Issuer or any Guarantor for 60&#160;days
    after receipt of written notice given by the Trustee or the
    Holders of not less than 30% in principal amount of the Notes to
    comply with any of its obligations, covenants or agreements
    (other than a default referred to in clauses&#160;(1) and
    (2)&#160;above) contained in the Indenture or the Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;default under any mortgage, indenture or instrument
    under which there is issued or by which there is secured or
    evidenced any Indebtedness for money borrowed by the Issuer or
    any of its Restricted Subsidiaries or the payment of which is
    guaranteed by the Issuer or any of its Restricted Subsidiaries,
    other than Indebtedness owed to the Issuer or a Restricted
    Subsidiary, whether such Indebtedness or guarantee now exists or
    is created after the issuance of the Notes, if both:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;such default either results from the failure to pay any
    principal of such Indebtedness at its stated final maturity
    (after giving effect to any applicable grace periods) or relates
    to an obligation other than the obligation to pay principal of
    any such Indebtedness at its stated final maturity and results
    in the holder or holders of such Indebtedness causing such
    Indebtedness to become due prior to its stated maturity;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the principal amount of such Indebtedness, together
    with the principal amount of any other such Indebtedness in
    default for failure to pay principal at stated final maturity
    (after giving effect to any applicable grace periods), or the
    maturity of which has been so accelerated, aggregate
    $200.0&#160;million or more at any one time outstanding;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;failure by the Issuer or any Significant Subsidiary to
    pay final judgments aggregating in excess of
    $200.0&#160;million, which final judgments remain unpaid,
    undischarged and unstayed for a period of more than 60&#160;days
    after such judgment becomes final, and in the event such
    judgment is covered by insurance, an enforcement proceeding has
    been commenced by any creditor upon such judgment or decree
    which is not promptly stayed;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;certain events of bankruptcy or insolvency with respect
    to the Issuer or any Significant Subsidiary;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;the Guarantee of any Significant Subsidiary shall for
    any reason cease to be in full force and effect or be declared
    null and void or any responsible officer of any Guarantor that
    is a Significant Subsidiary, as the case may be, denies that it
    has any further liability under its Guarantee or gives notice to
    such effect, other than by reason of the termination of the
    Indenture or the release of any such Guarantee in accordance
    with the Indenture;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;with respect to any Collateral having a fair market
    value in excess of $200&#160;million, individually or in the
    aggregate, (a)&#160;the security interest under the Security
    Documents, at any time, ceases to be in
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    225
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    full force and effect for any reason other than in accordance
    with the terms of the Indenture, the Security Documents and the
    Intercreditor Agreements, (b)&#160;any security interest created
    thereunder or under the Indenture is declared invalid or
    unenforceable by a court of competent jurisdiction or
    (c)&#160;the Issuer or any Guarantor asserts, in any pleading in
    any court of competent jurisdiction, that any such security
    interest is invalid or unenforceable.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If any Event of Default (other than of a type specified in
    clause&#160;(6) above) occurs and is continuing under the
    Indenture, the Trustee or the Holders of at least 30% in
    principal amount of the then total outstanding Notes may declare
    the principal, premium, if any, interest and any other monetary
    obligations on all the then outstanding Notes to be due and
    payable immediately.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Upon the effectiveness of such declaration, such principal and
    interest will be due and payable immediately. Notwithstanding
    the foregoing, in the case of an Event of Default arising under
    clause&#160;(6) of the first paragraph of this section, all
    outstanding Notes will become due and payable without further
    action or notice. The Indenture provides that the Trustee may
    withhold from the Holders notice of any continuing Default,
    except a Default relating to the payment of principal, premium,
    if any, or interest, if it determines that withholding notice is
    in their interest. In addition, the Trustee shall have no
    obligation to accelerate the Notes if in the best judgment of
    the Trustee acceleration is not in the best interest of the
    Holders of the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that the Holders of a majority in
    aggregate principal amount of the then outstanding Notes by
    notice to the Trustee may on behalf of the Holders of all of the
    Notes waive any existing Default and its consequences under the
    Indenture except a continuing Default in the payment of interest
    on, premium, if any, or the principal of any Note held by a
    non-consenting Holder. In the event of any Event of Default
    specified in clause&#160;(4) above, such Event of Default and
    all consequences thereof (excluding any resulting payment
    default, other than as a result of acceleration of the Notes)
    shall be annulled, waived and rescinded, automatically and
    without any action by the Trustee or the Holders, if within
    20&#160;days after such Event of Default arose:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the Indebtedness or guarantee that is the basis for
    such Event of Default has been discharged;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;holders thereof have rescinded or waived the
    acceleration, notice or action (as the case may be) giving rise
    to such Event of Default;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;the default that is the basis for such Event of Default
    has been cured.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Subject to the provisions of the Indenture relating to the
    duties of the Trustee thereunder, in case an Event of Default
    occurs and is continuing, the Trustee is under no obligation to
    exercise any of the rights or powers under the Indenture at the
    request or direction of any of the Holders of the Notes unless
    the Holders have offered to the Trustee indemnity or security
    reasonably satisfactory to it against any loss, liability or
    expense. Except to enforce the right to receive payment of
    principal, premium, if any, or interest when due, no Holder of a
    Note may pursue any remedy with respect to the Indenture or the
    Notes unless:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;such Holder has previously given the Trustee notice
    that an Event of Default is continuing;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;Holders of at least 30% in principal amount of the
    total outstanding Notes have requested the Trustee to pursue the
    remedy;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;Holders of the Notes have offered the Trustee
    reasonable security or indemnity against any loss, liability or
    expense;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;the Trustee has not complied with such request within
    60&#160;days after the receipt thereof and the offer of security
    or indemnity;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;Holders of a majority in principal amount of the total
    outstanding Notes have not given the Trustee a direction
    inconsistent with such request within such
    <FONT style="white-space: nowrap">60-day</FONT>
    period.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Subject to certain restrictions, under the Indenture the Holders
    of a majority in principal amount of the total outstanding Notes
    are given the right to direct the time, method and place of
    conducting any proceeding for any remedy available to the
    Trustee or of exercising any trust or power conferred on the
    Trustee. The
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    226
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Trustee, however, may refuse to follow any direction that
    conflicts with law or the Indenture or that the Trustee
    determines is unduly prejudicial to the rights of any other
    Holder of a Note or that would involve the Trustee in personal
    liability.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that the Issuer is required to deliver to
    the Trustee annually a statement regarding compliance with the
    Indenture, and the Issuer is required, within five Business
    Days, upon becoming aware of any Default, to deliver to the
    Trustee a statement specifying such Default.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">No
    Personal Liability of Directors, Officers, Employees and
    Stockholders</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    No director, officer, employee, incorporator or stockholder of
    the Issuer or any Guarantor or any of their parent companies
    (other than the Issuer and the Guarantors) shall have any
    liability for any obligations of the Issuer or the Guarantors
    under the Notes, the Guarantees or the Indenture or for any
    claim based on, in respect of, or by reason of such obligations
    or their creation. Each Holder by accepting the Notes waives and
    releases all such liability. The waiver and release are part of
    the consideration for issuance of the Notes. Such waiver may not
    be effective to waive liabilities under the federal securities
    laws, and it is the view of the SEC that such a waiver is
    against public policy.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Legal
    Defeasance and Covenant Defeasance</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The obligations of the Issuer and the Guarantors under the
    Indenture will terminate (other than certain obligations) and
    will be released upon payment in full of all of the Notes. The
    Issuer may, at its option and at any time, elect to have all of
    its obligations discharged with respect to the Notes and have
    the Issuer&#146;s and each Guarantor&#146;s obligation
    discharged with respect to its Guarantee <I>(&#147;Legal
    Defeasance&#148;</I>) and cure all then existing Events of
    Default except for:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the rights of Holders of the Notes to receive payments
    in respect of the principal of, premium, if any, and interest on
    the Notes when such payments are due solely out of the trust
    created pursuant to the Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the Issuer&#146;s obligations with respect to Notes
    concerning issuing temporary Notes, registration of such Notes,
    mutilated, destroyed, lost or stolen Notes and the maintenance
    of an office or agency for payment and money for security
    payments held in trust;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;the rights, powers, trusts, duties and immunities of
    the Trustee, and the Issuer&#146;s obligations in connection
    therewith;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;the Legal Defeasance provisions of the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, the Issuer may, at its option and at any time,
    elect to have its obligations and those of each Guarantor
    released with respect to certain covenants that are described in
    the Indenture <I>(&#147;Covenant Defeasance&#148;</I>) and
    thereafter any omission to comply with such obligations shall
    not constitute a Default with respect to the Notes. In the event
    Covenant Defeasance occurs, certain events (not including
    bankruptcy, receivership, rehabilitation and insolvency events
    pertaining to the Issuer) described under &#147;Events of
    Default and Remedies&#148; will no longer constitute an Event of
    Default with respect to the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In order to exercise either Legal Defeasance or Covenant
    Defeasance with respect to the Notes:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the Issuer must irrevocably deposit with the Trustee,
    in trust, for the benefit of the Holders of the Notes, cash in
    U.S.&#160;dollars, Government Securities, or a combination
    thereof, in such amounts as will be sufficient, in the opinion
    of a nationally recognized firm of independent public
    accountants, to pay the principal of, premium, if any, and
    interest due on the Notes on the stated maturity date or on the
    redemption date, as the case may be, of such principal, premium,
    if any, or interest on such Notes, and the Issuer must specify
    whether such Notes are being defeased to maturity or to a
    particular redemption date;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    227
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;in the case of Legal Defeasance, the Issuer shall have
    delivered to the Trustee an Opinion of Counsel reasonably
    acceptable to the Trustee confirming that, subject to customary
    assumptions and exclusions,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;the Issuer has received from, or there has been
    published by, the United States Internal Revenue Service a
    ruling,&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;since the issuance of the Notes, there has been a
    change in the applicable U.S.&#160;federal income tax law,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    in either case to the effect that, and based thereon such
    Opinion of Counsel shall confirm that, subject to customary
    assumptions and exclusions, the Holders of the Notes will not
    recognize income, gain or loss for U.S.&#160;federal income tax
    purposes, as applicable, as a result of such Legal Defeasance
    and will be subject to U.S.&#160;federal income tax on the same
    amounts, in the same manner and at the same times as would have
    been the case if such Legal Defeasance had not occurred;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;in the case of Covenant Defeasance, the Issuer shall
    have delivered to the Trustee an Opinion of Counsel reasonably
    acceptable to the Trustee confirming that, subject to customary
    assumptions and exclusions, the Holders of the Notes will not
    recognize income, gain or loss for U.S.&#160;federal income tax
    purposes as a result of such Covenant Defeasance and will be
    subject to such tax on the same amounts, in the same manner and
    at the same times as would have been the case if such Covenant
    Defeasance had not occurred;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;no Default (other than that resulting from borrowing
    funds to be applied to make such deposit and any similar and
    simultaneous deposit relating to other Indebtedness and, in each
    case, the granting of Liens in connection therewith) shall have
    occurred and be continuing on the date of such deposit;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;such Legal Defeasance or Covenant Defeasance shall not
    result in a breach or violation of, or constitute a default
    under the Senior Credit Facilities or any other material
    agreement or instrument (other than the Indenture) to which the
    Issuer or any Guarantor is a party or by which the Issuer or any
    Guarantor is bound (other than that resulting from borrowing
    funds to be applied to make such deposit and any similar and
    simultaneous deposit relating to other Indebtedness and, in each
    case, the granting of Liens in connection therewith);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;the Issuer shall have delivered to the Trustee an
    Opinion of Counsel to the effect that, as of the date of such
    opinion and subject to customary assumptions and exclusions
    following the deposit, the trust funds will not be subject to
    the effect of Section&#160;547 of Title&#160;11 of the United
    States Code;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;the Issuer shall have delivered to the Trustee an
    Officer&#146;s Certificate stating that the deposit was not made
    by the Issuer with the intent of defeating, hindering, delaying
    or defrauding any creditors of the Issuer or any Guarantor or
    others;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;the Issuer shall have delivered to the Trustee an
    Officer&#146;s Certificate and an Opinion of Counsel (which
    Opinion of Counsel may be subject to customary assumptions and
    exclusions) each stating that all conditions precedent provided
    for or relating to the Legal Defeasance or the Covenant
    Defeasance, as the case may be, have been complied with.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Satisfaction
    and Discharge</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture will be discharged and will cease to be of further
    effect as to all Notes, when either:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;all Notes theretofore authenticated and delivered,
    except lost, stolen or destroyed Notes which have been replaced
    or paid and Notes for whose payment money has theretofore been
    deposited in trust, have been delivered to the Trustee for
    cancellation;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;(a)&#160;all Notes not theretofore delivered to the
    Trustee for cancellation have become due and payable by reason
    of the making of a notice of redemption or otherwise, will
    become due and payable within one year or may be called for
    redemption within one year under arrangements satisfactory to
    the Trustee for the giving of notice of redemption by the
    Trustee in the name, and at the expense, of the
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    228
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Issuer, and the Issuer or any Guarantor has irrevocably
    deposited or caused to be deposited with the Trustee as trust
    funds in trust solely for the benefit of the Holders of the
    Notes, cash in U.S.&#160;dollars, Government Securities, or a
    combination thereof, in such amounts as will be sufficient
    without consideration of any reinvestment of interest to pay and
    discharge the entire indebtedness on the Notes not theretofore
    delivered to the Trustee for cancellation for principal,
    premium, if any, and accrued interest to the date of maturity or
    redemption;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;no Default (other than that resulting from borrowing
    funds to be applied to make such deposit and any similar and
    simultaneous deposit relating to other Indebtedness and, in each
    case, the granting of Liens in connection therewith) with
    respect to the Indenture or the Notes shall have occurred and be
    continuing on the date of such deposit or shall occur as a
    result of such deposit, and such deposit will not result in a
    breach or violation of, or constitute a default under, the
    Senior Credit Facilities or any other material agreement or
    instrument (other than the Indenture) to which the Issuer or any
    Guarantor is a party or by which the Issuer or any Guarantor is
    bound (other than that resulting from borrowing funds to be
    applied to make such deposit and any similar and simultaneous
    deposit relating to other Indebtedness and, in each case, the
    granting of Liens in connection therewith);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;the Issuer has paid or caused to be paid all sums
    payable by it under the Indenture;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;the Issuer has delivered irrevocable instructions to
    the Trustee to apply the deposited money toward the payment of
    the Notes at maturity or the redemption date, as the case may be.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, the Issuer must deliver an Officer&#146;s
    Certificate and an Opinion of Counsel to the Trustee stating
    that all conditions precedent to satisfaction and discharge have
    been satisfied.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Amendment,
    Supplement and Waiver</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Except as provided in the next two succeeding paragraphs, the
    Indenture, any Guarantee, any Security Document and the Notes
    may be amended or supplemented with the consent of the Holders
    of at least a majority in principal amount of the Notes then
    outstanding, including consents obtained in connection with a
    purchase of, or tender offer or exchange offer for, Notes, and
    any existing Default or compliance with any provision of the
    Indenture, the Notes issued thereunder, any Guarantee or the
    Security Documents may be waived with the consent of the Holders
    of a majority in principal amount of the then outstanding Notes,
    other than Notes beneficially owned by the Issuer or its
    Affiliates (including consents obtained in connection with a
    purchase of or tender offer or exchange offer for the Notes).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that, without the consent of each
    affected Holder of Notes, an amendment or waiver may not, with
    respect to any Notes held by a non-consenting Holder:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;reduce the principal amount of such Notes whose Holders
    must consent to an amendment, supplement or waiver;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;reduce the principal of or change the fixed final
    maturity of any such Note or alter or waive the provisions with
    respect to the redemption of such Notes (other than provisions
    relating to the covenants described above under the caption
    &#147;Repurchase at the Option of Holders&#148;);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;reduce the rate of or change the time for payment of
    interest on any Note;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;waive a Default in the payment of principal of or
    premium, if any, or interest on the Notes, except a rescission
    of acceleration of the Notes by the Holders of at least a
    majority in aggregate principal amount of the Notes and a waiver
    of the payment default that resulted from such acceleration, or
    in respect of a covenant or provision contained in the Indenture
    or any Guarantee which cannot be amended or modified without the
    consent of all Holders;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;make any Note payable in money other than that stated
    therein;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;make any change in the provisions of the Indenture
    relating to waivers of past Defaults or the rights of Holders to
    receive payments of principal of or premium, if any, or interest
    on the Notes;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    229
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;make any change in these amendment and waiver
    provisions;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;impair the right of any Holder to receive payment of
    principal of, or interest on such Holder&#146;s Notes on or
    after the due dates therefor or to institute suit for the
    enforcement of any payment on or with respect to such
    Holder&#146;s Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;make any change to or modify the ranking of the Notes
    or the subordination of the Liens with respect to the Notes that
    would adversely affect the Holders;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;except as expressly permitted by the Indenture, modify
    the Guarantees of any Significant Subsidiary in any manner
    adverse to the Holders of the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, without the consent of at least 75% in aggregate
    principal amount of Notes then outstanding, an amendment,
    supplement or waiver may not:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;modify any Security Document or the provisions of the
    Indenture dealing with the Security Documents or application of
    trust moneys, or otherwise release any Collateral, in any manner
    materially adverse to the Holders other than in accordance with
    the Indenture, the Security Documents and the Intercreditor
    Agreements;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;modify any Intercreditor Agreement in any manner
    materially adverse to the Holders other than in accordance with
    the Indenture, the Security Documents and the Intercreditor
    Agreements.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding the foregoing, the Issuer, any Guarantor (with
    respect to a Guarantee or the Indenture to which it is a party)
    and the Trustee may amend or supplement the Indenture, any
    Security Document and any Guarantee or Notes without the consent
    of any Holder;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;to cure any ambiguity, omission, mistake, defect or
    inconsistency;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;to provide for uncertificated Notes of such series in
    addition to or in place of certificated Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;to comply with the covenant relating to mergers,
    consolidations and sales of assets;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;to provide for the assumption of the Issuer&#146;s or
    any Guarantor&#146;s obligations to the Holders;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;to make any change that would provide any additional
    rights or benefits to the Holders or that does not adversely
    affect the legal rights under the Indenture of any such Holder;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;to add covenants for the benefit of the Holders or to
    surrender any right or power conferred upon the Issuer or any
    Guarantor;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;to comply with requirements of the SEC in order to
    effect or maintain the qualification of the Indenture under the
    Trust&#160;Indenture Act;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;to evidence and provide for the acceptance and
    appointment under the Indenture of a successor Trustee
    thereunder pursuant to the requirements thereof;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;to provide for the issuance of Exchange Notes or
    private exchange notes, which are identical to Exchange Notes
    except that they are not freely transferable;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;to add a Guarantor under the Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;to conform the text of the Indenture, Security
    Documents, Guarantees or the Notes to any provision of this
    &#147;Description of Notes&#148; to the extent that such
    provision in this &#147;Description of Notes&#148; was intended
    to be a verbatim recitation of a provision of the Indenture,
    Security Documents, Guarantee or Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;to make any amendment to the provisions of the
    Indenture relating to the transfer and legending of Notes as
    permitted by the Indenture, including, without limitation to
    facilitate the issuance and administration of the Notes;
    <I>provided</I>, <I>however</I>, that (i)&#160;compliance with
    the Indenture as so amended would not result in Notes being
    transferred in violation of the Securities Act or any applicable
    securities
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    230
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    law and (ii)&#160;such amendment does not materially and
    adversely affect the rights of Holders to transfer Notes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;to mortgage, pledge, hypothecate or grant any other
    Lien in favor of the Trustee for the benefit of the Holders of
    the Notes, as additional security for the payment and
    performance of all or any portion of the Obligations, in any
    property or assets, including any which are required to be
    mortgaged, pledged or hypothecated, or in which a Lien is
    required to be granted to or for the benefit of the Trustee or
    the Collateral Agent pursuant to the Indenture, any of the
    Security Documents or otherwise;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (14)&#160;to release Collateral from the Lien of the Indenture
    and the Security Documents when permitted or required by the
    Security Documents or the Indenture;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (15)&#160;to add Additional First Lien Secured Parties or
    additional ABL Secured Parties, to any Security Documents.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The consent of the Holders is not necessary under the Indenture
    to approve the particular form of any proposed amendment. It is
    sufficient if such consent approves the substance of the
    proposed amendment.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Notices</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notices given by publication will be deemed given on the first
    date on which publication is made and notices given by
    first-class mail, postage prepaid, will be deemed given five
    calendar days after mailing.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Concerning
    the Trustee</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture contains certain limitations on the rights of the
    Trustee thereunder, should it become a creditor of the Issuer,
    to obtain payment of claims in certain cases, or to realize on
    certain property received in respect of any such claim as
    security or otherwise. The Trustee is permitted to engage in
    other transactions; however, if it acquires any conflicting
    interest it must eliminate such conflict within 90&#160;days,
    apply to the SEC for permission to continue or resign.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture provides that the Holders of a majority in
    principal amount of the outstanding Notes will have the right to
    direct the time, method and place of conducting any proceeding
    for exercising any remedy available to the Trustee, subject to
    certain exceptions. The Indenture provides that in case an Event
    of Default shall occur (which shall not be cured), the Trustee
    will be required, in the exercise of its power, to use the
    degree of care of a prudent person in the conduct of his own
    affairs. Subject to such provisions, the Trustee is under no
    obligation to exercise any of its rights or powers under the
    Indenture at the request of any Holder of the Notes, unless such
    Holder shall have offered to the Trustee security and indemnity
    satisfactory to it against any loss, liability or expense.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Governing
    Law</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Indenture, the Notes and any Guarantee are governed by and
    construed in accordance with the laws of the State of New York.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Certain
    Definitions</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Set forth below are certain defined terms used in the Indenture.
    For purposes of the Indenture, unless otherwise specifically
    indicated, the term <I>&#147;consolidated&#148; </I>with respect
    to any Person refers to such Person on a consolidated basis in
    accordance with GAAP, but excluding from such consolidation any
    Unrestricted Subsidiary as if such Unrestricted Subsidiary were
    not an Affiliate of such Person.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;2006 Second Priority Notes&#148; </I>means the
    $1,000,000,000 aggregate principal amount of
    9<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;Senior
    Secured Notes due 2014, the $3,200,000,000 aggregate principal
    amount of
    9<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">4</FONT>%&#160;Senior
    Secured Notes due 2016 and the $1,500,000,000
    9<FONT style="vertical-align: text-top; font-size: 70%;">5</FONT>/<FONT style="font-size: 70%;">8</FONT>%/10<FONT style="vertical-align: text-top; font-size: 70%;">3</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;Senior
    Secured Toggle Notes due 2016, each issued by the Issuer under
    the 2006 Second Priority Notes Indenture.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    231
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;2006 Second Priority Notes Indenture&#148; </I>means
    that certain Indenture, dated as of November&#160;17, 2006,
    among the Issuer, the guarantors named on Schedule&#160;I
    thereto and The Bank of New York, as trustee.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;2009 Second Priority Notes&#148; </I>means the
    $310,000,000 aggregate principal amount of
    9<FONT style="vertical-align: text-top; font-size: 70%;">7</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;Senior
    Secured Notes due 2017, issued by the Issuer under the 2009
    Second Priority Notes Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;2009 Second Priority Notes Indenture&#148; </I>means
    that certain Indenture, dated as of February&#160;19, 2009,
    among the Issuer, the guarantors named on Schedule&#160;I
    thereto, The Bank of New York Mellon Trust&#160;Company, N.A.,
    as trustee, and The Bank of New York Mellon, as collateral agent.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;ABL Facility&#148; </I>means the Amended and Restated
    Asset-Based Revolving Credit Agreement, dated as of
    June&#160;20, 2007, by and among the Issuer, the lenders party
    thereto in their capacities as lenders thereunder and Bank of
    America, N.A., as Administrative Agent, as amended as of
    March&#160;2, 2009, including any guarantees, collateral
    documents, instruments and agreements executed in connection
    therewith, and any amendments, supplements, modifications,
    extensions, renewals, restatements, refundings or refinancings
    thereof and any indentures or credit facilities or commercial
    paper facilities with banks or other institutional lenders or
    investors that replace, refund or refinance any part of the
    loans, notes, other credit facilities or commitments thereunder,
    including any such replacement, refunding or refinancing
    facility or indenture that increases the amount borrowable
    thereunder or alters the maturity thereof (<I>provided </I>that
    such increase in borrowings is permitted under &#147;Certain
    Covenants &#151;&#160;Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock&#148;
    above).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;ABL Facility Cap&#148; </I>means an amount equal to the
    greater of (x)&#160;$2,000.0&#160;million and (y)&#160;75% of
    the consolidated accounts receivable of the Issuer and its
    subsidiaries determined in accordance with GAAP.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;ABL Financing Entity&#148; </I>means the Issuer and
    certain of its subsidiaries from time to time named as borrowers
    or guarantors under the ABL Facility.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;ABL Obligations&#148; </I>means Obligations under the
    ABL Facility.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;ABL Secured Parties&#148; </I>means each of
    (i)&#160;the ABL Collateral Agent on behalf of itself and the
    lenders under the ABL Facility and lenders or their affiliates
    counterparty to related Hedging Obligations and (ii)&#160;each
    other holder of ABL Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Acquired Indebtedness&#148; </I>means, with respect to
    any specified Person,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;Indebtedness of any other Person existing at the time
    such other Person is merged with or into or became a Restricted
    Subsidiary of such specified Person, including Indebtedness
    incurred in connection with, or in contemplation of, such other
    Person merging with or into or becoming a Restricted Subsidiary
    of such specified Person,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;Indebtedness secured by a Lien encumbering any asset
    acquired by such specified Person.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Additional First Lien Obligations&#148; </I>shall have
    the meaning given such term by the U.S.&#160;Security Agreement
    and shall include the Notes Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Additional First Lien Secured Party&#148; </I>means the
    holders of any Additional First Lien Obligations, including the
    Holders, and any Authorized Representative with respect thereto,
    including the Trustee.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Additional General Intercreditor Agreement&#148;
    </I>has the meaning set forth under &#147;Security&#160;&#151;
    Additional General Intercreditor Agreement.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Additional Interest&#148; </I>means all additional
    interest then owing pursuant to the Registration Rights
    Agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Additional Receivables Intercreditor Agreement&#148;
    </I>has the meaning set forth under &#147;Security&#160;&#151;
    Additional Receivables Intercreditor Agreement.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Affiliate&#148; </I>of any specified Person means any
    other Person directly or indirectly controlling or controlled by
    or under direct or indirect common control with such specified
    Person. For purposes of this definition, &#147;control&#148;
    (including, with correlative meanings, the terms
    &#147;controlling,&#148; &#147;controlled by&#148; and
    &#147;under common
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    232
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    control with&#148;), as used with respect to any Person, shall
    mean the possession, directly or indirectly, of the power to
    direct or cause the direction of the management or policies of
    such Person, whether through the ownership of voting securities,
    by agreement or otherwise.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Applicable Authorized Representative&#148; </I>means,
    with respect to any Common Collateral, (i)&#160;until the
    earlier of (x)&#160;the Discharge of General Credit Facility
    Obligations and (y)&#160;the Non-Controlling Authorized
    Representative Enforcement Date, the administrative agent under
    the General Credit Facility and (ii)&#160;from and after the
    earlier of (x)&#160;the Discharge of General Credit Facility
    Obligations and (y)&#160;the Non-Controlling Authorized
    Representative Enforcement Date, the Major Non-Controlling
    Authorized Representative.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Applicable Premium&#148; </I>means, with respect to any
    Note on any Redemption&#160;Date, the greater of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;1.0% of the principal amount of such Note;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the excess, if any, of (a)&#160;the present value at
    such Redemption&#160;Date of (i)&#160;the redemption price of
    such Note at April&#160;15, 2014 (such redemption price being
    set forth in the tables appearing above under the caption
    &#147;Optional Redemption&#148;), plus (ii)&#160;all required
    interest payments due on such Note through April&#160;15, 2014
    (excluding accrued but unpaid interest to the
    Redemption&#160;Date), computed using a discount rate equal to
    the Treasury Rate as of such Redemption&#160;Date plus
    50&#160;basis points; over (b)&#160;the principal amount of such
    Note.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Asset Sale&#148; </I>means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the sale, conveyance, transfer or other disposition,
    whether in a single transaction or a series of related
    transactions, of property or assets (including by way of a Sale
    and Lease-Back Transaction) of the Issuer or any of its
    Restricted Subsidiaries (each referred to in this definition as
    a &#147;disposition&#148;);&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the issuance or sale of Equity Interests of any
    Restricted Subsidiary, whether in a single transaction or a
    series of related transactions (other than Preferred Stock of
    Restricted Subsidiaries issued in compliance with the covenant
    described under &#147;Certain Covenants&#160;&#151; Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock&#148;);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    in each case, other than:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;any disposition of Cash Equivalents or Investment Grade
    Securities or obsolete or worn out equipment in the ordinary
    course of business or any disposition of inventory or goods (or
    other assets) held for sale in the ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the disposition of all or substantially all of the
    assets of the Issuer in a manner permitted pursuant to the
    provisions described above under &#147;Certain
    Covenants&#160;&#151; Merger, Consolidation or Sale of All or
    Substantially All Assets&#148; or any disposition that
    constitutes a Change of Control pursuant to the Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;the making of any Restricted Payment or Permitted
    Investment that is permitted to be made, and is made, under the
    covenant described above under &#147;Certain
    Covenants&#160;&#151; Limitation on Restricted Payments&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;any disposition of assets or issuance or sale of Equity
    Interests of any Restricted Subsidiary in any transaction or
    series of related transactions with an aggregate fair market
    value of less than $100.0&#160;million;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;any disposition of property or assets or issuance of
    securities by a Restricted Subsidiary of the Issuer to the
    Issuer or by the Issuer or a Restricted Subsidiary of the Issuer
    to another Restricted Subsidiary of the Issuer;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (f)&#160;to the extent allowable under Section&#160;1031 of the
    Code or any comparable or successor provision, any exchange of
    like property (excluding any boot thereon) for use in a Similar
    Business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (g)&#160;the lease, assignment or
    <FONT style="white-space: nowrap">sub-lease</FONT> of
    any real or personal property in the ordinary course of business;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    233
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (h)&#160;any issuance or sale of Equity Interests in, or
    Indebtedness or other securities of, an Unrestricted Subsidiary;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (i)&#160;foreclosures on assets;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (j)&#160;sales of accounts receivable, or participations
    therein, in connection with the ABL Facility or any Receivables
    Facility;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (k)&#160;any financing transaction with respect to property
    built or acquired by the Issuer or any Restricted Subsidiary
    after November&#160;17, 2006, including Sale and Lease-Back
    Transactions and asset securitizations permitted by the
    Indenture;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (l)&#160;dispositions in the ordinary course of business by any
    Restricted Subsidiary (including, without limitation, HCI)
    engaged in the insurance business in order to provide insurance
    to the Issuer and its Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (m)&#160;sales, transfers and other dispositions of Investments
    in joint ventures to the extent required by, or made pursuant
    to, customary buy/sell arrangements between the joint venture
    parties set forth in joint venture arrangements and similar
    binding arrangements;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (n)&#160;any issuance or sale of Equity Interests or
    dispositions in connection with ordinary course syndications of
    Subsidiaries or joint ventures owning or operating one or more
    health care facilities, including, without limitation,
    hospitals, ambulatory surgery centers, outpatient diagnostic
    centers or imaging centers in any transaction or series of
    related transactions with an aggregate fair market value of less
    than $100.0&#160;million;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (o)&#160;any issuance or sale of Equity Interests of any
    Restricted Subsidiary (including, without limitation,
    HealthTrust Purchasing Group, L.P.) to any Person operating in a
    Similar Business for which such Restricted Subsidiary provides
    shared purchasing, billing, collection or similar services in
    the ordinary course of business.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Asset Sale Offer&#148; </I>has the meaning set forth in
    the fourth paragraph under &#147;Repurchase at the Option of
    Holders&#160;&#151; Asset Sales.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Authorized Representative&#148; </I>means (i)&#160;in
    the case of any General Credit Facility Obligations or the
    General Credit Facility Secured Parties, the administrative
    agent under the General Credit Facility, (ii)&#160;in the case
    of the Notes Obligations or the Holders, the Trustee and
    (iii)&#160;in the case of any Series of Additional First Lien
    Obligations or Additional First Lien Secured Parties that become
    subject to the First Lien Intercreditor Agreement, the
    Authorized Representative named for such Series in the
    applicable joinder agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Bankruptcy Code&#148; </I>means Title&#160;11 of the
    United States Code, as amended.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Bankruptcy Law&#148; </I>means the Bankruptcy Code and
    any similar federal, state or foreign law for the relief of
    debtors.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Business Day&#148; </I>means each day which is not a
    Legal Holiday.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Capital Stock&#148; </I>means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;in the case of a corporation, corporate stock;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;in the case of an association or business entity, any
    and all shares, interests, participations, rights or other
    equivalents (however designated) of corporate stock;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;in the case of a partnership or limited liability
    company, partnership or membership interests (whether general or
    limited);&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;any other interest or participation that confers on a
    Person the right to receive a share of the profits and losses
    of, or distributions of assets of, the issuing Person.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    234
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Capitalized Lease Obligation&#148; </I>means, at the
    time any determination thereof is to be made, the amount of the
    liability in respect of a capital lease that would at such time
    be required to be capitalized and reflected as a liability on a
    balance sheet (excluding the footnotes thereto) in accordance
    with GAAP.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Capitalized Software Expenditures&#148; </I>means, for
    any period, the aggregate of all expenditures (whether paid in
    cash or accrued as liabilities) by a Person and its Restricted
    Subsidiaries during such period in respect of purchased software
    or internally developed software and software enhancements that,
    in conformity with GAAP, are or are required to be reflected as
    capitalized costs on the consolidated balance sheet of a Person
    and its Restricted Subsidiaries.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Cash Equivalents&#148; </I>means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;United States dollars;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;euros or any national currency of any participating
    member state of the EMU or such local currencies held by the
    Company and its Restricted Subsidiaries from time to time in the
    ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;securities issued or directly and fully and
    unconditionally guaranteed or insured by the
    U.S.&#160;government (or any agency or instrumentality thereof
    the securities of which are unconditionally guaranteed as a full
    faith and credit obligation of the U.S.&#160;government) with
    maturities of 24&#160;months or less from the date of
    acquisition;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;certificates of deposit, time deposits and eurodollar
    time deposits with maturities of one year or less from the date
    of acquisition, bankers&#146; acceptances with maturities not
    exceeding one year and overnight bank deposits, in each case
    with any commercial bank having capital and surplus of not less
    than $500.0&#160;million in the case of U.S.&#160;banks and
    $100.0&#160;million (or the U.S.&#160;dollar equivalent as of
    the date of determination) in the case of
    <FONT style="white-space: nowrap">non-U.S.&#160;banks;</FONT>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;repurchase obligations for underlying securities of the
    types described in clauses&#160;(3) and (4)&#160;entered into
    with any financial institution meeting the qualifications
    specified in clause&#160;(4) above;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;commercial paper rated at least
    <FONT style="white-space: nowrap">P-1</FONT> by
    Moody&#146;s or at least
    <FONT style="white-space: nowrap">A-1</FONT> by
    S&#038;P and in each case maturing within 24&#160;months after
    the date of creation thereof;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;marketable short-term money market and similar
    securities having a rating of at least
    <FONT style="white-space: nowrap">P-2</FONT> or
    <FONT style="white-space: nowrap">A-2</FONT> from
    either Moody&#146;s or S&#038;P, respectively (or, if at any
    time neither Moody&#146;s nor S&#038;P shall be rating such
    obligations, an equivalent rating from another Rating Agency)
    and in each case maturing within 24&#160;months after the date
    of creation thereof;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;investment funds investing 95% of their assets in
    securities of the types described in clauses&#160;(1) through
    (7)&#160;above;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;readily marketable direct obligations issued by any
    state, commonwealth or territory of the United States or any
    political subdivision or taxing authority thereof having an
    Investment Grade Rating from either Moody&#146;s or S&#038;P
    with maturities of 24&#160;months or less from the date of
    acquisition;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;Indebtedness or Preferred Stock issued by Persons with
    a rating of A or higher from S&#038;P or A2 or higher from
    Moody&#146;s with maturities of 24&#160;months or less from the
    date of acquisition;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;Investments with average maturities of 24&#160;months
    or less from the date of acquisition in money market funds rated
    AAA- (or the equivalent thereof) or better by S&#038;P or Aaa3
    (or the equivalent thereof) or better by Moody&#146;s.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding the foregoing, Cash Equivalents shall include
    amounts denominated in currencies other than those set forth in
    clauses&#160;(1) and (2)&#160;above; <I>provided </I>that such
    amounts are converted into any currency listed in
    clauses&#160;(1) and (2)&#160;as promptly as practicable and in
    any event within ten Business Days following the receipt of such
    amounts.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    235
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Change of Control&#148; </I>means the occurrence of any
    of the following:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the sale, lease or transfer, in one or a series of
    related transactions, of all or substantially all of the assets
    of the Issuer and its Subsidiaries, taken as a whole, to any
    Person other than a Permitted Holder;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the Issuer becomes aware (by way of a report or any
    other filing pursuant to Section 13(d) of the Exchange Act,
    proxy, vote, written notice or otherwise) of the acquisition by
    any Person or group (within the meaning of Section&#160;13(d)(3)
    or Section&#160;14(d)(2) of the Exchange Act, or any successor
    provision), including any group acting for the purpose of
    acquiring, holding or disposing of securities (within the
    meaning of
    <FONT style="white-space: nowrap">Rule&#160;13d-5(b)(1)</FONT>
    under the Exchange Act), other than the Permitted Holders, in a
    single transaction or in a related series of transactions, by
    way of merger, consolidation or other business combination or
    purchase of beneficial ownership (within the meaning of
    <FONT style="white-space: nowrap">Rule&#160;13d-3</FONT>
    under the Exchange Act, or any successor provision) of 50% or
    more of the total voting power of the Voting Stock of the Issuer
    or any of its direct or indirect parent companies holding
    directly or indirectly 100% of the total voting power of the
    Voting Stock of the Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Code&#148; </I>means the Internal Revenue Code of 1986,
    as amended, or any successor thereto.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Collateral&#148; </I>means, collectively, the Shared
    Receivables Collateral and Non-Receivables Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Collateral Asset Sale Offer&#148; </I>has the meaning
    set forth in the third paragraph under &#147;Repurchase at the
    Option of Holders&#160;&#151; Asset Sales.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Collateral Excess Proceeds&#148; </I>has the meaning
    set forth in the third paragraph under &#147;Repurchase at the
    Option of Holders&#160;&#151; Asset Sales.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Common Collateral&#148; </I>means, at any time,
    Collateral in which the holders of two or more Series of First
    Lien Obligations (or their respective Authorized
    Representatives) hold a valid and perfected security interest at
    such time. If more than two Series of First Lien Obligations are
    outstanding at any time and the holders of less than all Series
    of First Lien Obligations hold a valid and perfected security
    interest in any Collateral at such time then such Collateral
    shall constitute Common Collateral for those Series of First
    Lien Obligations that hold a valid security interest in such
    Collateral at such time and shall not constitute Common
    Collateral for any Series which does not have a valid and
    perfected security interest in such Collateral at such time.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Consolidated Depreciation and Amortization
    Expense&#148; </I>means with respect to any Person for any
    period, the total amount of depreciation and amortization
    expense, including the amortization of deferred financing fees,
    debt issuance costs, commissions, fees and expenses and
    Capitalized Software Expenditures, of such Person and its
    Restricted Subsidiaries for such period on a consolidated basis
    and otherwise determined in accordance with GAAP.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Consolidated Interest Expense&#148; </I>means, with
    respect to any Person for any period, without duplication, the
    sum of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;consolidated interest expense of such Person and its
    Restricted Subsidiaries for such period, to the extent such
    expense was deducted (and not added back) in computing
    Consolidated Net Income (including (a)&#160;amortization of
    original issue discount resulting from the issuance of
    Indebtedness at less than par, (b)&#160;all commissions,
    discounts and other fees and charges owed with respect to
    letters of credit or bankers&#146; acceptances,
    (c)&#160;non-cash interest payments (but excluding any non-cash
    interest expense attributable to the movement in the mark to
    market valuation of Hedging Obligations or other derivative
    instruments pursuant to GAAP), (d)&#160;the interest component
    of Capitalized Lease Obligations, and (e)&#160;net payments, if
    any, pursuant to interest rate Hedging Obligations with respect
    to Indebtedness, and excluding (u)&#160;accretion or accrual of
    discounted liabilities not constituting Indebtedness,
    (v)&#160;any expense resulting from the discounting of the
    Existing Notes or other Indebtedness in connection with the
    application of recapitalization accounting or, if applicable,
    purchase accounting, (w)&#160;any Additional Interest and any
    comparable &#147;additional interest&#148; with respect to other
    securities, (x)&#160;amortization of deferred financing fees,
    debt issuance costs, commissions, fees and expenses,
    (y)&#160;any expensing of bridge,
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    236
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    commitment and other financing fees and (z)&#160;commissions,
    discounts, yield and other fees and charges (including any
    interest expense) related to any Receivables Facility); plus
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;consolidated capitalized interest of such Person and
    its Restricted Subsidiaries for such period, whether paid or
    accrued; less
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;interest income for such period.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For purposes of this definition, interest on a Capitalized Lease
    Obligation shall be deemed to accrue at an interest rate
    reasonably determined by such Person to be the rate of interest
    implicit in such Capitalized Lease Obligation in accordance with
    GAAP.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Consolidated Leverage Ratio&#148;</I>, with respect to
    any Person as of any date of determination, means the ratio of
    (x)&#160;Consolidated Total Indebtedness of such Person as of
    the end of the most recent fiscal quarter for which internal
    financial statements are available immediately preceding the
    date on which such event for which such calculation is being
    made shall occur to (y)&#160;the aggregate amount of EBITDA of
    such Person for the period of the most recently ended four full
    consecutive fiscal quarters for which internal financial
    statements are available immediately preceding the date on which
    such event for which such calculation is being made shall occur,
    in each case with such pro forma adjustments to Consolidated
    Total Indebtedness and EBITDA as are appropriate and consistent
    with the pro forma adjustment provisions set forth in the
    definition of &#147;Fixed Charge Coverage Ratio.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Consolidated Net Income&#148; </I>means, with respect
    to any Person for any period, the aggregate of the Net Income of
    such Person for such period, on a consolidated basis, and
    otherwise determined in accordance with GAAP; <I>provided</I>,
    <I>however</I>, that, without duplication,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any after-tax effect of extraordinary, non-recurring or
    unusual gains or losses (less all fees and expenses relating
    thereto) or expenses, severance, relocation costs, consolidation
    and closing costs, integration and facilities opening costs,
    business optimization costs, transition costs, restructuring
    costs, signing, retention or completion bonuses, and
    curtailments or modifications to pension and post-retirement
    employee benefit plans shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the cumulative effect of a change in accounting
    principles during such period shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;any after-tax effect of income (loss) from disposed,
    abandoned or discontinued operations and any net after-tax gains
    or losses on disposal of disposed, abandoned, transferred,
    closed or discontinued operations shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;any after-tax effect of gains or losses (less all fees
    and expenses relating thereto) attributable to asset
    dispositions or abandonments other than in the ordinary course
    of business, as determined in good faith by the Issuer, shall be
    excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;the Net Income for such period of any Person that is an
    Unrestricted Subsidiary shall be excluded, and, solely for the
    purpose of determining the amount available for Restricted
    Payments under clause&#160;3(a) of the first paragraph of
    &#147;Certain Covenants&#160;&#151; Limitation on Restricted
    Payments,&#148; the Net Income for such period of any Person
    that is not a Subsidiary or that is accounted for by the equity
    method of accounting shall be excluded; <I>provided </I>that
    Consolidated Net Income of the Issuer shall be increased by the
    amount of dividends or distributions or other payments that are
    actually paid in cash (or to the extent converted into cash) to
    the referent Person or a Restricted Subsidiary thereof in
    respect of such period,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;solely for the purpose of determining the amount
    available for Restricted Payments under clause (3)(a) of the
    first paragraph of &#147;Certain Covenants&#160;&#151;
    Limitation on Restricted Payments,&#148; the Net Income for such
    period of any Restricted Subsidiary (other than any Guarantor)
    shall be excluded to the extent that the declaration or payment
    of dividends or similar distributions by that Restricted
    Subsidiary of its Net Income is not at the date of determination
    wholly permitted without any prior governmental approval (which
    has not been obtained) or, directly or indirectly, by the
    operation of the terms of its charter or any agreement,
    instrument, judgment, decree, order, statute, rule, or
    governmental regulation applicable to that Restricted Subsidiary
    or its stockholders, unless such restriction with respect to the
    payment of dividends or similar
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    237
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    distributions has been legally waived; <I>provided</I> that
    Consolidated Net Income of the Issuer will be increased by the
    amount of dividends or other distributions or other payments
    actually paid in cash (or to the extent converted into cash) or
    Cash Equivalents to the Issuer or a Restricted Subsidiary
    thereof in respect of such period, to the extent not already
    included therein,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;effects of adjustments (including the effects of such
    adjustments pushed down to the Issuer and its Restricted
    Subsidiaries) in the property, equipment, inventory, software
    and other intangible assets, deferred revenues and debt line
    items in such Person&#146;s consolidated financial statements
    pursuant to GAAP resulting from the application of
    recapitalization accounting or, if applicable, purchase
    accounting in relation to the Transactions or any consummated
    acquisition or the amortization or write-off of any amounts
    thereof, net of taxes, shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;any after-tax effect of income (loss) from the early
    extinguishment of Indebtedness or Hedging Obligations or other
    derivative instruments shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;any impairment charge or asset write-off, including,
    without limitation, impairment charges or asset write-offs
    related to intangible assets, long-lived assets or investments
    in debt and equity securities, in each case, pursuant to GAAP
    and the amortization of intangibles arising pursuant to GAAP
    shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;any non-cash compensation expense recorded from grants
    of stock appreciation or similar rights, stock options,
    restricted stock or other rights, and any cash charges
    associated with the rollover, acceleration or payout of Equity
    Interests by management of the Company or any of its direct or
    indirect parent companies in connection with the Transaction,
    shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;any fees and expenses incurred during such period, or
    any amortization thereof for such period, in connection with any
    acquisition, Investment, Asset Sale, issuance or repayment of
    Indebtedness, issuance of Equity Interests, refinancing
    transaction or amendment or modification of any debt instrument
    (in each case, including any such transaction consummated prior
    to the Issue Date and any such transaction undertaken but not
    completed) and any charges or non-recurring merger costs
    incurred during such period as a result of any such transaction
    shall be excluded,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;accruals and reserves that are established or adjusted
    within twelve months after November&#160;17, 2006 that are so
    required to be established as a result of the Transaction in
    accordance with GAAP, or changes as a result of adoption or
    modification of accounting policies, shall be excluded,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;to the extent covered by insurance and actually
    reimbursed, or, so long as the Issuer has made a determination
    that there exists reasonable evidence that such amount will in
    fact be reimbursed by the insurer and only to the extent that
    such amount is (a)&#160;not denied by the applicable carrier in
    writing within 180&#160;days and (b)&#160;in fact reimbursed
    within 365&#160;days of the date of such evidence (with a
    deduction for any amount so added back to the extent not so
    reimbursed within 365&#160;days), expenses with respect to
    liability or casualty events or business interruption shall be
    excluded.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notwithstanding the foregoing, for the purpose of the covenant
    described under &#147;Certain Covenants&#160;&#151; Limitation
    on Restricted Payments&#148; only (other than clause (3)(d)
    thereof), there shall be excluded from Consolidated Net Income
    any income arising from any sale or other disposition of
    Restricted Investments made by the Issuer and its Restricted
    Subsidiaries, any repurchases and redemptions of Restricted
    Investments from the Issuer and its Restricted Subsidiaries, any
    repayments of loans and advances which constitute Restricted
    Investments by the Issuer or any of its Restricted Subsidiaries,
    any sale of the stock of an Unrestricted Subsidiary or any
    distribution or dividend from an Unrestricted Subsidiary, in
    each case only to the extent such amounts increase the amount of
    Restricted Payments permitted under such covenant pursuant to
    clause (3)(d) thereof.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Consolidated Net Tangible Assets&#148; </I>means the
    total amount of assets (less applicable reserves and other
    properly deductible items) after deducting therefrom
    (a)&#160;all current liabilities as disclosed on the
    consolidated balance sheet of the Issuer (excluding any thereof
    which are by their terms extendible or renewable at the option
    of the obligor thereon to a time more than 12&#160;months after
    the time as of which the amount thereof is being computed and
    further excluding any deferred income taxes that are included in
    current liabilities) and
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    238
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;all goodwill, trade names, trademarks, patents,
    unamortized debt discount and expense and other like intangible
    assets, all as set forth on the most recent consolidated balance
    sheet of the Issuer and computed in accordance with generally
    accepted accounting principles.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Consolidated Secured Debt Ratio&#148; </I>as of any
    date of determination, means the ratio of (1)&#160;Consolidated
    Total Indebtedness of the Issuer and its Restricted Subsidiaries
    that is secured by Liens as of the end of the most recent fiscal
    period for which internal financial statements are available
    immediately preceding the date on which such event for which
    such calculation is being made shall occur to (2)&#160;the
    Issuer&#146;s EBITDA for the most recently ended four full
    fiscal quarters for which internal financial statements are
    available immediately preceding the date on which such event for
    which such calculation is being made shall occur, in each case
    with such pro forma adjustments to Consolidated Total
    Indebtedness and EBITDA as are appropriate and consistent with
    the pro forma adjustment provisions set forth in the definition
    of &#147;Fixed Charge Coverage Ratio.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Consolidated Total Indebtedness&#148; </I>means, as at
    any date of determination, an amount equal to the sum of
    (1)&#160;the aggregate amount of all outstanding Indebtedness of
    the Issuer and its Restricted Subsidiaries on a consolidated
    basis consisting of Indebtedness for borrowed money, Obligations
    in respect of Capitalized Lease Obligations and debt obligations
    evidenced by promissory notes and similar instruments (and
    excluding, for the avoidance of doubt, all obligations relating
    to Receivables Facilities) and (2)&#160;the aggregate amount of
    all outstanding Disqualified Stock of the Issuer and all
    Preferred Stock of its Restricted Subsidiaries on a consolidated
    basis, with the amount of such Disqualified Stock and Preferred
    Stock equal to the greater of their respective voluntary or
    involuntary liquidation preferences and maximum fixed repurchase
    prices, in each case determined on a consolidated basis in
    accordance with GAAP. For purposes hereof, the &#147;maximum
    fixed repurchase price&#148; of any Disqualified Stock or
    Preferred Stock that does not have a fixed repurchase price
    shall be calculated in accordance with the terms of such
    Disqualified Stock or Preferred Stock as if such Disqualified
    Stock or Preferred Stock were purchased on any date on which
    Consolidated Total Indebtedness shall be required to be
    determined pursuant to the Indenture, and if such price is based
    upon, or measured by, the fair market value of such Disqualified
    Stock or Preferred Stock, such fair market value shall be
    determined reasonably and in good faith by the Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Contingent Obligations&#148; </I>means, with respect to
    any Person, any obligation of such Person guaranteeing any
    leases, dividends or other obligations that do not constitute
    Indebtedness <I>(&#147;primary obligations&#148;</I>) of any
    other Person (the <I>&#147;primary obligor&#148;</I>) in any
    manner, whether directly or indirectly, including, without
    limitation, any obligation of such Person, whether or not
    contingent,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;to purchase any such primary obligation or any property
    constituting direct or indirect security therefor,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;to advance or supply funds
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;for the purchase or payment of any such primary
    obligation,&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;to maintain working capital or equity capital of the
    primary obligor or otherwise to maintain the net worth or
    solvency of the primary obligor,&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;to purchase property, securities or services primarily
    for the purpose of assuring the owner of any such primary
    obligation of the ability of the primary obligor to make payment
    of such primary obligation against loss in respect thereof.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Controlling Secured Parties&#148; </I>means, with
    respect to any Common Collateral, the Series of First Lien
    Secured Parties whose Authorized Representative is the
    Applicable Authorized Representative for such Common Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Credit Facilities&#148; </I>means, with respect to the
    Issuer or any of its Restricted Subsidiaries, one or more debt
    facilities, including the Senior Credit Facilities, or other
    financing arrangements (including, without limitation,
    commercial paper facilities or indentures) providing for
    revolving credit loans, term loans, letters of credit or other
    long-term indebtedness, including any notes, mortgages,
    guarantees, collateral documents, instruments and agreements
    executed in connection therewith, and any amendments,
    supplements,
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    239
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    modifications, extensions, renewals, restatements or refundings
    thereof and any indentures or credit facilities or commercial
    paper facilities that replace, refund or refinance any part of
    the loans, notes, other credit facilities or commitments
    thereunder, including any such replacement, refunding or
    refinancing facility or indenture that increases the amount
    permitted to be borrowed thereunder or alters the maturity
    thereof (<I>provided </I>that such increase in borrowings is
    permitted under &#147;Certain Covenants &#151;&#160;Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock&#148;) or adds Restricted Subsidiaries as
    additional borrowers or guarantors thereunder and whether by the
    same or any other agent, lender or group of lenders.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Default&#148; </I>means any event that is, or with the
    passage of time or the giving of notice or both would be, an
    Event of Default.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Delayed Equity Amount&#148; </I>means any equity
    contribution of the Investors, the Frist Entities or certain
    other management investors described in the Offering Memorandum
    on or before March&#160;31, 2007, the proceeds of which are used
    to repay borrowings under the senior secured revolving credit
    facility included in the General Credit Facility or the ABL
    Facility in the manner described in the Offering Memorandum.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Designated Non-cash Consideration&#148; </I>means the
    fair market value of non-cash consideration received by the
    Issuer or a Restricted Subsidiary in connection with an Asset
    Sale that is so designated as Designated Non-cash Consideration
    pursuant to an Officer&#146;s Certificate, setting forth the
    basis of such valuation, executed by the principal financial
    officer of the Issuer, less the amount of cash or Cash
    Equivalents received in connection with a subsequent sale of or
    collection on such Designated Non-cash Consideration.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Designated Preferred Stock&#148; </I>means Preferred
    Stock of the Issuer or any parent corporation thereof (in each
    case other than Disqualified Stock) that is issued for cash
    (other than to a Restricted Subsidiary or an employee stock
    ownership plan or trust established by the Issuer or any of its
    Subsidiaries) and is so designated as Designated Preferred
    Stock, pursuant to an Officer&#146;s Certificate executed by the
    principal financial officer of the Issuer or the applicable
    parent corporation thereof, as the case may be, on the issuance
    date thereof, the cash proceeds of which are excluded from the
    calculation set forth in clause&#160;(3) of the first paragraph
    under &#147;Certain Covenants&#160;&#151; Limitation on
    Restricted Payments.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Discharge of New First Lien Obligations&#148;
    </I>means, except to the extent any such New First Lien
    Obligations are reinstated pursuant to the Additional General
    Intercreditor Agreement, the discharge or legal defeasance or
    covenant defeasance of the Indenture in accordance with its
    terms; <I>provided </I>that the Discharge of New First Lien
    Obligations shall not be deemed to have occurred if such
    payments are made with proceeds of other New First Lien
    Obligations that constitute and exchange or replacement for or a
    refinancing, in whole or in part, of such New First Lien
    Obligations. In the event the New First Lien Obligations are
    modified and such Obligations are paid over time or otherwise
    modified pursuant to Section&#160;1129 of the Bankruptcy Code,
    the New First Lien Obligations shall be deemed to be discharged
    when the final payment is made, in cash, in respect of such
    indebtedness and any obligations pursuant to such new
    indebtedness shall have been satisfied.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Discharge of General Credit Facility Obligations&#148;
    </I>means, with respect to any Common Collateral, the date on
    which the General Credit Facility Obligations are no longer
    secured by such Common Collateral; <I>provided </I>that the
    Discharge of General Credit Facility Obligations shall not be
    deemed to have occurred in connection with a refinancing of such
    General Credit Facility Obligations with additional First Lien
    Obligations secured by such Common Collateral under an agreement
    relating to Additional First Lien Obligations which has been
    designated in writing by the administrative agent under the
    General Credit Facility so refinanced to the First Lien
    Collateral Agent and each other Authorized Representative as the
    General Credit Facility for purposes of the First Lien
    Intercreditor Agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Disqualified Stock&#148; </I>means, with respect to any
    Person, any Capital Stock of such Person which, by its terms, or
    by the terms of any security into which it is convertible or for
    which it is putable or exchangeable, or upon the happening of
    any event, matures or is mandatorily redeemable (other than
    solely as a result of a change of control or asset sale)
    pursuant to a sinking fund obligation or otherwise, or is
    redeemable at the option of the holder thereof (other than
    solely as a result of a change of control or asset sale), in
    whole or in part, in each case prior to the date 91&#160;days
    after the earlier of the maturity date of the Notes or the date
    the
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    240
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Notes are no longer outstanding; <I>provided</I>,
    <I>however</I>, that if such Capital Stock is issued to any plan
    for the benefit of employees of the Issuer or its Subsidiaries
    or by any such plan to such employees, such Capital Stock shall
    not constitute Disqualified Stock solely because it may be
    required to be repurchased by the Issuer or its Subsidiaries in
    order to satisfy applicable statutory or regulatory obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;EBITDA&#148; </I>means, with respect to any Person for
    any period, the Consolidated Net Income of such Person for such
    period
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;increased (without duplication) by:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;provision for taxes based on income or profits or
    capital gains, including, without limitation, foreign, federal,
    state, franchise and similar taxes (such as the Pennsylvania
    capital tax) and foreign withholding taxes (including penalties
    and interest related to such taxes or arising from tax
    examinations) of such Person paid or accrued during such period
    deducted (and not added back) in computing Consolidated Net
    Income; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;Fixed Charges of such Person for such period (including
    (x)&#160;net losses on Hedging Obligations or other derivative
    instruments entered into for the purpose of hedging interest
    rate risk and (y)&#160;costs of surety bonds in connection with
    financing activities, in each case, to the extent included in
    Fixed Charges), together with items excluded from the definition
    of &#147;Consolidated Interest Expense&#148; pursuant to clauses
    (1)(u), (v), (w), (x), (y)&#160;and (z)&#160;of the definition
    thereof, and, in each such case, to the extent the same were
    deducted (and not added back) in calculating such Consolidated
    Net Income; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;Consolidated Depreciation and Amortization Expense of
    such Person for such period to the extent the same was deducted
    (and not added back) in computing Consolidated Net Income;
    <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;any expenses or charges (other than depreciation or
    amortization expense) related to any Equity Offering, Permitted
    Investment, acquisition, disposition, recapitalization or the
    incurrence of Indebtedness permitted to be incurred by the
    Indenture (including a refinancing thereof) (whether or not
    successful), including (i)&#160;such fees, expenses or charges
    related to the offering of the Notes and any Credit Facilities
    and (ii)&#160;any amendment or other modification of the Notes,
    and, in each case, deducted (and not added back) in computing
    Consolidated Net Income; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;the amount of any restructuring charge or reserve
    deducted (and not added back) in such period in computing
    Consolidated Net Income, including any one-time costs incurred
    in connection with acquisitions after November&#160;17, 2006 and
    costs related to the closure
    <FONT style="white-space: nowrap">and/or</FONT>
    consolidation of facilities; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (f)&#160;any other non-cash charges, including any write-offs or
    write-downs, reducing Consolidated Net Income for such period
    (<I>provided </I>that if any such non-cash charges represent an
    accrual or reserve for potential cash items in any future
    period, the cash payment in respect thereof in such future
    period shall be subtracted from EBITDA to such extent, and
    excluding amortization of a prepaid cash item that was paid in a
    prior period); <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (g)&#160;the amount of any minority interest expense consisting
    of income attributable to minority equity interests of third
    parties deducted (and not added back) in such period in
    calculating Consolidated Net Income; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (h)&#160;the amount of management, monitoring, consulting and
    advisory fees and related expenses paid in such period to the
    Investors and the Frist Entities to the extent otherwise
    permitted under &#147;Certain Covenants&#160;&#151; Transactions
    with Affiliates&#148;; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (i)&#160;the amount of net cost savings projected by the Issuer
    in good faith to be realized as a result of specified actions
    taken or to be taken (calculated on a pro forma basis as though
    such cost savings had been realized on the first day of such
    period), net of the amount of actual benefits realized during
    such period from such actions; <I>provided </I>that
    (w)&#160;such cost savings are reasonably identifiable and
    factually supportable, (x)&#160;such actions have been taken or
    are to be taken within 15&#160;months after the date of
    determination to take such action, (y)&#160;no cost savings
    shall be added pursuant to this clause&#160;(i) to the
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    241
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    extent duplicative of any expenses or charges relating to such
    cost savings that are included in clause&#160;(e) above with
    respect to such period and (z)&#160;the aggregate amount of cost
    savings added pursuant to this clause&#160;(i) shall not exceed
    $150.0&#160;million for any four consecutive quarter period
    (which adjustments may be incremental to pro forma adjustments
    made pursuant to the second paragraph of the definition of
    &#147;Fixed Charge Coverage Ratio&#148;); <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (j)&#160;the amount of loss on sales of receivables and related
    assets to the Receivables Subsidiary in connection with a
    Receivables Facility; <I>plus</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (k)&#160;any costs or expense incurred by the Issuer or a
    Restricted Subsidiary pursuant to any management equity plan or
    stock option plan or any other management or employee benefit
    plan or agreement or any stock subscription or shareholder
    agreement, to the extent that such cost or expenses are funded
    with cash proceeds contributed to the capital of the Issuer or
    net cash proceeds of an issuance of Equity Interests of the
    Issuer (other than Disqualified Stock) solely to the extent that
    such net cash proceeds are excluded from the calculation set
    forth in clause&#160;(3) of the first paragraph under
    &#147;Certain Covenants&#160;&#151; Limitation on Restricted
    Payments&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;decreased by (without duplication) non-cash gains
    increasing Consolidated Net Income of such Person for such
    period, excluding any non-cash gains to the extent they
    represent the reversal of an accrual or reserve for a potential
    cash item that reduced EBITDA in any prior period;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;increased or decreased by (without duplication):
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;any net gain or loss resulting in such period from
    Hedging Obligations and the application of Statement of
    Financial Accounting Standards No.&#160;133; <I>plus </I>or
    <I>minus</I>, as applicable,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;any net gain or loss resulting in such period from
    currency translation gains or losses related to currency
    remeasurements of Indebtedness (including any net loss or gain
    resulting from Hedging Obligations for currency exchange risk).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;EMU&#148; </I>means the economic and monetary union as
    contemplated in the Treaty on European Union.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Equity Interests&#148; </I>means Capital Stock and all
    warrants, options or other rights to acquire Capital Stock, but
    excluding any debt security that is convertible into, or
    exchangeable for, Capital Stock.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Equity Offering&#148; </I>means any public or private
    sale of common stock or Preferred Stock of the Issuer or any of
    its direct or indirect parent companies (excluding Disqualified
    Stock), other than:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;public offerings with respect to the Issuer&#146;s or
    any direct or indirect parent company&#146;s common stock
    registered on
    <FONT style="white-space: nowrap">Form&#160;S-8;</FONT>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;issuances to any Subsidiary of the Issuer;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;any such public or private sale that constitutes an
    Excluded Contribution.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;euro&#148; </I>means the single currency of
    participating member states of the EMU.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;European Collateral&#148; </I>has the meaning set forth
    under &#147;Description of Other Indebtedness&#160;&#151; Senior
    Secured Credit Facilities&#160;&#151; Guarantee and
    Security.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Event of Default&#148; </I>has the meaning set forth
    under &#147;Events of Default and Remedies.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Excess Proceeds&#148; </I>has the meaning set forth in
    the fourth paragraph under &#147;Repurchase at the Option of
    Holders&#160;&#151; Asset Sales.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Exchange Act&#148; </I>means the Securities Exchange
    Act of 1934, as amended, and the rules and regulations of the
    SEC promulgated thereunder.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Exchange Notes&#148; </I>means any notes issued in
    exchange for the Notes pursuant to the Registration Rights
    Agreement or similar agreement.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    242
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Excluded Contribution&#148; </I>means net cash
    proceeds, marketable securities or Qualified Proceeds received
    by the Issuer after November&#160;17, 2006 from
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;contributions to its common equity capital,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the sale (other than to a Subsidiary of the Issuer or
    to any management equity plan or stock option plan or any other
    management or employee benefit plan or agreement of the Issuer)
    of Capital Stock (other than Disqualified Stock and Designated
    Preferred Stock) of the Issuer,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    in each case designated as Excluded Contributions pursuant to an
    Officer&#146;s Certificate executed by the principal financial
    officer of the Issuer on the date such capital contributions are
    made or the date such Equity Interests are sold, as the case may
    be, which are excluded from the calculation set forth in
    clause&#160;(3) of the first paragraph under &#147;Certain
    Covenants&#160;&#151; Limitation on Restricted Payments.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Existing Notes&#148; </I>means the $121.2&#160;million
    aggregate principal amount of 8.700% medium-term notes due 2010,
    $691.2&#160;million aggregate principal amount of
    8.750%&#160;notes due 2010, &#163;150.0&#160;million aggregate
    principal amount of 8.750%&#160;notes due 2010,
    $475.8&#160;million aggregate principal amount of
    7.875%&#160;notes due 2011, $500.0&#160;million aggregate
    principal amount of 6.950%&#160;notes due 2012,
    $500.0&#160;million aggregate principal amount of
    6.300%&#160;notes due 2012, $500.0&#160;million aggregate
    principal amount of 6.250%&#160;notes due 2013,
    $500.0&#160;million aggregate principal amount of
    6.750%&#160;notes due 2013, $500.0&#160;million aggregate
    principal amount of 5.750%&#160;notes due 2014,
    $121.1&#160;million aggregate principal amount of 9.000%
    medium-term notes due 2014, $750.0&#160;million aggregate
    principal amount of 6.375%&#160;notes due 2015,
    $150.0&#160;million aggregate principal amount of
    7.190%&#160;debentures due 2015, $1,000.0&#160;million aggregate
    principal amount of 6.500%&#160;notes due 2016,
    $135.6&#160;million aggregate principal amount of
    7.500%&#160;debentures due 2023, $150.0&#160;million aggregate
    principal amount of 8.360%&#160;debentures due 2024,
    $291.4&#160;million aggregate principal amount of
    7.690%&#160;notes due 2025, $125.0&#160;million aggregate
    principal amount of 7.580% medium-term notes due 2025,
    $150.0&#160;million aggregate principal amount of
    7.050%&#160;debentures due 2027, $250.0&#160;million aggregate
    principal amount of 7.500%&#160;notes due 2033,
    $100.0&#160;million aggregate principal amount of
    7.750%&#160;debentures due 2036 and $200.0&#160;million
    aggregate principal amount of 7.500%&#160;debentures due 2095,
    each issued by the Issuer and outstanding on November&#160;17,
    2006.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Existing Notes Indenture&#148; </I>means that certain
    Indenture, dated as of December&#160;16, 1993, between Columbia
    Healthcare Corporation and The First National Bank of Chicago,
    as Trustee, as amended by the First Supplemental Indenture,
    dated as of May&#160;25, 2000, between the Issuer and Bank One
    Trust&#160;Company, N.A., as Trustee, the Second Supplemental
    Indenture, dated as of July&#160;1, 2001, between the Issuer and
    Bank One Trust&#160;Company, N.A., as Trustee, and the Third
    Supplemental Indenture, dated as of December&#160;5, 2001,
    between the Issuer and The Bank of New York, as Trustee.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Existing Second Priority Notes&#148; </I>means the 2006
    Second Priority Notes and the 2009 Second Priority Notes and any
    refinancings thereof permitted pursuant to the terms of the
    Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Existing Second Priority Notes Indentures&#148;
    </I>means the 2006 Second Priority Notes Indenture and the 2009
    Second Priority Notes Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;First Lien Collateral Agent&#148; </I>shall mean Bank
    of America, N.A., in its capacity as administrative agent and
    collateral agent for the lenders and other secured parties under
    the General Credit Facility and the other First Lien Documents
    and in its capacity as collateral agent for the New First Lien
    Secured Parties, together with its successors and permitted
    assigns under the General Credit Facility, the Indenture and the
    First Lien Documents exercising substantially the same rights
    and powers; and in each case <I>provided </I>that if such First
    Lien Collateral Agent is not Bank of America, N.A., such First
    Lien Collateral Agent shall have become a party to the
    Additional General Intercreditor Agreement, the General
    Intercreditor Agreement, dated as of November&#160;17, 2006,
    among the First Lien Collateral Agent and the Junior Lien
    Collateral Agent, and the other applicable First Lien Security
    Documents.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;First Lien Documents&#148; </I>means the credit,
    guarantee and security documents governing the New First Lien
    Obligations, including, without limitation, the Indenture and
    the First Lien Security Documents.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    243
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;First Lien Event of Default&#148; </I>means an
    &#147;Event of Default&#148; under and as defined in the General
    Credit Facility, the Indenture or any other First Lien Documents
    governing First Lien Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;First Lien Obligations&#148; </I>means, collectively,
    (a)&#160;all General Credit Facility Obligations, (b)&#160;the
    Notes Obligations and (c)&#160;any Series of Additional First
    Lien Obligations. For the avoidance of doubt, Obligations with
    respect to the ABL Facility will not constitute First Lien
    Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;First Lien Secured Parties&#148; </I>means (a)&#160;the
    &#147;Secured Parties,&#148; as defined in the General Credit
    Facility, (b)&#160;the New First Lien Secured Parties and
    (c)&#160;any Additional First Lien Secured Parties.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;First Lien Security Documents&#148; </I>means the
    Security Documents (as defined in the Indenture) and any other
    agreement, document or instrument pursuant to which a Lien is
    granted or purported to be granted securing New First Lien
    Obligations or under which rights or remedies with respect to
    such Liens are governed, in each case to the extent relating to
    the collateral securing both the New First Lien Obligations and
    any Junior Lien Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;First Priority Liens&#148; </I>means the first priority
    Liens securing the New First Lien Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Fixed Charge Coverage Ratio&#148; </I>means, with
    respect to any Person for any period, the ratio of EBITDA of
    such Person for such period to the Fixed Charges of such Person
    for such period. In the event that the Issuer or any Restricted
    Subsidiary incurs, assumes, guarantees, redeems, retires or
    extinguishes any Indebtedness (other than Indebtedness incurred
    under any revolving credit facility unless such Indebtedness has
    been permanently repaid and has not been replaced) or issues or
    redeems Disqualified Stock or Preferred Stock subsequent to the
    commencement of the period for which the Fixed Charge Coverage
    Ratio is being calculated but prior to or simultaneously with
    the event for which the calculation of the Fixed Charge Coverage
    Ratio is made (the <I>&#147;Fixed Charge Coverage Ratio
    Calculation Date&#148;</I>), then the Fixed Charge Coverage
    Ratio shall be calculated giving pro forma effect to such
    incurrence, assumption, guarantee, redemption, retirement or
    extinguishment of Indebtedness, or such issuance or redemption
    of Disqualified Stock or Preferred Stock, as if the same had
    occurred at the beginning of the applicable four-quarter period.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For purposes of making the computation referred to above,
    Investments, acquisitions, dispositions, mergers, consolidations
    and disposed operations (as determined in accordance with GAAP)
    that have been made by the Issuer or any of its Restricted
    Subsidiaries during the four-quarter reference period or
    subsequent to such reference period and on or prior to or
    simultaneously with the Fixed Charge Coverage Ratio Calculation
    Date shall be calculated on a pro forma basis assuming that all
    such Investments, acquisitions, dispositions, mergers,
    consolidations and disposed operations (and the change in any
    associated fixed charge obligations and the change in EBITDA
    resulting therefrom) had occurred on the first day of the
    four-quarter reference period. If, since the beginning of such
    period, any Person that subsequently became a Restricted
    Subsidiary or was merged with or into the Issuer or any of its
    Restricted Subsidiaries since the beginning of such period shall
    have made any Investment, acquisition, disposition, merger,
    consolidation or disposed operation that would have required
    adjustment pursuant to this definition, then the Fixed Charge
    Coverage Ratio shall be calculated giving pro forma effect
    thereto for such period as if such Investment, acquisition,
    disposition, merger, consolidation or disposed operation had
    occurred at the beginning of the applicable four-quarter period.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For purposes of this definition, whenever pro forma effect is to
    be given to a transaction, the pro forma calculations shall be
    made in good faith by a responsible financial or accounting
    officer of the Issuer. If any Indebtedness bears a floating rate
    of interest and is being given pro forma effect, the interest on
    such Indebtedness shall be calculated as if the rate in effect
    on the Fixed Charge Coverage Ratio Calculation Date had been the
    applicable rate for the entire period (taking into account any
    Hedging Obligations applicable to such Indebtedness). Interest
    on a Capitalized Lease Obligation shall be deemed to accrue at
    an interest rate reasonably determined by a responsible
    financial or accounting officer of the Issuer to be the rate of
    interest implicit in such Capitalized Lease Obligation in
    accordance with GAAP. For purposes of making the computation
    referred to above, interest on any Indebtedness under a
    revolving credit facility computed on a pro forma basis shall be
    computed based upon the average daily balance of such
    Indebtedness during the applicable period except as set forth in
    the first paragraph of this definition. Interest on Indebtedness
    that may
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    244
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    optionally be determined at an interest rate based upon a factor
    of a prime or similar rate, a eurocurrency interbank offered
    rate or other rate shall be deemed to have been based upon the
    rate actually chosen, or, if none, then based upon such optional
    rate chosen as the Issuer may designate.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Fixed Charges&#148; </I>means, with respect to any
    Person for any period, the sum of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;Consolidated Interest Expense of such Person for such
    period;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;all cash dividends or other distributions paid
    (excluding items eliminated in consolidation) on any series of
    Preferred Stock during such period;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;all cash dividends or other distributions paid
    (excluding items eliminated in consolidation) on any series of
    Disqualified Stock during such period.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Foreign Subsidiary&#148; </I>means, with respect to any
    Person, any Restricted Subsidiary of such Person that is not
    organized or existing under the laws of the United States, any
    state thereof or the District of Columbia and any Restricted
    Subsidiary of such Foreign Subsidiary.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Frist Entities&#148; </I>means Dr.&#160;Thomas F.
    Frist,&#160;Jr., any Person controlled by Dr.&#160;Frist and any
    charitable organization selected by Dr.&#160;Frist that holds
    Equity Interests of the Issuer on November&#160;17, 2006.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;GAAP&#148; </I>means generally accepted accounting
    principles in the United States which are in effect on
    November&#160;17, 2006.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;General Credit Facility&#148; </I>means the credit
    agreement entered into as of November&#160;17, 2006 by and among
    the Issuer, the European subsidiary borrowers party thereto, the
    lenders party thereto in their capacities as lenders thereunder
    and Bank of America, N.A., as U.S.&#160;Administrative Agent and
    as European Administrative Agent, as amended as of
    February&#160;16, 2007 and as further amended as of
    March&#160;2, 2009, including any guarantees, collateral
    documents, instruments and agreements executed in connection
    therewith, and any amendments, supplements, modifications,
    extensions, renewals, restatements, refundings or refinancings
    thereof and any indentures or credit facilities or commercial
    paper facilities with banks or other institutional lenders or
    investors that replace, refund or refinance any part of the
    loans, notes, other credit facilities or commitments thereunder,
    including any such replacement, refunding or refinancing
    facility or indenture that increases the amount borrowable
    thereunder or alters the maturity thereof (<I>provided </I>that
    such increase in borrowings is permitted under &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock&#148;
    above).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;General Credit Facility Obligations&#148; </I>means
    &#147;Obligations&#148; as defined in the General Credit
    Facility.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Government Securities&#148; </I>means securities that
    are:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;direct obligations of the United States of America for
    the timely payment of which its full faith and credit is
    pledged;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;obligations of a Person controlled or supervised by and
    acting as an agency or instrumentality of the United States of
    America the timely payment of which is unconditionally
    guaranteed as a full faith and credit obligation by the United
    States of America,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    which, in either case, are not callable or redeemable at the
    option of the issuers thereof, and shall also include a
    depository receipt issued by a bank (as defined in
    Section&#160;3(a)(2) of the Securities Act), as custodian with
    respect to any such Government Securities or a specific payment
    of principal of or interest on any such Government Securities
    held by such custodian for the account of the holder of such
    depository receipt; <I>provided </I>that (except as required by
    law) such custodian is not authorized to make any deduction from
    the amount payable to the holder of such depository receipt from
    any amount received by the custodian in respect of the
    Government Securities or the specific payment of principal of or
    interest on the Government Securities evidenced by such
    depository receipt.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Guarantee&#148; </I>means a guarantee (other than by
    endorsement of negotiable instruments for collection in the
    ordinary course of business), direct or indirect, in any manner
    (including letters of credit and reimbursement agreements in
    respect thereof), of all or any part of any Indebtedness or
    other obligations.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    245
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Guarantee&#148; </I>means the guarantee by any
    Guarantor of the Issuer&#146;s Obligations under the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Guarantor&#148; </I>means each Restricted Subsidiary
    that Guarantees the Notes in accordance with the terms of the
    Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;HCI&#148; </I>means Health Care Indemnity, Inc., an
    insurance company formed under the laws of the State of Colorado
    and a Wholly-Owned Subsidiary of the Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Hedging Arrangements&#148; </I>means the fixed-pay
    interest rate swap agreements, entered into by Hercules Holding
    on or about September&#160;13, 2006 and with respect to which
    the Issuer will be the counterparty in connection with the
    Recapitalization, relating to $8,000&#160;million of the
    outstanding principal amount under the First Lien Obligations
    and the ABL Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Hedging Obligations&#148; </I>means, with respect to
    any Person, the obligations of such Person under any interest
    rate swap agreement, interest rate cap agreement, interest rate
    collar agreement, commodity swap agreement, commodity cap
    agreement, commodity collar agreement, foreign exchange
    contract, currency swap agreement or similar agreement providing
    for the transfer or mitigation of interest rate or currency
    risks either generally or under specific contingencies.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Holder&#148; </I>means the Person in whose name a Note
    is registered on the registrar&#146;s books.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Impairment&#148; </I>means, with respect to any Series
    of First Lien Obligations, (i)&#160;any determination by a court
    of competent jurisdiction that (x)&#160;any of the First Lien
    Obligations of such Series are unenforceable under applicable
    law or are subordinated to any other obligations (other than
    another Series of First Lien Obligations), (y)&#160;any of the
    First Lien Obligations of such Series do not have an enforceable
    security interest in any of the Collateral securing any other
    Series of First Lien Obligations
    <FONT style="white-space: nowrap">and/or</FONT>
    (z)&#160;any intervening security interest exists securing any
    other obligations (other than another Series of First Lien
    Obligations) on a basis ranking prior to the security interest
    of such Series of First Lien Obligations but junior to the
    security interest of any other Series of First Lien Obligations
    or (ii)&#160;the existence of any Collateral for any other
    Series of First Lien Obligations that is not Common Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Indebtedness&#148; </I>means, with respect to any
    Person, without duplication:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any indebtedness (including principal and premium) of
    such Person, whether or not contingent:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;in respect of borrowed money;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;evidenced by bonds, notes, debentures or similar
    instruments or letters of credit or bankers&#146; acceptances
    (or, without duplication, reimbursement agreements in respect
    thereof);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;representing the balance deferred and unpaid of the
    purchase price of any property (including Capitalized Lease
    Obligations), except (i)&#160;any such balance that constitutes
    a trade payable or similar obligation to a trade creditor, in
    each case accrued in the ordinary course of business and
    (ii)&#160;any earn-out obligations until such obligation becomes
    a liability on the balance sheet of such Person in accordance
    with GAAP;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;representing any Hedging Obligations;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    if and to the extent that any of the foregoing Indebtedness
    (other than letters of credit and Hedging Obligations) would
    appear as a liability upon a balance sheet (excluding the
    footnotes thereto) of such Person prepared in accordance with
    GAAP;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;to the extent not otherwise included, any obligation by
    such Person to be liable for, or to pay, as obligor, guarantor
    or otherwise on, the obligations of the type referred to in
    clause&#160;(1) of a third Person (whether or not such items
    would appear upon the balance sheet of the such obligor or
    guarantor), other than by endorsement of negotiable instruments
    for collection in the ordinary course of business;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;to the extent not otherwise included, the obligations
    of the type referred to in clause&#160;(1) of a third Person
    secured by a Lien on any asset owned by such first Person,
    whether or not such Indebtedness is assumed by such first Person;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    246
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided</I>, <I>however</I>, that notwithstanding the
    foregoing, Indebtedness shall be deemed not to include
    (a)&#160;Contingent Obligations incurred in the ordinary course
    of business or (b)&#160;obligations under or in respect of
    Receivables Facilities.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Independent Financial Advisor&#148; </I>means an
    accounting, appraisal, investment banking firm or consultant to
    Persons engaged in Similar Businesses of nationally recognized
    standing that is, in the good faith judgment of the Issuer,
    qualified to perform the task for which it has been engaged.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Initial Purchasers&#148; </I>means Citigroup Global
    Markets Inc., Banc of America Securities LLC, J.P.&#160;Morgan
    Securities Inc., Deutsche Bank Securities Inc., Goldman,
    Sachs&#160;&#038; Co. and the other initial purchasers party to
    the purchase agreement related to the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;insolvency or liquidation proceeding&#148; </I>means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any case commenced by or against the Issuer or any
    Guarantor under any Bankruptcy Law for the relief of debtors,
    any other proceeding for the reorganization, recapitalization or
    adjustment or marshalling of the assets or liabilities of the
    Issuer or any Guarantor, any receivership or assignment for the
    benefit of creditors relating to the Issuer or any Guarantor or
    any similar case or proceeding relative to the Issuer or any
    Guarantor or its creditors, as such, in each case whether or not
    voluntary;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any liquidation, dissolution, marshalling of assets or
    liabilities or other winding up of or relating to the Issuer or
    any Guarantor, in each case whether or not voluntary and whether
    or not involving bankruptcy or insolvency;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;any other proceeding of any type or nature in which
    substantially all claims of creditors of the Issuer or any
    Guarantor are determined and any payment or distribution is or
    may be made on account of such claims.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Intercreditor Agreements&#148; </I>means, collectively,
    the First Lien Intercreditor Agreement, the Additional
    Receivables Intercreditor Agreement and the Additional General
    Intercreditor Agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Investment Grade Rating&#148; </I>means a rating equal
    to or higher than Baa3 (or the equivalent) by Moody&#146;s and
    BBB- (or the equivalent) by S&#038;P, or an equivalent rating by
    any other Rating Agency.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Investment Grade Securities&#148; </I>means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;securities issued or directly and fully guaranteed or
    insured by the United States government or any agency or
    instrumentality thereof (other than Cash Equivalents);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;debt securities or debt instruments with an Investment
    Grade Rating, but excluding any debt securities or instruments
    constituting loans or advances among the Issuer and its
    Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;investments in any fund that invests exclusively in
    investments of the type described in clauses&#160;(1) and
    (2)&#160;which fund may also hold immaterial amounts of cash
    pending investment or distribution;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;corresponding instruments in countries other than the
    United States customarily utilized for high quality investments.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Investments&#148; </I>means, with respect to any
    Person, all investments by such Person in other Persons
    (including Affiliates) in the form of loans (including
    guarantees), advances or capital contributions (excluding
    accounts receivable, trade credit, advances to customers,
    commissions, travel and similar advances to officers and
    employees, in each case made in the ordinary course of
    business), purchases or other acquisitions for consideration of
    Indebtedness, Equity Interests or other securities issued by any
    other Person and investments that are required by GAAP to be
    classified on the balance sheet (excluding the footnotes) of the
    Issuer in the same manner as the other investments included in
    this definition to the extent such transactions involve the
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    247
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    transfer of cash or other property. For purposes of the
    definition of &#147;Unrestricted Subsidiary&#148; and the
    covenant described under &#147;Certain Covenants&#160;&#151;
    Limitation on Restricted Payments&#148;:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;<I>&#147;Investments&#148; </I>shall include the
    portion (proportionate to the Issuer&#146;s equity interest in
    such Subsidiary) of the fair market value of the net assets of a
    Subsidiary of the Issuer at the time that such Subsidiary is
    designated an Unrestricted Subsidiary; <I>provided</I>,
    <I>however</I>, that upon a redesignation of such Subsidiary as
    a Restricted Subsidiary, the Issuer shall be deemed to continue
    to have a permanent &#147;Investment&#148; in an Unrestricted
    Subsidiary in an amount (if positive) equal to:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;the Issuer&#146;s &#147;Investment&#148; in such
    Subsidiary at the time of such redesignation; <I>less</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;the portion (proportionate to the Issuer equity
    interest in such Subsidiary) of the fair market value of the net
    assets of such Subsidiary at the time of such
    redesignation;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any property transferred to or from an Unrestricted
    Subsidiary shall be valued at its fair market value at the time
    of such transfer, in each case as determined in good faith by
    the Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Investors&#148; </I>means Bain Capital Partners, LLC,
    Kohlberg Kravis Roberts&#160;&#038; Co. L.P., Merrill Lynch
    Global Private Equity, Inc. (formerly known as Merrill Lynch
    Global Partners, Inc.) and each of their respective Affiliates
    but not including, however, any portfolio companies of any of
    the foregoing.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Issue Date&#148; </I>means April&#160;22, 2009.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Issuer&#148; </I>has the meaning set forth in the first
    paragraph under &#147;General&#148;; <I>provided </I>that when
    used in the context of determining the fair market value of an
    asset or liability under the Indenture, &#147;Issuer&#148; shall
    be deemed to mean the board of directors of the Issuer when the
    fair market value is equal to or in excess of
    $500.0&#160;million (unless otherwise expressly stated).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Junior Lien Collateral Agent&#148; </I>shall mean
    (i)&#160;so long as the 2006 Second Priority Notes are
    outstanding, the trustee under the 2006 Second Priority Notes
    Indenture, in its capacity as trustee and collateral agent for
    the holders of 2006 Second Priority Notes and other secured
    parties under the 2006 Second Priority Notes Indenture and the
    related security documents (including the holders of the 2009
    Second Priority Notes), and (ii)&#160;at any time thereafter,
    such agent or trustee as is designated &#147;Junior Lien
    Collateral Agent&#148; by Junior Lien Secured Parties holding a
    majority in principal amount of the Junior Lien Obligations then
    outstanding or pursuant to such other arrangements as agreed to
    among the holders of the Junior Lien Obligations, it being
    understood that as of the Issue Date, the trustee under the 2006
    Second Priority Notes Indenture shall be the Junior Lien
    Collateral Agent.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Junior Lien Documents&#148; </I>means the credit and
    security documents governing the Junior Lien Obligations,
    including, without limitation, the Existing Second Priority
    Notes Indentures, the related security documents and
    intercreditor agreements.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Junior Lien Obligations&#148; </I>means the Existing
    Second Priority Notes and Obligations with respect to other
    Indebtedness permitted to be incurred under the Existing Second
    Priority Notes Indentures and the General Credit Facility which
    is by its terms intended to be secured equally and ratably with
    the Existing Second Priority Notes or on a basis junior to the
    Liens securing the Existing Second Priority Notes; <I>provided
    </I>such Lien is permitted to be incurred under the Existing
    Second Priority Notes Indentures and the General Credit
    Facility; <I>provided, further</I>, that the holders of such
    Indebtedness or their Junior Lien Representative is a party to
    the applicable security documents in accordance with the terms
    thereof and has appointed the Junior Lien Collateral Agent as
    collateral agent for such holders of Junior Lien Obligations
    with respect to all or a portion of the Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Junior Lien Representative&#148; </I>means any duly
    authorized representative of any holders of Junior Lien
    Obligations, which representative is party to the applicable
    security documents.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Junior Lien Secured Parties&#148; </I>means
    (i)&#160;holders of Existing Second Priority Notes (including
    the holders of any Additional Notes (as defined in the Existing
    Second Priority Notes Indentures) subsequently issued under and
    in compliance with the terms of the Existing Second Priority
    Notes Indentures), (ii)&#160;the Junior Lien
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    248
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Collateral Agent and (iii)&#160;the holders from time to time of
    any other Junior Lien Obligations and each Junior Lien
    Representative.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Legal Holiday&#148; </I>means a Saturday, a Sunday or a
    day on which commercial banking institutions are not required to
    be open in the State of New York.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Lien&#148; </I>means, with respect to any asset, any
    mortgage, lien (statutory or otherwise), pledge, hypothecation,
    charge, security interest, preference, priority or encumbrance
    of any kind in respect of such asset, whether or not filed,
    recorded or otherwise perfected under applicable law, including
    any conditional sale or other title retention agreement, any
    lease in the nature thereof, any option or other agreement to
    sell or give a security interest in and any filing of or
    agreement to give any financing statement under the Uniform
    Commercial Code (or equivalent statutes) of any jurisdiction;
    <I>provided </I>that in no event shall an operating lease be
    deemed to constitute a Lien.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Major Non-Controlling Authorized Representative&#148;
    </I>has the meaning set forth under &#147;Security&#160;&#151;
    First Lien Intercreditor.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Moody&#146;s&#148; </I>means Moody&#146;s Investors
    Service, Inc. and any successor to its rating agency business.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Net Income&#148; </I>means, with respect to any Person,
    the net income (loss) of such Person, determined in accordance
    with GAAP and before any reduction in respect of Preferred Stock
    dividends.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Net Proceeds&#148; </I>means the aggregate cash
    proceeds received by the Issuer or any of its Restricted
    Subsidiaries in respect of any Asset Sale, including any cash
    received upon the sale or other disposition of any Designated
    Non-cash Consideration received in any Asset Sale, net of the
    direct costs relating to such Asset Sale and the sale or
    disposition of such Designated Non-cash Consideration, including
    legal, accounting and investment banking fees, and brokerage and
    sales commissions, any relocation expenses incurred as a result
    thereof, taxes paid or payable as a result thereof (after taking
    into account any available tax credits or deductions and any tax
    sharing arrangements), amounts required to be applied to the
    repayment of principal, premium, if any, and interest on Senior
    Indebtedness required (other than required by clause&#160;(1) of
    the second paragraph of &#147;Repurchase at the Option of
    Holders&#160;&#151; Asset Sales&#148;) to be paid as a result of
    such transaction and any deduction of appropriate amounts to be
    provided by the Issuer or any of its Restricted Subsidiaries as
    a reserve in accordance with GAAP against any liabilities
    associated with the asset disposed of in such transaction and
    retained by the Issuer or any of its Restricted Subsidiaries
    after such sale or other disposition thereof, including pension
    and other post-employment benefit liabilities and liabilities
    related to environmental matters or against any indemnification
    obligations associated with such transaction.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;New First Lien Obligations&#148; </I>means all advances
    to, and debts, liabilities, obligations, covenants and duties
    of, the Issuer or any Guarantor arising under the Indenture and
    any other First Lien Documents, whether or not direct or
    indirect (including those acquired by assumption), absolute or
    contingent, due or to become due, now existing or hereafter
    arising and including interest and fees that accrue after the
    commencement by or against the Issuer, any Guarantor or any
    Affiliate thereof of any proceeding in bankruptcy or insolvency
    law naming such Person as the debtor in such proceeding,
    regardless of whether such interest and fees are allowed claims
    in such proceeding.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;New First Lien Secured Parties&#148; </I>means, at any
    relevant time, the holders of New First Lien Obligations at such
    time, including without limitation the Trustee, the Registrar,
    Paying Agent and Transfer Agent, and the Holders (including the
    Holders of any Additional Notes subsequently issued under and in
    compliance with the terms of the Indenture).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Non-Conforming Plan of Reorganization&#148; </I>means
    any Plan of Reorganization that grants the Junior Lien
    Collateral Agent or any Junior Lien Secured Party any right or
    benefit, directly or indirectly, which right or benefit is
    prohibited at such time by the provisions of the Additional
    General Intercreditor Agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Non-Controlling Authorized Representative Enforcement
    Date&#148; </I>has the meaning set forth under
    &#147;Security&#160;&#151; First Lien Intercreditor.&#148;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    249
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Non-Controlling Secured Parties&#148; </I>means, with
    respect to any Common Collateral, the First Lien Secured Parties
    which are not Controlling Secured Parties with respect to such
    Common Collateral.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Non-Receivables Collateral&#148; </I>has the meaning
    set forth under &#147;Description of Other
    Indebtedness&#160;&#151; Senior Secured Credit
    Facilities&#160;&#151; Guarantee and Security,&#148; subject to
    the provisions of the second sentence of the first paragraph
    under &#147;&#151;&#160;Security&#160;&#151; General.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Notes Documents&#148; </I>means the credit and security
    documents governing the Notes Obligations, including, without
    limitation, the Indenture, the related Security Documents and
    Intercreditor Agreements.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Notes Obligations&#148; </I>means Obligations in
    respect of the Notes, the Indenture or the Security Documents,
    including, for the avoidance of doubt, obligations in respect of
    exchange notes and guarantees thereof.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Obligations&#148; </I>means any principal, interest
    (including any interest accruing subsequent to the filing of a
    petition in bankruptcy, reorganization or similar proceeding at
    the rate provided for in the documentation with respect thereto,
    whether or not such interest is an allowed claim under
    applicable state, federal or foreign law), premium, penalties,
    fees, indemnifications, reimbursements (including reimbursement
    obligations with respect to letters of credit and bankers&#146;
    acceptances), damages and other liabilities, and guarantees of
    payment of such principal, interest, penalties, fees,
    indemnifications, reimbursements, damages and other liabilities,
    payable under the documentation governing any Indebtedness.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Offering Memorandum&#148; </I>means the offering
    memorandum, dated April&#160;15, 2009, relating to the initial
    private offering of the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Officer&#148; </I>means the Chairman of the Board, the
    Chief Executive Officer, the President, any Executive Vice
    President, Senior Vice President or Vice President, the
    Treasurer or the Secretary of the Issuer or a Guarantor, as
    applicable.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Officer&#146;s Certificate&#148; </I>means a
    certificate signed on behalf of the Issuer by an Officer of the
    Issuer or on behalf of a Guarantor by an Officer of such
    Guarantor, who must be the principal executive officer, the
    principal financial officer, the treasurer or the principal
    accounting officer of the Issuer or Guarantor, as applicable,
    that meets the requirements set forth in the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Opinion of Counsel&#148; </I>means a written opinion
    from legal counsel who is acceptable to the Trustee. The counsel
    may be an employee of or counsel to the Issuer or the Trustee.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Permitted Asset Swap&#148; </I>means the concurrent
    purchase and sale or exchange of Related Business Assets or a
    combination of Related Business Assets and cash or Cash
    Equivalents between the Issuer or any of its Restricted
    Subsidiaries and another Person; <I>provided</I>, that any cash
    or Cash Equivalents received must be applied in accordance with
    the covenant described under &#147;Repurchase at the Option of
    Holders&#160;&#151; Asset Sales.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Permitted Holders&#148; </I>means each of the
    Investors, the Frist Entities, members of management of the
    Issuer (or its direct or indirect parent) and any assignees of
    the equity commitments of the Investors on November&#160;17,
    2006 who are (or will be, pursuant to the agreements described
    under &#147;Management&#160;&#151; Equity Investment by Senior
    Management Participants&#148; and &#147;&#151;&#160;Equity
    Investment by Other Management Participants&#148;) holders of
    Equity Interests of the Issuer (or any of its direct or indirect
    parent companies) and any group (within the meaning of
    Section&#160;13(d)(3) or Section&#160;14(d)(2) of the Exchange
    Act or any successor provision) of which any of the foregoing
    are members; <I>provided </I>that, in the case of such group and
    without giving effect to the existence of such group or any
    other group, such Investors, Frist Entities, members of
    management and assignees of the equity commitments of the
    Investors, collectively, have beneficial ownership of more than
    50% of the total voting power of the Voting Stock of the Issuer
    or any of its direct or indirect parent companies.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Permitted Investments&#148; </I>means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any Investment in the Issuer or any of its Restricted
    Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any Investment in cash and Cash Equivalents or
    Investment Grade Securities;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    250
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;any Investment by the Issuer or any of its Restricted
    Subsidiaries in a Person that is engaged in a Similar Business
    if as a result of such Investment:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;such Person becomes a Restricted Subsidiary;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;such Person, in one transaction or a series of related
    transactions, is merged or consolidated with or into, or
    transfers or conveys substantially all of its assets to, or is
    liquidated into, the Issuer or a Restricted Subsidiary,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    and, in each case, any Investment held by such Person;
    <I>provided </I>that such Investment was not acquired by such
    Person in contemplation of such acquisition, merger,
    consolidation or transfer;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;any Investment in securities or other assets not
    constituting cash, Cash Equivalents or Investment Grade
    Securities and received in connection with an Asset Sale made
    pursuant to the provisions described under &#147;Repurchase at
    the Option of Holders&#160;&#151; Asset Sales&#148; or any other
    disposition of assets not constituting an Asset Sale;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;any Investment existing on the Issue Date;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;any Investment acquired by the Issuer or any of its
    Restricted Subsidiaries:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;in exchange for any other Investment or accounts
    receivable held by the Issuer or any such Restricted Subsidiary
    in connection with or as a result of a bankruptcy, workout,
    reorganization or recapitalization of the issuer of such other
    Investment or accounts receivable;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;as a result of a foreclosure by the Issuer or any of
    its Restricted Subsidiaries with respect to any secured
    Investment or other transfer of title with respect to any
    secured Investment in default;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;Hedging Obligations permitted under clause&#160;(10) of
    the second paragraph of the covenant described in &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;any Investment in a Similar Business having an
    aggregate fair market value, taken together with all other
    Investments made pursuant to this clause&#160;(8) that are at
    that time outstanding, not to exceed 5% of Total Assets at the
    time of such Investment (with the fair market value of each
    Investment being measured at the time made and without giving
    effect to subsequent changes in value);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;Investments the payment for which consists of Equity
    Interests (exclusive of Disqualified Stock) of the Issuer or any
    of its direct or indirect parent companies; provided, however,
    that such Equity Interests will not increase the amount
    available for Restricted Payments under clause&#160;(3) of the
    first paragraph under the covenant described in &#147;Certain
    Covenants&#160;&#151; Limitations on Restricted Payments&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;guarantees of Indebtedness permitted under the
    covenant described in &#147;Certain Covenants&#160;&#151;
    Limitation on Incurrence of Indebtedness and Issuance of
    Disqualified Stock and Preferred Stock&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;any transaction to the extent it constitutes an
    Investment that is permitted and made in accordance with the
    provisions of the second paragraph of the covenant described
    under &#147;Certain Covenants&#160;&#151; Transactions with
    Affiliates&#148; (except transactions described in clauses (2),
    (5)&#160;and (9)&#160;of such paragraph);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;Investments consisting of purchases and acquisitions
    of inventory, supplies, material or equipment;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;additional Investments having an aggregate fair market
    value, taken together with all other Investments made pursuant
    to this clause&#160;(13) that are at that time outstanding
    (without giving effect to the sale of an Unrestricted Subsidiary
    to the extent the proceeds of such sale do not consist of cash
    or marketable securities), not to exceed 5% of Total Assets at
    the time of such Investment (with the fair market value of each
    Investment being measured at the time made and without giving
    effect to subsequent changes in value);
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    251
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (14)&#160;Investments relating to an ABL Financing Entity or a
    Receivables Subsidiary that, in the good faith determination of
    the Issuer, are necessary or advisable to effect the ABL
    Facility or any Receivables Facility, as the case may be;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (15)&#160;advances to, or guarantees of Indebtedness of,
    employees not in excess of $50.0&#160;million outstanding at any
    one time, in the aggregate;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (16)&#160;loans and advances to officers, directors and
    employees for business-related travel expenses, moving expenses
    and other similar expenses, in each case incurred in the
    ordinary course of business or consistent with past practices or
    to fund such Person&#146;s purchase of Equity Interests of the
    Issuer or any direct or indirect parent company thereof;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (17)&#160;Physician Support Obligations made by the Issuer or
    any Restricted Subsidiary;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (18)&#160;any Investment in any joint venture existing on the
    Issue Date that owns or operates one or more health care
    facilities, including, without limitation, hospitals, ambulatory
    surgery centers, outpatient diagnostic centers or imaging
    centers to the extent contemplated by the organizational
    documents of such joint venture as in existence on the Issue
    Date;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (19)&#160;any Investment in the ordinary course of business or
    as may be required by applicable law by any Restricted
    Subsidiary (including, without limitation, HCI) engaged in the
    insurance business in order to provide insurance to the Issuer
    and its Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (20)&#160;any Investment pursuant to any customary buy/sell
    arrangement in favor of investors or joint venture parties in
    connection with syndications of health care facilities,
    including, without limitation, hospitals, ambulatory surgery
    centers, outpatient diagnostic centers or imaging
    centers;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (21)&#160;any Investment in any Subsidiary or any joint venture
    in connection with intercompany cash management arrangements or
    related activities arising in the ordinary course of business.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Permitted Liens&#148; </I>means, with respect to any
    Person:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;pledges or deposits by such Person under workmen&#146;s
    compensation laws, unemployment insurance laws or similar
    legislation, or good faith deposits in connection with bids,
    tenders, contracts (other than for the payment of Indebtedness)
    or leases to which such Person is a party, or deposits to secure
    public or statutory obligations of such Person or deposits of
    cash or U.S.&#160;government bonds to secure surety or appeal
    bonds to which such Person is a party, or deposits as security
    for contested taxes or import duties or for the payment of rent,
    in each case incurred in the ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;Liens imposed by law, such as carriers&#146;,
    warehousemen&#146;s and mechanics&#146; Liens, in each case for
    sums not yet overdue for a period of more than 30&#160;days or
    being contested in good faith by appropriate proceedings or
    other Liens arising out of judgments or awards against such
    Person with respect to which such Person shall then be
    proceeding with an appeal or other proceedings for review if
    adequate reserves with respect thereto are maintained on the
    books of such Person in accordance with GAAP;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;Liens for taxes, assessments or other governmental
    charges not yet overdue for a period of more than 30&#160;days
    or payable or subject to penalties for nonpayment or which are
    being contested in good faith by appropriate proceedings
    diligently conducted, if adequate reserves with respect thereto
    are maintained on the books of such Person in accordance with
    GAAP;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;Liens in favor of issuers of performance and surety
    bonds or bid bonds or with respect to other regulatory
    requirements or letters of credit issued pursuant to the request
    of and for the account of such Person in the ordinary course of
    its business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;minor survey exceptions, minor encumbrances, easements
    or reservations of, or rights of others for, licenses,
    <FONT style="white-space: nowrap">rights-of-way,</FONT>
    sewers, electric lines, telegraph and telephone lines and other
    similar purposes, or zoning or other restrictions as to the use
    of real properties or Liens incidental to the conduct of the
    business of such Person or to the ownership of its properties
    which were not incurred in connection
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    252
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    with Indebtedness and which do not in the aggregate materially
    adversely affect the value of said properties or materially
    impair their use in the operation of the business of such Person;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (6)&#160;Liens securing Indebtedness permitted to be incurred
    pursuant to clause (4), (12), (13), (18)&#160;or (19)&#160;of
    the second paragraph under &#147;Certain Covenants&#160;&#151;
    Limitation on Incurrence of Indebtedness and Issuance of
    Disqualified Stock and Preferred Stock&#148;; provided that
    (a)&#160;Liens securing Indebtedness, Disqualified Stock or
    Preferred Stock permitted to be incurred pursuant to
    clause&#160;(13) relate only to Refinancing Indebtedness that
    serves to refund or refinance Indebtedness, Disqualified Stock
    or Preferred Stock incurred under clause&#160;(4) or
    (12)&#160;of the second paragraph under &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock,&#148;
    (b)&#160;Liens securing Indebtedness permitted to be incurred
    pursuant to clause&#160;(18) extend only to the assets of
    Foreign Subsidiaries, (c)&#160;Liens securing Indebtedness
    permitted to be incurred pursuant to clause&#160;(19) are solely
    on acquired property or the assets of the acquired entity, as
    the case may be and (d)&#160;Liens securing Indebtedness,
    Disqualified Stock or Preferred Stock permitted to be incurred
    pursuant to clause&#160;(4) of the second paragraph under
    &#147;Certain Covenants&#160;&#151; Limitation on Incurrence of
    Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock&#148; extend only to the assets so financed, purchased,
    constructed or improved;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (7)&#160;Liens existing on the Issue Date (other than Liens in
    favor of (i)&#160;the lenders under the Senior Credit Facilities
    and (ii)&#160;the holders of the Existing Second Priority Notes);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (8)&#160;Liens on property or shares of stock of a Person at the
    time such Person becomes a Subsidiary; provided, however, such
    Liens are not created or incurred in connection with, or in
    contemplation of, such other Person becoming such a Subsidiary;
    provided, further, however, that such Liens may not extend to
    any other property owned by the Issuer or any of its Restricted
    Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (9)&#160;Liens on property at the time the Issuer or a
    Restricted Subsidiary acquired the property, including any
    acquisition by means of a merger or consolidation with or into
    the Issuer or any of its Restricted Subsidiaries;
    <I>provided</I>, <I>however</I>, that such Liens are not created
    or incurred in connection with, or in contemplation of, such
    acquisition; <I>provided</I>, <I>further</I>, <I>however</I>,
    that the Liens may not extend to any other property owned by the
    Issuer or any of its Restricted Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (10)&#160;Liens securing Indebtedness or other obligations of a
    Restricted Subsidiary owing to the Issuer or another Restricted
    Subsidiary permitted to be incurred in accordance with the
    covenant described under &#147;Certain Covenants&#160;&#151;
    Limitation on Incurrence of Indebtedness and Issuance of
    Disqualified Stock and Preferred Stock&#148;;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (11)&#160;Liens securing Hedging Obligations so long as the
    related Indebtedness is, and is permitted to be under the
    Indenture, secured by a Lien on the same property securing such
    Hedging Obligations;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (12)&#160;Liens on specific items of inventory or other goods
    and proceeds of any Person securing such Person&#146;s
    obligations in respect of bankers&#146; acceptances issued or
    created for the account of such Person to facilitate the
    purchase, shipment or storage of such inventory or other goods;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (13)&#160;leases, subleases, licenses or sublicenses granted to
    others in the ordinary course of business which do not
    materially interfere with the ordinary conduct of the business
    of the Issuer or any of its Restricted Subsidiaries and do not
    secure any Indebtedness;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (14)&#160;Liens arising from Uniform Commercial Code financing
    statement filings regarding operating leases entered into by the
    Issuer and its Restricted Subsidiaries in the ordinary course of
    business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (15)&#160;Liens in favor of the Issuer or any Guarantor;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (16)&#160;Liens on equipment of the Issuer or any of its
    Restricted Subsidiaries granted in the ordinary course of
    business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (17)&#160;Liens on accounts receivable and related assets
    incurred in connection with a Receivables Facility;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    253
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (18)&#160;Liens to secure any refinancing, refunding, extension,
    renewal or replacement (or successive refinancing, refunding,
    extensions, renewals or replacements) as a whole, or in part, of
    any Indebtedness secured by any Lien referred to in the
    foregoing clauses (6), (7), (8)&#160;and (9); <I>provided</I>,
    <I>however</I>, that (a)&#160;such new Lien shall be limited to
    all or part of the same property that secured the original Lien
    (plus improvements on such property), and (b)&#160;the
    Indebtedness secured by such Lien at such time is not increased
    to any amount greater than the sum of (i)&#160;the outstanding
    principal amount or, if greater, committed amount of the
    Indebtedness described under clauses (6), (7), (8)&#160;and
    (9)&#160;at the time the original Lien became a Permitted Lien
    under the Indenture, and (ii)&#160;an amount necessary to pay
    any fees and expenses, including premiums, related to such
    refinancing, refunding, extension, renewal or replacement;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (19)&#160;deposits made in the ordinary course of business to
    secure liability to insurance carriers;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (20)&#160;other Liens securing obligations incurred in the
    ordinary course of business which obligations do not exceed
    $100.0&#160;million at any one time outstanding;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (21)&#160;Liens securing judgments for the payment of money not
    constituting an Event of Default under clause&#160;(5) under the
    caption &#147;Events of Default and Remedies&#148; so long as
    such Liens are adequately bonded and any appropriate legal
    proceedings that may have been duly initiated for the review of
    such judgment have not been finally terminated or the period
    within which such proceedings may be initiated has not expired;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (22)&#160;Liens in favor of customs and revenue authorities
    arising as a matter of law to secure payment of customs duties
    in connection with the importation of goods in the ordinary
    course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (23)&#160;Liens (i)&#160;of a collection bank arising under
    <FONT style="white-space: nowrap">Section&#160;4-210</FONT>
    of the Uniform Commercial Code, or any comparable or successor
    provision, on items in the course of collection,
    (ii)&#160;attaching to commodity trading accounts or other
    commodity brokerage accounts incurred in the ordinary course of
    business, and (iii)&#160;in favor of banking institutions
    arising as a matter of law encumbering deposits (including the
    right of set-off) and which are within the general parameters
    customary in the banking industry;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (24)&#160;Liens deemed to exist in connection with Investments
    in repurchase agreements permitted under &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock&#148;;
    provided that such Liens do not extend to any assets other than
    those that are the subject of such repurchase agreements;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (25)&#160;Liens encumbering reasonable customary initial
    deposits and margin deposits and similar Liens attaching to
    commodity trading accounts or other brokerage accounts incurred
    in the ordinary course of business and not for speculative
    purposes;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (26)&#160;Liens that are contractual rights of set-off
    (i)&#160;relating to the establishment of depository relations
    with banks not given in connection with the issuance of
    Indebtedness, (ii)&#160;relating to pooled deposit or sweep
    accounts of the Issuer or any of its Restricted Subsidiaries to
    permit satisfaction of overdraft or similar obligations incurred
    in the ordinary course of business of the Issuer and its
    Restricted Subsidiaries or (iii)&#160;relating to purchase
    orders and other agreements entered into with customers of the
    Issuer or any of its Restricted Subsidiaries in the ordinary
    course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (27)&#160;Liens arising out of conditional sale, title
    retention, consignment or similar arrangements for the sale or
    purchase of goods entered into by the Issuer or any Restricted
    Subsidiary in the ordinary course of business;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (28)&#160;Liens that rank junior to the Liens securing the Notes
    securing the Junior Lien Obligations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    For purposes of this definition, the term
    &#147;Indebtedness&#148; shall be deemed to include interest on
    such Indebtedness.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Person&#148; </I>means any individual, corporation,
    limited liability company, partnership, joint venture,
    association, joint stock company, trust, unincorporated
    organization, government or any agency or political subdivision
    thereof or any other entity.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    254
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Physician Support Obligation&#148; </I>means (1)&#160;a
    loan to or on behalf of, or a guarantee of Indebtedness or
    income of, a physician or health care professional providing
    service to patients in the service area of a health care
    facility operated by the Issuer, any of its Restricted
    Subsidiaries or any affiliated joint venture otherwise permitted
    by the Indenture made or given by the Issuer or any Restricted
    Subsidiary of the Issuer in the ordinary course of business and
    pursuant to a written agreement having a period not to exceed
    five years or (2)&#160;guarantees by the Issuer or any
    Restricted Subsidiary of the Issuer of leases and loans to
    acquire property (real or personal) for or on behalf of a
    physician or health care professional providing service to
    patients in the service area of a health care facility operated
    by the Issuer, any of its Restricted Subsidiaries or any
    affiliated joint venture otherwise permitted by the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Plan of Reorganization&#148; </I>means any plan of
    reorganization, plan of liquidation, agreement for composition,
    or other type of plan of arrangement proposed in or in
    connection with any insolvency or liquidation proceeding.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Preferred Stock&#148; </I>means any Equity Interest
    with preferential rights of payment of dividends or upon
    liquidation, dissolution or winding up.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Principal Property&#148; </I>means each acute care
    hospital providing general medical and surgical services
    (excluding equipment, personal property and hospitals that
    primarily provide specialty medical services, such as
    psychiatric and obstetrical and gynecological services) owned
    solely by the Issuer
    <FONT style="white-space: nowrap">and/or</FONT> one
    or more of its Subsidiaries (used in this definition as defined
    in the Existing Notes Indenture) and located in the
    United&#160;States of America.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Purchase Money Obligations&#148; </I>means any
    Indebtedness incurred to finance or refinance the acquisition,
    leasing, construction or improvement of property (real or
    personal) or assets (other than Capital Stock), and whether
    acquired through the direct acquisition of such property or
    assets, or otherwise.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Qualified Proceeds&#148; </I>means assets that are used
    or useful in, or Capital Stock of any Person engaged in, a
    Similar Business; <I>provided </I>that the fair market value of
    any such assets or Capital Stock shall be determined by the
    Issuer in good faith.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Rating Agencies&#148; </I>means Moody&#146;s and
    S&#038;P or if Moody&#146;s or S&#038;P or both shall not make a
    rating on the Notes publicly available, a nationally recognized
    statistical rating agency or agencies, as the case may be,
    selected by the Issuer which shall be substituted for
    Moody&#146;s or S&#038;P or both, as the case may be.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Receivables Facility&#148; </I>means any of one or more
    receivables financing facilities as amended, supplemented,
    modified, extended, renewed, restated or refunded from time to
    time, the Obligations of which are non-recourse (except for
    customary representations, warranties, covenants and indemnities
    made in connection with such facilities) to the Issuer or any of
    its Restricted Subsidiaries (other than a Receivables
    Subsidiary) pursuant to which the Issuer or any of its
    Restricted Subsidiaries purports to sell its accounts receivable
    to either (a)&#160;a Person that is not a Restricted Subsidiary
    or (b)&#160;a Receivables Subsidiary that in turn funds such
    purchase by purporting to sell its accounts receivable to a
    Person that is not a Restricted Subsidiary or by borrowing from
    such a Person or from another Receivables Subsidiary that in
    turn funds itself by borrowing from such a Person.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Receivables Fees&#148; </I>means distributions or
    payments made directly or by means of discounts with respect to
    any accounts receivable or participation interest therein issued
    or sold in connection with, and other fees paid to a Person that
    is not a Restricted Subsidiary in connection with any
    Receivables Facility.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Receivables Subsidiary&#148; </I>means any Subsidiary
    formed for the purpose of facilitating or entering into one or
    more Receivables Facilities, and in each case engages only in
    activities reasonably related or incidental thereto.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Redemption&#160;Date&#148; </I>has the meaning set
    forth under &#147;Optional Redemption.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Registration Rights Agreement&#148; </I>means the
    Registration Rights Agreement related to the Notes, dated as of
    the Issue Date, among the Issuer, the Guarantors and the Initial
    Purchasers.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    255
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Related Business Assets&#148; </I>means assets (other
    than cash or Cash Equivalents) used or useful in a Similar
    Business; <I>provided </I>that any assets received by the Issuer
    or a Restricted Subsidiary in exchange for assets transferred by
    the Issuer or a Restricted Subsidiary will not be deemed to be
    Related Business Assets if they consist of securities of a
    Person, unless upon receipt of the securities of such Person,
    such Person would become a Restricted Subsidiary.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Restricted Investment&#148; </I>means an Investment
    other than a Permitted Investment.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Restricted Subsidiary&#148; </I>means, at any time, any
    direct or indirect Subsidiary of the Issuer (including any
    Foreign Subsidiary) that is not then an Unrestricted Subsidiary;
    <I>provided</I>, <I>however</I>, that upon an Unrestricted
    Subsidiary&#146;s ceasing to be an Unrestricted Subsidiary, such
    Subsidiary shall be included in the definition of
    &#147;Restricted Subsidiary.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;S&#038;P&#148; </I>means Standard&#160;&#038;
    Poor&#146;s, a division of The McGraw-Hill Companies, Inc., and
    any successor to its rating agency business.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Sale and Lease-Back Transaction&#148; </I>means any
    arrangement providing for the leasing by the Issuer or any of
    its Restricted Subsidiaries of any real or tangible personal
    property, which property has been or is to be sold or
    transferred by the Issuer or such Restricted Subsidiary to a
    third Person in contemplation of such leasing.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;SEC&#148; </I>means the U.S.&#160;Securities and
    Exchange Commission.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Secured Indebtedness&#148; </I>means any Indebtedness
    of the Issuer or any of its Restricted Subsidiaries secured by a
    Lien.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Securities Act&#148; </I>means the Securities Act of
    1933, as amended, and the rules and regulations of the SEC
    promulgated thereunder.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Security Agreement&#148; </I>means the amended and
    restated Security Agreement, dated as of March&#160;2, 2009, by
    and among the Issuer, the subsidiary grantors named therein and
    the First Lien Collateral Agent, as the same may be further
    amended, restated or modified from time to time, to which the
    Trustee, as Authorized Representative for the Holders were
    joined on the Issue Date.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Security Documents&#148; </I>means, collectively, the
    Intercreditor Agreements, the Security Agreement, other security
    agreements relating to the Collateral and the mortgages and
    instruments filed and recorded in appropriate jurisdictions to
    preserve and protect the Liens on the Collateral (including,
    without limitation, financing statements under the Uniform
    Commercial Code of the relevant states) applicable to the
    Collateral, each as in effect on the Issue Date and as amended,
    amended and restated, modified, renewed or replaced from time to
    time.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Senior Credit Facilities&#148; </I>means the ABL
    Facility and the General Credit Facility.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Senior Indebtedness&#148; </I>means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;all Indebtedness of the Issuer or any Guarantor
    outstanding under the Senior Credit Facilities or Notes and
    related Guarantees (including interest accruing on or after the
    filing of any petition in bankruptcy or similar proceeding or
    for reorganization of the Issuer or any Guarantor (at the rate
    provided for in the documentation with respect thereto,
    regardless of whether or not a claim for post-filing interest is
    allowed in such proceedings)), and any and all other fees,
    expense reimbursement obligations, indemnification amounts,
    penalties, and other amounts (whether existing on the Issue Date
    or thereafter created or incurred) and all obligations of the
    Issuer or any Guarantor to reimburse any bank or other Person in
    respect of amounts paid under letters of credit, acceptances or
    other similar instruments;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;all Hedging Obligations (and guarantees thereof) owing
    to a Lender (as defined in the Senior Credit Facilities) or any
    Affiliate of such Lender (or any Person that was a Lender or an
    Affiliate of such Lender at the time the applicable agreement
    giving rise to such Hedging Obligation was entered into);
    <I>provided </I>that such Hedging Obligations are permitted to
    be incurred under the terms of the Indenture;
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    256
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;any other Indebtedness of the Issuer or any Guarantor
    permitted to be incurred under the terms of the Indenture,
    unless the instrument under which such Indebtedness is incurred
    expressly provides that it is subordinated in right of payment
    to the Notes or any related Guarantee;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;all Obligations with respect to the items listed in the
    preceding clauses (1), (2)&#160;and (3);
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>provided</I>, <I>however</I>, that Senior Indebtedness shall
    not include:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;any obligation of such Person to the Issuer or any of
    its Subsidiaries;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;any liability for federal, state, local or other taxes
    owed or owing by such Person;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;any accounts payable or other liability to trade
    creditors arising in the ordinary course of business;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;any Indebtedness or other Obligation of such Person
    which is subordinate or junior in any respect to any other
    Indebtedness or other Obligation of such Person;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;that portion of any Indebtedness which at the time of
    incurrence is incurred in violation of the Indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Separate Receivables Collateral&#148; </I>has the
    meaning set forth under &#147;Description of Other
    Indebtedness&#160;&#151; Senior Secured Credit
    Facilities&#160;&#151; Guarantee and Security.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Series&#148; </I>means (a)&#160;with respect to the
    First Lien Secured Parties, each of (i)&#160;the General Credit
    Facility Secured Parties (in their capacities as such),
    (ii)&#160;the Holders and the Trustee, each in their capacity as
    such) and (iii)&#160;the Additional First Lien Secured Parties
    that become subject to the First Lien Intercreditor Agreement
    after the date hereof that are represented by a common
    Authorized Representative (in its capacity as such for such
    Additional First Lien Secured Parties) and (b)&#160;with respect
    to any First Lien Obligations, each of (i)&#160;the General
    Credit Facility Obligations, (ii)&#160;the Notes Obligations and
    (iii)&#160;the Additional First Lien Obligations incurred
    pursuant to any applicable agreement, which pursuant to any
    joinder agreement, are to be represented under the First Lien
    Intercreditor Agreement by a common Authorized Representative
    (in its capacity as such for such Additional First Lien
    Obligations).
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Shared Receivables Collateral&#148; </I>has the meaning
    set forth under &#147;Description of Other
    Indebtedness&#160;&#151; Senior Secured Credit
    Facilities&#160;&#151; Guarantee and Security.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Significant Subsidiary&#148; </I>means any Restricted
    Subsidiary that would be a &#147;significant subsidiary&#148; as
    defined in Article&#160;1,
    <FONT style="white-space: nowrap">Rule&#160;1-02</FONT>
    of
    <FONT style="white-space: nowrap">Regulation&#160;S-X,</FONT>
    promulgated pursuant to the Securities Act, as such regulation
    is in effect on the Issue Date.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Similar Business&#148; </I>means any business conducted
    or proposed to be conducted by the Issuer and its Restricted
    Subsidiaries on the Issue Date or any business that is similar,
    reasonably related, incidental or ancillary thereto.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Sponsor Management Agreement&#148; </I>means the
    management agreement between certain of the management companies
    associated with the Investors, the Frist Entities and the Issuer.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Subordinated Indebtedness&#148; </I>means, with respect
    to the Notes,
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any Indebtedness of the Issuer which is by its terms
    subordinated in right of payment to the Notes,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any Indebtedness of any Guarantor which is by its terms
    subordinated in right of payment to the Guarantee of such entity
    of the Notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Subsidiary&#148; </I>means, with respect to any Person:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any corporation, association, or other business entity
    (other than a partnership, joint venture, limited liability
    company or similar entity) of which more than 50% of the total
    voting power of shares of Capital Stock entitled (without regard
    to the occurrence of any contingency) to vote in the election of
    directors, managers or trustees thereof is at the time of
    determination owned or controlled, directly or
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    257
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    indirectly, by such Person or one or more of the other
    Subsidiaries of that Person or a combination thereof or is
    consolidated under GAAP with such Person at such time;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any partnership, joint venture, limited liability
    company or similar entity of which
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (x)&#160;more than 50% of the capital accounts, distribution
    rights, total equity and voting interests or general or limited
    partnership interests, as applicable, are owned or controlled,
    directly or indirectly, by such Person or one or more of the
    other Subsidiaries of that Person or a combination thereof
    whether in the form of membership, general, special or limited
    partnership or otherwise,&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (y)&#160;such Person or any Restricted Subsidiary of such Person
    is a controlling general partner or otherwise controls such
    entity.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Total Assets&#148; </I>means the total assets of the
    Issuer and its Restricted Subsidiaries on a consolidated basis,
    as shown on the most recent consolidated balance sheet of the
    Issuer or such other Person as may be expressly stated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Transaction&#148; </I>means the transactions
    contemplated by the Transaction Agreement, the issuance of the
    Notes and borrowings under the Senior Credit Facilities as in
    effect on November&#160;17, 2006.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Transaction Agreement&#148; </I>means the Agreement and
    Plan of Merger, dated as of July&#160;24, 2006, between Hercules
    Holding II, LLC, Hercules Acquisition Corporation and the
    Issuer, as the same may be amended prior to the Issue Date.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Treasury Rate&#148; </I>means, as of any
    Redemption&#160;Date, the yield to maturity as of such
    Redemption&#160;Date of United States Treasury securities with a
    constant maturity (as compiled and published in the most recent
    Federal Reserve Statistical Release H.15 (519)&#160;that has
    become publicly available at least two Business Days prior to
    the Redemption&#160;Date (or, if such Statistical Release is no
    longer published, any publicly available source of similar
    market data)) most nearly equal to the period from the
    Redemption&#160;Date to April&#160;15, 2014; <I>provided</I>,
    <I>however</I>, that if the period from the Redemption&#160;Date
    to April&#160;15, 2014 is less than one year, the weekly average
    yield on actually traded United States Treasury securities
    adjusted to a constant maturity of one year will be used.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Trust&#160;Indenture Act&#148; </I>means the
    Trust&#160;Indenture Act of 1939, as amended (15&#160;U.S.C.
    <FONT style="white-space: nowrap">&#167;&#167;&#160;77aaa-777bbbb).</FONT>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Unrestricted Subsidiary&#148; </I>means:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any Subsidiary of the Issuer which at the time of
    determination is an Unrestricted Subsidiary (as designated by
    the Issuer, as provided below);&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;any Subsidiary of an Unrestricted Subsidiary.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer may designate any Subsidiary of the Issuer (including
    any existing Subsidiary and any newly acquired or newly formed
    Subsidiary) to be an Unrestricted Subsidiary unless such
    Subsidiary or any of its Subsidiaries owns any Equity Interests
    or Indebtedness of, or owns or holds any Lien on, any property
    of, the Issuer or any Subsidiary of the Issuer (other than
    solely any Subsidiary of the Subsidiary to be so designated);
    <I>provided </I>that
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;any Unrestricted Subsidiary must be an entity of which
    the Equity Interests entitled to cast at least a majority of the
    votes that may be cast by all Equity Interests having ordinary
    voting power for the election of directors or Persons performing
    a similar function are owned, directly or indirectly, by the
    Issuer;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;such designation complies with the covenants described
    under &#147;Certain Covenants&#160;&#151; Limitation on
    Restricted Payments&#148;;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;each of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;the Subsidiary to be so designated;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;its Subsidiaries
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    258
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    has not at the time of designation, and does not thereafter,
    create, incur, issue, assume, guarantee or otherwise become
    directly or indirectly liable with respect to any Indebtedness
    pursuant to which the lender has recourse to any of the assets
    of the Issuer or any Restricted Subsidiary.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Issuer may designate any Unrestricted Subsidiary to be a
    Restricted Subsidiary; <I>provided</I> that, immediately after
    giving effect to such designation, no Default shall have
    occurred and be continuing and either:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the Issuer could incur at least $1.00 of additional
    Indebtedness pursuant to the Fixed Charge Coverage Ratio test
    described in the first paragraph under &#147;Certain
    Covenants&#160;&#151; Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred
    Stock&#148;;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the Fixed Charge Coverage Ratio for the Issuer and its
    Restricted Subsidiaries would be greater than such ratio for the
    Issuer and its Restricted Subsidiaries immediately prior to such
    designation, in each case on a pro forma basis taking into
    account such designation.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any such designation by the Issuer shall be notified by the
    Issuer to the Trustee by promptly filing with the Trustee a copy
    of the resolution of the board of directors of the Issuer or any
    committee thereof giving effect to such designation and an
    Officer&#146;s Certificate certifying that such designation
    complied with the foregoing provisions.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Voting Stock&#148; </I>of any Person as of any date
    means the Capital Stock of such Person that is at the time
    entitled to vote in the election of the board of directors of
    such Person.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Weighted Average Life to Maturity&#148; </I>means, when
    applied to any Indebtedness, Disqualified Stock or Preferred
    Stock, as the case may be, at any date, the quotient obtained by
    dividing:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the sum of the products of the number of years from the
    date of determination to the date of each successive scheduled
    principal payment of such Indebtedness or redemption or similar
    payment with respect to such Disqualified Stock or Preferred
    Stock multiplied by the amount of such payment; by
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the sum of all such payments.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>&#147;Wholly-Owned Subsidiary&#148; </I>of any Person means a
    Subsidiary of such Person, 100% of the outstanding Equity
    Interests of which (other than directors&#146; qualifying
    shares) shall at the time be owned by such Person or by one or
    more Wholly-Owned Subsidiaries of such Person.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    259
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->
<A name='107'>
<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">BOOK-ENTRY
    ISSUANCE</FONT></B>
</DIV>
</A>
<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We have issued each series of notes as global securities (the
    &#147;global securities&#148;). We have deposited each global
    security with, or on behalf of, The Depository
    Trust&#160;Company (&#147;DTC&#148;), as depositary, or its
    nominee and registered it in the name of a nominee of DTC.
    Except under the limited circumstances described below, global
    securities are not exchangeable for certificated securities.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Only institutions that have accounts with DTC or its nominee
    (&#147;participants&#148;) or persons that may hold interests
    through participants may own beneficial interests in a global
    security. DTC will maintain records evidencing ownership by
    participants in the global securities and transfers of those
    ownership interests. Participants maintain records evidencing
    ownership of beneficial interests in the global securities by
    persons that hold through those participants and transfers of
    those ownership interests within those participants. DTC has no
    knowledge of the actual beneficial owners of the securities. You
    will not receive written confirmation from DTC of your purchase,
    but we do expect that you will receive written confirmations
    providing details of the transaction, as well as periodic
    statements of your holdings from the participant through which
    you entered the transaction. The laws of some jurisdictions
    require that certain purchasers of securities take physical
    delivery of those securities in certificated form. Those laws
    may impair your ability to transfer beneficial interests in a
    global security.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    DTC has advised us that upon the issuance of a global security
    and the deposit of that global security with DTC, DTC will
    immediately credit, on its book-entry registration and transfer
    system, the respective principal amounts or number of shares
    represented by that global security to the accounts of its
    participants.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We will make payments on securities represented by a global
    security to DTC or its nominee, as the case may be, as the
    registered owner and holder of the global security representing
    those securities. DTC has advised us that upon receipt of any
    payment on a global security, DTC will immediately credit
    accounts of participants with payments in amounts proportionate
    to their respective beneficial interests in that security, as
    shown in the records of DTC. Standing instructions and customary
    practices will govern payments by participants to owners of
    beneficial interests in a global security held through those
    participants, as is now the case with securities held for the
    accounts of customers in bearer form or registered in
    &#147;street name.&#148; Those payments will be the sole
    responsibility of those participants, subject to any statutory
    or regulatory requirements in effect from time to time.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Neither we, the trustees, the agents nor any agent of ours or
    theirs will have any responsibility or liability for any aspect
    of the records of DTC, any nominee or any participant relating
    to, or payments made on account of, beneficial interests in a
    global security, for maintaining, supervising or reviewing any
    of the records of DTC, any nominee or any participant relating
    to those beneficial interests or for any other matter relating
    to the actions and practices of DTC, any nominee or any
    participant.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    A global security is exchangeable for certificated securities
    registered in the name of a person other than DTC or its nominee
    only if:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    DTC (1)&#160;notifies us that it is unwilling or unable to
    continue as Depositary for that global security or (2)&#160;has
    ceased to be a clearing agency registered under the Securities
    Exchange Act of 1934 and, in either case, we fail to appoint a
    successor depository;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    we, in our discretion at any time, determine not to require all
    of the notes of a particular series to be represented by a
    global security and so notify the applicable trustee;&#160;or
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    with respect to global securities representing any series of our
    senior secured notes, there has occurred and is continuing an
    event of default with respect to such senior secured notes.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, beneficial interests in a global security may be
    exchanged for certificated securities upon prior written notice
    given to the applicable trustee by or on behalf of DTC in
    accordance with the applicable indenture. In all cases,
    certificated securities delivered in exchange for any global
    security or beneficial interests in global securities will be
    registered in the names, and issued in any approved
    denominations, requested by or on behalf of the depositary (in
    accordance with its customary procedures).
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    260
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The registrar will register the certificated securities in the
    name or names instructed by DTC. We expect that those
    instructions may be based upon directions received by DTC from
    its participants with respect to ownership of beneficial
    interests in the global security. In the case of global debt
    securities, we will make payment of any principal and interest
    on the certificated securities and will register transfers and
    exchanges of those certificated securities at the corporate
    trust office of the respective transfer agent and registrar in
    the Borough of Manhattan, The City of New York. However, we may
    elect to pay interest by check mailed to the address of the
    person entitled to that interest payment as of the record date,
    as shown on the register for the securities.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Except as provided above, as an owner of a beneficial interest
    in a global security, you will not be entitled to receive
    physical delivery of securities in certificated form and will
    not be considered a holder of securities for any purpose under
    the indentures. No global security will be exchangeable except
    for another global security of like denomination and tenor to be
    registered in the name of DTC or its nominee. Accordingly, you
    must rely on the procedures of DTC and the participant through
    which you own your interest to exercise any rights of a holder
    under the global security or the applicable indenture.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We understand that, under existing industry practices, in the
    event that we request any action of holders, or an owner of a
    beneficial interest in a global security desires to take any
    action that a holder is entitled to take under the securities or
    the indentures, DTC would authorize the participants holding the
    relevant beneficial interests to take that action, and those
    participants would authorize beneficial owners owning through
    those participants to take that action or would otherwise act
    upon the instructions of beneficial owners owning through them.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    DTC has advised us that DTC is a limited purpose trust company
    organized under the New York Banking Law, a &#147;banking
    organization&#148; within the meaning of the New York Banking
    Law, a member of the U.S.&#160;Federal Reserve System, a
    &#147;clearing corporation&#148; within the meaning of the New
    York Uniform Commercial Code and a &#147;clearing agency&#148;
    registered under the Securities Exchange Act of 1934. DTC holds
    securities that its participants deposit with DTC. DTC also
    facilitates the clearance and settlement of securities
    transactions among its participants in deposited securities,
    such as transfers and pledges, through electronic computerized
    book-entry changes in accounts of the participants, thereby
    eliminating the need for physical movement of securities
    certificates. DTC&#146;s participants include securities brokers
    and dealers, banks, trust companies, clearing corporations and
    certain other organizations. DTC is owned by a number of its
    participants and by the New York Stock Exchange, Inc., the
    American Stock Exchange, Inc. and the National Association of
    Securities Dealers, Inc. Access to DTC&#146;s system is also
    available to others, such as banks, brokers, dealers and trust
    companies that clear through or maintain a custodial
    relationship with a participant, either directly or indirectly.
    The rules applicable to DTC and its participants are on file
    with the SEC.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Investors may elect to hold interests in securities outside the
    United States through Clearstream Banking, soci&#233;t&#233;
    anonyme (&#147;Clearstream&#148;) or Euroclear Bank S.A./N.V.,
    as operator of the Euroclear System (&#147;Euroclear&#148;), if
    they are participants in those systems, or indirectly through
    organizations that are participants in those systems.
    Clearstream and Euroclear will hold interests on behalf of their
    participants through customers&#146; securities accounts in
    Clearstream&#146;s and Euroclear&#146;s names on the books of
    their respective depositaries. Those depositaries in turn hold
    those interests in customers&#146; securities accounts in the
    depositaries&#146; names on the books of DTC.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Clearstream has advised us that it is incorporated under the
    laws of Luxembourg as a bank. Clearstream holds securities for
    its customers and facilitates the clearance and settlement of
    securities transactions between its customers through electronic
    book-entry changes in their accounts. Clearstream provides to
    its customers, among other things, services for safekeeping,
    administration, clearance and settlement of internationally
    traded securities and securities lending and borrowing.
    Clearstream interfaces with domestic securities markets in over
    30 countries through established depository and custodial
    relationships. As a bank, Clearstream is subject to regulation
    by the Luxembourg Commission for the Supervision of the
    Financial Sector, also known as the <I>Commission de
    Surveillance du Secteur Financier </I>and the Luxembourg Central
    Bank. Clearstream customers are financial institutions around
    the world, including underwriters, securities brokers and
    dealers, banks, trust companies, clearing corporations and other
    organizations. Its customers in the United States are limited to
    securities brokers and dealers and banks. Indirect access to
    Clearstream is also available to other institutions such as
    banks, brokers, dealers and trust companies that clear through
    or maintain a custodial relationship with the customer.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    261
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Distributions with respect to global securities held
    beneficially through Clearstream will be credited to cash
    accounts of Clearstream customers in accordance with its rules
    and procedures, to the extent received by the
    U.S.&#160;depositary for Clearstream.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Euroclear has advised us that it was created in 1968 to hold
    securities for its participants and to clear and settle
    transactions between Euroclear participants through simultaneous
    electronic book-entry delivery against payment, thereby
    eliminating the need for physical movement of certificates and
    any risk from lack of simultaneous transfers of securities and
    cash. Euroclear provides various other services, including
    securities lending and borrowing, and interfaces with domestic
    markets in several countries. Euroclear is operated by Euroclear
    Bank S.A./N.V. Euroclear Clearance Systems S.C. establishes
    policy for Euroclear on behalf of Euroclear participants.
    Euroclear participants include banks (including central banks),
    securities brokers and dealers and other professional financial
    intermediaries. Indirect access to Euroclear is also available
    to other firms that clear through or maintain a custodial
    relationship with a Euroclear participant, either directly or
    indirectly.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Distributions with respect to interests in global securities
    held beneficially through Euroclear will be credited to the cash
    accounts of Euroclear participants in accordance with
    Euroclear&#146;s terms and conditions and operating procedures
    and applicable Belgian law, to the extent received by the
    U.S.&#160;depositary for Euroclear.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Global
    Clearance and Settlement Procedures</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Unless otherwise specified with respect to a particular series
    of global securities, initial settlement for global securities
    will be made in immediately available funds. Transfers between
    DTC participants will be effected under DTC&#146;s procedures
    and will be settled in
    <FONT style="white-space: nowrap">same-day</FONT>
    funds.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If the interests in the global securities may be held through
    Clearstream or Euroclear, Clearstream customers
    <FONT style="white-space: nowrap">and/or</FONT>
    Euroclear participants will conduct secondary market trading
    with other Clearstream customers
    <FONT style="white-space: nowrap">and/or</FONT>
    Euroclear participants in the ordinary way in accordance with
    the applicable rules and operating procedures of Clearstream and
    Euroclear. Thereafter, secondary market trades will settle in
    immediately available funds.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Cross-market transfers between persons holding directly or
    indirectly through DTC participants on the one hand, and
    directly or indirectly through Clearstream customers or
    Euroclear participants, on the other, will be effected in DTC in
    accordance with DTC&#146;s rules on behalf of the relevant
    European international clearing system by the
    U.S.&#160;depositary for that system; however, those
    cross-market transactions will require delivery by the
    counterparty in the relevant European international clearing
    system of instructions to that system in accordance with its
    rules and procedures and within its established deadlines
    (European time). The relevant European international clearing
    system will, if the transaction meets its settlement
    requirements, deliver instructions to the U.S.&#160;depositary
    for that system to take action to effect final settlement on its
    behalf by delivering or receiving interests in global securities
    in DTC, and making or receiving payment in accordance with
    normal procedures for
    <FONT style="white-space: nowrap">same-day</FONT>
    funds settlement applicable to DTC. Clearstream customers and
    Euroclear participants may not deliver instructions directly to
    DTC.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Because of time-zone differences, credits of interests in global
    securities received by Clearstream or Euroclear as a result of a
    transaction with a DTC participant will be made during
    subsequent securities settlement processing and will be credited
    the business day following the DTC settlement date. Those
    credits or any transactions in global securities settled during
    that processing will be reported to the relevant Euroclear
    participants or Clearstream customers on that business day. Cash
    received by Clearstream or Euroclear as a result of sales of
    interests in global securities by or through a Clearstream
    customer or a Euroclear participant to a DTC participant will be
    received with value on the DTC settlement date but will be
    available in the relevant Clearstream or Euroclear cash account
    only as of the business day following settlement in DTC.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Although DTC, Clearstream and Euroclear have agreed to the
    procedures described above in order to facilitate transfers of
    interests in global securities among participants of DTC,
    Clearstream and Euroclear, they are under no obligation to
    perform those procedures and those procedures may be
    discontinued at any time.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    262
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->
<A name='108'>
<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">CERTAIN
    U.S. FEDERAL TAX CONSEQUENCES</FONT></B>
</DIV>
</A>
<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The following is a summary of certain U.S.&#160;federal income
    and, in the case of
    <FONT style="white-space: nowrap">non-U.S.&#160;holders</FONT>
    (as defined below), estate tax consequences of the purchase,
    ownership and disposition of the notes as of the date of this
    prospectus. Unless otherwise stated, this summary deals only
    with notes held as capital assets. For purposes of this
    discussion, &#147;toggle notes&#148; means the
    9<FONT style="vertical-align: text-top; font-size: 70%;">5</FONT>/<FONT style="font-size: 70%;">8</FONT>%/10<FONT style="vertical-align: text-top; font-size: 70%;">3</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;senior
    secured toggle notes due 2016, &#147;cash-pay OID notes&#148;
    means the
    9<FONT style="vertical-align: text-top; font-size: 70%;">7</FONT>/<FONT style="font-size: 70%;">8</FONT>%
    second lien senior secured notes due 2017 and the
    8<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">2</FONT>%
    first lien senior secured notes due 2019, and &#147;cash-pay
    notes&#148; means notes other than the toggle notes and cash-pay
    OID notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    As used herein, a &#147;U.S.&#160;holder&#148; means a
    beneficial owner of the notes that is for U.S.&#160;federal
    income tax purposes any of the following:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    an individual citizen or resident of the United States;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a corporation (or any other entity treated as a corporation for
    U.S.&#160;federal income tax purposes) created or organized in
    or under the laws of the United States, any state thereof or the
    District of Columbia;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    an estate the income of which is subject to U.S.&#160;federal
    income taxation regardless of its source;&#160;or
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a trust if it (1)&#160;is subject to the primary supervision of
    a court within the United States and one or more United States
    persons have the authority to control all substantial decisions
    of the trust or (2)&#160;has a valid election in effect under
    applicable United States Treasury regulations to be treated as a
    United&#160;States person.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The term
    <FONT style="white-space: nowrap">&#147;non-U.S.&#160;holder&#148;</FONT>
    means a beneficial owner of the notes (other than a partnership
    or any other entity treated as a partnership for
    U.S.&#160;federal income tax purposes) that is not a
    U.S.&#160;holder.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    This summary does not represent a detailed description of the
    U.S.&#160;federal income tax consequences applicable to you if
    you are a person subject to special tax treatment under the
    U.S.&#160;federal income tax laws, including, without limitation:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a dealer in securities or currencies;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a financial institution;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a regulated investment company;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a real estate investment trust;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a tax-exempt organization;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    an insurance company;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a person holding the notes as part of a hedging, integrated,
    conversion or constructive sale transaction or a straddle;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a trader in securities that has elected the
    <FONT style="white-space: nowrap">mark-to-market</FONT>
    method of accounting for your securities;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a person liable for alternative minimum tax;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a partnership or other pass-through entity for U.S.&#160;federal
    income tax purposes (or an investor in such entities);
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a U.S.&#160;holder whose &#147;functional currency&#148; is not
    the U.S.&#160;dollar;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a &#147;controlled foreign corporation&#148;;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a &#147;passive foreign investment company&#148;;&#160;or
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a United States expatriate.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    This summary is based on the Internal Revenue Code of 1986, as
    amended (the &#147;Code&#148;), United States Treasury
    regulations, administrative rulings and judicial decisions as of
    the date hereof. Those authorities may
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    263
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    be changed, possibly on a retroactive basis, so as to result in
    U.S.&#160;federal income and estate tax consequences different
    from those summarized below. We have not and will not seek any
    rulings from the Internal Revenue Service (&#147;IRS&#148;)
    regarding the matters discussed below. There can be no assurance
    that the IRS will not take positions concerning the tax
    consequences of the purchase, ownership or disposition of the
    notes that are different from those discussed below.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If a partnership (including any entity classified as a
    partnership for U.S.&#160;federal income tax purposes) holds
    notes, the tax treatment of a partner will generally depend upon
    the status of the partner and the activities of the partnership.
    If you are a partnership or a partner in a partnership holding
    notes, you should consult your own tax advisors.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    This summary does not represent a detailed description of the
    U.S.&#160;federal income and estate tax consequences to you in
    light of your particular circumstances and does not address the
    effects of any state, local or
    <FONT style="white-space: nowrap">non-U.S.&#160;tax</FONT>
    laws. It is not intended to be, and should not be construed to
    be, legal or tax advice to any particular purchaser of notes.
    <B>You should consult your own tax advisors concerning the
    particular U.S.&#160;federal income and estate tax consequences
    to you of the ownership of the notes, as well as the
    consequences to you arising under the laws of any other taxing
    jurisdiction.</B>
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Certain
    Tax Consequences to U.S. Holders</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The following is a summary of certain U.S.&#160;federal income
    tax consequences that will apply to U.S.&#160;holders of the
    notes.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Cash-Pay
    Notes</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Stated Interest on Cash-Pay Notes.</I>&#160;&#160;Stated
    interest on a cash-pay note will generally be taxable to you as
    ordinary income at the time it is received or accrued, depending
    on your method of accounting for U.S.&#160;federal income tax
    purposes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Market Discount.</I>&#160;&#160;If you purchase a cash-pay
    note for an amount that is less than its principal amount, the
    amount of the difference will be treated as &#147;market
    discount&#148; for U.S.&#160;federal income tax purposes, unless
    that difference is less than a specified de minimis amount.
    Under the market discount rules, you will be required to treat
    any principal payment on, or any gain on the sale, exchange,
    retirement or other disposition of, a cash-pay note as ordinary
    income to the extent of the market discount that you have not
    previously included in income and are treated as having accrued
    on the note at the time of the payment or disposition.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, you may be required to defer, until the maturity of
    the cash-pay note or its earlier disposition in a taxable
    transaction, the deduction of all or a portion of the interest
    expense on any indebtedness attributable to the note. You may
    elect, on a
    <FONT style="white-space: nowrap">note-by-note</FONT>
    basis, to deduct the deferred interest expense in a tax year
    prior to the year of disposition. You should consult your own
    tax advisors before making this election.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any market discount will be considered to accrue ratably during
    the period from the date of acquisition to the maturity date of
    the cash-pay note, unless you elect to accrue on a constant
    interest method. You may elect to include market discount in
    income currently as it accrues, on either a ratable or constant
    interest method, in which case the rule described above
    regarding deferral of interest deductions will not apply.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Amortizable Bond Premium.</I>&#160;&#160;If you purchase a
    cash-pay note for an amount in excess of its principal amount,
    you will be considered to have purchased the cash-pay note at a
    &#147;premium.&#148; You generally may elect to amortize the
    premium over the remaining term of the cash-pay note on a
    constant yield method as an offset to interest when includible
    in income under your regular accounting method. If you do not
    elect to amortize bond premium, that premium will decrease the
    gain or increase the loss you would otherwise recognize on
    disposition of the cash-pay note.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Sale, Exchange, Retirement, or Other Taxable Disposition of
    Cash-Pay Notes.</I>&#160;&#160;Upon the sale, exchange,
    retirement, redemption or other disposition of a cash-pay note,
    you generally will recognize gain or loss equal to the
    difference between the amount realized upon the sale, exchange,
    retirement, redemption or other
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    264
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    disposition (less an amount equal to any accrued and unpaid
    stated interest, which will be taxable as interest income as
    discussed above) and the adjusted tax basis of the cash-pay
    note. Your adjusted tax basis in a cash-pay note will, in
    general, be your cost for that cash-pay note, increased by any
    market discount previously included in income, and reduced by
    any amortized premium. Except as described above with respect to
    market discount, any gain or loss will be capital gain or loss.
    Capital gains of non-corporate U.S.&#160;holders derived in
    respect of capital assets held for more than one year are
    generally eligible for reduced rates of taxation. The
    deductibility of capital losses is subject to limitations.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Cash-Pay
    OID Notes</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Stated Interest on Cash-Pay OID Notes.</I>&#160;&#160;Stated
    interest on a cash-pay OID note will generally be taxable to you
    as ordinary income at the time it is received or accrued,
    depending on your method of accounting for U.S.&#160;federal
    income tax purposes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Original Issue Discount.</I>&#160;&#160;The cash-pay OID
    notes are treated as having been issued with original issue
    discount (&#147;OID&#148;) in an amount equal to the difference
    between their &#147;stated redemption price at maturity&#148;
    (the sum of all payments to be made on the cash-pay OID notes
    other than &#147;qualified stated interest&#148;) and their
    &#147;issue price.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The &#147;issue price&#148; of a cash-pay OID note is the first
    price at which a substantial amount of that particular offering
    of the cash-pay OID notes was sold (excluding sales to bond
    houses, brokers or similar persons or organizations acting in
    the capacity of underwiter, placement agent or wholesaler). The
    term &#147;qualified stated interest&#148; means stated interest
    that is unconditionally payable in cash or in property (other
    than debt instruments of the issuer) at least annually at a
    single fixed rate or, subject to certain conditions, based on
    one or more interest indices. The stated interest payments on
    the cash-pay OID notes are qualified stated interest, and are
    treated as described above under &#147;&#151;&#160;Stated
    Interest on Cash-Pay OID Notes.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    You generally must include OID in income in advance of the
    receipt of cash attributable to that income using the
    &#147;constant yield method&#148; described in the following
    paragraphs.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The amount of OID that you must include in income each year is
    the sum of the &#147;daily portions&#148; of OID with respect to
    the cash-pay OID note for each day during the taxable year or
    portion of the taxable year in which you held that cash-pay OID
    note (&#147;accrued OID&#148;). The daily portion is determined
    by allocating to each day in any &#147;accrual period&#148; a
    pro rata portion of the OID allocable to that accrual period.
    The &#147;accrual period&#148; for a cash-pay OID note may be of
    any length and may vary in length over the term of the cash-pay
    OID note, provided that each accrual period is no longer than
    one year and each scheduled payment of principal or interest
    occurs on the first day or the final day of an accrual period.
    The amount of OID allocable to any accrual period other than the
    final accrual period is an amount equal to the excess, if any,
    of:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the product of the cash-pay OID note&#146;s &#147;adjusted issue
    price&#148; at the beginning of such accrual period and its
    yield to maturity (determined on the basis of compounding at the
    close of each accrual period and properly adjusted for the
    length of the accrual period), over
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the aggregate of all qualified stated interest allocable to the
    accrual period.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    OID allocable to a final accrual period is the difference
    between the amount payable at maturity (other than a payment of
    qualified stated interest) and the adjusted issue price at the
    beginning of the final accrual period. The yield to maturity of
    the cash-pay OID note is the discount rate that causes the
    present value of all payments on the note as of its original
    issue date to equal the issue price of such note.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The &#147;adjusted issue price&#148; of a cash-pay OID note at
    the beginning of any accrual period is equal to its issue price
    increased by the accrued OID for each prior accrual period,
    determined without regard to the amortization of any acquisition
    or bond premium, as described below.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    You may elect to treat all interest on a cash-pay OID note as
    OID and calculate the amount includible in gross income under
    the constant yield method described above. The election is to be
    made for the taxable year in which you acquired the cash-pay OID
    note and may not be revoked without the consent of the IRS. You
    should consult with your own tax advisors about this election.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    265
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Market Discount.</I>&#160;&#160;If you purchase a cash-pay
    OID note for an amount that is less than its adjusted issue
    price, the amount of the difference will be treated as
    &#147;market discount&#148; for U.S.&#160;federal income tax
    purposes, unless that difference is less than a specified de
    minimis amount. Under the market discount rules, you will be
    required to treat any principal payment on, or any gain on the
    sale, exchange, retirement or other disposition of, a cash-pay
    OID note as ordinary income to the extent of the market discount
    that you have not previously included in income and are treated
    as having accrued on the note at the time of the payment or
    disposition.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, you may be required to defer, until the maturity of
    the cash-pay OID note or its earlier disposition in a taxable
    transaction, the deduction of all or a portion of the interest
    expense on any indebtedness attributable to the note. You may
    elect, on a
    <FONT style="white-space: nowrap">note-by-note</FONT>
    basis, to deduct the deferred interest expense in a tax year
    prior to the year of disposition. You should consult your own
    tax advisors before making this election.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any market discount will be considered to accrue ratably during
    the period from the date of acquisition to the maturity date of
    the cash-pay OID note, unless you elect to accrue on a constant
    interest method. You may elect to include market discount in
    income currently as it accrues, on either a ratable or constant
    interest method, in which case the rule described above
    regarding deferral of interest deductions will not apply.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Acquisition Premium, Amortizable Bond
    Premium.</I>&#160;&#160;If you purchase a cash-pay OID note for
    an amount that is greater than its adjusted issue price but
    equal to or less than its principal amount, you will be
    considered to have purchased that cash-pay OID note at an
    &#147;acquisition premium.&#148; Under the acquisition premium
    rules, the amount of OID that you must include in gross income
    with respect to the cash-pay OID note for any taxable year will
    be reduced by the portion of the acquisition premium properly
    allocable to that year.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If you purchase a cash-pay OID note for an amount in excess of
    its principal amount, you will be considered to have purchased
    the cash-pay OID note at a &#147;premium&#148; and you will not
    be required to include any OID in income. You generally may
    elect to amortize the premium over the remaining term of the
    cash-pay OID note on a constant yield method as an offset to
    interest when includible in income under your regular accounting
    method. If you do not elect to amortize bond premium, that
    premium will decrease the gain or increase the loss you would
    otherwise recognize on disposition of the cash-pay OID note.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Sale, Exchange, Retirement, or Other Taxable Disposition of
    Cash-Pay OID Notes.</I>&#160;&#160;Upon the sale, exchange,
    retirement, redemption or other disposition of a cash-pay OID
    note, you generally will recognize gain or loss equal to the
    difference between the amount realized upon the sale, exchange,
    retirement, redemption or other disposition (less an amount
    equal to any accrued and unpaid qualified stated interest, which
    will be taxable as interest income as discussed above) and the
    adjusted tax basis of the cash-pay OID note. Your adjusted tax
    basis in a cash-pay OID note will, in general, be your cost for
    that cash-pay OID note, increased by any OID or market discount
    previously included in income, and reduced by any amortized
    premium. Except as described above with respect to market
    discount, any gain or loss will be capital gain or loss. Capital
    gains of non-corporate U.S.&#160;holders derived in respect of
    capital assets held for more than one year are generally
    eligible for reduced rates of taxation. The deductibility of
    capital losses is subject to limitations.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">Toggle
    Notes</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Original Issue Discount.</I>&#160;&#160;The toggle notes are
    treated as having been issued with OID for U.S.&#160;federal
    income tax purposes, as described below. The issuance of PIK
    Notes generally is not treated as a payment of interest.
    Instead, the toggle note and any PIK Notes issued in respect of
    PIK Interest thereon are treated as a single debt instrument
    under the OID rules.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The toggle notes are treated as having been issued with OID in
    an amount equal to the difference between their &#147;stated
    redemption price at maturity&#148; (the sum of all payments to
    be made on the toggle notes other than &#147;qualified stated
    interest&#148;) and their &#147;issue price.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The &#147;issue price&#148; of a toggle note is the first price
    at which a substantial amount of the toggle notes was sold
    (excluding sales to bond houses, brokers or similar persons or
    organizations acting in the capacity of
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    266
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    underwiter, placement agent or wholesaler). The term
    &#147;qualified stated interest&#148; means stated interest that
    is unconditionally payable in cash or in property (other than
    debt instruments of the issuer) at least annually at a single
    fixed rate or, subject to certain conditions, based on one or
    more interest indices. Because we have the option in any
    interest payment period after the initial interest payment and
    prior to November&#160;15, 2011 to make interest payments in PIK
    Interest instead of paying cash, the stated interest payments on
    the toggle notes are not qualified stated interest.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    You generally must include OID in income in advance of the
    receipt of cash attributable to that income using the
    &#147;constant yield method&#148; described in the following
    paragraphs.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The amount of OID that you must include in income each year is
    the sum of the &#147;daily portions&#148; of OID with respect to
    the toggle note for each day during the taxable year or portion
    of the taxable year in which you held that toggle note
    (&#147;accrued OID&#148;). The daily portion is determined by
    allocating to each day in any &#147;accrual period&#148; a pro
    rata portion of the OID allocable to that accrual period. The
    &#147;accrual period&#148; for a toggle note may be of any
    length and may vary in length over the term of the toggle note,
    provided that each accrual period is no longer than one year and
    each scheduled payment of principal or interest occurs on the
    first day or the final day of an accrual period. The amount of
    OID allocable to any accrual period other than the final accrual
    period is an amount equal to the product of the toggle
    note&#146;s &#147;adjusted issue price&#148; at the beginning of
    such accrual period and its yield to maturity (determined on the
    basis of compounding at the close of each accrual period and
    properly adjusted for the length of the accrual period). OID
    allocable to a final accrual period is the difference between
    the amount payable at maturity and the adjusted issue price at
    the beginning of the final accrual period. The yield to maturity
    of the toggle note is the discount rate that causes the present
    value of all payments on the note as of its original issue date
    to equal the issue price of such note. For purposes of
    determining the yield to maturity, the assumption is that we
    will pay interest in cash and not exercise the option to pay PIK
    Interest, except in respect of any period in which we actually
    elect to pay PIK Interest.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The &#147;adjusted issue price&#148; of a toggle note at the
    beginning of any accrual period is equal to its issue price
    increased by the accrued OID for each prior accrual period,
    determined without regard to the amortization of any acquisition
    or bond premium, as described below, and reduced by any payments
    previously made on such toggle note.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If we in fact pay interest in cash on the toggle notes, you will
    not be required to adjust your OID inclusions. Each payment made
    in cash under a toggle note will be treated first as a payment
    of any accrued OID that has not been allocated to prior payments
    and second as a payment of principal. You generally will not be
    required to include separately in income cash payments received
    on the toggle notes to the extent such payments constitute
    payments of previously accrued OID or payments of principal.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    With respect to any interest payment period for which we
    exercise our option to pay interest in the form of PIK Interest,
    your OID calculation for future periods will be adjusted by
    treating the toggle note as if it had been retired and then
    reissued for an amount equal to its adjusted issue price on the
    date preceding the first date of such interest payment period,
    and recalculating the yield to maturity of the reissued note by
    treating the amount of PIK Interest (and of any prior PIK
    Interest) as a payment that will be made on the maturity date of
    such note.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The rules regarding OID are complex and the rules described
    above may not apply in all cases. Accordingly, you should
    consult your own tax advisors regarding their application.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Market Discount.</I>&#160;&#160;If you purchase a toggle note
    for an amount that is less than its adjusted issue price, the
    amount of the difference will be treated as &#147;market
    discount&#148; for U.S.&#160;federal income tax purposes, unless
    that difference is less than a specified de minimis amount.
    Under the market discount rules, you will be required to treat
    any principal payment on, or any gain on the sale, exchange,
    retirement or other disposition of, a toggle note as ordinary
    income to the extent of the market discount that you have not
    previously included in income and are treated as having accrued
    on the note at the time of the payment or disposition.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, you may be required to defer, until the maturity of
    the toggle note or its earlier disposition in a taxable
    transaction, the deduction of all or a portion of the interest
    expense on any indebtedness attributable
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    267
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    to the note. You may elect, on a
    <FONT style="white-space: nowrap">note-by-note</FONT>
    basis, to deduct the deferred interest expense in a tax year
    prior to the year of disposition. You should consult your own
    tax advisors before making this election.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Any market discount will be considered to accrue ratably during
    the period from the date of acquisition to the maturity date of
    the toggle note, unless you elect to accrue on a constant
    interest method. You may elect to include market discount in
    income currently as it accrues, on either a ratable or constant
    interest method, in which case the rule described above
    regarding deferral of interest deductions will not apply.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Acquisition Premium, Amortizable Bond
    Premium.</I>&#160;&#160;If you purchase a toggle note for an
    amount that is greater than its adjusted issue price but equal
    to or less than the sum of all amounts payable on the toggle
    note after the purchase date, you will be considered to have
    purchased that toggle note at an &#147;acquisition
    premium.&#148; Under the acquisition premium rules, the amount
    of OID that you must include in gross income with respect to the
    toggle note for any taxable year will be reduced by the portion
    of the acquisition premium properly allocable to that year.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If you purchase a toggle note for an amount in excess of the sum
    of all amounts payable on the toggle note after the purchase
    date, you will be considered to have purchased the toggle note
    at a &#147;premium&#148; and you will not be required to include
    any OID in income. You generally may elect to amortize the
    premium over the remaining term of the toggle note on a constant
    yield method as an offset to interest when includible in income
    under your regular accounting method. If you do not elect to
    amortize bond premium, that premium will decrease the gain or
    increase the loss you would otherwise recognize on disposition
    of the toggle note.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>Sale, Exchange, Retirement, or Other Taxable Disposition of
    Toggle Notes.</I>&#160;&#160;Subject to the discussion below
    regarding the Mandatory Principal Redemption, upon the sale,
    exchange, retirement, redemption or other disposition of a
    toggle note (or a PIK Note), you generally will recognize gain
    or loss equal to the difference between the amount realized upon
    the sale, exchange, retirement, redemption or other disposition
    and the adjusted tax basis of the toggle note (or the PIK Note).
    Your adjusted tax basis in a toggle note will, in general, be
    your cost for the toggle note, increased by OID or market
    discount previously included in income, and reduced by any
    amortized premium and any cash payments on the toggle note.
    Although not free from doubt, your adjusted tax basis in the
    toggle note should be allocated between the original toggle note
    and any PIK Notes received in respect of PIK Interest thereon in
    proportion to their relative principal amounts. Your holding
    period in any PIK Note received in respect of PIK Interest would
    likely be identical to your holding period for the original
    toggle note with respect to which the PIK Note was received.
    Except as described above with respect to market discount, any
    gain or loss will be capital gain or loss. Capital gains of
    non-corporate U.S.&#160;holders derived in respect of capital
    assets held for more than one year are generally eligible for
    reduced rates of taxation. The deductibility of capital losses
    is subject to limitations.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Payments received by a U.S.&#160;holder upon the Mandatory
    Principal Redemption of a portion of a toggle note will be
    treated as tax-free payments of a portion of the then accrued
    OID with respect to such toggle note in its entirety (including
    the portion of the toggle note not redeemed).
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Certain
    Tax Consequences to
    <FONT style="white-space: nowrap">Non-U.S.</FONT>
    Holders</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The following is a summary of certain U.S.&#160;federal income
    and estate tax consequences that will apply to
    <FONT style="white-space: nowrap">non-U.S.&#160;holders</FONT>
    of the notes.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">U.S.
    Federal Withholding Tax</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The 30% U.S.&#160;federal withholding tax will not apply to any
    payment of interest (which for purposes of this discussion
    includes OID) on the notes under the &#147;portfolio interest
    rule,&#148; provided that:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    interest paid on the notes (including OID) is not effectively
    connected with your conduct of a trade or business in the United
    States;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    you do not actually (or constructively) own 10% or more of the
    total combined voting power of all classes of our voting stock
    within the meaning of the Code and applicable United States
    Treasury regulations;
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    268
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    you are not a controlled foreign corporation that is related to
    us actually or constructively through stock ownership;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    you are not a bank whose receipt of interest (including OID) on
    the notes is described in Section&#160;881(c)(3)(A) of the
    Code;&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    either (a)&#160;you provide your name and address on an IRS
    <FONT style="white-space: nowrap">Form&#160;W-8BEN</FONT>
    (or other applicable form), and certify, under penalties of
    perjury, that you are not a United States person as defined
    under the Code or (b)&#160;you hold your notes through certain
    foreign intermediaries and satisfy the certification
    requirements of applicable United States Treasury regulations.
    Special certification rules apply to
    <FONT style="white-space: nowrap">non-U.S.&#160;holders</FONT>
    that are pass-through entities rather than corporations or
    individuals.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If you cannot satisfy the requirements described above, payments
    of interest (including OID) made to you will be subject to the
    30% U.S.&#160;federal withholding tax, unless you provide us
    with a properly executed:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    IRS
    <FONT style="white-space: nowrap">Form&#160;W-8BEN</FONT>
    (or other applicable form) certifying an exemption from or
    reduction in withholding under the benefit of an applicable
    income tax treaty;&#160;or
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    IRS
    <FONT style="white-space: nowrap">Form&#160;W-8ECI</FONT>
    (or other applicable form) certifying that interest (including
    OID) paid on the notes is not subject to withholding tax because
    it is effectively connected with your conduct of a trade or
    business in the United States (as discussed below under
    &#147;&#151;&#160;U.S.&#160;Federal Income Tax&#148;).
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The 30% U.S.&#160;federal withholding tax generally will not
    apply to any payment of principal or gain that you realize on
    the sale, exchange, retirement, redemption or other disposition
    of a note; provided, however, that payments received by a
    <FONT style="white-space: nowrap">non-U.S.&#160;holder</FONT>
    upon the Mandatory Principal Redemption of a portion of a toggle
    note will be treated as payments of a portion of the then
    accrued OID with respect to such toggle note in its entirety
    (including the portion of the toggle note not redeemed) and
    therefore possibly subject to the 30% U.S.&#160;federal
    withholding tax.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">U.S.
    Federal Income Tax</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If you are engaged in a trade or business in the United States
    and interest (including OID) on the notes is effectively
    connected with the conduct of that trade or business (and, if
    required by an applicable income tax treaty, is attributable to
    a United States permanent establishment), then you will be
    subject to U.S.&#160;federal income tax on that interest
    (including OID) on a net income in generally the same manner as
    if you were a United States person as defined under the Code. In
    addition, if you are a foreign corporation, you may be subject
    to a branch profits tax equal to 30% (or lower applicable income
    tax treaty rate) of such interest (including OID), subject to
    adjustments. If interest received with respect to the notes is
    effectively connected income (whether or not a treaty applies),
    the 30% withholding tax described above will not apply, provided
    the certification requirements discussed above in
    &#147;&#151;&#160;U.S.&#160;Federal Withholding Tax&#148; are
    satisfied.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Subject to the discussion of backup withholding below, any gain
    realized on the disposition of a note generally will not be
    subject to U.S.&#160;federal income tax unless:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    the gain is effectively connected with your conduct of a trade
    or business in the United States (and, if required by an
    applicable income tax treaty, is attributable to a United States
    permanent establishment);&#160;or
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    you are an individual who is present in the United States for
    183&#160;days or more in the taxable year of that disposition,
    and certain other conditions are met.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">U.S.
    Federal Estate Tax</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Your estate will not be subject to U.S.&#160;federal estate tax
    on notes beneficially owned by you at the time of your death,
    provided that any payment to you on the notes would be eligible
    for exemption from the 30% U.S.&#160;federal withholding tax
    under the &#147;portfolio interest rule&#148; described above
    under &#147;&#151;&#160;U.S.&#160;Federal Withholding Tax&#148;
    without regard to the statement requirement described in the
    fifth bullet point of that section.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    269
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Information
    Reporting and Backup Withholding</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times">U.S.
    Holders</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In general, information reporting requirements will apply to
    certain payments of principal and interest (including OID) paid
    on the notes and to the proceeds of sale or other disposition
    (including retirement or a redemption) of a note paid to you
    (unless you are an exempt recipient such as a corporation).
    Backup withholding (currently at a rate of 28%) may apply to
    such payments if you fail to provide a correct taxpayer
    identification number or a certification that you are not
    subject to backup withholding or if you fail to report in full
    dividend and interest income.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Backup withholding is not an additional tax and any amounts
    withheld under the backup withholding rules may be allowed as a
    refund or a credit against your U.S.&#160;federal income tax
    liability provided the required information is timely furnished
    to the IRS.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><I><FONT style="font-family: 'Times New Roman', Times"><FONT style="white-space: nowrap">Non-U.S.</FONT>
    Holders</FONT></I></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In general, we must report to the IRS and to you the amount of
    interest (including OID) paid to you and the amount of tax, if
    any, withheld with respect to those payments. Copies of the
    information returns reporting such interest payments and any
    withholding may also be made available to the tax authorities in
    the country in which you reside under the provisions of an
    applicable income tax treaty.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In general, you will not be subject to backup withholding with
    respect to payments of interest (including OID) on the notes
    that we make to you provided that we do not have actual
    knowledge or reason to know that you are a United States person
    as defined under the Code and we have received from you the
    required certification that you are a
    <FONT style="white-space: nowrap">non-U.S.&#160;holder</FONT>
    described above in the fifth bullet point under
    &#147;&#151;&#160;Certain Tax Consequences to
    <FONT style="white-space: nowrap">Non-U.S.&#160;Holders&#160;&#151;</FONT>
    U.S.&#160;Federal Withholding Tax.&#148;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Information reporting and, depending on the circumstances,
    backup withholding will apply to the proceeds of a sale or other
    disposition (including a retirement or redemption) of notes
    within the United States or conducted through certain United
    States-related financial intermediaries, unless you certify to
    the payor under penalties of perjury that you are a
    <FONT style="white-space: nowrap">non-U.S.&#160;holder</FONT>
    (and the payor does not have actual knowledge or reason to know
    that you are a United States person as defined under the Code),
    or you otherwise establish an exemption.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Backup withholding is not an additional tax and any amounts
    withheld under the backup withholding rules may be allowed as a
    refund or a credit against your U.S.&#160;federal income tax
    liability provided the required information is timely furnished
    to the IRS.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    270
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->
<A name='109'>
<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">PLAN OF
    DISTRIBUTION</FONT></B>
</DIV>
</A>
<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    This prospectus is to be used by Banc of America Securities LLC,
    Merrill Lynch, Pierce, Fenner&#160;&#038; Smith Incorporated and
    their affiliates in connection with offers and sales of the
    notes in market-making transactions effected from time to time.
    Such affiliates may act as principal or agent in such
    transactions, including as agent for the counterparty when
    acting as principal or as agent for both counterparties, and may
    receive compensation in the form of discounts and commissions,
    including from both counterparties, when they act as agents for
    both. Such sales will be made at prevailing market prices at the
    time of sale, at prices related thereto or at negotiated prices.
    We will not receive any of the proceeds from such sales.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Merrill Lynch Global Private Equity (previously the private
    equity arm of Merrill Lynch&#160;&#038; Co., Inc., which is a
    wholly-owned subsidiary of Bank of America Corporation), owned
    24.8% of our common stock, and other affiliates of Bank of
    America Corporation owned an additional 1.0% of our common
    stock, as of April&#160;30, 2009. The agreement among the
    investors in HCA Inc., including Merrill Lynch Global Private
    Equity, gives such investors the right to elect members to serve
    on our Board of Directors. In addition, Banc of America
    Securities LLC or its affiliates, is the administrative agent
    under our senior secured credit facilities and, as such, is
    entitled to receive and has received fees related thereto. Banc
    of America Securities LLC and its affiliates have also in the
    past engaged, and may in the future engage, in transactions with
    and perform services for, including commercial banking,
    financial advisory and investment banking services, us and our
    affiliates in the ordinary course of business for which they
    have received customary fees and expenses. This section and the
    applicable descriptions of certain agreements set forth herein
    (including those descriptions incorporated herein by reference
    to &#147;Item 13. Certain Relationships and Related
    Transactions&#148; of our 2008
    <FONT style="white-space: nowrap">10-K)</FONT>
    constitute notice to potential purchasers of the notes pursuant
    to Rule 312(f)(2) of the New York Stock Exchange to the extent
    that affiliates of Banc of America Securities LLC may be deemed
    to control us for purposes of such rule.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We have been advised by Banc of America Securities LLC that,
    subject to applicable laws and regulations, they currently
    intend to make a market in the notes. However, they are not
    obligated to do so, and any such market-making may be
    interrupted or discontinued at any time without notice.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We and Banc of America Securities LLC, among other parties, have
    entered into a registration rights agreement with respect to the
    use by Banc of America Securities LLC and its affiliates of this
    prospectus. Pursuant to such agreement, we agreed to indemnify
    Banc of America Securities LLC and Merrill Lynch, Pierce,
    Fenner&#160;&#038; Smith Incorporated and their affiliates, in
    their capacity as a market maker, against certain liabilities,
    including liabilities under the Securities Act.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    271
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->
<A name='110'>
<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">EXPERTS</FONT></B>
</DIV>
</A>
<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The consolidated financial statements of HCA Inc. appearing in
    HCA Inc.&#146;s Current Report
    <FONT style="white-space: nowrap">(Form&#160;8-K)</FONT>
    dated May&#160;27, 2009 for the year ended December&#160;31,
    2008, and the effectiveness of HCA Inc.&#146;s internal control
    over financial reporting as of December&#160;31, 2008 included
    in its Annual Report
    <FONT style="white-space: nowrap">(Form&#160;10-K)</FONT>
    have been audited by Ernst&#160;&#038; Young LLP, an independent
    registered public accounting firm, as set forth in their reports
    thereon, included therein, and incorporated herein by reference.
    Such consolidated financial statements and HCA Inc.
    management&#146;s assessment of the effectiveness of internal
    control over financial reporting as of December&#160;31, 2008
    are incorporated herein by reference in reliance upon such
    reports given on the authority of such firm as experts in
    accounting and auditing.
</DIV>
<A name='111'>
<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">LEGAL
    OPINIONS</FONT></B>
</DIV>
</A>
<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Robert A. Waterman,&#160;Esq., our Senior Vice President and
    General Counsel, and Simpson Thacher&#160;&#038; Bartlett LLP,
    New York, New York, have each provided an opinion regarding the
    validity of HCA Inc.&#146;s debt securities and the related
    guarantees referenced herein. An investment vehicle comprised of
    several partners of Simpson Thacher&#160;&#038; Bartlett LLP,
    members of their families, related persons and others own
    interests representing less than 1% of the capital commitments
    of the KKR Millennium Fund, L.P. and KKR 2006 Fund&#160;L.P,
    which indirectly own capital stock of HCA Inc. In addition,
    Robert A. Waterman, Esq. beneficially owns, directly and
    indirectly, less than 1% of the capital stock of HCA Inc.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    272
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="font-size: 0pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 2pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <IMG src="y77125y7712513.gif" alt="(HCA LOGO)">
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 18pt; font-family: Arial, Helvetica">HCA
    Inc.</FONT></B>
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 16pt; font-family: Arial, Helvetica">Debt
    Securities</FONT></B>
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<CENTER style="font-size: 1pt; width: 26%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=456 length=120 -->

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Prospectus
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
    2009
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<CENTER style="font-size: 1pt; width: 26%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=456 length=120 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="font-size: 1pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 2pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">PART&#160;II<BR>
    </FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">INFORMATION
    NOT REQUIRED IN PROSPECTUS</FONT></B>
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

<TR>
    <TD width="9%"></TD>
    <TD width="91%"></TD>
</TR>

<TR valign="top">
    <TD>
    <B><FONT style="font-family: 'Times New Roman', Times">Item&#160;13.&#160;&#160;</FONT></B>
</TD>
    <TD>
    <B><I><FONT style="font-family: 'Times New Roman', Times">Other
    Expenses of Issuance and Distribution</FONT></I></B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The registration rights agreement relating to the securities of
    the Registrant being registered hereby provides that HCA Inc.
    will bear all expenses in connection with the performance of its
    obligation relating to the market-making activities of Banc of
    America Securities LLC, Merrill Lynch, Pierce,
    Fenner&#160;&#038; Smith Incorporated or their affiliates. These
    expenses include the following:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="90%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="6%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    Attorneys&#146; fees and expenses
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    75,000
</TD>
<TD nowrap align="left" valign="bottom">
    *
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    Accountants&#146; fees and expenses
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    25,000
</TD>
<TD nowrap align="left" valign="bottom">
    *
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    Printing expenses
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    100,000
</TD>
<TD nowrap align="left" valign="bottom">
    *
</TD>
</TR>
<TR valign="bottom" style="font-size: 1pt">
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    Total
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    200,000
</TD>
<TD nowrap align="left" valign="bottom">
    *
</TD>
</TR>
<TR valign="bottom" style="font-size: 1pt">
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="font-size: 1pt; margin-left: 0%; width: 13%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=60 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>



<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

<TR>
    <TD width="2%"></TD>
    <TD width="1%"></TD>
    <TD width="97%"></TD>
</TR>

<TR>
    <TD align="right" valign="top">
    *&#160;</TD>
    <TD></TD>
    <TD valign="bottom">
    Estimated.</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

<TR>
    <TD width="9%"></TD>
    <TD width="91%"></TD>
</TR>

<TR valign="top">
    <TD>
    <B><FONT style="font-family: 'Times New Roman', Times">Item&#160;14.&#160;&#160;</FONT></B>
</TD>
    <TD>
    <B><I><FONT style="font-family: 'Times New Roman', Times">Indemnification
    of Directors and Officers.</FONT></I></B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Set forth below are summaries of the statutes, charter
    provisions, by-laws, contracts or other arrangements under which
    the directors and officers of the Company and the additional
    registrant guarantors may be indemnified against liability which
    they may incur in their capacity as such. In the summaries that
    follow, defined terms used in each respective subsection apply
    only to that subsection.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">California
    Registrants</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(a)&#160;Columbia ASC Management, L.P. and Riverside
    Healthcare System, L.P. are registered under the laws of
    California.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The partnership agreements of Columbia ASC Management, L.P. and
    Riverside Healthcare System, L.P. provide that the limited
    partner shall indemnify and hold harmless the general partner;
    its partners, managers, employees, agents and representatives;
    and the officers, directors, employees, agents and
    representatives of its partners to the fullest extent permitted
    by the California Limited Partnership Act and the California
    Revised Partnership Act. Neither of these acts, however,
    addresses indemnification.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Section&#160;15904.06 (Operative January&#160;1, 2008)&#160;of
    the 2008 California Revised Limited Partnership Act addresses
    the rights of a general partner with respect to its management
    and conduct of partnership activities. The 2008 California
    Revised Limited Partnership Act provides that a limited
    partnership shall reimburse a general partner for payments made,
    and indemnify a general partner for liabilities incurred by, the
    general partner in the ordinary course of the activities of the
    partnership or for the preservation of its activities or
    property.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(b)&#160;Columbia Riverside, Inc., Encino Hospital
    Corporation, Inc., Los Robles Regional Medical Center and MCA
    Investment Company are incorporated under the laws of
    California.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Section&#160;317 of the California General Corporation Law sets
    forth the provisions pertaining to the indemnification of
    corporate &#147;agents.&#148; For purposes of this law, an agent
    is any person who is or was a director, officer, employee or
    other agent of a corporation, or is or was serving at the
    request of the corporation in such capacity with respect to any
    other corporation, partnership, join venture, trust or other
    enterprise. Indemnification for expenses, including amounts paid
    on settling or otherwise disposing of a threatened or pending
    action or defending against the same, can be made in certain
    circumstances by action of the company through:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    a majority vote of a quorum of the corporation&#146;s Board of
    Directors consisting of directors who are not party to the
    proceedings;
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-1
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    approval of the shareholders, with the shares owned by the
    person to be indemnified not being entitled to vote
    thereon;&#160;or
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    such court in which the proceeding is or was pending upon
    application by designated parties.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under certain circumstances, an agent can be indemnified, even
    when found liable. Indemnification is mandatory where the
    agent&#146;s defense is successful on the merits. The law allows
    a corporation to make advances of expenses for certain actions
    upon the receipt of an undertaking that the agent will reimburse
    the corporation if the agent is found liable. The
    indemnification provided by Section&#160;317 for acts while
    serving as a director or officer of the corporation, but not
    involving breach of duty to the corporation and its
    shareholders, shall not be deemed exclusive of any other rights
    to which those seeking indemnification may be entitled under any
    bylaw to the extent authorized by the corporation&#146;s
    articles of the corporation.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The bylaws of each of the California Registrants in this
    section&#160;(b) provide, in relevant part, that each of the
    Registrants will indemnify its respective officers and
    directors, under the circumstances and to the extent provided
    for therein, for expenses, damages, judgments, fines and
    settlements such officers and directors may be required to pay
    in any action, suit or proceeding which they are or may be made
    a party by reason of their position as a director, officer or
    other agent of such Registrant, and otherwise to the full extent
    permitted under California law and our bylaws for any taken on
    behalf of the corporation that does not involve gross negligence
    or willful misconduct.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(c)&#160;Surgicare of Riverside, LLC is registered under the
    laws of California.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under Section&#160;17155 of the California Limited Liability
    Company Act, except for a breach of duty, the articles of
    organization or written operating agreement of a limited
    liability company may provide for indemnification of any person,
    including, without limitation, any manager, member, officer,
    employee or agent of the limited liability company, against
    judgments, settlements, penalties, fines or expenses of any kind
    incurred as a result of acting in that capacity. A limited
    liability company shall have the power to purchase and maintain
    insurance on behalf of any manager, member, officer, employee or
    agent of the limited liability company against any liability
    asserted against or incurred by the person in that capacity or
    arising out of the person&#146;s status as a manager, member,
    officer, employee or agent of the limited liability company.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The limited liability company agreement of Surgicare of
    Riverside, LLC states that the company shall indemnify its
    officers and managers against all reasonable expense incurred by
    them in defending claims or suits, irrespective of the time of
    the occurrence of the claims or causes of action in such suits,
    made or brought against them as officers or managers of the
    company, and against all liability in such suits, except in such
    cases as involve gross negligence or willful misconduct in the
    performance of their duties. Such indemnification extends to the
    payment of judgments against such officers and managers and to
    reimbursement of amounts paid in settlement of such claims or
    actions and may apply to judgments in favor of the company or
    amounts paid in settlement to the company. Such indemnification
    also extends to the payment of counsel fees and expenses of such
    officers and managers in suits against them where successfully
    defended by them or where unsuccessfully defended, if there is
    no finding or judgment that the claim or action arose from the
    gross negligence or willful misconduct of such officers or
    directors. Such right of indemnification is not exclusive of any
    right to which such officer or director may be entitled as a
    matter of law and shall extend and apply to the estates of
    deceased officers and directors.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Colorado
    Registrants</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(a)&#160;Colorado Health Systems, Inc., Columbine Psychiatric
    Center, Inc. and New Rose Holding Company, Inc. are incorporated
    under the laws of Colorado.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <FONT style="white-space: nowrap">Sections&#160;7-109-102</FONT>
    through 7-109-110 of the Colorado Business Corporation Act (the
    &#147;Act&#148;) grant the registrants&#146; broad powers to
    indemnify any person in connection with legal proceedings
    brought against him by reason of his present or past status as
    an officer or director of the registrant, provided with respect
    to conduct in an official capacity with the registrant, the
    person acted in good faith and in a manner he reasonably
    believed to be in the best interests of the registrant, with
    respect to all other conduct, the person believed the conduct to
    be at least not opposed to the best interests of the registrant,
    and with respect to any
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-2
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    criminal action or proceeding, the person had no reasonable
    cause to believe his conduct was unlawful. Indemnification is
    limited to reasonable expenses incurred in connection with the
    proceeding. No indemnification may be made (i)&#160;in
    connection with a proceeding by or in the right of the
    registrant in which the person was adjudged liable to the
    registrant; or (ii)&#160;in connection with any other
    proceedings charging that the person derived an improper
    personal benefit, whether or not involving action in an official
    capacity, in which proceeding the person was judged liable on
    the basis that he derived an improper personal benefit, unless
    and only to the extent the court in which such action was
    brought or another court of competent jurisdiction determines
    upon application that, despite such adjudication, but in view of
    all relevant circumstances, the person is fairly and reasonably
    entitled to indemnity for reasonable expenses as the court deems
    proper. In addition, to the extent that any such person is
    successful in the defense of any such legal proceeding, the
    registrant is required by the Act to indemnify him against
    reasonable expenses.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The bylaws of these Colorado registrants state that the
    corporation shall indemnify its officers and directors against
    all reasonable expense incurred by them in defending claims or
    suits, irrespective of the time of the occurrence of the claims
    or causes of action in such suits, made or brought against them
    as officers or directors of the corporation, and against all
    liability in such suits, except in such cases as involve gross
    negligence or willful misconduct in the performance of their
    duties. Such indemnification extends to the payment of judgments
    against such officers and directors and to reimbursement of
    amounts paid in settlement of such claims or actions and may
    apply to judgments in favor of the corporation or amounts paid
    in settlement to the corporation. Such indemnification also
    extends to the payment of counsel fees and expenses of such
    officers and directors in suits against them where successfully
    defended by them or where unsuccessfully defended, if there is
    no finding or judgment that the claim or action arose from the
    gross negligence or willful misconduct of such officers or
    directors. Such right of indemnification is not exclusive of any
    right to which such officer or director may be entitled as a
    matter of law and shall extend and apply to the estates of
    deceased officers and directors.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Delaware
    Registrants</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(a)&#160;HCA Inc., American Medicorp Development Co.,
    GPCH-GP, Inc., HCA&#160;&#151; IT&#038;S Field Operations, Inc.,
    HCA&#160;&#151; IT&#038;S Inventory Management, Inc., Management
    Services Holdings, Inc., Midwest Holdings, Inc., Hospital
    Development Properties, Inc., Riverside Hospital, Inc., Terre
    Haute Hospital GP, Inc. and Terre Haute Hospital Holdings, Inc.
    are incorporated under the laws of Delaware.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Section&#160;145 of the Delaware General Corporation Law (the
    &#147;DGCL&#148;) grants each corporation organized thereunder
    the power to indemnify any person who is or was a director,
    officer, employee or agent of a corporation or enterprise,
    against expenses, including attorneys&#146; fees, judgments,
    fines and amounts paid in settlement actually and reasonably
    incurred by him in connection with any threatened, pending or
    completed action, suit or proceeding, whether civil, criminal,
    administrative or investigative, other than an action by or in
    the right of the corporation, by reason of being or having been
    in any such capacity, if he acted in good faith in a manner
    reasonably believed to be in, or not opposed to, the best
    interests of the corporation, and, with respect to any criminal
    action or proceeding, had no reasonable cause to believe his
    conduct was unlawful.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Section&#160;102(b)(7) of the DGCL enables a corporation in its
    certificate of incorporation or an amendment thereto to
    eliminate or limit the personal liability of a director to the
    corporation or its stockholders of monetary damages for
    violations of the directors&#146; fiduciary duty of care, except
    (i)&#160;for any breach of the directors&#146; duty of loyalty
    to the corporation or its stockholders, (ii)&#160;for acts or
    omissions not in good faith or that involve intentional
    misconduct or a knowing violation of law, (iii)&#160;pursuant to
    Section&#160;174 of the DGCL (providing for liability of
    directors for unlawful payment of dividends or unlawful stock
    purchases or redemptions) or (iv)&#160;for any transaction from
    which a director derived an improper personal benefit.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    HCA Inc.&#146;s bylaws indemnify the directors and officers to
    the full extent of the DGCL and also allow the Board of
    Directors to indemnify all other employees. The bylaws of the
    remainder of the Delaware corporate registrants indemnify their
    officers and directors against all reasonable expense incurred
    by them in defending claims or suits, irrespective of the time
    of the occurrence of the claims or causes of action in such
    suits, made or brought against them as officers or directors of
    the corporation, and against all liability in such suits, except
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-3
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    in such cases as involve gross negligence or willful misconduct
    in the performance of their duties. Such indemnification extends
    to the payment of judgments against such officers and directors
    and to reimbursement of amounts paid in settlement of such
    claims or actions and may apply to judgments in favor of the
    corporation or amounts paid in settlement to the corporation.
    Such indemnification also extends to the payment of counsel fees
    and expenses of such officers and directors in suits against
    them where successfully defended by them or where unsuccessfully
    defended, if there is no finding or judgment that the claim or
    action arose from the gross negligence or willful misconduct of
    such officers or directors. Such right of indemnification is not
    exclusive of any right to which such officer or director may be
    entitled as a matter of law and shall extend and apply to the
    estates of deceased officers and directors.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(b)&#160;Nashville Shared Services General Partnership is a
    general partnership under the laws of Delaware and Integrated
    Regional Laboratories, LLP is registered under the laws of
    Delaware.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <FONT style="white-space: nowrap">Section&#160;15-110</FONT>
    of the Delaware Revised Uniform Partnership Act provides that
    subject to such standards and restrictions, if any, as are set
    forth in its partnership agreement, a partnership may, and shall
    have the power to, indemnify and hold harmless any partner or
    other person from and against any and all claims and demands
    whatsoever.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Nashville Shared Services General Partnership partnership
    agreement states that indemnification is controlled by the
    Delaware Revised Uniform Partnership Act. The partnership
    agreement of Integrated Regional Laboratories, LLP indemnifies
    its officers and directors against all reasonable expense
    incurred by them in defending claims or suits, irrespective of
    the time of the occurrence of the claims or causes of action in
    such suits, made or brought against them as officers or
    directors of the company, and against all liability in such
    suits, except in such cases as involve gross negligence or
    willful misconduct in the performance of their duties. Such
    indemnification extends to the payment of judgments against such
    officers and directors and to reimbursement of amounts paid in
    settlement of such claims or actions and may apply to judgments
    in favor of the company or amounts paid in settlement to the
    company. Such indemnification also extends to the payment of
    counsel fees and expenses of such officers and directors in
    suits against them where successfully defended by them or where
    unsuccessfully defended, if there is no finding or judgment that
    the claim or action arose from the gross negligence or willful
    misconduct of such officers or directors. Such right of
    indemnification is not exclusive of any right to which such
    officer or director may be entitled as a matter of law and shall
    extend and apply to the estates of deceased officers and
    directors.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(c)&#160;Centerpoint Medical Center of Independence, LLC, CMS
    GP, LLC, Dallas/Ft.&#160;Worth Physician, LLC, Edmond Regional
    Medical Center, LLC, EP Health, LLC, Fairview Park GP, LLC,
    General Healthserv, LLC, Goppert-Trinity Family Care, LLC, Grand
    Strand Regional Medical Center, LLC, Healthtrust MOB, LLC, HSS
    Holdco, LLC, HSS Systems VA, LLC, HSS Systems, LLC, Lakeland
    Medical Center, LLC, Lakeview Medical Center, LLC, Lewis-Gale
    Medical Center, LLC, Medical Centers of Oklahoma, LLC, Medical
    Office Buildings of Kansas, LLC, Midwest Division&#160;&#151;
    ACH, LLC, Midwest Division&#160;&#151; LRHC, LLC, Midwest
    Division&#160;&#151; LSH, LLC, Midwest Division&#160;&#151; MCI,
    LLC, Midwest Division&#160;&#151; MMC, LLC, Midwest
    Division&#160;&#151; OPRMC, LLC, Midwest Division&#160;&#151;
    PFC, LLC, Midwest Division&#160;&#151; RMC, LLC, Midwest
    Division&#160;&#151; RPC, LLC, Notami Hospitals, LLC, Outpatient
    Cardiovascular Center of Central Florida, LLC, Reston Hospital
    Center, LLC, Samaritan, LLC, San&#160;Jose Medical Center, LLC,
    San&#160;Jose, LLC, SJMC, LLC, Trident Medical Center, LLC, Utah
    Medco, LLC and Wesley Medical Center, LLC are registered under
    the laws of Delaware.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <FONT style="white-space: nowrap">Section&#160;18-108</FONT>
    of the Delaware Limited Liability Company Act empowers a
    Delaware limited liability company to indemnify and hold
    harmless any member or manager of the limited liability company
    from and against any and all claims and demands whatsoever.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The operating agreement of Healthtrust MOB, LLC indemnifies the
    directors and officers to the full extent of the law. The
    operating agreements of the remainder of the Delaware limited
    liability company registrants indemnify their officers and
    directors against all reasonable expense incurred by them in
    defending claims or suits, irrespective of the time of the
    occurrence of the claims or causes of action in such suits, made
    or brought against them as officers or directors of the company,
    and against all liability in such suits, except in such cases as
    involve gross negligence or willful misconduct in the
    performance of their duties. Such
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-4
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    indemnification extends to the payment of judgments against such
    officers and directors and to reimbursement of amounts paid in
    settlement of such claims or actions and may apply to judgments
    in favor of the company or amounts paid in settlement to the
    company. Such indemnification also extends to the payment of
    counsel fees and expenses of such officers and directors in
    suits against them where successfully defended by them or where
    unsuccessfully defended, if there is no finding or judgment that
    the claim or action arose from the gross negligence or willful
    misconduct of such officers or directors. Such right of
    indemnification is not exclusive of any right to which such
    officer or director may be entitled as a matter of law and shall
    extend and apply to the estates of deceased officers and
    directors.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(d)&#160;CHCA Bayshore, L.P., CHCA Conroe, L.P., CHCA
    Mainland, L.P., CHCA West Houston, L.P., CHCA Woman&#146;s
    Hospital, L.P., Columbia Valley Healthcare System, L.P.,
    Columbia Rio Grande Healthcare, L.P., HCA Management Services,
    L.P., Good Samaritan Hospital, L.P., JFK Medical Center Limited
    Partnership, Palms West Hospital Limited Partnership, Plantation
    General Hospital, L.P., San&#160;Jose Healthcare System, LP,
    Terre Haute Regional Hospital, L.P. and San&#160;Jose Hospital,
    L.P. are registered under the laws of Delaware.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <FONT style="white-space: nowrap">Section&#160;17-108</FONT>
    of the Delaware Revised Uniform Limited Partnership Act (DRULPA)
    permits a limited partnership to indemnify and hold harmless any
    partner or other person from and against any and all claims and
    demands whatsoever.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Columbia Valley Healthcare System, L.P. partnership
    agreement allows the partnership to indemnify the general
    partners for everything but willful misconduct or gross
    negligence. The other Delaware limited partnership registrants
    allow for indemnification to the fullest extent under the DRULPA.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Florida
    Registrants</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(a)&#160;Bay Hospital, Inc., Central Florida Regional
    Hospital, Inc., Columbia Jacksonville Healthcare System, Inc.,
    Edward White Hospital, Inc., HCA Health Services of Florida,
    Inc., HD&#038;S Corp. Successor, Inc., Largo Medical Center,
    Inc., Lawnwood Medical Center, Inc., Marion Community Hospital,
    Inc., Memorial Healthcare Group, Inc., New Port Richey Hospital,
    Inc., North Florida Immediate Care Center, Inc., North Florida
    Regional Medical Center, Inc., Okaloosa Hospital, Inc.,
    Okeechobee Hospital, Inc., Sarasota Doctors Hospital, Inc., Sun
    City Hospital, Inc., Surgicare of Brandon, Inc., Surgicare of
    Florida, Inc., Surgicare of Manatee, Inc., Surgicare of New Port
    Richey, Inc., Tallahassee Medical Center, Inc. and West Florida
    Regional Medical Center, Inc. are incorporated under the laws of
    Florida.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Section&#160;607.0831 of the Florida Business Corporation Act
    provides, among other things, that a director is not personally
    liable for monetary damages to a company or any other person for
    any statement, vote, decision, or failure to act, by the
    director, regarding corporate management or policy, unless the
    director breached or failed to perform his or her duties as a
    director and such breach or failure constitutes (a)&#160;a
    violation of criminal law, unless the director had reasonable
    cause to believe his or her conduct was lawful or had no
    reasonable cause to believe his or her conduct was unlawful;
    (b)&#160;a transaction from which the director derived an
    improper personal benefit; (c)&#160;a circumstance under which
    the liability provisions of Section&#160;607.0834 of the Florida
    Business Corporation Act (relating to the liability of the
    directors for improper distributions) are applicable;
    (d)&#160;willful misconduct or a conscious disregard for the
    best interest of the company in the case of a proceeding by or
    in the right of the company to procure a judgment in its favor
    or by or in the right of a stockholders; or
    (e)&#160;recklessness or an act or omission in bad faith or with
    malicious purpose of with wanton and willful disregard of human
    rights, safety or property, in a proceeding by or in the right
    of someone other than such company or a stockholder.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Section&#160;607.0850 of the Florida Business Corporation Act
    authorizes, among other things, a company to indemnify any
    person who was or is a party to any proceeding (other than an
    action by or in the right of the company) by reason of the fact
    that he is or was a director, officer, employee or agent of the
    company (or is or was serving at the request of the company in
    such a position for any entity) against liability incurred in
    connection with such proceedings, if he or she acted in good
    faith and in a manner reasonably believed to be
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-5
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    in the best interests of the company and, with respect to
    criminal proceedings, had no reasonable cause to believe his or
    her conduct was unlawful.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Florida Business Corporation Act requires that a director,
    officer or employee be indemnified for actual and reasonable
    expenses (including attorneys&#146; fees) to the extent that he
    or she has been successful on the merits or otherwise in the
    defense of any proceeding. Florida law also allows expenses of
    defending a proceeding to be advanced by a company before the
    final disposition of the proceedings, provided that the officer,
    director or employee undertakes to repay such advance if it is
    ultimately determined that indemnification is not permitted.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Florida Business Corporation Act states that the
    indemnification and advancement of expenses provided pursuant to
    Section&#160;607.0850 is not exclusive and that indemnification
    may be provided by a company pursuant to other means, including
    agreements or bylaw provisions. Florida law prohibits
    indemnification or advancement of expenses, however, if a
    judgment or other final adjudication establishes that the
    actions of a director, officer or employee constitute (i)&#160;a
    violation of criminal law, unless he or she had reasonable cause
    to believe his or her conduct was lawful or had no reasonable
    cause to believe his or her conduct was unlawful; (ii)&#160;a
    transaction from which such person derived an improper personal
    benefit; (iii)&#160;willful misconduct or conscious disregard
    for the best interests of the company in the case of a
    derivative action or a proceeding by or in the right of a
    stockholder, or (iv)&#160;in the case of a director, a
    circumstance under which the liability provisions of
    Section&#160;607.0834 of the Florida Business Corporation Act
    (relating to the liability of directors for improper
    distributions) are applicable.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The bylaws of all the Florida corporate registrants indemnify
    their officers and directors against all reasonable expense
    incurred by them in defending claims or suits, irrespective of
    the time of the occurrence of the claims or causes of action in
    such suits, made or brought against them as officers or
    directors of the corporation, and against all liability in such
    suits, except in such cases as involve gross negligence or
    willful misconduct in the performance of their duties. Such
    indemnification extends to the payment of judgments against such
    officers and directors and to reimbursement of amounts paid in
    settlement of such claims or actions and may apply to judgments
    in favor of the corporation or amounts paid in settlement to the
    corporation. Such indemnification also extends to the payment of
    counsel fees and expenses of such officers and directors in
    suits against them where successfully defended by them or where
    unsuccessfully defended, if there is no finding or judgment that
    the claim or action arose from the gross negligence or willful
    misconduct of such officers or directors. Such right of
    indemnification is not exclusive of any right to which such
    officer or director may be entitled as a matter of law and shall
    extend and apply to the estates of deceased officers and
    directors.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(b)&#160;Integrated Regional Lab, LLC and Surgicare of Palms
    West, LLC are registered under the laws of Florida.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Section&#160;608.4229 of the Florida Limited Liability Company
    Act indemnifies members, managers, managing members, officers,
    employees, and agents subject to such standards and
    restrictions, if any, as are set forth in its articles of
    organization or operating agreement. A limited liability company
    may, and has the power to, but is not be required to, indemnify
    and hold harmless any member or manager or other person from and
    against any and all claims and demands whatsoever.
    Notwithstanding the foregoing, indemnification or advancement of
    expenses should not be made to or on behalf of any member,
    manager, managing member, officer, employee, or agent if a
    judgment or other final adjudication establishes that the
    actions, or omissions to act, of such member, manager, managing
    member, officer, employee, or agent were material to the cause
    of action so adjudicated and constitute any of the following:
    (i)&#160;a violation of criminal law, unless the member,
    manager, managing member, officer, employee, or agent had no
    reasonable cause to believe such conduct was unlawful;
    (ii)&#160;a transaction from which the member, manager, managing
    member, officer, employee, or agent derived an improper personal
    benefit; (iii)&#160;in the case of a manager or managing member,
    a circumstance under which the liability provisions of s.
    608.426 are applicable; or (iv)&#160;willful misconduct or a
    conscious
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-6
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    disregard for the best interests of the limited liability
    company in a proceeding by or in the right of the limited
    liability company to procure a judgment in its favor or in a
    proceeding by or in the right of a member.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The operating agreements of both of the Florida limited
    liability company registrants indemnify their officers and
    managers against all reasonable expense incurred by them in
    defending claims or suits, irrespective of the time of the
    occurrence of the claims or causes of action in such suits, made
    or brought against them as officers or managers of the company,
    and against all liability in such suits, except in such cases as
    involve gross negligence or willful misconduct in the
    performance of their duties. Such indemnification extends to the
    payment of judgments against such officers and managers and to
    reimbursement of amounts paid in settlement of such claims or
    actions and may apply to judgments in favor of the company or
    amounts paid in settlement to the company. Such indemnification
    also extends to the payment of counsel fees and expenses of such
    officers and managers in suits against them where successfully
    defended by them or where unsuccessfully defended, if there is
    no finding or judgment that the claim or action arose from the
    gross negligence or willful misconduct of such officers or
    managers. Such right of indemnification is not exclusive of any
    right to which such officer or manager may be entitled as a
    matter of law and shall extend and apply to the estates of
    deceased officers and managers.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Georgia
    Registrants</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(a)&#160;Columbia Polk General Hospital, Inc., Columbus
    Cardiology, Inc., Marietta Surgical Center, Inc., Palmyra Park
    Hospital, Inc. and Redmond Physician Practice Company are
    incorporated under the laws of Georgia.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <FONT style="white-space: nowrap">Section&#160;14-2-202(b)(4)</FONT>
    of the Georgia Business Corporation Code provides that a
    corporation&#146;s articles of incorporation may include a
    provision that eliminates or limits the liability of directors
    for monetary damages to a corporation or its shareholders for
    any action taken, or failure to take any action, as a director.
    The section does not, however, authorize a corporation to
    eliminate or limit the liability of a director for
    appropriating, in violation of his or her duties, any business
    opportunity of the corporation, for acts or omissions which
    involve intentional misconduct or a knowing violation of law,
    for any transaction from which the director received an improper
    personal benefit, or authorizing a dividend, stock repurchase or
    redemption, distribution of assets or other distribution in
    violation of
    <FONT style="white-space: nowrap">Section&#160;14-2-640</FONT>
    of the Georgia Business Corporation Code if it is established
    that the director did not perform his or her duties in
    compliance with
    <FONT style="white-space: nowrap">Section&#160;14-2-832</FONT>
    of the Georgia Business Corporation Code, which sets forth
    general standards for directors.
    <FONT style="white-space: nowrap">Section&#160;14-2-202(b)(4)</FONT>
    also does not eliminate or limit the right of a corporation or
    any shareholder to seek an injunction, a rescission or any other
    equitable (non-monetary) relief for any action taken or not
    taken by a director. In addition,
    <FONT style="white-space: nowrap">Section&#160;14-2-202(b)(4)</FONT>
    applies only to claims against a director arising out of his or
    her role as a director and does not relieve a director from
    liability arising from his or her role as an officer or in any
    other capacity.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <FONT style="white-space: nowrap">Sections&#160;14-2-852</FONT>
    and <FONT style="white-space: nowrap">14-2-857</FONT>
    of the Georgia Business Corporation Code provide that any
    director or officer who is wholly successful in the defense of
    any proceeding to which he or she was a party because her or she
    was an officer or a director of the corporation are entitled to
    indemnification against reasonable expenses as of right. On the
    other hand, if the charges made in any action are sustained, the
    determination of whether the required standard of conduct has
    been met will be made, in accordance with the provisions of
    Georgia Business Corporation Code
    <FONT style="white-space: nowrap">Section&#160;14-2-855,</FONT>
    by either the board of directors or a committee thereof, acting
    by disinterested members, by special legal counsel or by the
    shareholders, but shares owned by or voted under the control of
    directors seeking indemnification may not be voted.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The bylaws of each of the Georgia corporate registrants
    indemnify their officers and directors against all reasonable
    expense incurred by them in defending claims or suits,
    irrespective of the time of the occurrence of the claims or
    causes of action in such suits, made or brought against them as
    officers or directors of the corporation, and against all
    liability in such suits, except in such cases as involve gross
    negligence or willful misconduct in the performance of their
    duties. Such indemnification extends to the payment of judgments
    against such officers and directors and to reimbursement of
    amounts paid in settlement of such claims or actions and may
    apply to judgments in favor of the corporation or amounts paid
    in settlement to the corporation. Such indemnification also
    extends to the payment of counsel fees and expenses of such
    officers
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-7
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    and directors in suits against them where successfully defended
    by them or where unsuccessfully defended, if there is no finding
    or judgment that the claim or action arose from the gross
    negligence or willful misconduct of such officers or directors.
    Such right of indemnification is not exclusive of any right to
    which such officer or director may be entitled as a matter of
    law and shall extend and apply to the estates of deceased
    officers and directors.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(b)&#160;Dublin Community Hospital, LLC, Northlake Medical
    Center, LLC and Redmond Park Hospital, LLC are registered under
    the laws of Georgia.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Georgia law provides that a limited liability company may
    indemnify a member, manager or other person against liability
    incurred in connection with the limited liability company
    subject to any standards or restrictions set forth in the
    articles of organization or operating agreement. Unless the
    member or manager is aware of information which would cause any
    reliance to be unwarranted, he or she is entitled to rely upon
    information prepared or presented by other members, managers,
    committees and employees of the limited liability company and
    legal counsel, public accountants or other professionals or
    experts.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    However, Georgia law does not permit indemnification if the
    member or manager has engaged in any intentional misconduct or a
    knowing violation of law or was involved in any transaction in
    which the member or manager received a personal benefit as a
    result of his or her breach of any provision in the operating
    agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The operating agreements of each of the Georgia limited
    liability companies indemnify their officers and managers
    against all reasonable expense incurred by them in defending
    claims or suits, irrespective of the time of the occurrence of
    the claims or causes of action in such suits, made or brought
    against them as officers or managers of the limited liability
    company, and against all liability in such suits, except in such
    cases as involve gross negligence or willful misconduct in the
    performance of their duties. Such indemnification extends to the
    payment of judgments against such officers and managers and to
    reimbursement of amounts paid in settlement of such claims or
    actions and may apply to judgments in favor of the company or
    amounts paid in settlement to the company. Such indemnification
    also extends to the payment of counsel fees and expenses of such
    officers and directors in suits against them where successfully
    defended by them or where unsuccessfully defended, if there is
    no finding or judgment that the claim or action arose from the
    gross negligence or willful misconduct of such officers or
    managers. Such right of indemnification is not exclusive of any
    right to which such officer or manager may be entitled as a
    matter of law and shall extend and apply to the estates of
    deceased officers and managers.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(c)&#160;Fairview Park, Limited Partnership is registered
    under the laws of Georgia.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <FONT style="white-space: nowrap">Section&#160;14-9-108</FONT>
    of the Georgia Revised Uniform Limited Partnership Act provides
    that:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;Subject to any limitations expressly set forth in the
    partnership agreement, a limited partnership may, and shall have
    the power to, indemnify and hold harmless any partner or other
    person from and against any and all claims and demands
    whatsoever, provided that the partnership shall not indemnify
    any person:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;For intentional misconduct or a knowing violation of
    law;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;For any transaction for which the person received a
    personal benefit in violation or breach of any provision of the
    partnership agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;To the extent that, at law or in equity, a partner has
    duties including but not limited to fiduciary duties and
    liabilities relating thereto to a limited partnership or another
    partner:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;The partner&#146;s duties and liabilities may be
    expanded, restricted, or eliminated by provisions in the
    partnership agreement; provided, however, that no such provision
    shall eliminate or limit the liability of a partner for
    intentional misconduct or a knowing violation of law or for any
    transaction for which the partner received a personal benefit in
    violation or breach of any provision of the partnership
    agreement;&#160;and
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-8
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;The partner shall have no liability to the limited
    partnership or to any other partner for his or her good faith
    reliance on the provisions of the partnership agreement,
    including, without limitation, provisions thereof that relate to
    the scope of duties including but not limited to fiduciary
    duties of partners.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Fairview Park Limited Partnership&#146;s Partnership Agreement
    allows the limited partnership to indemnify its general partner,
    directors and officers to the full extent of the Georgia Revised
    Uniform Limited Partnership Act.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Idaho
    Registrants</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(a)&#160;Eastern Idaho Health Services, Inc. and West Valley
    Medical Center, Inc. are incorporated under the laws of
    Idaho.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under Title&#160;30,
    <FONT style="white-space: nowrap">Section&#160;30-1-851</FONT>
    of the Idaho Code, the registrant&#146;s directors and officers
    may be indemnified against certain liabilities which they may
    incur in their capacities as such. The material terms of the
    indemnification provisions are indemnification:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    with respect to civil, criminal, administrative or investigative
    proceedings brought because the defendant is or was serving as
    an officer, director, employee or agent of the company;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    for judgments, fines and amounts paid in settlement reasonably
    incurred;
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    if the defendant acted in good faith and reasonably believed in
    the case of conduct in his official capacity that his conduct
    was in the best interests of the company, and in all other cases
    that his conduct was at least not opposed to the best interests
    of the company;&#160;and
</TD>
</TR>


<TR style="line-height: 6pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    if, with respect to a criminal proceeding, he had no reasonable
    cause to believe his conduct was unlawful.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Attorneys&#146; fees are included in such indemnification to the
    extent the indemnified party is successful on the merits in
    defense of the proceeding. If the foregoing criteria are met,
    indemnification also applies to a suit threatened or pending by
    the company against the officer, director, employee or agent
    with respect to attorneys&#146; fees unless there is negligence
    on the part of the indemnified party. Indemnification is made
    only upon a determination by the company that it is proper under
    the circumstances because the applicable standard is met.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Generally, expenses for defense may be paid in advance of final
    disposition of the proceeding if the indemnified party provides
    a written affirmation of his good faith belief that he has met
    the relevant standard of conduct under the Idaho Code and
    further provides a written undertaking to repay such amounts if
    it is determined that the applicable standard has not been met.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The bylaws of both of the Idaho corporate registrants indemnify
    their officers and directors against all reasonable expense
    incurred by them in defending claims or suits, irrespective of
    the time of the occurrence of the claims or causes of action in
    such suits, made or brought against them as officers or
    directors of the corporation, and against all liability in such
    suits, except in such cases as involve gross negligence or
    willful misconduct in the performance of their duties. Such
    indemnification extends to the payment of judgments against such
    officers and directors and to reimbursement of amounts paid in
    settlement of such claims or actions and may apply to judgments
    in favor of the corporation or amounts paid in settlement to the
    corporation. Such indemnification also extends to the payment of
    counsel fees and expenses of such officers and directors in
    suits against them where successfully defended by them or where
    unsuccessfully defended, if there is no finding or judgment that
    the claim or action arose from the gross negligence or willful
    misconduct of such officers or directors. Such right of
    indemnification is not exclusive of any right to which such
    officer or director may be entitled as a matter of law and shall
    extend and apply to the estates of deceased officers and
    directors.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-9
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Illinois
    Registrant</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(a)&#160;Columbia LaGrange Hospital, Inc. is incorporated
    under the laws of Illinois.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Section&#160;8.75 of the Illinois Business Corporation Act of
    1983, as amended (the &#147;IBCA&#148;), provides for a
    limitation of director liability. Under Section&#160;8.75 of the
    IBCA, directors and officers may be indemnified by the
    registrant against all expenses incurred in connection with
    actions (including, under certain circumstances, derivative
    actions) brought against such director or officer by reason of
    his or her status as our representative, or by reason of the
    fact that such director or officer serves or served as a
    representative of another entity at our request, so long as the
    director or officer acted in good faith and in a manner he or
    she reasonably believed to be in, or not opposed to, our best
    interests.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The bylaws of Columbia La&#160;Grange Hospital, Inc indemnify
    its officers and directors against all reasonable expense
    incurred by them in defending claims or suits, irrespective of
    the time of the occurrence of the claims or causes of action in
    such suits, made or brought against them as officers or
    directors of the corporation, and against all liability in such
    suits, except in such cases as involve gross negligence or
    willful misconduct in the performance of their duties. Such
    indemnification extends to the payment of judgments against such
    officers and directors and to reimbursement of amounts paid in
    settlement of such claims or actions and may apply to judgments
    in favor of the corporation or amounts paid in settlement to the
    corporation. Such indemnification also extends to the payment of
    counsel fees and expenses of such officers and directors in
    suits against them where successfully defended by them or where
    unsuccessfully defended, if there is no finding or judgment that
    the claim or action arose from the gross negligence or willful
    misconduct of such officers or directors. Such right of
    indemnification is not exclusive of any right to which such
    officer or director may be entitled as a matter of law and shall
    extend and apply to the estates of deceased officers and
    directors.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Indiana
    Registrant</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(a)&#160;Terre Haute MOB, L.P. is registered under the laws
    of Indiana.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Title&#160;23, Article&#160;16, Chapter&#160;2 of the Indiana
    Code provides that a domestic or foreign limited partnership may
    indemnify a person made a party to an action because the person
    is or was a partner or officer of the partnership against
    liability incurred in the action if:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;the person&#146;s conduct was in good faith;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;the person reasonably believed:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (A)&#160;in the case of conduct in the person&#146;s capacity as
    a partner, that the person&#146;s conduct was in the best
    interests of the partnership;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (B)&#160;in all other cases that the person&#146;s conduct was
    at least not opposed to the best interests of the limited
    partnership or foreign limited partnership;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;in the case of any criminal action, the person either:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (A)&#160;had reasonable cause to believe the person&#146;s
    conduct was lawful;&#160;or
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (B)&#160;had no reasonable cause to believe the person&#146;s
    conduct was unlawful.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The indemnification provided for above does not exclude any
    other rights to indemnification that a partner or officer of the
    limited partnership may have under the partnership agreement or
    with the written consent of all partners.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The general partners of Terre Haute MOB, L.P. are indemnified by
    the partnership pursuant to the partnership agreement for all
    actions relating to their performance or nonperformance on
    behalf of the partnership.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-10
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Kentucky
    Registrants</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(a)&#160;Frankfort Hospital, Inc. and Greenview Hospital,
    Inc. are incorporated under the laws of Kentucky.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <FONT style="white-space: nowrap">Sections&#160;271B.8-500</FONT>
    to 271B.8-580 of the Kentucky Business Corporation Act; provides
    that, subject to restrictions contained in the statute, a
    corporation may indemnify any person made or threatened to be
    made a party to any threatened, pending or completed action,
    suit or proceeding by reason of the fact that he is or was a
    director or officer of the corporation. A person who has been
    successful on the merits or otherwise in any suit or matter
    covered by the indemnification statute shall be indemnified
    against expenses (including attorneys&#146; fees) reasonably
    incurred by him in connection therewith. Indemnification is
    authorized upon a determination that the person to be
    indemnified has met the applicable standard of conduct required.
    Expenses incurred in defense may be paid in advance upon receipt
    by the corporation of a written affirmation by the director of
    his good faith belief that he has met the applicable standard of
    conduct required, a written undertaking by or on behalf of the
    director to repay such advance if it is ultimately determined
    that he did not meet the standard of conduct, and a
    determination that the facts then known to those making the
    determination would not preclude indemnification under the
    statute. The indemnification provided by statute shall not be
    deemed exclusive of any other rights to which those seeking
    indemnification may be entitled under any
    <FONT style="white-space: nowrap">by-law,</FONT>
    agreement, vote of shareholders or disinterested directors, or
    otherwise, which shall inure to the benefit of the heirs,
    executors and administrators of such a person. Insurance may be
    purchased on behalf of any person entitled to indemnification by
    the corporation against any liability incurred in an official
    capacity regardless of whether the person could be indemnified
    under the statute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The bylaws of Frankfort Hospital, Inc. and Greenview Hospital,
    Inc. indemnify their officers and directors against all
    reasonable expense incurred by them in defending claims or
    suits, irrespective of the time of the occurrence of the claims
    or causes of action in such suits, made or brought against them
    as officers or directors of the corporation, and against all
    liability in such suits, except in such cases as involve gross
    negligence or willful misconduct in the performance of their
    duties. Such indemnification extends to the payment of judgments
    against such officers and directors and to reimbursement of
    amounts paid in settlement of such claims or actions and may
    apply to judgments in favor of the corporation or amounts paid
    in settlement to the corporation. Such indemnification also
    extends to the payment of counsel fees and expenses of such
    officers and directors in suits against them where successfully
    defended by them or where unsuccessfully defended, if there is
    no finding or judgment that the claim or action arose from the
    gross negligence or willful misconduct of such officers or
    directors. Such right of indemnification is not exclusive of any
    right to which such officer or director may be entitled as a
    matter of law and shall extend and apply to the estates of
    deceased officers and directors.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Louisiana
    Registrants</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(a)&#160;Dauterive Hospital Corporation, Hamilton Medical
    Center, Inc., HCA Health Services of Louisiana, Inc., Notami
    Hospitals of Louisiana, Inc. and Women&#146;s and
    Children&#146;s Hospital, Inc. are incorporated under the laws
    of Louisiana.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Section&#160;83 of the Louisiana Business Corporation Law
    provides that a corporation may indemnify any person who was or
    is a party or is threatened to be made a party to any action,
    suit or proceeding, whether civil, criminal, administrative, or
    investigative (other than an action by or in the right of the
    corporation), by reason of the fact that he is or was a director
    or officer of the corporation. The indemnity may include
    expenses, including attorneys&#146; fees, judgments, fines, and
    amounts paid in settlement actually and reasonably incurred by
    him in connection with such action, suit, or proceeding if he
    acted in good faith and in a manner he reasonably believed to be
    in, or not opposed to, the best interests of the corporation,
    and, with respect to any criminal action or proceeding, had no
    reasonable cause to believe his conduct was unlawful.
    Section&#160;83 further provides that a Louisiana corporation
    may indemnify officers and directors in an action by or in the
    right of the corporation under the same conditions except that
    no indemnification is permitted without judicial approval if the
    director or officer shall have been adjudged to be liable for
    willful or intentional misconduct in the performance of his duty
    to the corporation. Where an officer or director is successful
    on the merits or
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-11
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    otherwise in any defense of any action referred to above or any
    claim therein, the corporation must indemnify him against such
    expenses that such officer or director actually incurred.
    Section&#160;83 permits a corporation to pay expenses incurred
    by the officer or director in defending an action, suit or
    proceeding in advance of the final disposition thereof if
    approved by the board of directors.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The bylaws of each of the Louisiana corporations indemnify their
    officers and directors against all reasonable expense incurred
    by them in defending claims or suits, irrespective of the time
    of the occurrence of the claims or causes of action in such
    suits, made or brought against them as officers or directors of
    the corporation, and against all liability in such suits, except
    in such cases as involve gross negligence or willful misconduct
    in the performance of their duties. Such indemnification extends
    to the payment of judgments against such officers and directors
    and to reimbursement of amounts paid in settlement of such
    claims or actions and may apply to judgments in favor of the
    corporation or amounts paid in settlement to the corporation.
    Such indemnification also extends to the payment of counsel fees
    and expenses of such officers and directors in suits against
    them where successfully defended by them or where unsuccessfully
    defended, if there is no finding or judgment that the claim or
    action arose from the gross negligence or willful misconduct of
    such officers or directors. Such right of indemnification is not
    exclusive of any right to which such officer or director may be
    entitled as a matter of law and shall extend and apply to the
    estates of deceased officers and directors.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Mississippi
    Registrant</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(a)&#160;Brookwood Medical Center of Gulfport, Inc. is
    incorporated under the laws of Mississippi.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Article&#160;8, Subarticle E of the Mississippi Business
    Corporation Act (&#147;MBCA&#148;) permits Mississippi
    corporations to indemnify officers and directors. MBCA
    <FONT style="white-space: nowrap">Section&#160;79-4-2.02(b)(5)</FONT>
    permits the corporation to include an obligatory indemnification
    for directors in its Articles of Incorporation for all acts
    other than: (i)&#160;distributions made in excess of standards
    established by Mississippi law or in the corporation&#146;s
    articles of incorporation, for which
    <FONT style="white-space: nowrap">Section&#160;79-4-8.33</FONT>
    imposes personal liability on directors to the corporation; and
    (ii)&#160;circumstances where, in his performance as a director,
    a director has received a financial benefit to which he is not
    entitled, he intentionally inflicts harm on the corporation or
    its stockholders or he intentionally violates any criminal law.
    The law further permits us to advance all expenses for defense
    of a director in any lawsuit brought against a director in his
    capacity as a director. The MBCA specifically provides in
    <FONT style="white-space: nowrap">Section&#160;79-4-8.53</FONT>
    that such advances are allowed by Mississippi law. Such advances
    may be made under the MBCA only after a determination that the
    director met all relevant standards of conduct.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <FONT style="white-space: nowrap">Section&#160;79-4-8.56</FONT>
    of the MBCA permits a Mississippi corporation to indemnify any
    officer to the same extent as to a director. Indemnification of
    officers and directors against reasonable expenses is mandatory
    under
    <FONT style="white-space: nowrap">Section&#160;79-4-8.52</FONT>
    of the MBCA to the extent the officer or director is successful
    on the merits or otherwise in the defense of any action or suit
    against him giving rise to a claim of indemnification.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The bylaws of Brookwood Medical Center of Gulfport, Inc
    indemnify its officers and directors against all reasonable
    expense incurred by them in defending claims or suits,
    irrespective of the time of the occurrence of the claims or
    causes of action in such suits, made or brought against them as
    officers or directors of the corporation, and against all
    liability in such suits, except in such cases as involve gross
    negligence or willful misconduct in the performance of their
    duties. Such indemnification extends to the payment of judgments
    against such officers and directors and to reimbursement of
    amounts paid in settlement of such claims or actions and may
    apply to judgments in favor of the corporation or amounts paid
    in settlement to the corporation. Such indemnification also
    extends to the payment of counsel fees and expenses of such
    officers and directors in suits against them where successfully
    defended by them or where unsuccessfully defended, if there is
    no finding or judgment that the claim or action arose from the
    gross negligence or willful misconduct of such officers or
    directors. Such right of indemnification is not exclusive of any
    right to which such officer or director may be entitled as a
    matter of law and shall extend and apply to the estates of
    deceased officers and directors.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-12
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Missouri
    Registrants</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(a)&#160;Health Midwest Office Facilities Corporation and
    Health Midwest Ventures Group, Inc. are incorporated under the
    laws of Missouri.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Section&#160;351.355(1) of the Revised Statutes of Missouri
    provides that a corporation may indemnify a director or officer
    of the corporation in any action, suit or proceeding other than
    an action by or in the right of the corporation, against
    expenses (including attorneys&#146; fees), judgments, fines and
    settlement amounts actually and reasonably incurred by him in
    connection with such action, suit or proceeding if he acted in
    good faith and in a manner he reasonably believed to be in or
    not opposed to the best interests of the corporation and, with
    respect to any criminal action, had no reasonable cause to
    believe his conduct was unlawful. Section&#160;351.355(2)
    provides that the corporation may indemnify any such person in
    any action or suit by or in the right of the corporation against
    expenses (including attorneys&#146; fees) and settlement amounts
    actually and reasonably incurred by him in connection with the
    defense or settlement of the action or suit if he acted in good
    faith and in a manner he reasonably believed to be in or not
    opposed to the best interests of the corporation, except that he
    may not be indemnified in respect of any matter in which he has
    been adjudged liable for negligence or misconduct in the
    performance of his duty to the corporation, unless authorized by
    the court. Section&#160;351.355(3) provides that a corporation
    shall indemnify any such person against expenses (including
    attorneys&#146; fees) actually and reasonably incurred by him in
    connection with the action, suit or proceeding if he has been
    successful in defense of such action, suit or proceeding and if
    such action, suit or proceeding is one for which the corporation
    may indemnify him under Section&#160;351.355(1) or (2).
    Section&#160;351.355(7) provides that a corporation shall have
    the power to give any further indemnity to any such person, in
    addition to the indemnity otherwise authorized under
    Section&#160;351.355, provided such further indemnity is either
    (i)&#160;authorized, directed or provided for in the articles of
    incorporation of the corporation or any duly adopted amendment
    thereof or (ii)&#160;is authorized, directed or provided for in
    any bylaw or agreement of the corporation which has been adopted
    by a vote of the shareholders of the corporation, provided that
    no such indemnity shall indemnify any person from or on account
    of such person&#146;s conduct which was finally adjudged to have
    been knowingly fraudulent, deliberately dishonest or willful
    misconduct.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The bylaws of both Health Midwest Office Facilities Corporation
    and Health Midwest Ventures Group, Inc indemnify their officers
    and directors against all reasonable expense incurred by them in
    defending claims or suits, irrespective of the time of the
    occurrence of the claims or causes of action in such suits, made
    or brought against them as officers or directors of the
    corporation, and against all liability in such suits, except in
    such cases as involve gross negligence or willful misconduct in
    the performance of their duties. Such indemnification extends to
    the payment of judgments against such officers and directors and
    to reimbursement of amounts paid in settlement of such claims or
    actions and may apply to judgments in favor of the corporation
    or amounts paid in settlement to the corporation. Such
    indemnification also extends to the payment of counsel fees and
    expenses of such officers and directors in suits against them
    where successfully defended by them or where unsuccessfully
    defended, if there is no finding or judgment that the claim or
    action arose from the gross negligence or willful misconduct of
    such officers or directors. Such right of indemnification is not
    exclusive of any right to which such officer or director may be
    entitled as a matter of law and shall extend and apply to the
    estates of deceased officers and directors.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(b)&#160;Midwest Division&#160;&#151; RBH, LLC is registered
    under the laws of Missouri.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The operating agreement of Midwest Division&#160;&#151; RBH, LLC
    indemnifies its officers and managers against all reasonable
    expense incurred by them in defending claims or suits,
    irrespective of the time of the occurrence of the claims or
    causes of action in such suits, made or brought against them as
    officers or directors of the company, and against all liability
    in such suits, except in such cases as involve gross negligence
    or willful misconduct in the performance of their duties. Such
    indemnification extends to the payment of judgments against such
    officers and directors and to reimbursement of amounts paid in
    settlement of such claims or actions and may apply to judgments
    in favor of the company or amounts paid in settlement to the
    company. Such indemnification also extends to the payment of
    counsel fees and expenses of such officers and managers in suits
    against them where successfully defended by them or where
    unsuccessfully defended, if there is no finding or judgment that
    the claim or action arose from the gross negligence or willful
    misconduct of such
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-13
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    officers or managers. Such right of indemnification is not
    exclusive of any right to which such officer or manager may be
    entitled as a matter of law and shall extend and apply to the
    estates of deceased officers and managers.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Missouri Limited Liability Company Act is silent with
    respect to the limits of a limited liability company&#146;s
    ability to provide for the indemnification of its officers and
    managers in its operating agreement. However,
    Section&#160;347.081(2) states that it is the policy of the
    Missouri Limited Liability Company Act to give the maximum
    effect to the principle of freedom of contract and to the
    enforceability of operating agreements.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Nevada
    Registrants</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(a)&#160;Las Vegas Surgicare, Inc., Sunrise Mountainview
    Hospital, Inc., VH Holdco, Inc., VH Holdings, Inc. and Western
    Plains Capital, Inc. are incorporated under the laws of
    Nevada.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Chapter&#160;78 of the Nevada Revised Statutes (&#147;NRS&#148;)
    allows directors and officers to be indemnified against
    liabilities they may incur while serving in such capacities.
    Under the applicable statutory provisions, the registrant may
    indemnify its directors or officers who were or are a party or
    are threatened to be made a party to any threatened, pending, or
    completed action, suit, or proceeding, whether civil, criminal,
    administrative, or investigative, by reason of the fact that
    they are or were directors or officers of the corporation, or
    are or were serving at the request of the corporation as
    directors or officers of another corporation, partnership, joint
    venture, trust, or other enterprise, against expenses, including
    attorneys&#146; fees, judgments, fines, and amounts paid in
    settlement, actually and reasonably incurred by them in
    connection with the action, suit, or proceeding, unless it is
    ultimately determined by a court of competent jurisdiction that
    they breached their fiduciary duties by intentional misconduct,
    fraud, or a knowing violation of law or did not act in good
    faith and in a manner which they reasonably believed to be in or
    not opposed to the best interests of the registrant, and, with
    respect to any criminal action or proceeding, had no reasonable
    cause to believe their conduct was unlawful. In addition, the
    applicable statutory provisions mandate that the registrant
    indemnify its directors and officers who have been successful on
    the merits or otherwise in defense of any action, suit, or
    proceeding against expenses, including attorneys&#146; fees,
    actually and reasonably incurred by him in connection with the
    defense. The registrant will advance expenses incurred by
    directors or officers in defending any such action, suit, or
    proceeding upon receipt of written confirmation from such
    officers or directors that they have met certain standards of
    conduct and an undertaking by or on behalf of such officers or
    directors to repay such advances if it is ultimately determined
    that they are not entitled to indemnification by the registrant.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The bylaws of all the Nevada corporate registrants indemnify
    their officers and directors against all reasonable expense
    incurred by them in defending claims or suits, irrespective of
    the time of the occurrence of the claims or causes of action in
    such suits, made or brought against them as officers or
    directors of the corporation, and against all liability in such
    suits, except in such cases as involve gross negligence or
    willful misconduct in the performance of their duties. Such
    indemnification extends to the payment of judgments against such
    officers and directors and to reimbursement of amounts paid in
    settlement of such claims or actions and may apply to judgments
    in favor of the corporation or amounts paid in settlement to the
    corporation. Such indemnification also extends to the payment of
    counsel fees and expenses of such officers and directors in
    suits against them where successfully defended by them or where
    unsuccessfully defended, if there is no finding or judgment that
    the claim or action arose from the gross negligence or willful
    misconduct of such officers or directors. Such right of
    indemnification is not exclusive of any right to which such
    officer or director may be entitled as a matter of law and shall
    extend and apply to the estates of deceased officers and
    directors.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(b)&#160;Southern Hills Medical Center, LLC is registered
    under the laws of Nevada.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Section&#160;86.411 of the NRS permits a limited liability
    company to indemnify any person who was or is a party or is
    threatened to be made a party to any threatened, pending or
    completed action, suit or proceeding (except an action by or in
    the right of the limited liability company), by reason of being
    or having been a manager or member of the limited liability
    company. As with corporations, indemnification may include
    attorneys&#146; fees, judgments, fines and amounts paid in
    settlement actually and reasonably incurred by the person to be
    indemnified. Section&#160;86.421 of the NRS permits a limited
    liability company to indemnify any
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-14
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    person who was or is a party or is threatened to be made a party
    to any threatened, pending or completed action or suit by or in
    the right of the limited liability company to procure a judgment
    in its favor by reason of being or having been a manager or
    member of the limited liability company except that
    indemnification may not be made for any claim, issue or matter
    as to which such a person has been finally adjudged by a court
    of competent jurisdiction to be liable to the limited liability
    company or for amounts paid in settlement to the limited
    liability company, unless and only to the extent that the court
    in which the action or suit was brought or other court of
    competent jurisdiction determines upon application that, in view
    of all the circumstances, the person is fairly and reasonably
    entitled to indemnity for such expenses as the court deems
    proper. In either case, however, to be entitled to
    indemnification, the person to be indemnified must have acted in
    good faith and in a manner which he or she reasonably believed
    to be in or not opposed to the best interests of the limited
    liability company and, with respect to any criminal action or
    proceeding, had no reasonable cause to believe his or her
    conduct was unlawful.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Section&#160;86.431 of the NRS also provides that to the extent
    a manager or member of a limited liability company has been
    successful on the merits or otherwise in defense of any such
    action, he or she must be indemnified by the limited liability
    company against expenses, including attorneys&#146; fees
    actually and reasonably incurred in connection with the defense.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Section&#160;86.441 of the NRS permits a limited liability
    company, in its articles of organization, operating agreement or
    other agreement, to provide for the payment of expenses incurred
    by members or managers in defending any civil or criminal
    action, suit or proceeding as they are incurred and in advance
    of the final disposition of the action, suit or proceeding, upon
    receipt of an undertaking to repay the amount if it is
    ultimately determined by a court of competent jurisdiction that
    the person is not entitled to indemnification.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Section&#160;86.461 of the NRS permits a limited liability
    company to purchase and maintain insurance or make other
    financial arrangements on behalf of the limited liability
    company&#146;s managers or members for any liability and
    expenses incurred by them in their capacities as managers or
    members or arising out of their status as such, whether or not
    the limited liability company has the authority to indemnify
    him, her or them against such liability and expenses.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The operating agreement of Southern Hills Medical Center, LLC
    indemnifies its officers and managers against all reasonable
    expense incurred by them in defending claims or suits,
    irrespective of the time of the occurrence of the claims or
    causes of action in such suits, made or brought against them as
    officers or managers of the company, and against all liability
    in such suits, except in such cases as involve gross negligence
    or willful misconduct in the performance of their duties. Such
    indemnification extends to the payment of judgments against such
    officers and managers and to reimbursement of amounts paid in
    settlement of such claims or actions and may apply to judgments
    in favor of the company or amounts paid in settlement to the
    company. Such indemnification also extends to the payment of
    counsel fees and expenses of such officers and managers in suits
    against them where successfully defended by them or where
    unsuccessfully defended, if there is no finding or judgment that
    the claim or action arose from the gross negligence or willful
    misconduct of such officers or managers. Such right of
    indemnification is not exclusive of any right to which such
    officer or manager may be entitled as a matter of law and shall
    extend and apply to the estates of deceased officers and
    managers.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Oklahoma
    Registrant</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(a)&#160;HCA Health Services of Oklahoma, Inc. is
    incorporated under the laws of Oklahoma.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Section&#160;1031 of the Oklahoma General Corporation Act
    provides that an Oklahoma corporation may indemnify any persons,
    including officers and directors, who are, or are threatened to
    be made, parties to any threatened, pending or completed legal
    action, suit or proceeding, whether civil, criminal,
    administrative or investigative (other than an action by or in
    the right of such corporation), by reason of the fact that such
    person was an officer or director of such corporation, or is or
    was serving at the request of such corporation as a director,
    officer, employee or agent of another corporation or enterprise.
    The indemnity may include expenses (including attorneys&#146;
    fees), judgments, fines and amounts paid in settlement actually
    and reasonably incurred by such person in connection with such
    action, suit or proceeding, provided such officer or director
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-15
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    acted in good faith and in a manner he reasonably believed to be
    in or not opposed to the corporation&#146;s best interests and,
    for criminal proceedings, had no reasonable cause to believe
    that his conduct was illegal. An Oklahoma corporation may
    indemnify officers and directors in an action by or in the right
    of the corporation under the same conditions, except that no
    indemnification is permitted without judicial approval if the
    officer or director is adjudged to be liable to the corporation.
    Where an officer or director is successful on the merits or
    otherwise in the defense of any action referred to above, the
    corporation must indemnify him against the expenses which such
    officer or director actually and reasonably incurred.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The bylaws of HCA Health Services of Oklahoma indemnify its
    officers and directors against all reasonable expense incurred
    by them in defending claims or suits, irrespective of the time
    of the occurrence of the claims or causes of action in such
    suits, made or brought against them as officers or directors of
    the corporation, and against all liability in such suits, except
    in such cases as involve gross negligence or willful misconduct
    in the performance of their duties. Such indemnification extends
    to the payment of judgments against such officers and directors
    and to reimbursement of amounts paid in settlement of such
    claims or actions and may apply to judgments in favor of the
    corporation or amounts paid in settlement to the corporation.
    Such indemnification also extends to the payment of counsel fees
    and expenses of such officers and directors in suits against
    them where successfully defended by them or where unsuccessfully
    defended, if there is no finding or judgment that the claim or
    action arose from the gross negligence or willful misconduct of
    such officers or directors. Such right of indemnification is not
    exclusive of any right to which such officer or director may be
    entitled as a matter of law and shall extend and apply to the
    estates of deceased officers and directors.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">South
    Carolina Registrant</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(a)&#160;Walterboro Community Hospital, Inc. is incorporated
    under the laws of South Carolina.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under Section&#160;33 of the South Carolina Code of Laws, a
    corporation may indemnify an individual made a party to a
    proceeding because he is or was a director or officer against
    liability incurred in the proceeding if: (1)&#160;he conducted
    himself in good faith; and (2)&#160;he reasonably believed:
    (i)&#160;in the case of conduct in his official capacity with
    the corporation, that his conduct was in its best interest; and
    (ii)&#160;in all other cases, that his conduct was at least not
    opposed to its best interest; and (3)&#160;in the case of any
    criminal proceeding, he had no reasonable cause to believe his
    conduct was unlawful.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The bylaws of Walterboro Community Hospital, Inc indemnify its
    officers and directors against all reasonable expense incurred
    by them in defending claims or suits, irrespective of the time
    of the occurrence of the claims or causes of action in such
    suits, made or brought against them as officers or directors of
    the corporation, and against all liability in such suits, except
    in such cases as involve gross negligence or willful misconduct
    in the performance of their duties. Such indemnification extends
    to the payment of judgments against such officers and directors
    and to reimbursement of amounts paid in settlement of such
    claims or actions and may apply to judgments in favor of the
    corporation or amounts paid in settlement to the corporation.
    Such indemnification also extends to the payment of counsel fees
    and expenses of such officers and directors in suits against
    them where successfully defended by them or where unsuccessfully
    defended, if there is no finding or judgment that the claim or
    action arose from the gross negligence or willful misconduct of
    such officers or directors. Such right of indemnification is not
    exclusive of any right to which such officer or director may be
    entitled as a matter of law and shall extend and apply to the
    estates of deceased officers and directors.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Tennessee
    Registrants</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(a)&#160;Central Tennessee Hospital Corporation, HCA Central
    Group, Inc., HCA Health Services of Tennessee, Inc., HCA Realty,
    Inc., Hendersonville Hospital Corporation, Hospital Corporation
    of Tennessee, HTI Memorial Hospital Corporation, Spring Hill
    Hospital, Inc. and TCMC
    <FONT style="white-space: nowrap">Madison-Portland,</FONT>
    Inc. are incorporated under the laws of Tennessee.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Tennessee Business Corporation Act (&#147;TBCA&#148;) sets
    forth in
    <FONT style="white-space: nowrap">Sections&#160;48-18-502</FONT>
    through
    <FONT style="white-space: nowrap">48-18-508</FONT>
    the circumstances governing the indemnification of directors and
    officers of a corporation against liability
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-16
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    incurred in the course of their official capacities.
    <FONT style="white-space: nowrap">Section&#160;48-18-502</FONT>
    of the TBCA provides that a corporation may indemnify any
    director against liability incurred in connection with a
    proceeding if (i)&#160;the director acted in good faith,
    (ii)&#160;the director reasonably believed, in the case of
    conduct in his or her official capacity with the corporation,
    that such conduct was in the corporation&#146;s best interest,
    or, in all other cases, that his or her conduct was not opposed
    to the best interests of the corporation and (iii)&#160;in
    connection with any criminal proceeding, the director had no
    reasonable cause to believe that his or her conduct was
    unlawful. In actions brought by or in the right of the
    corporation, however, the TBCA provides that no indemnification
    may be made if the director or officer is adjudged to be liable
    to the corporation. Similarly, the TBCA prohibits
    indemnification in connection with any proceeding charging
    improper personal benefit to a director, if such director is
    adjudged liable on the basis that a personal benefit was
    improperly received. In cases where the director is wholly
    successful, on the merits or otherwise, in the defense of any
    proceeding instigated because of his or her status as a director
    of a corporation,
    <FONT style="white-space: nowrap">Section&#160;48-18-503</FONT>
    of the TBCA mandates that the corporation indemnify the director
    against reasonable expenses incurred in the proceeding.
    Notwithstanding the foregoing,
    <FONT style="white-space: nowrap">Section&#160;48-18-505</FONT>
    of the TBCA provides that a court of competent jurisdiction,
    upon application, may order that a director or officer be
    indemnified for reasonable expense if, in consideration of all
    relevant circumstances, the court determines that such
    individual is fairly and reasonably entitled to indemnification,
    whether or not the standard of conduct set forth above was met.
    Officers who are not directors are entitled, through the
    provisions of
    <FONT style="white-space: nowrap">Section&#160;48-18-507</FONT>
    of the TBCA, to the same indemnification afforded to directors
    under
    <FONT style="white-space: nowrap">Sections&#160;48-18-503</FONT>
    and
    <FONT style="white-space: nowrap">48-18-505.</FONT>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The bylaws of each of the Tennessee corporations indemnify its
    officers and directors against all reasonable expense incurred
    by them in defending claims or suits, irrespective of the time
    of the occurrence of the claims or causes of action in such
    suits, made or brought against them as officers or directors of
    the corporation, and against all liability in such suits, except
    in such cases as involve gross negligence or willful misconduct
    in the performance of their duties. Such indemnification extends
    to the payment of judgments against such officers and directors
    and to reimbursement of amounts paid in settlement of such
    claims or actions and may apply to judgments in favor of the
    corporation or amounts paid in settlement to the corporation.
    Such indemnification also extends to the payment of counsel fees
    and expenses of such officers and directors in suits against
    them where successfully defended by them or where unsuccessfully
    defended, if there is no finding or judgment that the claim or
    action arose from the gross negligence or willful misconduct of
    such officers or directors. Such right of indemnification is not
    exclusive of any right to which such officer or director may be
    entitled as a matter of law and shall extend and apply to the
    estates of deceased officers and directors.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Texas
    Registrants</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(a)&#160;Columbia Medical Center of Las Colinas, Inc., Conroe
    Hospital Corporation, El&#160;Paso Surgicenter, Inc.,
    KPH-Consolidation, Inc., National Patient Account Services,
    Inc., Pasadena Bayshore Hospital, Inc., Rio Grande Regional
    Hospital, Inc., Spring Branch Medical Center, Inc., Surgicare of
    Houston Women&#146;s, Inc., W&#160;&#038; C Hospital, Inc.,
    WHMC, Inc. and Woman&#146;s Hospital of Texas, Incorporated are
    incorporated under the laws of Texas.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under
    <FONT style="white-space: nowrap">Article&#160;2.02-1</FONT>
    of the Texas Business Corporation Act (&#147;TBCA&#148;), a
    company may indemnify any person who was, is or is threatened to
    be made a named defendant or respondent in a proceeding because
    the person is or was a director or officer against judgment,
    penalties (including excise and similar taxes), fines,
    settlements, and reasonable expenses (including court costs and
    attorneys&#146; fees) actually incurred by the person in
    connection with the proceeding if it is determined that the
    person seeking indemnification acted in good faith, reasonably
    believed that his or her conduct was in or at least not opposed
    to our best interests and, in the case of a criminal proceeding,
    has no reasonable cause to believe his or her conduct was
    unlawful.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    A company is required by
    <FONT style="white-space: nowrap">Article&#160;2.02-1</FONT>
    of the TBCA to indemnify a director or officer against
    reasonable expenses (including court costs and attorneys&#146;
    fees) incurred by the director or officer in connection with a
    proceeding in which the director or officer is a named defendant
    or respondent because the director or officer is or was in that
    position if the director or officer has been wholly successful,
    on the merits or otherwise, in the defense of the proceeding.
    The TBCA prohibits a company from indemnifying a director or
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-17
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    officer in respect of a proceeding in which the person is found
    liable to the company or on the basis that a personal benefit
    was improperly received by him or her, other than for reasonable
    expenses (including court costs and attorneys&#146; fees)
    actually incurred by him or her in connection with the
    proceeding; provided, that the TBCA further prohibits a company
    from indemnifying a director or officer in respect of any such
    proceeding in which the person is found liable for willful or
    intentional misconduct in the performance of his or her duties.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under
    <FONT style="white-space: nowrap">Article&#160;2.02-1(J)</FONT>
    of the TBCA, a court of competent jurisdiction may order a
    company to indemnify a director or officer if the court
    determines that the director or officer is fairly and reasonably
    entitled to indemnification in view of all the relevant
    circumstances; however, if the director or officer is found
    liable to the company or is found liable on the basis that a
    personal benefit was improperly received by him or her, the
    indemnification will be limited to reasonable expenses
    (including court costs and attorneys&#146; fees) actually
    incurred by him or her in connection with the proceeding.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The bylaws of each of the Texas corporations indemnity its
    officers and directors against all reasonable expense incurred
    by them in defending claims or suits, irrespective of the time
    of the occurrence of the claims or causes of action in such
    suits, made or brought against them as officers or directors of
    the corporation, and against all liability in such suits, except
    in such cases as involve gross negligence or willful misconduct
    in the performance of their duties. Such indemnification extends
    to the payment of judgments against such officers and directors
    and to reimbursement of amounts paid in settlement of such
    claims or actions and may apply to judgments in favor of the
    corporation or amounts paid in settlement to the corporation.
    Such indemnification also extends to the payment of counsel fees
    and expenses of such officers and directors in suits against
    them where successfully defended by them or where unsuccessfully
    defended, if there is no finding or judgment that the claim or
    action arose from the gross negligence or willful misconduct of
    such officers or directors. Such right of indemnification is not
    exclusive of any right to which such officer or director may be
    entitled as a matter of law and shall extend and apply to the
    estates of deceased officers and directors.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(b)&#160;Columbia Medical Center of Arlington Subsidiary,
    L.P., Columbia Medical Center of Denton Subsidiary, L.P.,
    Columbia Medical Center of Lewisville Subsidiary, L.P., Columbia
    Medical Center of McKinney Subsidiary, L.P., Columbia Medical
    Center of Plano Subsidiary, L.P., Columbia North Hills Hospital
    Subsidiary, L.P., Columbia Plaza Medical Center of
    Fort&#160;Worth Subsidiary, L.P. and Green Oaks Hospital
    Subsidiary, L.P. are registered under the laws of Texas.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Article&#160;11 of the Texas Revised Limited Partnership Act
    (&#147;TRLPA&#148;) provides for the indemnification of a
    general partner or limited partner by the limited partnership
    under certain circumstances against expenses and liabilities
    incurred in legal proceedings involving such persons because of
    their being or having been a general partner or limited partner.
    Under the TRLPA, a limited partnership may purchase insurance on
    behalf of a general partner or limited partner against any
    liability incurred regardless of whether the person could be
    indemnified under the TLRPA.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The partnership agreement of each Texas limited partnership
    indemnifies the general partners to the fullest extent permitted
    under the TRLPA.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Utah
    Registrants</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(a)&#160;Brigham City Community Hospital, Inc., Columbia
    Ogden Medical Center, Inc., Hospital Corporation of Utah,
    Mountain View Hospital, Inc., Northern Utah Healthcare
    Corporation, St. Mark&#146;s Lone Peak Hospital, Inc. and
    Timpanogos Regional Medical Services, Inc. are incorporated
    under the laws of Utah.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <FONT style="white-space: nowrap">Section&#160;16-10a-902</FONT>
    of the Utah Revised Business Corporation Act (the &#147;Revised
    Act&#148;) provides that a corporation may indemnify any
    individual who was, is, or is threatened to be made a named
    defendant or respondent (a &#147;Party&#148;) in any threatened,
    pending or completed action, suit or proceeding, whether civil,
    criminal, administrative or investigative and whether formal or
    informal (a &#147;Proceeding&#148;), because he or she is or was
    a director of the corporation against any obligation incurred
    with respect to a Proceeding, including any judgment,
    settlement, penalty, fine or reasonable expenses (including
    attorneys&#146; fees), incurred in the
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-18
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Proceeding if his or her conduct was in good faith, he or she
    reasonably believed that his or her conduct was in, or not
    opposed to, the best interests of the corporation, and, in the
    case of any criminal Proceeding, had no reasonable cause to
    believe such conduct was unlawful; provided, however, that
    (i)&#160;pursuant to Subsection 902(5), indemnification under
    Section&#160;902 in connection with a Proceeding by or in the
    right of the corporation is limited to payment of reasonable
    expenses (including attorneys&#146; fees) incurred in connection
    with the Proceeding and (ii)&#160;pursuant to 902(4), the
    corporation may not indemnify an Indemnifiable Director in
    connection with a Proceeding by or in the right of the
    corporation in which the Indemnifiable Director was adjudged
    liable to the corporation, or in connection with any other
    Proceeding charging that the Indemnifiable Director derived an
    improper personal benefit, whether or not involving action in
    his or her official capacity, in which Proceeding he or she was
    adjudged liable on the basis that he or she derived an improper
    personal benefit.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <FONT style="white-space: nowrap">Section&#160;16-10a-907</FONT>
    of the Revised Act permits corporations to indemnify officers
    and advance expenses to the same extent as a director and in
    some cases to a greater extent than a director.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The bylaws of each of the Utah corporate registrants indemnify
    its officers and directors against all reasonable expense
    incurred by them in defending claims or suits, irrespective of
    the time of the occurrence of the claims or causes of action in
    such suits, made or brought against them as officers or
    directors of the corporation, and against all liability in such
    suits, except in such cases as involve gross negligence or
    willful misconduct in the performance of their duties. Such
    indemnification extends to the payment of judgments against such
    officers and directors and to reimbursement of amounts paid in
    settlement of such claims or actions and may apply to judgments
    in favor of the corporation or amounts paid in settlement to the
    corporation. Such indemnification also extends to the payment of
    counsel fees and expenses of such officers and directors in
    suits against them where successfully defended by them or where
    unsuccessfully defended, if there is no finding or judgment that
    the claim or action arose from the gross negligence or willful
    misconduct of such officers or directors. Such right of
    indemnification is not exclusive of any right to which such
    officer or director may be entitled as a matter of law and shall
    extend and apply to the estates of deceased officers and
    directors.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Virginia
    Registrants</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(a)&#160;Capital Division, Inc., Chippenham&#160;&#038;
    Johnston-Willis Hospitals, Inc., Columbia/Alleghany Regional
    Hospital, Incorporated, Columbia/HCA John Randolph, Inc., HCA
    Health Services of Virginia, Inc., Lewis-Gale Hospital,
    Incorporated, Montgomery Regional Hospital, Inc., Pulaski
    Community Hospital, Inc., Spotsylvania Medical Center, Inc and
    Virginia Psychiatric Company, Inc. are incorporated under the
    laws of Virginia.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Under
    <FONT style="white-space: nowrap">Sections&#160;13.1-697</FONT>
    and 13.1-702 of the Virginia Stock Corporation Act, a Virginia
    corporation generally is authorized to indemnify its directors
    and officers in civil and criminal actions if they acted in good
    faith and believed their conduct to be in the best interests of
    the corporation and, in the case of criminal actions, had no
    reasonable cause to believe that the conduct was unlawful. In
    addition, the Virginia Stock Corporation Act eliminates the
    liability for monetary damages of a director or officer in a
    shareholder or derivative proceeding. This elimination of
    liability will not apply in the event of willful misconduct or a
    knowing violation of criminal law or any federal or state
    securities law.
    <FONT style="white-space: nowrap">Sections&#160;13.1-692.1</FONT>
    and 13.1-696 through 704 of the Virginia Stock Corporation Act
    are incorporated into this paragraph by reference.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The bylaws of each of the Virginia corporate registrants
    indemnify its officers and directors against all reasonable
    expense incurred by them in defending claims or suits,
    irrespective of the time of the occurrence of the claims or
    causes of action in such suits, made or brought against them as
    officers or directors of the corporation, and against all
    liability in such suits, except in such cases as involve gross
    negligence or willful misconduct in the performance of their
    duties. Such indemnification extends to the payment of judgments
    against such officers and directors and to reimbursement of
    amounts paid in settlement of such claims or actions and may
    apply to judgments in favor of the corporation or amounts paid
    in settlement to the corporation. Such indemnification also
    extends to the payment of counsel fees and expenses of such
    officers and directors in suits against them where successfully
    defended by them or where unsuccessfully defended, if
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-19
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    there is no finding or judgment that the claim or action arose
    from the gross negligence or willful misconduct of such officers
    or directors. Such right of indemnification is not exclusive of
    any right to which such officer or director may be entitled as a
    matter of law and shall extend and apply to the estates of
    deceased officers and directors.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(b)&#160;Central Shared Services, LLC, Galen Property, LLC,
    Lewis-Gale Physicians, LLC, Northern Virginia Community
    Hospital, LLC and Retreat Hospital, LLC are registered under the
    laws of Virginia.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <FONT style="white-space: nowrap">Section&#160;13.1-1009(16)</FONT>
    of the Virginia Limited Liability Company Act permits a limited
    liability company to indemnify and hold harmless any member or
    manager or other person from and against any and all claims and
    demands whatsoever, and to pay for or reimburse any member or
    manager or other person for reasonable expenses incurred by such
    a person who is a party to a proceeding in advance of final
    disposition of the proceeding.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The operating agreements of each of the Virginia limited
    liability companies indemnifies its officers and managers
    against all reasonable expense incurred by them in defending
    claims or suits, irrespective of the time of the occurrence of
    the claims or causes of action in such suits, made or brought
    against them as officers or managers of the company, and against
    all liability in such suits, except in such cases as involve
    gross negligence or willful misconduct in the performance of
    their duties. Such indemnification extends to the payment of
    judgments against such officers and managers and to
    reimbursement of amounts paid in settlement of such claims or
    actions and may apply to judgments in favor of the company or
    amounts paid in settlement to the company. Such indemnification
    also extends to the payment of counsel fees and expenses of such
    officers and managers in suits against them where successfully
    defended by them or where unsuccessfully defended, if there is
    no finding or judgment that the claim or action arose from the
    gross negligence or willful misconduct of such officers or
    managers. Such right of indemnification is not exclusive of any
    right to which such officer or manager may be entitled as a
    matter of law and shall extend and apply to the estates of
    deceased officers and managers.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(c)&#160;HSS Virginia, L.P. is registered under the laws of
    Virginia</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    HSS Virginia, L.P. is governed by the Virginia Revised Uniform
    Limited Partnership Act. However, neither the partnership
    agreement nor the Virginia Revised Uniform Partnership Act
    specify the extent to which a limited partnership may indemnify
    its general partners.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">West
    Virginia Registrant</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(a)&#160;Columbia Parkersburg Healthcare System, LLC is
    registered under the laws of West Virginia.</B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <FONT style="white-space: nowrap">Section&#160;31B-4-403</FONT>
    of the West Virginia Uniform Limited Liability Company Act
    discusses members&#146; and managers&#146; rights to payments
    and reimbursement. A limited liability company shall reimburse a
    member or manager for payments made and indemnify a member or
    manager for liabilities incurred by the member or manager in the
    ordinary course of the business of the company or for the
    preservation of its business or property. A limited liability
    company shall reimburse a member for an advance to the company
    beyond the amount of contribution the member agreed to make. A
    payment or advance made by a member which gives rise to an
    obligation of a limited liability company under the West
    Virginia statute constitutes a loan to the company upon which
    interest accrues from the date of the payment or advance. A
    member is not entitled to remuneration for services performed
    for a limited liability company, except for reasonable
    compensation for services rendered in winding up the business of
    the company.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The organizational documents of Columbia Parkersburg Healthcare
    System, LLC indemnify its managers and officers to the fullest
    extent of the West Virginia Uniform Limited Liability Company
    Act.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-20
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Certain
    Other Arrangements</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    HCA Inc. maintains a directors&#146; and officers&#146;
    liability insurance policy that covers the directors and
    officers of each of the registrants in amounts that HCA Inc.
    believes are customary in its industry, including for
    liabilities in connection with the registration, offering and
    sale of the notes.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, pursuant to the Management Agreement entered into
    with the Sponsors and their affiliates and the Frists, the
    Company has agreed to customary exculpation and indemnification
    provisions for the benefit of the Sponsors, the Frists, their
    affiliates, directors, officers and certain other persons. See
    the section of our fiscal 2008
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    captioned &#147;Certain Relationships and Related Transactions,
    and Director Independence&#160;&#151; Sponsor Management
    Agreement.&#148;
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

<TR>
    <TD width="9%"></TD>
    <TD width="91%"></TD>
</TR>

<TR valign="top">
    <TD>
    <B><FONT style="font-family: 'Times New Roman', Times">Item&#160;15.&#160;&#160;</FONT></B>
</TD>
    <TD>
    <B><I><FONT style="font-family: 'Times New Roman', Times">Recent
    Sales of Unregistered Securities</FONT></I></B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On November&#160;17, 2006, we issued $4.200&#160;billion of
    senior secured notes (comprised of $1.000&#160;billion of
    9<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;notes
    due 2014 and $3.200&#160;billion of
    9<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">4</FONT>%&#160;notes
    due 2016)&#160;and $1.500&#160;billion of
    9<FONT style="vertical-align: text-top; font-size: 70%;">5</FONT>/<FONT style="font-size: 70%;">8</FONT>%/10<FONT style="vertical-align: text-top; font-size: 70%;">3</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;senior
    secured toggle notes due 2016 the proceeds of which were used to
    finance the acquisition by certain investors if HCA Inc.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On February&#160;19, 2009, we issued $310&#160;million aggregate
    principal amount of senior secured notes due 2017 at a price of
    96.673% of their face value resulting in approximately
    $300&#160;million of gross proceeds, which were used to repay
    outstanding indebtedness under our cash flow credit facility.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On April&#160;22, 2009, we issued $1.500&#160;billion aggregate
    principal amount of senior secured notes due 2019 at a price of
    96.755% of their face value resulting in approximately
    $1.451&#160;billion of gross proceeds, which were used to repay
    outstanding indebtedness under our cash flow credit facility.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each of the above transactions was offered to qualified
    institutional buyers pursuant to Rule&#160;144A under the
    Securities Act or to
    <FONT style="white-space: nowrap">non-U.S.&#160;investors</FONT>
    outside the United States in compliance with Regulation&#160;S
    of the Securities Act.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

<TR>
    <TD width="9%"></TD>
    <TD width="91%"></TD>
</TR>

<TR valign="top">
    <TD>
    <B><FONT style="font-family: 'Times New Roman', Times">Item&#160;16.<I>&#160;&#160;</I></FONT></B>
</TD>
    <TD>
    <B><I><FONT style="font-family: 'Times New Roman', Times">Exhibits
    and Financial Statement Schedules.</FONT></I></B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;&#160;<I>Exhibits</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    2
</TD>
<TD nowrap align="left" valign="top">
    .1
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Agreement and Plan of Merger, dated July&#160;24, 2006, by and
    among HCA Inc., Hercules Holding II, LLC and Hercules
    Acquisition Corporation (filed as Exhibit&#160;2.1 to the
    Company&#146;s Current Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    filed July&#160;25, 2006, and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .1
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Amended and Restated Certificate of Incorporation of the Company
    (filed as Exhibit&#160;3.1 to the Company&#146;s Annual Report
    on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2007, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .2
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Amended and Restated Bylaws of the Company (filed as
    Exhibit&#160;3.2 to the Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2007, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .3
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    American Medicorp Development Co. Articles of Incorporation*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .4
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    American Medicorp Development Co. By-Laws*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .5
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Bay Hospital, Inc. Articles of Incorporation (filed as
    Exhibit&#160;3.5 to the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .6
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Bay Hospital, Inc. By-Laws. (filed as Exhibit&#160;3.6 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .7
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Brigham City Community Hospital, Inc. Articles of Incorporation.
    (filed as Exhibit&#160;3.7 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .8
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Brigham City Community Hospital, Inc. By-Laws. (filed as
    Exhibit&#160;3.8 to the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-21
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .9
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Brookwood Medical Center of Gulfport, Inc. Certificate of
    Incorporation (filed as Exhibit&#160;3.9 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .10
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Brookwood Medical Center of Gulfport, Inc. By-Laws (filed as
    Exhibit&#160;3.10 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .11
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Capital Division, Inc. Articles of Incorporation (filed as
    Exhibit&#160;3.11 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .12
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Capital Division, Inc. By-Laws (filed as Exhibit&#160;3.12 to
    the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .13
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Centerpoint Medical Center of Independence, LLC Certificate of
    Formation (filed as Exhibit&#160;3.13 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .14
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Centerpoint Medical Center of Independence, LLC Limited
    Liability Company Agreement (filed as Exhibit&#160;3.14 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .15
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Central Florida Regional Hospital, Inc. Articles of
    Incorporation (filed as Exhibit&#160;3.15 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .16
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Central Florida Regional Hospital, Inc. By-Laws (filed as
    Exhibit&#160;3.16 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .17
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Central Shared Services, LLC Articles of Organization (filed as
    Exhibit&#160;3.17 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .18
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Central Shared Services, LLC Limited Liability Company Agreement
    (filed as Exhibit&#160;3.18 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .19
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Central Tennessee Hospital Corporation Charter (filed as
    Exhibit&#160;3.19 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .20
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Central Tennessee Hospital Corporation By-Laws (filed as
    Exhibit&#160;3.20 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .21
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    CHCA Bayshore, L.P. Certificate of Limited Partnership (filed as
    Exhibit&#160;3.21 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .22
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    CHCA Bayshore, L.P. Agreement of Limited Partnership (filed as
    Exhibit&#160;3.22 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .23
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    CHCA Conroe, L.P. Certificate of Limited Partnership (filed as
    Exhibit&#160;3.23 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .24
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    CHCA Conroe, L.P. Agreement of Limited Partnership (filed as
    Exhibit&#160;3.24 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .25
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    CHCA Mainland, L.P. Certificate of Limited Partnership (filed as
    Exhibit&#160;3.27 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .26
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    CHCA Mainland, L.P. Agreement of Limited Partnership (filed as
    Exhibit&#160;3.28 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .27
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    CHCA West Houston, L.P. Certificate of Limited Partnership
    (filed as Exhibit&#160;3.29 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .28
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    CHCA West Houston, L.P. Agreement of Limited Partnership (filed
    as Exhibit&#160;3.30 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .29
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    CHCA Woman&#146;s Hospital, L.P. Certificate of Limited
    Partnership (filed as Exhibit&#160;3.31 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-22
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .30
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    CHCA Woman&#146;s Hospital, L.P. Agreement of Limited
    Partnership (filed as Exhibit&#160;3.32 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .31
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Chippenham&#160;&#038; Johnston-Willis Hospitals, Inc. Articles
    of Incorporation (filed as Exhibit&#160;3.33 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .32
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Chippenham&#160;&#038; Johnston-Willis Hospitals, Inc. By-Laws
    (filed as Exhibit&#160;3.34 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .33
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    CMS GP, LLC Certificate of Formation (filed as Exhibit&#160;3.35
    to the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .34
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    CMS GP, LLC Limited Liability Company Agreement (filed as
    Exhibit&#160;3.36 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .35
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Colorado Health Systems, Inc. Articles of Incorporation (filed
    as Exhibit&#160;3.37 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .36
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Colorado Health Systems, Inc. By-Laws (filed as
    Exhibit&#160;3.38 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .37
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia ASC Management, L.P. Certificate of Limited Partnership
    (filed as Exhibit&#160;3.39 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .38
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia ASC Management, L.P. Agreement of Partnership (filed as
    Exhibit&#160;3.40 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File No. 333-145054), and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .39
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Jacksonville Healthcare System, Inc. Articles of
    Incorporation (filed as Exhibit&#160;3.41 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .40
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Jacksonville Healthcare System, Inc. By-Laws (filed as
    Exhibit&#160;3.42 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .41
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia LaGrange Hospital, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.43 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .42
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia LaGrange Hospital, Inc. By-Laws (filed as
    Exhibit&#160;3.44 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .43
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Medical Center of Arlington Subsidiary, L.P.
    Certificate of Limited Partnership (filed as Exhibit&#160;3.45
    to the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .44
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Medical Center of Arlington Subsidiary, L.P. Agreement
    of Limited Partnership (filed as Exhibit&#160;3.46 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .45
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Medical Center of Denton Subsidiary, L.P. Certificate
    of Limited Partnership (filed as Exhibit&#160;3.47 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .46
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Medical Center of Denton Subsidiary, L.P. Agreement of
    Limited Partnership (filed as Exhibit&#160;3.48 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .47
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Medical Center of Las Colinas, Inc. Articles of
    Incorporation (filed as Exhibit&#160;3.49 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .48
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Medical Center of Las Colinas, Inc. By-Laws (filed as
    Exhibit&#160;3.50 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .49
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Medical Center of Lewisville Subsidiary, L.P.
    Certificate of Limited Partnership (filed as Exhibit&#160;3.51
    to the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-23
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .50
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Medical Center of Lewisville Subsidiary, L.P. Agreement
    of Limited Partnership (filed as Exhibit&#160;3.52 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .51
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Medical Center of McKinney Subsidiary, L.P. Certificate
    of Limited Partnership (filed as Exhibit&#160;3.53 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .52
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Medical Center of McKinney Subsidiary, L.P. Agreement
    of Limited Partnership (filed as Exhibit&#160;3.54 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .53
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Medical Center of Plano Subsidiary, L.P. Certificate of
    Limited Partnership (filed as Exhibit&#160;3.55 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .54
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Medical Center of Plano Subsidiary, L.P. Agreement of
    Limited Partnership (filed as Exhibit&#160;3.56 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .55
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia North Hills Hospital Subsidiary, L.P. Certificate of
    Limited Partnership (filed as Exhibit&#160;3.57 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .56
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia North Hills Hospital Subsidiary, L.P. Agreement of
    Limited Partnership (filed as Exhibit&#160;3.58 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .57
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Ogden Medical Center, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.59 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .58
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Ogden Medical Center, Inc. By-Laws (filed as
    Exhibit&#160;3.60 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .59
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Parkersburg Healthcare System, LLC Articles of
    Incorporation (filed as Exhibit&#160;3.61 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .60
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Parkersburg Healthcare System, LLC, Articles of
    Conversion.*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .61
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Parkersburg Healthcare System, LLC Operating Agreement
    (filed as Exhibit&#160;3.62 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .62
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Plaza Medical Center of Fort&#160;Worth Subsidiary,
    L.P. Certificate of Limited Partnership (filed as
    Exhibit&#160;3.63 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .63
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Plaza Medical Center of Fort&#160;Worth Subsidiary,
    L.P. Agreement of Limited Partnership (filed as
    Exhibit&#160;3.64 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .64
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Polk General Hospital, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.65 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .65
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Polk General Hospital, Inc. By-Laws (filed as
    Exhibit&#160;3.66 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .66
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Rio Grande Healthcare, L.P. Certificate of Limited
    Partnership (filed as Exhibit&#160;3.67 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .67
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Rio Grande Healthcare, L.P. Amended and Restated
    Limited Partnership Agreement (filed as Exhibit&#160;3.68 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .68
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Riverside, Inc. Articles of Incorporation (filed as
    Exhibit&#160;3.69 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-24
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .69
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Riverside, Inc. By-Laws (filed as Exhibit&#160;3.70 to
    the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .70
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Valley Healthcare System, L.P. Certificate of Limited
    Partnership (filed as Exhibit&#160;3.71 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .71
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia Valley Healthcare System, L.P. Amended and Restated
    Limited Partnership Agreement (filed as Exhibit&#160;3.72 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .72
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia/Alleghany Regional Hospital, Incorporated Articles of
    Incorporation (filed as Exhibit&#160;3.73 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .73
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia/Alleghany Regional Hospital, Incorporated By-Laws
    (filed as Exhibit&#160;3.74 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .74
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia/HCA John Randolph, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.75 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .75
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia/HCA John Randolph, Inc. By-Laws (filed as
    Exhibit&#160;3.76 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .76
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbine Psychiatric Center, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.77 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .77
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbine Psychiatric Center, Inc. By-Laws (filed as
    Exhibit&#160;3.78 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .78
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbus Cardiology, Inc. Certificate of Incorporation (filed as
    Exhibit&#160;3.79 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .79
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbus Cardiology, Inc. By-Laws (filed as Exhibit&#160;3.80 to
    the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .80
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Conroe Hospital Corporation Articles of Incorporation (filed as
    Exhibit&#160;3.81 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .81
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Conroe Hospital Corporation By-Laws (filed as Exhibit&#160;3.82
    to the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .82
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Dallas/Ft.&#160;Worth Physician, LLC Certificate of Formation
    (filed as Exhibit&#160;3.83 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .83
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Dallas/Ft.&#160;Worth Physician, LLC Limited Liability Company
    Agreement (filed as Exhibit&#160;3.84 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .84
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Dauterive Hospital Corporation Articles of Incorporation (filed
    as Exhibit&#160;3.85 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .85
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Dauterive Hospital Corporation By-Laws (filed as
    Exhibit&#160;3.86 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .86
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Dublin Community Hospital, LLC Limited Liability Company
    Agreement (filed as Exhibit&#160;3.87 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .87
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Dublin Community Hospital, LLC Articles of Organization (filed
    as Exhibit&#160;3.88 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .88
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Eastern Idaho Health Services, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.89 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .89
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Eastern Idaho Health Services, Inc. By-Laws (filed as
    Exhibit&#160;3.90 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-25
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .90
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Edmond Regional Medical Center, LLC Certificate of Formation
    (filed as Exhibit&#160;3.91 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .91
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Edmond Regional Medical Center, LLC Limited Liability Company
    Agreement (filed as Exhibit&#160;3.92 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .92
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Edward White Hospital, Inc. Articles of Incorporation (filed as
    Exhibit&#160;3.95 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .93
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Edward White Hospital, Inc. By-Laws (filed as Exhibit&#160;3.96
    to the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .94
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    El&#160;Paso Surgicenter, Inc. Articles of Incorporation (filed
    as Exhibit&#160;3.93 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .95
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    El&#160;Paso Surgicenter, Inc. By-Laws (filed as
    Exhibit&#160;3.94 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .96
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Encino Hospital Corporation, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.97 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .97
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Encino Hospital Corporation, Inc. By-Laws (filed as
    Exhibit&#160;3.98 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .98
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    EP Health, LLC Limited Liability Company Agreement (filed as
    Exhibit&#160;3.99 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .99
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    EP Health, LLC Limited Liability Company Agreement (filed as
    Exhibit&#160;3.100 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .100
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Fairview Park GP, LLC Certificate of Formation (filed as
    Exhibit&#160;3.101 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .101
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Fairview Park GP, LLC Limited Liability Company Agreement (filed
    as Exhibit&#160;3.102 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .102
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Fairview Park, Limited Partnership Certificate of Limited
    Partnership (filed as Exhibit&#160;3.103 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .103
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Fairview Park, Limited Partnership Agreement of Limited
    Partnership (filed as Exhibit&#160;3.104 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .104
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Frankfort Hospital, Inc. Articles of Incorporation (filed as
    Exhibit&#160;3.105 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .105
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Frankfort Hospital, Inc. By-Laws (filed as Exhibit&#160;3.106 to
    the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .106
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Galen Property, LLC Articles of Organization (filed as
    Exhibit&#160;3.107 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .107
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Galen Property, LLC Operating Agreement (filed as
    Exhibit&#160;3.108 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .108
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    General Healthserv, LLC Certificate of Formation (filed as
    Exhibit&#160;3.109 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .109
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    General Healthserv, LLC Limited Liability Company Agreement
    (filed as Exhibit&#160;3.110 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .110
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Good Samaritan Hospital, L.P. Certificate of Limited Partnership
    (filed as Exhibit&#160;3.111 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .111
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Good Samaritan Hospital, L.P. Agreement of Limited Partnership
    (filed as Exhibit&#160;3.112 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-26
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .112
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Goppert-Trinity Family Care, LLC Certificate of Formation (filed
    as Exhibit&#160;3.113 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .113
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Goppert-Trinity Family Care, LLC Limited Liability Company
    Agreement (filed as Exhibit&#160;3.114 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .114
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    GPCH-GP, Inc. Certificate of Incorporation (filed as
    Exhibit&#160;3.115 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .115
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    GPCH-GP, Inc. By-Laws (filed as Exhibit&#160;3.116 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .116
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Grand Strand Regional Medical Center, LLC Certificate of
    Formation (filed as Exhibit&#160;3.117 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .117
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Grand Strand Regional Medical Center, LLC Limited Liability
    Company Agreement (filed as Exhibit&#160;3.118 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .118
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Green Oaks Hospital Subsidiary, L.P. Certificate of Limited
    Partnership (filed as Exhibit&#160;3.119 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .119
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Green Oaks Hospital Subsidiary, L.P. Agreement of Limited
    Partnership (filed as Exhibit&#160;3.120 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .120
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Greenview Hospital, Inc. Articles of Incorporation (filed as
    Exhibit&#160;3.121 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .121
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Greenview Hospital, Inc. By-Laws (filed as Exhibit&#160;3.122 to
    the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .122
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Hamilton Medical Center, Inc. Articles of Incorporation (filed
    as Exhibit&#160;3.123 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .123
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Hamilton Medical Center, Inc. By-Laws (filed as
    Exhibit&#160;3.124 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .124
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA&#160;&#151; IT&#038;S Field Operations, Inc. Articles of
    Incorporation*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .125
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA&#160;&#151; IT&#038;S Field Operations, Inc. By-Laws*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .126
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA&#160;&#151;  IT&#038;S Inventory Management, Inc. Articles
    of Incorporation*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .127
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA&#160;&#151;  IT&#038;S Inventory Management, Inc. By-Laws*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .128
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA Central Group, Inc. Certificate of Incorporation (filed as
    Exhibit&#160;3.125 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .129
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA Central Group, Inc. By-Laws (filed as Exhibit&#160;3.126 to
    the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .130
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA Health Services of Florida, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.127 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .131
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA Health Services of Florida, Inc. By-Laws (filed as
    Exhibit&#160;3.128 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .132
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA Health Services of Louisiana, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.129 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .133
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA Health Services of Louisiana, Inc. By-Laws (filed as
    Exhibit&#160;3.130 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .134
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA Health Services of Oklahoma, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.131 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-27
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .135
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA Health Services of Oklahoma, Inc. By-Laws (filed as
    Exhibit&#160;3.132 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .136
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA Health Services of Tennessee, Inc. Charter (filed as
    Exhibit&#160;3.133 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .137
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA Health Services of Tennessee, Inc. By-Laws (filed as
    Exhibit&#160;3.134 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .138
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA Health Services of Virginia, Inc. Certificate of
    Incorporation (filed as Exhibit&#160;3.135 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .139
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA Health Services of Virginia, Inc. By-Laws (filed as
    Exhibit&#160;3.136 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .140
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA Management Services, L.P. Certificate of Limited Partnership
    (filed as Exhibit&#160;3.137 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .141
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA Management Services, L.P. Agreement of Limited Partnership
    (filed as Exhibit&#160;3.138 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .142
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA Realty, Inc. Charter*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .143
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA Realty, Inc. By-Laws*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .144
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HD&#038;S Corp. Successor, Inc. Articles of Incorporation (filed
    as Exhibit&#160;3.139 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .145
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HD&#038;S Corp. Successor, Inc. By-Laws (filed as
    Exhibit&#160;3.140 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .146
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Health Midwest Office Facilities Corporation Articles of
    Incorporation (filed as Exhibit&#160;3.141 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .147
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Health Midwest Office Facilities Corporation By-Laws (filed as
    Exhibit&#160;3.142 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .148
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Health Midwest Ventures Group, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.143 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .149
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Health Midwest Ventures Group, Inc. By-Laws (filed as
    Exhibit&#160;3.144 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .150
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Healthtrust MOB, LLC Certificate of Formation (filed as
    Exhibit&#160;3.145 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .151
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Healthtrust MOB, LLC Limited Liability Company Agreement (filed
    as Exhibit&#160;3.146 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .152
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Hendersonville Hospital Corporation Charter (filed as
    Exhibit&#160;3.147 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .153
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Hendersonville Hospital Corporation By-Laws (filed as
    Exhibit&#160;3.148 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .154
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Hospital Corporation of Tennessee Charter (filed as
    Exhibit&#160;3.151 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .155
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Hospital Corporation of Tennessee By-Laws (filed as
    Exhibit&#160;3.152 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .156
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Hospital Corporation of Utah Articles of Incorporation (filed as
    Exhibit&#160;3.153 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .157
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Hospital Corporation of Utah By-Laws (filed as
    Exhibit&#160;3.154 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-28
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .158
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Hospital Development Properties, Inc. Certificate of
    Incorporation (filed as Exhibit&#160;3.155 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .159
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Hospital Development Properties, Inc. By-Laws (filed as
    Exhibit&#160;3.156 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .160
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HSS Holdco, LLC Certificate of Formation (filed as
    Exhibit&#160;3.157 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .161
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HSS Holdco, LLC Limited Liability Company Agreement (filed as
    Exhibit&#160;3.158 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .162
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HSS Systems VA, LLC Certificate of Formation (filed as
    Exhibit&#160;3.159 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .163
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HSS Systems VA, LLC Limited Liability Company Agreement (filed
    as Exhibit&#160;3.160 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .164
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HSS Systems, LLC Certificate of Formation (filed as
    Exhibit&#160;3.161 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .165
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HSS Systems, LLC Limited Liability Company Agreement (filed as
    Exhibit&#160;3.162 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .166
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HSS Virginia, L.P. Certificate of Limited Partnership (filed as
    Exhibit&#160;3.163 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .167
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HSS Virginia, L.P. Agreement of Limited Partnership (filed as
    Exhibit&#160;3.164 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .168
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HTI Memorial Hospital Corporation Articles of Incorporation
    (filed as Exhibit&#160;3.165 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .169
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HTI Memorial Hospital Corporation By-Laws (filed as
    Exhibit&#160;3.166 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .170
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Integrated Regional Lab, LLC Articles of Organization (filed as
    Exhibit&#160;3.167 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .171
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Integrated Regional Lab, LLC Operating Agreement (filed as
    Exhibit&#160;3.168 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .172
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Integrated Regional Laboratories, LLP Statement of Qualification
    of Limited Liability Partnership (filed as Exhibit&#160;3.169 to
    the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .173
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Integrated Regional Laboratories, LLP Partnership Agreement
    (filed as Exhibit&#160;3.170 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .174
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    JFK Medical Center Limited Partnership Articles of Limited
    Partnership (filed as Exhibit&#160;3.171 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .175
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    JFK Medical Center Limited Partnership Agreement of Limited
    Partnership (filed as Exhibit&#160;3.172 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .176
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    KPH-Consolidation, Inc. Articles of Incorporation (filed as
    Exhibit&#160;3.173 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .177
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    KPH-Consolidation, Inc. By-Laws (filed as Exhibit&#160;3.174 to
    the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .178
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Lakeland Medical Center, LLC Certificate of Formation (filed as
    Exhibit&#160;3.175 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-29
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .179
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Lakeland Medical Center, LLC Limited Liability Company Agreement
    (filed as Exhibit&#160;3.176 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .180
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Lakeview Medical Center, LLC Certificate of Formation (filed as
    Exhibit&#160;3.177 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .181
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Lakeview Medical Center, LLC Limited Liability Company Agreement
    (filed as Exhibit&#160;3.178 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .182
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Largo Medical Center, Inc. Articles of Incorporation (filed as
    Exhibit&#160;3.179 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .183
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Largo Medical Center, Inc. By-Laws (filed as Exhibit&#160;3.180
    to the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .184
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Las Vegas Surgicare, Inc. Articles of Incorporation (filed as
    Exhibit&#160;3.181 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .185
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Las Vegas Surgicare, Inc. By-Laws (filed as Exhibit&#160;3.182
    to the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .186
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Lawnwood Medical Center, Inc. Articles of Incorporation (filed
    as Exhibit&#160;3.183 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .187
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Lawnwood Medical Center, Inc. By-Laws (filed as
    Exhibit&#160;3.184 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .188
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Lewis-Gale Hospital, Incorporated Articles of Incorporation
    (filed as Exhibit&#160;3.185 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .189
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Lewis-Gale Hospital, Incorporated By-Laws (filed as
    Exhibit&#160;3.186 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .190
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Lewis-Gale Medical Center, LLC Certificate of Formation (filed
    as Exhibit&#160;3.187 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .191
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Lewis-Gale Medical Center, LLC Limited Liability Company
    Agreement (filed as Exhibit&#160;3.188 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File No.&#160;333-145054), and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .192
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Lewis-Gale Physicians, LLC Articles of Organization (filed as
    Exhibit&#160;3.189 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .193
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Lewis-Gale Physicians, LLC Operating Agreement (filed as
    Exhibit&#160;3.190 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .194
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Los Robles Regional Medical Center Articles of Incorporation
    (filed as Exhibit&#160;3.191 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .195
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Los Robles Regional Medical Center By-Laws (filed as
    Exhibit&#160;3.192 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .196
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Management Services Holdings, Inc. Certificate of Incorporation
    (filed as Exhibit&#160;3.193 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .197
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Management Services Holdings, Inc. By-Laws (filed as
    Exhibit&#160;3.194 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .198
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Marietta Surgical Center, Inc. Articles of Incorporation (filed
    as Exhibit&#160;3.195 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .199
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Marietta Surgical Center, Inc. By-Laws (filed as
    Exhibit&#160;3.196 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .200
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Marion Community Hospital, Inc. Articles of Incorporation (filed
    as Exhibit&#160;3.197 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-30
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .201
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Marion Community Hospital, Inc. By-Laws (filed as
    Exhibit&#160;3.198 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .202
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    MCA Investment Company Articles of Incorporation (filed as
    Exhibit&#160;3.199 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .203
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    MCA Investment Company By-Laws (filed as Exhibit&#160;3.200 to
    the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .204
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Medical Centers of Oklahoma, LLC Certificate of Formation (filed
    as Exhibit&#160;3.201 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .205
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Medical Centers of Oklahoma, LLC Limited Liability Company
    Agreement (filed as Exhibit&#160;3.202 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .206
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Medical Office Buildings of Kansas, LLC Certificate of Formation
    (filed as Exhibit&#160;3.203 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .207
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Medical Office Buildings of Kansas, LLC Operating Agreement
    (filed as Exhibit&#160;3.204 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .208
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Memorial Healthcare Group, Inc. Articles of Incorporation (filed
    as Exhibit&#160;3.205 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .209
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Memorial Healthcare Group, Inc. By-Laws (filed as
    Exhibit&#160;3.206 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .210
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Division&#160;&#151; ACH, LLC Certificate of Formation
    (filed as Exhibit&#160;3.207 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .211
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Division&#160;&#151; ACH, LLC Limited Liability Company
    Agreement (filed as Exhibit&#160;3.208 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .212
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Division&#160;&#151; LRHC, LLC Certificate of Formation
    (filed as Exhibit&#160;3.209 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .213
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Division&#160;&#151; LRHC, LLC Limited Liability Company
    Agreement (filed as Exhibit&#160;3.210 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .214
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Division&#160;&#151; LSH, LLC Certificate of Formation
    (filed as Exhibit&#160;3.211 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .215
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Division&#160;&#151; LSH, LLC Limited Liability Company
    Agreement (filed as Exhibit&#160;3.212 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .216
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Division&#160;&#151; MCI, LLC Certificate of Formation
    (filed as Exhibit&#160;3.213 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .217
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Division&#160;&#151; MCI, LLC Limited Liability Company
    Agreement (filed as Exhibit&#160;3.214 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .218
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Division&#160;&#151; MMC, LLC Certificate of Formation
    (filed as Exhibit&#160;3.215 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .219
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Division&#160;&#151; MMC, LLC Limited Liability Company
    Agreement (filed as Exhibit&#160;3.216 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .220
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Division&#160;&#151; OPRMC, LLC Certificate of Formation
    (filed as Exhibit&#160;3.217 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-31
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .221
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Division&#160;&#151; OPRMC, LLC Limited Liability
    Company Agreement (filed as Exhibit&#160;3.218 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .222
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Division&#160;&#151; PFC, LLC Certificate of Formation
    (filed as Exhibit&#160;3.219 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .223
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Division&#160;&#151; PFC, LLC Limited Liability Company
    Agreement (filed as Exhibit&#160;3.220 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .224
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Division&#160;&#151; RBH, LLC Articles of Organization
    (filed as Exhibit&#160;3.221 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .225
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Division&#160;&#151; RBH, LLC Limited Liability Company
    Agreement (filed as Exhibit&#160;3.222 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .226
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Division&#160;&#151; RMC, LLC Certificate of Formation
    (filed as Exhibit&#160;3.223 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .227
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Division&#160;&#151; RMC, LLC Limited Liability Company
    Agreement (filed as Exhibit&#160;3.224 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .228
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Division&#160;&#151; RPC, LLC Certificate of Formation
    (filed as Exhibit&#160;3.225 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .229
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Division&#160;&#151; RPC, LLC Limited Liability Company
    Agreement (filed as Exhibit&#160;3.226 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .230
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Holdings, Inc. Certificate of Incorporation (filed as
    Exhibit&#160;3.227 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .231
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Midwest Holdings, Inc. By-Laws (filed as Exhibit&#160;3.228 to
    the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .232
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Montgomery Regional Hospital, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.229 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .233
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Montgomery Regional Hospital, Inc. By-Laws (filed as
    Exhibit&#160;3.230 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .234
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Mountain View Hospital, Inc. Certificate of Incorporation (filed
    as Exhibit&#160;3.231 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .235
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Mountain View Hospital, Inc. By-Laws (filed as
    Exhibit&#160;3.232 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .236
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Nashville Shared Services General Partnership General
    Partnership Agreement (filed as Exhibit&#160;3.233 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .237
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    National Patient Account Services, Inc. Articles of
    Incorporation (filed as Exhibit&#160;3.235 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .238
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    National Patient Account Services, Inc. By-Laws (filed as
    Exhibit&#160;3.236 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .239
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    New Port Richey Hospital, Inc. Articles of Incorporation (filed
    as Exhibit&#160;3.237 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .240
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    New Port Richey Hospital, Inc. By-Laws (filed as
    Exhibit&#160;3.238 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .241
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    New Rose Holding Company, Inc. Articles of Incorporation (filed
    as Exhibit&#160;3.239 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-32
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .242
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    New Rose Holding Company, Inc. By-Laws (filed as
    Exhibit&#160;3.240 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .243
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    North Florida Immediate Care Center, Inc. Articles of
    Incorporation (filed as Exhibit&#160;3.241 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .244
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    North Florida Immediate Care Center, Inc. By-Laws (filed as
    Exhibit&#160;3.242 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .245
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    North Florida Regional Medical Center, Inc. Articles of
    Incorporation (filed as Exhibit&#160;3.243 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .246
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    North Florida Regional Medical Center, Inc. By-Laws (filed as
    Exhibit&#160;3.244 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .247
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Northern Utah Healthcare Corporation Articles of Incorporation
    (filed as Exhibit&#160;3.245 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .248
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Northern Utah Healthcare Corporation By-Laws (filed as
    Exhibit&#160;3.246 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .249
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Northern Virginia Community Hospital, LLC Articles of
    Organization (filed as Exhibit&#160;3.247 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .250
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Northern Virginia Community Hospital, LLC Limited Liability
    Company Agreement (filed as Exhibit&#160;3.248 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .251
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Northlake Medical Center, LLC Certificate of Formation (filed as
    Exhibit&#160;3.249 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .252
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Northlake Medical Center, LLC Limited Liability Company
    Agreement (filed as Exhibit&#160;3.250 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .253
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Notami Hospitals of Louisiana, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.251 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .254
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Notami Hospitals of Louisiana, Inc. By-Laws (filed as
    Exhibit&#160;3.252 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .255
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Notami Hospitals, LLC Certificate of Formation (filed as
    Exhibit&#160;3.253 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .256
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Notami Hospitals, LLC Limited Liability Company Agreement (filed
    as Exhibit&#160;3.254 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .257
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Okaloosa Hospital, Inc. Articles of Incorporation (filed as
    Exhibit&#160;3.255 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .258
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Okaloosa Hospital, Inc. By-Laws (filed as Exhibit&#160;3.256 to
    the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .259
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Okeechobee Hospital, Inc. Articles of Incorporation (filed as
    Exhibit&#160;3.257 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .260
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Okeechobee Hospital, Inc. By-Laws (filed as Exhibit&#160;3.258
    to the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .261
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Outpatient Cardiovascular Center of Central Florida, LLC
    Certificate of Formation (filed as Exhibit&#160;3.259 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .262
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Outpatient Cardiovascular Center of Central Florida, LLC
    Operating Agreement (filed as Exhibit&#160;3.260 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-33
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .263
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Palms West Hospital Limited Partnership Agreement of Limited
    Partnership (filed as Exhibit&#160;3.261 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .264
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Palms West Hospital Limited Partnership Certificate of Limited
    Partnership (filed as Exhibit&#160;3.262 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .265
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Palmyra Park Hospital, Inc. Articles of Incorporation (filed as
    Exhibit&#160;3.263 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .266
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Palmyra Park Hospital, Inc. By-Laws (filed as Exhibit&#160;3.264
    to the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .267
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Pasadena Bayshore Hospital, Inc. Articles of Incorporation*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .268
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Pasadena Bayshore Hospital Inc. By-Laws*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .269
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Plantation General Hospital, L.P. Agreement of Limited
    Partnership (filed as Exhibit&#160;3.265 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .270
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Plantation General Hospital, L.P. Agreement of Limited
    Partnership (filed as Exhibit&#160;3.266 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .271
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Pulaski Community Hospital, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.267 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .272
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Pulaski Community Hospital, Inc. By-Laws (filed as
    Exhibit&#160;3.268 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .273
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Redmond Park Hospital, LLC Articles of Organization (filed as
    Exhibit&#160;3.269 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .274
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Redmond Park Hospital, LLC Limited Liability Company Agreement
    (filed as Exhibit&#160;3.270 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .275
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Redmond Physician Practice Company Articles of Incorporation
    (filed as Exhibit&#160;3.271 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .276
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Redmond Physician Practice Company By-Laws (filed as
    Exhibit&#160;3.272 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .277
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Reston Hospital Center, LLC Certificate of Formation (filed as
    Exhibit&#160;3.273 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .278
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Reston Hospital Center, LLC Limited Liability Company Agreement
    (filed as Exhibit&#160;3.274 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .279
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Retreat Hospital, LLC Articles of Incorporation*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .280
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Retreat Hospital, LLC Limited Liability Company Agreement*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .281
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Rio Grande Regional Hospital, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.277 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .282
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Rio Grande Regional Hospital, Inc. By-Laws (filed as
    Exhibit&#160;3.278 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .283
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Riverside Healthcare System, L.P. Certificate of Limited
    Partnership (filed as Exhibit&#160;3.279 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .284
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Riverside Healthcare System, L.P. Limited Partnership Agreement
    (filed as Exhibit&#160;3.280 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-34
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .285
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Riverside Hospital, Inc. Certificate of Incorporation (filed as
    Exhibit&#160;3.281 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .286
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Riverside Hospital, Inc. By-Laws (filed as Exhibit&#160;3.282 to
    the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .287
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Samaritan, LLC Certificate of Formation (filed as
    Exhibit&#160;3.283 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .288
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Samaritan, LLC Limited Liability Company Agreement (filed as
    Exhibit&#160;3.284 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .289
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    San&#160;Jose Healthcare System, LP Certificate of Limited
    Partnership (filed as Exhibit&#160;3.285 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .290
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    San&#160;Jose Healthcare System, LP Limited Partnership
    Agreement (filed as Exhibit&#160;3.286 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .291
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    San&#160;Jose Hospital, L.P. Agreement of Limited Partnership
    (filed as Exhibit&#160;3.287 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .292
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    San&#160;Jose Hospital, L.P. Certificate of Limited Partnership
    (filed as Exhibit&#160;3.288 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .293
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    San&#160;Jose Medical Center, LLC Certificate of Formation
    (filed as Exhibit&#160;3.289 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .294
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    San&#160;Jose Medical Center, LLC Limited Liability Company
    Agreement (filed as Exhibit&#160;3.290 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .295
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    San&#160;Jose, LLC Certificate of Formation (filed as
    Exhibit&#160;3.291 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .296
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    San&#160;Jose, LLC Limited Liability Company Agreement (filed as
    Exhibit&#160;3.292 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .297
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Sarasota Doctors Hospital, Inc. Articles of Incorporation (filed
    as Exhibit&#160;3.293 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .298
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Sarasota Doctors Hospital, Inc. By-Laws (filed as
    Exhibit&#160;3.294 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .299
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    SJMC, LLC Certificate of Formation (filed as Exhibit&#160;3.295
    to the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .300
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    SJMC, LLC Limited Liability Company Agreement (filed as
    Exhibit&#160;3.296 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .301
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Southern Hills Medical Center, LLC Certificate of Formation
    (filed as Exhibit&#160;3.297 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .302
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Southern Hills Medical Center, LLC Limited Liability Company
    Agreement (filed as Exhibit&#160;3.298 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .303
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Spotsylvania Medical Center, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.299 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .304
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Spotsylvania Medical Center, Inc By-Laws (filed as
    Exhibit&#160;3.300 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .305
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Spring Branch Medical Center, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.301 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .306
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Spring Branch Medical Center, Inc. By-Laws (filed as
    Exhibit&#160;3.302 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-35
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .307
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Spring Hill Hospital, Inc. Charter (filed as Exhibit&#160;3.303
    to the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .308
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Spring Hill Hospital, Inc. By-Laws (filed as Exhibit&#160;3.304
    to the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .309
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    St. Mark&#146;s Lone Peak Hospital, Inc. Articles of
    Incorporation (filed as Exhibit&#160;3.305 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .310
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    St. Mark&#146;s Lone Peak Hospital, Inc. By-Laws (filed as
    Exhibit&#160;3.306 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .311
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Sun City Hospital, Inc. Articles of Incorporation (filed as
    Exhibit&#160;3.307 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .312
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Sun City Hospital, Inc. By-Laws (filed as Exhibit&#160;3.308 to
    the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .313
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Sunrise Mountainview Hospital, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.311 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .314
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Sunrise Mountainview Hospital, Inc. By-Laws (filed as
    Exhibit&#160;3.312 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .315
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Surgicare of Brandon, Inc. Articles of Incorporation (filed as
    Exhibit&#160;3.313 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .316
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Surgicare of Brandon, Inc. By-Laws (filed as Exhibit&#160;3.314
    to the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .317
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Surgicare of Florida, Inc. Articles of Incorporation (filed as
    Exhibit&#160;3.315 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .318
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Surgicare of Florida, Inc. By-Laws (filed as Exhibit&#160;3.316
    to the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .319
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Surgicare of Houston Women&#146;s, Inc. Articles of
    Incorporation (filed as Exhibit&#160;3.317 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .320
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Surgicare of Houston Women&#146;s, Inc. By-Laws (filed as
    Exhibit&#160;3.318 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .321
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Surgicare of Manatee, Inc. Articles of Incorporation (filed as
    Exhibit&#160;3.319 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .322
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Surgicare of Manatee, Inc. By-Laws (filed as Exhibit&#160;3.320
    to the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .323
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Surgicare of New Port Richey, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.321 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .324
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Surgicare of New Port Richey, Inc. By-Laws (filed as
    Exhibit&#160;3.322 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .325
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Surgicare of Palms West, LLC Articles of Organization (filed as
    Exhibit&#160;3.323 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .326
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Surgicare of Palms West, LLC Articles of Organization Agreement
    (filed as Exhibit&#160;3.324 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .327
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Surgicare of Riverside, LLC Articles of Organization (filed as
    Exhibit&#160;3.325 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .328
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Surgicare of Riverside, LLC Limited Liability Company Agreement
    (filed as Exhibit&#160;3.326 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-36
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .329
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Tallahassee Medical Center, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.327 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .330
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Tallahassee Medical Center, Inc. By-Laws (filed as
    Exhibit&#160;3.328 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .331
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    TCMC Madison-Portland, Inc. Articles of Incorporation (filed as
    Exhibit&#160;3.329 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .332
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    TCMC Madison-Portland, Inc. By-Laws (filed as Exhibit&#160;3.330
    to the Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .333
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Terre Haute Hospital GP, Inc. Certificate of Incorporation
    (filed as Exhibit&#160;3.331 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .334
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Terre Haute Hospital GP, Inc. By-Laws (filed as
    Exhibit&#160;3.332 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .335
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Terre Haute Hospital Holdings, Inc. Certificate of Incorporation
    (filed as Exhibit&#160;3.333 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .336
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Terre Haute Hospital Holdings, Inc. By-Laws (filed as
    Exhibit&#160;3.334 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .337
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Terre Haute MOB, L.P. Certificate of Limited Partnership (filed
    as Exhibit&#160;3.335 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .338
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Terre Haute MOB, L.P. Limited Partnership Agreement (filed as
    Exhibit&#160;3.336 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .339
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Terre Haute Regional Hospital, L.P. Certificate of Limited
    Partnership (filed as Exhibit&#160;3.337 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .340
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Terre Haute Regional Hospital, L.P. Limited Partnership
    Agreement (filed as Exhibit&#160;3.338 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .341
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Timpanogos Regional Medical Services, Inc. Certificate of
    Incorporation (filed as Exhibit&#160;3.339 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .342
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Timpanogos Regional Medical Services, Inc. By-Laws (filed as
    Exhibit&#160;3.340 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .343
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Trident Medical Center, LLC Certificate of Formation (filed as
    Exhibit&#160;3.341 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .344
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Trident Medical Center, LLC Limited Liability Company Agreement
    (filed as Exhibit&#160;3.342 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .345
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Utah Medco, LLC Certificate of Formation (filed as
    Exhibit&#160;3.343 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .346
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Utah Medco, LLC Limited Liability Company Agreement (filed as
    Exhibit&#160;3.344 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .347
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    VH Holdco, Inc. Articles of Incorporation (filed as
    Exhibit&#160;3.345 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .348
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    VH Holdco, Inc. By-Laws (filed as Exhibit&#160;3.346 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .349
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    VH Holdings, Inc. Articles of Incorporation (filed as
    Exhibit&#160;3.347 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .350
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    VH Holdings, Inc. By-Laws (filed as Exhibit&#160;3.348 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-37
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .351
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Virginia Psychiatric Company, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.349 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .352
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Virginia Psychiatric Company, Inc. By-Laws (filed as
    Exhibit&#160;3.350 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .353
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    W&#160;&#038; C Hospital, Inc. Articles of Incorporation (filed
    as Exhibit&#160;3.351 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .354
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    W&#160;&#038; C Hospital, Inc. By-Laws (filed as
    Exhibit&#160;3.352 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .355
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Walterboro Community Hospital, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.353 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .356
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Walterboro Community Hospital, Inc. By-Laws (filed as
    Exhibit&#160;3.354 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .357
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Wesley Medical Center, LLC Certificate of Formation (filed as
    Exhibit&#160;3.355 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .358
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Wesley Medical Center, LLC Limited Liability Company Agreement
    (filed as Exhibit&#160;3.356 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .359
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    West Florida Regional Medical Center, Inc. Articles of
    Incorporation (filed as Exhibit&#160;3.357 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .360
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    West Florida Regional Medical Center, Inc. By-Laws (filed as
    Exhibit&#160;3.358 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .361
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    West Valley Medical Center, Inc. Articles of Incorporation
    (filed as Exhibit&#160;3.359 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .362
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    West Valley Medical Center, Inc. By-Laws (filed as
    Exhibit&#160;3.360 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .363
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Western Plains Capital, Inc. Articles of Incorporation (filed as
    Exhibit&#160;3.361 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .364
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Western Plains Capital, Inc. By-Laws (filed as
    Exhibit&#160;3.362 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .365
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    WHMC, Inc. Articles of Incorporation (filed as
    Exhibit&#160;3.363 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .366
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    WHMC, Inc. By-Laws (filed as Exhibit&#160;3.364 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .367
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Woman&#146;s Hospital of Texas, Incorporated Certificate of
    Incorporation (filed as Exhibit&#160;3.365 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .368
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Woman&#146;s Hospital of Texas, Incorporated By-Laws (filed as
    Exhibit&#160;3.366 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .369
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Women&#146;s and Children&#146;s Hospital, Inc. Articles of
    Incorporation (filed as Exhibit&#160;3.367 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .370
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Women&#146;s and Children&#146;s Hospital, Inc. By-Laws (filed
    as Exhibit&#160;3.368 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .1
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Specimen Certificate for shares of Common Stock, par value $0.01
    per share, of the Company (filed as Exhibit&#160;3 to the
    Company&#146;s
    <FONT style="white-space: nowrap">Form&#160;8-A/A,</FONT>
    Amendment No.&#160;2, dated March&#160;11, 2004, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .2
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Indenture, dated November&#160;17, 2006, among HCA Inc., the
    guarantors party thereto and The Bank of New York, as trustee
    (filed as Exhibit&#160;4.1 to the Company&#146;s Current Report
    on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    filed November&#160;24, 2006, and incorporated herein by
    reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-38
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .3
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Security Agreement, dated as of November&#160;17, 2006, among
    HCA Inc., the subsidiary grantors party thereto and The Bank of
    New York, as collateral agent (filed as Exhibit&#160;4.2 to the
    Company&#146;s Current Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    filed November&#160;24, 2006, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .4
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Pledge Agreement, dated as of November&#160;17, 2006, among HCA
    Inc., the subsidiary pledgors party thereto and The Bank of New
    York, as collateral agent (filed as Exhibit&#160;4.3 to the
    Company&#146;s Current Report of
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    filed November&#160;24, 2006, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .5(a)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of
    9<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;Senior
    Secured Notes due 2014 (included in Exhibit&#160;4.2).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .5(b)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of
    9<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">4</FONT>%&#160;Senior
    Secured Notes due 2016 (included in Exhibit&#160;4.2).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .5(c)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of
    9<FONT style="vertical-align: text-top; font-size: 70%;">5</FONT>/<FONT style="font-size: 70%;">8</FONT>%/10<FONT style="vertical-align: text-top; font-size: 70%;">3</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;Senior
    Secured Toggle Notes due 1016 (included in Exhibit&#160;4.2).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .6
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Indenture, dated February&#160;19, 2009, among HCA Inc, the
    guarantors party thereto, The Bank of New York Mellon, as
    collateral agent and The Bank of New York Mellon
    Trust&#160;Company, N.A., as trustee. (filed as Exhibit&#160;4.1
    to the Company&#146;s Current Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    filed February&#160;25, 2009, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .7
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of
    9<FONT style="vertical-align: text-top; font-size: 70%;">7</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;Senior
    Secured Notes due 2017 (included in Exhibit&#160;4.6).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .8(a)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    $13,550,000,000&#160;&#151; &#128;1,000,000,000 Credit
    Agreement, dated as of November&#160;17, 2006, among HCA Inc.,
    HCA UK Capital Limited, the lending institutions from time to
    time parties thereto, Banc of America Securities LLC,
    J.P.&#160;Morgan Securities Inc., Citigroup Global Markets Inc.
    and Merrill Lynch, Pierce, Fenner&#160;&#038; Smith
    Incorporated, as joint lead arrangers and joint bookrunners,
    Bank of America, N.A., as administrative agent, JPMorgan Chase
    Bank, N.A. and Citicorp North America, Inc., as co-syndication
    agents and Merrill Lynch Capital Corporation, as documentation
    agent (filed as Exhibit&#160;4.8 to the Company&#146;s Current
    Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    filed November&#160;24, 2006, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .8(b)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Amendment No.&#160;1 to the Credit Agreement, dated as of
    February&#160;16, 2007, among HCA Inc., HCA UK Capital Limited,
    the lending institutions from time to time parties thereto, Bank
    of America, N.A., as administrative agent, JPMorgan Chase Bank,
    N.A., and Citicorp North America, Inc., as Co-Syndication
    Agents, Banc of America Securities, LLC, J.P.&#160;Morgan
    Securities Inc., Citigroup Global Markets Inc. and Merrill
    Lynch, Pierce, Fenner&#160;&#038; Smith Incorporated, as joint
    lead arrangers and bookrunners, Deutsche Bank Securities and
    Wachovia Capital Markets LLC, as joint bookrunners and Merrill
    Lynch Capital Corporation, as documentation agent (filed as
    Exhibit&#160;4.7(b) to the Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2006, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .8(c)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Amendment No.&#160;2 to the Credit Agreement, dated as of
    March&#160;2, 2009, among HCA Inc., HCA UK&#160;Capital Limited,
    the lending institutions from time to time parties thereto, Bank
    of America, N.A., as administrative agent, JPMorgan Chase Bank,
    N.A., and Citicorp North America, Inc., as Co-Syndication
    Agents, Banc of America Securities, LLC, J.P.&#160;Morgan
    Securities Inc., Citigroup Global Markets Inc. and Merrill
    Lynch, Pierce, Fenner&#160;&#038; Smith Incorporated, as joint
    lead arrangers and bookrunners, Deutsche Bank Securities and
    Wachovia Capital Markets LLC, as joint bookrunners and Merrill
    Lynch Capital Corporation, as documentation agent (filed as
    exhibit&#160;4.8(c) to the Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2008, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .9
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    U.S. Guarantee, dated November&#160;17, 2006, among HCA Inc.,
    the subsidiary guarantors party thereto and Bank of America,
    N.A., as administrative agent (filed as Exhibit&#160;4.9 to the
    Company&#146;s Current Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    filed November&#160;24, 2006, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .10
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Indenture, dated as of April&#160;22, 2009, among HCA Inc., the
    guarantors party thereto, Deutsche Bank Trust&#160;Company
    Americas, as paying agent, registrar and transfer agent, and Law
    Debenture Trust&#160;Company of New York, as trustee (filed as
    Exhibit&#160;4.1 to the Company&#146;s Current Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    filed April&#160;28, 2009, and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .11
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Security Agreement, dated as of November&#160;17, 2006, and
    amended and restated as of March&#160;2, 2009, among the
    Company, the Subsidiary Grantors named therein and Bank of
    America, N.A., as Collateral Agent (filed as exhibit&#160;4.10
    to the Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2008, and
    incorporated herein by reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-39
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .12
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Pledge Agreement, dated as of November&#160;17, 2006, and
    amended and restated as of March&#160;2, 2009, among the
    Company, the Subsidiary Pledgors named therein and Bank of
    America, N.A., as Collateral Agent (filed as exhibit&#160;4.11
    to the Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2008, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .13
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of
    8<FONT style="vertical-align: text-top; font-size: 70%;">1</FONT>/<FONT style="font-size: 70%;">2</FONT>%&#160;Senior
    Secured Notes due 2019 (included in Exhibit&#160;4.10).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .14(a)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    $2,000,000,000 Amended and Restated Credit Agreement, dated as
    of June&#160;20, 2007, among HCA Inc., the subsidiary borrowers
    parties thereto, the lending institutions from time to time
    parties thereto, Banc of America Securities LLC,
    J.P.&#160;Morgan Securities Inc., Citigroup Global Markets Inc.
    and Merrill Lynch, Pierce, Fenner&#160;&#038; Smith
    Incorporated, as joint lead arrangers and joint bookrunners,
    Bank of America, N.A., as administrative agent, JPMorgan Chase
    Bank, N.A. and Citicorp North America, Inc., as co-syndication
    agents, and Merrill Lynch Capital Corporation, as documentation
    agent (filed as Exhibit&#160;4.1 to the Company&#146;s Current
    Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    filed June&#160;26, 2007, and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .14(b)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Amendment No.&#160;1 to the $2,000,000,000 Amended and Restated
    Credit Agreement, dated as of March&#160;2, 2009, among HCA
    Inc., the subsidiary borrowers parties thereto, the lending
    institutions from time to time parties thereto, Banc of America
    Securities LLC, J.P.&#160;Morgan Securities Inc., Citigroup
    Global Markets Inc. and Merrill Lynch, Pierce,
    Fenner&#160;&#038; Smith Incorporated, as joint lead arrangers
    and joint bookrunners, Bank of America, N.A., as administrative
    agent, JPMorgan Chase Bank, N.A. and Citicorp North America,
    Inc., as co-syndication agents, and Merrill Lynch Capital
    Corporation, as documentation agent (filed as
    exhibit&#160;4.12(b) to the Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2008, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .15
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Security Agreement, dated as of November&#160;17, 2006, among
    HCA Inc., the subsidiary borrowers party thereto and Bank of
    America, N.A., as collateral agent (filed as Exhibit&#160;4.13
    to the Company&#146;s Current Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    filed November&#160;24, 2006, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .16(a)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    General Intercreditor Agreement, dated as of November&#160;17,
    2006, between Bank of America, N.A., as First Lien Collateral
    Agent, and The Bank of New York, as Junior Lien Collateral Agent
    (filed as Exhibit&#160;4.13(a) to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .16(b)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Additional General Intercreditor Agreement, dated as of
    April&#160;22, 2009, by and among Bank of America, N.A., in its
    capacity as First Lien Collateral Agent, The Bank of New York
    Mellon, in its capacity as Junior Lien Collateral Agent and in
    its capacity as 2006 Second Lien Trustee and The Bank of New
    York Mellon Trust&#160;Company, N.A., in its capacity as 2009
    Second Lien Trustee (filed as Exhibit&#160;4.6 to the
    Company&#146;s Current Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    filed April&#160;28, 2009, and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .16(c)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Receivables Intercreditor Agreement, dated as of
    November&#160;17, 2006, among Bank of America, N.A., as ABL
    Collateral Agent, Bank of America, N.A., as CF Collateral Agent
    and The Bank of New York, as Bonds Collateral Agent (filed as
    Exhibit&#160;4.13(b) to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .16(d)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Additional Receivables Intercreditor Agreement, dated as of
    April&#160;22, 2009, by and between Bank of America, N.A. as ABL
    Collateral Agent, and Bank of America, N.A. as New First Lien
    Collateral Agent (filed as Exhibit&#160;4.7 to the
    Company&#146;s Current Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    filed April&#160;28, 2009, and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .16(e)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    First Lien Intercreditor Agreement, dated as of April&#160;22,
    2009, among Bank of America, N.A. as Collateral Agent, Bank of
    America, N.A. as Authorized Representative under the Credit
    Agreement and Law Debenture Trust&#160;Company of New York as
    the Initial Additional Authorized Representative (filed as
    Exhibit&#160;4.5 to the Company&#146;s Current Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    filed April&#160;28, 2009, and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .17
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Registration Rights Agreement, dated as of November&#160;17,
    2006, among HCA Inc., Hercules Holding II, LLC and certain other
    parties thereto (filed as Exhibit&#160;4.4 to the Company&#146;s
    Current Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    filed November&#160;24, 2006, and incorporated herein by
    reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-40
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .18
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Registration Rights Agreement, dated as of March&#160;16, 1989,
    by and among HCA-Hospital Corporation of America and the persons
    listed on the signature pages thereto (filed as
    Exhibit&#160;4.14 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .19
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Assignment and Assumption Agreement, dated as of
    February&#160;10, 1994, between HCA-Hospital Corporation of
    America and the Company relating to the Registration Rights
    Agreement, as amended (filed as Exhibit&#160;4.15 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    <FONT style="white-space: nowrap">(File&#160;No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .20(a)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Indenture, dated as of December&#160;16, 1993 between the
    Company and The First National Bank of Chicago, as Trustee
    (filed as Exhibit&#160;4.16(a) to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .20(b)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    First Supplemental Indenture, dated as of May&#160;25, 2000
    between the Company and Bank One Trust&#160;Company, N.A., as
    Trustee (filed as Exhibit&#160;4.16(b) to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .20(c)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Second Supplemental Indenture, dated as of July&#160;1, 2001
    between the Company and Bank One Trust&#160;Company, N.A., as
    Trustee (filed as Exhibit&#160;4.16(c) to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .20(d)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Third Supplemental Indenture, dated as of December&#160;5, 2001
    between the Company and The Bank of New York, as Trustee (filed
    as Exhibit&#160;4.16(d) to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .20(e)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Fourth Supplemental Indenture, dated as of November&#160;14,
    2006, between the Company and The Bank of New York, as Trustee
    (filed as Exhibit&#160;4.1 to the Company&#146;s Current Report
    on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    filed November&#160;16, 2006, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .21
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of 7.5%&#160;Debentures due 2023 (filed as
    Exhibit&#160;4.17 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .22
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of 8.36%&#160;Debenture due 2024 (filed as
    Exhibit&#160;4.18 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .23
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of Fixed Rate Global Medium-Term Note (filed as
    Exhibit&#160;4.19 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .24
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of Floating Rate Global Medium-Term Note (filed as
    Exhibit&#160;4.20 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .25
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of 7.69%&#160;Note due 2025 (filed as Exhibit&#160;4.10 to
    the Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2004, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .26
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of 7.19%&#160;Debenture due 2015 (filed as
    Exhibit&#160;4.22 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .27
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of 7.50%&#160;Debenture due 2095 (filed as
    Exhibit&#160;4.23 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .24
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of 7.05%&#160;Debenture due 2027 (filed as
    Exhibit&#160;4.24 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .28
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of Fixed Rate Global Medium-Term Note (filed as
    Exhibit&#160;4.25 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .29(a)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    8.750%&#160;Note in the principal amount of $400,000,000 due
    2010 (filed as Exhibit&#160;4.26(a) to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .29(b)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    8.750%&#160;Note in the principal amount of $350,000,000 due
    2010 (filed as Exhibit&#160;4.26(b) to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .30
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    8.75%&#160;Note due 2010 in the principal amount of
    &#163;150,000,000 (filed as Exhibit&#160;4.27 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-41
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .31(a)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    7<FONT style="vertical-align: text-top; font-size: 70%;">7</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;Note
    in the principal amount of $100,000,000 due 2011 (filed as
    Exhibit&#160;4.28(a) to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .31(b)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    7<FONT style="vertical-align: text-top; font-size: 70%;">7</FONT>/<FONT style="font-size: 70%;">8</FONT>%&#160;Note
    in the principal amount of $400,000,000 due 2011 (filed as
    Exhibit&#160;4.28(b) to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .32(a)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    6.95%&#160;Note due 2012 in the principal amount of $400,000,000
    (filed as Exhibit&#160;4.29(a) to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .32(b)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    6.95%&#160;Note due 2012 in the principal amount of $100,000,000
    (filed as Exhibit&#160;4.29(b) to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .33(a)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    6.30%&#160;Note due 2012 in the principal amount of $400,000,000
    (filed as Exhibit&#160;4.1 to the Company&#146;s Current Report
    on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    dated September&#160;18, 2002, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .33(b)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    6.30%&#160;Note due 2012 in the principal amount of $100,000,000
    (filed as Exhibit&#160;4.2 to the Company&#146;s Current Report
    on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    dated September&#160;18, 2002, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .34(a)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    6.25%&#160;Note due 2013 in the principal amount of $400,000,000
    (filed as Exhibit&#160;4.1 to the Company&#146;s Current Report
    on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    dated February&#160;5, 2003, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .34(b)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    6.25%&#160;Note due 2013 in the principal amount of $100,000,000
    (filed as Exhibit&#160;4.2 to the Company&#146;s Current Report
    on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    dated February&#160;5, 2003, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .35(a)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    6<FONT style="vertical-align: text-top; font-size: 70%;">3</FONT>/<FONT style="font-size: 70%;">4</FONT>%&#160;Note
    due 2013 in the principal amount of $400,000,000 (filed as
    Exhibit&#160;4.1 to the Company&#146;s Current Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    dated July&#160;23, 2003, and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .35(b)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    6<FONT style="vertical-align: text-top; font-size: 70%;">3</FONT>/<FONT style="font-size: 70%;">4</FONT>%&#160;Note
    due 2013 in the principal amount of $100,000,000 (filed as
    Exhibit&#160;4.2 to the Company&#146;s Current Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    dated July&#160;23, 2003, and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .36
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    7.50%&#160;Note due 2033 in the principal amount of $250,000,000
    (filed as Exhibit&#160;4.2 to the Company&#146;s Current Report
    on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    dated November&#160;6, 2003, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .37
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    5.75%&#160;Note due 2014 in the principal amount of $500,000,000
    (filed as Exhibit&#160;4.1 to the Company&#146;s Current Report
    on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    dated March&#160;8, 2004, and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .38
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    5.500%&#160;Note due 2009 in the principal amount of
    $500,000,000 (filed as Exhibit&#160;4.1 to the Company&#146;s
    Current Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    dated November&#160;16, 2004, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .39(a)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    6.375%&#160;Note due 2015 in the principal amount of
    $500,000,000 (filed as Exhibit&#160;4.2 to the Company&#146;s
    Current Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    dated November&#160;16, 2004, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .39(b)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    6.375%&#160;Note due 2015 in the principal amount of
    $250,000,000 (filed as Exhibit&#160;4.3 to the Company&#146;s
    Current Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    dated November&#160;16, 2004, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .40(a)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    6.500%&#160;Note due 2016 in the principal amount of
    $500,000,000 (filed as Exhibit&#160;4.1 to the Company&#146;s
    Current Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    filed on February&#160;8, 2006, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .41(b)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    6.500%&#160;Note due 2016 in the principal amount of
    $500,000,000 (filed as Exhibit&#160;4.2 to the Company&#146;s
    Current Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    filed on February&#160;8, 2006, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    5
</TD>
<TD nowrap align="left" valign="top">
    .1
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Opinion of Simpson Thacher&#160;&#038; Bartlett LLP.*
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-42
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    5
</TD>
<TD nowrap align="left" valign="top">
    .2
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Opinion of Robert A. Waterman.*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .1(a)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Amended and Restated Columbia/HCA Healthcare Corporation 1992
    Stock and Incentive Plan (filed as Exhibit&#160;10.7(b) to the
    Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 1998, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .1(b)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    First Amendment to Amended and Restated Columbia/HCA Healthcare
    Corporation 1992 Stock and Incentive Plan (filed as
    Exhibit&#160;10.2 to the Company&#146;s Quarterly Report on
    <FONT style="white-space: nowrap">Form&#160;10-Q</FONT>
    for the quarter ended September&#160;30, 1999, and incorporated
    herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .2
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA-Hospital Corporation of America Nonqualified Initial Option
    Plan (filed as Exhibit&#160;4.6 to the Company&#146;s
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-3</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;33-52379),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .3
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of Indemnity Agreement with certain officers and directors
    (filed as Exhibit&#160;10.3 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;S-4</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;333-145054)</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .4
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of Galen Health Care, Inc. 1993 Adjustment Plan (filed as
    Exhibit&#160;4.15 to the Company&#146;s Registration Statement
    on
    <FONT style="white-space: nowrap">Form&#160;S-8</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;33-50147)</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .5
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of HCA-Hospital Corporation of America 1992 Stock
    Compensation Plan (filed as Exhibit&#160;4.2 to the
    Company&#146;s Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-8</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;33-52253),</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .6
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Columbia/HCA Healthcare Corporation 2000 Equity Incentive Plan
    (filed as Exhibit&#160;A to the Company&#146;s Proxy Statement
    for the Annual Meeting of Stockholders on May&#160;25, 2000, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .7
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of Non-Qualified Stock Option Award Agreement (Officers)
    (filed as Exhibit&#160;99.2 to the Company&#146;s Current Report
    on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    dated February&#160;2, 2005, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .8
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA 2005 Equity Incentive Plan (filed as Exhibit&#160;B to the
    Company&#146;s Proxy Statement for the Annual Meeting of
    Shareholders on May&#160;26, 2005, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .9
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of 2005 Non-Qualified Stock Option Agreement (Officers)
    (filed as Exhibit&#160;99.2 to the Company&#146;s Current Report
    on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    dated October&#160;6, 2005, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .10
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of 2006 Non-Qualified Stock Option Award Agreement
    (Officers) (filed as Exhibit&#160;10.2 to the Company&#146;s
    Current Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    dated February&#160;1, 2006, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .11
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    2006 Stock Incentive Plan for Key Employees of HCA Inc. and its
    Affiliates (filed as Exhibit&#160;10.11 to the Company&#146;s
    Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2006, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .12
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Management Stockholder&#146;s Agreement dated November&#160;17,
    2006 (filed as Exhibit&#160;10.12 to the Company&#146;s Annual
    Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2006, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .13
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Sale Participation Agreement dated November&#160;17, 2006 (filed
    as Exhibit&#160;10.13 to the Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2006, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .14
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of Option Rollover Agreement (filed as Exhibit&#160;10.14
    to the Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2006, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .15
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of Option Agreement (2007) (filed as Exhibit&#160;10.15 to
    the Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2006, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .16
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of Option Agreement (2008) (filed as Exhibit&#160;10.16 to
    the Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2007, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .17
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of Option Agreement (2009) (filed as Exhibit&#160;10.17 to
    the Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2008, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .18
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Exchange and Purchase Agreement (filed as Exhibit&#160;10.16 to
    the Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2006, and
    incorporated herein by reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-43
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .19
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Civil and Administrative Settlement Agreement, dated
    December&#160;14, 2000 between the Company, the United States
    Department of Justice and others (filed as Exhibit&#160;99.2 to
    the Company&#146;s Current Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    dated December&#160;20, 2000, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .20
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Plea Agreement, dated December&#160;14, 2000 between the
    Company, Columbia Homecare Group, Inc., Columbia Management
    Companies, Inc. and the United States Department of Justice
    (filed as Exhibit&#160;99.3 to the Company&#146;s Current Report
    on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    dated December&#160;20, 2000, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .21
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Corporate Integrity Agreement, dated December&#160;14, 2000
    between the Company and the Office of Inspector General of the
    United States Department of Health and Human Services (filed as
    Exhibit&#160;99.4 to the Company&#146;s Current Report on
    <FONT style="white-space: nowrap">Form&#160;8-K</FONT>
    dated December&#160;20, 2000, and incorporated herein by
    reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .22
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Management Agreement, dated November&#160;17, 2006, among HCA
    Inc., Bain Capital Partners, LLC, Kohlberg Kravis
    Roberts&#160;&#038; Co. L.P., Dr.&#160;Thomas F. Frist Jr.,
    Patricia F. Elcan, William R. Frist and Thomas F.
    Frist,&#160;III, and Merrill Lynch Global Partners, Inc. (filed
    as Exhibit&#160;10.20 to the Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2006, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .23
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Retirement Agreement between the Company and Thomas F. Frist,
    Jr.,&#160;M.D. dated as of January&#160;1, 2002 (filed as
    Exhibit&#160;10.30 to the Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2001, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .24
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Amended and Restated HCA Supplemental Executive Retirement Plan,
    effective January&#160;1, 2007, except as provided therein.)
    (filed as Exhibit&#160;10.24 to the Company&#146;s Annual Report
    on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2008, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .25
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Amended and Restated HCA Restoration Plan, effective
    January&#160;1, 2008.) (filed as Exhibit&#160;10.25 to the
    Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2008, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .26
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA Inc. 2006 Senior Officer Performance Excellence Program
    (filed as Exhibit&#160;10.3 to the Company&#146;s Current Report
    on <FONT style="white-space: nowrap">8-K</FONT> filed
    February&#160;1, 2006, and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .27
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA Inc. 2007 Senior Officer Performance Excellence Program
    (filed as Exhibit&#160;10.26 to the Company&#146;s Annual Report
    on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2006, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .28(a)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA Inc.
    <FONT style="white-space: nowrap">2008-2009</FONT>
    Senior Officer Performance Excellence Program (filed as
    Exhibit&#160;10.27 to the Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2007, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .28(b)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    HCA Inc. Amendment No.&#160;1 to the
    <FONT style="white-space: nowrap">2008-2009</FONT>
    Senior Officer Performance Excellence Program (filed as
    Exhibit&#160;10.28(b) to the Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2008, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .29(a)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Employment Agreement dated November&#160;16, 2006 (Jack O.
    Bovender, Jr.) (filed as Exhibit&#160;10.27(a) to the
    Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2006, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .29(b)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Employment Agreement dated November&#160;16, 2006 (Richard M.
    Bracken) (filed as Exhibit&#160;10.27(b) to the Company&#146;s
    Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2006, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .29(c)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Employment Agreement dated November&#160;16, 2006 (R. Milton
    Johnson) (filed as Exhibit&#160;10.27(c) to the Company&#146;s
    Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2006, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .29(d)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Employment Agreement dated November&#160;16, 2006 (Samuel N.
    Hazen) (filed as Exhibit&#160;10.27(d) to the Company&#146;s
    Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2006, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .29(e)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Employment Agreement dated November&#160;16, 2006 (Beverly B.
    Wallace) (filed as Exhibit&#160;10.28(e) to the Company&#146;s
    Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2007, and
    incorporated herein by reference).
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-44
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="3%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="90%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .29(f)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Amended and Restated Employment Agreement dated October&#160;27,
    2008 (Jack O. Bovender, Jr.) (filed as Exhibit&#160;10.29(f) to
    the Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2008, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .29(g)
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Amendment to Employment Agreement effective January&#160;1, 2009
    (Richard M. Bracken) (filed as Exhibit&#160;10.29(g) to the
    Company&#146;s Annual Report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2008, and
    incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .30
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Administrative Settlement Agreement dated June&#160;25, 2003 by
    and between the United States Department of Health and Human
    Services, acting through the Centers for Medicare and Medicaid
    Services, and the Company (filed as Exhibit&#160;10.1 to the
    Company&#146;s Quarterly Report on
    <FONT style="white-space: nowrap">Form&#160;10-Q</FONT>
    for the quarter ended June&#160;30, 2003, and incorporated
    herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .31
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Civil Settlement Agreement by and among the United States of
    America, acting through the United States Department of Justice
    and on behalf of the Office of Inspector General of the
    Department of Health and Human Services, the TRICARE Management
    Activity (filed as Exhibit&#160;10.2 to the Company&#146;s
    Quarterly Report of
    <FONT style="white-space: nowrap">Form&#160;10-Q</FONT>
    for the quarter ended June&#160;30, 2003, and incorporated
    herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .32
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of Amended and Restated Limited Liability Company Agreement
    of Hercules Holding II, LLC dated as of November&#160;17, 2006,
    among Hercules Holding II, LLC and certain other parties thereto
    (filed as Exhibit&#160;10.3 to the Company&#146;s Registration
    Statement on
    <FONT style="white-space: nowrap">Form&#160;8-A</FONT>
    (File
    <FONT style="white-space: nowrap">No.&#160;000-18406)</FONT>
    and incorporated herein by reference).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    12
</TD>
<TD nowrap align="left" valign="top">
    .1
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Statement Regarding Computation of Ratio of Earnings to Fixed
    Charges.*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    21
</TD>
<TD nowrap align="left" valign="top">
    .1
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    List of Subsidiaries.*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    23
</TD>
<TD nowrap align="left" valign="top">
    .1
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Consent of Simpson Thacher&#160;&#038; Bartlett LLP (included as
    part of its opinion filed as Exhibit&#160;5.1 hereto).*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    23
</TD>
<TD nowrap align="left" valign="top">
    .2
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Consent of Robert A. Waterman (included as part of opinion filed
    as Exhibit&#160;5.2).*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    23
</TD>
<TD nowrap align="left" valign="top">
    .3
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Consent of Ernst&#160;&#038; Young LLP.*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    24
</TD>
<TD nowrap align="left" valign="top">
    .1
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Powers of Attorney (included in signature pages of this
    Registration Statement).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    25
</TD>
<TD nowrap align="left" valign="top">
    .1
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    <FONT style="white-space: nowrap">Form&#160;T-1</FONT>
    Statement of Eligibility under the Trust&#160;Indenture Act of
    1939 of The Bank of New York Mellon as trustee under the
    Indenture, dated as of December&#160;16, 1993, between HCA Inc.
    and The Bank of New York Mellon (as successor trustee to The
    First National Bank of Chicago), as Trustee.*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    25
</TD>
<TD nowrap align="left" valign="top">
    .2
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    <FONT style="white-space: nowrap">Form&#160;T-1</FONT>
    Statement of Eligibility under the Trust&#160;Indenture Act of
    1939 of The Bank of New York Mellon as trustee under the
    Indenture, dated as of November&#160;17, 2006, among HCA Inc.,
    the guarantors party thereto and The Bank of New York Mellon, as
    Trustee.*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    25
</TD>
<TD nowrap align="left" valign="top">
    .3
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    <FONT style="white-space: nowrap">Form&#160;T-1</FONT>
    Statement of Eligibility under the Trust&#160;Indenture Act of
    1939 of The Bank of New York Mellon Trust&#160;Company, N.A. as
    trustee under the Indenture, dated as of February&#160;19, 2009,
    among HCA Inc., the guarantors party thereto, The Bank of New
    York Mellon, as collateral agent and The Bank of New York Mellon
    Trust&#160;Company, N.A., as Trustee.*
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    25
</TD>
<TD nowrap align="left" valign="top">
    .4
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    <FONT style="white-space: nowrap">Form&#160;T-1</FONT>
    Statement of Eligibility under the Trust&#160;Indenture Act of
    1939 of Law Debenture Trust&#160;Company of New York, as trustee
    under the Indenture, dated as of April&#160;22, 2009, among HCA
    Inc., the guarantors party thereto, Deutsche Bank
    Trust&#160;Company Americas as paying agent, registrar and
    transfer agent and Law Debenture Trust&#160;Company of New York,
    as Trustee.*
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="font-size: 1pt; margin-left: 0%; width: 13%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=60 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>



<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

<TR>
    <TD width="1%"></TD>
    <TD width="1%"></TD>
    <TD width="98%"></TD>
</TR>

<TR>
    <TD valign="top">
    * </TD>
    <TD></TD>
    <TD valign="bottom">
    Filed herewith</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;&#160;<I>Financial Statement Schedules</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    All schedules are omitted because the required information is
    either not present, not present in material amounts or presented
    within the consolidated financial statements included with our
    annual report on
    <FONT style="white-space: nowrap">Form&#160;10-K</FONT>
    for the fiscal year ended December&#160;31, 2008 and
    incorporated herein by reference.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-45
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

<TR>
    <TD width="9%"></TD>
    <TD width="91%"></TD>
</TR>

<TR valign="top">
    <TD>
    <B><FONT style="font-family: 'Times New Roman', Times">Item&#160;17.<I>&#160;&#160;</I></FONT></B>
</TD>
    <TD>
    <B><I><FONT style="font-family: 'Times New Roman', Times">Undertakings.</FONT></I></B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;Each of the undersigned registrants hereby undertakes:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;to file, during any period in which offers or sales are
    being made, a post-effective amendment to this registration
    statement:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (i)&#160;to include any prospectus required by
    Section&#160;10(a)(3) of the Securities Act of 1933;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (ii)&#160;to reflect in the prospectus any facts or events
    arising after the effective date of the registration statement
    (or the most recent post-effective amendment thereof) which,
    individually or in the aggregate, represent a fundamental change
    in the information set forth in the registration statement.
    Notwithstanding the foregoing, any increase or decrease in
    volume of securities offered (if the total dollar value of
    securities offered would not exceed that which was registered)
    and any deviation from the low or high end of the estimated
    maximum offering range may be reflected in the form of
    prospectus filed with the Commission pursuant to
    Rule&#160;424(b) if, in the aggregate, the changes in volume and
    price represent no more than 20% change in the maximum aggregate
    offering price set forth in the &#147;Calculation of
    Registration Fee&#148; table in the effective registration
    statement;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (iii)&#160;to include any material information with respect to
    the plan of distribution not previously disclosed in the
    registration statement or any material change to such
    information in the registration statement;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;that, for the purpose of determining any liability
    under the Securities Act of 1933, each such post-effective
    amendment shall be deemed to be a new registration statement
    relating to the securities offered therein, and the offering of
    such securities at that time shall be deemed to be the initial
    <I>bona fide </I>offering thereof;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;to remove from registration by means of a
    post-effective amendment any of the securities being registered
    which remain unsold at the termination of the offering;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;that, for the purpose of determining liability under
    the Securities Act of 1933 to any purchaser, each prospectus
    filed pursuant to Rule&#160;424(b) as part of a registration
    statement relating to an offering, other than registration
    statements relying on Rule&#160;430B or other than prospectuses
    filed in reliance on Rule&#160;430A, shall be deemed to be part
    of and included in the registration statement as of the date it
    is first used after effectiveness. Provided, however, that no
    statement made in a registration statement or prospectus that is
    part of the registration statement or made in a document
    incorporated or deemed incorporated by reference into the
    registration statement or prospectus that is part of the
    registration statement will, as to a purchaser with a time of
    contract of sale prior to such first use, supersede or modify
    any statement that was made in the registration statement or
    prospectus that was part of the registration statement or made
    in any such document immediately prior to such date of first
    use;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (5)&#160;that, for the purpose of determining liability of the
    registrants under the Securities Act of 1933 to any purchaser in
    the initial distribution of the securities:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The undersigned registrants undertake that in a primary offering
    of securities of the undersigned registrants pursuant to this
    registration statement, regardless of the underwriting method
    used to sell the securities to the purchaser, if the securities
    are offered or sold to such purchaser by means of any of the
    following communications, the undersigned registrants will be
    sellers to the purchaser and will be considered to offer or sell
    such securities to such purchaser:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (i)&#160;Any preliminary prospectus or prospectus of the
    undersigned registrants relating to the offering required to be
    filed pursuant to Rule&#160;424;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (ii)&#160;Any free writing prospectus relating to the offering
    prepared by or on behalf of the undersigned registrants or used
    or referred to by the undersigned registrants
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-46
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (iii)&#160;The portion of any other free writing prospectus
    relating to the offering containing material information about
    the undersigned registrants or their securities provided by or
    on behalf of the undersigned registrants;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 13%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (iv)&#160;Any other communication that is an offer in the
    offering made by the undersigned registrants to the purchaser.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;Insofar as indemnification for liabilities arising
    under the Securities Act of 1933&#160;may be permitted to
    directors, officers and controlling persons of the registrants
    pursuant to the foregoing provisions, or otherwise, the
    registrants have been advised that in the opinion of the
    Securities and Exchange Commission such indemnification is
    against public policy as expressed in the Securities Act and is,
    therefore, unenforceable. In the event that a claim for
    indemnification against such liabilities (other than the payment
    by the registrants of expenses incurred or paid by a director,
    officer or controlling person of the registrants in the
    successful defense of any action, suit or proceeding) is
    asserted by such director, officer or controlling person in
    connection with the securities being registered, the registrants
    will, unless in the opinion of their counsel the matter has been
    settled by controlling precedent, submit to a court of
    appropriate jurisdiction the question whether such
    indemnification by them is against public policy as expressed in
    the Securities Act and will be governed by the final
    adjudication of such issue.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-47
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>HCA INC.</B>
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R. Milton Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Executive Vice President and</B>
</TD>
</TR>

</TABLE>

<DIV align="left" style="margin-left: 61%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Chief Financial Officer</B>
</DIV>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes Jack O.
    Bovender,&#160;Jr., Richard M. Bracken and R.&#160;Milton
    Johnson, or any of them, as his or her attorney in fact and
    agent, with full power of substitution and resubstitution, to
    execute, in his name and on his behalf, in any and all
    capacities, a Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Jack
    O. Bovender, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Jack
    O. Bovender, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Chairman of the Board
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May 27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Richard
    M. Bracken</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Richard
    M. Bracken</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President, Chief Executive Officer<BR>
    and Director<BR>
    (Principal Executive Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May 27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.
    Milton Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Executive Vice President and<BR>
    Chief Financial Officer<BR>
    (Principal Financial Officer and<BR>
    Principal Accounting Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May 27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Christopher
    J. Birosak</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Christopher
    J. Birosak</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    Director
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May 27, 2009
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-48
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    P. Connaughton</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    P. Connaughton</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    Director
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May 27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">James
    D. Forbes</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>James
    D. Forbes</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    Director
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May 27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Kenneth
    W. Freeman</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Kenneth
    W. Freeman</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    Director
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May 27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Thomas
    F. Frist,&#160;III</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Thomas
    F. Frist,&#160;III</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    Director
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May 27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">William
    R. Frist</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>William
    R. Frist</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    Director
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May 27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Christopher
    R. Gordon</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Christopher
    R. Gordon</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    Director
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May 27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Michael
    W. Michelson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Michael
    W. Michelson</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    Director
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May 27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">James
    C. Momtazee</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>James
    C. Momtazee</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    Director
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May 27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Stephen
    G. Pagliuca</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Stephen
    G. Pagliuca</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    Director
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May 27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Nathan
    C. Thorne</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Nathan
    C. Thorne</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    Director
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May 27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-49
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>REGISTRANTS </B>(as listed on the attached<BR>
    Schedule&#160;I of Subsidiary Registrants)
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R. Milton Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Director</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or any of
    them, as his or her attorney in fact and agent, with full power
    of substitution and resubstitution, to execute, in his name and
    on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President and Director<BR>
    (Principal Executive Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.
    Milton Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director<BR>
    (Principal Accounting Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Director
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-50
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>REGISTRANTS </B>(as listed on the attached<BR>
    Schedule&#160;II of Subsidiary Registrants)
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R. Milton Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Director</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President and Director<BR>
    (Principal Executive Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.
    Milton Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director<BR>
    (Principal Accounting Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">William
    B. Rutherford</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>William
    B. Rutherford</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    Director
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-51
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>REGISTRANTS </B>(as listed on the attached<BR>
    Schedule&#160;III of Subsidiary Registrants)
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R. Milton Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Manager</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton Johnson, or any
    of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President and Manager<BR>
    (Principal Executive Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.
    Milton Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager<BR>
    (Principal Accounting Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Manager
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-52
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>REGISTRANTS </B>(as listed on the attached<BR>
    Schedule&#160;IV of Subsidiary Registrants)
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R. Milton Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Manager</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President and Manager<BR>
    (Principal Executive Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.
    Milton Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager<BR>
    (Principal Accounting Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">William
    B. Rutherford</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>William
    B. Rutherford</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    Manager
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-53
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>REGISTRANTS </B>(as listed on the attached<BR>
    Schedule&#160;V of Subsidiary Registrants)
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R. Milton Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Manager</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Beverly
    B. Wallace</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Beverly
    B. Wallace</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.
    Milton Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager<BR>
    (Principal Accounting Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Manager
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Manager
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-54
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in city the of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>REGISTRANTS </B>(as listed on the attached<BR>
    Schedule&#160;VI of Subsidiary Registrants)
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R. Milton Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Director</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Charles
    J. Hall</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Charles
    J. Hall</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.
    Milton Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director<BR>
    (Principal Accounting Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Director
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Director
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-55
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>REGISTRANTS </B>(as listed on the attached<BR>
    Schedule&#160;VII of Subsidiary Registrants)
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R. Milton Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Manager</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or any of
    them, as his or her attorney in fact and agent, with full power
    of substitution and resubstitution, to execute, in his name and
    on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Charles
    J. Hall</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Charles
    J. Hall</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.
    Milton Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager<BR>
    (Principal Accounting Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Manager
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Manager
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-56
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>REGISTRANTS </B>(as listed on the attached<BR>
    Schedule&#160;VIII of Subsidiary Registrants)
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R. Milton Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Director</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Gregary
    W. Beasley</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Gregary
    W. Beasley</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President and Director<BR>
    (Principal Executive Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.
    Milton Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director<BR>
    (Principal Accounting Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Assistant Secretary
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-57
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>REGISTRANTS </B>(as listed on the attached<BR>
    Schedule&#160;IX of Subsidiary Registrants)
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R. Milton Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Manager</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton Johnson, or any
    of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Gregary
    W. Beasley</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Gregary
    W. Beasley</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President and Manager<BR>
    (Principal Executive Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.
    Milton Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager<BR>
    (Principal Accounting Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Assistant Secretary
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-58
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>REGISTRANTS</B> (as listed on the attached<BR>
    Schedule&#160;X of Subsidiary Registrants)
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R. Milton Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Director</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton Johnson, or any
    of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Noel
    B. Williams</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Noel
    B. Williams</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President and Chief Information Officer<BR>
    (Principal Executive Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.
    Milton Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director<BR>
    (Principal Accounting Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Director
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Director
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-59
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>REGISTRANTS </B>(as listed on the attached<BR>
    Schedule&#160;XI of Subsidiary Registrants)
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R. Milton Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Director</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton Johnson, or any
    of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Paul
    Rutledge</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Paul
    Rutledge</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.
    Milton Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director<BR>
    (Principal Accounting Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck&#160;II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Director
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Director
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-60
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>REGISTRANTS </B>(as listed on the attached<BR>
    Schedule&#160;XII of Subsidiary Registrants)
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R. Milton Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Manager</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton Johnson, or any
    of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Paul
    Rutledge</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Paul
    Rutledge</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer)<BR>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.
    Milton Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager<BR>
    (Principal Accounting Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Manager
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Manager
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-61
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>REGISTRANTS </B>(as listed on the attached<BR>
    Schedule&#160;XIII of Subsidiary Registrants)
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">
    R. Milton Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R. Milton Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Director</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton Johnson, or any
    of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Samuel
    N. Hazen</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Samuel
    N. Hazen</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer)<BR>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.
    Milton Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director<BR>
    (Principal Accounting Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Director
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Director
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-62
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>REGISTRANTS </B>(as listed on the attached<BR>
    Schedule&#160;XIV of Subsidiary Registrants)
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R. Milton Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Manager</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton Johnson, or any
    of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Samuel
    N. Hazen</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Samuel
    N. Hazen</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.
    Milton Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager<BR>
    (Principal Accounting Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Manager
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Manager
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-63
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>REGISTRANTS </B>(as listed on the attached<BR>
    Schedule&#160;XV of Subsidiary Registrants)
</DIV>

<DIV style="margin-top: 36pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R. Milton Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Manager of the general partner
    Columbia North Texas Subsidiary GP, LLC</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 6pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Samuel
    N. Hazen</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Samuel
    N. Hazen</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)<BR>
    of the general partner Columbia North Texas  Subsidiary GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 6pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer) of the general partner  Columbia
    North Texas Subsidiary GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 6pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.
    Milton Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager (Principal Accounting Officer)
    of the general partner Columbia North Texas  Subsidiary GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 6pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and  Manager of the general
    partner Columbia North Texas Subsidiary GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 6pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Manager of the general  partner Columbia
    North Texas  Subsidiary&#160;GP,&#160;LLC
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-64
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>CHCA Bayshore, L.P.</B>
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R. Milton Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Director of the general partner,
    Pasadena Bayshore Hospital, Inc.</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Samuel
    N. Hazen</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Samuel
    N. Hazen</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)<BR>
    of the general partner, Pasadena
    Bayshore&#160;Hospital,&#160;Inc
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer) of the general partner, Pasadena
    Bayshore Hospital, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.
    Milton Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director (Principal Accounting
    Officer) of the general partner, Pasadena
    Bayshore&#160;Hospital,&#160;Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and  Director of the general
    partner, Pasadena Bayshore Hospital, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Director of the general  partner, Pasadena
    Bayshore Hospital, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-65
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>CHCA Conroe, L.P.</B>
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R. Milton Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Director of the general partner,
    Conroe Hospital Corporation</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Samuel
    N. Hazen</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Samuel
    N. Hazen</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer) of the  general partner
    Conroe Hospital Corporation
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer) of the general partner Conroe
    Hospital Corporation
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.
    Milton Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director  (Principal Accounting
    Officer) of the general partner Conroe Hospital Corporation
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and  Director of the general
    partner Conroe Hospital Corporation
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Director of the general  partner Conroe
    Hospital Corporation
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-66
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>CHCA Mainland, L.P.</B>
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.
    Milton Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R. Milton Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Director of the general partner,
    Danforth Hospital, Inc.</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 8pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Samuel
    N. Hazen</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Samuel
    N. Hazen</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)<BR>
    of the general partner, Danforth Hospital, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 8pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer) of the general partner, Danforth
    Hospital, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 8pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director<BR>
    (Principal Accounting Officer)<BR>
    of the general partner, Danforth Hospital, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 8pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and  Director of the general
    partner, Danforth Hospital, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 8pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Director of the general  partner Danforth
    Hospital, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-67
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>CHCA West Houston, L.P.</B>
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Director of general partner, WHMC,
    Inc.</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Samuel
    N. Hazen</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>
    Samuel N. Hazen</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)<BR>
    of the general partner, WHMC, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer)<BR>
    of the general partner, WHMC, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director<BR>
    (Principal Accounting Officer)<BR>
    of the general partner, WHMC, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Director of the general
    partner, WHMC, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Director of the general partner, WHMC,
    Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-68
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>CHCA Woman&#146;s Hospital, L.P.</B>
</DIV>

<DIV style="margin-top: 36pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President of general partner, Woman&#146;s
    Hospital of Texas, Incorporated</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Samuel
    N. Hazen</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>
    Samuel N. Hazen</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)<BR>
    of the general partner, Woman&#146;s Hospital of Texas,
    Incorporated
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer) of the general partner,
    Woman&#146;s Hospital of  Texas, Incorporated
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director (Principal Accounting
    Officer) of the general partner, Woman&#146;s Hospital of Texas,
    Incorporated
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Director of the general
    partner, Woman&#146;s Hospital of Texas, Incorporated
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Director of the general partner, Woman&#146;s
    Hospital of Texas, Incorporated
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-69
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>CMS GP, LLC</B>
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>President and Manager</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>
    R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President and Manager<BR>
    (Principal Executive Officer and Principal Accounting Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Manager
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-70
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Columbia ASC Management, L.P.</B>
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Manger of the general partner,
    Medical Care America, LLC</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Gregary
    W. Beasley</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>
    Gregary W. Beasley</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President and Manager<BR>
    (Principal Executive Officer) of the general partner, Medical
    Care America, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer) of the general partner, Medical
    Care America, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager<BR>
    (Principal Accounting Officer) of the general partner, Medical
    Care America, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager of the general partner,
    Medical Care America, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Assistant Secretary of the general partner,
    Medical Care America, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-71
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 20pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Columbia Rio Grande Healthcare, L.P.</B>
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Director of the general partner,
    Rio Grande Regional Hospital, Inc.</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 10pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Samuel
    N. Hazen</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>
    Samuel N. Hazen</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer) of the general partner,
    Rio Grande Regional Hospital, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer) of the general partner, Rio Grande
    Regional Hospital, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director<BR>
    (Principal Accounting Officer) of the general partner, Rio
    Grande Regional Hospital, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Director of the general
    partner, Rio Grande Regional Hospital, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Director of the general partner, Rio Grande
    Regional Hospital, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-72
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Columbia Valley Healthcare System, L.P.</B>
</DIV>

<DIV style="margin-top: 36pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Director of the general partner,
    Brownsville-Valley Regional Medical Center, Inc.</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 9pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 8pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Samuel
    N. Hazen</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>
    Samuel N. Hazen</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer) of the general partner,
    Brownsville-Valley Regional Medical Center, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 8pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer (Principal Financial Officer) of
    the general partner, Brownsville-Valley Regional Medical
    Center,&#160;Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 8pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director<BR>
    (Principal Accounting Officer) of the general partner,
    Brownsville-Valley Regional Medical Center, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 8pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Director of the general
    partner,  Brownsville-Valley Regional Medical Center, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 8pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Director of the general partner,
    Brownsville-Valley Regional Medical Center, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-73
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Fairview Park, Limited Partnership</B>
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Manager of general partner,
    Fairview Park GP, LLC</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Charles
    J. Hall</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>
    Charles J. Hall</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer) of the general partner,
    Fairview Park GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer (Principal Financial Officer) of
    the general partner, Fairview Park GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager<BR>
    (Principal Accounting Officer) of the general partner, Fairview
    Park GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Manager of the general
    partner, Fairview Park GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Manager of the general partner, Fairview Park
    GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-74
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Good Samaritan Hospital, L.P.</B>
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Manager of general partner,
    Samaritan, LLC</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Samuel
    N. Hazen</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>
    Samuel N. Hazen</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer) of the general partner,
    Samaritan, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer (Principal Financial Officer) of
    the general partner, Samaritan, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager (Principal Accounting Officer)
    of the general partner, Samaritan, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Manager of the general
    partner, Samaritan, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Manager of the general partner, Samaritan, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-75
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>HCA Management Services, L.P.</B>
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>President and Manager of general partner, CMS GP, LLC</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>
    R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President and Manager (Principal Executive Officer and Principal
    Accounting Officer) of the general partner, CMS GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer (Principal Financial Officer) of
    the general partner, CMS GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager of the general partner, CMS
    GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Manager of the general
    partner, CMS GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-76
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Healthtrust MOB, LLC</B>
</DIV>

<DIV style="margin-top: 36pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Director of managing member,
    Healthtrust, Inc.&#160;&#151; The Hospital Company</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>
    A. Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President and Director (Principal Executive Officer) of the
    managing member, Healthtrust, Inc.&#160;&#151; The Hospital
    Company
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Treasurer (Principal Financial
    Officer) of the managing member, Healthtrust, Inc.&#160;&#151;
    The Hospital Company
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director (Principal Accounting
    Officer) of the managing member, Healthtrust, Inc.&#160;&#151;
    The Hospital Company
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Dora
    A. Blackwood</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Dora
    A. Blackwood</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Secretary and Director of the managing member,
    Healthtrust, Inc.&#160;&#151; The Hospital Company
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-77
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Director of the managing
    member, Healthtrust, Inc.&#160;&#151; The Hospital Company
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">William
    B. Rutherford</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>William
    B. Rutherford</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Director of the managing member, Healthtrust,
    Inc.&#160;&#151; The Hospital Company
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Donald
    W. Stinnett</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Donald
    W. Stinnett</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Director of the managing member, Healthtrust,
    Inc.&#160;&#151; The Hospital Company
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-78
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>HSS Virginia, L.P.</B>
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Manger of the general partner, HSS
    Holdco, LLC</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>
    A. Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President and Manager (Principal Executive Officer) of the
    general partner,  HSS Holdco, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer) of the general partner, HSS
    Holdco, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager<BR>
    (Principal Accounting Officer) of the general partner, HSS
    Holdco, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Manager of the general
    partner,  HSS Holdco, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-79
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Integrated Regional Laboratories, LLP</B>
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Manager of the managing partner,
    Integrated Regional Lab, LLC</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 10pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Charles
    J. Hall</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>
    Charles J. Hall</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)  of the managing
    partner, Integrated  Regional Lab, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer) of the managing partner,
    Integrated Regional Lab, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manage (Principal Accounting
    Officer)   of the managing partner, Integrated  Regional Lab, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Manager of the managing
    partner, Integrated Regional Lab, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Manager of the managing partner, Integrated
    Regional Lab, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-80
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>JFK Medical Center Limited Partnership</B>
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Manager of the general partner,
    Columbia Palm Beach GP, LLC</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 6pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Charles
    J. Hall</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>
    Charles J. Hall</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)  of the general partner,
    Columbia Palm  Beach GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer) of the general partner, Columbia
    Palm Beach GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager  (Principal Accounting
    Officer)   of the general partner, Columbia Palm  Beach GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager  of the general partner,
    Columbia Palm  Beach GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Manager of the general
    partner, Columbia Palm Beach GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-81
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 20pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>MCA Investment Company</B>
</DIV>

<DIV style="margin-top: 40pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Director</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Gregary
    W. Beasley</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Gregary
    W. Beasley</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer <BR>
    (Principal Financial Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director (Principal Accounting Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Director
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-82
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Nashville Shared Services General Partnership</B>
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Manager of the managing partner,
    HSS Systems, LLC</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 9pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Beverly
    B. Wallace</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Beverly
    B. Wallace</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)<BR>
    of the managing partner, HSS Systems, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer) of the managing partner, HSS
    Systems, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager (Principal Accounting Officer)
    of the managing partner, HSS Systems, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary <BR>
    and Manager of the managing partner, <BR>
    HSS Systems, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Manager of the managing partner, HSS Systems,
    LLC
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-83
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>National Patient Account Services, Inc.</B>
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Director</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Beverly
    B. Wallace</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Beverly
    B. Wallace</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer <BR>
    (Principal Financial Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director<BR>
    (Principal Accounting Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary <BR>
    and Director
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Director
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-84
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 20pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Palms West Hospital Limited Partnership</B>
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Manager of the general partner,
    Columbia Palm Beach GP, LLC</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 9pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Charles
    J. Hall</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Charles
    J. Hall</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)<BR>
    of the general partner, Columbia Palm  Beach GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer) of the general partner, Columbia
    Palm Beach GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager <BR>
    (Principal Accounting Officer)<BR>
    of the general partner,  Columbia Palm Beach GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager<BR>
    of the general partner,  Columbia Palm Beach GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Manager of the general
    partner,  Columbia Palm Beach GP, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-85
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Plantation General Hospital, L.P.</B>
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Director of the general partner,
    HD&#038;S Corp. Successor, Inc.</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 10pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Charles
    J. Hall</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Charles
    J. Hall</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)<BR>
    of the general partner, HD&#038;S Corp. Successor, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer)  of the general partner, HD&#038;S
    Corp. Successor, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director (Principal Accounting
    Officer) of the general partner, HD&#038;S Corp. Successor,
    Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Director of the general
    partner, HD&#038;S Corp. Successor, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Director of the general partner, HD&#038;S
    Corp. Successor, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-86
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Riverside Healthcare System, L.P.</B>
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Director of the general partner,
    Columbia Riverside, Inc.</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Samuel
    N. Hazen</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Samuel
    N. Hazen</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)<BR>
    of the general partner, Columbia Riverside, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer (Principal Financial Officer) of
    the general partner, Columbia Riverside, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director  (Principal Accounting
    Officer) of the general partner, Columbia Riverside, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Director of the general
    partner, Columbia Riverside, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Director of the general partner, Columbia
    Riverside, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-87
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>San&#160;Jose Healthcare System, LP</B>
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Manager of the general partner,
    San&#160;Jose, LLC</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Samuel
    N. Hazen</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Samuel
    N. Hazen</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)<BR>
    of the general partner, San&#160;Jose, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer <BR>
    (Principal Financial Officer) of the general partner,
    San&#160;Jose, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager<BR>
    (Principal Accounting Officer) of the general partner,
    San&#160;Jose, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary <BR>
    and Manager of the general partner,  San&#160;Jose, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Manager of the general partner,
    San&#160;Jose, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-88
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>San&#160;Jose Hospital, L.P.</B>
</DIV>

<DIV style="margin-top: 44pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Manager of the general partner,
    San&#160;Jose Medical Center, LLC</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 9pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Samuel
    N. Hazen</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Samuel
    N. Hazen</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)<BR>
    of the general partner, San&#160;Jose Medical Center, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer) of the general partner,
    San&#160;Jose Medical Center, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager<BR>
    (Principal Accounting Officer)<BR>
    of the general partner, San&#160;Jose Medical Center, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Manager of the general
    partner, San&#160;Jose Medical Center, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 9pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Manager of the general partner, San&#160;Jose
    Medical Center, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-89
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Terre Haute MOB, L.P.</B>
</DIV>

<DIV style="margin-top: 48pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Manager of the managing general
    partner, HSS Holdco, LLC</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President and Manager (Principal Executive Officer) of the
    managing general partner, HSS Holdco, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer) of the managing general partner,
    HSS Holdco, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Manager (Principal Accounting Officer)
    of the managing general partner, HSS Holdco, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 12pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Manager of the managing
    general partner, HSS Holdco, LLC
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-90
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May&#160;27, 2009.
</DIV>

<DIV style="margin-top: 22pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Terre Haute Regional Hospital, L.P.</B>
</DIV>

<DIV style="margin-top: 44pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="left">
    <DIV style="display:inline; text-align:left;">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=456 length=0 -->

<DIV align="left" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Name:&#160;&#160;&#160;&#160;&#160;R.&#160;Milton&#160;Johnson</B>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="53%"></TD>
    <TD width="8%"></TD>
    <TD width="39%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    <B>Title:&#160;</B>
</TD>
    <TD align="left">
    <B>Senior Vice President and Director of the general partner,
    Terre Haute Hospital GP, Inc.</B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES
    AND POWERS OF ATTORNEY</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R.&#160;Milton&#160;Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="3%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="37%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="41%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="12%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Signature</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Title</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Date</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 10pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Paul
    Rutledge</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>Paul
    Rutledge</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President (Principal Executive Officer)<BR>
    of the general partner, Terre Haute Hospital&#160;GP, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">David
    G. Anderson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>David
    G. Anderson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Treasurer<BR>
    (Principal Financial Officer) of the general partner, Terre
    Haute Hospital GP, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">R.&#160;Milton&#160;Johnson</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>R.&#160;Milton&#160;Johnson</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Senior Vice President and Director<BR>
    (Principal Accounting Officer)<BR>
    of the general partner, Terre Haute  Hospital GP, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">John
    M. Franck II</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>John
    M. Franck II</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President, Assistant Secretary and Director of the general
    partner, Terre Haute Hospital GP, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
<TR valign="bottom" style="line-height: 10pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">A.
    Bruce Moore, Jr.</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=184 length=0 --><B>A.
    Bruce Moore, Jr.</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Vice President and Director of the general partner, Terre Haute
    Hospital GP, Inc.&#160;
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    May&#160;27, 2009
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-91
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 18pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SCHEDULE&#160;I
    OF SUBSIDIARY REGISTRANTS</FONT></B>
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="97%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    AMERICAN MEDICORP DEVELOPMENT CO.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    COLORADO HEALTH SYSTEMS, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    COLUMBIA JACKSONVILLE HEALTHCARE SYSTEM, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    COLUMBUS CARDIOLOGY, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    HCA REALTY, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    HOSPITAL DEVELOPMENT PROPERTIES, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    MANAGEMENT SERVICES HOLDINGS, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    TERRE HAUTE HOSPITAL HOLDINGS, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    VH HOLDCO, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    VH HOLDINGS, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    WESTERN PLAINS CAPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-92
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SCHEDULE&#160;II
    OF SUBSIDIARY REGISTRANTS</FONT></B>
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="97%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    NORTH FLORIDA IMMEDIATE CARE CENTER, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    REDMOND PHYSICIAN PRACTICE COMPANY
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-93
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SCHEDULE&#160;III
    OF SUBSIDIARY REGISTRANTS</FONT></B>
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="97%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    DUBLIN COMMUNITY HOSPITAL, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    EP HEALTH, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    GENERAL HEALTHSERV, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    HSS HOLDCO, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    MEDICAL CENTERS OF OKLAHOMA, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    NOTAMI HOSPITALS, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    SJMC, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    UTAH MEDCO, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-94
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SCHEDULE&#160;IV
    OF SUBSIDIARY REGISTRANTS</FONT></B>
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="97%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    DALLAS/FT. WORTH PHYSICIAN, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    GOPPERT-TRINITY FAMILY CARE, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    LEWIS-GALE PHYSICIANS, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    OUTPATIENT CARDIOVASCULAR CENTER OF CENTRAL FLORIDA, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-95
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SCHEDULE&#160;V
    OF SUBSIDIARY REGISTRANTS</FONT></B>
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="97%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    CENTRAL SHARED SERVICES, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    HSS SYSTEMS VA, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    HSS SYSTEMS, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-96
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SCHEDULE&#160;VI
    OF SUBSIDIARY REGISTRANTS</FONT></B>
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="97%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    BAY HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    CENTRAL FLORIDA REGIONAL HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    COLUMBIA LAGRANGE HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    EDWARD WHITE HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    HCA HEALTH SERVICES OF FLORIDA, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    HD&#038;S CORP. SUCCESSOR, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    LARGO MEDICAL CENTER, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    LAWNWOOD MEDICAL CENTER, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    MARION COMMUNITY HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    MEMORIAL HEALTHCARE GROUP, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    NEW PORT RICHEY HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    NORTH FLORIDA REGIONAL MEDICAL CENTER, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    OKALOOSA HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    OKEECHOBEE HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    PALMYRA PARK HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    SARASOTA DOCTORS HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    SUN CITY HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    TALLAHASSEE MEDICAL CENTER, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    WALTERBORO COMMUNITY HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    WEST FLORIDA REGIONAL MEDICAL CENTER, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-97
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SCHEDULE&#160;VII
    OF SUBSIDIARY REGISTRANTS</FONT></B>
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="97%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    FAIRVIEW PARK GP, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    GRAND STRAND REGIONAL MEDICAL CENTER, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    INTEGRATED REGIONAL LAB, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    TRIDENT MEDICAL CENTER, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-98
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SCHEDULE&#160;VIII
    OF SUBSIDIARY REGISTRANTS</FONT></B>
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="97%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    EL PASO SURGICENTER, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    LAS VEGAS SURGICARE, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    MARIETTA SURGICAL CENTER, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    SURGICARE OF BRANDON, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    SURGICARE OF FLORIDA, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    SURGICARE OF HOUSTON WOMEN&#146;S, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    SURGICARE OF MANATEE, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    SURGICARE OF NEW PORT RICHEY, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-99
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SCHEDULE&#160;IX
    OF SUBSIDIARY REGISTRANTS</FONT></B>
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="97%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    SURGICARE OF PALMS WEST, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    SURGICARE OF RIVERSIDE, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-100
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SCHEDULE&#160;X
    OF SUBSIDIARY REGISTRANTS</FONT></B>
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="97%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    HCA&#160;&#151; IT&#038;S FIELD OPERATIONS, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    HCA&#160;&#151; IT&#038;S INVENTORY MANAGEMENT, INC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-101
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SCHEDULE&#160;XI
    OF SUBSIDIARY REGISTRANTS</FONT></B>
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="97%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    BROOKWOOD MEDICAL CENTER OF GULFPORT, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    CAPITAL DIVISION, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    CENTRAL TENNESSEE HOSPITAL CORPORATION
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    CHIPPENHAM&#160;&#038; JOHNSTON-WILLIS HOSPITALS, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    COLUMBIA POLK GENERAL HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    COLUMBIA/ALLEGHANY REGIONAL HOSPITAL, INCORPORATED
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    COLUMBIA/HCA JOHN RANDOLPH, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    DAUTERIVE HOSPITAL CORPORATION
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    FRANKFORT HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    GPCH-GP, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    GREENVIEW HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    HAMILTON MEDICAL CENTER, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    HCA CENTRAL GROUP, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    HCA HEALTH SERVICES OF LOUISIANA, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    HCA HEALTH SERVICES OF TENNESSEE, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    HCA HEALTH SERVICES OF VIRGINIA, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    HEALTH MIDWEST OFFICE FACILITIES CORPORATION
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    HEALTH MIDWEST VENTURES GROUP, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    HENDERSONVILLE HOSPITAL CORPORATION
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    HOSPITAL CORPORATION OF TENNESSEE
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    HTI MEMORIAL HOSPITAL CORPORATION
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    LEWIS-GALE HOSPITAL, INCORPORATED
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    MIDWEST HOLDINGS, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    MONTGOMERY REGIONAL HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    NOTAMI HOSPITALS OF LOUISIANA, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    PULASKI COMMUNITY HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    SPOTSYLVANIA MEDICAL CENTER, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    SPRING HILL HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    TCMC MADISON-PORTLAND, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    TERRE HAUTE HOSPITAL GP, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    VIRGINIA PSYCHIATRIC COMPANY, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    WOMEN&#146;S AND CHILDREN&#146;S HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-102
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SCHEDULE&#160;XII
    OF SUBSIDIARY REGISTRANTS</FONT></B>
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="97%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    CENTERPOINT MEDICAL CENTER OF INDEPENDENCE, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    COLUMBIA PARKERSBURG HEALTHCARE SYSTEM, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    GALEN PROPERTY, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    LAKELAND MEDICAL CENTER, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    LAKEVIEW MEDICAL CENTER, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    LEWIS-GALE MEDICAL CENTER, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    MEDICAL OFFICE BUILDINGS OF KANSAS, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    MIDWEST DIVISION&#160;&#151; ACH, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    MIDWEST DIVISION&#160;&#151; LRHC, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    MIDWEST DIVISION&#160;&#151; LSH, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    MIDWEST DIVISION&#160;&#151; MCI, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    MIDWEST DIVISION&#160;&#151; MMC, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    MIDWEST DIVISION&#160;&#151; OPRMC, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    MIDWEST DIVISION&#160;&#151; PFC, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    MIDWEST DIVISION&#160;&#151; RBH, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    MIDWEST DIVISION&#160;&#151; RMC, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    MIDWEST DIVISION&#160;&#151; RPC, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    NORTHERN VIRGINIA COMMUNITY HOSPITAL, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    NORTHLAKE MEDICAL CENTER, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    REDMOND PARK HOSPITAL, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    RESTON HOSPITAL CENTER, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    RETREAT HOSPITAL, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    SOUTHERN HILLS MEDICAL CENTER, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-103
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SCHEDULE&#160;XIII
    OF SUBSIDIARY REGISTRANTS</FONT></B>
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="97%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    BRIGHAM CITY COMMUNITY HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    COLUMBIA MEDICAL CENTER OF LAS COLINAS, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    COLUMBIA OGDEN MEDICAL CENTER, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    COLUMBIA RIVERSIDE, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    COLUMBINE PSYCHIATRIC CENTER, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    CONROE HOSPITAL CORPORATION
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    EASTERN IDAHO HEALTH SERVICES, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    ENCINO HOSPITAL CORPORATION, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    HCA HEALTH SERVICES OF OKLAHOMA, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    HOSPITAL CORPORATION OF UTAH
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    KPH-CONSOLIDATION, INC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    LOS ROBLES REGIONAL MEDICAL CENTER
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    MOUNTAIN VIEW HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    NEW ROSE HOLDING COMPANY, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    NORTHERN UTAH HEALTHCARE CORPORATION
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    PASADENA BAYSHORE HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    RIO GRANDE REGIONAL HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    RIVERSIDE HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    SPRING BRANCH MEDICAL CENTER, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    ST. MARK&#146;S LONE PEAK HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    SUNRISE MOUNTAINVIEW HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    TIMPANOGOS REGIONAL MEDICAL SERVICES, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    W&#160;&#038; C HOSPITAL, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    WEST VALLEY MEDICAL CENTER, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    WHMC, INC.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    WOMAN&#146;S HOSPITAL OF TEXAS, INCORPORATED
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-104
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SCHEDULE&#160;XIV
    OF SUBSIDIARY REGISTRANTS</FONT></B>
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="97%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    EDMOND REGIONAL MEDICAL CENTER, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    SAMARITAN, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    SAN JOSE MEDICAL CENTER, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    SAN JOSE, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    WESLEY MEDICAL CENTER, LLC
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-105
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SCHEDULE&#160;XV
    OF SUBSIDIARY REGISTRANTS</FONT></B>
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="97%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    COLUMBIA MEDICAL CENTER OF ARLINGTON SUBSIDIARY, L.P.&#160;
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    COLUMBIA MEDICAL CENTER OF DENTON SUBSIDIARY, L.P.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    COLUMBIA MEDICAL CENTER OF LEWISVILLE SUBSIDIARY, L.P.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    COLUMBIA MEDICAL CENTER OF MCKINNEY SUBSIDIARY, L.P.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    COLUMBIA MEDICAL CENTER OF PLANO SUBSIDIARY, L.P.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    COLUMBIA NORTH HILLS HOSPITAL SUBSIDIARY, L.P.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    COLUMBIA PLAZA MEDICAL CENTER OF FORT&#160;WORTH SUBSIDIARY, L.P.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    GREEN OAKS HOSPITAL SUBSIDIARY, L.P.
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="left" valign="top">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-106
</DIV><!-- END PAGE WIDTH -->
</BODY>
</HTML>
[{"type": "S-1", "sequence": "1", "filename": "y77125sv1.htm", "description": "FORM S-1", "secsgml_size_bytes": 3471501}]
[{"company-data": {"conformed-name": "Retreat Hospital, LLC", "cik": "0001392803", "irs-number": "611272890", "state-of-incorporation": "VA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-01", "film-number": "09855292"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}, "former-company": {"former-conformed-name": "Retreat Hospital, Inc.", "date-changed": "20070312"}}, {"company-data": {"conformed-name": "HCA INC/TN", "cik": "0000860730", "assigned-sic": "8062", "irs-number": "752497104", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511", "film-number": "09855293"}, "business-address": {"street1": "ONE PARK PLZ", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}, "former-company": [{"former-conformed-name": "HCA THE HEALTHCARE CO", "date-changed": "20010419"}, {"former-conformed-name": "COLUMBIA HCA HEALTHCARE CORP", "date-changed": "20000502"}, {"former-conformed-name": "COLUMBIA HCA HEALTHCARE CORP/", "date-changed": "19940314"}]}, {"company-data": {"conformed-name": "Women's & Children's Hospital, Inc.", "cik": "0001392689", "irs-number": "581741726", "state-of-incorporation": "LA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-07", "film-number": "09855299"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Health Midwest Office Facilities CORP", "cik": "0001392690", "irs-number": "431175071", "state-of-incorporation": "MO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-118", "film-number": "09855409"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Health Midwest Ventures Group, Inc.", "cik": "0001392695", "irs-number": "431315348", "state-of-incorporation": "MO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-117", "film-number": "09855408"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Midwest Division - RBH, LLC", "cik": "0001392696", "irs-number": "200851062", "state-of-incorporation": "MO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-98", "film-number": "09855390"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Riverside Healthcare System, L.P.", "cik": "0001392697", "irs-number": "330751869", "state-of-incorporation": "CA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-50", "film-number": "09855342"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Columbia Riverside, Inc.", "cik": "0001392698", "irs-number": "621664328", "state-of-incorporation": "CA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-154", "film-number": "09855445"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Encino Hospital Corporation, Inc.", "cik": "0001392699", "irs-number": "954113862", "state-of-incorporation": "CA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-140", "film-number": "09855431"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "MCA Investment CO", "cik": "0001392700", "irs-number": "330539836", "state-of-incorporation": "CA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-110", "film-number": "09855401"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Columbine Psychiatric Center, Inc.", "cik": "0001392702", "irs-number": "841042212", "state-of-incorporation": "CO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-150", "film-number": "09855441"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Las Vegas Surgicare, Inc.", "cik": "0001392705", "irs-number": "751890731", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-77", "film-number": "09855369"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Sunrise Mountainview Hospital, Inc.", "cik": "0001392706", "irs-number": "621600397", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-35", "film-number": "09855327"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "VH Holdco, Inc.", "cik": "0001392708", "irs-number": "621749073", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-63", "film-number": "09855355"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "VH Holdings, Inc", "cik": "0001392709", "irs-number": "621720399", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-18", "film-number": "09855310"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Western Plains Capital, Inc.", "cik": "0001392710", "irs-number": "621727347", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-10", "film-number": "09855302"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Management Services Holdings, Inc.", "cik": "0001392711", "irs-number": "621874287", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-113", "film-number": "09855404"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Southern Hills Medical Center, LLC", "cik": "0001392712", "irs-number": "743048428", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-41", "film-number": "09855333"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Midwest Holdings, Inc.", "cik": "0001392713", "irs-number": "113676736", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-95", "film-number": "09855387"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "BROOKWOOD MEDICAL CENTER OF GULFPORT INC", "cik": "0000841985", "assigned-sic": "8062", "irs-number": "630751470", "state-of-incorporation": "MS", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-182", "film-number": "09855473"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "NOTAMI HOSPITALS OF LOUISIANA INC", "cik": "0000841994", "assigned-sic": "8062", "irs-number": "954176923", "state-of-incorporation": "LA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-17", "film-number": "09855309"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "HSS Holdco, LLC", "cik": "0001392745", "irs-number": "621839825", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-89", "film-number": "09855381"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "HSS Systems VA, LLC", "cik": "0001392746", "irs-number": "621804832", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-88", "film-number": "09855380"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "HSS Systems, LLC", "cik": "0001392747", "irs-number": "621804834", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-87", "film-number": "09855379"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Lewis-Gale Medical Center, LLC", "cik": "0001392748", "irs-number": "621760148", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-116", "film-number": "09855407"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Medical Office Buildings of Kansas, LLC", "cik": "0001392749", "irs-number": "621789791", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-108", "film-number": "09855399"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Outpatient Cardiovascular Center of Central Florida, LLC", "cik": "0001392750", "irs-number": "522448149", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-59", "film-number": "09855351"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Reston Hospital Center, LLC", "cik": "0001392751", "irs-number": "621777534", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-52", "film-number": "09855344"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Samaritan, LLC", "cik": "0001392752", "irs-number": "621762605", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-48", "film-number": "09855340"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "San Jose Medical Center, LLC", "cik": "0001392753", "irs-number": "621762609", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-45", "film-number": "09855337"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "SJMC, LLC", "cik": "0001392754", "irs-number": "621762613", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-42", "film-number": "09855334"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Utah Medco, LLC", "cik": "0001392755", "irs-number": "621769672", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-19", "film-number": "09855311"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Wesley Medical Center, LLC", "cik": "0001392756", "irs-number": "621762545", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-13", "film-number": "09855305"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "CHCA Bayshore, L.P.", "cik": "0001392757", "irs-number": "621801359", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-176", "film-number": "09855467"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "CHCA Conroe, L.P.", "cik": "0001392758", "irs-number": "621801361", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-175", "film-number": "09855466"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "CHCA Mainland, L.P.", "cik": "0001392760", "irs-number": "621801362", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-174", "film-number": "09855465"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "CHCA West Houston, L.P.", "cik": "0001392761", "irs-number": "621801363", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-173", "film-number": "09855464"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Capital Division, Inc.", "cik": "0001392762", "irs-number": "621668319", "state-of-incorporation": "VA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-181", "film-number": "09855472"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "COLUMBIA/HCA JOHN RANDOLPH, INC.", "cik": "0001392766", "irs-number": "611272888", "state-of-incorporation": "VA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-151", "film-number": "09855442"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Centerpoint Medical Center of Independence, LLC", "cik": "0001392763", "irs-number": "450503121", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-185", "film-number": "09855476"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Chippenham & Johnston-Willis Hospitals, Inc.", "cik": "0001392764", "irs-number": "541779911", "state-of-incorporation": "VA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-171", "film-number": "09855462"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Columbia/Alleghany Regional Hospital INC", "cik": "0001392765", "irs-number": "541761046", "state-of-incorporation": "VA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-152", "film-number": "09855443"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}, "former-company": {"former-conformed-name": "Columbia/ Alleghany Regional Hospital INC", "date-changed": "20070312"}}, {"company-data": {"conformed-name": "COLUMBIA PARKERSBURG HEALTHCARE SYSTEM, LLC", "cik": "0001392767", "irs-number": "621634494", "state-of-incorporation": "WV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-158", "film-number": "09855449"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "COLORADO HEALTH SYSTEMS, INC.", "cik": "0001392768", "irs-number": "621593008", "state-of-incorporation": "CO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-169", "film-number": "09855460"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Central Shared Services, LLC", "cik": "0001392769", "irs-number": "760771216", "state-of-incorporation": "VA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-178", "film-number": "09855469"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "COLUMBIA MEDICAL CENTER OF LAS COLINAS, INC.", "cik": "0001392770", "irs-number": "621650582", "state-of-incorporation": "TX", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-163", "film-number": "09855454"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "COLUMBIA ASC MANAGEMENT, L.P.", "cik": "0001392771", "irs-number": "330539838", "state-of-incorporation": "CA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-168", "film-number": "09855459"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "CONROE HOSPITAL CORP", "cik": "0001392772", "irs-number": "742467524", "state-of-incorporation": "TX", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-148", "film-number": "09855439"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "EDWARD WHITE HOSPITAL, INC.", "cik": "0001392773", "irs-number": "593089836", "state-of-incorporation": "TX", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-141", "film-number": "09855432"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "FAIRVIEW PARK GP, LLC.", "cik": "0001392774", "irs-number": "621815913", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-138", "film-number": "09855429"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "GOPPERT-TRINITY FAMILY CARE, LLC", "cik": "0001392775", "irs-number": "760726651", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-132", "film-number": "09855423"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Galen Property, LLC", "cik": "0001392776", "irs-number": "352260545", "state-of-incorporation": "VA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-135", "film-number": "09855426"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "HCA HEALTH SERVICES OF VIRGINIA, INC.", "cik": "0001392777", "irs-number": "621113733", "state-of-incorporation": "VA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-121", "film-number": "09855412"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "HSS VIRGINIA, L.P.", "cik": "0001392779", "irs-number": "621848294", "state-of-incorporation": "VA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-86", "film-number": "09855378"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "KPH-CONSOLIDATION, INC.", "cik": "0001392781", "irs-number": "621619857", "state-of-incorporation": "TX", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-81", "film-number": "09855373"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Hospital Development Properties, Inc.", "cik": "0001392714", "irs-number": "621321246", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-90", "film-number": "09855382"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "HCA HEALTH SERVICES OF OKLAHOMA, INC.", "cik": "0001392715", "irs-number": "621106156", "state-of-incorporation": "OK", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-123", "film-number": "09855414"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "WALTERBORO COMMUNITY HOSPITAL, INC.", "cik": "0001392716", "irs-number": "570712623", "state-of-incorporation": "SC", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-14", "film-number": "09855306"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Terre Haute Hospital GP, Inc.", "cik": "0001392717", "irs-number": "621861156", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-25", "film-number": "09855317"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "CENTRAL TENNESSEE HOSPITAL CORP", "cik": "0001392718", "irs-number": "621620866", "state-of-incorporation": "TN", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-177", "film-number": "09855468"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Terre Haute Hospital Holdings, Inc.", "cik": "0001392720", "irs-number": "621861158", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-24", "film-number": "09855316"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "HCA Central Group, Inc.", "cik": "0001392721", "irs-number": "020762180", "state-of-incorporation": "TN", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-126", "film-number": "09855417"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "HCA HEALTH SERVICES OF TENNESSEE, INC.", "cik": "0001392722", "irs-number": "621113737", "state-of-incorporation": "TN", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-122", "film-number": "09855413"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Hendersonville Hospital CORP", "cik": "0001392723", "irs-number": "621321255", "state-of-incorporation": "TN", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-93", "film-number": "09855385"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Nashville Shared Services General Partnership", "cik": "0001392724", "irs-number": "621841237", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-72", "film-number": "09855364"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "HOSPITAL CORP OF TENNESSEE", "cik": "0001392725", "irs-number": "621124446", "state-of-incorporation": "TN", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-92", "film-number": "09855384"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "HTI MEMORIAL HOSPITAL CORP", "cik": "0001392726", "irs-number": "621560757", "state-of-incorporation": "TN", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-85", "film-number": "09855377"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "CMS GP, LLC", "cik": "0001392727", "irs-number": "621778113", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-170", "film-number": "09855461"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "WHMC, INC.", "cik": "0001392728", "irs-number": "611261485", "state-of-incorporation": "TX", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-09", "film-number": "09855301"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "COLUMBIA MEDICAL CENTER OF ARLINGTON SUBSIDIARY, L.P.", "cik": "0001392729", "irs-number": "621682201", "state-of-incorporation": "TX", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-165", "film-number": "09855456"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "LEWIS-GALE HOSPITAL, INC", "cik": "0001392782", "irs-number": "540218835", "state-of-incorporation": "VA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-75", "film-number": "09855367"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Lewis-Gale Physicians, LLC", "cik": "0001392783", "irs-number": "061755234", "state-of-incorporation": "VA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-115", "film-number": "09855406"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "LOS ROBLES REGIONAL MEDICAL CENTER", "cik": "0001392784", "irs-number": "952321136", "state-of-incorporation": "CA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-114", "film-number": "09855405"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Medical Centers of Oklahoma, LLC", "cik": "0001392785", "irs-number": "621771846", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-109", "film-number": "09855400"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "MIDWEST DIVISION - ACH, LLC", "cik": "0001392786", "irs-number": "481301811", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-106", "film-number": "09855397"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "MIDWEST DIVISION - LRHC, LLC", "cik": "0001392787", "irs-number": "481301817", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-105", "film-number": "09855396"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "MIDWEST DIVISION - LSH, LLC", "cik": "0001392788", "irs-number": "450503141", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-104", "film-number": "09855395"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "MIDWEST DIVISION - MCI, LLC", "cik": "0001392789", "irs-number": "450503127", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-103", "film-number": "09855394"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "MIDWEST DIVISION - MMC, LLC", "cik": "0001392790", "irs-number": "481301826", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-102", "film-number": "09855393"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "MIDWEST DIVISION - OPRMC, LLC", "cik": "0001392791", "irs-number": "450503116", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-101", "film-number": "09855392"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "MIDWEST DIVISION - PFC, LLC", "cik": "0001392792", "irs-number": "481302330", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-100", "film-number": "09855391"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "MIDWEST DIVISION - RMC, LLC", "cik": "0001392793", "irs-number": "542092552", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-97", "film-number": "09855389"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "MIDWEST DIVISION - RPC, LLC", "cik": "0001392794", "irs-number": "481301829", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-96", "film-number": "09855388"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "MOUNTAIN VIEW HOSPITAL, INC.", "cik": "0001392795", "irs-number": "870333048", "state-of-incorporation": "UT", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-73", "film-number": "09855365"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "NEW ROSE HOLDING COMPANY, INC.", "cik": "0001392796", "irs-number": "621617432", "state-of-incorporation": "CO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-69", "film-number": "09855361"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Northern Utah Healthcare CORP", "cik": "0001392797", "irs-number": "621650573", "state-of-incorporation": "UT", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-66", "film-number": "09855358"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "NATIONAL PATIENT ACCOUNT SERVICES, INC.", "cik": "0001392798", "irs-number": "621645596", "state-of-incorporation": "TX", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-71", "film-number": "09855363"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Northern Virginia Community Hospital, LLC", "cik": "0001392799", "irs-number": "043665595", "state-of-incorporation": "VA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-65", "film-number": "09855357"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Spring Hill Hospital, Inc.", "cik": "0001392806", "irs-number": "841706716", "state-of-incorporation": "TN", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-38", "film-number": "09855330"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Spotsylvania Medical Center, Inc.", "cik": "0001392807", "irs-number": "061760818", "state-of-incorporation": "VA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-40", "film-number": "09855332"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "St. Mark's Lone Peak Hospital, Inc.", "cik": "0001392808", "irs-number": "251925376", "state-of-incorporation": "UT", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-37", "film-number": "09855329"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}, "former-company": {"former-conformed-name": "St. Mark's Loan Peak Hospital, Inc.", "date-changed": "20070312"}}, {"company-data": {"conformed-name": "San Jose Healthcare System, LP", "cik": "0001392810", "irs-number": "770408674", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-47", "film-number": "09855339"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023"}}, {"company-data": {"conformed-name": "SURGICARE OF HOUSTON WOMEN'S, INC.", "cik": "0001392811", "irs-number": "721563673", "state-of-incorporation": "TX", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-32", "film-number": "09855324"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "SURGICARE OF RIVERSIDE, LLC", "cik": "0001392812", "irs-number": "260047096", "state-of-incorporation": "CA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-28", "film-number": "09855320"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "TCMC Madison - Portland, Inc.", "cik": "0001392813", "irs-number": "760811731", "state-of-incorporation": "TN", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-26", "film-number": "09855318"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Terre Haute Regional Hospital, L.P.", "cik": "0001392814", "irs-number": "351461805", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-22", "film-number": "09855314"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Timpanogos Regional Medical Services, Inc.", "cik": "0001392815", "irs-number": "621831495", "state-of-incorporation": "UT", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-21", "film-number": "09855313"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "VIRGINIA PSYCHIATRIC COMPANY, INC.", "cik": "0001392816", "irs-number": "621410313", "state-of-incorporation": "VA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-16", "film-number": "09855308"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "W & C HOSPITAL, INC.", "cik": "0001392817", "irs-number": "611259838", "state-of-incorporation": "TX", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-15", "film-number": "09855307"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "GREENVIEW HOSPITAL, INC.", "cik": "0001392818", "irs-number": "610724492", "state-of-incorporation": "KY", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-128", "film-number": "09855419"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Fairview Park, Limited Partnership", "cik": "0001392819", "irs-number": "621817469", "state-of-incorporation": "GA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-137", "film-number": "09855428"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "NORTHLAKE MEDICAL CENTER, LLC", "cik": "0001392820", "irs-number": "582433434", "state-of-incorporation": "GA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-64", "film-number": "09855356"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "MARIETTA SURGICAL CENTER, INC.", "cik": "0001392821", "irs-number": "581539547", "state-of-incorporation": "GA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-112", "film-number": "09855403"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "COLUMBIA MEDICAL CENTER OF DENTON SUBSIDIARY, L.P.", "cik": "0001392730", "irs-number": "621682213", "state-of-incorporation": "TX", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-164", "film-number": "09855455"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "COLUMBIA MEDICAL CENTER OF LEWISVILLE SUBSIDIARY, L.P.", "cik": "0001392731", "irs-number": "621682210", "state-of-incorporation": "TX", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-162", "film-number": "09855453"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "COLUMBIA MEDICAL CENTER OF MCKINNEY SUBSIDIARY, L.P.", "cik": "0001392732", "irs-number": "621682207", "state-of-incorporation": "TX", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-161", "film-number": "09855452"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "COLUMBIA MEDICAL CENTER OF PLANO SUBSIDIARY, L.P.", "cik": "0001392733", "irs-number": "621682203", "state-of-incorporation": "TX", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-160", "film-number": "09855451"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "COLUMBIA NORTH HILLS HOSPITAL SUBSIDIARY, L.P.", "cik": "0001392734", "irs-number": "621682205", "state-of-incorporation": "TX", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-180", "film-number": "09855471"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "COLUMBIA PLAZA MEDICAL CENTER OF FORT WORTH SUBSIDIARY, L.P.", "cik": "0001392735", "irs-number": "621682202", "state-of-incorporation": "TX", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-157", "film-number": "09855448"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "GREEN OAKS HOSPITAL SUBSIDIARY, L.P.", "cik": "0001392736", "irs-number": "621797829", "state-of-incorporation": "TX", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-129", "film-number": "09855420"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "BRIGHAM CITY COMMUNITY HOSPITAL, INC.", "cik": "0001392737", "irs-number": "870318837", "state-of-incorporation": "UT", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-183", "film-number": "09855474"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "West Florida Regional Medical Center, Inc.", "cik": "0001392822", "irs-number": "591525468", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-12", "film-number": "09855304"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "SURGICARE OF FLORIDA, INC.", "cik": "0001392823", "irs-number": "953947578", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-33", "film-number": "09855325"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Dauterive Hospital CORP", "cik": "0001392824", "irs-number": "581741846", "state-of-incorporation": "LA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-146", "film-number": "09855437"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Frankfort Hospital, Inc.", "cik": "0001392825", "irs-number": "610859329", "state-of-incorporation": "IN", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-136", "film-number": "09855427"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Terre Haute MOB, L.P.", "cik": "0001392826", "irs-number": "760775694", "state-of-incorporation": "IN", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-23", "film-number": "09855315"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Columbia LaGrange Hospital, Inc.", "cik": "0001392827", "irs-number": "611276162", "state-of-incorporation": "IL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-166", "film-number": "09855457"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "WEST VALLEY MEDICAL CENTER, INC.", "cik": "0001392828", "irs-number": "363525049", "state-of-incorporation": "ID", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-11", "film-number": "09855303"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "EASTERN IDAHO HEALTH SERVICES, INC.", "cik": "0001392829", "irs-number": "820436622", "state-of-incorporation": "ID", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-144", "film-number": "09855435"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Okeechobee Hospital, Inc.", "cik": "0001392831", "irs-number": "591833934", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-60", "film-number": "09855352"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Redmond Park Hospital, LLC", "cik": "0001392832", "irs-number": "581123037", "state-of-incorporation": "GA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-54", "film-number": "09855346"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "HCA Management Services, L.P.", "cik": "0001392833", "irs-number": "621778108", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-120", "film-number": "09855411"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "DUBLIN COMMUNITY HOSPITAL, LLC", "cik": "0001392834", "irs-number": "581431023", "state-of-incorporation": "GA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-145", "film-number": "09855436"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "TRIDENT MEDICAL CENTER, LLC", "cik": "0001392835", "irs-number": "621768106", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-20", "film-number": "09855312"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Redmond Physician Practice CO", "cik": "0001392836", "irs-number": "810598767", "state-of-incorporation": "GA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-53", "film-number": "09855345"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "SAN JOSE, LLC", "cik": "0001392837", "irs-number": "621756992", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-44", "film-number": "09855336"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "PALMYRA PARK HOSPITAL, INC", "cik": "0001392838", "irs-number": "581091107", "state-of-incorporation": "GA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-57", "film-number": "09855349"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "COLUMBUS CARDIOLOGY, INC.", "cik": "0001392839", "irs-number": "581941109", "state-of-incorporation": "GA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-149", "film-number": "09855440"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Columbia Polk General Hospital, Inc.", "cik": "0001392840", "irs-number": "621619423", "state-of-incorporation": "GA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-156", "film-number": "09855447"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Surgicare of Palms West, LLC", "cik": "0001392841", "irs-number": "201008436", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-29", "film-number": "09855321"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Integrated Regional Lab, LLC", "cik": "0001392842", "irs-number": "364576441", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-84", "film-number": "09855376"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Sarasota Doctors Hospital, Inc.", "cik": "0001392843", "irs-number": "611258724", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-43", "film-number": "09855335"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023"}}, {"company-data": {"conformed-name": "TALLAHASSEE MEDICAL CENTER, INC.", "cik": "0001392844", "irs-number": "621091430", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-27", "film-number": "09855319"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Okaloosa Hospital, Inc.", "cik": "0001392845", "irs-number": "591836808", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-61", "film-number": "09855353"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023"}}, {"company-data": {"conformed-name": "SURGICARE OF NEWPORT RICHEY, INC.", "cik": "0001392846", "irs-number": "752243308", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-30", "film-number": "09855322"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "SURGICARE OF MANATEE, INC.", "cik": "0001392847", "irs-number": "752364410", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-31", "film-number": "09855323"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "North Florida Regional Medical Center, Inc.", "cik": "0001392848", "irs-number": "611269294", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-67", "film-number": "09855359"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023"}}, {"company-data": {"conformed-name": "North Florida Immediate Care Center, Inc.", "cik": "0001392849", "irs-number": "582075775", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-68", "film-number": "09855360"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023"}}, {"company-data": {"conformed-name": "New Port Richey Hospital, Inc.", "cik": "0001392850", "irs-number": "592047041", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-70", "film-number": "09855362"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023"}}, {"company-data": {"conformed-name": "Memorial Healthcare Group, Inc.", "cik": "0001392851", "irs-number": "593283127", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-107", "film-number": "09855398"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023"}}, {"company-data": {"conformed-name": "Marion Community Hospital, Inc.", "cik": "0001392852", "irs-number": "591479652", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-111", "film-number": "09855402"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023"}}, {"company-data": {"conformed-name": "Lawnwood Medical Center, Inc.", "cik": "0001392853", "irs-number": "591764486", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-76", "film-number": "09855368"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023"}}, {"company-data": {"conformed-name": "Largo Medical Center, Inc.", "cik": "0001392854", "irs-number": "621026428", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-78", "film-number": "09855370"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023"}}, {"company-data": {"conformed-name": "HD&S Corp. Successor, Inc.", "cik": "0001392855", "irs-number": "621657694", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-119", "film-number": "09855410"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023"}}, {"company-data": {"conformed-name": "GPCH-GP, Inc.", "cik": "0001394492", "irs-number": "640805500", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-131", "film-number": "09855422"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "HCA Health Services of Florida, Inc.", "cik": "0001392856", "irs-number": "621113740", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-125", "film-number": "09855416"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023"}}, {"company-data": {"conformed-name": "GRAND STRAND REGIONAL MEDICAL CENTER, LLC", "cik": "0001394499", "irs-number": "621768105", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-130", "film-number": "09855421"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "GOOD SAMARITAN HOSPITAL, L.P.", "cik": "0001395058", "irs-number": "621763090", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-133", "film-number": "09855424"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "HCA Realty, Inc.", "cik": "0001463894", "irs-number": "621106160", "state-of-incorporation": "TN", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-03", "film-number": "09855295"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "(615) 344-9551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "COLUMBIA OGDEN MEDICAL CENTER, INC.", "cik": "0001392738", "irs-number": "621650578", "state-of-incorporation": "UT", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-159", "film-number": "09855450"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "HOSPITAL CORP OF UTAH", "cik": "0001392739", "irs-number": "870322019", "state-of-incorporation": "UT", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-91", "film-number": "09855383"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Dallas/Ft. Worth Physician, LLC", "cik": "0001392740", "irs-number": "621769694", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-147", "film-number": "09855438"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Edmond Regional Medical Center, LLC", "cik": "0001392741", "irs-number": "621757655", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-143", "film-number": "09855434"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "EP Health, LLC", "cik": "0001392742", "irs-number": "621769682", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-139", "film-number": "09855430"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "General Healthserv, LLC", "cik": "0001392743", "irs-number": "621769690", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-134", "film-number": "09855425"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Healthtrust MOB, LLC", "cik": "0001392744", "irs-number": "621824860", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-94", "film-number": "09855386"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "PALMS WEST HOSPITAL LIMITED PARTNERSHIP", "cik": "0001392800", "irs-number": "621694178", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-58", "film-number": "09855350"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Plantation General Hospital, L.P.", "cik": "0001392801", "irs-number": "621372389", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-56", "film-number": "09855348"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023"}}, {"company-data": {"conformed-name": "PULASKI COMMUNITY HOSPITAL, INC.", "cik": "0001392802", "irs-number": "540941129", "state-of-incorporation": "VA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-55", "film-number": "09855347"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "RIO GRANDE REGIONAL HOSPITAL, INC.", "cik": "0001392804", "irs-number": "611276564", "state-of-incorporation": "TX", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-51", "film-number": "09855343"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "SPRING BRANCH MEDICAL CENTER, INC.", "cik": "0001392805", "irs-number": "611261492", "state-of-incorporation": "TX", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-39", "film-number": "09855331"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Lakeview Medical Center, LLC", "cik": "0001392948", "irs-number": "621762416", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-79", "film-number": "09855371"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Notami Hospitals, LLC", "cik": "0001392949", "irs-number": "621761993", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-62", "film-number": "09855354"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "MONTGOMERY REGIONAL HOSPITAL, INC.", "cik": "0001394490", "irs-number": "540889154", "state-of-incorporation": "VA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-74", "film-number": "09855366"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "RIVERSIDE HOSPITAL INC", "cik": "0000887120", "assigned-sic": "8062", "irs-number": "742600687", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-49", "film-number": "09855341"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "COLUMBIA VALLEY HEALTHCARE SYSTEMS L P", "cik": "0001033652", "irs-number": "621669572", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-153", "film-number": "09855444"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "JFK Medical Center Limited Partnership", "cik": "0001392684", "irs-number": "621694180", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-82", "film-number": "09855374"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Integrated Regional Laboratories, LLP", "cik": "0001392685", "irs-number": "621687140", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-83", "film-number": "09855375"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Columbia Rio Grande Healthcare, L.P.", "cik": "0001392686", "irs-number": "621656022", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-155", "film-number": "09855446"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "HCA Health Services of Louisiana, Inc.", "cik": "0001392687", "irs-number": "621113736", "state-of-incorporation": "LA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-124", "film-number": "09855415"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Woman's Hospital of Texas, INC", "cik": "0001392688", "irs-number": "741991484", "state-of-incorporation": "LA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-08", "film-number": "09855300"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "American Medicorp Development Co.", "cik": "0001463892", "irs-number": "231696018", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-06", "film-number": "09855298"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "(615) 344-9551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Pasadena Bayshore Hospital, Inc.", "cik": "0001463895", "irs-number": "741616679", "state-of-incorporation": "TX", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-02", "film-number": "09855294"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "(615) 344-9551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "HCA - IT&S Inventory Management, Inc.", "cik": "0001463896", "irs-number": "061796286", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-04", "film-number": "09855296"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "(615) 344-9551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "HCA - IT&S Field Operations, Inc.", "cik": "0001463897", "irs-number": "061795732", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-05", "film-number": "09855297"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "(615) 344-9551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "El Paso Surgicenter, Inc.", "cik": "0001392857", "irs-number": "742361005", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-142", "film-number": "09855433"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023"}}, {"company-data": {"conformed-name": "SURGICARE OF BRANDON, INC.", "cik": "0001392858", "irs-number": "581819994", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-34", "film-number": "09855326"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Columbia Jacksonville Healthcare System, Inc.", "cik": "0001392859", "irs-number": "611272241", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-167", "film-number": "09855458"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023"}}, {"company-data": {"conformed-name": "SUN CITY HOSPITAL, INC.", "cik": "0001392860", "irs-number": "592822337", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-36", "film-number": "09855328"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Central Florida Regional Hospital, Inc.", "cik": "0001392861", "irs-number": "591978725", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-179", "film-number": "09855470"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023"}}, {"company-data": {"conformed-name": "Bay Hospital, Inc.", "cik": "0001392862", "irs-number": "620976863", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-184", "film-number": "09855475"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023"}}, {"company-data": {"conformed-name": "San Jose Hospital, L.P.", "cik": "0001392863", "irs-number": "621763091", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-46", "film-number": "09855338"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37023"}}, {"company-data": {"conformed-name": "Hamilton Medical Center, Inc.", "cik": "0001392864", "irs-number": "581741727", "state-of-incorporation": "LA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-127", "film-number": "09855418"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "CHCA Woman's Hospital, L.P.", "cik": "0001392946", "irs-number": "621810381", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-172", "film-number": "09855463"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}, {"company-data": {"conformed-name": "Lakeland Medical Center, LLC", "cik": "0001392947", "irs-number": "621762603", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-159511-80", "film-number": "09855372"}, "business-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203", "phone": "6153449551"}, "mail-address": {"street1": "ONE PARK PLAZA", "city": "NASHVILLE", "state": "TN", "zip": "37203"}}]
FORM S-1
Table of Contents
As filed with the Securities and Exchange Commission on
    May 27, 2009
Registration
    No. 333-
UNITED STATES SECURITIES AND
    EXCHANGE COMMISSION
Washington, D.C.
    20549
Form S-1
REGISTRATION
    STATEMENT
UNDER
THE SECURITIES ACT OF
    1933
HCA Inc.
(Exact name of registrant issuer
    as specified in its charter)
SEE TABLE OF ADDITIONAL REGISTRANTS
Delaware
8062
75-2497104
(State or other jurisdiction
of incorporation)
(Primary Standard Industrial
Classification Code Number)
(I.R.S. Employer
Identification Number)
One Park Plaza
Nashville, Tennessee 37203
(615) 344-9551
(Address, including zip code,
    and telephone number, including area code, of registrants'
    principal executive offices)
John M. Franck II, Esq.
HCA Inc.
Vice President and Corporate Secretary
One Park Plaza
Nashville, Tennessee 37203
Telephone: (615) 344-9551
(Name, address, including zip
    code, and telephone number, including area code, of agent for
    service)
With a copy to:
Richard A. Fenyes, Esq.
John C. Ericson, Esq.
Simpson Thacher & Bartlett LLP
425 Lexington Avenue
New York, New York 10017-3954
Telephone: (212) 455-2000
Approximate date of commencement of proposed sale to
    public:
From time to time after this registration
    statement becomes effective.
If any of the securities being registered on this Form are to be
    offered on a delayed or continuous basis pursuant to
    Rule 415 under the Securities Act of 1933 check the
    following
    box:
þ
If this Form is filed to register additional securities for an
    offering pursuant to Rule 462(b) under the Securities Act,
    please check the following box and list the Securities Act
    registration statement number of the earlier effective
    registration statement for the same
    offering.
o
If this Form is a post-effective amendment filed pursuant to
    Rule 462(c) under the Securities Act, check the following
    box and list the Securities Act registration statement number of
    the earlier effective registration statement for the same
    offering.
o
If this Form is a post-effective amendment filed pursuant to
    Rule 462(d) under the Securities Act, check the following
    box and list the Securities Act registration statement number of
    the earlier effective registration statement for the same
    offering.
o
Indicate by check mark whether the registrant is a large
    accelerated filer, an accelerated filer, a non-accelerated
    filer, or a smaller reporting company. See the definitions of
    "large accelerated filer," "accelerated
    filer" and "smaller reporting company" in Rule
12b-2
of the
    Exchange Act. (Check one):
Large
    accelerated
    filer
o
Accelerated
    filer
o
Non-accelerated
filer
þ
Smaller
    reporting
    company
o
(Do not check if a smaller reporting company)
Table of Contents
CALCULATION
    OF REGISTRATION FEE
Proposed Maximum
Proposed Maximum
Amount of
Title of Each Class of
Amount to
Offering
Aggregate
Registration
Securities to be Registered
be Registered
Price per Note
Offering Price
Fee
5.50% Senior Notes due 2009
(1
)
(1
)
(1
)
(1
)
8.75% Senior Notes due 2010
(1
)
(1
)
(1
)
(1
)
8.75% Senior Notes due 2010
(1
)
(1
)
(1
)
(1
)
7.875% Senior Notes due 2011
(1
)
(1
)
(1
)
(1
)
6.95% Senior Notes due 2012
(1
)
(1
)
(1
)
(1
)
6.30% Senior Notes due 2012
(1
)
(1
)
(1
)
(1
)
6.25% Senior Notes due 2013
(1
)
(1
)
(1
)
(1
)
6.75% Senior Notes due 2013
(1
)
(1
)
(1
)
(1
)
5.75% Senior Notes due 2014
(1
)
(1
)
(1
)
(1
)
6.375% Senior Notes due 2015
(1
)
(1
)
(1
)
(1
)
6.50% Senior Notes due 2016
(1
)
(1
)
(1
)
(1
)
7.69% Notes due 2025
(1
)
(1
)
(1
)
(1
)
7.50% Senior Notes due 2033
(1
)
(1
)
(1
)
(1
)
7.19% Debentures due 2015
(1
)
(1
)
(1
)
(1
)
7.50% Debentures due 2023
(1
)
(1
)
(1
)
(1
)
8.36% Debentures due 2024
(1
)
(1
)
(1
)
(1
)
7.05% Debentures due 2027
(1
)
(1
)
(1
)
(1
)
7.75% Debentures due 2036
(1
)
(1
)
(1
)
(1
)
7.50% Debentures due 2095
(1
)
(1
)
(1
)
(1
)
8.70% Medium-Term Notes due 2010
(1
)
(1
)
(1
)
(1
)
9.00% Medium-Term Notes due 2014
(1
)
(1
)
(1
)
(1
)
7.58% Medium-Term Notes due 2025
(1
)
(1
)
(1
)
(1
)
9
1
/
8
% Senior
    Secured Notes due 2014
(1
)
(1
)
(1
)
(1
)
9
1
/
4
% Senior
    Secured Notes due 2016
(1
)
(1
)
(1
)
(1
)
9
5
/
8
/10
3
/
8
% Senior
    Secured Toggle Notes due 2016
(1
)
(1
)
(1
)
(1
)
9
7
/
8
% Senior
    Secured Notes due 2017
(1
)
(1
)
(1
)
(1
)
8
1
/
2
% Senior
    Secured Notes due 2019
(1
)
(1
)
(1
)
(1
)
Guarantees of
    9
1
/
8
% Senior
    Secured Notes due 2014(2)
(1
)
(1
)
(1
)
(1
)
Guarantees of
    9
1
/
4
% Senior
    Secured Notes due 2016(2)
(1
)
(1
)
(1
)
(1
)
Guarantees of
    9
5
/
8
/10
3
/
8
% Senior
    Secured Toggle Notes due 2016(2)
(1
)
(1
)
(1
)
(1
)
Guarantees of
    9
7
/
8
% Senior
    Secured Notes due 2017(2)
(1
)
(1
)
(1
)
(1
)
Guarantees of
    8
1
/
2
% Senior
    Secured Notes due 2019(2)
(1
)
(1
)
(1
)
(1
)
(1)
An indeterminate amount of securities are being registered
    hereby to be offered solely for market-making purposes by
    affiliates of the registrant. Pursuant to Rule 457(q) under
    the Securities Act of 1933, as amended, no filing fee is
    required.
(2)
See inside facing page for additional registrant guarantors.
The Registrants hereby amend this Registration Statement on
    such date or dates as may be necessary to delay its effective
    date until the Registrants shall file a further amendment which
    specifically states that this Registration Statement shall
    thereafter become effective in accordance with Section 8(a)
    of the Securities Act of 1933, as amended, or until the
    Registration Statement shall become effective on such date as
    the Securities and Exchange Commission, acting pursuant to said
    Section 8(a), may determine.
Table of Contents
Table of
    Additional Registrant Guarantors
Address, Including
Zip Code, and
Telephone Number,
Including Area
State or Other
Code, of Registrant
Jurisdiction of
I.R.S. Employer
Guarantor's
Exact Name of Registrant Guarantor as Specified
Incorporation or
Identification
Principal Executive
in its Charter (or Other Organizational Document)
Organization
Number
Offices
American Medicorp Development Co.
Delaware
23-1696018
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Bay Hospital, Inc.
Florida
62-0976863
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Brigham City Community Hospital, Inc.
Utah
87-0318837
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Brookwood Medical Center of Gulfport, Inc.
Mississippi
63-0751470
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Capital Division, Inc.
Virginia
62-1668319
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Centerpoint Medical Center of Independence, LLC
Delaware
45-0503121
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Central Florida Regional Hospital, Inc.
Florida
59-1978725
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Central Shared Services, LLC
Virginia
76-0771216
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Central Tennessee Hospital Corporation
Tennessee
62-1620866
One Park Plaza
Nashville, TN 37203
(615) 344-9551
CHCA Bayshore, L.P.
Delaware
62-1801359
One Park Plaza
Nashville, TN 37203
(615) 344-9551
CHCA Conroe, L.P.
Delaware
62-1801361
One Park Plaza
Nashville, TN 37203
(615) 344-9551
CHCA Mainland, L.P.
Delaware
62-1801362
One Park Plaza
Nashville, TN 37203
(615) 344-9551
CHCA West Houston, L.P.
Delaware
62-1801363
One Park Plaza
Nashville, TN 37203
(615) 344-9551
CHCA Woman's Hospital, L.P.
Delaware
62-1810381
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Chippenham & Johnston-Willis Hospitals, Inc.
Virginia
54-1779911
One Park Plaza
Nashville, TN 37203
(615) 344-9551
CMS GP, LLC
Delaware
62-1778113
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Table of Contents
Address, Including
Zip Code, and
Telephone Number,
Including Area
State or Other
Code, of Registrant
Jurisdiction of
I.R.S. Employer
Guarantor's
Exact Name of Registrant Guarantor as Specified
Incorporation or
Identification
Principal Executive
in its Charter (or Other Organizational Document)
Organization
Number
Offices
Colorado Health Systems, Inc.
Colorado
62-1593008
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Columbia ASC Management, L.P.
California
33-0539838
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Columbia Jacksonville Healthcare System, Inc.
Florida
61-1272241
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Columbia LaGrange Hospital, Inc.
Illinois
61-1276162
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Columbia Medical Center of Arlington Subsidiary, L.P.
Texas
62-1682201
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Columbia Medical Center of Denton Subsidiary, L.P.
Texas
62-1682213
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Columbia Medical Center of Las Colinas, Inc.
Texas
62-1650582
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Columbia Medical Center of Lewisville Subsidiary, L.P.
Texas
62-1682210
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Columbia Medical Center of McKinney Subsidiary, L.P.
Texas
62-1682207
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Columbia Medical Center of Plano Subsidiary, L.P.
Texas
62-1682203
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Columbia North Hills Hospital Subsidiary, L.P.
Texas
62-1682205
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Columbia Ogden Medical Center, Inc.
Utah
62-1650578
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Columbia Parkersburg Healthcare System, LLC
West Virginia
62-1634494
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Columbia Plaza Medical Center of Fort Worth Subsidiary,
    L.P.
Texas
62-1682202
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Columbia Polk General Hospital, Inc.
Georgia
62-1619423
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Columbia Rio Grande Healthcare, L.P.
Delaware
62-1656022
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Table of Contents
Address, Including
Zip Code, and
Telephone Number,
Including Area
State or Other
Code, of Registrant
Jurisdiction of
I.R.S. Employer
Guarantor's
Exact Name of Registrant Guarantor as Specified
Incorporation or
Identification
Principal Executive
in its Charter (or Other Organizational Document)
Organization
Number
Offices
Columbia Riverside, Inc.
California
62-1664328
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Columbia Valley Healthcare System, L.P.
Delaware
62-1669572
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Columbia/Alleghany Regional Hospital, Incorporated
Virginia
54-1761046
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Columbia/HCA John Randolph, Inc.
Virginia
61-1272888
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Columbine Psychiatric Center, Inc.
Colorado
84-1042212
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Columbus Cardiology, Inc.
Georgia
58-1941109
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Conroe Hospital Corporation
Texas
74-2467524
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Dallas/Ft. Worth Physician, LLC
Delaware
62-1769694
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Dauterive Hospital Corporation
Louisiana
58-1741846
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Dublin Community Hospital, LLC
Georgia
58-1431023
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Eastern Idaho Health Services, Inc.
Idaho
82-0436622
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Edmond Regional Medical Center, LLC
Delaware
62-1757655
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Edward White Hospital, Inc.
Florida
59-3089836
One Park Plaza
Nashville, TN 37203
(615) 344-9551
El Paso Surgicenter, Inc.
Texas
74-2361005
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Encino Hospital Corporation, Inc.
California
95-4113862
One Park Plaza
Nashville, TN 37203
(615) 344-9551
EP Health, LLC
Delaware
62-1769682
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Table of Contents
Address, Including
Zip Code, and
Telephone Number,
Including Area
State or Other
Code, of Registrant
Jurisdiction of
I.R.S. Employer
Guarantor's
Exact Name of Registrant Guarantor as Specified
Incorporation or
Identification
Principal Executive
in its Charter (or Other Organizational Document)
Organization
Number
Offices
Fairview Park GP, LLC
Delaware
62-1815913
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Fairview Park, Limited Partnership
Georgia
62-1817469
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Frankfort Hospital, Inc.
Kentucky
61-0859329
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Galen Property, LLC
Virginia
35-2260545
One Park Plaza
Nashville, TN 37203
(615) 344-9551
General Healthserv, LLC
Delaware
62-1769690
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Good Samaritan Hospital, L.P.
Delaware
62-1763090
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Goppert-Trinity Family Care, LLC
Delaware
76-0726651
One Park Plaza
Nashville, TN 37203
(615) 344-9551
GPCH-GP, Inc.
Delaware
64-0805500
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Grand Strand Regional Medical Center, LLC
Delaware
62-1768105
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Green Oaks Hospital Subsidiary, L.P.
Texas
62-1797829
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Greenview Hospital, Inc.
Kentucky
61-0724492
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Hamilton Medical Center, Inc.
Louisiana
58-1741727
One Park Plaza
Nashville, TN 37203
(615) 344-9551
HCA — IT&S Field Operations, Inc.
Delaware
06-1795732
One Park Plaza
Nashville, TN 37203
(615) 344-9551
HCA — IT&S Inventory Management, Inc.
Delaware
06-1796286
One Park Plaza
Nashville, TN 37203
(615) 344-9551
HCA Central Group, Inc.
Tennessee
02-0762180
One Park Plaza
Nashville, TN 37203
(615) 344-9551
HCA Health Services of Florida, Inc.
Florida
62-1113740
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Table of Contents
Address, Including
Zip Code, and
Telephone Number,
Including Area
State or Other
Code, of Registrant
Jurisdiction of
I.R.S. Employer
Guarantor's
Exact Name of Registrant Guarantor as Specified
Incorporation or
Identification
Principal Executive
in its Charter (or Other Organizational Document)
Organization
Number
Offices
HCA Health Services of Louisiana, Inc.
Louisiana
62-1113736
One Park Plaza
Nashville, TN 37203
(615) 344-9551
HCA Health Services of Oklahoma, Inc.
Oklahoma
62-1106156
One Park Plaza
Nashville, TN 37203
(615) 344-9551
HCA Health Services of Tennessee, Inc.
Tennessee
62-1113737
One Park Plaza
Nashville, TN 37203
(615) 344-9551
HCA Health Services of Virginia, Inc.
Virginia
62-1113733
One Park Plaza
Nashville, TN 37203
(615) 344-9551
HCA Management Services, L.P.
Delaware
62-1778108
One Park Plaza
Nashville, TN 37203
(615) 344-9551
HCA Realty, Inc.
Tennessee
06-1106160
One Park Plaza
Nashville, TN 37203
(615) 344-9551
HD&S Corp. Successor, Inc.
Florida
62-1657694
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Health Midwest Office Facilities Corporation
Missouri
43-1175071
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Health Midwest Ventures Group, Inc.
Missouri
43-1315348
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Healthtrust MOB, LLC
Delaware
62-1824860
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Hendersonville Hospital Corporation
Tennessee
62-1321255
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Hospital Corporation of Tennessee
Tennessee
62-1124446
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Hospital Corporation of Utah
Utah
87-0322019
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Hospital Development Properties, Inc.
Delaware
62-1321246
One Park Plaza
Nashville, TN 37203
(615) 344-9551
HSS Holdco, LLC
Delaware
62-1839825
One Park Plaza
Nashville, TN 37203
(615) 344-9551
HSS Systems VA, LLC
Delaware
62-1804832
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Table of Contents
Address, Including
Zip Code, and
Telephone Number,
Including Area
State or Other
Code, of Registrant
Jurisdiction of
I.R.S. Employer
Guarantor's
Exact Name of Registrant Guarantor as Specified
Incorporation or
Identification
Principal Executive
in its Charter (or Other Organizational Document)
Organization
Number
Offices
HSS Systems, LLC
Delaware
62-1804834
One Park Plaza
Nashville, TN 37203
(615) 344-9551
HSS Virginia, L.P.
Virginia
62-1848294
One Park Plaza
Nashville, TN 37203
(615) 344-9551
HTI Memorial Hospital Corporation
Tennessee
62-1560757
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Integrated Regional Lab, LLC
Florida
36-4576441
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Integrated Regional Laboratories, LLP
Delaware
62-1687140
One Park Plaza
Nashville, TN 37203
(615) 344-9551
JFK Medical Center Limited Partnership
Delaware
62-1694180
One Park Plaza
Nashville, TN 37203
(615) 344-9551
KPH-Consolidation, Inc.
Texas
62-1619857
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Lakeland Medical Center, LLC
Delaware
62-1762603
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Lakeview Medical Center, LLC
Delaware
62-1762416
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Largo Medical Center, Inc.
Florida
62-1026428
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Las Vegas Surgicare, Inc.
Nevada
75-1890731
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Lawnwood Medical Center, Inc.
Florida
59-1764486
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Lewis-Gale Hospital, Incorporated
Virginia
54-0218835
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Lewis-Gale Medical Center, LLC
Delaware
62-1760148
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Lewis-Gale Physicians, LLC
Virginia
06-1755234
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Los Robles Regional Medical Center
California
95-2321136
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Table of Contents
Address, Including
Zip Code, and
Telephone Number,
Including Area
State or Other
Code, of Registrant
Jurisdiction of
I.R.S. Employer
Guarantor's
Exact Name of Registrant Guarantor as Specified
Incorporation or
Identification
Principal Executive
in its Charter (or Other Organizational Document)
Organization
Number
Offices
Management Services Holdings, Inc.
Delaware
62-1874287
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Marietta Surgical Center, Inc.
Georgia
58-1539547
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Marion Community Hospital, Inc.
Florida
59-1479652
One Park Plaza
Nashville, TN 37203
(615) 344-9551
MCA Investment Company
California
33-0539836
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Medical Centers of Oklahoma, LLC
Delaware
62-1771846
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Medical Office Buildings of Kansas, LLC
Delaware
62-1789791
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Memorial Healthcare Group, Inc.
Florida
59-3283127
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Midwest Division — ACH, LLC
Delaware
48-1301811
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Midwest Division — LRHC, LLC
Delaware
48-1301817
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Midwest Division — LSH, LLC
Delaware
45-0503141
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Midwest Division — MCI, LLC
Delaware
45-0503127
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Midwest Division — MMC, LLC
Delaware
48-1301826
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Midwest Division — OPRMC, LLC
Delaware
45-0503116
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Midwest Division — PFC, LLC
Delaware
48-1302330
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Midwest Division — RBH, LLC
Missouri
20-0851062
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Midwest Division — RMC, LLC
Delaware
54-2092552
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Table of Contents
Address, Including
Zip Code, and
Telephone Number,
Including Area
State or Other
Code, of Registrant
Jurisdiction of
I.R.S. Employer
Guarantor's
Exact Name of Registrant Guarantor as Specified
Incorporation or
Identification
Principal Executive
in its Charter (or Other Organizational Document)
Organization
Number
Offices
Midwest Division — RPC, LLC
Delaware
48-1301829
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Midwest Holdings, Inc.
Delaware
11-3676736
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Montgomery Regional Hospital, Inc.
Virginia
54-0889154
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Mountain View Hospital, Inc.
Utah
87-0333048
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Nashville Shared Services General Partnership
Delaware
62-1841237
One Park Plaza
Nashville, TN 37203
(615) 344-9551
National Patient Account Services, Inc.
Texas
62-1645596
One Park Plaza
Nashville, TN 37203
(615) 344-9551
New Port Richey Hospital, Inc.
Florida
59-2047041
One Park Plaza
Nashville, TN 37203
(615) 344-9551
New Rose Holding Company, Inc.
Colorado
62-1617432
One Park Plaza
Nashville, TN 37203
(615) 344-9551
North Florida Immediate Care Center, Inc.
Florida
58-2075775
One Park Plaza
Nashville, TN 37203
(615) 344-9551
North Florida Regional Medical Center, Inc.
Florida
61-1269294
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Northern Utah Healthcare Corporation
Utah
62-1650573
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Northern Virginia Community Hospital, LLC
Virginia
04-3665595
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Northlake Medical Center, LLC
Georgia
58-2433434
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Notami Hospitals of Louisiana, Inc.
Louisiana
95-4176923
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Notami Hospitals, LLC
Delaware
62-1761993
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Okaloosa Hospital, Inc.
Florida
59-1836808
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Table of Contents
Address, Including
Zip Code, and
Telephone Number,
Including Area
State or Other
Code, of Registrant
Jurisdiction of
I.R.S. Employer
Guarantor's
Exact Name of Registrant Guarantor as Specified
Incorporation or
Identification
Principal Executive
in its Charter (or Other Organizational Document)
Organization
Number
Offices
Okeechobee Hospital, Inc.
Florida
59-1833934
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Outpatient Cardiovascular Center of Central Florida, LLC
Delaware
52-2448149
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Palms West Hospital Limited Partnership
Delaware
62-1694178
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Palmyra Park Hospital, Inc.
Georgia
58-1091107
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Pasadena Bayshore Hospital, Inc.
Texas
74-1616679
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Plantation General Hospital, L.P.
Delaware
62-1372389
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Pulaski Community Hospital, Inc.
Virginia
54-0941129
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Redmond Park Hospital, LLC
Georgia
58-1123037
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Redmond Physician Practice Company
Georgia
62-1662134
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Reston Hospital Center, LLC
Delaware
62-1777534
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Retreat Hospital, LLC
Virginia
61-1272890
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Rio Grande Regional Hospital, Inc.
Texas
61-1276564
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Riverside Healthcare System, L.P.
California
33-0751869
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Riverside Hospital, Inc.
Delaware
74-2600687
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Samaritan, LLC
Delaware
62-1762605
One Park Plaza
Nashville, TN 37203
(615) 344-9551
San Jose Healthcare System, LP
Delaware
77-0498674
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Table of Contents
Address, Including
Zip Code, and
Telephone Number,
Including Area
State or Other
Code, of Registrant
Jurisdiction of
I.R.S. Employer
Guarantor's
Exact Name of Registrant Guarantor as Specified
Incorporation or
Identification
Principal Executive
in its Charter (or Other Organizational Document)
Organization
Number
Offices
San Jose Hospital, L.P.
Delaware
62-1763091
One Park Plaza
Nashville, TN 37203
(615) 344-9551
San Jose Medical Center, LLC
Delaware
62-1762609
One Park Plaza
Nashville, TN 37203
(615) 344-9551
San Jose, LLC
Delaware
62-1756992
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Sarasota Doctors Hospital, Inc.
Florida
61-1258724
One Park Plaza
Nashville, TN 37203
(615) 344-9551
SJMC, LLC
Delaware
62-1762613
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Southern Hills Medical Center, LLC
Nevada
74-3048428
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Spotsylvania Medical Center, Inc
Virginia
06-1760818
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Spring Branch Medical Center, Inc.
Texas
61-1261492
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Spring Hill Hospital, Inc.
Tennessee
84-1706716
One Park Plaza
Nashville, TN 37203
(615) 344-9551
St. Mark's Lone Peak Hospital, Inc.
Utah
25-1925376
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Sun City Hospital, Inc.
Florida
59-2822337
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Sunrise Mountainview Hospital, Inc.
Nevada
62-1600397
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Surgicare of Brandon, Inc.
Florida
58-1819994
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Surgicare of Florida, Inc.
Florida
95-3947578
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Surgicare of Houston Women's, Inc.
Texas
72-1563673
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Surgicare of Manatee, Inc.
Florida
75-2364410
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Table of Contents
Address, Including
Zip Code, and
Telephone Number,
Including Area
State or Other
Code, of Registrant
Jurisdiction of
I.R.S. Employer
Guarantor's
Exact Name of Registrant Guarantor as Specified
Incorporation or
Identification
Principal Executive
in its Charter (or Other Organizational Document)
Organization
Number
Offices
Surgicare of New Port Richey, Inc.
Florida
75-2243308
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Surgicare of Palms West, LLC
Florida
20-1008436
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Surgicare of Riverside, LLC
California
26-0047096
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Tallahassee Medical Center, Inc.
Florida
62-1091430
One Park Plaza
Nashville, TN 37203
(615) 344-9551
TCMC Madison-Portland, Inc.
Tennessee
76-0811731
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Terre Haute Hospital GP, Inc.
Delaware
62-1861156
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Terre Haute Hospital Holdings, Inc.
Delaware
62-1861158
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Terre Haute MOB, L.P.
Indiana
76-0775694
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Terre Haute Regional Hospital, L.P.
Delaware
35-1461805
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Timpanogos Regional Medical Services, Inc.
Utah
62-1831495
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Trident Medical Center, LLC
Delaware
62-1768106
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Utah Medco, LLC
Delaware
62-1769672
One Park Plaza
Nashville, TN 37203
(615) 344-9551
VH Holdco, Inc.
Nevada
62-1749073
One Park Plaza
Nashville, TN 37203
(615) 344-9551
VH Holdings, Inc.
Nevada
62-1720399
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Virginia Psychiatric Company, Inc.
Virginia
62-1410313
One Park Plaza
Nashville, TN 37203
(615) 344-9551
W & C Hospital, Inc.
Texas
61-1259838
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Table of Contents
Address, Including
Zip Code, and
Telephone Number,
Including Area
State or Other
Code, of Registrant
Jurisdiction of
I.R.S. Employer
Guarantor's
Exact Name of Registrant Guarantor as Specified
Incorporation or
Identification
Principal Executive
in its Charter (or Other Organizational Document)
Organization
Number
Offices
Walterboro Community Hospital, Inc.
South Carolina
57-0712623
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Wesley Medical Center, LLC
Delaware
62-1762545
One Park Plaza
Nashville, TN 37203
(615) 344-9551
West Florida Regional Medical Center, Inc.
Florida
59-1525468
One Park Plaza
Nashville, TN 37203
(615) 344-9551
West Valley Medical Center, Inc.
Idaho
36-3525049
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Western Plains Capital, Inc.
Nevada
62-1727347
One Park Plaza
Nashville, TN 37203
(615) 344-9551
WHMC, Inc.
Texas
61-1261485
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Woman's Hospital of Texas, Incorporated
Texas
74-1991424
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Women's and Children's Hospital, Inc.
Louisiana
58-1741726
One Park Plaza
Nashville, TN 37203
(615) 344-9551
Table of Contents
The
information in this prospectus is not complete and may be
changed. We may not sell these securities until the registration
statement filed with the Securities and Exchange Commission is
effective. This prospectus is not an offer to sell these
securities and it is not soliciting an offer to buy these
securities in any state where the offer or sale is not
permitted.
SUBJECT TO COMPLETION, DATED MAY
    27, 2009
Preliminary Prospectus
HCA
    Inc.
Debt
    Securities
Neither the Securities and Exchange Commission nor any state
    securities commission has approved or disapproved of the notes
    or passed upon the adequacy or accuracy of this prospectus. Any
    representation to the contrary is a criminal offense.
This prospectus has been prepared for and may be used by Banc of
    America Securities LLC, Merrill Lynch, Pierce,
    Fenner & Smith Incorporated and their affiliates in
    connection with offers and sales of the debt securities
    referenced herein related to market-making transactions in such
    debt securities effected from time to time. Such affiliates may
    act as principal or agent in such transactions, including as
    agent for the counterparty when acting as principal or as agent
    for both counterparties, and may receive compensation in the
    form of discounts and commissions, including from both
    counterparties, when they act as agents for both. Such sales
    will be made at prevailing market prices at the time of sale, at
    prices related thereto or at negotiated prices. We will not
    receive any proceeds from such sales.
You should rely only on the information contained in this
    prospectus. We have not authorized anyone to provide you with
    different information. The prospectus may be used only for the
    purposes for which it has been published and no person has been
    authorized to give any information not contained herein. If you
    receive any other information, you should not rely on it. We are
    not making an offer of these securities in any state where the
    offer is not permitted.
Investing in the notes involves risks. See "Risk
    Factors" beginning on page 6 for a discussion of
    certain risks that you should consider before investing in the
    securities.
We are offering to sell these securities only in places where
    sales are permitted.
The date of this prospectus
    is          ,
    2009.
TABLE OF
    CONTENTS
Where You Can Find More Information About HCA
    Inc.
2
HCA Inc.
5
Risk Factors
6
Use of Proceeds
21
Description of Other Indebtedness
22
Description of Notes
28
Book-Entry Issuance
260
Certain U.S. Federal Tax Consequences
263
Plan of Distribution
271
Experts
272
Legal Opinions
272
EX-3.3: AMERICAN MEDICORP DEVELOPMENT CO. ARTICLES OF INCORPORATION
EX-3.4: AMERICAN MEDICORP DEVELOPMENT CO. BY-LAWS
EX-3.60: COLUMBIA PARKERSBURG HEALTHCARE SYSTEM, LLC ARTICLES OF CONVERSION
EX-3.124: HCA-IT&S FIELD OPERATIONS, INC. ARTICLES OF INCORPORATION
EX-3.125: HCA-IT&S FIELD OPERATIONS, INC. BY-LAWS
EX-3.126: HCA-IT&S INVENTORY MANAGEMENT, INC. ARTICLES OF INCORPORATION
EX-3.127: HCA-IT&S INVENTORY MANAGEMENT, INC. BY-LAWS
EX-3.142: HCA REALTY, INC. CHARTER
EX-3.143: HCA REALTY, INC. BY-LAWS
EX-3.267: PASADENA BAYSHORE HOSPITAL, INC. ARTICLES OF INCORPORATION
EX-3.268: PASADENA BAYSHORE HOSPITAL INC. BY-LAWS
EX-3.279: RETREAT HOSPITAL, LLC ARTICLES OF INCORPORATION
EX-3.280: RETREAT HOSPITAL, LLC LIMITED LIABILITY COMPANY AGREEMENT
EX-5.1: OPINION OF SIMPSON THACHER & BARTLETT LLP
EX-5.2: OPINION OF ROBERT A. WATERMAN
EX-12.1: STATEMENT REGARDING COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
EX-21.1: SUBSIDIARIES
EX-23.3: CONSENT OF ERNST & YOUNG LLP
EX-25.1: FORM T-1 STATEMENT OF ELIGIBILITY
EX-25.2: FORM T-1 STATEMENT OF ELIGIBILITY
EX-25.3: FORM T-1 STATEMENT OF ELIGIBILITY
EX-25.4: FORM T-1 STATEMENT OF ELIGIBILITY
Table of Contents
WHERE YOU
    CAN FIND MORE INFORMATION ABOUT HCA INC.
We file certain reports with the Securities and Exchange
    Commission (the "SEC"), including annual reports on
Form 10-K,
quarterly reports on
Form 10-Q
and current reports on
Form 8-K.
The public may read and copy any materials we file with the SEC
    at the SEC's Public Reference Room at
    100 F Street, N.E., Washington, DC 20549. The public
    may obtain information on the operation of the Public Reference
    Room by calling the SEC at
1-800-SEC-0330.
We are an electronic filer, and the SEC maintains an Internet
    site at
http://www.sec.gov
that contains the reports and other information we file
    electronically. Our website address is www.hcahealthcare.com.
    Please note that our website address is provided as an inactive
    textual reference only. The information provided on our website
    is not part of this prospectus and is therefore not incorporated
    by reference unless such information is specifically referenced
    elsewhere in this prospectus. We make available free of charge,
    through our website, our annual report on
Form 10-K,
quarterly reports on
Form 10-Q,
current reports on
Form 8-K
and all amendments to those reports filed or furnished pursuant
    to Section 15(d) of the Exchange Act, as soon as reasonably
    practicable after such material is electronically filed with or
    furnished to the SEC.
The SEC allows us to "incorporate by reference" into
    this prospectus the information in documents we file with the
    SEC, which means that we can disclose important information to
    you by referring you to those documents. The information
    incorporated by reference is considered to be a part of this
    prospectus, and later information that we file with the SEC will
    update and supersede this information. The information contained
    in this prospectus supersedes any inconsistent information
    contained in the documents incorporated by reference herein.
We incorporate by reference the documents listed below other
    than, in each case, those documents or the portions of those
    documents which are furnished and not filed:
•
HCA Inc.'s annual report on
Form 10-K
for the year ended December 31, 2008;
•
HCA Inc.'s quarterly report on
Form 10-Q
for the quarter ended March 31, 2009;
•
HCA Inc.'s current reports on
Form 8-K
filed on February 11, 2009 (Item 5.02),
    February 25, 2009, April 27, 2009, April 28,
    2009, May 7, 2009 and May 27, 2009; and
•
the descriptions of the terms of the specified debt securities
    contained under the captions indicated in the following
    documents filed with the SEC:
•
the description of the 5.50% Senior Notes Due 2009 and the
    6.375% Senior Notes Due 2015 set forth under the caption
    "Description of the Notes" in the prospectus
    supplement dated November 16, 2004, and under the caption
    "Description of the Debt Securities" in the prospectus
    dated October 16, 2003, each filed with the SEC on
    November 17, 2004 (SEC File
No. 333-107536);
•
the description of the $750,000,000 in aggregate principal
    amount of 8.75% Senior Notes Due 2010 set forth under the
    caption "Description of the Notes" in the prospectus
    supplement dated August 18, 2000, and under the caption
    "Description of the Debt Securities" in the prospectus
    dated August 5, 1999, each filed with the SEC on
    August 21, 2000 (SEC File
No. 333-82219);
•
the description of the £150,000,000 in aggregate principal
    amount of 8.75% Senior Notes Due 2010 set forth under the
    caption "Description of the Notes" in the prospectus
    supplement dated October 25, 2000, and under the caption
    "Description of the Debt Securities" in the prospectus
    dated August 5, 1999, each filed with the SEC on
    October 27, 2000 (SEC File
No. 333-82219);
•
the description of the 7.875% Senior Notes Due 2011 set
    forth under the caption "Description of the Notes" in
    the prospectus supplement dated January 23, 2001, and under
    the caption "Description of the Debt Securities" in
    the prospectus dated December 19, 2000, each filed with the
    SEC on January 24, 2001 (SEC File
No. 333-51540);
•
the description of the 6.95% Senior Notes Due 2012 set
    forth under the caption "Description of the Notes" in
    the prospectus supplement dated April 23, 2002, and under
    the caption "Description of the
2
Table of Contents
Debt Securities" in the prospectus dated December 19,
    2000, each filed with the SEC on April 26, 2002 (SEC File
No. 333-51540);
•
the description of the 6.30% Senior Notes Due 2012 set
    forth under the caption "Description of the Notes" in
    the prospectus supplement dated September 18, 2002, and
    under the caption "Description of the Debt Securities"
    in the prospectus dated May 16, 2002, each filed with the
    SEC on September 20, 2002 (SEC File
No. 333-87588);
•
the description of the 6.25% Senior Notes Due 2013 set
    forth under the caption "Description of the Notes" in
    the prospectus supplement dated February 5, 2003, and under
    the caption "Description of the Debt Securities" in
    the prospectus dated May 16, 2002, each filed with the SEC
    on February 7, 2003 (SEC File
No. 333-87588);
•
the description of the 6.75% Senior Notes Due 2013 set
    forth under the caption "Description of the Notes" in
    the prospectus supplement dated July 23, 2003, and under
    the caption "Description of the Debt Securities" in
    the prospectus dated May 16, 2002, each filed with the SEC
    on July 25, 2003 (SEC File
No. 333-87588);
•
the description of the 5.75% Senior Notes Due 2014 set
    forth under the caption "Description of the Notes" in
    the prospectus supplement dated March 3, 2004, and under
    the caption "Description of the Debt Securities" in
    the prospectus dated October 16, 2003, each filed with the
    SEC on March 5, 2004 (SEC File
No. 333-107536);
•
the description of the 6.50% Senior Notes Due 2016 set
    forth under the caption "Description of the Notes" in
    the prospectus supplement dated February 3, 2006, and under
    the caption "Description of the Debt Securities" in
    the prospectus dated April 21, 2005, each filed with the
    SEC on February 6, 2006 (SEC File
No. 333-121520);
•
the description of the 7.69% Notes Due 2025 set forth under
    the caption "Description of New Securities" in the
    prospectus and consent solicitation dated May 25, 1995,
    filed with the SEC on May 26,1995 (SEC File
No. 33-58919);
•
the description of the 7.50% Senior Notes Due 2033 set
    forth under the caption "Description of the Notes" in
    the prospectus supplement dated October 31, 2003, and under
    the caption "Description of the Debt Securities" in
    the prospectus dated October 16, 2003, each filed with the
    SEC on November 4, 2003 (SEC File
No. 333-107536);
•
the description of the 7.19% Debentures Due 2015 set forth
    under the caption "Description of the Notes" in the
    prospectus supplement dated November 20, 1995, and under
    the caption "Description of the Debt Securities" in
    the prospectus dated November 17, 1995, each filed with the
    SEC on November 22, 1995 (SEC File
No. 33-64105);
•
the description of the 7.50% Debentures Due 2023 set forth
    under the caption "Description of the Securities" in
    the prospectus supplement dated December 9, 1993, and under
    the caption "Description of the Debt Securities" in
    the prospectus dated November 22, 1993, each filed with the
    SEC on December 17, 1993 (SEC File
No. 33-50985);
•
the description of the 8.36% Debentures Due 2024 set forth
    under the caption "Description of the Debentures" in
    the prospectus supplement dated April 20, 1994, and under
    the caption "Description of the Debt Securities" in
    the prospectus dated November 22, 1993, each filed with the
    SEC on April 21, 1994 (SEC File
No. 33-50985);
•
the description of the 7.05% Debentures Due 2027 set forth
    under the caption "Description of the Debentures" in
    the prospectus supplement dated December 5, 1995, and under
    the caption "Description of the Debt Securities" in
    the prospectus dated November 17, 1995, each filed with the
    SEC on December 7, 1995 (SEC File
No. 33-64105);
•
the description of the 7.50% Debentures Due 2095 set forth
    under the caption "Description of the Debentures" in
    the prospectus supplement dated November 20, 1995, and
    under the caption
3
Table of Contents
"Description of the Debt Securities" in the prospectus
    dated November 17, 1995, each filed with the SEC on
    November 22, 1995 (SEC File
No. 33-64105);
•
the description of the 8.70% Medium-Term Notes Due 2010 set
    forth in the Pricing Supplement, dated February 1, 1995,
    filed with the SEC on February 2, 1995 (SEC File
No. 33-53409),
and under the caption "Description of Notes" in the
    prospectus supplement dated July 11, 1994, and under the
    caption "Description of the Debt Securities" in the
    prospectus dated May 13, 1994, each filed with the SEC on
    July 12, 1994 (SEC File
No. 33-53409);
•
the description of the 9.00% Medium-Term Notes Due 2014 set
    forth in the Pricing Supplement, dated January 12, 1995,
    filed with the SEC on January 13, 1995 (SEC File
No. 33-53409),
and under the caption "Description of Notes" in the
    prospectus supplement dated July 11, 1994, and under the
    caption "Description of the Debt Securities" in the
    prospectus dated May 13, 1994, each filed with the SEC on
    July 12, 1994 (SEC File
No. 33-53409); and
•
the description of the 7.58% Medium-Term Notes Due 2025 set
    forth in the Pricing Supplement, dated September 11, 1995,
    filed with the SEC on September 13, 1995 (SEC File
No. 33-53409),
and under the caption "Description of Notes" in the
    prospectus supplement dated July 11, 1994, and under the
    caption "Description of the Debt Securities" in the
    prospectus dated May 13, 1994, each filed with the SEC on
    July 12, 1994 (SEC File
No. 33-53409).
You may request a copy of these filings, at no cost, by writing
    or calling us at the following address or telephone number:
Corporate
    Secretary
HCA Inc.
One Park Plaza
Nashville, Tennessee 37203
(615) 344-9551
4
Table of Contents
HCA
    INC.
The terms "Company," "HCA,"
    "we," "our" or "us," as used
    herein, refer to HCA Inc. and its affiliates unless otherwise
    stated or indicated by context. The term "affiliates"
    means direct and indirect subsidiaries of HCA Inc. and
    partnerships and joint ventures in which such subsidiaries are
    partners.
We are one of the leading health care services companies in the
    United States. At March 31, 2009, we operated 163
    hospitals, comprised of 157 general, acute care hospitals; five
    psychiatric hospitals; and one rehabilitation hospital. The 163
    hospital total includes eight hospitals (seven general, acute
    care hospitals and one rehabilitation hospital) owned by joint
    ventures in which an affiliate of HCA is a partner, and these
    joint ventures are accounted for using the equity method. In
    addition, we operated 105 freestanding surgery centers, eight of
    which are owned by joint ventures in which an affiliate of HCA
    is a partner, and these joint ventures are accounted for using
    the equity method. Our facilities are located in 20 states
    and England. For the year ended December 31, 2008, we
    generated revenues of $28.374 billion and net income
    attributable to HCA Inc. of $673 million, and for the three
    months ended March 31, 2009, we generated revenues of
    $7.431 billion and net income attributable to HCA Inc. of
    $360 million.
Our primary objective is to provide a comprehensive array of
    quality health care services in the most cost-effective manner
    possible. Our general, acute care hospitals typically provide a
    full range of services to accommodate such medical specialties
    as internal medicine, general surgery, cardiology, oncology,
    neurosurgery, orthopedics and obstetrics, as well as diagnostic
    and emergency services. Outpatient and ancillary health care
    services are provided by our general, acute care hospitals,
    freestanding surgery centers, diagnostic centers and
    rehabilitation facilities. Our psychiatric hospitals provide a
    full range of mental health care services through inpatient,
    partial hospitalization and outpatient settings.
We also provide a variety of management services to our health
    care facilities, including patient safety programs; ethics and
    compliance programs; national supply contracts; equipment
    purchasing and leasing contracts; accounting, financial and
    clinical systems; governmental reimbursement assistance;
    construction planning and coordination; information technology
    systems and solutions; legal counsel; human resources services;
    and internal audit services.
HCA Inc. was incorporated in Nevada in January 1990 and
    reincorporated in Delaware in September 1993. Our principal
    executive offices are located at One Park Plaza, Nashville,
    Tennessee 37203, and our telephone number is
(615) 344-9551.
5
Table of Contents
RISK
    FACTORS
You should carefully consider the risk factors set forth
    below as well as the risk factors incorporated herein by
    reference to our annual report on
Form 10-K
for the fiscal year ended December 31, 2008 (the "2008
10-K")
and our quarterly report on
Form 10-Q
for the quarter ended March 31, 2009 (the "2009 First
    Quarter
10-Q")
and the other information contained in this prospectus before
    purchasing the notes. This prospectus contains forward-looking
    statements that involve risks and uncertainties. Any of the
    following risks could materially and adversely affect our
    business, financial condition or results of operations.
    Additional risks and uncertainties not currently known to us or
    those we currently view to be immaterial may also materially and
    adversely affect our business, financial condition or results of
    operations. In such a case, you may lose all or part of your
    original investment.
As used herein, the "senior secured credit
    facilities" refer to, collectively, our senior secured cash
    flow credit facility, dated as of November 17, 2006, as
    amended on February 16, 2007, and as amended on
    March 2, 2009 (the "cash flow credit facility"),
    and our senior secured asset-based revolving credit facility,
    dated as of November 17, 2006, as amended and restated as
    of June 20, 2007, and as amended on March 2, 2009 (the
    "asset-based revolving credit facility"). We refer to
    the "senior notes" as those notes, debentures and
    medium-term notes issued under the indenture, dated as of
    December 16, 1993, as amended or supplemented, to the
    "second lien notes" as those notes issued under,
    collectively, the indenture dated as of November 17, 2006
    and the indenture dated as of February 19, 2009, each as
    amended or supplemented, to the "first lien notes" as
    those notes issued under the indenture, dated as of
    April 22, 2009, as amended or supplemented, and to the
    "senior secured notes" as, collectively, the second
    lien notes and the first lien notes. We refer to the
    "notes" as, collectively, the senior notes and the
    senior secured notes. For a more detailed description of the
    notes and the indentures and agreements governing such notes,
    see "Description of Notes."
Risks
    Related to Our Indebtedness
Our
    substantial leverage could adversely affect our ability to raise
    additional capital to fund our operations, limit our ability to
    react to changes in the economy or our industry, expose us to
    interest rate risk to the extent of our variable rate debt and
    prevent us from meeting our obligations.
Since completing our recapitalization in November 2006 we are
    highly leveraged. As of March 31, 2009 our total
    indebtedness was $26.567 billion. Our high degree of
    leverage could have important consequences, including:
•
increasing our vulnerability to downturns or adverse changes in
    general economic, industry or competitive conditions and adverse
    changes in government regulations;
•
requiring a substantial portion of cash flow from operations to
    be dedicated to the payment of principal and interest on our
    indebtedness, therefore reducing our ability to use our cash
    flow to fund our operations, capital expenditures and future
    business opportunities;
•
exposing us to the risk of increased interest rates as certain
    of our unhedged borrowings are at variable rates of interest;
•
limiting our ability to make strategic acquisitions or causing
    us to make nonstrategic divestitures;
•
limiting our ability to obtain additional financing for working
    capital, capital expenditures, product or service line
    development, debt service requirements, acquisitions and general
    corporate or other purposes; and
•
limiting our ability to adjust to changing market conditions and
    placing us at a competitive disadvantage compared to our
    competitors who are less highly leveraged.
We and our subsidiaries have the ability to incur additional
    indebtedness in the future, subject to the restrictions
    contained in our senior secured credit facilities and the
    indentures governing our outstanding notes. If new indebtedness
    is added to our current debt levels, the related risks that we
    now face could intensify.
6
Table of Contents
We may
    not be able to generate sufficient cash to service all of our
    indebtedness and may not be able to refinance our indebtedness
    on favorable terms. If we are unable to do so, we may be forced
    to take other actions to satisfy our obligations under our
    indebtedness, which may not be successful.
Our ability to make scheduled payments on or to refinance our
    debt obligations depends on our financial condition and
    operating performance, which are subject to prevailing economic
    and competitive conditions and to certain financial, business
    and other factors beyond our control. We cannot assure you that
    we will maintain a level of cash flows from operating activities
    sufficient to permit us to pay the principal, premium, if any,
    and interest on our indebtedness.
As of March 31, 2009, our substantial indebtedness included
    $13.356 billion of indebtedness under our senior secured
    credit facilities that matures in 2012 and 2013,
    $6.000 billion of second lien notes maturing in 2014, 2016
    and 2017 and $6.826 billion of unsecured senior notes and
    debentures that mature on various dates from 2009 to 2095
    (including $5.437 billion maturing through 2016). Because a
    significant portion of our indebtedness matures in the next few
    years, we may find it necessary or prudent to refinance that
    indebtedness with longer-maturity debt at a higher interest
    rate. In April 2009, for example, we issued $1.500 billion
    of
    8
1
/
2
% Senior
    Secured Notes due 2019. We used the net proceeds of that
    offering to prepay term loans under our cash flow credit
    facility, which currently bears interest at a lower floating
    rate. Our ability to refinance our indebtedness on favorable
    terms, or at all, is directly affected by the current global
    economic and financial crisis. In addition, our ability to incur
    secured indebtedness (which may enable us to achieve better
    pricing than the incurrence of unsecured indebtedness) depends
    in part on the value of our assets, which depends, in turn, on
    the strength of our cash flows and results of operations, and on
    economic and market conditions and other factors.
If our cash flows and capital resources are insufficient to fund
    our debt service obligations or we are unable to refinance our
    indebtedness, we may be forced to reduce or delay investments
    and capital expenditures, or to sell assets, seek additional
    capital or restructure our indebtedness. These alternative
    measures may not be successful and may not permit us to meet our
    scheduled debt service obligations. If our operating results and
    available cash are insufficient to meet our debt service
    obligations, we could face substantial liquidity problems and
    might be required to dispose of material assets or operations to
    meet our debt service and other obligations. We may not be able
    to consummate those dispositions, or the proceeds from the
    dispositions may not be adequate to meet any debt service
    obligations then due.
Our
    debt agreements contain restrictions that limit our flexibility
    in operating our business.
Our senior secured credit facilities and the indentures
    governing our outstanding notes contain various covenants that
    limit our ability to engage in specified types of transactions.
    These covenants limit our and certain of our subsidiaries'
    ability to, among other things:
•
incur additional indebtedness or issue certain preferred shares;
•
pay dividends on, repurchase or make distributions in respect of
    our capital stock or make other restricted payments;
•
make certain investments;
•
sell or transfer assets;
•
create liens;
•
consolidate, merge, sell or otherwise dispose of all or
    substantially all of our assets; and
•
enter into certain transactions with our affiliates.
Under our asset-based revolving credit facility, when (and for
    as long as) the combined availability under our asset-based
    revolving credit facility and our senior secured revolving
    credit facility is less than a specified amount for a certain
    period of time or, if a payment or bankruptcy event of default
    has occurred and is continuing, funds deposited into any of our
    depository accounts will be transferred on a daily basis into a
7
Table of Contents
blocked account with the administrative agent and applied to
    prepay loans under the asset-based revolving credit facility and
    to cash collateralize letters of credit issued thereunder.
Under our senior secured credit facilities, we are required to
    satisfy and maintain specified financial ratios. Our ability to
    meet those financial ratios can be affected by events beyond our
    control, and there can be no assurance that we will continue to
    meet those ratios. A breach of any of these covenants could
    result in a default under both our cash flow credit facility and
    our asset-based revolving credit facility. Upon the occurrence
    of an event of default under our senior secured credit
    facilities, our lenders could elect to declare all amounts
    outstanding under our senior secured credit facilities to be
    immediately due and payable and terminate all commitments to
    extend further credit. If we were unable to repay those amounts,
    the lenders under our senior secured credit facilities could
    proceed against the collateral granted to them to secure such
    indebtedness. We have pledged a significant portion of our
    assets as collateral under our senior secured credit facilities.
    If any of the lenders under our senior secured credit facilities
    accelerate the repayment of borrowings, we cannot assure you
    that we will have sufficient assets to repay our senior secured
    credit facilities and the notes.
Risks
    Related to the Notes
Your
    ability to transfer the notes may be limited by the absence of
    an active trading market, and there is no assurance that any
    active trading market for the notes exists or will
    continue.
We do not intend to apply for a listing of the notes on a
    securities exchange or automated dealer quotation system. We
    cannot assure you as to the liquidity of markets that may
    develop for the notes, your ability to sell the notes or the
    price at which you would be able to sell the notes. No financial
    institution is obligated to make a market in any of the notes,
    and any financial institutions that do so may discontinue their
    market-making activities at any time without notice. Therefore,
    an active market for any of the notes, if developed, may not
    continue. Because Banc of America Securities LLC, Merrill Lynch,
    Pierce, Fenner & Smith Incorporated and their
    respective affiliates (collectively, the "market
    makers") may be considered affiliates of ours, they are
    required to deliver a current "market-maker"
    prospectus in connection with any secondary market sale of the
    notes, which may affect their ability to continue market-making
    activities. Historically, the market for non investment-grade
    debt has been subject to disruptions that have caused
    substantial volatility in the prices of securities similar to
    the notes. The market, if any, for any of the notes may not be
    free from similar disruptions and any such disruptions may
    adversely affect the prices at which you may sell your notes. In
    addition, the notes may trade at a discount from your purchase
    price, depending upon prevailing interest rates, the market for
    similar notes, our performance and other factors.
If we
    default on our obligations to pay our indebtedness, we may not
    be able to make payments on the notes.
Any default under the agreements governing our indebtedness,
    including a default under our senior secured credit facilities
    that is not waived by the required lenders or a default under
    any of the indentures governing the notes, and the remedies
    sought by the holders of such indebtedness, could prevent us
    from paying principal, premium, if any, and interest on the
    notes and substantially decrease the market value of the notes.
    If we are unable to generate sufficient cash flow and are
    otherwise unable to obtain funds necessary to meet required
    payments of principal, premium, if any, and interest on our
    indebtedness, or if we otherwise fail to comply with the various
    covenants, including financial and operating covenants, in the
    instruments governing our indebtedness (including covenants in
    our senior secured credit facilities and the indentures
    governing the notes), we could be in default under the terms of
    the agreements governing such indebtedness. In the event of such
    default, the holders of such indebtedness could elect to declare
    all the funds borrowed thereunder to be due and payable,
    together with accrued and unpaid interest, the lenders under our
    senior secured credit facilities could elect to terminate their
    commitments thereunder, cease making further loans and institute
    foreclosure proceedings against our assets, and we could be
    forced into bankruptcy or liquidation. If our operating
    performance declines, we may in the future need to obtain
    waivers from the required lenders under our senior secured
    credit facilities to avoid being in default. If we breach our
    covenants under our senior secured credit facilities and seek a
    waiver, we may not be able to obtain a waiver from the required
    lenders. If
8
Table of Contents
this occurs, we would be in default under the instruments
    governing that indebtedness, the lenders could exercise their
    rights, as described above, and we could be forced into
    bankruptcy or liquidation.
Federal
    and state fraudulent transfer laws may permit a court to void
    the notes, and with respect to the senior secured notes, the
    guarantees, and, if that occurs, you may not receive any
    payments on the notes.
Federal and state fraudulent transfer and conveyance statutes
    may apply to the issuance of the notes and, with respect to the
    senior secured notes, the incurrence of the guarantees. Under
    federal bankruptcy law and comparable provisions of state
    fraudulent transfer or conveyance laws, which may vary from
    state to state, the notes or guarantees could be voided as a
    fraudulent transfer or conveyance if (1) we or any of the
    guarantors, as applicable, issued the notes or incurred the
    guarantees with the intent of hindering, delaying or defrauding
    creditors or (2) we or any of the guarantors, as
    applicable, received less than reasonably equivalent value or
    fair consideration in return for either issuing the notes or
    incurring the guarantees and, in the case of (2) only, one
    of the following is also true at the time thereof:
•
we or any of the guarantors, as applicable, were insolvent or
    rendered insolvent by reason of the issuance of the notes or the
    incurrence of the guarantees;
•
the issuance of the notes or the incurrence of the guarantees
    left us or any of the guarantors, as applicable, with an
    unreasonably small amount of capital to carry on the business;
•
we or any of the guarantors intended to, or believed that we or
    such guarantor would, incur debts beyond our or such
    guarantor's ability to pay as they mature; or
•
we were or any of the guarantors was a defendant in an action
    for money damages, or had a judgment for money damages docketed
    against us or such guarantor if, in either case, after final
    judgment, the judgment was unsatisfied.
If a court were to find that the issuance of the notes or the
    incurrence of any guarantee were a fraudulent transfer or
    conveyance, the court could void the payment obligations under
    the notes or such guarantee or further subordinate the notes or
    such guarantee to presently existing and future indebtedness of
    ours or of the related guarantor, or require the holders of the
    notes to repay any amounts received with respect to such
    guarantee. In the event of a finding that a fraudulent transfer
    or conveyance occurred, you may not receive any repayment on the
    notes. Further, the voidance of the notes could result in an
    event of default with respect to our and our subsidiaries'
    other debt that could result in acceleration of such debt.
As a general matter, value is given for a transfer or an
    obligation if, in exchange for the transfer or obligation,
    property is transferred or an antecedent debt is secured or
    satisfied. A debtor will generally not be considered to have
    received value in connection with a debt offering if the debtor
    uses the proceeds of that offering to make a dividend payment or
    otherwise retire or redeem equity securities issued by the
    debtor.
We cannot be certain as to the standards a court would use to
    determine whether or not we or the guarantors were solvent at
    the relevant time or, regardless of the standard that a court
    uses, that the issuance of the guarantees would not be further
    subordinated to our or any of our guarantors' other debt.
    Generally, however, an entity would be considered insolvent if,
    at the time it incurred indebtedness:
•
the sum of its debts, including contingent liabilities, was
    greater than the fair saleable value of all its assets;
•
the present fair saleable value of its assets was less than the
    amount that would be required to pay its probable liability on
    its existing debts, including contingent liabilities, as they
    become absolute and mature; or
•
it could not pay its debts as they become due.
9
Table of Contents
Risks
    Related to the Senior Notes
The
    senior notes are unsecured and effectively junior to our secured
    indebtedness, including our senior secured credit facilities and
    our senior secured notes, to the extent of the value of the
    collateral securing such secured indebtedness.
Our obligations under our senior notes are unsecured and are
    effectively junior to our secured indebtedness to the extent of
    the value of the collateral securing such secured indebtedness.
    Our senior secured credit facilities and our senior secured
    notes are collateralized by, among other things, the capital
    stock of any wholly owned first-tier subsidiary of our company
    or of any U.S. subsidiary guarantor, substantially all of
    our and the U.S. subsidiary guarantors' other tangible
    and intangible assets and accounts receivable of our company and
    certain of our domestic subsidiaries, subject to exceptions. Our
    senior secured credit facilities and the indentures governing
    our senior secured notes also permit us to incur additional
    secured indebtedness. The senior notes are effectively
    subordinated to all such secured indebtedness to the extent of
    the value of that collateral. If an event of default occurs
    under the senior secured credit facilities or under the
    indentures governing our senior secured notes, the holders of
    such senior secured indebtedness will have a prior right to our
    assets, to the exclusion of the holders of our senior notes,
    even if we are in default with respect to such notes. In that
    event, our assets would first be used to repay in full all
    indebtedness and other obligations secured by them (including
    all amounts outstanding under the senior secured credit
    facilities and the senior secured notes), resulting in all or a
    portion of our assets being unavailable to satisfy the claims of
    the holders of the senior notes and other unsecured
    indebtedness. Therefore, in the event of any distribution or
    payment of our assets in any foreclosure, dissolution,
winding-up,
liquidation, reorganization, or other bankruptcy proceeding,
    holders of the senior notes will participate in our remaining
    assets ratably with each other and with all holders of our
    unsecured indebtedness that is deemed to be of the same class as
    such notes, and potentially with all of our other general
    creditors, based upon the respective amounts owed to each holder
    or creditor. In any of the foregoing events, we cannot assure
    you that there will be sufficient assets to pay amounts due on
    the senior notes. As a result, holders of such notes may receive
    less, ratably, than holders of secured indebtedness.
As of March 31, 2009, on an as adjusted basis after giving
    effect to our offering of $1.500 billion aggregate
    principal amount of first lien notes in April 2009 and the use
    of proceeds therefrom, we had outstanding an aggregate principal
    amount of $19.855 billion of senior secured indebtedness.
    This senior secured indebtedness includes that outstanding under
    our senior secured credit facilities, including letters of
    credit, the senior secured notes, capital leases and other
    secured debt. We also had an additional $2.198 billion
    available for borrowing under our senior secured revolving
    credit facilities after giving effect to certain outstanding
    letters of credit.
Claims
    of holders of our senior notes will be structurally subordinate
    to claims of creditors of all of our subsidiaries that do not
    guarantee such notes.
The senior notes are not guaranteed by any of our subsidiaries.
    Accordingly, claims of holders of the senior notes are
    structurally subordinate to the claims of creditors of these
    non-guarantor subsidiaries, including trade creditors. All
    obligations of our subsidiaries that do not guarantee the senior
    notes will have to be satisfied before any of the assets of such
    subsidiaries would be available for distribution, upon a
    liquidation or otherwise, to holders of the senior notes. In
    addition, the indentures governing the notes permit, subject to
    some limitations, these subsidiaries to incur additional
    indebtedness and do not contain limitations on the amount of
    certain other liabilities, such as trade payables, that may be
    incurred by these subsidiaries.
Risks
    Related to the Senior Secured Notes
The
    value of the collateral securing the senior secured notes may
    not be sufficient to satisfy our obligations under such
    notes.
No appraisal of the value of the collateral was made in
    connection with the offerings of each series of senior secured
    notes, and the fair market value of the collateral is subject to
    fluctuations based on factors that include, among others,
    general economic conditions and similar factors. The amount to
    be received upon a
10
Table of Contents
sale of the collateral would be dependent on numerous factors,
    including, but not limited to, the actual fair market value of
    the collateral at such time, the timing and the manner of the
    sale and the availability of buyers. By its nature, portions of
    the collateral may be illiquid and may have no readily
    ascertainable market value. In the event of a foreclosure,
    liquidation, bankruptcy or similar proceeding, the collateral
    may not be sold in a timely or orderly manner and the proceeds
    from any sale or liquidation of this collateral may not be
    sufficient to pay our obligations under the senior secured notes.
To the extent that liens securing obligations under the senior
    secured credit facilities, pre-existing liens, liens permitted
    under the indentures governing the senior secured notes and
    other rights, including liens on excluded assets, such as those
    securing purchase money obligations and capital lease
    obligations granted to other parties (in addition to the holders
    of any other obligations secured by higher-priority liens),
    encumber any of the collateral securing the senior secured notes
    and the guarantees, those parties have or may exercise rights
    and remedies with respect to the collateral that could adversely
    affect the value of the collateral and the ability of the
    collateral agents, the trustees or the holders of the senior
    secured notes to realize or foreclose on the collateral.
In addition, the senior secured notes and the related guarantees
    are not secured by any of the European collateral described
    under "Description of Other Indebtedness — Senior
    Secured Credit Facilities — Guarantee and
    Security."
There may not be sufficient collateral to pay off all amounts we
    may borrow under our senior secured credit facilities, the
    existing senior secured notes and additional notes that we may
    offer that would be secured on the same basis as the existing
    senior secured notes. Consequently, liquidating the collateral
    securing the senior secured notes may not result in proceeds in
    an amount sufficient to pay any amounts due under such notes
    after also satisfying the obligations to pay any creditors with
    prior liens. In addition, we may be required to repay
    obligations under our cash flow credit facility with proceeds
    from a sale of assets before repaying the senior secured notes.
    If the proceeds of any sale of collateral are not sufficient to
    repay all amounts due on the senior secured notes, the holders
    of such notes (to the extent not repaid from the proceeds of the
    sale of the collateral) would have only a senior unsecured,
    unsubordinated claim against our and the subsidiary
    guarantors' remaining assets.
Claims
    of holders of our senior secured notes are structurally
    subordinate to claims of creditors of all of our
non-U.S.
subsidiaries and some of our U.S. subsidiaries because they do
    not guarantee such notes.
The senior secured notes are not guaranteed by any of our
non-U.S. subsidiaries,
our less than wholly-owned U.S. subsidiaries or certain
    other U.S. subsidiaries. Accordingly, claims of holders of
    the senior secured notes are structurally subordinate to the
    claims of creditors of these non-guarantor subsidiaries,
    including trade creditors. All obligations of our non-guarantor
    subsidiaries will have to be satisfied before any of the assets
    of such subsidiaries would be available for distribution, upon a
    liquidation or otherwise, to us or a guarantor of the senior
    secured notes.
On an as adjusted basis after giving effect to our offering of
    $1.500 billion aggregate principal amount of first lien
    notes in April 2009 and the use of proceeds therefrom, our
    non-guarantor subsidiaries would have accounted for
    approximately $11.867 billion, or 41.8%, of our total
    revenues for the year ended December 31, 2008,
    approximately $3.038 billion, or 40.9%, of our total
    revenues for the three months ended March 31, 2009,
    approximately $9.876 billion, or 40.7%, of our total
    assets, and approximately $7.517 billion, or 22.5%, of our
    total liabilities, in each case as of December 31, 2008,
    and approximately $9.817 billion, or 40.4%, of our total
    assets, and approximately $7.224 billion, or 21.9%, of our
    total liabilities, in each case as of March 31, 2009.
There
    are circumstances other than repayment or discharge of the
    senior secured notes under which the collateral securing such
    notes and guarantees will be released automatically, without
    your consent or the consent of the applicable
    trustee.
Under various circumstances, collateral securing the senior
    secured notes will be released automatically, including:
•
a sale, transfer or other disposal of such collateral in a
    transaction not prohibited under the indentures governing the
    senior secured notes;
•
with respect to collateral held by a guarantor, upon the release
    of such guarantor from its guarantee;
11
Table of Contents
•
with respect to collateral that is capital stock, upon the
    dissolution of the issuer of such capital stock in accordance
    with the indentures governing the senior secured notes;
•
with respect to any collateral in which the second lien notes
    have a second-priority or third-priority lien, upon any release
    by the lenders under our senior secured credit facilities of
    their first-priority or second-priority security interest in
    such collateral unless such release occurs in connection with a
    discharge in full in cash of first lien obligations, which
    discharge is not in connection with a foreclosure of, or other
    exercise of remedies with respect to, non-receivables collateral
    by the first lien secured parties (such discharge not in
    connection with any such foreclosure or exercise of remedies, a
    "Payment Discharge"); provided that, in the case of a
    Payment Discharge, the lien on any non-receivables collateral
    disposed of in satisfaction in whole or in part of first lien
    obligations shall be automatically released but any proceeds
    thereof not used for purposes of the discharge of first lien
    obligations in full in cash or otherwise in accordance with the
    indentures governing the second lien notes shall be subject to a
    lien in favor of the collateral agent for the second lien
    noteholders;
•
with respect to any receivables collateral in which the first
    lien notes have a second-priority lien, upon any release by the
    lenders under our asset-based revolving credit facility of their
    first-priority security interest in such collateral; provided
    that, if the release occurs in connection with a foreclosure or
    exercise of remedies by the collateral agent for the lenders
    under our asset-based revolving credit facility, the lien on
    that collateral will be automatically released but any proceeds
    thereof not used to repay the obligations under our asset-based
    revolving credit facility will be subject to lien in favor of
    the collateral agent for the first lien noteholders and our cash
    flow credit facility; and
•
with respect to the collateral upon which the first notes have a
    first-priority lien, upon any release in connection with a
    foreclosure or exercise of remedies with respect to that
    collateral directed by the authorized representative of the
    lenders under our cash flow credit facility during any period
    that such authorized representative controls actions with
    respect to the collateral pursuant to the first lien
    intercreditor agreement. Even though the holders of the notes
    share ratably with the lenders under our cash flow credit
    facility, the authorized representative of the lenders under our
    cash flow credit facility will initially control actions with
    respect to the collateral, whether or not the holders of the
    first lien notes agree or disagree with those actions. See
    "— Risks Related to the First Lien Senior Secured
    Notes — Even though the holders of the first lien
    notes have the benefit of a first-priority lien on the
    collateral that secures our cash flow credit facility, the
    representative of the lenders under the cash flow credit
    facility will initially control most actions with respect to
    that collateral."
In addition, the guarantee of a subsidiary guarantor will be
    automatically released to the extent it is released under the
    senior secured credit facilities or in connection with a sale of
    such subsidiary guarantor in a transaction not prohibited by the
    indentures.
The indentures governing the senior secured notes also permit us
    to designate one or more of our restricted subsidiaries that is
    a guarantor of the senior secured notes as an unrestricted
    subsidiary. If we designate a subsidiary guarantor as an
    unrestricted subsidiary for purposes of the indentures governing
    the senior secured notes, all of the liens on any collateral
    owned by such subsidiary or any of its subsidiaries and any
    guarantees of the notes by such subsidiary or any of its
    subsidiaries will be released under the indentures but not
    necessarily under our senior secured credit facilities.
    Designation of an unrestricted subsidiary will reduce the
    aggregate value of the collateral securing the notes to the
    extent that liens on the assets of the unrestricted subsidiary
    and its subsidiaries are released. In addition, the creditors of
    the unrestricted subsidiary and its subsidiaries will have a
    senior claim on the assets of such unrestricted subsidiary and
    its subsidiaries. See "Description of Notes."
We
    will in most cases have control over the collateral, and the
    sale of particular assets by us could reduce the pool of assets
    securing the senior secured notes and the
    guarantees.
The collateral documents allow us to remain in possession of,
    retain exclusive control over, freely operate, and collect,
    invest and dispose of any income from, the collateral securing
    the senior secured notes and the
12
Table of Contents
guarantees, except, under certain circumstances, cash
    transferred to accounts controlled by the administrative agent
    under our asset-based revolving credit facility.
In addition, we are not required to comply with all or any
    portion of Section 314(d) of the Trust Indenture Act
    of 1939 (the "Trust Indenture Act") if we
    determine, in good faith based on advice of counsel, that, under
    the terms of that Section
and/or
any
    interpretation or guidance as to the meaning thereof of the SEC
    and its staff, including "no action" letters or
    exemptive orders, all or such portion of Section 314(d) of
    the Trust Indenture Act is inapplicable to the released
    collateral. For example, so long as no default or event of
    default under the indentures governing the senior secured notes
    would result therefrom and such transaction would not violate
    the Trust Indenture Act, we may, among other things,
    without any release or consent by the applicable trustees,
    conduct ordinary course activities with respect to collateral,
    such as selling, factoring, abandoning or otherwise disposing of
    collateral and making ordinary course cash payments (including
    repayments of indebtedness). See "Description of
    Notes."
The
    imposition of certain permitted liens will cause the assets on
    which such liens are imposed to be excluded from the collateral
    securing the senior secured notes and the guarantees. There are
    also certain other categories of property that are also excluded
    from the collateral.
The indentures governing the senior secured notes permit liens
    in favor of third parties to secure additional debt, including
    purchase money indebtedness and capital lease obligations, and
    any assets subject to such liens will be automatically excluded
    from the collateral securing the senior secured notes and the
    guarantees. Our ability to incur purchase money indebtedness and
    capital lease obligations is subject to the limitations as
    described in "Description of Notes." In addition,
    certain categories of assets are excluded from the collateral
    securing the senior secured notes and the guarantees. Excluded
    assets include the assets of our non-guarantor subsidiaries and
    equity investees, certain capital stock and other securities of
    our subsidiaries and equity investees, certain properties that
    do not secure our senior secured credit facilities, deposit
    accounts, other bank or securities accounts, cash, leaseholds
    and motor vehicles, and the proceeds from any of the foregoing.
    The assets excluded from the collateral for the second lien
    secured notes include the properties defined as "principal
    properties" under our indenture dated as of
    December 16, 1993, so long as that indenture remains in
    effect. Although the first lien secured notes share a lien on
    such "principal properties," that lien is limited to
    securing a portion of the indebtedness under the senior secured
    notes and our cash flow credit facility that, in the aggregate,
    does not exceed 10% of our consolidated net tangible assets. See
    "Description of Notes." If an event of default occurs
    and the senior secured notes are accelerated, such notes and the
    guarantees will rank equally with the holders of other
    unsubordinated and unsecured indebtedness of the relevant entity
    with respect to such excluded property.
On an as adjusted basis after giving effect to our offering of
    $1.500 billion aggregate principal amount of first lien
    notes in April 2009 and the use of proceeds therefrom, our
    non-guarantor subsidiaries would have accounted for
    approximately $9.817 billion, or 40.4%, of our total assets
    as of March 31, 2009.
The
    pledge of the capital stock, other securities and similar items
    of our subsidiaries that secure the senior secured notes will
    automatically be released from the lien on them and no longer
    constitute collateral for so long as the pledge of such capital
    stock or such other securities would require the filing of
    separate financial statements with the SEC for that
    subsidiary.
The senior secured notes and the guarantees are secured by a
    pledge of the stock of some of our subsidiaries. Under the SEC
    regulations in effect as of the issue date of the senior secured
    notes, if the par value, book value as carried by us or market
    value (whichever is greatest) of the capital stock, other
    securities or similar items of a subsidiary pledged as part of
    the collateral is greater than or equal to 20% of the aggregate
    principal amount of the senior secured notes then outstanding,
    such a subsidiary would be required to provide separate
    financial statements to the SEC. Therefore, the indentures
    governing the senior secured notes and the collateral documents
    provide that any capital stock and other securities of any of
    our subsidiaries will be excluded from the collateral for so
    long as the pledge of such capital stock or other securities to
    secure the senior secured notes would cause such subsidiary to
    be required to file separate financial statements with the SEC
    pursuant to
Rule 3-16
of
Regulation S-X
(as in effect from time to time).
13
Table of Contents
As a result, holders of the senior secured notes could lose a
    portion or all of their security interest in the capital stock
    or other securities of those subsidiaries during such period. It
    may be more difficult, costly and time-consuming for holders of
    the senior secured notes to foreclose on the assets of a
    subsidiary than to foreclose on its capital stock or other
    securities, so the proceeds realized upon any such foreclosure
    could be significantly less than those that would have been
    received upon any sale of the capital stock or other securities
    of such subsidiary. See "Description of Notes."
Your
    rights in the collateral may be adversely affected by the
    failure to perfect security interests in certain collateral in
    the future.
Applicable law requires that certain property and rights
    acquired after the grant of a general security interest, such as
    real property, equipment subject to a certificate and certain
    proceeds, can only be perfected at the time such property and
    rights are acquired and identified. The trustees or the
    collateral agents for the senior secured notes may not monitor,
    or we may not inform the trustees or the collateral agents for
    the senior secured notes of, the future acquisition of property
    and rights that constitute collateral, and necessary action may
    not be taken to properly perfect the security interest in such
    after-acquired collateral. The collateral agents for the senior
    secured notes have no obligation to monitor the acquisition of
    additional property or rights that constitute collateral or the
    perfection of any security interest in favor of the senior
    secured notes against third parties. Such failure may result in
    the loss of the security interest therein or the priority of the
    security interest in favor of the senior secured notes against
    third parties.
The
    collateral is subject to casualty risks.
We intend to maintain insurance or otherwise insure against
    hazards in a manner appropriate and customary for our business.
    There are, however, certain losses that may be either
    uninsurable or not economically insurable, in whole or in part.
    Insurance proceeds may not compensate us fully for our losses.
    If there is a complete or partial loss of any of the pledged
    collateral, the insurance proceeds may not be sufficient to
    satisfy all of the secured obligations, including the senior
    secured notes and the guarantees.
We may
    not be able to repurchase the senior secured notes upon a change
    of control.
Upon the occurrence of specific kinds of change of control
    events, we will be required to offer to repurchase all
    outstanding senior secured notes at 101% of their principal
    amount plus accrued and unpaid interest. The source of funds for
    any such purchase of such notes will be our available cash or
    cash generated from our subsidiaries' operations or other
    sources, including borrowings, sales of assets or sales of
    equity. We may not be able to repurchase the senior secured
    notes upon a change of control because we may not have
    sufficient financial resources to purchase all of the senior
    secured notes that are tendered upon a change of control.
    Further, we are contractually restricted under the terms of our
    senior secured credit facilities from repurchasing all of the
    notes tendered by holders upon a change of control. Accordingly,
    we may not be able to satisfy our obligations to purchase the
    senior secured notes unless we are able to refinance or obtain
    waivers under the instruments governing that indebtedness. Our
    failure to repurchase the senior secured notes upon a change of
    control would cause a default under the indentures governing the
    senior secured notes and a cross-default under the instruments
    governing our senior secured credit facilities. The instruments
    governing our senior secured credit facilities also provide that
    a change of control will be a default that permits lenders to
    accelerate the maturity of borrowings thereunder. Any of our
    future debt agreements may contain similar provisions.
In the
    event of our bankruptcy, the ability of the holders of the
    senior secured notes to realize upon the collateral will be
    subject to certain bankruptcy law limitations.
The ability of holders of the senior secured notes to realize
    upon the collateral will be subject to certain bankruptcy law
    limitations in the event of our bankruptcy. Under applicable
    U.S. federal bankruptcy laws, secured creditors are
    prohibited from repossessing their security from a debtor in a
    bankruptcy case without bankruptcy court approval and may be
    prohibited from disposing of security repossessed from such a
    debtor without bankruptcy court approval. Moreover, applicable
    federal bankruptcy laws generally permit the debtor
14
Table of Contents
to continue to retain collateral, including cash collateral,
    even though the debtor is in default under the applicable debt
    instruments, provided that the secured creditor is given
    "adequate protection."
The meaning of the term "adequate protection" may vary
    according to the circumstances, but is intended generally to
    protect the value of the secured creditor's interest in the
    collateral at the commencement of the bankruptcy case and may
    include cash payments or the granting of additional security if
    and at such times as the court, in its discretion, determines
    that a diminution in the value of the collateral occurs as a
    result of the stay of repossession or the disposition of the
    collateral during the pendency of the bankruptcy case. In view
    of the lack of a precise definition of the term "adequate
    protection" and the broad discretionary powers of a
    U.S. bankruptcy court, we cannot predict whether or when
    the collateral agents
and/or
the
    trustees under the indentures which govern senior secured notes
    could foreclose upon or sell the collateral or whether or to
    what extent holders of senior secured notes would be compensated
    for any delay in payment or loss of value of the collateral
    through the requirement of "adequate protection."
Moreover, the collateral agents for the senior secured notes may
    need to evaluate the impact of the potential liabilities before
    determining to foreclose on collateral consisting of real
    property, if any, because secured creditors that hold a security
    interest in real property may be held liable under environmental
    laws for the costs of remediating or preventing the release or
    threatened releases of hazardous substances at such real
    property. Consequently, the collateral agents for the senior
    secured notes may decline to foreclose on such collateral or
    exercise remedies available in respect thereof if they do not
    receive indemnification to their satisfaction from the holders
    of the senior secured notes.
Certain
    series of senior secured notes were issued with original issue
    discount for U.S. federal income tax purposes.
The
    9
5
/
8
%/10
3
/
8
% senior
    secured toggle notes due 2016, the
    9
7
/
8
% senior
    secured notes due 2017 and the
    8
1
/
2
% senior
    secured notes due 2019 (collectively, the "OID Notes")
    were issued with original issue discount ("OID") for
    U.S. federal income tax purposes. Thus, in addition to
    stated interest on the OID Notes, U.S. holders (as defined
    in "Certain U.S. Federal Tax Consequences") will
    be required to include amounts representing the OID in gross
    income on a constant yield to maturity basis in advance of the
    receipt of cash payment thereof, regardless of a
    U.S. holder's method of accounting for
    U.S. federal income tax purposes. With respect to the
    9
5
/
8
%/10
3
/
8
% senior
    secured toggle notes due 2016, U.S. holders will be
    required to include such OID in gross income even if we do not
    pay cash interest. For more information about the
    U.S. federal income tax consequences of owning the OID
    Notes, see "Certain U.S. Federal Tax
    Consequences."
If a
    bankruptcy petition were filed by or against us, holders of the
    OID Notes may receive a lesser amount for their claim than they
    would have been entitled to receive under the indenture
    governing such notes.
If a bankruptcy petition were filed by or against us under the
    U.S. Bankruptcy Code after the issuance of the OID Notes,
    the claim by any holder of the notes for the principal amount of
    the notes may be limited to an amount equal to the sum of:
•
the original issue price for such notes; and
•
that portion of the original issue discount that does not
    constitute "unmatured interest" for purposes of the
    U.S. Bankruptcy Code.
Any original issue discount that was not amortized as of the
    date of the bankruptcy filing would constitute unmatured
    interest. Accordingly, holders of the OID Notes under these
    circumstances may receive a lesser amount than they would be
    entitled to receive under the terms of the indenture governing
    such notes, even if sufficient funds are available.
15
Table of Contents
Risks
    Related to the Second Lien Senior Secured Notes
Other
    secured indebtedness, including our senior secured credit
    facilities and first lien notes, is effectively senior to the
    second lien notes to the extent of the value of the collateral
    securing such indebtedness on a higher priority
    basis.
Our cash flow credit facility and our first lien notes are
    collateralized by a first-priority lien, subject to permitted
    liens, in, among other things, the capital stock of any wholly
    owned first-tier subsidiary of our company or of any
    U.S. subsidiary guarantor and substantially all of our and
    the U.S. subsidiary guarantors' other tangible and
    intangible assets, subject to exceptions. In addition, our
    asset-based revolving credit facility has a first-priority lien
    in the accounts receivable of our company and certain of our
    subsidiaries, and our first lien notes and our cash flow credit
    facility, other than the European term loan facility, have a
    second-priority lien in those receivables (except for those of
    certain special purpose subsidiaries that only guarantee and
    pledge their assets under our asset-based revolving credit
    facility). Our senior secured credit facilities and the
    indentures governing our senior secured notes also permit us to
    incur additional indebtedness secured on a first-priority basis
    by such assets in the future. The first- and second-priority
    liens in the collateral securing indebtedness under our senior
    secured credit facilities and our first lien notes, as the case
    may be, and any such future indebtedness is higher in priority
    as to such collateral than the security interests securing the
    second lien notes and the guarantees of such notes. The second
    lien notes and the related guarantees are secured, subject to
    permitted liens, by a second-priority lien or a third-priority
    lien, as the case may be, in the assets that secure our cash
    flow credit facility and first lien notes on a first-priority or
    second-priority basis, as the case may be. Holders of the
    indebtedness under our senior secured credit facilities, the
    first lien notes and any other indebtedness collateralized by a
    higher-priority lien in such collateral will be entitled to
    receive proceeds from the realization of value of such
    collateral to repay such indebtedness in full before the holders
    of the second lien notes will be entitled to any recovery from
    such collateral. As a result, holders of the second lien notes
    will only be entitled to receive proceeds from the realization
    of value of assets securing our senior secured credit facilities
    and first lien notes on a higher-priority basis after all
    indebtedness and other obligations under our senior secured
    credit facilities, first lien notes and any other obligations
    secured by higher-priority liens on such assets are repaid in
    full. The second lien notes are effectively junior in right of
    payment to indebtedness under our senior secured credit
    facilities, the first lien notes and any other indebtedness
    collateralized by a higher-priority lien in our assets, to the
    extent of the realizable value of such collateral. In addition,
    the indentures governing the second lien notes permit us to
    incur additional indebtedness secured by a lien that ranks
    equally with the second lien notes. Any such indebtedness may
    further limit the recovery from the realization of the value of
    such collateral available to satisfy holders of the second lien
    notes.
As of March 31, 2009, on an as adjusted basis after giving
    effect to our offering of $1.500 billion aggregate
    principal amount of first lien notes in April 2009 and the use
    of proceeds therefrom, we had outstanding an aggregate principal
    amount of $13.855 billion of senior secured indebtedness
    secured by liens ranking senior to those securing the second
    lien notes. This indebtedness includes that outstanding under
    our senior secured credit facilities, including letters of
    credit, the first lien notes, capital leases and other debt
    secured on a first priority basis. We also had an additional
    $2.198 billion available for borrowing under our senior
    secured revolving credit facilities after giving effect to
    certain outstanding letters of credit.
The
    lien ranking provisions of the indentures and other agreements
    relating to the collateral securing the second lien notes limit
    the rights of holders of such notes with respect to that
    collateral, even during an event of default.
The rights of the holders of the second lien notes with respect
    to the collateral that secures the notes on a second-priority or
    third-priority basis, as the case may be, are substantially
    limited by the terms of the lien ranking agreements set forth in
    the indentures and the intercreditor agreements, even during an
    event of default. Under the indentures and the intercreditor
    agreements, at any time that obligations that have the benefit
    of the higher-priority liens are outstanding, any actions that
    may be taken with respect to such collateral, including the
    ability to cause the commencement of enforcement proceedings
    against such collateral and to control the conduct of such
    proceedings, and the approval of amendments to, releases of such
    collateral from the lien of, and waivers of past defaults under,
    such documents relating to such collateral, will be at the
16
Table of Contents
direction of the holders of the obligations secured by the
    first-priority and second-priority liens, as applicable, and the
    holders of the notes secured by lower-priority liens may be
    adversely affected.
In addition, the indentures and the intercreditor agreements
    contain certain provisions benefiting holders of indebtedness
    under our senior secured credit facilities, including provisions
    requiring the second lien trustees and the second lien
    collateral agent not to object following the filing of a
    bankruptcy petition to a number of important matters regarding
    the collateral. After such filing, the value of this collateral
    could materially deteriorate, and holders of the second lien
    notes would be unable to raise an objection. In addition, the
    right of holders of obligations secured by first-priority and
    second-priority liens, as applicable, to foreclose upon and sell
    such collateral upon the occurrence of an event of default also
    would be subject to limitations under applicable bankruptcy laws
    if we or any of our subsidiaries become subject to a bankruptcy
    proceeding.
The collateral that secures the second lien notes and guarantees
    on a lower-priority basis will also be subject to any and all
    exceptions, defects, encumbrances, liens and other imperfections
    as may be accepted by the lenders under our senior secured
    credit facilities, the holders of our first lien notes and other
    creditors that have the benefit of higher-priority liens on such
    collateral from time to time, whether on or after the date the
    second lien notes and guarantees are issued. The existence of
    any such exceptions, defects, encumbrances, liens and other
    imperfections could adversely affect the value of the collateral
    securing the second lien notes as well as the ability of the
    second lien collateral agent to realize or foreclose on such
    collateral.
The
    lenders under our senior secured credit facilities will have the
    discretion to release the guarantors under the instruments
    governing that indebtedness in a variety of circumstances, which
    will cause those guarantors to be released from their guarantees
    of the second lien notes.
While any obligations under our senior secured credit facilities
    remain outstanding, any guarantee of the second lien notes may
    be released without action by, or consent of, any holder of the
    second lien notes or the trustees under the indentures governing
    the second lien notes, at the discretion of lenders under our
    senior secured credit facilities, if the related guarantor is no
    longer a guarantor of obligations under that indebtedness or any
    other indebtedness. See "Description of Notes." The
    lenders under our senior secured credit facilities will have the
    discretion to release the guarantees under the senior secured
    credit facilities in a variety of circumstances. You will not
    have a claim as a creditor against any subsidiary that is no
    longer a guarantor of the second lien notes, and the
    indebtedness and other liabilities, including trade payables,
    whether secured or unsecured, of those subsidiaries will
    effectively be senior to claims of holders of such notes.
Risks
    Related to the First Lien Senior Secured Notes
The
    secured indebtedness under our senior secured asset-based
    revolving credit facility is effectively senior to the first
    lien notes to the extent of the value of the receivables
    collateral securing such facility on a first-priority
    basis.
Our asset-based revolving credit facility has a first-priority
    lien in the accounts receivable of our company and our domestic
    subsidiaries, with certain exceptions. Our other senior secured
    credit facilities have, and our first lien notes have, a
    second-priority lien in those receivables (except for those of
    certain special purpose subsidiaries that only guarantee and
    pledge their assets under our asset-based revolving credit
    facility). The indentures governing both the second lien notes
    and the first lien notes permit us to incur additional
    indebtedness secured on a first-priority basis by such assets in
    the future. The first-priority liens in the collateral securing
    indebtedness under our asset-based revolving credit facility and
    any such future indebtedness is higher in priority as to such
    collateral than the security interests securing the first lien
    notes and the guarantees. Holders of the indebtedness under our
    asset-based revolving credit facility and any other indebtedness
    secured by higher priority liens on such collateral will be
    entitled to receive proceeds from the realization of value of
    such collateral to repay such indebtedness in full before the
    holders of the first lien notes will be entitled to any recovery
    from such collateral. As a result, holders of the first lien
    notes will only be entitled to receive proceeds from the
    realization of value of assets securing our asset-based
    revolving credit facility on a higher priority basis after all
    indebtedness and other obligations under our asset-based
    revolving credit facility and any other obligations secured by
    higher priority liens on such assets are repaid in full. The
17
Table of Contents
first lien notes are effectively junior in right of payment to
    indebtedness under our asset-based revolving credit facility and
    any other indebtedness secured by higher priority liens on such
    collateral to the extent of the realizable value of such
    collateral. Even if there were receivables collateral or
    proceeds left over to pay the first lien notes and the cash flow
    credit facility after a foreclosure on that collateral and
    payment of the outstanding amounts under the asset-based
    revolving credit facility, that collateral would be subject to
    the first lien intercreditor agreement, and the representative
    of the lenders under the cash flow credit facility would
    initially control actions with respect to that collateral. See
    "— Even though the holders of the first lien
    notes have the benefit of a first-priority lien on the
    collateral that secures our cash flow credit facility, the
    representative of the lenders under the cash flow credit
    facility will initially control actions with respect to that
    collateral."
As of March 31, 2009, the first lien notes would have been
    effectively junior to $1.715 billion of indebtedness
    outstanding under our asset-based revolving credit facility to
    the extent of the value of collateral securing such indebtedness.
The
    lien ranking provisions of the indenture and other agreements
    relating to the collateral securing the first lien notes limit
    the rights of holders of the first lien notes with respect to
    that collateral, even during an event of default.
The rights of the holders of the first lien notes with respect
    to the receivables collateral that secures the asset-based
    revolving credit facility on a first-priority basis and that
    secures our cash flow credit facility and the first lien notes
    on a second-priority basis are substantially limited by the
    terms of the lien ranking agreements set forth in the indenture
    governing the first lien notes and the applicable receivables
    intercreditor agreement, even during an event of default. Under
    the indenture governing the first lien notes and the applicable
    receivables intercreditor agreement, at any time that
    obligations that have the benefit of the higher priority liens
    are outstanding, any actions that may be taken with respect to
    such collateral, including the ability to cause the commencement
    of enforcement proceedings against such collateral, to control
    the conduct of such proceedings and to approve amendments to
    releases of such collateral from the lien of, and waive past
    defaults under, such documents relating to such collateral, will
    be at the direction of the holders of the obligations secured by
    the first-priority liens, and the holders of the first lien
    notes secured by lower-priority liens may be adversely affected.
In addition, the indenture governing the first lien notes and
    the applicable receivables intercreditor agreement contain
    certain provisions benefiting holders of indebtedness under our
    asset-based revolving credit facility, including provisions
    requiring the trustee and the collateral agent for the first
    lien notes not to object following the filing of a bankruptcy
    petition to certain important matters regarding the receivables
    collateral. After such filing, the value of this collateral
    could materially deteriorate, and holders of the first lien
    notes would be unable to raise an objection.
The receivables collateral that secures the first lien notes and
    guarantees on a lower-priority basis will also be subject to any
    and all exceptions, defects, encumbrances, liens and other
    imperfections as may be accepted by the lenders under our
    asset-based revolving credit facility, whether on or after the
    date the first lien notes and guarantees were issued. The
    existence of any such exceptions, defects, encumbrances, liens
    and other imperfections could adversely affect the value of the
    collateral securing the first lien notes, as well as the ability
    of the collateral agent to realize or foreclose on such
    collateral.
Even
    though the holders of the first lien notes have the benefit of a
    first-priority lien on the collateral that secures our cash flow
    credit facility, the representative of the lenders under the
    cash flow credit facility will initially control actions with
    respect to that collateral.
The rights of the holders of the first lien notes with respect
    to the collateral that secures such notes on a first-priority
    basis are subject to a first lien intercreditor agreement among
    all holders of obligations secured by that collateral on a
    first-priority basis, including the obligations under our cash
    flow credit facility. Under that intercreditor agreement, any
    actions that may be taken with respect to such collateral,
    including the ability to cause the commencement of enforcement
    proceedings against such collateral, to control such proceedings
18
Table of Contents
and to approve amendments to releases of such collateral from
    the lien of, and waive past defaults under, such documents
    relating to such collateral, will be at the direction of the
    authorized representative of the lenders under the cash flow
    credit facility until (1) our obligations under the cash
    flow credit facility are discharged (which discharge does not
    include certain refinancings of the cash flow credit facility)
    or (2) 90 days after the occurrence of an event of
    default under the indenture governing the first lien notes, if
    the authorized representative of the holders of the first lien
    notes represents the largest outstanding principal amount of
    indebtedness secured by a first-priority lien on the collateral
    (other than the cash flow credit facility) and has complied with
    the applicable notice provisions.
However, even if the authorized representative of the first lien
    notes gains the right to direct the collateral agent in the
    circumstances described in clause (2) above, the authorized
    representative must stop doing so (and those powers with respect
    to the collateral would revert to the authorized representative
    of the lenders under the cash flow credit facility) if the
    lenders' authorized representative has commenced and is
    diligently pursuing enforcement action with respect to the
    collateral or the grantor of the security interest in that
    collateral (whether our company or the applicable subsidiary
    guarantor) is then a debtor under or with respect to (or
    otherwise subject to) an insolvency or liquidation proceeding.
In addition, the senior secured credit facilities and the
    indenture governing the first lien notes permit us to issue
    additional series of notes that also have a first-priority lien
    on the same collateral. At any time that the representative of
    the lenders under the cash flow credit facility does not have
    the right to take actions with respect to the collateral
    pursuant to the first lien intercreditor agreement, that right
    passes to the authorized representative of the holders of the
    next largest outstanding principal amount of indebtedness
    secured by a first-priority lien on the collateral. If we issue
    additional first lien notes in the future in a greater principal
    amount than the existing first lien notes, then the authorized
    representative for those additional notes would be next in line
    to exercise rights under the first lien intercreditor agreement,
    rather than the authorized representative for the existing first
    lien notes.
Under the first lien intercreditor agreement, the authorized
    representative of the holders of the first lien notes may not
    object following the filing of a bankruptcy petition to any
debtor-in-possession
financing or to the use of the shared collateral to secure that
    financing, subject to conditions and limited exceptions. After
    such a filing, the value of this collateral could materially
    deteriorate, and holders of the first lien notes would be unable
    to raise an objection.
The collateral that secures the first lien notes and guarantees
    on a first-priority basis will also be subject to any and all
    exceptions, defects, encumbrances, liens and other imperfections
    as may be accepted by the authorized representative of the
    lenders under our cash flow credit facility during any period
    that such authorized representative controls actions with
    respect to the collateral pursuant to the first lien
    intercreditor agreement. The existence of any such exceptions,
    defects, encumbrances, liens and other imperfections could
    adversely affect the value of the collateral securing the first
    lien notes as well as the ability of the collateral agent to
    realize or foreclose on such collateral for the benefit of the
    holders of the first lien notes.
FORWARD-LOOKING
    STATEMENTS
This prospectus and the documents incorporated herein by
    reference contain "forward-looking statements" within
    the meaning of the federal securities laws, which involve risks
    and uncertainties. Forward-looking statements include all
    statements that do not relate solely to historical or current
    facts, and you can identify forward-looking statements because
    they contain words such as "believes,"
    "expects," "may," "will,"
    "should," "seeks,"
    "approximately," "intends,"
    "plans," "estimates," "projects,"
    "continue," "initiative" or
    "anticipates" or similar expressions that concern our
    prospects, objectives, strategies, plans or intentions. All
    statements made relating to our estimated and projected
    earnings, margins, costs, expenditures, cash flows, growth rates
    and financial results or to the impact of existing or proposed
    laws or regulations described, or incorporated by reference, in
    this prospectus are forward-looking statements. These
    forward-looking statements are subject to risks and
    uncertainties that may change at any time, and, therefore, our
    actual results may differ materially from those expected. We
    derive many of our forward-looking statements from our operating
    budgets and forecasts, which are based upon many detailed
    assumptions. While we believe that our assumptions are
19
Table of Contents
reasonable, it is very difficult to predict the impact of known
    factors, and, of course, it is impossible to anticipate all
    factors that could affect our actual results.
Some of the important factors that could cause actual results to
    differ materially from our expectations are disclosed under
    "Risk Factors" and elsewhere in this prospectus as
    well as in our 2008
10-K
and
    2009 First Quarter
10-Q
incorporated herein by reference. All subsequent written and
    oral forward-looking statements attributable to us, or persons
    acting on our behalf, are expressly qualified in their entirety
    by these cautionary statements.
We do not undertake any obligation to publicly update or revise
    any forward-looking statement as a result of new information,
    future events or otherwise, except as otherwise required by law.
20
Table of Contents
USE OF
    PROCEEDS
This prospectus is delivered in connection with the sale of
    notes by Banc of America Securities LLC, Merrill Lynch, Pierce,
    Fenner & Smith Incorporated and their affiliates in
    market-making transactions. We will not receive any of the
    proceeds from such transactions.
21
Table of Contents
DESCRIPTION
    OF OTHER INDEBTEDNESS
Senior
    Secured Credit Facilities
On November 17, 2006 in connection with our
    recapitalization, we entered into the senior secured credit
    facilities with Banc of America Securities LLC, J.P. Morgan
    Securities Inc., Citigroup Global Markets Inc. and Merrill
    Lynch, Pierce, Fenner & Smith Incorporated, as joint
    lead arrangers and bookrunners, Bank of America, N.A., as
    administrative agent, JPMorgan Chase Bank, N.A. and Citicorp
    North America, Inc., as co-syndication agents and Merrill Lynch
    Capital Corporation, as documentation agent.
The senior secured credit facilities provide senior secured
    financing of $16.800 billion, consisting of:
•
$12.800 billion-equivalent in term loan facilities,
    comprised of a $2.750 billion senior secured term loan A
    facility with a term of six years, a $8.800 billion senior
    secured term loan B facility with a term of seven years and a
    €1.000 billion ($1.250 billion) senior secured
    European term loan facility with a term of seven years; and
•
$4.000 billion in revolving credit facilities, comprised of
    a $2.000 billion senior secured asset-based revolving
    credit facility available in dollars with a term of six years
    and a $2.000 billion senior secured revolving credit
    facility available in dollars, euros and pounds sterling with a
    term of six years. Availability under the asset-based revolving
    credit facility is subject to a borrowing base of 85% of
    eligible accounts receivable less customary reserves.
We refer to these senior secured credit facilities, excluding
    the asset-based revolving credit facility, as the "cash
    flow credit facility" and, collectively with the
    asset-based revolving credit facility, the "senior secured
    credit facilities."
HCA Inc. is the primary borrower under the senior secured credit
    facilities, except that a U.K. subsidiary is the borrower under
    the European term loan facility. The revolving credit facilities
    include capacity available for the issuance of letters of credit
    and for borrowings on
same-day
notice, referred to as the swingline loans. A portion of the
    letter of credit availability under the cash-flow revolving
    credit facility is available in euros, dollars and pounds
    sterling. Lenders under the cash flow credit facility are
    subject to a loss sharing agreement pursuant to which, upon the
    occurrence of certain events, including a bankruptcy event of
    default under the cash flow credit facility, each such lender
    will automatically be deemed to have exchanged its interest in a
    particular tranche of the cash flow credit facility for a pro
    rata percentage in all of the tranches of the cash flow credit
    facility.
The asset-based revolving credit facility is documented in a
    separate loan agreement from the other senior secured credit
    facilities.
On February 16, 2007, we amended our cash flow credit
    facility to reduce the applicable margins with respect to the
    term borrowings thereunder. On June 20, 2007, we amended
    our asset-based revolving credit facility to reduce the
    applicable margin with respect to borrowings thereunder.
On March 2, 2009, we amended our cash flow credit facility
    to allow for one or more future issuances of additional secured
    notes, which may include notes that are secured on a pari passu
    basis or on a junior basis with the obligations under the cash
    flow credit facility, so long as (1) such notes do not
    require, subject to certain exceptions, scheduled repayments,
    payment of principal or redemption prior to the scheduled term
    loan B maturity date as currently in effect, (2) the terms
    of such notes, taken as a whole, are not more restrictive than
    those in the cash flow credit facility and (3) the proceeds
    from any such issuance are used within three business days of
    receipt to permanently prepay term loans under the cash flow
    credit facility in accordance with the terms of the cash flow
    credit facility. The U.S. security documents related to the
    cash flow credit facility were also amended and restated or, in
    the case of the U.S. mortgages, will be amended and
    restated, in connection with the amendment in order to give
    effect to the security interests to be granted to holders of
    such additional secured notes.
On March 2, 2009, we also amended our asset-based revolving
    credit facility to allow for one or more future issuances of
    additional secured notes or loans, which may include notes or
    loans that are secured on a
22
Table of Contents
pari passu basis or on a junior basis with the obligations under
    the cash flow credit facility, so long as (1) such notes or
    loans do not require, subject to certain exceptions, scheduled
    repayments, payment of principal or redemption prior to the
    scheduled term loan B final maturity date as currently in
    effect, (2) the terms of such notes or loans, as
    applicable, taken as a whole, are not more restrictive than
    those in the cash flow credit facility and (3) the proceeds
    from any such issuance are used within three business days of
    receipt to permanently prepay term loans under the cash flow
    credit facility in accordance with the terms of the cash flow
    credit facility. The amendment to the asset-based revolving
    credit facility also altered the excess facility availability
    requirement to include a separate minimum facility availability
    requirement applicable to the asset-based revolving credit
    facility and increased the applicable LIBOR and asset-based
    revolving margins for all borrowings under the asset-based
    revolving credit facility by 0.25% each.
See also our 2008
10-K
under
    "Item 13. Certain Relationships and Related
    Transactions" for a description of certain relationships
    between our company and Bank of America, N.A., the
    administrative agent under the cash flow credit facility and the
    asset-based revolving credit facility.
Interest
    Rate and Fees
Borrowings under the senior secured credit facilities bear
    interest at a rate equal to, at our option, either
    (a) LIBOR for deposits in the applicable currency plus an
    applicable margin or (b) the higher of (1) the prime
    rate of Bank of America, N.A. and (2) the federal funds
    effective rate plus 0.50%, plus an applicable margin. The
    applicable margins currently in effect for borrowings are
    (w) under the asset-based revolving credit facility, 0.50%
    with respect to base rate borrowings and 1.50% with respect to
    LIBOR borrowings, (x) under the senior secured revolving
    credit facility and the term loan B facility, 1.25% with respect
    to base rate borrowings and 2.25% with respect to LIBOR
    borrowings, (y) under the term loan A facility, 1.00% with
    respect to base rate borrowings and 2.00% with respect to LIBOR
    borrowings and (z) under the European term loan facility,
    2.00% with respect to LIBOR borrowings. The applicable margins
    may be reduced or increased depending on our leverage ratios.
In addition to paying interest on outstanding principal under
    the senior secured credit facilities, we are required to pay a
    commitment fee to the lenders under the revolving credit
    facilities in respect of the unutilized commitments thereunder.
    The initial commitment fee rate is 0.50% per annum for the
    revolving credit facility and 0.375% for the asset-based
    revolving credit facility. Each of these commitment fee rates
    may be reduced subject to our reducing our leverage to specified
    ratios. We must also pay customary letter of credit fees.
Prepayments
The cash flow credit facility requires us to prepay outstanding
    term loans, subject to certain exceptions, with:
•
50% (which percentage will be reduced to 25% if our total
    leverage ratio is 5.50x or less and to 0% if our total leverage
    ratio is 5.00x or less) of our annual excess cash flow;
•
100% of the net cash proceeds of all nonordinary course asset
    sales or other dispositions of property, other than the
    Receivables Collateral, as defined below, if we do not
    (1) reinvest or commit to reinvest those proceeds in assets
    to be used in our business or to make certain other permitted
    investments within 15 months as long as, in the case of any
    such commitment to reinvest or make certain other permitted
    investments, such investment is completed within such
15-month
period or, if later, within 180 days after such commitment
    is made or (2) apply such proceeds within 15 months to
    repay debt of HCA Inc. that was outstanding on the effective
    date of the Merger scheduled to mature prior to the earliest
    final maturity of the senior secured credit facilities then
    outstanding; and
•
100% of the net cash proceeds of any incurrence of debt, other
    than proceeds from the receivables facilities and other debt
    permitted under the senior secured credit facilities.
The foregoing mandatory prepayments are applied among the term
    loan facilities (1) during the first three years after the
    effective date of the Merger, pro rata to such facilities based
    on the respective aggregate
23
Table of Contents
amounts of unpaid principal installments thereof due during such
    period, with amounts allocated to each facility being applied to
    the remaining installments thereof in direct order of maturity
    and (2) thereafter, pro rata to such facilities, with
    amounts allocated to each facility being applied, in the case of
    the term loan A facility, pro rata to the remaining installments
    thereof and, in the case of the term loan B facility or the
    European term loan facility, to the next eight unpaid scheduled
    installments of principal of such facility and then pro rata to
    the remaining amortization payments under such facility.
    Notwithstanding the foregoing, (i) proceeds of asset sales
    by foreign subsidiaries are applied solely to prepay European
    term loans until such term loans have been repaid in full and
    (ii) we are not required to prepay loans under the term
    loan A facility or the term loan B facility with net cash
    proceeds of asset sales or with excess cash flow, in each case
    attributable to foreign subsidiaries, to the extent that the
    repatriation of such amounts is prohibited or delayed by
    applicable local law or would result in material adverse tax
    consequences.
The asset-based revolving credit facility requires us to prepay
    outstanding loans if borrowings exceed the borrowing base.
We may voluntarily repay outstanding loans under the senior
    secured credit facilities at any time without premium or
    penalty, other than customary "breakage" costs with
    respect to LIBOR loans.
Amortization
We are required to repay the loans under the term loan
    facilities as follows:
•
the term loan A facility amortizes in quarterly installments
    such that the aggregate amount of the original funded principal
    amount of such facility repaid pursuant to such amortization
    payments in each year, commencing with the year ending
    December 31, 2007, is equal to $112.5 million in years
    1 and 2, $225 million in years 3 and 4, $450 million
    in year 5 and $1.625 billion in year 6; and
•
each of the term loan B facility and the European term loan
    facility amortizes in equal quarterly installments that
    commenced on March 31, 2007 in aggregate annual amounts
    equal to 1% of the original funded principal amount of such
    facility, with the balance being payable on the final maturity
    date of such term loans.
Principal amounts outstanding under the revolving credit
    facilities are due and payable in full at maturity, six years
    from the date of the closing of the senior secured credit
    facilities.
Guarantee
    and Security
All obligations under the senior secured credit facilities are
    unconditionally guaranteed by substantially all existing and
    future, direct and indirect, wholly-owned material domestic
    subsidiaries that are "Unrestricted Subsidiaries"
    under the 1993 Indenture (except for certain special purpose
    subsidiaries that only guarantee and pledge their assets under
    the asset-based revolving credit facility), and the obligations
    under the European term loan facility are also unconditionally
    guaranteed by HCA Inc. and each of our existing and future
    wholly owned material subsidiaries formed under the laws of
    England and Wales, subject, in each of the foregoing cases, to
    any applicable legal, regulatory or contractual constraints and
    to the requirement that such guarantee does not cause adverse
    tax consequences.
All obligations under the asset-based revolving credit facility,
    and the guarantees of those obligations, are secured, subject to
    permitted liens and other exceptions, by a first-priority lien
    on substantially all of the receivables of the borrowers and
    each guarantor under such asset-based revolving credit facility
    (the "Receivables Collateral").
All obligations under the cash flow credit facility and the
    guarantees of such obligations, are secured, subject to
    permitted liens and other exceptions, by:
•
a first-priority lien on the capital stock owned by HCA Inc. or
    by any U.S. guarantor in each of their respective
    first-tier subsidiaries (limited, in the case of foreign
    subsidiaries, to 65% of the voting stock of such subsidiaries);
24
Table of Contents
•
a first-priority lien on substantially all present and future
    assets of HCA Inc. and of each U.S. guarantor other than
    (i) "Principal Properties" (as defined in the
    1993 Indenture), except for certain "Principal
    Properties" the aggregate amount of indebtedness secured
    thereby in respect of the cash flow credit facility and the
    notes offered hereby and any future First Lien Obligations,
    taken as a whole, do not exceed 10% of "Consolidated Net
    Tangible Assets" (as defined under the 1993 Indenture),
    (ii) certain other real properties and (iii) deposit
    accounts, other bank or securities accounts, cash, leaseholds,
    motor-vehicles and certain other exceptions (such collateral
    under this and the preceding bullet, the "Non-Receivables
    Collateral"); and
•
a second-priority lien on certain of the Receivables Collateral
    (such portion of the Receivables Collateral, the "Shared
    Receivables Collateral"; the Receivables Collateral that
    does not secure such cash flow credit facility on a
    second-priority basis is referred to as the "Separate
    Receivables Collateral").
The obligations of the borrowers and the guarantors under the
    European term loan facility are also secured by substantially
    all present and future assets of the European subsidiary
    borrower and each European guarantor (the "European
    Collateral"), subject to permitted liens and other
    exceptions (including, without limitation, exceptions for
    deposit accounts, other bank or securities accounts, cash,
    leaseholds, motor-vehicles and certain other exceptions) and
    subject to such security interests otherwise being permitted by
    applicable law and contract and not resulting in adverse tax
    consequences. The notes offered hereby will not be secured by
    any of the European Collateral.
Certain
    Covenants and Events of Default
The senior secured credit facilities contain a number of
    covenants that, among other things, restrict, subject to certain
    exceptions, our ability to:
•
incur additional indebtedness;
•
create liens;
•
enter into sale and leaseback transactions;
•
engage in mergers or consolidations;
•
sell or transfer assets;
•
pay dividends and distributions or repurchase our capital stock;
•
make investments, loans or advances;
•
prepay certain subordinated indebtedness (including the notes
    and certain other indebtedness existing on the effective date of
    the Merger ("Retained Indebtedness")), subject to
    exceptions for repayments of Retained Indebtedness maturing
    prior to the senior secured credit facilities and, in certain
    cases, to satisfaction of a maximum first-lien leverage
    condition;
•
make certain acquisitions;
•
engage in certain transactions with affiliates;
•
amend material agreements governing certain subordinated
    indebtedness (including the senior secured second-lien notes
    offered hereby); and
•
change our lines of business.
In addition, the senior secured credit facilities require us to
    maintain the following financial covenants:
•
in the case of the asset-based revolving credit facility, a
    minimum interest coverage ratio (applicable only when
    availability under such facility is less than 10% of the
    borrowing base thereunder); and
•
in the case of the other senior secured credit facilities, a
    maximum total leverage ratio.
25
Table of Contents
The senior secured credit facilities also contain certain
    customary affirmative covenants and events of default, including
    a change of control.
Existing
    Indebtedness
Existing
    Senior Notes, Debentures and Medium-Term Notes
As of March 31, 2009, we had outstanding an aggregate
    principal amount of $6.296 billion and
    £122 million of senior notes and debentures,
    consisting of the following series:
•
$3,488,000 aggregate principal amount of 5.50% Senior Notes
    due 2009;
•
$440,020,000 aggregate principal amount of 8.75% Senior
    Notes due 2010;
•
£122, 259,000 aggregate principal amount of
    8.75% Senior Notes due 2010;
•
$273,321,000 aggregate principal amount of 7.875% Senior
    Notes due 2011;
•
$402,499,000 aggregate principal amount of 6.95% Senior
    Notes due 2012;
•
$500,000,000 aggregate principal amount of 6.30% Senior
    Notes due 2012;
•
$500,000,000 aggregate principal amount of 6.25% Senior
    Notes due 2013;
•
$500,000,000 aggregate principal amount of 6.75% Senior
    Notes due 2013;
•
$500,000,000 aggregate principal amount of 5.75% Senior
    Notes due 2014;
•
$750,000,000 aggregate principal amount of 6.375% Senior
    Notes due 2015;
•
$1,000,000,000 aggregate principal amount of 6.50% Senior
    Notes due 2016;
•
$291,436,000 aggregate principal amount of 7.69% Notes due
    2025;
•
$250,000,000 aggregate principal amount of 7.50% Senior
    Notes due 2033;
•
$150,000,000 aggregate principal amount of 7.19% Debentures
    due 2015;
•
$135,645,000 aggregate principal amount of 7.50% Debentures
    due 2023;
•
$150,000,000 aggregate principal amount of 8.36% Debentures
    due 2024;
•
$150,000,000 aggregate principal amount of 7.05% Debentures
    due 2027;
•
$100,000,000 aggregate principal amount of 7.75% Debentures
    due 2036; and
•
$200,000,000 aggregate principal amount of 7.50% Debentures
    due 2095.
As of March 31, 2009, we also had outstanding $121,180,000
    aggregate principal amount of our 8.70% Medium-Term Notes due
    2010; $121,110,000 aggregate principal amount of our 9.00%
    Medium-Term Notes due 2014; and $125,000,000 aggregate principal
    amount of our 7.58% Medium-Term Notes due 2025.
All of our outstanding series of senior notes, debentures and
    medium-term notes were issued under the 1993 Indenture. The
    terms of the 1993 Indenture governing the existing senior notes,
    debentures and medium-term notes provide that in addition to
    customary events of default and a customary covenant limiting
    mergers and consolidations of HCA, the aggregate amount of all
    other indebtedness of HCA secured by mortgages on
    "Principal Properties" (as such term is defined in the
    indenture) together with the aggregate principal amount of all
    indebtedness of restricted subsidiaries (as such term is defined
    in the indenture) and the attributable debt in respect of
    sale-leasebacks of Principal Properties, may not exceed 15% of
    the consolidated net tangible assets of HCA and its consolidated
    subsidiaries, subject to exceptions for certain permitted
    mortgages and debt. See "Description of Notes —
    Senior Notes, Debentures and Medium-Term Notes Issued Under the
    1993 Indenture."
26
Table of Contents
Existing
    Senior Secured Notes
Also in connection with the Recapitalization, we issued
    $4.200 billion of senior secured notes (comprised of
    $1.000 billion of
    9
1
/
8
% notes
    due 2014 and $3.200 billion of
    9
1
/
4
% notes
    due 2016) and $1.500 billion of
    9
5
/
8
/10
3
/
8
% senior
    secured toggle notes (which allow us, at our option, to pay
    interest in kind during the first five years at the higher
    interest rate of
    10
3
/
8
%)
    due 2016. See "Description of Notes — Senior
    Secured Notes Issued Under the 2006 Indenture."
As of March 31, 2009, we had outstanding an aggregate
    principal amount of $5.700 billion of senior secured notes
    consisting of the following series:
•
$1,000,000,000 aggregate principal amount of
    9
1
/
8
% Senior
    Secured Notes due 2014;
•
$3,200,000,000 aggregate principal amount of
    9
1
/
4
% Senior
    Secured Notes due 2016; and
•
$1,500,000,000 aggregate principal amount of
    9
5
/
8
/10
3
/
8
% Senior
    Secured Toggle Notes due 2016.
In November 2008, we elected to make an interest payment on the
    senior secured toggle notes for the interest period ending in
    May 2009 by paying in kind ("PIK") at the PIK interest
    rate of
    10
3
/
8
%
    instead of paying interest in cash. On May 15, 2009, the
    aggregate principal amount of the senior secured toggle notes
    increased by $77,813,000 as a result of the PIK interest payment.
On February 19, 2009, we issued $310 million aggregate
    principal amount of
    9
7
/
8
% senior
    secured notes due 2017 at a price of 96.673% of their face
    value, resulting in approximately $300 million of gross
    proceeds. These notes and the related guarantees are secured by
    second-priority liens, subject to permitted liens, on our and
    our subsidiary guarantors' assets, subject to certain
    exceptions, that secure our cash flow credit facility on a
    first-priority basis and are secured by third-priority liens,
    subject to permitted liens, on our and our subsidiary
    guarantors' assets that secure our asset-based revolving
    credit facility on a first priority basis and our other cash
    flow credit facility on a second-priority basis. See
    "Description of Notes — Senior Secured Notes
    Issued Under the 2009 Second Lien Indenture."
On April 22, 2009 we issued $1.500 billion aggregate
    principal amount of
    8
1
/
2
% senior
    secured notes due 2019 at a price of 96.755% of their face
    value, resulting in approximately $1.451 billion of gross
    proceeds. These notes and the related guarantees are secured by
    first-priority liens, subject to permitted liens, on our and our
    subsidiary guarantors' assets, subject to certain
    exceptions, that secure our cash flow credit facility on a
    first-priority basis and are secured by second priority liens,
    subject to permitted liens, on our and our subsidiary
    guarantors' assets that secure our asset-based revolving
    credit facility on a first priority basis and our other cash
    flow credit facility on a second-priority basis. See
    "Description of Notes — Senior Secured Notes
    Issued Under the 2009 First Lien Indenture."
Other
    Existing Secured Indebtedness
We had outstanding approximately $385 million of capital
    leases and other secured debt as of March 31, 2009.
Under our lease with HRT of Roanoke, Inc., effective
    December 20, 2005, we make annual payments for rent and
    additional expenses for the use of premises in Roanoke and
    Salem, Virginia. The rent payments will increase each year
    beginning January 1, 2007 by the lesser of 3% or the change
    in the Consumer Price Index. The lease is for a fixed-term of
    12 years with the option to extend the lease for another
    ten years.
Under our lease with Medical City Dallas Limited, effective
    March 18, 2004, we make annual payments for rent for the
    use of premises that are a part of a complex known as
    "Medical City Dallas" located in Dallas, Texas. The
    rent payment is adjusted yearly based on the fair market value
    of the premises and a capitalization rate. The initial term is
    240 months with the option to extend for two more terms of
    240 months each.
27
Table of Contents
DESCRIPTION
    OF NOTES
We have issued senior debt securities, debentures and
    medium-term notes, each as described below under
    "— Senior Notes, Debentures and Medium-Term Notes
    Issued Under the 1993 Indenture" and senior secured notes
    as described under "— Senior Secured Notes Issued
    Under the 2006 Indenture," "— Senior Secured
    Notes Issued Under the 2009 Second Lien Indenture" and
    "— Senior Secured Notes Issued Under the 2009
    First Lien Indenture." The terms used in each respective
    section apply only to that section, and the summaries contained
    therein are qualified in their entirety by the actual text of
    the applicable agreements and indentures, each of which are
    filed as an exhibit to the registration statement, of which this
    prospectus is a part or which may be requested by contacting us
    at the address set forth under "Where You Can Find More
    Information about HCA Inc."
Senior
    Notes, Debentures and Medium-Term Notes Issued Under the 1993
    Indenture
General
The below description of the debt securities begins with a
    summary of certain of the terms of the Indenture. Following that
    summary, specific securities and relevant terms are listed,
    divided into two categories of debt securities issued:
    (a) notes and debentures and (b) medium-term notes.
    Each series of these debt securities has been issued under the
    Indenture, dated as of December 16, 1993, between Columbia
    Healthcare Corporation and The First National Bank of Chicago,
    as Trustee, as supplemented or amended by the First Supplemental
    Indenture, dated as of May 25, 2000, between the Issuer and
    Bank One Trust Company, N.A., as Trustee, the Second
    Supplemental Indenture, dated as of July 1, 2001, between
    the Issuer and Bank One Trust Company, N.A., as Trustee,
    the Third Supplemental Indenture, dated as of December 5,
    2001, between the Issuer and The Bank of New York, and the
    Fourth Supplemental Indenture, dated as of November 14,
    2006, between the Company and The Bank of New York, as Trustee
("Trustee")
(as may be further amended or
    supplemented, the
"Indenture"
).
Ranking
The debt securities are our senior unsecured obligations and
    rank equally in right of payment to any of our existing and
    future senior indebtedness, are senior in right of payment to
    all of our existing and future subordinated indebtedness, are
    effectively subordinated in right of payment to our secured
    obligations to the extent of the value of the collateral
    securing such obligations and are structurally subordinated in
    right of payment to all existing and future indebtedness of our
    subsidiaries that do not guarantee the debt securities. In a
    liquidation or reorganization of any of our subsidiaries, the
    right of holders of the debt securities to participate in any
    distribution is subject to the prior claims of creditors of that
    subsidiary, except to the extent that we are a creditor.
Limitations
    on Us and Our Subsidiaries
Limitation
    on Mortgages
The Indenture provides that neither we nor any of our
    subsidiaries will issue, assume or guarantee any indebtedness or
    obligation secured by mortgages, liens, pledges or other
    encumbrances (referred to collectively as "mortgages")
    upon any principal property (as defined below under
    " — Certain Definitions"), unless the debt
    securities shall be secured equally and ratably with (or prior
    to) such debt. This restriction will not apply to:
•
mortgages securing the purchase price or cost of construction of
    property or additions, substantial repairs, alterations or
    improvements, if the debt and the mortgages are incurred within
    18 months of the acquisition or completion of construction
    and full operation or additions, repairs, alterations or
    improvements;
•
mortgages existing on property at the time of its acquisition by
    us or our subsidiary or on the property of a corporation at the
    time of the acquisition of such corporation by us or our
    subsidiary;
•
mortgages to secure debt on which the interest payments are
    exempt from federal income tax under Section 103 of the
    Internal Revenue Code;
•
mortgages in favor of us or a consolidated subsidiary;
28
Table of Contents
•
mortgages existing on the date of the Indenture;
•
certain mortgages to governmental entities;
•
mortgages incurred in connection with the borrowing of funds
    used to repay debt within 120 days in the same principal
    amount secured by other mortgages on principal property with at
    least the same appraised fair market value;
•
mortgages incurred within 90 days (or any longer period,
    not in excess of one year, as permitted by law) after
    acquisition of the related property or equipment arising solely
    in connection with the transfer of tax benefits in accordance
    with Section 168(f)(8) of the Internal Revenue Code; and
•
any extension, renewal or replacement of any mortgage referred
    to above, provided the amount secured is not increased and it
    relates to the same property.
Limitation
    on Sale and Lease-Back Transactions
The Indenture provides that neither we nor any subsidiary will
    enter into any sale and lease-back transaction with respect to
    any principal property involving a lease of more than three
    years with another person (other than our company or a
    subsidiary) unless either:
•
we or our subsidiary could incur indebtedness secured by a
    mortgage on the property to be leased; or
•
within 120 days, we apply the greater of the net proceeds
    of the sale of the leased property or the fair value of the
    leased property, as determined by our chief financial officer
    (less the principal amount of any debt securities delivered
    within 120 days for retirement or cancellation or other
    funded debt voluntarily retired within 120 days) to the
    voluntary retirement of our long-term funded debt or the
    acquisition or construction of a principal property.
Limitation
    on Subsidiary Debt and Preferred Stock
The Indenture provides that none of our restricted subsidiaries
    may, directly or indirectly, create, incur, issue, assume or
    otherwise become liable with respect to, extend the maturity of,
    or become responsible for the payment of, any debt or preferred
    stock except:
•
debt outstanding on the date of the Indenture; or
•
debt representing the assumption by one restricted subsidiary of
    debt of another;
•
debt or preferred stock of any corporation or partnership
    existing when it becomes a subsidiary;
•
debt of a restricted subsidiary arising from agreements
    providing for indemnification, adjustment of purchase price or
    similar obligations or from guarantees, letters of credit,
    surety bonds or performance bonds securing any of our
    obligations or those of our subsidiaries incurred or assumed in
    connection with the disposition of any business, property or
    subsidiary, except for the purpose of financing an acquisition,
    provided that the maximum aggregate liability does not exceed
    the gross proceeds from the disposition;
•
debt of a restricted subsidiary in respect of performance,
    surety and other similar bonds, bankers acceptances and letters
    of credit provided in the ordinary course of business;
•
debt secured by a mortgage incurred to finance the purchase
    price or cost of construction of property or additions,
    substantial repairs, alterations or improvements, if the
    mortgage and debt are incurred within 18 months of the
    later of the acquisition or completion of construction and full
    operation or additions, repairs, alterations or improvements and
    the mortgage does not relate to any other property;
•
permitted subsidiary refinancing debt (as defined below under
    "— Certain Definitions");
•
debt, including guarantees, of a restricted subsidiary to us or
    another subsidiary as long as we hold it; or
•
any obligation pursuant to a permitted sale and lease-back
    transaction.
29
Table of Contents
Exempted
    Transactions
Even if otherwise prohibited by these limitations, if the
    aggregate outstanding principal amount of all our other debt and
    that of our subsidiaries subject to these limitations does not
    exceed 15% of our consolidated net tangible assets, then:
•
we or any of our subsidiaries may issue, assume or guarantee
    debt secured by mortgages;
•
we or any of our subsidiaries may enter into any sale and
    lease-back transaction; and
•
any restricted subsidiary may issue, assume or become liable for
    any debt or preferred stock.
Events of
    Default
Under the Indenture, an event of default applicable to the debt
    securities of any series means:
•
failure to pay the principal or any premium on any debt
    securities of that series when due;
•
failure to pay any interest on any debt securities of that
    series when due, continued for 30 days;
•
failure to deposit any sinking fund payment in respect of any
    debt securities of that series when due;
•
failure to perform, or the breach of, any of our other
    applicable covenants or warranties in the Indenture, continued
    for 60 days after written notice;
•
events in bankruptcy, insolvency or reorganization; and
•
any other event of default provided with respect to debt
    securities of that series.
If any event of default with respect to debt securities of any
    series occurs and is continuing, either the Trustee or the
    holders of at least 25% in aggregate principal amount of the
    outstanding debt securities of that series may declare the
    principal amount, or in the case of discount securities, the
    applicable portion of the principal amount, of all the debt
    securities of that series to be due and payable immediately. The
    holders may, under certain circumstances, rescind and annul this
    acceleration prior to obtaining a judgment or decree.
Other than the duties of the Trustee during a default to act
    with the required standard of care, the Trustee is not obligated
    to exercise any of its rights or powers under the Indenture at
    the request or direction of any of the holders unless the
    holders shall have offered to the Trustee reasonable indemnity.
    Subject to these indemnification provisions and certain other
    conditions described in the Indenture, the holders of a majority
    in aggregate principal amount of the outstanding debt securities
    of any series may direct the time, method and place of
    conducting any proceeding for any remedy available to the
    Trustee, or exercising any trust or power conferred on the
    Trustee, with respect to the debt securities of that series.
We will furnish the Trustee annually with a statement as to our
    performance of our obligations under the Indenture and as to any
    default in our performance.
Modification
    and Waiver
We and the Trustee may modify and amend the Indenture with the
    consent of the holders of a majority in aggregate principal
    amount of the outstanding debt securities of each series
    affected voting separately. We must have the consent of the
    holder of each outstanding debt security affected to:
•
change the stated maturity of the principal of, or any
    installment of interest on, any debt security;
•
reduce the principal, premium or interest on any debt security;
•
reduce the amount of principal of discount securities payable
    upon acceleration of the maturity;
•
change the currency of payment of principal, premium or interest
    on any debt security;
•
impair the right to institute suit for the enforcement of any
    payment on or with respect to any debt securities; or
30
Table of Contents
•
reduce the percentage of holders of any series whose consent is
    required for modification or amendment of the Indenture or for
    waiver of compliance with certain provisions of the Indenture or
    certain defaults.
The holders of a majority in aggregate principal amount of the
    outstanding debt securities of each series may, on behalf of all
    holders of that series, waive any past default under the
    Indenture with respect to debt securities of that series.
    However, such holders may not waive a past default in the
    payment of principal, premium or interest, or any sinking fund
    installment with respect to the debt securities, or waive a
    covenant or provision that cannot be modified or amended without
    the consent of the holders of each outstanding debt security
    affected.
We and the Trustee may modify and amend the Indenture without
    the consent of the holders of the debt securities to, among
    other things:
•
evidence the succession of another corporation to our company;
•
add to the covenants for the benefit of the holders or surrender
    any right or power conferred upon our company;
•
add additional events of default;
•
secure the debt securities;
•
supplement the Indenture to the extent necessary to permit or
    facilitate defeasance and discharge of any series of debt
    securities;
provided
that this action does not adversely
    affect the holders of debt securities in any material respect;
•
establish the form and terms of debt securities of any new
    series;
•
provide for a successor trustee or for co-trustees;
•
cure any ambiguity, correct or supplement any provision of the
    Indenture that may be defective or inconsistent with any other
    provision, or make any other provisions that are not
    inconsistent with any provision of the Indenture;
provided
that those other provisions do not adversely affect the
    interests of the holders of outstanding debt securities of any
    series in any material respect; or
•
change any place where principal, premium (if any) and interest
    is payable, where debt securities may be surrendered for
    registration, transfer or exchange or where notices or demands
    on our company may be served.
Consolidation,
    Merger, Sale or Lease of Assets
We may consolidate with or merge into, or transfer or lease our
    assets substantially as an entirety to any corporation without
    the consent of the holders of any of the outstanding debt
    securities under the Indenture if:
•
the successor corporation is a corporation organized under the
    laws of the United States, any state there of or the
    District of Columbia and expressly assumes our obligations on
    the debt securities and under the Indenture;
•
after giving effect to the transaction, no event of default, and
    no event which, after notice or lapse of time or both, would
    become an event of default, shall have occurred and be
    continuing;
•
if, as a result of the transaction, our company would become
    subject to a mortgage, pledge, lien, security interest or other
    encumbrance that would not be permitted by the Indenture, we or
    the successor corporation will secure the debt securities
    equally and ratably with (or prior to) all indebtedness secured
    thereby; and
•
we have delivered to the Trustee an officers' certificate
    and an opinion of counsel stating that the transaction complies
    with the Indenture and that all conditions precedent have been
    complied with.
Defeasance
If so specified in the terms of any series of debt securities,
    we may be discharged from all obligations under the debt
    securities of any series, and we will not be subject to the
    limitations in the Indenture discussed in the above sections
    (known as legal defeasance) or we may cease to be under any
    obligation to comply with
31
Table of Contents
specified covenants in the Indenture (known as covenant
    defeasance), if (1) we deposit with the Trustee trust money or
    U.S. government obligations that are sufficient to pay all
    principal, premium and interest on the debt securities of the
    series and certain other conditions are met. We would deliver to
    the Trustee an opinion of counsel to the effect that the deposit
    and related defeasance would not (1) cause the holders of
    the debt securities of the series to recognize income, gain or
    loss for United States income tax purposes or (2) result in
    the delisting of the debt securities from any national
    securities exchange (if so listed).
Optional
    Redemption
If the terms of any series of debt securities (other than the
    £150,000,000 in aggregate principal amount of
    8.75% Senior Notes Due 2010, which are discussed below
    under the heading "— Provisions that Apply Only
    to the £150,000,000 8.75% Senior Notes Due 2010")
    indicate that they are redeemable at the option of our company,
    the debt securities of that series will be redeemable, at our
    option, at any time in whole, or in part from time to time, at a
    redemption price equal to the greater of (1) 100% of the
    principal amount of the notes to be redeemed or (2) the sum
    of the present values of the remaining scheduled payments of
    principal and interest on the notes to be redeemed (exclusive of
    interest accrued to the date of redemption) discounted to the
    date of redemption on a semiannual basis (assuming a
360-day
year
    consisting of twelve
30-day
months) at the then current Treasury Rate (as defined below),
    plus the number of basis points specified in the terms of the
    debt securities. In each case, we will pay accrued and unpaid
    interest on the principal amount being redeemed to the date of
    redemption.
We will mail notice of any redemption between 30 and
    60 days preceding the redemption date to each holder of the
    debt securities to be redeemed.
The notice of the redemption for such debt securities will
    state, among other things, the principal amount of the debt
    securities to be redeemed, the redemption price and the place or
    places that payment will be made upon presentation and surrender
    of the debt securities to be redeemed.
Unless we default in payment of the redemption price, on and
    after the redemption date, interest will cease to accrue on the
    debt securities or portions called for redemption.
Method
    for Determining the Treasury Rate for any Optional Redemption of
    the 5.50% Senior Notes due 2009, the 6.30% Senior
    Notes due 2012, the 6.25% Senior Notes due 2013, the
    6.75% Senior Notes due 2013, the 5.75% Senior Notes
    due 2014, the 6.375% Senior Notes due 2015, the
    6.50% Senior Notes due 2016 and the 7.50% Senior Notes
    due 2033
With respect to each of the series of redeemable debt securities
    listed above, for the purposes of determining the applicable
    redemption price, "Treasury Rate" and the other
    defined terms listed below have the respective meanings assigned
    to them in this subsection.
"Treasury Rate"
means, with respect to any
    redemption date, the rate per year equal to: (1) the yield
    under the heading which represents the average for the
    immediately preceding week, appearing in the most recently
    published statistical release designated "H.15(519)"
    or any successor publication which is published weekly by the
    Board of Governors of the Federal Reserve System and which
    establishes yields on actively traded United States Treasury
    securities adjusted to constant maturity under the caption
    "Treasury Constant Maturities," for the maturity
    corresponding to the Comparable Treasury Issue;
provided
that, if no maturity is within three months before or after
    the Remaining Life of the notes to be redeemed, yields for the
    two published maturities most closely corresponding to the
    Comparable Treasury Issue shall be determined and the Treasury
    Rate shall be interpolated or extrapolated from those yields on
    a straight line basis, rounding to the nearest month; or
    (2) if such release (or any successor release) is not
    published during the week preceding the calculation date or does
    not contain such yields, the rate per year equal to the
    semiannual equivalent yield to maturity of the Comparable
    Treasury Issue, calculated using a price for the Comparable
    Treasury Issue (expressed as a percentage of its principal
    amount) equal to the Comparable Treasury Price for such
    redemption date. The Treasury Rate shall be calculated on the
    third business day preceding the redemption date.
"Comparable Treasury Issue"
means the United
    States Treasury security selected by an Independent Investment
    Banker and having a maturity comparable to the remaining term of
    the debt securities to be
32
Table of Contents
redeemed that would be utilized, at the time of selection and in
    accordance with customary financial practice, in pricing new
    issues of corporate debt securities of comparable maturity to
    the remaining term of such debt securities.
"Remaining Life"
means the maturity of a United
    States Treasury security selected by an Independent Investment
    Banker that is comparable to the remaining term of such debt
    securities.
"Independent Investment Banker"
means one of
    the Reference Treasury Dealers appointed by the Trustee after
    consultation with us.
"Comparable Treasury Price"
means, with respect
    to any redemption date, (a) the average of the Reference
    Treasury Dealer Quotations for the redemption date, after
    excluding the highest and lowest Reference Treasury Dealer
    Quotations, or (b) if the Trustee obtains fewer than four
    Reference Treasury Dealer Quotations, the average of all the
    quotations.
"Reference Treasury Dealer Quotations"
means,
    with respect to each Reference Treasury Dealer and any
    redemption date, the average, as determined by the Trustee, of
    the bid and asked prices for the Comparable Treasury Issue
    (expressed in each case as a percentage of its principal amount)
    quoted in writing to the Trustee by the Reference Treasury
    Dealer at 5:00 p.m. on the third business day preceding the
    redemption date.
"Reference Treasury Dealer"
means each of the
    financial institutions specified in the terms of the securities
    and their respective successors;
provided however
, that
    if any of the foregoing shall cease to be a primary
    U.S. government securities dealer in New York City (a
"Primary Treasury Dealer"
), we shall substitute
    another Primary Treasury Dealer.
Method
    for Determining the Treasury Rate for any Optional Redemption of
    the 8.75% Senior Notes due 2010, the 7.875% Senior
    Notes due 2011, the 6.95% Senior Notes due 2012 and the
    7.19% Debentures due 2015
With respect to each of the series of redeemable debt securities
    listed above, for the purposes of determining the applicable
    redemption price, "Treasury Rate" and the other
    defined terms listed below have the respective meanings assigned
    to them in this subsection.
"Treasury Rate"
means, with respect to any
    redemption date, the rate per annum equal to the semiannual
    equivalent yield to maturity of the Comparable Treasury Issue,
    assuming a price for the Comparable Treasury Issue (expressed as
    a percentage of its principal amount) equal to the Comparable
    Treasury Price for the redemption date.
"Comparable Treasury Issue"
means the United
    States Treasury security selected by an Independent Investment
    Banker and having a maturity comparable to the remaining term of
    the debt securities to be redeemed that would be utilized, at
    the time of selection and in accordance with customary financial
    practice, in pricing new issues of corporate debt securities of
    comparable maturity to the remaining term of such debt
    securities.
"Independent Investment Banker"
means one of
    the Reference Treasury Dealers appointed by the Trustee after
    consultation with us, except that with respect to the
    7.19% Debentures due 2015, such term means Morgan
    Stanley & Co. Incorporated or, if such firm is
    unwilling or unable to select the Comparable Treasury Issue, an
    independent banking institution of national standing appointed
    by the Trustee.
"Comparable Treasury Price"
means, with respect
    to any redemption date, (1) the average of the bid and
    asked prices for the Comparable Treasury Issue (expressed in
    each case as a percentage of its principal amount) on the third
    business day preceding the redemption date, as set forth in the
    daily statistical release (or any successor release) published
    by the Federal Reserve Bank of New York and designated
    "Composite 3:30 p.m. Quotations for
    U.S. Government Securities" or (2) if the release
    (or any successor release) is not published or does not contain
    the prices on that business day, (a) the average of the
    Reference Treasury Dealer Quotations for the redemption date,
    after excluding the highest and lowest Reference Treasury Dealer
    Quotations, or (b) if the Trustee obtains fewer than four
    Reference Treasury Dealer Quotations, the average of all the
    quotations.
33
Table of Contents
"Reference Treasury Dealer Quotations"
means,
    with respect to each Reference Treasury Dealer and any
    redemption date, the average, as determined by the Trustee, of
    the bid and asked prices for the Comparable Treasury Issue
    (expressed in each case as a percentage of its principal amount)
    quoted in writing to the Trustee by the Reference Treasury
    Dealer at 5:00 p.m. on the third business day preceding the
    redemption date.
"Reference Treasury Dealer"
means each of the
    financial institutions specified in the terms of the securities
    and their respective successors;
provided however
, that
    if any of the foregoing shall cease to be a primary
    U.S. Government securities dealer in New York City (a
    "
Primary Treasury Dealer
"), we shall substitute
    another Primary Treasury Dealer.
Provisions
    that Apply Only to the £150,000,000 8.75% Senior Notes
    Due 2010
Optional
    Redemption of the £150,000,000 8.75% Senior Notes Due
    2010
The £150,000,000 in aggregate principal amount of
    8.75% Senior Notes Due 2010 (the
"2010 Pounds
    Sterling Notes"
) will be redeemable as a whole or in
    part, at our option, at any time after November 1, 2003, at
    a redemption price equal to the greater of (1) 100% of the
    principal amount of such notes and (2) as determined by the
    Calculation Agent, the price at which the Gross
    Redemption Yield on the outstanding principal amount of the
    notes on the Reference Date is equal to the Gross
    Redemption Yield (determined by reference to the
    middle-market price) at 3:00 p.m. (London time) on that
    date on the Benchmark Gilt, plus 50 basis points, in either
    case, plus accrued and unpaid interest on the notes up to, but
    excluding, the date specified as the redemption date (the
"Redemption Price"
).
"Gross Redemption Yield"
means a yield
    calculated on the basis indicated by the Joint Index and
    Classification Committee of the Institute and Faculty of
    Actuaries as reported in the Journal of the Institute of
    Actuaries, Vol. 105, Part 1, 1978, page 18 or on such
    other basis as the Trustee may approve.
"Reference Date"
means the date which is the
    first dealing day in London prior to the publication of the
    notice of redemption referred to below.
"Benchmark Gilt"
means the 5.75% Treasury Stock
    due December 7, 2009 or such other United Kingdom
    government stock as the Calculation Agent may, with the advice
    of three brokers
and/or
United Kingdom gilt-edged market makers or such other three
    persons operating in the United Kingdom gilt-edged market as the
    Calculation Agent may determine from time to time to be the most
    appropriate benchmark United Kingdom government stock for the
    notes.
"Calculation Agent"
means Deutsche Bank AG
    London or any successor entity.
We will give notice of any redemption between 30 and
    60 days preceding the redemption date to each holder of the
    notes to be redeemed.
In the case of any partial redemption, selection of the notes
    for redemption will be made by the Trustee in compliance with
    the requirements of the principal securities exchange, if any,
    on which the notes are listed or, if the notes are not so listed
    or such exchange prescribes no method of selection, on a pro
    rata basis, by lot or by such other method as the Trustee in its
    sole discretion shall deem to be fair and appropriate, although
    no note of £1,000 in original principal amount or less
    shall be redeemed in part. If any note is to be redeemed in part
    only, the notice of redemption relating to the note shall state
    the portion of the principal amount thereof to be redeemed. A
    new note in principal amount equal to the unredeemed portion
    thereof will be issued and delivered to the Trustee, or its
    nominee, or, in the case of notes in definitive form, issued in
    the name of the holder thereof, in each case upon cancellation
    of the original note.
Unless we default in payment of the Redemption Price, on
    and after the redemption date, interest will cease to accrue on
    the notes or portions called for redemption.
Tax
    Redemption of the £150,000,000 8.75% Senior Notes Due
    2010
The 2010 Pounds Sterling Notes may be redeemed at our option, in
    whole but not in part, at a redemption price equal to 100% of
    the principal amount of the notes to be redeemed, together with
    interest accrued and
34
Table of Contents
unpaid to the date fixed for redemption, at any time, on giving
    not less than 30 nor more than 60 days' notice, which
    notice shall be irrevocable, if:
•
we have or will become obliged to pay Additional Amounts (as
    defined under "— Additional Amounts" below)
    as a result of any change in or amendment to the laws,
    regulations or rulings of the United States or any political
    subdivision or any taxing authority of or in the United States
    affecting taxation, or any change in or amendment to an official
    application, interpretation, administration or enforcement of
    such laws, regulations or rulings, which change or amendment is
    announced or becomes effective on or after November 1,
    2000; or
•
any action shall have been taken by a taxing authority, or any
    action has been brought in a court of competent jurisdiction, in
    the United States or any political subdivision or taxing
    authority of or in the United States, including any of those
    actions specified in the first bullet point above, whether or
    not such action was taken or brought with respect to our
    company, or any change, clarification, amendment, application or
    interpretation of such laws, regulations or rulings shall be
    officially proposed, in any such case, on or after
    October 25, 2000, which results in a substantial likelihood
    that we will be required to pay Additional Amounts on the next
    interest payment date.
However, no such notice of redemption shall be given earlier
    than 90 days prior to the earliest date on which we would
    be, in the case of a redemption for the reasons specified in the
    first bullet point above, or there would be a substantial
    likelihood that we would be, in the case of a redemption for the
    reasons specified in the second bullet point above, obligated to
    pay such Additional Amounts if a payment in respect of the notes
    were then due.
Prior to the publication of any notice of redemption pursuant to
    this subsection, we will deliver to the Trustee:
•
a certificate signed by one of our duly authorized officers
    stating that we are entitled to effect such redemption and
    setting forth a statement of facts showing that the conditions
    precedent to our right so to redeem have occurred; and
•
a written opinion of independent legal counsel of recognized
    standing to the effect that we have or will become obligated to
    pay such Additional Amounts as a result of such change or
    amendment or that there is a substantial likelihood that we will
    be required to pay such Additional Amounts as a result of such
    action or proposed change, clarification, amendment, application
    or interpretation, as the case may be.
Such notice, once delivered by us to the Trustee, will be
    irrevocable.
Additional
    Amounts
All payments of principal and interest in respect of the 2010
    Pounds Sterling Notes will be made without deduction or
    withholding for or on account of any present or future taxes,
    duties, assessments or other governmental charges of whatsoever
    nature imposed, levied, collected, withheld or assessed by the
    United States or any political subdivision or taxing authority
    of or in the United States, unless such withholding or deduction
    is required by law.
In the event such withholding or deduction is required by law,
    subject to the limitations described below, we will pay as
    additional interest on the notes to the holder or beneficial
    owner of any note who is a
non-U.S. holder
(as defined below), such additional amounts
("Additional
    Amounts")
as may be necessary in order that every net
    payment by us or any paying agent of principal of or interest on
    the notes (including upon redemption), after deduction or
    withholding for or on account of any present or future tax,
    duty, assessment or other governmental charge imposed upon or as
    a result of such payment by the United States or any political
    subdivision or taxing authority of or in the United States, will
    not be less than the amount provided for in such note to be then
    due and payable before any such tax, duty, assessment or other
    governmental charge.
35
Table of Contents
However, our obligation to pay Additional Amounts shall not
    apply to:
(a) any tax, duty, assessment or other governmental charge
    which would not have been so imposed but for:
(1) the existence of any present or former connection
    between such holder or beneficial owner (or between a fiduciary,
    settlor, beneficiary, member or shareholder or other equity
    owner of, or a person having a power over, such holder or
    beneficial owner, if such holder or beneficial owner is an
    estate, a trust, a limited liability company, a partnership, a
    corporation or other entity) and the United States, including,
    without limitation, such holder or beneficial owner (or such
    fiduciary, settlor, beneficiary, member, shareholder or other
    equity owner or person having such a power) being or having been
    a citizen or resident or treated as a resident of the United
    States or being or having been engaged in a trade or business in
    the United States or being or having been present in the United
    States or having had a permanent establishment in the United
    States;
(2) the failure of such holder or beneficial owner to
    comply with any requirement under United States tax laws and
    regulations to establish entitlement to a partial or complete
    exemption from such tax, duty, assessment or other governmental
    charge (including, but not limited to, the requirement to
    provide Internal Revenue Service
Forms W-8BEN,
Forms W-8ECI,
or any subsequent versions thereof or successor thereto); or
(3) such holder's or beneficial owner's present
    or former status as a personal holding company or a foreign
    personal holding company with respect to the United States, as a
    controlled foreign corporation with respect to the United
    States, as a passive foreign investment company with respect to
    the United States, as a private foundation or other tax exempt
    organization with respect to the United States or as a
    corporation which accumulates earnings to avoid United States
    federal income tax;
(b) any tax, duty, assessment or other governmental charge
    imposed by reason of the holder or beneficial owner:
(1) owning or having owned, directly or indirectly,
    actually or constructively, 10% or more of the total combined
    voting power of all classes of HCA Inc.'s stock;
(2) being a bank receiving interest described in
    section 881(c)(3)(A) of the Internal Revenue Code; or
(3) being a controlled foreign corporation with respect to
    the United States that is related to HCA Inc. by stock ownership;
(c) any tax, duty, assessment or other governmental charge
    which would not have been so imposed but for the presentation by
    the holder or beneficial owner of such note for payment on a
    date more than 30 days after the date on which such payment
    became due and payable or the date on which payment of the note
    is duly provided for and notice is given to holders, whichever
    occurs later, except to the extent that the holder or beneficial
    owner would have been entitled to such additional amounts on
    presenting such note on any date during such
30-day
period;
(d) any estate, inheritance, gift, sales, transfer,
    personal property, wealth, interest equalization or similar tax,
    assessment or other governmental charge;
(e) any tax, duty, assessment or other governmental charge
    which is payable otherwise than by withholding from payment of
    principal of or interest on such note;
(f) any tax, duty, assessment or other governmental charge
    which is payable by a holder that is not the beneficial owner of
    the note, or a portion of the note, or that is a fiduciary,
    partnership, limited liability company or other similar entity,
    but only to the extent that a beneficial owner, a beneficiary or
    settlor with respect to such fiduciary or member of such
    partnership, limited liability company or similar entity would
    not have been entitled to the payment of an additional amount
    had such beneficial owner, settlor, beneficiary or member
    received directly its beneficial or distributive share of the
    payment;
36
Table of Contents
(g) any tax, duty, assessment or other governmental charge
    required to be withheld by any paying agent from any payment of
    principal of or interest on any note, if such payment can be
    made without such withholding by any other paying agent; or
(h) any combination of items (a), (b), (c), (d), (e),
    (f) and (g).
For purposes of this subsection, the holding of or the receipt
    of any payment with respect to a note will not constitute a
    connection (1) between the holder or beneficial owner and
    the United States or (2) between a fiduciary, settlor,
    beneficiary, member or shareholder or other equity owner of, or
    a person having a power over, such holder or beneficial owner,
    if such holder or beneficial owner is an estate, a trust, a
    limited liability company, a partnership, a corporation or other
    entity, and the United States or any political subdivision or
    taxing authority thereof or therein.
Any reference in this prospectus, in the Indenture or in the
    notes to principal or interest with respect to the 2010 Pounds
    Sterling Notes shall be deemed to refer also to Additional
    Amounts which may be payable under the provisions of this
    subsection.
We will pay all stamp and other duties, if any, which may be
    imposed by the United States or any political subdivision
    thereof or taxing authority therein with respect to the issuance
    of the notes.
Except as specifically provided in the notes, we will not be
    required to make any payment with respect to any tax, duty,
    assessment or other governmental charge imposed by any
    government or any political subdivision or taxing authority of
    or in the United States.
Unless previously redeemed or repurchased and cancelled, the
    notes will be payable at par, including Additional Amounts, if
    any, on November 1, 2010 or such earlier date on which the
    applicable notes shall be due and payable in accordance with the
    terms and conditions of the applicable notes. However, if the
    maturity date of the applicable notes is not a Business Day, the
    notes will be payable on the next succeeding business day and no
    interest shall accrue for the period from the maturity date to
    such payment date.
For purposes of the 2010 Pounds Sterling Notes, a
"non-U.S. holder"
is a beneficial owner of the notes that is not a
    U.S. holder. A
"U.S. holder"
is a
    beneficial owner of the notes that is for United States federal
    income tax purposes:
•
a United States citizen or resident alien individual;
•
a corporation or partnership created or organized in or under
    the laws of the United States or any State thereof (including
    the District of Columbia);
•
an estate if its income is subject to United States federal
    income taxation regardless of its source; or
•
a trust (1) that validly elects to be treated as a United
    States person for United States federal income tax purposes or
    (2)(a) the administration over which a U.S. court can
    exercise primary supervision and (b) all of the substantial
    decisions of which one or more United States persons has the
    authority to control.
Issuance
    of Additional Debt Securities
If the terms of any series of debt securities so indicate, we
    may, without the consent of the holders of that series of debt
    securities, increase the principal amount of the debt securities
    of that series by issuing additional debt securities in the
    future on the same terms and conditions, except for any
    differences in the issue price and interest accrued prior to the
    issue date of the additional debt securities, and with the same
    CUSIP number as existing debt securities of that series. The
    existing debt securities of that series and any additional debt
    securities of that series would rank equally and ratably for all
    purposes under the Indenture.
Governing
    Law
We will construe the Indenture and the debt securities in
    accordance with the laws of the State of New York.
Certain
    Definitions
Set forth below are certain defined terms used in the Indenture.
37
Table of Contents
"joint venture subsidiary"
means a subsidiary
    as of the date of the Indenture of which we, directly or
    indirectly, own less than 100% of the voting securities
    entitling the holders thereof to elect a majority of the
    directors (or, in the case of a partnership, of which we,
    directly or indirectly, own less than 100% of the general
    partnership interests therein).
"permitted subsidiary refinancing debt"
means
    debt of any subsidiary, the proceeds of which are used to renew,
    extend, refinance or refund outstanding debt of that subsidiary;
provided
that the debt is scheduled to mature no earlier
    than the debt being renewed, extended, refinanced or refunded;
provided
,
further
, that the debt will be permitted
    subsidiary refinancing debt only to the extent that the
    aggregate principal amount of that debt (or, if that debt is
    issued at a price less than the principal amount thereof, the
    aggregate amount of gross proceeds therefrom) does not exceed
    the aggregate principal amount then outstanding under the debt
    being renewed, extended, refinanced or refunded (or if the debt
    being renewed, extended, refinanced or refunded was issued at a
    price less than the principal amount thereof, then not in excess
    of the amount of liability in respect thereof determined in
    accordance with generally accepted accounting principles.)
"principal property"
means each acute care
    hospital providing general medical and surgical services
    (excluding equipment, personal property and hospitals that
    primarily provide specialty medical services, such as
    psychiatric and obstetrical and gynecological services) owned
    solely by our company
and/or
one
    or more of our subsidiaries and located in the United States of
    America.
"restricted subsidiary"
means (1) any
    subsidiary other than an unrestricted subsidiary and
    (2) any subsidiary that was an unrestricted subsidiary but
    which, subsequent to the date hereof, is designated by our
    company (by board resolution) to be a restricted subsidiary;
provided
, that we may not designate any such subsidiary
    to be a restricted subsidiary if we would thereby breach any
    covenant or agreement contained in the Indenture (on the
    assumption that any transaction to which that subsidiary was a
    party at the time of such designation and which would have given
    rise to debt or preferred stock or constituted a sale and
    lease-back transaction at the time it was entered into had that
    subsidiary then been a restricted subsidiary was entered into at
    the time of that designation).
"subsidiary"
means (1) any corporation of
    which at least a majority of the outstanding stock having
    ordinary voting power to elect a majority of the directors of
    that corporation, whether or not at the time stock of any other
    class or classes of that corporation have or might have voting
    power by reason of the happening of any contingency, is at the
    time, directly or indirectly, owned or controlled by our company
    or by one or more of our subsidiaries, or by our company and one
    or more of our subsidiaries or (2) any partnership or joint
    venture of which at least a majority of the equity ownership,
    whether in the form of membership, general, special or limited
    partnership interests or otherwise, is directly or indirectly
    owned or controlled by our company or by one or more of our
    subsidiaries, or by our company and one or more of our
    subsidiaries;
provided
, that the term
    "subsidiary" does not include any corporation or
    partnership controlled by our company (referred to in this
    definition as an
"affiliated entity"
) that:
•
does not transact any substantial portion of its business or
    regularly maintain any substantial portion of its operating
    assets within the continental limits of the United States of
    America;
•
is principally engaged in the business of financing (including,
    without limitation, the purchase, holding, sale or discounting
    of or lending upon any notes, contracts, leases or other forms
    of obligations) the sale or lease of merchandise, equipment or
    services (1) by our company, (2) by a subsidiary
    (whether such sales or leases have been made before or after the
    date when the corporation or partnership became a subsidiary),
    (3) by another affiliated entity or (4) by any
    corporation or partnership prior to the time when substantially
    all its assets have been or are acquired by our company;
•
is principally engaged in the business of owning, leasing,
    dealing in or developing real property;
•
is principally engaged in the holding of stock in,
and/or
the
    financing of operations of, an affiliated entity; or
•
is principally engaged in the business of (1) offering
    health benefit products or (2) insuring against
    professional and general liability risks of our company.
"unrestricted subsidiary"
means (1) any
    subsidiary acquired or organized after the date hereof;
provided
, that the subsidiary is not a successor,
    directly or indirectly, to, and does not directly or indirectly
    own any equity interest in, any restricted subsidiary;
    (2) any subsidiary the principal business of which consists
    of
38
Table of Contents
obtaining financing in capital markets outside the United States
    of America or financing the acquisition or disposition of
    machinery, equipment, inventory, accounts receivable and other
    real, personal and intangible property by persons including our
    company or a subsidiary; (3) any subsidiary the principal
    business of which is owning, leasing, dealing in or developing
    real property for residential or office building purposes or
    land, buildings or related real property owned by our company or
    any subsidiary as of the date of the Indenture; (4) any
    joint venture subsidiary; or (5) stock or other securities
    of an unrestricted subsidiary of the character described in
    clauses (1) through (4) of this definition, unless and
    until, in each of the cases specified in this paragraph, any
    such subsidiary has been designated a restricted subsidiary
    pursuant to clause (2) of the definition of
    "restricted subsidiary."
Senior
    Notes and Debentures
The principal terms of the debt securities issued and
    outstanding as of the date of this prospectus are set forth
    below. Interest on the below series of debt securities accrues
    at the annual rate indicated in the title of the series and is
    payable on the indicated interest payment dates to the
    registered holders on the preceding record date. The debt
    securities of the series listed below are not subject to a
    sinking fund.
5.50% Senior
    Notes Due 2009
•
Principal amount of the series: $500,000,000
•
Maturity date: December 1, 2009
•
Interest payment dates: June 1 and December 1
•
Record dates: May 15 and November 15
•
Issuance date: November 19, 2004
•
Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus 30 basis points)
8.75% Senior
    Notes Due 2010
•
Principal amount of the series: $750,000,000
•
Maturity date: September 1, 2010
•
Interest payment dates: March 1 and September 1
•
Record dates: February 15 and August 15
•
Issuance date: August 23, 2000
•
Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus 50 basis points)
8.75% Senior
    Notes Due 2010
•
Principal amount of the series: £150,000,000
•
Maturity date: November 1, 2010
•
Interest payment dates: May 1 and November 1
•
Record dates: April 15 and October 15
•
Issuance date: November 1, 2000
•
Redemption prior to maturity: Redeemable after November 1,
    2003 at an applicable premium and redeemable at any time upon
    certain events related to U.S. taxation, in each case as
    described above under "— Provisions that Apply Only to
    the 2010 Pounds Sterling Note"
7.875% Senior
    Notes Due 2011
•
Principal amount of the series: $500,000,000
•
Maturity date: February 1, 2011
39
Table of Contents
•
Interest payment dates: February 1 and August 1
•
Record dates: January 15 and July 15
•
Issuance date: January 26, 2001
•
Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus 50 basis points)
6.95% Senior
    Notes Due 2012
•
Principal amount of the series: $500,000,000
•
Maturity date: May 1, 2012
•
Interest payment dates: May 1 and November 1
•
Record dates: April 15 and October 15
•
Issuance date: April 26, 2002
•
Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus 25 basis points)
6.30% Senior
    Notes Due 2012
•
Principal amount of the series: $500,000,000
•
Maturity date: October 1, 2012
•
Interest payment dates: April 1 and October 1
•
Record dates: March 15 and September 15
•
Issuance date: September 23, 2002
•
Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus 37.5 basis points)
6.25% Senior
    Notes Due 2013
•
Principal amount of the series: $500,000,000
•
Maturity date: February 15, 2013
•
Interest payment dates: August 15 and February 15
•
Record dates: August 1 and February 1
•
Issuance date: February 10, 2003
•
Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus 35 basis points)
6.75% Senior
    Notes Due 2013
•
Principal amount of the series: $500,000,000
•
Maturity date: July 15, 2013
•
Interest payment dates: January 15 and July 15
•
Record dates: January 1 and July 1
•
Issuance date: July 28, 2003
•
Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus 35 basis points)
5.75% Senior
    Notes Due 2014
•
Principal amount of the series: $500,000,000
•
Maturity date: March 15, 2014
40
Table of Contents
•
Interest payment dates: March 15 and September 15
•
Record dates: March 1 and September 1
•
Issuance date: March 8, 2004
•
Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus 30 basis points)
6.375% Senior
    Notes Due 2015
•
Principal amount of the series: $750,000,000
•
Maturity date: January 15, 2015
•
Interest payment dates: January 15 and July 15
•
Record dates: January 1 and July 1
•
Issuance date: November 19, 2004
•
Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus 35 basis points)
6.50% Senior
    Notes due 2016
•
Principal amount of the series: $1,000,000,000
•
Maturity date: February 15, 2016
•
Interest payment dates: February 15 and August 15
•
Record dates: February 1 and August 1
•
Issuance date: February 8, 2006
•
Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus 30 basis points)
7.69% Notes
    Due 2025
•
Principal amount of the series: $300,000,000
•
Maturity date: June 15, 2025
•
Interest payment dates: June 15 and December 15
•
Record dates: June 1 and December 1
•
Issuance date: June 30, 1995
•
Redemption prior to maturity: Not redeemable prior to maturity
7.50% Senior
    Notes Due 2033
•
Principal amount of the series: $250,000,000
•
Maturity date: November 6, 2033
•
Interest payment dates: May 6 and November 6
•
Record dates: April 21, and October 21
•
Issuance date: November 6, 2003
•
Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus 37.5 basis points)
7.19% Debentures
    Due 2015
•
Principal amount of the series: $150,000,000
•
Maturity date: November 15, 2015
•
Interest payment dates: May 15 and November 15
41
Table of Contents
•
Record dates: May 1 and November 1
•
Issuance date: November 27, 1995
•
Redemption prior to maturity: Redeemable at any time at our
    option, in whole or in part, subject to an applicable premium
    (based on the Treasury Rate plus 20 basis points)
7.50% Debentures
    Due 2023
•
Principal amount of the series: $150,000,000
•
Maturity date: December 15, 2023
•
Interest payment dates: June 15 and December 15
•
Record dates: June 1 and December 1
•
Issuance date: December 16, 1993
•
Redemption prior to maturity: Not redeemable prior to maturity
8.36% Debentures
    Due 2024
•
Principal amount of the series: $150,000,000
•
Maturity date: April 15, 2024
•
Interest payment dates: April 15 and October 15
•
Record dates: April 1 and October 1
•
Issuance date: April 27, 1994
•
Redemption prior to maturity: Not redeemable prior to maturity
7.05% Debentures
    Due 2027
•
Principal amount of the series: $150,000,000
•
Maturity date: December 1, 2027
•
Interest payment dates: June 1 and December 1
•
Record dates: May 15 and November 15
•
Issuance date: December 8, 1995
•
Redemption prior to maturity: Not redeemable prior to maturity
7.75% Debentures
    Due 2036
•
Principal amount of the series: $100,000,000
•
Maturity date: July 15, 2036
•
Interest payment dates: July 15 and January 15
•
Record dates: July 1 and January 1
•
Issuance date: July 8, 1996
•
Redemption prior to maturity: Not redeemable prior to maturity
7.50% Debentures
    Due 2095
•
Principal amount of the series: $200,000,000
•
Maturity date: November 15, 2095
•
Interest payment dates: May 15 and November 15
•
Record dates: May 1 and November 1
•
Issuance date: November 27, 1995
•
Redemption prior to maturity: Not redeemable prior to maturity
42
Table of Contents
Medium-Term
    Notes
In the table below, we specify the following terms of the
    Medium-Term Notes (the "Medium-Term Notes"): issuance
    date; principal amount; maturity date; interest rate; and
    redemption terms, if any.
The Medium-Term Notes are not subject to a sinking fund and are
    not redeemable prior to maturity unless indicated below.
Issuance Date
Principal Amount
Maturity Date
Interest Rate/Redemption Terms
February 8, 1995
$
150,000,000
February 10, 2010
8.70%
Not redeemable prior to maturity
January 20, 1995
$
150,000,000
December 15, 2014
9.00%
Not redeemable prior to maturity
September 14, 1995
$
125,000,000
September 15, 2025
7.58%
Not redeemable prior to maturity
Senior
    Secured Notes Issued Under the 2006 Indenture
We have issued senior secured notes as described below under an
    indenture, dated as of November 17, 2006, among the
    Company, the guarantors named therein and The Bank of New York,
    as trustee. Terms used in this "— Senior Secured
    Notes Issued Under the 2006 Indenture" apply only to the
    Notes described herein.
General
Certain terms used in this description are defined under the
    subheading "Certain Definitions." In this description,
    the terms
"we
,"
"our,"
"us"
and
"the Company"
each
    refer to HCA Inc. (the
"Issuer"
) and its
    consolidated Subsidiaries.
The Issuer issued $1,000,000,000 aggregate principal amount of
    9
1
/
8
% senior
    secured notes due 2014 (the
"2014 Cash Pay
    Notes"
), $3,200,000,000 aggregate principal amount of
    9
1
/
4
% senior
    secured notes due 2016 (the
"2016 Cash Pay
    Notes"
and, together with the 2014 Cash Pay Notes, the
"Cash Pay Notes"
) and $1,500,000,000 aggregate
    principal amount of
    9
5
/
8
%/10
3
/
8
%
    optional PIK interest senior secured notes due 2016 (the
"Toggle Notes"
and, together with the Cash Pay
    Notes, the
"Notes"
) under the indenture dated
    November 17, 2006 (the
"Indenture"
) among
    the Issuer, the Guarantors and The Bank of New York, as trustee
    (the
"Trustee"
). The Notes were issued in a
    private transaction that was not subject to the registration
    requirements of the Securities Act. Except as set forth herein,
    the terms of the Notes are substantially identical and include
    those stated in the Indenture and those made part of the
    Indenture by reference to the Trust Indenture Act.
The following description is only a summary of the material
    provisions of the Indenture, does not purport to be complete and
    is qualified in its entirety by reference to the provisions of
    that agreement, including the definitions therein of certain
    terms used below. We urge you to read the Indenture because it,
    and not this description, will define your rights as Holders of
    the Notes.
Brief
    Description of Notes
The Notes are:
•
general senior obligations of the Issuer;
•
secured on a second-priority basis, equally and ratably with all
    existing and future obligations of the Issuer and the Guarantors
    under any future Junior Lien Obligations, by all of the assets
    of the Issuer and the Guarantors which are not Principal
    Properties and which secure the General Credit Facility (other
    than the European Collateral), subject to the Liens securing the
    Issuer's and the Guarantors' obligations under the
    General Credit Facility and any other Priority Lien Obligations
    and other Permitted Liens;
43
Table of Contents
•
secured on a third-priority basis, equally and ratably with all
    existing and future obligations of the Issuer and the Guarantors
    under any future Junior Lien Obligations, by all of the assets
    of the Issuer and the Guarantors securing the ABL Facility which
    also secure the General Credit Facility, subject to the Liens
    securing the Issuer's and the Guarantors' obligations
    under the Senior Credit Facilities and any other Priority Lien
    Obligations and other Permitted Liens;
•
effectively subordinated, to the extent of the value of the
    assets securing such Indebtedness (which, in any event, exclude
    the European Collateral, which does not secure the Notes), to
    the Issuer's and the Guarantors' obligations under the
    General Credit Facility and any future Priority Lien
    Obligations, that will be secured (A) on a first-priority
    basis by the same assets of the Issuer and the Guarantors that
    secure the Notes and by certain other assets of the Issuer and
    the Guarantors, including the Principal Properties, that do not
    secure the Notes and (B) on a second-priority basis by the
    Shared Receivables Collateral;
•
effectively subordinated to the Issuer's and the
    Guarantors' obligations under the ABL Facility, to the
    extent of the value of the Shared Receivables Collateral;
•
effectively subordinated to any obligations secured by Permitted
    Liens, to the extent of the value of the assets of the Issuer
    and the Guarantors subject to those Permitted Liens;
•
structurally subordinated to any existing and future
    indebtedness and liabilities of non-guarantor Subsidiaries,
    including the ABL Financing Entities and the Issuer's
    Foreign Subsidiaries and any Unrestricted Subsidiaries;
•
ranked equally in right of payment with all existing and future
    senior Indebtedness of the Issuer and the Guarantors but, to the
    extent of the value of the Collateral, are effectively senior to
    all of the Issuer's and the Guarantors' unsecured
    senior Indebtedness (including the Existing Notes);
•
senior in right of payment to any future Subordinated
    Indebtedness (as defined with respect to the Notes) of the
    Issuer; and
•
initially unconditionally guaranteed on a joint and several and
    senior basis by each Restricted Subsidiary that guarantees the
    General Credit Facility (other than any Foreign Subsidiary).
Guarantees
The Guarantors, as primary obligors and not merely as sureties,
    jointly and severally fully and unconditionally guaranteed, on a
    senior basis, the performance and full and punctual payment when
    due, whether at maturity, by acceleration or otherwise, of all
    obligations of the Issuer under the Indenture and the Notes,
    whether for payment of principal of, premium, if any, or
    interest or Additional Interest in respect of the Notes,
    expenses, indemnification or otherwise, on the terms set forth
    in the Indenture by executing the Indenture.
The Restricted Subsidiaries which guarantee the General Credit
    Facility guarantee the Notes. Each of the Guarantees of the
    Notes is a general senior obligation of each Guarantor and is
    secured by a second-priority lien on all of the assets of each
    Guarantor which secure the General Credit Facility and which are
    not Principal Properties and by a third-priority lien on all of
    the assets of each Guarantor which secure the ABL Facility. The
    Guarantees rank equally in right of payment with all existing
    and future senior Indebtedness of the Guarantor but, to the
    extent of the value of the Collateral, are effectively senior to
    all of the Guarantor's unsecured senior Indebtedness and,
    to the extent of the Collateral, are effectively subordinated to
    the Guarantor's Obligations under the Senior Credit
    Facilities and any future Priority Lien Obligations. The
    Guarantees are senior in right of payment to all existing and
    future Subordinated Indebtedness of each Guarantor. The Notes
    are structurally subordinated to Indebtedness and other
    liabilities of Subsidiaries of the Issuer that do not Guarantee
    the Notes.
Not all of the Issuer's Subsidiaries Guarantee the Notes.
    In the event of a bankruptcy, liquidation or reorganization of
    any of these non-guarantor Subsidiaries, the non-guarantor
    Subsidiaries will pay the holders of their debt and their trade
    creditors before they will be able to distribute any of their
    assets to the Issuer.
44
Table of Contents
None of our Subsidiaries which are "Restricted
    Subsidiaries" for purposes of the Existing Notes Indenture,
    Foreign Subsidiaries, ABL Financing Entities, non-Wholly Owned
    Subsidiaries or any Receivables Subsidiaries guarantee the
    Notes. The obligations of each Guarantor under its Guarantee are
    limited as necessary to prevent the Guarantee from constituting
    a fraudulent conveyance under applicable law.
On an as adjusted basis after giving effect to our offering of
    $1.500 billion aggregate principal amount of first lien
    notes in April 2009 and the use of proceeds therefrom, our
    non-guarantor subsidiaries would have accounted for
    approximately $11.867 billion, or 41.8%, of our total
    revenues for the year ended December 31, 2008,
    approximately $3.038 billion, or 40.9%, of our total
    revenues for the three months ended March 31, 2009,
    approximately $9.876 billion, or 40.7%, of our total
    assets, and approximately $7.517 billion, or 22.5%, of our
    total liabilities, in each case, as of December 31, 2008,
    and approximately $9.817 billion, or 40.4%, of our total
    assets, and approximately $7.224 billion, or 21.9%, of our
    total liabilities, in each case, as of March 31, 2009.
Any entity that makes a payment under its Guarantee is entitled
    upon payment in full of all guaranteed obligations under the
    Indenture to a contribution from each other Guarantor in an
    amount equal to such other Guarantor's pro rata portion of
    such payment based on the respective net assets of all the
    Guarantors at the time of such payment determined in accordance
    with GAAP.
If a Guarantee were rendered voidable, it could be subordinated
    by a court to all other indebtedness (including guarantees and
    other contingent liabilities) of the Guarantor, and, depending
    on the amount of such indebtedness, a Guarantor's liability
    on its Guarantee could be reduced to zero. See "Risk
    Factors — Risks Related to the Notes —
    Federal and state fraudulent transfer laws may permit a court to
    void the notes, and with respect to the senior secured notes,
    the guarantees, and, if that occurs, you may not receive any
    payment on the notes."
Each Guarantee by a Guarantor provides by its terms that it will
    be automatically and unconditionally released and discharged
    upon:
(1) (a) any sale, exchange or transfer (by merger or
    otherwise) of the Capital Stock of such Guarantor (including any
    sale, exchange or transfer), after which the applicable
    Guarantor is no longer a Restricted Subsidiary or all or
    substantially all the assets of such Guarantor, which sale,
    exchange or transfer is made in compliance with the applicable
    provisions of the Indenture;
(b) the release or discharge of the guarantee by such
    Guarantor of the Senior Credit Facilities or such other
    guarantee that resulted in the creation of such Guarantee,
    except a discharge or release by or as a result of payment under
    such guarantee;
(c) the designation of any Restricted Subsidiary that is a
    Guarantor as an Unrestricted Subsidiary in compliance with the
    applicable provisions of the Indenture; or
(d) the exercise by the Issuer of its legal defeasance
    option or covenant defeasance option as described under
    "Legal Defeasance and Covenant Defeasance" or the
    discharge of the Issuer's obligations under the Indenture
    in accordance with the terms of the Indenture; and
(2) such Guarantor delivering to the Trustee an
    Officer's Certificate and an Opinion of Counsel, each
    stating that all conditions precedent provided for in the
    Indenture relating to such transaction have been complied with.
Holding
    Company Structure
The Issuer is a holding company for its Subsidiaries, with no
    material operations of its own and only limited assets.
    Accordingly, the Issuer is dependent upon the distribution of
    the earnings of its Subsidiaries, whether in the form of
    dividends, advances or payments on account of intercompany
    obligations, to service its debt obligations.
45
Table of Contents
Security
General
The Notes and the Guarantees are secured by perfected
    second-priority security interests in the Non-Receivables
    Collateral (second in priority to the Liens on the
    Non-Receivables Collateral securing the First Lien Obligations)
    and by perfected third-priority security interests in the Shared
    Receivables Collateral (third in priority to the first-priority
    and second-priority Liens on the Shared Receivables Collateral
    securing the ABL Obligations and the First Lien Obligations,
    respectively), in each case, subject to Permitted Liens;
provided
, that with respect to the portion of the
    Collateral comprised of real property, the Issuer and the
    Guarantors have such time as is reasonably necessary from the
    Issue Date to complete the actions required to perfect the
    second-priority Lien on such Collateral. The Cash Pay Notes and
    the Toggle Notes share in the benefit of such security interests
pro rata
based on the respective amounts of the
    Obligations thereunder. Notwithstanding the foregoing, neither
    the Notes nor the Guarantees are or will be secured by the
    European Collateral or the Separate Receivables Collateral and,
    until after the Discharge of the First Lien Obligations, the
    Notes and the Guarantees will not be secured by any Principal
    Properties. Upon the Discharge of First Lien Obligations and so
    long as no First Lien Obligations are outstanding, the Principal
    Properties that constituted "Collateral" under the
    First Lien Security Documents Facility will become Collateral
    with respect to the Notes, subject to the same limitation on the
    amount of Obligations secured thereby as contained in the First
    Lien Security Documents. See also "— Certain
    Limitations on the Collateral" below. Priority Lien Secured
    Parties have rights and remedies with respect to the Collateral
    that, if exercised, could adversely affect the value of the
    Collateral or the ability of the respective agents under the
    Intercreditor Agreements to realize or foreclose on the
    Collateral on behalf of holders of the Notes. For a description
    of the Shared Receivables Collateral and the Non-Receivables
    Collateral, see "Description of Other
    Indebtedness — Senior Secured Credit
    Facilities — Guarantee and Security."
The Issuer and the Guarantors are and will be able to incur
    additional Indebtedness in the future which could share in the
    Collateral, including additional First Lien Obligations,
    additional ABL Obligations, additional Junior Lien Obligations
    and Obligations secured by Permitted Liens. The amount of such
    additional Obligations are and will be limited by the covenant
    described under "Certain Covenants — Liens"
    and the covenant described under "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock."
    Under certain circumstances, the amount of any such additional
    Obligations could be significant.
After-Acquired
    Collateral
From and after the Issue Date and subject to certain limitations
    and exceptions, (a) if the Issuer or any Guarantor creates
    any additional security interest upon any property or asset that
    would constitute Collateral to secure any First Lien Obligations
    (other than Principal Properties prior to the Discharge of First
    Lien Obligations and so long as no First Lien Obligations are
    outstanding and other than European Collateral and Separate
    Receivables Collateral), it must concurrently grant a
    second-priority perfected security interest (subject to
    Permitted Liens) upon such property as security for the Notes
    and (b) if the Issuer or any Guarantor creates any
    additional security interest upon any property or asset that
    would constitute Shared Receivables Collateral to secure any
    Priority Lien Obligations, it must concurrently grant a
    third-priority perfected security interest (subject to Permitted
    Liens) upon such property as security for the Notes.
Liens
    with Respect to the Collateral
Security
    Documents and Intercreditor Agreements
The Issuer, the Guarantors and the Junior Lien Collateral Agent
    entered into the Security Documents with respect to the
    Collateral defining the terms of the security interests that
    secure the Notes and the Guarantees with respect to such
    Collateral. These security interests secure the payment and
    performance when due of all of the Obligations of the Issuer and
    the Guarantors under the Notes, the Indenture, the Guarantees
    and the Security Documents, as provided in the Security
    Documents.
46
Table of Contents
The Junior Lien Collateral Agent and the First Lien Collateral
    Agent entered into the General Intercreditor Agreement (as the
    same may be amended from time to time, the
"General
    Intercreditor Agreement"
) with respect to the
    Collateral. The First Lien Collateral Agent is initially the
    Collateral Agent under the General Credit Facility. The Junior
    Lien Collateral Agent is initially the Trustee. Pursuant to the
    terms of the General Intercreditor Agreement, prior to the
    Discharge of First Lien Obligations, the First Lien Collateral
    Agent, acting on behalf of the First Lien Secured Parties, will
    determine the time and method by which the security interests in
    the Collateral will be enforced and will have the sole and
    exclusive right to manage, perform and enforce the terms of the
    Security Documents relating to the Collateral and to exercise
    and enforce all privileges, rights and remedies thereunder
    according to its direction, including to take or retake control
    or possession of such Collateral and to hold, prepare for sale,
    marshall, process, sell, lease, dispose of or liquidate such
    Collateral, including, without limitation, following the
    occurrence of a Default or Event of Default under the Indenture.
    The Junior Lien Collateral Agent will not be permitted to
    enforce the security interests even if any Event of Default
    under the Indenture has occurred and the Notes have been
    accelerated except (a) in any insolvency or liquidation
    proceeding, solely as necessary to file a proof of claim or
    statement of interest with respect to the Junior Lien
    Obligations or (b) as necessary to take any action in order
    to prove, preserve, perfect or protect (but not enforce) its
    security interest and rights in, and the perfection and priority
    of its Lien on, the Collateral. See "Risk
    Factors — Risks Related to the Notes — The
    lien ranking provisions of the Indenture and other agreements
    relating to the collateral securing the notes will limit the
    rights of holders of the notes with respect to that collateral,
    even during an event of default." After the Discharge of
    First Lien Obligations, the Junior Lien Collateral Agent in
    accordance with the provisions of the Junior Lien Documents will
    distribute all cash proceeds (after payment of the costs of
    enforcement and collateral administration and any other amounts
    owed to the Junior Lien Collateral Agent) of the Collateral
    received by it under the Security Documents for the ratable
    benefit of the holders of Junior Lien Obligations. The proceeds
    from the sale of the Collateral remaining after the satisfaction
    of all First Lien Obligations may not be sufficient to satisfy
    the Junior Lien Obligations. By its nature some or all of the
    Collateral is and will be illiquid and may have no readily
    ascertainable market value. Accordingly, the Collateral may not
    be able to be sold in a short period of time, if salable. See
    "Risk Factors — Risks Related to the
    Notes — The value of the collateral securing the notes
    may not be sufficient to satisfy our obligations under the
    notes."
The Junior Lien Collateral Agent, for itself and on behalf of
    each Junior Lien Secured Party, has agreed in the General
    Intercreditor Agreement that (a) it will not (and thereby
    waives any right to) take any action to challenge, contest or
    support any other Person in contesting or challenging, directly
    or indirectly, in any proceeding (including any insolvency or
    liquidation proceeding), the validity, perfection, priority or
    enforceability of a Lien securing any First Lien Obligations
    held (or purported to be held) by or on behalf of the First Lien
    Collateral Agent or any of the First Lien Secured Parties or any
    agent or trustee therefor in any Collateral or other First Lien
    Collateral and (b) it will not oppose or otherwise contest
    (or support any other Person contesting) any request for
    judicial relief made in any court by the First Lien Collateral
    Agent or any First Lien Secured Parties relating to the lawful
    enforcement of any First Priority Lien on Collateral or other
    First Lien Collateral.
In addition, the Security Documents provide that, prior to the
    Discharge of First Lien Obligations, (1) the First Lien
    Collateral Agent may take actions with respect to the Collateral
    (including the release of Collateral and the manner of
    realization (subject to the provisions described under
    "— Release of Collateral")) without the
    consent of the Junior Lien Collateral Agent or other Junior Lien
    Secured Parties and (2) the Issuer and the Guarantors may
    require the Junior Lien Collateral Agent to agree to modify the
    Security Documents, or the General Intercreditor Agreement,
    without the consent of the Junior Lien Collateral Agent or other
    Junior Lien Secured Parties, to secure additional extensions of
    credit and add additional First Lien Secured Parties or Junior
    Lien Secured Parties so long as such modifications do not
    expressly violate the provisions of the General Credit Facility
    or the Indenture. In addition, the General Intercreditor
    Agreement provides that with respect to Collateral in the event
    that the First Lien Collateral Agent or the First Lien Secured
    Parties enter into any amendment, waiver or consent in respect
    of or replace any of the First Lien Security Documents for the
    purpose of adding to, or deleting from, or waiving or consenting
    to any departures from any provisions of, any First Lien
    Security Document or changing in any manner the rights of the
    First Lien Collateral Agent, the First Lien Secured Parties, the
    Issuer or any Guarantor thereunder (including the release of any
    Liens in
47
Table of Contents
Collateral in accordance with the provisions described under
    "— Release of Collateral"), then such
    amendment, waiver or consent shall apply automatically to any
    comparable provision of each comparable Security Document in
    favor of the Junior Lien Obligations without the consent of the
    Junior Lien Collateral Agent, any Junior Lien Representative or
    any Junior Lien Secured Party and without any action by the
    Junior Lien Collateral Agent, any Junior Lien Representative,
    the Issuer or any Guarantor;
provided
that such
    amendment, waiver or consent does not materially adversely
    affect the rights of the Junior Lien Secured Parties or the
    interests of the Junior Lien Secured Parties in the Collateral
    in a manner materially different from that affecting the rights
    of the First Lien Secured Parties thereunder or therein. Any
    provider of additional extensions of credit shall be entitled to
    rely on the determination of an Officer that such modifications
    do not expressly violate the provisions of the General Credit
    Facility or the Indenture if such determination is set forth in
    an Officer's Certificate delivered to such provider.
So long as the Discharge of First Lien Obligations has not
    occurred, the Collateral or proceeds thereof received in
    connection with the sale or other disposition of, or collection
    on, such Non-Receivables Collateral upon the exercise of
    remedies will be applied by the First Lien Collateral Agent to
    the First Lien Obligations in such order as specified in the
    relevant First Lien Documents until the Discharge of First Lien
    Obligations has occurred. Upon the Discharge of First Lien
    Obligations, the First Lien Collateral Agent shall deliver to
    the Junior Lien Collateral Agent (for the benefit of all Junior
    Lien Secured Parties) any remaining proceeds of Collateral held
    by it in the same form as received, with any necessary
    endorsements or as a court of competent jurisdiction may
    otherwise direct to be applied by the Junior Lien Collateral
    Agent to the Junior Lien Obligations in such order as specified
    in the Junior Lien Documents.
In addition, so long as the Discharge of First Lien Obligations
    has not occurred, neither the Junior Lien Collateral Agent nor
    any Junior Lien Representative shall acquire or hold any Lien on
    any assets of the Issuer or any Subsidiary (and neither the
    Issuer nor any Subsidiary shall grant such Lien) securing any
    Junior Lien Obligations that are not also subject to the First
    Priority Lien in respect of the First Lien Obligations under the
    First Lien Documents. If the Junior Lien Collateral Agent or any
    Junior Lien Representative shall acquire or hold any Lien on any
    assets of the Issuer or any Subsidiary that is not also subject
    to the First Priority Lien in respect of the First Lien
    Obligations under the First Lien Documents, then such Junior
    Lien Collateral Agent or other Junior Lien Representative shall,
    without the need for any further consent of any party and
    notwithstanding anything to the contrary in any other document,
    be deemed to also hold and have held such Lien for the benefit
    of the First Lien Collateral Agent as security for the First
    Lien Obligations (subject to the lien priority and other terms
    hereof).
The Junior Lien Collateral Agent and each other Junior Lien
    Secured Party have agreed that any Lien purported to be granted
    on any Collateral as security for First Lien Obligations shall
    be deemed to be and shall be deemed to remain senior in all
    respects and prior to all Liens on the Collateral securing any
    Junior Lien Obligations for all purposes regardless of whether
    the Lien purported to be granted is found to be improperly
    granted, improperly perfected, preferential, a fraudulent
    conveyance or legally or otherwise deficient or invalid, in
    whole or in part, in any manner.
Any Collateral or proceeds thereof received by any Junior Lien
    Secured Party at a time when such receipt is not expressly
    permitted by the terms of the General Intercreditor Agreement or
    prior to the Discharge of First Lien Obligations shall be
    segregated and held in trust for the benefit of and forthwith
    paid over to the First Lien Collateral Agent (and/or its
    designees) for the benefit of the First Lien Secured Parties in
    the same form as received, with any necessary endorsements or as
    a court of competent jurisdiction may otherwise direct.
If any First Lien Secured Party is required in any insolvency or
    liquidation proceeding or otherwise to turn over or otherwise
    pay to the estate of the Issuer or any other Guarantor (or any
    trustee, receiver or similar person therefor), because the
    payment of such amount was declared to be fraudulent or
    preferential in any respect or for any other reason, any amount
    (a
"Recovery"
), whether received as proceeds of
    security, enforcement of any right of setoff or otherwise, then
    as among the parties hereto, the First Lien Obligations shall be
    deemed to be reinstated to the extent of such Recovery and to be
    outstanding as if such payment had not occurred and such First
    Lien Secured Party shall be entitled to a reinstatement of First
    Lien Obligations
48
Table of Contents
with respect to all such recovered amounts and shall have all
    rights hereunder. If the General Intercreditor Agreement shall
    have been terminated prior to such Recovery, the General
    Intercreditor Agreement shall be reinstated in full force and
    effect, and such prior termination shall not diminish, release,
    discharge, impair or otherwise affect the obligations of the
    parties thereto. Any Collateral or other First Lien Collateral
    or proceeds thereof received by any Junior Lien Secured Party
    prior to the time of such Recovery shall be deemed to have been
    received prior to the Discharge of First Lien Obligations and
    subject to the provisions of the immediately preceding paragraph.
In addition, if at any time in connection with or after the
    Discharge of First Lien Obligations the Issuer either in
    connection therewith or thereafter enters into any Refinancing
    of any First Lien Document evidencing a First Lien Obligation,
    then such Discharge of First Lien Obligations shall
    automatically be deemed not to have occurred for all purposes of
    the General Intercreditor Agreement, the First Lien Documents
    and the Junior Lien Documents, and the obligations under such
    Refinancing shall automatically be treated as First Lien
    Obligations for all purposes of the General Intercreditor
    Agreement, including for purposes of the Lien priorities and
    rights in respect of Collateral set forth therein, the related
    documents shall be treated as First Lien Documents for all
    purposes of the General Intercreditor Agreement and the first
    lien collateral agent under such Refinanced First Lien Documents
    shall be First Lien Collateral Agent for all purposes of the
    General Intercreditor Agreement.
The General Intercreditor Agreement provides that, prior to the
    Discharge of First Lien Obligations, neither the Junior Lien
    Collateral Agent nor any other Junior Lien Secured Parties may
    assert or enforce any right of marshalling accorded to a junior
    lienholder, as against the First Lien Collateral Agent or any
    First Lien Secured Party (in their capacity as priority
    lienholders). Following the Discharge of First Lien Obligations,
    the Junior Lien Secured Parties may assert their right under the
    Uniform Commercial Code or otherwise to any proceeds remaining
    following a sale or other disposition of Collateral by, or on
    behalf of, the First Lien Collateral Agent or the First Lien
    Secured Parties. This waiver of all rights of marshalling prior
    to the Discharge of First Lien Obligations may result in
    proceeds from the sale of Collateral (in which the Junior Lien
    Secured Parties have second-priority Liens) being applied to
    repay First Lien Obligations prior to the application of the
    proceeds of Shared Receivables Collateral (in which the Junior
    Lien Secured Parties have third-priority Liens), the Principal
    Properties (in which the Junior Lien Secured Parties will not
    have a security interest prior to the Discharge of First Lien
    Obligations and during any time that any First Lien Obligations
    are outstanding) or the European Collateral or the Separate
    Receivables Collateral (in which the Junior Lien Secured Parties
    do not have a security interest). In that scenario, Junior Lien
    Secured Parties may recover less than they would have if such
    proceeds were applied in the order most favorable to the Junior
    Lien Secured Parties.
So long as the Discharge of First Lien Obligations has not
    occurred, whether or not any insolvency or liquidation
    proceeding has been commenced by or against the Issuer or any
    Guarantor, (i) neither the Junior Lien Collateral Agent,
    any Junior Lien Representative nor any Junior Lien Secured Party
    will (x) exercise or seek to exercise any rights or
    remedies (including setoff or the right to credit bid debt
    (except as set forth in the next paragraph below)) with respect
    to any Collateral in respect of any applicable Junior Lien
    Obligations, or institute any action or proceeding with respect
    to such rights or remedies (including any action of
    foreclosure), (y) contest, protest or otherwise object to
    any foreclosure or enforcement proceeding or action brought with
    respect to the Collateral or any other collateral by the First
    Lien Collateral Agent or any First Lien Secured Party in respect
    of the First Lien Obligations, the exercise of any right by the
    First Lien Collateral Agent or any First Lien Secured Party (or
    any agent or
sub-agent
on
    their behalf) in respect of the First Lien Obligations under any
    control agreement, lockbox agreement, landlord waiver or
    bailee's letter or similar agreement or arrangement to
    which the Junior Lien Collateral Agent, any Junior Lien
    Representative or any Junior Lien Secured Party either is a
    party or may have rights as a third-party beneficiary, or any
    other exercise by any such party of any rights and remedies as a
    secured party relating to the Collateral or any other collateral
    under the First Lien Documents or otherwise in respect of First
    Lien Obligations, or (z) object to any waiver or
    forbearance by the First Lien Secured Parties from or in respect
    of bringing or pursuing any foreclosure proceeding or action or
    any other exercise of any rights or remedies relating to the
    Collateral or any other collateral in respect of First Lien
    Obligations and (ii) except as otherwise provided in the
    General
49
Table of Contents
Intercreditor Agreement, the First Lien Collateral Agent and the
    First Lien Secured Parties shall have the sole and exclusive
    right to enforce rights, exercise remedies (including setoff and
    the right to credit bid their debt), marshal, process and make
    determinations regarding the release, disposition or
    restrictions, or waiver or forbearance of rights or remedies
    with respect to the Collateral without any consultation with or
    the consent of the Junior Lien Collateral Agent, any Junior Lien
    Representative or any Junior Lien Secured Party.
Notwithstanding the foregoing, the General Intercreditor
    Agreement shall not be construed to in any way limit or impair
    the right of any Junior Lien Secured Party from exercising a
    credit bid with respect to the Junior Lien Obligations in a sale
    or other disposition of Collateral under Section 363 of the
    Bankruptcy Code;
provided
that in connection with and
    immediately after giving effect to such sale and credit bid
    there occurs a Discharge of First Lien Obligations.
In addition, the Junior Lien Collateral Agent, each Junior Lien
    Representative and each other Junior Lien Secured Party have
    agreed that if the Issuer or any Guarantor is subject to any
    insolvency or liquidation proceeding:
(1) if the First Lien Collateral Agent acting on behalf of
    First Lien Secured Parties desires to permit the use of cash
    collateral or to permit the Issuer or any Guarantor to obtain
    financing under Section 363 or Section 364 of the
    Bankruptcy Code or any similar provision in any Bankruptcy Law
("DIP Financing")
, including if such DIP
    Financing is secured by Liens senior in priority to the Liens
    securing the Notes or other Junior Lien Obligations, then the
    Junior Lien Collateral Agent and each Junior Lien
    Representative, on behalf of itself and each applicable Junior
    Lien Secured Party, agrees not to object to such use of cash
    collateral or DIP Financing and will not request adequate
    protection or any other relief in connection therewith (except
    to the extent permitted by the General Intercreditor Agreement,
    as set forth below) and, to the extent the Liens securing the
    First Lien Obligations are subordinated or
pari passu
with such DIP Financing, will subordinate its Liens in the
    Collateral and any other collateral to such DIP Financing (and
    all Obligations relating thereto) on the same basis as they are
    subordinated to the First Lien Obligations;
(2) none of them will object to, or otherwise contest (or
    support any other Person contesting), any motion for relief from
    the automatic stay or from any injunction against foreclosure or
    enforcement in respect of the First Lien Obligations made by the
    First Lien Collateral Agent or any First Lien Secured Party;
(3) none of them will object to, or otherwise contest (or
    support any other Person contesting), any order relating to a
    sale of assets of any Issuer or Guarantor for which the First
    Lien Collateral Agent has consented that provides, to the extent
    that sale is to be free and clear of Liens, that the Liens
    securing the First Lien Obligations and the Junior Lien
    Obligations will attach to the proceeds of the sale on the same
    basis of priority as the existing Liens in accordance with the
    General Intercreditor Agreement;
(4) none of them will seek relief from the automatic stay
    or any other stay in any insolvency or liquidation proceeding in
    respect of the Collateral or any other First Lien Collateral,
    without the prior written consent of the First Lien Collateral
    Agent;
(5) none of them will object to, or otherwise contest (or
    support any other Person contesting), (a) any request by
    the First Lien Collateral Agent or any First Lien Secured Party
    for adequate protection or (b) any objection by the First
    Lien Collateral Agent or any First Lien Secured Party to any
    motion, relief, action or proceeding based on the First Lien
    Collateral Agent's or such First Lien Secured Party's
    claiming a lack of adequate protection;
(6) none of them will assert or enforce (or support any
    Person asserting or enforcing) any claim under
    Section 506(c) of the Bankruptcy Code senior to or on a
    parity with the Liens securing the First Lien Obligations for
    costs or expenses of preserving or disposing of any Collateral
    or First Lien Collateral;
50
Table of Contents
(7) none of them will oppose or otherwise contest (or
    support any other Person contesting) any lawful exercise by the
    First Lien Collateral Agent or any First Lien Secured Party of
    the right to credit bid First Lien Obligations at any sale of
    Collateral or First Lien Collateral; and
(8) none of them will challenge (or support any other
    person challenging) the validity, enforceability, perfection or
    priority of the First Priority Liens on Collateral or First Lien
    Collateral (and the General Intercreditor Agreement will provide
    that the First Lien Secured Parties agree that none of them will
    challenge the validity, enforceability, perfection or priority
    of the Liens in favor of the Trustee and each other Junior Lien
    Secured Party on the Collateral).
In addition, neither the Junior Lien Collateral Agent, any
    Junior Lien Representative nor any other Junior Lien Secured
    Party will file or prosecute in any insolvency or liquidation
    proceeding any motion for adequate protection (or any comparable
    request for relief) based upon their respective security
    interests in the Collateral, except that:
(1) any of them may freely seek and obtain relief granting
    a junior Lien co-extensive in all respects with, but
    subordinated to, all Liens granted in the insolvency or
    liquidation proceeding to, or for the benefit of, the First Lien
    Secured Parties (and the General Intercreditor Agreement will
    provide that the First Lien Secured Parties will not object to
    the granting of such a junior Lien); and
(2) any of them may freely seek and obtain any relief upon
    a motion for adequate protection (or any comparable relief),
    without any condition or restriction whatsoever, at any time
    after the Discharge of First Lien Obligations.
Without limiting the generality of any provisions of the General
    Intercreditor Agreement, any vote to accept, and any other act
    to support the confirmation or approval of, any Non-Conforming
    Plan of Reorganization shall be inconsistent with and,
    accordingly, a violation of the terms of the General
    Intercreditor Agreement, and the First Lien Collateral Agent
    shall be entitled to have any such vote to accept a
    Non-Conforming Plan of Reorganization dismissed and any such
    support of any Non-Conforming Plan of Reorganization withdrawn.
Subject to the terms of the Security Documents, the Issuer and
    the Guarantors have the right to remain in possession and retain
    exclusive control of the Collateral securing the Notes and the
    Junior Lien Obligations (other than securities, instruments and
    chattel paper constituting part of the Collateral and deposited
    with the First Lien Collateral Agent in accordance with the
    provisions of the First Lien Security Documents and any Shared
    Receivables Collateral subject to a control agreement under the
    circumstances described in the First Lien Security Documents),
    to freely operate the Collateral and to collect, invest and
    dispose of any income therefrom.
The Junior Lien Collateral Agent and each Junior Lien
    Representative, on behalf of the Junior Lien Secured Parties,
    have acknowledged and agreed in the General Intercreditor
    Agreement that (a) the Junior Lien Secured Parties'
    claims against the Issuer
and/or
any
    Guarantor in respect of the Collateral constitute junior claims
    separate and apart (and of a different class) from the senior
    claims of the First Lien Secured Parties against the Issuer and
    the Guarantor in respect of the Collateral, (b) the First
    Lien Obligations include all interest that accrues after the
    commencement of any insolvency or liquidation proceeding of the
    Issuer or any Guarantor at the rate provided for in the
    applicable First Lien Documents governing the same, whether or
    not a claim for post-petition interest is allowed or allowable
    in any such insolvency or liquidation proceeding and
    (c) the Intercreditor Agreement constitutes a
    "subordination agreement" under Section 510 of
    the Bankruptcy Code.
51
Table of Contents
Release
    of Collateral
The Issuer and the Guarantors are entitled to the release of
    property and other assets constituting Collateral from the Liens
    securing the Notes and the Junior Lien Obligations under any one
    or more of the following circumstances:
(1) to enable us to consummate the sale, transfer or other
    disposition of such property or assets to the extent not
    prohibited under the covenant described under
    "— Repurchase at the Option of
    Holders — Asset Sales";
(2) the release of Excess Proceeds or Collateral Excess
    Proceeds that remain unexpended after the conclusion of an Asset
    Sale Offer or a Collateral Asset Sale Offer conducted in
    accordance with the Indenture;
(3) in the case of a Guarantor that is released from its
    Guarantee with respect to the Notes pursuant to the terms of the
    Indenture, the release of the property and assets of such
    Guarantor;
(4) with the consent of the holders of at least 75% of the
    aggregate principal amount of the Notes then outstanding and
    affected thereby and a majority of all Junior Lien Obligations
    (including the Notes) then outstanding and affected thereby
    (including, without limitation, consents obtained in connection
    with a tender offer or exchange offer for, or purchase of,
    Junior Lien Obligations); or
(5) as described under "— Amendment,
    Supplement and Waiver" below.
The Junior Liens on any Collateral securing the Junior Lien
    Obligations will also terminate and be released automatically if
    the First Priority Liens on such Collateral securing First Lien
    Obligations are released by the First Lien Collateral Agent on
    behalf of the First Lien Secured Parties, unless such release
    occurs in connection with, and after giving effect to, a
    Discharge of First Lien Obligations, which discharge is not in
    connection with a foreclosure of, or other exercise of remedies
    with respect to, Collateral by the First Lien Secured Parties
    (such discharge not in connection with any such foreclosure or
    exercise of remedies, a
"Payment Discharge"
)
    (
provided
that, in the case of a Payment Discharge, the
    Liens on any Collateral disposed of in connection with the
    satisfaction in whole or in part of First Lien Obligations shall
    be automatically released but any proceeds thereof not used for
    purposes of the Discharge of First Lien Obligations or otherwise
    in accordance with the Indenture shall be subject to Liens in
    favor of the Junior Lien Secured Parties). In the event of a
    Payment Discharge, the Junior Liens on Collateral shall become
    first-priority security interests, subject to Permitted Liens,
    any intercreditor agreements or arrangements among Junior Lien
    Secured Parties permitted under the General Intercreditor
    Agreement and, with respect to Shared Receivables Collateral,
    subject to the Shared Receivables Intercreditor Agreement;
provided
that if the Issuer or the Guarantors incur at
    any time thereafter any new or replacement First Lien
    Obligations permitted under the Indenture, then such Payment
    Discharge shall automatically be deemed not to have occurred for
    all purposes of the General Intercreditor Agreement, the First
    Lien Documents and the Junior Lien Documents, and such new
    Obligations shall automatically be treated as First Lien
    Obligations for all purposes of the General Intercreditor
    Agreement, including for purposes of the Lien priorities and
    rights in respect of Collateral set forth therein, and the
    related documents shall be treated as First Lien Documents.
To the extent necessary and for so long as required for such
    Subsidiary not to be subject to any requirement pursuant to
Rule 3-16
of
Regulation S-X
under the Securities Act to file separate financial statements
    with the SEC (or any other governmental agency), the Capital
    Stock of any Subsidiary of the Company shall not be included in
    the Collateral with respect to the respective Notes so affected
    (as described under "— Certain Limitations on the
    Collateral") and shall not be subject to the Liens securing
    such Notes and the Junior Lien Obligations.
The Junior Liens on the Collateral securing the Notes and the
    Guarantees also will be released upon (i) payment in full
    of the principal of, together with accrued and unpaid interest
    (including Additional Interest, if any) on, the Notes and all
    other Obligations under the Indenture, the Guarantees and the
    Security Documents that are due and payable at or prior to the
    time such principal, together with accrued and unpaid interest
    (including Additional Interest, if any), are paid or (ii) a
    legal defeasance or covenant defeasance under
52
Table of Contents
the Indenture as described below under "Legal Defeasance
    and Covenant Defeasance" or a discharge of the Indenture as
    described under "Satisfaction and Discharge."
Any certificate or opinion required by Section 314(d) of
    the Trust Indenture Act may be made by an Officer of the
    Company, except in cases where Section 314(d) requires that
    such certificate or opinion be made by an independent engineer,
    appraiser or other expert.
Notwithstanding anything to the contrary herein, the Issuer and
    its Subsidiaries will not be required to comply with all or any
    portion of Section 314(d) of the Trust Indenture Act
    if they determine, in good faith based on advice of counsel,
    that under the terms of that section
and/or
any
    interpretation or guidance as to the meaning thereof of the SEC
    and its staff, including "no action" letters or
    exemptive orders, all or any portion of Section 314(d) of
    the Trust Indenture Act is inapplicable to the released
    Collateral.
Without limiting the generality of the foregoing, certain no
    action letters issued by the SEC have permitted an indenture
    qualified under the Trust Indenture Act to contain
    provisions permitting the release of collateral from Liens under
    such indenture in the ordinary course of the issuer's
    business without requiring the issuer to provide certificates
    and other documents under Section 314(d) of the
    Trust Indenture Act. The Issuer and the Guarantors may,
    subject to the provisions of the Indenture, among other things,
    without any release or consent by the Junior Lien Collateral
    Agent, conduct ordinary course activities with respect to the
    Collateral, including, without limitation:
•
selling or otherwise disposing of, in any transaction or series
    of related transactions, any property subject to the Lien of the
    Security Documents that has become worn out, defective, obsolete
    or not used or useful in the business;
•
abandoning, terminating, canceling, releasing or making
    alterations in or substitutions of any leases or contracts
    subject to the Lien of the Indenture or any of the Security
    Documents;
•
surrendering or modifying any franchise, license or permit
    subject to the Lien of the Security Documents that it may own or
    under which it may be operating;
•
altering, repairing, replacing, changing the location or
    position of and adding to its structures, machinery, systems,
    equipment, fixtures and appurtenances;
•
granting a license of any intellectual property;
•
selling, transferring or otherwise disposing of inventory in the
    ordinary course of business;
•
collecting accounts receivable in the ordinary course of
    business as permitted by the covenant described under
    "Repurchase at the Option of Holders — Asset
    Sales";
•
making cash payments (including for the repayment of
    Indebtedness or interest) from cash that is at any time part of
    the Collateral in the ordinary course of business that are not
    otherwise prohibited by the Indenture and the Security
    Documents; and
•
abandoning any intellectual property that is no longer used or
    useful in the Issuer's business.
The Issuer must deliver an Officer's Certificate to the
    Junior Lien Collateral Agent within 30 calendar days following
    the end of each six-month period beginning on May 15 and
    November 15 of each year, to the effect that all such releases
    and withdrawals during the preceding six-month period (or since
    the Issue Date, in the case of the first such certificate) in
    the ordinary course of the Issuer's or the Guarantors'
    business, as described in the preceding paragraph, were not
    prohibited by the Indenture.
Shared
    Receivables Intercreditor Agreement
In addition, the Junior Lien Collateral Agent, the First Lien
    Collateral Agent and the collateral agent with respect to the
    ABL Facility (the
"ABL Collateral Agent"
)
    entered into a Shared Receivables Intercreditor Agreement (as
    the same may be amended from time to time, the
"Shared
    Receivables Intercreditor Agreement"
) with respect to
    the Shared Receivables Collateral. The Shared Receivables
    Intercreditor Agreement contains provisions with respect to the
    Shared Receivables Collateral and the relative rights,
53
Table of Contents
privileges and obligations relating thereto as between
    (a) the Junior Lien Collateral Agent, the other Junior Lien
    Secured Parties, the First Lien Collateral Agent and the First
    Lien Secured Parties and (b) the ABL Collateral Agent and
    the ABL Secured Parties. The Shared Receivables Intercreditor
    Agreement provides for first-priority Liens in the Shared
    Receivables Collateral in favor of the ABL Secured Parties,
    second-priority Liens in the Shared Receivables Collateral in
    favor of the First Lien Secured Parties and third-priority
    security interests in the Shared Receivables Collateral in favor
    of the Junior Lien Secured Parties, in each case, subject to
    Permitted Liens. The relative rights, privileges and obligations
    with respect to the Shared Receivables Collateral of the ABL
    Secured Parties, on the one hand, and the Junior Lien Collateral
    Agent, the other Junior Lien Secured Parties, the First Lien
    Collateral Agent and the First Lien Secured Parties, on the
    other, are substantially identical to the relative rights,
    privileges and obligations with respect to the Non-Receivables
    Collateral of the First Lien Secured Parties, on the one hand,
    and the Junior Lien Secured Parties, on the other, respectively,
    except that the Liens of the Junior Lien Secured Parties in the
    Shared Receivables Collateral are third-priority Liens and
    except to the extent customary or necessary with respect to
    collateral of the type that constitutes Shared Receivables
    Collateral.
Certain
    Limitations on the Collateral
The Collateral securing the Notes does not and will not include
    any of the following assets:
(1) the property or assets owned by any Subsidiary of the
    Issuer that is not a Guarantor, including each ABL Financing
    Entity;
(2) any rights or interests of the Issuer or any Guarantor
    in, to or under any agreement, contract, license, instrument,
    document or other general intangible (referred to solely for
    purposes of this clause (2) as a
"Contract"
), any intellectual property or any
    security or other investment property (i) to the extent the
    security interest in such Collateral is prohibited by any
    applicable contract, agreement or other instrument without the
    consent of any other party thereto (other than a party to the
    General Credit Facility or the Indenture or, in the case of
    investment property, a Wholly-Owned Subsidiary), (ii) to
    the extent the security interest in such Contract would give any
    other party (other than a party to the General Credit Facility
    or the Indenture or, in the case of investment property, a
    Wholly-Owned Subsidiary) to such Collateral the right to
    terminate its obligations thereunder or (iii) to the extent
    all necessary consents to such grant of a security interest have
    not been obtained from the other parties thereto (other than to
    the extent that any such prohibition referred to in clauses (i),
    (ii) and (iii) would be rendered ineffective pursuant
    to
Sections 9-406,
9-407, 9-408 or 9-409 of the Uniform Commercial Code (or any
    successor provision or provisions) of any relevant jurisdiction
    or any other applicable law));
provided
that this
    limitation shall not affect, limit, restrict or impair the grant
    by the Issuer or such Guarantor of a security interest in any
    account receivable or any money or other amounts due or to
    become due under any Contract;
(3) any equipment of the Issuer or any Guarantor that is
    subject to, or secured by, a Capitalized Lease Obligation or
    Purchase Money Obligations and any equipment that constitutes an
    asset of an entity acquired in a transaction permitted by the
    Indenture to the extent that such equipment subject to a Lien
    permitted by the Indenture and the terms of the Indebtedness
    secured by such Lien prohibit assignment of, or granting of a
    security interest in, the Issuer's or such Guarantor's
    rights and interests therein (other than to the extent that any
    such prohibition would be rendered ineffective pursuant to
Sections 9-406,
9-407,
9-408
    or 9-409 of the Uniform Commercial Code (or any successor
    provision or provisions) of any relevant jurisdiction or any
    other applicable law);
provided
that immediately upon the
    repayment of all Indebtedness secured by such Lien, the Issuer
    or the Guarantor, as the case may be, shall be deemed to have
    granted a security interest in all the rights and interests with
    respect to such equipment;
(4) any Voting Stock that is issued by any Foreign
    Subsidiary, if and to the extent that the inclusion of such
    Voting Stock in the Collateral would cause the Collateral
    pledged by the Issuer or the applicable Guarantor, as the case
    may be, to include in the aggregate more than 65% of the total
    combined voting power of all classes of Voting Stock of such
    Foreign Subsidiary;
54
Table of Contents
(5) any Capital Stock that is issued by a Subsidiary that
    is not owned directly by the Issuer or a Guarantor;
(6) prior to the Discharge of First Lien Obligations and so
    long as any First Lien Obligations are outstanding, any
    Principal Properties;
(7) any Capital Stock and other securities of a Subsidiary
    (excluding Healthtrust, Inc. — The Hospital Company, a
    Delaware corporation and its successors and assigns) to the
    extent that the pledge of such Capital Stock and other
    securities results in the Company's being required to file
    separate financial statements of such Subsidiary with the SEC,
    but only to the extent necessary to not be subject to such
    requirement and only for so long as such requirement is in
    existence and only with respect to the relevant Notes affected;
provided
that neither the Issuer nor any Subsidiary shall
    take any action in the form of a reorganization, merger or other
    restructuring a principal purpose of which is to provide for the
    release of the Lien on any Capital Stock pursuant to this clause
    (7). In addition, in the event that
Rule 3-16
of
Regulation S-X
under the Securities Act is amended, modified or interpreted by
    the SEC to require (or is replaced with another rule or
    regulation, or any other law, rule or regulation is adopted,
    which would require) the filing with the SEC (or any other
    governmental agency) of separate financial statements of any
    Subsidiary of the Company due to the fact that such
    Subsidiary's Capital Stock secures the Notes affected
    thereby, then the Capital Stock of such Subsidiary will
    automatically be deemed not to be part of the Collateral
    securing the relevant Notes affected thereby but only to the
    extent necessary to not be subject to such requirement and only
    for so long as required to not be subject to such requirement.
    In such event, the Security Documents may be amended or
    modified, without the consent of any holder of such Notes, to
    the extent necessary to release the security interests in favor
    of the applicable collateral agents on the shares of Capital
    Stock that are so deemed to no longer constitute part of the
    Collateral for the relevant Notes. In the event that Rule 3-16
    of
Regulation S-X
under the Securities Act is amended, modified or interpreted by
    the SEC to permit (or is replaced with another rule or
    regulation, or any other law, rule or regulation is adopted,
    which would permit) such Subsidiary's Capital Stock to
    secure the Notes in excess of the amount then pledged without
    the filing with the SEC (or any other governmental agency) of
    separate financial statements of such Subsidiary, then the
    Capital Stock of such Subsidiary will automatically be deemed to
    be a part of the Collateral for the relevant Notes but only to
    the extent necessary to not be subject to any such financial
    statement requirement;
(8) certain non-Principal Properties that do not constitute
    Non-Receivables Collateral;
(9) any deposit accounts, other bank or securities accounts
    or cash of the Issuer or any Guarantor;
(10) any leaseholds and motor vehicles of the Issuer or any
    Guarantor;
(11) any Capital Stock or securities convertible into or
    exchangeable for Capital Stock (i) if, in the reasonable
    judgment of the Issuer, the cost or other consequences of
    pledging such Collateral shall be excessive in view of the
    benefits to be obtained by the Junior Lien Secured Parties
    therefrom or (ii) the pledge of such Collateral would
    result in adverse tax consequences to the Issuer or any of its
    Subsidiaries as reasonably determined by the Issuer and
    identified in writing to the Junior Lien Collateral Agent;
(12) any collateral to the extent the grant of the security
    interest therein would violate any requirement of law; and
(13) proceeds and products from any and all of the
    foregoing excluded collateral described in clauses (1)
    through (12), unless such proceeds or products would otherwise
    constitute Collateral securing the Notes.
Sufficiency
    of Collateral
The fair market value of the Collateral is subject to
    fluctuations based on factors that include, among others, the
    condition of the healthcare industry, the ability to sell the
    Collateral in an orderly sale, general economic conditions, the
    availability of buyers and similar factors. The amount to be
    received upon a sale of the Collateral would also be dependent
    on numerous factors, including, but not limited to, the actual
    fair
55
Table of Contents
market value of the Collateral at such time and the timing and
    the manner of the sale. By their nature, portions of the
    Collateral may be illiquid and may have no readily ascertainable
    market value. Accordingly, there can be no assurance that the
    Collateral can be sold in a short period of time or in an
    orderly manner. In addition, in the event of a bankruptcy, the
    ability of the holders to realize upon any of the Collateral may
    be subject to certain bankruptcy law limitations as described
    below.
Certain
    Bankruptcy Limitations
The right of the Trustee to repossess and dispose of the
    Collateral upon the occurrence of an Event of Default would be
    significantly impaired by any Bankruptcy Law in the event that a
    bankruptcy case were to be commenced by or against the Company
    or any Guarantor prior to the Trustee's having repossessed
    and disposed of the Collateral. Upon the commencement of a case
    for relief under the Bankruptcy Code, a secured creditor such as
    the Trustee is prohibited from repossessing its security from a
    debtor in a bankruptcy case, or from disposing of security
    without bankruptcy court approval.
In view of the broad equitable powers of a U.S. bankruptcy
    court, it is impossible to predict how long payments under the
    Notes could be delayed following commencement of a bankruptcy
    case, whether or when the Trustee could repossess or dispose of
    the Collateral, the value of the Collateral at any time during a
    bankruptcy case or whether or to what extent holders of the
    Notes would be compensated for any delay in payment or loss of
    value of the Collateral. The Bankruptcy Code permits only the
    payment
and/or
accrual of post-petition interest, costs and attorneys'
    fees to a secured creditor during a debtor's bankruptcy
    case to the extent the value of such creditor's interest in
    the Collateral is determined by the bankruptcy court to exceed
    the aggregate outstanding principal amount of the obligations
    secured by the Collateral.
Furthermore, in the event a domestic or foreign bankruptcy court
    determines that the value of the Collateral is not sufficient to
    repay all amounts due on the Notes, the holders of the Notes
    would hold secured claims only to the extent of the value of the
    Collateral to which the holders of the Notes are entitled, and
    unsecured claims with respect to such shortfall.
Paying
    Agent and Registrar for the Notes
The Issuer must maintain one or more paying agents for the Notes
    in the Borough of Manhattan, City of New York. The initial
    paying agent for the Notes is the Trustee.
The Issuer must also maintain a registrar with offices in the
    Borough of Manhattan, City of New York. The initial registrar is
    the Trustee. The registrar maintains a register reflecting
    ownership of the Notes outstanding from time to time and makes
    payments on and facilitates transfer of Notes on behalf of the
    Issuer.
The Issuer may change the paying agents or the registrars
    without prior notice to the Holders. The Issuer or any of its
    Subsidiaries may act as a paying agent or registrar.
Transfer
    and Exchange
A Holder may transfer or exchange Notes in accordance with the
    Indenture. The registrar and the Trustee may require a Holder to
    furnish appropriate endorsements and transfer documents in
    connection with a transfer of Notes. Holders will be required to
    pay all taxes due on transfer. The Issuer will not be required
    to transfer or exchange any Note selected for redemption. Also,
    the Issuer will not be required to transfer or exchange any Note
    for a period of 15 days before a selection of Notes to be
    redeemed.
Principal,
    Maturity and Interest
The Issuer issued $5,700,000,000 in aggregate principal amount
    of Notes in a private transaction that was not subject to the
    registration requirements of the Securities Act, of which
    $1,000,000,000 in aggregate principal amount are 2014 Cash Pay
    Notes, $3,200,000,000 in aggregate principal amount are 2016
    Cash Pay Notes and $1,500,000,000 in aggregate principal amount
    are Toggle Notes. The 2014 Cash Pay Notes will mature on
    November 15, 2014, the 2016 Cash Pay Notes will mature on
    November 15, 2016 and the Toggle Notes will mature on
    November 15, 2016. Subject to compliance with the covenant
    described below under the
56
Table of Contents
caption "Certain Covenants — Limitation on
    Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock," the Issuer may issue additional 2014
    Cash Pay Notes, 2016 Cash Pay Notes
and/or
Toggle Notes from time to time after this offering under the
    Indenture (any such 2014 Cash Pay Notes, 2016 Cash Pay Notes or
    Toggle Notes,
"Additional Notes"
). In addition,
    in connection with the payment of PIK Interest or Partial PIK
    Interest in respect of the Toggle Notes, the Issuer is entitled
    to, without the consent of the Holders, increase the outstanding
    principal amount of the Toggle Notes or issue additional Toggle
    Notes (the
"PIK Notes"
) under the Indenture on
    the same terms and conditions as the Toggle Notes (in each case,
    the
"PIK Payment"
). The Cash Pay Notes and the
    Toggle Notes are each separate series of Notes but are treated
    as a single class of securities under the Indenture, except as
    otherwise stated herein. As a result, Holders of each series of
    Notes do not have separate rights to, among other things, give
    notice of Defaults or to direct the Trustee to exercise remedies
    during Event of Default or otherwise. Except as described under
    "Amendment, Supplement and Waiver," the Notes offered
    by the Issuer, the PIK Notes and any Additional Notes
    subsequently issued under the Indenture will be treated as a
    single class for all purposes under the Indenture, including
    waivers, amendments, redemptions and offers to purchase. Unless
    the context requires otherwise, references to "Notes"
    for all purposes of the Indenture and this "Description of
    Notes" include any PIK Notes and Additional Notes that are
    actually issued, and references to "principal amount"
    of the Notes includes any increase in the principal amount of
    the outstanding Notes as a result of a PIK Payment.
Cash
    Pay Notes
2014 Cash
    Pay Notes
Interest on the 2014 Cash Pay Notes accrues at the rate of
    9
1
/
8
%
    per annum and is payable semi-annually in arrears on May 15 and
    November 15, commencing on May 15, 2007, to the
    Holders of 2014 Cash Pay Notes of record on the immediately
    preceding May 1 and November 1. Interest on the 2014 Cash
    Pay Notes accrues from the most recent date to which interest
    has been paid or, if no interest has been paid, from and
    including the Issue Date. Interest on the 2014 Cash Pay Notes is
    computed on the basis of a
360-day
year
    comprised of twelve
30-day
months.
2016 Cash
    Pay Notes
Interest on the 2016 Cash Pay Notes accrues at the rate of
    9
1
/
4
%
    per annum and is payable semi-annually in arrears on May 15 and
    November 15, commencing on May 15, 2007, to the
    Holders of 2016 Cash Pay Notes of record on the immediately
    preceding May 1 and November 1. Interest on the 2016 Cash
    Pay Notes accrues from the most recent date to which interest
    has been paid or, if no interest has been paid, from and
    including the Issue Date. Interest on the 2016 Cash Pay Notes is
    computed on the basis of a
360-day
year
    comprised of twelve
30-day
months.
Toggle
    Notes
Interest on the Toggle Notes is payable semi-annually in arrears
    on May 15 and November 15, commencing on May 15, 2007,
    to the Holders of Toggle Notes of record on the immediately
    preceding May 1 and November 1. Interest on the Toggle
    Notes accrues from the most recent date to which interest has
    been paid or, if no interest has been paid, from and including
    the Issue Date. Interest on the Toggle Notes is computed on the
    basis of a
360-day
year
    comprised of twelve
30-day
months.
For any interest payment period after the initial interest
    payment period and prior to November 15, 2011, the Issuer
    may, at its option, elect to pay interest on the Toggle Notes:
•
entirely in cash
("Cash Interest")
;
•
entirely by increasing the principal amount of the outstanding
    Toggle Notes or by issuing PIK Notes
("PIK
    Interest")
; or
•
on 50% of the outstanding principal amount of the Toggle Notes
    in cash and on 50% of the principal amount by increasing the
    principal amount of the outstanding Toggle Notes or by issuing
    PIK Notes
("Partial PIK Interest")
.
57
Table of Contents
The Issuer must elect the form of interest payment with respect
    to each interest period by delivering a notice to the Trustee
    prior to the beginning of each interest period. The Trustee
    shall promptly deliver a corresponding notice to the Holders. In
    the absence of such an election for any interest period,
    interest on the Toggle Notes shall be payable according to the
    election for the previous interest period. Interest for the
    first interest period commencing on the Issue Date shall be
    payable entirely in cash. After November 15, 2011, the
    Issuer will make all interest payments on the Toggle Notes
    entirely in cash. Notwithstanding anything to the contrary, the
    payment of accrued interest in connection with any redemption of
    Toggle Notes as described under "— Optional
    Redemption — Toggle Notes" or "Repurchase at
    the Option of Holders" shall be made solely in cash.
Cash Interest on the Toggle Notes accrues at a rate of
    9
5
/
8
%
    per annum and is payable in cash. PIK Interest on the Toggle
    Notes accrues at a rate of
    10
3
/
8
%
    per annum and is payable (x) with respect to Toggle Notes
    represented by one or more global notes registered in the name
    of, or held by, The Depository Trust Company
("DTC")
or its nominee on the relevant record
    date, by increasing the principal amount of the outstanding
    global Toggle Note by an amount equal to the amount of PIK
    Interest for the applicable interest period (rounded up to the
    nearest $1,000) and (y) with respect to Toggle Notes
    represented by certificated notes, by issuing PIK Notes in
    certificated form in an aggregate principal amount equal to the
    amount of PIK Interest for the applicable period (rounded up to
    the nearest whole dollar), and the Trustee will, at the request
    of the Issuer, authenticate and deliver such PIK Notes in
    certificated form for original issuance to the Holders on the
    relevant record date, as shown by the records of the register of
    Holders. In the event that the Issuer elects to pay Partial PIK
    Interest for any interest period, each Holder will be entitled
    to receive Cash Interest in respect of 50% of the principal
    amount of the Toggle Notes held by such Holder on the relevant
    record date and PIK Interest in respect of 50% of the principal
    amount of the Toggle Notes held by such Holder on the relevant
    record date. Following an increase in the principal amount of
    the outstanding global Toggle Notes as a result of a PIK
    Payment, the global Toggle Notes will bear interest on such
    increased principal amount from and after the date of such PIK
    Payment. Any PIK Notes issued in certificated form will be dated
    as of the applicable interest payment date and will bear
    interest from and after such date. All Toggle Notes issued
    pursuant to a PIK Payment will mature on November 15, 2016
    and will be governed by, and subject to the terms, provisions
    and conditions of, the Indenture and shall have the same rights
    and benefits as the Toggle Notes issued on the Issue Date. Any
    certificated PIK Notes will be issued with the description PIK
    on the face of such PIK Note.
If the toggle notes would otherwise constitute "applicable
    high yield discount obligations" within the meaning of
    Section 163(i)(1) of the Code, at the end of the first
    accrual period ending after the fifth anniversary of the toggle
    notes' issuance (the
"AHYDO redemption
    date"
), the Issuer will be required to redeem for cash
    a portion of each toggle note then outstanding equal to the
    "Mandatory Principal Redemption Amount" (such
    redemption, a
"Mandatory Principal
    Redemption"
). The redemption price for the portion of
    each toggle note redeemed pursuant to a Mandatory Principal
    Redemption will be 100% of the principal amount of such portion
    plus any accrued interest thereon on the date of redemption. The
"Mandatory Principal Redemption Amount"
means the portion of a toggle note required to be redeemed to
    prevent such toggle note from being treated as an
    "applicable high yield discount obligation" within the
    meaning of Section 163(i)(1) of the Code. No partial
    redemption or repurchase of the toggle notes prior to the AHYDO
    redemption date pursuant to any other provision of the indenture
    will alter the Issuer's obligation to make the Mandatory
    Principal Redemption with respect to any toggle notes that
    remain outstanding on the AHYDO redemption date.
Additional
    Interest
Additional Interest may accrue on the Notes in certain
    circumstances pursuant to the Registration Rights Agreement. Any
    Additional Interest on the Notes will be payable in the same
    form elected by the Issuer for payment of interest for the
    applicable interest payment period. All references in the
    Indenture, in any context, to any interest or other amount
    payable on or with respect to the Notes shall be deemed to
    include any Additional Interest pursuant to the Registration
    Rights Agreement.
58
Table of Contents
Principal of, premium, if any, and interest on the Notes will be
    payable at the office or agency of the Issuer maintained for
    such purpose within the City and State of New York or, at the
    option of the Issuer, payment of interest may be made by check
    mailed to the Holders of the Notes at their respective addresses
    set forth in the register of Holders;
provided
that all
    payments of principal, premium, if any, and interest with
    respect to the Notes represented by one or more global notes
    registered in the name of or held by DTC or its nominee will be
    made by wire transfer of immediately available funds to the
    accounts specified by the Holder or Holders thereof. Until
    otherwise designated by the Issuer, the Issuer's office or
    agency in New York will be the office of the Trustee maintained
    for such purpose.
Mandatory
    Redemption; Offers to Purchase; Open Market Purchases
Except as set forth in the last paragraph under "Principal,
    Maturity and Interest — Toggle Notes" the Issuer
    is not required to make any mandatory redemption or sinking fund
    payments with respect to the Notes. However, under certain
    circumstances, the Issuer may be required to offer to purchase
    Notes as described under the caption "Repurchase at the
    Option of Holders." The Issuer may at any time and from
    time to time purchase Notes in the open market or otherwise.
Optional
    Redemption
2014
    Cash Pay Notes
Except as set forth below, the Issuer is not entitled to redeem
    2014 Cash Pay Notes at its option prior to November 15,
    2010.
At any time prior to November 15, 2010, the Issuer may
    redeem all or a part of the 2014 Cash Pay Notes, upon not less
    than 30 nor more than 60 days' prior notice mailed by
    first-class mail to the registered address of each Holder of
    2014 Cash Pay Notes or otherwise in accordance with the
    procedures of DTC, at a redemption price equal to 100% of the
    principal amount of the 2014 Cash Pay Notes redeemed plus the
    Applicable Premium as of, and accrued and unpaid interest and
    Additional Interest, if any, to the date of redemption (the
"Redemption Date"
), subject to the rights
    of Holders of 2014 Cash Pay Notes on the relevant record date to
    receive interest due on the relevant interest payment date.
On and after November 15, 2010, the Issuer may redeem the
    2014 Cash Pay Notes, in whole or in part, upon not less than 30
    nor more than 60 days' prior notice mailed by
    first-class mail to the registered address of each Holder of
    2014 Cash Pay Notes or otherwise in accordance with the
    procedures of DTC, at the redemption prices (expressed as
    percentages of principal amount of the 2014 Cash Pay Notes to be
    redeemed) set forth below, plus accrued and unpaid interest
    thereon and Additional Interest, if any, to the applicable
    Redemption Date, subject to the right of Holders of 2014
    Cash Pay Notes of record on the relevant record date to receive
    interest due on the relevant interest payment date, if redeemed
    during the twelve-month period beginning on November 15 of each
    of the years indicated below:
Year
Percentage
2010
104.563
%
2011
102.281
%
2012 and thereafter
100.000
%
In addition, until November 15, 2009, the Issuer may, at
    its option, on one or more occasions redeem up to 35% of the
    aggregate principal amount of 2014 Cash Pay Notes at a
    redemption price equal to 109.125% of the aggregate principal
    amount thereof, plus accrued and unpaid interest thereon and
    Additional Interest, if any, to the applicable
    Redemption Date, subject to the right of Holders of 2014
    Cash Pay Notes of record on the relevant record date to receive
    interest due on the relevant interest payment date, with the net
    cash proceeds of one or more Equity Offerings;
provided
that at least 50% of the sum of the original aggregate
    principal amount of 2014 Cash Pay Notes issued under the
    Indenture and the original principal amount of any Additional
    Notes that are 2014 Cash Pay Notes issued under the Indenture
    after the Issue Date remains outstanding immediately after the
    occurrence of each such redemption;
provided further
that
    each such redemption occurs within 90 days of the date of
    closing of each such Equity Offering.
59
Table of Contents
Any notice of any redemption may be given prior to the
    redemption thereof, and any such redemption or notice may, at
    the Issuer's discretion, be subject to one or more
    conditions precedent, including, but not limited to, completion
    of an Equity Offering or other corporate transaction.
If the Issuer redeems less than all of the outstanding 2014 Cash
    Pay Notes, the Trustee shall select the 2014 Cash Pay Notes to
    be redeemed in the manner described under "Repurchase at
    the Option of Holders — Selection and Notice."
2016
    Cash Pay Notes
Except as set forth below, the Issuer is not entitled to redeem
    2016 Cash Pay Notes at its option prior to November 15,
    2011.
At any time prior to November 15, 2011, the Issuer may
    redeem all or a part of the 2016 Cash Pay Notes, upon not less
    than 30 nor more than 60 days' prior notice mailed by
    first-class mail to the registered address of each Holder of
    2016 Cash Pay Notes or otherwise in accordance with the
    procedures of DTC, at a redemption price equal to 100% of the
    principal amount of the 2016 Cash Pay Notes redeemed plus the
    Applicable Premium as of, and accrued and unpaid interest and
    Additional Interest, if any, to the Redemption Date,
    subject to the rights of Holders of 2016 Cash Pay Notes on the
    relevant record date to receive interest due on the relevant
    interest payment date.
On and after November 15, 2011, the Issuer may redeem the
    2016 Cash Pay Notes, in whole or in part, upon not less than 30
    nor more than 60 days' prior notice mailed by
    first-class mail to the registered address of each Holder of
    2016 Cash Pay Notes or otherwise in accordance with the
    procedures of DTC, at the redemption prices (expressed as
    percentages of principal amount of the 2016 Cash Pay Notes to be
    redeemed) set forth below, plus accrued and unpaid interest
    thereon and Additional Interest, if any, to the applicable
    Redemption Date, subject to the right of Holders of 2016
    Cash Pay Notes of record on the relevant record date to receive
    interest due on the relevant interest payment date, if redeemed
    during the twelve-month period beginning on November 15 of each
    of the years indicated below:
Year
Percentage
2011
104.625
2012
103.083
2013
101.542
2014 and thereafter
100.000
In addition, until November 15, 2009, the Issuer may, at
    its option, on one or more occasions redeem up to 35% of the
    aggregate principal amount of 2016 Cash Pay Notes at a
    redemption price equal to 109.250% of the aggregate principal
    amount thereof, plus accrued and unpaid interest thereon and
    Additional Interest, if any, to the applicable
    Redemption Date, subject to the right of Holders of 2016
    Cash Pay Notes of record on the relevant record date to receive
    interest due on the relevant interest payment date, with the net
    cash proceeds of one or more Equity Offerings;
provided
that at least 50% of the sum of the original aggregate
    principal amount of 2016 Cash Pay Notes issued under the
    Indenture and the original principal amount of any Additional
    Notes that are 2016 Cash Pay Notes issued under the Indenture
    after the Issue Date remains outstanding immediately after the
    occurrence of each such redemption;
provided further
that
    each such redemption occurs within 90 days of the date of
    closing of each such Equity Offering.
Any notice of any redemption may be given prior to the
    redemption thereof, and any such redemption or notice may, at
    the Issuer's discretion, be subject to one or more
    conditions precedent, including, but not limited to, completion
    of an Equity Offering or other corporate transaction.
If the Issuer redeems less than all of the outstanding 2016 Cash
    Pay Notes, the Trustee shall select the 2016 Cash Pay Notes to
    be redeemed in the manner described under "Repurchase at
    the Option of Holders — Selection and Notice."
60
Table of Contents
Toggle
    Notes
Except as set forth below, the Issuer is not entitled to redeem
    Toggle Notes at its option prior to November 15, 2011.
At any time prior to November 15, 2011, the Issuer may
    redeem all or a part of the Toggle Notes, upon not less than 30
    nor more than 60 days' prior notice mailed by
    first-class mail to the registered address of each Holder of
    Toggle Notes or otherwise in accordance with the procedures of
    DTC, at a redemption price equal to 100% of the principal amount
    of the Toggle Notes redeemed plus the Applicable Premium as of,
    and accrued and unpaid interest and Additional Interest, if any,
    to the Redemption Date, subject to the rights of Holders of
    Toggle Notes on the relevant record date to receive interest due
    on the relevant interest payment date.
On and after November 15, 2011, the Issuer may redeem the
    Toggle Notes, in whole or in part, upon not less than 30 nor
    more than 60 days' prior notice mailed by first-class
    mail to the registered address of each Holder of Toggle Notes or
    otherwise in accordance with the procedures of DTC, at the
    redemption prices (expressed as percentages of principal amount
    of the Toggle Notes to be redeemed) set forth below, plus
    accrued and unpaid interest thereon and Additional Interest, if
    any, to the applicable Redemption Date, subject to the
    right of Holders of Toggle Notes of record on the relevant
    record date to receive interest due on the relevant interest
    payment date, if redeemed during the twelve-month period
    beginning on November 15 of each of the years indicated below:
Year
Percentage
2011
104.813
2012
103.208
2013
101.604
2014 and thereafter
100.000
In addition, until November 15, 2009, the Issuer may, at
    its option, on one or more occasions redeem up to 35% of the
    aggregate principal amount of Toggle Notes at a redemption price
    equal to 109.625% of the aggregate principal amount thereof,
    plus accrued and unpaid interest thereon and Additional
    Interest, if any, to the applicable Redemption Date,
    subject to the right of Holders of Toggle Notes of record on the
    relevant record date to receive interest due on the relevant
    interest payment date, with the net cash proceeds of one or more
    Equity Offerings;
provided
that at least 50% of the sum
    of the original aggregate principal amount of Toggle Notes
    issued under the Indenture and the original principal amount of
    any Additional Notes that are Toggle Notes issued under the
    Indenture after the Issue Date remains outstanding immediately
    after the occurrence of each such redemption;
provided
    further
that each such redemption occurs within 90 days
    of the date of closing of each such Equity Offering.
Any notice of any redemption may be given prior to the
    redemption thereof, and any such redemption or notice may, at
    the Issuer's discretion, be subject to one or more
    conditions precedent, including, but not limited to, completion
    of an Equity Offering or other corporate transaction.
If the Issuer redeems less than all of the outstanding Toggle
    Notes, the Trustee shall select the Toggle Notes to be redeemed
    in the manner described under "Repurchase at the Option of
    Holders — Selection and Notice."
Repurchase
    at the Option of Holders
Change
    of Control
The Notes provide that if a Change of Control occurs, unless the
    Issuer has previously or concurrently mailed a redemption notice
    with respect to all the outstanding Notes as described under
    "Optional Redemption," the Issuer will make an offer
    to purchase all of the Notes pursuant to the offer described
    below (the "Change of Control Offer") at a price in
    cash (the "Change of Control Payment") equal to 101%
    of the aggregate principal amount thereof plus accrued and
    unpaid interest and Additional Interest, if any, to the date of
    purchase, subject to the right of Holders of the Notes of record
    on the relevant record date to receive
61
Table of Contents
interest due on the relevant interest payment date. Within
    30 days following any Change of Control, the Issuer will
    send notice of such Change of Control Offer by first-class mail,
    with a copy to the Trustee, to each Holder of Notes to the
    address of such Holder appearing in the security register with a
    copy to the Trustee or otherwise in accordance with the
    procedures of DTC, with the following information:
(1) that a Change of Control Offer is being made pursuant
    to the covenant entitled "Change of Control" and that
    all Notes properly tendered pursuant to such Change of Control
    Offer will be accepted for payment by the Issuer;
(2) the purchase price and the purchase date, which will be
    no earlier than 30 days nor later than 60 days from
    the date such notice is mailed (the
"Change of Control
    Payment Date"
);
(3) that any Note not properly tendered will remain
    outstanding and continue to accrue interest;
(4) that unless the Issuer defaults in the payment of the
    Change of Control Payment, all Notes accepted for payment
    pursuant to the Change of Control Offer will cease to accrue
    interest on the Change of Control Payment Date;
(5) that Holders electing to have any Notes purchased
    pursuant to a Change of Control Offer will be required to
    surrender such Notes, with the form entitled "Option of
    Holder to Elect Purchase" on the reverse of such Notes
    completed, to the paying agent specified in the notice at the
    address specified in the notice prior to the close of business
    on the third Business Day preceding the Change of Control
    Payment Date;
(6) that Holders will be entitled to withdraw their
    tendered Notes and their election to require the Issuer to
    purchase such Notes;
provided
that the paying agent
    receives, not later than the close of business on the
    30th day following the date of the Change of Control
    notice, a telegram, facsimile transmission or letter setting
    forth the name of the Holder of the Notes, the principal amount
    of Notes tendered for purchase, and a statement that such Holder
    is withdrawing its tendered Notes and its election to have such
    Notes purchased;
(7) that if the Issuer is redeeming less than all of the
    Notes, the Holders of the remaining Notes will be issued new
    Notes and such new Notes will be equal in principal amount to
    the unpurchased portion of the Notes surrendered. The
    unpurchased portion of the Notes must be equal to $2,000 or an
    integral multiple of $1,000 in excess thereof; and
(8) the other instructions, as determined by us, consistent
    with the covenant described hereunder, that a Holder must follow.
The Issuer will comply with the requirements of
Rule 14e-1
under the Exchange Act and any other securities laws and
    regulations thereunder to the extent such laws or regulations
    are applicable in connection with the repurchase of Notes
    pursuant to a Change of Control Offer. To the extent that the
    provisions of any securities laws or regulations conflict with
    the provisions of the Indenture, the Issuer will comply with the
    applicable securities laws and regulations and shall not be
    deemed to have breached its obligations described in the
    Indenture by virtue thereof.
On the Change of Control Payment Date, the Issuer will, to the
    extent permitted by law,
(1) accept for payment all Notes issued by it or portions
    thereof properly tendered pursuant to the Change of Control
    Offer;
(2) deposit with the paying agent an amount equal to the
    aggregate Change of Control Payment in respect of all Notes or
    portions thereof so tendered; and
(3) deliver, or cause to be delivered, to the Trustee for
    cancellation the Notes so accepted together with an
    Officer's Certificate to the Trustee stating that such
    Notes or portions thereof have been tendered to and purchased by
    the Issuer.
The Senior Credit Facilities, and future credit agreements or
    other agreements relating to Senior Indebtedness to which the
    Issuer becomes a party may, provide that certain change of
    control events with
62
Table of Contents
respect to the Issuer would constitute a default thereunder
    (including a Change of Control under the Indenture). If we
    experience a change of control that triggers a default under our
    Senior Credit Facilities, we could seek a waiver of such default
    or seek to refinance our Senior Credit Facilities. In the event
    we do not obtain such a waiver or refinance the Senior Credit
    Facilities, such default could result in amounts outstanding
    under our Senior Credit Facilities being declared due and
    payable and could cause a Receivables Facility to be wound down.
Our ability to pay cash to the Holders of Notes following the
    occurrence of a Change of Control may be limited by our
    then-existing financial resources. Therefore, sufficient funds
    may not be available when necessary to make any required
    repurchases.
The Change of Control purchase feature of the Notes may in
    certain circumstances make more difficult or discourage a sale
    or takeover of us and, thus, the removal of incumbent
    management. The Change of Control purchase feature is a result
    of negotiations between the Initial Purchasers and us. We have
    no present intention to engage in a transaction involving a
    Change of Control, although it is possible that we could decide
    to do so in the future. Subject to the limitations discussed
    below, we could, in the future, enter into certain transactions,
    including acquisitions, refinancings or other recapitalizations,
    that would not constitute a Change of Control under the
    Indenture, but that could increase the amount of indebtedness
    outstanding at such time or otherwise affect our capital
    structure or credit ratings. Restrictions on our ability to
    incur additional Indebtedness are contained in the covenants
    described under "Certain Covenants — Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock" and "Certain
    Covenants — Liens." Such restrictions in the
    Indenture can be waived only with the consent of the Holders of
    a majority in principal amount of the Notes then outstanding.
    Except for the limitations contained in such covenants, however,
    the Indenture does not contain any covenants or provisions that
    may afford Holders of the Notes protection in the event of a
    highly leveraged transaction.
The Issuer is not required to make a Change of Control Offer
    following a Change of Control if a third party makes the Change
    of Control Offer in the manner, at the times and otherwise in
    compliance with the requirements set forth in the Indenture
    applicable to a Change of Control Offer made by us and purchases
    all Notes validly tendered and not withdrawn under such Change
    of Control Offer. Notwithstanding anything to the contrary
    herein, a Change of Control Offer may be made in advance of a
    Change of Control, conditional upon such Change of Control, if a
    definitive agreement is in place for the Change of Control at
    the time of making of the Change of Control Offer.
The definition of "Change of Control" includes a
    disposition of all or substantially all of the assets of the
    Issuer to any Person. Although there is a limited body of case
    law interpreting the phrase "substantially all," there
    is no precise established definition of the phrase under
    applicable law. Accordingly, in certain circumstances there may
    be a degree of uncertainty as to whether a particular
    transaction would involve a disposition of "all or
    substantially all" of the assets of the Issuer. As a
    result, it may be unclear as to whether a Change of Control has
    occurred and whether a Holder of Notes may require the Issuer to
    make an offer to repurchase the Notes as described above.
The provisions under the Indenture relating to the Issuer's
    obligation to make an offer to repurchase the Notes as a result
    of a Change of Control may be waived or modified with the
    written consent of the Holders of a majority in principal amount
    of the Notes.
Asset
    Sales
The Indenture provides that the Issuer will not, and will not
    permit any of its Restricted Subsidiaries to consummate,
    directly or indirectly, an Asset Sale, unless:
(1) the Issuer or such Restricted Subsidiary, as the case
    may be, receives consideration at the time of such Asset Sale at
    least equal to the fair market value (as determined in good
    faith by the Issuer) of the assets sold or otherwise disposed
    of; and
63
Table of Contents
(2) except in the case of a Permitted Asset Swap, at least
    75% of the consideration therefor received by the Issuer or such
    Restricted Subsidiary, as the case may be, is in the form of
    cash or Cash Equivalents;
provided
that the amount of:
(a) any liabilities (as shown on the Issuer's or such
    Restricted Subsidiary's most recent balance sheet or in the
    footnotes thereto) of the Issuer or such Restricted Subsidiary,
    other than liabilities that are by their terms subordinated to
    the Notes, that are assumed by the transferee of any such assets
    and for which the Issuer and all of its Restricted Subsidiaries
    have been validly released by all creditors in writing,
(b) any securities received by the Issuer or such
    Restricted Subsidiary from such transferee that are converted by
    the Issuer or such Restricted Subsidiary into cash (to the
    extent of the cash received) within 180 days following the
    closing of such Asset Sale, and
(c) any Designated Non-cash Consideration received by the
    Issuer or such Restricted Subsidiary in such Asset Sale having
    an aggregate fair market value, taken together with all other
    Designated Non-cash Consideration received pursuant to this
    clause (c) that is at that time outstanding, not to exceed
    5% of Total Assets at the time of the receipt of such Designated
    Non-cash Consideration, with the fair market value of each item
    of Designated Non-cash Consideration being measured at the time
    received and without giving effect to subsequent changes in
    value, shall be deemed to be cash for purposes of this provision
    and for no other purpose.
Within 450 days after the receipt of any Net Proceeds of
    any Asset Sale, the Issuer or such Restricted Subsidiary, at its
    option, may apply the Net Proceeds from such Asset Sale,
(1) to permanently reduce:
(a) Obligations under Priority Lien Obligations and to
    correspondingly reduce commitments with respect thereto;
(b) Obligations under Senior Indebtedness (other than any
    Junior Lien Obligation) that is secured by a Lien permitted
    under the Indenture (which Lien is senior to the Lien of the
    Notes with respect to the Collateral), and to correspondingly
    reduce commitments with respect thereto;
(c) Obligations under Junior Lien Obligations (and to
    correspondingly reduce commitments with respect thereto) through
    open-market purchases (to the extent such purchases are at or
    above 100% of the principal amount thereof) or by making an
    Asset Sale Offer or a Collateral Asset Sale Offer in accordance
    with the procedures set forth below;
provided
that the
    Issuer shall equally and ratably reduce Obligations under the
    Notes as provided under "Optional Redemption," through
    open-market purchases or otherwise by making an offer (in
    accordance with the procedures set forth below for an Asset Sale
    Offer or a Collateral Asset Sale Offer) to all Holders to
    purchase their Notes at 100% of the principal amount thereof,
    plus the amount of accrued but unpaid interest, if any, on the
    amount of the Notes that would otherwise be prepaid;
(d) Obligations under the Existing Notes which have a final
    maturity date (as in effect on the Issue Date) on or prior to
    November 15, 2016;
provided
that, at the time of,
    and after giving effect to, such repurchase, redemption or
    defeasance, the aggregate amount of Net Proceeds used to
    repurchase, redeem or defease Existing Notes pursuant to this
    subclause (d) following the Issue Date shall not exceed 5%
    of the consolidated total assets of the Issuer and its
    subsidiaries at such time; or
(e) Indebtedness of a Restricted Subsidiary that is not a
    Guarantor, other than Indebtedness owed to the Issuer or another
    Restricted Subsidiary (or any affiliate thereof);
(2) to make (a) an Investment in any one or more
    businesses,
provided
that such Investment in any business
    is in the form of the acquisition of Capital Stock and results
    in the Issuer or another of its Restricted Subsidiaries, as the
    case may be, owning an amount of the Capital Stock of such
    business such that it constitutes a Restricted Subsidiary,
    (b) capital expenditures or (c) acquisitions of other
    assets, in each of (a), (b) and (c), used or useful in a
    Similar Business; or
64
Table of Contents
(3) to make an investment in (a) any one or more
    businesses,
provided
that such Investment in any business
    is in the form of the acquisition of Capital Stock and results
    in the Issuer or another of its Restricted Subsidiaries, as the
    case may be, owning an amount of the Capital Stock of such
    business such that it constitutes a Restricted Subsidiary,
    (b) properties or (c) acquisitions of other assets
    that, in each of (a), (b) and (c), replace the businesses,
    properties
and/or
assets that are the subject of such Asset Sale;
provided
that, in the case of clauses (2) and
    (3) above, a binding commitment shall be treated as a
    permitted application of the Net Proceeds from the date of such
    commitment so long as the Issuer, or such other Restricted
    Subsidiary enters into such commitment with the good faith
    expectation that such Net Proceeds will be applied to satisfy
    such commitment within 180 days of such commitment (an
"Acceptable Commitment"
) and, in the event any
    Acceptable Commitment is later cancelled or terminated for any
    reason before the Net Proceeds are applied in connection
    therewith, the Issuer or such Restricted Subsidiary enters into
    another Acceptable Commitment (a
"Second
    Commitment"
) within 180 days of such cancellation
    or termination;
provided
,
further
, that if any
    Second Commitment is later cancelled or terminated for any
    reason before such Net Proceeds are applied, then such Net
    Proceeds shall constitute Excess Proceeds.
Any Net Proceeds from Asset Sales of Collateral that are not
    invested or applied as set forth in the first sentence of the
    preceding paragraph will be deemed to constitute
"Collateral Excess Proceeds
." When the
    aggregate amount of Collateral Excess Proceeds exceeds
    $200.0 million, the Issuer shall make an offer to all
    Holders of the Notes and, if required by the terms of any Junior
    Lien Obligations which are not subordinated to the Notes or
    Obligations secured by a Lien permitted under the Indenture
    (which Lien is not subordinate to the Lien of the Notes with
    respect to the Collateral), to the holders of such Junior Lien
    Obligations or such other Obligations (a
"Collateral
    Asset Sale Offer"
), to purchase the maximum aggregate
    principal amount of the Notes and such Junior Lien Obligations
    or such other Obligations that is a minimum of $2,000 or an
    integral multiple of $1,000 in excess thereof that may be
    purchased out of the Collateral Excess Proceeds at an offer
    price in cash in an amount equal to 100% of the principal amount
    thereof, plus accrued and unpaid interest and Additional
    Interest, if any, to the date fixed for the closing of such
    offer, in accordance with the procedures set forth in the
    Indenture. The Issuer will commence a Collateral Asset Sale
    Offer with respect to Collateral Excess Proceeds within ten
    Business Days after the date that Collateral Excess Proceeds
    exceed $200.0 million by mailing the notice required
    pursuant to the terms of the Indenture, with a copy to the
    Trustee.
Any Net Proceeds from Asset Sales of non-Collateral that are not
    invested or applied as provided and within the time period set
    forth in the first sentence of the second preceding paragraph
    will be deemed to constitute
"Excess Proceeds
."
    When the aggregate amount of Excess Proceeds exceeds
    $200.0 million, the Issuer shall make an offer to all
    Holders of the Notes and, if required or permitted by the terms
    of any Senior Indebtedness, to the holders of such Senior
    Indebtedness (an
"Asset Sale Offer"
), to
    purchase the maximum aggregate principal amount of the Notes and
    such Senior Indebtedness that is a minimum of $2,000 or an
    integral multiple of $1,000 in excess thereof that may be
    purchased out of the Excess Proceeds at an offer price in cash
    in an amount equal to 100% of the principal amount thereof, plus
    accrued and unpaid interest and Additional Interest, if any, to
    the date fixed for the closing of such offer, in accordance with
    the procedures set forth in the Indenture. The Issuer will
    commence an Asset Sale Offer with respect to Excess Proceeds
    within ten Business Days after the date that Excess Proceeds
    exceed $200.0 million by mailing the notice required
    pursuant to the terms of the Indenture, with a copy to the
    Trustee.
To the extent that the aggregate amount of Notes and such Junior
    Lien Obligations or Obligations secured by a Lien permitted by
    the Indenture (which Lien is not subordinate to the Lien of the
    Notes with respect to the Collateral) tendered pursuant to a
    Collateral Asset Sale Offer is less than the Collateral Excess
    Proceeds, the Issuer may use any remaining Collateral Excess
    Proceeds for general corporate purposes, subject to other
    covenants contained in the Indenture. To the extent that the
    aggregate amount of Notes and such Senior Indebtedness tendered
    pursuant to an Asset Sale Offer is less than the Excess
    Proceeds, the Issuer may use any remaining Excess Proceeds for
    general corporate purposes, subject to other covenants contained
    in the Indenture. If the aggregate principal amount of Notes or
    Junior Lien Obligations or such other Obligations surrendered by
    such holders thereof exceeds the amount of Collateral Excess
    Proceeds, the Trustee shall select the Notes and such Junior
    Lien Obligations or such other Obligations to be purchased on a
    pro rata basis
65
Table of Contents
based on the accreted value or principal amount of the Notes or
    such Junior Lien Obligations or such other Obligations tendered.
    If the aggregate principal amount of Notes or the Senior
    Indebtedness surrendered by such holders thereof exceeds the
    amount of Excess Proceeds, the Trustee shall select the Notes
    and such Senior Indebtedness to be purchased on a pro rata basis
    based on the accreted value or principal amount of the Notes or
    such Senior Indebtedness tendered. Upon completion of any such
    Collateral Asset Sale Offer or Asset Sale Offer, the amount of
    Collateral Excess Proceeds or Excess Proceeds, as the case may
    be, shall be reset at zero. Additionally, the Issuer may, at its
    option, make a Collateral Asset Sale Offer or an Asset Sale
    Offer using proceeds from any Asset Sale at any time after
    consummation of such Asset Sale;
provided
that such
    Collateral Asset Sale Offer or Asset Sale Offer shall be in an
    aggregate amount of not less than $50.0 million. Upon
    consummation of such Collateral Asset Sale Offer or Asset Sale
    Offer, any Net Proceeds not required to be used to purchase
    Notes shall not be deemed Excess Proceeds.
Pending the final application of any Net Proceeds pursuant to
    this covenant, the holder of such Net Proceeds may apply such
    Net Proceeds temporarily to reduce Indebtedness outstanding
    under a revolving credit facility or otherwise invest such Net
    Proceeds in any manner not prohibited by the Indenture.
The Issuer will comply with the requirements of
Rule 14e-1
under the Exchange Act and any other securities laws and
    regulations thereunder to the extent such laws or regulations
    are applicable in connection with the repurchase of the Notes
    pursuant to a Collateral Asset Sale Offer or an Asset Sale
    Offer. To the extent that the provisions of any securities laws
    or regulations conflict with the provisions of the Indenture,
    the Issuer will comply with the applicable securities laws and
    regulations and shall not be deemed to have breached its
    obligations described in the Indenture by virtue thereof.
Selection
    and Notice
If the Issuer is redeeming less than all of the Notes issued by
    it at any time, the Trustee will select the Notes to be redeemed
    (a) if the Notes are listed on any national securities
    exchange, in compliance with the requirements of the principal
    national securities exchange on which the Notes are listed,
    (b) on a pro rata basis to the extent practicable or
    (c) by lot or such other similar method in accordance with
    the procedures of DTC.
Notices of purchase or redemption shall be mailed by first-class
    mail, postage prepaid, at least 30 but not more than
    60 days before the purchase or Redemption Date to each
    Holder of Notes at such Holder's registered address or
    otherwise in accordance with the procedures of DTC, except that
    redemption notices may be mailed more than 60 days prior to
    a Redemption Date if the notice is issued in connection
    with a defeasance of the Notes or a satisfaction and discharge
    of the Indenture. If any Note is to be purchased or redeemed in
    part only, any notice of purchase or redemption that relates to
    such Note shall state the portion of the principal amount
    thereof that has been or is to be purchased or redeemed.
The Issuer will issue a new Note in a principal amount equal to
    the unredeemed portion of the original Note in the name of the
    Holder upon cancellation of the original Note. Notes called for
    redemption become due on the date fixed for redemption. On and
    after the Redemption Date, interest ceases to accrue on
    Notes or portions thereof called for redemption.
Certain
    Covenants
Set forth below are summaries of certain covenants contained in
    the Indenture. If on any date following the Issue Date
    (i) the Notes have Investment Grade Ratings from both
    Rating Agencies, and (ii) no Default has occurred and is
    continuing under the Indenture (the occurrence of the events
    described in the foregoing clauses (i) and (ii) being
    collectively referred to as a
"Covenant Suspension
    Event"
), the Issuer and the Restricted Subsidiaries
    will not be subject to the following covenants (collectively,
    the
"Suspended Covenants"
):
(1) "Repurchase at the Option of Holders";
(2) "— Limitation on Restricted Payments";
66
Table of Contents
(3) "— Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock";
(4) clause (4) of the first paragraph of
    "— Merger, Consolidation or Sale of All or
    Substantially All Assets";
(5) "— Transactions with
    Affiliates"; and
(6) "— Dividend and Other Payment Restrictions
    Affecting Restricted Subsidiaries."
In the event that the Issuer and the Restricted Subsidiaries are
    not subject to the Suspended Covenants under the Indenture for
    any period of time as a result of the foregoing, and on any
    subsequent date (the
"Reversion Date"
) one or
    both of the Rating Agencies (a) withdraw their Investment
    Grade Rating or downgrade the rating assigned to the Notes below
    an Investment Grade Rating
and/or
(b) the Issuer or any of its Affiliates enter into an
    agreement to effect a transaction that would result in a Change
    of Control and one or more of the Rating Agencies indicate that
    if consummated, such transaction (alone or together with any
    related recapitalization or refinancing transactions) would
    cause such Rating Agency to withdraw its Investment Grade Rating
    or downgrade the ratings assigned to the Notes below an
    Investment Grade Rating, then the Issuer and the Restricted
    Subsidiaries will thereafter again be subject to the Suspended
    Covenants under the Indenture with respect to future events,
    including, without limitation, a proposed transaction described
    in clause (b) above.
The period of time between the Suspension Date and the Reversion
    Date is referred to in this description as the
"Suspension Period
." Additionally, upon the
    occurrence of a Covenant Suspension Event, the amount of Excess
    Proceeds from Net Proceeds shall be reset at zero. In the event
    of any such reinstatement, no action taken or omitted to be
    taken by the Issuer or any of its Restricted Subsidiaries prior
    to such reinstatement will give rise to a Default or Event of
    Default under the Indentures with respect to Notes; provided
    that (1) with respect to Restricted Payments made after any
    such reinstatement, the amount of Restricted Payments made will
    be calculated as though the covenant described under the caption
    "— Limitation on Restricted Payments" had
    been in effect prior to, but not during the Suspension Period,
    provided that any Subsidiaries designated as Unrestricted
    Subsidiaries during the Suspension Period shall automatically
    become Restricted Subsidiaries on the Reversion Date (subject to
    the Issuer's right to subsequently designate them as
    Unrestricted Subsidiaries in compliance with the covenants set
    out below) and (2) all Indebtedness incurred, or
    Disqualified Stock or Preferred Stock issued, during the
    Suspension Period will be classified to have been incurred or
    issued pursuant to clause (3) of the second paragraph of
    "— Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock."
There can be no assurance that the Notes will ever achieve or
    maintain Investment Grade Ratings.
Limitation
    on Restricted Payments
The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, directly or indirectly:
(I) declare or pay any dividend or make any payment or
    distribution on account of the Issuer's, or any of its
    Restricted Subsidiaries' Equity Interests, including any
    dividend or distribution payable in connection with any merger
    or consolidation other than:
(a) dividends or distributions by the Issuer payable solely
    in Equity Interests (other than Disqualified Stock) of the
    Issuer; or
(b) dividends or distributions by a Restricted Subsidiary
    so long as, in the case of any dividend or distribution payable
    on or in respect of any class or series of securities issued by
    a Restricted Subsidiary other than a Wholly-Owned Subsidiary,
    the Issuer or a Restricted Subsidiary receives at least its pro
    rata share of such dividend or distribution in accordance with
    its Equity Interests in such class or series of securities;
67
Table of Contents
(II) purchase, redeem, defease or otherwise acquire or
    retire for value any Equity Interests of the Issuer or any
    direct or indirect parent of the Issuer, including in connection
    with any merger or consolidation;
(III) make any principal payment on, or redeem, repurchase,
    defease or otherwise acquire or retire for value in each case,
    prior to any scheduled repayment, sinking fund payment or
    maturity, any Subordinated Indebtedness, other than:
(a) Indebtedness permitted under clauses (7) and
    (8) of the covenant described under
    "— Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock"; or
(b) the purchase, repurchase or other acquisition of
    Subordinated Indebtedness purchased in anticipation of
    satisfying a sinking fund obligation, principal installment or
    final maturity, in each case due within one year of the date of
    purchase, repurchase or acquisition; or
(IV) make any Restricted Investment
(all such payments and other actions set forth in
    clauses (I) through (IV) above (other than any
    exception thereto) being collectively referred to as
"Restricted Payments"
), unless, at the time of
    such Restricted Payment:
(1) no Default shall have occurred and be continuing or
    would occur as a consequence thereof;
(2) immediately after giving effect to such transaction on
    a
pro forma
basis, the Issuer could incur $1.00 of
    additional Indebtedness under the provisions of the first
    paragraph of the covenant described under
    "— Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred
    Stock"; and
(3) such Restricted Payment, together with the aggregate
    amount of all other Restricted Payments made by the Issuer and
    its Restricted Subsidiaries after the Issue Date (including
    Restricted Payments permitted by clauses (1), (2) (with respect
    to the payment of dividends on Refunding Capital Stock (as
    defined below) pursuant to clause (b) thereof only),
    (6)(c), (9) and (14) of the next succeeding paragraph,
    but excluding all other Restricted Payments permitted by the
    next succeeding paragraph), is less than the sum of (without
    duplication):
(a) 50% of the Consolidated Net Income of the Issuer for
    the period (taken as one accounting period) beginning
    October 1, 2006, to the end of the Issuer's most
    recently ended fiscal quarter for which internal financial
    statements are available at the time of such Restricted Payment,
    or, in the case such Consolidated Net Income for such period is
    a deficit, minus 100% of such deficit;
plus
(b) 100% of the aggregate net cash proceeds and the fair
    market value, as determined in good faith by the Issuer, of
    marketable securities or other property received by the Issuer
    since immediately after the Issue Date (other than net cash
    proceeds to the extent such net cash proceeds have been used to
    incur Indebtedness, Disqualified Stock or Preferred Stock
    pursuant to clause (12)(a) of the second paragraph of
    "— Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock") from
    the issue or sale of:
(i) (A) Equity Interests of the Issuer, including
    Treasury Capital Stock (as defined below), but excluding cash
    proceeds and the fair market value, as determined in good faith
    by the Issuer, of marketable securities or other property
    received from the sale of:
(x) Equity Interests to members of management, directors or
    consultants of the Issuer, any direct or indirect parent company
    of the Issuer and the Issuer's Subsidiaries after the Issue
    Date to the extent such amounts have been applied to Restricted
    Payments made in accordance with clause (4) of the next
    succeeding paragraph; and
(y) Designated Preferred Stock; and
68
Table of Contents
(B) to the extent such net cash proceeds are actually
    contributed to the Issuer, Equity Interests of the Issuer's
    direct or indirect parent companies (excluding contributions of
    the proceeds from the sale of Designated Preferred Stock of such
    companies or contributions to the extent such amounts have been
    applied to Restricted Payments made in accordance with
    clause (4) of the next succeeding paragraph); or
(ii) debt securities of the Issuer that have been converted
    into or exchanged for such Equity Interests of the Issuer;
provided,
however
, that this clause (b) shall not
    include the proceeds from (V) Refunding Capital Stock (as
    defined below), (W) Equity Interests or convertible debt
    securities of the Issuer sold to a Restricted Subsidiary, as the
    case may be, (X) Disqualified Stock or debt securities that
    have been converted into Disqualified Stock, (Y) Excluded
    Contributions or (Z) the Delayed Equity Amount;
plus
(c) 100% of the aggregate amount of cash and the fair
    market value, as determined in good faith by the Issuer, of
    marketable securities or other property contributed to the
    capital of the Issuer following the Issue Date (other than net
    cash proceeds to the extent such net cash proceeds (i) have
    been used to incur Indebtedness, Disqualified Stock or Preferred
    Stock pursuant to clause (12)(a) of the second paragraph of
    "— Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock",
    (ii) are contributed by a Restricted Subsidiary,
    (iii) constitute Excluded Contributions or
    (iv) constitute the Delayed Equity Amount);
plus
(d) 100% of the aggregate amount received in cash and the
    fair market value, as determined in good faith by the Issuer, of
    marketable securities or other property received by means of:
(i) the sale or other disposition (other than to the Issuer
    or a Restricted Subsidiary) of Restricted Investments made by
    the Issuer or its Restricted Subsidiaries and repurchases and
    redemptions of such Restricted Investments from the Issuer or
    its Restricted Subsidiaries and repayments of loans or advances,
    and releases of guarantees, which constitute Restricted
    Investments by the Issuer or its Restricted Subsidiaries, in
    each case after the Issue Date; or
(ii) the sale (other than to the Issuer or a Restricted
    Subsidiary) of the stock of an Unrestricted Subsidiary or a
    distribution from an Unrestricted Subsidiary (other than in each
    case to the extent the Investment in such Unrestricted
    Subsidiary was made by the Issuer or a Restricted Subsidiary
    pursuant to clause (7) of the next succeeding paragraph or
    to the extent such Investment constituted a Permitted
    Investment) or a dividend from an Unrestricted Subsidiary after
    the Issue Date;
plus
(e) in the case of the redesignation of an Unrestricted
    Subsidiary as a Restricted Subsidiary after the Issue Date, the
    fair market value of the Investment in such Unrestricted
    Subsidiary, as determined by the Issuer in good faith (or if
    such fair market value exceeds $250.0 million, in writing
    by an Independent Financial Advisor), at the time of the
    redesignation of such Unrestricted Subsidiary as a Restricted
    Subsidiary other than to the extent the Investment in such
    Unrestricted Subsidiary was made by the Issuer or a Restricted
    Subsidiary pursuant to clause (7) of the next succeeding
    paragraph or to the extent such Investment constituted a
    Permitted Investment.
The foregoing provisions will not prohibit:
(1) the payment of any dividend within 60 days after
    the date of declaration thereof, if at the date of declaration
    such payment would have complied with the provisions of the
    Indenture;
(2) (a) the redemption, repurchase, retirement or
    other acquisition of any Equity Interests
("Treasury
    Capital Stock")
or Subordinated Indebtedness of the
    Issuer or any Equity Interests of any direct or indirect parent
    company of the Issuer, in exchange for, or out of the proceeds
    of the substantially concurrent sale (other than to a Restricted
    Subsidiary) of, Equity Interests of the Issuer or any direct or
    indirect parent company of the Issuer to the extent contributed
    to the Issuer (in each case, other than any Disqualified Stock)
("Refunding Capital Stock")
and (b) if
    immediately prior to the retirement of
69
Table of Contents
Treasury Capital Stock, the declaration and payment of dividends
    thereon was permitted under clause (6) of this paragraph,
    the declaration and payment of dividends on the Refunding
    Capital Stock (other than Refunding Capital Stock the proceeds
    of which were used to redeem, repurchase, retire or otherwise
    acquire any Equity Interests of any direct or indirect parent
    company of the Issuer) in an aggregate amount per year no
    greater than the aggregate amount of dividends per annum that
    were declarable and payable on such Treasury Capital Stock
    immediately prior to such retirement;
(3) the redemption, repurchase or other acquisition or
    retirement of Subordinated Indebtedness of the Issuer or a
    Guarantor made in exchange for, or out of the proceeds of the
    substantially concurrent sale of, new Indebtedness of the Issuer
    or a Guarantor, as the case may be, which is incurred in
    compliance with "— Limitation on Incurrence of
    Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock" so long as:
(a) the principal amount (or accreted value) of such new
    Indebtedness does not exceed the principal amount of (or
    accreted value, if applicable), plus any accrued and unpaid
    interest on, the Subordinated Indebtedness being so redeemed,
    repurchased, acquired or retired for value, plus the amount of
    any reasonable premium (including reasonable tender premiums),
    defeasance costs and any reasonable fees and expenses incurred
    in connection with the issuance of such new Indebtedness;
(b) such new Indebtedness is subordinated to the Notes or
    the applicable Guarantee at least to the same extent as such
    Subordinated Indebtedness so purchased, exchanged, redeemed,
    repurchased, acquired or retired for value;
(c) such new Indebtedness has a final scheduled maturity
    date equal to or later than the final scheduled maturity date of
    the Subordinated Indebtedness being so redeemed, repurchased,
    acquired or retired; and
(d) such new Indebtedness has a Weighted Average Life to
    Maturity equal to or greater than the remaining Weighted Average
    Life to Maturity of the Subordinated Indebtedness being so
    redeemed, repurchased, acquired or retired;
(4) a Restricted Payment to pay for the repurchase,
    retirement or other acquisition or retirement for value of
    Equity Interests (other than Disqualified Stock) of the Issuer
    or any of its direct or indirect parent companies held by any
    future, present or former employee, director or consultant of
    the Issuer, any of its Subsidiaries or any of its direct or
    indirect parent companies pursuant to any management equity plan
    or stock option plan or any other management or employee benefit
    plan or agreement, including any Equity Interests rolled over by
    management of the Company or any of its direct or indirect
    parent companies in connection with the Transaction;
provided
,
however
, that the aggregate Restricted
    Payments made under this clause (4) do not exceed in any
    calendar year $75.0 million (which shall increase to
    $150.0 million subsequent to the consummation of an
    underwritten public Equity Offering by the Issuer or any direct
    or indirect parent entity of the Issuer) (with unused amounts in
    any calendar year being carried over to succeeding calendar
    years subject to a maximum (without giving effect to the
    following proviso) of $225.0 million in any calendar year
    (which shall increase to $450.0 million subsequent to the
    consummation of an underwritten public Equity Offering by the
    Issuer or any direct or indirect parent corporation of the
    Issuer));
provided further
that such amount in any
    calendar year may be increased by an amount not to exceed:
(a) the cash proceeds from the sale of Equity Interests
    (other than Disqualified Stock) of the Issuer and, to the extent
    contributed to the Issuer, Equity Interests of any of the
    Issuer's direct or indirect parent companies, in each case
    to members of management, directors or consultants of the
    Issuer, any of its Subsidiaries or any of its direct or indirect
    parent companies that occurs after the Issue Date, to the extent
    the cash proceeds from the sale of such Equity Interests have
    not otherwise been applied to the payment of Restricted Payments
    by virtue of clause (3) of the preceding paragraph;
plus
70
Table of Contents
(b) the cash proceeds of key man life insurance policies
    received by the Issuer or its Restricted Subsidiaries after the
    Issue Date;
less
(c) the amount of any Restricted Payments previously made
    with the cash proceeds described in clauses (a) and
    (b) of this clause (4);
and
provided
,
further
, that cancellation of
    Indebtedness owing to the Issuer or any Restricted Subsidiary
    from members of management of the Issuer, any of the
    Issuer's direct or indirect parent companies or any of the
    Issuer's Restricted Subsidiaries in connection with a
    repurchase of Equity Interests of the Issuer or any of its
    direct or indirect parent companies will not be deemed to
    constitute a Restricted Payment for purposes of this covenant or
    any other provision of the Indenture;
(5) the declaration and payment of dividends to holders of
    any class or series of Disqualified Stock of the Issuer or any
    of its Restricted Subsidiaries or any class or series of
    Preferred Stock of any Restricted Subsidiary issued in
    accordance with the covenant described under
    "— Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock" to the
    extent such dividends are included in the definition of
    "Fixed Charges";
(6) (a) the declaration and payment of dividends to
    holders of any class or series of Designated Preferred Stock
    (other than Disqualified Stock) issued by the Issuer after the
    Issue Date;
(b) the declaration and payment of dividends to a direct or
    indirect parent company of the Issuer, the proceeds of which
    will be used to fund the payment of dividends to holders of any
    class or series of Designated Preferred Stock (other than
    Disqualified Stock) of such parent corporation issued after the
    Issue Date;
provided
that the amount of dividends paid
    pursuant to this clause (b) shall not exceed the aggregate
    amount of cash actually contributed to the Issuer from the sale
    of such Designated Preferred Stock; or
(c) the declaration and payment of dividends on Refunding
    Capital Stock that is Preferred Stock in excess of the dividends
    declarable and payable thereon pursuant to clause (2) of
    this paragraph;
provided
,
however
, in the case of each of
    (a) and (c) of this clause (6), that for the most
    recently ended four full fiscal quarters for which internal
    financial statements are available immediately preceding the
    date of issuance of such Designated Preferred Stock or the
    declaration of such dividends on Refunding Capital Stock that is
    Preferred Stock, after giving effect to such issuance or
    declaration on a
pro forma
basis, the Issuer and its
    Restricted Subsidiaries on a consolidated basis would have had a
    Fixed Charge Coverage Ratio of at least 2.00 to 1.00;
(7) Investments in Unrestricted Subsidiaries having an
    aggregate fair market value, taken together with all other
    Investments made pursuant to this clause (7) that are at
    the time outstanding, without giving effect to the sale of an
    Unrestricted Subsidiary to the extent the proceeds of such sale
    do not consist of cash or marketable securities, not to exceed
    2.5% of Total Assets at the time of such Investment (with the
    fair market value of each Investment being measured at the time
    made and without giving effect to subsequent changes in value);
(8) repurchases of Equity Interests deemed to occur upon
    exercise of stock options or warrants if such Equity Interests
    represent a portion of the exercise price of such options or
    warrants;
(9) the declaration and payment of dividends on the
    Issuer's common stock (or the payment of dividends to any
    direct or indirect parent entity to fund a payment of dividends
    on such entity's common stock), following consummation of
    the first public offering of the Issuer's common stock or
    the common stock of any of its direct or indirect parent
    companies after the Issue Date, of up to 6% per annum of the net
    cash proceeds received by or contributed to the Issuer in or
    from any such public offering, other than public offerings with
    respect to the Issuer's common stock registered on
Form S-8
and other than any public sale constituting an Excluded
    Contribution;
(10) Restricted Payments that are made with Excluded
    Contributions;
71
Table of Contents
(11) other Restricted Payments in an aggregate amount taken
    together with all other Restricted Payments made pursuant to
    this clause (11) not to exceed 3.0% of Total Assets at the
    time made;
(12) distributions or payments of Receivables Fees;
(13) any Restricted Payment made as part of the Transaction
    and the fees and expenses related thereto or used to fund
    amounts owed to Affiliates (including dividends to any direct or
    indirect parent of the Issuer to permit payment by such parent
    of such amount), in each case to the extent permitted by the
    covenant described under "— Transactions with
    Affiliates";
(14) the repurchase, redemption or other acquisition or
    retirement for value of any Subordinated Indebtedness in
    accordance with the provisions similar to those described under
    the captions "Repurchase at the Option of
    Holders — Change of Control" and "Repurchase
    at the Option of Holders — Asset Sales";
provided
that all Notes tendered by Holders in connection
    with a Change of Control Offer, Collateral Asset Sale Offer or
    Asset Sale Offer, as applicable, have been repurchased, redeemed
    or acquired for value;
(15) the declaration and payment of dividends by the Issuer
    to, or the making of loans to, any direct or indirect parent in
    amounts required for any direct or indirect parent companies to
    pay, in each case without duplication,
(a) franchise and excise taxes and other fees, taxes and
    expenses required to maintain their corporate existence;
(b) foreign, federal, state and local income taxes, to the
    extent such income taxes are attributable to the income of the
    Issuer and its Restricted Subsidiaries and, to the extent of the
    amount actually received from its Unrestricted Subsidiaries, in
    amounts required to pay such taxes to the extent attributable to
    the income of such Unrestricted Subsidiaries;
provided
that in each case the amount of such payments in any fiscal
    year does not exceed the amount that the Issuer and its
    Restricted Subsidiaries would be required to pay in respect of
    foreign, federal, state and local taxes for such fiscal year
    were the Issuer, its Restricted Subsidiaries and its
    Unrestricted Subsidiaries (to the extent described above) to pay
    such taxes separately from any such parent entity;
(c) for as long as Hercules Holding II, LLC is a parent of
    the Issuer, distributions equal to any taxable income of
    Hercules Holding II, LLC resulting from the Hedging Arrangements
    multiplied by 45%;
(d) customary salary, bonus and other benefits payable to
    officers and employees of any direct or indirect parent company
    of the Issuer to the extent such salaries, bonuses and other
    benefits are attributable to the ownership or operation of the
    Issuer and its Restricted Subsidiaries;
(e) general corporate operating and overhead costs and
    expenses of any direct or indirect parent company of the Issuer
    to the extent such costs and expenses are attributable to the
    ownership or operation of the Issuer and its Restricted
    Subsidiaries; and
(f) fees and expenses other than to Affiliates of the
    Issuer related to any unsuccessful equity or debt offering of
    such parent entity; and
(16) the distribution, by dividend or otherwise, of shares
    of Capital Stock of, or Indebtedness owed to the Issuer or a
    Restricted Subsidiary by, Unrestricted Subsidiaries (other than
    Unrestricted Subsidiaries, the primary assets of which are cash
and/or
Cash
    Equivalents);
provided
,
however
, that at the time of, and after
    giving effect to, any Restricted Payment permitted under
    clauses (11) and (16), no Default shall have occurred and
    be continuing or would occur as a consequence thereof.
As of the Issue Date, all of the Issuer's Subsidiaries were
    Restricted Subsidiaries. The Issuer will not permit any
    Unrestricted Subsidiary to become a Restricted Subsidiary except
    pursuant to the last sentence of the definition of
    "Unrestricted Subsidiary." For purposes of designating
    any Restricted Subsidiary as an
72
Table of Contents
Unrestricted Subsidiary, all outstanding Investments by the
    Issuer and its Restricted Subsidiaries (except to the extent
    repaid) in the Subsidiary so designated will be deemed to be
    Restricted Payments in an amount determined as set forth in the
    last sentence of the definition of "Investment." Such
    designation will be permitted only if a Restricted Payment in
    such amount would be permitted at such time, whether pursuant to
    the first paragraph of this covenant or under clause (7),
    (10) or (11) of the second paragraph of this covenant,
    or pursuant to the definition of "Permitted
    Investments," and if such Subsidiary otherwise meets the
    definition of an Unrestricted Subsidiary. Unrestricted
    Subsidiaries are not subject to any of the restrictive covenants
    set forth in the Indenture.
Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock
The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, directly or indirectly, create, incur, issue,
    assume, guarantee or otherwise become directly or indirectly
    liable, contingently or otherwise (collectively,
"incur"
and collectively, an
"incurrence"
) with respect to any Indebtedness
    (including Acquired Indebtedness), and the Issuer will not issue
    any shares of Disqualified Stock and will not permit any
    Restricted Subsidiary to issue any shares of Disqualified Stock
    or Preferred Stock;
provided
,
however
, that the
    Issuer may incur Indebtedness (including Acquired Indebtedness)
    or issue shares of Disqualified Stock, and any of its Restricted
    Subsidiaries may incur Indebtedness (including Acquired
    Indebtedness), issue shares of Disqualified Stock and issue
    shares of Preferred Stock, if the Fixed Charge Coverage Ratio on
    a consolidated basis for the Issuer and its Restricted
    Subsidiaries' most recently ended four fiscal quarters for
    which internal financial statements are available immediately
    preceding the date on which such additional Indebtedness is
    incurred or such Disqualified Stock or Preferred Stock is issued
    would have been at least 2.00 to 1.00, determined on a
pro
    forma
basis (including a
pro forma
application of the
    net proceeds therefrom), as if the additional Indebtedness had
    been incurred, or the Disqualified Stock or Preferred Stock had
    been issued, as the case may be, and the application of proceeds
    therefrom had occurred at the beginning of such four-quarter
    period;
provided, further,
that Restricted Subsidiaries
    that are not Guarantors may not incur Indebtedness or
    Disqualified Stock or Preferred Stock if, after giving
pro
    forma
effect to such incurrence or issuance (including a
pro forma
application of the net proceeds therefrom),
    more than an aggregate of $2,000.0 million of Indebtedness
    or Disqualified Stock or Preferred Stock of Restricted
    Subsidiaries that are not Guarantors would be outstanding
    pursuant to this paragraph and clauses (12), (14) and
    (19) below at such time.
The foregoing limitations will not apply to:
(1) the incurrence of Indebtedness under (x) Credit
    Facilities (other than the ABL Facility) by the Issuer or any of
    its Restricted Subsidiaries and the issuance and creation of
    letters of credit and bankers' acceptances thereunder (with
    letters of credit and bankers' acceptances being deemed to
    have a principal amount equal to the face amount thereof), up to
    an aggregate principal amount of $16,500.0 million
    outstanding at any one time and (y) the ABL Facility by the
    Issuer or any of its Restricted Subsidiaries and the issuance
    and creation of letters of credit and bankers' acceptances
    thereunder (with letters of credit and bankers' acceptances
    being deemed to have a principal amount equal to the face amount
    thereof), up to an aggregate principal amount equal to the ABL
    Facility Cap;
(2) the incurrence by the Issuer and any Guarantor of
    Indebtedness represented by the Notes (including any PIK Notes
    and any Guarantee) (other than any Additional Notes (including
    Guarantees thereof));
(3) Indebtedness of the Issuer and its Restricted
    Subsidiaries in existence on the Issue Date (other than
    Indebtedness described in clauses (1) and (2)), including
    the Existing Notes;
(4) Indebtedness consisting of Capitalized Lease
    Obligations and Purchase Money Obligations; so long as such
    Indebtedness exists at the date of such purchase, lease or
    improvement, or is created within 270 days thereafter;
(5) Indebtedness incurred by the Issuer or any of its
    Restricted Subsidiaries constituting reimbursement obligations
    with respect to letters of credit issued in the ordinary course
    of business, including letters of credit in respect of
    workers' compensation, medical malpractice or employee
    health claims, or
73
Table of Contents
other Indebtedness with respect to reimbursement-type
    obligations regarding workers' compensation, medical
    malpractice or employee health claims;
provided
,
however
, that upon the drawing of such letters of credit
    or the incurrence of such Indebtedness, such obligations are
    reimbursed within 30 days following such drawing or
    incurrence;
(6) Indebtedness arising from agreements of the Issuer or
    its Restricted Subsidiaries providing for indemnification,
    adjustment of purchase price or similar obligations, in each
    case, incurred or assumed in connection with the disposition of
    any business, assets or a Subsidiary, other than guarantees of
    Indebtedness incurred by any Person acquiring all or any portion
    of such business, assets or a Subsidiary for the purpose of
    financing such acquisition;
provided
,
however
,
    that such Indebtedness is not reflected on the balance sheet of
    the Issuer, or any of its Restricted Subsidiaries (contingent
    obligations referred to in a footnote to financial statements
    and not otherwise reflected on the balance sheet will not be
    deemed to be reflected on such balance sheet for purposes of
    this clause (6));
(7) Indebtedness of the Issuer to a Restricted Subsidiary;
provided
that any such Indebtedness owing to a Restricted
    Subsidiary that is not a Guarantor is expressly subordinated in
    right of payment to the Notes;
provided
,
further
,
    that any subsequent issuance or transfer of any Capital Stock or
    any other event which results in any Restricted Subsidiary
    ceasing to be a Restricted Subsidiary or any other subsequent
    transfer of any such Indebtedness (except to the Issuer or
    another Restricted Subsidiary) shall be deemed, in each case, to
    be an incurrence of such Indebtedness;
(8) Indebtedness of a Restricted Subsidiary to the Issuer
    or another Restricted Subsidiary;
provided
that if a
    Guarantor incurs such Indebtedness to a Restricted Subsidiary
    that is not a Guarantor, such Indebtedness is expressly
    subordinated in right of payment to the Guarantee of the Notes
    of such Guarantor;
provided
,
further
, that any
    subsequent transfer of any such Indebtedness (except to the
    Issuer or another Restricted Subsidiary) shall be deemed, in
    each case, to be an incurrence of such Indebtedness not
    permitted by this clause;
(9) shares of Preferred Stock of a Restricted Subsidiary
    issued to the Issuer or another Restricted Subsidiary;
provided
that any subsequent issuance or transfer of any
    Capital Stock or any other event which results in any such
    Restricted Subsidiary ceasing to be a Restricted Subsidiary or
    any other subsequent transfer of any such shares of Preferred
    Stock (except to the Issuer or another of its Restricted
    Subsidiaries) shall be deemed in each case to be an issuance of
    such shares of Preferred Stock not permitted by this clause;
(10) Hedging Obligations (excluding Hedging Obligations
    entered into for speculative purposes) for the purpose of
    limiting interest rate risk with respect to any Indebtedness
    permitted to be incurred pursuant to
    "— Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock,"
    exchange rate risk or commodity pricing risk;
(11) obligations in respect of performance, bid, appeal and
    surety bonds and completion guarantees provided by the Issuer or
    any of its Restricted Subsidiaries in the ordinary course of
    business;
(12) (a) Indebtedness or Disqualified Stock of the
    Issuer and Indebtedness, Disqualified Stock or Preferred Stock
    of the Issuer or any Restricted Subsidiary equal to 200.0% of
    the net cash proceeds received by the Issuer since immediately
    after the Issue Date from the issue or sale of Equity Interests
    of the Issuer or cash contributed to the capital of the Issuer
    (in each case, other than Excluded Contributions or proceeds of
    Disqualified Stock or sales of Equity Interests to the Issuer or
    any of its Subsidiaries) as determined in accordance with
    clauses (3)(b) and (3)(c) of the first paragraph of
    "— Limitation on Restricted Payments" to the
    extent such net cash proceeds or cash have not been applied
    pursuant to such clauses to make Restricted Payments or to make
    other Investments, payments or exchanges pursuant to the second
    paragraph of "— Limitation on Restricted
    Payments" or to make Permitted Investments (other than
    Permitted Investments specified in clauses (1) and
    (3) of the definition thereof) and (b) Indebtedness or
    Disqualified Stock of Issuer and Indebtedness, Disqualified
    Stock or Preferred Stock of the Issuer or any Restricted
    Subsidiary not otherwise permitted hereunder in an aggregate
    principal amount or liquidation preference, which when
    aggregated with the principal amount and liquidation preference
    of all
74
Table of Contents
other Indebtedness, Disqualified Stock and Preferred Stock then
    outstanding and incurred pursuant to this clause (12)(b), does
    not at any one time outstanding exceed $1,500.0 million;
provided
,
however
that on a pro forma basis,
    together with any amounts incurred and outstanding by Restricted
    Subsidiaries that are not Guarantors pursuant to the second
    proviso to the first paragraph of this covenant and
    clauses (14) and (19), no more than $2,000.0 million
    of Indebtedness, Disqualified Stock or Preferred Stock at any
    one time outstanding and incurred pursuant to this clause
    (12)(b) shall be incurred by Restricted Subsidiaries that are
    not Guarantors (it being understood that any Indebtedness,
    Disqualified Stock or Preferred Stock incurred pursuant to this
    clause (12)(b) shall cease to be deemed incurred or outstanding
    for purposes of this clause (12)(b) but shall be deemed incurred
    for the purposes of the first paragraph of this covenant from
    and after the first date on which the Issuer or such Restricted
    Subsidiary could have incurred such Indebtedness, Disqualified
    Stock or Preferred Stock under the first paragraph of this
    covenant without reliance on this clause (12)(b));
(13) the incurrence or issuance by the Issuer or any
    Restricted Subsidiary of Indebtedness, Disqualified Stock or
    Preferred Stock which serves to refund or refinance any
    Indebtedness, Disqualified Stock or Preferred Stock of the
    Issuer or any Restricted Subsidiary incurred as permitted under
    the first paragraph of this covenant and clauses (2), (3),
    (4) and (12)(a) above, this clause (13) and
    clause (14) below or any Indebtedness, Disqualified Stock
    or Preferred Stock of the Issuer or any Restricted Subsidiary
    issued to so refund or refinance such Indebtedness, Disqualified
    Stock or Preferred Stock of the Issuer or any Restricted
    Subsidiary including additional Indebtedness, Disqualified Stock
    or Preferred Stock incurred to pay premiums (including
    reasonable tender premiums), defeasance costs and fees in
    connection therewith (the
"Refinancing
    Indebtedness"
) prior to its respective maturity;
provided
,
however
, that such Refinancing
    Indebtedness:
(a) has a Weighted Average Life to Maturity at the time
    such Refinancing Indebtedness is incurred which is not less than
    the remaining Weighted Average Life to Maturity of the
    Indebtedness, Disqualified Stock or Preferred Stock being
    refunded or refinanced,
(b) to the extent such Refinancing Indebtedness refinances
    (i) Indebtedness subordinated or
pari passu
to the
    Notes or any Guarantee thereof, such Refinancing Indebtedness is
    subordinated or
pari passu
to the Notes or the Guarantee
    at least to the same extent as the Indebtedness being refinanced
    or refunded or (ii) Disqualified Stock or Preferred Stock,
    such Refinancing Indebtedness must be Disqualified Stock or
    Preferred Stock, respectively, and
(c) shall not include Indebtedness, Disqualified Stock or
    Preferred Stock of a Subsidiary of the Issuer that is not a
    Guarantor that refinances Indebtedness, Disqualified Stock or
    Preferred Stock of the Issuer or a Guarantor;
and,
provided further,
that subclause (a) of this
    clause (13) will not apply to any refunding or refinancing
    of any Priority Lien Obligations and Obligations secured by
    Permitted Liens;
(14) Indebtedness, Disqualified Stock or Preferred Stock of
    (x) the Issuer or a Restricted Subsidiary incurred to
    finance an acquisition or (y) Persons that are acquired by
    the Issuer or any Restricted Subsidiary or merged into the
    Issuer or a Restricted Subsidiary in accordance with the terms
    of the Indenture;
provided
that after giving effect to
    such acquisition or merger, either
(a) the Issuer would be permitted to incur at least $1.00
    of additional Indebtedness pursuant to the Fixed Charge Coverage
    Ratio test set forth in the first sentence of this
    covenant, or
(b) the Fixed Charge Coverage Ratio of the Issuer and the
    Restricted Subsidiaries is greater than immediately prior to
    such acquisition or merger;
provided
,
however
that on a pro forma basis,
    together with amounts incurred and outstanding pursuant to the
    second proviso to the first paragraph of this covenant and
    clauses (12) and (19), no more than $2,000.0 million
    of Indebtedness, Disqualified Stock or Preferred Stock at any
    one time outstanding and incurred by Restricted Subsidiaries
    that are not Guarantors pursuant to this clause (14) shall
    be incurred and outstanding;
75
Table of Contents
(15) Indebtedness arising from the honoring by a bank or
    other financial institution of a check, draft or similar
    instrument drawn against insufficient funds in the ordinary
    course of business;
provided
that such Indebtedness is
    extinguished within two Business Days of its incurrence;
(16) Indebtedness of the Issuer or any of its Restricted
    Subsidiaries supported by a letter of credit issued pursuant to
    any Credit Facilities, in a principal amount not in excess of
    the stated amount of such letter of credit;
(17) (a) any guarantee by the Issuer or a Restricted
    Subsidiary of Indebtedness or other obligations of any
    Restricted Subsidiary, so long as the incurrence of such
    Indebtedness incurred by such Restricted Subsidiary is permitted
    under the terms of the Indenture, or (b) any guarantee by a
    Restricted Subsidiary of Indebtedness of the Issuer;
provided
that such guarantee is incurred in accordance with the
    covenant described below under "— Limitation on
    Guarantees of Indebtedness by Restricted Subsidiaries";
(18) Indebtedness of Foreign Subsidiaries of the Issuer in
    an amount not to exceed at any one time outstanding and together
    with any other Indebtedness incurred under this clause (18)
    7.5% of the Total Assets of the Foreign Subsidiaries (it being
    understood that any Indebtedness incurred pursuant to this
    clause (18) shall cease to be deemed incurred or
    outstanding for purposes of this clause (18) but shall be
    deemed incurred for the purposes of the first paragraph of this
    covenant from and after the first date on which the Issuer or
    such Restricted Subsidiaries could have incurred such
    Indebtedness under the first paragraph of this covenant without
    reliance on this clause (18));
(19) Indebtedness, Disqualified Stock or Preferred Stock of
    a Restricted Subsidiary incurred to finance or assumed in
    connection with an acquisition in a principal amount not to
    exceed $200.0 million in the aggregate at any one time
    outstanding together with all other Indebtedness, Disqualified
    Stock
and/or
Preferred Stock issued under this clause (19) (it being
    understood that any Indebtedness, Disqualified Stock or
    Preferred Stock incurred pursuant to this clause (19) shall
    cease to be deemed incurred or outstanding for purposes of this
    clause (19) but shall be deemed incurred for the purposes
    of the first paragraph of this covenant from and after the first
    date on which such Restricted Subsidiary could have incurred
    such Indebtedness, Disqualified Stock or Preferred Stock under
    the first paragraph of this covenant without reliance on this
    clause (19));
provided, however
, that, on a pro forma
    basis, together with amounts incurred and outstanding by
    Restricted Subsidiaries that are not Guarantors pursuant to the
    second proviso to the first paragraph of this covenant and
    clauses (12) and (14), no more than $2,000.0 million
    of Indebtedness would be incurred and outstanding by Restricted
    Subsidiaries that are not Guarantors;
(20) Indebtedness of the Issuer or any of its Restricted
    Subsidiaries consisting of (i) the financing of insurance
    premiums or
(ii) take-or-pay
obligations contained in supply arrangements, in each case,
    incurred in the ordinary course of business;
(21) Indebtedness consisting of Indebtedness issued by the
    Issuer or any of its Restricted Subsidiaries to current or
    former officers, directors and employees thereof, their
    respective estates, spouses or former spouses, in each case to
    finance the purchase or redemption of Equity Interests of the
    Issuer or any direct or indirect parent company of the Issuer to
    the extent described in clause (4) of the second paragraph
    under the caption "— Limitation on Restricted
    Payments";
(22) Physician Support Obligations incurred by the Issuer
    or any Restricted Subsidiary; and
(23) Indebtedness of the Issuer or any of its Restricted
    Subsidiaries undertaken in connection with cash management and
    related activities with respect to any Subsidiary or joint
    venture operating one or more healthcare facilities, including,
    without limitation, hospitals, ambulatory surgery centers,
    outpatient diagnostic centers or imaging centers, in each case,
    in the ordinary course of business.
For purposes of determining compliance with this covenant:
(1) in the event that an item of Indebtedness, Disqualified
    Stock or Preferred Stock (or any portion thereof) meets the
    criteria of more than one of the categories of permitted
    Indebtedness, Disqualified Stock or Preferred Stock described in
    clauses (1) through (23) above or is entitled to be
    incurred pursuant
76
Table of Contents
to the first paragraph of this covenant, the Issuer, in its sole
    discretion, will classify or reclassify such item of
    Indebtedness, Disqualified Stock or Preferred Stock (or any
    portion thereof) and will only be required to include the amount
    and type of such Indebtedness, Disqualified Stock or Preferred
    Stock in one of the above clauses;
provided
that all
    Indebtedness outstanding under the Credit Facilities on the
    Issue Date will be treated as incurred on the Issue Date under
    clause (1) of the preceding paragraph; and
(2) at the time of incurrence, the Issuer will be entitled
    to divide and classify an item of Indebtedness in more than one
    of the types of Indebtedness described in the first and second
    paragraphs above.
Accrual of interest, the accretion of accreted value and the
    payment of interest in the form of additional Indebtedness,
    Disqualified Stock or Preferred Stock will not be deemed to be
    an incurrence of Indebtedness, Disqualified Stock or Preferred
    Stock for purposes of this covenant.
For purposes of determining compliance with any
    U.S. dollar-denominated restriction on the incurrence of
    Indebtedness, the U.S. dollar-equivalent principal amount
    of Indebtedness denominated in a foreign currency shall be
    calculated based on the relevant currency exchange rate in
    effect on the date such Indebtedness was incurred, in the case
    of term debt, or first committed, in the case of revolving
    credit debt;
provided
that if such Indebtedness is
    incurred to refinance other Indebtedness denominated in a
    foreign currency, and such refinancing would cause the
    applicable U.S. dollar-denominated restriction to be
    exceeded if calculated at the relevant currency exchange rate in
    effect on the date of such refinancing, such
    U.S. dollar-denominated restriction shall be deemed not to
    have been exceeded so long as the principal amount of such
    refinancing Indebtedness does not exceed the principal amount of
    such Indebtedness being refinanced.
The principal amount of any Indebtedness incurred to refinance
    other Indebtedness, if incurred in a different currency from the
    Indebtedness being refinanced, shall be calculated based on the
    currency exchange rate applicable to the currencies in which
    such respective Indebtedness is denominated that is in effect on
    the date of such refinancing.
The Indenture provides that the Issuer will not, and will not
    permit any Guarantor to, directly or indirectly, incur any
    Indebtedness (including Acquired Indebtedness) that is
    subordinated or junior in right of payment to any Indebtedness
    of the Issuer or such Guarantor, as the case may be, unless such
    Indebtedness is expressly subordinated in right of payment to
    the Notes or such Guarantor's Guarantee to the extent and
    in the same manner as such Indebtedness is subordinated to other
    Indebtedness of the Issuer or such Guarantor, as the case may be.
The Indenture does not treat (1) unsecured Indebtedness as
    subordinated or junior to Secured Indebtedness merely because it
    is unsecured or (2) Senior Indebtedness as subordinated or
    junior to any other Senior Indebtedness merely because it has a
    junior priority with respect to the same collateral.
Limitation
    on Prepayment or Modification of Existing Notes
The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, directly or indirectly purchase, redeem,
    defease or otherwise acquire or retire for value any of the
    Existing Notes prior to the final maturity date thereof (as in
    effect on the Issue Date);
provided
that the Issuer may:
(1) purchase, redeem, defease or otherwise acquire or
    retire for value any of the Existing Notes which have a final
    maturity date (as in effect on the Issue Date) on or prior to
    December 31, 2011; and
(2) purchase, redeem, defease or otherwise acquire or
    retire for value any other Existing Notes which have a final
    maturity date (as in effect on the Issue Date) on or prior to
    November 15, 2016;
provided
that, in the case of any
    such prepayment funded with the proceeds of the issuance of
    Secured Indebtedness, at the time of incurrence and after giving
pro forma
effect thereto and to the application of the
    proceeds thereof, (x) the Consolidated Secured Debt Ratio
    would be no greater than 5.25 to 1.0 and (y) the
    Consolidated Leverage Ratio would be no greater than 7.0 to 1.0.
The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, amend the Existing Notes Indenture, or any
    supplemental indenture in respect thereof, in any way to advance
    the final maturity date or
77
Table of Contents
shorten the Weighted Average Life to Maturity of any series of
    the Existing Notes such that any Existing Notes with a maturity
    date following the maturity of the Notes would have a maturity
    date on or prior to the date one year following the maturity
    date of the 2016 Cash Pay Notes or which would prohibit the
    making of the Guarantees or the creation of Liens in favor of
    the Notes and the Guarantees on the Collateral.
The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, designate any additional subsidiaries as
    "Restricted Subsidiaries" (as defined in the Existing
    Notes Indenture) for purposes of the Existing Notes Indenture.
Liens
The Issuer will not, and will not permit any Guarantor to,
    directly or indirectly, create, incur, assume or suffer to exist
    any Lien (except Permitted Liens) that secures obligations under
    any Indebtedness or any related Guarantee, on any asset or
    property of the Issuer or any Guarantor, or any income or
    profits therefrom, or assign or convey any right to receive
    income therefrom, unless:
(1) in the case of Liens securing Subordinated
    Indebtedness, the Notes and related Guarantees are secured by a
    Lien on such property, assets or proceeds that is senior in
    priority to such Liens; or
(2) in all other cases, the Notes or the Guarantees are
    equally and ratably secured or are secured by a Lien on such
    property, assets or proceeds that is senior in priority to such
    Liens;
except that the foregoing shall not apply to (a) Liens
    securing the Notes and the related Guarantees, (b) Liens
    securing Indebtedness permitted to be incurred under Credit
    Facilities, including any letter of credit relating thereto,
    that was permitted by the terms of the Indenture to be incurred
    pursuant to clause (1) of the second paragraph under
    "— Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock";
provided
that, with respect to Liens securing Obligations
    permitted under this subclause (b), the Notes and the related
    Guarantees are secured by Liens on the assets subject to such
    Liens (except any European Collateral) to the extent, with the
    priority and subject to intercreditor arrangements, in each case
    no less favorable to the holders of the Notes than those
    described under "Security" above and (c) Liens
    which are senior in priority to the Liens securing the Notes and
    related Guarantees and are incurred to secure Obligations in
    respect of any Indebtedness permitted to be incurred pursuant to
    the covenant described above under "— Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock";
provided
that, with respect to
    Liens securing Obligations permitted under this subclause (c),
    (i) at the time of incurrence and after giving pro forma
    effect thereto, the ratio of (1) the aggregate amount of
    Indebtedness subject to a Lien incurred pursuant to
    subclause (b) above, this subclause (c) and
    clause (6) of the definition of "Permitted Liens"
    (other than Liens securing Indebtedness incurred pursuant to
    clauses (4) and (18) of the covenant described above
    under "— Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock") to
    (2) the Issuer's EBITDA for the most recently ended
    four full fiscal quarters for which internal financial
    statements are available immediately preceding the date on which
    such event for which such calculation is being made shall occur,
    in each case with such
pro forma
adjustments to
    Indebtedness and EBITDA as are appropriate and consistent with
    the
pro forma
adjustment provisions set forth in the
    definition of Fixed Charge Coverage Ratio would be no greater
    than 4.25 to 1.0 and (ii) the Notes and the Guarantees are
    secured by Liens with the priority and subject to intercreditor
    arrangements no less favorable to the holders of the Notes than
    those described under "— Security" above.
Merger,
    Consolidation or Sale of All or Substantially All
    Assets
The Issuer may not consolidate or merge with or into or wind up
    into (whether or not the Issuer is the surviving corporation),
    or sell, assign, transfer, lease, convey or otherwise dispose of
    all or substantially all of its properties or assets, in one or
    more related transactions, to any Person unless:
(1) the Issuer is the surviving corporation or the Person
    formed by or surviving any such consolidation or merger (if
    other than the Issuer) or to which such sale, assignment,
    transfer, lease, conveyance or other disposition will have been
    made is a corporation organized or existing under the
78
Table of Contents
laws of the jurisdiction of organization of the Issuer or the
    laws of the United States, any state thereof, the District of
    Columbia, or any territory thereof (such Person, as the case may
    be, being herein called the
"Successor
    Company"
);
(2) the Successor Company, if other than the Issuer,
    expressly assumes all the obligations of the Issuer under the
    Notes and the Security Documents pursuant to supplemental
    indentures or other documents or instruments in form reasonably
    satisfactory to the Trustee;
(3) immediately after such transaction, no Default exists;
(4) immediately after giving
pro forma
effect to
    such transaction and any related financing transactions, as if
    such transactions had occurred at the beginning of the
    applicable four-quarter period,
(a) the Successor Company would be permitted to incur at
    least $1.00 of additional Indebtedness pursuant to the Fixed
    Charge Coverage Ratio test set forth in the first sentence of
    the covenant described under "— Limitation on
    Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock," or
(b) the Fixed Charge Coverage Ratio for the Successor
    Company, the Issuer and its Restricted Subsidiaries would be
    greater than such ratio for the Issuer and its Restricted
    Subsidiaries immediately prior to such transaction;
(5) each Guarantor, unless it is the other party to the
    transactions described above, in which case clause (b) of
    the second succeeding paragraph shall apply, shall have by
    supplemental indenture confirmed that its Guarantee shall apply
    to such Person's obligations under the Indenture, the Notes
    and the Registration Rights Agreement;
(6) the Collateral owned by the Successor Company will
    (a) continue to constitute Collateral under the Indenture
    and the Security Documents, (b) be subject to a Lien in
    favor of the Junior Lien Collateral Agent for the benefit of the
    Trustee and the Holders of the Notes and (c) not be subject
    to any other Lien, other than Permitted Liens;
(7) to the extent any assets of the Person which is merged
    or consolidated with or into the Successor Company are assets of
    the type which would constitute Collateral under the Security
    Documents, the Successor Company will take such action as may be
    reasonably necessary to cause such property and assets to be
    made subject to the Lien of the Security Documents in the manner
    and to the extent required in the Indenture or any of the
    Security Documents and shall take all reasonably necessary
    action so that such Lien is perfected to the extent required by
    the Security Documents; and
(8) the Issuer shall have delivered to the Trustee an
    Officer's Certificate and an Opinion of Counsel, each
    stating that such consolidation, merger or transfer and such
    supplemental indentures, if any, comply with the Indenture and,
    if a supplemental indenture or any supplement to any Security
    Document is required in connection with such transaction, such
    supplement shall comply with the applicable provisions of the
    Indenture.
The Successor Company will succeed to, and be substituted for
    the Issuer, as the case may be, under the Indenture, the
    Guarantees and the Notes, as applicable. Notwithstanding the
    foregoing clauses (3) and (4),
(1) any Restricted Subsidiary may consolidate with or merge
    into or transfer all or part of its properties and assets to the
    Issuer, and
(2) the Issuer may merge with an Affiliate of the Issuer,
    as the case may be, solely for the purpose of reincorporating
    the Issuer in a State of the United States or any state thereof,
    the District of Columbia or any territory thereof so long as the
    amount of Indebtedness of the Issuer and its Restricted
    Subsidiaries is not increased thereby.
Subject to certain limitations described in the Indenture
    governing release of a Guarantee upon the sale, disposition or
    transfer of a Guarantor, no Guarantor will, and the Issuer will
    not permit any Guarantor to, consolidate or merge with or into
    or wind up into (whether or not the Issuer or Guarantor is the
    surviving
79
Table of Contents
corporation), or sell, assign, transfer, lease, convey or
    otherwise dispose of all or substantially all of its properties
    or assets, in one or more related transactions, to any Person
    unless:
(1) (a) such Guarantor is the surviving corporation or
    the Person formed by or surviving any such consolidation or
    merger (if other than such Guarantor) or to which such sale,
    assignment, transfer, lease, conveyance or other disposition
    will have been made is a corporation, partnership, limited
    partnership, limited liability corporation or trust organized or
    existing under the laws of the jurisdiction of organization of
    such Guarantor, as the case may be, or the laws of the United
    States, any state thereof, the District of Columbia, or any
    territory thereof (such Guarantor or such Person, as the case
    may be, being herein called the
"Successor
    Person"
);
(b) the Successor Person, if other than such Guarantor,
    expressly assumes all the obligations of such Guarantor under
    the Indenture and such Guarantor's related Guarantee
    pursuant to supplemental indentures or other documents or
    instruments in form reasonably satisfactory to the Trustee;
(c) immediately after such transaction, no Default
    exists; and
(d) the Issuer shall have delivered to the Trustee an
    Officer's Certificate, each stating that such
    consolidation, merger or transfer and such supplemental
    indentures, if any, comply with the Indenture; or
(2) the transaction is made in compliance with the covenant
    described under "Repurchase at the Option of
    Holders — Asset Sales."
Subject to certain limitations described in the Indenture, the
    Successor Person will succeed to, and be substituted for, such
    Guarantor under the Indenture and such Guarantor's
    Guarantee. Notwithstanding the foregoing, any Guarantor may
    (i) merge into or transfer all or part of its properties
    and assets to another Guarantor or the Issuer, (ii) merge
    with an Affiliate of the Company solely for the purpose of
    reincorporating the Guarantor in the United States, any state
    thereof, the District of Columbia or any territory thereof or
    (iii) convert into a corporation, partnership, limited
    partnership, limited liability corporation or trust organized or
    existing under the laws of the jurisdiction of organization of
    such Guarantor.
Transactions
    with Affiliates
The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, make any payment to, or sell, lease, transfer
    or otherwise dispose of any of its properties or assets to, or
    purchase any property or assets from, or enter into or make or
    amend any transaction, contract, agreement, understanding, loan,
    advance or guarantee with, or for the benefit of, any Affiliate
    of the Issuer (each of the foregoing, an
"Affiliate
    Transaction"
) involving aggregate payments or
    consideration in excess of $40.0 million, unless:
(1) such Affiliate Transaction is on terms that are not
    materially less favorable to the Issuer or its relevant
    Restricted Subsidiary than those that would have been obtained
    in a comparable transaction by the Issuer or such Restricted
    Subsidiary with an unrelated Person on an arm's-length
    basis; and
(2) the Issuer delivers to the Trustee with respect to any
    Affiliate Transaction or series of related Affiliate
    Transactions involving aggregate payments or consideration in
    excess of $80.0 million, a resolution adopted by the
    majority of the board of directors of the Issuer approving such
    Affiliate Transaction and set forth in an Officer's
    Certificate certifying that such Affiliate Transaction complies
    with clause (1) above.
The foregoing provisions will not apply to the following:
(1) transactions between or among the Issuer or any of its
    Restricted Subsidiaries;
(2) Restricted Payments permitted by the provisions of the
    Indenture described above under the covenant
    "— Limitation on Restricted Payments" and
    the definition of "Permitted Investments";
(3) the payment of management, consulting, monitoring and
    advisory fees and related expenses to the Investors and the
    Frist Entities pursuant to the Sponsor Management Agreement
    (plus any unpaid management, consulting, monitoring and advisory
    fees and related expenses accrued in any prior year)
80
Table of Contents
and the termination fees pursuant to the Sponsor Management
    Agreement, in each case as in effect on the Issue Date, or any
    amendment thereto (so long as any such amendment is not
    disadvantageous in the good faith judgment of the board of
    directors of the Issuer to the Holders when taken as a whole as
    compared to the Sponsor Management Agreement in effect on the
    Issue Date);
(4) the payment of reasonable and customary fees paid to,
    and indemnities provided for the benefit of, officers,
    directors, employees or consultants of Issuer, any of its direct
    or indirect parent companies or any of its Restricted
    Subsidiaries;
(5) transactions in which the Issuer or any of its
    Restricted Subsidiaries, as the case may be, delivers to the
    Trustee a letter from an Independent Financial Advisor stating
    that such transaction is fair to the Issuer or such Restricted
    Subsidiary from a financial point of view or stating that the
    terms are not materially less favorable to the Issuer or its
    relevant Restricted Subsidiary than those that would have been
    obtained in a comparable transaction by the Issuer or such
    Restricted Subsidiary with an unrelated Person on an
    arm's-length basis;
(6) any agreement as in effect as of the Issue Date, or any
    amendment thereto (so long as any such amendment is not
    disadvantageous to the Holders when taken as a whole as compared
    to the applicable agreement as in effect on the Issue Date);
(7) the existence of, or the performance by the Issuer or
    any of its Restricted Subsidiaries of its obligations under the
    terms of, any stockholders agreement (including any registration
    rights agreement or purchase agreement related thereto) to which
    it is a party as of the Issue Date and any similar agreements
    which it may enter into thereafter;
provided
,
however
, that the existence of, or the performance by the
    Issuer or any of its Restricted Subsidiaries of obligations
    under any future amendment to any such existing agreement or
    under any similar agreement entered into after the Issue Date
    shall only be permitted by this clause (7) to the extent
    that the terms of any such amendment or new agreement are not
    otherwise disadvantageous to the Holders when taken as a whole;
(8) the Transaction and the payment of all fees and
    expenses related to the Transaction, in each case as disclosed
    in the Offering Memorandum;
(9) transactions with customers, clients, suppliers, or
    purchasers or sellers of goods or services, in each case in the
    ordinary course of business and otherwise in compliance with the
    terms of the Indenture which are fair to the Issuer and its
    Restricted Subsidiaries, in the reasonable determination of the
    board of directors of the Issuer or the senior management
    thereof, or are on terms at least as favorable as might
    reasonably have been obtained at such time from an unaffiliated
    party;
(10) the issuance of Equity Interests (other than
    Disqualified Stock) of the Issuer to any Permitted Holder or to
    any director, officer, employee or consultant;
(11) sales of accounts receivable, or participations
    therein, in connection with the ABL Facility and any Receivables
    Facility;
(12) payments by the Issuer or any of its Restricted
    Subsidiaries to any of the Investors made for any financial
    advisory, financing, underwriting or placement services or in
    respect of other investment banking activities, including,
    without limitation, in connection with acquisitions or
    divestitures, which payments are approved by a majority of the
    board of directors of the Issuer in good faith;
(13) payments or loans (or cancellation of loans) to
    employees or consultants of the Issuer, any of its direct or
    indirect parent companies or any of its Restricted Subsidiaries
    and employment agreements, stock option plans and other similar
    arrangements with such employees or consultants which, in each
    case, are approved by the Issuer in good faith;
(14) investments by the Investors or the Frist Entities in
    securities of the Issuer or any of its Restricted Subsidiaries
    so long as (i) the investment is being offered generally to
    other investors on the same or more favorable terms and
    (ii) the investment constitutes less than 5% of the
    proposed or outstanding issue amount of such class of securities;
81
Table of Contents
(15) payments to or from, and transactions with, any joint
    venture owning or operating one or more healthcare facilities,
    including, without limitation, hospitals, ambulatory surgery
    centers, outpatient diagnostic centers or imaging centers, in
    each case in the ordinary course of business (including, without
    limitation, any cash management activities related
    thereto); and
(16) payments by the Issuer (and any direct or indirect
    parent thereof) and its Subsidiaries pursuant to tax sharing
    agreements among the Issuer (and any such parent) and its
    Subsidiaries on customary terms to the extent attributable to
    the ownership or operation of the Issuer and its Subsidiaries;
provided
that in each case the amount of such payments in
    any fiscal year does not exceed the amount that the Issuer, its
    Restricted Subsidiaries and its Unrestricted Subsidiaries (to
    the extent of amounts received from Unrestricted Subsidiaries)
    would be required to pay in respect of foreign, federal, state
    and local taxes for such fiscal year were the Issuer and its
    Restricted Subsidiaries (to the extent described above) to pay
    such taxes separately from any such parent entity.
Dividend
    and Other Payment Restrictions Affecting Restricted
    Subsidiaries
The Issuer will not, and will not permit any of its Restricted
    Subsidiaries that are not Guarantors to, directly or indirectly,
    create or otherwise cause or suffer to exist or become effective
    any consensual encumbrance or consensual restriction on the
    ability of any such Restricted Subsidiary to:
(1) (a) pay dividends or make any other distributions
    to the Issuer or any of its Restricted Subsidiaries on its
    Capital Stock or with respect to any other interest or
    participation in, or measured by, its profits, or
(b) pay any Indebtedness owed to the Issuer or any of its
    Restricted Subsidiaries;
(2) make loans or advances to the Issuer or any of its
    Restricted Subsidiaries; or
(3) sell, lease or transfer any of its properties or assets
    to the Issuer or any of its Restricted Subsidiaries,
except (in each case) for such encumbrances or restrictions
    existing under or by reason of:
(a) contractual encumbrances or restrictions in effect on
    the Issue Date, including pursuant to the Senior Credit
    Facilities and the related documentation and the Existing Notes
    Indenture and the related documentation;
(b) the Indenture and the Notes;
(c) purchase money obligations for property acquired in the
    ordinary course of business that impose restrictions of the
    nature discussed in clause (3) above on the property so
    acquired;
(d) applicable law or any applicable rule, regulation or
    order;
(e) any agreement or other instrument of a Person acquired
    by the Issuer or any Restricted Subsidiary in existence at the
    time of such acquisition (but not created in contemplation
    thereof), which encumbrance or restriction is not applicable to
    any Person, or the properties or assets of any Person, other
    than the Person and its Subsidiaries, or the property or assets
    of the Person and its Subsidiaries, so acquired;
(f) contracts for the sale of assets, including customary
    restrictions with respect to a Subsidiary of the Issuer pursuant
    to an agreement that has been entered into for the sale or
    disposition of all or substantially all of the Capital Stock or
    assets of such Subsidiary;
(g) Secured Indebtedness that limits the right of the
    debtor to dispose of the assets securing such Indebtedness that
    is otherwise permitted to be incurred pursuant to the covenants
    described under "— Limitation on Incurrence of
    Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock" and "— Liens";
82
Table of Contents
(h) restrictions on cash or other deposits or net worth
    imposed by customers under contracts entered into in the
    ordinary course of business;
(i) other Indebtedness, Disqualified Stock or Preferred
    Stock of Foreign Subsidiaries permitted to be incurred
    subsequent to the Issue Date pursuant to the provisions of the
    covenant described under "— Limitation on
    Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock";
(j) customary provisions in joint venture agreements and
    other agreements or arrangements relating solely to such joint
    venture;
(k) customary provisions contained in leases or licenses of
    intellectual property and other agreements, in each case entered
    into in the ordinary course of business;
(l) any encumbrances or restrictions of the type referred
    to in clauses (1), (2) and (3) above imposed by any
    amendments, modifications, restatements, renewals, increases,
    supplements, refundings, replacements or refinancings of the
    contracts, instruments or obligations referred to in
    clauses (a) through (k) above;
provided
that
    such amendments, modifications, restatements, renewals,
    increases, supplements, refundings, replacements or refinancings
    are, in the good faith judgment of the Issuer, no more
    restrictive with respect to such encumbrance and other
    restrictions taken as a whole than those prior to such
    amendment, modification, restatement, renewal, increase,
    supplement, refunding, replacement or refinancing; and
(m) restrictions created in connection with any Receivables
    Facility that, in the good faith determination of the Issuer,
    are necessary or advisable to effect the transactions
    contemplated under such Receivables Facility.
Limitation
    on Guarantees of Indebtedness by Restricted
    Subsidiaries
The Issuer will not permit any of its Wholly-Owned Subsidiaries
    that are Restricted Subsidiaries (and non-Wholly-Owned
    Subsidiaries if such non-Wholly-Owned Subsidiaries guarantee
    other capital markets debt securities of the Issuer or any
    Guarantor), other than a Guarantor, a Foreign Subsidiary or a
    Receivables Subsidiary, to guarantee the payment of any
    Indebtedness of the Issuer or any other Guarantor unless:
(1) such Restricted Subsidiary within 30 days executes
    and delivers a supplemental indenture to the Indenture providing
    for a Guarantee by such Restricted Subsidiary, except that with
    respect to a guarantee of Indebtedness of the Issuer or any
    Guarantor:
(a) if the Notes or such Guarantor's Guarantee are
    subordinated in right of payment to such Indebtedness, the
    Guarantee under the supplemental indenture shall be subordinated
    to such Restricted Subsidiary's guarantee with respect to
    such Indebtedness substantially to the same extent as the Notes
    are subordinated to such Indebtedness; and
(b) if such Indebtedness is by its express terms
    subordinated in right of payment to the Notes or such
    Guarantor's Guarantee, any such guarantee by such
    Restricted Subsidiary with respect to such Indebtedness shall be
    subordinated in right of payment to such Guarantee substantially
    to the same extent as such Indebtedness is subordinated to the
    Notes; and
(2) such Restricted Subsidiary waives, and will not in any
    manner whatsoever claim or take the benefit or advantage of, any
    rights of reimbursement, indemnity or subrogation or any other
    rights against the Issuer or any other Restricted Subsidiary as
    a result of any payment by such Restricted Subsidiary under its
    Guarantee;
provided
that this covenant shall not be applicable to
    (i) any guarantee of any Restricted Subsidiary that existed
    at the time such Person became a Restricted Subsidiary and was
    not incurred in connection with, or in contemplation of, such
    Person becoming a Restricted Subsidiary and (ii) guarantees
    of the ABL Facility by the ABL Financing Entities or of any
    Receivables Facility by any Receivables Subsidiary.
83
Table of Contents
Reports
    and Other Information
Notwithstanding that the Issuer may not be subject to the
    reporting requirements of Section 13 or 15(d) of the
    Exchange Act or otherwise report on an annual and quarterly
    basis on forms provided for such annual and quarterly reporting
    pursuant to rules and regulations promulgated by the SEC, the
    Indenture requires the Issuer to file with the SEC (and make
    available to the Trustee and Holders of the Notes (without
    exhibits), without cost to any Holder, within 15 days after
    it files them with the SEC) from and after the Issue Date,
(1) within 90 days (or any other time period then in
    effect under the rules and regulations of the Exchange Act with
    respect to the filing of a
Form 10-K
by a non-accelerated filer) after the end of each fiscal year,
    annual reports on
Form 10-K,
or any successor or comparable form, containing the information
    required to be contained therein, or required in such successor
    or comparable form;
(2) within 45 days after the end of each of the first
    three fiscal quarters of each fiscal year, reports on
Form 10-Q
containing all quarterly information that would be required to
    be contained in
Form 10-Q,
or any successor or comparable form;
(3) promptly from time to time after the occurrence of an
    event required to be therein reported, such other reports on
Form 8-K,
or any successor or comparable form; and
(4) any other information, documents and other reports
    which the Issuer would be required to file with the SEC if it
    were subject to Section 13 or 15(d) of the Exchange Act;
in each case in a manner that complies in all material respects
    with the requirements specified in such form;
provided
that the Issuer shall not be so obligated to file such
    reports with the SEC if the SEC does not permit such filing, in
    which event the Issuer will make available such information to
    prospective purchasers of Notes, in addition to providing such
    information to the Trustee and the Holders of the Notes, in each
    case within 15 days after the time the Issuer would be
    required to file such information with the SEC if it were
    subject to Section 13 or 15(d) of the Exchange Act. In
    addition, to the extent not satisfied by the foregoing, the
    Issuer has agreed that, for so long as any Notes are
    outstanding, it will furnish to Holders and to securities
    analysts and prospective investors, upon their request, the
    information required to be delivered pursuant to
    Rule 144A(d)(4) under the Securities Act.
In the event that any direct or indirect parent company of the
    Issuer becomes a Guarantor of the Notes, the Indenture permits
    the Issuer to satisfy its obligations in this covenant with
    respect to financial information relating to the Issuer by
    furnishing financial information relating to such parent;
provided
that the same is accompanied by consolidating
    information that explains in reasonable detail the differences
    between the information relating to such parent, on the one
    hand, and the information relating to the Issuer and its
    Restricted Subsidiaries on a standalone basis, on the other hand.
Notwithstanding the foregoing, such requirements shall be deemed
    satisfied prior to the commencement of the exchange offers or
    the effectiveness of the shelf registration statement described
    in the Registration Rights Agreement (1) by the filing with
    the SEC of the exchange offer registration statement or shelf
    registration statement (or any other similar registration
    statement), and any amendments thereto, with such financial
    information that satisfies
Regulation S-X,
subject to exceptions consistent with the presentation of
    financial information in the Offering Memorandum, to the extent
    filed within the times specified above, or (2) by posting
    reports that would be required to be filed substantially in the
    form required by the SEC on the Company's website (or that
    of any of its parent companies) or providing such reports to the
    Trustee within 15 days after the time the Issuer would be
    required to file such information with the SEC if it were
    subject to Section 13 or 15(d) of the Exchange Act, the
    financial information (including a "Management's
    Discussion and Analysis of Financial Condition and Results of
    Operations" section) that would be required to be included
    in such reports, subject to exceptions consistent with the
    presentation of financial information in the Offering
    Memorandum, to the extent filed within the times specified above.
84
Table of Contents
Events of
    Default and Remedies
The Indenture provides that each of the following is an
"Event of Default"
:
(1) default in payment when due and payable, upon
    redemption, acceleration or otherwise, of principal of, or
    premium, if any, on the Notes;
(2) default for 30 days or more in the payment when
    due of interest or Additional Interest on or with respect to the
    Notes;
(3) failure by the Issuer or any Guarantor for 60 days
    after receipt of written notice given by the Trustee or the
    Holders of not less 30% in principal amount of the Notes to
    comply with any of its obligations, covenants or agreements
    (other than a default referred to in clauses (1) and
    (2) above) contained in the Indenture or the Notes;
(4) default under any mortgage, indenture or instrument
    under which there is issued or by which there is secured or
    evidenced any Indebtedness for money borrowed by the Issuer or
    any of its Restricted Subsidiaries or the payment of which is
    guaranteed by the Issuer or any of its Restricted Subsidiaries,
    other than Indebtedness owed to the Issuer or a Restricted
    Subsidiary, whether such Indebtedness or guarantee now exists or
    is created after the issuance of the Notes, if both:
(a) such default either results from the failure to pay any
    principal of such Indebtedness at its stated final maturity
    (after giving effect to any applicable grace periods) or relates
    to an obligation other than the obligation to pay principal of
    any such Indebtedness at its stated final maturity and results
    in the holder or holders of such Indebtedness causing such
    Indebtedness to become due prior to its stated maturity; and
(b) the principal amount of such Indebtedness, together
    with the principal amount of any other such Indebtedness in
    default for failure to pay principal at stated final maturity
    (after giving effect to any applicable grace periods), or the
    maturity of which has been so accelerated, aggregate
    $200.0 million or more at any one time outstanding;
(5) failure by the Issuer or any Significant Subsidiary to
    pay final judgments aggregating in excess of
    $200.0 million, which final judgments remain unpaid,
    undischarged and unstayed for a period of more than 60 days
    after such judgment becomes final, and in the event such
    judgment is covered by insurance, an enforcement proceeding has
    been commenced by any creditor upon such judgment or decree
    which is not promptly stayed;
(6) certain events of bankruptcy or insolvency with respect
    to the Issuer or any Significant Subsidiary;
(7) the Guarantee of any Significant Subsidiary shall for
    any reason cease to be in full force and effect or be declared
    null and void or any responsible officer of any Guarantor that
    is a Significant Subsidiary, as the case may be, denies that it
    has any further liability under its Guarantee or gives notice to
    such effect, other than by reason of the termination of the
    Indenture or the release of any such Guarantee in accordance
    with the Indenture; or
(8) with respect to any Collateral having a fair market
    value in excess of $200 million, individually or in the
    aggregate, (a) the security interest under the Security
    Documents, at any time, ceases to be in full force and effect
    for any reason other than in accordance with the terms of the
    Indenture, the Security Documents and the Intercreditor
    Agreements, (b) any security interest created thereunder or
    under the Indenture is declared invalid or unenforceable by a
    court of competent jurisdiction or (c) the Issuer or any
    Guarantor asserts, in any pleading in any court of competent
    jurisdiction, that any such security interest is invalid or
    unenforceable.
If any Event of Default (other than of a type specified in
    clause (6) above) occurs and is continuing under the
    Indenture, the Trustee or the Holders of at least 30% in
    principal amount of the then total outstanding Notes may declare
    the principal, premium, if any, interest and any other monetary
    obligations on all the then outstanding Notes to be due and
    payable immediately.
85
Table of Contents
Upon the effectiveness of such declaration, such principal and
    interest will be due and payable immediately. Notwithstanding
    the foregoing, in the case of an Event of Default arising under
    clause (6) of the first paragraph of this section, all
    outstanding Notes will become due and payable without further
    action or notice. The Indenture provides that the Trustee may
    withhold from the Holders notice of any continuing Default,
    except a Default relating to the payment of principal, premium,
    if any, or interest, if it determines that withholding notice is
    in their interest. In addition, the Trustee shall have no
    obligation to accelerate the Notes if in the best judgment of
    the Trustee acceleration is not in the best interest of the
    Holders of the Notes.
The Indenture provides that the Holders of a majority in
    aggregate principal amount of the then outstanding Notes by
    notice to the Trustee may on behalf of the Holders of all of the
    Notes waive any existing Default and its consequences under the
    Indenture except a continuing Default in the payment of interest
    on, premium, if any, or the principal of any Note held by a
    non-consenting Holder. In the event of any Event of Default
    specified in clause (4) above, such Event of Default and
    all consequences thereof (excluding any resulting payment
    default, other than as a result of acceleration of the Notes)
    shall be annulled, waived and rescinded, automatically and
    without any action by the Trustee or the Holders, if within
    20 days after such Event of Default arose:
(1) the Indebtedness or guarantee that is the basis for
    such Event of Default has been discharged; or
(2) holders thereof have rescinded or waived the
    acceleration, notice or action (as the case may be) giving rise
    to such Event of Default; or
(3) the default that is the basis for such Event of Default
    has been cured.
Subject to the provisions of the Indenture relating to the
    duties of the Trustee thereunder, in case an Event of Default
    occurs and is continuing, the Trustee is under no obligation to
    exercise any of the rights or powers under the Indenture at the
    request or direction of any of the Holders of the Notes unless
    the Holders have offered to the Trustee reasonable indemnity or
    security against any loss, liability or expense. Except to
    enforce the right to receive payment of principal, premium, if
    any, or interest when due, no Holder of a Note may pursue any
    remedy with respect to the Indenture or the Notes unless:
(1) such Holder has previously given the Trustee notice
    that an Event of Default is continuing;
(2) Holders of at least 30% in principal amount of the
    total outstanding Notes have requested the Trustee to pursue the
    remedy;
(3) Holders of the Notes have offered the Trustee
    reasonable security or indemnity against any loss, liability or
    expense;
(4) the Trustee has not complied with such request within
    60 days after the receipt thereof and the offer of security
    or indemnity; and
(5) Holders of a majority in principal amount of the total
    outstanding Notes have not given the Trustee a direction
    inconsistent with such request within such
60-day
period.
Subject to certain restrictions, under the Indenture the Holders
    of a majority in principal amount of the total outstanding Notes
    are given the right to direct the time, method and place of
    conducting any proceeding for any remedy available to the
    Trustee or of exercising any trust or power conferred on the
    Trustee. The Trustee, however, may refuse to follow any
    direction that conflicts with law or the Indenture or that the
    Trustee determines is unduly prejudicial to the rights of any
    other Holder of a Note or that would involve the Trustee in
    personal liability.
The Indenture provides that the Issuer is required to deliver to
    the Trustee annually a statement regarding compliance with the
    Indenture, and the Issuer is required, within five Business
    Days, upon becoming aware of any Default, to deliver to the
    Trustee a statement specifying such Default.
86
Table of Contents
No
    Personal Liability of Directors, Officers, Employees and
    Stockholders
No director, officer, employee, incorporator or stockholder of
    the Issuer or any Guarantor or any of their parent companies
    (other than the Issuer and the Guarantors) shall have any
    liability for any obligations of the Issuer or the Guarantors
    under the Notes, the Guarantees or the Indenture or for any
    claim based on, in respect of, or by reason of such obligations
    or their creation. Each Holder by accepting the Notes waives and
    releases all such liability. The waiver and release are part of
    the consideration for issuance of the Notes. Such waiver may not
    be effective to waive liabilities under the federal securities
    laws, and it is the view of the SEC that such a waiver is
    against public policy.
Legal
    Defeasance and Covenant Defeasance
The obligations of the Issuer and the Guarantors under the
    Indenture will terminate (other than certain obligations) and
    will be released upon payment in full of all of the Notes. The
    Issuer may, at its option and at any time, elect to have all of
    its obligations discharged with respect to the Notes and have
    the Issuer's and each Guarantor's obligation
    discharged with respect to its Guarantee
("Legal
    Defeasance")
and cure all then existing Events of
    Default except for:
(1) the rights of Holders of Notes to receive payments in
    respect of the principal of, premium, if any, and interest on
    the Notes when such payments are due solely out of the trust
    created pursuant to the Indenture;
(2) the Issuer's obligations with respect to Notes
    concerning issuing temporary Notes, registration of such Notes,
    mutilated, destroyed, lost or stolen Notes and the maintenance
    of an office or agency for payment and money for security
    payments held in trust;
(3) the rights, powers, trusts, duties and immunities of
    the Trustee, and the Issuer's obligations in connection
    therewith; and
(4) the Legal Defeasance provisions of the Indenture.
In addition, the Issuer may, at its option and at any time,
    elect to have its obligations and those of each Guarantor
    released with respect to certain covenants that are described in
    the Indenture
("Covenant Defeasance")
and
    thereafter any omission to comply with such obligations shall
    not constitute a Default with respect to the Notes. In the event
    Covenant Defeasance occurs, certain events (not including
    bankruptcy, receivership, rehabilitation and insolvency events
    pertaining to the Issuer) described under "Events of
    Default and Remedies" will no longer constitute an Event of
    Default with respect to the Notes.
In order to exercise either Legal Defeasance or Covenant
    Defeasance with respect to the Notes:
(1) the Issuer must irrevocably deposit with the Trustee,
    in trust, for the benefit of the Holders of the Notes, cash in
    U.S. dollars, Government Securities, or a combination
    thereof, in such amounts as will be sufficient, in the opinion
    of a nationally recognized firm of independent public
    accountants, to pay the principal of, premium, if any, and
    interest due on the Notes on the stated maturity date or on the
    redemption date, as the case may be, of such principal, premium,
    if any, or interest on such Notes, and the Issuer must specify
    whether such Notes are being defeased to maturity or to a
    particular redemption date;
(2) in the case of Legal Defeasance, the Issuer shall have
    delivered to the Trustee an Opinion of Counsel reasonably
    acceptable to the Trustee confirming that, subject to customary
    assumptions and exclusions,
(a) the Issuer has received from, or there has been
    published by, the United States Internal Revenue Service a
    ruling, or
(b) since the issuance of the Notes, there has been a
    change in the applicable U.S. federal income tax law,
87
Table of Contents
in either case to the effect that, and based thereon such
    Opinion of Counsel shall confirm that, subject to customary
    assumptions and exclusions, the Holders of the Notes will not
    recognize income, gain or loss for U.S. federal income tax
    purposes, as applicable, as a result of such Legal Defeasance
    and will be subject to U.S. federal income tax on the same
    amounts, in the same manner and at the same times as would have
    been the case if such Legal Defeasance had not occurred;
(3) in the case of Covenant Defeasance, the Issuer shall
    have delivered to the Trustee an Opinion of Counsel reasonably
    acceptable to the Trustee confirming that, subject to customary
    assumptions and exclusions, the Holders of the Notes will not
    recognize income, gain or loss for U.S. federal income tax
    purposes as a result of such Covenant Defeasance and will be
    subject to such tax on the same amounts, in the same manner and
    at the same times as would have been the case if such Covenant
    Defeasance had not occurred;
(4) no Default (other than that resulting from borrowing
    funds to be applied to make such deposit and any similar and
    simultaneous deposit relating to other Indebtedness and, in each
    case, the granting of Liens in connection therewith) shall have
    occurred and be continuing on the date of such deposit;
(5) such Legal Defeasance or Covenant Defeasance shall not
    result in a breach or violation of, or constitute a default
    under the Senior Credit Facilities or any other material
    agreement or instrument (other than the Indenture) to which the
    Issuer or any Guarantor is a party or by which the Issuer or any
    Guarantor is bound (other than that resulting from borrowing
    funds to be applied to make such deposit and any similar and
    simultaneous deposit relating to other Indebtedness and, in each
    case, the granting of Liens in connection therewith);
(6) the Issuer shall have delivered to the Trustee an
    Opinion of Counsel to the effect that, as of the date of such
    opinion and subject to customary assumptions and exclusions
    following the deposit, the trust funds will not be subject to
    the effect of Section 547 of Title 11 of the United
    States Code;
(7) the Issuer shall have delivered to the Trustee an
    Officer's Certificate stating that the deposit was not made
    by the Issuer with the intent of defeating, hindering, delaying
    or defrauding any creditors of the Issuer or any Guarantor or
    others; and
(8) the Issuer shall have delivered to the Trustee an
    Officer's Certificate and an Opinion of Counsel (which
    Opinion of Counsel may be subject to customary assumptions and
    exclusions) each stating that all conditions precedent provided
    for or relating to the Legal Defeasance or the Covenant
    Defeasance, as the case may be, have been complied with.
Satisfaction
    and Discharge
The Indenture will be discharged and will cease to be of further
    effect as to all Notes, when either:
(1) all Notes theretofore authenticated and delivered,
    except lost, stolen or destroyed Notes which have been replaced
    or paid and Notes for whose payment money has theretofore been
    deposited in trust, have been delivered to the Trustee for
    cancellation; or
(2) (a) all Notes not theretofore delivered to the
    Trustee for cancellation have become due and payable by reason
    of the making of a notice of redemption or otherwise, will
    become due and payable within one year or may be called for
    redemption within one year under arrangements satisfactory to
    the Trustee for the giving of notice of redemption by the
    Trustee in the name, and at the expense, of the Issuer, and the
    Issuer or any Guarantor has irrevocably deposited or caused to
    be deposited with the Trustee as trust funds in trust solely for
    the benefit of the Holders of the Notes, cash in
    U.S. dollars, Government Securities, or a combination
    thereof, in such amounts as will be sufficient without
    consideration of any reinvestment of interest to pay and
    discharge the entire indebtedness on the Notes not theretofore
    delivered to the Trustee for cancellation for principal,
    premium, if any, and accrued interest to the date of maturity or
    redemption;
(b) no Default (other than that resulting from borrowing
    funds to be applied to make such deposit and any similar and
    simultaneous deposit relating to other Indebtedness and, in each
    case, the granting of
88
Table of Contents
Liens in connection therewith) with respect to the Indenture or
    the Notes shall have occurred and be continuing on the date of
    such deposit or shall occur as a result of such deposit, and
    such deposit will not result in a breach or violation of, or
    constitute a default under, the Senior Credit Facilities or any
    other material agreement or instrument (other than the
    Indenture) to which the Issuer or any Guarantor is a party or by
    which the Issuer or any Guarantor is bound (other than that
    resulting from borrowing funds to be applied to make such
    deposit and any similar and simultaneous deposit relating to
    other Indebtedness and, in each case, the granting of Liens in
    connection therewith);
(c) the Issuer has paid or caused to be paid all sums
    payable by it under the Indenture; and
(d) the Issuer has delivered irrevocable instructions to
    the Trustee to apply the deposited money toward the payment of
    the Notes at maturity or the redemption date, as the case may be.
In addition, the Issuer must deliver an Officer's
    Certificate and an Opinion of Counsel to the Trustee stating
    that all conditions precedent to satisfaction and discharge have
    been satisfied.
Amendment,
    Supplement and Waiver
Except as provided in the next two succeeding paragraphs, the
    Indenture, any Guarantee, any Security Document and the Notes
    may be amended or supplemented with the consent of the Holders
    of at least a majority in principal amount of the Notes then
    outstanding, including consents obtained in connection with a
    purchase of, or tender offer or exchange offer for, Notes, and
    any existing Default or compliance with any provision of the
    Indenture, the Notes issued thereunder, any Guarantee or the
    Security Documents may be waived with the consent of the Holders
    of a majority in principal amount of the then outstanding Notes,
    other than Notes beneficially owned by the Issuer or its
    Affiliates (including consents obtained in connection with a
    purchase of or tender offer or exchange offer for the Notes);
provided
,
however
, that that if any amendment,
    waiver or other modification will affect only the Cash Pay Notes
    or Toggle Notes, only the consent of the Holders of at least a
    majority in principal amount of the then outstanding Cash Pay
    Notes or Toggle Notes (and not the consent of at least a
    majority of all Notes), as the case may be, shall be required.
The Indenture provides that, without the consent of each
    affected Holder of Notes, an amendment or waiver may not, with
    respect to any Notes held by a non-consenting Holder:
(1) reduce the principal amount of such Notes whose Holders
    must consent to an amendment, supplement or waiver;
(2) reduce the principal of or change the fixed final
    maturity of any such Note or alter or waive the provisions with
    respect to the redemption of such Notes (other than provisions
    relating to the covenants described above under the caption
    "Repurchase at the Option of Holders");
(3) reduce the rate of or change the time for payment of
    interest on any Note;
(4) waive a Default in the payment of principal of or
    premium, if any, or interest on the Notes, except a rescission
    of acceleration of the Notes by the Holders of at least a
    majority in aggregate principal amount of the Notes and a waiver
    of the payment default that resulted from such acceleration, or
    in respect of a covenant or provision contained in the Indenture
    or any Guarantee which cannot be amended or modified without the
    consent of all Holders;
(5) make any Note payable in money other than that stated
    therein;
(6) make any change in the provisions of the Indenture
    relating to waivers of past Defaults or the rights of Holders to
    receive payments of principal of or premium, if any, or interest
    on the Notes;
(7) make any change in these amendment and waiver
    provisions;
(8) impair the right of any Holder to receive payment of
    principal of, or interest on such Holder's Notes on or
    after the due dates therefor or to institute suit for the
    enforcement of any payment on or with respect to such
    Holder's Notes;
89
Table of Contents
(9) make any change to or modify the ranking of the Notes
    or the subordination of the Liens with respect to the Notes that
    would adversely affect the Holders; or
(10) except as expressly permitted by the Indenture, modify
    the Guarantees of any Significant Subsidiary in any manner
    adverse to the Holders of the Notes.
In addition, without the consent of at least 75% in aggregate
    principal amount of Notes then outstanding, an amendment,
    supplement or waiver may not:
(1) modify any Security Document or the provisions of the
    Indenture dealing with the Security Documents or application of
    trust moneys, or otherwise release any Collateral, in any manner
    materially adverse to the Holders other than in accordance with
    the Indenture, the Security Documents and the Intercreditor
    Agreements; or
(2) modify any Intercreditor Agreement in any manner
    materially adverse to the Holders other than in accordance with
    the Indenture, the Security Documents and the Intercreditor
    Agreements.
Notwithstanding the foregoing, the Issuer, any Guarantor (with
    respect to a Guarantee or the Indenture to which it is a party)
    and the Trustee may amend or supplement the Indenture, any
    Security Document and any Guarantee or Notes without the consent
    of any Holder;
(1) to cure any ambiguity, omission, mistake, defect or
    inconsistency;
(2) to provide for uncertificated Notes of such series in
    addition to or in place of certificated Notes;
(3) to comply with the covenant relating to mergers,
    consolidations and sales of assets;
(4) to provide for the assumption of the Issuer's or
    any Guarantor's obligations to the Holders;
(5) to make any change that would provide any additional
    rights or benefits to the Holders or that does not adversely
    affect the legal rights under the Indenture of any such Holder;
(6) to add covenants for the benefit of the Holders or to
    surrender any right or power conferred upon the Issuer or any
    Guarantor;
(7) to comply with requirements of the SEC in order to
    effect or maintain the qualification of the Indenture under the
    Trust Indenture Act;
(8) to evidence and provide for the acceptance and
    appointment under the Indenture of a successor Trustee
    thereunder pursuant to the requirements thereof;
(9) to provide for the issuance of Exchange Notes or
    private exchange notes, which are identical to Exchange Notes
    except that they are not freely transferable;
(10) to add a Guarantor under the Indenture;
(11) to conform the text of the Indenture, Security
    Documents, Guarantees or the Notes to any provision of this
    "Description of Notes" to the extent that such
    provision in this "Description of Notes" was intended
    to be a verbatim recitation of a provision of the Indenture,
    Security Documents, Guarantee or Notes;
(12) to make any amendment to the provisions of the
    Indenture relating to the transfer and legending of Notes as
    permitted by the Indenture, including, without limitation to
    facilitate the issuance and administration of the Notes;
provided
,
however
, that (i) compliance with
    the Indenture as so amended would not result in Notes being
    transferred in violation of the Securities Act or any applicable
    securities law and (ii) such amendment does not materially
    and adversely affect the rights of Holders to transfer Notes;
(13) to mortgage, pledge, hypothecate or grant any other
    Lien in favor of the Trustee for the benefit of the Holders of
    the Notes, as additional security for the payment and
    performance of all or any portion of the Obligations, in any
    property or assets, including any which are required to be
    mortgaged, pledged
90
Table of Contents
or hypothecated, or in which a Lien is required to be granted to
    or for the benefit of the Trustee or the Collateral Agent
    pursuant to the Indenture, any of the Security Documents or
    otherwise; or
(14) to release Collateral from the Lien of the Indenture
    and the Security Documents when permitted or required by the
    Security Documents or the Indenture.
The consent of the Holders is not necessary under the Indenture
    to approve the particular form of any proposed amendment. It is
    sufficient if such consent approves the substance of the
    proposed amendment.
Notices
Notices given by publication will be deemed given on the first
    date on which publication is made and notices given by
    first-class mail, postage prepaid, will be deemed given five
    calendar days after mailing.
Concerning
    the Trustee
The Indenture contains certain limitations on the rights of the
    Trustee thereunder, should it become a creditor of the Issuer,
    to obtain payment of claims in certain cases, or to realize on
    certain property received in respect of any such claim as
    security or otherwise. The Trustee is permitted to engage in
    other transactions; however, if it acquires any conflicting
    interest it must eliminate such conflict within 90 days,
    apply to the SEC for permission to continue or resign.
The Indenture provides that the Holders of a majority in
    principal amount of the outstanding Notes have the right to
    direct the time, method and place of conducting any proceeding
    for exercising any remedy available to the Trustee, subject to
    certain exceptions. The Indenture provides that in case an Event
    of Default shall occur (which shall not be cured), the Trustee
    will be required, in the exercise of its power, to use the
    degree of care of a prudent person in the conduct of his own
    affairs. Subject to such provisions, the Trustee is under no
    obligation to exercise any of its rights or powers under the
    Indenture at the request of any Holder of the Notes, unless such
    Holder shall have offered to the Trustee security and indemnity
    satisfactory to it against any loss, liability or expense.
Governing
    Law
The Indenture, the Notes and any Guarantee are governed by and
    construed in accordance with the laws of the State of New York.
Certain
    Definitions
Set forth below are certain defined terms used in the Indenture.
    For purposes of the Indenture, unless otherwise specifically
    indicated, the term "consolidated" with respect to any
    Person refers to such Person on a consolidated basis in
    accordance with GAAP, but excluding from such consolidation any
    Unrestricted Subsidiary as if such Unrestricted Subsidiary were
    not an Affiliate of such Person.
"ABL Facility"
means the Asset-Based Revolving
    Credit Agreement entered into as of the Issue Date by and among
    the Issuer, the lenders party thereto in their capacities as
    lenders thereunder and Bank of America, N.A., as Administrative
    Agent, including any guarantees, collateral documents,
    instruments and agreements executed in connection therewith, and
    any amendments, supplements, modifications, extensions,
    renewals, restatements, refundings or refinancings thereof and
    any indentures or credit facilities or commercial paper
    facilities with banks or other institutional lenders or
    investors that replace, refund or refinance any part of the
    loans, notes, other credit facilities or commitments thereunder,
    including any such replacement, refunding or refinancing
    facility or indenture that increases the amount borrowable
    thereunder or alters the maturity thereof (
provided
that
    such increase in borrowings is permitted under "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock"
    above).
"ABL Facility Cap"
means an amount equal to the
    greater of (x) $2,000.0 million and (y) 75% of
    the consolidated accounts receivable of the Issuer and its
    subsidiaries determined in accordance with GAAP.
91
Table of Contents
"ABL Financing Entity"
means the Issuer and
    certain of its subsidiaries from time to time named as borrowers
    or guarantors under the ABL Facility.
"ABL Obligations"
means Obligations under the
    ABL Facility.
"ABL Secured Parties"
means each of
    (i) the ABL Collateral Agent on behalf of itself and the
    lenders under the ABL Facility and lenders or their affiliates
    counterparty to related Hedging Obligations and (ii) each
    other holder of ABL Obligations.
"Acquired Indebtedness"
means, with respect to
    any specified Person,
(1) Indebtedness of any other Person existing at the time
    such other Person is merged with or into or became a Restricted
    Subsidiary of such specified Person, including Indebtedness
    incurred in connection with, or in contemplation of, such other
    Person merging with or into or becoming a Restricted Subsidiary
    of such specified Person, and
(2) Indebtedness secured by a Lien encumbering any asset
    acquired by such specified Person.
"Additional Interest"
means all additional
    interest then owing pursuant to the Registration Rights
    Agreement.
"Affiliate"
of any specified Person means any
    other Person directly or indirectly controlling or controlled by
    or under direct or indirect common control with such specified
    Person. For purposes of this definition, "control"
    (including, with correlative meanings, the terms
    "controlling," "controlled by" and
    "under common control with"), as used with respect to
    any Person, shall mean the possession, directly or indirectly,
    of the power to direct or cause the direction of the management
    or policies of such Person, whether through the ownership of
    voting securities, by agreement or otherwise.
"Applicable Premium"
means, with respect to any
    Note on any Redemption Date, the greater of:
(1) 1.0% of the principal amount of such Note; and
(2) (A) with respect to the 2016 Cash Pay Notes and
    the Toggle Notes, the excess, if any, of (a) the present
    value at such Redemption Date of (i) the redemption
    price of such Note at November 15, 2011 (such redemption
    price being set forth in the tables appearing above under the
    captions "Optional Redemption — 2016 Cash Pay
    Notes" and "Optional Redemption — Toggle
    Notes"), plus (ii) all required interest payments (in
    the case of the Toggle Notes, calculated based on the cash
    interest rate payable on the Toggle Notes) due on such Note
    through November 15, 2011 (excluding accrued but unpaid
    interest to the Redemption Date), computed using a discount
    rate equal to the Treasury Rate as of such Redemption Date
    plus 50 basis points; over (b) the principal amount of
    such Note, or
(B) with respect to the 2014 Cash Pay Notes, the excess, if
    any, of (a) the present value at such Redemption Date
    of (i) the redemption price of such 2014 Cash Pay Note at
    November 15, 2010 (such redemption price being set forth in
    the tables appearing above under the caption "Optional
    Redemption — 2014 Cash Pay Notes"),
plus
(ii) all required interest payments due on such 2014
    Cash Pay Note through November 15, 2010 (excluding accrued
    but unpaid interest to the Redemption Date), computed using
    a discount rate equal to the Treasury Rate as of such
    Redemption Date plus 50 basis points; over
    (b) the principal amount of such 2014 Cash Pay Note.
"Asset Sale"
means:
(1) the sale, conveyance, transfer or other disposition,
    whether in a single transaction or a series of related
    transactions, of property or assets (including by way of a Sale
    and Lease-Back Transaction) of the Issuer or any of its
    Restricted Subsidiaries (each referred to in this definition as
    a "
disposition
"); or
(2) the issuance or sale of Equity Interests of any
    Restricted Subsidiary, whether in a single transaction or a
    series of related transactions (other than Preferred Stock of
    Restricted Subsidiaries issued in compliance with the covenant
    described under "Certain Covenants — Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock");
92
Table of Contents
in each case, other than:
(a) any disposition of Cash Equivalents or Investment Grade
    Securities or obsolete or worn out equipment in the ordinary
    course of business or any disposition of inventory or goods (or
    other assets) held for sale in the ordinary course of business;
(b) the disposition of all or substantially all of the
    assets of the Issuer in a manner permitted pursuant to the
    provisions described above under "Certain
    Covenants — Merger, Consolidation or Sale of All or
    Substantially All Assets" or any disposition that
    constitutes a Change of Control pursuant to the Indenture;
(c) the making of any Restricted Payment or Permitted
    Investment that is permitted to be made, and is made, under the
    covenant described above under "Certain
    Covenants — Limitation on Restricted Payments";
(d) any disposition of assets or issuance or sale of Equity
    Interests of any Restricted Subsidiary in any transaction or
    series of related transactions with an aggregate fair market
    value of less than $100.0 million;
(e) any disposition of property or assets or issuance of
    securities by a Restricted Subsidiary of the Issuer to the
    Issuer or by the Issuer or a Restricted Subsidiary of the Issuer
    to another Restricted Subsidiary of the Issuer;
(f) to the extent allowable under Section 1031 of the
    Code or any comparable or successor provision, any exchange of
    like property (excluding any boot thereon) for use in a Similar
    Business;
(g) the lease, assignment or
sub-lease
of
    any real or personal property in the ordinary course of business;
(h) any issuance or sale of Equity Interests in, or
    Indebtedness or other securities of, an Unrestricted Subsidiary;
(i) foreclosures on assets;
(j) sales of accounts receivable, or participations
    therein, in connection with the ABL Facility or any Receivables
    Facility;
(k) any financing transaction with respect to property
    built or acquired by the Issuer or any Restricted Subsidiary
    after the Issue Date, including Sale and Lease-Back Transactions
    and asset securitizations permitted by the Indenture;
(l) dispositions in the ordinary course of business by any
    Restricted Subsidiary (including, without limitation, HCI)
    engaged in the insurance business in order to provide insurance
    to the Issuer and its Subsidiaries;
(m) sales, transfers and other dispositions of Investments
    in joint ventures to the extent required by, or made pursuant
    to, customary buy/sell arrangements between the joint venture
    parties set forth in joint venture arrangements and similar
    binding arrangements;
(n) any issuance or sale of Equity Interests or
    dispositions in connection with ordinary course syndications of
    Subsidiaries or joint ventures owning or operating one or more
    healthcare facilities, including, without limitation, hospitals,
    ambulatory surgery centers, outpatient diagnostic centers or
    imaging centers in any transaction or series of related
    transactions with an aggregate fair market value of less than
    $100.0 million; and
(o) any issuance or sale of Equity Interests of any
    Restricted Subsidiary (including, without limitation,
    HealthTrust Purchasing Group, L.P.) to any Person operating in a
    Similar Business for which such Restricted Subsidiary provides
    shared purchasing, billing, collection or similar services in
    the ordinary course of business.
93
Table of Contents
"Asset Sale Offer"
has the meaning set forth in
    the fourth paragraph under "Repurchase at the Option of
    Holders — Asset Sales."
"Bankruptcy Code"
means Title 11 of the
    United States Code, as amended.
"Bankruptcy Law"
means the Bankruptcy Code and
    any similar federal, state or foreign law for the relief of
    debtors.
"Business Day"
means each day which is not a
    Legal Holiday.
"Capital Stock"
means:
(1) in the case of a corporation, corporate stock;
(2) in the case of an association or business entity, any
    and all shares, interests, participations, rights or other
    equivalents (however designated) of corporate stock;
(3) in the case of a partnership or limited liability
    company, partnership or membership interests (whether general or
    limited); and
(4) any other interest or participation that confers on a
    Person the right to receive a share of the profits and losses
    of, or distributions of assets of, the issuing Person.
"Capitalized Lease Obligation"
means, at the
    time any determination thereof is to be made, the amount of the
    liability in respect of a capital lease that would at such time
    be required to be capitalized and reflected as a liability on a
    balance sheet (excluding the footnotes thereto) in accordance
    with GAAP.
"Capitalized Software Expenditures"
means, for
    any period, the aggregate of all expenditures (whether paid in
    cash or accrued as liabilities) by a Person and its Restricted
    Subsidiaries during such period in respect of purchased software
    or internally developed software and software enhancements that,
    in conformity with GAAP, are or are required to be reflected as
    capitalized costs on the consolidated balance sheet of a Person
    and its Restricted Subsidiaries.
"Cash Equivalents"
means:
(1) United States dollars;
(2) euro or any national currency of any participating
    member state of the EMU or such local currencies held by the
    Company and its Restricted Subsidiaries from time to time in the
    ordinary course of business;
(3) securities issued or directly and fully and
    unconditionally guaranteed or insured by the
    U.S. government (or any agency or instrumentality thereof
    the securities of which are unconditionally guaranteed as a full
    faith and credit obligation of the U.S. government) with
    maturities of 24 months or less from the date of
    acquisition;
(4) certificates of deposit, time deposits and eurodollar
    time deposits with maturities of one year or less from the date
    of acquisition, bankers' acceptances with maturities not
    exceeding one year and overnight bank deposits, in each case
    with any commercial bank having capital and surplus of not less
    than $500.0 million in the case of U.S. banks and
    $100.0 million (or the U.S. dollar equivalent as of
    the date of determination) in the case of
non-U.S. banks;
(5) repurchase obligations for underlying securities of the
    types described in clauses (3) and (4) entered into
    with any financial institution meeting the qualifications
    specified in clause (4) above;
(6) commercial paper rated at least
P-1
by
    Moody's or at least
A-1
by
    S&P and in each case maturing within 24 months after
    the date of creation thereof;
(7) marketable short-term money market and similar
    securities having a rating of at least
P-2
or
A-2
from
    either Moody's or S&P, respectively (or, if at any
    time neither Moody's nor S&P shall be rating such
    obligations, an equivalent rating from another Rating Agency)
    and in each case maturing within 24 months after the date
    of creation thereof;
94
Table of Contents
(8) investment funds investing 95% of their assets in
    securities of the types described in clauses (1) through
    (7) above;
(9) readily marketable direct obligations issued by any
    state, commonwealth or territory of the United States or any
    political subdivision or taxing authority thereof having an
    Investment Grade Rating from either Moody's or S&P
    with maturities of 24 months or less from the date of
    acquisition;
(10) Indebtedness or Preferred Stock issued by Persons with
    a rating of "A" or higher from S&P or
    "A2" or higher from Moody's with maturities of
    24 months or less from the date of acquisition; and
(11) Investments with average maturities of 24 months
    or less from the date of acquisition in money market funds rated
    AAA- (or the equivalent thereof) or better by S&P or Aaa3
    (or the equivalent thereof) or better by Moody's.
Notwithstanding the foregoing, Cash Equivalents shall include
    amounts denominated in currencies other than those set forth in
    clauses (1) and (2) above;
provided
that such
    amounts are converted into any currency listed in
    clauses (1) and (2) as promptly as practicable and in
    any event within ten Business Days following the receipt of such
    amounts.
"Cash Interest"
has the meaning set forth under
    "Principal, Maturity and Interest — Toggle
    Notes."
"Change of Control"
means the occurrence of any
    of the following:
(1) the sale, lease or transfer, in one or a series of
    related transactions, of all or substantially all of the assets
    of the Issuer and its Subsidiaries, taken as a whole, to any
    Person other than a Permitted Holder; or
(2) the Issuer becomes aware (by way of a report or any
    other filing pursuant to Section 13(d) of the Exchange Act,
    proxy, vote, written notice or otherwise) of the acquisition by
    any Person or group (within the meaning of Section 13(d)(3)
    or Section 14(d)(2) of the Exchange Act, or any successor
    provision), including any group acting for the purpose of
    acquiring, holding or disposing of securities (within the
    meaning of
Rule 13d-5(b)(1)
under the Exchange Act), other than the Permitted Holders, in a
    single transaction or in a related series of transactions, by
    way of merger, consolidation or other business combination or
    purchase of beneficial ownership (within the meaning of
Rule 13d-3
under the Exchange Act, or any successor provision) of 50% or
    more of the total voting power of the Voting Stock of the Issuer
    or any of its direct or indirect parent companies holding
    directly or indirectly 100% of the total voting power of the
    Voting Stock of the Issuer.
"Code"
means the Internal Revenue Code of 1986,
    as amended, or any successor thereto.
"Collateral"
means, collectively, the Shared
    Receivables Collateral and Non-Receivables Collateral.
"Collateral Asset Sale Offer"
has the meaning
    set forth in the third paragraph under "Repurchase at the
    Option of Holders — Asset Sales."
"Collateral Excess Proceeds"
has the meaning
    set forth in the third paragraph under "Repurchase at the
    Option of Holders — Asset Sales."
"Consolidated Depreciation and Amortization
    Expense"
means with respect to any Person for any
    period, the total amount of depreciation and amortization
    expense, including the amortization of deferred financing fees,
    debt issuance costs, commissions, fees and expenses and
    Capitalized Software Expenditures, of such Person and its
    Restricted Subsidiaries for such period on a consolidated basis
    and otherwise determined in accordance with GAAP.
"Consolidated Interest Expense"
means, with
    respect to any Person for any period, without duplication, the
    sum of:
(1) consolidated interest expense of such Person and its
    Restricted Subsidiaries for such period, to the extent such
    expense was deducted (and not added back) in computing
    Consolidated Net Income (including (a) amortization of
    original issue discount resulting from the issuance of
    Indebtedness at less
95
Table of Contents
than par, (b) all commissions, discounts and other fees and
    charges owed with respect to letters of credit or bankers'
    acceptances, (c) non-cash interest payments (but excluding
    any non-cash interest expense attributable to the movement in
    the mark to market valuation of Hedging Obligations or other
    derivative instruments pursuant to GAAP), (d) the interest
    component of Capitalized Lease Obligations, and (e) net
    payments, if any, pursuant to interest rate Hedging Obligations
    with respect to Indebtedness, and excluding (u) accretion
    or accrual of discounted liabilities not constituting
    Indebtedness, (v) any expense resulting from the
    discounting of the Existing Notes or other Indebtedness in
    connection with the application of recapitalization accounting
    or, if applicable, purchase accounting, (w) any Additional
    Interest and any comparable "additional interest" with
    respect to other securities, (x) amortization of deferred
    financing fees, debt issuance costs, commissions, fees and
    expenses, (y) any expensing of bridge, commitment and other
    financing fees and (z) commissions, discounts, yield and
    other fees and charges (including any interest expense) related
    to any Receivables Facility); plus
(2) consolidated capitalized interest of such Person and
    its Restricted Subsidiaries for such period, whether paid or
    accrued; less
(3) interest income for such period.
For purposes of this definition, interest on a Capitalized Lease
    Obligation shall be deemed to accrue at an interest rate
    reasonably determined by such Person to be the rate of interest
    implicit in such Capitalized Lease Obligation in accordance with
    GAAP.
"Consolidated Leverage Ratio"
, with respect to
    any Person as of any date of determination, means the ratio of
    (x) Consolidated Total Indebtedness of such Person as of
    the end of the most recent fiscal quarter for which internal
    financial statements are available immediately preceding the
    date on which such event for which such calculation is being
    made shall occur to (y) the aggregate amount of EBITDA of
    such Person for the period of the most recently ended four full
    consecutive fiscal quarters for which internal financial
    statements are available immediately preceding the date on which
    such event for which such calculation is being made shall occur,
    in each case with such
pro forma
adjustments to
    Consolidated Total Indebtedness and EBITDA as are appropriate
    and consistent with the
pro forma
adjustment provisions
    set forth in the definition of "Fixed Charge Coverage
    Ratio."
"Consolidated Net Income"
means, with respect
    to any Person for any period, the aggregate of the Net Income of
    such Person for such period, on a consolidated basis, and
    otherwise determined in accordance with GAAP;
provided
,
however
, that, without duplication,
(1) any after-tax effect of extraordinary, non-recurring or
    unusual gains or losses (less all fees and expenses relating
    thereto) or expenses (including relating to the Transaction to
    the extent incurred on or prior to December 31, 2007),
    severance, relocation costs, consolidation and closing costs,
    integration and facilities opening costs, business optimization
    costs, transition costs, restructuring costs, signing, retention
    or completion bonuses, and curtailments or modifications to
    pension and post-retirement employee benefit plans shall be
    excluded,
(2) the cumulative effect of a change in accounting
    principles during such period shall be excluded,
(3) any after-tax effect of income (loss) from disposed,
    abandoned or discontinued operations and any net after-tax gains
    or losses on disposal of disposed, abandoned, transferred,
    closed or discontinued operations shall be excluded,
(4) any after-tax effect of gains or losses (less all fees
    and expenses relating thereto) attributable to asset
    dispositions or abandonments other than in the ordinary course
    of business, as determined in good faith by the Issuer, shall be
    excluded,
(5) the Net Income for such period of any Person that is an
    Unrestricted Subsidiary shall be excluded, and, solely for the
    purpose of determining the amount available for Restricted
    Payments under clause 3(a) of the first paragraph of
    "Certain Covenants — Limitation on Restricted
    Payments," the Net Income for such period of any Person
    that is not a Subsidiary or that is accounted for by the equity
    method of accounting shall be excluded;
provided
that
    Consolidated Net Income of the Issuer shall be increased by the
    amount of
96
Table of Contents
dividends or distributions or other payments that are actually
    paid in cash (or to the extent converted into cash) to the
    referent Person or a Restricted Subsidiary thereof in respect of
    such period,
(6) solely for the purpose of determining the amount
    available for Restricted Payments under clause (3)(a) of the
    first paragraph of "Certain Covenants —
    Limitation on Restricted Payments," the Net Income for such
    period of any Restricted Subsidiary (other than any Guarantor)
    shall be excluded to the extent that the declaration or payment
    of dividends or similar distributions by that Restricted
    Subsidiary of its Net Income is not at the date of determination
    wholly permitted without any prior governmental approval (which
    has not been obtained) or, directly or indirectly, by the
    operation of the terms of its charter or any agreement,
    instrument, judgment, decree, order, statute, rule, or
    governmental regulation applicable to that Restricted Subsidiary
    or its stockholders, unless such restriction with respect to the
    payment of dividends or similar distributions has been legally
    waived;
provided
that Consolidated Net Income of the
    Issuer will be increased by the amount of dividends or other
    distributions or other payments actually paid in cash (or to the
    extent converted into cash) or Cash Equivalents to the Issuer or
    a Restricted Subsidiary thereof in respect of such period, to
    the extent not already included therein,
(7) effects of adjustments (including the effects of such
    adjustments pushed down to the Issuer and its Restricted
    Subsidiaries) in the property, equipment, inventory, software
    and other intangible assets, deferred revenue and debt line
    items in such Person's consolidated financial statements
    pursuant to GAAP resulting from the application of
    recapitalization accounting or, if applicable, purchase
    accounting in relation to the Transaction or any consummated
    acquisition or the amortization or write-off of any amounts
    thereof, net of taxes, shall be excluded,
(8) any after-tax effect of income (loss) from the early
    extinguishment of Indebtedness or Hedging Obligations or other
    derivative instruments shall be excluded,
(9) any impairment charge or asset write-off, including,
    without limitation, impairment charges or asset write-offs
    related to intangible assets, long-lived assets or investments
    in debt and equity securities, in each case, pursuant to GAAP
    and the amortization of intangibles arising pursuant to GAAP
    shall be excluded,
(10) any non-cash compensation expense recorded from grants
    of stock appreciation or similar rights, stock options,
    restricted stock or other rights, and any cash charges
    associated with the rollover, acceleration or payout of Equity
    Interests by management of the Company or any of its direct or
    indirect parent companies in connection with the Transaction,
    shall be excluded,
(11) any fees and expenses incurred during such period, or
    any amortization thereof for such period, in connection with any
    acquisition, Investment, Asset Sale, issuance or repayment of
    Indebtedness, issuance of Equity Interests, refinancing
    transaction or amendment or modification of any debt instrument
    (in each case, including any such transaction consummated prior
    to the Issue Date and any such transaction undertaken but not
    completed) and any charges or non-recurring merger costs
    incurred during such period as a result of any such transaction
    shall be excluded,
(12) accruals and reserves that are established or adjusted
    within twelve months after the Issue Date that are so required
    to be established as a result of the Transaction in accordance
    with GAAP, or changes as a result of adoption or modification of
    accounting policies, shall be excluded, and
(13) to the extent covered by insurance and actually
    reimbursed, or, so long as the Issuer has made a determination
    that there exists reasonable evidence that such amount will in
    fact be reimbursed by the insurer and only to the extent that
    such amount is (a) not denied by the applicable carrier in
    writing within 180 days and (b) in fact reimbursed
    within 365 days of the date of such evidence (with a
    deduction for any amount so added back to the extent not so
    reimbursed within 365 days), expenses with respect to
    liability or casualty events or business interruption shall be
    excluded.
Notwithstanding the foregoing, for the purpose of the covenant
    described under "Certain Covenants — Limitation
    on Restricted Payments" only (other than clause (3)(d)
    thereof), there shall be excluded from Consolidated Net Income
    any income arising from any sale or other disposition of
    Restricted Investments made by the Issuer and its Restricted
    Subsidiaries, any repurchases and redemptions of Restricted
    Investments
97
Table of Contents
from the Issuer and its Restricted Subsidiaries, any repayments
    of loans and advances which constitute Restricted Investments by
    the Issuer or any of its Restricted Subsidiaries, any sale of
    the stock of an Unrestricted Subsidiary or any distribution or
    dividend from an Unrestricted Subsidiary, in each case only to
    the extent such amounts increase the amount of Restricted
    Payments permitted under such covenant pursuant to clause (3)(d)
    thereof.
"Consolidated Secured Debt Ratio"
as of any
    date of determination, means the ratio of (1) Consolidated
    Total Indebtedness of the Issuer and its Restricted Subsidiaries
    that is secured by Liens as of the end of the most recent fiscal
    period for which internal financial statements are available
    immediately preceding the date on which such event for which
    such calculation is being made shall occur to (2) the
    Issuer's EBITDA for the most recently ended four full
    fiscal quarters for which internal financial statements are
    available immediately preceding the date on which such event for
    which such calculation is being made shall occur, in each case
    with such
pro forma
adjustments to Consolidated Total
    Indebtedness and EBITDA as are appropriate and consistent with
    the
pro forma
adjustment provisions set forth in the
    definition of "Fixed Charge Coverage Ratio."
"Consolidated Total Indebtedness"
means, as at
    any date of determination, an amount equal to the sum of
    (1) the aggregate amount of all outstanding Indebtedness of
    the Issuer and its Restricted Subsidiaries on a consolidated
    basis consisting of Indebtedness for borrowed money, Obligations
    in respect of Capitalized Lease Obligations and debt obligations
    evidenced by promissory notes and similar instruments (and
    excluding, for the avoidance of doubt, all obligations relating
    to Receivables Facilities) and (2) the aggregate amount of
    all outstanding Disqualified Stock of the Issuer and all
    Preferred Stock of its Restricted Subsidiaries on a consolidated
    basis, with the amount of such Disqualified Stock and Preferred
    Stock equal to the greater of their respective voluntary or
    involuntary liquidation preferences and maximum fixed repurchase
    prices, in each case determined on a consolidated basis in
    accordance with GAAP. For purposes hereof, the "maximum
    fixed repurchase price" of any Disqualified Stock or
    Preferred Stock that does not have a fixed repurchase price
    shall be calculated in accordance with the terms of such
    Disqualified Stock or Preferred Stock as if such Disqualified
    Stock or Preferred Stock were purchased on any date on which
    Consolidated Total Indebtedness shall be required to be
    determined pursuant to the Indenture, and if such price is based
    upon, or measured by, the fair market value of such Disqualified
    Stock or Preferred Stock, such fair market value shall be
    determined reasonably and in good faith by the Issuer.
"Contingent Obligations"
means, with respect to
    any Person, any obligation of such Person guaranteeing any
    leases, dividends or other obligations that do not constitute
    Indebtedness
("primary obligations")
of any
    other Person (the
"primary obligor"
) in any
    manner, whether directly or indirectly, including, without
    limitation, any obligation of such Person, whether or not
    contingent,
(1) to purchase any such primary obligation or any property
    constituting direct or indirect security therefor,
(2) to advance or supply funds
(a) for the purchase or payment of any such primary
    obligation, or
(b) to maintain working capital or equity capital of the
    primary obligor or otherwise to maintain the net worth or
    solvency of the primary obligor, or
(3) to purchase property, securities or services primarily
    for the purpose of assuring the owner of any such primary
    obligation of the ability of the primary obligor to make payment
    of such primary obligation against loss in respect thereof.
"Credit Facilities"
means, with respect to the
    Issuer or any of its Restricted Subsidiaries, one or more debt
    facilities, including the Senior Credit Facilities, or other
    financing arrangements (including, without limitation,
    commercial paper facilities or indentures) providing for
    revolving credit loans, term loans, letters of credit or other
    long-term indebtedness, including any notes, mortgages,
    guarantees, collateral documents, instruments and agreements
    executed in connection therewith, and any amendments,
    supplements, modifications, extensions, renewals, restatements
    or refundings thereof and any indentures or credit facilities or
    commercial paper facilities that replace, refund or refinance
    any part of the loans, notes, other credit facilities
98
Table of Contents
or commitments thereunder, including any such replacement,
    refunding or refinancing facility or indenture that increases
    the amount permitted to be borrowed thereunder or alters the
    maturity thereof (
provided
that such increase in
    borrowings is permitted under "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock") or
    adds Restricted Subsidiaries as additional borrowers or
    guarantors thereunder and whether by the same or any other
    agent, lender or group of lenders.
"Default"
means any event that is, or with the
    passage of time or the giving of notice or both would be, an
    Event of Default.
"Delayed Equity Amount"
means any equity
    contribution of the Investors, the Frist Entities or certain
    other management investors described in the Offering Memorandum
    on or before March 31, 2007, the proceeds of which were
    used to repay borrowings under the senior secured revolving
    credit facility included in the General Credit Facility or the
    ABL Facility in the manner described in the Offering Memorandum.
"Designated Non-cash Consideration"
means the
    fair market value of non-cash consideration received by the
    Issuer or a Restricted Subsidiary in connection with an Asset
    Sale that is so designated as Designated Non-cash Consideration
    pursuant to an Officer's Certificate, setting forth the
    basis of such valuation, executed by the principal financial
    officer of the Issuer, less the amount of cash or Cash
    Equivalents received in connection with a subsequent sale of or
    collection on such Designated Non-cash Consideration.
"Designated Preferred Stock"
means Preferred
    Stock of the Issuer or any parent corporation thereof (in each
    case other than Disqualified Stock) that is issued for cash
    (other than to a Restricted Subsidiary or an employee stock
    ownership plan or trust established by the Issuer or any of its
    Subsidiaries) and is so designated as Designated Preferred
    Stock, pursuant to an Officer's Certificate executed by the
    principal financial officer of the Issuer or the applicable
    parent corporation thereof, as the case may be, on the issuance
    date thereof, the cash proceeds of which are excluded from the
    calculation set forth in clause (3) of the first paragraph
    under "Certain Covenants — Limitation on
    Restricted Payments."
"Discharge of First Lien Obligations"
shall
    mean the satisfaction and discharge of all of the First Lien
    Obligations in full in cash, pursuant to the First Lien
    Documents and the General Intercreditor Agreement.
"Disqualified Stock"
means, with respect to any
    Person, any Capital Stock of such Person which, by its terms, or
    by the terms of any security into which it is convertible or for
    which it is putable or exchangeable, or upon the happening of
    any event, matures or is mandatorily redeemable (other than
    solely as a result of a change of control or asset sale)
    pursuant to a sinking fund obligation or otherwise, or is
    redeemable at the option of the holder thereof (other than
    solely as a result of a change of control or asset sale), in
    whole or in part, in each case prior to the date 91 days
    after the earlier of the maturity date of the Notes or the date
    the Notes are no longer outstanding;
provided
,
however
, that if such Capital Stock is issued to any plan
    for the benefit of employees of the Issuer or its Subsidiaries
    or by any such plan to such employees, such Capital Stock shall
    not constitute Disqualified Stock solely because it may be
    required to be repurchased by the Issuer or its Subsidiaries in
    order to satisfy applicable statutory or regulatory obligations.
"EBITDA"
means, with respect to any Person for
    any period, the Consolidated Net Income of such Person for such
    period
(1) increased (without duplication) by:
(a) provision for taxes based on income or profits or
    capital gains, including, without limitation, foreign, federal,
    state, franchise and similar taxes (such as the Pennsylvania
    capital tax) and foreign withholding taxes (including penalties
    and interest related to such taxes or arising from tax
    examinations) of such Person paid or accrued during such period
    deducted (and not added back) in computing Consolidated Net
    Income;
plus
(b) Fixed Charges of such Person for such period (including
    (x) net losses on Hedging Obligations or other derivative
    instruments entered into for the purpose of hedging interest
    rate risk and (y) costs of surety bonds in connection with
    financing activities, in each case, to the extent included in
    Fixed Charges), together with items excluded from the definition
    of "Consolidated Interest Expense" pursuant
99
Table of Contents
to clauses (1)(u), (v), (w), (x), (y) and (z) of the
    definition thereof, and, in each such case, to the extent the
    same were deducted (and not added back) in calculating such
    Consolidated Net Income;
plus
(c) Consolidated Depreciation and Amortization Expense of
    such Person for such period to the extent the same was deducted
    (and not added back) in computing Consolidated Net Income;
plus
(d) any expenses or charges (other than depreciation or
    amortization expense) related to any Equity Offering, Permitted
    Investment, acquisition, disposition, recapitalization or the
    incurrence of Indebtedness permitted to be incurred by the
    Indenture (including a refinancing thereof) (whether or not
    successful), including (i) such fees, expenses or charges
    related to the offering of the Notes and any Credit Facilities
    and (ii) any amendment or other modification of the Notes,
    and, in each case, deducted (and not added back) in computing
    Consolidated Net Income;
plus
(e) the amount of any restructuring charge or reserve
    deducted (and not added back) in such period in computing
    Consolidated Net Income, including any one-time costs incurred
    in connection with acquisitions after the Issue Date and costs
    related to the closure
and/or
consolidation of facilities;
plus
(f) any other non-cash charges, including any write-offs or
    write-downs, reducing Consolidated Net Income for such period
    (
provided
that if any such non-cash charges represent an
    accrual or reserve for potential cash items in any future
    period, the cash payment in respect thereof in such future
    period shall be subtracted from EBITDA to such extent, and
    excluding amortization of a prepaid cash item that was paid in a
    prior period);
plus
(g) the amount of any minority interest expense consisting
    of income attributable to minority equity interests of third
    parties deducted (and not added back) in such period in
    calculating Consolidated Net Income;
plus
(h) the amount of management, monitoring, consulting and
    advisory fees and related expenses paid in such period to the
    Investors and the Frist Entities to the extent otherwise
    permitted under "Certain Covenants — Transactions
    with Affiliates";
plus
(i) the amount of net cost savings projected by the Issuer
    in good faith to be realized as a result of specified actions
    taken or to be taken (calculated on a
pro forma
basis as
    though such cost savings had been realized on the first day of
    such period), net of the amount of actual benefits realized
    during such period from such actions;
provided
that
    (w) such cost savings are reasonably identifiable and
    factually supportable, (x) such actions have been taken or
    are to be taken within 15 months after the date of
    determination to take such action, (y) no cost savings
    shall be added pursuant to this clause (i) to the extent
    duplicative of any expenses or charges relating to such cost
    savings that are included in clause (e) above with respect
    to such period and (z) the aggregate amount of cost savings
    added pursuant to this clause (i) shall not exceed
    $150.0 million for any four consecutive quarter period
    (which adjustments may be incremental to
pro forma
adjustments made pursuant to the second paragraph of the
    definition of "Fixed Charge Coverage Ratio");
plus
(j) the amount of loss on sales of receivables and related
    assets to the Receivables Subsidiary in connection with a
    Receivables Facility;
plus
(k) any costs or expense incurred by the Issuer or a
    Restricted Subsidiary pursuant to any management equity plan or
    stock option plan or any other management or employee benefit
    plan or agreement or any stock subscription or shareholder
    agreement, to the extent that such cost or expenses are funded
    with cash proceeds contributed to the capital of the Issuer or
    net cash proceeds of an issuance of Equity Interests of the
    Issuer (other than Disqualified Stock) solely to the extent that
    such net cash proceeds are excluded from the calculation set
    forth in clause (3) of the first paragraph under
    "Certain Covenants — Limitation on Restricted
    Payments";
(2) decreased by (without duplication) non-cash gains
    increasing Consolidated Net Income of such Person for such
    period, excluding any non-cash gains to the extent they
    represent the reversal of an accrual or reserve for a potential
    cash item that reduced EBITDA in any prior period; and
100
Table of Contents
(3) increased or decreased by (without duplication):
(a) any net gain or loss resulting in such period from
    Hedging Obligations and the application of Statement of
    Financial Accounting Standards No. 133;
plus
or
minus
, as applicable,
(b) any net gain or loss resulting in such period from
    currency translation gains or losses related to currency
    remeasurements of Indebtedness (including any net loss or gain
    resulting from Hedging Obligations for currency exchange risk).
"EMU"
means the economic and monetary union as
    contemplated in the Treaty on European Union.
"Equity Interests"
means Capital Stock and all
    warrants, options or other rights to acquire Capital Stock, but
    excluding any debt security that is convertible into, or
    exchangeable for, Capital Stock.
"Equity Offering"
means any public or private
    sale of common stock or Preferred Stock of the Issuer or any of
    its direct or indirect parent companies (excluding Disqualified
    Stock), other than:
(1) public offerings with respect to the Issuer's or
    any direct or indirect parent company's common stock
    registered on
Form S-8;
(2) issuances to any Subsidiary of the Issuer; and
(3) any such public or private sale that constitutes an
    Excluded Contribution.
"euro"
means the single currency of
    participating member states of the EMU.
"European Collateral"
has the meaning set forth
    under "Description of Other Indebtedness — Senior
    Secured Credit Facilities — Guarantee and
    Security."
"Event of Default"
has the meaning set forth
    under "Events of Default and Remedies."
"Excess Proceeds"
has the meaning set forth in
    the fourth paragraph under "Repurchase at the Option of
    Holders — Asset Sales."
"Exchange Act"
means the Securities Exchange
    Act of 1934, as amended, and the rules and regulations of the
    SEC promulgated thereunder.
"Exchange Notes"
means any notes issued in
    exchange for the Notes pursuant to the Registration Rights
    Agreement or similar agreement.
"Excluded Contribution"
means net cash
    proceeds, marketable securities or Qualified Proceeds received
    by the Issuer after the Issue Date from
(1) contributions to its common equity capital, and
(2) the sale (other than to a Subsidiary of the Issuer or
    to any management equity plan or stock option plan or any other
    management or employee benefit plan or agreement of the Issuer)
    of Capital Stock (other than Disqualified Stock and Designated
    Preferred Stock) of the Issuer,
in each case designated as Excluded Contributions pursuant to an
    Officer's Certificate executed by the principal financial
    officer of the Issuer on the date such capital contributions are
    made or the date such Equity Interests are sold, as the case may
    be, which are excluded from the calculation set forth in
    clause (3) of the first paragraph under "Certain
    Covenants — Limitation on Restricted Payments."
"Existing Notes"
means the $121.2 million
    aggregate principal amount of 8.700% medium-term notes due 2010,
    $691.2 million aggregate principal amount of
    8.750% notes due 2010, £150.0 million aggregate
    principal amount of 8.750% notes due 2010,
    $475.8 million aggregate principal amount of
    7.875% notes due 2011, $500.0 million aggregate
    principal amount of 6.950% notes due 2012,
    $500.0 million aggregate principal amount of
    6.300% notes due 2012, $500.0 million aggregate
    principal amount of 6.250% notes due 2013,
    $500.0 million aggregate principal amount of
    6.750% notes due 2013, $500.0 million aggregate
    principal amount of 5.750% notes due 2014,
    $121.1 million aggregate principal amount of 9.000%
    medium-term notes due 2014, $750.0 million aggregate
    principal amount of 6.375% notes due 2015,
    $150.0 million aggregate
101
Table of Contents
principal amount of 7.190% debentures due 2015,
    $1,000.0 million aggregate principal amount of
    6.500% notes due 2016, $135.6 million aggregate
    principal amount of 7.500% debentures due 2023,
    $150.0 million aggregate principal amount of
    8.360% debentures due 2024, $291.4 million aggregate
    principal amount of 7.690% notes due 2025,
    $125.0 million aggregate principal amount of 7.580%
    medium-term notes due 2025, $150.0 million aggregate
    principal amount of 7.050% debentures due 2027,
    $250.0 million aggregate principal amount of
    7.500% notes due 2033, $100.0 million aggregate
    principal amount of 7.750% debentures due 2036 and
    $200.0 million aggregate principal amount of
    7.500% debentures due 2095, each issued by the Issuer and
    outstanding on the Issue Date.
"Existing Notes Indenture"
means that certain
    Indenture, dated as of December 16, 1993, between Columbia
    Healthcare Corporation and The First National Bank of Chicago,
    as Trustee, as amended by the First Supplemental Indenture,
    dated as of May 25, 2000, between the Issuer and Bank One
    Trust Company, N.A., as Trustee, the Second Supplemental
    Indenture, dated as of July 1, 2001, between the Issuer and
    Bank One Trust Company, N.A., as Trustee, and the Third
    Supplemental Indenture, dated as of December 5, 2001,
    between the Issuer and The Bank of New York, as Trustee.
"First Lien Collateral"
means all of the assets
    of the Issuer or any Guarantor, whether real, personal or mixed,
    with respect to which a Lien has been granted as security for
    any First Lien Obligations pursuant to a First Lien Document.
"First Lien Collateral Agent"
shall mean Bank
    of America, N.A., in its capacity as administrative agent and
    collateral agent for the lenders and other secured parties under
    the General Credit Facility and the other First Lien Documents,
    together with its successors and permitted assigns under the
    General Credit Facility exercising substantially the same rights
    and powers; and in each case provided that if such First Lien
    Collateral Agent is not Bank of America, N.A., such First Lien
    Collateral Agent shall have become a party to the Intercreditor
    Agreements and the other applicable First Lien Security
    Documents.
"First Lien Documents"
means the credit,
    guarantee and security documents governing the First Lien
    Obligations, including, without limitation, the General Credit
    Facility and the First Lien Security Documents.
"First Lien Obligations"
shall mean
    (a) all General Credit Facility Obligations and
    (b) all other Obligations of the Issuer and its
    Subsidiaries under any refinancings of the General Credit
    Facility Obligations (and any related Hedging Obligations). For
    the avoidance of doubt, Obligations with respect to the ABL
    Facility shall not constitute First Lien Obligations.
"First Lien Secured Parties"
means, at any
    relevant time, the holders of First Lien Obligations at such
    time, including, without limitation, the lenders and agents
    under the General Credit Facility and the First Lien Collateral
    Agent.
"First Lien Security Documents"
means the
    Security Documents (as defined in the General Credit Facility)
    and any other agreement, document or instrument pursuant to
    which a Lien is granted or purported to be granted securing
    First Lien Obligations or under which rights or remedies with
    respect to such Liens are governed.
"First Priority Liens"
means the first priority
    Liens securing the First Lien Obligations.
"Fixed Charge Coverage Ratio"
means, with
    respect to any Person for any period, the ratio of EBITDA of
    such Person for such period to the Fixed Charges of such Person
    for such period. In the event that the Issuer or any Restricted
    Subsidiary incurs, assumes, guarantees, redeems, retires or
    extinguishes any Indebtedness (other than Indebtedness incurred
    under any revolving credit facility unless such Indebtedness has
    been permanently repaid and has not been replaced) or issues or
    redeems Disqualified Stock or Preferred Stock subsequent to the
    commencement of the period for which the Fixed Charge Coverage
    Ratio is being calculated but prior to or simultaneously with
    the event for which the calculation of the Fixed Charge Coverage
    Ratio is made (the
"Fixed Charge Coverage Ratio
    Calculation Date"
), then the Fixed Charge Coverage
    Ratio shall be calculated giving
pro forma
effect to such
    incurrence, assumption, guarantee, redemption, retirement or
    extinguishment of Indebtedness, or such issuance or redemption
    of Disqualified Stock or Preferred Stock, as if the same had
    occurred at the beginning of the applicable four-quarter period.
102
Table of Contents
For purposes of making the computation referred to above,
    Investments, acquisitions, dispositions, mergers, consolidations
    and disposed operations (as determined in accordance with GAAP)
    that have been made by the Issuer or any of its Restricted
    Subsidiaries during the four-quarter reference period or
    subsequent to such reference period and on or prior to or
    simultaneously with the Fixed Charge Coverage Ratio Calculation
    Date shall be calculated on a
pro forma
basis assuming
    that all such Investments, acquisitions, dispositions, mergers,
    consolidations and disposed operations (and the change in any
    associated fixed charge obligations and the change in EBITDA
    resulting therefrom) had occurred on the first day of the
    four-quarter reference period. If, since the beginning of such
    period, any Person that subsequently became a Restricted
    Subsidiary or was merged with or into the Issuer or any of its
    Restricted Subsidiaries since the beginning of such period shall
    have made any Investment, acquisition, disposition, merger,
    consolidation or disposed operation that would have required
    adjustment pursuant to this definition, then the Fixed Charge
    Coverage Ratio shall be calculated giving
pro forma
effect thereto for such period as if such Investment,
    acquisition, disposition, merger, consolidation or disposed
    operation had occurred at the beginning of the applicable
    four-quarter period.
For purposes of this definition, whenever
pro forma
effect is to be given to a transaction, the
pro forma
calculations shall be made in good faith by a responsible
    financial or accounting officer of the Issuer. If any
    Indebtedness bears a floating rate of interest and is being
    given
pro forma
effect, the interest on such Indebtedness
    shall be calculated as if the rate in effect on the Fixed Charge
    Coverage Ratio Calculation Date had been the applicable rate for
    the entire period (taking into account any Hedging Obligations
    applicable to such Indebtedness). Interest on a Capitalized
    Lease Obligation shall be deemed to accrue at an interest rate
    reasonably determined by a responsible financial or accounting
    officer of the Issuer to be the rate of interest implicit in
    such Capitalized Lease Obligation in accordance with GAAP. For
    purposes of making the computation referred to above, interest
    on any Indebtedness under a revolving credit facility computed
    on a
pro forma
basis shall be computed based upon the
    average daily balance of such Indebtedness during the applicable
    period except as set forth in the first paragraph of this
    definition. Interest on Indebtedness that may optionally be
    determined at an interest rate based upon a factor of a prime or
    similar rate, a eurocurrency interbank offered rate or other
    rate shall be deemed to have been based upon the rate actually
    chosen, or, if none, then based upon such optional rate chosen
    as the Issuer may designate.
"Fixed Charges"
means, with respect to any
    Person for any period, the sum of:
(1) Consolidated Interest Expense of such Person for such
    period;
(2) all cash dividends or other distributions paid
    (excluding items eliminated in consolidation) on any series of
    Preferred Stock during such period; and
(3) all cash dividends or other distributions paid
    (excluding items eliminated in consolidation) on any series of
    Disqualified Stock during such period.
"Foreign Subsidiary"
means, with respect to any
    Person, any Restricted Subsidiary of such Person that is not
    organized or existing under the laws of the United States, any
    state thereof or the District of Columbia and any Restricted
    Subsidiary of such Foreign Subsidiary.
"Frist Entities"
means Dr. Thomas F.
    Frist, Jr., any Person controlled by Dr. Frist and any
    charitable organization selected by Dr. Frist that holds
    Equity Interests of the Issuer on the Issue Date.
"GAAP"
means generally accepted accounting
    principles in the United States which are in effect on the Issue
    Date.
"General Credit Facility"
means the credit
    agreement entered into as of the Issue Date by and among the
    Issuer, the European subsidiary borrowers party thereto, the
    lenders party thereto in their capacities as lenders thereunder
    and Bank of America, N.A., as U.S. Administrative Agent and
    as European Administrative Agent, including any guarantees,
    collateral documents, instruments and agreements executed in
    connection therewith, and any amendments, supplements,
    modifications, extensions, renewals, restatements, refundings or
    refinancings thereof and any indentures or credit facilities or
    commercial paper facilities with banks or other institutional
    lenders or investors that replace, refund or refinance any part
    of the loans, notes, other credit
103
Table of Contents
facilities or commitments thereunder, including any such
    replacement, refunding or refinancing facility or indenture that
    increases the amount borrowable thereunder or alters the
    maturity thereof (
provided
that such increase in
    borrowings is permitted under "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock"
    above).
"General Credit Facility Obligations"
means
"Obligations"
as defined in the General Credit
    Facility.
"General Intercreditor Agreement"
has the
    meaning set forth under "Security — Liens with
    Respect to the Collateral."
"Government Securities"
means securities that
    are:
(1) direct obligations of the United States of America for
    the timely payment of which its full faith and credit is
    pledged; or
(2) obligations of a Person controlled or supervised by and
    acting as an agency or instrumentality of the United States of
    America the timely payment of which is unconditionally
    guaranteed as a full faith and credit obligation by the United
    States of America,
which, in either case, are not callable or redeemable at the
    option of the issuers thereof, and shall also include a
    depository receipt issued by a bank (as defined in
    Section 3(a)(2) of the Securities Act), as custodian with
    respect to any such Government Securities or a specific payment
    of principal of or interest on any such Government Securities
    held by such custodian for the account of the holder of such
    depository receipt;
provided
that (except as required by
    law) such custodian is not authorized to make any deduction from
    the amount payable to the holder of such depository receipt from
    any amount received by the custodian in respect of the
    Government Securities or the specific payment of principal of or
    interest on the Government Securities evidenced by such
    depository receipt.
"guarantee"
means a guarantee (other than by
    endorsement of negotiable instruments for collection in the
    ordinary course of business), direct or indirect, in any manner
    (including letters of credit and reimbursement agreements in
    respect thereof), of all or any part of any Indebtedness or
    other obligations.
"Guarantee"
means the guarantee by any
    Guarantor of the Issuer's Obligations under the Indenture.
"Guarantor"
means each Restricted Subsidiary
    that Guarantees the Notes in accordance with the terms of the
    Indenture.
"HCI"
means Health Care Indemnity, Inc., an
    insurance company formed under the laws of the State of Colorado
    and a Wholly-Owned Subsidiary of the Issuer.
"Hedging Arrangements"
means the fixed-pay
    interest rate swap agreements, entered into by Hercules Holding
    on or about September 13, 2006 and with respect to which
    the Issuer will be the counterparty in connection with the
    Recapitalization, relating to $8,000 million of the
    outstanding principal amount under the First Lien Obligations
    and the ABL Obligations.
"Hedging Obligations"
means, with respect to
    any Person, the obligations of such Person under any interest
    rate swap agreement, interest rate cap agreement, interest rate
    collar agreement, commodity swap agreement, commodity cap
    agreement, commodity collar agreement, foreign exchange
    contract, currency swap agreement or similar agreement providing
    for the transfer or mitigation of interest rate or currency
    risks either generally or under specific contingencies.
"Holder"
means the Person in whose name a Note
    is registered on the registrar's books.
"Indebtedness"
means, with respect to any
    Person, without duplication:
(1) any indebtedness (including principal and premium) of
    such Person, whether or not contingent:
(a) in respect of borrowed money;
(b) evidenced by bonds, notes, debentures or similar
    instruments or letters of credit or bankers' acceptances
    (or, without duplication, reimbursement agreements in respect
    thereof);
104
Table of Contents
(c) representing the balance deferred and unpaid of the
    purchase price of any property (including Capitalized Lease
    Obligations), except (i) any such balance that constitutes
    a trade payable or similar obligation to a trade creditor, in
    each case accrued in the ordinary course of business and
    (ii) any earn-out obligations until such obligation becomes
    a liability on the balance sheet of such Person in accordance
    with GAAP; or
(d) representing any Hedging Obligations;
if and to the extent that any of the foregoing Indebtedness
    (other than letters of credit and Hedging Obligations) would
    appear as a liability upon a balance sheet (excluding the
    footnotes thereto) of such Person prepared in accordance with
    GAAP;
(2) to the extent not otherwise included, any obligation by
    such Person to be liable for, or to pay, as obligor, guarantor
    or otherwise on, the obligations of the type referred to in
    clause (1) of a third Person (whether or not such items
    would appear upon the balance sheet of the such obligor or
    guarantor), other than by endorsement of negotiable instruments
    for collection in the ordinary course of business; and
(3) to the extent not otherwise included, the obligations
    of the type referred to in clause (1) of a third Person
    secured by a Lien on any asset owned by such first Person,
    whether or not such Indebtedness is assumed by such first Person;
provided
,
however
, that notwithstanding the
    foregoing, Indebtedness shall be deemed not to include
    (a) Contingent Obligations incurred in the ordinary course
    of business or (b) obligations under or in respect of
    Receivables Facilities.
"Independent Financial Advisor"
means an
    accounting, appraisal, investment banking firm or consultant to
    Persons engaged in Similar Businesses of nationally recognized
    standing that is, in the good faith judgment of the Issuer,
    qualified to perform the task for which it has been engaged.
"Initial Purchasers"
means Citigroup Global
    Markets Inc., Banc of America Securities LLC, J.P. Morgan
    Securities Inc., Merrill Lynch, Pierce, Fenner & Smith
    Incorporated, Deutsche Bank Securities Inc. and Wachovia Capital
    Markets, LLC.
"insolvency or liquidation proceeding"
means:
(1) any case commenced by or against the Issuer or any
    Guarantor under any Bankruptcy Law for the relief of debtors,
    any other proceeding for the reorganization, recapitalization or
    adjustment or marshalling of the assets or liabilities of the
    Issuer or any Guarantor, any receivership or assignment for the
    benefit of creditors relating to the Issuer or any Guarantor or
    any similar case or proceeding relative to the Issuer or any
    Guarantor or its creditors, as such, in each case whether or not
    voluntary;
(2) any liquidation, dissolution, marshalling of assets or
    liabilities or other winding up of or relating to the Issuer or
    any Guarantor, in each case whether or not voluntary and whether
    or not involving bankruptcy or insolvency; or
(3) any other proceeding of any type or nature in which
    substantially all claims of creditors of the Issuer or any
    Guarantor are determined and any payment or distribution is or
    may be made on account of such claims.
"Intercreditor Agreements"
means, collectively,
    the Shared Receivables Intercreditor Agreement and the General
    Intercreditor Agreement.
"Investment Grade Rating"
means a rating equal
    to or higher than Baa3 (or the equivalent) by Moody's and
    BBB- (or the equivalent) by S&P, or an equivalent rating by
    any other Rating Agency.
"Investment Grade Securities"
means:
(1) securities issued or directly and fully guaranteed or
    insured by the United States government or any agency or
    instrumentality thereof (other than Cash Equivalents);
105
Table of Contents
(2) debt securities or debt instruments with an Investment
    Grade Rating, but excluding any debt securities or instruments
    constituting loans or advances among the Issuer and its
    Subsidiaries;
(3) investments in any fund that invests exclusively in
    investments of the type described in clauses (1) and
    (2) which fund may also hold immaterial amounts of cash
    pending investment or distribution; and
(4) corresponding instruments in countries other than the
    United States customarily utilized for high quality investments.
"Investments"
means, with respect to any
    Person, all investments by such Person in other Persons
    (including Affiliates) in the form of loans (including
    guarantees), advances or capital contributions (excluding
    accounts receivable, trade credit, advances to customers,
    commissions, travel and similar advances to officers and
    employees, in each case made in the ordinary course of
    business), purchases or other acquisitions for consideration of
    Indebtedness, Equity Interests or other securities issued by any
    other Person and investments that are required by GAAP to be
    classified on the balance sheet (excluding the footnotes) of the
    Issuer in the same manner as the other investments included in
    this definition to the extent such transactions involve the
    transfer of cash or other property. For purposes of the
    definition of "Unrestricted Subsidiary" and the
    covenant described under "Certain Covenants —
    Limitation on Restricted Payments":
(1)
"Investments"
shall include the
    portion (proportionate to the Issuer's equity interest in
    such Subsidiary) of the fair market value of the net assets of a
    Subsidiary of the Issuer at the time that such Subsidiary is
    designated an Unrestricted Subsidiary;
provided
,
however
, that upon a redesignation of such Subsidiary as
    a Restricted Subsidiary, the Issuer shall be deemed to continue
    to have a permanent "Investment" in an Unrestricted
    Subsidiary in an amount (if positive) equal to:
(a) the Issuer's "Investment" in such
    Subsidiary at the time of such redesignation;
less
(b) the portion (proportionate to the Issuer equity
    interest in such Subsidiary) of the fair market value of the net
    assets of such Subsidiary at the time of such
    redesignation; and
(2) any property transferred to or from an Unrestricted
    Subsidiary shall be valued at its fair market value at the time
    of such transfer, in each case as determined in good faith by
    the Issuer.
"Investors"
means Bain Capital Partners, LLC,
    Kohlberg Kravis Roberts & Co. L.P., Merrill Lynch
    Global Partners, Inc. and each of their respective Affiliates
    but not including, however, any portfolio companies of any of
    the foregoing.
"Issue Date"
means November 17, 2006.
"Issuer"
has the meaning set forth in the first
    paragraph under "General";
provided
that when
    used in the context of determining the fair market value of an
    asset or liability under the Indenture, "Issuer" shall
    be deemed to mean the board of directors of the Issuer when the
    fair market value is equal to or in excess of
    $500.0 million (unless otherwise expressly stated).
"Junior Lien Collateral Agent"
shall mean
    (i) so long as the Notes are outstanding, the Trustee, in
    its capacity as Trustee and collateral agent for the Holders and
    other secured parties under the Indenture and the Security
    Documents, and (ii) at any time thereafter, such agent or
    trustee as is designated "Junior Lien Collateral
    Agent" by Junior Lien Secured Parties holding a majority in
    principal amount of the Junior Lien Obligations then outstanding
    or pursuant to such other arrangements as agreed to among the
    holders of the Junior Lien Obligations, it being understood that
    as of the Issue Date, the Trustee shall be so designated Junior
    Lien Collateral Agent.
"Junior Lien Documents"
means the credit and
    security documents governing the Junior Lien Obligations,
    including, without limitation, the Indenture, the related
    Security Documents and Intercreditor Agreements.
"Junior Lien Obligations"
means the Notes and
    Obligations with respect to other Indebtedness permitted to be
    incurred under the Indenture and the General Credit Facility
    which is by its terms intended to be secured equally and ratably
    with the Notes or on a basis junior to the Liens securing the
    Notes;
provided
such Lien is
106
Table of Contents
permitted to be incurred under the Indenture and the General
    Credit Facility;
provided, further
, that the holders of
    such Indebtedness or their Junior Lien Representative is a party
    to the Security Documents in accordance with the terms thereof
    and has appointed the Junior Lien Collateral Agent as collateral
    agent for such holders of Junior Lien Obligations with respect
    to all or a portion of the Collateral.
"Junior Lien Representative"
means any duly
    authorized representative of any holders of Junior Lien
    Obligations, which representative is party to the Security
    Documents.
"Junior Lien Secured Parties"
means
    (i) Holders (including the Holders of any Additional Notes
    subsequently issued under and in compliance with the terms of
    the Indenture), (ii) the Junior Lien Collateral Agent and
    (iii) the holders from time to time of any other Junior
    Lien Obligations and each Junior Lien Representative.
"Junior Liens"
means the Liens securing the
    Junior Lien Obligations.
"Legal Holiday"
means a Saturday, a Sunday or a
    day on which commercial banking institutions are not required to
    be open in the State of New York.
"Lien"
means, with respect to any asset, any
    mortgage, lien (statutory or otherwise), pledge, hypothecation,
    charge, security interest, preference, priority or encumbrance
    of any kind in respect of such asset, whether or not filed,
    recorded or otherwise perfected under applicable law, including
    any conditional sale or other title retention agreement, any
    lease in the nature thereof, any option or other agreement to
    sell or give a security interest in and any filing of or
    agreement to give any financing statement under the Uniform
    Commercial Code (or equivalent statutes) of any jurisdiction;
provided
that in no event shall an operating lease be
    deemed to constitute a Lien.
"Moody's"
means Moody's Investors
    Service, Inc. and any successor to its rating agency business.
"Net Income"
means, with respect to any Person,
    the net income (loss) of such Person, determined in accordance
    with GAAP and before any reduction in respect of Preferred Stock
    dividends.
"Net Proceeds"
means the aggregate cash
    proceeds received by the Issuer or any of its Restricted
    Subsidiaries in respect of any Asset Sale, including any cash
    received upon the sale or other disposition of any Designated
    Non-cash Consideration received in any Asset Sale, net of the
    direct costs relating to such Asset Sale and the sale or
    disposition of such Designated Non-cash Consideration, including
    legal, accounting and investment banking fees, and brokerage and
    sales commissions, any relocation expenses incurred as a result
    thereof, taxes paid or payable as a result thereof (after taking
    into account any available tax credits or deductions and any tax
    sharing arrangements), amounts required to be applied to the
    repayment of principal, premium, if any, and interest on Senior
    Indebtedness required (other than required by clause (1) of
    the second paragraph of "Repurchase at the Option of
    Holders — Asset Sales") to be paid as a result of
    such transaction and any deduction of appropriate amounts to be
    provided by the Issuer or any of its Restricted Subsidiaries as
    a reserve in accordance with GAAP against any liabilities
    associated with the asset disposed of in such transaction and
    retained by the Issuer or any of its Restricted Subsidiaries
    after such sale or other disposition thereof, including pension
    and other post-employment benefit liabilities and liabilities
    related to environmental matters or against any indemnification
    obligations associated with such transaction.
"Non-Conforming Plan of Reorganization"
means
    any Plan of Reorganization that grants the Junior Lien
    Collateral Agent or any Junior Lien Secured Party any right or
    benefit, directly or indirectly, which right or benefit is
    prohibited at such time by the provisions of the General
    Intercreditor Agreement.
"Non-Receivables Collateral"
has the meaning
    set forth under "Description of Other
    Indebtedness — Senior Secured Credit
    Facilities — Guarantee and Security," subject to
    the provisions of the third and fourth sentences of the first
    paragraph under "— Security —
    General."
"Obligations"
means any principal, interest
    (including any interest accruing subsequent to the filing of a
    petition in bankruptcy, reorganization or similar proceeding at
    the rate provided for in the documentation with respect thereto,
    whether or not such interest is an allowed claim under
    applicable state, federal or foreign law), premium, penalties,
    fees, indemnifications, reimbursements (including reimbursement
    obligations with respect
107
Table of Contents
to letters of credit and bankers' acceptances), damages and
    other liabilities, and guarantees of payment of such principal,
    interest, penalties, fees, indemnifications, reimbursements,
    damages and other liabilities, payable under the documentation
    governing any Indebtedness.
"Offering Memorandum"
means the offering
    memorandum, dated November 9, 2006, relating to the initial
    private offering of the Notes.
"Officer"
means the Chairman of the Board, the
    Chief Executive Officer, the President, any Executive Vice
    President, Senior Vice President or Vice President, the
    Treasurer or the Secretary of the Issuer.
"Officer's Certificate"
means a
    certificate signed on behalf of the Issuer by an Officer of the
    Issuer, who must be the principal executive officer, the
    principal financial officer, the treasurer or the principal
    accounting officer of the Issuer, that meets the requirements
    set forth in the Indenture.
"Opinion of Counsel"
means a written opinion
    from legal counsel who is acceptable to the Trustee. The counsel
    may be an employee of or counsel to the Issuer or the Trustee.
"Partial PIK Interest"
has the meaning set
    forth under "Principal, Maturity and Interest —
    Toggle Notes."
"Permitted Asset Swap"
means the concurrent
    purchase and sale or exchange of Related Business Assets or a
    combination of Related Business Assets and cash or Cash
    Equivalents between the Issuer or any of its Restricted
    Subsidiaries and another Person;
provided
, that any cash
    or Cash Equivalents received must be applied in accordance with
    the covenant described under "Repurchase at the Option of
    Holders — Asset Sales."
"Permitted Holders"
means each of the
    Investors, the Frist Entities, the Management Participants (as
    defined in the Offering Memorandum), Citigroup Inc. and Banc of
    America Securities LLC (which institutions are assignees of
    certain equity commitments of the Investors as of the Issue
    Date) who are holders of Equity Interests of the Issuer (or any
    of its direct or indirect parent companies) and any group
    (within the meaning of Section 13(d)(3) or
    Section 14(d)(2) of the Exchange Act or any successor
    provision) of which any of the foregoing are members;
provided
that, in the case of such group and without
    giving effect to the existence of such group or any other group,
    such Investors, Frist Entities, members of management and
    assignees of the equity commitments of the Investors,
    collectively, have beneficial ownership of more than 50% of the
    total voting power of the Voting Stock of the Issuer or any of
    its direct or indirect parent companies.
"Permitted Investments"
means:
(1) any Investment in the Issuer or any of its Restricted
    Subsidiaries;
(2) any Investment in cash and Cash Equivalents or
    Investment Grade Securities;
(3) any Investment by the Issuer or any of its Restricted
    Subsidiaries in a Person that is engaged in a Similar Business
    if as a result of such Investment:
(a) such Person becomes a Restricted Subsidiary; or
(b) such Person, in one transaction or a series of related
    transactions, is merged or consolidated with or into, or
    transfers or conveys substantially all of its assets to, or is
    liquidated into, the Issuer or a Restricted Subsidiary, and, in
    each case, any Investment held by such Person;
provided,
that such Investment was not acquired by such Person in
    contemplation of such acquisition, merger, consolidation or
    transfer;
(4) any Investment in securities or other assets not
    constituting cash, Cash Equivalents or Investment Grade
    Securities and received in connection with an Asset Sale made
    pursuant to the provisions described under "Repurchase at
    the Option of Holders — Asset Sales" or any other
    disposition of assets not constituting an Asset Sale;
(5) any Investment existing on the Issue Date;
108
Table of Contents
(6) any Investment acquired by the Issuer or any of its
    Restricted Subsidiaries:
(a) in exchange for any other Investment or accounts
    receivable held by the Issuer or any such Restricted Subsidiary
    in connection with or as a result of a bankruptcy, workout,
    reorganization or recapitalization of the issuer of such other
    Investment or accounts receivable; or
(b) as a result of a foreclosure by the Issuer or any of
    its Restricted Subsidiaries with respect to any secured
    Investment or other transfer of title with respect to any
    secured Investment in default;
(7) Hedging Obligations permitted under clause (10) of
    the second paragraph of the covenant described in "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock";
(8) any Investment in a Similar Business having an
    aggregate fair market value, taken together with all other
    Investments made pursuant to this clause (8) that are at
    that time outstanding, not to exceed 5% of Total Assets at the
    time of such Investment (with the fair market value of each
    Investment being measured at the time made and without giving
    effect to subsequent changes in value);
(9) Investments the payment for which consists of Equity
    Interests (exclusive of Disqualified Stock) of the Issuer or any
    of its direct or indirect parent companies;
provided
,
however
, that such Equity Interests will not increase the
    amount available for Restricted Payments under clause (3)
    of the first paragraph under the covenant described in
    "Certain Covenants — Limitations on Restricted
    Payments";
(10) guarantees of Indebtedness permitted under the
    covenant described in "Certain Covenants —
    Limitation on Incurrence of Indebtedness and Issuance of
    Disqualified Stock and Preferred Stock";
(11) any transaction to the extent it constitutes an
    Investment that is permitted and made in accordance with the
    provisions of the second paragraph of the covenant described
    under "Certain Covenants — Transactions with
    Affiliates" (except transactions described in clauses (2),
    (5) and (9) of such paragraph);
(12) Investments consisting of purchases and acquisitions
    of inventory, supplies, material or equipment;
(13) additional Investments having an aggregate fair market
    value, taken together with all other Investments made pursuant
    to this clause (13) that are at that time outstanding
    (without giving effect to the sale of an Unrestricted Subsidiary
    to the extent the proceeds of such sale do not consist of cash
    or marketable securities), not to exceed 5% of Total Assets at
    the time of such Investment (with the fair market value of each
    Investment being measured at the time made and without giving
    effect to subsequent changes in value);
(14) Investments relating to an ABL Financing Entity or a
    Receivables Subsidiary that, in the good faith determination of
    the Issuer, are necessary or advisable to effect the ABL
    Facility or any Receivables Facility, as the case may be;
(15) advances to, or guarantees of Indebtedness of,
    employees not in excess of $50.0 million outstanding at any
    one time, in the aggregate;
(16) loans and advances to officers, directors and
    employees for business-related travel expenses, moving expenses
    and other similar expenses, in each case incurred in the
    ordinary course of business or consistent with past practices or
    to fund such Person's purchase of Equity Interests of the
    Issuer or any direct or indirect parent company thereof;
(17) Physician Support Obligations made by the Issuer or
    any Restricted Subsidiary;
(18) any Investment in any joint venture existing on the
    Issue Date that owns or operates one or more healthcare
    facilities, including, without limitation, hospitals, ambulatory
    surgery centers, outpatient diagnostic centers or imaging
    centers to the extent contemplated by the organizational
    documents of such joint venture as in existence on the Issue
    Date;
109
Table of Contents
(19) any Investment in the ordinary course of business or
    as may be required by applicable law by any Restricted
    Subsidiary (including, without limitation, HCI) engaged in the
    insurance business in order to provide insurance to the Issuer
    and its Subsidiaries;
(20) any Investment pursuant to any customary buy/sell
    arrangement in favor of investors or joint venture parties in
    connection with syndications of healthcare facilities,
    including, without limitation, hospitals, ambulatory surgery
    centers, outpatient diagnostic centers or imaging
    centers; and
(21) any Investment in any Subsidiary or any joint venture
    in connection with intercompany cash management arrangements or
    related activities arising in the ordinary course of business.
"Permitted Liens"
means, with respect to any
    Person:
(1) pledges or deposits by such Person under workmen's
    compensation laws, unemployment insurance laws or similar
    legislation, or good faith deposits in connection with bids,
    tenders, contracts (other than for the payment of Indebtedness)
    or leases to which such Person is a party, or deposits to secure
    public or statutory obligations of such Person or deposits of
    cash or U.S. government bonds to secure surety or appeal
    bonds to which such Person is a party, or deposits as security
    for contested taxes or import duties or for the payment of rent,
    in each case incurred in the ordinary course of business;
(2) Liens imposed by law, such as carriers',
    warehousemen's and mechanics' Liens, in each case for
    sums not yet overdue for a period of more than 30 days or
    being contested in good faith by appropriate proceedings or
    other Liens arising out of judgments or awards against such
    Person with respect to which such Person shall then be
    proceeding with an appeal or other proceedings for review if
    adequate reserves with respect thereto are maintained on the
    books of such Person in accordance with GAAP;
(3) Liens for taxes, assessments or other governmental
    charges not yet overdue for a period of more than 30 days
    or payable or subject to penalties for nonpayment or which are
    being contested in good faith by appropriate proceedings
    diligently conducted, if adequate reserves with respect thereto
    are maintained on the books of such Person in accordance with
    GAAP;
(4) Liens in favor of issuers of performance and surety
    bonds or bid bonds or with respect to other regulatory
    requirements or letters of credit issued pursuant to the request
    of and for the account of such Person in the ordinary course of
    its business;
(5) minor survey exceptions, minor encumbrances, easements
    or reservations of, or rights of others for, licenses,
rights-of-way,
sewers, electric lines, telegraph and telephone lines and other
    similar purposes, or zoning or other restrictions as to the use
    of real properties or Liens incidental to the conduct of the
    business of such Person or to the ownership of its properties
    which were not incurred in connection with Indebtedness and
    which do not in the aggregate materially adversely affect the
    value of said properties or materially impair their use in the
    operation of the business of such Person;
(6) Liens securing Indebtedness permitted to be incurred
    pursuant to clause (4), (12), (13), (18) or (19) of
    the second paragraph under "Certain Covenants —
    Limitation on Incurrence of Indebtedness and Issuance of
    Disqualified Stock and Preferred Stock";
provided
that (a) Liens securing Indebtedness, Disqualified
    Stock or Preferred Stock permitted to be incurred pursuant to
    clause (13) relate only to Refinancing Indebtedness that
    serves to refund or refinance Indebtedness, Disqualified Stock
    or Preferred Stock incurred under clause (4) or
    (12) of the second paragraph under "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock,"
    (b) Liens securing Indebtedness permitted to be incurred
    pursuant to clause (18) extend only to the assets of
    Foreign Subsidiaries, (c) Liens securing Indebtedness
    permitted to be incurred pursuant to clause (19) are solely
    on acquired property or the assets of the acquired entity, as
    the case may be and (d) Liens securing Indebtedness,
    Disqualified Stock or Preferred Stock permitted to be incurred
    pursuant to clause (4) of the second paragraph under
    "Certain Covenants — Limitation on Incurrence of
    Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock" extend only to the assets so financed, purchased,
    constructed or improved;
110
Table of Contents
(7) Liens existing on the Issue Date (other than Liens in
    favor of the lenders under the Senior Credit Facilities);
(8) Liens on property or shares of stock of a Person at the
    time such Person becomes a Subsidiary;
provided
,
however
, such Liens are not created or incurred in
    connection with, or in contemplation of, such other Person
    becoming such a Subsidiary;
provided
,
further
,
however
, that such Liens may not extend to any other
    property owned by the Issuer or any of its Restricted
    Subsidiaries;
(9) Liens on property at the time the Issuer or a
    Restricted Subsidiary acquired the property, including any
    acquisition by means of a merger or consolidation with or into
    the Issuer or any of its Restricted Subsidiaries;
provided
,
however
, that such Liens are not created
    or incurred in connection with, or in contemplation of, such
    acquisition;
provided
,
further
,
however
,
    that the Liens may not extend to any other property owned by the
    Issuer or any of its Restricted Subsidiaries;
(10) Liens securing Indebtedness or other obligations of a
    Restricted Subsidiary owing to the Issuer or another Restricted
    Subsidiary permitted to be incurred in accordance with the
    covenant described under "Certain Covenants —
    Limitation on Incurrence of Indebtedness and Issuance of
    Disqualified Stock and Preferred Stock";
(11) Liens securing Hedging Obligations so long as the
    related Indebtedness is, and is permitted to be under the
    Indenture, secured by a Lien on the same property securing such
    Hedging Obligations;
(12) Liens on specific items of inventory or other goods
    and proceeds of any Person securing such Person's
    obligations in respect of bankers' acceptances issued or
    created for the account of such Person to facilitate the
    purchase, shipment or storage of such inventory or other goods;
(13) leases, subleases, licenses or sublicenses granted to
    others in the ordinary course of business which do not
    materially interfere with the ordinary conduct of the business
    of the Issuer or any of its Restricted Subsidiaries and do not
    secure any Indebtedness;
(14) Liens arising from Uniform Commercial Code financing
    statement filings regarding operating leases entered into by the
    Issuer and its Restricted Subsidiaries in the ordinary course of
    business;
(15) Liens in favor of the Issuer or any Guarantor;
(16) Liens on equipment of the Issuer or any of its
    Restricted Subsidiaries granted in the ordinary course of
    business;
(17) Liens on accounts receivable and related assets
    incurred in connection with a Receivables Facility;
(18) Liens to secure any refinancing, refunding, extension,
    renewal or replacement (or successive refinancing, refunding,
    extensions, renewals or replacements) as a whole, or in part, of
    any Indebtedness secured by any Lien referred to in the
    foregoing clauses (6), (7), (8) and (9);
provided
,
however
, that (a) such new Lien shall be limited to
    all or part of the same property that secured the original Lien
    (plus improvements on such property), and (b) the
    Indebtedness secured by such Lien at such time is not increased
    to any amount greater than the sum of (i) the outstanding
    principal amount or, if greater, committed amount of the
    Indebtedness described under clauses (6), (7), (8) and
    (9) at the time the original Lien became a Permitted Lien
    under the Indenture, and (ii) an amount necessary to pay
    any fees and expenses, including premiums, related to such
    refinancing, refunding, extension, renewal or replacement;
(19) deposits made in the ordinary course of business to
    secure liability to insurance carriers;
(20) other Liens securing obligations incurred in the
    ordinary course of business which obligations do not exceed
    $100.0 million at any one time outstanding;
(21) Liens securing judgments for the payment of money not
    constituting an Event of Default under clause (5) under the
    caption "Events of Default and Remedies" so long as
    such Liens are adequately bonded and any appropriate legal
    proceedings that may have been duly initiated for the review of
    such
111
Table of Contents
judgment have not been finally terminated or the period within
    which such proceedings may be initiated has not expired;
(22) Liens in favor of customs and revenue authorities
    arising as a matter of law to secure payment of customs duties
    in connection with the importation of goods in the ordinary
    course of business;
(23) Liens (i) of a collection bank arising under
Section 4-210
of the Uniform Commercial Code, or any comparable or successor
    provision, on items in the course of collection,
    (ii) attaching to commodity trading accounts or other
    commodity brokerage accounts incurred in the ordinary course of
    business, and (iii) in favor of banking institutions
    arising as a matter of law encumbering deposits (including the
    right of set-off) and which are within the general parameters
    customary in the banking industry;
(24) Liens deemed to exist in connection with Investments
    in repurchase agreements permitted under "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock";
provided
that such Liens do not extend to any assets
    other than those that are the subject of such repurchase
    agreements;
(25) Liens encumbering reasonable customary initial
    deposits and margin deposits and similar Liens attaching to
    commodity trading accounts or other brokerage accounts incurred
    in the ordinary course of business and not for speculative
    purposes;
(26) Liens that are contractual rights of set-off
    (i) relating to the establishment of depository relations
    with banks not given in connection with the issuance of
    Indebtedness, (ii) relating to pooled deposit or sweep
    accounts of the Issuer or any of its Restricted Subsidiaries to
    permit satisfaction of overdraft or similar obligations incurred
    in the ordinary course of business of the Issuer and its
    Restricted Subsidiaries or (iii) relating to purchase
    orders and other agreements entered into with customers of the
    Issuer or any of its Restricted Subsidiaries in the ordinary
    course of business; and
(27) Liens arising out of conditional sale, title
    retention, consignment or similar arrangements for the sale or
    purchase of goods entered into by the Issuer or any Restricted
    Subsidiary in the ordinary course of business.
For purposes of this definition, the term
    "Indebtedness" shall be deemed to include interest on
    such Indebtedness.
"Person"
means any individual, corporation,
    limited liability company, partnership, joint venture,
    association, joint stock company, trust, unincorporated
    organization, government or any agency or political subdivision
    thereof or any other entity.
"Physician Support Obligation"
means (1) a
    loan to or on behalf of, or a guarantee of Indebtedness or
    income of, a physician or healthcare professional providing
    service to patients in the service area of a healthcare facility
    operated by the Issuer, any of its Restricted Subsidiaries or
    any affiliated joint venture otherwise permitted by the
    Indenture made or given by the Issuer or any Restricted
    Subsidiary of the Issuer in the ordinary course of business and
    pursuant to a written agreement having a period not to exceed
    five years or (2) guarantees by the Issuer or any
    Restricted Subsidiary of the Issuer of leases and loans to
    acquire property (real or personal) for or on behalf of a
    physician or healthcare professional providing service to
    patients in the service area of a healthcare facility operated
    by the Issuer, any of its Restricted Subsidiaries or any
    affiliated joint venture otherwise permitted by the Indenture.
"PIK Interest"
has the meaning set forth under
    "Principal, Maturity and Interest — Toggle
    Notes."
"PIK Notes"
has the meaning set forth under
    "Principal, Maturity and Interest."
"PIK Payment"
has the meaning set forth under
    "Principal, Maturity and Interest."
"Plan of Reorganization"
means any plan of
    reorganization, plan of liquidation, agreement for composition,
    or other type of plan of arrangement proposed in or in
    connection with any insolvency or liquidation proceeding.
112
Table of Contents
"Preferred Stock"
means any Equity Interest
    with preferential rights of payment of dividends or upon
    liquidation, dissolution or winding up.
"Principal Property"
means each acute care
    hospital providing general medical and surgical services
    (excluding equipment, personal property and hospitals that
    primarily provide specialty medical services, such as
    psychiatric and obstetrical and gynecological services) owned
    solely by the Issuer
and/or
one
    or more of its Subsidiaries (used in this definition as defined
    in the Existing Notes Indenture) and located in the
    United States of America.
"Priority Lien Obligations"
means,
    collectively, ABL Obligations and First Lien Obligations.
"Priority Lien Secured Parties"
means,
    collectively, the ABL Secured Parties and the First Lien Secured
    Parties.
"Purchase Money Obligations"
means any
    Indebtedness incurred to finance or refinance the acquisition,
    leasing, construction or improvement of property (real or
    personal) or assets (other than Capital Stock), and whether
    acquired through the direct acquisition of such property or
    assets, or otherwise.
"Qualified Proceeds"
means assets that are used
    or useful in, or Capital Stock of any Person engaged in, a
    Similar Business;
provided
that the fair market value of
    any such assets or Capital Stock shall be determined by the
    Issuer in good faith.
"Rating Agencies"
means Moody's and
    S&P or if Moody's or S&P or both shall not make a
    rating on the Notes publicly available, a nationally recognized
    statistical rating agency or agencies, as the case may be,
    selected by the Issuer which shall be substituted for
    Moody's or S&P or both, as the case may be.
"Receivables Facility"
means any of one or more
    receivables financing facilities as amended, supplemented,
    modified, extended, renewed, restated or refunded from time to
    time, the Obligations of which are non-recourse (except for
    customary representations, warranties, covenants and indemnities
    made in connection with such facilities) to the Issuer or any of
    its Restricted Subsidiaries (other than a Receivables
    Subsidiary) pursuant to which the Issuer or any of its
    Restricted Subsidiaries purports to sell its accounts receivable
    to either (a) a Person that is not a Restricted Subsidiary
    or (b) a Receivables Subsidiary that in turn funds such
    purchase by purporting to sell its accounts receivable to a
    Person that is not a Restricted Subsidiary or by borrowing from
    such a Person or from another Receivables Subsidiary that in
    turn funds itself by borrowing from such a Person.
"Receivables Fees"
means distributions or
    payments made directly or by means of discounts with respect to
    any accounts receivable or participation interest therein issued
    or sold in connection with, and other fees paid to a Person that
    is not a Restricted Subsidiary in connection with any
    Receivables Facility.
"Receivables Subsidiary"
means any Subsidiary
    formed for the purpose of facilitating or entering into one or
    more Receivables Facilities, and in each case engages only in
    activities reasonably related or incidental thereto.
"Redemption Date"
has the meaning set
    forth under "Optional Redemption — Cash Pay
    Notes."
"Registration Rights Agreement"
means the
    Registration Rights Agreement related to the Notes, dated as of
    the Issue Date, among the Issuer, the Guarantors and the Initial
    Purchasers.
"Related Business Assets"
means assets (other
    than cash or Cash Equivalents) used or useful in a Similar
    Business;
provided
that any assets received by the Issuer
    or a Restricted Subsidiary in exchange for assets transferred by
    the Issuer or a Restricted Subsidiary will not be deemed to be
    Related Business Assets if they consist of securities of a
    Person, unless upon receipt of the securities of such Person,
    such Person would become a Restricted Subsidiary.
"Restricted Investment"
means an Investment
    other than a Permitted Investment.
"Restricted Subsidiary"
means, at any time, any
    direct or indirect Subsidiary of the Issuer (including any
    Foreign Subsidiary) that is not then an Unrestricted Subsidiary;
provided
,
however
, that upon an Unrestricted
113
Table of Contents
Subsidiary's ceasing to be an Unrestricted Subsidiary, such
    Subsidiary shall be included in the definition of
    "Restricted Subsidiary."
"S&P"
means Standard &
    Poor's, a division of The McGraw-Hill Companies, Inc., and
    any successor to its rating agency business.
"Sale and Lease-Back Transaction"
means any
    arrangement providing for the leasing by the Issuer or any of
    its Restricted Subsidiaries of any real or tangible personal
    property, which property has been or is to be sold or
    transferred by the Issuer or such Restricted Subsidiary to a
    third Person in contemplation of such leasing.
"SEC"
means the U.S. Securities and
    Exchange Commission.
"Secured Indebtedness"
means any Indebtedness
    of the Issuer or any of its Restricted Subsidiaries secured by a
    Lien.
"Securities Act"
means the Securities Act of
    1933, as amended, and the rules and regulations of the SEC
    promulgated thereunder.
"Security Documents"
means, collectively, the
    Intercreditor Agreements, the security agreements relating to
    the Collateral and the mortgages and instruments filed and
    recorded in appropriate jurisdictions to preserve and protect
    the Liens on the Collateral (including, without limitation,
    financing statements under the Uniform Commercial Code of the
    relevant states) applicable to the Collateral, each as in effect
    on the Issue Date and as amended, amended and restated,
    modified, renewed or replaced from time to time.
"Senior Credit Facilities"
means the ABL
    Facility and the General Credit Facility.
"Senior Indebtedness"
means:
(1) all Indebtedness of the Issuer or any Guarantor
    outstanding under the Senior Credit Facilities or Notes and
    related Guarantees (including interest accruing on or after the
    filing of any petition in bankruptcy or similar proceeding or
    for reorganization of the Issuer or any Guarantor (at the rate
    provided for in the documentation with respect thereto,
    regardless of whether or not a claim for post-filing interest is
    allowed in such proceedings)), and any and all other fees,
    expense reimbursement obligations, indemnification amounts,
    penalties, and other amounts (whether existing on the Issue Date
    or thereafter created or incurred) and all obligations of the
    Issuer or any Guarantor to reimburse any bank or other Person in
    respect of amounts paid under letters of credit, acceptances or
    other similar instruments;
(2) all Hedging Obligations (and guarantees thereof) owing
    to a Lender (as defined in the Senior Credit Facilities) or any
    Affiliate of such Lender (or any Person that was a Lender or an
    Affiliate of such Lender at the time the applicable agreement
    giving rise to such Hedging Obligation was entered into);
provided
that such Hedging Obligations are permitted to
    be incurred under the terms of the Indenture;
(3) any other Indebtedness of the Issuer or any Guarantor
    permitted to be incurred under the terms of the Indenture,
    unless the instrument under which such Indebtedness is incurred
    expressly provides that it is subordinated in right of payment
    to the Notes or any related Guarantee; and
(4) all Obligations with respect to the items listed in the
    preceding clauses (1), (2) and (3);
provided
,
however
, that Senior Indebtedness shall
    not include:
(a) any obligation of such Person to the Issuer or any of
    its Subsidiaries;
(b) any liability for federal, state, local or other taxes
    owed or owing by such Person;
(c) any accounts payable or other liability to trade
    creditors arising in the ordinary course of business;
(d) any Indebtedness or other Obligation of such Person
    which is subordinate or junior in any respect to any other
    Indebtedness or other Obligation of such Person; or
114
Table of Contents
(e) that portion of any Indebtedness which at the time of
    incurrence is incurred in violation of the Indenture.
"Separate Receivables Collateral"
has the
    meaning set forth under "Description of Other
    Indebtedness — Senior Secured Credit
    Facilities — Guarantee and Security."
"Shared Receivables Collateral"
has the meaning
    set forth under "Description of Other
    Indebtedness — Senior Secured Credit
    Facilities — Guarantee and Security."
"Shared Receivables Intercreditor Agreement"
has the meaning set forth under "Security — Liens
    with Respect to Shared Receivables Collateral."
"Significant Subsidiary"
means any Restricted
    Subsidiary that would be a "significant subsidiary" as
    defined in Article 1,
Rule 1-02
of
Regulation S-X,
promulgated pursuant to the Securities Act, as such regulation
    is in effect on the Issue Date.
"Similar Business"
means any business conducted
    or proposed to be conducted by the Issuer and its Restricted
    Subsidiaries on the Issue Date or any business that is similar,
    reasonably related, incidental or ancillary thereto.
"Sponsor Management Agreement"
means the
    management agreement between certain of the management companies
    associated with the Investors, the Frist Entities and the Issuer.
"Subordinated Indebtedness"
means, with respect
    to the Notes,
(1) any Indebtedness of the Issuer which is by its terms
    subordinated in right of payment to the Notes, and
(2) any Indebtedness of any Guarantor which is by its terms
    subordinated in right of payment to the Guarantee of such entity
    of the Notes.
"Subsidiary"
means, with respect to any Person:
(1) any corporation, association, or other business entity
    (other than a partnership, joint venture, limited liability
    company or similar entity) of which more than 50% of the total
    voting power of shares of Capital Stock entitled (without regard
    to the occurrence of any contingency) to vote in the election of
    directors, managers or trustees thereof is at the time of
    determination owned or controlled, directly or indirectly, by
    such Person or one or more of the other Subsidiaries of that
    Person or a combination thereof or is consolidated under GAAP
    with such Person at such time; and
(2) any partnership, joint venture, limited liability
    company or similar entity of which
(x) more than 50% of the capital accounts, distribution
    rights, total equity and voting interests or general or limited
    partnership interests, as applicable, are owned or controlled,
    directly or indirectly, by such Person or one or more of the
    other Subsidiaries of that Person or a combination thereof
    whether in the form of membership, general, special or limited
    partnership or otherwise, and
(y) such Person or any Restricted Subsidiary of such Person
    is a controlling general partner or otherwise controls such
    entity.
"Total Assets"
means the total assets of the
    Issuer and its Restricted Subsidiaries on a consolidated basis,
    as shown on the most recent consolidated balance sheet of the
    Issuer or such other Person as may be expressly stated.
"Transaction"
means the transactions
    contemplated by the Transaction Agreement, the issuance of the
    Notes and borrowings under the Senior Credit Facilities as in
    effect on the Issue Date.
"Transaction Agreement"
means the Agreement and
    Plan of Merger, dated as of July 24, 2006, between Hercules
    Holding II, LLC, Hercules Acquisition Corporation and the
    Issuer, as amended prior to the Issue Date.
115
Table of Contents
"Treasury Rate"
means, as of any
    Redemption Date, the yield to maturity as of such
    Redemption Date of United States Treasury securities with a
    constant maturity (as compiled and published in the most recent
    Federal Reserve Statistical Release H.15 (519) that has
    become publicly available at least two Business Days prior to
    the Redemption Date (or, if such Statistical Release is no
    longer published, any publicly available source of similar
    market data)) most nearly equal to the period from the
    Redemption Date to November 15, 2010 with respect to
    the 2014 Cash Pay Notes and November 15, 2011 with respect
    to the 2016 Cash Pay Notes and the Toggle Notes;
provided
,
however
, that if the period from the
    Redemption Date to November 15, 2010 with respect to
    the 2014 Cash Pay Notes and November 15, 2011 with respect
    to the 2016 Cash Pay Notes and the Toggle Notes is less than one
    year, the weekly average yield on actually traded United States
    Treasury securities adjusted to a constant maturity of one year
    will be used.
"Trust Indenture Act"
means the
    Trust Indenture Act of 1939, as amended (15 U.S.C.
§§ 77aaa-777bbbb).
"Unrestricted Subsidiary"
means:
(1) any Subsidiary of the Issuer which at the time of
    determination is an Unrestricted Subsidiary (as designated by
    the Issuer, as provided below); and
(2) any Subsidiary of an Unrestricted Subsidiary.
The Issuer may designate any Subsidiary of the Issuer (including
    any existing Subsidiary and any newly acquired or newly formed
    Subsidiary) to be an Unrestricted Subsidiary unless such
    Subsidiary or any of its Subsidiaries owns any Equity Interests
    or Indebtedness of, or owns or holds any Lien on, any property
    of, the Issuer or any Subsidiary of the Issuer (other than
    solely any Subsidiary of the Subsidiary to be so designated);
provided
that
(1) any Unrestricted Subsidiary must be an entity of which
    the Equity Interests entitled to cast at least a majority of the
    votes that may be cast by all Equity Interests having ordinary
    voting power for the election of directors or Persons performing
    a similar function are owned, directly or indirectly, by the
    Issuer;
(2) such designation complies with the covenants described
    under "Certain Covenants — Limitation on
    Restricted Payments"; and
(3) each of:
(a) the Subsidiary to be so designated; and
(b) its Subsidiaries has not at the time of designation,
    and does not thereafter, create, incur, issue, assume, guarantee
    or otherwise become directly or indirectly liable with respect
    to any Indebtedness pursuant to which the lender has recourse to
    any of the assets of the Issuer or any Restricted Subsidiary.
The Issuer may designate any Unrestricted Subsidiary to be a
    Restricted Subsidiary;
provided
that, immediately after
    giving effect to such designation, no Default shall have
    occurred and be continuing and either:
(1) the Issuer could incur at least $1.00 of additional
    Indebtedness pursuant to the Fixed Charge Coverage Ratio test
    described in the first paragraph under "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred
    Stock"; or
(2) the Fixed Charge Coverage Ratio for the Issuer and its
    Restricted Subsidiaries would be greater than such ratio for the
    Issuer and its Restricted Subsidiaries immediately prior to such
    designation, in each case on a
pro forma
basis taking
    into account such designation.
Any such designation by the Issuer shall be notified by the
    Issuer to the Trustee by promptly filing with the Trustee a copy
    of the resolution of the board of directors of the Issuer or any
    committee thereof giving effect to such designation and an
    Officer's Certificate certifying that such designation
    complied with the foregoing provisions.
"Voting Stock"
of any Person as of any date
    means the Capital Stock of such Person that is at the time
    entitled to vote in the election of the board of directors of
    such Person.
116
Table of Contents
"Weighted Average Life to Maturity"
means, when
    applied to any Indebtedness, Disqualified Stock or Preferred
    Stock, as the case may be, at any date, the quotient obtained by
    dividing:
(1) the sum of the products of the number of years from the
    date of determination to the date of each successive scheduled
    principal payment of such Indebtedness or redemption or similar
    payment with respect to such Disqualified Stock or Preferred
    Stock multiplied by the amount of such payment; by
(2) the sum of all such payments.
"Wholly-Owned Subsidiary"
of any Person means a
    Subsidiary of such Person, 100% of the outstanding Equity
    Interests of which (other than directors' qualifying
    shares) shall at the time be owned by such Person or by one or
    more Wholly-Owned Subsidiaries of such Person.
Senior
    Secured Notes Issued Under the 2009 Second Lien
    Indenture
HCA Inc. has issued senior secured notes as described below
    under an indenture, dated as of February 19, 2009, among
    the Issuer, the Guarantors, The Bank of New York Mellon as
    collateral agent and The Bank of New York Mellon
    Trust Company, N.A., as trustee. Terms used in this
    "— Senior Secured Notes Issued Under the 2009
    Second Lien Indenture" apply only to the Notes described
    herein.
General
Certain terms used in this description are defined under the
    subheading "Certain Definitions." In this description,
    the terms
"we
,"
"our,"
"us"
and
"the Company"
each
    refer to HCA Inc. (the
"Issuer"
) and its
    consolidated Subsidiaries.
The Issuer issued $310.0 million aggregate principal amount
    of
    9
7
/
8
% senior
    secured notes due 2017 (the
"Notes"
) under an
    indenture dated as of February 19, 2009 (the
"Indenture"
) among the Issuer, the Guarantors
    and The Bank of New York Mellon Trust Company, N.A., as
    trustee (the
"Trustee"
). The Notes were issued
    in a private transaction that was not subject to the
    registration requirements of the Securities Act. Except as set
    forth herein, the terms of the Notes are substantially identical
    and include those stated in the Indenture and those made part of
    the Indenture by reference to the Trust Indenture Act.
The following description is only a summary of the material
    provisions of the Indenture, does not purport to be complete and
    is qualified in its entirety by reference to the provisions of
    those agreements, including the definitions therein of certain
    terms used below. We urge you to read the Indenture because it,
    and not this description, will define your rights as Holders of
    the Notes.
Brief
    Description of Notes
The Notes:
•
are general senior obligations of the Issuer;
•
are secured on a second-priority basis, equally and ratably with
    the 2006 Notes and all future obligations of the Issuer and the
    Guarantors under any future Junior Lien Obligations, by all of
    the assets of the Issuer and the Guarantors which are not
    Principal Properties and which secure the General Credit
    Facility (other than the European Collateral), subject to the
    Liens securing the Issuer's and the Guarantors'
    obligations under the General Credit Facility and any other
    Priority Lien Obligations and other Permitted Liens;
•
are secured on a third-priority basis, equally and ratably with
    the 2006 Notes and all future obligations of the Issuer and the
    Guarantors under any future Junior Lien Obligations, by all of
    the assets of the Issuer and the Guarantors securing the ABL
    Facility which also secure the General Credit Facility, subject
    to the Liens securing the Issuer's and the Guarantors'
    obligations under the Senior Credit Facilities and any other
    Priority Lien Obligations and other Permitted Liens;
•
are effectively subordinated, to the extent of the value of the
    assets securing such Indebtedness (which, in any event, exclude
    the European Collateral, which does not secure the Notes), to
    the Issuer's and the
117
Table of Contents
Guarantors' obligations under the General Credit Facility
    and any future Priority Lien Obligations, that will be secured
    (A) on a first-priority basis by the same assets of the
    Issuers and the Guarantors that secure the Notes and by certain
    other assets of the Issuer and the Guarantors, including the
    Principal Properties, that do not secure the Notes and
    (B) on a second-priority basis by the Shared Receivables
    Collateral;
•
are effectively subordinated to the Issuer's and the
    Guarantors' obligations under the ABL Facility, to the
    extent of the value of the Shared Receivables Collateral;
•
are effectively subordinated to any obligations secured by
    Permitted Liens, to the extent of the value of the assets of the
    Issuer and the Guarantors subject to those Permitted Liens;
•
are structurally subordinated to any existing and future
    indebtedness and liabilities of non-guarantor Subsidiaries,
    including the ABL Financing Entities and the Issuer's
    Foreign Subsidiaries and any Unrestricted Subsidiaries;
•
rank equally in right of payment with all existing and future
    senior Indebtedness of the Issuer and the Guarantors but, to the
    extent of the value of the Collateral, will be effectively
    senior to all of the Issuer's and the Guarantors'
    unsecured senior Indebtedness (including the Existing Notes);
•
are senior in right of payment to any future Subordinated
    Indebtedness (as defined with respect to the Notes) of the
    Issuer;
•
are initially unconditionally guaranteed on a joint and several
    and senior basis by each Restricted Subsidiary that guarantees
    the General Credit Facility (other than any Foreign
    Subsidiary); and
•
are subject to registration with the SEC pursuant to the
    Registration Rights Agreement.
Guarantees
The Guarantors, as primary obligors and not merely as sureties,
    jointly and severally fully and unconditionally guaranteed, on a
    senior basis, the performance and full and punctual payment when
    due, whether at maturity, by acceleration or otherwise, of all
    obligations of the Issuer under the Indenture and the Notes,
    whether for payment of principal of, premium, if any, or
    interest or Additional Interest in respect of the Notes,
    expenses, indemnification or otherwise, on the terms set forth
    in the Indenture by executing the Indenture.
The Restricted Subsidiaries which guarantee the General Credit
    Facility guarantee the Notes. Each of the Guarantees of the
    Notes is a general senior obligation of each Guarantor and is
    secured by a second-priority lien on all of the assets of each
    Guarantor which secure the General Credit Facility and which are
    not Principal Properties and by a third-priority lien on all of
    the assets of each Guarantor which secure the ABL Facility. The
    Guarantees rank equally in right of payment with all existing
    and future senior Indebtedness of the Guarantor but, to the
    extent of the value of the Collateral, are effectively senior to
    all of the Guarantor's unsecured senior Indebtedness and,
    to the extent of the Collateral, are effectively subordinated to
    the Guarantor's Obligations under the Senior Credit
    Facilities and any future Priority Lien Obligations. The
    Guarantees are senior in right of payment to all existing and
    future Subordinated Indebtedness of each Guarantor. The Notes
    are structurally subordinated to Indebtedness and other
    liabilities of Subsidiaries of the Issuer that do not Guarantee
    the Notes.
Not all of the Issuer's Subsidiaries Guarantee the Notes.
    In the event of a bankruptcy, liquidation or reorganization of
    any of these non-guarantor Subsidiaries, the non-guarantor
    Subsidiaries will pay the holders of their debt and their trade
    creditors before they will be able to distribute any of their
    assets to the Issuer. None of our Subsidiaries which are
    "Restricted Subsidiaries" for purposes of the Existing
    Notes Indenture, Foreign Subsidiaries, ABL Financing Entities,
    non-Wholly Owned Subsidiaries or any Receivables Subsidiaries
    will guarantee the Notes.
On an as adjusted basis after giving effect to our offering of
    $1.500 billion aggregate principal amount of first lien
    notes in April 2009 and the use of proceeds therefrom, our
    non-guarantor subsidiaries would have
118
Table of Contents
accounted for approximately $11.867 billion, or 41.8%, of
    our total revenues for the year ended December 31, 2008,
    approximately $3.038 billion, or 40.9%, of our total
    revenues for the three months ended March 31, 2009,
    approximately $9.876 billion, or 40.7%, of our total
    assets, and approximately $7.517 billion, or 22.5%, of our
    total liabilities, in each case, as of December 31, 2008,
    and approximately $9.817 billion, or 40.4%, of our total
    assets, and approximately $7.224 billion, or 21.9%, of our
    total liabilities, in each case, as of March 31, 2009.
The obligations of each Guarantor under its Guarantee are
    limited as necessary to prevent the Guarantee from constituting
    a fraudulent conveyance under applicable law.
Any entity that makes a payment under its Guarantee is entitled
    upon payment in full of all guaranteed obligations under the
    Indenture to a contribution from each other Guarantor in an
    amount equal to such other Guarantor's pro rata portion of
    such payment based on the respective net assets of all the
    Guarantors at the time of such payment determined in accordance
    with GAAP.
If a Guarantee were rendered voidable, it could be subordinated
    by a court to all other indebtedness (including guarantees and
    other contingent liabilities) of the Guarantor, and, depending
    on the amount of such indebtedness, a Guarantor's liability
    on its Guarantee could be reduced to zero. See "Risk
    Factors — Risks Related to the Notes —
    Federal and state fraudulent transfer laws may permit a court to
    void the notes, and with respect to the senior secured notes,
    the guarantees, and, if that occurs, you may not receive any
    payment on the notes."
Each Guarantee by a Guarantor provides by its terms that it will
    be automatically and unconditionally released and discharged
    upon:
(1) (a) any sale, exchange or transfer (by merger or
    otherwise) of the Capital Stock of such Guarantor (including any
    sale, exchange or transfer), after which the applicable
    Guarantor is no longer a Restricted Subsidiary or all or
    substantially all the assets of such Guarantor, which sale,
    exchange or transfer is made in compliance with the applicable
    provisions of the Indenture;
(b) the release or discharge of the guarantee by such
    Guarantor of the Senior Credit Facilities or such other
    guarantee that resulted in the creation of such Guarantee,
    except a discharge or release by or as a result of payment under
    such guarantee;
(c) the designation of any Restricted Subsidiary that is a
    Guarantor as an Unrestricted Subsidiary in compliance with the
    applicable provisions of the Indenture; or
(d) the exercise by the Issuer of its legal defeasance
    option or covenant defeasance option as described under
    "Legal Defeasance and Covenant Defeasance" or the
    discharge of the Issuer's obligations under the Indenture
    in accordance with the terms of the Indenture; and
(2) such Guarantor delivering to the Trustee an
    Officer's Certificate and an Opinion of Counsel, each
    stating that all conditions precedent provided for in the
    Indenture relating to such transaction have been complied with.
Holding
    Company Structure
The Issuer is a holding company for its Subsidiaries, with no
    material operations of its own and only limited assets.
    Accordingly, the Issuer is dependent upon the distribution of
    the earnings of its Subsidiaries, whether in the form of
    dividends, advances or payments on account of intercompany
    obligations, to service its debt obligations.
Security
General
The Notes and the Guarantees are secured by perfected
    second-priority security interests in the Non-Receivables
    Collateral (second in priority to the Liens on the
    Non-Receivables Collateral securing the First Lien Obligations)
    and by perfected third-priority security interests in the Shared
    Receivables Collateral (third
119
Table of Contents
in priority to the first-priority and second-priority Liens on
    the Shared Receivables Collateral securing the ABL Obligations
    and the First Lien Obligations, respectively), in each case,
    equally and ratably with the 2006 Notes and subject to Permitted
    Liens. Notwithstanding the foregoing, neither the Notes nor the
    Guarantees are secured by the European Collateral or the
    Separate Receivables Collateral and, until after the Discharge
    of the First Lien Obligations, the Notes and the Guarantees will
    not be secured by any Principal Properties. Upon the Discharge
    of First Lien Obligations and so long as no First Lien
    Obligations are outstanding, the Principal Properties that
    constituted "Collateral" under the First Lien Security
    Documents Facility will become Collateral with respect to the
    Notes, subject to the same limitation on the amount of
    Obligations secured thereby as contained in the First Lien
    Security Documents. See also "— Certain
    Limitations on the Collateral" below. Priority Lien Secured
    Parties have rights and remedies with respect to the Collateral
    that, if exercised, could adversely affect the value of the
    Collateral or the ability of the respective agents under the
    Intercreditor Agreements to realize or foreclose on the
    Collateral on behalf of holders of the Notes. For a description
    of the Shared Receivables Collateral and the Non-Receivables
    Collateral, see "Description of Other
    Indebtedness — Senior Secured Credit
    Facilities — Guarantee and Security."
The Issuer and the Guarantors are and will be able to incur
    additional Indebtedness in the future which could share in the
    Collateral, including additional First Lien Obligations,
    additional ABL Obligations, additional Junior Lien Obligations
    and Obligations secured by Permitted Liens. The amount of such
    additional Obligations is and will be limited by the covenant
    described under "Certain Covenants — Liens"
    and the covenant described under "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock."
    Under certain circumstances, the amount of any such additional
    Obligations could be significant.
After-Acquired
    Collateral
From and after the Issue Date and subject to certain limitations
    and exceptions, (a) if the Issuer or any Guarantor creates
    any additional security interest upon any property or asset that
    would constitute Collateral to secure any First Lien Obligations
    (other than Principal Properties prior to the Discharge of First
    Lien Obligations and so long as no First Lien Obligations are
    outstanding and other than European Collateral and Separate
    Receivables Collateral), it must concurrently grant a
    second-priority perfected security interest (subject to
    Permitted Liens) upon such property as security for the Notes
    and (b) if the Issuer or any Guarantor creates any
    additional security interest upon any property or asset that
    would constitute Shared Receivables Collateral to secure any
    Priority Lien Obligations, it must concurrently grant a
    third-priority perfected security interest (subject to Permitted
    Liens) upon such property as security for the Notes.
Liens
    with Respect to the Collateral
Security
    Documents and Intercreditor Agreements
The Issuer, the Guarantors and the Junior Lien Collateral Agent
    entered into Security Documents in connection with the 2006
    Notes with respect to the Collateral defining the terms of the
    security interests that secure the 2006 Notes and the Guarantees
    with respect to such Collateral and that will define the terms
    of the security interests that secure the Notes and the
    Guarantees with respect to such collateral. These security
    interests will secure the payment and performance when due of
    all of the Obligations of the Issuers and the Guarantors under
    the Notes, the Indenture, the Guarantees and the Security
    Documents, as provided in the Security Documents.
The Junior Lien Collateral Agent and the First Lien Collateral
    Agent entered into a joinder to the General Intercreditor
    Agreement dated as of November 17, 2006 by and among the
    trustee under the 2006 Notes and the administrative agent under
    the General Credit Facility (as the same may be amended from
    time to time, the
"General Intercreditor
    Agreement"
) with respect to the Collateral. The First
    Lien Collateral Agent is initially the Collateral Agent under
    the General Credit Facility. The Junior Lien Collateral Agent is
    initially the trustee under the 2006 Notes. Pursuant to the
    terms of the General Intercreditor Agreement, prior to the
    Discharge of First Lien Obligations, the First Lien Collateral
    Agent, acting on behalf of the First Lien Secured Parties, will
    determine the time and method by which the security interests in
    the Collateral will be enforced
120
Table of Contents
and will have the sole and exclusive right to manage, perform
    and enforce the terms of the Security Documents relating to the
    Collateral and to exercise and enforce all privileges, rights
    and remedies thereunder according to its direction, including to
    take or retake control or possession of such Collateral and to
    hold, prepare for sale, marshall, process, sell, lease, dispose
    of or liquidate such Collateral, including, without limitation,
    following the occurrence of a Default or Event of Default under
    the Indenture. The Junior Lien Collateral Agent will not be
    permitted to enforce the security interests even if any Event of
    Default under the Indenture has occurred and the Notes have been
    accelerated except (a) in any insolvency or liquidation
    proceeding, solely as necessary to file a proof of claim or
    statement of interest with respect to the Junior Lien
    Obligations or (b) as necessary to take any action in order
    to prove, preserve, perfect or protect (but not enforce) its
    security interest and rights in, and the perfection and priority
    of its Lien on, the Collateral. See "Risk
    Factors — Risks Related to the Notes — The
    lien ranking provisions of the Indenture and other agreements
    relating to the collateral securing the notes will limit the
    rights of holders of the notes with respect to that collateral,
    even during an event of default." After the Discharge of
    First Lien Obligations, the Junior Lien Collateral Agent in
    accordance with the provisions of the Junior Lien Documents will
    distribute all cash proceeds (after payment of the costs of
    enforcement and collateral administration and any other amounts
    owed to the Junior Lien Collateral Agent) of the Collateral
    received by it under the Security Documents for the ratable
    benefit of the holders of Junior Lien Obligations. The proceeds
    from the sale of the Collateral remaining after the satisfaction
    of all First Lien Obligations may not be sufficient to satisfy
    the Junior Lien Obligations. By its nature some or all of the
    Collateral is and will be illiquid and may have no readily
    ascertainable market value. Accordingly, the Collateral may not
    be able to be sold in a short period of time, if salable. See
    "Risk Factors — Risks Related to the
    Notes — The value of the collateral securing the notes
    may not be sufficient to satisfy our obligations under the
    notes."
The Junior Lien Collateral Agent, for itself and on behalf of
    each Junior Lien Secured Party, has agreed pursuant to the
    General Intercreditor Agreement that (a) it will not (and
    thereby waives any right to) take any action to challenge,
    contest or support any other Person in contesting or
    challenging, directly or indirectly, in any proceeding
    (including any insolvency or liquidation proceeding), the
    validity, perfection, priority or enforceability of a Lien
    securing any First Lien Obligations held (or purported to be
    held) by or on behalf of the First Lien Collateral Agent or any
    of the First Lien Secured Parties or any agent or trustee
    therefor in any Collateral or other First Lien Collateral and
    (b) it will not oppose or otherwise contest (or support any
    other Person contesting) any request for judicial relief made in
    any court by the First Lien Collateral Agent or any First Lien
    Secured Parties relating to the lawful enforcement of any First
    Priority Lien on Collateral or other First Lien Collateral.
In addition, the Security Documents provide that, prior to the
    Discharge of First Lien Obligations, (1) the First Lien
    Collateral Agent may take actions with respect to the Collateral
    (including the release of Collateral and the manner of
    realization (subject to the provisions described under
    "— Release of Collateral")) without the
    consent of the Junior Lien Collateral Agent or other Junior Lien
    Secured Parties and (2) the Issuer and the Guarantors may
    require the Junior Lien Collateral Agent to agree to modify the
    Security Documents, or the General Intercreditor Agreement,
    without the consent of the Junior Lien Collateral Agent or other
    Junior Lien Secured Parties, to secure additional extensions of
    credit and add additional First Lien Secured Parties or Junior
    Lien Secured Parties so long as such modifications do not
    expressly violate the provisions of the General Credit Facility
    or the Indenture. In addition, the General Intercreditor
    Agreement provides that with respect to Collateral in the event
    that the First Lien Collateral Agent or the First Lien Secured
    Parties enter into any amendment, waiver or consent in respect
    of or replace any of the First Lien Security Documents for the
    purpose of adding to, or deleting from, or waiving or consenting
    to any departures from any provisions of, any First Lien
    Security Document or changing in any manner the rights of the
    First Lien Collateral Agent, the First Lien Secured Parties, the
    Issuer or any Guarantor thereunder (including the release of any
    Liens in Collateral in accordance with the provisions described
    under "— Release of Collateral"), then such
    amendment, waiver or consent shall apply automatically to any
    comparable provision of each comparable Security Document in
    favor of the Junior Lien Obligations without the consent of the
    Junior Lien Collateral Agent, any Junior Lien Representative or
    any Junior Lien Secured Party and without any action by the
    Junior Lien Collateral Agent, any Junior Lien Representative,
    the Issuer or any Guarantor;
provided
that such
    amendment, waiver or consent does not materially adversely
    affect the rights of the Junior Lien Secured Parties or the
121
Table of Contents
interests of the Junior Lien Secured Parties in the Collateral
    in a manner materially different from that affecting the rights
    of the First Lien Secured Parties thereunder or therein. Any
    provider of additional extensions of credit shall be entitled to
    rely on the determination of an Officer that such modifications
    do not expressly violate the provisions of the General Credit
    Facility or the Indenture if such determination is set forth in
    an Officer's Certificate delivered to such provider.
So long as the Discharge of First Lien Obligations has not
    occurred, the Collateral or proceeds thereof received in
    connection with the sale or other disposition of, or collection
    on, such Non-Receivables Collateral upon the exercise of
    remedies will be applied by the First Lien Collateral Agent to
    the First Lien Obligations in such order as specified in the
    relevant First Lien Documents until the Discharge of First Lien
    Obligations has occurred. Upon the Discharge of First Lien
    Obligations, the First Lien Collateral Agent shall deliver to
    the Junior Lien Collateral Agent (for the benefit of all Junior
    Lien Secured Parties) any remaining proceeds of Collateral held
    by it in the same form as received, with any necessary
    endorsements or as a court of competent jurisdiction may
    otherwise direct to be applied by the Junior Lien Collateral
    Agent to the Junior Lien Obligations in such order as specified
    in the Junior Lien Documents.
In addition, so long as the Discharge of First Lien Obligations
    has not occurred, neither the Junior Lien Collateral Agent nor
    any Junior Lien Representative shall acquire or hold any Lien on
    any assets of the Issuer or any Subsidiary (and neither the
    Issuer nor any Subsidiary shall grant such Lien) securing any
    Junior Lien Obligations that are not also subject to the First
    Priority Lien in respect of the First Lien Obligations under the
    First Lien Documents. If the Junior Lien Collateral Agent or any
    Junior Lien Representative shall acquire or hold any Lien on any
    assets of the Issuer or any Subsidiary that is not also subject
    to the First Priority Lien in respect of the First Lien
    Obligations under the First Lien Documents, then such Junior
    Lien Collateral Agent or other Junior Lien Representative shall,
    without the need for any further consent of any party and
    notwithstanding anything to the contrary in any other document,
    be deemed to also hold and have held such Lien for the benefit
    of the First Lien Collateral Agent as security for the First
    Lien Obligations (subject to the lien priority and other terms
    hereof).
The Junior Lien Collateral Agent and each other Junior Lien
    Secured Party have agreed that any Lien purported to be granted
    on any Collateral as security for First Lien Obligations shall
    be deemed to be and shall be deemed to remain senior in all
    respects and prior to all Liens on the Collateral securing any
    Junior Lien Obligations for all purposes regardless of whether
    the Lien purported to be granted is found to be improperly
    granted, improperly perfected, preferential, a fraudulent
    conveyance or legally or otherwise deficient or invalid, in
    whole or in part, in any manner.
Any Collateral or proceeds thereof received by any Junior Lien
    Secured Party at a time when such receipt is not expressly
    permitted by the terms of the General Intercreditor Agreement or
    prior to the Discharge of First Lien Obligations shall be
    segregated and held in trust for the benefit of and forthwith
    paid over to the First Lien Collateral Agent (and/or its
    designees) for the benefit of the First Lien Secured Parties in
    the same form as received, with any necessary endorsements or as
    a court of competent jurisdiction may otherwise direct.
If any First Lien Secured Party is required in any insolvency or
    liquidation proceeding or otherwise to turn over or otherwise
    pay to the estate of the Issuer or any other Guarantor (or any
    trustee, receiver or similar person therefor), because the
    payment of such amount was declared to be fraudulent or
    preferential in any respect or for any other reason, any amount
    (a
"Recovery"
), whether received as proceeds of
    security, enforcement of any right of setoff or otherwise, then
    as among the parties hereto, the First Lien Obligations shall be
    deemed to be reinstated to the extent of such Recovery and to be
    outstanding as if such payment had not occurred and such First
    Lien Secured Party shall be entitled to a reinstatement of First
    Lien Obligations with respect to all such recovered amounts and
    shall have all rights hereunder. If the General Intercreditor
    Agreement shall have been terminated prior to such Recovery, the
    General Intercreditor Agreement shall be reinstated in full
    force and effect, and such prior termination shall not diminish,
    release, discharge, impair or otherwise affect the obligations
    of the parties thereto. Any Collateral or other First Lien
    Collateral or proceeds thereof received by any Junior Lien
    Secured Party prior to the time of such Recovery shall be deemed
    to have
122
Table of Contents
been received prior to the Discharge of First Lien Obligations
    and subject to the provisions of the immediately preceding
    paragraph.
In addition, if at any time in connection with or after the
    Discharge of First Lien Obligations the Issuer either in
    connection therewith or thereafter enters into any Refinancing
    of any First Lien Document evidencing a First Lien Obligation,
    then such Discharge of First Lien Obligations shall
    automatically be deemed not to have occurred for all purposes of
    the General Intercreditor Agreement, the First Lien Documents
    and the Junior Lien Documents, and the obligations under such
    Refinancing shall automatically be treated as First Lien
    Obligations for all purposes of the General Intercreditor
    Agreement, including for purposes of the Lien priorities and
    rights in respect of Collateral set forth therein, the related
    documents shall be treated as First Lien Documents for all
    purposes of the General Intercreditor Agreement and the first
    lien collateral agent under such Refinanced First Lien Documents
    shall be First Lien Collateral Agent for all purposes of the
    General Intercreditor Agreement.
The General Intercreditor Agreement provides that, prior to the
    Discharge of First Lien Obligations, neither the Junior Lien
    Collateral Agent nor any other Junior Lien Secured Parties may
    assert or enforce any right of marshalling accorded to a junior
    lienholder, as against the First Lien Collateral Agent or any
    First Lien Secured Party (in their capacity as priority
    lienholders). Following the Discharge of First Lien Obligations,
    the Junior Lien Secured Parties may assert their right under the
    Uniform Commercial Code or otherwise to any proceeds remaining
    following a sale or other disposition of Collateral by, or on
    behalf of, the First Lien Collateral Agent or the First Lien
    Secured Parties. This waiver of all rights of marshalling prior
    to the Discharge of First Lien Obligations may result in
    proceeds from the sale of Collateral (in which the Junior Lien
    Secured Parties have second-priority Liens) being applied to
    repay First Lien Obligations prior to the application of the
    proceeds of Shared Receivables Collateral (in which the Junior
    Lien Secured Parties have third-priority Liens), the Principal
    Properties (in which the Junior Lien Secured Parties will not
    have a security interest prior to the Discharge of First Lien
    Obligations and during any time that any First Lien Obligations
    are outstanding) or the European Collateral or the Separate
    Receivables Collateral (in which the Junior Lien Secured Parties
    do not have a security interest). In that scenario, Junior Lien
    Secured Parties may recover less than they would have if such
    proceeds were applied in the order most favorable to the Junior
    Lien Secured Parties.
So long as the Discharge of First Lien Obligations has not
    occurred, whether or not any insolvency or liquidation
    proceeding has been commenced by or against the Issuer or any
    Guarantor, (i) neither the Junior Lien Collateral Agent,
    any Junior Lien Representative nor any Junior Lien Secured Party
    will (x) exercise or seek to exercise any rights or
    remedies (including setoff or the right to credit bid debt
    (except as set forth in the next paragraph below)) with respect
    to any Collateral in respect of any applicable Junior Lien
    Obligations, or institute any action or proceeding with respect
    to such rights or remedies (including any action of
    foreclosure), (y) contest, protest or otherwise object to
    any foreclosure or enforcement proceeding or action brought with
    respect to the Collateral or any other collateral by the First
    Lien Collateral Agent or any First Lien Secured Party in respect
    of the First Lien Obligations, the exercise of any right by the
    First Lien Collateral Agent or any First Lien Secured Party (or
    any agent or
sub-agent
on
    their behalf) in respect of the First Lien Obligations under any
    control agreement, lockbox agreement, landlord waiver or
    bailee's letter or similar agreement or arrangement to
    which the Junior Lien Collateral Agent, any Junior Lien
    Representative or any Junior Lien Secured Party either is a
    party or may have rights as a third-party beneficiary, or any
    other exercise by any such party of any rights and remedies as a
    secured party relating to the Collateral or any other collateral
    under the First Lien Documents or otherwise in respect of First
    Lien Obligations, or (z) object to any waiver or
    forbearance by the First Lien Secured Parties from or in respect
    of bringing or pursuing any foreclosure proceeding or action or
    any other exercise of any rights or remedies relating to the
    Collateral or any other collateral in respect of First Lien
    Obligations and (ii) except as otherwise provided in the
    General Intercreditor Agreement, the First Lien Collateral Agent
    and the First Lien Secured Parties shall have the sole and
    exclusive right to enforce rights, exercise remedies (including
    setoff and the right to credit bid their debt), marshal, process
    and make determinations regarding the release, disposition or
    restrictions, or waiver or forbearance of rights or remedies
    with respect to the Collateral without any consultation with or
    the consent of the Junior Lien Collateral Agent, any Junior Lien
    Representative or any Junior Lien Secured Party.
123
Table of Contents
Notwithstanding the foregoing, the General Intercreditor
    Agreement shall not be construed to in any way limit or impair
    the right of any Junior Lien Secured Party from exercising a
    credit bid with respect to the Junior Lien Obligations in a sale
    or other disposition of Collateral under Section 363 of the
    Bankruptcy Code;
provided
that in connection with and
    immediately after giving effect to such sale and credit bid
    there occurs a Discharge of First Lien Obligations.
In addition, the Junior Lien Collateral Agent, each Junior Lien
    Representative and each other Junior Lien Secured Party have
    agreed that if the Issuer or any Guarantor is subject to any
    insolvency or liquidation proceeding:
(1) if the First Lien Collateral Agent acting on behalf of
    First Lien Secured Parties desires to permit the use of cash
    collateral or to permit the Issuer or any Guarantor to obtain
    financing under Section 363 or Section 364 of the
    Bankruptcy Code or any similar provision in any Bankruptcy Law
    (
"DIP Financing"
), including if such DIP
    Financing is secured by Liens senior in priority to the Liens
    securing the Notes or other Junior Lien Obligations, then the
    Junior Lien Collateral Agent and each Junior Lien
    Representative, on behalf of itself and each applicable Junior
    Lien Secured Party, agrees not to object to such use of cash
    collateral or DIP Financing and will not request adequate
    protection or any other relief in connection therewith (except
    to the extent permitted by the General Intercreditor Agreement,
    as set forth below) and, to the extent the Liens securing the
    First Lien Obligations are subordinated or
pari passu
with such DIP Financing, will subordinate its Liens in the
    Collateral and any other collateral to such DIP Financing (and
    all Obligations relating thereto) on the same basis as they are
    subordinated to the First Lien Obligations;
(2) none of them will object to, or otherwise contest (or
    support any other Person contesting), any motion for relief from
    the automatic stay or from any injunction against foreclosure or
    enforcement in respect of the First Lien Obligations made by the
    First Lien Collateral Agent or any First Lien Secured Party;
(3) none of them will object to, or otherwise contest (or
    support any other Person contesting), any order relating to a
    sale of assets of any Issuer or Guarantor for which the First
    Lien Collateral Agent has consented that provides, to the extent
    that sale is to be free and clear of Liens, that the Liens
    securing the First Lien Obligations and the Junior Lien
    Obligations will attach to the proceeds of the sale on the same
    basis of priority as the existing Liens in accordance with the
    General Intercreditor Agreement;
(4) none of them will seek relief from the automatic stay
    or any other stay in any insolvency or liquidation proceeding in
    respect of the Collateral or any other First Lien Collateral,
    without the prior written consent of the First Lien Collateral
    Agent;
(5) none of them will object to, or otherwise contest (or
    support any other Person contesting), (a) any request by
    the First Lien Collateral Agent or any First Lien Secured Party
    for adequate protection or (b) any objection by the First
    Lien Collateral Agent or any First Lien Secured Party to any
    motion, relief, action or proceeding based on the First Lien
    Collateral Agent's or such First Lien Secured Party's
    claiming a lack of adequate protection;
(6) none of them will assert or enforce (or support any
    Person asserting or enforcing) any claim under
    Section 506(c) of the Bankruptcy Code senior to or on a
    parity with the Liens securing the First Lien Obligations for
    costs or expenses of preserving or disposing of any Collateral
    or First Lien Collateral;
(7) none of them will oppose or otherwise contest (or
    support any other Person contesting) any lawful exercise by the
    First Lien Collateral Agent or any First Lien Secured Party of
    the right to credit bid First Lien Obligations at any sale of
    Collateral or First Lien Collateral; and
(8) none of them will challenge (or support any other
    person challenging) the validity, enforceability, perfection or
    priority of the First Priority Liens on Collateral or First Lien
    Collateral (and the General Intercreditor Agreement will provide
    that the First Lien Secured Parties agree that none of them will
124
Table of Contents
challenge the validity, enforceability, perfection or priority
    of the Liens in favor of the Trustee and each other Junior Lien
    Secured Party on the Collateral).
In addition, neither the Junior Lien Collateral Agent, any
    Junior Lien Representative nor any other Junior Lien Secured
    Party will file or prosecute in any insolvency or liquidation
    proceeding any motion for adequate protection (or any comparable
    request for relief) based upon their respective security
    interests in the Collateral, except that:
(1) any of them may freely seek and obtain relief granting
    a junior Lien co-extensive in all respects with, but
    subordinated to, all Liens granted in the insolvency or
    liquidation proceeding to, or for the benefit of, the First Lien
    Secured Parties (and the General Intercreditor Agreement will
    provide that the First Lien Secured Parties will not object to
    the granting of such a junior Lien); and
(2) any of them may freely seek and obtain any relief upon
    a motion for adequate protection (or any comparable relief),
    without any condition or restriction whatsoever, at any time
    after the Discharge of First Lien Obligations.
Without limiting the generality of any provisions of the General
    Intercreditor Agreement, any vote to accept, and any other act
    to support the confirmation or approval of, any Non-Conforming
    Plan of Reorganization shall be inconsistent with and,
    accordingly, a violation of the terms of the General
    Intercreditor Agreement, and the First Lien Collateral Agent
    shall be entitled to have any such vote to accept a
    Non-Conforming Plan of Reorganization dismissed and any such
    support of any Non-Conforming Plan of Reorganization withdrawn.
Subject to the terms of the Security Documents, the Issuer and
    the Guarantors have the right to remain in possession and retain
    exclusive control of the Collateral securing the Notes and the
    Junior Lien Obligations (other than securities, instruments and
    chattel paper constituting part of the Collateral and deposited
    with the First Lien Collateral Agent in accordance with the
    provisions of the First Lien Security Documents and any Shared
    Receivables Collateral subject to a control agreement under the
    circumstances described in the First Lien Security Documents),
    to freely operate the Collateral and to collect, invest and
    dispose of any income therefrom.
The Junior Lien Collateral Agent and each Junior Lien
    Representative, on behalf of the Junior Lien Secured Parties,
    have acknowledged and agreed in the General Intercreditor
    Agreement that (a) the Junior Lien Secured Parties'
    claims against the Issuer
and/or
any
    Guarantor in respect of the Collateral constitute junior claims
    separate and apart (and of a different class) from the senior
    claims of the First Lien Secured Parties against the Issuer and
    the Guarantor in respect of the Collateral, (b) the First
    Lien Obligations include all interest that accrues after the
    commencement of any insolvency or liquidation proceeding of the
    Issuer or any Guarantor at the rate provided for in the
    applicable First Lien Documents governing the same, whether or
    not a claim for post-petition interest is allowed or allowable
    in any such insolvency or liquidation proceeding and
    (c) the Intercreditor Agreement constitutes a
    "subordination agreement" under Section 510 of
    the Bankruptcy Code.
Release
    of Collateral
The Issuer and the Guarantors are entitled to the release of
    property and other assets constituting Collateral from the Liens
    securing the Notes and the Junior Lien Obligations under any one
    or more of the following circumstances:
(1) to enable us to consummate the sale, transfer or other
    disposition of such property or assets to the extent not
    prohibited under the covenant described under
    "— Repurchase at the Option of
    Holders — Asset Sales";
(2) the release of Excess Proceeds or Collateral Excess
    Proceeds that remain unexpended after the conclusion of an Asset
    Sale Offer or a Collateral Asset Sale Offer conducted in
    accordance with the Indenture;
125
Table of Contents
(3) in the case of a Guarantor that is released from its
    Guarantee with respect to the Notes pursuant to the terms of the
    Indenture, the release of the property and assets of such
    Guarantor;
(4) with the consent of the holders of at least 75% of the
    aggregate principal amount of the Notes then outstanding and
    affected thereby and a majority of all Junior Lien Obligations
    (including the Notes) then outstanding and affected thereby
    (including, without limitation, consents obtained in connection
    with a tender offer or exchange offer for, or purchase of,
    Junior Lien Obligations); or
(5) as described under "— Amendment,
    Supplement and Waiver" below.
The Junior Liens on any Collateral securing the Junior Lien
    Obligations will also terminate and be released automatically if
    the First Priority Liens on such Collateral securing First Lien
    Obligations are released by the First Lien Collateral Agent on
    behalf of the First Lien Secured Parties, unless such release
    occurs in connection with, and after giving effect to, a
    Discharge of First Lien Obligations, which discharge is not in
    connection with a foreclosure of, or other exercise of remedies
    with respect to, Collateral by the First Lien Secured Parties
    (such discharge not in connection with any such foreclosure or
    exercise of remedies, a
"Payment Discharge"
)
    (
provided
that, in the case of a Payment Discharge, the
    Liens on any Collateral disposed of in connection with the
    satisfaction in whole or in part of First Lien Obligations shall
    be automatically released but any proceeds thereof not used for
    purposes of the Discharge of First Lien Obligations or otherwise
    in accordance with the Indenture shall be subject to Liens in
    favor of the Junior Lien Secured Parties). In the event of a
    Payment Discharge, the Junior Liens on Collateral shall become
    first-priority security interests, subject to Permitted Liens,
    any intercreditor agreements or arrangements among Junior Lien
    Secured Parties permitted under the General Intercreditor
    Agreement and, with respect to Shared Receivables Collateral,
    subject to the Shared Receivables Intercreditor Agreement;
provided
that if the Issuer or the Guarantors incur at
    any time thereafter any new or replacement First Lien
    Obligations permitted under the Indenture, then such Payment
    Discharge shall automatically be deemed not to have occurred for
    all purposes of the General Intercreditor Agreement, the First
    Lien Documents and the Junior Lien Documents, and such new
    Obligations shall automatically be treated as First Lien
    Obligations for all purposes of the General Intercreditor
    Agreement, including for purposes of the Lien priorities and
    rights in respect of Collateral set forth therein, and the
    related documents shall be treated as First Lien Documents.
To the extent necessary and for so long as required for such
    Subsidiary not to be subject to any requirement pursuant to
Rule 3-16
of
Regulation S-X
under the Securities Act to file separate financial statements
    with the SEC (or any other governmental agency), the Capital
    Stock of any Subsidiary of the Company (excluding Healthtrust,
    Inc. — The Hospital Company, a Delaware corporation
    and its successors and assigns) shall not be included in the
    Collateral with respect to the respective Notes so affected (as
    described under "— Certain Limitations on the
    Collateral") and shall not be subject to the Liens securing
    such Notes and the Junior Lien Obligations.
The Junior Liens on the Collateral securing the Notes and the
    Guarantees also will be released upon (i) payment in full
    of the principal of, together with accrued and unpaid interest
    (including Additional Interest, if any) on, the Notes and all
    other Obligations under the Indenture, the Guarantees and the
    Security Documents (including the 2006 Notes) that are due and
    payable at or prior to the time such principal, together with
    accrued and unpaid interest (including Additional Interest, if
    any), are paid or (ii) a legal defeasance or covenant
    defeasance under the Indenture as described below under
    "Legal Defeasance and Covenant Defeasance" or a
    discharge of the Indenture as described under "Satisfaction
    and Discharge."
Any certificate or opinion required by Section 314(d) of
    the Trust Indenture Act may be made by an Officer of the
    Company, except in cases where Section 314(d) requires that
    such certificate or opinion be made by an independent engineer,
    appraiser or other expert.
Notwithstanding anything to the contrary herein, the Issuer and
    its Subsidiaries will not be required to comply with all or any
    portion of Section 314(d) of the Trust Indenture Act
    if they determine, in good faith based on advice of counsel,
    that under the terms of that section
and/or
any
    interpretation or guidance as to the meaning thereof of the SEC
    and its staff, including "no action" letters or
    exemptive orders, all or any portion of Section 314(d) of
    the Trust Indenture Act is inapplicable to the released
    Collateral.
126
Table of Contents
Without limiting the generality of the foregoing, certain no
    action letters issued by the SEC have permitted an indenture
    qualified under the Trust Indenture Act to contain
    provisions permitting the release of collateral from Liens under
    such indenture in the ordinary course of the issuer's
    business without requiring the issuer to provide certificates
    and other documents under Section 314(d) of the
    Trust Indenture Act. The Issuer and the Guarantors may,
    subject to the provisions of the Indenture, among other things,
    without any release or consent by the Junior Lien Collateral
    Agent, conduct ordinary course activities with respect to the
    Collateral, including, without limitation:
•
selling or otherwise disposing of, in any transaction or series
    of related transactions, any property subject to the Lien of the
    Security Documents that has become worn out, defective, obsolete
    or not used or useful in the business;
•
abandoning, terminating, canceling, releasing or making
    alterations in or substitutions of any leases or contracts
    subject to the Lien of the Indenture or any of the Security
    Documents;
•
surrendering or modifying any franchise, license or permit
    subject to the Lien of the Security Documents that it may own or
    under which it may be operating;
•
altering, repairing, replacing, changing the location or
    position of and adding to its structures, machinery, systems,
    equipment, fixtures and appurtenances;
•
granting a license of any intellectual property;
•
selling, transferring or otherwise disposing of inventory in the
    ordinary course of business;
•
collecting accounts receivable in the ordinary course of
    business as permitted by the covenant described under
    "Repurchase at the Option of Holders — Asset
    Sales";
•
making cash payments (including for the repayment of
    Indebtedness or interest) from cash that is at any time part of
    the Collateral in the ordinary course of business that are not
    otherwise prohibited by the Indenture and the Security
    Documents; and
•
abandoning any intellectual property that is no longer used or
    useful in the Issuer's business.
The Issuer must deliver an Officer's Certificate to the
    Junior Lien Collateral Agent within 30 calendar days following
    the end of each six-month period beginning on May 15 and
    November 15 of each year, to the effect that all such releases
    and withdrawals during the preceding six-month period in the
    ordinary course of the Issuer's or the Guarantors'
    business, as described in the preceding paragraph, were not
    prohibited by the Indenture.
Shared
    Receivables Intercreditor Agreement
In addition, the Junior Lien Collateral Agent, have entered into
    a joinder to the Shared Receivables Intercreditor Agreement
    dated as of November 17, 2006 by and among the trustee
    under the 2006 Notes, the administrative agent under the General
    Credit Facility and the administrative agent under the ABL
    Facility (as the same may be amended from time to time, the
"Shared Receivables Intercreditor Agreement"
)
    with respect to the Shared Receivables Collateral. The Shared
    Receivables Intercreditor Agreement contains provisions with
    respect to the Shared Receivables Collateral and the relative
    rights, privileges and obligations relating thereto as between
    (a) the Junior Lien Collateral Agent, the other Junior Lien
    Secured Parties, the First Lien Collateral Agent and the First
    Lien Secured Parties and (b) the collateral agent with
    respect to the ABL Facility (the "ABL Collateral
    Agent") and the ABL Secured Parties. The Shared Receivables
    Intercreditor Agreement provides for first-priority Liens in the
    Shared Receivables Collateral in favor of the ABL Secured
    Parties, second-priority Liens in the Shared Receivables
    Collateral in favor of the First Lien Secured Parties and
    third-priority security interests in the Shared Receivables
    Collateral in favor of the Junior Lien Secured Parties, in each
    case, subject to Permitted Liens. The relative rights,
    privileges and obligations with respect to the Shared
    Receivables Collateral of the ABL Secured Parties, on the one
    hand, and the Junior Lien Collateral Agent, the other Junior
    Lien Secured Parties, the First Lien Collateral Agent and the
    First Lien Secured Parties, on the other, are substantially
    identical to the relative rights, privileges and obligations
    with respect to the Non-
127
Table of Contents
Receivables Collateral of the First Lien Secured Parties, on the
    one hand, and the Junior Lien Secured Parties, on the other,
    respectively, except that the Liens of the Junior Lien Secured
    Parties in the Shared Receivables Collateral are third-priority
    Liens and except to the extent customary or necessary with
    respect to collateral of the type that constitutes Shared
    Receivables Collateral.
Certain
    Limitations on the Collateral
The Collateral securing the Notes does not include any of the
    following assets:
(1) the property or assets owned by any Subsidiary of the
    Issuer that is not a Guarantor, including each ABL Financing
    Entity;
(2) any rights or interests of the Issuer or any Guarantor
    in, to or under any agreement, contract, license, instrument,
    document or other general intangible (referred to solely for
    purposes of this clause (2) as a
"Contract"
), any intellectual property or any
    security or other investment property (i) to the extent the
    security interest in such Collateral is prohibited by any
    applicable contract, agreement or other instrument without the
    consent of any other party thereto (other than a party to the
    General Credit Facility or the Indenture or, in the case of
    investment property, a Wholly-Owned Subsidiary), (ii) to
    the extent the security interest in such Contract would give any
    other party (other than a party to the General Credit Facility
    or the Indenture or, in the case of investment property, a
    Wholly-Owned Subsidiary) to such Collateral the right to
    terminate its obligations thereunder or (iii) to the extent
    all necessary consents to such grant of a security interest have
    not been obtained from the other parties thereto (other than to
    the extent that any such prohibition referred to in clauses (i),
    (ii) and (iii) would be rendered ineffective pursuant
    to
Sections 9-406,
9-407, 9-408 or 9-409 of the Uniform Commercial Code (or any
    successor provision or provisions) of any relevant jurisdiction
    or any other applicable law);
provided
that this
    limitation shall not affect, limit, restrict or impair the grant
    by the Issuer or such Guarantor of a security interest in any
    account receivable or any money or other amounts due or to
    become due under any Contract;
(3) any equipment of the Issuer or any Guarantor that is
    subject to, or secured by, a Capitalized Lease Obligation or
    Purchase Money Obligations and any equipment that constitutes an
    asset of an entity acquired in a transaction permitted by the
    Indenture to the extent that such equipment subject to a Lien
    permitted by the Indenture and the terms of the Indebtedness
    secured by such Lien prohibit assignment of, or granting of a
    security interest in, the Issuer's or such Guarantor's
    rights and interests therein (other than to the extent that any
    such prohibition would be rendered ineffective pursuant to
Sections 9-406,
9-407, 9-408 or 9-409 of the Uniform Commercial Code (or any
    successor provision or provisions) of any relevant jurisdiction
    or any other applicable law);
provided
that immediately
    upon the repayment of all Indebtedness secured by such Lien, the
    Issuer or the Guarantor, as the case may be, shall be deemed to
    have granted a security interest in all the rights and interests
    with respect to such equipment;
(4) any Voting Stock that is issued by any Foreign
    Subsidiary, if and to the extent that the inclusion of such
    Voting Stock in the Collateral would cause the Collateral
    pledged by the Issuer or the applicable Guarantor, as the case
    may be, to include in the aggregate more than 65% of the total
    combined voting power of all classes of Voting Stock of such
    Foreign Subsidiary;
(5) any Capital Stock that is issued by a Subsidiary that
    is not owned directly by the Issuer or a Guarantor;
(6) prior to the Discharge of First Lien Obligations and so
    long as any First Lien Obligations are outstanding, any
    Principal Properties;
(7) any Capital Stock and other securities of a Subsidiary
    (excluding Healthtrust, Inc. — The Hospital Company, a
    Delaware corporation and its successors and assigns) to the
    extent that the pledge of such Capital Stock and other
    securities results in the Company's being required to file
    separate financial statements of such Subsidiary with the SEC,
    but only to the extent necessary to not be subject to such
    requirement and only for so long as such requirement is in
    existence and only with respect to the relevant Notes affected;
provided
that neither the Issuer nor any Subsidiary shall
    take any action in the form of a
128
Table of Contents
reorganization, merger or other restructuring a principal
    purpose of which is to provide for the release of the Lien on
    any Capital Stock pursuant to this clause (7). In addition, in
    the event that
Rule 3-16
of
Regulation S-X
under the Securities Act is amended, modified or interpreted by
    the SEC to require (or is replaced with another rule or
    regulation, or any other law, rule or regulation is adopted,
    which would require) the filing with the SEC (or any other
    governmental agency) of separate financial statements of any
    Subsidiary of the Company (excluding Healthtrust,
    Inc. — The Hospital Company, a Delaware corporation
    and its successors and assigns) due to the fact that such
    Subsidiary's Capital Stock secures the Notes affected
    thereby, then the Capital Stock of such Subsidiary will
    automatically be deemed not to be part of the Collateral
    securing the relevant Notes affected thereby but only to the
    extent necessary to not be subject to such requirement and only
    for so long as required to not be subject to such requirement.
    In such event, the Security Documents may be amended or
    modified, without the consent of any holder of such Notes, to
    the extent necessary to release the security interests in favor
    of the applicable collateral agents on the shares of Capital
    Stock that are so deemed to no longer constitute part of the
    Collateral for the relevant Notes. In the event that
Rule 3-16
of
Regulation S-X
under the Securities Act is amended, modified or interpreted by
    the SEC to permit (or is replaced with another rule or
    regulation, or any other law, rule or regulation is adopted,
    which would permit) such Subsidiary's Capital Stock to
    secure the Notes in excess of the amount then pledged without
    the filing with the SEC (or any other governmental agency) of
    separate financial statements of such Subsidiary, then the
    Capital Stock of such Subsidiary will automatically be deemed to
    be a part of the Collateral for the relevant Notes but only to
    the extent necessary to not be subject to any such financial
    statement requirement;
(8) certain non-Principal Properties that do not constitute
    Non-Receivables Collateral;
(9) any deposit accounts, other bank or securities accounts
    or cash of the Issuer or any Guarantor;
(10) any leaseholds and motor vehicles of the Issuer or any
    Guarantor;
(11) any Capital Stock or securities convertible into or
    exchangeable for Capital Stock (i) if, in the reasonable
    judgment of the Issuer, the cost or other consequences of
    pledging such Collateral shall be excessive in view of the
    benefits to be obtained by the Junior Lien Secured Parties
    therefrom or (ii) the pledge of such Collateral would
    result in adverse tax consequences to the Issuer or any of its
    Subsidiaries as reasonably determined by the Issuer and
    identified in writing to the Junior Lien Collateral Agent;
(12) any collateral to the extent the grant of the security
    interest therein would violate any requirement of law; and
(13) proceeds and products from any and all of the
    foregoing excluded collateral described in clauses (1)
    through (12), unless such proceeds or products would otherwise
    constitute Collateral securing the Notes.
Sufficiency
    of Collateral
The fair market value of the Collateral is subject to
    fluctuations based on factors that include, among others, the
    condition of the healthcare industry, the ability to sell the
    Collateral in an orderly sale, general economic conditions, the
    availability of buyers and similar factors. The amount to be
    received upon a sale of the Collateral would also be dependent
    on numerous factors, including, but not limited to, the actual
    fair market value of the Collateral at such time and the timing
    and the manner of the sale. By their nature, portions of the
    Collateral may be illiquid and may have no readily ascertainable
    market value. Accordingly, there can be no assurance that the
    Collateral can be sold in a short period of time or in an
    orderly manner. In addition, in the event of a bankruptcy, the
    ability of the holders to realize upon any of the Collateral may
    be subject to certain bankruptcy law limitations as described
    below.
Certain
    Bankruptcy Limitations
The right of the Trustee to repossess and dispose of the
    Collateral upon the occurrence of an Event of Default would be
    significantly impaired by any Bankruptcy Law in the event that a
    bankruptcy case were to be commenced by or against the Company
    or any Guarantor prior to the Trustee's having repossessed
    and
129
Table of Contents
disposed of the Collateral. Upon the commencement of a case for
    relief under the Bankruptcy Code, a secured creditor such as the
    Trustee is prohibited from repossessing its security from a
    debtor in a bankruptcy case, or from disposing of security
    without bankruptcy court approval.
In view of the broad equitable powers of a U.S. bankruptcy
    court, it is impossible to predict how long payments under the
    Notes could be delayed following commencement of a bankruptcy
    case, whether or when the Trustee could repossess or dispose of
    the Collateral, the value of the Collateral at any time during a
    bankruptcy case or whether or to what extent holders of the
    Notes would be compensated for any delay in payment or loss of
    value of the Collateral. The Bankruptcy Code permits only the
    payment
and/or
accrual of post-petition interest, costs and attorneys'
    fees to a secured creditor during a debtor's bankruptcy
    case to the extent the value of such creditor's interest in
    the Collateral is determined by the bankruptcy court to exceed
    the aggregate outstanding principal amount of the obligations
    secured by the Collateral.
Furthermore, in the event a domestic or foreign bankruptcy court
    determines that the value of the Collateral is not sufficient to
    repay all amounts due on the Notes, the holders of the Notes
    would hold secured claims only to the extent of the value of the
    Collateral to which the holders of the Notes are entitled, and
    unsecured claims with respect to such shortfall.
Paying
    Agent and Registrar for the Notes
The Issuer must maintain one or more paying agents for the Notes
    in the Borough of Manhattan, City of New York or Atlanta,
    Georgia. The initial paying agent for the Notes is the Trustee.
The Issuer must also maintain a registrar with offices in the
    Borough of Manhattan, City of New York or Atlanta, Georgia. The
    initial registrar is the Trustee. The registrar maintains a
    register reflecting ownership of the Notes outstanding from time
    to time and makes payments on and facilitates transfer of Notes
    on behalf of the Issuer.
The Issuer may change the paying agents or the registrars
    without prior notice to the Holders. The Issuer or any of its
    Subsidiaries may act as a paying agent or registrar.
Transfer
    and Exchange
A Holder may transfer or exchange Notes in accordance with the
    Indenture. The registrar and the Trustee may require a Holder to
    furnish appropriate endorsements and transfer documents in
    connection with a transfer of Notes. Holders will be required to
    pay all taxes due on transfer. The Issuer will not be required
    to transfer or exchange any Note selected for redemption. Also,
    the Issuer will not be required to transfer or exchange any Note
    for a period of 15 days before a selection of Notes to be
    redeemed.
Principal,
    Maturity and Interest
The Issuer issued $310.0 million in aggregate principal
    amount of Notes in this offering. The Notes will mature on
    February 15, 2017. Subject to compliance with the covenant
    described below under the caption "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock,"
    the Issuer may issue additional Notes, from time to time after
    this offering under the Indenture (any such Notes,
"Additional Notes"
). Except as described under
    "Amendment, Supplement and Waiver," the Notes offered
    by the Issuer and any Additional Notes subsequently issued under
    the Indenture will be treated as a single class for all purposes
    under the Indenture, including waivers, amendments, redemptions
    and offers to purchase. Unless the context requires otherwise,
    references to "Notes" for all purposes of the
    Indenture and this "Description of Notes" include any
    Additional Notes that are actually issued.
Interest on the Notes will accrue at the rate of
    9
7
/
8
%
    per annum and is payable semi-annually in arrears on February 15
    and August 15 commencing August 15, 2009, to the Holders of
    record on the immediately preceding February 1 and
    August 1. Interest on the Notes will accrue from the most
    recent date to which interest has been paid or, if no interest
    has been paid, from and including the Issue Date. Interest on
    the Notes will be computed on the basis of a
360-day
year
    comprised of twelve
30-day
months.
130
Table of Contents
Additional
    Interest
Additional Interest may accrue on the Notes in certain
    circumstances pursuant to the Registration Rights Agreement. All
    references in the Indenture, in any context, to any interest or
    other amount payable on or with respect to the Notes shall be
    deemed to include any Additional Interest pursuant to the
    Registration Rights Agreement. Principal of, premium, if any,
    and interest on the Notes will be payable at the office or
    agency of the Issuer maintained for such purpose within the City
    and State of New York or, at the option of the Issuer, payment
    of interest may be made by check mailed to the Holders of the
    Notes at their respective addresses set forth in the register of
    Holders;
provided
that all payments of principal,
    premium, if any, and interest with respect to the Notes
    represented by one or more global notes registered in the name
    of or held by DTC or its nominee will be made by wire transfer
    of immediately available funds to the accounts specified by the
    Holder or Holders thereof. Until otherwise designated by the
    Issuer, the Issuer's office or agency in New York will be
    the office of the Trustee maintained for such purpose.
Mandatory
    Redemption; Offers to Purchase; Open Market Purchases
The Issuer will not be required to make any mandatory redemption
    or sinking fund payments with respect to the Notes. However,
    under certain circumstances, the Issuer may be required to offer
    to purchase Notes as described under the caption
    "Repurchase at the Option of Holders." The Issuer may
    at any time and from time to time purchase Notes in the open
    market or otherwise.
Optional
    Redemption
Except as set forth below, the Issuer is not entitled to redeem
    Notes at its option prior to February 15, 2013.
At any time prior to February 15, 2013, the Issuer may
    redeem all or a part of the Notes, upon not less than 30 nor
    more than 60 days' prior notice mailed by first-class
    mail to the registered address of each Holder or otherwise in
    accordance with the procedures of DTC, at a redemption price
    equal to 100% of the principal amount of the Notes redeemed plus
    the Applicable Premium as of, and accrued and unpaid interest
    and Additional Interest, if any, to the date of redemption (the
"Redemption Date"
), subject to the rights
    of Holders of Notes on the relevant record date to receive
    interest due on the relevant interest payment date.
On and after February 15, 2013, the Issuer may redeem the
    Notes, in whole or in part, upon not less than 30 nor more than
    60 days' prior notice mailed by first-class mail to
    the registered address of each Holder or otherwise in accordance
    with the procedures of DTC, at the redemption prices (expressed
    as percentages of principal amount of the Notes to be redeemed)
    set forth below, plus accrued and unpaid interest thereon and
    Additional Interest, if any, to the applicable
    Redemption Date, subject to the right of Holders of record
    on the relevant record date to receive interest due on the
    relevant interest payment date, if redeemed during the
    twelve-month period beginning on February 15 of each of the
    years indicated below:
Year
Percentage
2013
104.938
%
2014
102.469
%
2015 and thereafter
100.000
%
In addition, until February 15, 2012, the Issuer may, at
    its option, on one or more occasions redeem up to 35% of the
    aggregate principal amount of Notes at a redemption price equal
    to 109.875% of the aggregate principal amount thereof, plus
    accrued and unpaid interest thereon and Additional Interest, if
    any, to the applicable Redemption Date, subject to the
    right of Holders of record on the relevant record date to
    receive interest due on the relevant interest payment date, with
    the net cash proceeds of one or more Equity Offerings;
provided
that at least 50% of the sum of the original
    aggregate principal amount of Notes issued under the Indenture
    and the original principal amount of any Additional Notes that
    are Notes issued under the Indenture after the Issue Date
    remains outstanding immediately after the occurrence of each
    such redemption;
provided further
that each such
    redemption occurs within 90 days of the date of closing of
    each such Equity Offering.
131
Table of Contents
Any notice of any redemption may be given prior to the
    redemption thereof, and any such redemption or notice may, at
    the Issuer's discretion, be subject to one or more
    conditions precedent, including, but not limited to, completion
    of an Equity Offering or other corporate transaction.
If the Issuer redeems less than all of the outstanding Notes,
    the Trustee shall select the Notes to be redeemed in the manner
    described under "Repurchase at the Option of
    Holders — Selection and Notice."
Repurchase
    at the Option of Holders
Change
    of Control
The Notes provide that if a Change of Control occurs, unless the
    Issuer has previously or concurrently mailed a redemption notice
    with respect to all the outstanding Notes as described under
    "Optional Redemption," the Issuer will make an offer
    to purchase all of the Notes pursuant to the offer described
    below (the
"Change of Control Offer"
) at a
    price in cash (the
"Change of Control Payment"
)
    equal to 101% of the aggregate principal amount thereof plus
    accrued and unpaid interest and Additional Interest, if any, to
    the date of purchase, subject to the right of Holders of the
    Notes of record on the relevant record date to receive interest
    due on the relevant interest payment date. Within 30 days
    following any Change of Control, the Issuer will send notice of
    such Change of Control Offer by first-class mail, with a copy to
    the Trustee, to each Holder of Notes to the address of such
    Holder appearing in the security register with a copy to the
    Trustee or otherwise in accordance with the procedures of DTC,
    with the following information:
(1) that a Change of Control Offer is being made pursuant
    to the covenant entitled "Change of Control" and that
    all Notes properly tendered pursuant to such Change of Control
    Offer will be accepted for payment by the Issuer;
(2) the purchase price and the purchase date, which will be
    no earlier than 30 days nor later than 60 days from
    the date such notice is mailed (the
"Change of Control
    Payment Date"
);
(3) that any Note not properly tendered will remain
    outstanding and continue to accrue interest;
(4) that unless the Issuer defaults in the payment of the
    Change of Control Payment, all Notes accepted for payment
    pursuant to the Change of Control Offer will cease to accrue
    interest on the Change of Control Payment Date;
(5) that Holders electing to have any Notes purchased
    pursuant to a Change of Control Offer will be required to
    surrender such Notes, with the form entitled "Option of
    Holder to Elect Purchase" on the reverse of such Notes
    completed, to the paying agent specified in the notice at the
    address specified in the notice prior to the close of business
    on the third Business Day preceding the Change of Control
    Payment Date;
(6) that Holders will be entitled to withdraw their
    tendered Notes and their election to require the Issuer to
    purchase such Notes; provided that the paying agent receives,
    not later than the close of business on the 30th day
    following the date of the Change of Control notice, a telegram,
    facsimile transmission or letter setting forth the name of the
    Holder of the Notes, the principal amount of Notes tendered for
    purchase, and a statement that such Holder is withdrawing its
    tendered Notes and its election to have such Notes purchased;
(7) that if the Issuer is redeeming less than all of the
    Notes, the Holders of the remaining Notes will be issued new
    Notes and such new Notes will be equal in principal amount to
    the unpurchased portion of the Notes surrendered. The
    unpurchased portion of the Notes must be equal to $2,000 or an
    integral multiple of $1,000 in excess thereof; and
(8) the other instructions, as determined by us, consistent
    with the covenant described hereunder, that a Holder must follow.
The Issuer will comply with the requirements of
Rule 14e-1
under the Exchange Act and any other securities laws and
    regulations thereunder to the extent such laws or regulations
    are applicable in connection with the repurchase of Notes
    pursuant to a Change of Control Offer. To the extent that the
    provisions of any
132
Table of Contents
securities laws or regulations conflict with the provisions of
    the Indenture, the Issuer will comply with the applicable
    securities laws and regulations and shall not be deemed to have
    breached its obligations described in the Indenture by virtue
    thereof.
On the Change of Control Payment Date, the Issuer will, to the
    extent permitted by law,
(1) accept for payment all Notes issued by it or portions
    thereof properly tendered pursuant to the Change of Control
    Offer;
(2) deposit with the paying agent an amount equal to the
    aggregate Change of Control Payment in respect of all Notes or
    portions thereof so tendered; and
(3) deliver, or cause to be delivered, to the Trustee for
    cancellation the Notes so accepted together with an
    Officer's Certificate to the Trustee stating that such
    Notes or portions thereof have been tendered to and purchased by
    the Issuer.
The Senior Credit Facilities provide, and future credit
    agreements or other agreements relating to Senior Indebtedness
    to which the Issuer becomes a party may, provide that certain
    change of control events with respect to the Issuer would
    constitute a default thereunder (including a Change of Control
    under the Indenture). If we experience a change of control that
    triggers a default under our Senior Credit Facilities, we could
    seek a waiver of such default or seek to refinance our Senior
    Credit Facilities. In the event we do not obtain such a waiver
    or refinance the Senior Credit Facilities, such default could
    result in amounts outstanding under our Senior Credit Facilities
    being declared due and payable and could cause a Receivables
    Facility to be wound down.
Our ability to pay cash to the Holders of Notes following the
    occurrence of a Change of Control may be limited by our
    then-existing financial resources. Therefore, sufficient funds
    may not be available when necessary to make any required
    repurchases.
The Change of Control purchase feature of the Notes may in
    certain circumstances make more difficult or discourage a sale
    or takeover of us and, thus, the removal of incumbent
    management. The Change of Control purchase feature is a result
    of negotiations between the Initial Purchasers and us. We have
    no present intention to engage in a transaction involving a
    Change of Control, although it is possible that we could decide
    to do so in the future. Subject to the limitations discussed
    below, we could, in the future, enter into certain transactions,
    including acquisitions, refinancings or other recapitalizations,
    that would not constitute a Change of Control under the
    Indenture, but that could increase the amount of indebtedness
    outstanding at such time or otherwise affect our capital
    structure or credit ratings. Restrictions on our ability to
    incur additional Indebtedness are contained in the covenants
    described under "Certain Covenants — Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock" and "Certain
    Covenants — Liens." Such restrictions in the
    Indenture can be waived only with the consent of the Holders of
    a majority in principal amount of the Notes then outstanding.
    Except for the limitations contained in such covenants, however,
    the Indenture does not contain any covenants or provisions that
    may afford Holders of the Notes protection in the event of a
    highly leveraged transaction.
The Issuer is not required to make a Change of Control Offer
    following a Change of Control if a third party makes the Change
    of Control Offer in the manner, at the times and otherwise in
    compliance with the requirements set forth in the Indenture
    applicable to a Change of Control Offer made by us and purchases
    all Notes validly tendered and not withdrawn under such Change
    of Control Offer. Notwithstanding anything to the contrary
    herein, a Change of Control Offer may be made in advance of a
    Change of Control, conditional upon such Change of Control, if a
    definitive agreement is in place for the Change of Control at
    the time of making of the Change of Control Offer.
The definition of "Change of Control" includes a
    disposition of all or substantially all of the assets of the
    Issuer to any Person. Although there is a limited body of case
    law interpreting the phrase "substantially all," there
    is no precise established definition of the phrase under
    applicable law. Accordingly, in certain circumstances there may
    be a degree of uncertainty as to whether a particular
    transaction would involve a disposition of "all or
    substantially all" of the assets of the Issuer. As a
    result, it may be unclear as to whether
133
Table of Contents
a Change of Control has occurred and whether a Holder of Notes
    may require the Issuer to make an offer to repurchase the Notes
    as described above.
The provisions under the Indenture relating to the Issuer's
    obligation to make an offer to repurchase the Notes as a result
    of a Change of Control may be waived or modified with the
    written consent of the Holders of a majority in principal amount
    of the Notes.
Asset
    Sales
The Indenture provides that the Issuer will not, and will not
    permit any of its Restricted Subsidiaries to consummate,
    directly or indirectly, an Asset Sale, unless:
(1) the Issuer or such Restricted Subsidiary, as the case
    may be, receives consideration at the time of such Asset Sale at
    least equal to the fair market value (as determined in good
    faith by the Issuer) of the assets sold or otherwise disposed
    of; and
(2) except in the case of a Permitted Asset Swap, at least
    75% of the consideration therefor received by the Issuer or such
    Restricted Subsidiary, as the case may be, is in the form of
    cash or Cash Equivalents;
provided
that the amount of:
(a) any liabilities (as shown on the Issuer's or such
    Restricted Subsidiary's most recent balance sheet or in the
    footnotes thereto) of the Issuer or such Restricted Subsidiary,
    other than liabilities that are by their terms subordinated to
    the Notes, that are assumed by the transferee of any such assets
    and for which the Issuer and all of its Restricted Subsidiaries
    have been validly released by all creditors in writing,
(b) any securities received by the Issuer or such
    Restricted Subsidiary from such transferee that are converted by
    the Issuer or such Restricted Subsidiary into cash (to the
    extent of the cash received) within 180 days following the
    closing of such Asset Sale, and
(c) any Designated Non-cash Consideration received by the
    Issuer or such Restricted Subsidiary in such Asset Sale having
    an aggregate fair market value, taken together with all other
    Designated Non-cash Consideration received pursuant to this
    clause (c) that is at that time outstanding, not to exceed
    5% of Total Assets at the time of the receipt of such Designated
    Non-cash Consideration, with the fair market value of each item
    of Designated Non-cash Consideration being measured at the time
    received and without giving effect to subsequent changes in
    value, shall be deemed to be cash for purposes of this provision
    and for no other purpose.
Within 450 days after the receipt of any Net Proceeds of
    any Asset Sale, the Issuer or such Restricted Subsidiary, at its
    option, may apply the Net Proceeds from such Asset Sale,
(1) to permanently reduce:
(a) Obligations under Priority Lien Obligations and to
    correspondingly reduce commitments with respect thereto;
(b) Obligations under Senior Indebtedness (other than any
    Junior Lien Obligation) that is secured by a Lien permitted
    under the Indenture (which Lien is senior to the Lien of the
    Notes with respect to the Collateral), and to correspondingly
    reduce commitments with respect thereto;
(c) Obligations under Junior Lien Obligations (and to
    correspondingly reduce commitments with respect thereto) through
    open-market purchases (to the extent such purchases are at or
    above 100% of the principal amount thereof) or by making an
    Asset Sale Offer or a Collateral Asset Sale Offer in accordance
    with the procedures set forth below;
provided
that the
    Issuer shall equally and ratably reduce Obligations under the
    Notes as provided under "Optional Redemption", through
    open-market purchases or otherwise by making an offer (in
    accordance with the procedures set forth below for an Asset Sale
    Offer or a Collateral Asset Sale Offer) to all Holders to
    purchase their Notes at 100% of the principal amount thereof,
    plus the amount of accrued but unpaid interest, if any, on the
    amount of the Notes that would otherwise be prepaid;
134
Table of Contents
(d) Obligations under the Existing Notes which have a final
    maturity date (as in effect on the Issue Date) on or prior to
    November 15, 2016;
provided
that, at the time of,
    and after giving effect to, such repurchase, redemption or
    defeasance, the aggregate amount of Net Proceeds used to
    repurchase, redeem or defease Existing Notes pursuant to this
    subclause (d) following the Issue Date shall not exceed 5%
    of the consolidated total assets of the Issuer and its
    subsidiaries at such time; or
(e) Indebtedness of a Restricted Subsidiary that is not a
    Guarantor, other than Indebtedness owed to the Issuer or another
    Restricted Subsidiary (or any affiliate thereof);
(2) to make (a) an Investment in any one or more
    businesses,
provided
that such Investment in any business
    is in the form of the acquisition of Capital Stock and results
    in the Issuer or another of its Restricted Subsidiaries, as the
    case may be, owning an amount of the Capital Stock of such
    business such that it constitutes a Restricted Subsidiary,
    (b) capital expenditures or (c) acquisitions of other
    assets, in each of (a), (b) and (c), used or useful in a
    Similar Business; or
(3) to make an investment in (a) any one or more
    businesses,
provided
that such Investment in any business
    is in the form of the acquisition of Capital Stock and results
    in the Issuer or another of its Restricted Subsidiaries, as the
    case may be, owning an amount of the Capital Stock of such
    business such that it constitutes a Restricted Subsidiary,
    (b) properties or (c) acquisitions of other assets
    that, in each of (a), (b) and (c), replace the businesses,
    properties
and/or
assets that are the subject of such Asset Sale;
provided
that, in the case of clauses (2) and
    (3) above, a binding commitment shall be treated as a
    permitted application of the Net Proceeds from the date of such
    commitment so long as the Issuer, or such other Restricted
    Subsidiary enters into such commitment with the good faith
    expectation that such Net Proceeds will be applied to satisfy
    such commitment within 180 days of such commitment (an
"Acceptable Commitment"
) and, in the event any
    Acceptable Commitment is later cancelled or terminated for any
    reason before the Net Proceeds are applied in connection
    therewith, the Issuer or such Restricted Subsidiary enters into
    another Acceptable Commitment (a
"Second
    Commitment"
) within 180 days of such cancellation
    or termination;
provided
,
further
, that if any
    Second Commitment is later cancelled or terminated for any
    reason before such Net Proceeds are applied, then such Net
    Proceeds shall constitute Excess Proceeds.
Any Net Proceeds from Asset Sales of Collateral that are not
    invested or applied as set forth in the first sentence of the
    preceding paragraph will be deemed to constitute
"Collateral Excess Proceeds
." When the
    aggregate amount of Collateral Excess Proceeds exceeds
    $200.0 million, the Issuer shall make an offer to all
    Holders of the Notes and, if required by the terms of any Junior
    Lien Obligations, including the 2006 Notes, which are not
    subordinated to the Notes or Obligations secured by a Lien
    permitted under the Indenture (which Lien is not subordinate to
    the Lien of the Notes with respect to the Collateral), to the
    holders of such Junior Lien Obligations or such other
    Obligations (a
"Collateral Asset Sale Offer"
),
    to purchase the maximum aggregate principal amount of the Notes
    and such Junior Lien Obligations or such other Obligations that
    is a minimum of $2,000 or an integral multiple of $1,000 in
    excess thereof that may be purchased out of the Collateral
    Excess Proceeds at an offer price in cash in an amount equal to
    100% of the principal amount thereof, plus accrued and unpaid
    interest and Additional Interest, if any, to the date fixed for
    the closing of such offer, in accordance with the procedures set
    forth in the Indenture. The Issuer will commence a Collateral
    Asset Sale Offer with respect to Collateral Excess Proceeds
    within ten Business Days after the date that Collateral Excess
    Proceeds exceed $200.0 million by mailing the notice
    required pursuant to the terms of the Indenture, with a copy to
    the Trustee.
Any Net Proceeds from Asset Sales of non-Collateral that are not
    invested or applied as provided and within the time period set
    forth in the first sentence of the second preceding paragraph
    will be deemed to constitute
"Excess Proceeds
."
    When the aggregate amount of Excess Proceeds exceeds
    $200.0 million, the Issuer shall make an offer to all
    Holders of the Notes and, if required or permitted by the terms
    of any Senior Indebtedness, to the holders of such Senior
    Indebtedness (an
"Asset Sale Offer"
), to
    purchase the maximum aggregate principal amount of the Notes and
    such Senior Indebtedness that is a minimum of $2,000 or an
    integral multiple of $1,000 in excess thereof that may be
    purchased out of the Excess Proceeds at an offer price in cash
    in an amount equal to 100% of the principal amount thereof, plus
    accrued and unpaid interest and Additional Interest, if any, to
    the date fixed for the closing of such offer, in accordance with
    the
135
Table of Contents
procedures set forth in the Indenture. The Issuer will commence
    an Asset Sale Offer with respect to Excess Proceeds within ten
    Business Days after the date that Excess Proceeds exceed
    $200.0 million by mailing the notice required pursuant to
    the terms of the Indenture, with a copy to the Trustee.
To the extent that the aggregate amount of Notes and such Junior
    Lien Obligations or Obligations secured by a Lien permitted by
    the Indenture (which Lien is not subordinate to the Lien of the
    Notes with respect to the Collateral) tendered pursuant to a
    Collateral Asset Sale Offer is less than the Collateral Excess
    Proceeds, the Issuer may use any remaining Collateral Excess
    Proceeds for general corporate purposes, subject to other
    covenants contained in the Indenture. To the extent that the
    aggregate amount of Notes and such Senior Indebtedness tendered
    pursuant to an Asset Sale Offer is less than the Excess
    Proceeds, the Issuer may use any remaining Excess Proceeds for
    general corporate purposes, subject to other covenants contained
    in the Indenture. If the aggregate principal amount of Notes or
    Junior Lien Obligations or such other Obligations surrendered by
    such holders thereof exceeds the amount of Collateral Excess
    Proceeds, the Trustee shall select the Notes and such Junior
    Lien Obligations or such other Obligations to be purchased on a
    pro rata basis based on the accreted value or principal amount
    of the Notes or such Junior Lien Obligations or such other
    Obligations tendered. If the aggregate principal amount of Notes
    or the Senior Indebtedness surrendered by such holders thereof
    exceeds the amount of Excess Proceeds, the Trustee shall select
    the Notes and such Senior Indebtedness to be purchased on a pro
    rata basis based on the accreted value or principal amount of
    the Notes or such Senior Indebtedness tendered. Upon completion
    of any such Collateral Asset Sale Offer or Asset Sale Offer, the
    amount of Collateral Excess Proceeds or Excess Proceeds, as the
    case may be, shall be reset at zero. Additionally, the Issuer
    may, at its option, make a Collateral Asset Sale Offer or an
    Asset Sale Offer using proceeds from any Asset Sale at any time
    after consummation of such Asset Sale;
provided
that such
    Collateral Asset Sale Offer or Asset Sale Offer shall be in an
    aggregate amount of not less than $50.0 million. Upon
    consummation of such Collateral Asset Sale Offer or Asset Sale
    Offer, any Net Proceeds not required to be used to purchase
    Notes shall not be deemed Excess Proceeds.
Pending the final application of any Net Proceeds pursuant to
    this covenant, the holder of such Net Proceeds may apply such
    Net Proceeds temporarily to reduce Indebtedness outstanding
    under a revolving credit facility or otherwise invest such Net
    Proceeds in any manner not prohibited by the Indenture.
The Issuer will comply with the requirements of
Rule 14e-1
under the Exchange Act and any other securities laws and
    regulations thereunder to the extent such laws or regulations
    are applicable in connection with the repurchase of the Notes
    pursuant to a Collateral Asset Sale Offer or an Asset Sale
    Offer. To the extent that the provisions of any securities laws
    or regulations conflict with the provisions of the Indenture,
    the Issuer will comply with the applicable securities laws and
    regulations and shall not be deemed to have breached its
    obligations described in the Indenture by virtue thereof.
Selection
    and Notice
If the Issuer is redeeming less than all of the Notes issued by
    it at any time, the Trustee will select the Notes to be redeemed
    (a) if the Notes are listed on any national securities
    exchange, in compliance with the requirements of the principal
    national securities exchange on which the Notes are listed,
    (b) on a pro rata basis to the extent practicable or
    (c) by lot or such other similar method in accordance with
    the procedures of DTC.
Notices of purchase or redemption shall be mailed by first-class
    mail, postage prepaid, at least 30 but not more than
    60 days before the purchase or Redemption Date to each
    Holder of Notes at such Holder's registered address or
    otherwise in accordance with the procedures of DTC, except that
    redemption notices may be mailed more than 60 days prior to
    a Redemption Date if the notice is issued in connection
    with a defeasance of the Notes or a satisfaction and discharge
    of the Indenture. If any Note is to be purchased or redeemed in
    part only, any notice of purchase or redemption that relates to
    such Note shall state the portion of the principal amount
    thereof that has been or is to be purchased or redeemed.
The Issuer will issue a new Note in a principal amount equal to
    the unredeemed portion of the original Note in the name of the
    Holder upon cancellation of the original Note. Notes called for
    redemption become due on the date fixed for redemption. On and
    after the Redemption Date, interest ceases to accrue on
    Notes or portions thereof called for redemption.
136
Table of Contents
Certain
    Covenants
Set forth below are summaries of certain covenants contained in
    the Indenture. If on any date following the Issue Date
    (i) the Notes have Investment Grade Ratings from both
    Rating Agencies, and (ii) no Default has occurred and is
    continuing under the Indenture (the occurrence of the events
    described in the foregoing clauses (i) and (ii) being
    collectively referred to as a
"Covenant Suspension
    Event"
), the Issuer and the Restricted Subsidiaries
    will not be subject to the following covenants (collectively,
    the
"Suspended Covenants"
):
(1) "Repurchase at the Option of Holders";
(2) "— Limitation on Restricted Payments";
(3) "— Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock";
(4) clause (4) of the first paragraph of
    "— Merger, Consolidation or Sale of All or
    Substantially All Assets";
(5) "— Transactions with
    Affiliates"; and
(6) "— Dividend and Other Payment Restrictions
    Affecting Restricted Subsidiaries."
In the event that the Issuer and the Restricted Subsidiaries are
    not subject to the Suspended Covenants under the Indenture for
    any period of time as a result of the foregoing, and on any
    subsequent date (the
"Reversion Date"
) one or
    both of the Rating Agencies (a) withdraw their Investment
    Grade Rating or downgrade the rating assigned to the Notes below
    an Investment Grade Rating
and/or
(b) the Issuer or any of its Affiliates enters into an
    agreement to effect a transaction that would result in a Change
    of Control and one or more of the Rating Agencies indicate that
    if consummated, such transaction (alone or together with any
    related recapitalization or refinancing transactions) would
    cause such Rating Agency to withdraw its Investment Grade Rating
    or downgrade the ratings assigned to the Notes below an
    Investment Grade Rating, then the Issuer and the Restricted
    Subsidiaries will thereafter again be subject to the Suspended
    Covenants under the Indenture with respect to future events,
    including, without limitation, a proposed transaction described
    in clause (b) above.
The period of time between the Suspension Date and the Reversion
    Date is referred to in this description as the
"Suspension Period
." Additionally, upon the
    occurrence of a Covenant Suspension Event, the amount of Excess
    Proceeds from Net Proceeds shall be reset at zero. In the event
    of any such reinstatement, no action taken or omitted to be
    taken by the Issuer or any of its Restricted Subsidiaries prior
    to such reinstatement will give rise to a Default or Event of
    Default under the Indentures with respect to Notes;
provided
that (1) with respect to Restricted Payments made after
    any such reinstatement, the amount of Restricted Payments made
    will be calculated as though the covenant described under the
    caption "— Limitation on Restricted
    Payments" had been in effect prior to, but not during the
    Suspension Period,
provided
that any Subsidiaries
    designated as Unrestricted Subsidiaries during the Suspension
    Period shall automatically become Restricted Subsidiaries on the
    Reversion Date (subject to the Issuer's right to
    subsequently designate them as Unrestricted Subsidiaries in
    compliance with the covenants set out below), and (2) all
    Indebtedness incurred, or Disqualified Stock or Preferred Stock
    issued, during the Suspension Period will be classified to have
    been incurred or issued pursuant to clause (3) of the
    second paragraph of "— Limitation on Incurrence
    of Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock."
There can be no assurance that the Notes will ever achieve or
    maintain Investment Grade Ratings.
137
Table of Contents
Limitation
    on Restricted Payments
The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, directly or indirectly:
(I) declare or pay any dividend or make any payment or
    distribution on account of the Issuer's, or any of its
    Restricted Subsidiaries' Equity Interests, including any
    dividend or distribution payable in connection with any merger
    or consolidation other than:
(a) dividends or distributions by the Issuer payable solely
    in Equity Interests (other than Disqualified Stock) of the
    Issuer; or
(b) dividends or distributions by a Restricted Subsidiary
    so long as, in the case of any dividend or distribution payable
    on or in respect of any class or series of securities issued by
    a Restricted Subsidiary other than a Wholly-Owned Subsidiary,
    the Issuer or a Restricted Subsidiary receives at least its pro
    rata share of such dividend or distribution in accordance with
    its Equity Interests in such class or series of securities;
(II) purchase, redeem, defease or otherwise acquire or
    retire for value any Equity Interests of the Issuer or any
    direct or indirect parent of the Issuer, including in connection
    with any merger or consolidation;
(III) make any principal payment on, or redeem, repurchase,
    defease or otherwise acquire or retire for value in each case,
    prior to any scheduled repayment, sinking fund payment or
    maturity, any Subordinated Indebtedness, other than:
(a) Indebtedness permitted under clauses (7) and
    (8) of the covenant described under
    "— Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock"; or
(b) the purchase, repurchase or other acquisition of
    Subordinated Indebtedness purchased in anticipation of
    satisfying a sinking fund obligation, principal installment or
    final maturity, in each case due within one year of the date of
    purchase, repurchase or acquisition; or
(IV) make any Restricted Investment
(all such payments and other actions set forth in
    clauses (I) through (IV) above (other than any
    exception thereto) being collectively referred to as
"Restricted Payments"
), unless, at the time of
    such Restricted Payment:
(1) no Default shall have occurred and be continuing or
    would occur as a consequence thereof;
(2) immediately after giving effect to such transaction on
    a pro forma basis, the Issuer could incur $1.00 of additional
    Indebtedness under the provisions of the first paragraph of the
    covenant described under "— Limitation on
    Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock"; and
(3) such Restricted Payment, together with the aggregate
    amount of all other Restricted Payments made by the Issuer and
    its Restricted Subsidiaries after November 17, 2006
    (including Restricted Payments permitted by clauses (1), (2)
    (with respect to the payment of dividends on Refunding Capital
    Stock (as defined below) pursuant to clause (b) thereof
    only), (6)(c), (9) and (14) of the next succeeding
    paragraph, but excluding all other Restricted Payments permitted
    by the next succeeding paragraph), is less than the sum of
    (without duplication):
(a) 50% of the Consolidated Net Income of the Issuer for
    the period (taken as one accounting period) beginning
    October 1, 2006, to the end of the Issuer's most
    recently ended fiscal quarter for which internal financial
    statements are available at the time of such Restricted Payment,
    or, in the case such Consolidated Net Income for such period is
    a deficit, minus 100% of such deficit;
plus
(b) 100% of the aggregate net cash proceeds and the fair
    market value, as determined in good faith by the Issuer, of
    marketable securities or other property received by the Issuer
    since
138
Table of Contents
immediately after November 17, 2006 (other than net cash
    proceeds to the extent such net cash proceeds have been used to
    incur Indebtedness, Disqualified Stock or Preferred Stock
    pursuant to clause (12)(a) of the second paragraph of
    "— Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock") from
    the issue or sale of:
(i) (A) Equity Interests of the Issuer, including
    Treasury Capital Stock (as defined below), but excluding cash
    proceeds and the fair market value, as determined in good faith
    by the Issuer, of marketable securities or other property
    received from the sale of:
(x) Equity Interests to members of management, directors or
    consultants of the Issuer, any direct or indirect parent company
    of the Issuer and the Issuer's Subsidiaries after
    November 17, 2006 to the extent such amounts have been
    applied to Restricted Payments made in accordance with
    clause (4) of the next succeeding paragraph; and
(y) Designated Preferred Stock; and
(B) to the extent such net cash proceeds are actually
    contributed to the Issuer, Equity Interests of the Issuer's
    direct or indirect parent companies (excluding contributions of
    the proceeds from the sale of Designated Preferred Stock of such
    companies or contributions to the extent such amounts have been
    applied to Restricted Payments made in accordance with
    clause (4) of the next succeeding paragraph); or
(ii) debt securities of the Issuer that have been converted
    into or exchanged for such Equity Interests of the Issuer;
provided
,
however
, that this clause (b) shall
    not include the proceeds from (V) Refunding Capital Stock
    (as defined below), (W) Equity Interests or convertible
    debt securities of the Issuer sold to a Restricted Subsidiary,
    as the case may be, (X) Disqualified Stock or debt
    securities that have been converted into Disqualified Stock,
    (Y) Excluded Contributions or (Z) the Delayed Equity
    Amount;
plus
(c) 100% of the aggregate amount of cash and the fair
    market value, as determined in good faith by the Issuer, of
    marketable securities or other property contributed to the
    capital of the Issuer following November 17, 2006 (other
    than net cash proceeds to the extent such net cash proceeds
    (i) have been used to incur Indebtedness, Disqualified
    Stock or Preferred Stock pursuant to clause (12)(a) of the
    second paragraph of "— Limitation on Incurrence
    of Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock," (ii) are contributed by a Restricted
    Subsidiary, (iii) constitute Excluded Contributions or
    (iv) constitute the Delayed Equity Amount);
plus
(d) 100% of the aggregate amount received in cash and the
    fair market value, as determined in good faith by the Issuer, of
    marketable securities or other property received by means of:
(i) the sale or other disposition (other than to the Issuer
    or a Restricted Subsidiary) of Restricted Investments made by
    the Issuer or its Restricted Subsidiaries and repurchases and
    redemptions of such Restricted Investments from the Issuer or
    its Restricted Subsidiaries and repayments of loans or advances,
    and releases of guarantees, which constitute Restricted
    Investments by the Issuer or its Restricted Subsidiaries, in
    each case after November 17, 2006; or
(ii) the sale (other than to the Issuer or a Restricted
    Subsidiary) of the stock of an Unrestricted Subsidiary or a
    distribution from an Unrestricted Subsidiary (other than in each
    case to the extent the Investment in such Unrestricted
    Subsidiary was made by the Issuer or a Restricted Subsidiary
    pursuant to clause (7) of the next succeeding paragraph or
    to the extent such Investment constituted a Permitted
    Investment) or a dividend from an Unrestricted Subsidiary after
    November 17, 2006;
plus
(e) in the case of the redesignation of an Unrestricted
    Subsidiary as a Restricted Subsidiary after November 17,
    2006, the fair market value of the Investment in such
    Unrestricted Subsidiary, as
139
Table of Contents
determined by the Issuer in good faith (or if such fair market
    value exceeds $250.0 million, in writing by an Independent
    Financial Advisor), at the time of the redesignation of such
    Unrestricted Subsidiary as a Restricted Subsidiary other than to
    the extent the Investment in such Unrestricted Subsidiary was
    made by the Issuer or a Restricted Subsidiary pursuant to
    clause (7) of the next succeeding paragraph or to the
    extent such Investment constituted a Permitted Investment.
The foregoing provisions will not prohibit:
(1) the payment of any dividend within 60 days after
    the date of declaration thereof, if at the date of declaration
    such payment would have complied with the provisions of the
    Indenture;
(2) (a) the redemption, repurchase, retirement or
    other acquisition of any Equity Interests
("Treasury
    Capital Stock")
or Subordinated Indebtedness of the
    Issuer or any Equity Interests of any direct or indirect parent
    company of the Issuer, in exchange for, or out of the proceeds
    of the substantially concurrent sale (other than to a Restricted
    Subsidiary) of, Equity Interests of the Issuer or any direct or
    indirect parent company of the Issuer to the extent contributed
    to the Issuer (in each case, other than any Disqualified Stock)
("Refunding Capital Stock")
and (b) if
    immediately prior to the retirement of Treasury Capital Stock,
    the declaration and payment of dividends thereon was permitted
    under clause (6) of this paragraph, the declaration and
    payment of dividends on the Refunding Capital Stock (other than
    Refunding Capital Stock the proceeds of which were used to
    redeem, repurchase, retire or otherwise acquire any Equity
    Interests of any direct or indirect parent company of the
    Issuer) in an aggregate amount per year no greater than the
    aggregate amount of dividends per annum that were declarable and
    payable on such Treasury Capital Stock immediately prior to such
    retirement;
(3) the redemption, repurchase or other acquisition or
    retirement of Subordinated Indebtedness of the Issuer or a
    Guarantor made in exchange for, or out of the proceeds of the
    substantially concurrent sale of, new Indebtedness of the Issuer
    or a Guarantor, as the case may be, which is incurred in
    compliance with "— Limitation on Incurrence of
    Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock" so long as:
(a) the principal amount (or accreted value) of such new
    Indebtedness does not exceed the principal amount of (or
    accreted value, if applicable), plus any accrued and unpaid
    interest on, the Subordinated Indebtedness being so redeemed,
    repurchased, acquired or retired for value, plus the amount of
    any reasonable premium (including reasonable tender premiums),
    defeasance costs and any reasonable fees and expenses incurred
    in connection with the issuance of such new Indebtedness;
(b) such new Indebtedness is subordinated to the Notes or
    the applicable Guarantee at least to the same extent as such
    Subordinated Indebtedness so purchased, exchanged, redeemed,
    repurchased, acquired or retired for value;
(c) such new Indebtedness has a final scheduled maturity
    date equal to or later than the final scheduled maturity date of
    the Subordinated Indebtedness being so redeemed, repurchased,
    acquired or retired; and
(d) such new Indebtedness has a Weighted Average Life to
    Maturity equal to or greater than the remaining Weighted Average
    Life to Maturity of the Subordinated Indebtedness being so
    redeemed, repurchased, acquired or retired;
(4) a Restricted Payment to pay for the repurchase,
    retirement or other acquisition or retirement for value of
    Equity Interests (other than Disqualified Stock) of the Issuer
    or any of its direct or indirect parent companies held by any
    future, present or former employee, director or consultant of
    the Issuer, any of its Subsidiaries or any of its direct or
    indirect parent companies pursuant to any management equity plan
    or stock option plan or any other management or employee benefit
    plan or agreement, including any Equity Interests rolled over by
    management of the Company or any of its direct or indirect
    parent companies in connection with the Transaction;
provided
,
however
, that the aggregate Restricted
    Payments made under this clause (4) do not exceed in any
    calendar year $75.0 million (which shall increase to
140
Table of Contents
$150.0 million subsequent to the consummation of an
    underwritten public Equity Offering by the Issuer or any direct
    or indirect parent entity of the Issuer) (with unused amounts in
    any calendar year being carried over to succeeding calendar
    years subject to a maximum (without giving effect to the
    following proviso) of $225.0 million in any calendar year
    (which shall increase to $450.0 million subsequent to the
    consummation of an underwritten public Equity Offering by the
    Issuer or any direct or indirect parent corporation of the
    Issuer));
provided further
that such amount in any
    calendar year may be increased by an amount not to exceed:
(a) the cash proceeds from the sale of Equity Interests
    (other than Disqualified Stock) of the Issuer and, to the extent
    contributed to the Issuer, Equity Interests of any of the
    Issuer's direct or indirect parent companies, in each case
    to members of management, directors or consultants of the
    Issuer, any of its Subsidiaries or any of its direct or indirect
    parent companies that occurs after November 17, 2006, to
    the extent the cash proceeds from the sale of such Equity
    Interests have not otherwise been applied to the payment of
    Restricted Payments by virtue of clause (3) of the
    preceding paragraph; plus
(b) the cash proceeds of key man life insurance policies
    received by the Issuer or its Restricted Subsidiaries after
    November 17, 2006; less
(c) the amount of any Restricted Payments previously made
    with the cash proceeds described in clauses (a) and
    (b) of this clause (4);
and
provided
,
further
, that cancellation of
    Indebtedness owing to the Issuer or any Restricted Subsidiary
    from members of management of the Issuer, any of the
    Issuer's direct or indirect parent companies or any of the
    Issuer's Restricted Subsidiaries in connection with a
    repurchase of Equity Interests of the Issuer or any of its
    direct or indirect parent companies will not be deemed to
    constitute a Restricted Payment for purposes of this covenant or
    any other provision of the Indenture;
(5) the declaration and payment of dividends to holders of
    any class or series of Disqualified Stock of the Issuer or any
    of its Restricted Subsidiaries or any class or series of
    Preferred Stock of any Restricted Subsidiary issued in
    accordance with the covenant described under
    "— Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock" to the
    extent such dividends are included in the definition of
    "Fixed Charges";
(6) (a) the declaration and payment of dividends to
    holders of any class or series of Designated Preferred Stock
    (other than Disqualified Stock) issued by the Issuer after
    November 17, 2006;
(b) the declaration and payment of dividends to a direct or
    indirect parent company of the Issuer, the proceeds of which
    will be used to fund the payment of dividends to holders of any
    class or series of Designated Preferred Stock (other than
    Disqualified Stock) of such parent corporation issued after the
    Issue Date; provided that the amount of dividends paid pursuant
    to this clause (b) shall not exceed the aggregate amount of
    cash actually contributed to the Issuer from the sale of such
    Designated Preferred Stock; or
(c) the declaration and payment of dividends on Refunding
    Capital Stock that is Preferred Stock in excess of the dividends
    declarable and payable thereon pursuant to clause (2) of
    this paragraph;
provided
,
however
, in the case of each of
    (a) and (c) of this clause (6), that for the most
    recently ended four full fiscal quarters for which internal
    financial statements are available immediately preceding the
    date of issuance of such Designated Preferred Stock or the
    declaration of such dividends on Refunding Capital Stock that is
    Preferred Stock, after giving effect to such issuance or
    declaration on a pro forma basis, the Issuer and its Restricted
    Subsidiaries on a consolidated basis would have had a Fixed
    Charge Coverage Ratio of at least 2.00 to 1.00;
(7) Investments in Unrestricted Subsidiaries having an
    aggregate fair market value, taken together with all other
    Investments made pursuant to this clause (7) that are at
    the time outstanding, without giving effect to the sale of an
    Unrestricted Subsidiary to the extent the proceeds of such sale
    do not consist of cash or marketable securities, not to exceed
    2.5% of Total Assets at the time of such Investment (with the
141
Table of Contents
fair market value of each Investment being measured at the time
    made and without giving effect to subsequent changes in value);
(8) repurchases of Equity Interests deemed to occur upon
    exercise of stock options or warrants if such Equity Interests
    represent a portion of the exercise price of such options or
    warrants;
(9) the declaration and payment of dividends on the
    Issuer's common stock (or the payment of dividends to any
    direct or indirect parent entity to fund a payment of dividends
    on such entity's common stock), following consummation of
    the first public offering of the Issuer's common stock or
    the common stock of any of its direct or indirect parent
    companies after November 17, 2006, of up to 6% per annum of
    the net cash proceeds received by or contributed to the Issuer
    in or from any such public offering, other than public offerings
    with respect to the Issuer's common stock registered on
Form S-8
and other than any public sale constituting an Excluded
    Contribution;
(10) Restricted Payments that are made with Excluded
    Contributions;
(11) other Restricted Payments in an aggregate amount taken
    together with all other Restricted Payments made pursuant to
    this clause (11) not to exceed 3.0% of Total Assets at the
    time made;
(12) distributions or payments of Receivables Fees;
(13) any Restricted Payment used to fund amounts owed to
    Affiliates (including dividends to any direct or indirect parent
    of the Issuer to permit payment by such parent of such amount),
    in each case to the extent permitted by the covenant described
    under "— Transactions with Affiliates";
(14) the repurchase, redemption or other acquisition or
    retirement for value of any Subordinated Indebtedness in
    accordance with the provisions similar to those described under
    the captions "Repurchase at the Option of
    Holders — Change of Control" and "Repurchase
    at the Option of Holders — Asset Sales"; provided
    that all Notes tendered by Holders in connection with a Change
    of Control Offer, Collateral Asset Sale Offer or Asset Sale
    Offer, as applicable, have been repurchased, redeemed or
    acquired for value;
(15) the declaration and payment of dividends by the Issuer
    to, or the making of loans to, any direct or indirect parent in
    amounts required for any direct or indirect parent companies to
    pay, in each case without duplication,
(a) franchise and excise taxes and other fees, taxes and
    expenses required to maintain their corporate existence;
(b) foreign, federal, state and local income taxes, to the
    extent such income taxes are attributable to the income of the
    Issuer and its Restricted Subsidiaries and, to the extent of the
    amount actually received from its Unrestricted Subsidiaries, in
    amounts required to pay such taxes to the extent attributable to
    the income of such Unrestricted Subsidiaries; provided that in
    each case the amount of such payments in any fiscal year does
    not exceed the amount that the Issuer and its Restricted
    Subsidiaries would be required to pay in respect of foreign,
    federal, state and local taxes for such fiscal year were the
    Issuer, its Restricted Subsidiaries and its Unrestricted
    Subsidiaries (to the extent described above) to pay such taxes
    separately from any such parent entity;
(c) for as long as Hercules Holding II, LLC is a parent of
    the Issuer, distributions equal to any taxable income of
    Hercules Holding II, LLC resulting from the Hedging Arrangements
    multiplied by 45%;
(d) customary salary, bonus and other benefits payable to
    officers and employees of any direct or indirect parent company
    of the Issuer to the extent such salaries, bonuses and other
    benefits are attributable to the ownership or operation of the
    Issuer and its Restricted Subsidiaries;
(e) general corporate operating and overhead costs and
    expenses of any direct or indirect parent company of the Issuer
    to the extent such costs and expenses are attributable to the
    ownership or operation of the Issuer and its Restricted
    Subsidiaries; and
142
Table of Contents
(f) fees and expenses other than to Affiliates of the
    Issuer related to any unsuccessful equity or debt offering of
    such parent entity; and
(16) the distribution, by dividend or otherwise, of shares
    of Capital Stock of, or Indebtedness owed to the Issuer or a
    Restricted Subsidiary by, Unrestricted Subsidiaries (other than
    Unrestricted Subsidiaries, the primary assets of which are cash
and/or
Cash
    Equivalents);
provided
,
however
, that at the time of, and after
    giving effect to, any Restricted Payment permitted under
    clauses (11) and (16), no Default shall have occurred and
    be continuing or would occur as a consequence thereof.
As of the Issue Date, all of the Issuer's Subsidiaries are
    Restricted Subsidiaries. The Issuer will not permit any
    Unrestricted Subsidiary to become a Restricted Subsidiary except
    pursuant to the last sentence of the definition of
    "Unrestricted Subsidiary." For purposes of designating
    any Restricted Subsidiary as an Unrestricted Subsidiary, all
    outstanding Investments by the Issuer and its Restricted
    Subsidiaries (except to the extent repaid) in the Subsidiary so
    designated will be deemed to be Restricted Payments in an amount
    determined as set forth in the last sentence of the definition
    of "Investment." Such designation will be permitted
    only if a Restricted Payment in such amount would be permitted
    at such time, whether pursuant to the first paragraph of this
    covenant or under clause (7), (10) or (11) of the
    second paragraph of this covenant, or pursuant to the definition
    of "Permitted Investments," and if such Subsidiary
    otherwise meets the definition of an Unrestricted Subsidiary.
    Unrestricted Subsidiaries are not be subject to any of the
    restrictive covenants set forth in the Indenture.
Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock
The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, directly or indirectly, create, incur, issue,
    assume, guarantee or otherwise become directly or indirectly
    liable, contingently or otherwise (collectively,
"incur"
and collectively, an
"incurrence"
) with respect to any Indebtedness
    (including Acquired Indebtedness), and the Issuer will not issue
    any shares of Disqualified Stock and will not permit any
    Restricted Subsidiary to issue any shares of Disqualified Stock
    or Preferred Stock;
provided
,
however
, that the
    Issuer may incur Indebtedness (including Acquired Indebtedness)
    or issue shares of Disqualified Stock, and any of its Restricted
    Subsidiaries may incur Indebtedness (including Acquired
    Indebtedness), issue shares of Disqualified Stock and issue
    shares of Preferred Stock, if the Fixed Charge Coverage Ratio on
    a consolidated basis for the Issuer and its Restricted
    Subsidiaries' most recently ended four fiscal quarters for
    which internal financial statements are available immediately
    preceding the date on which such additional Indebtedness is
    incurred or such Disqualified Stock or Preferred Stock is issued
    would have been at least 2.00 to 1.00, determined on a pro forma
    basis (including a pro forma application of the net proceeds
    therefrom), as if the additional Indebtedness had been incurred,
    or the Disqualified Stock or Preferred Stock had been issued, as
    the case may be, and the application of proceeds therefrom had
    occurred at the beginning of such four-quarter period;
provided, further,
that Restricted Subsidiaries that are
    not Guarantors may not incur Indebtedness or Disqualified Stock
    or Preferred Stock if, after giving pro forma effect to such
    incurrence or issuance (including a pro forma application of the
    net proceeds therefrom), more than an aggregate of
    $2,000.0 million of Indebtedness or Disqualified Stock or
    Preferred Stock of Restricted Subsidiaries that are not
    Guarantors would be outstanding pursuant to this paragraph and
    clauses (12), (14) and (19) below at such time.
The foregoing limitations will not apply to:
(1) the incurrence of Indebtedness under (x) Credit
    Facilities (other than the ABL Facility) by the Issuer or any of
    its Restricted Subsidiaries and the issuance and creation of
    letters of credit and bankers' acceptances thereunder (with
    letters of credit and bankers' acceptances being deemed to
    have a principal amount equal to the face amount thereof), up to
    an aggregate principal amount of $16,500.0 million
    outstanding at any one time and (y) the ABL Facility by the
    Issuer or any of its Restricted Subsidiaries and the issuance
    and creation of letters of credit and bankers' acceptances
    thereunder (with letters of credit and bankers' acceptances
    being deemed to have a principal amount equal to the face amount
    thereof), up to an aggregate principal amount equal to the ABL
    Facility Cap;
143
Table of Contents
(2) the incurrence by the Issuer and any Guarantor of
    Indebtedness represented by the Notes (including any Guarantee)
    (other than any Additional Notes and any Exchange Notes
    (including Guarantees thereof));
(3) Indebtedness of the Issuer and its Restricted
    Subsidiaries in existence on the Issue Date (other than
    Indebtedness described in clauses (1) and (2)), including
    the 2006 Notes and the Existing Notes;
(4) Indebtedness consisting of Capitalized Lease
    Obligations and Purchase Money Obligations; so long as such
    Indebtedness exists at the date of such purchase, lease or
    improvement, or is created within 270 days thereafter;
(5) Indebtedness incurred by the Issuer or any of its
    Restricted Subsidiaries constituting reimbursement obligations
    with respect to letters of credit issued in the ordinary course
    of business, including letters of credit in respect of
    workers' compensation, medical malpractice or employee
    health claims, or other Indebtedness with respect to
    reimbursement-type obligations regarding workers'
    compensation, medical malpractice or employee health claims;
    provided, however, that upon the drawing of such letters of
    credit or the incurrence of such Indebtedness, such obligations
    are reimbursed within 30 days following such drawing or
    incurrence;
(6) Indebtedness arising from agreements of the Issuer or
    its Restricted Subsidiaries providing for indemnification,
    adjustment of purchase price or similar obligations, in each
    case, incurred or assumed in connection with the disposition of
    any business, assets or a Subsidiary, other than guarantees of
    Indebtedness incurred by any Person acquiring all or any portion
    of such business, assets or a Subsidiary for the purpose of
    financing such acquisition; provided, however, that such
    Indebtedness is not reflected on the balance sheet of the
    Issuer, or any of its Restricted Subsidiaries (contingent
    obligations referred to in a footnote to financial statements
    and not otherwise reflected on the balance sheet will not be
    deemed to be reflected on such balance sheet for purposes of
    this clause (6));
(7) Indebtedness of the Issuer to a Restricted Subsidiary;
    provided that any such Indebtedness owing to a Restricted
    Subsidiary that is not a Guarantor is expressly subordinated in
    right of payment to the Notes; provided, further, that any
    subsequent issuance or transfer of any Capital Stock or any
    other event which results in any Restricted Subsidiary ceasing
    to be a Restricted Subsidiary or any other subsequent transfer
    of any such Indebtedness (except to the Issuer or another
    Restricted Subsidiary) shall be deemed, in each case, to be an
    incurrence of such Indebtedness;
(8) Indebtedness of a Restricted Subsidiary to the Issuer
    or another Restricted Subsidiary; provided that if a Guarantor
    incurs such Indebtedness to a Restricted Subsidiary that is not
    a Guarantor, such Indebtedness is expressly subordinated in
    right of payment to the Guarantee of the Notes of such
    Guarantor; provided, further, that any subsequent transfer of
    any such Indebtedness (except to the Issuer or another
    Restricted Subsidiary) shall be deemed, in each case, to be an
    incurrence of such Indebtedness not permitted by this clause (8);
(9) shares of Preferred Stock of a Restricted Subsidiary
    issued to the Issuer or another Restricted Subsidiary; provided
    that any subsequent issuance or transfer of any Capital Stock or
    any other event which results in any such Restricted Subsidiary
    ceasing to be a Restricted Subsidiary or any other subsequent
    transfer of any such shares of Preferred Stock (except to the
    Issuer or another of its Restricted Subsidiaries) shall be
    deemed in each case to be an issuance of such shares of
    Preferred Stock not permitted by this clause (9);
(10) Hedging Obligations (excluding Hedging Obligations
    entered into for speculative purposes) for the purpose of
    limiting interest rate risk with respect to any Indebtedness
    permitted to be incurred pursuant to
    "— Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock,"
    exchange rate risk or commodity pricing risk;
(11) obligations in respect of performance, bid, appeal and
    surety bonds and completion guarantees provided by the Issuer or
    any of its Restricted Subsidiaries in the ordinary course of
    business;
144
Table of Contents
(12) (a) Indebtedness or Disqualified Stock of the
    Issuer and Indebtedness, Disqualified Stock or Preferred Stock
    of the Issuer or any Restricted Subsidiary equal to 200.0% of
    the net cash proceeds received by the Issuer since immediately
    after November 17, 2006 from the issue or sale of Equity
    Interests of the Issuer or cash contributed to the capital of
    the Issuer (in each case, other than Excluded Contributions or
    proceeds of Disqualified Stock or sales of Equity Interests to
    the Issuer or any of its Subsidiaries) as determined in
    accordance with clauses (3)(b) and (3)(c) of the first paragraph
    of "— Limitation on Restricted Payments" to
    the extent such net cash proceeds or cash have not been applied
    pursuant to such clauses to make Restricted Payments or to make
    other Investments, payments or exchanges pursuant to the second
    paragraph of "— Limitation on Restricted
    Payments" or to make Permitted Investments (other than
    Permitted Investments specified in clauses (1) and
    (3) of the definition thereof) and (b) Indebtedness or
    Disqualified Stock of Issuer and Indebtedness, Disqualified
    Stock or Preferred Stock of the Issuer or any Restricted
    Subsidiary not otherwise permitted hereunder in an aggregate
    principal amount or liquidation preference, which when
    aggregated with the principal amount and liquidation preference
    of all other Indebtedness, Disqualified Stock and Preferred
    Stock then outstanding and incurred pursuant to this clause
    (12)(b), does not at any one time outstanding exceed
    $1,500.0 million; provided, however, that on a pro forma
    basis, together with any amounts incurred and outstanding by
    Restricted Subsidiaries that are not Guarantors pursuant to the
    second proviso to the first paragraph of this covenant and
    clauses (14) and (19), no more than $2,000.0 million
    of Indebtedness, Disqualified Stock or Preferred Stock at any
    one time outstanding and incurred pursuant to this clause
    (12)(b) shall be incurred by Restricted Subsidiaries that are
    not Guarantors (it being understood that any Indebtedness,
    Disqualified Stock or Preferred Stock incurred pursuant to this
    clause (12)(b) shall cease to be deemed incurred or outstanding
    for purposes of this clause (12)(b) but shall be deemed incurred
    for the purposes of the first paragraph of this covenant from
    and after the first date on which the Issuer or such Restricted
    Subsidiary could have incurred such Indebtedness, Disqualified
    Stock or Preferred Stock under the first paragraph of this
    covenant without reliance on this clause (12)(b));
(13) the incurrence or issuance by the Issuer or any
    Restricted Subsidiary of Indebtedness, Disqualified Stock or
    Preferred Stock which serves to refund or refinance any
    Indebtedness, Disqualified Stock or Preferred Stock of the
    Issuer or any Restricted Subsidiary incurred as permitted under
    the first paragraph of this covenant and clauses (2), (3),
    (4) and (12)(a) above, this clause (13) and
    clause (14) below or any Indebtedness, Disqualified Stock
    or Preferred Stock of the Issuer or any Restricted Subsidiary
    issued to so refund or refinance such Indebtedness, Disqualified
    Stock or Preferred Stock of the Issuer or any Restricted
    Subsidiary including additional Indebtedness, Disqualified Stock
    or Preferred Stock incurred to pay premiums (including
    reasonable tender premiums), defeasance costs and fees in
    connection therewith (the "Refinancing Indebtedness")
    prior to its respective maturity; provided, however, that such
    Refinancing Indebtedness:
(a) has a Weighted Average Life to Maturity at the time
    such Refinancing Indebtedness is incurred which is not less than
    the remaining Weighted Average Life to Maturity of the
    Indebtedness, Disqualified Stock or Preferred Stock being
    refunded or refinanced,
(b) to the extent such Refinancing Indebtedness refinances
    (i) Indebtedness subordinated or
pari passu
to the
    Notes or any Guarantee thereof, such Refinancing Indebtedness is
    subordinated or
pari passu
to the Notes or the Guarantee
    at least to the same extent as the Indebtedness being refinanced
    or refunded or (ii) Disqualified Stock or Preferred Stock,
    such Refinancing Indebtedness must be Disqualified Stock or
    Preferred Stock, respectively, and
(c) shall not include Indebtedness, Disqualified Stock or
    Preferred Stock of a Subsidiary of the Issuer that is not a
    Guarantor that refinances Indebtedness, Disqualified Stock or
    Preferred Stock of the Issuer or a Guarantor;
and,
provided
,
further
, that subclause (a) of
    this clause (13) will not apply to any refunding or
    refinancing of any Priority Lien Obligations and Obligations
    secured by Permitted Liens;
(14) Indebtedness, Disqualified Stock or Preferred Stock of
    (x) the Issuer or a Restricted Subsidiary incurred to
    finance an acquisition or (y) Persons that are acquired by
    the Issuer or any Restricted
145
Table of Contents
Subsidiary or merged into the Issuer or a Restricted Subsidiary
    in accordance with the terms of the Indenture;
provided
that after giving effect to such acquisition or merger,
    either
(a) the Issuer would be permitted to incur at least $1.00
    of additional Indebtedness pursuant to the Fixed Charge Coverage
    Ratio test set forth in the first sentence of this
    covenant, or
(b) the Fixed Charge Coverage Ratio of the Issuer and the
    Restricted Subsidiaries is greater than immediately prior to
    such acquisition or merger;
provided
,
however
, that on a pro forma basis,
    together with amounts incurred and outstanding pursuant to the
    second proviso to the first paragraph of this covenant and
    clauses (12) and (19), no more than $2,000.0 million
    of Indebtedness, Disqualified Stock or Preferred Stock at any
    one time outstanding and incurred by Restricted Subsidiaries
    that are not Guarantors pursuant to this clause (14) shall
    be incurred and outstanding;
(15) Indebtedness arising from the honoring by a bank or
    other financial institution of a check, draft or similar
    instrument drawn against insufficient funds in the ordinary
    course of business;
provided
that such Indebtedness is
    extinguished within two Business Days of its incurrence;
(16) Indebtedness of the Issuer or any of its Restricted
    Subsidiaries supported by a letter of credit issued pursuant to
    any Credit Facilities, in a principal amount not in excess of
    the stated amount of such letter of credit;
(17) (a) any guarantee by the Issuer or a Restricted
    Subsidiary of Indebtedness or other obligations of any
    Restricted Subsidiary, so long as the incurrence of such
    Indebtedness incurred by such Restricted Subsidiary is permitted
    under the terms of the Indenture, or (b) any guarantee by a
    Restricted Subsidiary of Indebtedness of the Issuer;
provided
that such guarantee is incurred in accordance with the
    covenant described below under "— Limitation on
    Guarantees of Indebtedness by Restricted Subsidiaries";
(18) Indebtedness of Foreign Subsidiaries of the Issuer in
    an amount not to exceed at any one time outstanding and together
    with any other Indebtedness incurred under this clause (18)
    7.5% of the Total Assets of the Foreign Subsidiaries (it being
    understood that any Indebtedness incurred pursuant to this
    clause (18) shall cease to be deemed incurred or
    outstanding for purposes of this clause (18) but shall be
    deemed incurred for the purposes of the first paragraph of this
    covenant from and after the first date on which the Issuer or
    such Restricted Subsidiaries could have incurred such
    Indebtedness under the first paragraph of this covenant without
    reliance on this clause (18));
(19) Indebtedness, Disqualified Stock or Preferred Stock of
    a Restricted Subsidiary incurred to finance or assumed in
    connection with an acquisition in a principal amount not to
    exceed $200.0 million in the aggregate at any one time
    outstanding together with all other Indebtedness, Disqualified
    Stock
and/or
Preferred Stock issued under this clause (19) (it being
    understood that any Indebtedness, Disqualified Stock or
    Preferred Stock incurred pursuant to this clause (19) shall
    cease to be deemed incurred or outstanding for purposes of this
    clause (19) but shall be deemed incurred for the purposes
    of the first paragraph of this covenant from and after the first
    date on which such Restricted Subsidiary could have incurred
    such Indebtedness, Disqualified Stock or Preferred Stock under
    the first paragraph of this covenant without reliance on this
    clause (19));
provided
,
however
, that on a pro
    forma basis, together with amounts incurred and outstanding by
    Restricted Subsidiaries that are not Guarantors pursuant to the
    second proviso to the first paragraph of this covenant and
    clauses (12) and (14), no more than $2,000.0 million
    of Indebtedness would be incurred and outstanding by Restricted
    Subsidiaries that are not Guarantors;
(20) Indebtedness of the Issuer or any of its Restricted
    Subsidiaries consisting of (i) the financing of insurance
    premiums or
(ii) take-or-pay
obligations contained in supply arrangements, in each case,
    incurred in the ordinary course of business;
(21) Indebtedness consisting of Indebtedness issued by the
    Issuer or any of its Restricted Subsidiaries to current or
    former officers, directors and employees thereof, their
    respective estates, spouses or former spouses, in each case to
    finance the purchase or redemption of Equity Interests of the
    Issuer or
146
Table of Contents
any direct or indirect parent company of the Issuer to the
    extent described in clause (4) of the second paragraph
    under the caption "— Limitation on Restricted
    Payments";
(22) Physician Support Obligations incurred by the Issuer
    or any Restricted Subsidiary; and
(23) Indebtedness of the Issuer or any of its Restricted
    Subsidiaries undertaken in connection with cash management and
    related activities with respect to any Subsidiary or joint
    venture operating one or more healthcare facilities, including,
    without limitation, hospitals, ambulatory surgery centers,
    outpatient diagnostic centers or imaging centers, in each case,
    in the ordinary course of business.
For purposes of determining compliance with this covenant:
(1) in the event that an item of Indebtedness, Disqualified
    Stock or Preferred Stock (or any portion thereof) meets the
    criteria of more than one of the categories of permitted
    Indebtedness, Disqualified Stock or Preferred Stock described in
    clauses (1) through (23) above or is entitled to be
    incurred pursuant to the first paragraph of this covenant, the
    Issuer, in its sole discretion, will classify or reclassify such
    item of Indebtedness, Disqualified Stock or Preferred Stock (or
    any portion thereof) and will only be required to include the
    amount and type of such Indebtedness, Disqualified Stock or
    Preferred Stock in one of the above clauses;
provided
that all Indebtedness outstanding under the Credit
    Facilities on November 17, 2006 will be treated as incurred
    on November 17, 2006 under clause (1) of the preceding
    paragraph; and
(2) at the time of incurrence, the Issuer will be entitled
    to divide and classify an item of Indebtedness in more than one
    of the types of Indebtedness described in the first and second
    paragraphs above.
Accrual of interest, the accretion of accreted value and the
    payment of interest in the form of additional Indebtedness,
    Disqualified Stock or Preferred Stock will not be deemed to be
    an incurrence of Indebtedness, Disqualified Stock or Preferred
    Stock for purposes of this covenant.
For purposes of determining compliance with any
    U.S. dollar-denominated restriction on the incurrence of
    Indebtedness, the U.S. dollar-equivalent principal amount
    of Indebtedness denominated in a foreign currency shall be
    calculated based on the relevant currency exchange rate in
    effect on the date such Indebtedness was incurred, in the case
    of term debt, or first committed, in the case of revolving
    credit debt;
provided
that if such Indebtedness is
    incurred to refinance other Indebtedness denominated in a
    foreign currency, and such refinancing would cause the
    applicable U.S. dollar-denominated restriction to be
    exceeded if calculated at the relevant currency exchange rate in
    effect on the date of such refinancing, such
    U.S. dollar-denominated restriction shall be deemed not to
    have been exceeded so long as the principal amount of such
    refinancing Indebtedness does not exceed the principal amount of
    such Indebtedness being refinanced.
The principal amount of any Indebtedness incurred to refinance
    other Indebtedness, if incurred in a different currency from the
    Indebtedness being refinanced, shall be calculated based on the
    currency exchange rate applicable to the currencies in which
    such respective Indebtedness is denominated that is in effect on
    the date of such refinancing.
The Indenture provides that the Issuer will not, and will not
    permit any Guarantor to, directly or indirectly, incur any
    Indebtedness (including Acquired Indebtedness) that is
    subordinated or junior in right of payment to any Indebtedness
    of the Issuer or such Guarantor, as the case may be, unless such
    Indebtedness is expressly subordinated in right of payment to
    the Notes or such Guarantor's Guarantee to the extent and
    in the same manner as such Indebtedness is subordinated to other
    Indebtedness of the Issuer or such Guarantor, as the case may be.
The Indenture does not treat (1) unsecured Indebtedness as
    subordinated or junior to Secured Indebtedness merely because it
    is unsecured or (2) Senior Indebtedness as subordinated or
    junior to any other Senior Indebtedness merely because it has a
    junior priority with respect to the same collateral.
147
Table of Contents
Limitation
    on Prepayment or Modification of Existing Notes
The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, directly or indirectly purchase, redeem,
    defease or otherwise acquire or retire for value any of the
    Existing Notes prior to the final maturity date thereof (as in
    effect on November 17, 2006);
provided
that the
    Issuer may:
(1) purchase, redeem, defease or otherwise acquire or
    retire for value any of the Existing Notes which have a final
    maturity date (as in effect on November 17, 2006) on
    or prior to December 31, 2011; and
(2) purchase, redeem, defease or otherwise acquire or
    retire for value any other Existing Notes which have a final
    maturity date (as in effect on November 17, 2006) on
    or prior to November 15, 2016;
provided
that, in the
    case of any such prepayment funded with the proceeds of the
    issuance of Secured Indebtedness, at the time of incurrence and
    after giving pro forma effect thereto and to the application of
    the proceeds thereof, (x) the Consolidated Secured Debt
    Ratio would be no greater than 5.25 to 1.0 and (y) the
    Consolidated Leverage Ratio would be no greater than 7.0 to 1.0.
The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, amend the Existing Notes Indenture, or any
    supplemental indenture in respect thereof, in any way to advance
    the final maturity date or shorten the Weighted Average Life to
    Maturity of any series of the Existing Notes such that any
    Existing Notes with a maturity date following the maturity of
    the Notes would have a maturity date on or prior to the date one
    year following the maturity date of the
    9
1
/
4
%
    2006 Notes or which would prohibit the making of the Guarantees
    or the creation of Liens in favor of the Notes and the
    Guarantees on the Collateral.
The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, designate any additional subsidiaries as
    "Restricted Subsidiaries" (as defined in the Existing
    Notes Indenture) for purposes of the Existing Notes Indenture.
Liens
The Issuer will not, and will not permit any Guarantor to,
    directly or indirectly, create, incur, assume or suffer to exist
    any Lien (except Permitted Liens) that secures obligations under
    any Indebtedness or any related Guarantee, on any asset or
    property of the Issuer or any Guarantor, or any income or
    profits therefrom, or assign or convey any right to receive
    income therefrom, unless:
(1) in the case of Liens securing Subordinated
    Indebtedness, the Notes and related Guarantees are secured by a
    Lien on such property, assets or proceeds that is senior in
    priority to such Liens; or
(2) in all other cases, the Notes or the Guarantees are
    equally and ratably secured or are secured by a Lien on such
    property, assets or proceeds that is senior in priority to such
    Liens;
except that the foregoing shall not apply to (a) Liens
    securing the Notes and the related Guarantees, (b) Liens
    securing Indebtedness permitted to be incurred under Credit
    Facilities, including any letter of credit relating thereto,
    that was permitted by the terms of the Indenture to be incurred
    pursuant to clause (1) of the second paragraph under
    "— Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock";
provided
that, with respect to Liens securing Obligations
    permitted under this subclause (b), the Notes and the related
    Guarantees are secured by Liens on the assets subject to such
    Liens (except any European Collateral) to the extent, with the
    priority and subject to intercreditor arrangements, in each case
    no less favorable to the holders of the Notes than those
    described under "Security" above and (c) Liens
    which are senior in priority to the Liens securing the Notes and
    related Guarantees and are incurred to secure Obligations in
    respect of any Indebtedness permitted to be incurred pursuant to
    the covenant described above under "— Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock";
provided
that, with respect to
    Liens securing Obligations permitted under this subclause (c),
    (i) at the time of incurrence and after giving pro forma
    effect thereto, the ratio of (1) the aggregate amount of
    Indebtedness subject to a Lien incurred pursuant to
    subclause (b) above, this subclause (c) and
    clause (6) of the definition of "Permitted Liens"
    (other than Liens securing Indebtedness incurred pursuant to
    clauses (4) and (18) of the covenant
148
Table of Contents
described above under "— Limitation on Incurrence
    of Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock") to (2) the Issuer's EBITDA for the most
    recently ended four full fiscal quarters for which internal
    financial statements are available immediately preceding the
    date on which such event for which such calculation is being
    made shall occur, in each case with such pro forma adjustments
    to Indebtedness and EBITDA as are appropriate and consistent
    with the pro forma adjustment provisions set forth in the
    definition of Fixed Charge Coverage Ratio would be no greater
    than 4.25 to 1.0 and (ii) the Notes and the Guarantees are
    secured by Liens with the priority and subject to intercreditor
    arrangements no less favorable to the holders of the Notes than
    those described under "— Security" above.
Merger,
    Consolidation or Sale of All or Substantially All
    Assets
The Issuer may not consolidate or merge with or into or wind up
    into (whether or not the Issuer is the surviving corporation),
    or sell, assign, transfer, lease, convey or otherwise dispose of
    all or substantially all of its properties or assets, in one or
    more related transactions, to any Person unless:
(1) the Issuer is the surviving corporation or the Person
    formed by or surviving any such consolidation or merger (if
    other than the Issuer) or to which such sale, assignment,
    transfer, lease, conveyance or other disposition will have been
    made is a corporation organized or existing under the laws of
    the jurisdiction of organization of the Issuer or the laws of
    the United States, any state thereof, the District of Columbia,
    or any territory thereof (such Person, as the case may be, being
    herein called the
"Successor Company"
);
(2) the Successor Company, if other than the Issuer,
    expressly assumes all the obligations of the Issuer under the
    Notes and the Security Documents pursuant to supplemental
    indentures or other documents or instruments in form reasonably
    satisfactory to the Trustee;
(3) immediately after such transaction, no Default exists;
(4) immediately after giving pro forma effect to such
    transaction and any related financing transactions, as if such
    transactions had occurred at the beginning of the applicable
    four-quarter period,
(a) the Successor Company would be permitted to incur at
    least $1.00 of additional Indebtedness pursuant to the Fixed
    Charge Coverage Ratio test set forth in the first sentence of
    the covenant described under "— Limitation on
    Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock," or
(b) the Fixed Charge Coverage Ratio for the Successor
    Company, the Issuer and its Restricted Subsidiaries would be
    greater than such ratio for the Issuer and its Restricted
    Subsidiaries immediately prior to such transaction;
(5) each Guarantor, unless it is the other party to the
    transactions described above, in which case clause (b) of
    the second succeeding paragraph shall apply, shall have by
    supplemental indenture confirmed that its Guarantee shall apply
    to such Person's obligations under the Indenture, the Notes
    and the Registration Rights Agreement;
(6) the Collateral owned by the Successor Company will
    (a) continue to constitute Collateral under the Indenture
    and the Security Documents, (b) be subject to a Lien in
    favor of the Junior Lien Collateral Agent for the benefit of the
    Trustee and the Holders of the Notes and (c) not be subject
    to any other Lien, other than Permitted Liens;
(7) to the extent any assets of the Person which is merged
    or consolidated with or into the Successor Company are assets of
    the type which would constitute Collateral under the Security
    Documents, the Successor Company will take such action as may be
    reasonably necessary to cause such property and assets to be
    made subject to the Lien of the Security Documents in the manner
    and to the extent required in the Indenture or any of the
    Security Documents and shall take all reasonably necessary
    action so that such Lien is perfected to the extent required by
    the Security Documents; and
149
Table of Contents
(8) the Issuer shall have delivered to the Trustee an
    Officer's Certificate and an Opinion of Counsel, each
    stating that such consolidation, merger or transfer and such
    supplemental indentures, if any, comply with the Indenture and,
    if a supplemental indenture or any supplement to any Security
    Document is required in connection with such transaction, such
    supplement shall comply with the applicable provisions of the
    Indenture.
The Successor Company will succeed to, and be substituted for
    the Issuer, as the case may be, under the Indenture, the
    Guarantees and the Notes, as applicable. Notwithstanding the
    foregoing clauses (3) and (4),
(1) any Restricted Subsidiary may consolidate with or merge
    into or transfer all or part of its properties and assets to the
    Issuer, and
(2) the Issuer may merge with an Affiliate of the Issuer,
    as the case may be, solely for the purpose of reincorporating
    the Issuer in a State of the United States or any state thereof,
    the District of Columbia or any territory thereof so long as the
    amount of Indebtedness of the Issuer and its Restricted
    Subsidiaries is not increased thereby.
Subject to certain limitations described in the Indenture
    governing release of a Guarantee upon the sale, disposition or
    transfer of a Guarantor, no Guarantor will, and the Issuer will
    not permit any Guarantor to, consolidate or merge with or into
    or wind up into (whether or not the Issuer or Guarantor is the
    surviving corporation), or sell, assign, transfer, lease, convey
    or otherwise dispose of all or substantially all of its
    properties or assets, in one or more related transactions, to
    any Person unless:
(1) (a) such Guarantor is the surviving corporation or
    the Person formed by or surviving any such consolidation or
    merger (if other than such Guarantor) or to which such sale,
    assignment, transfer, lease, conveyance or other disposition
    will have been made is a corporation, partnership, limited
    partnership, limited liability corporation or trust organized or
    existing under the laws of the jurisdiction of organization of
    such Guarantor, as the case may be, or the laws of the United
    States, any state thereof, the District of Columbia, or any
    territory thereof (such Guarantor or such Person, as the case
    may be, being herein called the "Successor Person");
(b) the Successor Person, if other than such Guarantor,
    expressly assumes all the obligations of such Guarantor under
    the Indenture and such Guarantor's related Guarantee
    pursuant to supplemental indentures or other documents or
    instruments in form reasonably satisfactory to the Trustee;
(c) immediately after such transaction, no Default
    exists; and
(d) the Issuer shall have delivered to the Trustee an
    Officer's Certificate, each stating that such
    consolidation, merger or transfer and such supplemental
    indentures, if any, comply with the Indenture; or
(2) the transaction is made in compliance with the covenant
    described under "Repurchase at the Option of
    Holders — Asset Sales."
Subject to certain limitations described in the Indenture, the
    Successor Person will succeed to, and be substituted for, such
    Guarantor under the Indenture and such Guarantor's
    Guarantee. Notwithstanding the foregoing, any Guarantor may
    (i) merge into or transfer all or part of its properties
    and assets to another Guarantor or the Issuer, (ii) merge
    with an Affiliate of the Company solely for the purpose of
    reincorporating the Guarantor in the United States, any state
    thereof, the District of Columbia or any territory thereof or
    (iii) convert into a corporation, partnership, limited
    partnership, limited liability corporation or trust organized or
    existing under the laws of the jurisdiction of organization of
    such Guarantor.
Transactions
    with Affiliates
The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, make any payment to, or sell, lease, transfer
    or otherwise dispose of any of its properties or assets to, or
    purchase any property or assets from, or enter into or make or
    amend any transaction, contract, agreement, understanding, loan,
    advance or
150
Table of Contents
guarantee with, or for the benefit of, any Affiliate of the
    Issuer (each of the foregoing, an
"Affiliate
    Transaction"
) involving aggregate payments or
    consideration in excess of $40.0 million, unless:
(1) such Affiliate Transaction is on terms that are not
    materially less favorable to the Issuer or its relevant
    Restricted Subsidiary than those that would have been obtained
    in a comparable transaction by the Issuer or such Restricted
    Subsidiary with an unrelated Person on an arm's-length
    basis; and
(2) the Issuer delivers to the Trustee with respect to any
    Affiliate Transaction or series of related Affiliate
    Transactions involving aggregate payments or consideration in
    excess of $80.0 million, a resolution adopted by the
    majority of the board of directors of the Issuer approving such
    Affiliate Transaction and set forth in an Officer's
    Certificate certifying that such Affiliate Transaction complies
    with clause (1) above.
The foregoing provisions will not apply to the following:
(1) transactions between or among the Issuer or any of its
    Restricted Subsidiaries;
(2) Restricted Payments permitted by the provisions of the
    Indenture described above under the covenant
    "— Limitation on Restricted Payments" and
    the definition of "Permitted Investments";
(3) the payment of management, consulting, monitoring and
    advisory fees and related expenses to the Investors and the
    Frist Entities pursuant to the Sponsor Management Agreement
    (plus any unpaid management, consulting, monitoring and advisory
    fees and related expenses accrued in any prior year) and the
    termination fees pursuant to the Sponsor Management Agreement,
    in each case as in effect on the Issue Date, or any amendment
    thereto (so long as any such amendment is not disadvantageous in
    the good faith judgment of the board of directors of the Issuer
    to the Holders when taken as a whole as compared to the Sponsor
    Management Agreement in effect on the Issue Date);
(4) the payment of reasonable and customary fees paid to,
    and indemnities provided for the benefit of, officers,
    directors, employees or consultants of Issuer, any of its direct
    or indirect parent companies or any of its Restricted
    Subsidiaries;
(5) transactions in which the Issuer or any of its
    Restricted Subsidiaries, as the case may be, delivers to the
    Trustee a letter from an Independent Financial Advisor stating
    that such transaction is fair to the Issuer or such Restricted
    Subsidiary from a financial point of view or stating that the
    terms are not materially less favorable to the Issuer or its
    relevant Restricted Subsidiary than those that would have been
    obtained in a comparable transaction by the Issuer or such
    Restricted Subsidiary with an unrelated Person on an
    arm's-length basis;
(6) any agreement as in effect as of the Issue Date, or any
    amendment thereto (so long as any such amendment is not
    disadvantageous to the Holders when taken as a whole as compared
    to the applicable agreement as in effect on the Issue Date);
(7) the existence of, or the performance by the Issuer or
    any of its Restricted Subsidiaries of its obligations under the
    terms of, any stockholders agreement (including any registration
    rights agreement or purchase agreement related thereto) to which
    it is a party as of the Issue Date and any similar agreements
    which it may enter into thereafter; provided, however, that the
    existence of, or the performance by the Issuer or any of its
    Restricted Subsidiaries of obligations under any future
    amendment to any such existing agreement or under any similar
    agreement entered into after the Issue Date shall only be
    permitted by this clause (7) to the extent that the terms
    of any such amendment or new agreement are not otherwise
    disadvantageous to the Holders when taken as a whole;
(8) [reserved];
(9) transactions with customers, clients, suppliers, or
    purchasers or sellers of goods or services, in each case in the
    ordinary course of business and otherwise in compliance with the
    terms of the Indenture which are fair to the Issuer and its
    Restricted Subsidiaries, in the reasonable determination of the
    board of directors of the Issuer or the senior management
    thereof, or are on terms at least as favorable as might
    reasonably have been obtained at such time from an unaffiliated
    party;
151
Table of Contents
(10) the issuance of Equity Interests (other than
    Disqualified Stock) of the Issuer to any Permitted Holder or to
    any director, officer, employee or consultant;
(11) sales of accounts receivable, or participations
    therein, in connection with the ABL Facility and any Receivables
    Facility;
(12) payments by the Issuer or any of its Restricted
    Subsidiaries to any of the Investors made for any financial
    advisory, financing, underwriting or placement services or in
    respect of other investment banking activities, including,
    without limitation, in connection with acquisitions or
    divestitures, which payments are approved by a majority of the
    board of directors of the Issuer in good faith;
(13) payments or loans (or cancellation of loans) to
    employees or consultants of the Issuer, any of its direct or
    indirect parent companies or any of its Restricted Subsidiaries
    and employment agreements, stock option plans and other similar
    arrangements with such employees or consultants which, in each
    case, are approved by the Issuer in good faith;
(14) investments by the Investors or the Frist Entities in
    securities of the Issuer or any of its Restricted Subsidiaries
    so long as (i) the investment is being offered generally to
    other investors on the same or more favorable terms and
    (ii) the investment constitutes less than 5% of the
    proposed or outstanding issue amount of such class of securities;
(15) payments to or from, and transactions with, any joint
    venture owning or operating one or more healthcare facilities,
    including, without limitation, hospitals, ambulatory surgery
    centers, outpatient diagnostic centers or imaging centers, in
    each case in the ordinary course of business (including, without
    limitation, any cash management activities related
    thereto); and
(16) payments by the Issuer (and any direct or indirect
    parent thereof) and its Subsidiaries pursuant to tax sharing
    agreements among the Issuer (and any such parent) and its
    Subsidiaries on customary terms to the extent attributable to
    the ownership or operation of the Issuer and its Subsidiaries;
    provided that in each case the amount of such payments in any
    fiscal year does not exceed the amount that the Issuer, its
    Restricted Subsidiaries and its Unrestricted Subsidiaries (to
    the extent of amounts received from Unrestricted Subsidiaries)
    would be required to pay in respect of foreign, federal, state
    and local taxes for such fiscal year were the Issuer and its
    Restricted Subsidiaries (to the extent described above) to pay
    such taxes separately from any such parent entity.
Dividend
    and Other Payment Restrictions Affecting Restricted
    Subsidiaries
The Issuer will not, and will not permit any of its Restricted
    Subsidiaries that are not Guarantors to, directly or indirectly,
    create or otherwise cause or suffer to exist or become effective
    any consensual encumbrance or consensual restriction on the
    ability of any such Restricted Subsidiary to:
(1) (a) pay dividends or make any other distributions
    to the Issuer or any of its Restricted Subsidiaries on its
    Capital Stock or with respect to any other interest or
    participation in, or measured by, its profits, or
(b) pay any Indebtedness owed to the Issuer or any of its
    Restricted Subsidiaries;
(2) make loans or advances to the Issuer or any of its
    Restricted Subsidiaries; or
(3) sell, lease or transfer any of its properties or assets
    to the Issuer or any of its Restricted Subsidiaries, except (in
    each case) for such encumbrances or restrictions existing under
    or by reason of:
(a) contractual encumbrances or restrictions in effect on
    the Issue Date, including pursuant to the Senior Credit
    Facilities and the related documentation, the Existing Notes
    Indenture and the related documentation and the 2006 Notes
    Indenture and the related documentation;
(b) the Indenture and the Notes;
(c) purchase money obligations for property acquired in the
    ordinary course of business that impose restrictions of the
    nature discussed in clause (3) above on the property so
    acquired;
152
Table of Contents
(d) applicable law or any applicable rule, regulation or
    order;
(e) any agreement or other instrument of a Person acquired
    by the Issuer or any Restricted Subsidiary in existence at the
    time of such acquisition (but not created in contemplation
    thereof), which encumbrance or restriction is not applicable to
    any Person, or the properties or assets of any Person, other
    than the Person and its Subsidiaries, or the property or assets
    of the Person and its Subsidiaries, so acquired;
(f) contracts for the sale of assets, including customary
    restrictions with respect to a Subsidiary of the Issuer pursuant
    to an agreement that has been entered into for the sale or
    disposition of all or substantially all of the Capital Stock or
    assets of such Subsidiary;
(g) Secured Indebtedness that limits the right of the
    debtor to dispose of the assets securing such Indebtedness that
    is otherwise permitted to be incurred pursuant to the covenants
    described under "— Limitation on Incurrence of
    Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock" and "— Liens";
(h) restrictions on cash or other deposits or net worth
    imposed by customers under contracts entered into in the
    ordinary course of business;
(i) other Indebtedness, Disqualified Stock or Preferred
    Stock of Foreign Subsidiaries permitted to be incurred
    subsequent to the Issue Date pursuant to the provisions of the
    covenant described under "— Limitation on
    Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock";
(j) customary provisions in joint venture agreements and
    other agreements or arrangements relating solely to such joint
    venture;
(k) customary provisions contained in leases or licenses of
    intellectual property and other agreements, in each case entered
    into in the ordinary course of business;
(l) any encumbrances or restrictions of the type referred
    to in clauses (1), (2) and (3) above imposed by any
    amendments, modifications, restatements, renewals, increases,
    supplements, refundings, replacements or refinancings of the
    contracts, instruments or obligations referred to in
    clauses (a) through (k) above; provided that such
    amendments, modifications, restatements, renewals, increases,
    supplements, refundings, replacements or refinancings are, in
    the good faith judgment of the Issuer, no more restrictive with
    respect to such encumbrance and other restrictions taken as a
    whole than those prior to such amendment, modification,
    restatement, renewal, increase, supplement, refunding,
    replacement or refinancing; and
(m) restrictions created in connection with any Receivables
    Facility that, in the good faith determination of the Issuer,
    are necessary or advisable to effect the transactions
    contemplated under such Receivables Facility.
Limitation
    on Guarantees of Indebtedness by Restricted
    Subsidiaries
The Issuer will not permit any of its Wholly-Owned Subsidiaries
    that are Restricted Subsidiaries (and non-Wholly-Owned
    Subsidiaries if such non-Wholly-Owned Subsidiaries guarantee
    other capital markets debt securities of the Issuer or any
    Guarantor), other than a Guarantor, a Foreign Subsidiary or a
    Receivables Subsidiary, to guarantee the payment of any
    Indebtedness of the Issuer or any other Guarantor unless:
(1) such Restricted Subsidiary within 30 days executes
    and delivers a supplemental indenture to the Indenture providing
    for a Guarantee by such Restricted Subsidiary, except that with
    respect to a guarantee of Indebtedness of the Issuer or any
    Guarantor:
(a) if the Notes or such Guarantor's Guarantee is
    subordinated in right of payment to such Indebtedness, the
    Guarantee under the supplemental indenture shall be subordinated
    to such Restricted Subsidiary's guarantee with respect to
    such Indebtedness substantially to the same extent as the Notes
    are subordinated to such Indebtedness; and
153
Table of Contents
(b) if such Indebtedness is by its express terms
    subordinated in right of payment to the Notes or such
    Guarantor's Guarantee, any such guarantee by such
    Restricted Subsidiary with respect to such Indebtedness shall be
    subordinated in right of payment to such Guarantee substantially
    to the same extent as such Indebtedness is subordinated to the
    Notes; and
(2) such Restricted Subsidiary waives, and will not in any
    manner whatsoever claim or take the benefit or advantage of, any
    rights of reimbursement, indemnity or subrogation or any other
    rights against the Issuer or any other Restricted Subsidiary as
    a result of any payment by such Restricted Subsidiary under its
    Guarantee;
provided
that this covenant shall not be applicable to
    (i) any guarantee of any Restricted Subsidiary that existed
    at the time such Person became a Restricted Subsidiary and was
    not incurred in connection with, or in contemplation of, such
    Person becoming a Restricted Subsidiary and (ii) guarantees
    of the ABL Facility by the ABL Financing Entities or of any
    Receivables Facility by any Receivables Subsidiary.
Reports
    and Other Information
Notwithstanding that the Issuer may not be subject to the
    reporting requirements of Section 13 or 15(d) of the
    Exchange Act or otherwise report on an annual and quarterly
    basis on forms provided for such annual and quarterly reporting
    pursuant to rules and regulations promulgated by the SEC, the
    Indenture requires the Issuer to file with the SEC (and make
    available to the Trustee and Holders of the Notes (without
    exhibits), without cost to any Holder, within 15 days after
    it files them with the SEC) from and after the Issue Date,
(1) within 90 days (or any other time period then in
    effect under the rules and regulations of the Exchange Act with
    respect to the filing of a
Form 10-K
by a non-accelerated filer) after the end of each fiscal year,
    annual reports on
Form 10-K,
or any successor or comparable form, containing the information
    required to be contained therein, or required in such successor
    or comparable form;
(2) within 45 days after the end of each of the first
    three fiscal quarters of each fiscal year, reports on
Form 10-Q
containing all quarterly information that would be required to
    be contained in
Form 10-Q,
or any successor or comparable form;
(3) promptly from time to time after the occurrence of an
    event required to be therein reported, such other reports on
Form 8-K,
or any successor or comparable form; and
(4) any other information, documents and other reports
    which the Issuer would be required to file with the SEC if it
    were subject to Section 13 or 15(d) of the Exchange Act;
in each case in a manner that complies in all material respects
    with the requirements specified in such form;
provided
that the Issuer shall not be so obligated to file such
    reports with the SEC if the SEC does not permit such filing, in
    which event the Issuer will make available such information to
    prospective purchasers of Notes, in addition to providing such
    information to the Trustee and the Holders of the Notes, in each
    case within 15 days after the time the Issuer would be
    required to file such information with the SEC if it were
    subject to Section 13 or 15(d) of the Exchange Act. In
    addition, to the extent not satisfied by the foregoing, the
    Issuer has agreed that, for so long as any Notes are
    outstanding, it will furnish to Holders and to securities
    analysts and prospective investors, upon their request, the
    information required to be delivered pursuant to
    Rule 144A(d)(4) under the Securities Act.
In the event that any direct or indirect parent company of the
    Issuer becomes a Guarantor of the Notes, the Indenture permits
    the Issuer to satisfy its obligations in this covenant with
    respect to financial information relating to the Issuer by
    furnishing financial information relating to such parent;
provided
that the same is accompanied by consolidating
    information that explains in reasonable detail the differences
    between the information relating to such parent, on the one
    hand, and the information relating to the Issuer and its
    Restricted Subsidiaries on a standalone basis, on the other hand.
Notwithstanding the foregoing, such requirements shall be deemed
    satisfied prior to the commencement of the exchange offer or the
    effectiveness of the shelf registration statement described in
    the Registration Rights Agreement (1) by the filing with
    the SEC of the exchange offer registration statement or shelf
154
Table of Contents
registration statement (or any other similar registration
    statement), and any amendments thereto, with such financial
    information that satisfies
Regulation S-X,
subject to exceptions consistent with the presentation of
    financial information in the Offering Memorandum, to the extent
    filed within the times specified above, or (2) by posting
    reports that would be required to be filed substantially in the
    form required by the SEC on the Company's website (or that
    of any of its parent companies) or providing such reports to the
    Trustee within 15 days after the time the Issuer would be
    required to file such information with the SEC if it were
    subject to Section 13 or 15(d) of the Exchange Act, the
    financial information (including a "Management's
    Discussion and Analysis of Financial Condition and Results of
    Operations" section) that would be required to be included
    in such reports, subject to exceptions consistent with the
    presentation of financial information in the Offering
    Memorandum, to the extent filed within the times specified above.
Events of
    Default and Remedies
The Indenture provides that each of the following is an
"Event of Default"
:
(1) default in payment when due and payable, upon
    redemption, acceleration or otherwise, of principal of, or
    premium, if any, on the Notes;
(2) default for 30 days or more in the payment when
    due of interest or Additional Interest on or with respect to the
    Notes;
(3) failure by the Issuer or any Guarantor for 60 days
    after receipt of written notice given by the Trustee or the
    Holders of not less 30% in principal amount of the Notes to
    comply with any of its obligations, covenants or agreements
    (other than a default referred to in clauses (1) and
    (2) above) contained in the Indenture or the Notes;
(4) default under any mortgage, indenture or instrument
    under which there is issued or by which there is secured or
    evidenced any Indebtedness for money borrowed by the Issuer or
    any of its Restricted Subsidiaries or the payment of which is
    guaranteed by the Issuer or any of its Restricted Subsidiaries,
    other than Indebtedness owed to the Issuer or a Restricted
    Subsidiary, whether such Indebtedness or guarantee now exists or
    is created after the issuance of the Notes, if both:
(a) such default either results from the failure to pay any
    principal of such Indebtedness at its stated final maturity
    (after giving effect to any applicable grace periods) or relates
    to an obligation other than the obligation to pay principal of
    any such Indebtedness at its stated final maturity and results
    in the holder or holders of such Indebtedness causing such
    Indebtedness to become due prior to its stated maturity; and
(b) the principal amount of such Indebtedness, together
    with the principal amount of any other such Indebtedness in
    default for failure to pay principal at stated final maturity
    (after giving effect to any applicable grace periods), or the
    maturity of which has been so accelerated, aggregate
    $200.0 million or more at any one time outstanding;
(5) failure by the Issuer or any Significant Subsidiary to
    pay final judgments aggregating in excess of
    $200.0 million, which final judgments remain unpaid,
    undischarged and unstayed for a period of more than 60 days
    after such judgment becomes final, and in the event such
    judgment is covered by insurance, an enforcement proceeding has
    been commenced by any creditor upon such judgment or decree
    which is not promptly stayed;
(6) certain events of bankruptcy or insolvency with respect
    to the Issuer or any Significant Subsidiary;
(7) the Guarantee of any Significant Subsidiary shall for
    any reason cease to be in full force and effect or be declared
    null and void or any responsible officer of any Guarantor that
    is a Significant Subsidiary, as the case may be, denies that it
    has any further liability under its Guarantee or gives notice to
    such effect, other than by reason of the termination of the
    Indenture or the release of any such Guarantee in accordance
    with the Indenture; or
155
Table of Contents
(8) with respect to any Collateral having a fair market
    value in excess of $200 million, individually or in the
    aggregate, (a) the security interest under the Security
    Documents, at any time, ceases to be in full force and effect
    for any reason other than in accordance with the terms of the
    Indenture, the Security Documents and the Intercreditor
    Agreements, (b) any security interest created thereunder or
    under the Indenture is declared invalid or unenforceable by a
    court of competent jurisdiction or (c) the Issuer or any
    Guarantor asserts, in any pleading in any court of competent
    jurisdiction, that any such security interest is invalid or
    unenforceable.
If any Event of Default (other than of a type specified in
    clause (6) above) occurs and is continuing under the
    Indenture, the Trustee or the Holders of at least 30% in
    principal amount of the then total outstanding Notes may declare
    the principal, premium, if any, interest and any other monetary
    obligations on all the then outstanding Notes to be due and
    payable immediately.
Upon the effectiveness of such declaration, such principal and
    interest will be due and payable immediately. Notwithstanding
    the foregoing, in the case of an Event of Default arising under
    clause (6) of the first paragraph of this section, all
    outstanding Notes will become due and payable without further
    action or notice. The Indenture provides that the Trustee may
    withhold from the Holders notice of any continuing Default,
    except a Default relating to the payment of principal, premium,
    if any, or interest, if it determines that withholding notice is
    in their interest. In addition, the Trustee shall have no
    obligation to accelerate the Notes if in the best judgment of
    the Trustee acceleration is not in the best interest of the
    Holders of the Notes.
The Indenture provides that the Holders of a majority in
    aggregate principal amount of the then outstanding Notes by
    notice to the Trustee may on behalf of the Holders of all of the
    Notes waive any existing Default and its consequences under the
    Indenture except a continuing Default in the payment of interest
    on, premium, if any, or the principal of any Note held by a
    non-consenting Holder. In the event of any Event of Default
    specified in clause (4) above, such Event of Default and
    all consequences thereof (excluding any resulting payment
    default, other than as a result of acceleration of the Notes)
    shall be annulled, waived and rescinded, automatically and
    without any action by the Trustee or the Holders, if within
    20 days after such Event of Default arose:
(1) the Indebtedness or guarantee that is the basis for
    such Event of Default has been discharged; or
(2) holders thereof have rescinded or waived the
    acceleration, notice or action (as the case may be) giving rise
    to such Event of Default; or
(3) the default that is the basis for such Event of Default
    has been cured.
Subject to the provisions of the Indenture relating to the
    duties of the Trustee thereunder, in case an Event of Default
    occurs and is continuing, the Trustee is under no obligation to
    exercise any of the rights or powers under the Indenture at the
    request or direction of any of the Holders of the Notes unless
    the Holders have offered to the Trustee reasonable indemnity or
    security against any loss, liability or expense. Except to
    enforce the right to receive payment of principal, premium, if
    any, or interest when due, no Holder of a Note may pursue any
    remedy with respect to the Indenture or the Notes unless:
(1) such Holder has previously given the Trustee notice
    that an Event of Default is continuing;
(2) Holders of at least 30% in principal amount of the
    total outstanding Notes have requested the Trustee to pursue the
    remedy;
(3) Holders of the Notes have offered the Trustee
    reasonable security or indemnity against any loss, liability or
    expense;
(4) the Trustee has not complied with such request within
    60 days after the receipt thereof and the offer of security
    or indemnity; and
(5) Holders of a majority in principal amount of the total
    outstanding Notes have not given the Trustee a direction
    inconsistent with such request within such
60-day
period.
156
Table of Contents
Subject to certain restrictions, under the Indenture the Holders
    of a majority in principal amount of the total outstanding Notes
    are given the right to direct the time, method and place of
    conducting any proceeding for any remedy available to the
    Trustee or of exercising any trust or power conferred on the
    Trustee. The Trustee, however, may refuse to follow any
    direction that conflicts with law or the Indenture or that the
    Trustee determines is unduly prejudicial to the rights of any
    other Holder of a Note or that would involve the Trustee in
    personal liability.
The Indenture provides that the Issuer is required to deliver to
    the Trustee annually a statement regarding compliance with the
    Indenture, and the Issuer is required, within five Business
    Days, upon becoming aware of any Default, to deliver to the
    Trustee a statement specifying such Default.
No
    Personal Liability of Directors, Officers, Employees and
    Stockholders
No director, officer, employee, incorporator or stockholder of
    the Issuer or any Guarantor or any of their parent companies
    (other than the Issuer and the Guarantors) shall have any
    liability for any obligations of the Issuer or the Guarantors
    under the Notes, the Guarantees or the Indenture or for any
    claim based on, in respect of, or by reason of such obligations
    or their creation. Each Holder by accepting the Notes waives and
    releases all such liability. The waiver and release are part of
    the consideration for issuance of the Notes. Such waiver may not
    be effective to waive liabilities under the federal securities
    laws, and it is the view of the SEC that such a waiver is
    against public policy.
Legal
    Defeasance and Covenant Defeasance
The obligations of the Issuer and the Guarantors under the
    Indenture will terminate (other than certain obligations) and
    will be released upon payment in full of all of the Notes. The
    Issuer may, at its option and at any time, elect to have all of
    its obligations discharged with respect to the Notes and have
    the Issuer's and each Guarantor's obligation
    discharged with respect to its Guarantee
("Legal
    Defeasance")
and cure all then existing Events of
    Default except for:
(1) the rights of Holders of Notes to receive payments in
    respect of the principal of, premium, if any, and interest on
    the Notes when such payments are due solely out of the trust
    created pursuant to the Indenture;
(2) the Issuer's obligations with respect to Notes
    concerning issuing temporary Notes, registration of such Notes,
    mutilated, destroyed, lost or stolen Notes and the maintenance
    of an office or agency for payment and money for security
    payments held in trust;
(3) the rights, powers, trusts, duties and immunities of
    the Trustee, and the Issuer's obligations in connection
    therewith; and
(4) the Legal Defeasance provisions of the Indenture.
In addition, the Issuer may, at its option and at any time,
    elect to have its obligations and those of each Guarantor
    released with respect to certain covenants that are described in
    the Indenture
("Covenant Defeasance")
and
    thereafter any omission to comply with such obligations shall
    not constitute a Default with respect to the Notes. In the event
    Covenant Defeasance occurs, certain events (not including
    bankruptcy, receivership, rehabilitation and insolvency events
    pertaining to the Issuer) described under "Events of
    Default and Remedies" will no longer constitute an Event of
    Default with respect to the Notes.
In order to exercise either Legal Defeasance or Covenant
    Defeasance with respect to the Notes:
(1) the Issuer must irrevocably deposit with the Trustee,
    in trust, for the benefit of the Holders of the Notes, cash in
    U.S. dollars, Government Securities, or a combination
    thereof, in such amounts as will be sufficient, in the opinion
    of a nationally recognized firm of independent public
    accountants, to pay the principal of, premium, if any, and
    interest due on the Notes on the stated maturity date or on the
    redemption date, as the case may be, of such principal, premium,
    if any, or interest on such Notes, and the Issuer must specify
    whether such Notes are being defeased to maturity or to a
    particular redemption date;
157
Table of Contents
(2) in the case of Legal Defeasance, the Issuer shall have
    delivered to the Trustee an Opinion of Counsel reasonably
    acceptable to the Trustee confirming that, subject to customary
    assumptions and exclusions,
(a) the Issuer has received from, or there has been
    published by, the United States Internal Revenue Service a
    ruling, or
(b) since the issuance of the Notes, there has been a
    change in the applicable U.S. federal income tax law,
in either case to the effect that, and based thereon such
    Opinion of Counsel shall confirm that, subject to customary
    assumptions and exclusions, the Holders of the Notes will not
    recognize income, gain or loss for U.S. federal income tax
    purposes, as applicable, as a result of such Legal Defeasance
    and will be subject to U.S. federal income tax on the same
    amounts, in the same manner and at the same times as would have
    been the case if such Legal Defeasance had not occurred;
(3) in the case of Covenant Defeasance, the Issuer shall
    have delivered to the Trustee an Opinion of Counsel reasonably
    acceptable to the Trustee confirming that, subject to customary
    assumptions and exclusions, the Holders of the Notes will not
    recognize income, gain or loss for U.S. federal income tax
    purposes as a result of such Covenant Defeasance and will be
    subject to such tax on the same amounts, in the same manner and
    at the same times as would have been the case if such Covenant
    Defeasance had not occurred;
(4) no Default (other than that resulting from borrowing
    funds to be applied to make such deposit and any similar and
    simultaneous deposit relating to other Indebtedness and, in each
    case, the granting of Liens in connection therewith) shall have
    occurred and be continuing on the date of such deposit;
(5) such Legal Defeasance or Covenant Defeasance shall not
    result in a breach or violation of, or constitute a default
    under the Senior Credit Facilities or any other material
    agreement or instrument (other than the Indenture) to which the
    Issuer or any Guarantor is a party or by which the Issuer or any
    Guarantor is bound (other than that resulting from borrowing
    funds to be applied to make such deposit and any similar and
    simultaneous deposit relating to other Indebtedness and, in each
    case, the granting of Liens in connection therewith);
(6) the Issuer shall have delivered to the Trustee an
    Opinion of Counsel to the effect that, as of the date of such
    opinion and subject to customary assumptions and exclusions
    following the deposit, the trust funds will not be subject to
    the effect of Section 547 of Title 11 of the United
    States Code;
(7) the Issuer shall have delivered to the Trustee an
    Officer's Certificate stating that the deposit was not made
    by the Issuer with the intent of defeating, hindering, delaying
    or defrauding any creditors of the Issuer or any Guarantor or
    others; and
(8) the Issuer shall have delivered to the Trustee an
    Officer's Certificate and an Opinion of Counsel (which
    Opinion of Counsel may be subject to customary assumptions and
    exclusions) each stating that all conditions precedent provided
    for or relating to the Legal Defeasance or the Covenant
    Defeasance, as the case may be, have been complied with.
Satisfaction
    and Discharge
The Indenture will be discharged and will cease to be of further
    effect as to all Notes, when either:
(1) all Notes theretofore authenticated and delivered,
    except lost, stolen or destroyed Notes which have been replaced
    or paid and Notes for whose payment money has theretofore been
    deposited in trust, have been delivered to the Trustee for
    cancellation; or
(2) (a) all Notes not theretofore delivered to the
    Trustee for cancellation have become due and payable by reason
    of the making of a notice of redemption or otherwise, will
    become due and payable within one year or may be called for
    redemption within one year under arrangements satisfactory to
    the Trustee for the giving of notice of redemption by the
    Trustee in the name, and at the expense, of the
158
Table of Contents
Issuer, and the Issuer or any Guarantor has irrevocably
    deposited or caused to be deposited with the Trustee as trust
    funds in trust solely for the benefit of the Holders of the
    Notes, cash in U.S. dollars, Government Securities, or a
    combination thereof, in such amounts as will be sufficient
    without consideration of any reinvestment of interest to pay and
    discharge the entire indebtedness on the Notes not theretofore
    delivered to the Trustee for cancellation for principal,
    premium, if any, and accrued interest to the date of maturity or
    redemption;
(b) no Default (other than that resulting from borrowing
    funds to be applied to make such deposit and any similar and
    simultaneous deposit relating to other Indebtedness and, in each
    case, the granting of Liens in connection therewith) with
    respect to the Indenture or the Notes shall have occurred and be
    continuing on the date of such deposit or shall occur as a
    result of such deposit, and such deposit will not result in a
    breach or violation of, or constitute a default under, the
    Senior Credit Facilities or any other material agreement or
    instrument (other than the Indenture) to which the Issuer or any
    Guarantor is a party or by which the Issuer or any Guarantor is
    bound (other than that resulting from borrowing funds to be
    applied to make such deposit and any similar and simultaneous
    deposit relating to other Indebtedness and, in each case, the
    granting of Liens in connection therewith);
(c) the Issuer has paid or caused to be paid all sums
    payable by it under the Indenture; and
(d) the Issuer has delivered irrevocable instructions to
    the Trustee to apply the deposited money toward the payment of
    the Notes at maturity or the redemption date, as the case may be.
In addition, the Issuer must deliver an Officer's
    Certificate and an Opinion of Counsel to the Trustee stating
    that all conditions precedent to satisfaction and discharge have
    been satisfied.
Amendment,
    Supplement and Waiver
Except as provided in the next two succeeding paragraphs, the
    Indenture, any Guarantee, any Security Document and the Notes
    may be amended or supplemented with the consent of the Holders
    of at least a majority in principal amount of the Notes then
    outstanding, including consents obtained in connection with a
    purchase of, or tender offer or exchange offer for, Notes, and
    any existing Default or compliance with any provision of the
    Indenture, the Notes issued thereunder, any Guarantee or the
    Security Documents may be waived with the consent of the Holders
    of a majority in principal amount of the then outstanding Notes,
    other than Notes beneficially owned by the Issuer or its
    Affiliates (including consents obtained in connection with a
    purchase of or tender offer or exchange offer for the Notes).
The Indenture provides that, without the consent of each
    affected Holder of Notes, an amendment or waiver may not, with
    respect to any Notes held by a non-consenting Holder:
(1) reduce the principal amount of such Notes whose Holders
    must consent to an amendment, supplement or waiver;
(2) reduce the principal of or change the fixed final
    maturity of any such Note or alter or waive the provisions with
    respect to the redemption of such Notes (other than provisions
    relating to the covenants described above under the caption
    "Repurchase at the Option of Holders");
(3) reduce the rate of or change the time for payment of
    interest on any Note;
(4) waive a Default in the payment of principal of or
    premium, if any, or interest on the Notes, except a rescission
    of acceleration of the Notes by the Holders of at least a
    majority in aggregate principal amount of the Notes and a waiver
    of the payment default that resulted from such acceleration, or
    in respect of a covenant or provision contained in the Indenture
    or any Guarantee which cannot be amended or modified without the
    consent of all Holders;
(5) make any Note payable in money other than that stated
    therein;
(6) make any change in the provisions of the Indenture
    relating to waivers of past Defaults or the rights of Holders to
    receive payments of principal of or premium, if any, or interest
    on the Notes;
159
Table of Contents
(7) make any change in these amendment and waiver
    provisions;
(8) impair the right of any Holder to receive payment of
    principal of, or interest on such Holder's Notes on or
    after the due dates therefor or to institute suit for the
    enforcement of any payment on or with respect to such
    Holder's Notes;
(9) make any change to or modify the ranking of the Notes
    or the subordination of the Liens with respect to the Notes that
    would adversely affect the Holders; or
(10) except as expressly permitted by the Indenture, modify
    the Guarantees of any Significant Subsidiary in any manner
    adverse to the Holders of the Notes.
In addition, without the consent of at least 75% in aggregate
    principal amount of Notes then outstanding, an amendment,
    supplement or waiver may not:
(1) modify any Security Document or the provisions of the
    Indenture dealing with the Security Documents or application of
    trust moneys, or otherwise release any Collateral, in any manner
    materially adverse to the Holders other than in accordance with
    the Indenture, the Security Documents and the Intercreditor
    Agreements; or
(2) modify any Intercreditor Agreement in any manner
    materially adverse to the Holders other than in accordance with
    the Indenture, the Security Documents and the Intercreditor
    Agreements.
Notwithstanding the foregoing, the Issuer, any Guarantor (with
    respect to a Guarantee or the Indenture to which it is a party)
    and the Trustee may amend or supplement the Indenture, any
    Security Document and any Guarantee or Notes without the consent
    of any Holder;
(1) to cure any ambiguity, omission, mistake, defect or
    inconsistency;
(2) to provide for uncertificated Notes of such series in
    addition to or in place of certificated Notes;
(3) to comply with the covenant relating to mergers,
    consolidations and sales of assets;
(4) to provide for the assumption of the Issuer's or
    any Guarantor's obligations to the Holders;
(5) to make any change that would provide any additional
    rights or benefits to the Holders or that does not adversely
    affect the legal rights under the Indenture of any such Holder;
(6) to add covenants for the benefit of the Holders or to
    surrender any right or power conferred upon the Issuer or any
    Guarantor;
(7) to comply with requirements of the SEC in order to
    effect or maintain the qualification of the Indenture under the
    Trust Indenture Act;
(8) to evidence and provide for the acceptance and
    appointment under the Indenture of a successor Trustee
    thereunder pursuant to the requirements thereof;
(9) to provide for the issuance of Exchange Notes or
    private exchange notes, which are identical to Exchange Notes
    except that they are not freely transferable;
(10) to add a Guarantor under the Indenture;
(11) to conform the text of the Indenture, Security
    Documents, Guarantees or the Notes to any provision of this
    "Description of Notes" to the extent that such
    provision in this "Description of Notes" was intended
    to be a verbatim recitation of a provision of the Indenture,
    Security Documents, Guarantee or Notes;
(12) to make any amendment to the provisions of the
    Indenture relating to the transfer and legending of Notes as
    permitted by the Indenture, including, without limitation to
    facilitate the issuance and administration of the Notes;
provided
,
however
, that (i) compliance with
    the Indenture as so amended would not result in Notes being
    transferred in violation of the Securities Act or any applicable
    securities
160
Table of Contents
law and (ii) such amendment does not materially and
    adversely affect the rights of Holders to transfer Notes;
(13) to mortgage, pledge, hypothecate or grant any other
    Lien in favor of the Trustee for the benefit of the Holders of
    the Notes, as additional security for the payment and
    performance of all or any portion of the Obligations, in any
    property or assets, including any which are required to be
    mortgaged, pledged or hypothecated, or in which a Lien is
    required to be granted to or for the benefit of the Trustee or
    the Collateral Agent pursuant to the Indenture, any of the
    Security Documents or otherwise; or
(14) to release Collateral from the Lien of the Indenture
    and the Security Documents when permitted or required by the
    Security Documents or the Indenture.
The consent of the Holders is not necessary under the Indenture
    to approve the particular form of any proposed amendment. It is
    sufficient if such consent approves the substance of the
    proposed amendment.
Notices
Notices given by publication will be deemed given on the first
    date on which publication is made and notices given by
    first-class mail, postage prepaid, will be deemed given five
    calendar days after mailing.
Concerning
    the Trustee
The Indenture contains certain limitations on the rights of the
    Trustee thereunder, should it become a creditor of the Issuer,
    to obtain payment of claims in certain cases, or to realize on
    certain property received in respect of any such claim as
    security or otherwise. The Trustee is permitted to engage in
    other transactions; however, if it acquires any conflicting
    interest it must eliminate such conflict within 90 days,
    apply to the SEC for permission to continue or resign.
The Indenture provides that the Holders of a majority in
    principal amount of the outstanding Notes will have the right to
    direct the time, method and place of conducting any proceeding
    for exercising any remedy available to the Trustee, subject to
    certain exceptions. The Indenture provides that in case an Event
    of Default shall occur (which shall not be cured), the Trustee
    will be required, in the exercise of its power, to use the
    degree of care of a prudent person in the conduct of his own
    affairs. Subject to such provisions, the Trustee is under no
    obligation to exercise any of its rights or powers under the
    Indenture at the request of any Holder of the Notes, unless such
    Holder shall have offered to the Trustee security and indemnity
    satisfactory to it against any loss, liability or expense.
Governing
    Law
The Indenture, the Notes and any Guarantee are governed by and
    construed in accordance with the laws of the State of New York.
Certain
    Definitions
Set forth below are certain defined terms used in the Indenture.
    For purposes of the Indenture, unless otherwise specifically
    indicated, the term
"consolidated"
with respect
    to any Person refers to such Person on a consolidated basis in
    accordance with GAAP, but excluding from such consolidation any
    Unrestricted Subsidiary as if such Unrestricted Subsidiary were
    not an Affiliate of such Person.
"2006 Notes"
means the $1,000,000,000 aggregate
    principal amount of
    9
1
/
8
% Senior
    Secured Notes due 2014, the $3,200,000,000 aggregate principal
    amount of
    9
1
/
4
% Senior
    Secured Notes due 2016 and the $1,500,000,000
    9
5
/
8
%/10
3
/
8
% Senior
    Secured Toggle Notes due 2016, each issued by the Issuer under
    the 2006 Notes Indenture.
"2006 Notes Indenture"
means that certain
    Indenture, dated as of November 17, 2006, among the Issuer,
    the guarantors named on Schedule I thereto and The Bank of
    New York, as trustee.
161
Table of Contents
"ABL Facility"
means the Asset-Based Revolving
    Credit Agreement entered into as of November 17, 2006 by
    and among the Issuer, the lenders party thereto in their
    capacities as lenders thereunder and Bank of America, N.A., as
    Administrative Agent, including any guarantees, collateral
    documents, instruments and agreements executed in connection
    therewith, and any amendments, supplements, modifications,
    extensions, renewals, restatements, refundings or refinancings
    thereof and any indentures or credit facilities or commercial
    paper facilities with banks or other institutional lenders or
    investors that replace, refund or refinance any part of the
    loans, notes, other credit facilities or commitments thereunder,
    including any such replacement, refunding or refinancing
    facility or indenture that increases the amount borrowable
    thereunder or alters the maturity thereof (
provided
that
    such increase in borrowings is permitted under "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock"
    above).
"ABL Facility Cap"
means an amount equal to the
    greater of (x) $2,000.0 million and (y) 75% of
    the consolidated accounts receivable of the Issuer and its
    subsidiaries determined in accordance with GAAP.
"ABL Financing Entity"
means the Issuer and
    certain of its subsidiaries from time to time named as borrowers
    or guarantors under the ABL Facility.
"ABL Obligations"
means Obligations under the
    ABL Facility.
"ABL Secured Parties"
means each of
    (i) the ABL Collateral Agent on behalf of itself and the
    lenders under the ABL Facility and lenders or their affiliates
    counterparty to related Hedging Obligations and (ii) each
    other holder of ABL Obligations.
"Acquired Indebtedness"
means, with respect to
    any specified Person,
(1) Indebtedness of any other Person existing at the time
    such other Person is merged with or into or became a Restricted
    Subsidiary of such specified Person, including Indebtedness
    incurred in connection with, or in contemplation of, such other
    Person merging with or into or becoming a Restricted Subsidiary
    of such specified Person, and
(2) Indebtedness secured by a Lien encumbering any asset
    acquired by such specified Person.
"Additional Interest"
means all additional
    interest then owing pursuant to the Registration Rights
    Agreement.
"Affiliate"
of any specified Person means any
    other Person directly or indirectly controlling or controlled by
    or under direct or indirect common control with such specified
    Person. For purposes of this definition, "control"
    (including, with correlative meanings, the terms
    "controlling," "controlled by" and
    "under common control with"), as used with respect to
    any Person, shall mean the possession, directly or indirectly,
    of the power to direct or cause the direction of the management
    or policies of such Person, whether through the ownership of
    voting securities, by agreement or otherwise.
"Applicable Premium"
means, with respect to any
    Note on any Redemption Date, the greater of:
(1) 1.0% of the principal amount of such Note; and
(2) the excess, if any, of (a) the present value at
    such Redemption Date of (i) the redemption price of
    such Note at February 15, 2013 (such redemption price being
    set forth in the tables appearing above under the caption
    "Optional Redemption"), plus (ii) all required
    interest payments due on such Note through February 15,
    2013 (excluding accrued but unpaid interest to the
    Redemption Date), computed using a discount rate equal to
    the Treasury Rate as of such Redemption Date plus
    50 basis points; over (b) the principal amount of such
    Note.
"Asset Sale"
means:
(1) the sale, conveyance, transfer or other disposition,
    whether in a single transaction or a series of related
    transactions, of property or assets (including by way of a Sale
    and Lease-Back Transaction) of the Issuer or any of its
    Restricted Subsidiaries (each referred to in this definition as
    a "disposition"); or
162
Table of Contents
(2) the issuance or sale of Equity Interests of any
    Restricted Subsidiary, whether in a single transaction or a
    series of related transactions (other than Preferred Stock of
    Restricted Subsidiaries issued in compliance with the covenant
    described under "Certain Covenants — Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock");
in each case, other than:
(a) any disposition of Cash Equivalents or Investment Grade
    Securities or obsolete or worn out equipment in the ordinary
    course of business or any disposition of inventory or goods (or
    other assets) held for sale in the ordinary course of business;
(b) the disposition of all or substantially all of the
    assets of the Issuer in a manner permitted pursuant to the
    provisions described above under "Certain
    Covenants — Merger, Consolidation or Sale of All or
    Substantially All Assets" or any disposition that
    constitutes a Change of Control pursuant to the Indenture;
(c) the making of any Restricted Payment or Permitted
    Investment that is permitted to be made, and is made, under the
    covenant described above under "Certain
    Covenants — Limitation on Restricted Payments";
(d) any disposition of assets or issuance or sale of Equity
    Interests of any Restricted Subsidiary in any transaction or
    series of related transactions with an aggregate fair market
    value of less than $100.0 million;
(e) any disposition of property or assets or issuance of
    securities by a Restricted Subsidiary of the Issuer to the
    Issuer or by the Issuer or a Restricted Subsidiary of the Issuer
    to another Restricted Subsidiary of the Issuer;
(f) to the extent allowable under Section 1031 of the
    Code or any comparable or successor provision, any exchange of
    like property (excluding any boot thereon) for use in a Similar
    Business;
(g) the lease, assignment or
sub-lease
of
    any real or personal property in the ordinary course of business;
(h) any issuance or sale of Equity Interests in, or
    Indebtedness or other securities of, an Unrestricted Subsidiary;
(i) foreclosures on assets;
(j) sales of accounts receivable, or participations
    therein, in connection with the ABL Facility or any Receivables
    Facility;
(k) any financing transaction with respect to property
    built or acquired by the Issuer or any Restricted Subsidiary
    after November 17, 2006, including Sale and Lease-Back
    Transactions and asset securitizations permitted by the
    Indenture;
(l) dispositions in the ordinary course of business by any
    Restricted Subsidiary (including, without limitation, HCI)
    engaged in the insurance business in order to provide insurance
    to the Issuer and its Subsidiaries;
(m) sales, transfers and other dispositions of Investments
    in joint ventures to the extent required by, or made pursuant
    to, customary buy/sell arrangements between the joint venture
    parties set forth in joint venture arrangements and similar
    binding arrangements;
(n) any issuance or sale of Equity Interests or
    dispositions in connection with ordinary course syndications of
    Subsidiaries or joint ventures owning or operating one or more
    healthcare facilities, including, without limitation, hospitals,
    ambulatory surgery centers, outpatient diagnostic centers or
    imaging centers in any transaction or series of related
    transactions with an aggregate fair market value of less than
    $100.0 million; and
163
Table of Contents
(o) any issuance or sale of Equity Interests of any
    Restricted Subsidiary (including, without limitation,
    HealthTrust Purchasing Group, L.P.) to any Person operating in a
    Similar Business for which such Restricted Subsidiary provides
    shared purchasing, billing, collection or similar services in
    the ordinary course of business.
"Asset Sale Offer"
has the meaning set forth in
    the fourth paragraph under "Repurchase at the Option of
    Holders — Asset Sales."
"Bankruptcy Code"
means Title 11 of the
    United States Code, as amended.
"Bankruptcy Law"
means the Bankruptcy Code and
    any similar federal, state or foreign law for the relief of
    debtors.
"Business Day"
means each day which is not a
    Legal Holiday.
"Capital Stock"
means:
(1) in the case of a corporation, corporate stock;
(2) in the case of an association or business entity, any
    and all shares, interests, participations, rights or other
    equivalents (however designated) of corporate stock;
(3) in the case of a partnership or limited liability
    company, partnership or membership interests (whether general or
    limited); and
(4) any other interest or participation that confers on a
    Person the right to receive a share of the profits and losses
    of, or distributions of assets of, the issuing Person.
"Capitalized Lease Obligation"
means, at the
    time any determination thereof is to be made, the amount of the
    liability in respect of a capital lease that would at such time
    be required to be capitalized and reflected as a liability on a
    balance sheet (excluding the footnotes thereto) in accordance
    with GAAP.
"Capitalized Software Expenditures"
means, for
    any period, the aggregate of all expenditures (whether paid in
    cash or accrued as liabilities) by a Person and its Restricted
    Subsidiaries during such period in respect of purchased software
    or internally developed software and software enhancements that,
    in conformity with GAAP, are or are required to be reflected as
    capitalized costs on the consolidated balance sheet of a Person
    and its Restricted Subsidiaries.
"Cash Equivalents"
means:
(1) United States dollars;
(2) euros or any national currency of any participating
    member state of the EMU or such local currencies held by the
    Company and its Restricted Subsidiaries from time to time in the
    ordinary course of business;
(3) securities issued or directly and fully and
    unconditionally guaranteed or insured by the
    U.S. government (or any agency or instrumentality thereof
    the securities of which are unconditionally guaranteed as a full
    faith and credit obligation of the U.S. government) with
    maturities of 24 months or less from the date of
    acquisition;
(4) certificates of deposit, time deposits and eurodollar
    time deposits with maturities of one year or less from the date
    of acquisition, bankers' acceptances with maturities not
    exceeding one year and overnight bank deposits, in each case
    with any commercial bank having capital and surplus of not less
    than $500.0 million in the case of U.S. banks and
    $100.0 million (or the U.S. dollar equivalent as of
    the date of determination) in the case of
non-U.S. banks;
(5) repurchase obligations for underlying securities of the
    types described in clauses (3) and (4) entered into
    with any financial institution meeting the qualifications
    specified in clause (4) above;
(6) commercial paper rated at least
P-1
by
    Moody's or at least
A-1
by
    S&P and in each case maturing within 24 months after
    the date of creation thereof;
164
Table of Contents
(7) marketable short-term money market and similar
    securities having a rating of at least
P-2
or
A-2
from
    either Moody's or S&P, respectively (or, if at any
    time neither Moody's nor S&P shall be rating such
    obligations, an equivalent rating from another Rating Agency)
    and in each case maturing within 24 months after the date
    of creation thereof;
(8) investment funds investing 95% of their assets in
    securities of the types described in clauses (1) through
    (7) above;
(9) readily marketable direct obligations issued by any
    state, commonwealth or territory of the United States or any
    political subdivision or taxing authority thereof having an
    Investment Grade Rating from either Moody's or S&P
    with maturities of 24 months or less from the date of
    acquisition;
(10) Indebtedness or Preferred Stock issued by Persons with
    a rating of A or higher from S&P or A2 or higher from
    Moody's with maturities of 24 months or less from the
    date of acquisition; and
(11) Investments with average maturities of 24 months
    or less from the date of acquisition in money market funds rated
    AAA- (or the equivalent thereof) or better by S&P or Aaa3
    (or the equivalent thereof) or better by Moody's.
Notwithstanding the foregoing, Cash Equivalents shall include
    amounts denominated in currencies other than those set forth in
    clauses (1) and (2) above;
provided
that such
    amounts are converted into any currency listed in
    clauses (1) and (2) as promptly as practicable and in
    any event within ten Business Days following the receipt of such
    amounts.
"Change of Control"
means the occurrence of any
    of the following:
(1) the sale, lease or transfer, in one or a series of
    related transactions, of all or substantially all of the assets
    of the Issuer and its Subsidiaries, taken as a whole, to any
    Person other than a Permitted Holder; or
(2) the Issuer becomes aware (by way of a report or any
    other filing pursuant to Section 13(d) of the Exchange Act,
    proxy, vote, written notice or otherwise) of the acquisition by
    any Person or group (within the meaning of Section 13(d)(3)
    or Section 14(d)(2) of the Exchange Act, or any successor
    provision), including any group acting for the purpose of
    acquiring, holding or disposing of securities (within the
    meaning of
Rule 13d-5(b)(1)
under the Exchange Act), other than the Permitted Holders, in a
    single transaction or in a related series of transactions, by
    way of merger, consolidation or other business combination or
    purchase of beneficial ownership (within the meaning of
Rule 13d-3
under the Exchange Act, or any successor provision) of 50% or
    more of the total voting power of the Voting Stock of the Issuer
    or any of its direct or indirect parent companies holding
    directly or indirectly 100% of the total voting power of the
    Voting Stock of the Issuer.
"Code"
means the Internal Revenue Code of 1986,
    as amended, or any successor thereto.
"Collateral"
means, collectively, the Shared
    Receivables Collateral and Non-Receivables Collateral.
"Collateral Asset Sale Offer"
has the meaning
    set forth in the third paragraph under "Repurchase at the
    Option of Holders — Asset Sales."
"Collateral Excess Proceeds"
has the meaning
    set forth in the third paragraph under "Repurchase at the
    Option of Holders — Asset Sales."
"Consolidated Depreciation and Amortization
    Expense"
means with respect to any Person for any
    period, the total amount of depreciation and amortization
    expense, including the amortization of deferred financing fees,
    debt issuance costs, commissions, fees and expenses and
    Capitalized Software Expenditures, of such Person and its
    Restricted Subsidiaries for such period on a consolidated basis
    and otherwise determined in accordance with GAAP.
165
Table of Contents
"Consolidated Interest Expense"
means, with
    respect to any Person for any period, without duplication, the
    sum of:
(1) consolidated interest expense of such Person and its
    Restricted Subsidiaries for such period, to the extent such
    expense was deducted (and not added back) in computing
    Consolidated Net Income (including (a) amortization of
    original issue discount resulting from the issuance of
    Indebtedness at less than par, (b) all commissions,
    discounts and other fees and charges owed with respect to
    letters of credit or bankers' acceptances,
    (c) non-cash interest payments (but excluding any non-cash
    interest expense attributable to the movement in the mark to
    market valuation of Hedging Obligations or other derivative
    instruments pursuant to GAAP), (d) the interest component
    of Capitalized Lease Obligations, and (e) net payments, if
    any, pursuant to interest rate Hedging Obligations with respect
    to Indebtedness, and excluding (u) accretion or accrual of
    discounted liabilities not constituting Indebtedness,
    (v) any expense resulting from the discounting of the
    Existing Notes or other Indebtedness in connection with the
    application of recapitalization accounting or, if applicable,
    purchase accounting, (w) any Additional Interest and any
    comparable "additional interest" with respect to other
    securities, (x) amortization of deferred financing fees,
    debt issuance costs, commissions, fees and expenses,
    (y) any expensing of bridge, commitment and other financing
    fees and (z) commissions, discounts, yield and other fees
    and charges (including any interest expense) related to any
    Receivables Facility); plus
(2) consolidated capitalized interest of such Person and
    its Restricted Subsidiaries for such period, whether paid or
    accrued; less
(3) interest income for such period.
For purposes of this definition, interest on a Capitalized Lease
    Obligation shall be deemed to accrue at an interest rate
    reasonably determined by such Person to be the rate of interest
    implicit in such Capitalized Lease Obligation in accordance with
    GAAP.
"Consolidated Leverage Ratio"
, with respect to
    any Person as of any date of determination, means the ratio of
    (x) Consolidated Total Indebtedness of such Person as of
    the end of the most recent fiscal quarter for which internal
    financial statements are available immediately preceding the
    date on which such event for which such calculation is being
    made shall occur to (y) the aggregate amount of EBITDA of
    such Person for the period of the most recently ended four full
    consecutive fiscal quarters for which internal financial
    statements are available immediately preceding the date on which
    such event for which such calculation is being made shall occur,
    in each case with such pro forma adjustments to Consolidated
    Total Indebtedness and EBITDA as are appropriate and consistent
    with the pro forma adjustment provisions set forth in the
    definition of "Fixed Charge Coverage Ratio."
"Consolidated Net Income"
means, with respect
    to any Person for any period, the aggregate of the Net Income of
    such Person for such period, on a consolidated basis, and
    otherwise determined in accordance with GAAP;
provided
,
however
, that, without duplication,
(1) any after-tax effect of extraordinary, non-recurring or
    unusual gains or losses (less all fees and expenses relating
    thereto) or expenses, severance, relocation costs, consolidation
    and closing costs, integration and facilities opening costs,
    business optimization costs, transition costs, restructuring
    costs, signing, retention or completion bonuses, and
    curtailments or modifications to pension and post-retirement
    employee benefit plans shall be excluded,
(2) the cumulative effect of a change in accounting
    principles during such period shall be excluded,
(3) any after-tax effect of income (loss) from disposed,
    abandoned or discontinued operations and any net after-tax gains
    or losses on disposal of disposed, abandoned, transferred,
    closed or discontinued operations shall be excluded,
(4) any after-tax effect of gains or losses (less all fees
    and expenses relating thereto) attributable to asset
    dispositions or abandonments other than in the ordinary course
    of business, as determined in good faith by the Issuer, shall be
    excluded,
166
Table of Contents
(5) the Net Income for such period of any Person that is an
    Unrestricted Subsidiary shall be excluded, and, solely for the
    purpose of determining the amount available for Restricted
    Payments under clause 3(a) of the first paragraph of
    "Certain Covenants — Limitation on Restricted
    Payments," the Net Income for such period of any Person
    that is not a Subsidiary or that is accounted for by the equity
    method of accounting shall be excluded; provided that
    Consolidated Net Income of the Issuer shall be increased by the
    amount of dividends or distributions or other payments that are
    actually paid in cash (or to the extent converted into cash) to
    the referent Person or a Restricted Subsidiary thereof in
    respect of such period,
(6) solely for the purpose of determining the amount
    available for Restricted Payments under clause (3)(a) of the
    first paragraph of "Certain Covenants —
    Limitation on Restricted Payments," the Net Income for such
    period of any Restricted Subsidiary (other than any Guarantor)
    shall be excluded to the extent that the declaration or payment
    of dividends or similar distributions by that Restricted
    Subsidiary of its Net Income is not at the date of determination
    wholly permitted without any prior governmental approval (which
    has not been obtained) or, directly or indirectly, by the
    operation of the terms of its charter or any agreement,
    instrument, judgment, decree, order, statute, rule, or
    governmental regulation applicable to that Restricted Subsidiary
    or its stockholders, unless such restriction with respect to the
    payment of dividends or similar distributions has been legally
    waived; provided that Consolidated Net Income of the Issuer will
    be increased by the amount of dividends or other distributions
    or other payments actually paid in cash (or to the extent
    converted into cash) or Cash Equivalents to the Issuer or a
    Restricted Subsidiary thereof in respect of such period, to the
    extent not already included therein,
(7) effects of adjustments (including the effects of such
    adjustments pushed down to the Issuer and its Restricted
    Subsidiaries) in the property, equipment, inventory, software
    and other intangible assets, deferred revenue and debt line
    items in such Person's consolidated financial statements
    pursuant to GAAP resulting from the application of
    recapitalization accounting or, if applicable, purchase
    accounting in relation to the Transactions or any consummated
    acquisition or the amortization or write-off of any amounts
    thereof, net of taxes, shall be excluded,
(8) any after-tax effect of income (loss) from the early
    extinguishment of Indebtedness or Hedging Obligations or other
    derivative instruments shall be excluded,
(9) any impairment charge or asset write-off, including,
    without limitation, impairment charges or asset write-offs
    related to intangible assets, long-lived assets or investments
    in debt and equity securities, in each case, pursuant to GAAP
    and the amortization of intangibles arising pursuant to GAAP
    shall be excluded,
(10) any non-cash compensation expense recorded from grants
    of stock appreciation or similar rights, stock options,
    restricted stock or other rights, and any cash charges
    associated with the rollover, acceleration or payout of Equity
    Interests by management of the Company or any of its direct or
    indirect parent companies in connection with the Transaction,
    shall be excluded,
(11) any fees and expenses incurred during such period, or
    any amortization thereof for such period, in connection with any
    acquisition, Investment, Asset Sale, issuance or repayment of
    Indebtedness, issuance of Equity Interests, refinancing
    transaction or amendment or modification of any debt instrument
    (in each case, including any such transaction consummated prior
    to the Issue Date and any such transaction undertaken but not
    completed) and any charges or non-recurring merger costs
    incurred during such period as a result of any such transaction
    shall be excluded,
(12) accruals and reserves that are established or adjusted
    within twelve months after November 17, 2006 that are so
    required to be established as a result of the Transaction in
    accordance with GAAP, or changes as a result of adoption or
    modification of accounting policies, shall be excluded, and
(13) to the extent covered by insurance and actually
    reimbursed, or, so long as the Issuer has made a determination
    that there exists reasonable evidence that such amount will in
    fact be reimbursed by the insurer and only to the extent that
    such amount is (a) not denied by the applicable carrier in
    writing within 180 days and (b) in fact reimbursed
    within 365 days of the date of such evidence (with a
    deduction for any amount so added back to the extent not so
    reimbursed within 365 days), expenses with respect to
    liability or casualty events or business interruption shall be
    excluded.
167
Table of Contents
Notwithstanding the foregoing, for the purpose of the covenant
    described under "Certain Covenants — Limitation
    on Restricted Payments" only (other than clause (3)(d)
    thereof), there shall be excluded from Consolidated Net Income
    any income arising from any sale or other disposition of
    Restricted Investments made by the Issuer and its Restricted
    Subsidiaries, any repurchases and redemptions of Restricted
    Investments from the Issuer and its Restricted Subsidiaries, any
    repayments of loans and advances which constitute Restricted
    Investments by the Issuer or any of its Restricted Subsidiaries,
    any sale of the stock of an Unrestricted Subsidiary or any
    distribution or dividend from an Unrestricted Subsidiary, in
    each case only to the extent such amounts increase the amount of
    Restricted Payments permitted under such covenant pursuant to
    clause (3)(d) thereof.
"Consolidated Secured Debt Ratio"
as of any
    date of determination, means the ratio of (1) Consolidated
    Total Indebtedness of the Issuer and its Restricted Subsidiaries
    that is secured by Liens as of the end of the most recent fiscal
    period for which internal financial statements are available
    immediately preceding the date on which such event for which
    such calculation is being made shall occur to (2) the
    Issuer's EBITDA for the most recently ended four full
    fiscal quarters for which internal financial statements are
    available immediately preceding the date on which such event for
    which such calculation is being made shall occur, in each case
    with such pro forma adjustments to Consolidated Total
    Indebtedness and EBITDA as are appropriate and consistent with
    the pro forma adjustment provisions set forth in the definition
    of "Fixed Charge Coverage Ratio."
"Consolidated Total Indebtedness"
means, as at
    any date of determination, an amount equal to the sum of
    (1) the aggregate amount of all outstanding Indebtedness of
    the Issuer and its Restricted Subsidiaries on a consolidated
    basis consisting of Indebtedness for borrowed money, Obligations
    in respect of Capitalized Lease Obligations and debt obligations
    evidenced by promissory notes and similar instruments (and
    excluding, for the avoidance of doubt, all obligations relating
    to Receivables Facilities) and (2) the aggregate amount of
    all outstanding Disqualified Stock of the Issuer and all
    Preferred Stock of its Restricted Subsidiaries on a consolidated
    basis, with the amount of such Disqualified Stock and Preferred
    Stock equal to the greater of their respective voluntary or
    involuntary liquidation preferences and maximum fixed repurchase
    prices, in each case determined on a consolidated basis in
    accordance with GAAP. For purposes hereof, the "maximum
    fixed repurchase price" of any Disqualified Stock or
    Preferred Stock that does not have a fixed repurchase price
    shall be calculated in accordance with the terms of such
    Disqualified Stock or Preferred Stock as if such Disqualified
    Stock or Preferred Stock were purchased on any date on which
    Consolidated Total Indebtedness shall be required to be
    determined pursuant to the Indenture, and if such price is based
    upon, or measured by, the fair market value of such Disqualified
    Stock or Preferred Stock, such fair market value shall be
    determined reasonably and in good faith by the Issuer.
"Contingent Obligations"
means, with respect to
    any Person, any obligation of such Person guaranteeing any
    leases, dividends or other obligations that do not constitute
    Indebtedness
("primary obligations")
of any
    other Person (the
"primary obligor"
) in any
    manner, whether directly or indirectly, including, without
    limitation, any obligation of such Person, whether or not
    contingent,
(1) to purchase any such primary obligation or any property
    constituting direct or indirect security therefor,
(2) to advance or supply funds
(a) for the purchase or payment of any such primary
    obligation, or
(b) to maintain working capital or equity capital of the
    primary obligor or otherwise to maintain the net worth or
    solvency of the primary obligor, or
(3) to purchase property, securities or services primarily
    for the purpose of assuring the owner of any such primary
    obligation of the ability of the primary obligor to make payment
    of such primary obligation against loss in respect thereof.
"Credit Facilities"
means, with respect to the
    Issuer or any of its Restricted Subsidiaries, one or more debt
    facilities, including the Senior Credit Facilities, or other
    financing arrangements (including, without
168
Table of Contents
limitation, commercial paper facilities or indentures) providing
    for revolving credit loans, term loans, letters of credit or
    other long-term indebtedness, including any notes, mortgages,
    guarantees, collateral documents, instruments and agreements
    executed in connection therewith, and any amendments,
    supplements, modifications, extensions, renewals, restatements
    or refundings thereof and any indentures or credit facilities or
    commercial paper facilities that replace, refund or refinance
    any part of the loans, notes, other credit facilities or
    commitments thereunder, including any such replacement,
    refunding or refinancing facility or indenture that increases
    the amount permitted to be borrowed thereunder or alters the
    maturity thereof (
provided
that such increase in
    borrowings is permitted under "Certain Covenants
    — Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock") or
    adds Restricted Subsidiaries as additional borrowers or
    guarantors thereunder and whether by the same or any other
    agent, lender or group of lenders.
"Default"
means any event that is, or with the
    passage of time or the giving of notice or both would be, an
    Event of Default.
"Delayed Equity Amount"
means any equity
    contribution of the Investors, the Frist Entities or certain
    other management investors described in the Offering Memorandum
    on or before March 31, 2007, the proceeds of which are used
    to repay borrowings under the senior secured revolving credit
    facility included in the General Credit Facility or the ABL
    Facility in the manner described in the Offering Memorandum.
"Designated Non-cash Consideration"
means the
    fair market value of non-cash consideration received by the
    Issuer or a Restricted Subsidiary in connection with an Asset
    Sale that is so designated as Designated Non-cash Consideration
    pursuant to an Officer's Certificate, setting forth the
    basis of such valuation, executed by the principal financial
    officer of the Issuer, less the amount of cash or Cash
    Equivalents received in connection with a subsequent sale of or
    collection on such Designated Non-cash Consideration.
"Designated Preferred Stock"
means Preferred
    Stock of the Issuer or any parent corporation thereof (in each
    case other than Disqualified Stock) that is issued for cash
    (other than to a Restricted Subsidiary or an employee stock
    ownership plan or trust established by the Issuer or any of its
    Subsidiaries) and is so designated as Designated Preferred
    Stock, pursuant to an Officer's Certificate executed by the
    principal financial officer of the Issuer or the applicable
    parent corporation thereof, as the case may be, on the issuance
    date thereof, the cash proceeds of which are excluded from the
    calculation set forth in clause (3) of the first paragraph
    under "Certain Covenants — Limitation on
    Restricted Payments."
"Discharge of First Lien Obligations"
shall
    mean the satisfaction and discharge of all of the First Lien
    Obligations in full in cash, pursuant to the First Lien
    Documents and the General Intercreditor Agreement.
"Disqualified Stock"
means, with respect to any
    Person, any Capital Stock of such Person which, by its terms, or
    by the terms of any security into which it is convertible or for
    which it is putable or exchangeable, or upon the happening of
    any event, matures or is mandatorily redeemable (other than
    solely as a result of a change of control or asset sale)
    pursuant to a sinking fund obligation or otherwise, or is
    redeemable at the option of the holder thereof (other than
    solely as a result of a change of control or asset sale), in
    whole or in part, in each case prior to the date 91 days
    after the earlier of the maturity date of the Notes or the date
    the Notes are no longer outstanding;
provided
,
however
, that if such Capital Stock is issued to any plan
    for the benefit of employees of the Issuer or its Subsidiaries
    or by any such plan to such employees, such Capital Stock shall
    not constitute Disqualified Stock solely because it may be
    required to be repurchased by the Issuer or its Subsidiaries in
    order to satisfy applicable statutory or regulatory obligations.
"EBITDA"
means, with respect to any Person for
    any period, the Consolidated Net Income of such Person for such
    period
(1) increased (without duplication) by:
(a) provision for taxes based on income or profits or
    capital gains, including, without limitation, foreign, federal,
    state, franchise and similar taxes (such as the Pennsylvania
    capital tax) and foreign withholding taxes (including penalties
    and interest related to such taxes or arising from tax
    examinations) of such Person paid or accrued during such period
    deducted (and not added back) in computing Consolidated Net
    Income;
plus
169
Table of Contents
(b) Fixed Charges of such Person for such period (including
    (x) net losses on Hedging Obligations or other derivative
    instruments entered into for the purpose of hedging interest
    rate risk and (y) costs of surety bonds in connection with
    financing activities, in each case, to the extent included in
    Fixed Charges), together with items excluded from the definition
    of "Consolidated Interest Expense" pursuant to clauses
    (1)(u), (v), (w), (x), (y) and (z) of the definition
    thereof, and, in each such case, to the extent the same were
    deducted (and not added back) in calculating such Consolidated
    Net Income;
plus
(c) Consolidated Depreciation and Amortization Expense of
    such Person for such period to the extent the same was deducted
    (and not added back) in computing Consolidated Net Income;
plus
(d) any expenses or charges (other than depreciation or
    amortization expense) related to any Equity Offering, Permitted
    Investment, acquisition, disposition, recapitalization or the
    incurrence of Indebtedness permitted to be incurred by the
    Indenture (including a refinancing thereof) (whether or not
    successful), including (i) such fees, expenses or charges
    related to the offering of the Notes and any Credit Facilities
    and (ii) any amendment or other modification of the Notes,
    and, in each case, deducted (and not added back) in computing
    Consolidated Net Income;
plus
(e) the amount of any restructuring charge or reserve
    deducted (and not added back) in such period in computing
    Consolidated Net Income, including any one-time costs incurred
    in connection with acquisitions after November 17, 2006 and
    costs related to the closure
and/or
consolidation of facilities;
plus
(f) any other non-cash charges, including any write-offs or
    write-downs, reducing Consolidated Net Income for such period
    (provided that if any such non-cash charges represent an accrual
    or reserve for potential cash items in any future period, the
    cash payment in respect thereof in such future period shall be
    subtracted from EBITDA to such extent, and excluding
    amortization of a prepaid cash item that was paid in a prior
    period);
plus
(g) the amount of any minority interest expense consisting
    of income attributable to minority equity interests of third
    parties deducted (and not added back) in such period in
    calculating Consolidated Net Income;
plus
(h) the amount of management, monitoring, consulting and
    advisory fees and related expenses paid in such period to the
    Investors and the Frist Entities to the extent otherwise
    permitted under "Certain Covenants — Transactions
    with Affiliates"; plus
(i) the amount of net cost savings projected by the Issuer
    in good faith to be realized as a result of specified actions
    taken or to be taken (calculated on a pro forma basis as though
    such cost savings had been realized on the first day of such
    period), net of the amount of actual benefits realized during
    such period from such actions; provided that (w) such cost
    savings are reasonably identifiable and factually supportable,
    (x) such actions have been taken or are to be taken within
    15 months after the date of determination to take such
    action, (y) no cost savings shall be added pursuant to this
    clause (i) to the extent duplicative of any expenses or
    charges relating to such cost savings that are included in
    clause (e) above with respect to such period and
    (z) the aggregate amount of cost savings added pursuant to
    this clause (i) shall not exceed $150.0 million for
    any four consecutive quarter period (which adjustments may be
    incremental to pro forma adjustments made pursuant to the second
    paragraph of the definition of "Fixed Charge Coverage
    Ratio"); plus
(j) the amount of loss on sales of receivables and related
    assets to the Receivables Subsidiary in connection with a
    Receivables Facility; plus
(k) any costs or expense incurred by the Issuer or a
    Restricted Subsidiary pursuant to any management equity plan or
    stock option plan or any other management or employee benefit
    plan or agreement or any stock subscription or shareholder
    agreement, to the extent that such cost or expenses are funded
    with cash proceeds contributed to the capital of the Issuer or
    net cash proceeds of an issuance of Equity Interests of the
    Issuer (other than Disqualified Stock) solely to the extent that
    such net cash
170
Table of Contents
proceeds are excluded from the calculation set forth in
    clause (3) of the first paragraph under "Certain
    Covenants — Limitation on Restricted Payments";
(2) decreased by (without duplication) non-cash gains
    increasing Consolidated Net Income of such Person for such
    period, excluding any non-cash gains to the extent they
    represent the reversal of an accrual or reserve for a potential
    cash item that reduced EBITDA in any prior period; and
(3) increased or decreased by (without duplication):
(a) any net gain or loss resulting in such period from
    Hedging Obligations and the application of Statement of
    Financial Accounting Standards No. 133; plus or minus, as
    applicable,
(b) any net gain or loss resulting in such period from
    currency translation gains or losses related to currency
    remeasurements of Indebtedness (including any net loss or gain
    resulting from Hedging Obligations for currency exchange risk).
"EMU"
means the economic and monetary union as
    contemplated in the Treaty on European Union.
"Equity Interests"
means Capital Stock and all
    warrants, options or other rights to acquire Capital Stock, but
    excluding any debt security that is convertible into, or
    exchangeable for, Capital Stock.
"Equity Offering"
means any public or private
    sale of common stock or Preferred Stock of the Issuer or any of
    its direct or indirect parent companies (excluding Disqualified
    Stock), other than:
(1) public offerings with respect to the Issuer's or
    any direct or indirect parent company's common stock
    registered on
Form S-8;
(2) issuances to any Subsidiary of the Issuer; and
(3) any such public or private sale that constitutes an
    Excluded Contribution.
"euro"
means the single currency of
    participating member states of the EMU.
"European Collateral"
has the meaning set forth
    under "Description of Other Indebtedness — Senior
    Secured Credit Facilities — Guarantee and
    Security."
"Event of Default"
has the meaning set forth
    under "Events of Default and Remedies."
"Excess Proceeds"
has the meaning set forth in
    the fourth paragraph under "Repurchase at the Option of
    Holders — Asset Sales."
"Exchange Act"
means the Securities Exchange
    Act of 1934, as amended, and the rules and regulations of the
    SEC promulgated thereunder.
"Exchange Notes"
means any notes issued in
    exchange for the Notes pursuant to the Registration Rights
    Agreement or similar agreement.
"Excluded Contribution"
means net cash
    proceeds, marketable securities or Qualified Proceeds received
    by the Issuer after November 17, 2006 from
(1) contributions to its common equity capital, and
(2) the sale (other than to a Subsidiary of the Issuer or
    to any management equity plan or stock option plan or any other
    management or employee benefit plan or agreement of the Issuer)
    of Capital Stock (other than Disqualified Stock and Designated
    Preferred Stock) of the Issuer,
in each case designated as Excluded Contributions pursuant to an
    Officer's Certificate executed by the principal financial
    officer of the Issuer on the date such capital contributions are
    made or the date such Equity Interests are sold, as the case may
    be, which are excluded from the calculation set forth in
    clause (3) of the first paragraph under "Certain
    Covenants — Limitation on Restricted Payments."
"Existing Notes"
means the $121.2 million
    aggregate principal amount of 8.700% medium-term notes due 2010,
    $691.2 million aggregate principal amount of
    8.750% notes due 2010, £150.0 million aggregate
171
Table of Contents
principal amount of 8.750% notes due 2010,
    $475.8 million aggregate principal amount of
    7.875% notes due 2011, $500.0 million aggregate
    principal amount of 6.950% notes due 2012,
    $500.0 million aggregate principal amount of
    6.300% notes due 2012, $500.0 million aggregate
    principal amount of 6.250% notes due 2013,
    $500.0 million aggregate principal amount of
    6.750% notes due 2013, $500.0 million aggregate
    principal amount of 5.750% notes due 2014,
    $121.1 million aggregate principal amount of 9.000%
    medium-term notes due 2014, $750.0 million aggregate
    principal amount of 6.375% notes due 2015,
    $150.0 million aggregate principal amount of
    7.190% debentures due 2015, $1,000.0 million aggregate
    principal amount of 6.500% notes due 2016,
    $135.6 million aggregate principal amount of
    7.500% debentures due 2023, $150.0 million aggregate
    principal amount of 8.360% debentures due 2024,
    $291.4 million aggregate principal amount of
    7.690% notes due 2025, $125.0 million aggregate
    principal amount of 7.580% medium-term notes due 2025,
    $150.0 million aggregate principal amount of
    7.050% debentures due 2027, $250.0 million aggregate
    principal amount of 7.500% notes due 2033,
    $100.0 million aggregate principal amount of
    7.750% debentures due 2036 and $200.0 million
    aggregate principal amount of 7.500% debentures due 2095,
    each issued by the Issuer and outstanding on November 17,
    2006.
"Existing Notes Indenture"
means that certain
    Indenture, dated as of December 16, 1993, between Columbia
    Healthcare Corporation and The First National Bank of Chicago,
    as Trustee, as amended by the First Supplemental Indenture,
    dated as of May 25, 2000, between the Issuer and Bank One
    Trust Company, N.A., as Trustee, the Second Supplemental
    Indenture, dated as of July 1, 2001, between the Issuer and
    Bank One Trust Company, N.A., as Trustee, and the Third
    Supplemental Indenture, dated as of December 5, 2001,
    between the Issuer and The Bank of New York, as Trustee.
"First Lien Collateral"
means all of the assets
    of the Issuer or any Guarantor, whether real, personal or mixed,
    with respect to which a Lien has been granted as security for
    any First Lien Obligations pursuant to a First Lien Document.
"First Lien Collateral Agent"
shall mean Bank
    of America, N.A., in its capacity as administrative agent and
    collateral agent for the lenders and other secured parties under
    the General Credit Facility and the other First Lien Documents,
    together with its successors and permitted assigns under the
    General Credit Facility exercising substantially the same rights
    and powers; and in each case provided that if such First Lien
    Collateral Agent is not Bank of America, N.A., such First Lien
    Collateral Agent shall have become a party to the Intercreditor
    Agreements and the other applicable First Lien Security
    Documents.
"First Lien Documents"
means the credit,
    guarantee and security documents governing the First Lien
    Obligations, including, without limitation, the General Credit
    Facility and the First Lien Security Documents.
"First Lien Obligations"
shall mean
    (a) all General Credit Facility Obligations and
    (b) all other Obligations of the Issuer and its
    Subsidiaries under any refinancings of the General Credit
    Facility Obligations (and any related Hedging Obligations). For
    the avoidance of doubt, Obligations with respect to the ABL
    Facility shall not constitute First Lien Obligations.
"First Lien Secured Parties"
means, at any
    relevant time, the holders of First Lien Obligations at such
    time, including, without limitation, the lenders and agents
    under the General Credit Facility and the First Lien Collateral
    Agent.
"First Lien Security Documents"
means the
    Security Documents (as defined in the General Credit Facility)
    and any other agreement, document or instrument pursuant to
    which a Lien is granted or purported to be granted securing
    First Lien Obligations or under which rights or remedies with
    respect to such Liens are governed.
"First Priority Liens"
means the first priority
    Liens securing the First Lien Obligations.
"Fixed Charge Coverage Ratio"
means, with
    respect to any Person for any period, the ratio of EBITDA of
    such Person for such period to the Fixed Charges of such Person
    for such period. In the event that the Issuer or any Restricted
    Subsidiary incurs, assumes, guarantees, redeems, retires or
    extinguishes any Indebtedness (other than Indebtedness incurred
    under any revolving credit facility unless such Indebtedness has
    been permanently repaid and has not been replaced) or issues or
    redeems Disqualified Stock or Preferred Stock
172
Table of Contents
subsequent to the commencement of the period for which the Fixed
    Charge Coverage Ratio is being calculated but prior to or
    simultaneously with the event for which the calculation of the
    Fixed Charge Coverage Ratio is made (the
"Fixed Charge
    Coverage Ratio Calculation Date"
), then the Fixed
    Charge Coverage Ratio shall be calculated giving pro forma
    effect to such incurrence, assumption, guarantee, redemption,
    retirement or extinguishment of Indebtedness, or such issuance
    or redemption of Disqualified Stock or Preferred Stock, as if
    the same had occurred at the beginning of the applicable
    four-quarter period.
For purposes of making the computation referred to above,
    Investments, acquisitions, dispositions, mergers, consolidations
    and disposed operations (as determined in accordance with GAAP)
    that have been made by the Issuer or any of its Restricted
    Subsidiaries during the four-quarter reference period or
    subsequent to such reference period and on or prior to or
    simultaneously with the Fixed Charge Coverage Ratio Calculation
    Date shall be calculated on a pro forma basis assuming that all
    such Investments, acquisitions, dispositions, mergers,
    consolidations and disposed operations (and the change in any
    associated fixed charge obligations and the change in EBITDA
    resulting therefrom) had occurred on the first day of the
    four-quarter reference period. If, since the beginning of such
    period, any Person that subsequently became a Restricted
    Subsidiary or was merged with or into the Issuer or any of its
    Restricted Subsidiaries since the beginning of such period shall
    have made any Investment, acquisition, disposition, merger,
    consolidation or disposed operation that would have required
    adjustment pursuant to this definition, then the Fixed Charge
    Coverage Ratio shall be calculated giving pro forma effect
    thereto for such period as if such Investment, acquisition,
    disposition, merger, consolidation or disposed operation had
    occurred at the beginning of the applicable four-quarter period.
For purposes of this definition, whenever pro forma effect is to
    be given to a transaction, the pro forma calculations shall be
    made in good faith by a responsible financial or accounting
    officer of the Issuer. If any Indebtedness bears a floating rate
    of interest and is being given pro forma effect, the interest on
    such Indebtedness shall be calculated as if the rate in effect
    on the Fixed Charge Coverage Ratio Calculation Date had been the
    applicable rate for the entire period (taking into account any
    Hedging Obligations applicable to such Indebtedness). Interest
    on a Capitalized Lease Obligation shall be deemed to accrue at
    an interest rate reasonably determined by a responsible
    financial or accounting officer of the Issuer to be the rate of
    interest implicit in such Capitalized Lease Obligation in
    accordance with GAAP. For purposes of making the computation
    referred to above, interest on any Indebtedness under a
    revolving credit facility computed on a pro forma basis shall be
    computed based upon the average daily balance of such
    Indebtedness during the applicable period except as set forth in
    the first paragraph of this definition. Interest on Indebtedness
    that may optionally be determined at an interest rate based upon
    a factor of a prime or similar rate, a eurocurrency interbank
    offered rate or other rate shall be deemed to have been based
    upon the rate actually chosen, or, if none, then based upon such
    optional rate chosen as the Issuer may designate.
"Fixed Charges"
means, with respect to any
    Person for any period, the sum of:
(1) Consolidated Interest Expense of such Person for such
    period;
(2) all cash dividends or other distributions paid
    (excluding items eliminated in consolidation) on any series of
    Preferred Stock during such period; and
(3) all cash dividends or other distributions paid
    (excluding items eliminated in consolidation) on any series of
    Disqualified Stock during such period.
"Foreign Subsidiary"
means, with respect to any
    Person, any Restricted Subsidiary of such Person that is not
    organized or existing under the laws of the United States, any
    state thereof or the District of Columbia and any Restricted
    Subsidiary of such Foreign Subsidiary.
"Frist Entities"
means Dr. Thomas F.
    Frist, Jr., any Person controlled by Dr. Frist and any
    charitable organization selected by Dr. Frist that holds
    Equity Interests of the Issuer on November 17, 2006.
"GAAP"
means generally accepted accounting
    principles in the United States which are in effect on
    November 17, 2006.
173
Table of Contents
"General Credit Facility"
means the credit
    agreement entered into as of November 17, 2006 by and among
    the Issuer, the European subsidiary borrowers party thereto, the
    lenders party thereto in their capacities as lenders thereunder
    and Bank of America, N.A., as U.S. Administrative Agent and
    as European Administrative Agent, including any guarantees,
    collateral documents, instruments and agreements executed in
    connection therewith, and any amendments, supplements,
    modifications, extensions, renewals, restatements, refundings or
    refinancings thereof and any indentures or credit facilities or
    commercial paper facilities with banks or other institutional
    lenders or investors that replace, refund or refinance any part
    of the loans, notes, other credit facilities or commitments
    thereunder, including any such replacement, refunding or
    refinancing facility or indenture that increases the amount
    borrowable thereunder or alters the maturity thereof
    (
provided
that such increase in borrowings is permitted
    under "Certain Covenants — Limitation on
    Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock" above).
"General Credit Facility Obligations"
means
    "Obligations" as defined in the General Credit
    Facility.
"General Intercreditor Agreement"
has the
    meaning set forth under "Security — Liens with
    Respect to the Collateral."
"Government Securities"
means securities that
    are:
(1) direct obligations of the United States of America for
    the timely payment of which its full faith and credit is
    pledged; or
(2) obligations of a Person controlled or supervised by and
    acting as an agency or instrumentality of the United States of
    America the timely payment of which is unconditionally
    guaranteed as a full faith and credit obligation by the United
    States of America,
which, in either case, are not callable or redeemable at the
    option of the issuers thereof, and shall also include a
    depository receipt issued by a bank (as defined in
    Section 3(a)(2) of the Securities Act), as custodian with
    respect to any such Government Securities or a specific payment
    of principal of or interest on any such Government Securities
    held by such custodian for the account of the holder of such
    depository receipt;
provided
that (except as required by
    law) such custodian is not authorized to make any deduction from
    the amount payable to the holder of such depository receipt from
    any amount received by the custodian in respect of the
    Government Securities or the specific payment of principal of or
    interest on the Government Securities evidenced by such
    depository receipt.
"guarantee"
means a guarantee (other than by
    endorsement of negotiable instruments for collection in the
    ordinary course of business), direct or indirect, in any manner
    (including letters of credit and reimbursement agreements in
    respect thereof), of all or any part of any Indebtedness or
    other obligations.
"Guarantee"
means the guarantee by any
    Guarantor of the Issuer's Obligations under the Indenture.
"Guarantor"
means each Restricted Subsidiary
    that Guarantees the Notes in accordance with the terms of the
    Indenture.
"HCI"
means Health Care Indemnity, Inc., an
    insurance company formed under the laws of the State of Colorado
    and a Wholly-Owned Subsidiary of the Issuer.
"Hedging Arrangements"
means the fixed-pay
    interest rate swap agreements, entered into by Hercules Holding
    on or about September 13, 2006 and with respect to which
    the Issuer will be the counterparty in connection with the
    Recapitalization, relating to $8,000 million of the
    outstanding principal amount under the First Lien Obligations
    and the ABL Obligations.
"Hedging Obligations"
means, with respect to
    any Person, the obligations of such Person under any interest
    rate swap agreement, interest rate cap agreement, interest rate
    collar agreement, commodity swap agreement, commodity cap
    agreement, commodity collar agreement, foreign exchange
    contract, currency swap agreement or similar agreement providing
    for the transfer or mitigation of interest rate or currency
    risks either generally or under specific contingencies.
"Holder"
means the Person in whose name a Note
    is registered on the registrar's books.
174
Table of Contents
"Indebtedness"
means, with respect to any
    Person, without duplication:
(1) any indebtedness (including principal and premium) of
    such Person, whether or not contingent:
(a) in respect of borrowed money;
(b) evidenced by bonds, notes, debentures or similar
    instruments or letters of credit or bankers' acceptances
    (or, without duplication, reimbursement agreements in respect
    thereof);
(c) representing the balance deferred and unpaid of the
    purchase price of any property (including Capitalized Lease
    Obligations), except (i) any such balance that constitutes
    a trade payable or similar obligation to a trade creditor, in
    each case accrued in the ordinary course of business and
    (ii) any earn-out obligations until such obligation becomes
    a liability on the balance sheet of such Person in accordance
    with GAAP; or
(d) representing any Hedging Obligations;
if and to the extent that any of the foregoing Indebtedness
    (other than letters of credit and Hedging Obligations) would
    appear as a liability upon a balance sheet (excluding the
    footnotes thereto) of such Person prepared in accordance with
    GAAP;
(2) to the extent not otherwise included, any obligation by
    such Person to be liable for, or to pay, as obligor, guarantor
    or otherwise on, the obligations of the type referred to in
    clause (1) of a third Person (whether or not such items
    would appear upon the balance sheet of the such obligor or
    guarantor), other than by endorsement of negotiable instruments
    for collection in the ordinary course of business; and
(3) to the extent not otherwise included, the obligations
    of the type referred to in clause (1) of a third Person
    secured by a Lien on any asset owned by such first Person,
    whether or not such Indebtedness is assumed by such first Person;
provided
,
however
, that notwithstanding the
    foregoing, Indebtedness shall be deemed not to include
    (a) Contingent Obligations incurred in the ordinary course
    of business or (b) obligations under or in respect of
    Receivables Facilities.
"Independent Financial Advisor"
means an
    accounting, appraisal, investment banking firm or consultant to
    Persons engaged in Similar Businesses of nationally recognized
    standing that is, in the good faith judgment of the Issuer,
    qualified to perform the task for which it has been engaged.
"Initial Purchasers"
means Banc of America
    Securities LLC, Citigroup Global Markets, Inc., J.P. Morgan
    Securities Inc., Wachovia Capital Markets, LLC and the other
    initial purchasers party to the purchase agreement related to
    the Notes.
"insolvency or liquidation proceeding"
means:
(1) any case commenced by or against the Issuer or any
    Guarantor under any Bankruptcy Law for the relief of debtors,
    any other proceeding for the reorganization, recapitalization or
    adjustment or marshalling of the assets or liabilities of the
    Issuer or any Guarantor, any receivership or assignment for the
    benefit of creditors relating to the Issuer or any Guarantor or
    any similar case or proceeding relative to the Issuer or any
    Guarantor or its creditors, as such, in each case whether or not
    voluntary;
(2) any liquidation, dissolution, marshalling of assets or
    liabilities or other winding up of or relating to the Issuer or
    any Guarantor, in each case whether or not voluntary and whether
    or not involving bankruptcy or insolvency; or
(3) any other proceeding of any type or nature in which
    substantially all claims of creditors of the Issuer or any
    Guarantor are determined and any payment or distribution is or
    may be made on account of such claims.
"Intercreditor Agreements"
means, collectively,
    the Shared Receivables Intercreditor Agreement and the General
    Intercreditor Agreement.
175
Table of Contents
"Investment Grade Rating"
means a rating equal
    to or higher than Baa3 (or the equivalent) by Moody's and
    BBB- (or the equivalent) by S&P, or an equivalent rating by
    any other Rating Agency.
"Investment Grade Securities"
means:
(1) securities issued or directly and fully guaranteed or
    insured by the United States government or any agency or
    instrumentality thereof (other than Cash Equivalents);
(2) debt securities or debt instruments with an Investment
    Grade Rating, but excluding any debt securities or instruments
    constituting loans or advances among the Issuer and its
    Subsidiaries;
(3) investments in any fund that invests exclusively in
    investments of the type described in clauses (1) and
    (2) which fund may also hold immaterial amounts of cash
    pending investment or distribution; and
(4) corresponding instruments in countries other than the
    United States customarily utilized for high quality investments.
"Investments"
means, with respect to any
    Person, all investments by such Person in other Persons
    (including Affiliates) in the form of loans (including
    guarantees), advances or capital contributions (excluding
    accounts receivable, trade credit, advances to customers,
    commissions, travel and similar advances to officers and
    employees, in each case made in the ordinary course of
    business), purchases or other acquisitions for consideration of
    Indebtedness, Equity Interests or other securities issued by any
    other Person and investments that are required by GAAP to be
    classified on the balance sheet (excluding the footnotes) of the
    Issuer in the same manner as the other investments included in
    this definition to the extent such transactions involve the
    transfer of cash or other property. For purposes of the
    definition of "Unrestricted Subsidiary" and the
    covenant described under "Certain Covenants —
    Limitation on Restricted Payments":
(1)
"Investments"
shall include the
    portion (proportionate to the Issuer's equity interest in
    such Subsidiary) of the fair market value of the net assets of a
    Subsidiary of the Issuer at the time that such Subsidiary is
    designated an Unrestricted Subsidiary;
provided
,
however
, that upon a redesignation of such Subsidiary as
    a Restricted Subsidiary, the Issuer shall be deemed to continue
    to have a permanent "Investment" in an Unrestricted
    Subsidiary in an amount (if positive) equal to:
(a) the Issuer's "Investment" in such
    Subsidiary at the time of such redesignation;
less
(b) the portion (proportionate to the Issuer equity
    interest in such Subsidiary) of the fair market value of the net
    assets of such Subsidiary at the time of such
    redesignation; and
(2) any property transferred to or from an Unrestricted
    Subsidiary shall be valued at its fair market value at the time
    of such transfer, in each case as determined in good faith by
    the Issuer.
"Investors"
means Bain Capital Partners, LLC,
    Kohlberg Kravis Roberts & Co. L.P., Merrill Lynch
    Global Partners, Inc. and each of their respective Affiliates
    but not including, however, any portfolio companies of any of
    the foregoing.
"Issue Date"
means February 19, 2009.
"Issuer"
has the meaning set forth in the first
    paragraph under "General";
provided
that when
    used in the context of determining the fair market value of an
    asset or liability under the Indenture, "Issuer" shall
    be deemed to mean the board of directors of the Issuer when the
    fair market value is equal to or in excess of
    $500.0 million (unless otherwise expressly stated).
"Junior Lien Collateral Agent"
shall mean
    (i) so long as the Notes are outstanding, The Bank of New
    York Mellon, in its capacity as trustee and collateral agent for
    the holders of the 2006 Notes and other secured parties under
    the 2006 Notes Indenture and the Security Documents (including
    the Holders), and (ii) at any time thereafter, such agent
    or trustee as is designated "Junior Lien Collateral
    Agent" by Junior Lien Secured Parties holding a majority in
    principal amount of the Junior Lien Obligations then outstanding
    or pursuant to such other arrangements as agreed to among the
    holders of the Junior Lien Obligations, it being understood that
    as of the Issue Date, the trustee under the 2006 Notes Indenture
    shall be the Junior Lien Collateral Agent.
176
Table of Contents
"Junior Lien Documents"
means the credit and
    security documents governing the Junior Lien Obligations,
    including, without limitation, the Indenture, the related
    Security Documents and Intercreditor Agreements.
"Junior Lien Obligations"
means the Notes and
    Obligations with respect to other Indebtedness (including the
    2006 Notes and any permitted refinancing thereof) permitted to
    be incurred under the Indenture and the General Credit Facility
    which is by its terms intended to be secured equally and ratably
    with the Notes or on a basis junior to the Liens securing the
    Notes;
provided
such Lien is permitted to be incurred
    under the Indenture and the General Credit Facility;
provided, further
, that the holders of such Indebtedness
    or their Junior Lien Representative is a party to the Security
    Documents in accordance with the terms thereof and has appointed
    the Junior Lien Collateral Agent as collateral agent for such
    holders of Junior Lien Obligations with respect to all or a
    portion of the Collateral.
"Junior Lien Representative"
means any duly
    authorized representative of any holders of Junior Lien
    Obligations, which representative is party to the Security
    Documents.
"Junior Lien Secured Parties"
means
    (i) Holders (including the Holders of any Additional Notes
    subsequently issued under and in compliance with the terms of
    the Indenture), (ii) the Junior Lien Collateral Agent and
    (iii) the holders from time to time of any other Junior
    Lien Obligations and each Junior Lien Representative.
"Junior Liens"
means the Liens securing the
    Junior Lien Obligations.
"Legal Holiday"
means a Saturday, a Sunday or a
    day on which commercial banking institutions are not required to
    be open in the State of New York.
"Lien"
means, with respect to any asset, any
    mortgage, lien (statutory or otherwise), pledge, hypothecation,
    charge, security interest, preference, priority or encumbrance
    of any kind in respect of such asset, whether or not filed,
    recorded or otherwise perfected under applicable law, including
    any conditional sale or other title retention agreement, any
    lease in the nature thereof, any option or other agreement to
    sell or give a security interest in and any filing of or
    agreement to give any financing statement under the Uniform
    Commercial Code (or equivalent statutes) of any jurisdiction;
provided
that in no event shall an operating lease be
    deemed to constitute a Lien.
"Moody's"
means Moody's Investors
    Service, Inc. and any successor to its rating agency business.
"Net Income"
means, with respect to any Person,
    the net income (loss) of such Person, determined in accordance
    with GAAP and before any reduction in respect of Preferred Stock
    dividends.
"Net Proceeds"
means the aggregate cash
    proceeds received by the Issuer or any of its Restricted
    Subsidiaries in respect of any Asset Sale, including any cash
    received upon the sale or other disposition of any Designated
    Non-cash Consideration received in any Asset Sale, net of the
    direct costs relating to such Asset Sale and the sale or
    disposition of such Designated Non-cash Consideration, including
    legal, accounting and investment banking fees, and brokerage and
    sales commissions, any relocation expenses incurred as a result
    thereof, taxes paid or payable as a result thereof (after taking
    into account any available tax credits or deductions and any tax
    sharing arrangements), amounts required to be applied to the
    repayment of principal, premium, if any, and interest on Senior
    Indebtedness required (other than required by clause (1) of
    the second paragraph of "Repurchase at the Option of
    Holders — Asset Sales") to be paid as a result of
    such transaction and any deduction of appropriate amounts to be
    provided by the Issuer or any of its Restricted Subsidiaries as
    a reserve in accordance with GAAP against any liabilities
    associated with the asset disposed of in such transaction and
    retained by the Issuer or any of its Restricted Subsidiaries
    after such sale or other disposition thereof, including pension
    and other post-employment benefit liabilities and liabilities
    related to environmental matters or against any indemnification
    obligations associated with such transaction.
"Non-Conforming Plan of Reorganization"
means
    any Plan of Reorganization that grants the Junior Lien
    Collateral Agent or any Junior Lien Secured Party any right or
    benefit, directly or indirectly, which right or benefit is
    prohibited at such time by the provisions of the General
    Intercreditor Agreement.
177
Table of Contents
"Non-Receivables Collateral"
has the meaning
    set forth under "Description of Other
    Indebtedness — Senior Secured Credit
    Facilities — Guarantee and Security," subject to
    the provisions of the third and fourth sentences of the first
    paragraph under "— Security —
    General."
"Obligations"
means any principal, interest
    (including any interest accruing subsequent to the filing of a
    petition in bankruptcy, reorganization or similar proceeding at
    the rate provided for in the documentation with respect thereto,
    whether or not such interest is an allowed claim under
    applicable state, federal or foreign law), premium, penalties,
    fees, indemnifications, reimbursements (including reimbursement
    obligations with respect to letters of credit and bankers'
    acceptances), damages and other liabilities, and guarantees of
    payment of such principal, interest, penalties, fees,
    indemnifications, reimbursements, damages and other liabilities,
    payable under the documentation governing any Indebtedness.
"Offering Memorandum"
means the offering
    memorandum, dated February 11, 2009, relating to the
    initial private offering of the Notes.
"Officer"
means the Chairman of the Board, the
    Chief Executive Officer, the President, any Executive Vice
    President, Senior Vice President or Vice President, the
    Treasurer or the Secretary of the Issuer or a Guarantor, as
    applicable.
"Officer's Certificate"
means a
    certificate signed on behalf of the Issuer by an Officer of the
    Issuer or on behalf of a Guarantor by an Officer of such
    Guarantor, who must be the principal executive officer, the
    principal financial officer, the treasurer or the principal
    accounting officer of the Issuer or Guarantor, as applicable,
    that meets the requirements set forth in the Indenture.
"Opinion of Counsel"
means a written opinion
    from legal counsel who is acceptable to the Trustee. The counsel
    may be an employee of or counsel to the Issuer or the Trustee.
"Permitted Asset Swap"
means the concurrent
    purchase and sale or exchange of Related Business Assets or a
    combination of Related Business Assets and cash or Cash
    Equivalents between the Issuer or any of its Restricted
    Subsidiaries and another Person;
provided
, that any cash
    or Cash Equivalents received must be applied in accordance with
    the covenant described under "Repurchase at the Option of
    Holders — Asset Sales."
"Permitted Holders"
means each of the
    Investors, the Frist Entities, members of management of the
    Issuer (or its direct or indirect parent) and any assignees of
    the equity commitments of the Investors on November 17,
    2006 who are (or will be, pursuant to the agreements described
    under "Management — Equity Investment by Senior
    Management Participants" and "— Equity
    Investment by Other Management Participants") holders of
    Equity Interests of the Issuer (or any of its direct or indirect
    parent companies) and any group (within the meaning of
    Section 13(d)(3) or Section 14(d)(2) of the Exchange
    Act or any successor provision) of which any of the foregoing
    are members;
provided
that, in the case of such group and
    without giving effect to the existence of such group or any
    other group, such Investors, Frist Entities, members of
    management and assignees of the equity commitments of the
    Investors, collectively, have beneficial ownership of more than
    50% of the total voting power of the Voting Stock of the Issuer
    or any of its direct or indirect parent companies.
"Permitted Investments"
means:
(1) any Investment in the Issuer or any of its Restricted
    Subsidiaries;
(2) any Investment in cash and Cash Equivalents or
    Investment Grade Securities;
(3) any Investment by the Issuer or any of its Restricted
    Subsidiaries in a Person that is engaged in a Similar Business
    if as a result of such Investment:
(a) such Person becomes a Restricted Subsidiary; or
(b) such Person, in one transaction or a series of related
    transactions, is merged or consolidated with or into, or
    transfers or conveys substantially all of its assets to, or is
    liquidated into, the Issuer or a Restricted Subsidiary, and, in
    each case, any Investment held by such Person;
provided
that such
178
Table of Contents
Investment was not acquired by such Person in contemplation of
    such acquisition, merger, consolidation or transfer;
(4) any Investment in securities or other assets not
    constituting cash, Cash Equivalents or Investment Grade
    Securities and received in connection with an Asset Sale made
    pursuant to the provisions described under "Repurchase at
    the Option of Holders — Asset Sales" or any other
    disposition of assets not constituting an Asset Sale;
(5) any Investment existing on the Issue Date;
(6) any Investment acquired by the Issuer or any of its
    Restricted Subsidiaries:
(a) in exchange for any other Investment or accounts
    receivable held by the Issuer or any such Restricted Subsidiary
    in connection with or as a result of a bankruptcy, workout,
    reorganization or recapitalization of the issuer of such other
    Investment or accounts receivable; or
(b) as a result of a foreclosure by the Issuer or any of
    its Restricted Subsidiaries with respect to any secured
    Investment or other transfer of title with respect to any
    secured Investment in default;
(7) Hedging Obligations permitted under clause (10) of
    the second paragraph of the covenant described in "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock";
(8) any Investment in a Similar Business having an
    aggregate fair market value, taken together with all other
    Investments made pursuant to this clause (8) that are at
    that time outstanding, not to exceed 5% of Total Assets at the
    time of such Investment (with the fair market value of each
    Investment being measured at the time made and without giving
    effect to subsequent changes in value);
(9) Investments the payment for which consists of Equity
    Interests (exclusive of Disqualified Stock) of the Issuer or any
    of its direct or indirect parent companies;
provided
,
however
, that such Equity Interests will not increase the
    amount available for Restricted Payments under clause (3)
    of the first paragraph under the covenant described in
    "Certain Covenants — Limitations on Restricted
    Payments";
(10) guarantees of Indebtedness permitted under the
    covenant described in "Certain Covenants —
    Limitation on Incurrence of Indebtedness and Issuance of
    Disqualified Stock and Preferred Stock";
(11) any transaction to the extent it constitutes an
    Investment that is permitted and made in accordance with the
    provisions of the second paragraph of the covenant described
    under "Certain Covenants — Transactions with
    Affiliates" (except transactions described in clauses (2),
    (5) and (9) of such paragraph);
(12) Investments consisting of purchases and acquisitions
    of inventory, supplies, material or equipment;
(13) additional Investments having an aggregate fair market
    value, taken together with all other Investments made pursuant
    to this clause (13) that are at that time outstanding
    (without giving effect to the sale of an Unrestricted Subsidiary
    to the extent the proceeds of such sale do not consist of cash
    or marketable securities), not to exceed 5% of Total Assets at
    the time of such Investment (with the fair market value of each
    Investment being measured at the time made and without giving
    effect to subsequent changes in value);
(14) Investments relating to an ABL Financing Entity or a
    Receivables Subsidiary that, in the good faith determination of
    the Issuer, are necessary or advisable to effect the ABL
    Facility or any Receivables Facility, as the case may be;
(15) advances to, or guarantees of Indebtedness of,
    employees not in excess of $50.0 million outstanding at any
    one time, in the aggregate;
(16) loans and advances to officers, directors and
    employees for business-related travel expenses, moving expenses
    and other similar expenses, in each case incurred in the
    ordinary course of business or
179
Table of Contents
consistent with past practices or to fund such Person's
    purchase of Equity Interests of the Issuer or any direct or
    indirect parent company thereof;
(17) Physician Support Obligations made by the Issuer or
    any Restricted Subsidiary;
(18) any Investment in any joint venture existing on the
    Issue Date that owns or operates one or more healthcare
    facilities, including, without limitation, hospitals, ambulatory
    surgery centers, outpatient diagnostic centers or imaging
    centers to the extent contemplated by the organizational
    documents of such joint venture as in existence on the Issue
    Date;
(19) any Investment in the ordinary course of business or
    as may be required by applicable law by any Restricted
    Subsidiary (including, without limitation, HCI) engaged in the
    insurance business in order to provide insurance to the Issuer
    and its Subsidiaries;
(20) any Investment pursuant to any customary buy/sell
    arrangement in favor of investors or joint venture parties in
    connection with syndications of healthcare facilities,
    including, without limitation, hospitals, ambulatory surgery
    centers, outpatient diagnostic centers or imaging
    centers; and
(21) any Investment in any Subsidiary or any joint venture
    in connection with intercompany cash management arrangements or
    related activities arising in the ordinary course of business.
"Permitted Liens"
means, with respect to any
    Person:
(1) pledges or deposits by such Person under workmen's
    compensation laws, unemployment insurance laws or similar
    legislation, or good faith deposits in connection with bids,
    tenders, contracts (other than for the payment of Indebtedness)
    or leases to which such Person is a party, or deposits to secure
    public or statutory obligations of such Person or deposits of
    cash or U.S. government bonds to secure surety or appeal
    bonds to which such Person is a party, or deposits as security
    for contested taxes or import duties or for the payment of rent,
    in each case incurred in the ordinary course of business;
(2) Liens imposed by law, such as carriers',
    warehousemen's and mechanics' Liens, in each case for
    sums not yet overdue for a period of more than 30 days or
    being contested in good faith by appropriate proceedings or
    other Liens arising out of judgments or awards against such
    Person with respect to which such Person shall then be
    proceeding with an appeal or other proceedings for review if
    adequate reserves with respect thereto are maintained on the
    books of such Person in accordance with GAAP;
(3) Liens for taxes, assessments or other governmental
    charges not yet overdue for a period of more than 30 days
    or payable or subject to penalties for nonpayment or which are
    being contested in good faith by appropriate proceedings
    diligently conducted, if adequate reserves with respect thereto
    are maintained on the books of such Person in accordance with
    GAAP;
(4) Liens in favor of issuers of performance and surety
    bonds or bid bonds or with respect to other regulatory
    requirements or letters of credit issued pursuant to the request
    of and for the account of such Person in the ordinary course of
    its business;
(5) minor survey exceptions, minor encumbrances, easements
    or reservations of, or rights of others for, licenses,
rights-of-way,
sewers, electric lines, telegraph and telephone lines and other
    similar purposes, or zoning or other restrictions as to the use
    of real properties or Liens incidental to the conduct of the
    business of such Person or to the ownership of its properties
    which were not incurred in connection with Indebtedness and
    which do not in the aggregate materially adversely affect the
    value of said properties or materially impair their use in the
    operation of the business of such Person;
(6) Liens securing Indebtedness permitted to be incurred
    pursuant to clause (4), (12), (13), (18) or (19) of
    the second paragraph under "Certain Covenants —
    Limitation on Incurrence of Indebtedness and Issuance of
    Disqualified Stock and Preferred Stock"; provided that
    (a) Liens securing Indebtedness, Disqualified Stock or
    Preferred Stock permitted to be incurred pursuant to
    clause (13) relate only to Refinancing Indebtedness that
    serves to refund or refinance Indebtedness, Disqualified Stock
    or Preferred Stock incurred under clause (4) or
    (12) of the second paragraph under "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock,"
    (b) Liens securing
180
Table of Contents
Indebtedness permitted to be incurred pursuant to
    clause (18) extend only to the assets of Foreign
    Subsidiaries, (c) Liens securing Indebtedness permitted to
    be incurred pursuant to clause (19) are solely on acquired
    property or the assets of the acquired entity, as the case may
    be and (d) Liens securing Indebtedness, Disqualified Stock
    or Preferred Stock permitted to be incurred pursuant to
    clause (4) of the second paragraph under "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock"
    extend only to the assets so financed, purchased, constructed or
    improved;
(7) Liens existing on the Issue Date (other than Liens in
    favor of (i) the lenders under the Senior Credit Facilities
    ranking senior to the Liens securing the Notes and (ii) the
    holders of the 2006 Notes);
(8) Liens on property or shares of stock of a Person at the
    time such Person becomes a Subsidiary; provided, however, such
    Liens are not created or incurred in connection with, or in
    contemplation of, such other Person becoming such a Subsidiary;
    provided, further, however, that such Liens may not extend to
    any other property owned by the Issuer or any of its Restricted
    Subsidiaries;
(9) Liens on property at the time the Issuer or a
    Restricted Subsidiary acquired the property, including any
    acquisition by means of a merger or consolidation with or into
    the Issuer or any of its Restricted Subsidiaries; provided,
    however, that such Liens are not created or incurred in
    connection with, or in contemplation of, such acquisition;
    provided, further, however, that the Liens may not extend to any
    other property owned by the Issuer or any of its Restricted
    Subsidiaries;
(10) Liens securing Indebtedness or other obligations of a
    Restricted Subsidiary owing to the Issuer or another Restricted
    Subsidiary permitted to be incurred in accordance with the
    covenant described under "Certain Covenants —
    Limitation on Incurrence of Indebtedness and Issuance of
    Disqualified Stock and Preferred Stock";
(11) Liens securing Hedging Obligations so long as the
    related Indebtedness is, and is permitted to be under the
    Indenture, secured by a Lien on the same property securing such
    Hedging Obligations;
(12) Liens on specific items of inventory or other goods
    and proceeds of any Person securing such Person's
    obligations in respect of bankers' acceptances issued or
    created for the account of such Person to facilitate the
    purchase, shipment or storage of such inventory or other goods;
(13) leases, subleases, licenses or sublicenses granted to
    others in the ordinary course of business which do not
    materially interfere with the ordinary conduct of the business
    of the Issuer or any of its Restricted Subsidiaries and do not
    secure any Indebtedness;
(14) Liens arising from Uniform Commercial Code financing
    statement filings regarding operating leases entered into by the
    Issuer and its Restricted Subsidiaries in the ordinary course of
    business;
(15) Liens in favor of the Issuer or any Guarantor;
(16) Liens on equipment of the Issuer or any of its
    Restricted Subsidiaries granted in the ordinary course of
    business;
(17) Liens on accounts receivable and related assets
    incurred in connection with a Receivables Facility;
(18) Liens to secure any refinancing, refunding, extension,
    renewal or replacement (or successive refinancing, refunding,
    extensions, renewals or replacements) as a whole, or in part, of
    any Indebtedness secured by any Lien referred to in the
    foregoing clauses (6), (7), (8) and (9); provided, however,
    that (a) such new Lien shall be limited to all or part of
    the same property that secured the original Lien (plus
    improvements on such property), and (b) the Indebtedness
    secured by such Lien at such time is not increased to any amount
    greater than the sum of (i) the outstanding principal
    amount or, if greater, committed amount of the Indebtedness
    described under clauses (6), (7), (8) and (9) at the
    time the original Lien became a Permitted Lien under the
    Indenture, and (ii) an amount necessary to pay any fees and
    expenses, including premiums, related to such refinancing,
    refunding, extension, renewal or replacement;
181
Table of Contents
(19) deposits made in the ordinary course of business to
    secure liability to insurance carriers;
(20) other Liens securing obligations incurred in the
    ordinary course of business which obligations do not exceed
    $100.0 million at any one time outstanding;
(21) Liens securing judgments for the payment of money not
    constituting an Event of Default under clause (5) under the
    caption "Events of Default and Remedies" so long as
    such Liens are adequately bonded and any appropriate legal
    proceedings that may have been duly initiated for the review of
    such judgment have not been finally terminated or the period
    within which such proceedings may be initiated has not expired;
(22) Liens in favor of customs and revenue authorities
    arising as a matter of law to secure payment of customs duties
    in connection with the importation of goods in the ordinary
    course of business;
(23) Liens (i) of a collection bank arising under
Section 4-210
of the Uniform Commercial Code, or any comparable or successor
    provision, on items in the course of collection,
    (ii) attaching to commodity trading accounts or other
    commodity brokerage accounts incurred in the ordinary course of
    business, and (iii) in favor of banking institutions
    arising as a matter of law encumbering deposits (including the
    right of set-off) and which are within the general parameters
    customary in the banking industry;
(24) Liens deemed to exist in connection with Investments
    in repurchase agreements permitted under "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock";
    provided that such Liens do not extend to any assets other than
    those that are the subject of such repurchase agreements;
(25) Liens encumbering reasonable customary initial
    deposits and margin deposits and similar Liens attaching to
    commodity trading accounts or other brokerage accounts incurred
    in the ordinary course of business and not for speculative
    purposes;
(26) Liens that are contractual rights of set-off
    (i) relating to the establishment of depository relations
    with banks not given in connection with the issuance of
    Indebtedness, (ii) relating to pooled deposit or sweep
    accounts of the Issuer or any of its Restricted Subsidiaries to
    permit satisfaction of overdraft or similar obligations incurred
    in the ordinary course of business of the Issuer and its
    Restricted Subsidiaries or (iii) relating to purchase
    orders and other agreements entered into with customers of the
    Issuer or any of its Restricted Subsidiaries in the ordinary
    course of business; and
(27) Liens arising out of conditional sale, title
    retention, consignment or similar arrangements for the sale or
    purchase of goods entered into by the Issuer or any Restricted
    Subsidiary in the ordinary course of business.
For purposes of this definition, the term
    "Indebtedness" shall be deemed to include interest on
    such Indebtedness.
"Person"
means any individual, corporation,
    limited liability company, partnership, joint venture,
    association, joint stock company, trust, unincorporated
    organization, government or any agency or political subdivision
    thereof or any other entity.
"Physician Support Obligation"
means (1) a
    loan to or on behalf of, or a guarantee of Indebtedness or
    income of, a physician or healthcare professional providing
    service to patients in the service area of a healthcare facility
    operated by the Issuer, any of its Restricted Subsidiaries or
    any affiliated joint venture otherwise permitted by the
    Indenture made or given by the Issuer or any Restricted
    Subsidiary of the Issuer in the ordinary course of business and
    pursuant to a written agreement having a period not to exceed
    five years or (2) guarantees by the Issuer or any
    Restricted Subsidiary of the Issuer of leases and loans to
    acquire property (real or personal) for or on behalf of a
    physician or healthcare professional providing service to
    patients in the service area of a healthcare facility operated
    by the Issuer, any of its Restricted Subsidiaries or any
    affiliated joint venture otherwise permitted by the Indenture.
182
Table of Contents
"Plan of Reorganization"
means any plan of
    reorganization, plan of liquidation, agreement for composition,
    or other type of plan of arrangement proposed in or in
    connection with any insolvency or liquidation proceeding.
"Preferred Stock"
means any Equity Interest
    with preferential rights of payment of dividends or upon
    liquidation, dissolution or winding up.
"Principal Property"
means each acute care
    hospital providing general medical and surgical services
    (excluding equipment, personal property and hospitals that
    primarily provide specialty medical services, such as
    psychiatric and obstetrical and gynecological services) owned
    solely by the Issuer
and/or
one
    or more of its Subsidiaries (used in this definition as defined
    in the Existing Notes Indenture) and located in the
    United States of America.
"Priority Lien Obligations"
means,
    collectively, ABL Obligations and First Lien Obligations.
"Priority Lien Secured Parties"
means,
    collectively, the ABL Secured Parties and the First Lien Secured
    Parties.
"Purchase Money Obligations"
means any
    Indebtedness incurred to finance or refinance the acquisition,
    leasing, construction or improvement of property (real or
    personal) or assets (other than Capital Stock), and whether
    acquired through the direct acquisition of such property or
    assets, or otherwise.
"Qualified Proceeds"
means assets that are used
    or useful in, or Capital Stock of any Person engaged in, a
    Similar Business;
provided
that the fair market value of
    any such assets or Capital Stock shall be determined by the
    Issuer in good faith.
"Rating Agencies"
means Moody's and
    S&P or if Moody's or S&P or both shall not make a
    rating on the Notes publicly available, a nationally recognized
    statistical rating agency or agencies, as the case may be,
    selected by the Issuer which shall be substituted for
    Moody's or S&P or both, as the case may be.
"Receivables Facility"
means any of one or more
    receivables financing facilities as amended, supplemented,
    modified, extended, renewed, restated or refunded from time to
    time, the Obligations of which are non-recourse (except for
    customary representations, warranties, covenants and indemnities
    made in connection with such facilities) to the Issuer or any of
    its Restricted Subsidiaries (other than a Receivables
    Subsidiary) pursuant to which the Issuer or any of its
    Restricted Subsidiaries purports to sell its accounts receivable
    to either (a) a Person that is not a Restricted Subsidiary
    or (b) a Receivables Subsidiary that in turn funds such
    purchase by purporting to sell its accounts receivable to a
    Person that is not a Restricted Subsidiary or by borrowing from
    such a Person or from another Receivables Subsidiary that in
    turn funds itself by borrowing from such a Person.
"Receivables Fees"
means distributions or
    payments made directly or by means of discounts with respect to
    any accounts receivable or participation interest therein issued
    or sold in connection with, and other fees paid to a Person that
    is not a Restricted Subsidiary in connection with any
    Receivables Facility.
"Receivables Subsidiary"
means any Subsidiary
    formed for the purpose of facilitating or entering into one or
    more Receivables Facilities, and in each case engages only in
    activities reasonably related or incidental thereto.
"Redemption Date"
has the meaning set
    forth under "Optional Redemption."
"Registration Rights Agreement"
means the
    Registration Rights Agreement related to the Notes, dated as of
    the Issue Date, among the Issuer, the Guarantors and the Initial
    Purchasers.
"Related Business Assets"
means assets (other
    than cash or Cash Equivalents) used or useful in a Similar
    Business;
provided
that any assets received by the Issuer
    or a Restricted Subsidiary in exchange for assets transferred by
    the Issuer or a Restricted Subsidiary will not be deemed to be
    Related Business Assets if they consist of securities of a
    Person, unless upon receipt of the securities of such Person,
    such Person would become a Restricted Subsidiary.
"Restricted Investment"
means an Investment
    other than a Permitted Investment.
183
Table of Contents
"Restricted Subsidiary"
means, at any time, any
    direct or indirect Subsidiary of the Issuer (including any
    Foreign Subsidiary) that is not then an Unrestricted Subsidiary;
provided
,
however
, that upon an Unrestricted
    Subsidiary's ceasing to be an Unrestricted Subsidiary, such
    Subsidiary shall be included in the definition of
    "Restricted Subsidiary."
"S&P"
means Standard &
    Poor's, a division of The McGraw-Hill Companies, Inc., and
    any successor to its rating agency business.
"Sale and Lease-Back Transaction"
means any
    arrangement providing for the leasing by the Issuer or any of
    its Restricted Subsidiaries of any real or tangible personal
    property, which property has been or is to be sold or
    transferred by the Issuer or such Restricted Subsidiary to a
    third Person in contemplation of such leasing.
"SEC"
means the U.S. Securities and
    Exchange Commission.
"Secured Indebtedness"
means any Indebtedness
    of the Issuer or any of its Restricted Subsidiaries secured by a
    Lien.
"Securities Act"
means the Securities Act of
    1933, as amended, and the rules and regulations of the SEC
    promulgated thereunder.
"Security Documents"
means, collectively, the
    Intercreditor Agreements, the security agreements relating to
    the Collateral and the mortgages and instruments filed and
    recorded in appropriate jurisdictions to preserve and protect
    the Liens on the Collateral (including, without limitation,
    financing statements under the Uniform Commercial Code of the
    relevant states) applicable to the Collateral, each as in effect
    on the Issue Date and as amended, amended and restated,
    modified, renewed or replaced from time to time.
"Senior Credit Facilities"
means the ABL
    Facility and the General Credit Facility.
"Senior Indebtedness"
means:
(1) all Indebtedness of the Issuer or any Guarantor
    outstanding under the Senior Credit Facilities or Notes and
    related Guarantees (including interest accruing on or after the
    filing of any petition in bankruptcy or similar proceeding or
    for reorganization of the Issuer or any Guarantor (at the rate
    provided for in the documentation with respect thereto,
    regardless of whether or not a claim for post-filing interest is
    allowed in such proceedings)), and any and all other fees,
    expense reimbursement obligations, indemnification amounts,
    penalties, and other amounts (whether existing on the Issue Date
    or thereafter created or incurred) and all obligations of the
    Issuer or any Guarantor to reimburse any bank or other Person in
    respect of amounts paid under letters of credit, acceptances or
    other similar instruments;
(2) all Hedging Obligations (and guarantees thereof) owing
    to a Lender (as defined in the Senior Credit Facilities) or any
    Affiliate of such Lender (or any Person that was a Lender or an
    Affiliate of such Lender at the time the applicable agreement
    giving rise to such Hedging Obligation was entered into);
    provided that such Hedging Obligations are permitted to be
    incurred under the terms of the Indenture;
(3) any other Indebtedness of the Issuer or any Guarantor
    permitted to be incurred under the terms of the Indenture,
    unless the instrument under which such Indebtedness is incurred
    expressly provides that it is subordinated in right of payment
    to the Notes or any related Guarantee; and
(4) all Obligations with respect to the items listed in the
    preceding clauses (1), (2) and (3);
provided
,
however
, that Senior Indebtedness shall
    not include:
(a) any obligation of such Person to the Issuer or any of
    its Subsidiaries;
(b) any liability for federal, state, local or other taxes
    owed or owing by such Person;
(c) any accounts payable or other liability to trade
    creditors arising in the ordinary course of business;
184
Table of Contents
(d) any Indebtedness or other Obligation of such Person
    which is subordinate or junior in any respect to any other
    Indebtedness or other Obligation of such Person; or
(e) that portion of any Indebtedness which at the time of
    incurrence is incurred in violation of the Indenture.
"Separate Receivables Collateral"
has the
    meaning set forth under "Description of Other
    Indebtedness — Senior Secured Credit
    Facilities — Guarantee and Security."
"Shared Receivables Collateral"
has the meaning
    set forth under "Description of Other
    Indebtedness — Senior Secured Credit
    Facilities — Guarantee and Security."
"Shared Receivables Intercreditor Agreement"
has the meaning set forth under "Security — Liens
    with Respect to Shared Receivables Collateral."
"Significant Subsidiary"
means any Restricted
    Subsidiary that would be a "significant subsidiary" as
    defined in Article 1,
Rule 1-02
of
Regulation S-X,
promulgated pursuant to the Securities Act, as such regulation
    is in effect on the Issue Date.
"Similar Business"
means any business conducted
    or proposed to be conducted by the Issuer and its Restricted
    Subsidiaries on the Issue Date or any business that is similar,
    reasonably related, incidental or ancillary thereto.
"Sponsor Management Agreement"
means the
    management agreement between certain of the management companies
    associated with the Investors, the Frist Entities and the Issuer.
"Subordinated Indebtedness"
means, with respect
    to the Notes,
(1) any Indebtedness of the Issuer which is by its terms
    subordinated in right of payment to the Notes, and
(2) any Indebtedness of any Guarantor which is by its terms
    subordinated in right of payment to the Guarantee of such entity
    of the Notes.
"Subsidiary"
means, with respect to any Person:
(1) any corporation, association, or other business entity
    (other than a partnership, joint venture, limited liability
    company or similar entity) of which more than 50% of the total
    voting power of shares of Capital Stock entitled (without regard
    to the occurrence of any contingency) to vote in the election of
    directors, managers or trustees thereof is at the time of
    determination owned or controlled, directly or indirectly, by
    such Person or one or more of the other Subsidiaries of that
    Person or a combination thereof or is consolidated under GAAP
    with such Person at such time; and
(2) any partnership, joint venture, limited liability
    company or similar entity of which
(x) more than 50% of the capital accounts, distribution
    rights, total equity and voting interests or general or limited
    partnership interests, as applicable, are owned or controlled,
    directly or indirectly, by such Person or one or more of the
    other Subsidiaries of that Person or a combination thereof
    whether in the form of membership, general, special or limited
    partnership or otherwise, and
(y) such Person or any Restricted Subsidiary of such Person
    is a controlling general partner or otherwise controls such
    entity.
"Total Assets"
means the total assets of the
    Issuer and its Restricted Subsidiaries on a consolidated basis,
    as shown on the most recent consolidated balance sheet of the
    Issuer or such other Person as may be expressly stated.
"Transaction"
means the transactions
    contemplated by the Transaction Agreement, the issuance of the
    Notes and borrowings under the Senior Credit Facilities as in
    effect on November 17, 2006.
185
Table of Contents
"Transaction Agreement"
means the Agreement and
    Plan of Merger, dated as of July 24, 2006, between Hercules
    Holding II, LLC, Hercules Acquisition Corporation and the
    Issuer, as the same may be amended prior to the Issue Date.
"Treasury Rate"
means, as of any
    Redemption Date, the yield to maturity as of such
    Redemption Date of United States Treasury securities with a
    constant maturity (as compiled and published in the most recent
    Federal Reserve Statistical Release H.15 (519) that has
    become publicly available at least two Business Days prior to
    the Redemption Date (or, if such Statistical Release is no
    longer published, any publicly available source of similar
    market data)) most nearly equal to the period from the
    Redemption Date to February 15, 2013;
provided
,
however
, that if the period from the Redemption Date
    to February 15, 2013 is less than one year, the weekly
    average yield on actually traded United States Treasury
    securities adjusted to a constant maturity of one year will be
    used.
"Trust Indenture Act"
means the
    Trust Indenture Act of 1939, as amended (15 U.S.C.
§§ 77aaa-777bbbb).
"Unrestricted Subsidiary"
means:
(1) any Subsidiary of the Issuer which at the time of
    determination is an Unrestricted Subsidiary (as designated by
    the Issuer, as provided below); and
(2) any Subsidiary of an Unrestricted Subsidiary.
The Issuer may designate any Subsidiary of the Issuer (including
    any existing Subsidiary and any newly acquired or newly formed
    Subsidiary) to be an Unrestricted Subsidiary unless such
    Subsidiary or any of its Subsidiaries owns any Equity Interests
    or Indebtedness of, or owns or holds any Lien on, any property
    of, the Issuer or any Subsidiary of the Issuer (other than
    solely any Subsidiary of the Subsidiary to be so designated);
provided
that
(1) any Unrestricted Subsidiary must be an entity of which
    the Equity Interests entitled to cast at least a majority of the
    votes that may be cast by all Equity Interests having ordinary
    voting power for the election of directors or Persons performing
    a similar function are owned, directly or indirectly, by the
    Issuer;
(2) such designation complies with the covenants described
    under "Certain Covenants — Limitation on
    Restricted Payments"; and
(3) each of:
(a) the Subsidiary to be so designated; and
(b) its Subsidiaries has not at the time of designation,
    and does not thereafter, create, incur, issue, assume, guarantee
    or otherwise become directly or indirectly liable with respect
    to any Indebtedness pursuant to which the lender has recourse to
    any of the assets of the Issuer or any Restricted Subsidiary.
The Issuer may designate any Unrestricted Subsidiary to be a
    Restricted Subsidiary;
provided
that, immediately after
    giving effect to such designation, no Default shall have
    occurred and be continuing and either:
(1) the Issuer could incur at least $1.00 of additional
    Indebtedness pursuant to the Fixed Charge Coverage Ratio test
    described in the first paragraph under "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred
    Stock"; or
(2) the Fixed Charge Coverage Ratio for the Issuer and its
    Restricted Subsidiaries would be greater than such ratio for the
    Issuer and its Restricted Subsidiaries immediately prior to such
    designation, in each case on a pro forma basis taking into
    account such designation.
Any such designation by the Issuer shall be notified by the
    Issuer to the Trustee by promptly filing with the Trustee a copy
    of the resolution of the board of directors of the Issuer or any
    committee thereof giving effect to such designation and an
    Officer's Certificate certifying that such designation
    complied with the foregoing provisions.
186
Table of Contents
"Voting Stock"
of any Person as of any date
    means the Capital Stock of such Person that is at the time
    entitled to vote in the election of the board of directors of
    such Person.
"Weighted Average Life to Maturity"
means, when
    applied to any Indebtedness, Disqualified Stock or Preferred
    Stock, as the case may be, at any date, the quotient obtained by
    dividing:
(1) the sum of the products of the number of years from the
    date of determination to the date of each successive scheduled
    principal payment of such Indebtedness or redemption or similar
    payment with respect to such Disqualified Stock or Preferred
    Stock multiplied by the amount of such payment; by
(2) the sum of all such payments.
"Wholly-Owned Subsidiary"
of any Person means a
    Subsidiary of such Person, 100% of the outstanding Equity
    Interests of which (other than directors' qualifying
    shares) shall at the time be owned by such Person or by one or
    more Wholly-Owned Subsidiaries of such Person.
Senior
    Secured Notes Issued Under the 2009 First Lien
    Indenture
HCA Inc. has issued senior secured notes as described below
    under an indenture, dated as of April 22, 2009, among the
    Issuer, the Guarantors, Deutsche Bank Trust Company
    Americas, paying agent, registrar and transfer agent and Law
    Debenture Trust Company of New York, as trustee. Terms used
    in this "— Senior Secured Notes Issued Under the
    2009 First Lien Indenture" apply only to the Notes
    described herein.
General
Certain terms used in this description are defined under the
    subheading "Certain Definitions. " In this
    description, the terms
"we," "our,"
"us"
and
"the Company"
each
    refer to HCA Inc. (the
"Issuer"
) and its
    consolidated Subsidiaries.
The Issuer issued $1,500,000,000 aggregate principal amount of
    8
1
/
2
% senior
    secured notes due 2019 (the
"Notes"
) under an
    indenture to be dated as of the closing date of the offering of
    the Notes (the
"Indenture"
) among the Issuer,
    the Guarantors and Law Debenture Trust Company of New York,
    as trustee (the
"Trustee"
), Deutsche Bank
    Trust Company Americas, as Paying Agent, Registrar and
    Transfer Agent and Bank of America, N.A., as collateral agent.
    The Notes were issued in a private transaction that was not
    subject to the registration requirements of the Securities Act.
    Except as set forth herein, the terms of the Notes include those
    stated in the Indenture and those made part of the Indenture by
    reference to the Trust Indenture Act.
The following description is only a summary of the material
    provisions of the Indenture, does not purport to be complete and
    is qualified in its entirety by reference to the provisions of
    those agreements, including the definitions therein of certain
    terms used below. We urge you to read the Indenture because it,
    and not this description, will define your rights as Holders of
    the Notes.
Brief
    Description of Notes
The Notes:
•
are general senior obligations of the Issuer;
•
are secured on a first-priority basis, equally and ratably with
    all existing and future obligations of the Issuer and the
    Guarantors under any existing and future First Lien Obligations,
    by all of the assets of the Issuer and the Guarantors which
    secure the General Credit Facility (other than the European
    Collateral), subject to the Liens securing the Issuer's and
    the Guarantors' ABL Obligations and other Permitted Liens;
•
are secured on a second-priority basis, equally and ratably with
    all existing and future obligations of the Issuer and the
    Guarantors under any existing and future First Lien Obligations,
    by all of the assets of the Issuer and the Guarantors securing
    the ABL Facility which also secure the General Credit Facility,
    subject to the Liens securing the Issuer's and the
    Guarantors' ABL Obligations and other Permitted Liens;
187
Table of Contents
•
are effectively subordinated to the Issuer's and the
    Guarantors' obligations under the ABL Facility, to the
    extent of the value of the Shared Receivables Collateral;
•
are effectively subordinated to any obligations secured by
    Permitted Liens, to the extent of the value of the assets of the
    Issuer and the Guarantors subject to those Permitted Liens;
•
are structurally subordinated to any existing and future
    indebtedness and liabilities of non-guarantor Subsidiaries,
    including the ABL Financing Entities and the Issuer's
    Foreign Subsidiaries and any Unrestricted Subsidiaries and
    including indebtedness under the Company's senior secured
    European term loan facility included in the General Credit
    Facility;
•
rank equally in right of payment with all existing and future
    senior Indebtedness of the Issuer and the Guarantors but, to the
    extent of the value of the Collateral, are effectively senior to
    all of the Issuer's and the Guarantors' unsecured
    senior Indebtedness (including the Existing Notes) and Junior
    Lien Obligations (including the Existing Second Priority Notes);
•
are senior in right of payment to any future Subordinated
    Indebtedness (as defined with respect to the Notes) of the
    Issuer;
•
are initially unconditionally guaranteed on a joint and several
    and senior basis by each Restricted Subsidiary that guarantees
    the General Credit Facility (other than any Foreign
    Subsidiary); and
•
are subject to registration with the SEC pursuant to the
    Registration Rights Agreement.
Guarantees
The Guarantors, as primary obligors and not merely as sureties,
    jointly and severally fully and unconditionally guaranteed, on a
    senior basis, the performance and full and punctual payment when
    due, whether at maturity, by acceleration or otherwise, of all
    obligations of the Issuer under the Indenture and the Notes,
    whether for payment of principal of, premium, if any, or
    interest or Additional Interest in respect of the Notes,
    expenses, indemnification or otherwise, on the terms set forth
    in the Indenture by executing the Indenture.
The Restricted Subsidiaries which guarantee the General Credit
    Facility guarantee the Notes. Each of the Guarantees of the
    Notes is a general senior obligation of each Guarantor and is
    secured by a first-priority lien on all of the assets of each
    Guarantor which secure the General Credit Facility (other than
    the European Collateral) and by a second-priority lien on all of
    the assets of each Guarantor which secure the ABL Facility. The
    Guarantees rank equally in right of payment with all existing
    and future senior Indebtedness of the Guarantor but, to the
    extent of the value of the Collateral, are effectively senior to
    all of the Guarantor's unsecured senior Indebtedness and
    Junior Lien Obligations and, to the extent of the Shared
    Receivables Collateral, are effectively subordinated to the
    Guarantor's Obligations under the ABL Facility and any
    future ABL Obligations. The Guarantees are senior in right of
    payment to all existing and future Subordinated Indebtedness of
    each Guarantor. The Notes are structurally subordinated to
    Indebtedness and other liabilities of Subsidiaries of the Issuer
    that do not Guarantee the Notes.
Not all of the Issuer's Subsidiaries Guarantee the Notes.
    In the event of a bankruptcy, liquidation or reorganization of
    any of these non-guarantor Subsidiaries, the non-guarantor
    Subsidiaries will pay the holders of their debt and their trade
    creditors before they will be able to distribute any of their
    assets to the Issuer. None of our Subsidiaries which are
    "Restricted Subsidiaries" for purposes of the Existing
    Notes Indenture, Foreign Subsidiaries, ABL Financing Entities,
    non-Wholly Owned Subsidiaries or any Receivables Subsidiaries
    will guarantee the Notes.
On an as adjusted basis after giving effect to our offering of
    $1.500 billion aggregate principal amount of first lien
    notes in April 2009 and the use of proceeds therefrom, our
    non-guarantor subsidiaries would have accounted for
    approximately $11.867 billion, or 41.8%, of our total
    revenues for the year ended December 31, 2008,
    approximately $3.038 billion, or 40.9%, of our total
    revenues for the three months ended March 31, 2009,
    approximately $9.876 billion, or 40.7%, of our total
    assets, and approximately $7.517 billion, or 22.5%, of our
    total liabilities, in each case, as of December 31, 2008,
    and approximately $9.817 billion, or 40.4%, of
188
Table of Contents
our total assets, and approximately $7.224 billion, or
    21.9%, of our total liabilities, in each case, as of
    March 31, 2009.
The obligations of each Guarantor under its Guarantee are
    limited as necessary to prevent the Guarantee from constituting
    a fraudulent conveyance under applicable law.
Any entity that makes a payment under its Guarantee is entitled
    upon payment in full of all guaranteed obligations under the
    Indenture to a contribution from each other Guarantor in an
    amount equal to such other Guarantor's pro rata portion of
    such payment based on the respective net assets of all the
    Guarantors at the time of such payment determined in accordance
    with GAAP.
If a Guarantee were rendered voidable, it could be subordinated
    by a court to all other indebtedness (including guarantees and
    other contingent liabilities) of the Guarantor, and, depending
    on the amount of such indebtedness, a Guarantor's liability
    on its Guarantee could be reduced to zero. See "Risk
    Factors — Risks Related to the Notes —
    Federal and state fraudulent transfer laws may permit a court to
    void the notes, and with respect to the senior secured notes,
    the guarantees, and, if that occurs, you may not receive any
    payment on the notes."
Each Guarantee by a Guarantor provides by its terms that it will
    be automatically and unconditionally released and discharged
    upon:
1. (a) any sale, exchange or transfer (by merger or
    otherwise) of the Capital Stock of such Guarantor (including any
    sale, exchange or transfer), after which the applicable
    Guarantor is no longer a Restricted Subsidiary or all or
    substantially all the assets of such Guarantor, which sale,
    exchange or transfer is made in compliance with the applicable
    provisions of the Indenture;
the release or discharge of the guarantee by such Guarantor of
    the Senior Credit Facilities or such other guarantee that
    resulted in the creation of such Guarantee, except a discharge
    or release by or as a result of payment under such guarantee;
the designation of any Restricted Subsidiary that is a Guarantor
    as an Unrestricted Subsidiary in compliance with the applicable
    provisions of the Indenture; or
the exercise by the Issuer of its legal defeasance option or
    covenant defeasance option as described under "Legal
    Defeasance and Covenant Defeasance" or the discharge of the
    Issuer's obligations under the Indenture in accordance with
    the terms of the Indenture; and
2. such Guarantor delivering to the Trustee an
    Officer's Certificate and an Opinion of Counsel, each
    stating that all conditions precedent provided for in the
    Indenture relating to such transaction have been complied with.
Holding
    Company Structure
The Issuer is a holding company for its Subsidiaries, with no
    material operations of its own and only limited assets.
    Accordingly, the Issuer is dependent upon the distribution of
    the earnings of its Subsidiaries, whether in the form of
    dividends, advances or payments on account of intercompany
    obligations, to service its debt obligations.
Security
General
The Notes and the Guarantees are secured by perfected
    first-priority security interests in the Non-Receivables
    Collateral and by perfected second-priority security interests
    in the Shared Receivables Collateral (second in priority to the
    first-priority Liens on the Shared Receivables Collateral
    securing the ABL Obligations), in each case, subject to
    Permitted Liens. Notwithstanding the foregoing, neither the
    Notes nor the Guarantees are secured by the European Collateral
    or the Separate Receivables Collateral. The ABL Secured Parties
    have rights and remedies with respect to the Shared Receivables
    Collateral that, if exercised, could adversely affect the value
    of the Shared Receivables Collateral or the ability of the
    respective agents
189
Table of Contents
under the Intercreditor Agreements to realize or foreclose on
    the Shared Receivables Collateral on behalf of the First Lien
    Secured Parties. First Lien Secured Parties other than the
    Holders of the Notes have rights and remedies with respect to
    the Collateral that, if exercised, could also adversely affect
    the value of the Collateral on behalf of the Holders of the
    Notes, particularly the rights described below under
    "— First Lien Intercreditor Agreement." For
    a description of the Shared Receivables Collateral and the
    Non-Receivables Collateral, see "Description of Other
    Indebtedness — Senior Secured Credit
    Facilities — Guarantee and Security."
The Issuer and the Guarantors are and will be able to incur
    additional Indebtedness in the future which could share in the
    Collateral, including additional First Lien Obligations,
    additional ABL Obligations, additional Junior Lien Obligations
    and Obligations secured by Permitted Liens. The amount of such
    additional Obligations is and will be limited by the covenant
    described under "Certain Covenants — Liens"
    and the covenant described under "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock."
    Under certain circumstances, the amount of any such additional
    Obligations could be significant.
After-Acquired
    Collateral
From and after the Issue Date and subject to certain limitations
    and exceptions, (a) if the Issuer or any Guarantor creates
    any additional security interest upon any property or asset that
    would constitute Collateral to secure any First Lien Obligations
    (other than European Collateral and Separate Receivables
    Collateral), it must concurrently grant a first-priority
    perfected security interest (subject to Permitted Liens) upon
    such property as security for the Notes and (b) if the
    Issuer or any Guarantor creates any additional security interest
    upon any property or asset that would constitute Shared
    Receivables Collateral to secure any ABL Obligations, it must
    concurrently grant a second-priority perfected security interest
    (subject to Permitted Liens) upon such property as security for
    the Notes.
Liens
    with Respect to the Collateral
The Issuer, the Guarantors and the First Lien Collateral Agent
    entered into Security Documents in connection with the General
    Credit Facility with respect to the Collateral defining the
    terms of the security interests that secure the General Credit
    Facility with respect to such Collateral and that also define
    the terms of the security interests that secure the Notes and
    the Guarantees with respect to such Collateral. These security
    interests secure the payment and performance when due of all of
    the Obligations of the Issuers and the Guarantors under the
    Notes, the Indenture, the Guarantees and the Security Documents,
    as provided in the Security Documents.
First
    Lien Intercreditor Agreement
The Trustee and the First Lien Collateral Agent entered into a
    First Lien Intercreditor Agreement (as the same may be amended
    from time to time, the
"First Lien Intercreditor
    Agreement"
) with the Authorized Representative of the
    General Credit Facility Obligations with respect to the
    Collateral, which may be amended from time to time without the
    consent of the Holders to add other parties holding First Lien
    Obligations permitted to be incurred under the Indenture,
    General Credit Facility and the First Lien Intercreditor
    Agreement. The First Lien Collateral Agent is initially the
    collateral agent under the General Credit Facility.
Under the First Lien Intercreditor Agreement, as described
    below, the "Applicable Authorized Representative" has
    the right to direct foreclosures and take other actions with
    respect to the Common Collateral, and the Authorized
    Representatives of other Series of First Lien Obligations have
    no right to take actions with respect to the Common Collateral.
    The Applicable Authorized Representative is initially the
    administrative agent under the General Credit Facility, and the
    Trustee for the Holders, as Authorized Representative in respect
    of the Notes, has no rights to take any action under the First
    Lien Intercreditor Agreement.
The administrative agent under the General Credit Facility will
    remain the Applicable Authorized Representative until the
    earlier of (1) the Discharge of General Credit Facility
    Obligations and (2) the Non-Controlling Authorized
    Representative Enforcement Date (such date, the
"Applicable Authorized Agent
190
Table of Contents
Date"
). After the Applicable Authorized Agent Date,
    the Applicable Authorized Representative will be the Authorized
    Representative of the Series of Additional First Lien
    Obligations that constitutes the largest outstanding principal
    amount of any then outstanding Series of First Lien Obligations,
    other than the General Credit Facility Obligations, with respect
    to the Common Collateral (the
"Major Non-Controlling
    Authorized Representative"
).
The
"Non-Controlling Authorized Representative
    Enforcement Date"
is the date that is 90 days
    (throughout which
90-day
period the applicable Authorized Representative was the Major
    Non-Controlling Authorized Representative) after the occurrence
    of both (a) an event of default, as defined in the
    Indenture or other applicable indenture for that Series of First
    Lien Obligations, and (b) the First Lien Collateral
    Agent's and each other Authorized Representative's
    receipt of written notice from that Authorized Representative
    certifying that (i) such Authorized Representative is the
    Major Non-Controlling Authorized Representative and that an
    event of default, as defined in the Indenture or other
    applicable indenture for that Series of First Lien Obligations,
    has occurred and is continuing and (ii) the First Lien
    Obligations of that Series are currently due and payable in full
    (whether as a result of acceleration thereof or otherwise) in
    accordance with the Indenture or other applicable indenture for
    that Series of First Lien Obligations;
provided
that the
    Non-Controlling Authorized Representative Enforcement Date shall
    be stayed and shall not occur and shall be deemed not to have
    occurred with respect to any Shared Collateral (1) at any
    time the administrative agent under the General Credit Facility
    or the First Lien Collateral Agent has commenced and is
    diligently pursuing any enforcement action with respect to such
    Common Collateral or (2) at any time the Issuer or the
    Guarantor that has granted a security interest in such Common
    Collateral is then a debtor under or with respect to (or
    otherwise subject to) any insolvency or liquidation proceeding.
The Applicable Authorized Representative shall have the sole
    right to instruct the First Lien Collateral Agent to act or
    refrain from acting with respect to the Common Collateral,
    (b) the First Lien Collateral Agent shall not follow any
    instructions with respect to such Common Collateral from any
    representative of any Non-Controlling Secured Party or other
    First Lien Secured Party (other than the Applicable Authorized
    Representative), and (c) no Authorized Representative of
    any Non-Controlling Secured Party or other First Lien Secured
    Party (other than the Applicable Authorized Representative) will
    instruct the First Lien Collateral Agent to commence any
    judicial or non-judicial foreclosure proceedings with respect
    to, seek to have a trustee, receiver, liquidator or similar
    official appointed for or over, attempt any action to take
    possession of, exercise any right, remedy or power with respect
    to, or otherwise take any action to enforce its interests in or
    realize upon, or take any other action available to it in
    respect of, the Common Collateral.
Notwithstanding the equal priority of the Liens, the First Lien
    Collateral Agent, acting on the instructions of the Applicable
    Authorized Representative, may deal with the Common Collateral
    as if such Applicable Authorized Representative had a senior
    Lien on such Collateral. No representative of any
    Non-Controlling Secured Party may contest, protest or object to
    any foreclosure proceeding or action brought by the First Lien
    Collateral Agent, Applicable Authorized Representative or
    Controlling Secured Party. The Trustee and each other Authorized
    Representative will agree that it will not accept any Lien on
    any Collateral for the benefit of the Holders (other than funds
    deposited for the discharge or defeasance of the Notes) other
    than pursuant to the First Lien Security Documents. Each of the
    First Lien Secured Parties also will agree that it will not
    contest or support any other person in contesting, in any
    proceeding (including any insolvency or liquidation proceeding),
    the perfection, priority, validity or enforceability of a Lien
    held by or on behalf of any of the First Lien Secured Parties in
    all or any part of the Collateral, or the provisions of the
    First Lien Intercreditor Agreement.
If a First Lien Event of Default has occurred and is continuing
    and the First Lien Collateral Agent is taking action to enforce
    rights in respect of any Common Collateral, or any distribution
    is made with respect to any Common Collateral in any bankruptcy
    case of the Issuer or any Guarantor, the proceeds of any sale,
    collection or other liquidation of any such Collateral by the
    First Lien Collateral Agent or any other First Lien Secured
    Party (or received pursuant to any other intercreditor
    agreement), as applicable, and proceeds of any such distribution
    (subject, in the case of any such distribution, to the paragraph
    immediately following) to which the First Lien Obligations are
    entitled under any other intercreditor agreement shall be
    applied among
191
Table of Contents
the First Lien Obligations to the payment in full of the First
    Lien Obligations on a ratable basis, after payment of all
    amounts owing to the First Lien Collateral Agent.
Notwithstanding the foregoing, with respect to any Common
    Collateral for which a third party (other than a First Lien
    Secured Party) has a lien or security interest that is junior in
    priority to the security interest of any Series of First Lien
    Obligations but senior (as determined by appropriate legal
    proceedings in the case of any dispute) to the security interest
    of any other Series of First Lien Obligations (such third party,
    an
"Intervening Creditor"
), the value of any
    Common Collateral or proceeds which are allocated to such
    Intervening Creditor shall be deducted on a ratable basis solely
    from the Common Collateral or proceeds to be distributed in
    respect of the Series of First Lien Obligations with respect to
    which such Impairment exists.
None of the First Lien Secured Parties may institute any suit or
    assert in any suit, bankruptcy, insolvency or other proceeding
    any claim against the First Lien Collateral Agent or any other
    First Lien Secured Party seeking damages from or other relief by
    way of specific performance, instructions or otherwise with
    respect to any Common Collateral. In addition, none of the First
    Lien Secured Parties may seek to have any Common Collateral or
    any part thereof marshaled upon any foreclosure or other
    disposition of such Collateral. If any First Lien Secured Party
    obtains possession of any Common Collateral or realizes any
    proceeds or payment in respect thereof, at any time prior to the
    discharge of each of the First Lien Obligations, then it must
    hold such Common Collateral, proceeds or payment in trust for
    the other First Lien Secured Parties and promptly transfer such
    Common Collateral, proceeds or payment to the First Lien
    Collateral Agent to be distributed in accordance with the First
    Lien Intercreditor Agreement.
If the Issuer or any Guarantor becomes subject to any bankruptcy
    case, the First Lien Intercreditor Agreement provides that
    (1) if the Issuer or any Guarantor shall, as
    debtor(s)-in-possession, move for approval of financing (the
"DIP Financing"
) to be provided by one or more
    lenders (the
"DIP Lenders"
) under
    Section 364 of the Bankruptcy Code or the use of cash
    collateral under Section 363 of the Bankruptcy Code, each
    First Lien Secured Party will agree not to object to any such
    financing or to the Liens on the Common Collateral securing the
    same (the
"DIP Financing Liens"
) or to any use
    of cash collateral that constitutes Common Collateral, unless
    any Controlling Secured Party, or an Authorized Representative
    of any Controlling Secured Party, shall then oppose or object to
    such DIP Financing or such DIP Financing Liens or use of cash
    collateral (and (i) to the extent that such DIP Financing
    Liens are senior to the Liens on any such Common Collateral for
    the benefit of the Controlling Secured Parties, each
    Non-Controlling Secured Party will subordinate its Liens with
    respect to such Common Collateral on the same terms as the Liens
    of the Controlling Secured Parties (other than any Liens of any
    First Lien Secured Parties constituting DIP Financing Liens) are
    subordinated thereto, and (ii) to the extent that such DIP
    Financing Liens rank
pari passu
with the Liens on any
    such Common Collateral granted to secure the First Lien
    Obligations of the Controlling Secured Parties, each
    Non-Controlling Secured Party will confirm the priorities with
    respect to such Common Collateral as set forth in the First Lien
    Intercreditor Agreement), in each case so long as;
(A) the First Lien Secured Parties of each Series retain
    the benefit of their Liens on all such Common Collateral pledged
    to the DIP Lenders, including proceeds thereof arising after the
    commencement of such proceeding, with the same priority
vis-a-vis
all the other First Lien Secured Parties (other than any Liens
    of the First Lien Secured Parties constituting DIP Financing
    Liens) as existed prior to the commencement of the bankruptcy
    case,
(B) the First Lien Secured Parties of each Series are
    granted Liens on any additional collateral pledged to any First
    Lien Secured Parties as adequate protection or otherwise in
    connection with such DIP Financing or use of cash collateral,
    with the same priority
vis-a-vis
the First Lien Secured Parties as set forth in the First Lien
    Intercreditor Agreement,
(C) if any amount of such DIP Financing or cash collateral
    is applied to repay any of the First Lien Obligations, such
    amount is applied pursuant to the First Lien Intercreditor
    Agreement, and
(D) if any First Lien Secured Parties are granted adequate
    protection, including in the form of periodic payments, in
    connection with such DIP Financing or use of cash collateral,
    the proceeds of such adequate protection is applied pursuant to
    the First Lien Intercreditor Agreement;
192
Table of Contents
provided
that the First Lien Secured Parties of each
    Series shall have a right to object to the grant of a Lien to
    secure the DIP Financing over any Collateral subject to Liens in
    favor of the First Lien Secured Parties of such Series or its
    representative that shall not constitute Common Collateral; and
provided
,
further
, that the First Lien Secured
    Parties receiving adequate protection shall not object to any
    other First Lien Secured Party receiving adequate protection
    comparable to any adequate protection granted to such First Lien
    Secured Parties in connection with a DIP Financing or use of
    cash collateral.
The First Lien Secured Parties acknowledge that the First Lien
    Obligations of any Series may, subject to the limitations set
    forth in the other First Lien Documents, be increased, extended,
    renewed, replaced, restated, supplemented, restructured, repaid,
    refunded, refinanced or otherwise amended or modified from time
    to time, all without affecting the priorities set forth in the
    First Lien Intercreditor Agreement defining the relative rights
    of the First Lien Secured Parties of any Series.
Additional
    General Intercreditor Agreement
The First Lien Collateral Agent is a party to an Additional
    General Intercreditor Agreement dated as of the Issue Date, (as
    the same may be amended from time to time, the
"Additional General Intercreditor Agreement"
),
    by and among the First Lien Collateral Agent, the Junior Lien
    Collateral Agent and the trustees under the Existing Second
    Priority Notes Indentures, by which the Notes are given the same
    ranking and rights with respect to the Collateral as provided to
    the General Credit Facility under the General Intercreditor
    Agreement, dated as of November 17, 2006, by and among the
    First Lien Collateral Agent and the Junior Lien Collateral
    Agent. Pursuant to the terms of the Additional General
    Intercreditor Agreement and subject to the First-Lien
    Intercreditor Agreement, prior to the Discharge of New First
    Lien Obligations, the First Lien Collateral Agent, acting on
    behalf of the New First Lien Secured Parties, will determine the
    time and method by which the security interests in the
    Collateral will be enforced and will have the sole and exclusive
    right to manage, perform and enforce the terms of the Security
    Documents relating to the Collateral and to exercise and enforce
    all privileges, rights and remedies thereunder according to its
    direction, including to take or retake control or possession of
    such Collateral and to hold, prepare for sale, marshall,
    process, sell, lease, dispose of or liquidate such Collateral,
    including, without limitation, following the occurrence of a
    Default or Event of Default under the Indenture. The Junior Lien
    Collateral Agent will not be permitted to enforce the security
    interests even if any event of default under an Existing Second
    Priority Notes Indenture has occurred and the Existing Second
    Priority Notes issued thereunder have been accelerated except
    (a) in any insolvency or liquidation proceeding, solely as
    necessary to file a proof of claim or statement of interest with
    respect to the Junior Lien Obligations or (b) as necessary
    to take any action in order to prove, preserve, perfect or
    protect (but not enforce) its security interest and rights in,
    and the perfection and priority of its Lien on, the Collateral.
The Junior Lien Collateral Agent, for itself and on behalf of
    each Junior Lien Secured Party, has agreed pursuant to the
    Additional General Intercreditor Agreement that (a) it will
    not (and thereby waives any right to) take any action to
    challenge, contest or support any other Person in contesting or
    challenging, directly or indirectly, in any proceeding
    (including any insolvency or liquidation proceeding), the
    validity, perfection, priority or enforceability of a Lien
    securing any New First Lien Obligations held (or purported to be
    held) by or on behalf of the First Lien Collateral Agent or any
    of the New First Lien Secured Parties or any agent or trustee
    therefor in any Collateral or other collateral securing both the
    New First Lien Obligations and any Junior Lien Obligations and
    (b) it will not oppose or otherwise contest (or support any
    other Person contesting) any request for judicial relief made in
    any court by the First Lien Collateral Agent or any New First
    Lien Secured Parties relating to the lawful enforcement of any
    First Priority Lien on Collateral or other collateral securing
    both the New First Lien Obligations and any Junior Lien
    Obligations.
In addition, the Security Documents provide that, subject to the
    First Lien Intercreditor Agreement, prior to the Discharge of
    New First Lien Obligations, the First Lien Collateral Agent may
    take actions with respect to the Collateral (including the
    release of Collateral and the manner of realization (subject to
    the provisions described under "— Release of
    Collateral")) without the consent of the Junior Lien
    Collateral Agent or other Junior Lien Secured Parties.
193
Table of Contents
The Collateral or proceeds thereof received in connection with
    the sale or other disposition of, or collection on, such
    Non-Receivables Collateral upon the exercise of remedies will be
    applied to the First Lien Obligations to be distributed in
    accordance with the First Lien Intercreditor Agreement prior to
    application to any Junior Lien Obligations in such order as
    specified in the relevant First Lien Documents until the
    Discharge of New First Lien Obligations has occurred.
In addition, so long as the Discharge of New First Lien
    Obligations has not occurred, neither the Junior Lien Collateral
    Agent nor any Junior Lien Representative shall acquire or hold
    any Lien on any assets of the Issuer or any Subsidiary (and
    neither the Issuer nor any Subsidiary shall grant such Lien)
    securing any Junior Lien Obligations that are not also subject
    to the First Priority Lien in respect of the New First Lien
    Obligations under the First Lien Documents.
The Junior Lien Collateral Agent and each other Junior Lien
    Secured Party have agreed that any Lien purported to be granted
    on any collateral as security for New First Lien Obligations
    shall be deemed to be and shall be deemed to remain senior in
    all respects and prior to all Liens on such collateral securing
    any Junior Lien Obligations for all purposes regardless of
    whether the Lien purported to be granted is found to be
    improperly granted, improperly perfected, preferential, a
    fraudulent conveyance or legally or otherwise deficient in any
    manner.
If any New First Lien Secured Party is required in any
    insolvency or liquidation proceeding or otherwise to turn over
    or otherwise pay to the estate of the Issuer or any other
    Guarantor (or any trustee, receiver or similar person therefor),
    because the payment of such amount was declared to be fraudulent
    or preferential in any respect or for any other reason, any
    amount (a
"Recovery"
), whether received as
    proceeds of security, enforcement of any right of setoff or
    otherwise, then as among the parties hereto, the New First Lien
    Obligations shall be deemed to be reinstated to the extent of
    such Recovery and to be outstanding as if such payment had not
    occurred and such New First Lien Secured Party shall be entitled
    to a reinstatement of New First Lien Obligations with respect to
    all such recovered amounts and shall have all rights hereunder.
    If the Additional General Intercreditor Agreement shall have
    been terminated prior to such Recovery, the Additional General
    Intercreditor Agreement shall be reinstated in full force and
    effect, and such prior termination shall not diminish, release,
    discharge, impair or otherwise affect the obligations of the
    parties thereto.
The Additional General Intercreditor Agreement provides that so
    long as the Discharge of New First Lien Obligations has not
    occurred, whether or not any insolvency or liquidation
    proceeding has been commenced by or against the Issuer or any
    Guarantor, (i) neither the Junior Lien Collateral Agent,
    any Junior Lien Representative nor any Junior Lien Secured Party
    will (x) exercise or seek to exercise any rights or
    remedies (including setoff or the right to credit bid debt
    (except under limited circumstances)) with respect to any
    collateral securing both the New First Lien Obligations and any
    Junior Lien Obligations in respect of any applicable Junior Lien
    Obligations, or institute any action or proceeding with respect
    to such rights or remedies (including any action of
    foreclosure), (y) contest, protest or otherwise object to
    any foreclosure or enforcement proceeding or action brought with
    respect to the Collateral or any other collateral by the First
    Lien Collateral Agent or any New First Lien Secured Party in
    respect of the New First Lien Obligations, the exercise of any
    right by the First Lien Collateral Agent or any New First Lien
    Secured Party (or any agent or
sub-agent
on
    their behalf) in respect of the New First Lien Obligations under
    any control agreement, lockbox agreement, landlord waiver or
    bailee's letter or similar agreement or arrangement to
    which the Junior Lien Collateral Agent, any Junior Lien
    Representative or any Junior Lien Secured Party either is a
    party or may have rights as a third-party beneficiary, or any
    other exercise by any such party of any rights and remedies as a
    secured party relating to such collateral or any other
    collateral under the First Lien Documents or otherwise in
    respect of New First Lien Obligations, or (z) object to any
    waiver or forbearance by the First Lien Secured Parties from or
    in respect of bringing or pursuing any foreclosure proceeding or
    action or any other exercise of any rights or remedies relating
    to such collateral or any other collateral in respect of New
    First Lien Obligations and (ii) except as otherwise
    provided in the Additional General Intercreditor Agreement, the
    First Lien Collateral Agent and the New First Lien Secured
    Parties shall have the sole and exclusive right to enforce
    rights, exercise remedies (including setoff and the right to
    credit bid their debt), marshal, process and make determinations
    regarding the release, disposition or restrictions, or waiver or
    forbearance of rights or remedies
194
Table of Contents
with respect to such collateral without any consultation with or
    the consent of the Junior Lien Collateral Agent, any Junior Lien
    Representative or any Junior Lien Secured Party.
In addition, the Junior Lien Collateral Agent, each Junior Lien
    Representative and each other Junior Lien Secured Party have
    agreed, among other things, that if the Issuer or any Guarantor
    is subject to any insolvency or liquidation proceeding if the
    First Lien Collateral Agent, subject to the First Lien
    Intercreditor Agreement, desires to permit the use of cash
    collateral or to permit the Issuer or any Guarantor to obtain
    financing under Section 363 or Section 364 of the
    Bankruptcy Code or any similar provision in any Bankruptcy Law
    (
"DIP Financing"
), including if such DIP
    Financing is secured by Liens senior in priority to the Liens
    securing the Junior Lien Obligations, then the Junior Lien
    Collateral Agent and each Junior Lien Representative, on behalf
    of itself and each applicable Junior Lien Secured Party, agrees
    not to object to such use of cash collateral or DIP Financing
    and will not request adequate protection or any other relief in
    connection therewith (except to the extent permitted by the
    Additional General Intercreditor Agreement) and, to the extent
    the Liens securing the new First Lien Obligations are
    subordinated or
pari passu
with such DIP Financing, will
    subordinate its Liens in the Collateral and any other collateral
    to such DIP Financing (and all Obligations relating thereto) on
    the same basis as they are subordinated to the New First Lien
    Obligations.
Subject to the terms of the Security Documents, the Issuer and
    the Guarantors have the right to remain in possession and retain
    exclusive control of the Collateral securing the Notes and the
    Notes Obligations (other than securities, instruments and
    chattel paper constituting part of the Collateral and deposited
    with the First Lien Collateral Agent in accordance with the
    provisions of the First Lien Security Documents and any Shared
    Receivables Collateral subject to a control agreement under the
    circumstances described in the First Lien Security Documents),
    to freely operate the Collateral and to collect, invest and
    dispose of any income therefrom.
Release
    of Collateral
Under the First Lien Intercreditor Agreement, if at any time the
    Applicable Authorized Representative forecloses upon or
    otherwise exercises remedies against any Common Collateral, then
    (whether or not any insolvency or liquidation proceeding is
    pending at the time) the Liens in favor of the First Lien
    Collateral Agent for the benefit of the Trustee and the Holders
    of the Notes and each other Series of First Lien Secured Parties
    upon such Common Collateral will automatically be released and
    discharged. However, any proceeds of any Common Collateral
    realized therefrom will be applied as described under
    "— First Lien Intercreditor Agreement."
Under the Additional Receivables Intercreditor Agreement, if at
    any time the Issuer or any Guarantor or any ABL Secured Party
    delivers notice that any Shared Receivables Collateral is sold,
    transferred or otherwise disposed of by the owner of that
    Collateral in a transaction permitted under the ABL Facility,
    the General Credit Facility and the Indenture or the ABL Secured
    Parties are releasing or have released their Liens on such
    Shared Receivables Collateral in connection with a disposition
    in connection with an exercise of remedies with respect to such
    Collateral, then the Liens on such Shared Receivables Collateral
    securing New First Lien Obligations or Junior Lien Obligations
    will automatically be released and discharged as and when, but
    only to the extent, such Liens on such Shared Receivables
    Collateral securing ABL Obligations are released and discharged,
    provided that in the case of a disposition in connection with an
    exercise of remedies, any proceeds thereof not applied to repay
    ABL Obligations shall be subject to the Liens securing the First
    Lien Obligations and the Junior Lien Obligations and shall be
    applied pursuant to the Additional Receivables Intercreditor
    Agreement and the First Lien Intercreditor Agreement.
The Issuer and the Guarantors are entitled to the release of
    property and other assets constituting Collateral from the Liens
    securing the Notes and the Notes Obligations under any one or
    more of the following circumstances:
(1) to enable us to consummate the sale, transfer or other
    disposition of such property or assets to the extent not
    prohibited under the covenant described under
    "— Repurchase at the Option of
    Holders — Asset Sales";
195
Table of Contents
(2) the release of Excess Proceeds or Collateral Excess
    Proceeds that remain unexpended after the conclusion of an Asset
    Sale Offer or a Collateral Asset Sale Offer conducted in
    accordance with the Indenture;
(3) in the case of a Guarantor that is released from its
    Guarantee with respect to the Notes pursuant to the terms of the
    Indenture, the release of the property and assets of such
    Guarantor;
(4) with the consent of the holders of at least 75% of the
    aggregate principal amount of the Notes then outstanding and
    affected thereby and a majority of all Junior Lien Obligations
    (including the Existing Second Priority Notes) then outstanding
    and affected thereby (including, without limitation, consents
    obtained in connection with a tender offer or exchange offer
    for, or purchase of, Junior Lien Obligations); or
(5) as described under "— Amendment,
    Supplement and Waiver" below.
To the extent necessary and for so long as required for such
    Subsidiary not to be subject to any requirement pursuant to
Rule 3-16
of
Regulation S-X
under the Securities Act to file separate financial statements
    with the SEC (or any other governmental agency), the Capital
    Stock of any Subsidiary of the Company (excluding Healthtrust,
    Inc. — The Hospital Company, a Delaware corporation
    and its successors and assigns) shall not be included in the
    Collateral with respect to the respective Notes so affected (as
    described under "— Certain Limitations on the
    Collateral") and shall not be subject to the Liens securing
    such Notes and the Notes Obligations.
The Liens on the Collateral securing the Notes and the
    Guarantees also will be released upon (i) payment in full
    of the principal of, together with accrued and unpaid interest
    (including Additional Interest, if any) on, the Notes and all
    other Obligations under the Indenture, the Guarantees and the
    Security Documents that are due and payable at or prior to the
    time such principal, together with accrued and unpaid interest
    (including Additional Interest, if any), are paid or (ii) a
    legal defeasance or covenant defeasance under the Indenture as
    described below under "Legal Defeasance and Covenant
    Defeasance" or a discharge of the Indenture as described
    under "Satisfaction and Discharge."
Any certificate or opinion required by Section 314(d) of
    the Trust Indenture Act may be made by an Officer of the
    Company, except in cases where Section 314(d) requires that
    such certificate or opinion be made by an independent engineer,
    appraiser or other expert.
Notwithstanding anything to the contrary herein, the Issuer and
    its Subsidiaries will not be required to comply with all or any
    portion of Section 314(d) of the Trust Indenture Act
    if they determine, in good faith based on advice of counsel,
    that under the terms of that section
and/or
any
    interpretation or guidance as to the meaning thereof of the SEC
    and its staff, including "no action" letters or
    exemptive orders, all or any portion of Section 314(d) of
    the Trust Indenture Act is inapplicable to the released
    Collateral.
Without limiting the generality of the foregoing, certain no
    action letters issued by the SEC have permitted an indenture
    qualified under the Trust Indenture Act to contain
    provisions permitting the release of collateral from Liens under
    such indenture in the ordinary course of the issuer's
    business without requiring the issuer to provide certificates
    and other documents under Section 314(d) of the
    Trust Indenture Act. The Issuer and the Guarantors may,
    subject to the provisions of the Indenture, among other things,
    without any release or consent by the First Lien Collateral
    Agent, conduct ordinary course activities with respect to the
    Collateral, including, without limitation:
•
selling or otherwise disposing of, in any transaction or series
    of related transactions, any property subject to the Lien of the
    Security Documents that has become worn out, defective, obsolete
    or not used or useful in the business;
•
abandoning, terminating, canceling, releasing or making
    alterations in or substitutions of any leases or contracts
    subject to the Lien of the Indenture or any of the Security
    Documents;
•
surrendering or modifying any franchise, license or permit
    subject to the Lien of the Security Documents that it may own or
    under which it may be operating;
196
Table of Contents
•
altering, repairing, replacing, changing the location or
    position of and adding to its structures, machinery, systems,
    equipment, fixtures and appurtenances;
•
granting a license of any intellectual property;
•
selling, transferring or otherwise disposing of inventory in the
    ordinary course of business;
•
collecting accounts receivable in the ordinary course of
    business as permitted by the covenant described under
    "Repurchase at the Option of Holders — Asset
    Sales";
•
making cash payments (including for the repayment of
    Indebtedness or interest) from cash that is at any time part of
    the Collateral in the ordinary course of business that are not
    otherwise prohibited by the Indenture and the Security
    Documents; and
•
abandoning any intellectual property that is no longer used or
    useful in the Issuer's business.
The Issuer must deliver an Officer's Certificate to the
    First Lien Collateral Agent within 30 calendar days following
    the end of each six-month period beginning on May 15 and
    November 15 of each year, to the effect that all such releases
    and withdrawals during the preceding six-month period in the
    ordinary course of the Issuer's or the Guarantors'
    business, as described in the preceding paragraph, were not
    prohibited by the Indenture.
Additional
    Receivables Intercreditor Agreement
In addition, the First Lien Collateral Agent is a party to an
    Additional Receivables Intercreditor Agreement, dated as of the
    Issue Date, (as the same may be amended from time to time, the
"Additional Receivables Intercreditor
    Agreement"
), by and between the First Lien Collateral
    Agent and the collateral agent under the ABL Facility (the
"ABL Collateral Agent"
), by which the Notes are
    given the same ranking and rights with respect to the Shared
    Receivables Collateral as provided to the General Credit
    Facility under the Receivables Intercreditor Agreement dated as
    of November 17, 2006 by and among the Junior Lien
    Collateral Agent, the First Lien Collateral Agent and the ABL
    Collateral Agent. The Additional Receivables Intercreditor
    Agreement contains provisions with respect to the Shared
    Receivables Collateral and the relative rights, privileges and
    obligations relating thereto as between (a) the First Lien
    Collateral Agent and the New First Lien Secured Parties and
    (b) the ABL Collateral Agent and the ABL Secured Parties.
    The Additional Receivables Intercreditor Agreement provides for
    first-priority Liens in the Shared Receivables Collateral in
    favor of the ABL Secured Parties and junior priority Liens in
    the Shared Receivables Collateral in favor of the New First Lien
    Secured Parties, subject to Permitted Liens. The relative
    rights, privileges and obligations with respect to the Shared
    Receivables Collateral of the ABL Secured Parties, on the one
    hand, and the New First Lien Secured Parties, on the other, are
    substantially similar to the relative rights, privileges and
    obligations with respect to the Non-Receivables Collateral of
    the New First Lien Secured Parties, on the one hand, and the
    Junior Lien Secured Parties, on the other, respectively, except
    that the Liens of the New First Lien Secured Parties in the
    Shared Receivables Collateral are second-priority Liens and the
    Liens of the ABL Secured Parties in the Shared Receivables
    Collateral are first-priority liens and except to the extent
    customary or necessary with respect to collateral of the type
    that constitutes Shared Receivables Collateral.
The relative rights, privileges and obligations with respect to
    the Shared Receivables Collateral (a) as between the First
    Lien Collateral Agent and the First Lien Secured Parties, on the
    one hand, and the Junior Lien Collateral Agent and the Junior
    Lien Secured Parties, on the other, are governed by the
    Additional General Intercreditor Agreement described above and
    (b) as among the First Lien Secured Parties, are governed
    by the First Lien Intercreditor Agreement described above.
Certain
    Limitations on the Collateral
The Collateral securing the Notes does not include any of the
    following assets:
(1) the property or assets owned by any Subsidiary of the
    Issuer that is not a Guarantor, including each ABL Financing
    Entity;
197
Table of Contents
(2) any rights or interests of the Issuer or any Guarantor
    in, to or under any agreement, contract, license, instrument,
    document or other general intangible (referred to solely for
    purposes of this clause (2) as a
"Contract"
), any intellectual property or any
    security or other investment property (i) to the extent the
    security interest in such Collateral is prohibited by any
    applicable contract, agreement or other instrument without the
    consent of any other party thereto (other than a party to the
    General Credit Facility or the Indenture or, in the case of
    investment property, a Wholly-Owned Subsidiary), (ii) to
    the extent the security interest in such Contract would give any
    other party (other than a party to the General Credit Facility
    or the Indenture or, in the case of investment property, a
    Wholly-Owned Subsidiary) to such Collateral the right to
    terminate its obligations thereunder or (iii) to the extent
    all necessary consents to such grant of a security interest have
    not been obtained from the other parties thereto (other than to
    the extent that any such prohibition referred to in clauses (i),
    (ii) and (iii) would be rendered ineffective pursuant
    to
Sections 9-406,
9-407, 9-408 or 9-409 of the Uniform Commercial Code (or any
    successor provision or provisions) of any relevant jurisdiction
    or any other applicable law);
provided
that this
    limitation shall not affect, limit, restrict or impair the grant
    by the Issuer or such Guarantor of a security interest in any
    account receivable or any money or other amounts due or to
    become due under any Contract;
(3) any equipment of the Issuer or any Guarantor that is
    subject to, or secured by, a Capitalized Lease Obligation or
    Purchase Money Obligations and any equipment that constitutes an
    asset of an entity acquired in a transaction permitted by the
    Indenture to the extent that such equipment subject to a Lien
    permitted by the Indenture and the terms of the Indebtedness
    secured by such Lien prohibit assignment of, or granting of a
    security interest in, the Issuer's or such Guarantor's
    rights and interests therein (other than to the extent that any
    such prohibition would be rendered ineffective pursuant to
Sections 9-406,
9-407,
9-408
    or 9-409 of the Uniform Commercial Code (or any successor
    provision or provisions) of any relevant jurisdiction or any
    other applicable law);
provided
that immediately upon the
    repayment of all Indebtedness secured by such Lien, the Issuer
    or the Guarantor, as the case may be, shall be deemed to have
    granted a security interest in all the rights and interests with
    respect to such equipment;
(4) any Voting Stock that is issued by any Foreign
    Subsidiary, if and to the extent that the inclusion of such
    Voting Stock in the Collateral would cause the Collateral
    pledged by the Issuer or the applicable Guarantor, as the case
    may be, to include in the aggregate more than 65% of the total
    combined voting power of all classes of Voting Stock of such
    Foreign Subsidiary;
(5) any Capital Stock that is issued by a Subsidiary that
    is not owned directly by the Issuer or a Guarantor;
(6) any Capital Stock and other securities of a Subsidiary
    (excluding Healthtrust, Inc. — The Hospital Company, a
    Delaware corporation and its successors and assigns) to the
    extent that the pledge of such Capital Stock and other
    securities results in the Company's being required to file
    separate financial statements of such Subsidiary with the SEC,
    but only to the extent necessary to not be subject to such
    requirement and only for so long as such requirement is in
    existence and only with respect to the relevant Notes affected;
provided
that neither the Issuer nor any Subsidiary shall
    take any action in the form of a reorganization, merger or other
    restructuring a principal purpose of which is to provide for the
    release of the Lien on any Capital Stock pursuant to this clause
    (6). In addition, in the event that
Rule 3-16
of
Regulation S-X
under the Securities Act is amended, modified or interpreted by
    the SEC to require (or is replaced with another rule or
    regulation, or any other law, rule or regulation is adopted,
    which would require) the filing with the SEC (or any other
    governmental agency) of separate financial statements of any
    Subsidiary of the Company (excluding Healthtrust,
    Inc. — The Hospital Company, a Delaware corporation
    and its successors and assigns) due to the fact that such
    Subsidiary's Capital Stock secures the Notes affected
    thereby, then the Capital Stock of such Subsidiary will
    automatically be deemed not to be part of the Collateral
    securing the relevant Notes affected thereby but only to the
    extent necessary to not be subject to such requirement and only
    for so long as required to not be subject to such requirement.
    In such event, the Security Documents may be amended or
    modified, without the consent of any holder of such Notes, to
    the extent necessary to release the security interests in favor
    of the First Lien Collateral Agent on the shares of Capital
    Stock that are so deemed to no longer constitute part of the
    Collateral for
198
Table of Contents
the relevant Notes. In the event that
Rule 3-16
of
Regulation S-X
under the Securities Act is amended, modified or interpreted by
    the SEC to permit (or is replaced with another rule or
    regulation, or any other law, rule or regulation is adopted,
    which would permit) such Subsidiary's Capital Stock to
    secure the Notes in excess of the amount then pledged without
    the filing with the SEC (or any other governmental agency) of
    separate financial statements of such Subsidiary, then the
    Capital Stock of such Subsidiary will automatically be deemed to
    be a part of the Collateral for the relevant Notes;
(7) certain non-Principal Properties that do not constitute
    Non-Receivables Collateral;
(8) any deposit accounts, other bank or securities accounts
    or cash of the Issuer or any Guarantor;
(9) any leaseholds and motor vehicles of the Issuer or any
    Guarantor;
(10) any Capital Stock or securities convertible into or
    exchangeable for Capital Stock (i) if, in the reasonable
    judgment of the Issuer, the cost or other consequences of
    pledging such Collateral shall be excessive in view of the
    benefits to be obtained by the First Lien Secured Parties
    therefrom or (ii) the pledge of such Collateral would
    result in adverse tax consequences to the Issuer or any of its
    Subsidiaries as reasonably determined by the Issuer and
    identified in writing to the First Lien Collateral Agent;
(11) any collateral to the extent the grant of the security
    interest therein would violate any requirement of law; and
(12) proceeds and products from any and all of the
    foregoing excluded collateral described in clauses (1)
    through (11), unless such proceeds or products would otherwise
    constitute Collateral securing the Notes.
Sufficiency
    of Collateral
The fair market value of the Collateral is subject to
    fluctuations based on factors that include, among others, the
    condition of the health care industry, the ability to sell the
    Collateral in an orderly sale, general economic conditions, the
    availability of buyers and similar factors. The amount to be
    received upon a sale of the Collateral would also be dependent
    on numerous factors, including, but not limited to, the actual
    fair market value of the Collateral at such time and the timing
    and the manner of the sale. By their nature, portions of the
    Collateral may be illiquid and may have no readily ascertainable
    market value. Accordingly, there can be no assurance that the
    Collateral can be sold in a short period of time or in an
    orderly manner. In addition, in the event of a bankruptcy, the
    ability of the holders to realize upon any of the Collateral may
    be subject to certain bankruptcy law limitations as described
    below.
Certain
    Bankruptcy Limitations
The right of the Trustee to repossess and dispose of the
    Collateral upon the occurrence of an Event of Default would be
    significantly impaired by any Bankruptcy Law in the event that a
    bankruptcy case were to be commenced by or against the Company
    or any Guarantor prior to the Trustee's having repossessed
    and disposed of the Collateral. Upon the commencement of a case
    for relief under the Bankruptcy Code, a secured creditor such as
    the Trustee is prohibited from repossessing its security from a
    debtor in a bankruptcy case, or from disposing of security
    without bankruptcy court approval.
In view of the broad equitable powers of a U.S. bankruptcy
    court, it is impossible to predict how long payments under the
    Notes could be delayed following commencement of a bankruptcy
    case, whether or when the Trustee could repossess or dispose of
    the Collateral, the value of the Collateral at any time during a
    bankruptcy case or whether or to what extent Holders of the
    Notes would be compensated for any delay in payment or loss of
    value of the Collateral. The Bankruptcy Code permits only the
    payment
and/or
accrual of post-petition interest, costs and attorneys'
    fees to a secured creditor during a debtor's bankruptcy
    case to the extent the value of such creditor's interest in
    the Collateral is determined by the bankruptcy court to exceed
    the aggregate outstanding principal amount of the obligations
    secured by the Collateral.
Furthermore, in the event a domestic or foreign bankruptcy court
    determines that the value of the Collateral is not sufficient to
    repay all amounts due on the Notes, the Holders of the Notes
    would hold secured
199
Table of Contents
claims only to the extent of the value of the Collateral to
    which the Holders of the Notes are entitled, and unsecured
    claims with respect to such shortfall.
Paying
    Agent and Registrar for the Notes
The Issuer must maintain one or more paying agents for the Notes
    in the Borough of Manhattan, City of New York. The initial
    paying agent for the Notes is Deutsche Bank Trust Company
    Americas.
The Issuer must also maintain a registrar with offices in the
    Borough of Manhattan, City of New York. The initial registrar is
    Deutsche Bank Trust Company Americas. The registrar
    maintains a register reflecting ownership of the Notes
    outstanding from time to time and will make payments on and
    facilitate transfer of Notes on behalf of the Issuer.
The Issuer may change the paying agents or the registrars
    without prior notice to the Holders. The Issuer or any of its
    Subsidiaries may act as a paying agent or registrar.
Transfer
    and Exchange
A Holder may transfer or exchange Notes in accordance with the
    Indenture. The registrar and the Trustee may require a Holder to
    furnish appropriate endorsements and transfer documents in
    connection with a transfer of Notes. Holders will be required to
    pay all taxes due on transfer. The Issuer will not be required
    to transfer or exchange any Note selected for redemption. Also,
    the Issuer will not be required to transfer or exchange any Note
    for a period of 15 days before a selection of Notes to be
    redeemed.
Principal,
    Maturity and Interest
The Issuer issued $1,500,000,000 in aggregate principal amount
    of Notes in this offering. The Notes will mature on
    April 15, 2019. Subject to compliance with the covenant
    described below under the caption "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock,"
    the Issuer may issue additional Notes, from time to time after
    this offering under the Indenture (any such Notes,
"Additional Notes"
). Except as described under
    "Amendment, Supplement and Waiver," the Notes of the
    Issuer and any Additional Notes subsequently issued under the
    Indenture will be treated as a single class for all purposes
    under the Indenture, including waivers, amendments, redemptions
    and offers to purchase. Unless the context requires otherwise,
    references to "Notes" for all purposes of the
    Indenture and this "Description of Notes" include any
    Additional Notes that are actually issued.
Interest on the Notes will accrue at the rate of
    8
1
/
2
%
    per annum and is payable semi-annually in arrears on April 15
    and October 15 commencing October 15, 2009, to the Holders
    of record on the immediately preceding April 1 and
    October 1. Interest on the Notes will accrue from the most
    recent date to which interest has been paid or, if no interest
    has been paid, from and including the Issue Date. Interest on
    the Notes is computed on the basis of a
360-day
year
    comprised of twelve
30-day
months.
Additional
    Interest
Additional Interest may accrue on the Notes in certain
    circumstances pursuant to the Registration Rights Agreement. All
    references in the Indenture, in any context, to any interest or
    other amount payable on or with respect to the Notes shall be
    deemed to include any Additional Interest pursuant to the
    Registration Rights Agreement. Principal of, premium, if any,
    and interest on the Notes is payable at the office or agency of
    the Issuer maintained for such purpose within the City and State
    of New York or, at the option of the Issuer, payment of interest
    may be made by check mailed to the Holders of the Notes at their
    respective addresses set forth in the register of Holders;
provided
that all payments of principal, premium, if any,
    and interest with respect to the Notes represented by one or
    more global notes registered in the name of or held by DTC or
    its nominee will be made by wire transfer of immediately
    available funds to the accounts specified by the Holder or
    Holders thereof. Until otherwise designated by the Issuer, the
    Issuer's office or agency in New York will be the office of
    the Registrar and Paying Agent maintained for such purpose.
200
Table of Contents
Mandatory
    Redemption; Offers to Purchase; Open Market Purchases
The Issuer will not be required to make any mandatory redemption
    or sinking fund payments with respect to the Notes. However,
    under certain circumstances, the Issuer may be required to offer
    to purchase Notes as described under the caption
    "Repurchase at the Option of Holders." The Issuer may
    at any time and from time to time purchase Notes in the open
    market or otherwise.
Optional
    Redemption
Except as set forth below, the Issuer is not entitled to redeem
    Notes at its option prior to April 15, 2014.
At any time prior to April 15, 2014, the Issuer may redeem
    all or a part of the Notes, upon not less than 30 nor more than
    60 days' prior notice mailed by first-class mail to
    the registered address of each Holder or otherwise in accordance
    with the procedures of DTC, at a redemption price equal to 100%
    of the principal amount of the Notes redeemed plus the
    Applicable Premium as of, and accrued and unpaid interest and
    Additional Interest, if any, to the date of redemption (the
"Redemption Date"
), subject to the rights
    of Holders of the Notes on the relevant record date to receive
    interest due on the relevant interest payment date.
On and after April 15, 2014 the Issuer may redeem the
    Notes, in whole or in part, upon not less than 30 nor more than
    60 days' prior notice mailed by first-class mail to
    the registered address of each Holder or otherwise in accordance
    with the procedures of DTC, at the redemption prices (expressed
    as percentages of principal amount of the Notes to be redeemed)
    set forth below, plus accrued and unpaid interest thereon and
    Additional Interest, if any, to the applicable
    Redemption Date, subject to the right of Holders of record
    on the relevant record date to receive interest due on the
    relevant interest payment date, if redeemed during the
    twelve-month period beginning on April 15 of each of the years
    indicated below:
Year
Percentage
2014
104.250
%
2015
102.833
%
2016
101.417
%
2017 and thereafter
100.000
%
In addition, until April 15, 2012, the Issuer may, at its
    option, on one or more occasions redeem up to 35% of the
    aggregate principal amount of Notes at a redemption price equal
    to 108.500% of the aggregate principal amount thereof, plus
    accrued and unpaid interest thereon and Additional Interest, if
    any, to the applicable Redemption Date, subject to the
    right of Holders of record on the relevant record date to
    receive interest due on the relevant interest payment date, with
    the net cash proceeds of one or more Equity Offerings;
provided
that at least 50% of the sum of the original
    aggregate principal amount of Notes issued under the Indenture
    and the original principal amount of any Additional Notes that
    are Notes issued under the Indenture after the Issue Date
    remains outstanding immediately after the occurrence of each
    such redemption;
provided further
that each such
    redemption occurs within 90 days of the date of closing of
    each such Equity Offering.
Any notice of any redemption may be given prior to the
    redemption thereof, and any such redemption or notice may, at
    the Issuer's discretion, be subject to one or more
    conditions precedent, including, but not limited to, completion
    of an Equity Offering or other corporate transaction.
If the Issuer redeems less than all of the outstanding Notes,
    the Registrar and Paying Agent shall select the Notes to be
    redeemed in the manner described under "Repurchase at the
    Option of Holders — Selection and Notice."
Repurchase
    at the Option of Holders
Change
    of Control
The Notes provide that if a Change of Control occurs, unless the
    Issuer has previously or concurrently mailed a redemption notice
    with respect to all the outstanding Notes as described under
    "Optional Redemption," the Issuer will make an offer
    to purchase all of the Notes pursuant to the offer described
    below
201
Table of Contents
(the
"Change of Control Offer"
) at a price in
    cash (the
"Change of Control Payment"
) equal to
    101% of the aggregate principal amount thereof plus accrued and
    unpaid interest and Additional Interest, if any, to the date of
    purchase, subject to the right of Holders of the Notes of record
    on the relevant record date to receive interest due on the
    relevant interest payment date. Within 30 days following
    any Change of Control, the Issuer will send notice of such
    Change of Control Offer by first-class mail, with a copy to the
    Trustee and the Registrar, to each Holder of Notes to the
    address of such Holder appearing in the security register with a
    copy to the Trustee and the Registrar or otherwise in accordance
    with the procedures of DTC, with the following information:
(1) that a Change of Control Offer is being made pursuant
    to the covenant entitled "Change of Control" and that
    all Notes properly tendered pursuant to such Change of Control
    Offer will be accepted for payment by the Issuer;
(2) the purchase price and the purchase date, which will be
    no earlier than 30 days nor later than 60 days from
    the date such notice is mailed (the
"Change of Control
    Payment Date"
);
(3) that any Note not properly tendered will remain
    outstanding and continue to accrue interest;
(4) that unless the Issuer defaults in the payment of the
    Change of Control Payment, all Notes accepted for payment
    pursuant to the Change of Control Offer will cease to accrue
    interest on the Change of Control Payment Date;
(5) that Holders electing to have any Notes purchased
    pursuant to a Change of Control Offer will be required to
    surrender such Notes, with the form entitled "Option of
    Holder to Elect Purchase" on the reverse of such Notes
    completed, to the paying agent specified in the notice at the
    address specified in the notice prior to the close of business
    on the third Business Day preceding the Change of Control
    Payment Date;
(6) that Holders will be entitled to withdraw their
    tendered Notes and their election to require the Issuer to
    purchase such Notes;
provided
that the paying agent
    receives, not later than the close of business on the
    30th day following the date of the Change of Control
    notice, a telegram, facsimile transmission or letter setting
    forth the name of the Holder of the Notes, the principal amount
    of Notes tendered for purchase, and a statement that such Holder
    is withdrawing its tendered Notes and its election to have such
    Notes purchased;
(7) that if the Issuer is redeeming less than all of the
    Notes, the Holders of the remaining Notes will be issued new
    Notes and such new Notes will be equal in principal amount to
    the unpurchased portion of the Notes surrendered. The
    unpurchased portion of the Notes must be equal to $2,000 or an
    integral multiple of $1,000 in excess thereof; and
(8) the other instructions, as determined by us, consistent
    with the covenant described hereunder, that a Holder must follow.
The Issuer will comply with the requirements of
Rule 14e-1
under the Exchange Act and any other securities laws and
    regulations thereunder to the extent such laws or regulations
    are applicable in connection with the repurchase of Notes
    pursuant to a Change of Control Offer. To the extent that the
    provisions of any securities laws or regulations conflict with
    the provisions of the Indenture, the Issuer will comply with the
    applicable securities laws and regulations and shall not be
    deemed to have breached its obligations described in the
    Indenture by virtue thereof.
On the Change of Control Payment Date, the Issuer will, to the
    extent permitted by law,
(1) accept for payment all Notes issued by it or portions
    thereof properly tendered pursuant to the Change of Control
    Offer;
(2) deposit with the paying agent an amount equal to the
    aggregate Change of Control Payment in respect of all Notes or
    portions thereof so tendered; and
202
Table of Contents
(3) deliver, or cause to be delivered, to the Trustee for
    cancellation the Notes so accepted together with an
    Officer's Certificate to the Trustee stating that such
    Notes or portions thereof have been tendered to and purchased by
    the Issuer.
The Senior Credit Facilities provide, and future credit
    agreements or other agreements relating to Senior Indebtedness
    to which the Issuer becomes a party may provide, that certain
    change of control events with respect to the Issuer would
    constitute a default thereunder (including a Change of Control
    under the Indenture). If we experience a change of control that
    triggers a default under our Senior Credit Facilities, we could
    seek a waiver of such default or seek to refinance our Senior
    Credit Facilities. In the event we do not obtain such a waiver
    or refinance the Senior Credit Facilities, such default could
    result in amounts outstanding under our Senior Credit Facilities
    being declared due and payable and could cause a Receivables
    Facility to be wound down.
Our ability to pay cash to the Holders of the Notes following
    the occurrence of a Change of Control may be limited by our
    then-existing financial resources. Therefore, sufficient funds
    may not be available when necessary to make any required
    repurchases.
The Change of Control purchase feature of the Notes may in
    certain circumstances make more difficult or discourage a sale
    or takeover of us and, thus, the removal of incumbent
    management. The Change of Control purchase feature is a result
    of negotiations between the Initial Purchasers and us. After the
    Issue Date, we have no present intention to engage in a
    transaction involving a Change of Control, although it is
    possible that we could decide to do so in the future. Subject to
    the limitations discussed below, we could, in the future, enter
    into certain transactions, including acquisitions, refinancings
    or other recapitalizations, that would not constitute a Change
    of Control under the Indenture, but that could increase the
    amount of indebtedness outstanding at such time or otherwise
    affect our capital structure or credit ratings. Restrictions on
    our ability to incur additional Indebtedness are contained in
    the covenants described under "Certain Covenants
    — Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock" and
    "Certain Covenants — Liens." Such
    restrictions in the Indenture can be waived only with the
    consent of the Holders of a majority in principal amount of the
    Notes then outstanding. Except for the limitations contained in
    such covenants, however, the Indenture will not contain any
    covenants or provisions that may afford Holders of the Notes
    protection in the event of a highly leveraged transaction.
The Issuer is not required to make a Change of Control Offer
    following a Change of Control if a third party makes the Change
    of Control Offer in the manner, at the times and otherwise in
    compliance with the requirements set forth in the Indenture
    applicable to a Change of Control Offer made by us and purchases
    all Notes validly tendered and not withdrawn under such Change
    of Control Offer. Notwithstanding anything to the contrary
    herein, a Change of Control Offer may be made in advance of a
    Change of Control, conditional upon such Change of Control, if a
    definitive agreement is in place for the Change of Control at
    the time of making of the Change of Control Offer.
The definition of "Change of Control" includes a
    disposition of all or substantially all of the assets of the
    Issuer to any Person. Although there is a limited body of case
    law interpreting the phrase "substantially all," there
    is no precise established definition of the phrase under
    applicable law. Accordingly, in certain circumstances there may
    be a degree of uncertainty as to whether a particular
    transaction would involve a disposition of "all or
    substantially all" of the assets of the Issuer. As a
    result, it may be unclear as to whether a Change of Control has
    occurred and whether a Holder of Notes may require the Issuer to
    make an offer to repurchase the Notes as described above.
The provisions under the Indenture relating to the Issuer's
    obligation to make an offer to repurchase the Notes as a result
    of a Change of Control may be waived or modified with the
    written consent of the Holders of a majority in principal amount
    of the Notes.
203
Table of Contents
Asset
    Sales
The Indenture provides that the Issuer will not, and will not
    permit any of its Restricted Subsidiaries to consummate,
    directly or indirectly, an Asset Sale, unless:
(1) the Issuer or such Restricted Subsidiary, as the case
    may be, receives consideration at the time of such Asset Sale at
    least equal to the fair market value (as determined in good
    faith by the Issuer) of the assets sold or otherwise disposed
    of; and
(2) except in the case of a Permitted Asset Swap, at least
    75% of the consideration therefor received by the Issuer or such
    Restricted Subsidiary, as the case may be, is in the form of
    cash or Cash Equivalents; provided that the amount of:
(a) any liabilities (as shown on the Issuer's or such
    Restricted Subsidiary's most recent balance sheet or in the
    footnotes thereto) of the Issuer or such Restricted Subsidiary,
    other than liabilities that are by their terms subordinated to
    the Notes, that are assumed by the transferee of any such assets
    and for which the Issuer and all of its Restricted Subsidiaries
    have been validly released by all creditors in writing,
(b) any securities received by the Issuer or such
    Restricted Subsidiary from such transferee that are converted by
    the Issuer or such Restricted Subsidiary into cash (to the
    extent of the cash received) within 180 days following the
    closing of such Asset Sale, and
(c) any Designated Non-cash Consideration received by the
    Issuer or such Restricted Subsidiary in such Asset Sale having
    an aggregate fair market value, taken together with all other
    Designated Non-cash Consideration received pursuant to this
    clause (c) that is at that time outstanding, not to exceed
    5% of Total Assets at the time of the receipt of such Designated
    Non-cash Consideration, with the fair market value of each item
    of Designated Non-cash Consideration being measured at the time
    received and without giving effect to subsequent changes in
    value,
shall be deemed to be cash for purposes of this provision and
    for no other purpose.
Within 450 days after the receipt of any Net Proceeds of
    any Asset Sale, the Issuer or such Restricted Subsidiary, at its
    option, may apply the Net Proceeds from such Asset Sale,
(1) to permanently reduce:
(a) Obligations constituting First Lien Obligations (and,
    if the Indebtedness repaid is revolving credit Indebtedness, to
    correspondingly reduce commitments with respect thereto)
    (
provided
that (x) to the extent that the terms of
    First Lien Obligations other than Obligations under the Notes
    require that such First Lien Obligations are repaid with the Net
    Proceeds of Asset Sales prior to repayment of other
    Indebtedness, the Issuer and its Restricted Subsidiaries shall
    be entitled to repay such other First Lien Obligations prior to
    repaying the Obligations under the Notes and (y) subject to
    the foregoing clause (x), if the Issuer or any Guarantor shall
    so reduce First Lien Obligations, the Issuer will equally and
    ratably reduce Obligations under the Notes through open-market
    purchases (
provided
that such purchases are at or above
    100% of the principal amount thereof) or by making an offer (in
    accordance with the procedures set forth below for an Asset Sale
    Offer) to all holders to purchase at a purchase price equal to
    100% of the principal amount thereof, plus accrued and unpaid
    interest and additional interest, if any, on the pro rata
    principal amount of Notes);
(b) Obligations under the Existing Notes which have a final
    maturity date (as in effect on the Issue Date) on or prior to
    the maturity date of the Notes;
provided
that, at the
    time of, and after giving effect to, such repurchase, redemption
    or defeasance, the aggregate amount of Net Proceeds used to
    repurchase, redeem or defease Existing Notes pursuant to this
    subclause (b) following the Issue Date shall not exceed 5%
    of the consolidated total assets of the Issuer and is
    subsidiaries at such time; or
(c) Indebtedness of a Restricted Subsidiary that is not a
    Guarantor, other than Indebtedness owed to the Issuer or another
    Restricted Subsidiary (or any affiliate thereof);
204
Table of Contents
(2) to make (a) an Investment in any one or more
    businesses,
provided
that such Investment in any business
    is in the form of the acquisition of Capital Stock and results
    in the Issuer or another of its Restricted Subsidiaries, as the
    case may be, owning an amount of the Capital Stock of such
    business such that it constitutes a Restricted Subsidiary,
    (b) capital expenditures or (c) acquisitions of other
    assets, in each of (a), (b) and (c), used or useful in a
    Similar Business; or
(3) to make an investment in (a) any one or more
    businesses,
provided
that such Investment in any business
    is in the form of the acquisition of Capital Stock and results
    in the Issuer or another of its Restricted Subsidiaries, as the
    case may be, owning an amount of the Capital Stock of such
    business such that it constitutes a Restricted Subsidiary,
    (b) properties or (c) acquisitions of other assets
    that, in each of (a), (b) and (c), replace the businesses,
    properties
and/or
assets that are the subject of such Asset Sale;
provided
that, in the case of clauses (2) and
    (3) above, a binding commitment shall be treated as a
    permitted application of the Net Proceeds from the date of such
    commitment so long as the Issuer, or such other Restricted
    Subsidiary enters into such commitment with the good faith
    expectation that such Net Proceeds will be applied to satisfy
    such commitment within 180 days of such commitment (an
"Acceptable Commitment"
) and, in the event any
    Acceptable Commitment is later cancelled or terminated for any
    reason before the Net Proceeds are applied in connection
    therewith, the Issuer or such Restricted Subsidiary enters into
    another Acceptable Commitment (a
"Second
    Commitment"
) within 180 days of such cancellation
    or termination;
provided
,
further
, that if any
    Second Commitment is later cancelled or terminated for any
    reason before such Net Proceeds are applied, then such Net
    Proceeds shall constitute Excess Proceeds.
Any Net Proceeds from Asset Sales of Collateral that are not
    invested or applied as set forth in the first sentence of the
    preceding paragraph will be deemed to constitute
"Collateral Excess Proceeds."
When the
    aggregate amount of Collateral Excess Proceeds exceeds
    $200.0 million, the Issuer shall make an offer to all
    Holders of the Notes and, if required by the terms of any First
    Lien Obligations or Obligations secured by a Lien permitted
    under the Indenture (which Lien is not subordinate to the Lien
    of the Notes with respect to the Collateral), to the holders of
    such First Lien Obligations or such other Obligations (a
"Collateral Asset Sale Offer"
), to purchase the
    maximum aggregate principal amount of the Notes and such First
    Lien Obligations or such other Obligations that is a minimum of
    $2,000 or an integral multiple of $1,000 in excess thereof that
    may be purchased out of the Collateral Excess Proceeds at an
    offer price in cash in an amount equal to 100% of the principal
    amount thereof, plus accrued and unpaid interest and Additional
    Interest, if any, to the date fixed for the closing of such
    offer, in accordance with the procedures set forth in the
    Indenture. The Issuer will commence a Collateral Asset Sale
    Offer with respect to Collateral Excess Proceeds within ten
    Business Days after the date that Collateral Excess Proceeds
    exceed $200.0 million by mailing the notice required
    pursuant to the terms of the Indenture, with a copy to the
    Trustee.
Any Net Proceeds from Asset Sales of non-Collateral that are not
    invested or applied as provided and within the time period set
    forth in the first sentence of the second preceding paragraph
    will be deemed to constitute
"Excess Proceeds."
When the aggregate amount of Excess Proceeds exceeds
    $200.0 million, the Issuer shall make an offer to all
    Holders of the Notes and, if required or permitted by the terms
    of any Senior Indebtedness, to the holders of such Senior
    Indebtedness (an
"Asset Sale Offer"
), to
    purchase the maximum aggregate principal amount of the Notes and
    such Senior Indebtedness that is a minimum of $2,000 or an
    integral multiple of $1,000 in excess thereof that may be
    purchased out of the Excess Proceeds at an offer price in cash
    in an amount equal to 100% of the principal amount thereof, plus
    accrued and unpaid interest and Additional Interest, if any, to
    the date fixed for the closing of such offer, in accordance with
    the procedures set forth in the Indenture. The Issuer will
    commence an Asset Sale Offer with respect to Excess Proceeds
    within ten Business Days after the date that Excess Proceeds
    exceed $200.0 million by mailing the notice required
    pursuant to the terms of the Indenture, with a copy to the
    Trustee.
To the extent that the aggregate amount of Notes and such other
    First Lien Obligations or Obligations secured by a Lien
    permitted by the Indenture (which Lien is not subordinate to the
    Lien of the Notes with respect to the Collateral) tendered
    pursuant to a Collateral Asset Sale Offer is less than the
    Collateral Excess Proceeds, the Issuer may use any remaining
    Collateral Excess Proceeds for general corporate purposes,
    subject to other covenants contained in the Indenture. To the
    extent that the aggregate amount of Notes and such
205
Table of Contents
Senior Indebtedness tendered pursuant to an Asset Sale Offer is
    less than the Excess Proceeds, the Issuer may use any remaining
    Excess Proceeds for general corporate purposes, subject to other
    covenants contained in the Indenture. If the aggregate principal
    amount of Notes or other First Lien Obligations or such other
    Obligations surrendered by such holders thereof exceeds the
    amount of Collateral Excess Proceeds, the Trustee shall select
    the Notes and such other First Lien Obligations or such other
    Obligations to be purchased on a pro rata basis based on the
    accreted value or principal amount of the Notes or such other
    First Lien Obligations or such other Obligations tendered. If
    the aggregate principal amount of Notes or the Senior
    Indebtedness surrendered by such holders thereof exceeds the
    amount of Excess Proceeds, the Trustee shall select the Notes
    and such Senior Indebtedness to be purchased on a pro rata basis
    based on the accreted value or principal amount of the Notes or
    such Senior Indebtedness tendered. Upon completion of any such
    Collateral Asset Sale Offer or Asset Sale Offer, the amount of
    Collateral Excess Proceeds or Excess Proceeds, as the case may
    be, shall be reset at zero. Additionally, the Issuer may, at its
    option, make a Collateral Asset Sale Offer or an Asset Sale
    Offer using proceeds from any Asset Sale at any time after
    consummation of such Asset Sale;
provided
that such
    Collateral Asset Sale Offer or Asset Sale Offer shall be in an
    aggregate amount of not less than $50.0 million. Upon
    consummation of such Collateral Asset Sale Offer or Asset Sale
    Offer, any Net Proceeds not required to be used to purchase
    Notes shall not be deemed Excess Proceeds.
Pending the final application of any Net Proceeds pursuant to
    this covenant, the holder of such Net Proceeds may apply such
    Net Proceeds temporarily to reduce Indebtedness outstanding
    under a revolving credit facility or otherwise invest such Net
    Proceeds in any manner not prohibited by the Indenture.
The Issuer will comply with the requirements of
Rule 14e-1
under the Exchange Act and any other securities laws and
    regulations thereunder to the extent such laws or regulations
    are applicable in connection with the repurchase of the Notes
    pursuant to a Collateral Asset Sale Offer or an Asset Sale
    Offer. To the extent that the provisions of any securities laws
    or regulations conflict with the provisions of the Indenture,
    the Issuer will comply with the applicable securities laws and
    regulations and shall not be deemed to have breached its
    obligations described in the Indenture by virtue thereof.
Selection
    and Notice
If the Issuer is redeeming less than all of the Notes issued by
    it at any time, the Registrar and Paying Agent will select the
    Notes to be redeemed (a) if the Notes are listed on any
    national securities exchange, in compliance with the
    requirements of the principal national securities exchange on
    which the Notes are listed, (b) on a pro rata basis to the
    extent practicable or (c) by lot or such other similar
    method in accordance with the procedures of DTC.
Notices of purchase or redemption shall be mailed by first-class
    mail, postage prepaid, at least 30 but not more than
    60 days before the purchase or Redemption Date to each
    Holder of Notes at such Holder's registered address or
    otherwise in accordance with the procedures of DTC, except that
    redemption notices may be mailed more than 60 days prior to
    a Redemption Date if the notice is issued in connection
    with a defeasance of the Notes or a satisfaction and discharge
    of the Indenture. If any Note is to be purchased or redeemed in
    part only, any notice of purchase or redemption that relates to
    such Note shall state the portion of the principal amount
    thereof that has been or is to be purchased or redeemed.
The Issuer will issue a new Note in a principal amount equal to
    the unredeemed portion of the original Note in the name of the
    Holder upon cancellation of the original Note. Notes called for
    redemption become due on the date fixed for redemption. On and
    after the Redemption Date, interest ceases to accrue on
    Notes or portions thereof called for redemption.
Certain
    Covenants
Set forth below are summaries of certain covenants contained in
    the Indenture. If on any date following the Issue Date
    (i) the Notes have Investment Grade Ratings from both
    Rating Agencies, and (ii) no Default has occurred and is
    continuing under the Indenture (the occurrence of the events
    described in the foregoing clauses (i) and (ii) being
    collectively referred to as a
"Covenant Suspension
    Event"
), the Issuer and the
206
Table of Contents
Restricted Subsidiaries will not be subject to the following
    covenants (collectively, the
"Suspended
    Covenants"
):
(1) "Repurchase at the Option of Holders";
(2) "— Limitation on Restricted
    Payments";
(3) "— Limitation on Incurrence of
    Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock";
(4) clause (4) of the first paragraph of
    "— Merger, Consolidation or Sale of All or
    Substantially All Assets";
(5) "— Transactions with
    Affiliates"; and
(6) "— Dividend and Other Payment Restrictions
    Affecting Restricted Subsidiaries."
In the event that the Issuer and the Restricted Subsidiaries are
    not subject to the Suspended Covenants under the Indenture for
    any period of time as a result of the foregoing, and on any
    subsequent date (the
"Reversion Date"
) one or
    both of the Rating Agencies (a) withdraw their Investment
    Grade Rating or downgrade the rating assigned to the Notes below
    an Investment Grade Rating
and/or
(b) the Issuer or any of its Affiliates enters into an
    agreement to effect a transaction that would result in a Change
    of Control and one or more of the Rating Agencies indicate that
    if consummated, such transaction (alone or together with any
    related recapitalization or refinancing transactions) would
    cause such Rating Agency to withdraw its Investment Grade Rating
    or downgrade the ratings assigned to the Notes below an
    Investment Grade Rating, then the Issuer and the Restricted
    Subsidiaries will thereafter again be subject to the Suspended
    Covenants under the Indenture with respect to future events,
    including, without limitation, a proposed transaction described
    in clause (b) above.
The period of time between the Suspension Date and the Reversion
    Date is referred to in this description as the
"Suspension Period."
Additionally, upon the
    occurrence of a Covenant Suspension Event, the amount of Excess
    Proceeds from Net Proceeds shall be reset at zero. In the event
    of any such reinstatement, no action taken or omitted to be
    taken by the Issuer or any of its Restricted Subsidiaries prior
    to such reinstatement will give rise to a Default or Event of
    Default under the Indentures with respect to Notes;
provided
that (1) with respect to Restricted Payments made after
    any such reinstatement, the amount of Restricted Payments made
    will be calculated as though the covenant described under the
    caption "— Limitation on Restricted
    Payments" had been in effect prior to, but not during the
    Suspension Period,
provided
that any Subsidiaries
    designated as Unrestricted Subsidiaries during the Suspension
    Period shall automatically become Restricted Subsidiaries on the
    Reversion Date (subject to the Issuer's right to
    subsequently designate them as Unrestricted Subsidiaries in
    compliance with the covenants set out below), and (2) all
    Indebtedness incurred, or Disqualified Stock or Preferred Stock
    issued, during the Suspension Period will be classified to have
    been incurred or issued pursuant to clause (3) of the
    second paragraph of "— Limitation on Incurrence
    of Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock."
There can be no assurance that the Notes will ever achieve or
    maintain Investment Grade Ratings.
Limitation
    on Restricted Payments
The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, directly or indirectly:
(I) declare or pay any dividend or make any payment or
    distribution on account of the Issuer's, or any of its
    Restricted Subsidiaries' Equity Interests, including any
    dividend or distribution payable in connection with any merger
    or consolidation other than:
(a) dividends or distributions by the Issuer payable solely
    in Equity Interests (other than Disqualified Stock) of the
    Issuer; or
(b) dividends or distributions by a Restricted Subsidiary
    so long as, in the case of any dividend or distribution payable
    on or in respect of any class or series of securities issued by
    a Restricted
207
Table of Contents
Subsidiary other than a Wholly-Owned Subsidiary, the Issuer or a
    Restricted Subsidiary receives at least its pro rata share of
    such dividend or distribution in accordance with its Equity
    Interests in such class or series of securities;
(II) purchase, redeem, defease or otherwise acquire or
    retire for value any Equity Interests of the Issuer or any
    direct or indirect parent of the Issuer, including in connection
    with any merger or consolidation;
(III) make any principal payment on, or redeem, repurchase,
    defease or otherwise acquire or retire for value in each case,
    prior to any scheduled repayment, sinking fund payment or
    maturity, any Subordinated Indebtedness, other than:
(a) Indebtedness permitted under clauses (7) and
    (8) of the covenant described under
    "— Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock"; or
(b) the purchase, repurchase or other acquisition of
    Subordinated Indebtedness purchased in anticipation of
    satisfying a sinking fund obligation, principal installment or
    final maturity, in each case due within one year of the date of
    purchase, repurchase or acquisition; or
(IV) make any Restricted Investment
(all such payments and other actions set forth in
    clauses (I) through (IV) above (other than any
    exception thereto) being collectively referred to as
"Restricted Payments"
), unless, at the time of
    such Restricted Payment:
(1) no Default shall have occurred and be continuing or
    would occur as a consequence thereof;
(2) immediately after giving effect to such transaction on
    a pro forma basis, the Issuer could incur $1.00 of additional
    Indebtedness under the provisions of the first paragraph of the
    covenant described under "— Limitation on
    Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock"; and
(3) such Restricted Payment, together with the aggregate
    amount of all other Restricted Payments made by the Issuer and
    its Restricted Subsidiaries after November 17, 2006
    (including Restricted Payments permitted by clauses (1), (2)
    (with respect to the payment of dividends on Refunding Capital
    Stock (as defined below) pursuant to clause (b) thereof
    only), (6)(c), (9) and (14) of the next succeeding
    paragraph, but excluding all other Restricted Payments permitted
    by the next succeeding paragraph), is less than the sum of
    (without duplication):
(a) 50% of the Consolidated Net Income of the Issuer for
    the period (taken as one accounting period) beginning
    October 1, 2006, to the end of the Issuer's most
    recently ended fiscal quarter for which internal financial
    statements are available at the time of such Restricted Payment,
    or, in the case such Consolidated Net Income for such period is
    a deficit, minus 100% of such deficit;
plus
(b) 100% of the aggregate net cash proceeds and the fair
    market value, as determined in good faith by the Issuer, of
    marketable securities or other property received by the Issuer
    since immediately after November 17, 2006 (other than net
    cash proceeds to the extent such net cash proceeds have been
    used to incur Indebtedness, Disqualified Stock or Preferred
    Stock pursuant to clause (12)(a) of the second paragraph of
    "— Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock") from
    the issue or sale of:
(i) (A) Equity Interests of the Issuer, including
    Treasury Capital Stock (as defined below), but excluding cash
    proceeds and the fair market value, as determined in good faith
    by the Issuer, of marketable securities or other property
    received from the sale of:
(x) Equity Interests to members of management, directors or
    consultants of the Issuer, any direct or indirect parent company
    of the Issuer and the Issuer's Subsidiaries after
208
Table of Contents
November 17, 2006 to the extent such amounts have been
    applied to Restricted Payments made in accordance with
    clause (4) of the next succeeding paragraph; and
(y) Designated Preferred Stock; and
(B) to the extent such net cash proceeds are actually
    contributed to the Issuer, Equity Interests of the Issuer's
    direct or indirect parent companies (excluding contributions of
    the proceeds from the sale of Designated Preferred Stock of such
    companies or contributions to the extent such amounts have been
    applied to Restricted Payments made in accordance with
    clause (4) of the next succeeding paragraph); or
(ii) debt securities of the Issuer that have been converted
    into or exchanged for such Equity Interests of the Issuer;
provided
,
however
, that this clause (b) shall
    not include the proceeds from (V) Refunding Capital Stock
    (as defined below), (W) Equity Interests or convertible
    debt securities of the Issuer sold to a Restricted Subsidiary,
    as the case may be, (X) Disqualified Stock or debt
    securities that have been converted into Disqualified Stock,
    (Y) Excluded Contributions or (Z) the Delayed Equity
    Amount;
plus
(c) 100% of the aggregate amount of cash and the fair
    market value, as determined in good faith by the Issuer, of
    marketable securities or other property contributed to the
    capital of the Issuer following November 17, 2006 (other
    than net cash proceeds to the extent such net cash proceeds
    (i) have been used to incur Indebtedness, Disqualified
    Stock or Preferred Stock pursuant to clause (12)(a) of the
    second paragraph of "— Limitation on Incurrence
    of Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock," (ii) are contributed by a Restricted
    Subsidiary, (iii) constitute Excluded Contributions or
    (iv) constitute the Delayed Equity Amount);
plus
(d) 100% of the aggregate amount received in cash and the
    fair market value, as determined in good faith by the Issuer, of
    marketable securities or other property received by means of:
(i) the sale or other disposition (other than to the Issuer
    or a Restricted Subsidiary) of Restricted Investments made by
    the Issuer or its Restricted Subsidiaries and repurchases and
    redemptions of such Restricted Investments from the Issuer or
    its Restricted Subsidiaries and repayments of loans or advances,
    and releases of guarantees, which constitute Restricted
    Investments by the Issuer or its Restricted Subsidiaries, in
    each case after November 17, 2006; or
(ii) the sale (other than to the Issuer or a Restricted
    Subsidiary) of the stock of an Unrestricted Subsidiary or a
    distribution from an Unrestricted Subsidiary (other than in each
    case to the extent the Investment in such Unrestricted
    Subsidiary was made by the Issuer or a Restricted Subsidiary
    pursuant to clause (7) of the next succeeding paragraph or
    to the extent such Investment constituted a Permitted
    Investment) or a dividend from an Unrestricted Subsidiary after
    November 17, 2006;
plus
(e) in the case of the redesignation of an Unrestricted
    Subsidiary as a Restricted Subsidiary after November 17,
    2006, the fair market value of the Investment in such
    Unrestricted Subsidiary, as determined by the Issuer in good
    faith (or if such fair market value exceeds $250.0 million,
    in writing by an Independent Financial Advisor), at the time of
    the redesignation of such Unrestricted Subsidiary as a
    Restricted Subsidiary other than to the extent the Investment in
    such Unrestricted Subsidiary was made by the Issuer or a
    Restricted Subsidiary pursuant to clause (7) of the next
    succeeding paragraph or to the extent such Investment
    constituted a Permitted Investment.
The foregoing provisions will not prohibit:
(1) the payment of any dividend within 60 days after
    the date of declaration thereof, if at the date of declaration
    such payment would have complied with the provisions of the
    Indenture;
209
Table of Contents
(2) (a) the redemption, repurchase, retirement or
    other acquisition of any Equity Interests
("Treasury
    Capital Stock")
or Subordinated Indebtedness of the
    Issuer or any Equity Interests of any direct or indirect parent
    company of the Issuer, in exchange for, or out of the proceeds
    of the substantially concurrent sale (other than to a Restricted
    Subsidiary) of, Equity Interests of the Issuer or any direct or
    indirect parent company of the Issuer to the extent contributed
    to the Issuer (in each case, other than any Disqualified Stock)
("Refunding Capital Stock")
and (b) if
    immediately prior to the retirement of Treasury Capital Stock,
    the declaration and payment of dividends thereon was permitted
    under clause (6) of this paragraph, the declaration and
    payment of dividends on the Refunding Capital Stock (other than
    Refunding Capital Stock the proceeds of which were used to
    redeem, repurchase, retire or otherwise acquire any Equity
    Interests of any direct or indirect parent company of the
    Issuer) in an aggregate amount per year no greater than the
    aggregate amount of dividends per annum that were declarable and
    payable on such Treasury Capital Stock immediately prior to such
    retirement;
(3) the redemption, repurchase or other acquisition or
    retirement of Subordinated Indebtedness of the Issuer or a
    Guarantor made in exchange for, or out of the proceeds of the
    substantially concurrent sale of, new Indebtedness of the Issuer
    or a Guarantor, as the case may be, which is incurred in
    compliance with "— Limitation on Incurrence of
    Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock" so long as:
(a) the principal amount (or accreted value) of such new
    Indebtedness does not exceed the principal amount of (or
    accreted value, if applicable), plus any accrued and unpaid
    interest on, the Subordinated Indebtedness being so redeemed,
    repurchased, acquired or retired for value, plus the amount of
    any reasonable premium (including reasonable tender premiums),
    defeasance costs and any reasonable fees and expenses incurred
    in connection with the issuance of such new Indebtedness;
(b) such new Indebtedness is subordinated to the Notes or
    the applicable Guarantee at least to the same extent as such
    Subordinated Indebtedness so purchased, exchanged, redeemed,
    repurchased, acquired or retired for value;
(c) such new Indebtedness has a final scheduled maturity
    date equal to or later than the final scheduled maturity date of
    the Subordinated Indebtedness being so redeemed, repurchased,
    acquired or retired; and
(d) such new Indebtedness has a Weighted Average Life to
    Maturity equal to or greater than the remaining Weighted Average
    Life to Maturity of the Subordinated Indebtedness being so
    redeemed, repurchased, acquired or retired;
(4) a Restricted Payment to pay for the repurchase,
    retirement or other acquisition or retirement for value of
    Equity Interests (other than Disqualified Stock) of the Issuer
    or any of its direct or indirect parent companies held by any
    future, present or former employee, director or consultant of
    the Issuer, any of its Subsidiaries or any of its direct or
    indirect parent companies pursuant to any management equity plan
    or stock option plan or any other management or employee benefit
    plan or agreement, including any Equity Interests rolled over by
    management of the Company or any of its direct or indirect
    parent companies in connection with the Transaction;
provided
,
however
, that the aggregate Restricted
    Payments made under this clause (4) do not exceed in any
    calendar year $75.0 million (which shall increase to
    $150.0 million subsequent to the consummation of an
    underwritten public Equity Offering by the Issuer or any direct
    or indirect parent entity of the Issuer) (with unused amounts in
    any calendar year being carried over to succeeding calendar
    years subject to a maximum (without giving effect to the
    following proviso) of $225.0 million in any calendar year
    (which shall increase to $450.0 million subsequent to the
    consummation of an underwritten public Equity Offering by the
    Issuer or any direct or indirect parent corporation of the
    Issuer));
provided further
that such amount in any
    calendar year may be increased by an amount not to exceed:
(a) the cash proceeds from the sale of Equity Interests
    (other than Disqualified Stock) of the Issuer and, to the extent
    contributed to the Issuer, Equity Interests of any of the
    Issuer's direct or
210
Table of Contents
indirect parent companies, in each case to members of
    management, directors or consultants of the Issuer, any of its
    Subsidiaries or any of its direct or indirect parent companies
    that occurs after November 17, 2006, to the extent the cash
    proceeds from the sale of such Equity Interests have not
    otherwise been applied to the payment of Restricted Payments by
    virtue of clause (3) of the preceding paragraph;
plus
(b) the cash proceeds of key man life insurance policies
    received by the Issuer or its Restricted Subsidiaries after
    November 17, 2006;
less
(c) the amount of any Restricted Payments previously made
    with the cash proceeds described in clauses (a) and
    (b) of this clause (4);
and
provided
,
further
, that cancellation of
    Indebtedness owing to the Issuer or any Restricted Subsidiary
    from members of management of the Issuer, any of the
    Issuer's direct or indirect parent companies or any of the
    Issuer's Restricted Subsidiaries in connection with a
    repurchase of Equity Interests of the Issuer or any of its
    direct or indirect parent companies will not be deemed to
    constitute a Restricted Payment for purposes of this covenant or
    any other provision of the Indenture;
(5) the declaration and payment of dividends to holders of
    any class or series of Disqualified Stock of the Issuer or any
    of its Restricted Subsidiaries or any class or series of
    Preferred Stock of any Restricted Subsidiary issued in
    accordance with the covenant described under
    "— Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock" to the
    extent such dividends are included in the definition of
    "Fixed Charges";
(6) (a) the declaration and payment of dividends to
    holders of any class or series of Designated Preferred Stock
    (other than Disqualified Stock) issued by the Issuer after
    November 17, 2006;
(b) the declaration and payment of dividends to a direct or
    indirect parent company of the Issuer, the proceeds of which
    will be used to fund the payment of dividends to holders of any
    class or series of Designated Preferred Stock (other than
    Disqualified Stock) of such parent corporation issued after the
    Issue Date;
provided
that the amount of dividends paid
    pursuant to this clause (b) shall not exceed the aggregate
    amount of cash actually contributed to the Issuer from the sale
    of such Designated Preferred Stock; or
(c) the declaration and payment of dividends on Refunding
    Capital Stock that is Preferred Stock in excess of the dividends
    declarable and payable thereon pursuant to clause (2) of
    this paragraph;
provided
,
however
, in the case of each of
    (a) and (c) of this clause (6), that for the most
    recently ended four full fiscal quarters for which internal
    financial statements are available immediately preceding the
    date of issuance of such Designated Preferred Stock or the
    declaration of such dividends on Refunding Capital Stock that is
    Preferred Stock, after giving effect to such issuance or
    declaration on a pro forma basis, the Issuer and its Restricted
    Subsidiaries on a consolidated basis would have had a Fixed
    Charge Coverage Ratio of at least 2.00 to 1.00;
(7) Investments in Unrestricted Subsidiaries having an
    aggregate fair market value, taken together with all other
    Investments made pursuant to this clause (7) that are at
    the time outstanding, without giving effect to the sale of an
    Unrestricted Subsidiary to the extent the proceeds of such sale
    do not consist of cash or marketable securities, not to exceed
    2.5% of Total Assets at the time of such Investment (with the
    fair market value of each Investment being measured at the time
    made and without giving effect to subsequent changes in value);
(8) repurchases of Equity Interests deemed to occur upon
    exercise of stock options or warrants if such Equity Interests
    represent a portion of the exercise price of such options or
    warrants;
(9) the declaration and payment of dividends on the
    Issuer's common stock (or the payment of dividends to any
    direct or indirect parent entity to fund a payment of dividends
    on such entity's common stock), following consummation of
    the first public offering of the Issuer's common stock or
    the common
211
Table of Contents
stock of any of its direct or indirect parent companies after
    November 17, 2006, of up to 6% per annum of the net cash
    proceeds received by or contributed to the Issuer in or from any
    such public offering, other than public offerings with respect
    to the Issuer's common stock registered on
Form S-8
and other than any public sale constituting an Excluded
    Contribution;
(10) Restricted Payments that are made with Excluded
    Contributions;
(11) other Restricted Payments in an aggregate amount taken
    together with all other Restricted Payments made pursuant to
    this clause (11) not to exceed 3.0% of Total Assets at the
    time made;
(12) distributions or payments of Receivables Fees;
(13) any Restricted Payment used to fund amounts owed to
    Affiliates (including dividends to any direct or indirect parent
    of the Issuer to permit payment by such parent of such amount),
    in each case to the extent permitted by the covenant described
    under "— Transactions with Affiliates";
(14) the repurchase, redemption or other acquisition or
    retirement for value of any Subordinated Indebtedness in
    accordance with the provisions similar to those described under
    the captions "Repurchase at the Option of
    Holders — Change of Control" and "Repurchase
    at the Option of Holders — Asset Sales";
provided
that all Notes tendered by Holders in connection
    with a Change of Control Offer, Collateral Asset Sale Offer or
    Asset Sale Offer, as applicable, have been repurchased, redeemed
    or acquired for value;
(15) the declaration and payment of dividends by the Issuer
    to, or the making of loans to, any direct or indirect parent in
    amounts required for any direct or indirect parent companies to
    pay, in each case without duplication,
(a) franchise and excise taxes and other fees, taxes and
    expenses required to maintain their corporate existence;
(b) foreign, federal, state and local income taxes, to the
    extent such income taxes are attributable to the income of the
    Issuer and its Restricted Subsidiaries and, to the extent of the
    amount actually received from its Unrestricted Subsidiaries, in
    amounts required to pay such taxes to the extent attributable to
    the income of such Unrestricted Subsidiaries;
provided
that in each case the amount of such payments in any fiscal
    year does not exceed the amount that the Issuer and its
    Restricted Subsidiaries would be required to pay in respect of
    foreign, federal, state and local taxes for such fiscal year
    were the Issuer, its Restricted Subsidiaries and its
    Unrestricted Subsidiaries (to the extent described above) to pay
    such taxes separately from any such parent entity;
(c) for as long as Hercules Holding II, LLC is a parent of
    the Issuer, distributions equal to any taxable income of
    Hercules Holding II, LLC resulting from the Hedging Arrangements
    multiplied by 45%;
(d) customary salary, bonus and other benefits payable to
    officers and employees of any direct or indirect parent company
    of the Issuer to the extent such salaries, bonuses and other
    benefits are attributable to the ownership or operation of the
    Issuer and its Restricted Subsidiaries;
(e) general corporate operating and overhead costs and
    expenses of any direct or indirect parent company of the Issuer
    to the extent such costs and expenses are attributable to the
    ownership or operation of the Issuer and its Restricted
    Subsidiaries; and
(f) fees and expenses other than to Affiliates of the
    Issuer related to any unsuccessful equity or debt offering of
    such parent entity; and
(16) the distribution, by dividend or otherwise, of shares
    of Capital Stock of, or Indebtedness owed to the Issuer or a
    Restricted Subsidiary by, Unrestricted Subsidiaries (other than
    Unrestricted Subsidiaries, the primary assets of which are cash
and/or
Cash
    Equivalents);
212
Table of Contents
provided
,
however
, that at the time of, and after
    giving effect to, any Restricted Payment permitted under
    clauses (11) and (16), no Default shall have occurred and
    be continuing or would occur as a consequence thereof.
As of the Issue Date, all of the Issuer's Subsidiaries are
    Restricted Subsidiaries. The Issuer will not permit any
    Unrestricted Subsidiary to become a Restricted Subsidiary except
    pursuant to the last sentence of the definition of
    "Unrestricted Subsidiary." For purposes of designating
    any Restricted Subsidiary as an Unrestricted Subsidiary, all
    outstanding Investments by the Issuer and its Restricted
    Subsidiaries (except to the extent repaid) in the Subsidiary so
    designated will be deemed to be Restricted Payments in an amount
    determined as set forth in the last sentence of the definition
    of "Investment." Such designation will be permitted
    only if a Restricted Payment in such amount would be permitted
    at such time, whether pursuant to the first paragraph of this
    covenant or under clause (7), (10) or (11) of the
    second paragraph of this covenant, or pursuant to the definition
    of "Permitted Investments," and if such Subsidiary
    otherwise meets the definition of an Unrestricted Subsidiary.
    Unrestricted Subsidiaries are not subject to any of the
    restrictive covenants set forth in the Indenture.
Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock
The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, directly or indirectly, create, incur, issue,
    assume, guarantee or otherwise become directly or indirectly
    liable, contingently or otherwise (collectively,
"incur"
and collectively, an
"incurrence"
) with respect to any Indebtedness
    (including Acquired Indebtedness), and the Issuer will not issue
    any shares of Disqualified Stock and will not permit any
    Restricted Subsidiary to issue any shares of Disqualified Stock
    or Preferred Stock;
provided
,
however
, that the
    Issuer may incur Indebtedness (including Acquired Indebtedness)
    or issue shares of Disqualified Stock, and any of its Restricted
    Subsidiaries may incur Indebtedness (including Acquired
    Indebtedness), issue shares of Disqualified Stock and issue
    shares of Preferred Stock, if the Fixed Charge Coverage Ratio on
    a consolidated basis for the Issuer and its Restricted
    Subsidiaries' most recently ended four fiscal quarters for
    which internal financial statements are available immediately
    preceding the date on which such additional Indebtedness is
    incurred or such Disqualified Stock or Preferred Stock is issued
    would have been at least 2.00 to 1.00, determined on a pro forma
    basis (including a pro forma application of the net proceeds
    therefrom), as if the additional Indebtedness had been incurred,
    or the Disqualified Stock or Preferred Stock had been issued, as
    the case may be, and the application of proceeds therefrom had
    occurred at the beginning of such four-quarter period;
provided, further
, that Restricted Subsidiaries that are
    not Guarantors may not incur Indebtedness or Disqualified Stock
    or Preferred Stock if, after giving pro forma effect to such
    incurrence or issuance (including a pro forma application of the
    net proceeds therefrom), more than an aggregate of
    $2,000.0 million of Indebtedness or Disqualified Stock or
    Preferred Stock of Restricted Subsidiaries that are not
    Guarantors would be outstanding pursuant to this paragraph and
    clauses (12), (14) and (19) below at such time.
The foregoing limitations will not apply to:
(1) the incurrence of Indebtedness under (x) Credit
    Facilities (other than the ABL Facility) by the Issuer or any of
    its Restricted Subsidiaries and the issuance and creation of
    letters of credit and bankers' acceptances thereunder (with
    letters of credit and bankers' acceptances being deemed to
    have a principal amount equal to the face amount thereof), up to
    an aggregate principal amount of $16,500.0 million
    (including any Indebtedness incurred and represented by the
    Notes (including the Guarantees) or any Additional First Lien
    Obligations by the Issuer or any Guarantor, the proceeds of
    which Notes or Additional First Lien Obligations are used to
    repay such Credit Facilities) outstanding at any one time and
    (y) the ABL Facility by the Issuer or any of its Restricted
    Subsidiaries and the issuance and creation of letters of credit
    and bankers' acceptances thereunder (with letters of credit
    and bankers' acceptances being deemed to have a principal
    amount equal to the face amount thereof), up to an aggregate
    principal amount equal to the ABL Facility Cap;
(2) reserved;
213
Table of Contents
(3) Indebtedness of the Issuer and its Restricted
    Subsidiaries in existence on the Issue Date (other than
    Indebtedness described in clause (1)), including the Existing
    Second Priority Notes and the Existing Notes;
(4) Indebtedness consisting of Capitalized Lease
    Obligations and Purchase Money Obligations; so long as such
    Indebtedness exists at the date of such purchase, lease or
    improvement, or is created within 270 days thereafter;
(5) Indebtedness incurred by the Issuer or any of its
    Restricted Subsidiaries constituting reimbursement obligations
    with respect to letters of credit issued in the ordinary course
    of business, including letters of credit in respect of
    workers' compensation, medical malpractice or employee
    health claims, or other Indebtedness with respect to
    reimbursement-type obligations regarding workers'
    compensation, medical malpractice or employee health claims;
provided
,
however
, that upon the drawing of such
    letters of credit or the incurrence of such Indebtedness, such
    obligations are reimbursed within 30 days following such
    drawing or incurrence;
(6) Indebtedness arising from agreements of the Issuer or
    its Restricted Subsidiaries providing for indemnification,
    adjustment of purchase price or similar obligations, in each
    case, incurred or assumed in connection with the disposition of
    any business, assets or a Subsidiary, other than guarantees of
    Indebtedness incurred by any Person acquiring all or any portion
    of such business, assets or a Subsidiary for the purpose of
    financing such acquisition;
provided
,
however
,
    that such Indebtedness is not reflected on the balance sheet of
    the Issuer, or any of its Restricted Subsidiaries (contingent
    obligations referred to in a footnote to financial statements
    and not otherwise reflected on the balance sheet will not be
    deemed to be reflected on such balance sheet for purposes of
    this clause (6));
(7) Indebtedness of the Issuer to a Restricted Subsidiary;
provided
that any such Indebtedness owing to a Restricted
    Subsidiary that is not a Guarantor is expressly subordinated in
    right of payment to the Notes;
provided
,
further
,
    that any subsequent issuance or transfer of any Capital Stock or
    any other event which results in any Restricted Subsidiary
    ceasing to be a Restricted Subsidiary or any other subsequent
    transfer of any such Indebtedness (except to the Issuer or
    another Restricted Subsidiary) shall be deemed, in each case, to
    be an incurrence of such Indebtedness;
(8) Indebtedness of a Restricted Subsidiary to the Issuer
    or another Restricted Subsidiary;
provided
that if a
    Guarantor incurs such Indebtedness to a Restricted Subsidiary
    that is not a Guarantor, such Indebtedness is expressly
    subordinated in right of payment to the Guarantee of the Notes
    of such Guarantor;
provided
,
further
, that any
    subsequent transfer of any such Indebtedness (except to the
    Issuer or another Restricted Subsidiary) shall be deemed, in
    each case, to be an incurrence of such Indebtedness not
    permitted by this clause (8);
(9) shares of Preferred Stock of a Restricted Subsidiary
    issued to the Issuer or another Restricted Subsidiary;
provided
that any subsequent issuance or transfer of any
    Capital Stock or any other event which results in any such
    Restricted Subsidiary ceasing to be a Restricted Subsidiary or
    any other subsequent transfer of any such shares of Preferred
    Stock (except to the Issuer or another of its Restricted
    Subsidiaries) shall be deemed in each case to be an issuance of
    such shares of Preferred Stock not permitted by this clause (9);
(10) Hedging Obligations (excluding Hedging Obligations
    entered into for speculative purposes) for the purpose of
    limiting interest rate risk with respect to any Indebtedness
    permitted to be incurred pursuant to
    "— Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock,"
    exchange rate risk or commodity pricing risk;
(11) obligations in respect of performance, bid, appeal and
    surety bonds and completion guarantees provided by the Issuer or
    any of its Restricted Subsidiaries in the ordinary course of
    business;
(12) (a) Indebtedness or Disqualified Stock of the
    Issuer and Indebtedness, Disqualified Stock or Preferred Stock
    of the Issuer or any Restricted Subsidiary equal to 200.0% of
    the net cash proceeds received by the Issuer since immediately
    after November 17, 2006 from the issue or sale of Equity
214
Table of Contents
Interests of the Issuer or cash contributed to the capital of
    the Issuer (in each case, other than Excluded Contributions or
    proceeds of Disqualified Stock or sales of Equity Interests to
    the Issuer or any of its Subsidiaries) as determined in
    accordance with clauses (3)(b) and (3)(c) of the first paragraph
    of "— Limitation on Restricted Payments" to
    the extent such net cash proceeds or cash have not been applied
    pursuant to such clauses to make Restricted Payments or to make
    other Investments, payments or exchanges pursuant to the second
    paragraph of "— Limitation on Restricted
    Payments" or to make Permitted Investments (other than
    Permitted Investments specified in clauses (1) and
    (3) of the definition thereof) and (b) Indebtedness or
    Disqualified Stock of Issuer and Indebtedness, Disqualified
    Stock or Preferred Stock of the Issuer or any Restricted
    Subsidiary not otherwise permitted hereunder in an aggregate
    principal amount or liquidation preference, which when
    aggregated with the principal amount and liquidation preference
    of all other Indebtedness, Disqualified Stock and Preferred
    Stock then outstanding and incurred pursuant to this clause
    (12)(b), does not at any one time outstanding exceed
    $1,500.0 million;
provided
,
however
, that on
    a pro forma basis, together with any amounts incurred and
    outstanding by Restricted Subsidiaries that are not Guarantors
    pursuant to the second proviso to the first paragraph of this
    covenant and clauses (14) and (19), no more than
    $2,000.0 million of Indebtedness, Disqualified Stock or
    Preferred Stock at any one time outstanding and incurred
    pursuant to this clause (12)(b) shall be incurred by Restricted
    Subsidiaries that are not Guarantors (it being understood that
    any Indebtedness, Disqualified Stock or Preferred Stock incurred
    pursuant to this clause (12)(b) shall cease to be deemed
    incurred or outstanding for purposes of this clause (12)(b) but
    shall be deemed incurred for the purposes of the first paragraph
    of this covenant from and after the first date on which the
    Issuer or such Restricted Subsidiary could have incurred such
    Indebtedness, Disqualified Stock or Preferred Stock under the
    first paragraph of this covenant without reliance on this clause
    (12)(b));
(13) the incurrence or issuance by the Issuer or any
    Restricted Subsidiary of Indebtedness, Disqualified Stock or
    Preferred Stock which serves to refund or refinance any
    Indebtedness, Disqualified Stock or Preferred Stock of the
    Issuer or any Restricted Subsidiary incurred as permitted under
    the first paragraph of this covenant and clauses (3),
    (4) and (12)(a) above, this clause (13) and
    clause (14) below or any Indebtedness, Disqualified Stock
    or Preferred Stock of the Issuer or any Restricted Subsidiary
    issued to so refund or refinance such Indebtedness, Disqualified
    Stock or Preferred Stock of the Issuer or any Restricted
    Subsidiary including additional Indebtedness, Disqualified Stock
    or Preferred Stock incurred to pay premiums (including
    reasonable tender premiums), defeasance costs and fees in
    connection therewith (the
"Refinancing
    Indebtedness"
) prior to its respective maturity;
provided
,
however
, that such Refinancing
    Indebtedness:
(a) has a Weighted Average Life to Maturity at the time
    such Refinancing Indebtedness is incurred which is not less than
    the remaining Weighted Average Life to Maturity of the
    Indebtedness, Disqualified Stock or Preferred Stock being
    refunded or refinanced,
(b) to the extent such Refinancing Indebtedness refinances
    (i) Indebtedness subordinated or
pari passu
to the
    Notes or any Guarantee thereof, such Refinancing Indebtedness is
    subordinated or
pari passu
to the Notes or the Guarantee
    at least to the same extent as the Indebtedness being refinanced
    or refunded or (ii) Disqualified Stock or Preferred Stock,
    such Refinancing Indebtedness must be Disqualified Stock or
    Preferred Stock, respectively, and
(c) shall not include Indebtedness, Disqualified Stock or
    Preferred Stock of a Subsidiary of the Issuer that is not a
    Guarantor that refinances Indebtedness, Disqualified Stock or
    Preferred Stock of the Issuer or a Guarantor;
and,
provided
,
further
, that subclause (a) of
    this clause (13) will not apply to any refunding or
    refinancing of any ABL Obligations and Obligations secured by
    Permitted Liens;
(14) Indebtedness, Disqualified Stock or Preferred Stock of
    (x) the Issuer or a Restricted Subsidiary incurred to
    finance an acquisition or (y) Persons that are acquired by
    the Issuer or any Restricted Subsidiary or merged into the
    Issuer or a Restricted Subsidiary in accordance with the terms
    of the Indenture;
provided
that after giving effect to
    such acquisition or merger, either
215
Table of Contents
(a) the Issuer would be permitted to incur at least $1.00
    of additional Indebtedness pursuant to the Fixed Charge Coverage
    Ratio test set forth in the first sentence of this
    covenant, or
(b) the Fixed Charge Coverage Ratio of the Issuer and the
    Restricted Subsidiaries is greater than immediately prior to
    such acquisition or merger;
provided
,
however
, that on a pro forma basis,
    together with amounts incurred and outstanding pursuant to the
    second proviso to the first paragraph of this covenant and
    clauses (12) and (19), no more than $2,000.0 million
    of Indebtedness, Disqualified Stock or Preferred Stock at any
    one time outstanding and incurred by Restricted Subsidiaries
    that are not Guarantors pursuant to this clause (14) shall
    be incurred and outstanding;
(15) Indebtedness arising from the honoring by a bank or
    other financial institution of a check, draft or similar
    instrument drawn against insufficient funds in the ordinary
    course of business;
provided
that such Indebtedness is
    extinguished within two Business Days of its incurrence;
(16) Indebtedness of the Issuer or any of its Restricted
    Subsidiaries supported by a letter of credit issued pursuant to
    any Credit Facilities, in a principal amount not in excess of
    the stated amount of such letter of credit;
(17) (a) any guarantee by the Issuer or a Restricted
    Subsidiary of Indebtedness or other obligations of any
    Restricted Subsidiary, so long as the incurrence of such
    Indebtedness incurred by such Restricted Subsidiary is permitted
    under the terms of the Indenture, or (b) any guarantee by a
    Restricted Subsidiary of Indebtedness of the Issuer;
provided
that such guarantee is incurred in accordance with the
    covenant described below under "— Limitation on
    Guarantees of Indebtedness by Restricted Subsidiaries";
(18) Indebtedness of Foreign Subsidiaries of the Issuer in
    an amount not to exceed at any one time outstanding and together
    with any other Indebtedness incurred under this clause (18)
    7.5% of the Total Assets of the Foreign Subsidiaries (it being
    understood that any Indebtedness incurred pursuant to this
    clause (18) shall cease to be deemed incurred or
    outstanding for purposes of this clause (18) but shall be
    deemed incurred for the purposes of the first paragraph of this
    covenant from and after the first date on which the Issuer or
    such Restricted Subsidiaries could have incurred such
    Indebtedness under the first paragraph of this covenant without
    reliance on this clause (18));
(19) Indebtedness, Disqualified Stock or Preferred Stock of
    a Restricted Subsidiary incurred to finance or assumed in
    connection with an acquisition in a principal amount not to
    exceed $200.0 million in the aggregate at any one time
    outstanding together with all other Indebtedness, Disqualified
    Stock
and/or
Preferred Stock issued under this clause (19) (it being
    understood that any Indebtedness, Disqualified Stock or
    Preferred Stock incurred pursuant to this clause (19) shall
    cease to be deemed incurred or outstanding for purposes of this
    clause (19) but shall be deemed incurred for the purposes
    of the first paragraph of this covenant from and after the first
    date on which such Restricted Subsidiary could have incurred
    such Indebtedness, Disqualified Stock or Preferred Stock under
    the first paragraph of this covenant without reliance on this
    clause (19));
provided
,
however
, that on a pro
    forma basis, together with amounts incurred and outstanding by
    Restricted Subsidiaries that are not Guarantors pursuant to the
    second proviso to the first paragraph of this covenant and
    clauses (12) and (14), no more than $2,000.0 million
    of Indebtedness would be incurred and outstanding by Restricted
    Subsidiaries that are not Guarantors;
(20) Indebtedness of the Issuer or any of its Restricted
    Subsidiaries consisting of (i) the financing of insurance
    premiums or
(ii) take-or-pay
obligations contained in supply arrangements, in each case,
    incurred in the ordinary course of business;
(21) Indebtedness consisting of Indebtedness issued by the
    Issuer or any of its Restricted Subsidiaries to current or
    former officers, directors and employees thereof, their
    respective estates, spouses or former spouses, in each case to
    finance the purchase or redemption of Equity Interests of the
    Issuer or any direct or indirect parent company of the Issuer to
    the extent described in clause (4) of the second paragraph
    under the caption "— Limitation on Restricted
    Payments";
216
Table of Contents
(22) Physician Support Obligations incurred by the Issuer
    or any Restricted Subsidiary; and
(23) Indebtedness of the Issuer or any of its Restricted
    Subsidiaries undertaken in connection with cash management and
    related activities with respect to any Subsidiary or joint
    venture operating one or more health care facilities, including,
    without limitation, hospitals, ambulatory surgery centers,
    outpatient diagnostic centers or imaging centers, in each case,
    in the ordinary course of business.
For purposes of determining compliance with this covenant:
(1) in the event that an item of Indebtedness, Disqualified
    Stock or Preferred Stock (or any portion thereof) meets the
    criteria of more than one of the categories of permitted
    Indebtedness, Disqualified Stock or Preferred Stock described in
    clauses (1) through (23) above or is entitled to be
    incurred pursuant to the first paragraph of this covenant, the
    Issuer, in its sole discretion, will classify or reclassify such
    item of Indebtedness, Disqualified Stock or Preferred Stock (or
    any portion thereof) and will only be required to include the
    amount and type of such Indebtedness, Disqualified Stock or
    Preferred Stock in one of the above clauses;
provided
that all Indebtedness outstanding under the Credit
    Facilities on November 17, 2006 will be treated as incurred
    on November 17, 2006 under clause (1) of the preceding
    paragraph; and
(2) at the time of incurrence, the Issuer will be entitled
    to divide and classify an item of Indebtedness in more than one
    of the types of Indebtedness described in the first and second
    paragraphs above.
Accrual of interest, the accretion of accreted value and the
    payment of interest in the form of additional Indebtedness,
    Disqualified Stock or Preferred Stock will not be deemed to be
    an incurrence of Indebtedness, Disqualified Stock or Preferred
    Stock for purposes of this covenant.
For purposes of determining compliance with any
    U.S. dollar-denominated restriction on the incurrence of
    Indebtedness, the U.S. dollar-equivalent principal amount
    of Indebtedness denominated in a foreign currency shall be
    calculated based on the relevant currency exchange rate in
    effect on the date such Indebtedness was incurred, in the case
    of term debt, or first committed, in the case of revolving
    credit debt;
provided
that if such Indebtedness is
    incurred to refinance other Indebtedness denominated in a
    foreign currency, and such refinancing would cause the
    applicable U.S. dollar-denominated restriction to be
    exceeded if calculated at the relevant currency exchange rate in
    effect on the date of such refinancing, such
    U.S. dollar-denominated restriction shall be deemed not to
    have been exceeded so long as the principal amount of such
    refinancing Indebtedness does not exceed the principal amount of
    such Indebtedness being refinanced.
The principal amount of any Indebtedness incurred to refinance
    other Indebtedness, if incurred in a different currency from the
    Indebtedness being refinanced, shall be calculated based on the
    currency exchange rate applicable to the currencies in which
    such respective Indebtedness is denominated that is in effect on
    the date of such refinancing.
The Indenture provides that the Issuer will not, and will not
    permit any Guarantor to, directly or indirectly, incur any
    Indebtedness (including Acquired Indebtedness) that is
    subordinated or junior in right of payment to any Indebtedness
    of the Issuer or such Guarantor, as the case may be, unless such
    Indebtedness is expressly subordinated in right of payment to
    the Notes or such Guarantor's Guarantee to the extent and
    in the same manner as such Indebtedness is subordinated to other
    Indebtedness of the Issuer or such Guarantor, as the case may be.
The Indenture does not treat (1) unsecured Indebtedness as
    subordinated or junior to Secured Indebtedness merely because it
    is unsecured or (2) Senior Indebtedness as subordinated or
    junior to any other Senior Indebtedness merely because it has a
    junior priority with respect to the same collateral.
217
Table of Contents
Limitation
    on Prepayment or Modification of Existing Notes
The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, directly or indirectly purchase, redeem,
    defease or otherwise acquire or retire for value any of the
    Existing Notes prior to the final maturity date thereof (as in
    effect on the Issue Date);
provided
that the Issuer may:
(1) purchase, redeem, defease or otherwise acquire or
    retire for value any of the Existing Notes which have a final
    maturity date (as in effect on the Issue Date) on or prior to
    December 31, 2011; and
(2) purchase, redeem, defease or otherwise acquire or
    retire for value any other Existing Notes which have a final
    maturity date (as in effect on the Issue Date) on or prior to
    the maturity date of the Notes;
provided
that, in the
    case of any such prepayment funded with the proceeds of the
    issuance of Secured Indebtedness, at the time of incurrence and
    after giving pro forma effect thereto and to the application of
    the proceeds thereof, (x) the Consolidated Secured Debt
    Ratio would be no greater than 5.25 to 1.0 and (y) the
    Consolidated Leverage Ratio would be no greater than 7.0 to 1.0.
The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, amend the Existing Notes Indenture, or any
    supplemental indenture in respect thereof, in any way to advance
    the final maturity date or shorten the Weighted Average Life to
    Maturity of any series of the Existing Notes such that any
    Existing Notes with a maturity date following the maturity of
    the Notes would have a maturity date on or prior to the date one
    year following the maturity date of the Notes or which would
    prohibit the making of the Guarantees or the creation of Liens
    in favor of the Notes and the Guarantees on the Collateral.
The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, designate any additional subsidiaries as
    "Restricted Subsidiaries" (as defined in the Existing
    Notes Indenture) for purposes of the Existing Notes Indenture.
Liens
The Issuer will not, and will not permit any Guarantor to,
    directly or indirectly, create, incur, assume or suffer to exist
    any Lien (except Permitted Liens) that secures obligations under
    any Indebtedness or any related Guarantee, on any asset or
    property of the Issuer or any Guarantor, or any income or
    profits therefrom, or assign or convey any right to receive
    income therefrom, other than Liens securing Indebtedness that
    are junior in priority to the Liens on such property, assets or
    proceeds securing the Notes and related Guarantees.
The foregoing shall not apply to (a) Liens securing the
    Notes and the related Guarantees, (b) Liens securing
    Indebtedness permitted to be incurred under Credit Facilities,
    including any letter of credit relating thereto, that was
    permitted by the terms of the Indenture to be incurred pursuant
    to clause (1) of the second paragraph under
    "— Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock";
provided
that, with respect to Liens securing Obligations
    permitted under this subclause (b), the Notes and the related
    Guarantees are secured by Liens on the assets subject to such
    Liens (except any European Collateral) to the extent, with the
    priority and subject to intercreditor arrangements, in each case
    no less favorable to the Holders of the Notes than those
    described under "Security" above and (c) Liens
    which are
pari passu
in priority to the Liens securing
    the Notes and related Guarantees and are incurred to secure
    Obligations in respect of any Indebtedness permitted to be
    incurred pursuant to the covenant described above under
    "— Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock";
provided
that, with respect to Liens securing Obligations
    permitted under this subclause (c), at the time of incurrence
    and after giving pro forma effect thereto, the ratio of
    (1) the aggregate amount of Indebtedness secured by
    property, assets or proceeds that secure the Notes and related
    Guarantees that are subject to a Lien that is
pari passu
or senior in priority to the Liens securing the Notes and
    the related Guarantees incurred pursuant to subclause (b)
    above, this subclause (c) and clause (6) of the
    definition of "Permitted Liens" (other than Liens
    securing Indebtedness incurred pursuant to clauses (4) and
    (18) of the covenant described above under
    "— Limitation on Incurrence of Indebtedness and
    Issuance of Disqualified Stock and Preferred Stock") to
    (2) the Issuer's EBITDA for the most recently ended
    four full fiscal quarters for which internal financial
    statements are available immediately preceding the date on which
    such event for which such calculation is being made shall occur,
    in each case with such pro forma adjustments to Indebtedness and
    EBITDA as are
218
Table of Contents
appropriate and consistent with the pro forma adjustment
    provisions set forth in the definition of Fixed Charge Coverage
    Ratio would be no greater than 4.25 to 1.0;
provided
that, with respect to Liens securing Obligations permitted
    under this subclause (c), the Notes and the related Guarantees
    are secured by Liens on the assets subject to such Liens (except
    any European Collateral) to the extent, with the priority and
    subject to intercreditor arrangements, in each case no less
    favorable to the Holders of the Notes than those described under
    "Security" above.
Merger,
    Consolidation or Sale of All or Substantially All
    Assets
The Issuer may not consolidate or merge with or into or wind up
    into (whether or not the Issuer is the surviving corporation),
    or sell, assign, transfer, lease, convey or otherwise dispose of
    all or substantially all of its properties or assets, in one or
    more related transactions, to any Person unless:
(1) the Issuer is the surviving corporation or the Person
    formed by or surviving any such consolidation or merger (if
    other than the Issuer) or to which such sale, assignment,
    transfer, lease, conveyance or other disposition will have been
    made is a corporation organized or existing under the laws of
    the jurisdiction of organization of the Issuer or the laws of
    the United States, any state thereof, the District of Columbia,
    or any territory thereof (such Person, as the case may be, being
    herein called the
"Successor Company"
);
(2) the Successor Company, if other than the Issuer,
    expressly assumes all the obligations of the Issuer under the
    Notes and the Security Documents pursuant to supplemental
    indentures or other documents or instruments in form reasonably
    satisfactory to the Trustee;
(3) immediately after such transaction, no Default exists;
(4) immediately after giving pro forma effect to such
    transaction and any related financing transactions, as if such
    transactions had occurred at the beginning of the applicable
    four-quarter period,
(a) the Successor Company would be permitted to incur at
    least $1.00 of additional Indebtedness pursuant to the Fixed
    Charge Coverage Ratio test set forth in the first sentence of
    the covenant described under "— Limitation on
    Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock," or
(b) the Fixed Charge Coverage Ratio for the Successor
    Company, the Issuer and its Restricted Subsidiaries would be
    greater than such ratio for the Issuer and its Restricted
    Subsidiaries immediately prior to such transaction;
(5) each Guarantor, unless it is the other party to the
    transactions described above, in which case clause (b) of
    the second succeeding paragraph shall apply, shall have by
    supplemental indenture confirmed that its Guarantee shall apply
    to such Person's obligations under the Indenture, the Notes
    and the Registration Rights Agreement;
(6) the Collateral owned by the Successor Company will
    (a) continue to constitute Collateral under the Indenture
    and the Security Documents, (b) be subject to a Lien in
    favor of the Junior Lien Collateral Agent for the benefit of the
    Trustee and the Holders of the Notes and (c) not be subject
    to any other Lien, other than Permitted Liens;
(7) to the extent any assets of the Person which is merged
    or consolidated with or into the Successor Company are assets of
    the type which would constitute Collateral under the Security
    Documents, the Successor Company will take such action as may be
    reasonably necessary to cause such property and assets to be
    made subject to the Lien of the Security Documents in the manner
    and to the extent required in the Indenture or any of the
    Security Documents and shall take all reasonably necessary
    action so that such Lien is perfected to the extent required by
    the Security Documents; and
(8) the Issuer shall have delivered to the Trustee an
    Officer's Certificate and an Opinion of Counsel, each
    stating that such consolidation, merger or transfer and such
    supplemental indentures, if any, comply with the Indenture and,
    if a supplemental indenture or any supplement to any Security
    Document is
219
Table of Contents
required in connection with such transaction, such supplement
    shall comply with the applicable provisions of the Indenture.
The Successor Company will succeed to, and be substituted for
    the Issuer, as the case may be, under the Indenture, the
    Guarantees and the Notes, as applicable. Notwithstanding the
    foregoing clauses (3) and (4),
(1) any Restricted Subsidiary may consolidate with or merge
    into or transfer all or part of its properties and assets to the
    Issuer, and
(2) the Issuer may merge with an Affiliate of the Issuer,
    as the case may be, solely for the purpose of reincorporating
    the Issuer in a State of the United States or any state thereof,
    the District of Columbia or any territory thereof so long as the
    amount of Indebtedness of the Issuer and its Restricted
    Subsidiaries is not increased thereby.
Subject to certain limitations described in the Indenture
    governing release of a Guarantee upon the sale, disposition or
    transfer of a Guarantor, no Guarantor will, and the Issuer will
    not permit any Guarantor to, consolidate or merge with or into
    or wind up into (whether or not the Issuer or Guarantor is the
    surviving corporation), or sell, assign, transfer, lease, convey
    or otherwise dispose of all or substantially all of its
    properties or assets, in one or more related transactions, to
    any Person unless:
(1) (a) such Guarantor is the surviving corporation or
    the Person formed by or surviving any such consolidation or
    merger (if other than such Guarantor) or to which such sale,
    assignment, transfer, lease, conveyance or other disposition
    will have been made is a corporation, partnership, limited
    partnership, limited liability corporation or trust organized or
    existing under the laws of the jurisdiction of organization of
    such Guarantor, as the case may be, or the laws of the United
    States, any state thereof, the District of Columbia, or any
    territory thereof (such Guarantor or such Person, as the case
    may be, being herein called the
"Successor
    Person"
);
(b) the Successor Person, if other than such Guarantor,
    expressly assumes all the obligations of such Guarantor under
    the Indenture and such Guarantor's related Guarantee
    pursuant to supplemental indentures or other documents or
    instruments in form reasonably satisfactory to the Trustee;
(c) immediately after such transaction, no Default
    exists; and
(d) the Issuer shall have delivered to the Trustee an
    Officer's Certificate, each stating that such
    consolidation, merger or transfer and such supplemental
    indentures, if any, comply with the Indenture; or
(2) the transaction is made in compliance with the covenant
    described under "Repurchase at the Option of
    Holders — Asset Sales."
Subject to certain limitations described in the Indenture, the
    Successor Person will succeed to, and be substituted for, such
    Guarantor under the Indenture and such Guarantor's
    Guarantee. Notwithstanding the foregoing, any Guarantor may
    (i) merge into or transfer all or part of its properties
    and assets to another Guarantor or the Issuer, (ii) merge
    with an Affiliate of the Company solely for the purpose of
    reincorporating the Guarantor in the United States, any state
    thereof, the District of Columbia or any territory thereof or
    (iii) convert into a corporation, partnership, limited
    partnership, limited liability corporation or trust organized or
    existing under the laws of the jurisdiction of organization of
    such Guarantor.
Transactions
    with Affiliates
The Issuer will not, and will not permit any of its Restricted
    Subsidiaries to, make any payment to, or sell, lease, transfer
    or otherwise dispose of any of its properties or assets to, or
    purchase any property or assets from, or enter into or make or
    amend any transaction, contract, agreement, understanding, loan,
    advance or guarantee with, or for the benefit of, any Affiliate
    of the Issuer (each of the foregoing, an
"Affiliate
    Transaction"
) involving aggregate payments or
    consideration in excess of $40.0 million, unless:
(1) such Affiliate Transaction is on terms that are not
    materially less favorable to the Issuer or its relevant
    Restricted Subsidiary than those that would have been obtained
    in a comparable transaction by the Issuer or such Restricted
    Subsidiary with an unrelated Person on an arm's-length
    basis; and
220
Table of Contents
(2) the Issuer delivers to the Trustee with respect to any
    Affiliate Transaction or series of related Affiliate
    Transactions involving aggregate payments or consideration in
    excess of $80.0 million, a resolution adopted by the
    majority of the board of directors of the Issuer approving such
    Affiliate Transaction and set forth in an Officer's
    Certificate certifying that such Affiliate Transaction complies
    with clause (1) above.
The foregoing provisions will not apply to the following:
(1) transactions between or among the Issuer or any of its
    Restricted Subsidiaries;
(2) Restricted Payments permitted by the provisions of the
    Indenture described above under the covenant
    "— Limitation on Restricted Payments" and
    the definition of "Permitted Investments";
(3) the payment of management, consulting, monitoring and
    advisory fees and related expenses to the Investors and the
    Frist Entities pursuant to the Sponsor Management Agreement
    (plus any unpaid management, consulting, monitoring and advisory
    fees and related expenses accrued in any prior year) and the
    termination fees pursuant to the Sponsor Management Agreement,
    in each case as in effect on the Issue Date, or any amendment
    thereto (so long as any such amendment is not disadvantageous in
    the good faith judgment of the board of directors of the Issuer
    to the Holders when taken as a whole as compared to the Sponsor
    Management Agreement in effect on the Issue Date);
(4) the payment of reasonable and customary fees paid to,
    and indemnities provided for the benefit of, officers,
    directors, employees or consultants of Issuer, any of its direct
    or indirect parent companies or any of its Restricted
    Subsidiaries;
(5) transactions in which the Issuer or any of its
    Restricted Subsidiaries, as the case may be, delivers to the
    Trustee a letter from an Independent Financial Advisor stating
    that such transaction is fair to the Issuer or such Restricted
    Subsidiary from a financial point of view or stating that the
    terms are not materially less favorable to the Issuer or its
    relevant Restricted Subsidiary than those that would have been
    obtained in a comparable transaction by the Issuer or such
    Restricted Subsidiary with an unrelated Person on an
    arm's-length basis;
(6) any agreement as in effect as of the Issue Date, or any
    amendment thereto (so long as any such amendment is not
    disadvantageous to the Holders when taken as a whole as compared
    to the applicable agreement as in effect on the Issue Date);
(7) the existence of, or the performance by the Issuer or
    any of its Restricted Subsidiaries of its obligations under the
    terms of, any stockholders agreement (including any registration
    rights agreement or purchase agreement related thereto) to which
    it is a party as of the Issue Date and any similar agreements
    which it may enter into thereafter; provided, however, that the
    existence of, or the performance by the Issuer or any of its
    Restricted Subsidiaries of obligations under any future
    amendment to any such existing agreement or under any similar
    agreement entered into after the Issue Date shall only be
    permitted by this clause (7) to the extent that the terms
    of any such amendment or new agreement are not otherwise
    disadvantageous to the Holders when taken as a whole;
(8) reserved;
(9) transactions with customers, clients, suppliers, or
    purchasers or sellers of goods or services, in each case in the
    ordinary course of business and otherwise in compliance with the
    terms of the Indenture which are fair to the Issuer and its
    Restricted Subsidiaries, in the reasonable determination of the
    board of directors of the Issuer or the senior management
    thereof, or are on terms at least as favorable as might
    reasonably have been obtained at such time from an unaffiliated
    party;
(10) the issuance of Equity Interests (other than
    Disqualified Stock) of the Issuer to any Permitted Holder or to
    any director, officer, employee or consultant;
(11) sales of accounts receivable, or participations
    therein, in connection with the ABL Facility and any Receivables
    Facility;
221
Table of Contents
(12) payments by the Issuer or any of its Restricted
    Subsidiaries to any of the Investors made for any financial
    advisory, financing, underwriting or placement services or in
    respect of other investment banking activities, including,
    without limitation, in connection with acquisitions or
    divestitures, which payments are approved by a majority of the
    board of directors of the Issuer in good faith;
(13) payments or loans (or cancellation of loans) to
    employees or consultants of the Issuer, any of its direct or
    indirect parent companies or any of its Restricted Subsidiaries
    and employment agreements, stock option plans and other similar
    arrangements with such employees or consultants which, in each
    case, are approved by the Issuer in good faith;
(14) investments by the Investors or the Frist Entities in
    securities of the Issuer or any of its Restricted Subsidiaries
    so long as (i) the investment is being offered generally to
    other investors on the same or more favorable terms and
    (ii) the investment constitutes less than 5% of the
    proposed or outstanding issue amount of such class of securities;
(15) payments to or from, and transactions with, any joint
    venture owning or operating one or more health care facilities,
    including, without limitation, hospitals, ambulatory surgery
    centers, outpatient diagnostic centers or imaging centers, in
    each case in the ordinary course of business (including, without
    limitation, any cash management activities related
    thereto); and
(16) payments by the Issuer (and any direct or indirect
    parent thereof) and its Subsidiaries pursuant to tax sharing
    agreements among the Issuer (and any such parent) and its
    Subsidiaries on customary terms to the extent attributable to
    the ownership or operation of the Issuer and its Subsidiaries;
    provided that in each case the amount of such payments in any
    fiscal year does not exceed the amount that the Issuer, its
    Restricted Subsidiaries and its Unrestricted Subsidiaries (to
    the extent of amounts received from Unrestricted Subsidiaries)
    would be required to pay in respect of foreign, federal, state
    and local taxes for such fiscal year were the Issuer and its
    Restricted Subsidiaries (to the extent described above) to pay
    such taxes separately from any such parent entity.
Dividend
    and Other Payment Restrictions Affecting Restricted
    Subsidiaries
The Issuer will not, and will not permit any of its Restricted
    Subsidiaries that are not Guarantors to, directly or indirectly,
    create or otherwise cause or suffer to exist or become effective
    any consensual encumbrance or consensual restriction on the
    ability of any such Restricted Subsidiary to:
(1) (a) pay dividends or make any other distributions
    to the Issuer or any of its Restricted Subsidiaries on its
    Capital Stock or with respect to any other interest or
    participation in, or measured by, its profits, or
(b) pay any Indebtedness owed to the Issuer or any of its
    Restricted Subsidiaries;
(2) make loans or advances to the Issuer or any of its
    Restricted Subsidiaries; or
(3) sell, lease or transfer any of its properties or assets
    to the Issuer or any of its Restricted Subsidiaries,
except (in each case) for such encumbrances or restrictions
    existing under or by reason of:
(a) contractual encumbrances or restrictions in effect on
    the Issue Date, including pursuant to the Senior Credit
    Facilities and the related documentation, the Existing Notes
    Indenture and the related documentation and the Existing Second
    Priority Notes Indentures and the related documentation;
(b) the Indenture and the Notes;
(c) purchase money obligations for property acquired in the
    ordinary course of business that impose restrictions of the
    nature discussed in clause (3) above on the property so
    acquired;
(d) applicable law or any applicable rule, regulation or
    order;
222
Table of Contents
(e) any agreement or other instrument of a Person acquired
    by the Issuer or any Restricted Subsidiary in existence at the
    time of such acquisition (but not created in contemplation
    thereof), which encumbrance or restriction is not applicable to
    any Person, or the properties or assets of any Person, other
    than the Person and its Subsidiaries, or the property or assets
    of the Person and its Subsidiaries, so acquired;
(f) contracts for the sale of assets, including customary
    restrictions with respect to a Subsidiary of the Issuer pursuant
    to an agreement that has been entered into for the sale or
    disposition of all or substantially all of the Capital Stock or
    assets of such Subsidiary;
(g) Secured Indebtedness that limits the right of the
    debtor to dispose of the assets securing such Indebtedness that
    is otherwise permitted to be incurred pursuant to the covenants
    described under "— Limitation on Incurrence of
    Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock" and "— Liens";
(h) restrictions on cash or other deposits or net worth
    imposed by customers under contracts entered into in the
    ordinary course of business;
(i) other Indebtedness, Disqualified Stock or Preferred
    Stock of Foreign Subsidiaries permitted to be incurred
    subsequent to the Issue Date pursuant to the provisions of the
    covenant described under "— Limitation on
    Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock";
(j) customary provisions in joint venture agreements and
    other agreements or arrangements relating solely to such joint
    venture;
(k) customary provisions contained in leases or licenses of
    intellectual property and other agreements, in each case entered
    into in the ordinary course of business;
(l) any encumbrances or restrictions of the type referred
    to in clauses (1), (2) and (3) above imposed by any
    amendments, modifications, restatements, renewals, increases,
    supplements, refundings, replacements or refinancings of the
    contracts, instruments or obligations referred to in
    clauses (a) through (k) above;
provided
that
    such amendments, modifications, restatements, renewals,
    increases, supplements, refundings, replacements or refinancings
    are, in the good faith judgment of the Issuer, no more
    restrictive with respect to such encumbrance and other
    restrictions taken as a whole than those prior to such
    amendment, modification, restatement, renewal, increase,
    supplement, refunding, replacement or refinancing; and
(m) restrictions created in connection with any Receivables
    Facility that, in the good faith determination of the Issuer,
    are necessary or advisable to effect the transactions
    contemplated under such Receivables Facility.
Limitation
    on Guarantees of Indebtedness by Restricted
    Subsidiaries
The Issuer will not permit any of its Wholly-Owned Subsidiaries
    that are Restricted Subsidiaries (and non-Wholly-Owned
    Subsidiaries if such non-Wholly-Owned Subsidiaries guarantee
    other capital markets debt securities of the Issuer or any
    Guarantor), other than a Guarantor, a Foreign Subsidiary or a
    Receivables Subsidiary, to guarantee the payment of any
    Indebtedness of the Issuer or any other Guarantor unless:
(1) such Restricted Subsidiary within 30 days executes
    and delivers a supplemental indenture to the Indenture providing
    for a Guarantee by such Restricted Subsidiary, except that with
    respect to a guarantee of Indebtedness of the Issuer or any
    Guarantor:
(a) if the Notes or such Guarantor's Guarantee is
    subordinated in right of payment to such Indebtedness, the
    Guarantee under the supplemental indenture shall be subordinated
    to such Restricted Subsidiary's guarantee with respect to
    such Indebtedness substantially to the same extent as the Notes
    are subordinated to such Indebtedness; and
(b) if such Indebtedness is by its express terms
    subordinated in right of payment to the Notes or such
    Guarantor's Guarantee, any such guarantee by such
    Restricted Subsidiary with respect to
223
Table of Contents
such Indebtedness shall be subordinated in right of payment to
    such Guarantee substantially to the same extent as such
    Indebtedness is subordinated to the Notes; and
(2) such Restricted Subsidiary waives, and will not in any
    manner whatsoever claim or take the benefit or advantage of, any
    rights of reimbursement, indemnity or subrogation or any other
    rights against the Issuer or any other Restricted Subsidiary as
    a result of any payment by such Restricted Subsidiary under its
    Guarantee;
provided
that this covenant shall not be applicable to
    (i) any guarantee of any Restricted Subsidiary that existed
    at the time such Person became a Restricted Subsidiary and was
    not incurred in connection with, or in contemplation of, such
    Person becoming a Restricted Subsidiary and (ii) guarantees
    of the ABL Facility by the ABL Financing Entities or of any
    Receivables Facility by any Receivables Subsidiary.
Reports
    and Other Information
Notwithstanding that the Issuer may not be subject to the
    reporting requirements of Section 13 or 15(d) of the
    Exchange Act or otherwise report on an annual and quarterly
    basis on forms provided for such annual and quarterly reporting
    pursuant to rules and regulations promulgated by the SEC, the
    Indenture requires the Issuer to file with the SEC (and make
    available to the Trustee and Holders of the Notes (without
    exhibits), without cost to any Holder, within 15 days after
    it files them with the SEC) from and after the Issue Date,
(1) within 90 days (or any other time period then in
    effect under the rules and regulations of the Exchange Act with
    respect to the filing of a
Form 10-K
by a non-accelerated filer) after the end of each fiscal year,
    annual reports on
Form 10-K,
or any successor or comparable form, containing the information
    required to be contained therein, or required in such successor
    or comparable form;
(2) within 45 days after the end of each of the first
    three fiscal quarters of each fiscal year, reports on
Form 10-Q
containing all quarterly information that would be required to
    be contained in
Form 10-Q,
or any successor or comparable form;
(3) promptly from time to time after the occurrence of an
    event required to be therein reported, such other reports on
Form 8-K,
or any successor or comparable form; and
(4) any other information, documents and other reports
    which the Issuer would be required to file with the SEC if it
    were subject to Section 13 or 15(d) of the Exchange Act;
in each case in a manner that complies in all material respects
    with the requirements specified in such form;
provided
that the Issuer shall not be so obligated to file such
    reports with the SEC if the SEC does not permit such filing, in
    which event the Issuer will make available such information to
    prospective purchasers of Notes, in addition to providing such
    information to the Trustee and the Holders of the Notes, in each
    case within 15 days after the time the Issuer would be
    required to file such information with the SEC if it were
    subject to Section 13 or 15(d) of the Exchange Act. In
    addition, to the extent not satisfied by the foregoing, the
    Issuer has agreed that, for so long as any Notes are
    outstanding, it will furnish to Holders and to securities
    analysts and prospective investors, upon their request, the
    information required to be delivered pursuant to
    Rule 144A(d)(4) under the Securities Act.
In the event that any direct or indirect parent company of the
    Issuer becomes a Guarantor of the Notes, the Indenture permits
    the Issuer to satisfy its obligations in this covenant with
    respect to financial information relating to the Issuer by
    furnishing financial information relating to such parent;
provided
that the same is accompanied by consolidating
    information that explains in reasonable detail the differences
    between the information relating to such parent, on the one
    hand, and the information relating to the Issuer and its
    Restricted Subsidiaries on a standalone basis, on the other hand.
Notwithstanding the foregoing, such requirements shall be deemed
    satisfied prior to the commencement of the exchange offer or the
    effectiveness of the shelf registration statement described in
    the Registration Rights Agreement (1) by the filing with
    the SEC of the exchange offer registration statement or shelf
    registration statement (or any other similar registration
    statement), and any amendments thereto, with such financial
    information that satisfies
Regulation S-X,
subject to exceptions consistent with the presentation of
224
Table of Contents
financial information in the Offering Memorandum, to the extent
    filed within the times specified above, or (2) by posting
    reports that would be required to be filed substantially in the
    form required by the SEC on the Company's website (or that
    of any of its parent companies) or providing such reports to the
    Trustee within 15 days after the time the Issuer would be
    required to file such information with the SEC if it were
    subject to Section 13 or 15(d) of the Exchange Act, the
    financial information (including a "Management's
    Discussion and Analysis of Financial Condition and Results of
    Operations" section) that would be required to be included
    in such reports, subject to exceptions consistent with the
    presentation of financial information in the Offering
    Memorandum, to the extent filed within the times specified above.
Events
    of Default and Remedies
The Indenture provides that each of the following is an
"Event of Default"
:
(1) default in payment when due and payable, upon
    redemption, acceleration or otherwise, of principal of, or
    premium, if any, on the Notes;
(2) default for 30 days or more in the payment when
    due of interest or Additional Interest on or with respect to the
    Notes;
(3) failure by the Issuer or any Guarantor for 60 days
    after receipt of written notice given by the Trustee or the
    Holders of not less than 30% in principal amount of the Notes to
    comply with any of its obligations, covenants or agreements
    (other than a default referred to in clauses (1) and
    (2) above) contained in the Indenture or the Notes;
(4) default under any mortgage, indenture or instrument
    under which there is issued or by which there is secured or
    evidenced any Indebtedness for money borrowed by the Issuer or
    any of its Restricted Subsidiaries or the payment of which is
    guaranteed by the Issuer or any of its Restricted Subsidiaries,
    other than Indebtedness owed to the Issuer or a Restricted
    Subsidiary, whether such Indebtedness or guarantee now exists or
    is created after the issuance of the Notes, if both:
(a) such default either results from the failure to pay any
    principal of such Indebtedness at its stated final maturity
    (after giving effect to any applicable grace periods) or relates
    to an obligation other than the obligation to pay principal of
    any such Indebtedness at its stated final maturity and results
    in the holder or holders of such Indebtedness causing such
    Indebtedness to become due prior to its stated maturity; and
(b) the principal amount of such Indebtedness, together
    with the principal amount of any other such Indebtedness in
    default for failure to pay principal at stated final maturity
    (after giving effect to any applicable grace periods), or the
    maturity of which has been so accelerated, aggregate
    $200.0 million or more at any one time outstanding;
(5) failure by the Issuer or any Significant Subsidiary to
    pay final judgments aggregating in excess of
    $200.0 million, which final judgments remain unpaid,
    undischarged and unstayed for a period of more than 60 days
    after such judgment becomes final, and in the event such
    judgment is covered by insurance, an enforcement proceeding has
    been commenced by any creditor upon such judgment or decree
    which is not promptly stayed;
(6) certain events of bankruptcy or insolvency with respect
    to the Issuer or any Significant Subsidiary;
(7) the Guarantee of any Significant Subsidiary shall for
    any reason cease to be in full force and effect or be declared
    null and void or any responsible officer of any Guarantor that
    is a Significant Subsidiary, as the case may be, denies that it
    has any further liability under its Guarantee or gives notice to
    such effect, other than by reason of the termination of the
    Indenture or the release of any such Guarantee in accordance
    with the Indenture; or
(8) with respect to any Collateral having a fair market
    value in excess of $200 million, individually or in the
    aggregate, (a) the security interest under the Security
    Documents, at any time, ceases to be in
225
Table of Contents
full force and effect for any reason other than in accordance
    with the terms of the Indenture, the Security Documents and the
    Intercreditor Agreements, (b) any security interest created
    thereunder or under the Indenture is declared invalid or
    unenforceable by a court of competent jurisdiction or
    (c) the Issuer or any Guarantor asserts, in any pleading in
    any court of competent jurisdiction, that any such security
    interest is invalid or unenforceable.
If any Event of Default (other than of a type specified in
    clause (6) above) occurs and is continuing under the
    Indenture, the Trustee or the Holders of at least 30% in
    principal amount of the then total outstanding Notes may declare
    the principal, premium, if any, interest and any other monetary
    obligations on all the then outstanding Notes to be due and
    payable immediately.
Upon the effectiveness of such declaration, such principal and
    interest will be due and payable immediately. Notwithstanding
    the foregoing, in the case of an Event of Default arising under
    clause (6) of the first paragraph of this section, all
    outstanding Notes will become due and payable without further
    action or notice. The Indenture provides that the Trustee may
    withhold from the Holders notice of any continuing Default,
    except a Default relating to the payment of principal, premium,
    if any, or interest, if it determines that withholding notice is
    in their interest. In addition, the Trustee shall have no
    obligation to accelerate the Notes if in the best judgment of
    the Trustee acceleration is not in the best interest of the
    Holders of the Notes.
The Indenture provides that the Holders of a majority in
    aggregate principal amount of the then outstanding Notes by
    notice to the Trustee may on behalf of the Holders of all of the
    Notes waive any existing Default and its consequences under the
    Indenture except a continuing Default in the payment of interest
    on, premium, if any, or the principal of any Note held by a
    non-consenting Holder. In the event of any Event of Default
    specified in clause (4) above, such Event of Default and
    all consequences thereof (excluding any resulting payment
    default, other than as a result of acceleration of the Notes)
    shall be annulled, waived and rescinded, automatically and
    without any action by the Trustee or the Holders, if within
    20 days after such Event of Default arose:
(1) the Indebtedness or guarantee that is the basis for
    such Event of Default has been discharged; or
(2) holders thereof have rescinded or waived the
    acceleration, notice or action (as the case may be) giving rise
    to such Event of Default; or
(3) the default that is the basis for such Event of Default
    has been cured.
Subject to the provisions of the Indenture relating to the
    duties of the Trustee thereunder, in case an Event of Default
    occurs and is continuing, the Trustee is under no obligation to
    exercise any of the rights or powers under the Indenture at the
    request or direction of any of the Holders of the Notes unless
    the Holders have offered to the Trustee indemnity or security
    reasonably satisfactory to it against any loss, liability or
    expense. Except to enforce the right to receive payment of
    principal, premium, if any, or interest when due, no Holder of a
    Note may pursue any remedy with respect to the Indenture or the
    Notes unless:
(1) such Holder has previously given the Trustee notice
    that an Event of Default is continuing;
(2) Holders of at least 30% in principal amount of the
    total outstanding Notes have requested the Trustee to pursue the
    remedy;
(3) Holders of the Notes have offered the Trustee
    reasonable security or indemnity against any loss, liability or
    expense;
(4) the Trustee has not complied with such request within
    60 days after the receipt thereof and the offer of security
    or indemnity; and
(5) Holders of a majority in principal amount of the total
    outstanding Notes have not given the Trustee a direction
    inconsistent with such request within such
60-day
period.
Subject to certain restrictions, under the Indenture the Holders
    of a majority in principal amount of the total outstanding Notes
    are given the right to direct the time, method and place of
    conducting any proceeding for any remedy available to the
    Trustee or of exercising any trust or power conferred on the
    Trustee. The
226
Table of Contents
Trustee, however, may refuse to follow any direction that
    conflicts with law or the Indenture or that the Trustee
    determines is unduly prejudicial to the rights of any other
    Holder of a Note or that would involve the Trustee in personal
    liability.
The Indenture provides that the Issuer is required to deliver to
    the Trustee annually a statement regarding compliance with the
    Indenture, and the Issuer is required, within five Business
    Days, upon becoming aware of any Default, to deliver to the
    Trustee a statement specifying such Default.
No
    Personal Liability of Directors, Officers, Employees and
    Stockholders
No director, officer, employee, incorporator or stockholder of
    the Issuer or any Guarantor or any of their parent companies
    (other than the Issuer and the Guarantors) shall have any
    liability for any obligations of the Issuer or the Guarantors
    under the Notes, the Guarantees or the Indenture or for any
    claim based on, in respect of, or by reason of such obligations
    or their creation. Each Holder by accepting the Notes waives and
    releases all such liability. The waiver and release are part of
    the consideration for issuance of the Notes. Such waiver may not
    be effective to waive liabilities under the federal securities
    laws, and it is the view of the SEC that such a waiver is
    against public policy.
Legal
    Defeasance and Covenant Defeasance
The obligations of the Issuer and the Guarantors under the
    Indenture will terminate (other than certain obligations) and
    will be released upon payment in full of all of the Notes. The
    Issuer may, at its option and at any time, elect to have all of
    its obligations discharged with respect to the Notes and have
    the Issuer's and each Guarantor's obligation
    discharged with respect to its Guarantee
("Legal
    Defeasance"
) and cure all then existing Events of
    Default except for:
(1) the rights of Holders of the Notes to receive payments
    in respect of the principal of, premium, if any, and interest on
    the Notes when such payments are due solely out of the trust
    created pursuant to the Indenture;
(2) the Issuer's obligations with respect to Notes
    concerning issuing temporary Notes, registration of such Notes,
    mutilated, destroyed, lost or stolen Notes and the maintenance
    of an office or agency for payment and money for security
    payments held in trust;
(3) the rights, powers, trusts, duties and immunities of
    the Trustee, and the Issuer's obligations in connection
    therewith; and
(4) the Legal Defeasance provisions of the Indenture.
In addition, the Issuer may, at its option and at any time,
    elect to have its obligations and those of each Guarantor
    released with respect to certain covenants that are described in
    the Indenture
("Covenant Defeasance"
) and
    thereafter any omission to comply with such obligations shall
    not constitute a Default with respect to the Notes. In the event
    Covenant Defeasance occurs, certain events (not including
    bankruptcy, receivership, rehabilitation and insolvency events
    pertaining to the Issuer) described under "Events of
    Default and Remedies" will no longer constitute an Event of
    Default with respect to the Notes.
In order to exercise either Legal Defeasance or Covenant
    Defeasance with respect to the Notes:
(1) the Issuer must irrevocably deposit with the Trustee,
    in trust, for the benefit of the Holders of the Notes, cash in
    U.S. dollars, Government Securities, or a combination
    thereof, in such amounts as will be sufficient, in the opinion
    of a nationally recognized firm of independent public
    accountants, to pay the principal of, premium, if any, and
    interest due on the Notes on the stated maturity date or on the
    redemption date, as the case may be, of such principal, premium,
    if any, or interest on such Notes, and the Issuer must specify
    whether such Notes are being defeased to maturity or to a
    particular redemption date;
227
Table of Contents
(2) in the case of Legal Defeasance, the Issuer shall have
    delivered to the Trustee an Opinion of Counsel reasonably
    acceptable to the Trustee confirming that, subject to customary
    assumptions and exclusions,
(a) the Issuer has received from, or there has been
    published by, the United States Internal Revenue Service a
    ruling, or
(b) since the issuance of the Notes, there has been a
    change in the applicable U.S. federal income tax law,
in either case to the effect that, and based thereon such
    Opinion of Counsel shall confirm that, subject to customary
    assumptions and exclusions, the Holders of the Notes will not
    recognize income, gain or loss for U.S. federal income tax
    purposes, as applicable, as a result of such Legal Defeasance
    and will be subject to U.S. federal income tax on the same
    amounts, in the same manner and at the same times as would have
    been the case if such Legal Defeasance had not occurred;
(3) in the case of Covenant Defeasance, the Issuer shall
    have delivered to the Trustee an Opinion of Counsel reasonably
    acceptable to the Trustee confirming that, subject to customary
    assumptions and exclusions, the Holders of the Notes will not
    recognize income, gain or loss for U.S. federal income tax
    purposes as a result of such Covenant Defeasance and will be
    subject to such tax on the same amounts, in the same manner and
    at the same times as would have been the case if such Covenant
    Defeasance had not occurred;
(4) no Default (other than that resulting from borrowing
    funds to be applied to make such deposit and any similar and
    simultaneous deposit relating to other Indebtedness and, in each
    case, the granting of Liens in connection therewith) shall have
    occurred and be continuing on the date of such deposit;
(5) such Legal Defeasance or Covenant Defeasance shall not
    result in a breach or violation of, or constitute a default
    under the Senior Credit Facilities or any other material
    agreement or instrument (other than the Indenture) to which the
    Issuer or any Guarantor is a party or by which the Issuer or any
    Guarantor is bound (other than that resulting from borrowing
    funds to be applied to make such deposit and any similar and
    simultaneous deposit relating to other Indebtedness and, in each
    case, the granting of Liens in connection therewith);
(6) the Issuer shall have delivered to the Trustee an
    Opinion of Counsel to the effect that, as of the date of such
    opinion and subject to customary assumptions and exclusions
    following the deposit, the trust funds will not be subject to
    the effect of Section 547 of Title 11 of the United
    States Code;
(7) the Issuer shall have delivered to the Trustee an
    Officer's Certificate stating that the deposit was not made
    by the Issuer with the intent of defeating, hindering, delaying
    or defrauding any creditors of the Issuer or any Guarantor or
    others; and
(8) the Issuer shall have delivered to the Trustee an
    Officer's Certificate and an Opinion of Counsel (which
    Opinion of Counsel may be subject to customary assumptions and
    exclusions) each stating that all conditions precedent provided
    for or relating to the Legal Defeasance or the Covenant
    Defeasance, as the case may be, have been complied with.
Satisfaction
    and Discharge
The Indenture will be discharged and will cease to be of further
    effect as to all Notes, when either:
(1) all Notes theretofore authenticated and delivered,
    except lost, stolen or destroyed Notes which have been replaced
    or paid and Notes for whose payment money has theretofore been
    deposited in trust, have been delivered to the Trustee for
    cancellation; or
(2) (a) all Notes not theretofore delivered to the
    Trustee for cancellation have become due and payable by reason
    of the making of a notice of redemption or otherwise, will
    become due and payable within one year or may be called for
    redemption within one year under arrangements satisfactory to
    the Trustee for the giving of notice of redemption by the
    Trustee in the name, and at the expense, of the
228
Table of Contents
Issuer, and the Issuer or any Guarantor has irrevocably
    deposited or caused to be deposited with the Trustee as trust
    funds in trust solely for the benefit of the Holders of the
    Notes, cash in U.S. dollars, Government Securities, or a
    combination thereof, in such amounts as will be sufficient
    without consideration of any reinvestment of interest to pay and
    discharge the entire indebtedness on the Notes not theretofore
    delivered to the Trustee for cancellation for principal,
    premium, if any, and accrued interest to the date of maturity or
    redemption;
(b) no Default (other than that resulting from borrowing
    funds to be applied to make such deposit and any similar and
    simultaneous deposit relating to other Indebtedness and, in each
    case, the granting of Liens in connection therewith) with
    respect to the Indenture or the Notes shall have occurred and be
    continuing on the date of such deposit or shall occur as a
    result of such deposit, and such deposit will not result in a
    breach or violation of, or constitute a default under, the
    Senior Credit Facilities or any other material agreement or
    instrument (other than the Indenture) to which the Issuer or any
    Guarantor is a party or by which the Issuer or any Guarantor is
    bound (other than that resulting from borrowing funds to be
    applied to make such deposit and any similar and simultaneous
    deposit relating to other Indebtedness and, in each case, the
    granting of Liens in connection therewith);
(c) the Issuer has paid or caused to be paid all sums
    payable by it under the Indenture; and
(d) the Issuer has delivered irrevocable instructions to
    the Trustee to apply the deposited money toward the payment of
    the Notes at maturity or the redemption date, as the case may be.
In addition, the Issuer must deliver an Officer's
    Certificate and an Opinion of Counsel to the Trustee stating
    that all conditions precedent to satisfaction and discharge have
    been satisfied.
Amendment,
    Supplement and Waiver
Except as provided in the next two succeeding paragraphs, the
    Indenture, any Guarantee, any Security Document and the Notes
    may be amended or supplemented with the consent of the Holders
    of at least a majority in principal amount of the Notes then
    outstanding, including consents obtained in connection with a
    purchase of, or tender offer or exchange offer for, Notes, and
    any existing Default or compliance with any provision of the
    Indenture, the Notes issued thereunder, any Guarantee or the
    Security Documents may be waived with the consent of the Holders
    of a majority in principal amount of the then outstanding Notes,
    other than Notes beneficially owned by the Issuer or its
    Affiliates (including consents obtained in connection with a
    purchase of or tender offer or exchange offer for the Notes).
The Indenture provides that, without the consent of each
    affected Holder of Notes, an amendment or waiver may not, with
    respect to any Notes held by a non-consenting Holder:
(1) reduce the principal amount of such Notes whose Holders
    must consent to an amendment, supplement or waiver;
(2) reduce the principal of or change the fixed final
    maturity of any such Note or alter or waive the provisions with
    respect to the redemption of such Notes (other than provisions
    relating to the covenants described above under the caption
    "Repurchase at the Option of Holders");
(3) reduce the rate of or change the time for payment of
    interest on any Note;
(4) waive a Default in the payment of principal of or
    premium, if any, or interest on the Notes, except a rescission
    of acceleration of the Notes by the Holders of at least a
    majority in aggregate principal amount of the Notes and a waiver
    of the payment default that resulted from such acceleration, or
    in respect of a covenant or provision contained in the Indenture
    or any Guarantee which cannot be amended or modified without the
    consent of all Holders;
(5) make any Note payable in money other than that stated
    therein;
(6) make any change in the provisions of the Indenture
    relating to waivers of past Defaults or the rights of Holders to
    receive payments of principal of or premium, if any, or interest
    on the Notes;
229
Table of Contents
(7) make any change in these amendment and waiver
    provisions;
(8) impair the right of any Holder to receive payment of
    principal of, or interest on such Holder's Notes on or
    after the due dates therefor or to institute suit for the
    enforcement of any payment on or with respect to such
    Holder's Notes;
(9) make any change to or modify the ranking of the Notes
    or the subordination of the Liens with respect to the Notes that
    would adversely affect the Holders; or
(10) except as expressly permitted by the Indenture, modify
    the Guarantees of any Significant Subsidiary in any manner
    adverse to the Holders of the Notes.
In addition, without the consent of at least 75% in aggregate
    principal amount of Notes then outstanding, an amendment,
    supplement or waiver may not:
(1) modify any Security Document or the provisions of the
    Indenture dealing with the Security Documents or application of
    trust moneys, or otherwise release any Collateral, in any manner
    materially adverse to the Holders other than in accordance with
    the Indenture, the Security Documents and the Intercreditor
    Agreements; or
(2) modify any Intercreditor Agreement in any manner
    materially adverse to the Holders other than in accordance with
    the Indenture, the Security Documents and the Intercreditor
    Agreements.
Notwithstanding the foregoing, the Issuer, any Guarantor (with
    respect to a Guarantee or the Indenture to which it is a party)
    and the Trustee may amend or supplement the Indenture, any
    Security Document and any Guarantee or Notes without the consent
    of any Holder;
(1) to cure any ambiguity, omission, mistake, defect or
    inconsistency;
(2) to provide for uncertificated Notes of such series in
    addition to or in place of certificated Notes;
(3) to comply with the covenant relating to mergers,
    consolidations and sales of assets;
(4) to provide for the assumption of the Issuer's or
    any Guarantor's obligations to the Holders;
(5) to make any change that would provide any additional
    rights or benefits to the Holders or that does not adversely
    affect the legal rights under the Indenture of any such Holder;
(6) to add covenants for the benefit of the Holders or to
    surrender any right or power conferred upon the Issuer or any
    Guarantor;
(7) to comply with requirements of the SEC in order to
    effect or maintain the qualification of the Indenture under the
    Trust Indenture Act;
(8) to evidence and provide for the acceptance and
    appointment under the Indenture of a successor Trustee
    thereunder pursuant to the requirements thereof;
(9) to provide for the issuance of Exchange Notes or
    private exchange notes, which are identical to Exchange Notes
    except that they are not freely transferable;
(10) to add a Guarantor under the Indenture;
(11) to conform the text of the Indenture, Security
    Documents, Guarantees or the Notes to any provision of this
    "Description of Notes" to the extent that such
    provision in this "Description of Notes" was intended
    to be a verbatim recitation of a provision of the Indenture,
    Security Documents, Guarantee or Notes;
(12) to make any amendment to the provisions of the
    Indenture relating to the transfer and legending of Notes as
    permitted by the Indenture, including, without limitation to
    facilitate the issuance and administration of the Notes;
provided
,
however
, that (i) compliance with
    the Indenture as so amended would not result in Notes being
    transferred in violation of the Securities Act or any applicable
    securities
230
Table of Contents
law and (ii) such amendment does not materially and
    adversely affect the rights of Holders to transfer Notes;
(13) to mortgage, pledge, hypothecate or grant any other
    Lien in favor of the Trustee for the benefit of the Holders of
    the Notes, as additional security for the payment and
    performance of all or any portion of the Obligations, in any
    property or assets, including any which are required to be
    mortgaged, pledged or hypothecated, or in which a Lien is
    required to be granted to or for the benefit of the Trustee or
    the Collateral Agent pursuant to the Indenture, any of the
    Security Documents or otherwise;
(14) to release Collateral from the Lien of the Indenture
    and the Security Documents when permitted or required by the
    Security Documents or the Indenture; or
(15) to add Additional First Lien Secured Parties or
    additional ABL Secured Parties, to any Security Documents.
The consent of the Holders is not necessary under the Indenture
    to approve the particular form of any proposed amendment. It is
    sufficient if such consent approves the substance of the
    proposed amendment.
Notices
Notices given by publication will be deemed given on the first
    date on which publication is made and notices given by
    first-class mail, postage prepaid, will be deemed given five
    calendar days after mailing.
Concerning
    the Trustee
The Indenture contains certain limitations on the rights of the
    Trustee thereunder, should it become a creditor of the Issuer,
    to obtain payment of claims in certain cases, or to realize on
    certain property received in respect of any such claim as
    security or otherwise. The Trustee is permitted to engage in
    other transactions; however, if it acquires any conflicting
    interest it must eliminate such conflict within 90 days,
    apply to the SEC for permission to continue or resign.
The Indenture provides that the Holders of a majority in
    principal amount of the outstanding Notes will have the right to
    direct the time, method and place of conducting any proceeding
    for exercising any remedy available to the Trustee, subject to
    certain exceptions. The Indenture provides that in case an Event
    of Default shall occur (which shall not be cured), the Trustee
    will be required, in the exercise of its power, to use the
    degree of care of a prudent person in the conduct of his own
    affairs. Subject to such provisions, the Trustee is under no
    obligation to exercise any of its rights or powers under the
    Indenture at the request of any Holder of the Notes, unless such
    Holder shall have offered to the Trustee security and indemnity
    satisfactory to it against any loss, liability or expense.
Governing
    Law
The Indenture, the Notes and any Guarantee are governed by and
    construed in accordance with the laws of the State of New York.
Certain
    Definitions
Set forth below are certain defined terms used in the Indenture.
    For purposes of the Indenture, unless otherwise specifically
    indicated, the term
"consolidated"
with respect
    to any Person refers to such Person on a consolidated basis in
    accordance with GAAP, but excluding from such consolidation any
    Unrestricted Subsidiary as if such Unrestricted Subsidiary were
    not an Affiliate of such Person.
"2006 Second Priority Notes"
means the
    $1,000,000,000 aggregate principal amount of
    9
1
/
8
% Senior
    Secured Notes due 2014, the $3,200,000,000 aggregate principal
    amount of
    9
1
/
4
% Senior
    Secured Notes due 2016 and the $1,500,000,000
    9
5
/
8
%/10
3
/
8
% Senior
    Secured Toggle Notes due 2016, each issued by the Issuer under
    the 2006 Second Priority Notes Indenture.
231
Table of Contents
"2006 Second Priority Notes Indenture"
means
    that certain Indenture, dated as of November 17, 2006,
    among the Issuer, the guarantors named on Schedule I
    thereto and The Bank of New York, as trustee.
"2009 Second Priority Notes"
means the
    $310,000,000 aggregate principal amount of
    9
7
/
8
% Senior
    Secured Notes due 2017, issued by the Issuer under the 2009
    Second Priority Notes Indenture.
"2009 Second Priority Notes Indenture"
means
    that certain Indenture, dated as of February 19, 2009,
    among the Issuer, the guarantors named on Schedule I
    thereto, The Bank of New York Mellon Trust Company, N.A.,
    as trustee, and The Bank of New York Mellon, as collateral agent.
"ABL Facility"
means the Amended and Restated
    Asset-Based Revolving Credit Agreement, dated as of
    June 20, 2007, by and among the Issuer, the lenders party
    thereto in their capacities as lenders thereunder and Bank of
    America, N.A., as Administrative Agent, as amended as of
    March 2, 2009, including any guarantees, collateral
    documents, instruments and agreements executed in connection
    therewith, and any amendments, supplements, modifications,
    extensions, renewals, restatements, refundings or refinancings
    thereof and any indentures or credit facilities or commercial
    paper facilities with banks or other institutional lenders or
    investors that replace, refund or refinance any part of the
    loans, notes, other credit facilities or commitments thereunder,
    including any such replacement, refunding or refinancing
    facility or indenture that increases the amount borrowable
    thereunder or alters the maturity thereof (
provided
that
    such increase in borrowings is permitted under "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock"
    above).
"ABL Facility Cap"
means an amount equal to the
    greater of (x) $2,000.0 million and (y) 75% of
    the consolidated accounts receivable of the Issuer and its
    subsidiaries determined in accordance with GAAP.
"ABL Financing Entity"
means the Issuer and
    certain of its subsidiaries from time to time named as borrowers
    or guarantors under the ABL Facility.
"ABL Obligations"
means Obligations under the
    ABL Facility.
"ABL Secured Parties"
means each of
    (i) the ABL Collateral Agent on behalf of itself and the
    lenders under the ABL Facility and lenders or their affiliates
    counterparty to related Hedging Obligations and (ii) each
    other holder of ABL Obligations.
"Acquired Indebtedness"
means, with respect to
    any specified Person,
(1) Indebtedness of any other Person existing at the time
    such other Person is merged with or into or became a Restricted
    Subsidiary of such specified Person, including Indebtedness
    incurred in connection with, or in contemplation of, such other
    Person merging with or into or becoming a Restricted Subsidiary
    of such specified Person, and
(2) Indebtedness secured by a Lien encumbering any asset
    acquired by such specified Person.
"Additional First Lien Obligations"
shall have
    the meaning given such term by the U.S. Security Agreement
    and shall include the Notes Obligations.
"Additional First Lien Secured Party"
means the
    holders of any Additional First Lien Obligations, including the
    Holders, and any Authorized Representative with respect thereto,
    including the Trustee.
"Additional General Intercreditor Agreement"
has the meaning set forth under "Security —
    Additional General Intercreditor Agreement."
"Additional Interest"
means all additional
    interest then owing pursuant to the Registration Rights
    Agreement.
"Additional Receivables Intercreditor Agreement"
has the meaning set forth under "Security —
    Additional Receivables Intercreditor Agreement."
"Affiliate"
of any specified Person means any
    other Person directly or indirectly controlling or controlled by
    or under direct or indirect common control with such specified
    Person. For purposes of this definition, "control"
    (including, with correlative meanings, the terms
    "controlling," "controlled by" and
    "under common
232
Table of Contents
control with"), as used with respect to any Person, shall
    mean the possession, directly or indirectly, of the power to
    direct or cause the direction of the management or policies of
    such Person, whether through the ownership of voting securities,
    by agreement or otherwise.
"Applicable Authorized Representative"
means,
    with respect to any Common Collateral, (i) until the
    earlier of (x) the Discharge of General Credit Facility
    Obligations and (y) the Non-Controlling Authorized
    Representative Enforcement Date, the administrative agent under
    the General Credit Facility and (ii) from and after the
    earlier of (x) the Discharge of General Credit Facility
    Obligations and (y) the Non-Controlling Authorized
    Representative Enforcement Date, the Major Non-Controlling
    Authorized Representative.
"Applicable Premium"
means, with respect to any
    Note on any Redemption Date, the greater of:
(1) 1.0% of the principal amount of such Note; and
(2) the excess, if any, of (a) the present value at
    such Redemption Date of (i) the redemption price of
    such Note at April 15, 2014 (such redemption price being
    set forth in the tables appearing above under the caption
    "Optional Redemption"), plus (ii) all required
    interest payments due on such Note through April 15, 2014
    (excluding accrued but unpaid interest to the
    Redemption Date), computed using a discount rate equal to
    the Treasury Rate as of such Redemption Date plus
    50 basis points; over (b) the principal amount of such
    Note.
"Asset Sale"
means:
(1) the sale, conveyance, transfer or other disposition,
    whether in a single transaction or a series of related
    transactions, of property or assets (including by way of a Sale
    and Lease-Back Transaction) of the Issuer or any of its
    Restricted Subsidiaries (each referred to in this definition as
    a "disposition"); or
(2) the issuance or sale of Equity Interests of any
    Restricted Subsidiary, whether in a single transaction or a
    series of related transactions (other than Preferred Stock of
    Restricted Subsidiaries issued in compliance with the covenant
    described under "Certain Covenants — Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock");
in each case, other than:
(a) any disposition of Cash Equivalents or Investment Grade
    Securities or obsolete or worn out equipment in the ordinary
    course of business or any disposition of inventory or goods (or
    other assets) held for sale in the ordinary course of business;
(b) the disposition of all or substantially all of the
    assets of the Issuer in a manner permitted pursuant to the
    provisions described above under "Certain
    Covenants — Merger, Consolidation or Sale of All or
    Substantially All Assets" or any disposition that
    constitutes a Change of Control pursuant to the Indenture;
(c) the making of any Restricted Payment or Permitted
    Investment that is permitted to be made, and is made, under the
    covenant described above under "Certain
    Covenants — Limitation on Restricted Payments";
(d) any disposition of assets or issuance or sale of Equity
    Interests of any Restricted Subsidiary in any transaction or
    series of related transactions with an aggregate fair market
    value of less than $100.0 million;
(e) any disposition of property or assets or issuance of
    securities by a Restricted Subsidiary of the Issuer to the
    Issuer or by the Issuer or a Restricted Subsidiary of the Issuer
    to another Restricted Subsidiary of the Issuer;
(f) to the extent allowable under Section 1031 of the
    Code or any comparable or successor provision, any exchange of
    like property (excluding any boot thereon) for use in a Similar
    Business;
(g) the lease, assignment or
sub-lease
of
    any real or personal property in the ordinary course of business;
233
Table of Contents
(h) any issuance or sale of Equity Interests in, or
    Indebtedness or other securities of, an Unrestricted Subsidiary;
(i) foreclosures on assets;
(j) sales of accounts receivable, or participations
    therein, in connection with the ABL Facility or any Receivables
    Facility;
(k) any financing transaction with respect to property
    built or acquired by the Issuer or any Restricted Subsidiary
    after November 17, 2006, including Sale and Lease-Back
    Transactions and asset securitizations permitted by the
    Indenture;
(l) dispositions in the ordinary course of business by any
    Restricted Subsidiary (including, without limitation, HCI)
    engaged in the insurance business in order to provide insurance
    to the Issuer and its Subsidiaries;
(m) sales, transfers and other dispositions of Investments
    in joint ventures to the extent required by, or made pursuant
    to, customary buy/sell arrangements between the joint venture
    parties set forth in joint venture arrangements and similar
    binding arrangements;
(n) any issuance or sale of Equity Interests or
    dispositions in connection with ordinary course syndications of
    Subsidiaries or joint ventures owning or operating one or more
    health care facilities, including, without limitation,
    hospitals, ambulatory surgery centers, outpatient diagnostic
    centers or imaging centers in any transaction or series of
    related transactions with an aggregate fair market value of less
    than $100.0 million; and
(o) any issuance or sale of Equity Interests of any
    Restricted Subsidiary (including, without limitation,
    HealthTrust Purchasing Group, L.P.) to any Person operating in a
    Similar Business for which such Restricted Subsidiary provides
    shared purchasing, billing, collection or similar services in
    the ordinary course of business.
"Asset Sale Offer"
has the meaning set forth in
    the fourth paragraph under "Repurchase at the Option of
    Holders — Asset Sales."
"Authorized Representative"
means (i) in
    the case of any General Credit Facility Obligations or the
    General Credit Facility Secured Parties, the administrative
    agent under the General Credit Facility, (ii) in the case
    of the Notes Obligations or the Holders, the Trustee and
    (iii) in the case of any Series of Additional First Lien
    Obligations or Additional First Lien Secured Parties that become
    subject to the First Lien Intercreditor Agreement, the
    Authorized Representative named for such Series in the
    applicable joinder agreement.
"Bankruptcy Code"
means Title 11 of the
    United States Code, as amended.
"Bankruptcy Law"
means the Bankruptcy Code and
    any similar federal, state or foreign law for the relief of
    debtors.
"Business Day"
means each day which is not a
    Legal Holiday.
"Capital Stock"
means:
(1) in the case of a corporation, corporate stock;
(2) in the case of an association or business entity, any
    and all shares, interests, participations, rights or other
    equivalents (however designated) of corporate stock;
(3) in the case of a partnership or limited liability
    company, partnership or membership interests (whether general or
    limited); and
(4) any other interest or participation that confers on a
    Person the right to receive a share of the profits and losses
    of, or distributions of assets of, the issuing Person.
234
Table of Contents
"Capitalized Lease Obligation"
means, at the
    time any determination thereof is to be made, the amount of the
    liability in respect of a capital lease that would at such time
    be required to be capitalized and reflected as a liability on a
    balance sheet (excluding the footnotes thereto) in accordance
    with GAAP.
"Capitalized Software Expenditures"
means, for
    any period, the aggregate of all expenditures (whether paid in
    cash or accrued as liabilities) by a Person and its Restricted
    Subsidiaries during such period in respect of purchased software
    or internally developed software and software enhancements that,
    in conformity with GAAP, are or are required to be reflected as
    capitalized costs on the consolidated balance sheet of a Person
    and its Restricted Subsidiaries.
"Cash Equivalents"
means:
(1) United States dollars;
(2) euros or any national currency of any participating
    member state of the EMU or such local currencies held by the
    Company and its Restricted Subsidiaries from time to time in the
    ordinary course of business;
(3) securities issued or directly and fully and
    unconditionally guaranteed or insured by the
    U.S. government (or any agency or instrumentality thereof
    the securities of which are unconditionally guaranteed as a full
    faith and credit obligation of the U.S. government) with
    maturities of 24 months or less from the date of
    acquisition;
(4) certificates of deposit, time deposits and eurodollar
    time deposits with maturities of one year or less from the date
    of acquisition, bankers' acceptances with maturities not
    exceeding one year and overnight bank deposits, in each case
    with any commercial bank having capital and surplus of not less
    than $500.0 million in the case of U.S. banks and
    $100.0 million (or the U.S. dollar equivalent as of
    the date of determination) in the case of
non-U.S. banks;
(5) repurchase obligations for underlying securities of the
    types described in clauses (3) and (4) entered into
    with any financial institution meeting the qualifications
    specified in clause (4) above;
(6) commercial paper rated at least
P-1
by
    Moody's or at least
A-1
by
    S&P and in each case maturing within 24 months after
    the date of creation thereof;
(7) marketable short-term money market and similar
    securities having a rating of at least
P-2
or
A-2
from
    either Moody's or S&P, respectively (or, if at any
    time neither Moody's nor S&P shall be rating such
    obligations, an equivalent rating from another Rating Agency)
    and in each case maturing within 24 months after the date
    of creation thereof;
(8) investment funds investing 95% of their assets in
    securities of the types described in clauses (1) through
    (7) above;
(9) readily marketable direct obligations issued by any
    state, commonwealth or territory of the United States or any
    political subdivision or taxing authority thereof having an
    Investment Grade Rating from either Moody's or S&P
    with maturities of 24 months or less from the date of
    acquisition;
(10) Indebtedness or Preferred Stock issued by Persons with
    a rating of A or higher from S&P or A2 or higher from
    Moody's with maturities of 24 months or less from the
    date of acquisition; and
(11) Investments with average maturities of 24 months
    or less from the date of acquisition in money market funds rated
    AAA- (or the equivalent thereof) or better by S&P or Aaa3
    (or the equivalent thereof) or better by Moody's.
Notwithstanding the foregoing, Cash Equivalents shall include
    amounts denominated in currencies other than those set forth in
    clauses (1) and (2) above;
provided
that such
    amounts are converted into any currency listed in
    clauses (1) and (2) as promptly as practicable and in
    any event within ten Business Days following the receipt of such
    amounts.
235
Table of Contents
"Change of Control"
means the occurrence of any
    of the following:
(1) the sale, lease or transfer, in one or a series of
    related transactions, of all or substantially all of the assets
    of the Issuer and its Subsidiaries, taken as a whole, to any
    Person other than a Permitted Holder; or
(2) the Issuer becomes aware (by way of a report or any
    other filing pursuant to Section 13(d) of the Exchange Act,
    proxy, vote, written notice or otherwise) of the acquisition by
    any Person or group (within the meaning of Section 13(d)(3)
    or Section 14(d)(2) of the Exchange Act, or any successor
    provision), including any group acting for the purpose of
    acquiring, holding or disposing of securities (within the
    meaning of
Rule 13d-5(b)(1)
under the Exchange Act), other than the Permitted Holders, in a
    single transaction or in a related series of transactions, by
    way of merger, consolidation or other business combination or
    purchase of beneficial ownership (within the meaning of
Rule 13d-3
under the Exchange Act, or any successor provision) of 50% or
    more of the total voting power of the Voting Stock of the Issuer
    or any of its direct or indirect parent companies holding
    directly or indirectly 100% of the total voting power of the
    Voting Stock of the Issuer.
"Code"
means the Internal Revenue Code of 1986,
    as amended, or any successor thereto.
"Collateral"
means, collectively, the Shared
    Receivables Collateral and Non-Receivables Collateral.
"Collateral Asset Sale Offer"
has the meaning
    set forth in the third paragraph under "Repurchase at the
    Option of Holders — Asset Sales."
"Collateral Excess Proceeds"
has the meaning
    set forth in the third paragraph under "Repurchase at the
    Option of Holders — Asset Sales."
"Common Collateral"
means, at any time,
    Collateral in which the holders of two or more Series of First
    Lien Obligations (or their respective Authorized
    Representatives) hold a valid and perfected security interest at
    such time. If more than two Series of First Lien Obligations are
    outstanding at any time and the holders of less than all Series
    of First Lien Obligations hold a valid and perfected security
    interest in any Collateral at such time then such Collateral
    shall constitute Common Collateral for those Series of First
    Lien Obligations that hold a valid security interest in such
    Collateral at such time and shall not constitute Common
    Collateral for any Series which does not have a valid and
    perfected security interest in such Collateral at such time.
"Consolidated Depreciation and Amortization
    Expense"
means with respect to any Person for any
    period, the total amount of depreciation and amortization
    expense, including the amortization of deferred financing fees,
    debt issuance costs, commissions, fees and expenses and
    Capitalized Software Expenditures, of such Person and its
    Restricted Subsidiaries for such period on a consolidated basis
    and otherwise determined in accordance with GAAP.
"Consolidated Interest Expense"
means, with
    respect to any Person for any period, without duplication, the
    sum of:
(1) consolidated interest expense of such Person and its
    Restricted Subsidiaries for such period, to the extent such
    expense was deducted (and not added back) in computing
    Consolidated Net Income (including (a) amortization of
    original issue discount resulting from the issuance of
    Indebtedness at less than par, (b) all commissions,
    discounts and other fees and charges owed with respect to
    letters of credit or bankers' acceptances,
    (c) non-cash interest payments (but excluding any non-cash
    interest expense attributable to the movement in the mark to
    market valuation of Hedging Obligations or other derivative
    instruments pursuant to GAAP), (d) the interest component
    of Capitalized Lease Obligations, and (e) net payments, if
    any, pursuant to interest rate Hedging Obligations with respect
    to Indebtedness, and excluding (u) accretion or accrual of
    discounted liabilities not constituting Indebtedness,
    (v) any expense resulting from the discounting of the
    Existing Notes or other Indebtedness in connection with the
    application of recapitalization accounting or, if applicable,
    purchase accounting, (w) any Additional Interest and any
    comparable "additional interest" with respect to other
    securities, (x) amortization of deferred financing fees,
    debt issuance costs, commissions, fees and expenses,
    (y) any expensing of bridge,
236
Table of Contents
commitment and other financing fees and (z) commissions,
    discounts, yield and other fees and charges (including any
    interest expense) related to any Receivables Facility); plus
(2) consolidated capitalized interest of such Person and
    its Restricted Subsidiaries for such period, whether paid or
    accrued; less
(3) interest income for such period.
For purposes of this definition, interest on a Capitalized Lease
    Obligation shall be deemed to accrue at an interest rate
    reasonably determined by such Person to be the rate of interest
    implicit in such Capitalized Lease Obligation in accordance with
    GAAP.
"Consolidated Leverage Ratio"
, with respect to
    any Person as of any date of determination, means the ratio of
    (x) Consolidated Total Indebtedness of such Person as of
    the end of the most recent fiscal quarter for which internal
    financial statements are available immediately preceding the
    date on which such event for which such calculation is being
    made shall occur to (y) the aggregate amount of EBITDA of
    such Person for the period of the most recently ended four full
    consecutive fiscal quarters for which internal financial
    statements are available immediately preceding the date on which
    such event for which such calculation is being made shall occur,
    in each case with such pro forma adjustments to Consolidated
    Total Indebtedness and EBITDA as are appropriate and consistent
    with the pro forma adjustment provisions set forth in the
    definition of "Fixed Charge Coverage Ratio."
"Consolidated Net Income"
means, with respect
    to any Person for any period, the aggregate of the Net Income of
    such Person for such period, on a consolidated basis, and
    otherwise determined in accordance with GAAP;
provided
,
however
, that, without duplication,
(1) any after-tax effect of extraordinary, non-recurring or
    unusual gains or losses (less all fees and expenses relating
    thereto) or expenses, severance, relocation costs, consolidation
    and closing costs, integration and facilities opening costs,
    business optimization costs, transition costs, restructuring
    costs, signing, retention or completion bonuses, and
    curtailments or modifications to pension and post-retirement
    employee benefit plans shall be excluded,
(2) the cumulative effect of a change in accounting
    principles during such period shall be excluded,
(3) any after-tax effect of income (loss) from disposed,
    abandoned or discontinued operations and any net after-tax gains
    or losses on disposal of disposed, abandoned, transferred,
    closed or discontinued operations shall be excluded,
(4) any after-tax effect of gains or losses (less all fees
    and expenses relating thereto) attributable to asset
    dispositions or abandonments other than in the ordinary course
    of business, as determined in good faith by the Issuer, shall be
    excluded,
(5) the Net Income for such period of any Person that is an
    Unrestricted Subsidiary shall be excluded, and, solely for the
    purpose of determining the amount available for Restricted
    Payments under clause 3(a) of the first paragraph of
    "Certain Covenants — Limitation on Restricted
    Payments," the Net Income for such period of any Person
    that is not a Subsidiary or that is accounted for by the equity
    method of accounting shall be excluded;
provided
that
    Consolidated Net Income of the Issuer shall be increased by the
    amount of dividends or distributions or other payments that are
    actually paid in cash (or to the extent converted into cash) to
    the referent Person or a Restricted Subsidiary thereof in
    respect of such period,
(6) solely for the purpose of determining the amount
    available for Restricted Payments under clause (3)(a) of the
    first paragraph of "Certain Covenants —
    Limitation on Restricted Payments," the Net Income for such
    period of any Restricted Subsidiary (other than any Guarantor)
    shall be excluded to the extent that the declaration or payment
    of dividends or similar distributions by that Restricted
    Subsidiary of its Net Income is not at the date of determination
    wholly permitted without any prior governmental approval (which
    has not been obtained) or, directly or indirectly, by the
    operation of the terms of its charter or any agreement,
    instrument, judgment, decree, order, statute, rule, or
    governmental regulation applicable to that Restricted Subsidiary
    or its stockholders, unless such restriction with respect to the
    payment of dividends or similar
237
Table of Contents
distributions has been legally waived;
provided
that
    Consolidated Net Income of the Issuer will be increased by the
    amount of dividends or other distributions or other payments
    actually paid in cash (or to the extent converted into cash) or
    Cash Equivalents to the Issuer or a Restricted Subsidiary
    thereof in respect of such period, to the extent not already
    included therein,
(7) effects of adjustments (including the effects of such
    adjustments pushed down to the Issuer and its Restricted
    Subsidiaries) in the property, equipment, inventory, software
    and other intangible assets, deferred revenues and debt line
    items in such Person's consolidated financial statements
    pursuant to GAAP resulting from the application of
    recapitalization accounting or, if applicable, purchase
    accounting in relation to the Transactions or any consummated
    acquisition or the amortization or write-off of any amounts
    thereof, net of taxes, shall be excluded,
(8) any after-tax effect of income (loss) from the early
    extinguishment of Indebtedness or Hedging Obligations or other
    derivative instruments shall be excluded,
(9) any impairment charge or asset write-off, including,
    without limitation, impairment charges or asset write-offs
    related to intangible assets, long-lived assets or investments
    in debt and equity securities, in each case, pursuant to GAAP
    and the amortization of intangibles arising pursuant to GAAP
    shall be excluded,
(10) any non-cash compensation expense recorded from grants
    of stock appreciation or similar rights, stock options,
    restricted stock or other rights, and any cash charges
    associated with the rollover, acceleration or payout of Equity
    Interests by management of the Company or any of its direct or
    indirect parent companies in connection with the Transaction,
    shall be excluded,
(11) any fees and expenses incurred during such period, or
    any amortization thereof for such period, in connection with any
    acquisition, Investment, Asset Sale, issuance or repayment of
    Indebtedness, issuance of Equity Interests, refinancing
    transaction or amendment or modification of any debt instrument
    (in each case, including any such transaction consummated prior
    to the Issue Date and any such transaction undertaken but not
    completed) and any charges or non-recurring merger costs
    incurred during such period as a result of any such transaction
    shall be excluded,
(12) accruals and reserves that are established or adjusted
    within twelve months after November 17, 2006 that are so
    required to be established as a result of the Transaction in
    accordance with GAAP, or changes as a result of adoption or
    modification of accounting policies, shall be excluded, and
(13) to the extent covered by insurance and actually
    reimbursed, or, so long as the Issuer has made a determination
    that there exists reasonable evidence that such amount will in
    fact be reimbursed by the insurer and only to the extent that
    such amount is (a) not denied by the applicable carrier in
    writing within 180 days and (b) in fact reimbursed
    within 365 days of the date of such evidence (with a
    deduction for any amount so added back to the extent not so
    reimbursed within 365 days), expenses with respect to
    liability or casualty events or business interruption shall be
    excluded.
Notwithstanding the foregoing, for the purpose of the covenant
    described under "Certain Covenants — Limitation
    on Restricted Payments" only (other than clause (3)(d)
    thereof), there shall be excluded from Consolidated Net Income
    any income arising from any sale or other disposition of
    Restricted Investments made by the Issuer and its Restricted
    Subsidiaries, any repurchases and redemptions of Restricted
    Investments from the Issuer and its Restricted Subsidiaries, any
    repayments of loans and advances which constitute Restricted
    Investments by the Issuer or any of its Restricted Subsidiaries,
    any sale of the stock of an Unrestricted Subsidiary or any
    distribution or dividend from an Unrestricted Subsidiary, in
    each case only to the extent such amounts increase the amount of
    Restricted Payments permitted under such covenant pursuant to
    clause (3)(d) thereof.
"Consolidated Net Tangible Assets"
means the
    total amount of assets (less applicable reserves and other
    properly deductible items) after deducting therefrom
    (a) all current liabilities as disclosed on the
    consolidated balance sheet of the Issuer (excluding any thereof
    which are by their terms extendible or renewable at the option
    of the obligor thereon to a time more than 12 months after
    the time as of which the amount thereof is being computed and
    further excluding any deferred income taxes that are included in
    current liabilities) and
238
Table of Contents
(b) all goodwill, trade names, trademarks, patents,
    unamortized debt discount and expense and other like intangible
    assets, all as set forth on the most recent consolidated balance
    sheet of the Issuer and computed in accordance with generally
    accepted accounting principles.
"Consolidated Secured Debt Ratio"
as of any
    date of determination, means the ratio of (1) Consolidated
    Total Indebtedness of the Issuer and its Restricted Subsidiaries
    that is secured by Liens as of the end of the most recent fiscal
    period for which internal financial statements are available
    immediately preceding the date on which such event for which
    such calculation is being made shall occur to (2) the
    Issuer's EBITDA for the most recently ended four full
    fiscal quarters for which internal financial statements are
    available immediately preceding the date on which such event for
    which such calculation is being made shall occur, in each case
    with such pro forma adjustments to Consolidated Total
    Indebtedness and EBITDA as are appropriate and consistent with
    the pro forma adjustment provisions set forth in the definition
    of "Fixed Charge Coverage Ratio."
"Consolidated Total Indebtedness"
means, as at
    any date of determination, an amount equal to the sum of
    (1) the aggregate amount of all outstanding Indebtedness of
    the Issuer and its Restricted Subsidiaries on a consolidated
    basis consisting of Indebtedness for borrowed money, Obligations
    in respect of Capitalized Lease Obligations and debt obligations
    evidenced by promissory notes and similar instruments (and
    excluding, for the avoidance of doubt, all obligations relating
    to Receivables Facilities) and (2) the aggregate amount of
    all outstanding Disqualified Stock of the Issuer and all
    Preferred Stock of its Restricted Subsidiaries on a consolidated
    basis, with the amount of such Disqualified Stock and Preferred
    Stock equal to the greater of their respective voluntary or
    involuntary liquidation preferences and maximum fixed repurchase
    prices, in each case determined on a consolidated basis in
    accordance with GAAP. For purposes hereof, the "maximum
    fixed repurchase price" of any Disqualified Stock or
    Preferred Stock that does not have a fixed repurchase price
    shall be calculated in accordance with the terms of such
    Disqualified Stock or Preferred Stock as if such Disqualified
    Stock or Preferred Stock were purchased on any date on which
    Consolidated Total Indebtedness shall be required to be
    determined pursuant to the Indenture, and if such price is based
    upon, or measured by, the fair market value of such Disqualified
    Stock or Preferred Stock, such fair market value shall be
    determined reasonably and in good faith by the Issuer.
"Contingent Obligations"
means, with respect to
    any Person, any obligation of such Person guaranteeing any
    leases, dividends or other obligations that do not constitute
    Indebtedness
("primary obligations"
) of any
    other Person (the
"primary obligor"
) in any
    manner, whether directly or indirectly, including, without
    limitation, any obligation of such Person, whether or not
    contingent,
(1) to purchase any such primary obligation or any property
    constituting direct or indirect security therefor,
(2) to advance or supply funds
(a) for the purchase or payment of any such primary
    obligation, or
(b) to maintain working capital or equity capital of the
    primary obligor or otherwise to maintain the net worth or
    solvency of the primary obligor, or
(3) to purchase property, securities or services primarily
    for the purpose of assuring the owner of any such primary
    obligation of the ability of the primary obligor to make payment
    of such primary obligation against loss in respect thereof.
"Controlling Secured Parties"
means, with
    respect to any Common Collateral, the Series of First Lien
    Secured Parties whose Authorized Representative is the
    Applicable Authorized Representative for such Common Collateral.
"Credit Facilities"
means, with respect to the
    Issuer or any of its Restricted Subsidiaries, one or more debt
    facilities, including the Senior Credit Facilities, or other
    financing arrangements (including, without limitation,
    commercial paper facilities or indentures) providing for
    revolving credit loans, term loans, letters of credit or other
    long-term indebtedness, including any notes, mortgages,
    guarantees, collateral documents, instruments and agreements
    executed in connection therewith, and any amendments,
    supplements,
239
Table of Contents
modifications, extensions, renewals, restatements or refundings
    thereof and any indentures or credit facilities or commercial
    paper facilities that replace, refund or refinance any part of
    the loans, notes, other credit facilities or commitments
    thereunder, including any such replacement, refunding or
    refinancing facility or indenture that increases the amount
    permitted to be borrowed thereunder or alters the maturity
    thereof (
provided
that such increase in borrowings is
    permitted under "Certain Covenants — Limitation
    on Incurrence of Indebtedness and Issuance of Disqualified Stock
    and Preferred Stock") or adds Restricted Subsidiaries as
    additional borrowers or guarantors thereunder and whether by the
    same or any other agent, lender or group of lenders.
"Default"
means any event that is, or with the
    passage of time or the giving of notice or both would be, an
    Event of Default.
"Delayed Equity Amount"
means any equity
    contribution of the Investors, the Frist Entities or certain
    other management investors described in the Offering Memorandum
    on or before March 31, 2007, the proceeds of which are used
    to repay borrowings under the senior secured revolving credit
    facility included in the General Credit Facility or the ABL
    Facility in the manner described in the Offering Memorandum.
"Designated Non-cash Consideration"
means the
    fair market value of non-cash consideration received by the
    Issuer or a Restricted Subsidiary in connection with an Asset
    Sale that is so designated as Designated Non-cash Consideration
    pursuant to an Officer's Certificate, setting forth the
    basis of such valuation, executed by the principal financial
    officer of the Issuer, less the amount of cash or Cash
    Equivalents received in connection with a subsequent sale of or
    collection on such Designated Non-cash Consideration.
"Designated Preferred Stock"
means Preferred
    Stock of the Issuer or any parent corporation thereof (in each
    case other than Disqualified Stock) that is issued for cash
    (other than to a Restricted Subsidiary or an employee stock
    ownership plan or trust established by the Issuer or any of its
    Subsidiaries) and is so designated as Designated Preferred
    Stock, pursuant to an Officer's Certificate executed by the
    principal financial officer of the Issuer or the applicable
    parent corporation thereof, as the case may be, on the issuance
    date thereof, the cash proceeds of which are excluded from the
    calculation set forth in clause (3) of the first paragraph
    under "Certain Covenants — Limitation on
    Restricted Payments."
"Discharge of New First Lien Obligations"
means, except to the extent any such New First Lien
    Obligations are reinstated pursuant to the Additional General
    Intercreditor Agreement, the discharge or legal defeasance or
    covenant defeasance of the Indenture in accordance with its
    terms;
provided
that the Discharge of New First Lien
    Obligations shall not be deemed to have occurred if such
    payments are made with proceeds of other New First Lien
    Obligations that constitute and exchange or replacement for or a
    refinancing, in whole or in part, of such New First Lien
    Obligations. In the event the New First Lien Obligations are
    modified and such Obligations are paid over time or otherwise
    modified pursuant to Section 1129 of the Bankruptcy Code,
    the New First Lien Obligations shall be deemed to be discharged
    when the final payment is made, in cash, in respect of such
    indebtedness and any obligations pursuant to such new
    indebtedness shall have been satisfied.
"Discharge of General Credit Facility Obligations"
means, with respect to any Common Collateral, the date on
    which the General Credit Facility Obligations are no longer
    secured by such Common Collateral;
provided
that the
    Discharge of General Credit Facility Obligations shall not be
    deemed to have occurred in connection with a refinancing of such
    General Credit Facility Obligations with additional First Lien
    Obligations secured by such Common Collateral under an agreement
    relating to Additional First Lien Obligations which has been
    designated in writing by the administrative agent under the
    General Credit Facility so refinanced to the First Lien
    Collateral Agent and each other Authorized Representative as the
    General Credit Facility for purposes of the First Lien
    Intercreditor Agreement.
"Disqualified Stock"
means, with respect to any
    Person, any Capital Stock of such Person which, by its terms, or
    by the terms of any security into which it is convertible or for
    which it is putable or exchangeable, or upon the happening of
    any event, matures or is mandatorily redeemable (other than
    solely as a result of a change of control or asset sale)
    pursuant to a sinking fund obligation or otherwise, or is
    redeemable at the option of the holder thereof (other than
    solely as a result of a change of control or asset sale), in
    whole or in part, in each case prior to the date 91 days
    after the earlier of the maturity date of the Notes or the date
    the
240
Table of Contents
Notes are no longer outstanding;
provided
,
however
, that if such Capital Stock is issued to any plan
    for the benefit of employees of the Issuer or its Subsidiaries
    or by any such plan to such employees, such Capital Stock shall
    not constitute Disqualified Stock solely because it may be
    required to be repurchased by the Issuer or its Subsidiaries in
    order to satisfy applicable statutory or regulatory obligations.
"EBITDA"
means, with respect to any Person for
    any period, the Consolidated Net Income of such Person for such
    period
(1) increased (without duplication) by:
(a) provision for taxes based on income or profits or
    capital gains, including, without limitation, foreign, federal,
    state, franchise and similar taxes (such as the Pennsylvania
    capital tax) and foreign withholding taxes (including penalties
    and interest related to such taxes or arising from tax
    examinations) of such Person paid or accrued during such period
    deducted (and not added back) in computing Consolidated Net
    Income;
plus
(b) Fixed Charges of such Person for such period (including
    (x) net losses on Hedging Obligations or other derivative
    instruments entered into for the purpose of hedging interest
    rate risk and (y) costs of surety bonds in connection with
    financing activities, in each case, to the extent included in
    Fixed Charges), together with items excluded from the definition
    of "Consolidated Interest Expense" pursuant to clauses
    (1)(u), (v), (w), (x), (y) and (z) of the definition
    thereof, and, in each such case, to the extent the same were
    deducted (and not added back) in calculating such Consolidated
    Net Income;
plus
(c) Consolidated Depreciation and Amortization Expense of
    such Person for such period to the extent the same was deducted
    (and not added back) in computing Consolidated Net Income;
plus
(d) any expenses or charges (other than depreciation or
    amortization expense) related to any Equity Offering, Permitted
    Investment, acquisition, disposition, recapitalization or the
    incurrence of Indebtedness permitted to be incurred by the
    Indenture (including a refinancing thereof) (whether or not
    successful), including (i) such fees, expenses or charges
    related to the offering of the Notes and any Credit Facilities
    and (ii) any amendment or other modification of the Notes,
    and, in each case, deducted (and not added back) in computing
    Consolidated Net Income;
plus
(e) the amount of any restructuring charge or reserve
    deducted (and not added back) in such period in computing
    Consolidated Net Income, including any one-time costs incurred
    in connection with acquisitions after November 17, 2006 and
    costs related to the closure
and/or
consolidation of facilities;
plus
(f) any other non-cash charges, including any write-offs or
    write-downs, reducing Consolidated Net Income for such period
    (
provided
that if any such non-cash charges represent an
    accrual or reserve for potential cash items in any future
    period, the cash payment in respect thereof in such future
    period shall be subtracted from EBITDA to such extent, and
    excluding amortization of a prepaid cash item that was paid in a
    prior period);
plus
(g) the amount of any minority interest expense consisting
    of income attributable to minority equity interests of third
    parties deducted (and not added back) in such period in
    calculating Consolidated Net Income;
plus
(h) the amount of management, monitoring, consulting and
    advisory fees and related expenses paid in such period to the
    Investors and the Frist Entities to the extent otherwise
    permitted under "Certain Covenants — Transactions
    with Affiliates";
plus
(i) the amount of net cost savings projected by the Issuer
    in good faith to be realized as a result of specified actions
    taken or to be taken (calculated on a pro forma basis as though
    such cost savings had been realized on the first day of such
    period), net of the amount of actual benefits realized during
    such period from such actions;
provided
that
    (w) such cost savings are reasonably identifiable and
    factually supportable, (x) such actions have been taken or
    are to be taken within 15 months after the date of
    determination to take such action, (y) no cost savings
    shall be added pursuant to this clause (i) to the
241
Table of Contents
extent duplicative of any expenses or charges relating to such
    cost savings that are included in clause (e) above with
    respect to such period and (z) the aggregate amount of cost
    savings added pursuant to this clause (i) shall not exceed
    $150.0 million for any four consecutive quarter period
    (which adjustments may be incremental to pro forma adjustments
    made pursuant to the second paragraph of the definition of
    "Fixed Charge Coverage Ratio");
plus
(j) the amount of loss on sales of receivables and related
    assets to the Receivables Subsidiary in connection with a
    Receivables Facility;
plus
(k) any costs or expense incurred by the Issuer or a
    Restricted Subsidiary pursuant to any management equity plan or
    stock option plan or any other management or employee benefit
    plan or agreement or any stock subscription or shareholder
    agreement, to the extent that such cost or expenses are funded
    with cash proceeds contributed to the capital of the Issuer or
    net cash proceeds of an issuance of Equity Interests of the
    Issuer (other than Disqualified Stock) solely to the extent that
    such net cash proceeds are excluded from the calculation set
    forth in clause (3) of the first paragraph under
    "Certain Covenants — Limitation on Restricted
    Payments";
(2) decreased by (without duplication) non-cash gains
    increasing Consolidated Net Income of such Person for such
    period, excluding any non-cash gains to the extent they
    represent the reversal of an accrual or reserve for a potential
    cash item that reduced EBITDA in any prior period; and
(3) increased or decreased by (without duplication):
(a) any net gain or loss resulting in such period from
    Hedging Obligations and the application of Statement of
    Financial Accounting Standards No. 133;
plus
or
minus
, as applicable,
(b) any net gain or loss resulting in such period from
    currency translation gains or losses related to currency
    remeasurements of Indebtedness (including any net loss or gain
    resulting from Hedging Obligations for currency exchange risk).
"EMU"
means the economic and monetary union as
    contemplated in the Treaty on European Union.
"Equity Interests"
means Capital Stock and all
    warrants, options or other rights to acquire Capital Stock, but
    excluding any debt security that is convertible into, or
    exchangeable for, Capital Stock.
"Equity Offering"
means any public or private
    sale of common stock or Preferred Stock of the Issuer or any of
    its direct or indirect parent companies (excluding Disqualified
    Stock), other than:
(1) public offerings with respect to the Issuer's or
    any direct or indirect parent company's common stock
    registered on
Form S-8;
(2) issuances to any Subsidiary of the Issuer; and
(3) any such public or private sale that constitutes an
    Excluded Contribution.
"euro"
means the single currency of
    participating member states of the EMU.
"European Collateral"
has the meaning set forth
    under "Description of Other Indebtedness — Senior
    Secured Credit Facilities — Guarantee and
    Security."
"Event of Default"
has the meaning set forth
    under "Events of Default and Remedies."
"Excess Proceeds"
has the meaning set forth in
    the fourth paragraph under "Repurchase at the Option of
    Holders — Asset Sales."
"Exchange Act"
means the Securities Exchange
    Act of 1934, as amended, and the rules and regulations of the
    SEC promulgated thereunder.
"Exchange Notes"
means any notes issued in
    exchange for the Notes pursuant to the Registration Rights
    Agreement or similar agreement.
242
Table of Contents
"Excluded Contribution"
means net cash
    proceeds, marketable securities or Qualified Proceeds received
    by the Issuer after November 17, 2006 from
(1) contributions to its common equity capital, and
(2) the sale (other than to a Subsidiary of the Issuer or
    to any management equity plan or stock option plan or any other
    management or employee benefit plan or agreement of the Issuer)
    of Capital Stock (other than Disqualified Stock and Designated
    Preferred Stock) of the Issuer,
in each case designated as Excluded Contributions pursuant to an
    Officer's Certificate executed by the principal financial
    officer of the Issuer on the date such capital contributions are
    made or the date such Equity Interests are sold, as the case may
    be, which are excluded from the calculation set forth in
    clause (3) of the first paragraph under "Certain
    Covenants — Limitation on Restricted Payments."
"Existing Notes"
means the $121.2 million
    aggregate principal amount of 8.700% medium-term notes due 2010,
    $691.2 million aggregate principal amount of
    8.750% notes due 2010, £150.0 million aggregate
    principal amount of 8.750% notes due 2010,
    $475.8 million aggregate principal amount of
    7.875% notes due 2011, $500.0 million aggregate
    principal amount of 6.950% notes due 2012,
    $500.0 million aggregate principal amount of
    6.300% notes due 2012, $500.0 million aggregate
    principal amount of 6.250% notes due 2013,
    $500.0 million aggregate principal amount of
    6.750% notes due 2013, $500.0 million aggregate
    principal amount of 5.750% notes due 2014,
    $121.1 million aggregate principal amount of 9.000%
    medium-term notes due 2014, $750.0 million aggregate
    principal amount of 6.375% notes due 2015,
    $150.0 million aggregate principal amount of
    7.190% debentures due 2015, $1,000.0 million aggregate
    principal amount of 6.500% notes due 2016,
    $135.6 million aggregate principal amount of
    7.500% debentures due 2023, $150.0 million aggregate
    principal amount of 8.360% debentures due 2024,
    $291.4 million aggregate principal amount of
    7.690% notes due 2025, $125.0 million aggregate
    principal amount of 7.580% medium-term notes due 2025,
    $150.0 million aggregate principal amount of
    7.050% debentures due 2027, $250.0 million aggregate
    principal amount of 7.500% notes due 2033,
    $100.0 million aggregate principal amount of
    7.750% debentures due 2036 and $200.0 million
    aggregate principal amount of 7.500% debentures due 2095,
    each issued by the Issuer and outstanding on November 17,
    2006.
"Existing Notes Indenture"
means that certain
    Indenture, dated as of December 16, 1993, between Columbia
    Healthcare Corporation and The First National Bank of Chicago,
    as Trustee, as amended by the First Supplemental Indenture,
    dated as of May 25, 2000, between the Issuer and Bank One
    Trust Company, N.A., as Trustee, the Second Supplemental
    Indenture, dated as of July 1, 2001, between the Issuer and
    Bank One Trust Company, N.A., as Trustee, and the Third
    Supplemental Indenture, dated as of December 5, 2001,
    between the Issuer and The Bank of New York, as Trustee.
"Existing Second Priority Notes"
means the 2006
    Second Priority Notes and the 2009 Second Priority Notes and any
    refinancings thereof permitted pursuant to the terms of the
    Indenture.
"Existing Second Priority Notes Indentures"
means the 2006 Second Priority Notes Indenture and the 2009
    Second Priority Notes Indenture.
"First Lien Collateral Agent"
shall mean Bank
    of America, N.A., in its capacity as administrative agent and
    collateral agent for the lenders and other secured parties under
    the General Credit Facility and the other First Lien Documents
    and in its capacity as collateral agent for the New First Lien
    Secured Parties, together with its successors and permitted
    assigns under the General Credit Facility, the Indenture and the
    First Lien Documents exercising substantially the same rights
    and powers; and in each case
provided
that if such First
    Lien Collateral Agent is not Bank of America, N.A., such First
    Lien Collateral Agent shall have become a party to the
    Additional General Intercreditor Agreement, the General
    Intercreditor Agreement, dated as of November 17, 2006,
    among the First Lien Collateral Agent and the Junior Lien
    Collateral Agent, and the other applicable First Lien Security
    Documents.
"First Lien Documents"
means the credit,
    guarantee and security documents governing the New First Lien
    Obligations, including, without limitation, the Indenture and
    the First Lien Security Documents.
243
Table of Contents
"First Lien Event of Default"
means an
    "Event of Default" under and as defined in the General
    Credit Facility, the Indenture or any other First Lien Documents
    governing First Lien Obligations.
"First Lien Obligations"
means, collectively,
    (a) all General Credit Facility Obligations, (b) the
    Notes Obligations and (c) any Series of Additional First
    Lien Obligations. For the avoidance of doubt, Obligations with
    respect to the ABL Facility will not constitute First Lien
    Obligations.
"First Lien Secured Parties"
means (a) the
    "Secured Parties," as defined in the General Credit
    Facility, (b) the New First Lien Secured Parties and
    (c) any Additional First Lien Secured Parties.
"First Lien Security Documents"
means the
    Security Documents (as defined in the Indenture) and any other
    agreement, document or instrument pursuant to which a Lien is
    granted or purported to be granted securing New First Lien
    Obligations or under which rights or remedies with respect to
    such Liens are governed, in each case to the extent relating to
    the collateral securing both the New First Lien Obligations and
    any Junior Lien Obligations.
"First Priority Liens"
means the first priority
    Liens securing the New First Lien Obligations.
"Fixed Charge Coverage Ratio"
means, with
    respect to any Person for any period, the ratio of EBITDA of
    such Person for such period to the Fixed Charges of such Person
    for such period. In the event that the Issuer or any Restricted
    Subsidiary incurs, assumes, guarantees, redeems, retires or
    extinguishes any Indebtedness (other than Indebtedness incurred
    under any revolving credit facility unless such Indebtedness has
    been permanently repaid and has not been replaced) or issues or
    redeems Disqualified Stock or Preferred Stock subsequent to the
    commencement of the period for which the Fixed Charge Coverage
    Ratio is being calculated but prior to or simultaneously with
    the event for which the calculation of the Fixed Charge Coverage
    Ratio is made (the
"Fixed Charge Coverage Ratio
    Calculation Date"
), then the Fixed Charge Coverage
    Ratio shall be calculated giving pro forma effect to such
    incurrence, assumption, guarantee, redemption, retirement or
    extinguishment of Indebtedness, or such issuance or redemption
    of Disqualified Stock or Preferred Stock, as if the same had
    occurred at the beginning of the applicable four-quarter period.
For purposes of making the computation referred to above,
    Investments, acquisitions, dispositions, mergers, consolidations
    and disposed operations (as determined in accordance with GAAP)
    that have been made by the Issuer or any of its Restricted
    Subsidiaries during the four-quarter reference period or
    subsequent to such reference period and on or prior to or
    simultaneously with the Fixed Charge Coverage Ratio Calculation
    Date shall be calculated on a pro forma basis assuming that all
    such Investments, acquisitions, dispositions, mergers,
    consolidations and disposed operations (and the change in any
    associated fixed charge obligations and the change in EBITDA
    resulting therefrom) had occurred on the first day of the
    four-quarter reference period. If, since the beginning of such
    period, any Person that subsequently became a Restricted
    Subsidiary or was merged with or into the Issuer or any of its
    Restricted Subsidiaries since the beginning of such period shall
    have made any Investment, acquisition, disposition, merger,
    consolidation or disposed operation that would have required
    adjustment pursuant to this definition, then the Fixed Charge
    Coverage Ratio shall be calculated giving pro forma effect
    thereto for such period as if such Investment, acquisition,
    disposition, merger, consolidation or disposed operation had
    occurred at the beginning of the applicable four-quarter period.
For purposes of this definition, whenever pro forma effect is to
    be given to a transaction, the pro forma calculations shall be
    made in good faith by a responsible financial or accounting
    officer of the Issuer. If any Indebtedness bears a floating rate
    of interest and is being given pro forma effect, the interest on
    such Indebtedness shall be calculated as if the rate in effect
    on the Fixed Charge Coverage Ratio Calculation Date had been the
    applicable rate for the entire period (taking into account any
    Hedging Obligations applicable to such Indebtedness). Interest
    on a Capitalized Lease Obligation shall be deemed to accrue at
    an interest rate reasonably determined by a responsible
    financial or accounting officer of the Issuer to be the rate of
    interest implicit in such Capitalized Lease Obligation in
    accordance with GAAP. For purposes of making the computation
    referred to above, interest on any Indebtedness under a
    revolving credit facility computed on a pro forma basis shall be
    computed based upon the average daily balance of such
    Indebtedness during the applicable period except as set forth in
    the first paragraph of this definition. Interest on Indebtedness
    that may
244
Table of Contents
optionally be determined at an interest rate based upon a factor
    of a prime or similar rate, a eurocurrency interbank offered
    rate or other rate shall be deemed to have been based upon the
    rate actually chosen, or, if none, then based upon such optional
    rate chosen as the Issuer may designate.
"Fixed Charges"
means, with respect to any
    Person for any period, the sum of:
(1) Consolidated Interest Expense of such Person for such
    period;
(2) all cash dividends or other distributions paid
    (excluding items eliminated in consolidation) on any series of
    Preferred Stock during such period; and
(3) all cash dividends or other distributions paid
    (excluding items eliminated in consolidation) on any series of
    Disqualified Stock during such period.
"Foreign Subsidiary"
means, with respect to any
    Person, any Restricted Subsidiary of such Person that is not
    organized or existing under the laws of the United States, any
    state thereof or the District of Columbia and any Restricted
    Subsidiary of such Foreign Subsidiary.
"Frist Entities"
means Dr. Thomas F.
    Frist, Jr., any Person controlled by Dr. Frist and any
    charitable organization selected by Dr. Frist that holds
    Equity Interests of the Issuer on November 17, 2006.
"GAAP"
means generally accepted accounting
    principles in the United States which are in effect on
    November 17, 2006.
"General Credit Facility"
means the credit
    agreement entered into as of November 17, 2006 by and among
    the Issuer, the European subsidiary borrowers party thereto, the
    lenders party thereto in their capacities as lenders thereunder
    and Bank of America, N.A., as U.S. Administrative Agent and
    as European Administrative Agent, as amended as of
    February 16, 2007 and as further amended as of
    March 2, 2009, including any guarantees, collateral
    documents, instruments and agreements executed in connection
    therewith, and any amendments, supplements, modifications,
    extensions, renewals, restatements, refundings or refinancings
    thereof and any indentures or credit facilities or commercial
    paper facilities with banks or other institutional lenders or
    investors that replace, refund or refinance any part of the
    loans, notes, other credit facilities or commitments thereunder,
    including any such replacement, refunding or refinancing
    facility or indenture that increases the amount borrowable
    thereunder or alters the maturity thereof (
provided
that
    such increase in borrowings is permitted under "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock"
    above).
"General Credit Facility Obligations"
means
    "Obligations" as defined in the General Credit
    Facility.
"Government Securities"
means securities that
    are:
(1) direct obligations of the United States of America for
    the timely payment of which its full faith and credit is
    pledged; or
(2) obligations of a Person controlled or supervised by and
    acting as an agency or instrumentality of the United States of
    America the timely payment of which is unconditionally
    guaranteed as a full faith and credit obligation by the United
    States of America,
which, in either case, are not callable or redeemable at the
    option of the issuers thereof, and shall also include a
    depository receipt issued by a bank (as defined in
    Section 3(a)(2) of the Securities Act), as custodian with
    respect to any such Government Securities or a specific payment
    of principal of or interest on any such Government Securities
    held by such custodian for the account of the holder of such
    depository receipt;
provided
that (except as required by
    law) such custodian is not authorized to make any deduction from
    the amount payable to the holder of such depository receipt from
    any amount received by the custodian in respect of the
    Government Securities or the specific payment of principal of or
    interest on the Government Securities evidenced by such
    depository receipt.
"Guarantee"
means a guarantee (other than by
    endorsement of negotiable instruments for collection in the
    ordinary course of business), direct or indirect, in any manner
    (including letters of credit and reimbursement agreements in
    respect thereof), of all or any part of any Indebtedness or
    other obligations.
245
Table of Contents
"Guarantee"
means the guarantee by any
    Guarantor of the Issuer's Obligations under the Indenture.
"Guarantor"
means each Restricted Subsidiary
    that Guarantees the Notes in accordance with the terms of the
    Indenture.
"HCI"
means Health Care Indemnity, Inc., an
    insurance company formed under the laws of the State of Colorado
    and a Wholly-Owned Subsidiary of the Issuer.
"Hedging Arrangements"
means the fixed-pay
    interest rate swap agreements, entered into by Hercules Holding
    on or about September 13, 2006 and with respect to which
    the Issuer will be the counterparty in connection with the
    Recapitalization, relating to $8,000 million of the
    outstanding principal amount under the First Lien Obligations
    and the ABL Obligations.
"Hedging Obligations"
means, with respect to
    any Person, the obligations of such Person under any interest
    rate swap agreement, interest rate cap agreement, interest rate
    collar agreement, commodity swap agreement, commodity cap
    agreement, commodity collar agreement, foreign exchange
    contract, currency swap agreement or similar agreement providing
    for the transfer or mitigation of interest rate or currency
    risks either generally or under specific contingencies.
"Holder"
means the Person in whose name a Note
    is registered on the registrar's books.
"Impairment"
means, with respect to any Series
    of First Lien Obligations, (i) any determination by a court
    of competent jurisdiction that (x) any of the First Lien
    Obligations of such Series are unenforceable under applicable
    law or are subordinated to any other obligations (other than
    another Series of First Lien Obligations), (y) any of the
    First Lien Obligations of such Series do not have an enforceable
    security interest in any of the Collateral securing any other
    Series of First Lien Obligations
and/or
(z) any intervening security interest exists securing any
    other obligations (other than another Series of First Lien
    Obligations) on a basis ranking prior to the security interest
    of such Series of First Lien Obligations but junior to the
    security interest of any other Series of First Lien Obligations
    or (ii) the existence of any Collateral for any other
    Series of First Lien Obligations that is not Common Collateral.
"Indebtedness"
means, with respect to any
    Person, without duplication:
(1) any indebtedness (including principal and premium) of
    such Person, whether or not contingent:
(a) in respect of borrowed money;
(b) evidenced by bonds, notes, debentures or similar
    instruments or letters of credit or bankers' acceptances
    (or, without duplication, reimbursement agreements in respect
    thereof);
(c) representing the balance deferred and unpaid of the
    purchase price of any property (including Capitalized Lease
    Obligations), except (i) any such balance that constitutes
    a trade payable or similar obligation to a trade creditor, in
    each case accrued in the ordinary course of business and
    (ii) any earn-out obligations until such obligation becomes
    a liability on the balance sheet of such Person in accordance
    with GAAP; or
(d) representing any Hedging Obligations;
if and to the extent that any of the foregoing Indebtedness
    (other than letters of credit and Hedging Obligations) would
    appear as a liability upon a balance sheet (excluding the
    footnotes thereto) of such Person prepared in accordance with
    GAAP;
(2) to the extent not otherwise included, any obligation by
    such Person to be liable for, or to pay, as obligor, guarantor
    or otherwise on, the obligations of the type referred to in
    clause (1) of a third Person (whether or not such items
    would appear upon the balance sheet of the such obligor or
    guarantor), other than by endorsement of negotiable instruments
    for collection in the ordinary course of business; and
(3) to the extent not otherwise included, the obligations
    of the type referred to in clause (1) of a third Person
    secured by a Lien on any asset owned by such first Person,
    whether or not such Indebtedness is assumed by such first Person;
246
Table of Contents
provided
,
however
, that notwithstanding the
    foregoing, Indebtedness shall be deemed not to include
    (a) Contingent Obligations incurred in the ordinary course
    of business or (b) obligations under or in respect of
    Receivables Facilities.
"Independent Financial Advisor"
means an
    accounting, appraisal, investment banking firm or consultant to
    Persons engaged in Similar Businesses of nationally recognized
    standing that is, in the good faith judgment of the Issuer,
    qualified to perform the task for which it has been engaged.
"Initial Purchasers"
means Citigroup Global
    Markets Inc., Banc of America Securities LLC, J.P. Morgan
    Securities Inc., Deutsche Bank Securities Inc., Goldman,
    Sachs & Co. and the other initial purchasers party to
    the purchase agreement related to the Notes.
"insolvency or liquidation proceeding"
means:
(1) any case commenced by or against the Issuer or any
    Guarantor under any Bankruptcy Law for the relief of debtors,
    any other proceeding for the reorganization, recapitalization or
    adjustment or marshalling of the assets or liabilities of the
    Issuer or any Guarantor, any receivership or assignment for the
    benefit of creditors relating to the Issuer or any Guarantor or
    any similar case or proceeding relative to the Issuer or any
    Guarantor or its creditors, as such, in each case whether or not
    voluntary;
(2) any liquidation, dissolution, marshalling of assets or
    liabilities or other winding up of or relating to the Issuer or
    any Guarantor, in each case whether or not voluntary and whether
    or not involving bankruptcy or insolvency; or
(3) any other proceeding of any type or nature in which
    substantially all claims of creditors of the Issuer or any
    Guarantor are determined and any payment or distribution is or
    may be made on account of such claims.
"Intercreditor Agreements"
means, collectively,
    the First Lien Intercreditor Agreement, the Additional
    Receivables Intercreditor Agreement and the Additional General
    Intercreditor Agreement.
"Investment Grade Rating"
means a rating equal
    to or higher than Baa3 (or the equivalent) by Moody's and
    BBB- (or the equivalent) by S&P, or an equivalent rating by
    any other Rating Agency.
"Investment Grade Securities"
means:
(1) securities issued or directly and fully guaranteed or
    insured by the United States government or any agency or
    instrumentality thereof (other than Cash Equivalents);
(2) debt securities or debt instruments with an Investment
    Grade Rating, but excluding any debt securities or instruments
    constituting loans or advances among the Issuer and its
    Subsidiaries;
(3) investments in any fund that invests exclusively in
    investments of the type described in clauses (1) and
    (2) which fund may also hold immaterial amounts of cash
    pending investment or distribution; and
(4) corresponding instruments in countries other than the
    United States customarily utilized for high quality investments.
"Investments"
means, with respect to any
    Person, all investments by such Person in other Persons
    (including Affiliates) in the form of loans (including
    guarantees), advances or capital contributions (excluding
    accounts receivable, trade credit, advances to customers,
    commissions, travel and similar advances to officers and
    employees, in each case made in the ordinary course of
    business), purchases or other acquisitions for consideration of
    Indebtedness, Equity Interests or other securities issued by any
    other Person and investments that are required by GAAP to be
    classified on the balance sheet (excluding the footnotes) of the
    Issuer in the same manner as the other investments included in
    this definition to the extent such transactions involve the
247
Table of Contents
transfer of cash or other property. For purposes of the
    definition of "Unrestricted Subsidiary" and the
    covenant described under "Certain Covenants —
    Limitation on Restricted Payments":
(1)
"Investments"
shall include the
    portion (proportionate to the Issuer's equity interest in
    such Subsidiary) of the fair market value of the net assets of a
    Subsidiary of the Issuer at the time that such Subsidiary is
    designated an Unrestricted Subsidiary;
provided
,
however
, that upon a redesignation of such Subsidiary as
    a Restricted Subsidiary, the Issuer shall be deemed to continue
    to have a permanent "Investment" in an Unrestricted
    Subsidiary in an amount (if positive) equal to:
(a) the Issuer's "Investment" in such
    Subsidiary at the time of such redesignation;
less
(b) the portion (proportionate to the Issuer equity
    interest in such Subsidiary) of the fair market value of the net
    assets of such Subsidiary at the time of such
    redesignation; and
(2) any property transferred to or from an Unrestricted
    Subsidiary shall be valued at its fair market value at the time
    of such transfer, in each case as determined in good faith by
    the Issuer.
"Investors"
means Bain Capital Partners, LLC,
    Kohlberg Kravis Roberts & Co. L.P., Merrill Lynch
    Global Private Equity, Inc. (formerly known as Merrill Lynch
    Global Partners, Inc.) and each of their respective Affiliates
    but not including, however, any portfolio companies of any of
    the foregoing.
"Issue Date"
means April 22, 2009.
"Issuer"
has the meaning set forth in the first
    paragraph under "General";
provided
that when
    used in the context of determining the fair market value of an
    asset or liability under the Indenture, "Issuer" shall
    be deemed to mean the board of directors of the Issuer when the
    fair market value is equal to or in excess of
    $500.0 million (unless otherwise expressly stated).
"Junior Lien Collateral Agent"
shall mean
    (i) so long as the 2006 Second Priority Notes are
    outstanding, the trustee under the 2006 Second Priority Notes
    Indenture, in its capacity as trustee and collateral agent for
    the holders of 2006 Second Priority Notes and other secured
    parties under the 2006 Second Priority Notes Indenture and the
    related security documents (including the holders of the 2009
    Second Priority Notes), and (ii) at any time thereafter,
    such agent or trustee as is designated "Junior Lien
    Collateral Agent" by Junior Lien Secured Parties holding a
    majority in principal amount of the Junior Lien Obligations then
    outstanding or pursuant to such other arrangements as agreed to
    among the holders of the Junior Lien Obligations, it being
    understood that as of the Issue Date, the trustee under the 2006
    Second Priority Notes Indenture shall be the Junior Lien
    Collateral Agent.
"Junior Lien Documents"
means the credit and
    security documents governing the Junior Lien Obligations,
    including, without limitation, the Existing Second Priority
    Notes Indentures, the related security documents and
    intercreditor agreements.
"Junior Lien Obligations"
means the Existing
    Second Priority Notes and Obligations with respect to other
    Indebtedness permitted to be incurred under the Existing Second
    Priority Notes Indentures and the General Credit Facility which
    is by its terms intended to be secured equally and ratably with
    the Existing Second Priority Notes or on a basis junior to the
    Liens securing the Existing Second Priority Notes;
provided
such Lien is permitted to be incurred under the Existing
    Second Priority Notes Indentures and the General Credit
    Facility;
provided, further
, that the holders of such
    Indebtedness or their Junior Lien Representative is a party to
    the applicable security documents in accordance with the terms
    thereof and has appointed the Junior Lien Collateral Agent as
    collateral agent for such holders of Junior Lien Obligations
    with respect to all or a portion of the Collateral.
"Junior Lien Representative"
means any duly
    authorized representative of any holders of Junior Lien
    Obligations, which representative is party to the applicable
    security documents.
"Junior Lien Secured Parties"
means
    (i) holders of Existing Second Priority Notes (including
    the holders of any Additional Notes (as defined in the Existing
    Second Priority Notes Indentures) subsequently issued under and
    in compliance with the terms of the Existing Second Priority
    Notes Indentures), (ii) the Junior Lien
248
Table of Contents
Collateral Agent and (iii) the holders from time to time of
    any other Junior Lien Obligations and each Junior Lien
    Representative.
"Legal Holiday"
means a Saturday, a Sunday or a
    day on which commercial banking institutions are not required to
    be open in the State of New York.
"Lien"
means, with respect to any asset, any
    mortgage, lien (statutory or otherwise), pledge, hypothecation,
    charge, security interest, preference, priority or encumbrance
    of any kind in respect of such asset, whether or not filed,
    recorded or otherwise perfected under applicable law, including
    any conditional sale or other title retention agreement, any
    lease in the nature thereof, any option or other agreement to
    sell or give a security interest in and any filing of or
    agreement to give any financing statement under the Uniform
    Commercial Code (or equivalent statutes) of any jurisdiction;
provided
that in no event shall an operating lease be
    deemed to constitute a Lien.
"Major Non-Controlling Authorized Representative"
has the meaning set forth under "Security —
    First Lien Intercreditor."
"Moody's"
means Moody's Investors
    Service, Inc. and any successor to its rating agency business.
"Net Income"
means, with respect to any Person,
    the net income (loss) of such Person, determined in accordance
    with GAAP and before any reduction in respect of Preferred Stock
    dividends.
"Net Proceeds"
means the aggregate cash
    proceeds received by the Issuer or any of its Restricted
    Subsidiaries in respect of any Asset Sale, including any cash
    received upon the sale or other disposition of any Designated
    Non-cash Consideration received in any Asset Sale, net of the
    direct costs relating to such Asset Sale and the sale or
    disposition of such Designated Non-cash Consideration, including
    legal, accounting and investment banking fees, and brokerage and
    sales commissions, any relocation expenses incurred as a result
    thereof, taxes paid or payable as a result thereof (after taking
    into account any available tax credits or deductions and any tax
    sharing arrangements), amounts required to be applied to the
    repayment of principal, premium, if any, and interest on Senior
    Indebtedness required (other than required by clause (1) of
    the second paragraph of "Repurchase at the Option of
    Holders — Asset Sales") to be paid as a result of
    such transaction and any deduction of appropriate amounts to be
    provided by the Issuer or any of its Restricted Subsidiaries as
    a reserve in accordance with GAAP against any liabilities
    associated with the asset disposed of in such transaction and
    retained by the Issuer or any of its Restricted Subsidiaries
    after such sale or other disposition thereof, including pension
    and other post-employment benefit liabilities and liabilities
    related to environmental matters or against any indemnification
    obligations associated with such transaction.
"New First Lien Obligations"
means all advances
    to, and debts, liabilities, obligations, covenants and duties
    of, the Issuer or any Guarantor arising under the Indenture and
    any other First Lien Documents, whether or not direct or
    indirect (including those acquired by assumption), absolute or
    contingent, due or to become due, now existing or hereafter
    arising and including interest and fees that accrue after the
    commencement by or against the Issuer, any Guarantor or any
    Affiliate thereof of any proceeding in bankruptcy or insolvency
    law naming such Person as the debtor in such proceeding,
    regardless of whether such interest and fees are allowed claims
    in such proceeding.
"New First Lien Secured Parties"
means, at any
    relevant time, the holders of New First Lien Obligations at such
    time, including without limitation the Trustee, the Registrar,
    Paying Agent and Transfer Agent, and the Holders (including the
    Holders of any Additional Notes subsequently issued under and in
    compliance with the terms of the Indenture).
"Non-Conforming Plan of Reorganization"
means
    any Plan of Reorganization that grants the Junior Lien
    Collateral Agent or any Junior Lien Secured Party any right or
    benefit, directly or indirectly, which right or benefit is
    prohibited at such time by the provisions of the Additional
    General Intercreditor Agreement.
"Non-Controlling Authorized Representative Enforcement
    Date"
has the meaning set forth under
    "Security — First Lien Intercreditor."
249
Table of Contents
"Non-Controlling Secured Parties"
means, with
    respect to any Common Collateral, the First Lien Secured Parties
    which are not Controlling Secured Parties with respect to such
    Common Collateral.
"Non-Receivables Collateral"
has the meaning
    set forth under "Description of Other
    Indebtedness — Senior Secured Credit
    Facilities — Guarantee and Security," subject to
    the provisions of the second sentence of the first paragraph
    under "— Security — General."
"Notes Documents"
means the credit and security
    documents governing the Notes Obligations, including, without
    limitation, the Indenture, the related Security Documents and
    Intercreditor Agreements.
"Notes Obligations"
means Obligations in
    respect of the Notes, the Indenture or the Security Documents,
    including, for the avoidance of doubt, obligations in respect of
    exchange notes and guarantees thereof.
"Obligations"
means any principal, interest
    (including any interest accruing subsequent to the filing of a
    petition in bankruptcy, reorganization or similar proceeding at
    the rate provided for in the documentation with respect thereto,
    whether or not such interest is an allowed claim under
    applicable state, federal or foreign law), premium, penalties,
    fees, indemnifications, reimbursements (including reimbursement
    obligations with respect to letters of credit and bankers'
    acceptances), damages and other liabilities, and guarantees of
    payment of such principal, interest, penalties, fees,
    indemnifications, reimbursements, damages and other liabilities,
    payable under the documentation governing any Indebtedness.
"Offering Memorandum"
means the offering
    memorandum, dated April 15, 2009, relating to the initial
    private offering of the Notes.
"Officer"
means the Chairman of the Board, the
    Chief Executive Officer, the President, any Executive Vice
    President, Senior Vice President or Vice President, the
    Treasurer or the Secretary of the Issuer or a Guarantor, as
    applicable.
"Officer's Certificate"
means a
    certificate signed on behalf of the Issuer by an Officer of the
    Issuer or on behalf of a Guarantor by an Officer of such
    Guarantor, who must be the principal executive officer, the
    principal financial officer, the treasurer or the principal
    accounting officer of the Issuer or Guarantor, as applicable,
    that meets the requirements set forth in the Indenture.
"Opinion of Counsel"
means a written opinion
    from legal counsel who is acceptable to the Trustee. The counsel
    may be an employee of or counsel to the Issuer or the Trustee.
"Permitted Asset Swap"
means the concurrent
    purchase and sale or exchange of Related Business Assets or a
    combination of Related Business Assets and cash or Cash
    Equivalents between the Issuer or any of its Restricted
    Subsidiaries and another Person;
provided
, that any cash
    or Cash Equivalents received must be applied in accordance with
    the covenant described under "Repurchase at the Option of
    Holders — Asset Sales."
"Permitted Holders"
means each of the
    Investors, the Frist Entities, members of management of the
    Issuer (or its direct or indirect parent) and any assignees of
    the equity commitments of the Investors on November 17,
    2006 who are (or will be, pursuant to the agreements described
    under "Management — Equity Investment by Senior
    Management Participants" and "— Equity
    Investment by Other Management Participants") holders of
    Equity Interests of the Issuer (or any of its direct or indirect
    parent companies) and any group (within the meaning of
    Section 13(d)(3) or Section 14(d)(2) of the Exchange
    Act or any successor provision) of which any of the foregoing
    are members;
provided
that, in the case of such group and
    without giving effect to the existence of such group or any
    other group, such Investors, Frist Entities, members of
    management and assignees of the equity commitments of the
    Investors, collectively, have beneficial ownership of more than
    50% of the total voting power of the Voting Stock of the Issuer
    or any of its direct or indirect parent companies.
"Permitted Investments"
means:
(1) any Investment in the Issuer or any of its Restricted
    Subsidiaries;
(2) any Investment in cash and Cash Equivalents or
    Investment Grade Securities;
250
Table of Contents
(3) any Investment by the Issuer or any of its Restricted
    Subsidiaries in a Person that is engaged in a Similar Business
    if as a result of such Investment:
(a) such Person becomes a Restricted Subsidiary; or
(b) such Person, in one transaction or a series of related
    transactions, is merged or consolidated with or into, or
    transfers or conveys substantially all of its assets to, or is
    liquidated into, the Issuer or a Restricted Subsidiary,
and, in each case, any Investment held by such Person;
provided
that such Investment was not acquired by such
    Person in contemplation of such acquisition, merger,
    consolidation or transfer;
(4) any Investment in securities or other assets not
    constituting cash, Cash Equivalents or Investment Grade
    Securities and received in connection with an Asset Sale made
    pursuant to the provisions described under "Repurchase at
    the Option of Holders — Asset Sales" or any other
    disposition of assets not constituting an Asset Sale;
(5) any Investment existing on the Issue Date;
(6) any Investment acquired by the Issuer or any of its
    Restricted Subsidiaries:
(a) in exchange for any other Investment or accounts
    receivable held by the Issuer or any such Restricted Subsidiary
    in connection with or as a result of a bankruptcy, workout,
    reorganization or recapitalization of the issuer of such other
    Investment or accounts receivable; or
(b) as a result of a foreclosure by the Issuer or any of
    its Restricted Subsidiaries with respect to any secured
    Investment or other transfer of title with respect to any
    secured Investment in default;
(7) Hedging Obligations permitted under clause (10) of
    the second paragraph of the covenant described in "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock";
(8) any Investment in a Similar Business having an
    aggregate fair market value, taken together with all other
    Investments made pursuant to this clause (8) that are at
    that time outstanding, not to exceed 5% of Total Assets at the
    time of such Investment (with the fair market value of each
    Investment being measured at the time made and without giving
    effect to subsequent changes in value);
(9) Investments the payment for which consists of Equity
    Interests (exclusive of Disqualified Stock) of the Issuer or any
    of its direct or indirect parent companies; provided, however,
    that such Equity Interests will not increase the amount
    available for Restricted Payments under clause (3) of the
    first paragraph under the covenant described in "Certain
    Covenants — Limitations on Restricted Payments";
(10) guarantees of Indebtedness permitted under the
    covenant described in "Certain Covenants —
    Limitation on Incurrence of Indebtedness and Issuance of
    Disqualified Stock and Preferred Stock";
(11) any transaction to the extent it constitutes an
    Investment that is permitted and made in accordance with the
    provisions of the second paragraph of the covenant described
    under "Certain Covenants — Transactions with
    Affiliates" (except transactions described in clauses (2),
    (5) and (9) of such paragraph);
(12) Investments consisting of purchases and acquisitions
    of inventory, supplies, material or equipment;
(13) additional Investments having an aggregate fair market
    value, taken together with all other Investments made pursuant
    to this clause (13) that are at that time outstanding
    (without giving effect to the sale of an Unrestricted Subsidiary
    to the extent the proceeds of such sale do not consist of cash
    or marketable securities), not to exceed 5% of Total Assets at
    the time of such Investment (with the fair market value of each
    Investment being measured at the time made and without giving
    effect to subsequent changes in value);
251
Table of Contents
(14) Investments relating to an ABL Financing Entity or a
    Receivables Subsidiary that, in the good faith determination of
    the Issuer, are necessary or advisable to effect the ABL
    Facility or any Receivables Facility, as the case may be;
(15) advances to, or guarantees of Indebtedness of,
    employees not in excess of $50.0 million outstanding at any
    one time, in the aggregate;
(16) loans and advances to officers, directors and
    employees for business-related travel expenses, moving expenses
    and other similar expenses, in each case incurred in the
    ordinary course of business or consistent with past practices or
    to fund such Person's purchase of Equity Interests of the
    Issuer or any direct or indirect parent company thereof;
(17) Physician Support Obligations made by the Issuer or
    any Restricted Subsidiary;
(18) any Investment in any joint venture existing on the
    Issue Date that owns or operates one or more health care
    facilities, including, without limitation, hospitals, ambulatory
    surgery centers, outpatient diagnostic centers or imaging
    centers to the extent contemplated by the organizational
    documents of such joint venture as in existence on the Issue
    Date;
(19) any Investment in the ordinary course of business or
    as may be required by applicable law by any Restricted
    Subsidiary (including, without limitation, HCI) engaged in the
    insurance business in order to provide insurance to the Issuer
    and its Subsidiaries;
(20) any Investment pursuant to any customary buy/sell
    arrangement in favor of investors or joint venture parties in
    connection with syndications of health care facilities,
    including, without limitation, hospitals, ambulatory surgery
    centers, outpatient diagnostic centers or imaging
    centers; and
(21) any Investment in any Subsidiary or any joint venture
    in connection with intercompany cash management arrangements or
    related activities arising in the ordinary course of business.
"Permitted Liens"
means, with respect to any
    Person:
(1) pledges or deposits by such Person under workmen's
    compensation laws, unemployment insurance laws or similar
    legislation, or good faith deposits in connection with bids,
    tenders, contracts (other than for the payment of Indebtedness)
    or leases to which such Person is a party, or deposits to secure
    public or statutory obligations of such Person or deposits of
    cash or U.S. government bonds to secure surety or appeal
    bonds to which such Person is a party, or deposits as security
    for contested taxes or import duties or for the payment of rent,
    in each case incurred in the ordinary course of business;
(2) Liens imposed by law, such as carriers',
    warehousemen's and mechanics' Liens, in each case for
    sums not yet overdue for a period of more than 30 days or
    being contested in good faith by appropriate proceedings or
    other Liens arising out of judgments or awards against such
    Person with respect to which such Person shall then be
    proceeding with an appeal or other proceedings for review if
    adequate reserves with respect thereto are maintained on the
    books of such Person in accordance with GAAP;
(3) Liens for taxes, assessments or other governmental
    charges not yet overdue for a period of more than 30 days
    or payable or subject to penalties for nonpayment or which are
    being contested in good faith by appropriate proceedings
    diligently conducted, if adequate reserves with respect thereto
    are maintained on the books of such Person in accordance with
    GAAP;
(4) Liens in favor of issuers of performance and surety
    bonds or bid bonds or with respect to other regulatory
    requirements or letters of credit issued pursuant to the request
    of and for the account of such Person in the ordinary course of
    its business;
(5) minor survey exceptions, minor encumbrances, easements
    or reservations of, or rights of others for, licenses,
rights-of-way,
sewers, electric lines, telegraph and telephone lines and other
    similar purposes, or zoning or other restrictions as to the use
    of real properties or Liens incidental to the conduct of the
    business of such Person or to the ownership of its properties
    which were not incurred in connection
252
Table of Contents
with Indebtedness and which do not in the aggregate materially
    adversely affect the value of said properties or materially
    impair their use in the operation of the business of such Person;
(6) Liens securing Indebtedness permitted to be incurred
    pursuant to clause (4), (12), (13), (18) or (19) of
    the second paragraph under "Certain Covenants —
    Limitation on Incurrence of Indebtedness and Issuance of
    Disqualified Stock and Preferred Stock"; provided that
    (a) Liens securing Indebtedness, Disqualified Stock or
    Preferred Stock permitted to be incurred pursuant to
    clause (13) relate only to Refinancing Indebtedness that
    serves to refund or refinance Indebtedness, Disqualified Stock
    or Preferred Stock incurred under clause (4) or
    (12) of the second paragraph under "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock,"
    (b) Liens securing Indebtedness permitted to be incurred
    pursuant to clause (18) extend only to the assets of
    Foreign Subsidiaries, (c) Liens securing Indebtedness
    permitted to be incurred pursuant to clause (19) are solely
    on acquired property or the assets of the acquired entity, as
    the case may be and (d) Liens securing Indebtedness,
    Disqualified Stock or Preferred Stock permitted to be incurred
    pursuant to clause (4) of the second paragraph under
    "Certain Covenants — Limitation on Incurrence of
    Indebtedness and Issuance of Disqualified Stock and Preferred
    Stock" extend only to the assets so financed, purchased,
    constructed or improved;
(7) Liens existing on the Issue Date (other than Liens in
    favor of (i) the lenders under the Senior Credit Facilities
    and (ii) the holders of the Existing Second Priority Notes);
(8) Liens on property or shares of stock of a Person at the
    time such Person becomes a Subsidiary; provided, however, such
    Liens are not created or incurred in connection with, or in
    contemplation of, such other Person becoming such a Subsidiary;
    provided, further, however, that such Liens may not extend to
    any other property owned by the Issuer or any of its Restricted
    Subsidiaries;
(9) Liens on property at the time the Issuer or a
    Restricted Subsidiary acquired the property, including any
    acquisition by means of a merger or consolidation with or into
    the Issuer or any of its Restricted Subsidiaries;
provided
,
however
, that such Liens are not created
    or incurred in connection with, or in contemplation of, such
    acquisition;
provided
,
further
,
however
,
    that the Liens may not extend to any other property owned by the
    Issuer or any of its Restricted Subsidiaries;
(10) Liens securing Indebtedness or other obligations of a
    Restricted Subsidiary owing to the Issuer or another Restricted
    Subsidiary permitted to be incurred in accordance with the
    covenant described under "Certain Covenants —
    Limitation on Incurrence of Indebtedness and Issuance of
    Disqualified Stock and Preferred Stock";
(11) Liens securing Hedging Obligations so long as the
    related Indebtedness is, and is permitted to be under the
    Indenture, secured by a Lien on the same property securing such
    Hedging Obligations;
(12) Liens on specific items of inventory or other goods
    and proceeds of any Person securing such Person's
    obligations in respect of bankers' acceptances issued or
    created for the account of such Person to facilitate the
    purchase, shipment or storage of such inventory or other goods;
(13) leases, subleases, licenses or sublicenses granted to
    others in the ordinary course of business which do not
    materially interfere with the ordinary conduct of the business
    of the Issuer or any of its Restricted Subsidiaries and do not
    secure any Indebtedness;
(14) Liens arising from Uniform Commercial Code financing
    statement filings regarding operating leases entered into by the
    Issuer and its Restricted Subsidiaries in the ordinary course of
    business;
(15) Liens in favor of the Issuer or any Guarantor;
(16) Liens on equipment of the Issuer or any of its
    Restricted Subsidiaries granted in the ordinary course of
    business;
(17) Liens on accounts receivable and related assets
    incurred in connection with a Receivables Facility;
253
Table of Contents
(18) Liens to secure any refinancing, refunding, extension,
    renewal or replacement (or successive refinancing, refunding,
    extensions, renewals or replacements) as a whole, or in part, of
    any Indebtedness secured by any Lien referred to in the
    foregoing clauses (6), (7), (8) and (9);
provided
,
however
, that (a) such new Lien shall be limited to
    all or part of the same property that secured the original Lien
    (plus improvements on such property), and (b) the
    Indebtedness secured by such Lien at such time is not increased
    to any amount greater than the sum of (i) the outstanding
    principal amount or, if greater, committed amount of the
    Indebtedness described under clauses (6), (7), (8) and
    (9) at the time the original Lien became a Permitted Lien
    under the Indenture, and (ii) an amount necessary to pay
    any fees and expenses, including premiums, related to such
    refinancing, refunding, extension, renewal or replacement;
(19) deposits made in the ordinary course of business to
    secure liability to insurance carriers;
(20) other Liens securing obligations incurred in the
    ordinary course of business which obligations do not exceed
    $100.0 million at any one time outstanding;
(21) Liens securing judgments for the payment of money not
    constituting an Event of Default under clause (5) under the
    caption "Events of Default and Remedies" so long as
    such Liens are adequately bonded and any appropriate legal
    proceedings that may have been duly initiated for the review of
    such judgment have not been finally terminated or the period
    within which such proceedings may be initiated has not expired;
(22) Liens in favor of customs and revenue authorities
    arising as a matter of law to secure payment of customs duties
    in connection with the importation of goods in the ordinary
    course of business;
(23) Liens (i) of a collection bank arising under
Section 4-210
of the Uniform Commercial Code, or any comparable or successor
    provision, on items in the course of collection,
    (ii) attaching to commodity trading accounts or other
    commodity brokerage accounts incurred in the ordinary course of
    business, and (iii) in favor of banking institutions
    arising as a matter of law encumbering deposits (including the
    right of set-off) and which are within the general parameters
    customary in the banking industry;
(24) Liens deemed to exist in connection with Investments
    in repurchase agreements permitted under "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred Stock";
    provided that such Liens do not extend to any assets other than
    those that are the subject of such repurchase agreements;
(25) Liens encumbering reasonable customary initial
    deposits and margin deposits and similar Liens attaching to
    commodity trading accounts or other brokerage accounts incurred
    in the ordinary course of business and not for speculative
    purposes;
(26) Liens that are contractual rights of set-off
    (i) relating to the establishment of depository relations
    with banks not given in connection with the issuance of
    Indebtedness, (ii) relating to pooled deposit or sweep
    accounts of the Issuer or any of its Restricted Subsidiaries to
    permit satisfaction of overdraft or similar obligations incurred
    in the ordinary course of business of the Issuer and its
    Restricted Subsidiaries or (iii) relating to purchase
    orders and other agreements entered into with customers of the
    Issuer or any of its Restricted Subsidiaries in the ordinary
    course of business;
(27) Liens arising out of conditional sale, title
    retention, consignment or similar arrangements for the sale or
    purchase of goods entered into by the Issuer or any Restricted
    Subsidiary in the ordinary course of business; and
(28) Liens that rank junior to the Liens securing the Notes
    securing the Junior Lien Obligations.
For purposes of this definition, the term
    "Indebtedness" shall be deemed to include interest on
    such Indebtedness.
"Person"
means any individual, corporation,
    limited liability company, partnership, joint venture,
    association, joint stock company, trust, unincorporated
    organization, government or any agency or political subdivision
    thereof or any other entity.
254
Table of Contents
"Physician Support Obligation"
means (1) a
    loan to or on behalf of, or a guarantee of Indebtedness or
    income of, a physician or health care professional providing
    service to patients in the service area of a health care
    facility operated by the Issuer, any of its Restricted
    Subsidiaries or any affiliated joint venture otherwise permitted
    by the Indenture made or given by the Issuer or any Restricted
    Subsidiary of the Issuer in the ordinary course of business and
    pursuant to a written agreement having a period not to exceed
    five years or (2) guarantees by the Issuer or any
    Restricted Subsidiary of the Issuer of leases and loans to
    acquire property (real or personal) for or on behalf of a
    physician or health care professional providing service to
    patients in the service area of a health care facility operated
    by the Issuer, any of its Restricted Subsidiaries or any
    affiliated joint venture otherwise permitted by the Indenture.
"Plan of Reorganization"
means any plan of
    reorganization, plan of liquidation, agreement for composition,
    or other type of plan of arrangement proposed in or in
    connection with any insolvency or liquidation proceeding.
"Preferred Stock"
means any Equity Interest
    with preferential rights of payment of dividends or upon
    liquidation, dissolution or winding up.
"Principal Property"
means each acute care
    hospital providing general medical and surgical services
    (excluding equipment, personal property and hospitals that
    primarily provide specialty medical services, such as
    psychiatric and obstetrical and gynecological services) owned
    solely by the Issuer
and/or
one
    or more of its Subsidiaries (used in this definition as defined
    in the Existing Notes Indenture) and located in the
    United States of America.
"Purchase Money Obligations"
means any
    Indebtedness incurred to finance or refinance the acquisition,
    leasing, construction or improvement of property (real or
    personal) or assets (other than Capital Stock), and whether
    acquired through the direct acquisition of such property or
    assets, or otherwise.
"Qualified Proceeds"
means assets that are used
    or useful in, or Capital Stock of any Person engaged in, a
    Similar Business;
provided
that the fair market value of
    any such assets or Capital Stock shall be determined by the
    Issuer in good faith.
"Rating Agencies"
means Moody's and
    S&P or if Moody's or S&P or both shall not make a
    rating on the Notes publicly available, a nationally recognized
    statistical rating agency or agencies, as the case may be,
    selected by the Issuer which shall be substituted for
    Moody's or S&P or both, as the case may be.
"Receivables Facility"
means any of one or more
    receivables financing facilities as amended, supplemented,
    modified, extended, renewed, restated or refunded from time to
    time, the Obligations of which are non-recourse (except for
    customary representations, warranties, covenants and indemnities
    made in connection with such facilities) to the Issuer or any of
    its Restricted Subsidiaries (other than a Receivables
    Subsidiary) pursuant to which the Issuer or any of its
    Restricted Subsidiaries purports to sell its accounts receivable
    to either (a) a Person that is not a Restricted Subsidiary
    or (b) a Receivables Subsidiary that in turn funds such
    purchase by purporting to sell its accounts receivable to a
    Person that is not a Restricted Subsidiary or by borrowing from
    such a Person or from another Receivables Subsidiary that in
    turn funds itself by borrowing from such a Person.
"Receivables Fees"
means distributions or
    payments made directly or by means of discounts with respect to
    any accounts receivable or participation interest therein issued
    or sold in connection with, and other fees paid to a Person that
    is not a Restricted Subsidiary in connection with any
    Receivables Facility.
"Receivables Subsidiary"
means any Subsidiary
    formed for the purpose of facilitating or entering into one or
    more Receivables Facilities, and in each case engages only in
    activities reasonably related or incidental thereto.
"Redemption Date"
has the meaning set
    forth under "Optional Redemption."
"Registration Rights Agreement"
means the
    Registration Rights Agreement related to the Notes, dated as of
    the Issue Date, among the Issuer, the Guarantors and the Initial
    Purchasers.
255
Table of Contents
"Related Business Assets"
means assets (other
    than cash or Cash Equivalents) used or useful in a Similar
    Business;
provided
that any assets received by the Issuer
    or a Restricted Subsidiary in exchange for assets transferred by
    the Issuer or a Restricted Subsidiary will not be deemed to be
    Related Business Assets if they consist of securities of a
    Person, unless upon receipt of the securities of such Person,
    such Person would become a Restricted Subsidiary.
"Restricted Investment"
means an Investment
    other than a Permitted Investment.
"Restricted Subsidiary"
means, at any time, any
    direct or indirect Subsidiary of the Issuer (including any
    Foreign Subsidiary) that is not then an Unrestricted Subsidiary;
provided
,
however
, that upon an Unrestricted
    Subsidiary's ceasing to be an Unrestricted Subsidiary, such
    Subsidiary shall be included in the definition of
    "Restricted Subsidiary."
"S&P"
means Standard &
    Poor's, a division of The McGraw-Hill Companies, Inc., and
    any successor to its rating agency business.
"Sale and Lease-Back Transaction"
means any
    arrangement providing for the leasing by the Issuer or any of
    its Restricted Subsidiaries of any real or tangible personal
    property, which property has been or is to be sold or
    transferred by the Issuer or such Restricted Subsidiary to a
    third Person in contemplation of such leasing.
"SEC"
means the U.S. Securities and
    Exchange Commission.
"Secured Indebtedness"
means any Indebtedness
    of the Issuer or any of its Restricted Subsidiaries secured by a
    Lien.
"Securities Act"
means the Securities Act of
    1933, as amended, and the rules and regulations of the SEC
    promulgated thereunder.
"Security Agreement"
means the amended and
    restated Security Agreement, dated as of March 2, 2009, by
    and among the Issuer, the subsidiary grantors named therein and
    the First Lien Collateral Agent, as the same may be further
    amended, restated or modified from time to time, to which the
    Trustee, as Authorized Representative for the Holders were
    joined on the Issue Date.
"Security Documents"
means, collectively, the
    Intercreditor Agreements, the Security Agreement, other security
    agreements relating to the Collateral and the mortgages and
    instruments filed and recorded in appropriate jurisdictions to
    preserve and protect the Liens on the Collateral (including,
    without limitation, financing statements under the Uniform
    Commercial Code of the relevant states) applicable to the
    Collateral, each as in effect on the Issue Date and as amended,
    amended and restated, modified, renewed or replaced from time to
    time.
"Senior Credit Facilities"
means the ABL
    Facility and the General Credit Facility.
"Senior Indebtedness"
means:
(1) all Indebtedness of the Issuer or any Guarantor
    outstanding under the Senior Credit Facilities or Notes and
    related Guarantees (including interest accruing on or after the
    filing of any petition in bankruptcy or similar proceeding or
    for reorganization of the Issuer or any Guarantor (at the rate
    provided for in the documentation with respect thereto,
    regardless of whether or not a claim for post-filing interest is
    allowed in such proceedings)), and any and all other fees,
    expense reimbursement obligations, indemnification amounts,
    penalties, and other amounts (whether existing on the Issue Date
    or thereafter created or incurred) and all obligations of the
    Issuer or any Guarantor to reimburse any bank or other Person in
    respect of amounts paid under letters of credit, acceptances or
    other similar instruments;
(2) all Hedging Obligations (and guarantees thereof) owing
    to a Lender (as defined in the Senior Credit Facilities) or any
    Affiliate of such Lender (or any Person that was a Lender or an
    Affiliate of such Lender at the time the applicable agreement
    giving rise to such Hedging Obligation was entered into);
provided
that such Hedging Obligations are permitted to
    be incurred under the terms of the Indenture;
256
Table of Contents
(3) any other Indebtedness of the Issuer or any Guarantor
    permitted to be incurred under the terms of the Indenture,
    unless the instrument under which such Indebtedness is incurred
    expressly provides that it is subordinated in right of payment
    to the Notes or any related Guarantee; and
(4) all Obligations with respect to the items listed in the
    preceding clauses (1), (2) and (3);
provided
,
however
, that Senior Indebtedness shall
    not include:
(a) any obligation of such Person to the Issuer or any of
    its Subsidiaries;
(b) any liability for federal, state, local or other taxes
    owed or owing by such Person;
(c) any accounts payable or other liability to trade
    creditors arising in the ordinary course of business;
(d) any Indebtedness or other Obligation of such Person
    which is subordinate or junior in any respect to any other
    Indebtedness or other Obligation of such Person; or
(e) that portion of any Indebtedness which at the time of
    incurrence is incurred in violation of the Indenture.
"Separate Receivables Collateral"
has the
    meaning set forth under "Description of Other
    Indebtedness — Senior Secured Credit
    Facilities — Guarantee and Security."
"Series"
means (a) with respect to the
    First Lien Secured Parties, each of (i) the General Credit
    Facility Secured Parties (in their capacities as such),
    (ii) the Holders and the Trustee, each in their capacity as
    such) and (iii) the Additional First Lien Secured Parties
    that become subject to the First Lien Intercreditor Agreement
    after the date hereof that are represented by a common
    Authorized Representative (in its capacity as such for such
    Additional First Lien Secured Parties) and (b) with respect
    to any First Lien Obligations, each of (i) the General
    Credit Facility Obligations, (ii) the Notes Obligations and
    (iii) the Additional First Lien Obligations incurred
    pursuant to any applicable agreement, which pursuant to any
    joinder agreement, are to be represented under the First Lien
    Intercreditor Agreement by a common Authorized Representative
    (in its capacity as such for such Additional First Lien
    Obligations).
"Shared Receivables Collateral"
has the meaning
    set forth under "Description of Other
    Indebtedness — Senior Secured Credit
    Facilities — Guarantee and Security."
"Significant Subsidiary"
means any Restricted
    Subsidiary that would be a "significant subsidiary" as
    defined in Article 1,
Rule 1-02
of
Regulation S-X,
promulgated pursuant to the Securities Act, as such regulation
    is in effect on the Issue Date.
"Similar Business"
means any business conducted
    or proposed to be conducted by the Issuer and its Restricted
    Subsidiaries on the Issue Date or any business that is similar,
    reasonably related, incidental or ancillary thereto.
"Sponsor Management Agreement"
means the
    management agreement between certain of the management companies
    associated with the Investors, the Frist Entities and the Issuer.
"Subordinated Indebtedness"
means, with respect
    to the Notes,
(1) any Indebtedness of the Issuer which is by its terms
    subordinated in right of payment to the Notes, and
(2) any Indebtedness of any Guarantor which is by its terms
    subordinated in right of payment to the Guarantee of such entity
    of the Notes.
"Subsidiary"
means, with respect to any Person:
(1) any corporation, association, or other business entity
    (other than a partnership, joint venture, limited liability
    company or similar entity) of which more than 50% of the total
    voting power of shares of Capital Stock entitled (without regard
    to the occurrence of any contingency) to vote in the election of
    directors, managers or trustees thereof is at the time of
    determination owned or controlled, directly or
257
Table of Contents
indirectly, by such Person or one or more of the other
    Subsidiaries of that Person or a combination thereof or is
    consolidated under GAAP with such Person at such time; and
(2) any partnership, joint venture, limited liability
    company or similar entity of which
(x) more than 50% of the capital accounts, distribution
    rights, total equity and voting interests or general or limited
    partnership interests, as applicable, are owned or controlled,
    directly or indirectly, by such Person or one or more of the
    other Subsidiaries of that Person or a combination thereof
    whether in the form of membership, general, special or limited
    partnership or otherwise, and
(y) such Person or any Restricted Subsidiary of such Person
    is a controlling general partner or otherwise controls such
    entity.
"Total Assets"
means the total assets of the
    Issuer and its Restricted Subsidiaries on a consolidated basis,
    as shown on the most recent consolidated balance sheet of the
    Issuer or such other Person as may be expressly stated.
"Transaction"
means the transactions
    contemplated by the Transaction Agreement, the issuance of the
    Notes and borrowings under the Senior Credit Facilities as in
    effect on November 17, 2006.
"Transaction Agreement"
means the Agreement and
    Plan of Merger, dated as of July 24, 2006, between Hercules
    Holding II, LLC, Hercules Acquisition Corporation and the
    Issuer, as the same may be amended prior to the Issue Date.
"Treasury Rate"
means, as of any
    Redemption Date, the yield to maturity as of such
    Redemption Date of United States Treasury securities with a
    constant maturity (as compiled and published in the most recent
    Federal Reserve Statistical Release H.15 (519) that has
    become publicly available at least two Business Days prior to
    the Redemption Date (or, if such Statistical Release is no
    longer published, any publicly available source of similar
    market data)) most nearly equal to the period from the
    Redemption Date to April 15, 2014;
provided
,
however
, that if the period from the Redemption Date
    to April 15, 2014 is less than one year, the weekly average
    yield on actually traded United States Treasury securities
    adjusted to a constant maturity of one year will be used.
"Trust Indenture Act"
means the
    Trust Indenture Act of 1939, as amended (15 U.S.C.
§§ 77aaa-777bbbb).
"Unrestricted Subsidiary"
means:
(1) any Subsidiary of the Issuer which at the time of
    determination is an Unrestricted Subsidiary (as designated by
    the Issuer, as provided below); and
(2) any Subsidiary of an Unrestricted Subsidiary.
The Issuer may designate any Subsidiary of the Issuer (including
    any existing Subsidiary and any newly acquired or newly formed
    Subsidiary) to be an Unrestricted Subsidiary unless such
    Subsidiary or any of its Subsidiaries owns any Equity Interests
    or Indebtedness of, or owns or holds any Lien on, any property
    of, the Issuer or any Subsidiary of the Issuer (other than
    solely any Subsidiary of the Subsidiary to be so designated);
provided
that
(1) any Unrestricted Subsidiary must be an entity of which
    the Equity Interests entitled to cast at least a majority of the
    votes that may be cast by all Equity Interests having ordinary
    voting power for the election of directors or Persons performing
    a similar function are owned, directly or indirectly, by the
    Issuer;
(2) such designation complies with the covenants described
    under "Certain Covenants — Limitation on
    Restricted Payments"; and
(3) each of:
(a) the Subsidiary to be so designated; and
(b) its Subsidiaries
258
Table of Contents
has not at the time of designation, and does not thereafter,
    create, incur, issue, assume, guarantee or otherwise become
    directly or indirectly liable with respect to any Indebtedness
    pursuant to which the lender has recourse to any of the assets
    of the Issuer or any Restricted Subsidiary.
The Issuer may designate any Unrestricted Subsidiary to be a
    Restricted Subsidiary;
provided
that, immediately after
    giving effect to such designation, no Default shall have
    occurred and be continuing and either:
(1) the Issuer could incur at least $1.00 of additional
    Indebtedness pursuant to the Fixed Charge Coverage Ratio test
    described in the first paragraph under "Certain
    Covenants — Limitation on Incurrence of Indebtedness
    and Issuance of Disqualified Stock and Preferred
    Stock"; or
(2) the Fixed Charge Coverage Ratio for the Issuer and its
    Restricted Subsidiaries would be greater than such ratio for the
    Issuer and its Restricted Subsidiaries immediately prior to such
    designation, in each case on a pro forma basis taking into
    account such designation.
Any such designation by the Issuer shall be notified by the
    Issuer to the Trustee by promptly filing with the Trustee a copy
    of the resolution of the board of directors of the Issuer or any
    committee thereof giving effect to such designation and an
    Officer's Certificate certifying that such designation
    complied with the foregoing provisions.
"Voting Stock"
of any Person as of any date
    means the Capital Stock of such Person that is at the time
    entitled to vote in the election of the board of directors of
    such Person.
"Weighted Average Life to Maturity"
means, when
    applied to any Indebtedness, Disqualified Stock or Preferred
    Stock, as the case may be, at any date, the quotient obtained by
    dividing:
(1) the sum of the products of the number of years from the
    date of determination to the date of each successive scheduled
    principal payment of such Indebtedness or redemption or similar
    payment with respect to such Disqualified Stock or Preferred
    Stock multiplied by the amount of such payment; by
(2) the sum of all such payments.
"Wholly-Owned Subsidiary"
of any Person means a
    Subsidiary of such Person, 100% of the outstanding Equity
    Interests of which (other than directors' qualifying
    shares) shall at the time be owned by such Person or by one or
    more Wholly-Owned Subsidiaries of such Person.
259
Table of Contents
BOOK-ENTRY
    ISSUANCE
We have issued each series of notes as global securities (the
    "global securities"). We have deposited each global
    security with, or on behalf of, The Depository
    Trust Company ("DTC"), as depositary, or its
    nominee and registered it in the name of a nominee of DTC.
    Except under the limited circumstances described below, global
    securities are not exchangeable for certificated securities.
Only institutions that have accounts with DTC or its nominee
    ("participants") or persons that may hold interests
    through participants may own beneficial interests in a global
    security. DTC will maintain records evidencing ownership by
    participants in the global securities and transfers of those
    ownership interests. Participants maintain records evidencing
    ownership of beneficial interests in the global securities by
    persons that hold through those participants and transfers of
    those ownership interests within those participants. DTC has no
    knowledge of the actual beneficial owners of the securities. You
    will not receive written confirmation from DTC of your purchase,
    but we do expect that you will receive written confirmations
    providing details of the transaction, as well as periodic
    statements of your holdings from the participant through which
    you entered the transaction. The laws of some jurisdictions
    require that certain purchasers of securities take physical
    delivery of those securities in certificated form. Those laws
    may impair your ability to transfer beneficial interests in a
    global security.
DTC has advised us that upon the issuance of a global security
    and the deposit of that global security with DTC, DTC will
    immediately credit, on its book-entry registration and transfer
    system, the respective principal amounts or number of shares
    represented by that global security to the accounts of its
    participants.
We will make payments on securities represented by a global
    security to DTC or its nominee, as the case may be, as the
    registered owner and holder of the global security representing
    those securities. DTC has advised us that upon receipt of any
    payment on a global security, DTC will immediately credit
    accounts of participants with payments in amounts proportionate
    to their respective beneficial interests in that security, as
    shown in the records of DTC. Standing instructions and customary
    practices will govern payments by participants to owners of
    beneficial interests in a global security held through those
    participants, as is now the case with securities held for the
    accounts of customers in bearer form or registered in
    "street name." Those payments will be the sole
    responsibility of those participants, subject to any statutory
    or regulatory requirements in effect from time to time.
Neither we, the trustees, the agents nor any agent of ours or
    theirs will have any responsibility or liability for any aspect
    of the records of DTC, any nominee or any participant relating
    to, or payments made on account of, beneficial interests in a
    global security, for maintaining, supervising or reviewing any
    of the records of DTC, any nominee or any participant relating
    to those beneficial interests or for any other matter relating
    to the actions and practices of DTC, any nominee or any
    participant.
A global security is exchangeable for certificated securities
    registered in the name of a person other than DTC or its nominee
    only if:
•
DTC (1) notifies us that it is unwilling or unable to
    continue as Depositary for that global security or (2) has
    ceased to be a clearing agency registered under the Securities
    Exchange Act of 1934 and, in either case, we fail to appoint a
    successor depository;
•
we, in our discretion at any time, determine not to require all
    of the notes of a particular series to be represented by a
    global security and so notify the applicable trustee; or
•
with respect to global securities representing any series of our
    senior secured notes, there has occurred and is continuing an
    event of default with respect to such senior secured notes.
In addition, beneficial interests in a global security may be
    exchanged for certificated securities upon prior written notice
    given to the applicable trustee by or on behalf of DTC in
    accordance with the applicable indenture. In all cases,
    certificated securities delivered in exchange for any global
    security or beneficial interests in global securities will be
    registered in the names, and issued in any approved
    denominations, requested by or on behalf of the depositary (in
    accordance with its customary procedures).
260
Table of Contents
The registrar will register the certificated securities in the
    name or names instructed by DTC. We expect that those
    instructions may be based upon directions received by DTC from
    its participants with respect to ownership of beneficial
    interests in the global security. In the case of global debt
    securities, we will make payment of any principal and interest
    on the certificated securities and will register transfers and
    exchanges of those certificated securities at the corporate
    trust office of the respective transfer agent and registrar in
    the Borough of Manhattan, The City of New York. However, we may
    elect to pay interest by check mailed to the address of the
    person entitled to that interest payment as of the record date,
    as shown on the register for the securities.
Except as provided above, as an owner of a beneficial interest
    in a global security, you will not be entitled to receive
    physical delivery of securities in certificated form and will
    not be considered a holder of securities for any purpose under
    the indentures. No global security will be exchangeable except
    for another global security of like denomination and tenor to be
    registered in the name of DTC or its nominee. Accordingly, you
    must rely on the procedures of DTC and the participant through
    which you own your interest to exercise any rights of a holder
    under the global security or the applicable indenture.
We understand that, under existing industry practices, in the
    event that we request any action of holders, or an owner of a
    beneficial interest in a global security desires to take any
    action that a holder is entitled to take under the securities or
    the indentures, DTC would authorize the participants holding the
    relevant beneficial interests to take that action, and those
    participants would authorize beneficial owners owning through
    those participants to take that action or would otherwise act
    upon the instructions of beneficial owners owning through them.
DTC has advised us that DTC is a limited purpose trust company
    organized under the New York Banking Law, a "banking
    organization" within the meaning of the New York Banking
    Law, a member of the U.S. Federal Reserve System, a
    "clearing corporation" within the meaning of the New
    York Uniform Commercial Code and a "clearing agency"
    registered under the Securities Exchange Act of 1934. DTC holds
    securities that its participants deposit with DTC. DTC also
    facilitates the clearance and settlement of securities
    transactions among its participants in deposited securities,
    such as transfers and pledges, through electronic computerized
    book-entry changes in accounts of the participants, thereby
    eliminating the need for physical movement of securities
    certificates. DTC's participants include securities brokers
    and dealers, banks, trust companies, clearing corporations and
    certain other organizations. DTC is owned by a number of its
    participants and by the New York Stock Exchange, Inc., the
    American Stock Exchange, Inc. and the National Association of
    Securities Dealers, Inc. Access to DTC's system is also
    available to others, such as banks, brokers, dealers and trust
    companies that clear through or maintain a custodial
    relationship with a participant, either directly or indirectly.
    The rules applicable to DTC and its participants are on file
    with the SEC.
Investors may elect to hold interests in securities outside the
    United States through Clearstream Banking, société
    anonyme ("Clearstream") or Euroclear Bank S.A./N.V.,
    as operator of the Euroclear System ("Euroclear"), if
    they are participants in those systems, or indirectly through
    organizations that are participants in those systems.
    Clearstream and Euroclear will hold interests on behalf of their
    participants through customers' securities accounts in
    Clearstream's and Euroclear's names on the books of
    their respective depositaries. Those depositaries in turn hold
    those interests in customers' securities accounts in the
    depositaries' names on the books of DTC.
Clearstream has advised us that it is incorporated under the
    laws of Luxembourg as a bank. Clearstream holds securities for
    its customers and facilitates the clearance and settlement of
    securities transactions between its customers through electronic
    book-entry changes in their accounts. Clearstream provides to
    its customers, among other things, services for safekeeping,
    administration, clearance and settlement of internationally
    traded securities and securities lending and borrowing.
    Clearstream interfaces with domestic securities markets in over
    30 countries through established depository and custodial
    relationships. As a bank, Clearstream is subject to regulation
    by the Luxembourg Commission for the Supervision of the
    Financial Sector, also known as the
Commission de
    Surveillance du Secteur Financier
and the Luxembourg Central
    Bank. Clearstream customers are financial institutions around
    the world, including underwriters, securities brokers and
    dealers, banks, trust companies, clearing corporations and other
    organizations. Its customers in the United States are limited to
    securities brokers and dealers and banks. Indirect access to
    Clearstream is also available to other institutions such as
    banks, brokers, dealers and trust companies that clear through
    or maintain a custodial relationship with the customer.
261
Table of Contents
Distributions with respect to global securities held
    beneficially through Clearstream will be credited to cash
    accounts of Clearstream customers in accordance with its rules
    and procedures, to the extent received by the
    U.S. depositary for Clearstream.
Euroclear has advised us that it was created in 1968 to hold
    securities for its participants and to clear and settle
    transactions between Euroclear participants through simultaneous
    electronic book-entry delivery against payment, thereby
    eliminating the need for physical movement of certificates and
    any risk from lack of simultaneous transfers of securities and
    cash. Euroclear provides various other services, including
    securities lending and borrowing, and interfaces with domestic
    markets in several countries. Euroclear is operated by Euroclear
    Bank S.A./N.V. Euroclear Clearance Systems S.C. establishes
    policy for Euroclear on behalf of Euroclear participants.
    Euroclear participants include banks (including central banks),
    securities brokers and dealers and other professional financial
    intermediaries. Indirect access to Euroclear is also available
    to other firms that clear through or maintain a custodial
    relationship with a Euroclear participant, either directly or
    indirectly.
Distributions with respect to interests in global securities
    held beneficially through Euroclear will be credited to the cash
    accounts of Euroclear participants in accordance with
    Euroclear's terms and conditions and operating procedures
    and applicable Belgian law, to the extent received by the
    U.S. depositary for Euroclear.
Global
    Clearance and Settlement Procedures
Unless otherwise specified with respect to a particular series
    of global securities, initial settlement for global securities
    will be made in immediately available funds. Transfers between
    DTC participants will be effected under DTC's procedures
    and will be settled in
same-day
funds.
If the interests in the global securities may be held through
    Clearstream or Euroclear, Clearstream customers
and/or
Euroclear participants will conduct secondary market trading
    with other Clearstream customers
and/or
Euroclear participants in the ordinary way in accordance with
    the applicable rules and operating procedures of Clearstream and
    Euroclear. Thereafter, secondary market trades will settle in
    immediately available funds.
Cross-market transfers between persons holding directly or
    indirectly through DTC participants on the one hand, and
    directly or indirectly through Clearstream customers or
    Euroclear participants, on the other, will be effected in DTC in
    accordance with DTC's rules on behalf of the relevant
    European international clearing system by the
    U.S. depositary for that system; however, those
    cross-market transactions will require delivery by the
    counterparty in the relevant European international clearing
    system of instructions to that system in accordance with its
    rules and procedures and within its established deadlines
    (European time). The relevant European international clearing
    system will, if the transaction meets its settlement
    requirements, deliver instructions to the U.S. depositary
    for that system to take action to effect final settlement on its
    behalf by delivering or receiving interests in global securities
    in DTC, and making or receiving payment in accordance with
    normal procedures for
same-day
funds settlement applicable to DTC. Clearstream customers and
    Euroclear participants may not deliver instructions directly to
    DTC.
Because of time-zone differences, credits of interests in global
    securities received by Clearstream or Euroclear as a result of a
    transaction with a DTC participant will be made during
    subsequent securities settlement processing and will be credited
    the business day following the DTC settlement date. Those
    credits or any transactions in global securities settled during
    that processing will be reported to the relevant Euroclear
    participants or Clearstream customers on that business day. Cash
    received by Clearstream or Euroclear as a result of sales of
    interests in global securities by or through a Clearstream
    customer or a Euroclear participant to a DTC participant will be
    received with value on the DTC settlement date but will be
    available in the relevant Clearstream or Euroclear cash account
    only as of the business day following settlement in DTC.
Although DTC, Clearstream and Euroclear have agreed to the
    procedures described above in order to facilitate transfers of
    interests in global securities among participants of DTC,
    Clearstream and Euroclear, they are under no obligation to
    perform those procedures and those procedures may be
    discontinued at any time.
262
Table of Contents
CERTAIN
    U.S. FEDERAL TAX CONSEQUENCES
The following is a summary of certain U.S. federal income
    and, in the case of
non-U.S. holders
(as defined below), estate tax consequences of the purchase,
    ownership and disposition of the notes as of the date of this
    prospectus. Unless otherwise stated, this summary deals only
    with notes held as capital assets. For purposes of this
    discussion, "toggle notes" means the
    9
5
/
8
%/10
3
/
8
% senior
    secured toggle notes due 2016, "cash-pay OID notes"
    means the
    9
7
/
8
%
    second lien senior secured notes due 2017 and the
    8
1
/
2
%
    first lien senior secured notes due 2019, and "cash-pay
    notes" means notes other than the toggle notes and cash-pay
    OID notes.
As used herein, a "U.S. holder" means a
    beneficial owner of the notes that is for U.S. federal
    income tax purposes any of the following:
•
an individual citizen or resident of the United States;
•
a corporation (or any other entity treated as a corporation for
    U.S. federal income tax purposes) created or organized in
    or under the laws of the United States, any state thereof or the
    District of Columbia;
•
an estate the income of which is subject to U.S. federal
    income taxation regardless of its source; or
•
a trust if it (1) is subject to the primary supervision of
    a court within the United States and one or more United States
    persons have the authority to control all substantial decisions
    of the trust or (2) has a valid election in effect under
    applicable United States Treasury regulations to be treated as a
    United States person.
The term
"non-U.S. holder"
means a beneficial owner of the notes (other than a partnership
    or any other entity treated as a partnership for
    U.S. federal income tax purposes) that is not a
    U.S. holder.
This summary does not represent a detailed description of the
    U.S. federal income tax consequences applicable to you if
    you are a person subject to special tax treatment under the
    U.S. federal income tax laws, including, without limitation:
•
a dealer in securities or currencies;
•
a financial institution;
•
a regulated investment company;
•
a real estate investment trust;
•
a tax-exempt organization;
•
an insurance company;
•
a person holding the notes as part of a hedging, integrated,
    conversion or constructive sale transaction or a straddle;
•
a trader in securities that has elected the
mark-to-market
method of accounting for your securities;
•
a person liable for alternative minimum tax;
•
a partnership or other pass-through entity for U.S. federal
    income tax purposes (or an investor in such entities);
•
a U.S. holder whose "functional currency" is not
    the U.S. dollar;
•
a "controlled foreign corporation";
•
a "passive foreign investment company"; or
•
a United States expatriate.
This summary is based on the Internal Revenue Code of 1986, as
    amended (the "Code"), United States Treasury
    regulations, administrative rulings and judicial decisions as of
    the date hereof. Those authorities may
263
Table of Contents
be changed, possibly on a retroactive basis, so as to result in
    U.S. federal income and estate tax consequences different
    from those summarized below. We have not and will not seek any
    rulings from the Internal Revenue Service ("IRS")
    regarding the matters discussed below. There can be no assurance
    that the IRS will not take positions concerning the tax
    consequences of the purchase, ownership or disposition of the
    notes that are different from those discussed below.
If a partnership (including any entity classified as a
    partnership for U.S. federal income tax purposes) holds
    notes, the tax treatment of a partner will generally depend upon
    the status of the partner and the activities of the partnership.
    If you are a partnership or a partner in a partnership holding
    notes, you should consult your own tax advisors.
This summary does not represent a detailed description of the
    U.S. federal income and estate tax consequences to you in
    light of your particular circumstances and does not address the
    effects of any state, local or
non-U.S. tax
laws. It is not intended to be, and should not be construed to
    be, legal or tax advice to any particular purchaser of notes.
You should consult your own tax advisors concerning the
    particular U.S. federal income and estate tax consequences
    to you of the ownership of the notes, as well as the
    consequences to you arising under the laws of any other taxing
    jurisdiction.
Certain
    Tax Consequences to U.S. Holders
The following is a summary of certain U.S. federal income
    tax consequences that will apply to U.S. holders of the
    notes.
Cash-Pay
    Notes
Stated Interest on Cash-Pay Notes.
Stated
    interest on a cash-pay note will generally be taxable to you as
    ordinary income at the time it is received or accrued, depending
    on your method of accounting for U.S. federal income tax
    purposes.
Market Discount.
If you purchase a cash-pay
    note for an amount that is less than its principal amount, the
    amount of the difference will be treated as "market
    discount" for U.S. federal income tax purposes, unless
    that difference is less than a specified de minimis amount.
    Under the market discount rules, you will be required to treat
    any principal payment on, or any gain on the sale, exchange,
    retirement or other disposition of, a cash-pay note as ordinary
    income to the extent of the market discount that you have not
    previously included in income and are treated as having accrued
    on the note at the time of the payment or disposition.
In addition, you may be required to defer, until the maturity of
    the cash-pay note or its earlier disposition in a taxable
    transaction, the deduction of all or a portion of the interest
    expense on any indebtedness attributable to the note. You may
    elect, on a
note-by-note
basis, to deduct the deferred interest expense in a tax year
    prior to the year of disposition. You should consult your own
    tax advisors before making this election.
Any market discount will be considered to accrue ratably during
    the period from the date of acquisition to the maturity date of
    the cash-pay note, unless you elect to accrue on a constant
    interest method. You may elect to include market discount in
    income currently as it accrues, on either a ratable or constant
    interest method, in which case the rule described above
    regarding deferral of interest deductions will not apply.
Amortizable Bond Premium.
If you purchase a
    cash-pay note for an amount in excess of its principal amount,
    you will be considered to have purchased the cash-pay note at a
    "premium." You generally may elect to amortize the
    premium over the remaining term of the cash-pay note on a
    constant yield method as an offset to interest when includible
    in income under your regular accounting method. If you do not
    elect to amortize bond premium, that premium will decrease the
    gain or increase the loss you would otherwise recognize on
    disposition of the cash-pay note.
Sale, Exchange, Retirement, or Other Taxable Disposition of
    Cash-Pay Notes.
Upon the sale, exchange,
    retirement, redemption or other disposition of a cash-pay note,
    you generally will recognize gain or loss equal to the
    difference between the amount realized upon the sale, exchange,
    retirement, redemption or other
264
Table of Contents
disposition (less an amount equal to any accrued and unpaid
    stated interest, which will be taxable as interest income as
    discussed above) and the adjusted tax basis of the cash-pay
    note. Your adjusted tax basis in a cash-pay note will, in
    general, be your cost for that cash-pay note, increased by any
    market discount previously included in income, and reduced by
    any amortized premium. Except as described above with respect to
    market discount, any gain or loss will be capital gain or loss.
    Capital gains of non-corporate U.S. holders derived in
    respect of capital assets held for more than one year are
    generally eligible for reduced rates of taxation. The
    deductibility of capital losses is subject to limitations.
Cash-Pay
    OID Notes
Stated Interest on Cash-Pay OID Notes.
Stated
    interest on a cash-pay OID note will generally be taxable to you
    as ordinary income at the time it is received or accrued,
    depending on your method of accounting for U.S. federal
    income tax purposes.
Original Issue Discount.
The cash-pay OID
    notes are treated as having been issued with original issue
    discount ("OID") in an amount equal to the difference
    between their "stated redemption price at maturity"
    (the sum of all payments to be made on the cash-pay OID notes
    other than "qualified stated interest") and their
    "issue price."
The "issue price" of a cash-pay OID note is the first
    price at which a substantial amount of that particular offering
    of the cash-pay OID notes was sold (excluding sales to bond
    houses, brokers or similar persons or organizations acting in
    the capacity of underwiter, placement agent or wholesaler). The
    term "qualified stated interest" means stated interest
    that is unconditionally payable in cash or in property (other
    than debt instruments of the issuer) at least annually at a
    single fixed rate or, subject to certain conditions, based on
    one or more interest indices. The stated interest payments on
    the cash-pay OID notes are qualified stated interest, and are
    treated as described above under "— Stated
    Interest on Cash-Pay OID Notes."
You generally must include OID in income in advance of the
    receipt of cash attributable to that income using the
    "constant yield method" described in the following
    paragraphs.
The amount of OID that you must include in income each year is
    the sum of the "daily portions" of OID with respect to
    the cash-pay OID note for each day during the taxable year or
    portion of the taxable year in which you held that cash-pay OID
    note ("accrued OID"). The daily portion is determined
    by allocating to each day in any "accrual period" a
    pro rata portion of the OID allocable to that accrual period.
    The "accrual period" for a cash-pay OID note may be of
    any length and may vary in length over the term of the cash-pay
    OID note, provided that each accrual period is no longer than
    one year and each scheduled payment of principal or interest
    occurs on the first day or the final day of an accrual period.
    The amount of OID allocable to any accrual period other than the
    final accrual period is an amount equal to the excess, if any,
    of:
•
the product of the cash-pay OID note's "adjusted issue
    price" at the beginning of such accrual period and its
    yield to maturity (determined on the basis of compounding at the
    close of each accrual period and properly adjusted for the
    length of the accrual period), over
•
the aggregate of all qualified stated interest allocable to the
    accrual period.
OID allocable to a final accrual period is the difference
    between the amount payable at maturity (other than a payment of
    qualified stated interest) and the adjusted issue price at the
    beginning of the final accrual period. The yield to maturity of
    the cash-pay OID note is the discount rate that causes the
    present value of all payments on the note as of its original
    issue date to equal the issue price of such note.
The "adjusted issue price" of a cash-pay OID note at
    the beginning of any accrual period is equal to its issue price
    increased by the accrued OID for each prior accrual period,
    determined without regard to the amortization of any acquisition
    or bond premium, as described below.
You may elect to treat all interest on a cash-pay OID note as
    OID and calculate the amount includible in gross income under
    the constant yield method described above. The election is to be
    made for the taxable year in which you acquired the cash-pay OID
    note and may not be revoked without the consent of the IRS. You
    should consult with your own tax advisors about this election.
265
Table of Contents
Market Discount.
If you purchase a cash-pay
    OID note for an amount that is less than its adjusted issue
    price, the amount of the difference will be treated as
    "market discount" for U.S. federal income tax
    purposes, unless that difference is less than a specified de
    minimis amount. Under the market discount rules, you will be
    required to treat any principal payment on, or any gain on the
    sale, exchange, retirement or other disposition of, a cash-pay
    OID note as ordinary income to the extent of the market discount
    that you have not previously included in income and are treated
    as having accrued on the note at the time of the payment or
    disposition.
In addition, you may be required to defer, until the maturity of
    the cash-pay OID note or its earlier disposition in a taxable
    transaction, the deduction of all or a portion of the interest
    expense on any indebtedness attributable to the note. You may
    elect, on a
note-by-note
basis, to deduct the deferred interest expense in a tax year
    prior to the year of disposition. You should consult your own
    tax advisors before making this election.
Any market discount will be considered to accrue ratably during
    the period from the date of acquisition to the maturity date of
    the cash-pay OID note, unless you elect to accrue on a constant
    interest method. You may elect to include market discount in
    income currently as it accrues, on either a ratable or constant
    interest method, in which case the rule described above
    regarding deferral of interest deductions will not apply.
Acquisition Premium, Amortizable Bond
    Premium.
If you purchase a cash-pay OID note for
    an amount that is greater than its adjusted issue price but
    equal to or less than its principal amount, you will be
    considered to have purchased that cash-pay OID note at an
    "acquisition premium." Under the acquisition premium
    rules, the amount of OID that you must include in gross income
    with respect to the cash-pay OID note for any taxable year will
    be reduced by the portion of the acquisition premium properly
    allocable to that year.
If you purchase a cash-pay OID note for an amount in excess of
    its principal amount, you will be considered to have purchased
    the cash-pay OID note at a "premium" and you will not
    be required to include any OID in income. You generally may
    elect to amortize the premium over the remaining term of the
    cash-pay OID note on a constant yield method as an offset to
    interest when includible in income under your regular accounting
    method. If you do not elect to amortize bond premium, that
    premium will decrease the gain or increase the loss you would
    otherwise recognize on disposition of the cash-pay OID note.
Sale, Exchange, Retirement, or Other Taxable Disposition of
    Cash-Pay OID Notes.
Upon the sale, exchange,
    retirement, redemption or other disposition of a cash-pay OID
    note, you generally will recognize gain or loss equal to the
    difference between the amount realized upon the sale, exchange,
    retirement, redemption or other disposition (less an amount
    equal to any accrued and unpaid qualified stated interest, which
    will be taxable as interest income as discussed above) and the
    adjusted tax basis of the cash-pay OID note. Your adjusted tax
    basis in a cash-pay OID note will, in general, be your cost for
    that cash-pay OID note, increased by any OID or market discount
    previously included in income, and reduced by any amortized
    premium. Except as described above with respect to market
    discount, any gain or loss will be capital gain or loss. Capital
    gains of non-corporate U.S. holders derived in respect of
    capital assets held for more than one year are generally
    eligible for reduced rates of taxation. The deductibility of
    capital losses is subject to limitations.
Toggle
    Notes
Original Issue Discount.
The toggle notes are
    treated as having been issued with OID for U.S. federal
    income tax purposes, as described below. The issuance of PIK
    Notes generally is not treated as a payment of interest.
    Instead, the toggle note and any PIK Notes issued in respect of
    PIK Interest thereon are treated as a single debt instrument
    under the OID rules.
The toggle notes are treated as having been issued with OID in
    an amount equal to the difference between their "stated
    redemption price at maturity" (the sum of all payments to
    be made on the toggle notes other than "qualified stated
    interest") and their "issue price."
The "issue price" of a toggle note is the first price
    at which a substantial amount of the toggle notes was sold
    (excluding sales to bond houses, brokers or similar persons or
    organizations acting in the capacity of
266
Table of Contents
underwiter, placement agent or wholesaler). The term
    "qualified stated interest" means stated interest that
    is unconditionally payable in cash or in property (other than
    debt instruments of the issuer) at least annually at a single
    fixed rate or, subject to certain conditions, based on one or
    more interest indices. Because we have the option in any
    interest payment period after the initial interest payment and
    prior to November 15, 2011 to make interest payments in PIK
    Interest instead of paying cash, the stated interest payments on
    the toggle notes are not qualified stated interest.
You generally must include OID in income in advance of the
    receipt of cash attributable to that income using the
    "constant yield method" described in the following
    paragraphs.
The amount of OID that you must include in income each year is
    the sum of the "daily portions" of OID with respect to
    the toggle note for each day during the taxable year or portion
    of the taxable year in which you held that toggle note
    ("accrued OID"). The daily portion is determined by
    allocating to each day in any "accrual period" a pro
    rata portion of the OID allocable to that accrual period. The
    "accrual period" for a toggle note may be of any
    length and may vary in length over the term of the toggle note,
    provided that each accrual period is no longer than one year and
    each scheduled payment of principal or interest occurs on the
    first day or the final day of an accrual period. The amount of
    OID allocable to any accrual period other than the final accrual
    period is an amount equal to the product of the toggle
    note's "adjusted issue price" at the beginning of
    such accrual period and its yield to maturity (determined on the
    basis of compounding at the close of each accrual period and
    properly adjusted for the length of the accrual period). OID
    allocable to a final accrual period is the difference between
    the amount payable at maturity and the adjusted issue price at
    the beginning of the final accrual period. The yield to maturity
    of the toggle note is the discount rate that causes the present
    value of all payments on the note as of its original issue date
    to equal the issue price of such note. For purposes of
    determining the yield to maturity, the assumption is that we
    will pay interest in cash and not exercise the option to pay PIK
    Interest, except in respect of any period in which we actually
    elect to pay PIK Interest.
The "adjusted issue price" of a toggle note at the
    beginning of any accrual period is equal to its issue price
    increased by the accrued OID for each prior accrual period,
    determined without regard to the amortization of any acquisition
    or bond premium, as described below, and reduced by any payments
    previously made on such toggle note.
If we in fact pay interest in cash on the toggle notes, you will
    not be required to adjust your OID inclusions. Each payment made
    in cash under a toggle note will be treated first as a payment
    of any accrued OID that has not been allocated to prior payments
    and second as a payment of principal. You generally will not be
    required to include separately in income cash payments received
    on the toggle notes to the extent such payments constitute
    payments of previously accrued OID or payments of principal.
With respect to any interest payment period for which we
    exercise our option to pay interest in the form of PIK Interest,
    your OID calculation for future periods will be adjusted by
    treating the toggle note as if it had been retired and then
    reissued for an amount equal to its adjusted issue price on the
    date preceding the first date of such interest payment period,
    and recalculating the yield to maturity of the reissued note by
    treating the amount of PIK Interest (and of any prior PIK
    Interest) as a payment that will be made on the maturity date of
    such note.
The rules regarding OID are complex and the rules described
    above may not apply in all cases. Accordingly, you should
    consult your own tax advisors regarding their application.
Market Discount.
If you purchase a toggle note
    for an amount that is less than its adjusted issue price, the
    amount of the difference will be treated as "market
    discount" for U.S. federal income tax purposes, unless
    that difference is less than a specified de minimis amount.
    Under the market discount rules, you will be required to treat
    any principal payment on, or any gain on the sale, exchange,
    retirement or other disposition of, a toggle note as ordinary
    income to the extent of the market discount that you have not
    previously included in income and are treated as having accrued
    on the note at the time of the payment or disposition.
In addition, you may be required to defer, until the maturity of
    the toggle note or its earlier disposition in a taxable
    transaction, the deduction of all or a portion of the interest
    expense on any indebtedness attributable
267
Table of Contents
to the note. You may elect, on a
note-by-note
basis, to deduct the deferred interest expense in a tax year
    prior to the year of disposition. You should consult your own
    tax advisors before making this election.
Any market discount will be considered to accrue ratably during
    the period from the date of acquisition to the maturity date of
    the toggle note, unless you elect to accrue on a constant
    interest method. You may elect to include market discount in
    income currently as it accrues, on either a ratable or constant
    interest method, in which case the rule described above
    regarding deferral of interest deductions will not apply.
Acquisition Premium, Amortizable Bond
    Premium.
If you purchase a toggle note for an
    amount that is greater than its adjusted issue price but equal
    to or less than the sum of all amounts payable on the toggle
    note after the purchase date, you will be considered to have
    purchased that toggle note at an "acquisition
    premium." Under the acquisition premium rules, the amount
    of OID that you must include in gross income with respect to the
    toggle note for any taxable year will be reduced by the portion
    of the acquisition premium properly allocable to that year.
If you purchase a toggle note for an amount in excess of the sum
    of all amounts payable on the toggle note after the purchase
    date, you will be considered to have purchased the toggle note
    at a "premium" and you will not be required to include
    any OID in income. You generally may elect to amortize the
    premium over the remaining term of the toggle note on a constant
    yield method as an offset to interest when includible in income
    under your regular accounting method. If you do not elect to
    amortize bond premium, that premium will decrease the gain or
    increase the loss you would otherwise recognize on disposition
    of the toggle note.
Sale, Exchange, Retirement, or Other Taxable Disposition of
    Toggle Notes.
Subject to the discussion below
    regarding the Mandatory Principal Redemption, upon the sale,
    exchange, retirement, redemption or other disposition of a
    toggle note (or a PIK Note), you generally will recognize gain
    or loss equal to the difference between the amount realized upon
    the sale, exchange, retirement, redemption or other disposition
    and the adjusted tax basis of the toggle note (or the PIK Note).
    Your adjusted tax basis in a toggle note will, in general, be
    your cost for the toggle note, increased by OID or market
    discount previously included in income, and reduced by any
    amortized premium and any cash payments on the toggle note.
    Although not free from doubt, your adjusted tax basis in the
    toggle note should be allocated between the original toggle note
    and any PIK Notes received in respect of PIK Interest thereon in
    proportion to their relative principal amounts. Your holding
    period in any PIK Note received in respect of PIK Interest would
    likely be identical to your holding period for the original
    toggle note with respect to which the PIK Note was received.
    Except as described above with respect to market discount, any
    gain or loss will be capital gain or loss. Capital gains of
    non-corporate U.S. holders derived in respect of capital
    assets held for more than one year are generally eligible for
    reduced rates of taxation. The deductibility of capital losses
    is subject to limitations.
Payments received by a U.S. holder upon the Mandatory
    Principal Redemption of a portion of a toggle note will be
    treated as tax-free payments of a portion of the then accrued
    OID with respect to such toggle note in its entirety (including
    the portion of the toggle note not redeemed).
Certain
    Tax Consequences to
Non-U.S.
Holders
The following is a summary of certain U.S. federal income
    and estate tax consequences that will apply to
non-U.S. holders
of the notes.
U.S.
    Federal Withholding Tax
The 30% U.S. federal withholding tax will not apply to any
    payment of interest (which for purposes of this discussion
    includes OID) on the notes under the "portfolio interest
    rule," provided that:
•
interest paid on the notes (including OID) is not effectively
    connected with your conduct of a trade or business in the United
    States;
•
you do not actually (or constructively) own 10% or more of the
    total combined voting power of all classes of our voting stock
    within the meaning of the Code and applicable United States
    Treasury regulations;
268
Table of Contents
•
you are not a controlled foreign corporation that is related to
    us actually or constructively through stock ownership;
•
you are not a bank whose receipt of interest (including OID) on
    the notes is described in Section 881(c)(3)(A) of the
    Code; and
•
either (a) you provide your name and address on an IRS
Form W-8BEN
(or other applicable form), and certify, under penalties of
    perjury, that you are not a United States person as defined
    under the Code or (b) you hold your notes through certain
    foreign intermediaries and satisfy the certification
    requirements of applicable United States Treasury regulations.
    Special certification rules apply to
non-U.S. holders
that are pass-through entities rather than corporations or
    individuals.
If you cannot satisfy the requirements described above, payments
    of interest (including OID) made to you will be subject to the
    30% U.S. federal withholding tax, unless you provide us
    with a properly executed:
•
IRS
Form W-8BEN
(or other applicable form) certifying an exemption from or
    reduction in withholding under the benefit of an applicable
    income tax treaty; or
•
IRS
Form W-8ECI
(or other applicable form) certifying that interest (including
    OID) paid on the notes is not subject to withholding tax because
    it is effectively connected with your conduct of a trade or
    business in the United States (as discussed below under
    "— U.S. Federal Income Tax").
The 30% U.S. federal withholding tax generally will not
    apply to any payment of principal or gain that you realize on
    the sale, exchange, retirement, redemption or other disposition
    of a note; provided, however, that payments received by a
non-U.S. holder
upon the Mandatory Principal Redemption of a portion of a toggle
    note will be treated as payments of a portion of the then
    accrued OID with respect to such toggle note in its entirety
    (including the portion of the toggle note not redeemed) and
    therefore possibly subject to the 30% U.S. federal
    withholding tax.
U.S.
    Federal Income Tax
If you are engaged in a trade or business in the United States
    and interest (including OID) on the notes is effectively
    connected with the conduct of that trade or business (and, if
    required by an applicable income tax treaty, is attributable to
    a United States permanent establishment), then you will be
    subject to U.S. federal income tax on that interest
    (including OID) on a net income in generally the same manner as
    if you were a United States person as defined under the Code. In
    addition, if you are a foreign corporation, you may be subject
    to a branch profits tax equal to 30% (or lower applicable income
    tax treaty rate) of such interest (including OID), subject to
    adjustments. If interest received with respect to the notes is
    effectively connected income (whether or not a treaty applies),
    the 30% withholding tax described above will not apply, provided
    the certification requirements discussed above in
    "— U.S. Federal Withholding Tax" are
    satisfied.
Subject to the discussion of backup withholding below, any gain
    realized on the disposition of a note generally will not be
    subject to U.S. federal income tax unless:
•
the gain is effectively connected with your conduct of a trade
    or business in the United States (and, if required by an
    applicable income tax treaty, is attributable to a United States
    permanent establishment); or
•
you are an individual who is present in the United States for
    183 days or more in the taxable year of that disposition,
    and certain other conditions are met.
U.S.
    Federal Estate Tax
Your estate will not be subject to U.S. federal estate tax
    on notes beneficially owned by you at the time of your death,
    provided that any payment to you on the notes would be eligible
    for exemption from the 30% U.S. federal withholding tax
    under the "portfolio interest rule" described above
    under "— U.S. Federal Withholding Tax"
    without regard to the statement requirement described in the
    fifth bullet point of that section.
269
Table of Contents
Information
    Reporting and Backup Withholding
U.S.
    Holders
In general, information reporting requirements will apply to
    certain payments of principal and interest (including OID) paid
    on the notes and to the proceeds of sale or other disposition
    (including retirement or a redemption) of a note paid to you
    (unless you are an exempt recipient such as a corporation).
    Backup withholding (currently at a rate of 28%) may apply to
    such payments if you fail to provide a correct taxpayer
    identification number or a certification that you are not
    subject to backup withholding or if you fail to report in full
    dividend and interest income.
Backup withholding is not an additional tax and any amounts
    withheld under the backup withholding rules may be allowed as a
    refund or a credit against your U.S. federal income tax
    liability provided the required information is timely furnished
    to the IRS.
Non-U.S.
Holders
In general, we must report to the IRS and to you the amount of
    interest (including OID) paid to you and the amount of tax, if
    any, withheld with respect to those payments. Copies of the
    information returns reporting such interest payments and any
    withholding may also be made available to the tax authorities in
    the country in which you reside under the provisions of an
    applicable income tax treaty.
In general, you will not be subject to backup withholding with
    respect to payments of interest (including OID) on the notes
    that we make to you provided that we do not have actual
    knowledge or reason to know that you are a United States person
    as defined under the Code and we have received from you the
    required certification that you are a
non-U.S. holder
described above in the fifth bullet point under
    "— Certain Tax Consequences to
Non-U.S. Holders —
U.S. Federal Withholding Tax."
Information reporting and, depending on the circumstances,
    backup withholding will apply to the proceeds of a sale or other
    disposition (including a retirement or redemption) of notes
    within the United States or conducted through certain United
    States-related financial intermediaries, unless you certify to
    the payor under penalties of perjury that you are a
non-U.S. holder
(and the payor does not have actual knowledge or reason to know
    that you are a United States person as defined under the Code),
    or you otherwise establish an exemption.
Backup withholding is not an additional tax and any amounts
    withheld under the backup withholding rules may be allowed as a
    refund or a credit against your U.S. federal income tax
    liability provided the required information is timely furnished
    to the IRS.
270
Table of Contents
PLAN OF
    DISTRIBUTION
This prospectus is to be used by Banc of America Securities LLC,
    Merrill Lynch, Pierce, Fenner & Smith Incorporated and
    their affiliates in connection with offers and sales of the
    notes in market-making transactions effected from time to time.
    Such affiliates may act as principal or agent in such
    transactions, including as agent for the counterparty when
    acting as principal or as agent for both counterparties, and may
    receive compensation in the form of discounts and commissions,
    including from both counterparties, when they act as agents for
    both. Such sales will be made at prevailing market prices at the
    time of sale, at prices related thereto or at negotiated prices.
    We will not receive any of the proceeds from such sales.
Merrill Lynch Global Private Equity (previously the private
    equity arm of Merrill Lynch & Co., Inc., which is a
    wholly-owned subsidiary of Bank of America Corporation), owned
    24.8% of our common stock, and other affiliates of Bank of
    America Corporation owned an additional 1.0% of our common
    stock, as of April 30, 2009. The agreement among the
    investors in HCA Inc., including Merrill Lynch Global Private
    Equity, gives such investors the right to elect members to serve
    on our Board of Directors. In addition, Banc of America
    Securities LLC or its affiliates, is the administrative agent
    under our senior secured credit facilities and, as such, is
    entitled to receive and has received fees related thereto. Banc
    of America Securities LLC and its affiliates have also in the
    past engaged, and may in the future engage, in transactions with
    and perform services for, including commercial banking,
    financial advisory and investment banking services, us and our
    affiliates in the ordinary course of business for which they
    have received customary fees and expenses. This section and the
    applicable descriptions of certain agreements set forth herein
    (including those descriptions incorporated herein by reference
    to "Item 13. Certain Relationships and Related
    Transactions" of our 2008
10-K)
constitute notice to potential purchasers of the notes pursuant
    to Rule 312(f)(2) of the New York Stock Exchange to the extent
    that affiliates of Banc of America Securities LLC may be deemed
    to control us for purposes of such rule.
We have been advised by Banc of America Securities LLC that,
    subject to applicable laws and regulations, they currently
    intend to make a market in the notes. However, they are not
    obligated to do so, and any such market-making may be
    interrupted or discontinued at any time without notice.
We and Banc of America Securities LLC, among other parties, have
    entered into a registration rights agreement with respect to the
    use by Banc of America Securities LLC and its affiliates of this
    prospectus. Pursuant to such agreement, we agreed to indemnify
    Banc of America Securities LLC and Merrill Lynch, Pierce,
    Fenner & Smith Incorporated and their affiliates, in
    their capacity as a market maker, against certain liabilities,
    including liabilities under the Securities Act.
271
Table of Contents
EXPERTS
The consolidated financial statements of HCA Inc. appearing in
    HCA Inc.'s Current Report
(Form 8-K)
dated May 27, 2009 for the year ended December 31,
    2008, and the effectiveness of HCA Inc.'s internal control
    over financial reporting as of December 31, 2008 included
    in its Annual Report
(Form 10-K)
have been audited by Ernst & Young LLP, an independent
    registered public accounting firm, as set forth in their reports
    thereon, included therein, and incorporated herein by reference.
    Such consolidated financial statements and HCA Inc.
    management's assessment of the effectiveness of internal
    control over financial reporting as of December 31, 2008
    are incorporated herein by reference in reliance upon such
    reports given on the authority of such firm as experts in
    accounting and auditing.
LEGAL
    OPINIONS
Robert A. Waterman, Esq., our Senior Vice President and
    General Counsel, and Simpson Thacher & Bartlett LLP,
    New York, New York, have each provided an opinion regarding the
    validity of HCA Inc.'s debt securities and the related
    guarantees referenced herein. An investment vehicle comprised of
    several partners of Simpson Thacher & Bartlett LLP,
    members of their families, related persons and others own
    interests representing less than 1% of the capital commitments
    of the KKR Millennium Fund, L.P. and KKR 2006 Fund L.P,
    which indirectly own capital stock of HCA Inc. In addition,
    Robert A. Waterman, Esq. beneficially owns, directly and
    indirectly, less than 1% of the capital stock of HCA Inc.
272
Table of Contents
HCA
    Inc.
Debt
    Securities
Prospectus
,
    2009
Table of Contents
PART II
INFORMATION
    NOT REQUIRED IN PROSPECTUS
Item 13.
Other
    Expenses of Issuance and Distribution
The registration rights agreement relating to the securities of
    the Registrant being registered hereby provides that HCA Inc.
    will bear all expenses in connection with the performance of its
    obligation relating to the market-making activities of Banc of
    America Securities LLC, Merrill Lynch, Pierce,
    Fenner & Smith Incorporated or their affiliates. These
    expenses include the following:
Attorneys' fees and expenses
75,000
*
Accountants' fees and expenses
25,000
*
Printing expenses
100,000
*
Total
$
200,000
*
*
Estimated.
Item 14.
Indemnification
    of Directors and Officers.
Set forth below are summaries of the statutes, charter
    provisions, by-laws, contracts or other arrangements under which
    the directors and officers of the Company and the additional
    registrant guarantors may be indemnified against liability which
    they may incur in their capacity as such. In the summaries that
    follow, defined terms used in each respective subsection apply
    only to that subsection.
California
    Registrants
(a) Columbia ASC Management, L.P. and Riverside
    Healthcare System, L.P. are registered under the laws of
    California.
The partnership agreements of Columbia ASC Management, L.P. and
    Riverside Healthcare System, L.P. provide that the limited
    partner shall indemnify and hold harmless the general partner;
    its partners, managers, employees, agents and representatives;
    and the officers, directors, employees, agents and
    representatives of its partners to the fullest extent permitted
    by the California Limited Partnership Act and the California
    Revised Partnership Act. Neither of these acts, however,
    addresses indemnification.
Section 15904.06 (Operative January 1, 2008) of
    the 2008 California Revised Limited Partnership Act addresses
    the rights of a general partner with respect to its management
    and conduct of partnership activities. The 2008 California
    Revised Limited Partnership Act provides that a limited
    partnership shall reimburse a general partner for payments made,
    and indemnify a general partner for liabilities incurred by, the
    general partner in the ordinary course of the activities of the
    partnership or for the preservation of its activities or
    property.
(b) Columbia Riverside, Inc., Encino Hospital
    Corporation, Inc., Los Robles Regional Medical Center and MCA
    Investment Company are incorporated under the laws of
    California.
Section 317 of the California General Corporation Law sets
    forth the provisions pertaining to the indemnification of
    corporate "agents." For purposes of this law, an agent
    is any person who is or was a director, officer, employee or
    other agent of a corporation, or is or was serving at the
    request of the corporation in such capacity with respect to any
    other corporation, partnership, join venture, trust or other
    enterprise. Indemnification for expenses, including amounts paid
    on settling or otherwise disposing of a threatened or pending
    action or defending against the same, can be made in certain
    circumstances by action of the company through:
•
a majority vote of a quorum of the corporation's Board of
    Directors consisting of directors who are not party to the
    proceedings;
II-1
Table of Contents
•
approval of the shareholders, with the shares owned by the
    person to be indemnified not being entitled to vote
    thereon; or
•
such court in which the proceeding is or was pending upon
    application by designated parties.
Under certain circumstances, an agent can be indemnified, even
    when found liable. Indemnification is mandatory where the
    agent's defense is successful on the merits. The law allows
    a corporation to make advances of expenses for certain actions
    upon the receipt of an undertaking that the agent will reimburse
    the corporation if the agent is found liable. The
    indemnification provided by Section 317 for acts while
    serving as a director or officer of the corporation, but not
    involving breach of duty to the corporation and its
    shareholders, shall not be deemed exclusive of any other rights
    to which those seeking indemnification may be entitled under any
    bylaw to the extent authorized by the corporation's
    articles of the corporation.
The bylaws of each of the California Registrants in this
    section (b) provide, in relevant part, that each of the
    Registrants will indemnify its respective officers and
    directors, under the circumstances and to the extent provided
    for therein, for expenses, damages, judgments, fines and
    settlements such officers and directors may be required to pay
    in any action, suit or proceeding which they are or may be made
    a party by reason of their position as a director, officer or
    other agent of such Registrant, and otherwise to the full extent
    permitted under California law and our bylaws for any taken on
    behalf of the corporation that does not involve gross negligence
    or willful misconduct.
(c) Surgicare of Riverside, LLC is registered under the
    laws of California.
Under Section 17155 of the California Limited Liability
    Company Act, except for a breach of duty, the articles of
    organization or written operating agreement of a limited
    liability company may provide for indemnification of any person,
    including, without limitation, any manager, member, officer,
    employee or agent of the limited liability company, against
    judgments, settlements, penalties, fines or expenses of any kind
    incurred as a result of acting in that capacity. A limited
    liability company shall have the power to purchase and maintain
    insurance on behalf of any manager, member, officer, employee or
    agent of the limited liability company against any liability
    asserted against or incurred by the person in that capacity or
    arising out of the person's status as a manager, member,
    officer, employee or agent of the limited liability company.
The limited liability company agreement of Surgicare of
    Riverside, LLC states that the company shall indemnify its
    officers and managers against all reasonable expense incurred by
    them in defending claims or suits, irrespective of the time of
    the occurrence of the claims or causes of action in such suits,
    made or brought against them as officers or managers of the
    company, and against all liability in such suits, except in such
    cases as involve gross negligence or willful misconduct in the
    performance of their duties. Such indemnification extends to the
    payment of judgments against such officers and managers and to
    reimbursement of amounts paid in settlement of such claims or
    actions and may apply to judgments in favor of the company or
    amounts paid in settlement to the company. Such indemnification
    also extends to the payment of counsel fees and expenses of such
    officers and managers in suits against them where successfully
    defended by them or where unsuccessfully defended, if there is
    no finding or judgment that the claim or action arose from the
    gross negligence or willful misconduct of such officers or
    directors. Such right of indemnification is not exclusive of any
    right to which such officer or director may be entitled as a
    matter of law and shall extend and apply to the estates of
    deceased officers and directors.
Colorado
    Registrants
(a) Colorado Health Systems, Inc., Columbine Psychiatric
    Center, Inc. and New Rose Holding Company, Inc. are incorporated
    under the laws of Colorado.
Sections 7-109-102
through 7-109-110 of the Colorado Business Corporation Act (the
    "Act") grant the registrants' broad powers to
    indemnify any person in connection with legal proceedings
    brought against him by reason of his present or past status as
    an officer or director of the registrant, provided with respect
    to conduct in an official capacity with the registrant, the
    person acted in good faith and in a manner he reasonably
    believed to be in the best interests of the registrant, with
    respect to all other conduct, the person believed the conduct to
    be at least not opposed to the best interests of the registrant,
    and with respect to any
II-2
Table of Contents
criminal action or proceeding, the person had no reasonable
    cause to believe his conduct was unlawful. Indemnification is
    limited to reasonable expenses incurred in connection with the
    proceeding. No indemnification may be made (i) in
    connection with a proceeding by or in the right of the
    registrant in which the person was adjudged liable to the
    registrant; or (ii) in connection with any other
    proceedings charging that the person derived an improper
    personal benefit, whether or not involving action in an official
    capacity, in which proceeding the person was judged liable on
    the basis that he derived an improper personal benefit, unless
    and only to the extent the court in which such action was
    brought or another court of competent jurisdiction determines
    upon application that, despite such adjudication, but in view of
    all relevant circumstances, the person is fairly and reasonably
    entitled to indemnity for reasonable expenses as the court deems
    proper. In addition, to the extent that any such person is
    successful in the defense of any such legal proceeding, the
    registrant is required by the Act to indemnify him against
    reasonable expenses.
The bylaws of these Colorado registrants state that the
    corporation shall indemnify its officers and directors against
    all reasonable expense incurred by them in defending claims or
    suits, irrespective of the time of the occurrence of the claims
    or causes of action in such suits, made or brought against them
    as officers or directors of the corporation, and against all
    liability in such suits, except in such cases as involve gross
    negligence or willful misconduct in the performance of their
    duties. Such indemnification extends to the payment of judgments
    against such officers and directors and to reimbursement of
    amounts paid in settlement of such claims or actions and may
    apply to judgments in favor of the corporation or amounts paid
    in settlement to the corporation. Such indemnification also
    extends to the payment of counsel fees and expenses of such
    officers and directors in suits against them where successfully
    defended by them or where unsuccessfully defended, if there is
    no finding or judgment that the claim or action arose from the
    gross negligence or willful misconduct of such officers or
    directors. Such right of indemnification is not exclusive of any
    right to which such officer or director may be entitled as a
    matter of law and shall extend and apply to the estates of
    deceased officers and directors.
Delaware
    Registrants
(a) HCA Inc., American Medicorp Development Co.,
    GPCH-GP, Inc., HCA — IT&S Field Operations, Inc.,
    HCA — IT&S Inventory Management, Inc., Management
    Services Holdings, Inc., Midwest Holdings, Inc., Hospital
    Development Properties, Inc., Riverside Hospital, Inc., Terre
    Haute Hospital GP, Inc. and Terre Haute Hospital Holdings, Inc.
    are incorporated under the laws of Delaware.
Section 145 of the Delaware General Corporation Law (the
    "DGCL") grants each corporation organized thereunder
    the power to indemnify any person who is or was a director,
    officer, employee or agent of a corporation or enterprise,
    against expenses, including attorneys' fees, judgments,
    fines and amounts paid in settlement actually and reasonably
    incurred by him in connection with any threatened, pending or
    completed action, suit or proceeding, whether civil, criminal,
    administrative or investigative, other than an action by or in
    the right of the corporation, by reason of being or having been
    in any such capacity, if he acted in good faith in a manner
    reasonably believed to be in, or not opposed to, the best
    interests of the corporation, and, with respect to any criminal
    action or proceeding, had no reasonable cause to believe his
    conduct was unlawful.
Section 102(b)(7) of the DGCL enables a corporation in its
    certificate of incorporation or an amendment thereto to
    eliminate or limit the personal liability of a director to the
    corporation or its stockholders of monetary damages for
    violations of the directors' fiduciary duty of care, except
    (i) for any breach of the directors' duty of loyalty
    to the corporation or its stockholders, (ii) for acts or
    omissions not in good faith or that involve intentional
    misconduct or a knowing violation of law, (iii) pursuant to
    Section 174 of the DGCL (providing for liability of
    directors for unlawful payment of dividends or unlawful stock
    purchases or redemptions) or (iv) for any transaction from
    which a director derived an improper personal benefit.
HCA Inc.'s bylaws indemnify the directors and officers to
    the full extent of the DGCL and also allow the Board of
    Directors to indemnify all other employees. The bylaws of the
    remainder of the Delaware corporate registrants indemnify their
    officers and directors against all reasonable expense incurred
    by them in defending claims or suits, irrespective of the time
    of the occurrence of the claims or causes of action in such
    suits, made or brought against them as officers or directors of
    the corporation, and against all liability in such suits, except
II-3
Table of Contents
in such cases as involve gross negligence or willful misconduct
    in the performance of their duties. Such indemnification extends
    to the payment of judgments against such officers and directors
    and to reimbursement of amounts paid in settlement of such
    claims or actions and may apply to judgments in favor of the
    corporation or amounts paid in settlement to the corporation.
    Such indemnification also extends to the payment of counsel fees
    and expenses of such officers and directors in suits against
    them where successfully defended by them or where unsuccessfully
    defended, if there is no finding or judgment that the claim or
    action arose from the gross negligence or willful misconduct of
    such officers or directors. Such right of indemnification is not
    exclusive of any right to which such officer or director may be
    entitled as a matter of law and shall extend and apply to the
    estates of deceased officers and directors.
(b) Nashville Shared Services General Partnership is a
    general partnership under the laws of Delaware and Integrated
    Regional Laboratories, LLP is registered under the laws of
    Delaware.
Section 15-110
of the Delaware Revised Uniform Partnership Act provides that
    subject to such standards and restrictions, if any, as are set
    forth in its partnership agreement, a partnership may, and shall
    have the power to, indemnify and hold harmless any partner or
    other person from and against any and all claims and demands
    whatsoever.
The Nashville Shared Services General Partnership partnership
    agreement states that indemnification is controlled by the
    Delaware Revised Uniform Partnership Act. The partnership
    agreement of Integrated Regional Laboratories, LLP indemnifies
    its officers and directors against all reasonable expense
    incurred by them in defending claims or suits, irrespective of
    the time of the occurrence of the claims or causes of action in
    such suits, made or brought against them as officers or
    directors of the company, and against all liability in such
    suits, except in such cases as involve gross negligence or
    willful misconduct in the performance of their duties. Such
    indemnification extends to the payment of judgments against such
    officers and directors and to reimbursement of amounts paid in
    settlement of such claims or actions and may apply to judgments
    in favor of the company or amounts paid in settlement to the
    company. Such indemnification also extends to the payment of
    counsel fees and expenses of such officers and directors in
    suits against them where successfully defended by them or where
    unsuccessfully defended, if there is no finding or judgment that
    the claim or action arose from the gross negligence or willful
    misconduct of such officers or directors. Such right of
    indemnification is not exclusive of any right to which such
    officer or director may be entitled as a matter of law and shall
    extend and apply to the estates of deceased officers and
    directors.
(c) Centerpoint Medical Center of Independence, LLC, CMS
    GP, LLC, Dallas/Ft. Worth Physician, LLC, Edmond Regional
    Medical Center, LLC, EP Health, LLC, Fairview Park GP, LLC,
    General Healthserv, LLC, Goppert-Trinity Family Care, LLC, Grand
    Strand Regional Medical Center, LLC, Healthtrust MOB, LLC, HSS
    Holdco, LLC, HSS Systems VA, LLC, HSS Systems, LLC, Lakeland
    Medical Center, LLC, Lakeview Medical Center, LLC, Lewis-Gale
    Medical Center, LLC, Medical Centers of Oklahoma, LLC, Medical
    Office Buildings of Kansas, LLC, Midwest Division —
    ACH, LLC, Midwest Division — LRHC, LLC, Midwest
    Division — LSH, LLC, Midwest Division — MCI,
    LLC, Midwest Division — MMC, LLC, Midwest
    Division — OPRMC, LLC, Midwest Division —
    PFC, LLC, Midwest Division — RMC, LLC, Midwest
    Division — RPC, LLC, Notami Hospitals, LLC, Outpatient
    Cardiovascular Center of Central Florida, LLC, Reston Hospital
    Center, LLC, Samaritan, LLC, San Jose Medical Center, LLC,
    San Jose, LLC, SJMC, LLC, Trident Medical Center, LLC, Utah
    Medco, LLC and Wesley Medical Center, LLC are registered under
    the laws of Delaware.
Section 18-108
of the Delaware Limited Liability Company Act empowers a
    Delaware limited liability company to indemnify and hold
    harmless any member or manager of the limited liability company
    from and against any and all claims and demands whatsoever.
The operating agreement of Healthtrust MOB, LLC indemnifies the
    directors and officers to the full extent of the law. The
    operating agreements of the remainder of the Delaware limited
    liability company registrants indemnify their officers and
    directors against all reasonable expense incurred by them in
    defending claims or suits, irrespective of the time of the
    occurrence of the claims or causes of action in such suits, made
    or brought against them as officers or directors of the company,
    and against all liability in such suits, except in such cases as
    involve gross negligence or willful misconduct in the
    performance of their duties. Such
II-4
Table of Contents
indemnification extends to the payment of judgments against such
    officers and directors and to reimbursement of amounts paid in
    settlement of such claims or actions and may apply to judgments
    in favor of the company or amounts paid in settlement to the
    company. Such indemnification also extends to the payment of
    counsel fees and expenses of such officers and directors in
    suits against them where successfully defended by them or where
    unsuccessfully defended, if there is no finding or judgment that
    the claim or action arose from the gross negligence or willful
    misconduct of such officers or directors. Such right of
    indemnification is not exclusive of any right to which such
    officer or director may be entitled as a matter of law and shall
    extend and apply to the estates of deceased officers and
    directors.
(d) CHCA Bayshore, L.P., CHCA Conroe, L.P., CHCA
    Mainland, L.P., CHCA West Houston, L.P., CHCA Woman's
    Hospital, L.P., Columbia Valley Healthcare System, L.P.,
    Columbia Rio Grande Healthcare, L.P., HCA Management Services,
    L.P., Good Samaritan Hospital, L.P., JFK Medical Center Limited
    Partnership, Palms West Hospital Limited Partnership, Plantation
    General Hospital, L.P., San Jose Healthcare System, LP,
    Terre Haute Regional Hospital, L.P. and San Jose Hospital,
    L.P. are registered under the laws of Delaware.
Section 17-108
of the Delaware Revised Uniform Limited Partnership Act (DRULPA)
    permits a limited partnership to indemnify and hold harmless any
    partner or other person from and against any and all claims and
    demands whatsoever.
The Columbia Valley Healthcare System, L.P. partnership
    agreement allows the partnership to indemnify the general
    partners for everything but willful misconduct or gross
    negligence. The other Delaware limited partnership registrants
    allow for indemnification to the fullest extent under the DRULPA.
Florida
    Registrants
(a) Bay Hospital, Inc., Central Florida Regional
    Hospital, Inc., Columbia Jacksonville Healthcare System, Inc.,
    Edward White Hospital, Inc., HCA Health Services of Florida,
    Inc., HD&S Corp. Successor, Inc., Largo Medical Center,
    Inc., Lawnwood Medical Center, Inc., Marion Community Hospital,
    Inc., Memorial Healthcare Group, Inc., New Port Richey Hospital,
    Inc., North Florida Immediate Care Center, Inc., North Florida
    Regional Medical Center, Inc., Okaloosa Hospital, Inc.,
    Okeechobee Hospital, Inc., Sarasota Doctors Hospital, Inc., Sun
    City Hospital, Inc., Surgicare of Brandon, Inc., Surgicare of
    Florida, Inc., Surgicare of Manatee, Inc., Surgicare of New Port
    Richey, Inc., Tallahassee Medical Center, Inc. and West Florida
    Regional Medical Center, Inc. are incorporated under the laws of
    Florida.
Section 607.0831 of the Florida Business Corporation Act
    provides, among other things, that a director is not personally
    liable for monetary damages to a company or any other person for
    any statement, vote, decision, or failure to act, by the
    director, regarding corporate management or policy, unless the
    director breached or failed to perform his or her duties as a
    director and such breach or failure constitutes (a) a
    violation of criminal law, unless the director had reasonable
    cause to believe his or her conduct was lawful or had no
    reasonable cause to believe his or her conduct was unlawful;
    (b) a transaction from which the director derived an
    improper personal benefit; (c) a circumstance under which
    the liability provisions of Section 607.0834 of the Florida
    Business Corporation Act (relating to the liability of the
    directors for improper distributions) are applicable;
    (d) willful misconduct or a conscious disregard for the
    best interest of the company in the case of a proceeding by or
    in the right of the company to procure a judgment in its favor
    or by or in the right of a stockholders; or
    (e) recklessness or an act or omission in bad faith or with
    malicious purpose of with wanton and willful disregard of human
    rights, safety or property, in a proceeding by or in the right
    of someone other than such company or a stockholder.
Section 607.0850 of the Florida Business Corporation Act
    authorizes, among other things, a company to indemnify any
    person who was or is a party to any proceeding (other than an
    action by or in the right of the company) by reason of the fact
    that he is or was a director, officer, employee or agent of the
    company (or is or was serving at the request of the company in
    such a position for any entity) against liability incurred in
    connection with such proceedings, if he or she acted in good
    faith and in a manner reasonably believed to be
II-5
Table of Contents
in the best interests of the company and, with respect to
    criminal proceedings, had no reasonable cause to believe his or
    her conduct was unlawful.
The Florida Business Corporation Act requires that a director,
    officer or employee be indemnified for actual and reasonable
    expenses (including attorneys' fees) to the extent that he
    or she has been successful on the merits or otherwise in the
    defense of any proceeding. Florida law also allows expenses of
    defending a proceeding to be advanced by a company before the
    final disposition of the proceedings, provided that the officer,
    director or employee undertakes to repay such advance if it is
    ultimately determined that indemnification is not permitted.
The Florida Business Corporation Act states that the
    indemnification and advancement of expenses provided pursuant to
    Section 607.0850 is not exclusive and that indemnification
    may be provided by a company pursuant to other means, including
    agreements or bylaw provisions. Florida law prohibits
    indemnification or advancement of expenses, however, if a
    judgment or other final adjudication establishes that the
    actions of a director, officer or employee constitute (i) a
    violation of criminal law, unless he or she had reasonable cause
    to believe his or her conduct was lawful or had no reasonable
    cause to believe his or her conduct was unlawful; (ii) a
    transaction from which such person derived an improper personal
    benefit; (iii) willful misconduct or conscious disregard
    for the best interests of the company in the case of a
    derivative action or a proceeding by or in the right of a
    stockholder, or (iv) in the case of a director, a
    circumstance under which the liability provisions of
    Section 607.0834 of the Florida Business Corporation Act
    (relating to the liability of directors for improper
    distributions) are applicable.
The bylaws of all the Florida corporate registrants indemnify
    their officers and directors against all reasonable expense
    incurred by them in defending claims or suits, irrespective of
    the time of the occurrence of the claims or causes of action in
    such suits, made or brought against them as officers or
    directors of the corporation, and against all liability in such
    suits, except in such cases as involve gross negligence or
    willful misconduct in the performance of their duties. Such
    indemnification extends to the payment of judgments against such
    officers and directors and to reimbursement of amounts paid in
    settlement of such claims or actions and may apply to judgments
    in favor of the corporation or amounts paid in settlement to the
    corporation. Such indemnification also extends to the payment of
    counsel fees and expenses of such officers and directors in
    suits against them where successfully defended by them or where
    unsuccessfully defended, if there is no finding or judgment that
    the claim or action arose from the gross negligence or willful
    misconduct of such officers or directors. Such right of
    indemnification is not exclusive of any right to which such
    officer or director may be entitled as a matter of law and shall
    extend and apply to the estates of deceased officers and
    directors.
(b) Integrated Regional Lab, LLC and Surgicare of Palms
    West, LLC are registered under the laws of Florida.
Section 608.4229 of the Florida Limited Liability Company
    Act indemnifies members, managers, managing members, officers,
    employees, and agents subject to such standards and
    restrictions, if any, as are set forth in its articles of
    organization or operating agreement. A limited liability company
    may, and has the power to, but is not be required to, indemnify
    and hold harmless any member or manager or other person from and
    against any and all claims and demands whatsoever.
    Notwithstanding the foregoing, indemnification or advancement of
    expenses should not be made to or on behalf of any member,
    manager, managing member, officer, employee, or agent if a
    judgment or other final adjudication establishes that the
    actions, or omissions to act, of such member, manager, managing
    member, officer, employee, or agent were material to the cause
    of action so adjudicated and constitute any of the following:
    (i) a violation of criminal law, unless the member,
    manager, managing member, officer, employee, or agent had no
    reasonable cause to believe such conduct was unlawful;
    (ii) a transaction from which the member, manager, managing
    member, officer, employee, or agent derived an improper personal
    benefit; (iii) in the case of a manager or managing member,
    a circumstance under which the liability provisions of s.
    608.426 are applicable; or (iv) willful misconduct or a
    conscious
II-6
Table of Contents
disregard for the best interests of the limited liability
    company in a proceeding by or in the right of the limited
    liability company to procure a judgment in its favor or in a
    proceeding by or in the right of a member.
The operating agreements of both of the Florida limited
    liability company registrants indemnify their officers and
    managers against all reasonable expense incurred by them in
    defending claims or suits, irrespective of the time of the
    occurrence of the claims or causes of action in such suits, made
    or brought against them as officers or managers of the company,
    and against all liability in such suits, except in such cases as
    involve gross negligence or willful misconduct in the
    performance of their duties. Such indemnification extends to the
    payment of judgments against such officers and managers and to
    reimbursement of amounts paid in settlement of such claims or
    actions and may apply to judgments in favor of the company or
    amounts paid in settlement to the company. Such indemnification
    also extends to the payment of counsel fees and expenses of such
    officers and managers in suits against them where successfully
    defended by them or where unsuccessfully defended, if there is
    no finding or judgment that the claim or action arose from the
    gross negligence or willful misconduct of such officers or
    managers. Such right of indemnification is not exclusive of any
    right to which such officer or manager may be entitled as a
    matter of law and shall extend and apply to the estates of
    deceased officers and managers.
Georgia
    Registrants
(a) Columbia Polk General Hospital, Inc., Columbus
    Cardiology, Inc., Marietta Surgical Center, Inc., Palmyra Park
    Hospital, Inc. and Redmond Physician Practice Company are
    incorporated under the laws of Georgia.
Section 14-2-202(b)(4)
of the Georgia Business Corporation Code provides that a
    corporation's articles of incorporation may include a
    provision that eliminates or limits the liability of directors
    for monetary damages to a corporation or its shareholders for
    any action taken, or failure to take any action, as a director.
    The section does not, however, authorize a corporation to
    eliminate or limit the liability of a director for
    appropriating, in violation of his or her duties, any business
    opportunity of the corporation, for acts or omissions which
    involve intentional misconduct or a knowing violation of law,
    for any transaction from which the director received an improper
    personal benefit, or authorizing a dividend, stock repurchase or
    redemption, distribution of assets or other distribution in
    violation of
Section 14-2-640
of the Georgia Business Corporation Code if it is established
    that the director did not perform his or her duties in
    compliance with
Section 14-2-832
of the Georgia Business Corporation Code, which sets forth
    general standards for directors.
Section 14-2-202(b)(4)
also does not eliminate or limit the right of a corporation or
    any shareholder to seek an injunction, a rescission or any other
    equitable (non-monetary) relief for any action taken or not
    taken by a director. In addition,
Section 14-2-202(b)(4)
applies only to claims against a director arising out of his or
    her role as a director and does not relieve a director from
    liability arising from his or her role as an officer or in any
    other capacity.
Sections 14-2-852
and
14-2-857
of the Georgia Business Corporation Code provide that any
    director or officer who is wholly successful in the defense of
    any proceeding to which he or she was a party because her or she
    was an officer or a director of the corporation are entitled to
    indemnification against reasonable expenses as of right. On the
    other hand, if the charges made in any action are sustained, the
    determination of whether the required standard of conduct has
    been met will be made, in accordance with the provisions of
    Georgia Business Corporation Code
Section 14-2-855,
by either the board of directors or a committee thereof, acting
    by disinterested members, by special legal counsel or by the
    shareholders, but shares owned by or voted under the control of
    directors seeking indemnification may not be voted.
The bylaws of each of the Georgia corporate registrants
    indemnify their officers and directors against all reasonable
    expense incurred by them in defending claims or suits,
    irrespective of the time of the occurrence of the claims or
    causes of action in such suits, made or brought against them as
    officers or directors of the corporation, and against all
    liability in such suits, except in such cases as involve gross
    negligence or willful misconduct in the performance of their
    duties. Such indemnification extends to the payment of judgments
    against such officers and directors and to reimbursement of
    amounts paid in settlement of such claims or actions and may
    apply to judgments in favor of the corporation or amounts paid
    in settlement to the corporation. Such indemnification also
    extends to the payment of counsel fees and expenses of such
    officers
II-7
Table of Contents
and directors in suits against them where successfully defended
    by them or where unsuccessfully defended, if there is no finding
    or judgment that the claim or action arose from the gross
    negligence or willful misconduct of such officers or directors.
    Such right of indemnification is not exclusive of any right to
    which such officer or director may be entitled as a matter of
    law and shall extend and apply to the estates of deceased
    officers and directors.
(b) Dublin Community Hospital, LLC, Northlake Medical
    Center, LLC and Redmond Park Hospital, LLC are registered under
    the laws of Georgia.
Georgia law provides that a limited liability company may
    indemnify a member, manager or other person against liability
    incurred in connection with the limited liability company
    subject to any standards or restrictions set forth in the
    articles of organization or operating agreement. Unless the
    member or manager is aware of information which would cause any
    reliance to be unwarranted, he or she is entitled to rely upon
    information prepared or presented by other members, managers,
    committees and employees of the limited liability company and
    legal counsel, public accountants or other professionals or
    experts.
However, Georgia law does not permit indemnification if the
    member or manager has engaged in any intentional misconduct or a
    knowing violation of law or was involved in any transaction in
    which the member or manager received a personal benefit as a
    result of his or her breach of any provision in the operating
    agreement.
The operating agreements of each of the Georgia limited
    liability companies indemnify their officers and managers
    against all reasonable expense incurred by them in defending
    claims or suits, irrespective of the time of the occurrence of
    the claims or causes of action in such suits, made or brought
    against them as officers or managers of the limited liability
    company, and against all liability in such suits, except in such
    cases as involve gross negligence or willful misconduct in the
    performance of their duties. Such indemnification extends to the
    payment of judgments against such officers and managers and to
    reimbursement of amounts paid in settlement of such claims or
    actions and may apply to judgments in favor of the company or
    amounts paid in settlement to the company. Such indemnification
    also extends to the payment of counsel fees and expenses of such
    officers and directors in suits against them where successfully
    defended by them or where unsuccessfully defended, if there is
    no finding or judgment that the claim or action arose from the
    gross negligence or willful misconduct of such officers or
    managers. Such right of indemnification is not exclusive of any
    right to which such officer or manager may be entitled as a
    matter of law and shall extend and apply to the estates of
    deceased officers and managers.
(c) Fairview Park, Limited Partnership is registered
    under the laws of Georgia.
Section 14-9-108
of the Georgia Revised Uniform Limited Partnership Act provides
    that:
(a) Subject to any limitations expressly set forth in the
    partnership agreement, a limited partnership may, and shall have
    the power to, indemnify and hold harmless any partner or other
    person from and against any and all claims and demands
    whatsoever, provided that the partnership shall not indemnify
    any person:
(1) For intentional misconduct or a knowing violation of
    law; or
(2) For any transaction for which the person received a
    personal benefit in violation or breach of any provision of the
    partnership agreement.
(b) To the extent that, at law or in equity, a partner has
    duties including but not limited to fiduciary duties and
    liabilities relating thereto to a limited partnership or another
    partner:
(1) The partner's duties and liabilities may be
    expanded, restricted, or eliminated by provisions in the
    partnership agreement; provided, however, that no such provision
    shall eliminate or limit the liability of a partner for
    intentional misconduct or a knowing violation of law or for any
    transaction for which the partner received a personal benefit in
    violation or breach of any provision of the partnership
    agreement; and
II-8
Table of Contents
(2) The partner shall have no liability to the limited
    partnership or to any other partner for his or her good faith
    reliance on the provisions of the partnership agreement,
    including, without limitation, provisions thereof that relate to
    the scope of duties including but not limited to fiduciary
    duties of partners.
Fairview Park Limited Partnership's Partnership Agreement
    allows the limited partnership to indemnify its general partner,
    directors and officers to the full extent of the Georgia Revised
    Uniform Limited Partnership Act.
Idaho
    Registrants
(a) Eastern Idaho Health Services, Inc. and West Valley
    Medical Center, Inc. are incorporated under the laws of
    Idaho.
Under Title 30,
Section 30-1-851
of the Idaho Code, the registrant's directors and officers
    may be indemnified against certain liabilities which they may
    incur in their capacities as such. The material terms of the
    indemnification provisions are indemnification:
•
with respect to civil, criminal, administrative or investigative
    proceedings brought because the defendant is or was serving as
    an officer, director, employee or agent of the company;
•
for judgments, fines and amounts paid in settlement reasonably
    incurred;
•
if the defendant acted in good faith and reasonably believed in
    the case of conduct in his official capacity that his conduct
    was in the best interests of the company, and in all other cases
    that his conduct was at least not opposed to the best interests
    of the company; and
•
if, with respect to a criminal proceeding, he had no reasonable
    cause to believe his conduct was unlawful.
Attorneys' fees are included in such indemnification to the
    extent the indemnified party is successful on the merits in
    defense of the proceeding. If the foregoing criteria are met,
    indemnification also applies to a suit threatened or pending by
    the company against the officer, director, employee or agent
    with respect to attorneys' fees unless there is negligence
    on the part of the indemnified party. Indemnification is made
    only upon a determination by the company that it is proper under
    the circumstances because the applicable standard is met.
Generally, expenses for defense may be paid in advance of final
    disposition of the proceeding if the indemnified party provides
    a written affirmation of his good faith belief that he has met
    the relevant standard of conduct under the Idaho Code and
    further provides a written undertaking to repay such amounts if
    it is determined that the applicable standard has not been met.
The bylaws of both of the Idaho corporate registrants indemnify
    their officers and directors against all reasonable expense
    incurred by them in defending claims or suits, irrespective of
    the time of the occurrence of the claims or causes of action in
    such suits, made or brought against them as officers or
    directors of the corporation, and against all liability in such
    suits, except in such cases as involve gross negligence or
    willful misconduct in the performance of their duties. Such
    indemnification extends to the payment of judgments against such
    officers and directors and to reimbursement of amounts paid in
    settlement of such claims or actions and may apply to judgments
    in favor of the corporation or amounts paid in settlement to the
    corporation. Such indemnification also extends to the payment of
    counsel fees and expenses of such officers and directors in
    suits against them where successfully defended by them or where
    unsuccessfully defended, if there is no finding or judgment that
    the claim or action arose from the gross negligence or willful
    misconduct of such officers or directors. Such right of
    indemnification is not exclusive of any right to which such
    officer or director may be entitled as a matter of law and shall
    extend and apply to the estates of deceased officers and
    directors.
II-9
Table of Contents
Illinois
    Registrant
(a) Columbia LaGrange Hospital, Inc. is incorporated
    under the laws of Illinois.
Section 8.75 of the Illinois Business Corporation Act of
    1983, as amended (the "IBCA"), provides for a
    limitation of director liability. Under Section 8.75 of the
    IBCA, directors and officers may be indemnified by the
    registrant against all expenses incurred in connection with
    actions (including, under certain circumstances, derivative
    actions) brought against such director or officer by reason of
    his or her status as our representative, or by reason of the
    fact that such director or officer serves or served as a
    representative of another entity at our request, so long as the
    director or officer acted in good faith and in a manner he or
    she reasonably believed to be in, or not opposed to, our best
    interests.
The bylaws of Columbia La Grange Hospital, Inc indemnify
    its officers and directors against all reasonable expense
    incurred by them in defending claims or suits, irrespective of
    the time of the occurrence of the claims or causes of action in
    such suits, made or brought against them as officers or
    directors of the corporation, and against all liability in such
    suits, except in such cases as involve gross negligence or
    willful misconduct in the performance of their duties. Such
    indemnification extends to the payment of judgments against such
    officers and directors and to reimbursement of amounts paid in
    settlement of such claims or actions and may apply to judgments
    in favor of the corporation or amounts paid in settlement to the
    corporation. Such indemnification also extends to the payment of
    counsel fees and expenses of such officers and directors in
    suits against them where successfully defended by them or where
    unsuccessfully defended, if there is no finding or judgment that
    the claim or action arose from the gross negligence or willful
    misconduct of such officers or directors. Such right of
    indemnification is not exclusive of any right to which such
    officer or director may be entitled as a matter of law and shall
    extend and apply to the estates of deceased officers and
    directors.
Indiana
    Registrant
(a) Terre Haute MOB, L.P. is registered under the laws
    of Indiana.
Title 23, Article 16, Chapter 2 of the Indiana
    Code provides that a domestic or foreign limited partnership may
    indemnify a person made a party to an action because the person
    is or was a partner or officer of the partnership against
    liability incurred in the action if:
(1) the person's conduct was in good faith; and
(2) the person reasonably believed:
(A) in the case of conduct in the person's capacity as
    a partner, that the person's conduct was in the best
    interests of the partnership; and
(B) in all other cases that the person's conduct was
    at least not opposed to the best interests of the limited
    partnership or foreign limited partnership; and
(3) in the case of any criminal action, the person either:
(A) had reasonable cause to believe the person's
    conduct was lawful; or
(B) had no reasonable cause to believe the person's
    conduct was unlawful.
The indemnification provided for above does not exclude any
    other rights to indemnification that a partner or officer of the
    limited partnership may have under the partnership agreement or
    with the written consent of all partners.
The general partners of Terre Haute MOB, L.P. are indemnified by
    the partnership pursuant to the partnership agreement for all
    actions relating to their performance or nonperformance on
    behalf of the partnership.
II-10
Table of Contents
Kentucky
    Registrants
(a) Frankfort Hospital, Inc. and Greenview Hospital,
    Inc. are incorporated under the laws of Kentucky.
Sections 271B.8-500
to 271B.8-580 of the Kentucky Business Corporation Act; provides
    that, subject to restrictions contained in the statute, a
    corporation may indemnify any person made or threatened to be
    made a party to any threatened, pending or completed action,
    suit or proceeding by reason of the fact that he is or was a
    director or officer of the corporation. A person who has been
    successful on the merits or otherwise in any suit or matter
    covered by the indemnification statute shall be indemnified
    against expenses (including attorneys' fees) reasonably
    incurred by him in connection therewith. Indemnification is
    authorized upon a determination that the person to be
    indemnified has met the applicable standard of conduct required.
    Expenses incurred in defense may be paid in advance upon receipt
    by the corporation of a written affirmation by the director of
    his good faith belief that he has met the applicable standard of
    conduct required, a written undertaking by or on behalf of the
    director to repay such advance if it is ultimately determined
    that he did not meet the standard of conduct, and a
    determination that the facts then known to those making the
    determination would not preclude indemnification under the
    statute. The indemnification provided by statute shall not be
    deemed exclusive of any other rights to which those seeking
    indemnification may be entitled under any
by-law,
agreement, vote of shareholders or disinterested directors, or
    otherwise, which shall inure to the benefit of the heirs,
    executors and administrators of such a person. Insurance may be
    purchased on behalf of any person entitled to indemnification by
    the corporation against any liability incurred in an official
    capacity regardless of whether the person could be indemnified
    under the statute.
The bylaws of Frankfort Hospital, Inc. and Greenview Hospital,
    Inc. indemnify their officers and directors against all
    reasonable expense incurred by them in defending claims or
    suits, irrespective of the time of the occurrence of the claims
    or causes of action in such suits, made or brought against them
    as officers or directors of the corporation, and against all
    liability in such suits, except in such cases as involve gross
    negligence or willful misconduct in the performance of their
    duties. Such indemnification extends to the payment of judgments
    against such officers and directors and to reimbursement of
    amounts paid in settlement of such claims or actions and may
    apply to judgments in favor of the corporation or amounts paid
    in settlement to the corporation. Such indemnification also
    extends to the payment of counsel fees and expenses of such
    officers and directors in suits against them where successfully
    defended by them or where unsuccessfully defended, if there is
    no finding or judgment that the claim or action arose from the
    gross negligence or willful misconduct of such officers or
    directors. Such right of indemnification is not exclusive of any
    right to which such officer or director may be entitled as a
    matter of law and shall extend and apply to the estates of
    deceased officers and directors.
Louisiana
    Registrants
(a) Dauterive Hospital Corporation, Hamilton Medical
    Center, Inc., HCA Health Services of Louisiana, Inc., Notami
    Hospitals of Louisiana, Inc. and Women's and
    Children's Hospital, Inc. are incorporated under the laws
    of Louisiana.
Section 83 of the Louisiana Business Corporation Law
    provides that a corporation may indemnify any person who was or
    is a party or is threatened to be made a party to any action,
    suit or proceeding, whether civil, criminal, administrative, or
    investigative (other than an action by or in the right of the
    corporation), by reason of the fact that he is or was a director
    or officer of the corporation. The indemnity may include
    expenses, including attorneys' fees, judgments, fines, and
    amounts paid in settlement actually and reasonably incurred by
    him in connection with such action, suit, or proceeding if he
    acted in good faith and in a manner he reasonably believed to be
    in, or not opposed to, the best interests of the corporation,
    and, with respect to any criminal action or proceeding, had no
    reasonable cause to believe his conduct was unlawful.
    Section 83 further provides that a Louisiana corporation
    may indemnify officers and directors in an action by or in the
    right of the corporation under the same conditions except that
    no indemnification is permitted without judicial approval if the
    director or officer shall have been adjudged to be liable for
    willful or intentional misconduct in the performance of his duty
    to the corporation. Where an officer or director is successful
    on the merits or
II-11
Table of Contents
otherwise in any defense of any action referred to above or any
    claim therein, the corporation must indemnify him against such
    expenses that such officer or director actually incurred.
    Section 83 permits a corporation to pay expenses incurred
    by the officer or director in defending an action, suit or
    proceeding in advance of the final disposition thereof if
    approved by the board of directors.
The bylaws of each of the Louisiana corporations indemnify their
    officers and directors against all reasonable expense incurred
    by them in defending claims or suits, irrespective of the time
    of the occurrence of the claims or causes of action in such
    suits, made or brought against them as officers or directors of
    the corporation, and against all liability in such suits, except
    in such cases as involve gross negligence or willful misconduct
    in the performance of their duties. Such indemnification extends
    to the payment of judgments against such officers and directors
    and to reimbursement of amounts paid in settlement of such
    claims or actions and may apply to judgments in favor of the
    corporation or amounts paid in settlement to the corporation.
    Such indemnification also extends to the payment of counsel fees
    and expenses of such officers and directors in suits against
    them where successfully defended by them or where unsuccessfully
    defended, if there is no finding or judgment that the claim or
    action arose from the gross negligence or willful misconduct of
    such officers or directors. Such right of indemnification is not
    exclusive of any right to which such officer or director may be
    entitled as a matter of law and shall extend and apply to the
    estates of deceased officers and directors.
Mississippi
    Registrant
(a) Brookwood Medical Center of Gulfport, Inc. is
    incorporated under the laws of Mississippi.
Article 8, Subarticle E of the Mississippi Business
    Corporation Act ("MBCA") permits Mississippi
    corporations to indemnify officers and directors. MBCA
Section 79-4-2.02(b)(5)
permits the corporation to include an obligatory indemnification
    for directors in its Articles of Incorporation for all acts
    other than: (i) distributions made in excess of standards
    established by Mississippi law or in the corporation's
    articles of incorporation, for which
Section 79-4-8.33
imposes personal liability on directors to the corporation; and
    (ii) circumstances where, in his performance as a director,
    a director has received a financial benefit to which he is not
    entitled, he intentionally inflicts harm on the corporation or
    its stockholders or he intentionally violates any criminal law.
    The law further permits us to advance all expenses for defense
    of a director in any lawsuit brought against a director in his
    capacity as a director. The MBCA specifically provides in
Section 79-4-8.53
that such advances are allowed by Mississippi law. Such advances
    may be made under the MBCA only after a determination that the
    director met all relevant standards of conduct.
Section 79-4-8.56
of the MBCA permits a Mississippi corporation to indemnify any
    officer to the same extent as to a director. Indemnification of
    officers and directors against reasonable expenses is mandatory
    under
Section 79-4-8.52
of the MBCA to the extent the officer or director is successful
    on the merits or otherwise in the defense of any action or suit
    against him giving rise to a claim of indemnification.
The bylaws of Brookwood Medical Center of Gulfport, Inc
    indemnify its officers and directors against all reasonable
    expense incurred by them in defending claims or suits,
    irrespective of the time of the occurrence of the claims or
    causes of action in such suits, made or brought against them as
    officers or directors of the corporation, and against all
    liability in such suits, except in such cases as involve gross
    negligence or willful misconduct in the performance of their
    duties. Such indemnification extends to the payment of judgments
    against such officers and directors and to reimbursement of
    amounts paid in settlement of such claims or actions and may
    apply to judgments in favor of the corporation or amounts paid
    in settlement to the corporation. Such indemnification also
    extends to the payment of counsel fees and expenses of such
    officers and directors in suits against them where successfully
    defended by them or where unsuccessfully defended, if there is
    no finding or judgment that the claim or action arose from the
    gross negligence or willful misconduct of such officers or
    directors. Such right of indemnification is not exclusive of any
    right to which such officer or director may be entitled as a
    matter of law and shall extend and apply to the estates of
    deceased officers and directors.
II-12
Table of Contents
Missouri
    Registrants
(a) Health Midwest Office Facilities Corporation and
    Health Midwest Ventures Group, Inc. are incorporated under the
    laws of Missouri.
Section 351.355(1) of the Revised Statutes of Missouri
    provides that a corporation may indemnify a director or officer
    of the corporation in any action, suit or proceeding other than
    an action by or in the right of the corporation, against
    expenses (including attorneys' fees), judgments, fines and
    settlement amounts actually and reasonably incurred by him in
    connection with such action, suit or proceeding if he acted in
    good faith and in a manner he reasonably believed to be in or
    not opposed to the best interests of the corporation and, with
    respect to any criminal action, had no reasonable cause to
    believe his conduct was unlawful. Section 351.355(2)
    provides that the corporation may indemnify any such person in
    any action or suit by or in the right of the corporation against
    expenses (including attorneys' fees) and settlement amounts
    actually and reasonably incurred by him in connection with the
    defense or settlement of the action or suit if he acted in good
    faith and in a manner he reasonably believed to be in or not
    opposed to the best interests of the corporation, except that he
    may not be indemnified in respect of any matter in which he has
    been adjudged liable for negligence or misconduct in the
    performance of his duty to the corporation, unless authorized by
    the court. Section 351.355(3) provides that a corporation
    shall indemnify any such person against expenses (including
    attorneys' fees) actually and reasonably incurred by him in
    connection with the action, suit or proceeding if he has been
    successful in defense of such action, suit or proceeding and if
    such action, suit or proceeding is one for which the corporation
    may indemnify him under Section 351.355(1) or (2).
    Section 351.355(7) provides that a corporation shall have
    the power to give any further indemnity to any such person, in
    addition to the indemnity otherwise authorized under
    Section 351.355, provided such further indemnity is either
    (i) authorized, directed or provided for in the articles of
    incorporation of the corporation or any duly adopted amendment
    thereof or (ii) is authorized, directed or provided for in
    any bylaw or agreement of the corporation which has been adopted
    by a vote of the shareholders of the corporation, provided that
    no such indemnity shall indemnify any person from or on account
    of such person's conduct which was finally adjudged to have
    been knowingly fraudulent, deliberately dishonest or willful
    misconduct.
The bylaws of both Health Midwest Office Facilities Corporation
    and Health Midwest Ventures Group, Inc indemnify their officers
    and directors against all reasonable expense incurred by them in
    defending claims or suits, irrespective of the time of the
    occurrence of the claims or causes of action in such suits, made
    or brought against them as officers or directors of the
    corporation, and against all liability in such suits, except in
    such cases as involve gross negligence or willful misconduct in
    the performance of their duties. Such indemnification extends to
    the payment of judgments against such officers and directors and
    to reimbursement of amounts paid in settlement of such claims or
    actions and may apply to judgments in favor of the corporation
    or amounts paid in settlement to the corporation. Such
    indemnification also extends to the payment of counsel fees and
    expenses of such officers and directors in suits against them
    where successfully defended by them or where unsuccessfully
    defended, if there is no finding or judgment that the claim or
    action arose from the gross negligence or willful misconduct of
    such officers or directors. Such right of indemnification is not
    exclusive of any right to which such officer or director may be
    entitled as a matter of law and shall extend and apply to the
    estates of deceased officers and directors.
(b) Midwest Division — RBH, LLC is registered
    under the laws of Missouri.
The operating agreement of Midwest Division — RBH, LLC
    indemnifies its officers and managers against all reasonable
    expense incurred by them in defending claims or suits,
    irrespective of the time of the occurrence of the claims or
    causes of action in such suits, made or brought against them as
    officers or directors of the company, and against all liability
    in such suits, except in such cases as involve gross negligence
    or willful misconduct in the performance of their duties. Such
    indemnification extends to the payment of judgments against such
    officers and directors and to reimbursement of amounts paid in
    settlement of such claims or actions and may apply to judgments
    in favor of the company or amounts paid in settlement to the
    company. Such indemnification also extends to the payment of
    counsel fees and expenses of such officers and managers in suits
    against them where successfully defended by them or where
    unsuccessfully defended, if there is no finding or judgment that
    the claim or action arose from the gross negligence or willful
    misconduct of such
II-13
Table of Contents
officers or managers. Such right of indemnification is not
    exclusive of any right to which such officer or manager may be
    entitled as a matter of law and shall extend and apply to the
    estates of deceased officers and managers.
The Missouri Limited Liability Company Act is silent with
    respect to the limits of a limited liability company's
    ability to provide for the indemnification of its officers and
    managers in its operating agreement. However,
    Section 347.081(2) states that it is the policy of the
    Missouri Limited Liability Company Act to give the maximum
    effect to the principle of freedom of contract and to the
    enforceability of operating agreements.
Nevada
    Registrants
(a) Las Vegas Surgicare, Inc., Sunrise Mountainview
    Hospital, Inc., VH Holdco, Inc., VH Holdings, Inc. and Western
    Plains Capital, Inc. are incorporated under the laws of
    Nevada.
Chapter 78 of the Nevada Revised Statutes ("NRS")
    allows directors and officers to be indemnified against
    liabilities they may incur while serving in such capacities.
    Under the applicable statutory provisions, the registrant may
    indemnify its directors or officers who were or are a party or
    are threatened to be made a party to any threatened, pending, or
    completed action, suit, or proceeding, whether civil, criminal,
    administrative, or investigative, by reason of the fact that
    they are or were directors or officers of the corporation, or
    are or were serving at the request of the corporation as
    directors or officers of another corporation, partnership, joint
    venture, trust, or other enterprise, against expenses, including
    attorneys' fees, judgments, fines, and amounts paid in
    settlement, actually and reasonably incurred by them in
    connection with the action, suit, or proceeding, unless it is
    ultimately determined by a court of competent jurisdiction that
    they breached their fiduciary duties by intentional misconduct,
    fraud, or a knowing violation of law or did not act in good
    faith and in a manner which they reasonably believed to be in or
    not opposed to the best interests of the registrant, and, with
    respect to any criminal action or proceeding, had no reasonable
    cause to believe their conduct was unlawful. In addition, the
    applicable statutory provisions mandate that the registrant
    indemnify its directors and officers who have been successful on
    the merits or otherwise in defense of any action, suit, or
    proceeding against expenses, including attorneys' fees,
    actually and reasonably incurred by him in connection with the
    defense. The registrant will advance expenses incurred by
    directors or officers in defending any such action, suit, or
    proceeding upon receipt of written confirmation from such
    officers or directors that they have met certain standards of
    conduct and an undertaking by or on behalf of such officers or
    directors to repay such advances if it is ultimately determined
    that they are not entitled to indemnification by the registrant.
The bylaws of all the Nevada corporate registrants indemnify
    their officers and directors against all reasonable expense
    incurred by them in defending claims or suits, irrespective of
    the time of the occurrence of the claims or causes of action in
    such suits, made or brought against them as officers or
    directors of the corporation, and against all liability in such
    suits, except in such cases as involve gross negligence or
    willful misconduct in the performance of their duties. Such
    indemnification extends to the payment of judgments against such
    officers and directors and to reimbursement of amounts paid in
    settlement of such claims or actions and may apply to judgments
    in favor of the corporation or amounts paid in settlement to the
    corporation. Such indemnification also extends to the payment of
    counsel fees and expenses of such officers and directors in
    suits against them where successfully defended by them or where
    unsuccessfully defended, if there is no finding or judgment that
    the claim or action arose from the gross negligence or willful
    misconduct of such officers or directors. Such right of
    indemnification is not exclusive of any right to which such
    officer or director may be entitled as a matter of law and shall
    extend and apply to the estates of deceased officers and
    directors.
(b) Southern Hills Medical Center, LLC is registered
    under the laws of Nevada.
Section 86.411 of the NRS permits a limited liability
    company to indemnify any person who was or is a party or is
    threatened to be made a party to any threatened, pending or
    completed action, suit or proceeding (except an action by or in
    the right of the limited liability company), by reason of being
    or having been a manager or member of the limited liability
    company. As with corporations, indemnification may include
    attorneys' fees, judgments, fines and amounts paid in
    settlement actually and reasonably incurred by the person to be
    indemnified. Section 86.421 of the NRS permits a limited
    liability company to indemnify any
II-14
Table of Contents
person who was or is a party or is threatened to be made a party
    to any threatened, pending or completed action or suit by or in
    the right of the limited liability company to procure a judgment
    in its favor by reason of being or having been a manager or
    member of the limited liability company except that
    indemnification may not be made for any claim, issue or matter
    as to which such a person has been finally adjudged by a court
    of competent jurisdiction to be liable to the limited liability
    company or for amounts paid in settlement to the limited
    liability company, unless and only to the extent that the court
    in which the action or suit was brought or other court of
    competent jurisdiction determines upon application that, in view
    of all the circumstances, the person is fairly and reasonably
    entitled to indemnity for such expenses as the court deems
    proper. In either case, however, to be entitled to
    indemnification, the person to be indemnified must have acted in
    good faith and in a manner which he or she reasonably believed
    to be in or not opposed to the best interests of the limited
    liability company and, with respect to any criminal action or
    proceeding, had no reasonable cause to believe his or her
    conduct was unlawful.
Section 86.431 of the NRS also provides that to the extent
    a manager or member of a limited liability company has been
    successful on the merits or otherwise in defense of any such
    action, he or she must be indemnified by the limited liability
    company against expenses, including attorneys' fees
    actually and reasonably incurred in connection with the defense.
Section 86.441 of the NRS permits a limited liability
    company, in its articles of organization, operating agreement or
    other agreement, to provide for the payment of expenses incurred
    by members or managers in defending any civil or criminal
    action, suit or proceeding as they are incurred and in advance
    of the final disposition of the action, suit or proceeding, upon
    receipt of an undertaking to repay the amount if it is
    ultimately determined by a court of competent jurisdiction that
    the person is not entitled to indemnification.
Section 86.461 of the NRS permits a limited liability
    company to purchase and maintain insurance or make other
    financial arrangements on behalf of the limited liability
    company's managers or members for any liability and
    expenses incurred by them in their capacities as managers or
    members or arising out of their status as such, whether or not
    the limited liability company has the authority to indemnify
    him, her or them against such liability and expenses.
The operating agreement of Southern Hills Medical Center, LLC
    indemnifies its officers and managers against all reasonable
    expense incurred by them in defending claims or suits,
    irrespective of the time of the occurrence of the claims or
    causes of action in such suits, made or brought against them as
    officers or managers of the company, and against all liability
    in such suits, except in such cases as involve gross negligence
    or willful misconduct in the performance of their duties. Such
    indemnification extends to the payment of judgments against such
    officers and managers and to reimbursement of amounts paid in
    settlement of such claims or actions and may apply to judgments
    in favor of the company or amounts paid in settlement to the
    company. Such indemnification also extends to the payment of
    counsel fees and expenses of such officers and managers in suits
    against them where successfully defended by them or where
    unsuccessfully defended, if there is no finding or judgment that
    the claim or action arose from the gross negligence or willful
    misconduct of such officers or managers. Such right of
    indemnification is not exclusive of any right to which such
    officer or manager may be entitled as a matter of law and shall
    extend and apply to the estates of deceased officers and
    managers.
Oklahoma
    Registrant
(a) HCA Health Services of Oklahoma, Inc. is
    incorporated under the laws of Oklahoma.
Section 1031 of the Oklahoma General Corporation Act
    provides that an Oklahoma corporation may indemnify any persons,
    including officers and directors, who are, or are threatened to
    be made, parties to any threatened, pending or completed legal
    action, suit or proceeding, whether civil, criminal,
    administrative or investigative (other than an action by or in
    the right of such corporation), by reason of the fact that such
    person was an officer or director of such corporation, or is or
    was serving at the request of such corporation as a director,
    officer, employee or agent of another corporation or enterprise.
    The indemnity may include expenses (including attorneys'
    fees), judgments, fines and amounts paid in settlement actually
    and reasonably incurred by such person in connection with such
    action, suit or proceeding, provided such officer or director
II-15
Table of Contents
acted in good faith and in a manner he reasonably believed to be
    in or not opposed to the corporation's best interests and,
    for criminal proceedings, had no reasonable cause to believe
    that his conduct was illegal. An Oklahoma corporation may
    indemnify officers and directors in an action by or in the right
    of the corporation under the same conditions, except that no
    indemnification is permitted without judicial approval if the
    officer or director is adjudged to be liable to the corporation.
    Where an officer or director is successful on the merits or
    otherwise in the defense of any action referred to above, the
    corporation must indemnify him against the expenses which such
    officer or director actually and reasonably incurred.
The bylaws of HCA Health Services of Oklahoma indemnify its
    officers and directors against all reasonable expense incurred
    by them in defending claims or suits, irrespective of the time
    of the occurrence of the claims or causes of action in such
    suits, made or brought against them as officers or directors of
    the corporation, and against all liability in such suits, except
    in such cases as involve gross negligence or willful misconduct
    in the performance of their duties. Such indemnification extends
    to the payment of judgments against such officers and directors
    and to reimbursement of amounts paid in settlement of such
    claims or actions and may apply to judgments in favor of the
    corporation or amounts paid in settlement to the corporation.
    Such indemnification also extends to the payment of counsel fees
    and expenses of such officers and directors in suits against
    them where successfully defended by them or where unsuccessfully
    defended, if there is no finding or judgment that the claim or
    action arose from the gross negligence or willful misconduct of
    such officers or directors. Such right of indemnification is not
    exclusive of any right to which such officer or director may be
    entitled as a matter of law and shall extend and apply to the
    estates of deceased officers and directors.
South
    Carolina Registrant
(a) Walterboro Community Hospital, Inc. is incorporated
    under the laws of South Carolina.
Under Section 33 of the South Carolina Code of Laws, a
    corporation may indemnify an individual made a party to a
    proceeding because he is or was a director or officer against
    liability incurred in the proceeding if: (1) he conducted
    himself in good faith; and (2) he reasonably believed:
    (i) in the case of conduct in his official capacity with
    the corporation, that his conduct was in its best interest; and
    (ii) in all other cases, that his conduct was at least not
    opposed to its best interest; and (3) in the case of any
    criminal proceeding, he had no reasonable cause to believe his
    conduct was unlawful.
The bylaws of Walterboro Community Hospital, Inc indemnify its
    officers and directors against all reasonable expense incurred
    by them in defending claims or suits, irrespective of the time
    of the occurrence of the claims or causes of action in such
    suits, made or brought against them as officers or directors of
    the corporation, and against all liability in such suits, except
    in such cases as involve gross negligence or willful misconduct
    in the performance of their duties. Such indemnification extends
    to the payment of judgments against such officers and directors
    and to reimbursement of amounts paid in settlement of such
    claims or actions and may apply to judgments in favor of the
    corporation or amounts paid in settlement to the corporation.
    Such indemnification also extends to the payment of counsel fees
    and expenses of such officers and directors in suits against
    them where successfully defended by them or where unsuccessfully
    defended, if there is no finding or judgment that the claim or
    action arose from the gross negligence or willful misconduct of
    such officers or directors. Such right of indemnification is not
    exclusive of any right to which such officer or director may be
    entitled as a matter of law and shall extend and apply to the
    estates of deceased officers and directors.
Tennessee
    Registrants
(a) Central Tennessee Hospital Corporation, HCA Central
    Group, Inc., HCA Health Services of Tennessee, Inc., HCA Realty,
    Inc., Hendersonville Hospital Corporation, Hospital Corporation
    of Tennessee, HTI Memorial Hospital Corporation, Spring Hill
    Hospital, Inc. and TCMC
Madison-Portland,
Inc. are incorporated under the laws of Tennessee.
The Tennessee Business Corporation Act ("TBCA") sets
    forth in
Sections 48-18-502
through
48-18-508
the circumstances governing the indemnification of directors and
    officers of a corporation against liability
II-16
Table of Contents
incurred in the course of their official capacities.
Section 48-18-502
of the TBCA provides that a corporation may indemnify any
    director against liability incurred in connection with a
    proceeding if (i) the director acted in good faith,
    (ii) the director reasonably believed, in the case of
    conduct in his or her official capacity with the corporation,
    that such conduct was in the corporation's best interest,
    or, in all other cases, that his or her conduct was not opposed
    to the best interests of the corporation and (iii) in
    connection with any criminal proceeding, the director had no
    reasonable cause to believe that his or her conduct was
    unlawful. In actions brought by or in the right of the
    corporation, however, the TBCA provides that no indemnification
    may be made if the director or officer is adjudged to be liable
    to the corporation. Similarly, the TBCA prohibits
    indemnification in connection with any proceeding charging
    improper personal benefit to a director, if such director is
    adjudged liable on the basis that a personal benefit was
    improperly received. In cases where the director is wholly
    successful, on the merits or otherwise, in the defense of any
    proceeding instigated because of his or her status as a director
    of a corporation,
Section 48-18-503
of the TBCA mandates that the corporation indemnify the director
    against reasonable expenses incurred in the proceeding.
    Notwithstanding the foregoing,
Section 48-18-505
of the TBCA provides that a court of competent jurisdiction,
    upon application, may order that a director or officer be
    indemnified for reasonable expense if, in consideration of all
    relevant circumstances, the court determines that such
    individual is fairly and reasonably entitled to indemnification,
    whether or not the standard of conduct set forth above was met.
    Officers who are not directors are entitled, through the
    provisions of
Section 48-18-507
of the TBCA, to the same indemnification afforded to directors
    under
Sections 48-18-503
and
48-18-505.
The bylaws of each of the Tennessee corporations indemnify its
    officers and directors against all reasonable expense incurred
    by them in defending claims or suits, irrespective of the time
    of the occurrence of the claims or causes of action in such
    suits, made or brought against them as officers or directors of
    the corporation, and against all liability in such suits, except
    in such cases as involve gross negligence or willful misconduct
    in the performance of their duties. Such indemnification extends
    to the payment of judgments against such officers and directors
    and to reimbursement of amounts paid in settlement of such
    claims or actions and may apply to judgments in favor of the
    corporation or amounts paid in settlement to the corporation.
    Such indemnification also extends to the payment of counsel fees
    and expenses of such officers and directors in suits against
    them where successfully defended by them or where unsuccessfully
    defended, if there is no finding or judgment that the claim or
    action arose from the gross negligence or willful misconduct of
    such officers or directors. Such right of indemnification is not
    exclusive of any right to which such officer or director may be
    entitled as a matter of law and shall extend and apply to the
    estates of deceased officers and directors.
Texas
    Registrants
(a) Columbia Medical Center of Las Colinas, Inc., Conroe
    Hospital Corporation, El Paso Surgicenter, Inc.,
    KPH-Consolidation, Inc., National Patient Account Services,
    Inc., Pasadena Bayshore Hospital, Inc., Rio Grande Regional
    Hospital, Inc., Spring Branch Medical Center, Inc., Surgicare of
    Houston Women's, Inc., W & C Hospital, Inc.,
    WHMC, Inc. and Woman's Hospital of Texas, Incorporated are
    incorporated under the laws of Texas.
Under
Article 2.02-1
of the Texas Business Corporation Act ("TBCA"), a
    company may indemnify any person who was, is or is threatened to
    be made a named defendant or respondent in a proceeding because
    the person is or was a director or officer against judgment,
    penalties (including excise and similar taxes), fines,
    settlements, and reasonable expenses (including court costs and
    attorneys' fees) actually incurred by the person in
    connection with the proceeding if it is determined that the
    person seeking indemnification acted in good faith, reasonably
    believed that his or her conduct was in or at least not opposed
    to our best interests and, in the case of a criminal proceeding,
    has no reasonable cause to believe his or her conduct was
    unlawful.
A company is required by
Article 2.02-1
of the TBCA to indemnify a director or officer against
    reasonable expenses (including court costs and attorneys'
    fees) incurred by the director or officer in connection with a
    proceeding in which the director or officer is a named defendant
    or respondent because the director or officer is or was in that
    position if the director or officer has been wholly successful,
    on the merits or otherwise, in the defense of the proceeding.
    The TBCA prohibits a company from indemnifying a director or
II-17
Table of Contents
officer in respect of a proceeding in which the person is found
    liable to the company or on the basis that a personal benefit
    was improperly received by him or her, other than for reasonable
    expenses (including court costs and attorneys' fees)
    actually incurred by him or her in connection with the
    proceeding; provided, that the TBCA further prohibits a company
    from indemnifying a director or officer in respect of any such
    proceeding in which the person is found liable for willful or
    intentional misconduct in the performance of his or her duties.
Under
Article 2.02-1(J)
of the TBCA, a court of competent jurisdiction may order a
    company to indemnify a director or officer if the court
    determines that the director or officer is fairly and reasonably
    entitled to indemnification in view of all the relevant
    circumstances; however, if the director or officer is found
    liable to the company or is found liable on the basis that a
    personal benefit was improperly received by him or her, the
    indemnification will be limited to reasonable expenses
    (including court costs and attorneys' fees) actually
    incurred by him or her in connection with the proceeding.
The bylaws of each of the Texas corporations indemnity its
    officers and directors against all reasonable expense incurred
    by them in defending claims or suits, irrespective of the time
    of the occurrence of the claims or causes of action in such
    suits, made or brought against them as officers or directors of
    the corporation, and against all liability in such suits, except
    in such cases as involve gross negligence or willful misconduct
    in the performance of their duties. Such indemnification extends
    to the payment of judgments against such officers and directors
    and to reimbursement of amounts paid in settlement of such
    claims or actions and may apply to judgments in favor of the
    corporation or amounts paid in settlement to the corporation.
    Such indemnification also extends to the payment of counsel fees
    and expenses of such officers and directors in suits against
    them where successfully defended by them or where unsuccessfully
    defended, if there is no finding or judgment that the claim or
    action arose from the gross negligence or willful misconduct of
    such officers or directors. Such right of indemnification is not
    exclusive of any right to which such officer or director may be
    entitled as a matter of law and shall extend and apply to the
    estates of deceased officers and directors.
(b) Columbia Medical Center of Arlington Subsidiary,
    L.P., Columbia Medical Center of Denton Subsidiary, L.P.,
    Columbia Medical Center of Lewisville Subsidiary, L.P., Columbia
    Medical Center of McKinney Subsidiary, L.P., Columbia Medical
    Center of Plano Subsidiary, L.P., Columbia North Hills Hospital
    Subsidiary, L.P., Columbia Plaza Medical Center of
    Fort Worth Subsidiary, L.P. and Green Oaks Hospital
    Subsidiary, L.P. are registered under the laws of Texas.
Article 11 of the Texas Revised Limited Partnership Act
    ("TRLPA") provides for the indemnification of a
    general partner or limited partner by the limited partnership
    under certain circumstances against expenses and liabilities
    incurred in legal proceedings involving such persons because of
    their being or having been a general partner or limited partner.
    Under the TRLPA, a limited partnership may purchase insurance on
    behalf of a general partner or limited partner against any
    liability incurred regardless of whether the person could be
    indemnified under the TLRPA.
The partnership agreement of each Texas limited partnership
    indemnifies the general partners to the fullest extent permitted
    under the TRLPA.
Utah
    Registrants
(a) Brigham City Community Hospital, Inc., Columbia
    Ogden Medical Center, Inc., Hospital Corporation of Utah,
    Mountain View Hospital, Inc., Northern Utah Healthcare
    Corporation, St. Mark's Lone Peak Hospital, Inc. and
    Timpanogos Regional Medical Services, Inc. are incorporated
    under the laws of Utah.
Section 16-10a-902
of the Utah Revised Business Corporation Act (the "Revised
    Act") provides that a corporation may indemnify any
    individual who was, is, or is threatened to be made a named
    defendant or respondent (a "Party") in any threatened,
    pending or completed action, suit or proceeding, whether civil,
    criminal, administrative or investigative and whether formal or
    informal (a "Proceeding"), because he or she is or was
    a director of the corporation against any obligation incurred
    with respect to a Proceeding, including any judgment,
    settlement, penalty, fine or reasonable expenses (including
    attorneys' fees), incurred in the
II-18
Table of Contents
Proceeding if his or her conduct was in good faith, he or she
    reasonably believed that his or her conduct was in, or not
    opposed to, the best interests of the corporation, and, in the
    case of any criminal Proceeding, had no reasonable cause to
    believe such conduct was unlawful; provided, however, that
    (i) pursuant to Subsection 902(5), indemnification under
    Section 902 in connection with a Proceeding by or in the
    right of the corporation is limited to payment of reasonable
    expenses (including attorneys' fees) incurred in connection
    with the Proceeding and (ii) pursuant to 902(4), the
    corporation may not indemnify an Indemnifiable Director in
    connection with a Proceeding by or in the right of the
    corporation in which the Indemnifiable Director was adjudged
    liable to the corporation, or in connection with any other
    Proceeding charging that the Indemnifiable Director derived an
    improper personal benefit, whether or not involving action in
    his or her official capacity, in which Proceeding he or she was
    adjudged liable on the basis that he or she derived an improper
    personal benefit.
Section 16-10a-907
of the Revised Act permits corporations to indemnify officers
    and advance expenses to the same extent as a director and in
    some cases to a greater extent than a director.
The bylaws of each of the Utah corporate registrants indemnify
    its officers and directors against all reasonable expense
    incurred by them in defending claims or suits, irrespective of
    the time of the occurrence of the claims or causes of action in
    such suits, made or brought against them as officers or
    directors of the corporation, and against all liability in such
    suits, except in such cases as involve gross negligence or
    willful misconduct in the performance of their duties. Such
    indemnification extends to the payment of judgments against such
    officers and directors and to reimbursement of amounts paid in
    settlement of such claims or actions and may apply to judgments
    in favor of the corporation or amounts paid in settlement to the
    corporation. Such indemnification also extends to the payment of
    counsel fees and expenses of such officers and directors in
    suits against them where successfully defended by them or where
    unsuccessfully defended, if there is no finding or judgment that
    the claim or action arose from the gross negligence or willful
    misconduct of such officers or directors. Such right of
    indemnification is not exclusive of any right to which such
    officer or director may be entitled as a matter of law and shall
    extend and apply to the estates of deceased officers and
    directors.
Virginia
    Registrants
(a) Capital Division, Inc., Chippenham &
    Johnston-Willis Hospitals, Inc., Columbia/Alleghany Regional
    Hospital, Incorporated, Columbia/HCA John Randolph, Inc., HCA
    Health Services of Virginia, Inc., Lewis-Gale Hospital,
    Incorporated, Montgomery Regional Hospital, Inc., Pulaski
    Community Hospital, Inc., Spotsylvania Medical Center, Inc and
    Virginia Psychiatric Company, Inc. are incorporated under the
    laws of Virginia.
Under
Sections 13.1-697
and 13.1-702 of the Virginia Stock Corporation Act, a Virginia
    corporation generally is authorized to indemnify its directors
    and officers in civil and criminal actions if they acted in good
    faith and believed their conduct to be in the best interests of
    the corporation and, in the case of criminal actions, had no
    reasonable cause to believe that the conduct was unlawful. In
    addition, the Virginia Stock Corporation Act eliminates the
    liability for monetary damages of a director or officer in a
    shareholder or derivative proceeding. This elimination of
    liability will not apply in the event of willful misconduct or a
    knowing violation of criminal law or any federal or state
    securities law.
Sections 13.1-692.1
and 13.1-696 through 704 of the Virginia Stock Corporation Act
    are incorporated into this paragraph by reference.
The bylaws of each of the Virginia corporate registrants
    indemnify its officers and directors against all reasonable
    expense incurred by them in defending claims or suits,
    irrespective of the time of the occurrence of the claims or
    causes of action in such suits, made or brought against them as
    officers or directors of the corporation, and against all
    liability in such suits, except in such cases as involve gross
    negligence or willful misconduct in the performance of their
    duties. Such indemnification extends to the payment of judgments
    against such officers and directors and to reimbursement of
    amounts paid in settlement of such claims or actions and may
    apply to judgments in favor of the corporation or amounts paid
    in settlement to the corporation. Such indemnification also
    extends to the payment of counsel fees and expenses of such
    officers and directors in suits against them where successfully
    defended by them or where unsuccessfully defended, if
II-19
Table of Contents
there is no finding or judgment that the claim or action arose
    from the gross negligence or willful misconduct of such officers
    or directors. Such right of indemnification is not exclusive of
    any right to which such officer or director may be entitled as a
    matter of law and shall extend and apply to the estates of
    deceased officers and directors.
(b) Central Shared Services, LLC, Galen Property, LLC,
    Lewis-Gale Physicians, LLC, Northern Virginia Community
    Hospital, LLC and Retreat Hospital, LLC are registered under the
    laws of Virginia.
Section 13.1-1009(16)
of the Virginia Limited Liability Company Act permits a limited
    liability company to indemnify and hold harmless any member or
    manager or other person from and against any and all claims and
    demands whatsoever, and to pay for or reimburse any member or
    manager or other person for reasonable expenses incurred by such
    a person who is a party to a proceeding in advance of final
    disposition of the proceeding.
The operating agreements of each of the Virginia limited
    liability companies indemnifies its officers and managers
    against all reasonable expense incurred by them in defending
    claims or suits, irrespective of the time of the occurrence of
    the claims or causes of action in such suits, made or brought
    against them as officers or managers of the company, and against
    all liability in such suits, except in such cases as involve
    gross negligence or willful misconduct in the performance of
    their duties. Such indemnification extends to the payment of
    judgments against such officers and managers and to
    reimbursement of amounts paid in settlement of such claims or
    actions and may apply to judgments in favor of the company or
    amounts paid in settlement to the company. Such indemnification
    also extends to the payment of counsel fees and expenses of such
    officers and managers in suits against them where successfully
    defended by them or where unsuccessfully defended, if there is
    no finding or judgment that the claim or action arose from the
    gross negligence or willful misconduct of such officers or
    managers. Such right of indemnification is not exclusive of any
    right to which such officer or manager may be entitled as a
    matter of law and shall extend and apply to the estates of
    deceased officers and managers.
(c) HSS Virginia, L.P. is registered under the laws of
    Virginia
HSS Virginia, L.P. is governed by the Virginia Revised Uniform
    Limited Partnership Act. However, neither the partnership
    agreement nor the Virginia Revised Uniform Partnership Act
    specify the extent to which a limited partnership may indemnify
    its general partners.
West
    Virginia Registrant
(a) Columbia Parkersburg Healthcare System, LLC is
    registered under the laws of West Virginia.
Section 31B-4-403
of the West Virginia Uniform Limited Liability Company Act
    discusses members' and managers' rights to payments
    and reimbursement. A limited liability company shall reimburse a
    member or manager for payments made and indemnify a member or
    manager for liabilities incurred by the member or manager in the
    ordinary course of the business of the company or for the
    preservation of its business or property. A limited liability
    company shall reimburse a member for an advance to the company
    beyond the amount of contribution the member agreed to make. A
    payment or advance made by a member which gives rise to an
    obligation of a limited liability company under the West
    Virginia statute constitutes a loan to the company upon which
    interest accrues from the date of the payment or advance. A
    member is not entitled to remuneration for services performed
    for a limited liability company, except for reasonable
    compensation for services rendered in winding up the business of
    the company.
The organizational documents of Columbia Parkersburg Healthcare
    System, LLC indemnify its managers and officers to the fullest
    extent of the West Virginia Uniform Limited Liability Company
    Act.
II-20
Table of Contents
Certain
    Other Arrangements
HCA Inc. maintains a directors' and officers'
    liability insurance policy that covers the directors and
    officers of each of the registrants in amounts that HCA Inc.
    believes are customary in its industry, including for
    liabilities in connection with the registration, offering and
    sale of the notes.
In addition, pursuant to the Management Agreement entered into
    with the Sponsors and their affiliates and the Frists, the
    Company has agreed to customary exculpation and indemnification
    provisions for the benefit of the Sponsors, the Frists, their
    affiliates, directors, officers and certain other persons. See
    the section of our fiscal 2008
Form 10-K
captioned "Certain Relationships and Related Transactions,
    and Director Independence — Sponsor Management
    Agreement."
Item 15.
Recent
    Sales of Unregistered Securities
On November 17, 2006, we issued $4.200 billion of
    senior secured notes (comprised of $1.000 billion of
    9
1
/
8
% notes
    due 2014 and $3.200 billion of
    9
1
/
4
% notes
    due 2016) and $1.500 billion of
    9
5
/
8
%/10
3
/
8
% senior
    secured toggle notes due 2016 the proceeds of which were used to
    finance the acquisition by certain investors if HCA Inc.
On February 19, 2009, we issued $310 million aggregate
    principal amount of senior secured notes due 2017 at a price of
    96.673% of their face value resulting in approximately
    $300 million of gross proceeds, which were used to repay
    outstanding indebtedness under our cash flow credit facility.
On April 22, 2009, we issued $1.500 billion aggregate
    principal amount of senior secured notes due 2019 at a price of
    96.755% of their face value resulting in approximately
    $1.451 billion of gross proceeds, which were used to repay
    outstanding indebtedness under our cash flow credit facility.
Each of the above transactions was offered to qualified
    institutional buyers pursuant to Rule 144A under the
    Securities Act or to
non-U.S. investors
outside the United States in compliance with Regulation S
    of the Securities Act.
Item 16.
Exhibits
    and Financial Statement Schedules.
(a)
Exhibits
2
.1
Agreement and Plan of Merger, dated July 24, 2006, by and
    among HCA Inc., Hercules Holding II, LLC and Hercules
    Acquisition Corporation (filed as Exhibit 2.1 to the
    Company's Current Report on
Form 8-K
filed July 25, 2006, and incorporated herein by reference).
3
.1
Amended and Restated Certificate of Incorporation of the Company
    (filed as Exhibit 3.1 to the Company's Annual Report
    on
Form 10-K
for the fiscal year ended December 31, 2007, and
    incorporated herein by reference).
3
.2
Amended and Restated Bylaws of the Company (filed as
    Exhibit 3.2 to the Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007, and
    incorporated herein by reference).
3
.3
American Medicorp Development Co. Articles of Incorporation*
3
.4
American Medicorp Development Co. By-Laws*
3
.5
Bay Hospital, Inc. Articles of Incorporation (filed as
    Exhibit 3.5 to the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.6
Bay Hospital, Inc. By-Laws. (filed as Exhibit 3.6 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.7
Brigham City Community Hospital, Inc. Articles of Incorporation.
    (filed as Exhibit 3.7 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.8
Brigham City Community Hospital, Inc. By-Laws. (filed as
    Exhibit 3.8 to the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
II-21
Table of Contents
3
.9
Brookwood Medical Center of Gulfport, Inc. Certificate of
    Incorporation (filed as Exhibit 3.9 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.10
Brookwood Medical Center of Gulfport, Inc. By-Laws (filed as
    Exhibit 3.10 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.11
Capital Division, Inc. Articles of Incorporation (filed as
    Exhibit 3.11 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.12
Capital Division, Inc. By-Laws (filed as Exhibit 3.12 to
    the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.13
Centerpoint Medical Center of Independence, LLC Certificate of
    Formation (filed as Exhibit 3.13 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.14
Centerpoint Medical Center of Independence, LLC Limited
    Liability Company Agreement (filed as Exhibit 3.14 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.15
Central Florida Regional Hospital, Inc. Articles of
    Incorporation (filed as Exhibit 3.15 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.16
Central Florida Regional Hospital, Inc. By-Laws (filed as
    Exhibit 3.16 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.17
Central Shared Services, LLC Articles of Organization (filed as
    Exhibit 3.17 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.18
Central Shared Services, LLC Limited Liability Company Agreement
    (filed as Exhibit 3.18 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.19
Central Tennessee Hospital Corporation Charter (filed as
    Exhibit 3.19 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.20
Central Tennessee Hospital Corporation By-Laws (filed as
    Exhibit 3.20 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.21
CHCA Bayshore, L.P. Certificate of Limited Partnership (filed as
    Exhibit 3.21 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.22
CHCA Bayshore, L.P. Agreement of Limited Partnership (filed as
    Exhibit 3.22 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.23
CHCA Conroe, L.P. Certificate of Limited Partnership (filed as
    Exhibit 3.23 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.24
CHCA Conroe, L.P. Agreement of Limited Partnership (filed as
    Exhibit 3.24 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.25
CHCA Mainland, L.P. Certificate of Limited Partnership (filed as
    Exhibit 3.27 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.26
CHCA Mainland, L.P. Agreement of Limited Partnership (filed as
    Exhibit 3.28 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.27
CHCA West Houston, L.P. Certificate of Limited Partnership
    (filed as Exhibit 3.29 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.28
CHCA West Houston, L.P. Agreement of Limited Partnership (filed
    as Exhibit 3.30 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.29
CHCA Woman's Hospital, L.P. Certificate of Limited
    Partnership (filed as Exhibit 3.31 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
II-22
Table of Contents
3
.30
CHCA Woman's Hospital, L.P. Agreement of Limited
    Partnership (filed as Exhibit 3.32 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.31
Chippenham & Johnston-Willis Hospitals, Inc. Articles
    of Incorporation (filed as Exhibit 3.33 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.32
Chippenham & Johnston-Willis Hospitals, Inc. By-Laws
    (filed as Exhibit 3.34 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.33
CMS GP, LLC Certificate of Formation (filed as Exhibit 3.35
    to the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.34
CMS GP, LLC Limited Liability Company Agreement (filed as
    Exhibit 3.36 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.35
Colorado Health Systems, Inc. Articles of Incorporation (filed
    as Exhibit 3.37 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.36
Colorado Health Systems, Inc. By-Laws (filed as
    Exhibit 3.38 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.37
Columbia ASC Management, L.P. Certificate of Limited Partnership
    (filed as Exhibit 3.39 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.38
Columbia ASC Management, L.P. Agreement of Partnership (filed as
    Exhibit 3.40 to the Company's Registration Statement
    on
Form S-4
(File No. 333-145054), and incorporated herein by reference).
3
.39
Columbia Jacksonville Healthcare System, Inc. Articles of
    Incorporation (filed as Exhibit 3.41 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.40
Columbia Jacksonville Healthcare System, Inc. By-Laws (filed as
    Exhibit 3.42 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.41
Columbia LaGrange Hospital, Inc. Articles of Incorporation
    (filed as Exhibit 3.43 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.42
Columbia LaGrange Hospital, Inc. By-Laws (filed as
    Exhibit 3.44 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.43
Columbia Medical Center of Arlington Subsidiary, L.P.
    Certificate of Limited Partnership (filed as Exhibit 3.45
    to the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.44
Columbia Medical Center of Arlington Subsidiary, L.P. Agreement
    of Limited Partnership (filed as Exhibit 3.46 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.45
Columbia Medical Center of Denton Subsidiary, L.P. Certificate
    of Limited Partnership (filed as Exhibit 3.47 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.46
Columbia Medical Center of Denton Subsidiary, L.P. Agreement of
    Limited Partnership (filed as Exhibit 3.48 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.47
Columbia Medical Center of Las Colinas, Inc. Articles of
    Incorporation (filed as Exhibit 3.49 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.48
Columbia Medical Center of Las Colinas, Inc. By-Laws (filed as
    Exhibit 3.50 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.49
Columbia Medical Center of Lewisville Subsidiary, L.P.
    Certificate of Limited Partnership (filed as Exhibit 3.51
    to the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
II-23
Table of Contents
3
.50
Columbia Medical Center of Lewisville Subsidiary, L.P. Agreement
    of Limited Partnership (filed as Exhibit 3.52 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.51
Columbia Medical Center of McKinney Subsidiary, L.P. Certificate
    of Limited Partnership (filed as Exhibit 3.53 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.52
Columbia Medical Center of McKinney Subsidiary, L.P. Agreement
    of Limited Partnership (filed as Exhibit 3.54 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.53
Columbia Medical Center of Plano Subsidiary, L.P. Certificate of
    Limited Partnership (filed as Exhibit 3.55 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.54
Columbia Medical Center of Plano Subsidiary, L.P. Agreement of
    Limited Partnership (filed as Exhibit 3.56 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.55
Columbia North Hills Hospital Subsidiary, L.P. Certificate of
    Limited Partnership (filed as Exhibit 3.57 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.56
Columbia North Hills Hospital Subsidiary, L.P. Agreement of
    Limited Partnership (filed as Exhibit 3.58 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.57
Columbia Ogden Medical Center, Inc. Articles of Incorporation
    (filed as Exhibit 3.59 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.58
Columbia Ogden Medical Center, Inc. By-Laws (filed as
    Exhibit 3.60 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.59
Columbia Parkersburg Healthcare System, LLC Articles of
    Incorporation (filed as Exhibit 3.61 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.60
Columbia Parkersburg Healthcare System, LLC, Articles of
    Conversion.*
3
.61
Columbia Parkersburg Healthcare System, LLC Operating Agreement
    (filed as Exhibit 3.62 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.62
Columbia Plaza Medical Center of Fort Worth Subsidiary,
    L.P. Certificate of Limited Partnership (filed as
    Exhibit 3.63 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.63
Columbia Plaza Medical Center of Fort Worth Subsidiary,
    L.P. Agreement of Limited Partnership (filed as
    Exhibit 3.64 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.64
Columbia Polk General Hospital, Inc. Articles of Incorporation
    (filed as Exhibit 3.65 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.65
Columbia Polk General Hospital, Inc. By-Laws (filed as
    Exhibit 3.66 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.66
Columbia Rio Grande Healthcare, L.P. Certificate of Limited
    Partnership (filed as Exhibit 3.67 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.67
Columbia Rio Grande Healthcare, L.P. Amended and Restated
    Limited Partnership Agreement (filed as Exhibit 3.68 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.68
Columbia Riverside, Inc. Articles of Incorporation (filed as
    Exhibit 3.69 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
II-24
Table of Contents
3
.69
Columbia Riverside, Inc. By-Laws (filed as Exhibit 3.70 to
    the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.70
Columbia Valley Healthcare System, L.P. Certificate of Limited
    Partnership (filed as Exhibit 3.71 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.71
Columbia Valley Healthcare System, L.P. Amended and Restated
    Limited Partnership Agreement (filed as Exhibit 3.72 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.72
Columbia/Alleghany Regional Hospital, Incorporated Articles of
    Incorporation (filed as Exhibit 3.73 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.73
Columbia/Alleghany Regional Hospital, Incorporated By-Laws
    (filed as Exhibit 3.74 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.74
Columbia/HCA John Randolph, Inc. Articles of Incorporation
    (filed as Exhibit 3.75 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.75
Columbia/HCA John Randolph, Inc. By-Laws (filed as
    Exhibit 3.76 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.76
Columbine Psychiatric Center, Inc. Articles of Incorporation
    (filed as Exhibit 3.77 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.77
Columbine Psychiatric Center, Inc. By-Laws (filed as
    Exhibit 3.78 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.78
Columbus Cardiology, Inc. Certificate of Incorporation (filed as
    Exhibit 3.79 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.79
Columbus Cardiology, Inc. By-Laws (filed as Exhibit 3.80 to
    the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.80
Conroe Hospital Corporation Articles of Incorporation (filed as
    Exhibit 3.81 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.81
Conroe Hospital Corporation By-Laws (filed as Exhibit 3.82
    to the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.82
Dallas/Ft. Worth Physician, LLC Certificate of Formation
    (filed as Exhibit 3.83 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.83
Dallas/Ft. Worth Physician, LLC Limited Liability Company
    Agreement (filed as Exhibit 3.84 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.84
Dauterive Hospital Corporation Articles of Incorporation (filed
    as Exhibit 3.85 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.85
Dauterive Hospital Corporation By-Laws (filed as
    Exhibit 3.86 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.86
Dublin Community Hospital, LLC Limited Liability Company
    Agreement (filed as Exhibit 3.87 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.87
Dublin Community Hospital, LLC Articles of Organization (filed
    as Exhibit 3.88 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.88
Eastern Idaho Health Services, Inc. Articles of Incorporation
    (filed as Exhibit 3.89 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.89
Eastern Idaho Health Services, Inc. By-Laws (filed as
    Exhibit 3.90 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
II-25
Table of Contents
3
.90
Edmond Regional Medical Center, LLC Certificate of Formation
    (filed as Exhibit 3.91 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.91
Edmond Regional Medical Center, LLC Limited Liability Company
    Agreement (filed as Exhibit 3.92 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.92
Edward White Hospital, Inc. Articles of Incorporation (filed as
    Exhibit 3.95 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.93
Edward White Hospital, Inc. By-Laws (filed as Exhibit 3.96
    to the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.94
El Paso Surgicenter, Inc. Articles of Incorporation (filed
    as Exhibit 3.93 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.95
El Paso Surgicenter, Inc. By-Laws (filed as
    Exhibit 3.94 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.96
Encino Hospital Corporation, Inc. Articles of Incorporation
    (filed as Exhibit 3.97 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.97
Encino Hospital Corporation, Inc. By-Laws (filed as
    Exhibit 3.98 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.98
EP Health, LLC Limited Liability Company Agreement (filed as
    Exhibit 3.99 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.99
EP Health, LLC Limited Liability Company Agreement (filed as
    Exhibit 3.100 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.100
Fairview Park GP, LLC Certificate of Formation (filed as
    Exhibit 3.101 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.101
Fairview Park GP, LLC Limited Liability Company Agreement (filed
    as Exhibit 3.102 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.102
Fairview Park, Limited Partnership Certificate of Limited
    Partnership (filed as Exhibit 3.103 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.103
Fairview Park, Limited Partnership Agreement of Limited
    Partnership (filed as Exhibit 3.104 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.104
Frankfort Hospital, Inc. Articles of Incorporation (filed as
    Exhibit 3.105 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.105
Frankfort Hospital, Inc. By-Laws (filed as Exhibit 3.106 to
    the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.106
Galen Property, LLC Articles of Organization (filed as
    Exhibit 3.107 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.107
Galen Property, LLC Operating Agreement (filed as
    Exhibit 3.108 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.108
General Healthserv, LLC Certificate of Formation (filed as
    Exhibit 3.109 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.109
General Healthserv, LLC Limited Liability Company Agreement
    (filed as Exhibit 3.110 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.110
Good Samaritan Hospital, L.P. Certificate of Limited Partnership
    (filed as Exhibit 3.111 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.111
Good Samaritan Hospital, L.P. Agreement of Limited Partnership
    (filed as Exhibit 3.112 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
II-26
Table of Contents
3
.112
Goppert-Trinity Family Care, LLC Certificate of Formation (filed
    as Exhibit 3.113 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.113
Goppert-Trinity Family Care, LLC Limited Liability Company
    Agreement (filed as Exhibit 3.114 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.114
GPCH-GP, Inc. Certificate of Incorporation (filed as
    Exhibit 3.115 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.115
GPCH-GP, Inc. By-Laws (filed as Exhibit 3.116 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.116
Grand Strand Regional Medical Center, LLC Certificate of
    Formation (filed as Exhibit 3.117 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.117
Grand Strand Regional Medical Center, LLC Limited Liability
    Company Agreement (filed as Exhibit 3.118 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.118
Green Oaks Hospital Subsidiary, L.P. Certificate of Limited
    Partnership (filed as Exhibit 3.119 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.119
Green Oaks Hospital Subsidiary, L.P. Agreement of Limited
    Partnership (filed as Exhibit 3.120 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.120
Greenview Hospital, Inc. Articles of Incorporation (filed as
    Exhibit 3.121 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.121
Greenview Hospital, Inc. By-Laws (filed as Exhibit 3.122 to
    the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.122
Hamilton Medical Center, Inc. Articles of Incorporation (filed
    as Exhibit 3.123 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.123
Hamilton Medical Center, Inc. By-Laws (filed as
    Exhibit 3.124 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.124
HCA — IT&S Field Operations, Inc. Articles of
    Incorporation*
3
.125
HCA — IT&S Field Operations, Inc. By-Laws*
3
.126
HCA —  IT&S Inventory Management, Inc. Articles
    of Incorporation*
3
.127
HCA —  IT&S Inventory Management, Inc. By-Laws*
3
.128
HCA Central Group, Inc. Certificate of Incorporation (filed as
    Exhibit 3.125 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.129
HCA Central Group, Inc. By-Laws (filed as Exhibit 3.126 to
    the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.130
HCA Health Services of Florida, Inc. Articles of Incorporation
    (filed as Exhibit 3.127 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.131
HCA Health Services of Florida, Inc. By-Laws (filed as
    Exhibit 3.128 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.132
HCA Health Services of Louisiana, Inc. Articles of Incorporation
    (filed as Exhibit 3.129 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.133
HCA Health Services of Louisiana, Inc. By-Laws (filed as
    Exhibit 3.130 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.134
HCA Health Services of Oklahoma, Inc. Articles of Incorporation
    (filed as Exhibit 3.131 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
II-27
Table of Contents
3
.135
HCA Health Services of Oklahoma, Inc. By-Laws (filed as
    Exhibit 3.132 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.136
HCA Health Services of Tennessee, Inc. Charter (filed as
    Exhibit 3.133 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.137
HCA Health Services of Tennessee, Inc. By-Laws (filed as
    Exhibit 3.134 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.138
HCA Health Services of Virginia, Inc. Certificate of
    Incorporation (filed as Exhibit 3.135 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.139
HCA Health Services of Virginia, Inc. By-Laws (filed as
    Exhibit 3.136 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.140
HCA Management Services, L.P. Certificate of Limited Partnership
    (filed as Exhibit 3.137 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.141
HCA Management Services, L.P. Agreement of Limited Partnership
    (filed as Exhibit 3.138 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.142
HCA Realty, Inc. Charter*
3
.143
HCA Realty, Inc. By-Laws*
3
.144
HD&S Corp. Successor, Inc. Articles of Incorporation (filed
    as Exhibit 3.139 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.145
HD&S Corp. Successor, Inc. By-Laws (filed as
    Exhibit 3.140 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.146
Health Midwest Office Facilities Corporation Articles of
    Incorporation (filed as Exhibit 3.141 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.147
Health Midwest Office Facilities Corporation By-Laws (filed as
    Exhibit 3.142 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.148
Health Midwest Ventures Group, Inc. Articles of Incorporation
    (filed as Exhibit 3.143 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.149
Health Midwest Ventures Group, Inc. By-Laws (filed as
    Exhibit 3.144 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.150
Healthtrust MOB, LLC Certificate of Formation (filed as
    Exhibit 3.145 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.151
Healthtrust MOB, LLC Limited Liability Company Agreement (filed
    as Exhibit 3.146 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.152
Hendersonville Hospital Corporation Charter (filed as
    Exhibit 3.147 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.153
Hendersonville Hospital Corporation By-Laws (filed as
    Exhibit 3.148 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.154
Hospital Corporation of Tennessee Charter (filed as
    Exhibit 3.151 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.155
Hospital Corporation of Tennessee By-Laws (filed as
    Exhibit 3.152 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.156
Hospital Corporation of Utah Articles of Incorporation (filed as
    Exhibit 3.153 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.157
Hospital Corporation of Utah By-Laws (filed as
    Exhibit 3.154 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
II-28
Table of Contents
3
.158
Hospital Development Properties, Inc. Certificate of
    Incorporation (filed as Exhibit 3.155 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.159
Hospital Development Properties, Inc. By-Laws (filed as
    Exhibit 3.156 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.160
HSS Holdco, LLC Certificate of Formation (filed as
    Exhibit 3.157 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.161
HSS Holdco, LLC Limited Liability Company Agreement (filed as
    Exhibit 3.158 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.162
HSS Systems VA, LLC Certificate of Formation (filed as
    Exhibit 3.159 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.163
HSS Systems VA, LLC Limited Liability Company Agreement (filed
    as Exhibit 3.160 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.164
HSS Systems, LLC Certificate of Formation (filed as
    Exhibit 3.161 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.165
HSS Systems, LLC Limited Liability Company Agreement (filed as
    Exhibit 3.162 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.166
HSS Virginia, L.P. Certificate of Limited Partnership (filed as
    Exhibit 3.163 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.167
HSS Virginia, L.P. Agreement of Limited Partnership (filed as
    Exhibit 3.164 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.168
HTI Memorial Hospital Corporation Articles of Incorporation
    (filed as Exhibit 3.165 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.169
HTI Memorial Hospital Corporation By-Laws (filed as
    Exhibit 3.166 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.170
Integrated Regional Lab, LLC Articles of Organization (filed as
    Exhibit 3.167 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.171
Integrated Regional Lab, LLC Operating Agreement (filed as
    Exhibit 3.168 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.172
Integrated Regional Laboratories, LLP Statement of Qualification
    of Limited Liability Partnership (filed as Exhibit 3.169 to
    the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.173
Integrated Regional Laboratories, LLP Partnership Agreement
    (filed as Exhibit 3.170 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.174
JFK Medical Center Limited Partnership Articles of Limited
    Partnership (filed as Exhibit 3.171 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.175
JFK Medical Center Limited Partnership Agreement of Limited
    Partnership (filed as Exhibit 3.172 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.176
KPH-Consolidation, Inc. Articles of Incorporation (filed as
    Exhibit 3.173 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.177
KPH-Consolidation, Inc. By-Laws (filed as Exhibit 3.174 to
    the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.178
Lakeland Medical Center, LLC Certificate of Formation (filed as
    Exhibit 3.175 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
II-29
Table of Contents
3
.179
Lakeland Medical Center, LLC Limited Liability Company Agreement
    (filed as Exhibit 3.176 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.180
Lakeview Medical Center, LLC Certificate of Formation (filed as
    Exhibit 3.177 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.181
Lakeview Medical Center, LLC Limited Liability Company Agreement
    (filed as Exhibit 3.178 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.182
Largo Medical Center, Inc. Articles of Incorporation (filed as
    Exhibit 3.179 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.183
Largo Medical Center, Inc. By-Laws (filed as Exhibit 3.180
    to the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.184
Las Vegas Surgicare, Inc. Articles of Incorporation (filed as
    Exhibit 3.181 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.185
Las Vegas Surgicare, Inc. By-Laws (filed as Exhibit 3.182
    to the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.186
Lawnwood Medical Center, Inc. Articles of Incorporation (filed
    as Exhibit 3.183 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.187
Lawnwood Medical Center, Inc. By-Laws (filed as
    Exhibit 3.184 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.188
Lewis-Gale Hospital, Incorporated Articles of Incorporation
    (filed as Exhibit 3.185 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.189
Lewis-Gale Hospital, Incorporated By-Laws (filed as
    Exhibit 3.186 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.190
Lewis-Gale Medical Center, LLC Certificate of Formation (filed
    as Exhibit 3.187 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.191
Lewis-Gale Medical Center, LLC Limited Liability Company
    Agreement (filed as Exhibit 3.188 to the Company's
    Registration Statement on
Form S-4
(File No. 333-145054), and incorporated herein by
    reference).
3
.192
Lewis-Gale Physicians, LLC Articles of Organization (filed as
    Exhibit 3.189 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.193
Lewis-Gale Physicians, LLC Operating Agreement (filed as
    Exhibit 3.190 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.194
Los Robles Regional Medical Center Articles of Incorporation
    (filed as Exhibit 3.191 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.195
Los Robles Regional Medical Center By-Laws (filed as
    Exhibit 3.192 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.196
Management Services Holdings, Inc. Certificate of Incorporation
    (filed as Exhibit 3.193 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.197
Management Services Holdings, Inc. By-Laws (filed as
    Exhibit 3.194 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.198
Marietta Surgical Center, Inc. Articles of Incorporation (filed
    as Exhibit 3.195 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.199
Marietta Surgical Center, Inc. By-Laws (filed as
    Exhibit 3.196 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.200
Marion Community Hospital, Inc. Articles of Incorporation (filed
    as Exhibit 3.197 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
II-30
Table of Contents
3
.201
Marion Community Hospital, Inc. By-Laws (filed as
    Exhibit 3.198 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.202
MCA Investment Company Articles of Incorporation (filed as
    Exhibit 3.199 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.203
MCA Investment Company By-Laws (filed as Exhibit 3.200 to
    the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.204
Medical Centers of Oklahoma, LLC Certificate of Formation (filed
    as Exhibit 3.201 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.205
Medical Centers of Oklahoma, LLC Limited Liability Company
    Agreement (filed as Exhibit 3.202 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.206
Medical Office Buildings of Kansas, LLC Certificate of Formation
    (filed as Exhibit 3.203 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.207
Medical Office Buildings of Kansas, LLC Operating Agreement
    (filed as Exhibit 3.204 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.208
Memorial Healthcare Group, Inc. Articles of Incorporation (filed
    as Exhibit 3.205 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.209
Memorial Healthcare Group, Inc. By-Laws (filed as
    Exhibit 3.206 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.210
Midwest Division — ACH, LLC Certificate of Formation
    (filed as Exhibit 3.207 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.211
Midwest Division — ACH, LLC Limited Liability Company
    Agreement (filed as Exhibit 3.208 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.212
Midwest Division — LRHC, LLC Certificate of Formation
    (filed as Exhibit 3.209 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.213
Midwest Division — LRHC, LLC Limited Liability Company
    Agreement (filed as Exhibit 3.210 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.214
Midwest Division — LSH, LLC Certificate of Formation
    (filed as Exhibit 3.211 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.215
Midwest Division — LSH, LLC Limited Liability Company
    Agreement (filed as Exhibit 3.212 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.216
Midwest Division — MCI, LLC Certificate of Formation
    (filed as Exhibit 3.213 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.217
Midwest Division — MCI, LLC Limited Liability Company
    Agreement (filed as Exhibit 3.214 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.218
Midwest Division — MMC, LLC Certificate of Formation
    (filed as Exhibit 3.215 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.219
Midwest Division — MMC, LLC Limited Liability Company
    Agreement (filed as Exhibit 3.216 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.220
Midwest Division — OPRMC, LLC Certificate of Formation
    (filed as Exhibit 3.217 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
II-31
Table of Contents
3
.221
Midwest Division — OPRMC, LLC Limited Liability
    Company Agreement (filed as Exhibit 3.218 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.222
Midwest Division — PFC, LLC Certificate of Formation
    (filed as Exhibit 3.219 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.223
Midwest Division — PFC, LLC Limited Liability Company
    Agreement (filed as Exhibit 3.220 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.224
Midwest Division — RBH, LLC Articles of Organization
    (filed as Exhibit 3.221 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.225
Midwest Division — RBH, LLC Limited Liability Company
    Agreement (filed as Exhibit 3.222 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.226
Midwest Division — RMC, LLC Certificate of Formation
    (filed as Exhibit 3.223 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.227
Midwest Division — RMC, LLC Limited Liability Company
    Agreement (filed as Exhibit 3.224 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.228
Midwest Division — RPC, LLC Certificate of Formation
    (filed as Exhibit 3.225 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.229
Midwest Division — RPC, LLC Limited Liability Company
    Agreement (filed as Exhibit 3.226 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.230
Midwest Holdings, Inc. Certificate of Incorporation (filed as
    Exhibit 3.227 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.231
Midwest Holdings, Inc. By-Laws (filed as Exhibit 3.228 to
    the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.232
Montgomery Regional Hospital, Inc. Articles of Incorporation
    (filed as Exhibit 3.229 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.233
Montgomery Regional Hospital, Inc. By-Laws (filed as
    Exhibit 3.230 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.234
Mountain View Hospital, Inc. Certificate of Incorporation (filed
    as Exhibit 3.231 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.235
Mountain View Hospital, Inc. By-Laws (filed as
    Exhibit 3.232 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.236
Nashville Shared Services General Partnership General
    Partnership Agreement (filed as Exhibit 3.233 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.237
National Patient Account Services, Inc. Articles of
    Incorporation (filed as Exhibit 3.235 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.238
National Patient Account Services, Inc. By-Laws (filed as
    Exhibit 3.236 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.239
New Port Richey Hospital, Inc. Articles of Incorporation (filed
    as Exhibit 3.237 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.240
New Port Richey Hospital, Inc. By-Laws (filed as
    Exhibit 3.238 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.241
New Rose Holding Company, Inc. Articles of Incorporation (filed
    as Exhibit 3.239 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
II-32
Table of Contents
3
.242
New Rose Holding Company, Inc. By-Laws (filed as
    Exhibit 3.240 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.243
North Florida Immediate Care Center, Inc. Articles of
    Incorporation (filed as Exhibit 3.241 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.244
North Florida Immediate Care Center, Inc. By-Laws (filed as
    Exhibit 3.242 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.245
North Florida Regional Medical Center, Inc. Articles of
    Incorporation (filed as Exhibit 3.243 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.246
North Florida Regional Medical Center, Inc. By-Laws (filed as
    Exhibit 3.244 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.247
Northern Utah Healthcare Corporation Articles of Incorporation
    (filed as Exhibit 3.245 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.248
Northern Utah Healthcare Corporation By-Laws (filed as
    Exhibit 3.246 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.249
Northern Virginia Community Hospital, LLC Articles of
    Organization (filed as Exhibit 3.247 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.250
Northern Virginia Community Hospital, LLC Limited Liability
    Company Agreement (filed as Exhibit 3.248 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.251
Northlake Medical Center, LLC Certificate of Formation (filed as
    Exhibit 3.249 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.252
Northlake Medical Center, LLC Limited Liability Company
    Agreement (filed as Exhibit 3.250 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.253
Notami Hospitals of Louisiana, Inc. Articles of Incorporation
    (filed as Exhibit 3.251 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.254
Notami Hospitals of Louisiana, Inc. By-Laws (filed as
    Exhibit 3.252 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.255
Notami Hospitals, LLC Certificate of Formation (filed as
    Exhibit 3.253 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.256
Notami Hospitals, LLC Limited Liability Company Agreement (filed
    as Exhibit 3.254 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.257
Okaloosa Hospital, Inc. Articles of Incorporation (filed as
    Exhibit 3.255 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.258
Okaloosa Hospital, Inc. By-Laws (filed as Exhibit 3.256 to
    the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.259
Okeechobee Hospital, Inc. Articles of Incorporation (filed as
    Exhibit 3.257 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.260
Okeechobee Hospital, Inc. By-Laws (filed as Exhibit 3.258
    to the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.261
Outpatient Cardiovascular Center of Central Florida, LLC
    Certificate of Formation (filed as Exhibit 3.259 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.262
Outpatient Cardiovascular Center of Central Florida, LLC
    Operating Agreement (filed as Exhibit 3.260 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
II-33
Table of Contents
3
.263
Palms West Hospital Limited Partnership Agreement of Limited
    Partnership (filed as Exhibit 3.261 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.264
Palms West Hospital Limited Partnership Certificate of Limited
    Partnership (filed as Exhibit 3.262 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.265
Palmyra Park Hospital, Inc. Articles of Incorporation (filed as
    Exhibit 3.263 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.266
Palmyra Park Hospital, Inc. By-Laws (filed as Exhibit 3.264
    to the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.267
Pasadena Bayshore Hospital, Inc. Articles of Incorporation*
3
.268
Pasadena Bayshore Hospital Inc. By-Laws*
3
.269
Plantation General Hospital, L.P. Agreement of Limited
    Partnership (filed as Exhibit 3.265 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.270
Plantation General Hospital, L.P. Agreement of Limited
    Partnership (filed as Exhibit 3.266 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.271
Pulaski Community Hospital, Inc. Articles of Incorporation
    (filed as Exhibit 3.267 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.272
Pulaski Community Hospital, Inc. By-Laws (filed as
    Exhibit 3.268 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.273
Redmond Park Hospital, LLC Articles of Organization (filed as
    Exhibit 3.269 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.274
Redmond Park Hospital, LLC Limited Liability Company Agreement
    (filed as Exhibit 3.270 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.275
Redmond Physician Practice Company Articles of Incorporation
    (filed as Exhibit 3.271 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.276
Redmond Physician Practice Company By-Laws (filed as
    Exhibit 3.272 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.277
Reston Hospital Center, LLC Certificate of Formation (filed as
    Exhibit 3.273 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.278
Reston Hospital Center, LLC Limited Liability Company Agreement
    (filed as Exhibit 3.274 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.279
Retreat Hospital, LLC Articles of Incorporation*
3
.280
Retreat Hospital, LLC Limited Liability Company Agreement*
3
.281
Rio Grande Regional Hospital, Inc. Articles of Incorporation
    (filed as Exhibit 3.277 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.282
Rio Grande Regional Hospital, Inc. By-Laws (filed as
    Exhibit 3.278 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.283
Riverside Healthcare System, L.P. Certificate of Limited
    Partnership (filed as Exhibit 3.279 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.284
Riverside Healthcare System, L.P. Limited Partnership Agreement
    (filed as Exhibit 3.280 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
II-34
Table of Contents
3
.285
Riverside Hospital, Inc. Certificate of Incorporation (filed as
    Exhibit 3.281 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.286
Riverside Hospital, Inc. By-Laws (filed as Exhibit 3.282 to
    the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.287
Samaritan, LLC Certificate of Formation (filed as
    Exhibit 3.283 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.288
Samaritan, LLC Limited Liability Company Agreement (filed as
    Exhibit 3.284 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.289
San Jose Healthcare System, LP Certificate of Limited
    Partnership (filed as Exhibit 3.285 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.290
San Jose Healthcare System, LP Limited Partnership
    Agreement (filed as Exhibit 3.286 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.291
San Jose Hospital, L.P. Agreement of Limited Partnership
    (filed as Exhibit 3.287 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.292
San Jose Hospital, L.P. Certificate of Limited Partnership
    (filed as Exhibit 3.288 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.293
San Jose Medical Center, LLC Certificate of Formation
    (filed as Exhibit 3.289 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.294
San Jose Medical Center, LLC Limited Liability Company
    Agreement (filed as Exhibit 3.290 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.295
San Jose, LLC Certificate of Formation (filed as
    Exhibit 3.291 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.296
San Jose, LLC Limited Liability Company Agreement (filed as
    Exhibit 3.292 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.297
Sarasota Doctors Hospital, Inc. Articles of Incorporation (filed
    as Exhibit 3.293 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.298
Sarasota Doctors Hospital, Inc. By-Laws (filed as
    Exhibit 3.294 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.299
SJMC, LLC Certificate of Formation (filed as Exhibit 3.295
    to the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.300
SJMC, LLC Limited Liability Company Agreement (filed as
    Exhibit 3.296 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.301
Southern Hills Medical Center, LLC Certificate of Formation
    (filed as Exhibit 3.297 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.302
Southern Hills Medical Center, LLC Limited Liability Company
    Agreement (filed as Exhibit 3.298 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.303
Spotsylvania Medical Center, Inc. Articles of Incorporation
    (filed as Exhibit 3.299 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.304
Spotsylvania Medical Center, Inc By-Laws (filed as
    Exhibit 3.300 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.305
Spring Branch Medical Center, Inc. Articles of Incorporation
    (filed as Exhibit 3.301 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.306
Spring Branch Medical Center, Inc. By-Laws (filed as
    Exhibit 3.302 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
II-35
Table of Contents
3
.307
Spring Hill Hospital, Inc. Charter (filed as Exhibit 3.303
    to the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.308
Spring Hill Hospital, Inc. By-Laws (filed as Exhibit 3.304
    to the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.309
St. Mark's Lone Peak Hospital, Inc. Articles of
    Incorporation (filed as Exhibit 3.305 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.310
St. Mark's Lone Peak Hospital, Inc. By-Laws (filed as
    Exhibit 3.306 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.311
Sun City Hospital, Inc. Articles of Incorporation (filed as
    Exhibit 3.307 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.312
Sun City Hospital, Inc. By-Laws (filed as Exhibit 3.308 to
    the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.313
Sunrise Mountainview Hospital, Inc. Articles of Incorporation
    (filed as Exhibit 3.311 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.314
Sunrise Mountainview Hospital, Inc. By-Laws (filed as
    Exhibit 3.312 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.315
Surgicare of Brandon, Inc. Articles of Incorporation (filed as
    Exhibit 3.313 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.316
Surgicare of Brandon, Inc. By-Laws (filed as Exhibit 3.314
    to the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.317
Surgicare of Florida, Inc. Articles of Incorporation (filed as
    Exhibit 3.315 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.318
Surgicare of Florida, Inc. By-Laws (filed as Exhibit 3.316
    to the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.319
Surgicare of Houston Women's, Inc. Articles of
    Incorporation (filed as Exhibit 3.317 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.320
Surgicare of Houston Women's, Inc. By-Laws (filed as
    Exhibit 3.318 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.321
Surgicare of Manatee, Inc. Articles of Incorporation (filed as
    Exhibit 3.319 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.322
Surgicare of Manatee, Inc. By-Laws (filed as Exhibit 3.320
    to the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.323
Surgicare of New Port Richey, Inc. Articles of Incorporation
    (filed as Exhibit 3.321 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.324
Surgicare of New Port Richey, Inc. By-Laws (filed as
    Exhibit 3.322 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.325
Surgicare of Palms West, LLC Articles of Organization (filed as
    Exhibit 3.323 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.326
Surgicare of Palms West, LLC Articles of Organization Agreement
    (filed as Exhibit 3.324 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.327
Surgicare of Riverside, LLC Articles of Organization (filed as
    Exhibit 3.325 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.328
Surgicare of Riverside, LLC Limited Liability Company Agreement
    (filed as Exhibit 3.326 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
II-36
Table of Contents
3
.329
Tallahassee Medical Center, Inc. Articles of Incorporation
    (filed as Exhibit 3.327 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.330
Tallahassee Medical Center, Inc. By-Laws (filed as
    Exhibit 3.328 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.331
TCMC Madison-Portland, Inc. Articles of Incorporation (filed as
    Exhibit 3.329 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.332
TCMC Madison-Portland, Inc. By-Laws (filed as Exhibit 3.330
    to the Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.333
Terre Haute Hospital GP, Inc. Certificate of Incorporation
    (filed as Exhibit 3.331 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.334
Terre Haute Hospital GP, Inc. By-Laws (filed as
    Exhibit 3.332 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.335
Terre Haute Hospital Holdings, Inc. Certificate of Incorporation
    (filed as Exhibit 3.333 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.336
Terre Haute Hospital Holdings, Inc. By-Laws (filed as
    Exhibit 3.334 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.337
Terre Haute MOB, L.P. Certificate of Limited Partnership (filed
    as Exhibit 3.335 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.338
Terre Haute MOB, L.P. Limited Partnership Agreement (filed as
    Exhibit 3.336 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.339
Terre Haute Regional Hospital, L.P. Certificate of Limited
    Partnership (filed as Exhibit 3.337 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.340
Terre Haute Regional Hospital, L.P. Limited Partnership
    Agreement (filed as Exhibit 3.338 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.341
Timpanogos Regional Medical Services, Inc. Certificate of
    Incorporation (filed as Exhibit 3.339 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.342
Timpanogos Regional Medical Services, Inc. By-Laws (filed as
    Exhibit 3.340 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.343
Trident Medical Center, LLC Certificate of Formation (filed as
    Exhibit 3.341 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.344
Trident Medical Center, LLC Limited Liability Company Agreement
    (filed as Exhibit 3.342 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.345
Utah Medco, LLC Certificate of Formation (filed as
    Exhibit 3.343 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.346
Utah Medco, LLC Limited Liability Company Agreement (filed as
    Exhibit 3.344 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.347
VH Holdco, Inc. Articles of Incorporation (filed as
    Exhibit 3.345 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.348
VH Holdco, Inc. By-Laws (filed as Exhibit 3.346 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.349
VH Holdings, Inc. Articles of Incorporation (filed as
    Exhibit 3.347 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.350
VH Holdings, Inc. By-Laws (filed as Exhibit 3.348 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
II-37
Table of Contents
3
.351
Virginia Psychiatric Company, Inc. Articles of Incorporation
    (filed as Exhibit 3.349 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.352
Virginia Psychiatric Company, Inc. By-Laws (filed as
    Exhibit 3.350 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.353
W & C Hospital, Inc. Articles of Incorporation (filed
    as Exhibit 3.351 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.354
W & C Hospital, Inc. By-Laws (filed as
    Exhibit 3.352 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.355
Walterboro Community Hospital, Inc. Articles of Incorporation
    (filed as Exhibit 3.353 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.356
Walterboro Community Hospital, Inc. By-Laws (filed as
    Exhibit 3.354 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.357
Wesley Medical Center, LLC Certificate of Formation (filed as
    Exhibit 3.355 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.358
Wesley Medical Center, LLC Limited Liability Company Agreement
    (filed as Exhibit 3.356 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.359
West Florida Regional Medical Center, Inc. Articles of
    Incorporation (filed as Exhibit 3.357 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.360
West Florida Regional Medical Center, Inc. By-Laws (filed as
    Exhibit 3.358 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.361
West Valley Medical Center, Inc. Articles of Incorporation
    (filed as Exhibit 3.359 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.362
West Valley Medical Center, Inc. By-Laws (filed as
    Exhibit 3.360 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.363
Western Plains Capital, Inc. Articles of Incorporation (filed as
    Exhibit 3.361 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.364
Western Plains Capital, Inc. By-Laws (filed as
    Exhibit 3.362 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.365
WHMC, Inc. Articles of Incorporation (filed as
    Exhibit 3.363 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.366
WHMC, Inc. By-Laws (filed as Exhibit 3.364 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.367
Woman's Hospital of Texas, Incorporated Certificate of
    Incorporation (filed as Exhibit 3.365 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.368
Woman's Hospital of Texas, Incorporated By-Laws (filed as
    Exhibit 3.366 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.369
Women's and Children's Hospital, Inc. Articles of
    Incorporation (filed as Exhibit 3.367 to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
3
.370
Women's and Children's Hospital, Inc. By-Laws (filed
    as Exhibit 3.368 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.1
Specimen Certificate for shares of Common Stock, par value $0.01
    per share, of the Company (filed as Exhibit 3 to the
    Company's
Form 8-A/A,
Amendment No. 2, dated March 11, 2004, and
    incorporated herein by reference).
4
.2
Indenture, dated November 17, 2006, among HCA Inc., the
    guarantors party thereto and The Bank of New York, as trustee
    (filed as Exhibit 4.1 to the Company's Current Report
    on
Form 8-K
filed November 24, 2006, and incorporated herein by
    reference).
II-38
Table of Contents
4
.3
Security Agreement, dated as of November 17, 2006, among
    HCA Inc., the subsidiary grantors party thereto and The Bank of
    New York, as collateral agent (filed as Exhibit 4.2 to the
    Company's Current Report on
Form 8-K
filed November 24, 2006, and incorporated herein by
    reference).
4
.4
Pledge Agreement, dated as of November 17, 2006, among HCA
    Inc., the subsidiary pledgors party thereto and The Bank of New
    York, as collateral agent (filed as Exhibit 4.3 to the
    Company's Current Report of
Form 8-K
filed November 24, 2006, and incorporated herein by
    reference).
4
.5(a)
Form of
    9
1
/
8
% Senior
    Secured Notes due 2014 (included in Exhibit 4.2).
4
.5(b)
Form of
    9
1
/
4
% Senior
    Secured Notes due 2016 (included in Exhibit 4.2).
4
.5(c)
Form of
    9
5
/
8
%/10
3
/
8
% Senior
    Secured Toggle Notes due 1016 (included in Exhibit 4.2).
4
.6
Indenture, dated February 19, 2009, among HCA Inc, the
    guarantors party thereto, The Bank of New York Mellon, as
    collateral agent and The Bank of New York Mellon
    Trust Company, N.A., as trustee. (filed as Exhibit 4.1
    to the Company's Current Report on
Form 8-K
filed February 25, 2009, and incorporated herein by
    reference).
4
.7
Form of
    9
7
/
8
% Senior
    Secured Notes due 2017 (included in Exhibit 4.6).
4
.8(a)
$13,550,000,000 — €1,000,000,000 Credit
    Agreement, dated as of November 17, 2006, among HCA Inc.,
    HCA UK Capital Limited, the lending institutions from time to
    time parties thereto, Banc of America Securities LLC,
    J.P. Morgan Securities Inc., Citigroup Global Markets Inc.
    and Merrill Lynch, Pierce, Fenner & Smith
    Incorporated, as joint lead arrangers and joint bookrunners,
    Bank of America, N.A., as administrative agent, JPMorgan Chase
    Bank, N.A. and Citicorp North America, Inc., as co-syndication
    agents and Merrill Lynch Capital Corporation, as documentation
    agent (filed as Exhibit 4.8 to the Company's Current
    Report on
Form 8-K
filed November 24, 2006, and incorporated herein by
    reference).
4
.8(b)
Amendment No. 1 to the Credit Agreement, dated as of
    February 16, 2007, among HCA Inc., HCA UK Capital Limited,
    the lending institutions from time to time parties thereto, Bank
    of America, N.A., as administrative agent, JPMorgan Chase Bank,
    N.A., and Citicorp North America, Inc., as Co-Syndication
    Agents, Banc of America Securities, LLC, J.P. Morgan
    Securities Inc., Citigroup Global Markets Inc. and Merrill
    Lynch, Pierce, Fenner & Smith Incorporated, as joint
    lead arrangers and bookrunners, Deutsche Bank Securities and
    Wachovia Capital Markets LLC, as joint bookrunners and Merrill
    Lynch Capital Corporation, as documentation agent (filed as
    Exhibit 4.7(b) to the Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
    incorporated herein by reference).
4
.8(c)
Amendment No. 2 to the Credit Agreement, dated as of
    March 2, 2009, among HCA Inc., HCA UK Capital Limited,
    the lending institutions from time to time parties thereto, Bank
    of America, N.A., as administrative agent, JPMorgan Chase Bank,
    N.A., and Citicorp North America, Inc., as Co-Syndication
    Agents, Banc of America Securities, LLC, J.P. Morgan
    Securities Inc., Citigroup Global Markets Inc. and Merrill
    Lynch, Pierce, Fenner & Smith Incorporated, as joint
    lead arrangers and bookrunners, Deutsche Bank Securities and
    Wachovia Capital Markets LLC, as joint bookrunners and Merrill
    Lynch Capital Corporation, as documentation agent (filed as
    exhibit 4.8(c) to the Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008, and
    incorporated herein by reference).
4
.9
U.S. Guarantee, dated November 17, 2006, among HCA Inc.,
    the subsidiary guarantors party thereto and Bank of America,
    N.A., as administrative agent (filed as Exhibit 4.9 to the
    Company's Current Report on
Form 8-K
filed November 24, 2006, and incorporated herein by
    reference).
4
.10
Indenture, dated as of April 22, 2009, among HCA Inc., the
    guarantors party thereto, Deutsche Bank Trust Company
    Americas, as paying agent, registrar and transfer agent, and Law
    Debenture Trust Company of New York, as trustee (filed as
    Exhibit 4.1 to the Company's Current Report on
Form 8-K
filed April 28, 2009, and incorporated herein by reference).
4
.11
Security Agreement, dated as of November 17, 2006, and
    amended and restated as of March 2, 2009, among the
    Company, the Subsidiary Grantors named therein and Bank of
    America, N.A., as Collateral Agent (filed as exhibit 4.10
    to the Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008, and
    incorporated herein by reference).
II-39
Table of Contents
4
.12
Pledge Agreement, dated as of November 17, 2006, and
    amended and restated as of March 2, 2009, among the
    Company, the Subsidiary Pledgors named therein and Bank of
    America, N.A., as Collateral Agent (filed as exhibit 4.11
    to the Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008, and
    incorporated herein by reference).
4
.13
Form of
    8
1
/
2
% Senior
    Secured Notes due 2019 (included in Exhibit 4.10).
4
.14(a)
$2,000,000,000 Amended and Restated Credit Agreement, dated as
    of June 20, 2007, among HCA Inc., the subsidiary borrowers
    parties thereto, the lending institutions from time to time
    parties thereto, Banc of America Securities LLC,
    J.P. Morgan Securities Inc., Citigroup Global Markets Inc.
    and Merrill Lynch, Pierce, Fenner & Smith
    Incorporated, as joint lead arrangers and joint bookrunners,
    Bank of America, N.A., as administrative agent, JPMorgan Chase
    Bank, N.A. and Citicorp North America, Inc., as co-syndication
    agents, and Merrill Lynch Capital Corporation, as documentation
    agent (filed as Exhibit 4.1 to the Company's Current
    Report on
Form 8-K
filed June 26, 2007, and incorporated herein by reference).
4
.14(b)
Amendment No. 1 to the $2,000,000,000 Amended and Restated
    Credit Agreement, dated as of March 2, 2009, among HCA
    Inc., the subsidiary borrowers parties thereto, the lending
    institutions from time to time parties thereto, Banc of America
    Securities LLC, J.P. Morgan Securities Inc., Citigroup
    Global Markets Inc. and Merrill Lynch, Pierce,
    Fenner & Smith Incorporated, as joint lead arrangers
    and joint bookrunners, Bank of America, N.A., as administrative
    agent, JPMorgan Chase Bank, N.A. and Citicorp North America,
    Inc., as co-syndication agents, and Merrill Lynch Capital
    Corporation, as documentation agent (filed as
    exhibit 4.12(b) to the Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008, and
    incorporated herein by reference).
4
.15
Security Agreement, dated as of November 17, 2006, among
    HCA Inc., the subsidiary borrowers party thereto and Bank of
    America, N.A., as collateral agent (filed as Exhibit 4.13
    to the Company's Current Report on
Form 8-K
filed November 24, 2006, and incorporated herein by
    reference).
4
.16(a)
General Intercreditor Agreement, dated as of November 17,
    2006, between Bank of America, N.A., as First Lien Collateral
    Agent, and The Bank of New York, as Junior Lien Collateral Agent
    (filed as Exhibit 4.13(a) to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.16(b)
Additional General Intercreditor Agreement, dated as of
    April 22, 2009, by and among Bank of America, N.A., in its
    capacity as First Lien Collateral Agent, The Bank of New York
    Mellon, in its capacity as Junior Lien Collateral Agent and in
    its capacity as 2006 Second Lien Trustee and The Bank of New
    York Mellon Trust Company, N.A., in its capacity as 2009
    Second Lien Trustee (filed as Exhibit 4.6 to the
    Company's Current Report on
Form 8-K
filed April 28, 2009, and incorporated herein by reference).
4
.16(c)
Receivables Intercreditor Agreement, dated as of
    November 17, 2006, among Bank of America, N.A., as ABL
    Collateral Agent, Bank of America, N.A., as CF Collateral Agent
    and The Bank of New York, as Bonds Collateral Agent (filed as
    Exhibit 4.13(b) to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.16(d)
Additional Receivables Intercreditor Agreement, dated as of
    April 22, 2009, by and between Bank of America, N.A. as ABL
    Collateral Agent, and Bank of America, N.A. as New First Lien
    Collateral Agent (filed as Exhibit 4.7 to the
    Company's Current Report on
Form 8-K
filed April 28, 2009, and incorporated herein by reference).
4
.16(e)
First Lien Intercreditor Agreement, dated as of April 22,
    2009, among Bank of America, N.A. as Collateral Agent, Bank of
    America, N.A. as Authorized Representative under the Credit
    Agreement and Law Debenture Trust Company of New York as
    the Initial Additional Authorized Representative (filed as
    Exhibit 4.5 to the Company's Current Report on
Form 8-K
filed April 28, 2009, and incorporated herein by reference).
4
.17
Registration Rights Agreement, dated as of November 17,
    2006, among HCA Inc., Hercules Holding II, LLC and certain other
    parties thereto (filed as Exhibit 4.4 to the Company's
    Current Report on
Form 8-K
filed November 24, 2006, and incorporated herein by
    reference).
II-40
Table of Contents
4
.18
Registration Rights Agreement, dated as of March 16, 1989,
    by and among HCA-Hospital Corporation of America and the persons
    listed on the signature pages thereto (filed as
    Exhibit 4.14 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.19
Assignment and Assumption Agreement, dated as of
    February 10, 1994, between HCA-Hospital Corporation of
    America and the Company relating to the Registration Rights
    Agreement, as amended (filed as Exhibit 4.15 to the
    Company's Registration Statement on
Form S-4
(File No. 333-145054),
and incorporated herein by reference).
4
.20(a)
Indenture, dated as of December 16, 1993 between the
    Company and The First National Bank of Chicago, as Trustee
    (filed as Exhibit 4.16(a) to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.20(b)
First Supplemental Indenture, dated as of May 25, 2000
    between the Company and Bank One Trust Company, N.A., as
    Trustee (filed as Exhibit 4.16(b) to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.20(c)
Second Supplemental Indenture, dated as of July 1, 2001
    between the Company and Bank One Trust Company, N.A., as
    Trustee (filed as Exhibit 4.16(c) to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.20(d)
Third Supplemental Indenture, dated as of December 5, 2001
    between the Company and The Bank of New York, as Trustee (filed
    as Exhibit 4.16(d) to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.20(e)
Fourth Supplemental Indenture, dated as of November 14,
    2006, between the Company and The Bank of New York, as Trustee
    (filed as Exhibit 4.1 to the Company's Current Report
    on
Form 8-K
filed November 16, 2006, and incorporated herein by
    reference).
4
.21
Form of 7.5% Debentures due 2023 (filed as
    Exhibit 4.17 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.22
Form of 8.36% Debenture due 2024 (filed as
    Exhibit 4.18 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.23
Form of Fixed Rate Global Medium-Term Note (filed as
    Exhibit 4.19 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.24
Form of Floating Rate Global Medium-Term Note (filed as
    Exhibit 4.20 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.25
Form of 7.69% Note due 2025 (filed as Exhibit 4.10 to
    the Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2004, and
    incorporated herein by reference).
4
.26
Form of 7.19% Debenture due 2015 (filed as
    Exhibit 4.22 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.27
Form of 7.50% Debenture due 2095 (filed as
    Exhibit 4.23 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.24
Form of 7.05% Debenture due 2027 (filed as
    Exhibit 4.24 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.28
Form of Fixed Rate Global Medium-Term Note (filed as
    Exhibit 4.25 to the Company's Registration Statement
    on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.29(a)
8.750% Note in the principal amount of $400,000,000 due
    2010 (filed as Exhibit 4.26(a) to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.29(b)
8.750% Note in the principal amount of $350,000,000 due
    2010 (filed as Exhibit 4.26(b) to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.30
8.75% Note due 2010 in the principal amount of
    £150,000,000 (filed as Exhibit 4.27 to the
    Company's Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
II-41
Table of Contents
4
.31(a)
7
7
/
8
% Note
    in the principal amount of $100,000,000 due 2011 (filed as
    Exhibit 4.28(a) to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.31(b)
7
7
/
8
% Note
    in the principal amount of $400,000,000 due 2011 (filed as
    Exhibit 4.28(b) to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.32(a)
6.95% Note due 2012 in the principal amount of $400,000,000
    (filed as Exhibit 4.29(a) to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.32(b)
6.95% Note due 2012 in the principal amount of $100,000,000
    (filed as Exhibit 4.29(b) to the Company's
    Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
4
.33(a)
6.30% Note due 2012 in the principal amount of $400,000,000
    (filed as Exhibit 4.1 to the Company's Current Report
    on
Form 8-K
dated September 18, 2002, and incorporated herein by
    reference).
4
.33(b)
6.30% Note due 2012 in the principal amount of $100,000,000
    (filed as Exhibit 4.2 to the Company's Current Report
    on
Form 8-K
dated September 18, 2002, and incorporated herein by
    reference).
4
.34(a)
6.25% Note due 2013 in the principal amount of $400,000,000
    (filed as Exhibit 4.1 to the Company's Current Report
    on
Form 8-K
dated February 5, 2003, and incorporated herein by
    reference).
4
.34(b)
6.25% Note due 2013 in the principal amount of $100,000,000
    (filed as Exhibit 4.2 to the Company's Current Report
    on
Form 8-K
dated February 5, 2003, and incorporated herein by
    reference).
4
.35(a)
6
3
/
4
% Note
    due 2013 in the principal amount of $400,000,000 (filed as
    Exhibit 4.1 to the Company's Current Report on
Form 8-K
dated July 23, 2003, and incorporated herein by reference).
4
.35(b)
6
3
/
4
% Note
    due 2013 in the principal amount of $100,000,000 (filed as
    Exhibit 4.2 to the Company's Current Report on
Form 8-K
dated July 23, 2003, and incorporated herein by reference).
4
.36
7.50% Note due 2033 in the principal amount of $250,000,000
    (filed as Exhibit 4.2 to the Company's Current Report
    on
Form 8-K
dated November 6, 2003, and incorporated herein by
    reference).
4
.37
5.75% Note due 2014 in the principal amount of $500,000,000
    (filed as Exhibit 4.1 to the Company's Current Report
    on
Form 8-K
dated March 8, 2004, and incorporated herein by reference).
4
.38
5.500% Note due 2009 in the principal amount of
    $500,000,000 (filed as Exhibit 4.1 to the Company's
    Current Report on
Form 8-K
dated November 16, 2004, and incorporated herein by
    reference).
4
.39(a)
6.375% Note due 2015 in the principal amount of
    $500,000,000 (filed as Exhibit 4.2 to the Company's
    Current Report on
Form 8-K
dated November 16, 2004, and incorporated herein by
    reference).
4
.39(b)
6.375% Note due 2015 in the principal amount of
    $250,000,000 (filed as Exhibit 4.3 to the Company's
    Current Report on
Form 8-K
dated November 16, 2004, and incorporated herein by
    reference).
4
.40(a)
6.500% Note due 2016 in the principal amount of
    $500,000,000 (filed as Exhibit 4.1 to the Company's
    Current Report on
Form 8-K
filed on February 8, 2006, and incorporated herein by
    reference).
4
.41(b)
6.500% Note due 2016 in the principal amount of
    $500,000,000 (filed as Exhibit 4.2 to the Company's
    Current Report on
Form 8-K
filed on February 8, 2006, and incorporated herein by
    reference).
5
.1
Opinion of Simpson Thacher & Bartlett LLP.*
II-42
Table of Contents
5
.2
Opinion of Robert A. Waterman.*
10
.1(a)
Amended and Restated Columbia/HCA Healthcare Corporation 1992
    Stock and Incentive Plan (filed as Exhibit 10.7(b) to the
    Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 1998, and
    incorporated herein by reference).
10
.1(b)
First Amendment to Amended and Restated Columbia/HCA Healthcare
    Corporation 1992 Stock and Incentive Plan (filed as
    Exhibit 10.2 to the Company's Quarterly Report on
Form 10-Q
for the quarter ended September 30, 1999, and incorporated
    herein by reference).
10
.2
HCA-Hospital Corporation of America Nonqualified Initial Option
    Plan (filed as Exhibit 4.6 to the Company's
    Registration Statement on
Form S-3
(File
No. 33-52379),
and incorporated herein by reference).
10
.3
Form of Indemnity Agreement with certain officers and directors
    (filed as Exhibit 10.3 to the Company's Registration
    Statement on
Form S-4
(File
No. 333-145054)
and incorporated herein by reference).
10
.4
Form of Galen Health Care, Inc. 1993 Adjustment Plan (filed as
    Exhibit 4.15 to the Company's Registration Statement
    on
Form S-8
(File
No. 33-50147)
and incorporated herein by reference).
10
.5
Form of HCA-Hospital Corporation of America 1992 Stock
    Compensation Plan (filed as Exhibit 4.2 to the
    Company's Registration Statement on
Form S-8
(File
No. 33-52253),
and incorporated herein by reference).
10
.6
Columbia/HCA Healthcare Corporation 2000 Equity Incentive Plan
    (filed as Exhibit A to the Company's Proxy Statement
    for the Annual Meeting of Stockholders on May 25, 2000, and
    incorporated herein by reference).
10
.7
Form of Non-Qualified Stock Option Award Agreement (Officers)
    (filed as Exhibit 99.2 to the Company's Current Report
    on
Form 8-K
dated February 2, 2005, and incorporated herein by
    reference).
10
.8
HCA 2005 Equity Incentive Plan (filed as Exhibit B to the
    Company's Proxy Statement for the Annual Meeting of
    Shareholders on May 26, 2005, and incorporated herein by
    reference).
10
.9
Form of 2005 Non-Qualified Stock Option Agreement (Officers)
    (filed as Exhibit 99.2 to the Company's Current Report
    on
Form 8-K
dated October 6, 2005, and incorporated herein by
    reference).
10
.10
Form of 2006 Non-Qualified Stock Option Award Agreement
    (Officers) (filed as Exhibit 10.2 to the Company's
    Current Report on
Form 8-K
dated February 1, 2006, and incorporated herein by
    reference).
10
.11
2006 Stock Incentive Plan for Key Employees of HCA Inc. and its
    Affiliates (filed as Exhibit 10.11 to the Company's
    Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
    incorporated herein by reference).
10
.12
Management Stockholder's Agreement dated November 17,
    2006 (filed as Exhibit 10.12 to the Company's Annual
    Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
    incorporated herein by reference).
10
.13
Sale Participation Agreement dated November 17, 2006 (filed
    as Exhibit 10.13 to the Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
    incorporated herein by reference).
10
.14
Form of Option Rollover Agreement (filed as Exhibit 10.14
    to the Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
    incorporated herein by reference).
10
.15
Form of Option Agreement (2007) (filed as Exhibit 10.15 to
    the Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
    incorporated herein by reference).
10
.16
Form of Option Agreement (2008) (filed as Exhibit 10.16 to
    the Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007, and
    incorporated herein by reference).
10
.17
Form of Option Agreement (2009) (filed as Exhibit 10.17 to
    the Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008, and
    incorporated herein by reference).
10
.18
Exchange and Purchase Agreement (filed as Exhibit 10.16 to
    the Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
    incorporated herein by reference).
II-43
Table of Contents
10
.19
Civil and Administrative Settlement Agreement, dated
    December 14, 2000 between the Company, the United States
    Department of Justice and others (filed as Exhibit 99.2 to
    the Company's Current Report on
Form 8-K
dated December 20, 2000, and incorporated herein by
    reference).
10
.20
Plea Agreement, dated December 14, 2000 between the
    Company, Columbia Homecare Group, Inc., Columbia Management
    Companies, Inc. and the United States Department of Justice
    (filed as Exhibit 99.3 to the Company's Current Report
    on
Form 8-K
dated December 20, 2000, and incorporated herein by
    reference).
10
.21
Corporate Integrity Agreement, dated December 14, 2000
    between the Company and the Office of Inspector General of the
    United States Department of Health and Human Services (filed as
    Exhibit 99.4 to the Company's Current Report on
Form 8-K
dated December 20, 2000, and incorporated herein by
    reference).
10
.22
Management Agreement, dated November 17, 2006, among HCA
    Inc., Bain Capital Partners, LLC, Kohlberg Kravis
    Roberts & Co. L.P., Dr. Thomas F. Frist Jr.,
    Patricia F. Elcan, William R. Frist and Thomas F.
    Frist, III, and Merrill Lynch Global Partners, Inc. (filed
    as Exhibit 10.20 to the Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
    incorporated herein by reference).
10
.23
Retirement Agreement between the Company and Thomas F. Frist,
    Jr., M.D. dated as of January 1, 2002 (filed as
    Exhibit 10.30 to the Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2001, and
    incorporated herein by reference).
10
.24
Amended and Restated HCA Supplemental Executive Retirement Plan,
    effective January 1, 2007, except as provided therein.)
    (filed as Exhibit 10.24 to the Company's Annual Report
    on
Form 10-K
for the fiscal year ended December 31, 2008, and
    incorporated herein by reference).
10
.25
Amended and Restated HCA Restoration Plan, effective
    January 1, 2008.) (filed as Exhibit 10.25 to the
    Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008, and
    incorporated herein by reference).
10
.26
HCA Inc. 2006 Senior Officer Performance Excellence Program
    (filed as Exhibit 10.3 to the Company's Current Report
    on
8-K
filed
    February 1, 2006, and incorporated herein by reference).
10
.27
HCA Inc. 2007 Senior Officer Performance Excellence Program
    (filed as Exhibit 10.26 to the Company's Annual Report
    on
Form 10-K
for the fiscal year ended December 31, 2006, and
    incorporated herein by reference).
10
.28(a)
HCA Inc.
2008-2009
Senior Officer Performance Excellence Program (filed as
    Exhibit 10.27 to the Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007, and
    incorporated herein by reference).
10
.28(b)
HCA Inc. Amendment No. 1 to the
2008-2009
Senior Officer Performance Excellence Program (filed as
    Exhibit 10.28(b) to the Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008, and
    incorporated herein by reference).
10
.29(a)
Employment Agreement dated November 16, 2006 (Jack O.
    Bovender, Jr.) (filed as Exhibit 10.27(a) to the
    Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
    incorporated herein by reference).
10
.29(b)
Employment Agreement dated November 16, 2006 (Richard M.
    Bracken) (filed as Exhibit 10.27(b) to the Company's
    Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
    incorporated herein by reference).
10
.29(c)
Employment Agreement dated November 16, 2006 (R. Milton
    Johnson) (filed as Exhibit 10.27(c) to the Company's
    Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
    incorporated herein by reference).
10
.29(d)
Employment Agreement dated November 16, 2006 (Samuel N.
    Hazen) (filed as Exhibit 10.27(d) to the Company's
    Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
    incorporated herein by reference).
10
.29(e)
Employment Agreement dated November 16, 2006 (Beverly B.
    Wallace) (filed as Exhibit 10.28(e) to the Company's
    Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007, and
    incorporated herein by reference).
II-44
Table of Contents
10
.29(f)
Amended and Restated Employment Agreement dated October 27,
    2008 (Jack O. Bovender, Jr.) (filed as Exhibit 10.29(f) to
    the Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008, and
    incorporated herein by reference).
10
.29(g)
Amendment to Employment Agreement effective January 1, 2009
    (Richard M. Bracken) (filed as Exhibit 10.29(g) to the
    Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008, and
    incorporated herein by reference).
10
.30
Administrative Settlement Agreement dated June 25, 2003 by
    and between the United States Department of Health and Human
    Services, acting through the Centers for Medicare and Medicaid
    Services, and the Company (filed as Exhibit 10.1 to the
    Company's Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2003, and incorporated
    herein by reference).
10
.31
Civil Settlement Agreement by and among the United States of
    America, acting through the United States Department of Justice
    and on behalf of the Office of Inspector General of the
    Department of Health and Human Services, the TRICARE Management
    Activity (filed as Exhibit 10.2 to the Company's
    Quarterly Report of
Form 10-Q
for the quarter ended June 30, 2003, and incorporated
    herein by reference).
10
.32
Form of Amended and Restated Limited Liability Company Agreement
    of Hercules Holding II, LLC dated as of November 17, 2006,
    among Hercules Holding II, LLC and certain other parties thereto
    (filed as Exhibit 10.3 to the Company's Registration
    Statement on
Form 8-A
(File
No. 000-18406)
and incorporated herein by reference).
12
.1
Statement Regarding Computation of Ratio of Earnings to Fixed
    Charges.*
21
.1
List of Subsidiaries.*
23
.1
Consent of Simpson Thacher & Bartlett LLP (included as
    part of its opinion filed as Exhibit 5.1 hereto).*
23
.2
Consent of Robert A. Waterman (included as part of opinion filed
    as Exhibit 5.2).*
23
.3
Consent of Ernst & Young LLP.*
24
.1
Powers of Attorney (included in signature pages of this
    Registration Statement).
25
.1
Form T-1
Statement of Eligibility under the Trust Indenture Act of
    1939 of The Bank of New York Mellon as trustee under the
    Indenture, dated as of December 16, 1993, between HCA Inc.
    and The Bank of New York Mellon (as successor trustee to The
    First National Bank of Chicago), as Trustee.*
25
.2
Form T-1
Statement of Eligibility under the Trust Indenture Act of
    1939 of The Bank of New York Mellon as trustee under the
    Indenture, dated as of November 17, 2006, among HCA Inc.,
    the guarantors party thereto and The Bank of New York Mellon, as
    Trustee.*
25
.3
Form T-1
Statement of Eligibility under the Trust Indenture Act of
    1939 of The Bank of New York Mellon Trust Company, N.A. as
    trustee under the Indenture, dated as of February 19, 2009,
    among HCA Inc., the guarantors party thereto, The Bank of New
    York Mellon, as collateral agent and The Bank of New York Mellon
    Trust Company, N.A., as Trustee.*
25
.4
Form T-1
Statement of Eligibility under the Trust Indenture Act of
    1939 of Law Debenture Trust Company of New York, as trustee
    under the Indenture, dated as of April 22, 2009, among HCA
    Inc., the guarantors party thereto, Deutsche Bank
    Trust Company Americas as paying agent, registrar and
    transfer agent and Law Debenture Trust Company of New York,
    as Trustee.*
*
Filed herewith
(b)
Financial Statement Schedules
All schedules are omitted because the required information is
    either not present, not present in material amounts or presented
    within the consolidated financial statements included with our
    annual report on
Form 10-K
for the fiscal year ended December 31, 2008 and
    incorporated herein by reference.
II-45
Table of Contents
Item 17.
Undertakings.
(a) Each of the undersigned registrants hereby undertakes:
(1) to file, during any period in which offers or sales are
    being made, a post-effective amendment to this registration
    statement:
(i) to include any prospectus required by
    Section 10(a)(3) of the Securities Act of 1933;
(ii) to reflect in the prospectus any facts or events
    arising after the effective date of the registration statement
    (or the most recent post-effective amendment thereof) which,
    individually or in the aggregate, represent a fundamental change
    in the information set forth in the registration statement.
    Notwithstanding the foregoing, any increase or decrease in
    volume of securities offered (if the total dollar value of
    securities offered would not exceed that which was registered)
    and any deviation from the low or high end of the estimated
    maximum offering range may be reflected in the form of
    prospectus filed with the Commission pursuant to
    Rule 424(b) if, in the aggregate, the changes in volume and
    price represent no more than 20% change in the maximum aggregate
    offering price set forth in the "Calculation of
    Registration Fee" table in the effective registration
    statement; and
(iii) to include any material information with respect to
    the plan of distribution not previously disclosed in the
    registration statement or any material change to such
    information in the registration statement;
(2) that, for the purpose of determining any liability
    under the Securities Act of 1933, each such post-effective
    amendment shall be deemed to be a new registration statement
    relating to the securities offered therein, and the offering of
    such securities at that time shall be deemed to be the initial
bona fide
offering thereof;
(3) to remove from registration by means of a
    post-effective amendment any of the securities being registered
    which remain unsold at the termination of the offering;
(4) that, for the purpose of determining liability under
    the Securities Act of 1933 to any purchaser, each prospectus
    filed pursuant to Rule 424(b) as part of a registration
    statement relating to an offering, other than registration
    statements relying on Rule 430B or other than prospectuses
    filed in reliance on Rule 430A, shall be deemed to be part
    of and included in the registration statement as of the date it
    is first used after effectiveness. Provided, however, that no
    statement made in a registration statement or prospectus that is
    part of the registration statement or made in a document
    incorporated or deemed incorporated by reference into the
    registration statement or prospectus that is part of the
    registration statement will, as to a purchaser with a time of
    contract of sale prior to such first use, supersede or modify
    any statement that was made in the registration statement or
    prospectus that was part of the registration statement or made
    in any such document immediately prior to such date of first
    use; and
(5) that, for the purpose of determining liability of the
    registrants under the Securities Act of 1933 to any purchaser in
    the initial distribution of the securities:
The undersigned registrants undertake that in a primary offering
    of securities of the undersigned registrants pursuant to this
    registration statement, regardless of the underwriting method
    used to sell the securities to the purchaser, if the securities
    are offered or sold to such purchaser by means of any of the
    following communications, the undersigned registrants will be
    sellers to the purchaser and will be considered to offer or sell
    such securities to such purchaser:
(i) Any preliminary prospectus or prospectus of the
    undersigned registrants relating to the offering required to be
    filed pursuant to Rule 424;
(ii) Any free writing prospectus relating to the offering
    prepared by or on behalf of the undersigned registrants or used
    or referred to by the undersigned registrants
II-46
Table of Contents
(iii) The portion of any other free writing prospectus
    relating to the offering containing material information about
    the undersigned registrants or their securities provided by or
    on behalf of the undersigned registrants; and
(iv) Any other communication that is an offer in the
    offering made by the undersigned registrants to the purchaser.
(b) Insofar as indemnification for liabilities arising
    under the Securities Act of 1933 may be permitted to
    directors, officers and controlling persons of the registrants
    pursuant to the foregoing provisions, or otherwise, the
    registrants have been advised that in the opinion of the
    Securities and Exchange Commission such indemnification is
    against public policy as expressed in the Securities Act and is,
    therefore, unenforceable. In the event that a claim for
    indemnification against such liabilities (other than the payment
    by the registrants of expenses incurred or paid by a director,
    officer or controlling person of the registrants in the
    successful defense of any action, suit or proceeding) is
    asserted by such director, officer or controlling person in
    connection with the securities being registered, the registrants
    will, unless in the opinion of their counsel the matter has been
    settled by controlling precedent, submit to a court of
    appropriate jurisdiction the question whether such
    indemnification by them is against public policy as expressed in
    the Securities Act and will be governed by the final
    adjudication of such issue.
II-47
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
HCA INC.
By:
/s/
R.
    Milton Johnson
Name:     R. Milton Johnson
Title:
Executive Vice President and
Chief Financial Officer
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes Jack O.
    Bovender, Jr., Richard M. Bracken and R. Milton
    Johnson, or any of them, as his or her attorney in fact and
    agent, with full power of substitution and resubstitution, to
    execute, in his name and on his behalf, in any and all
    capacities, a Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Jack
    O. Bovender, Jr.
Jack
    O. Bovender, Jr.
Chairman of the Board
May 27, 2009
/s/
Richard
    M. Bracken
Richard
    M. Bracken
President, Chief Executive Officer
and Director
(Principal Executive Officer)
May 27, 2009
/s/
R.
    Milton Johnson
R.
    Milton Johnson
Executive Vice President and
Chief Financial Officer
(Principal Financial Officer and
Principal Accounting Officer)
May 27, 2009
/s/
Christopher
    J. Birosak
Christopher
    J. Birosak
Director
May 27, 2009
II-48
Table of Contents
Signature
Title
Date
/s/
John
    P. Connaughton
John
    P. Connaughton
Director
May 27, 2009
/s/
James
    D. Forbes
James
    D. Forbes
Director
May 27, 2009
/s/
Kenneth
    W. Freeman
Kenneth
    W. Freeman
Director
May 27, 2009
/s/
Thomas
    F. Frist, III
Thomas
    F. Frist, III
Director
May 27, 2009
/s/
William
    R. Frist
William
    R. Frist
Director
May 27, 2009
/s/
Christopher
    R. Gordon
Christopher
    R. Gordon
Director
May 27, 2009
/s/
Michael
    W. Michelson
Michael
    W. Michelson
Director
May 27, 2009
/s/
James
    C. Momtazee
James
    C. Momtazee
Director
May 27, 2009
/s/
Stephen
    G. Pagliuca
Stephen
    G. Pagliuca
Director
May 27, 2009
/s/
Nathan
    C. Thorne
Nathan
    C. Thorne
Director
May 27, 2009
II-49
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
REGISTRANTS
(as listed on the attached
Schedule I of Subsidiary Registrants)
By:
/s/
R.
    Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Director
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or any of
    them, as his or her attorney in fact and agent, with full power
    of substitution and resubstitution, to execute, in his name and
    on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
President and Director
(Principal Executive Officer)
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer)
May 27, 2009
/s/
R.
    Milton Johnson
R.
    Milton Johnson
Senior Vice President and Director
(Principal Accounting Officer)
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Director
May 27, 2009
II-50
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
REGISTRANTS
(as listed on the attached
Schedule II of Subsidiary Registrants)
By:
/s/
R.
    Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Director
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
President and Director
(Principal Executive Officer)
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer)
May 27, 2009
/s/
R.
    Milton Johnson
R.
    Milton Johnson
Senior Vice President and Director
(Principal Accounting Officer)
May 27, 2009
/s/
William
    B. Rutherford
William
    B. Rutherford
Director
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary
May 27, 2009
II-51
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized in the city of Nashville, State of Tennessee, on
    May 27, 2009.
REGISTRANTS
(as listed on the attached
Schedule III of Subsidiary Registrants)
By:
/s/
R.
    Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Manager
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or any
    of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
President and Manager
(Principal Executive Officer)
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer)
May 27, 2009
/s/
R.
    Milton Johnson
R.
    Milton Johnson
Senior Vice President and Manager
(Principal Accounting Officer)
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Manager
May 27, 2009
II-52
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized in the city of Nashville, State of Tennessee, on
    May 27, 2009.
REGISTRANTS
(as listed on the attached
Schedule IV of Subsidiary Registrants)
By:
/s/
R.
    Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Manager
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
President and Manager
(Principal Executive Officer)
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer)
May 27, 2009
/s/
R.
    Milton Johnson
R.
    Milton Johnson
Senior Vice President and Manager
(Principal Accounting Officer)
May 27, 2009
/s/
William
    B. Rutherford
William
    B. Rutherford
Manager
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary
May 27, 2009
II-53
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized in the city of Nashville, State of Tennessee, on
    May 27, 2009.
REGISTRANTS
(as listed on the attached
Schedule V of Subsidiary Registrants)
By:
/s/
R.
    Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Manager
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Beverly
    B. Wallace
Beverly
    B. Wallace
President (Principal Executive Officer)
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer)
May 27, 2009
/s/
R.
    Milton Johnson
R.
    Milton Johnson
Senior Vice President and Manager
(Principal Accounting Officer)
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Manager
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Manager
May 27, 2009
II-54
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in city the of Nashville, State of Tennessee, on
    May 27, 2009.
REGISTRANTS
(as listed on the attached
Schedule VI of Subsidiary Registrants)
By:
/s/
R.
    Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Director
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Charles
    J. Hall
Charles
    J. Hall
President (Principal Executive Officer)
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer)
May 27, 2009
/s/
R.
    Milton Johnson
R.
    Milton Johnson
Senior Vice President and Director
(Principal Accounting Officer)
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Director
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Director
May 27, 2009
II-55
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
REGISTRANTS
(as listed on the attached
Schedule VII of Subsidiary Registrants)
By:
/s/
R.
    Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Manager
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or any of
    them, as his or her attorney in fact and agent, with full power
    of substitution and resubstitution, to execute, in his name and
    on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Charles
    J. Hall
Charles
    J. Hall
President (Principal Executive Officer)
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer)
May 27, 2009
/s/
R.
    Milton Johnson
R.
    Milton Johnson
Senior Vice President and Manager
(Principal Accounting Officer)
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Manager
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Manager
May 27, 2009
II-56
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
REGISTRANTS
(as listed on the attached
Schedule VIII of Subsidiary Registrants)
By:
/s/
R.
    Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Director
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Gregary
    W. Beasley
Gregary
    W. Beasley
President and Director
(Principal Executive Officer)
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer)
May 27, 2009
/s/
R.
    Milton Johnson
R.
    Milton Johnson
Senior Vice President and Director
(Principal Accounting Officer)
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Senior Vice President and Director
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President and Assistant Secretary
May 27, 2009
II-57
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
REGISTRANTS
(as listed on the attached
Schedule IX of Subsidiary Registrants)
By:
/s/
R.
    Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Manager
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or any
    of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Gregary
    W. Beasley
Gregary
    W. Beasley
President and Manager
(Principal Executive Officer)
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer)
May 27, 2009
/s/
R.
    Milton Johnson
R.
    Milton Johnson
Senior Vice President and Manager
(Principal Accounting Officer)
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Senior Vice President and Manager
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President and Assistant Secretary
May 27, 2009
II-58
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
REGISTRANTS
(as listed on the attached
Schedule X of Subsidiary Registrants)
By:
/s/
R.
    Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Director
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or any
    of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Noel
    B. Williams
Noel
    B. Williams
President and Chief Information Officer
(Principal Executive Officer)
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer)
May 27, 2009
/s/
R.
    Milton Johnson
R.
    Milton Johnson
Senior Vice President and Director
(Principal Accounting Officer)
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Director
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Director
May 27, 2009
II-59
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
REGISTRANTS
(as listed on the attached
Schedule XI of Subsidiary Registrants)
By:
/s/
R.
    Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Director
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or any
    of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Paul
    Rutledge
Paul
    Rutledge
President (Principal Executive Officer)
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer)
May 27, 2009
/s/
R.
    Milton Johnson
R.
    Milton Johnson
Senior Vice President and Director
(Principal Accounting Officer)
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Director
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Director
May 27, 2009
II-60
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
REGISTRANTS
(as listed on the attached
Schedule XII of Subsidiary Registrants)
By:
/s/
R.
    Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Manager
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or any
    of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Paul
    Rutledge
Paul
    Rutledge
President (Principal Executive Officer)
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer)
May 27, 2009
/s/
R.
    Milton Johnson
R.
    Milton Johnson
Senior Vice President and Manager
(Principal Accounting Officer)
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Manager
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Manager
May 27, 2009
II-61
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
REGISTRANTS
(as listed on the attached
Schedule XIII of Subsidiary Registrants)
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Director
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or any
    of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Samuel
    N. Hazen
Samuel
    N. Hazen
President (Principal Executive Officer)
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer)
May 27, 2009
/s/
R.
    Milton Johnson
R.
    Milton Johnson
Senior Vice President and Director
(Principal Accounting Officer)
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Director
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Director
May 27, 2009
II-62
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
REGISTRANTS
(as listed on the attached
Schedule XIV of Subsidiary Registrants)
By:
/s/
R.
    Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Manager
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or any
    of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Samuel
    N. Hazen
Samuel
    N. Hazen
President (Principal Executive Officer)
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer)
May 27, 2009
/s/
R.
    Milton Johnson
R.
    Milton Johnson
Senior Vice President and Manager
(Principal Accounting Officer)
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Manager
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Manager
May 27, 2009
II-63
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
REGISTRANTS
(as listed on the attached
Schedule XV of Subsidiary Registrants)
By:
/s/
R.
    Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Manager of the general partner
    Columbia North Texas Subsidiary GP, LLC
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Samuel
    N. Hazen
Samuel
    N. Hazen
President (Principal Executive Officer)
of the general partner Columbia North Texas  Subsidiary GP, LLC
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer) of the general partner  Columbia
    North Texas Subsidiary GP, LLC
May 27, 2009
/s/
R.
    Milton Johnson
R.
    Milton Johnson
Senior Vice President and Manager (Principal Accounting Officer)
    of the general partner Columbia North Texas  Subsidiary GP, LLC
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and  Manager of the general
    partner Columbia North Texas Subsidiary GP, LLC
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Manager of the general  partner Columbia
    North Texas  Subsidiary GP, LLC
May 27, 2009
II-64
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
CHCA Bayshore, L.P.
By:
/s/
R.
    Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Director of the general partner,
    Pasadena Bayshore Hospital, Inc.
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Samuel
    N. Hazen
Samuel
    N. Hazen
President (Principal Executive Officer)
of the general partner, Pasadena
    Bayshore Hospital, Inc
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer) of the general partner, Pasadena
    Bayshore Hospital, Inc.
May 27, 2009
/s/
R.
    Milton Johnson
R.
    Milton Johnson
Senior Vice President and Director (Principal Accounting
    Officer) of the general partner, Pasadena
    Bayshore Hospital, Inc.
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and  Director of the general
    partner, Pasadena Bayshore Hospital, Inc.
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Director of the general  partner, Pasadena
    Bayshore Hospital, Inc.
May 27, 2009
II-65
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
CHCA Conroe, L.P.
By:
/s/
R.
    Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Director of the general partner,
    Conroe Hospital Corporation
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Samuel
    N. Hazen
Samuel
    N. Hazen
President (Principal Executive Officer) of the  general partner
    Conroe Hospital Corporation
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer) of the general partner Conroe
    Hospital Corporation
May 27, 2009
/s/
R.
    Milton Johnson
R.
    Milton Johnson
Senior Vice President and Director  (Principal Accounting
    Officer) of the general partner Conroe Hospital Corporation
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and  Director of the general
    partner Conroe Hospital Corporation
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Director of the general  partner Conroe
    Hospital Corporation
May 27, 2009
II-66
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
CHCA Mainland, L.P.
By:
/s/
R.
    Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Director of the general partner,
    Danforth Hospital, Inc.
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Samuel
    N. Hazen
Samuel
    N. Hazen
President (Principal Executive Officer)
of the general partner, Danforth Hospital, Inc.
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer) of the general partner, Danforth
    Hospital, Inc.
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Director
(Principal Accounting Officer)
of the general partner, Danforth Hospital, Inc.
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and  Director of the general
    partner, Danforth Hospital, Inc.
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Director of the general  partner Danforth
    Hospital, Inc.
May 27, 2009
II-67
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
CHCA West Houston, L.P.
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Director of general partner, WHMC,
    Inc.
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Samuel
    N. Hazen
Samuel N. Hazen
President (Principal Executive Officer)
of the general partner, WHMC, Inc.
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer)
of the general partner, WHMC, Inc.
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Director
(Principal Accounting Officer)
of the general partner, WHMC, Inc.
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Director of the general
    partner, WHMC, Inc.
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Director of the general partner, WHMC,
    Inc.
May 27, 2009
II-68
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
CHCA Woman's Hospital, L.P.
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President of general partner, Woman's
    Hospital of Texas, Incorporated
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Samuel
    N. Hazen
Samuel N. Hazen
President (Principal Executive Officer)
of the general partner, Woman's Hospital of Texas,
    Incorporated
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer) of the general partner,
    Woman's Hospital of  Texas, Incorporated
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Director (Principal Accounting
    Officer) of the general partner, Woman's Hospital of Texas,
    Incorporated
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Director of the general
    partner, Woman's Hospital of Texas, Incorporated
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Director of the general partner, Woman's
    Hospital of Texas, Incorporated
May 27, 2009
II-69
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
CMS GP, LLC
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
President and Manager
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
R. Milton Johnson
R. Milton Johnson
President and Manager
(Principal Executive Officer and Principal Accounting Officer)
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer)
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Senior Vice President and Manager
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Manager
May 27, 2009
II-70
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
Columbia ASC Management, L.P.
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Manger of the general partner,
    Medical Care America, LLC
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Gregary
    W. Beasley
Gregary W. Beasley
President and Manager
(Principal Executive Officer) of the general partner, Medical
    Care America, LLC
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer) of the general partner, Medical
    Care America, LLC
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Manager
(Principal Accounting Officer) of the general partner, Medical
    Care America, LLC
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Senior Vice President and Manager of the general partner,
    Medical Care America, LLC
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President and Assistant Secretary of the general partner,
    Medical Care America, LLC
May 27, 2009
II-71
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
Columbia Rio Grande Healthcare, L.P.
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Director of the general partner,
    Rio Grande Regional Hospital, Inc.
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Samuel
    N. Hazen
Samuel N. Hazen
President (Principal Executive Officer) of the general partner,
    Rio Grande Regional Hospital, Inc.
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer) of the general partner, Rio Grande
    Regional Hospital, Inc.
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Director
(Principal Accounting Officer) of the general partner, Rio
    Grande Regional Hospital, Inc.
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Director of the general
    partner, Rio Grande Regional Hospital, Inc.
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Director of the general partner, Rio Grande
    Regional Hospital, Inc.
May 27, 2009
II-72
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
Columbia Valley Healthcare System, L.P.
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Director of the general partner,
    Brownsville-Valley Regional Medical Center, Inc.
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Samuel
    N. Hazen
Samuel N. Hazen
President (Principal Executive Officer) of the general partner,
    Brownsville-Valley Regional Medical Center, Inc.
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer (Principal Financial Officer) of
    the general partner, Brownsville-Valley Regional Medical
    Center, Inc.
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Director
(Principal Accounting Officer) of the general partner,
    Brownsville-Valley Regional Medical Center, Inc.
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Director of the general
    partner,  Brownsville-Valley Regional Medical Center, Inc.
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Director of the general partner,
    Brownsville-Valley Regional Medical Center, Inc.
May 27, 2009
II-73
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
Fairview Park, Limited Partnership
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Manager of general partner,
    Fairview Park GP, LLC
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Charles
    J. Hall
Charles J. Hall
President (Principal Executive Officer) of the general partner,
    Fairview Park GP, LLC
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer (Principal Financial Officer) of
    the general partner, Fairview Park GP, LLC
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Manager
(Principal Accounting Officer) of the general partner, Fairview
    Park GP, LLC
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Manager of the general
    partner, Fairview Park GP, LLC
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Manager of the general partner, Fairview Park
    GP, LLC
May 27, 2009
II-74
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
Good Samaritan Hospital, L.P.
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Manager of general partner,
    Samaritan, LLC
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Samuel
    N. Hazen
Samuel N. Hazen
President (Principal Executive Officer) of the general partner,
    Samaritan, LLC
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer (Principal Financial Officer) of
    the general partner, Samaritan, LLC
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Manager (Principal Accounting Officer)
    of the general partner, Samaritan, LLC
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Manager of the general
    partner, Samaritan, LLC
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Manager of the general partner, Samaritan, LLC
May 27, 2009
II-75
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
HCA Management Services, L.P.
By:
/s/
R. Milton Johnson
Name: R. Milton Johnson
Title:
President and Manager of general partner, CMS GP, LLC
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
R. Milton Johnson
R. Milton Johnson
President and Manager (Principal Executive Officer and Principal
    Accounting Officer) of the general partner, CMS GP, LLC
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer (Principal Financial Officer) of
    the general partner, CMS GP, LLC
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Senior Vice President and Manager of the general partner, CMS
    GP, LLC
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Manager of the general
    partner, CMS GP, LLC
May 27, 2009
II-76
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized in the city of Nashville, State of Tennessee, on
    May 27, 2009.
Healthtrust MOB, LLC
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Director of managing member,
    Healthtrust, Inc. — The Hospital Company
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
A.
    Bruce Moore, Jr.
A. Bruce Moore, Jr.
President and Director (Principal Executive Officer) of the
    managing member, Healthtrust, Inc. — The Hospital
    Company
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Senior Vice President and Treasurer (Principal Financial
    Officer) of the managing member, Healthtrust, Inc. —
    The Hospital Company
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Director (Principal Accounting
    Officer) of the managing member, Healthtrust, Inc. —
    The Hospital Company
May 27, 2009
/s/
Dora
    A. Blackwood
Dora
    A. Blackwood
Vice President, Secretary and Director of the managing member,
    Healthtrust, Inc. — The Hospital Company
May 27, 2009
II-77
Table of Contents
Signature
Title
Date
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Director of the managing
    member, Healthtrust, Inc. — The Hospital Company
May 27, 2009
/s/
William
    B. Rutherford
William
    B. Rutherford
Vice President and Director of the managing member, Healthtrust,
    Inc. — The Hospital Company
May 27, 2009
/s/
Donald
    W. Stinnett
Donald
    W. Stinnett
Vice President and Director of the managing member, Healthtrust,
    Inc. — The Hospital Company
May 27, 2009
II-78
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
HSS Virginia, L.P.
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Manger of the general partner, HSS
    Holdco, LLC
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
A.
    Bruce Moore, Jr.
A. Bruce Moore, Jr.
President and Manager (Principal Executive Officer) of the
    general partner,  HSS Holdco, LLC
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer) of the general partner, HSS
    Holdco, LLC
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Manager
(Principal Accounting Officer) of the general partner, HSS
    Holdco, LLC
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Manager of the general
    partner,  HSS Holdco, LLC
May 27, 2009
II-79
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
Integrated Regional Laboratories, LLP
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Manager of the managing partner,
    Integrated Regional Lab, LLC
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Charles
    J. Hall
Charles J. Hall
President (Principal Executive Officer)  of the managing
    partner, Integrated  Regional Lab, LLC
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer) of the managing partner,
    Integrated Regional Lab, LLC
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Manage (Principal Accounting
    Officer)   of the managing partner, Integrated  Regional Lab, LLC
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Manager of the managing
    partner, Integrated Regional Lab, LLC
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Manager of the managing partner, Integrated
    Regional Lab, LLC
May 27, 2009
II-80
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
JFK Medical Center Limited Partnership
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Manager of the general partner,
    Columbia Palm Beach GP, LLC
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Charles
    J. Hall
Charles J. Hall
President (Principal Executive Officer)  of the general partner,
    Columbia Palm  Beach GP, LLC
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer) of the general partner, Columbia
    Palm Beach GP, LLC
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Manager  (Principal Accounting
    Officer)   of the general partner, Columbia Palm  Beach GP, LLC
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Senior Vice President and Manager  of the general partner,
    Columbia Palm  Beach GP, LLC
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Manager of the general
    partner, Columbia Palm Beach GP, LLC
May 27, 2009
II-81
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
MCA Investment Company
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Director
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Gregary
    W. Beasley
Gregary
    W. Beasley
President (Principal Executive Officer)
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer)
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Director (Principal Accounting Officer)
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Senior Vice President and Director
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Director
May 27, 2009
II-82
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
Nashville Shared Services General Partnership
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Manager of the managing partner,
    HSS Systems, LLC
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Beverly
    B. Wallace
Beverly
    B. Wallace
President (Principal Executive Officer)
of the managing partner, HSS Systems, LLC
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer) of the managing partner, HSS
    Systems, LLC
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Manager (Principal Accounting Officer)
    of the managing partner, HSS Systems, LLC
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary
and Manager of the managing partner,
HSS Systems, LLC
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Manager of the managing partner, HSS Systems,
    LLC
May 27, 2009
II-83
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
National Patient Account Services, Inc.
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Director
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Beverly
    B. Wallace
Beverly
    B. Wallace
President (Principal Executive Officer)
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer)
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Director
(Principal Accounting Officer)
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary
and Director
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Director
May 27, 2009
II-84
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
Palms West Hospital Limited Partnership
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Manager of the general partner,
    Columbia Palm Beach GP, LLC
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Charles
    J. Hall
Charles
    J. Hall
President (Principal Executive Officer)
of the general partner, Columbia Palm  Beach GP, LLC
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer) of the general partner, Columbia
    Palm Beach GP, LLC
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Manager
(Principal Accounting Officer)
of the general partner,  Columbia Palm Beach GP, LLC
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Senior Vice President and Manager
of the general partner,  Columbia Palm Beach GP, LLC
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Manager of the general
    partner,  Columbia Palm Beach GP, LLC
May 27, 2009
II-85
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
Plantation General Hospital, L.P.
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Director of the general partner,
    HD&S Corp. Successor, Inc.
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Charles
    J. Hall
Charles
    J. Hall
President (Principal Executive Officer)
of the general partner, HD&S Corp. Successor, Inc.
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer)  of the general partner, HD&S
    Corp. Successor, Inc.
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Director (Principal Accounting
    Officer) of the general partner, HD&S Corp. Successor,
    Inc.
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Director of the general
    partner, HD&S Corp. Successor, Inc.
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Director of the general partner, HD&S
    Corp. Successor, Inc.
May 27, 2009
II-86
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
Riverside Healthcare System, L.P.
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Director of the general partner,
    Columbia Riverside, Inc.
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Samuel
    N. Hazen
Samuel
    N. Hazen
President (Principal Executive Officer)
of the general partner, Columbia Riverside, Inc.
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer (Principal Financial Officer) of
    the general partner, Columbia Riverside, Inc.
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Director  (Principal Accounting
    Officer) of the general partner, Columbia Riverside, Inc.
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Director of the general
    partner, Columbia Riverside, Inc.
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Director of the general partner, Columbia
    Riverside, Inc.
May 27, 2009
II-87
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
San Jose Healthcare System, LP
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Manager of the general partner,
    San Jose, LLC
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities a Market-Maker
    Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Samuel
    N. Hazen
Samuel
    N. Hazen
President (Principal Executive Officer)
of the general partner, San Jose, LLC
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer) of the general partner,
    San Jose, LLC
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Manager
(Principal Accounting Officer) of the general partner,
    San Jose, LLC
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary
and Manager of the general partner,  San Jose, LLC
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Manager of the general partner,
    San Jose, LLC
May 27, 2009
II-88
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
San Jose Hospital, L.P.
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Manager of the general partner,
    San Jose Medical Center, LLC
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Samuel
    N. Hazen
Samuel
    N. Hazen
President (Principal Executive Officer)
of the general partner, San Jose Medical Center, LLC
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer) of the general partner,
    San Jose Medical Center, LLC
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Manager
(Principal Accounting Officer)
of the general partner, San Jose Medical Center, LLC
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Manager of the general
    partner, San Jose Medical Center, LLC
May 27, 2009
/s/
A.
    Bruce Moore, Jr
A.
    Bruce Moore, Jr.
Vice President and Manager of the general partner, San Jose
    Medical Center, LLC
May 27, 2009
II-89
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
Terre Haute MOB, L.P.
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Manager of the managing general
    partner, HSS Holdco, LLC
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
President and Manager (Principal Executive Officer) of the
    managing general partner, HSS Holdco, LLC
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer) of the managing general partner,
    HSS Holdco, LLC
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Manager (Principal Accounting Officer)
    of the managing general partner, HSS Holdco, LLC
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Manager of the managing
    general partner, HSS Holdco, LLC
May 27, 2009
II-90
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
    registrant has duly caused this Registration Statement to be
    signed on its behalf by the undersigned, thereunto duly
    authorized, in the city of Nashville, State of Tennessee, on
    May 27, 2009.
Terre Haute Regional Hospital, L.P.
By:
/s/
R. Milton Johnson
Name:     R. Milton Johnson
Title:
Senior Vice President and Director of the general partner,
    Terre Haute Hospital GP, Inc.
SIGNATURES
    AND POWERS OF ATTORNEY
Each person whose signature appears below authorizes John M.
    Franck II, David G. Anderson and R. Milton Johnson, or
    any of them, as his or her attorney in fact and agent, with full
    power of substitution and resubstitution, to execute, in his
    name and on his behalf, in any and all capacities, a
    Market-Maker Registration Statement on
Form S-1
and any amendments including post-effective amendments thereto
    related to the notes described herein, and to file the same,
    with all the exhibits thereto, and all other documents in
    connection therewith, with the Securities and Exchange
    Commission, necessary or advisable to enable the registrant to
    comply with the Securities Act of 1933, and any rules,
    regulations and requirements of the Securities and Exchange
    Commission, in respect thereof, in connection with the
    registration of the notes described herein which are the subject
    of such Market-Maker Registration Statement, as the case may be,
    which amendments may make such changes in such Market Maker
    Registration Statement, as the case may be, as such attorney may
    deem appropriate, and with full power and authority to perform
    and do any and all acts and things, whatsoever which any such
    attorney or substitute may deem necessary or advisable to be
    performed or done in connection with any or all of the
    above-described matters, as fully as each of the undersigned
    could do if personally present and acting, hereby ratifying and
    approving all acts of any such attorney or substitute.
Pursuant to the requirements of the Securities Act of 1933, this
    Registration Statement has been signed by the following persons
    in the capacities and on the dates indicated.
Signature
Title
Date
/s/
Paul
    Rutledge
Paul
    Rutledge
President (Principal Executive Officer)
of the general partner, Terre Haute Hospital GP, Inc.
May 27, 2009
/s/
David
    G. Anderson
David
    G. Anderson
Vice President and Treasurer
(Principal Financial Officer) of the general partner, Terre
    Haute Hospital GP, Inc.
May 27, 2009
/s/
R. Milton Johnson
R. Milton Johnson
Senior Vice President and Director
(Principal Accounting Officer)
of the general partner, Terre Haute  Hospital GP, Inc.
May 27, 2009
/s/
John
    M. Franck II
John
    M. Franck II
Vice President, Assistant Secretary and Director of the general
    partner, Terre Haute Hospital GP, Inc.
May 27, 2009
/s/
A.
    Bruce Moore, Jr.
A.
    Bruce Moore, Jr.
Vice President and Director of the general partner, Terre Haute
    Hospital GP, Inc.
May 27, 2009
II-91
Table of Contents
SCHEDULE I
    OF SUBSIDIARY REGISTRANTS
AMERICAN MEDICORP DEVELOPMENT CO.
COLORADO HEALTH SYSTEMS, INC.
COLUMBIA JACKSONVILLE HEALTHCARE SYSTEM, INC.
COLUMBUS CARDIOLOGY, INC.
HCA REALTY, INC.
HOSPITAL DEVELOPMENT PROPERTIES, INC.
MANAGEMENT SERVICES HOLDINGS, INC.
TERRE HAUTE HOSPITAL HOLDINGS, INC.
VH HOLDCO, INC.
VH HOLDINGS, INC.
WESTERN PLAINS CAPITAL, INC.
II-92
Table of Contents
SCHEDULE II
    OF SUBSIDIARY REGISTRANTS
NORTH FLORIDA IMMEDIATE CARE CENTER, INC.
REDMOND PHYSICIAN PRACTICE COMPANY
II-93
Table of Contents
SCHEDULE III
    OF SUBSIDIARY REGISTRANTS
DUBLIN COMMUNITY HOSPITAL, LLC
EP HEALTH, LLC
GENERAL HEALTHSERV, LLC
HSS HOLDCO, LLC
MEDICAL CENTERS OF OKLAHOMA, LLC
NOTAMI HOSPITALS, LLC
SJMC, LLC
UTAH MEDCO, LLC
II-94
Table of Contents
SCHEDULE IV
    OF SUBSIDIARY REGISTRANTS
DALLAS/FT. WORTH PHYSICIAN, LLC
GOPPERT-TRINITY FAMILY CARE, LLC
LEWIS-GALE PHYSICIANS, LLC
OUTPATIENT CARDIOVASCULAR CENTER OF CENTRAL FLORIDA, LLC
II-95
Table of Contents
SCHEDULE V
    OF SUBSIDIARY REGISTRANTS
CENTRAL SHARED SERVICES, LLC
HSS SYSTEMS VA, LLC
HSS SYSTEMS, LLC
II-96
Table of Contents
SCHEDULE VI
    OF SUBSIDIARY REGISTRANTS
BAY HOSPITAL, INC.
CENTRAL FLORIDA REGIONAL HOSPITAL, INC.
COLUMBIA LAGRANGE HOSPITAL, INC.
EDWARD WHITE HOSPITAL, INC.
HCA HEALTH SERVICES OF FLORIDA, INC.
HD&S CORP. SUCCESSOR, INC.
LARGO MEDICAL CENTER, INC.
LAWNWOOD MEDICAL CENTER, INC.
MARION COMMUNITY HOSPITAL, INC.
MEMORIAL HEALTHCARE GROUP, INC.
NEW PORT RICHEY HOSPITAL, INC.
NORTH FLORIDA REGIONAL MEDICAL CENTER, INC.
OKALOOSA HOSPITAL, INC.
OKEECHOBEE HOSPITAL, INC.
PALMYRA PARK HOSPITAL, INC.
SARASOTA DOCTORS HOSPITAL, INC.
SUN CITY HOSPITAL, INC.
TALLAHASSEE MEDICAL CENTER, INC.
WALTERBORO COMMUNITY HOSPITAL, INC.
WEST FLORIDA REGIONAL MEDICAL CENTER, INC.
II-97
Table of Contents
SCHEDULE VII
    OF SUBSIDIARY REGISTRANTS
FAIRVIEW PARK GP, LLC
GRAND STRAND REGIONAL MEDICAL CENTER, LLC
INTEGRATED REGIONAL LAB, LLC
TRIDENT MEDICAL CENTER, LLC
II-98
Table of Contents
SCHEDULE VIII
    OF SUBSIDIARY REGISTRANTS
EL PASO SURGICENTER, INC.
LAS VEGAS SURGICARE, INC.
MARIETTA SURGICAL CENTER, INC.
SURGICARE OF BRANDON, INC.
SURGICARE OF FLORIDA, INC.
SURGICARE OF HOUSTON WOMEN'S, INC.
SURGICARE OF MANATEE, INC.
SURGICARE OF NEW PORT RICHEY, INC.
II-99
Table of Contents
SCHEDULE IX
    OF SUBSIDIARY REGISTRANTS
SURGICARE OF PALMS WEST, LLC
SURGICARE OF RIVERSIDE, LLC
II-100
Table of Contents
SCHEDULE X
    OF SUBSIDIARY REGISTRANTS
HCA — IT&S FIELD OPERATIONS, INC.
HCA — IT&S INVENTORY MANAGEMENT, INC
II-101
Table of Contents
SCHEDULE XI
    OF SUBSIDIARY REGISTRANTS
BROOKWOOD MEDICAL CENTER OF GULFPORT, INC.
CAPITAL DIVISION, INC.
CENTRAL TENNESSEE HOSPITAL CORPORATION
CHIPPENHAM & JOHNSTON-WILLIS HOSPITALS, INC.
COLUMBIA POLK GENERAL HOSPITAL, INC.
COLUMBIA/ALLEGHANY REGIONAL HOSPITAL, INCORPORATED
COLUMBIA/HCA JOHN RANDOLPH, INC.
DAUTERIVE HOSPITAL CORPORATION
FRANKFORT HOSPITAL, INC.
GPCH-GP, INC.
GREENVIEW HOSPITAL, INC.
HAMILTON MEDICAL CENTER, INC.
HCA CENTRAL GROUP, INC.
HCA HEALTH SERVICES OF LOUISIANA, INC.
HCA HEALTH SERVICES OF TENNESSEE, INC.
HCA HEALTH SERVICES OF VIRGINIA, INC.
HEALTH MIDWEST OFFICE FACILITIES CORPORATION
HEALTH MIDWEST VENTURES GROUP, INC.
HENDERSONVILLE HOSPITAL CORPORATION
HOSPITAL CORPORATION OF TENNESSEE
HTI MEMORIAL HOSPITAL CORPORATION
LEWIS-GALE HOSPITAL, INCORPORATED
MIDWEST HOLDINGS, INC.
MONTGOMERY REGIONAL HOSPITAL, INC.
NOTAMI HOSPITALS OF LOUISIANA, INC.
PULASKI COMMUNITY HOSPITAL, INC.
SPOTSYLVANIA MEDICAL CENTER, INC.
SPRING HILL HOSPITAL, INC.
TCMC MADISON-PORTLAND, INC.
TERRE HAUTE HOSPITAL GP, INC.
VIRGINIA PSYCHIATRIC COMPANY, INC.
WOMEN'S AND CHILDREN'S HOSPITAL, INC.
II-102
Table of Contents
SCHEDULE XII
    OF SUBSIDIARY REGISTRANTS
CENTERPOINT MEDICAL CENTER OF INDEPENDENCE, LLC
COLUMBIA PARKERSBURG HEALTHCARE SYSTEM, LLC
GALEN PROPERTY, LLC
LAKELAND MEDICAL CENTER, LLC
LAKEVIEW MEDICAL CENTER, LLC
LEWIS-GALE MEDICAL CENTER, LLC
MEDICAL OFFICE BUILDINGS OF KANSAS, LLC
MIDWEST DIVISION — ACH, LLC
MIDWEST DIVISION — LRHC, LLC
MIDWEST DIVISION — LSH, LLC
MIDWEST DIVISION — MCI, LLC
MIDWEST DIVISION — MMC, LLC
MIDWEST DIVISION — OPRMC, LLC
MIDWEST DIVISION — PFC, LLC
MIDWEST DIVISION — RBH, LLC
MIDWEST DIVISION — RMC, LLC
MIDWEST DIVISION — RPC, LLC
NORTHERN VIRGINIA COMMUNITY HOSPITAL, LLC
NORTHLAKE MEDICAL CENTER, LLC
REDMOND PARK HOSPITAL, LLC
RESTON HOSPITAL CENTER, LLC
RETREAT HOSPITAL, LLC
SOUTHERN HILLS MEDICAL CENTER, LLC
II-103
Table of Contents
SCHEDULE XIII
    OF SUBSIDIARY REGISTRANTS
BRIGHAM CITY COMMUNITY HOSPITAL, INC.
COLUMBIA MEDICAL CENTER OF LAS COLINAS, INC.
COLUMBIA OGDEN MEDICAL CENTER, INC.
COLUMBIA RIVERSIDE, INC.
COLUMBINE PSYCHIATRIC CENTER, INC.
CONROE HOSPITAL CORPORATION
EASTERN IDAHO HEALTH SERVICES, INC.
ENCINO HOSPITAL CORPORATION, INC.
HCA HEALTH SERVICES OF OKLAHOMA, INC.
HOSPITAL CORPORATION OF UTAH
KPH-CONSOLIDATION, INC
LOS ROBLES REGIONAL MEDICAL CENTER
MOUNTAIN VIEW HOSPITAL, INC.
NEW ROSE HOLDING COMPANY, INC.
NORTHERN UTAH HEALTHCARE CORPORATION
PASADENA BAYSHORE HOSPITAL, INC.
RIO GRANDE REGIONAL HOSPITAL, INC.
RIVERSIDE HOSPITAL, INC.
SPRING BRANCH MEDICAL CENTER, INC.
ST. MARK'S LONE PEAK HOSPITAL, INC.
SUNRISE MOUNTAINVIEW HOSPITAL, INC.
TIMPANOGOS REGIONAL MEDICAL SERVICES, INC.
W & C HOSPITAL, INC.
WEST VALLEY MEDICAL CENTER, INC.
WHMC, INC.
WOMAN'S HOSPITAL OF TEXAS, INCORPORATED
II-104
Table of Contents
SCHEDULE XIV
    OF SUBSIDIARY REGISTRANTS
EDMOND REGIONAL MEDICAL CENTER, LLC
SAMARITAN, LLC
SAN JOSE MEDICAL CENTER, LLC
SAN JOSE, LLC
WESLEY MEDICAL CENTER, LLC
II-105
Table of Contents
SCHEDULE XV
    OF SUBSIDIARY REGISTRANTS
COLUMBIA MEDICAL CENTER OF ARLINGTON SUBSIDIARY, L.P.
COLUMBIA MEDICAL CENTER OF DENTON SUBSIDIARY, L.P.
COLUMBIA MEDICAL CENTER OF LEWISVILLE SUBSIDIARY, L.P.
COLUMBIA MEDICAL CENTER OF MCKINNEY SUBSIDIARY, L.P.
COLUMBIA MEDICAL CENTER OF PLANO SUBSIDIARY, L.P.
COLUMBIA NORTH HILLS HOSPITAL SUBSIDIARY, L.P.
COLUMBIA PLAZA MEDICAL CENTER OF FORT WORTH SUBSIDIARY, L.P.
GREEN OAKS HOSPITAL SUBSIDIARY, L.P.
II-106